Citrus Sinensis ID: 019360

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340--
Protein Sequence
MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL
Secondary Structure (PSIPRED)
cccccccccccEEccEEEEEEEEccccEEEEEEEEcccccEEEEEEEEHHHHHcccHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccccccccccccccccccccccccccHHccccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccHHHHHHcccccHHHHHHHccccccccccccHHHHHHHcccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccHHHEEEEEEEEEcccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccccHHHcEccccEccccccHHHccHHHHccccEcccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccEEEHHHHHccHHHHcccccccccccccccccHHHHccccccccccccccccccccccccccHEHEEEcccccccHHHHHccccc
Coil and Loop (DISEMBL)
masrtggasrtrvgkyelgrtlgegsfakvkfarntetgenVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDychsrgvchrdlkpenllldangvlkvsdfglsalpqqvrddgllhttcgtpnyvapevinnkgydgakadlWSCGVILYVLMAGYLPFEESNLMALYKKIFKadfksppwfstSAKKLISrildpnpvtrITMAEVIEnewfkkgykppsfeqpnidlddvdsiFNESMDSRNLVVerreegpvapltmNAFELISTSQGLNLSSLLKSKWDL
Flexible Loop (DISEMBL)
masrtggasrtrvgkyelgrtlgegsfakvkfarntetgenvaikildkekvlkHKMIGQIkreistmklirhpNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKklisrildpnpvtRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVAPLTMNAFElistsqglnlssllkskwdl
Low Complexity Region (SEG)
MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL
Disordered region (IsUnstruct)
***************YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK*****************************************MNAFELI******************
Disordered Region (DISOPRED)
****************ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSI***********************TMNAFELISTSQGLNLSSLLK*****
Disordered Region (DISEMBL)
***********RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL
Disordered Region (DISPRO)
*********RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP***********************************APLTMNAFELISTSQGLNLSSLLKS****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	342	2.2.26 [Sep-21-2011]
Q93VD3	482	CBL-interacting serine/th	yes	no	0.964	0.684	0.845	1e-168
Q6ZLP5	450	CBL-interacting protein k	yes	no	0.970	0.737	0.830	1e-166
Q9MAM1	447	CBL-interacting serine/th	no	no	0.961	0.736	0.715	1e-145
Q2RAX3	454	CBL-interacting protein k	no	no	0.956	0.720	0.724	1e-142
Q2V452	441	CBL-interacting serine/th	no	no	0.941	0.730	0.719	1e-142
Q2QY53	438	CBL-interacting protein k	no	no	0.956	0.746	0.721	1e-142
Q6X4A2	449	CBL-interacting protein k	no	no	0.950	0.723	0.694	1e-136
Q84VQ3	439	CBL-interacting serine/th	no	no	0.944	0.735	0.708	1e-135
Q10SC8	456	CBL-interacting protein k	no	no	0.938	0.703	0.685	1e-134
Q8LIG4	445	CBL-interacting protein k	no	no	0.970	0.746	0.646	1e-126

>sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1

 Score =  592 bits (1526), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 279/330 (84%), Positives = 302/330 (91%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           VGKYELGRTLGEG+FAKVKFARN E G+NVAIK++DKEKVLK+KMI QIKREISTMKLI+
Sbjct: 28  VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPNVIRM+EVMASKTKIY VLEFVTGGELFDKI+S GRLKEDEARKYFQQLINAVDYCHS
Sbjct: 88  HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           RGV HRDLKPENLLLDANG LKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVINNKG
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
           YDGAKADLWSCGVIL+VLMAGYLPFE+SNL +LYKKIFKA+F  PPWFS SAKKLI RIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267

Query: 253 DPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGP 312
           DPNP TRIT AEVIENEWFKKGYK P FE  ++ LDDVD+IF++S +S+NLVVERREEG 
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGL 327

Query: 313 VAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
             P+TMNAFELISTSQGLNL SL + +  L
Sbjct: 328 KTPVTMNAFELISTSQGLNLGSLFEKQMGL 357

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1

 Score =  583 bits (1502), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 280/337 (83%), Positives = 306/337 (90%), Gaps = 5/337 (1%)

Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S +GG  RTRVG+YELGRTLGEG+FAKVKFARN ++GENVAIKILDK+KVLKHKMI QIK
Sbjct: 2   SVSGG--RTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIK 59

Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           REISTMKLIRHPNVIRM+EVMASKTKIYIV+E VTGGELFDKIASRGRLKED+ARKYFQQ
Sbjct: 60  REISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQ 119

Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           LINAVDYCHSRGV HRDLKPENLLLDA+G LKVSDFGLSAL QQVR+DGLLHTTCGTPNY
Sbjct: 120 LINAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNY 179

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
           VAPEVINNKGYDGAKADLWSCGVIL+VLMAGYLPFE+SNLM+LYKKIFKADF  P WFST
Sbjct: 180 VAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFST 239

Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           SAKKLI +ILDPNP TRIT+AE+I NEWFKKGY+PP FE  +++LDD++SIFNES D   
Sbjct: 240 SAKKLIKKILDPNPSTRITIAELINNEWFKKGYQPPRFETADVNLDDINSIFNESGDQTQ 299

Query: 303 LVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSK 339
           LVVERREE    P  MNAFELISTSQGLNL +L + +
Sbjct: 300 LVVERREE---RPSVMNAFELISTSQGLNLGTLFEKQ 333

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2

 Score =  514 bits (1323), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 241/337 (71%), Positives = 290/337 (86%), Gaps = 8/337 (2%)

Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           ASRTRVG YE+GRTLGEGSFAKVK+A+NT TG+  AIKILD+EKV +HKM+ Q+KREIST
Sbjct: 11  ASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREIST 70

Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           MKLI+HPNV+ + EVMASKTKIYIVLE V GGELFDKIA +GRLKEDEAR+YFQQLINAV
Sbjct: 71  MKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAV 130

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           DYCHSRGV HRDLKPENL+LDANGVLKVSDFGLSA  +QVR+DGLLHT CGTPNYVAPEV
Sbjct: 131 DYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEV 190

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           +++KGYDGA AD+WSCGVIL+VLMAGYLPF+E NLM LYK+I KA+F  PPWFS  AK++
Sbjct: 191 LSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAKRV 250

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ--PNIDLDDVDSIFNESMDSRNLVV 305
           I RIL+PNP+TRI++AE++E+EWFKKGYKPPSF+Q   +I +DDVD+ F+ S +   LV 
Sbjct: 251 IKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKEC--LVT 308

Query: 306 ERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
           E++E+    P++MNAFELIS+S   +L +L + +  L
Sbjct: 309 EKKEK----PVSMNAFELISSSSEFSLENLFEKQAQL 341

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1

 Score =  505 bits (1301), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 242/334 (72%), Positives = 286/334 (85%), Gaps = 7/334 (2%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + RVGKYELGRT+GEG+FAKVKFAR+TETG+ VAIKILDKEKVLKHKM+ QIKREISTMK
Sbjct: 7   KRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMK 66

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           LI+HPNV+R+YEVM SKT IYIVLE+VTGGELFD I + GR++EDEAR+YFQQLINAVDY
Sbjct: 67  LIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDY 126

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           CHSRGV HRDLKPENLLLD+ G LKVSDFGLSAL QQ++DDGLLHTTCGTPNYVAPEV+ 
Sbjct: 127 CHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLE 186

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           ++GYDGA ADLWSCGVIL+VL+AGYLPFE+SNLM LYKKI  A+F  PPW S  AK+L++
Sbjct: 187 DQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLT 246

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSF-EQPNIDLDDVDSIFNESMDSRNLVVERR 308
           RILDPNP+TRIT+ E++E+EWFKKGYK P F E+ +  LDDVD++FN+S +    V E++
Sbjct: 247 RILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHH--VTEKK 304

Query: 309 EEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
           EE    P  +NAFELIS S GLNL +L  S+ + 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF 334

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2

 Score =  505 bits (1300), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 236/328 (71%), Positives = 285/328 (86%), Gaps = 6/328 (1%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + RVGKYE+GRT+GEG+FAKVKFARN+ETGE VA+KILDKEKVLKHKM  QI+REI+TMK
Sbjct: 8   KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMK 67

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           LI+HPNV+++YEVMASKTKI+I+LE+VTGGELFDKI + GR+KEDEAR+YFQQLI+AVDY
Sbjct: 68  LIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDY 127

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           CHSRGV HRDLKPENLLLD+ G LK+SDFGLSAL QQVRDDGLLHT+CGTPNYVAPEV+N
Sbjct: 128 CHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLN 187

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           ++GYDGA AD+WSCGV+LYVL+AGYLPF++SNLM LYKKI   +F  PPW S  A KLI+
Sbjct: 188 DRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLIT 247

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ-PNIDLDDVDSIFNESMDSRNLVVERR 308
           RILDPNP+TR+T  EV E+EWFKK YKPP FE+  + ++DD+D++F +S    +LV E+R
Sbjct: 248 RILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDS--EEHLVTEKR 305

Query: 309 EEGPVAPLTMNAFELISTSQGLNLSSLL 336
           EE P A   +NAFE+IS S+GLNL +L 
Sbjct: 306 EEQPAA---INAFEIISMSRGLNLENLF 330

Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2

 Score =  504 bits (1298), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 241/334 (72%), Positives = 286/334 (85%), Gaps = 7/334 (2%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + RVGKYELGRT+GEG+FAKVKFAR+TETG+ VAIKILDKEKVLKHKM+ QIKREISTMK
Sbjct: 7   KRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMK 66

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           LI+HPNV+R+YEVM SKTKIYIVLE+VTGGELFD I + GR++EDEAR+YFQQLINAVDY
Sbjct: 67  LIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDY 126

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           CHSRGV HRDLKPENLLLD+ G LKVSDFGLSAL QQ++DDGLLHTTCGTPNYVAPEV+ 
Sbjct: 127 CHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLE 186

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           ++GYDGA ADLWSCGVIL+VL+AGYLPFE+SNLM LYKKI  A+F  PPW S  AK+L++
Sbjct: 187 DQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLT 246

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSF-EQPNIDLDDVDSIFNESMDSRNLVVERR 308
           RILDPNP+TR+T+ E++E+EWFKKGYK P F E+ +  LDDV ++FN+S +    V E++
Sbjct: 247 RILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHH--VTEKK 304

Query: 309 EEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
           EE    P  +NAFELIS S GLNL +L  S+ + 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF 334

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1

 Score =  485 bits (1248), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 230/331 (69%), Positives = 280/331 (84%), Gaps = 6/331 (1%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + RVGKYELGRT+GEG+FAKV+FA+NTE  E VAIKILDKEKV KH+++ QI+REI TMK
Sbjct: 14  KRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREICTMK 73

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           L++HPNV+R++EVM SK +I+IVLE+VTGGELF+ IA+ GRLKE+EARKYFQQLINAVDY
Sbjct: 74  LVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINAVDY 133

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           CHSRGV HRDLK ENLLLDA+G LKVSDFGLSAL +QV+ DGLLHTTCGTPNYVAPEVI 
Sbjct: 134 CHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPEVIE 193

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           ++GYDGA AD+WSCGVILYVL+AG+LPFE+ N++ALYKKI +A F  P WFST AKKLI+
Sbjct: 194 DRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKKLIT 253

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSF-EQPNIDLDDVDSIFNESMDSRNLVVERR 308
           RILDPNP TRIT+++++E+ WFKKGYKPP F E+     DDVD+ F +S D R++    +
Sbjct: 254 RILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSED-RHV----K 308

Query: 309 EEGPVAPLTMNAFELISTSQGLNLSSLLKSK 339
           EE    P +MNAFELIS +Q LNL +L ++K
Sbjct: 309 EETEDQPTSMNAFELISLNQALNLDNLFEAK 339

Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2

 Score =  482 bits (1240), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 233/329 (70%), Positives = 271/329 (82%), Gaps = 6/329 (1%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           RVGKYE+G+TLG+G+FAKV+ A NTETGE VA+KILDKEKVLKHKM  QI+REI TMKLI
Sbjct: 9   RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            HPNV+R+YEV+ASKTKIYIVLEF TGGELFDKI   GRLKE+ ARKYFQQLINAVDYCH
Sbjct: 69  NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           SRGV HRDLKPENLLLDA G LKVSDFGLSAL +QVR DGLLHT CGTPNY APEV+N++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
           GYDGA ADLWSCGVIL+VL+AGYLPFE+SNLM LYKKI   ++  PPW S  AK LI RI
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248

Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPSFEQ-PNIDLDDVDSIFNESMDSRNLVVERREE 310
           LDPNP+TRIT+ EV+ + WFKK YKP  FE+    +LDDVD++F +S +    V E++EE
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHH--VTEKKEE 306

Query: 311 GPVAPLTMNAFELISTSQGLNLSSLLKSK 339
            P    +MNAFELIS S+ L+L +L + +
Sbjct: 307 QPT---SMNAFELISMSRALDLGNLFEEE 332

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1

 Score =  477 bits (1228), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 225/328 (68%), Positives = 272/328 (82%), Gaps = 7/328 (2%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           TRVG+YELG+T+GEGSFAKVK AR+T TG+ +AIK+LD+  VL+HKM+ QIKREISTMKL
Sbjct: 22  TRVGRYELGKTIGEGSFAKVKVARDTRTGDTLAIKVLDRNHVLRHKMVEQIKREISTMKL 81

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           I+HPNV++++EVMASK+KIY+VLE+V GGELFDKI + GRL EDEAR+YF QLINAVDYC
Sbjct: 82  IKHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLINAVDYC 141

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HSRGV HRDLKPENLLLD++G LKVSDFGLSA   Q ++DGLLHT CGTPNYVAPEV+ +
Sbjct: 142 HSRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAPEVLAD 201

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGYDG  AD+WSCG+IL+VLMAGYLPF++ NLM LYK I KA    P WFS+ AKK I R
Sbjct: 202 KGYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHWFSSGAKKFIKR 261

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ-PNIDLDDVDSIFNESMDSRNLVVERRE 309
           ILDPNP TRIT+A+++E++WFKK YKPP FEQ  ++ LDDVD+ F+ S    NLV E+RE
Sbjct: 262 ILDPNPCTRITIAQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCS--EENLVAEKRE 319

Query: 310 EGPVAPLTMNAFELISTSQGLNLSSLLK 337
           +    P +MNAF LIS SQG NL +L +
Sbjct: 320 K----PESMNAFALISRSQGFNLGNLFE 343

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1

 Score =  450 bits (1157), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/339 (64%), Positives = 266/339 (78%), Gaps = 7/339 (2%)

Query: 2   ASRTGGASRTR-VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           A RT      R +GKYELGR +G+G+FAKV+FA+N ETG++VAIKILDK KV KH+++ Q
Sbjct: 4   AKRTAAQKVRRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQ 63

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           I+REI TMKLI+HPNV+ ++EVM SKT+I+IVLE+V GGEL D IA+ GRLKEDEARKYF
Sbjct: 64  IRREICTMKLIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYF 123

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           QQLINAVDYCHSRGV HRDLK ENLLLD  G +KVSDFGLSA+ +QV+ DGLLHTTCGTP
Sbjct: 124 QQLINAVDYCHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTP 183

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           NYVAPEVI +KGYDGA ADLWSCGVIL+VL+AGYLPFE+ N+++LY KI  A F  P WF
Sbjct: 184 NYVAPEVIEDKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWF 243

Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID-LDDVDSIFNESMD 299
           S  AK+LI+RILDPNP TRIT ++V++++WFKKGY+ P F+        DV   F +S +
Sbjct: 244 SAEAKRLIARILDPNPATRITTSQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSEE 303

Query: 300 SRNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKS 338
               V E  EE P     MNAFELIS ++GLNL +  +S
Sbjct: 304 KH--VKEAMEEQPT---LMNAFELISLNKGLNLDNFFES 337

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	342
224993590	460	CBL-interacting protein kinase 24 [Popul	0.970	0.721	0.898	1e-178
224120484	464	predicted protein [Populus trichocarpa]	0.970	0.715	0.895	1e-178
116265964	457	CBL-interacting protein kinase 24 [Popul	0.970	0.726	0.895	1e-178
224144097	446	predicted protein [Populus trichocarpa]	0.985	0.755	0.876	1e-177
255584495	468	CBL-interacting serine/threonine-protein	0.967	0.707	0.900	1e-177
297740758	455	unnamed protein product [Vitis vinifera]	0.982	0.738	0.890	1e-176
359483902	449	PREDICTED: CBL-interacting serine/threon	0.982	0.748	0.890	1e-176
116265966	466	CBL-interacting protein kinase 25 [Popul	0.973	0.714	0.880	1e-176
224993592	463	CBL-interacting protein kinase 25 [Popul	0.973	0.719	0.863	1e-173
449454969	464	PREDICTED: CBL-interacting serine/threon	0.988	0.728	0.860	1e-172

>gi|224993590|gb|ACN76474.1| CBL-interacting protein kinase 24 [Populus euphratica]

 Score =  630 bits (1625), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 301/335 (89%), Positives = 320/335 (95%), Gaps = 3/335 (0%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           TRVG+YELGRTLGEG+FAKVKFARN ETGENVAIKILDKEKVLKHKMIGQIKREISTMKL
Sbjct: 16  TRVGRYELGRTLGEGTFAKVKFARNVETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 75

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           IRHPNV+RMYEVMASKTKIYIVLEFVTGGELFDKIAS+GRLKEDEARKYFQQLINAVDYC
Sbjct: 76  IRHPNVVRMYEVMASKTKIYIVLEFVTGGELFDKIASKGRLKEDEARKYFQQLINAVDYC 135

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HSRGV HRDLKPENLLLDA+GVLKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVINN
Sbjct: 136 HSRGVYHRDLKPENLLLDASGVLKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINN 195

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGYDGAKADLWSCGVIL+VLMAGYLPFEESNLMALYKKIFKADF  PPWFS+SAKKLI R
Sbjct: 196 KGYDGAKADLWSCGVILFVLMAGYLPFEESNLMALYKKIFKADFACPPWFSSSAKKLIKR 255

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           ILDPNP TRIT++E+IENEWFKKGYKPP+FE+ N+ LDDVDSIFNESMDS+NLVVERREE
Sbjct: 256 ILDPNPSTRITISELIENEWFKKGYKPPTFEKANVGLDDVDSIFNESMDSQNLVVERREE 315

Query: 311 ---GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
              GP+AP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 316 GFIGPMAPVTMNAFELISTSQGLNLSSLFEKQMGL 350

Source: Populus euphratica

Species: Populus euphratica

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120484|ref|XP_002331059.1| predicted protein [Populus trichocarpa] gi|222872989|gb|EEF10120.1| predicted protein [Populus trichocarpa]

 Score =  630 bits (1624), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 300/335 (89%), Positives = 319/335 (95%), Gaps = 3/335 (0%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           TRVG+YELGRTLGEG+FAKVKFARN ETGENVAIKILDKEKVLKHKMIGQIKREISTMKL
Sbjct: 13  TRVGRYELGRTLGEGTFAKVKFARNVETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 72

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           IRHPNV+RMYEVMASKTKIYIVLEFVTGGELFDKIAS+GRLKEDEARKYFQQLINAVDYC
Sbjct: 73  IRHPNVVRMYEVMASKTKIYIVLEFVTGGELFDKIASKGRLKEDEARKYFQQLINAVDYC 132

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HSRGV HRDLKPENLLLDA+G LKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVINN
Sbjct: 133 HSRGVYHRDLKPENLLLDASGFLKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINN 192

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGYDGAKADLWSCGVIL+VLMAGYLPFEESNLMALYKKIFKADF  PPWFS+SAKKLI R
Sbjct: 193 KGYDGAKADLWSCGVILFVLMAGYLPFEESNLMALYKKIFKADFTCPPWFSSSAKKLIKR 252

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           ILDPNP TRIT++E+IENEWFKKGYKPP+FE+ N+ LDDVDSIFNESMDS+NLVVERREE
Sbjct: 253 ILDPNPSTRITISELIENEWFKKGYKPPTFEKANVSLDDVDSIFNESMDSQNLVVERREE 312

Query: 311 ---GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
              GP+AP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 313 GFIGPMAPVTMNAFELISTSQGLNLSSLFEKQMGL 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116265964|gb|ABJ91230.1| CBL-interacting protein kinase 24 [Populus trichocarpa]

 Score =  630 bits (1624), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 300/335 (89%), Positives = 319/335 (95%), Gaps = 3/335 (0%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           TRVG+YELGRTLGEG+FAKVKFARN ETGENVAIKILDKEKVLKHKMIGQIKREISTMKL
Sbjct: 13  TRVGRYELGRTLGEGTFAKVKFARNVETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 72

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           IRHPNV+RMYEVMASKTKIYIVLEFVTGGELFDKIAS+GRLKEDEARKYFQQLINAVDYC
Sbjct: 73  IRHPNVVRMYEVMASKTKIYIVLEFVTGGELFDKIASKGRLKEDEARKYFQQLINAVDYC 132

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HSRGV HRDLKPENLLLDA+G LKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVINN
Sbjct: 133 HSRGVYHRDLKPENLLLDASGFLKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINN 192

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGYDGAKADLWSCGVIL+VLMAGYLPFEESNLMALYKKIFKADF  PPWFS+SAKKLI R
Sbjct: 193 KGYDGAKADLWSCGVILFVLMAGYLPFEESNLMALYKKIFKADFTCPPWFSSSAKKLIKR 252

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           ILDPNP TRIT++E+IENEWFKKGYKPP+FE+ N+ LDDVDSIFNESMDS+NLVVERREE
Sbjct: 253 ILDPNPSTRITISELIENEWFKKGYKPPTFEKANVSLDDVDSIFNESMDSQNLVVERREE 312

Query: 311 ---GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
              GP+AP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 313 GFIGPMAPVTMNAFELISTSQGLNLSSLFEKQMGL 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224144097|ref|XP_002325185.1| predicted protein [Populus trichocarpa] gi|222866619|gb|EEF03750.1| predicted protein [Populus trichocarpa]

 Score =  626 bits (1615), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 298/340 (87%), Positives = 320/340 (94%), Gaps = 3/340 (0%)

Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G  S+TRVG+YELGRTLGEG+FAKVKFARN ET ENVAIKILDKE VLKHKMIGQIKREI
Sbjct: 3   GSGSKTRVGRYELGRTLGEGNFAKVKFARNVETKENVAIKILDKENVLKHKMIGQIKREI 62

Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
           STMKLIRHPNV+RMYEVMASKTKIYIVL+FVTGGELFDKIAS+GRLKEDEARKYFQQLI 
Sbjct: 63  STMKLIRHPNVVRMYEVMASKTKIYIVLQFVTGGELFDKIASKGRLKEDEARKYFQQLIC 122

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           AVDYCHSRGV HRDLKPENLL+DANG+LKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAP
Sbjct: 123 AVDYCHSRGVYHRDLKPENLLMDANGILKVSDFGLSALPQQVREDGLLHTTCGTPNYVAP 182

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           EVINNKGYDGAKADLWSCGVIL+VLMAGYLPFEE+NLMALYKKIFKADF  PPWFS+SAK
Sbjct: 183 EVINNKGYDGAKADLWSCGVILFVLMAGYLPFEEANLMALYKKIFKADFTCPPWFSSSAK 242

Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVV 305
           KLI RILDPNP TRIT+AE+IENEWFKKGYKPP+FEQ N+ LDDV+SIFNES+DSRNLVV
Sbjct: 243 KLIKRILDPNPSTRITIAELIENEWFKKGYKPPAFEQANVSLDDVNSIFNESVDSRNLVV 302

Query: 306 ERREE---GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
           ERREE   GP+AP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 303 ERREEGFIGPMAPVTMNAFELISTSQGLNLSSLFEKQMGL 342

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255584495|ref|XP_002532976.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223527240|gb|EEF29400.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  625 bits (1613), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 300/333 (90%), Positives = 316/333 (94%), Gaps = 2/333 (0%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           RVG+YELGRTLGEG+FAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI
Sbjct: 20  RVGRYELGRTLGEGTFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 79

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR KEDEARKYFQQLINAVDYCH
Sbjct: 80  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRFKEDEARKYFQQLINAVDYCH 139

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           SRGV HRDLKPENLLLDANGVLKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVINNK
Sbjct: 140 SRGVYHRDLKPENLLLDANGVLKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 199

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
           GYDGAKADLWSCGVIL+VLMAGYLPFEESNLMALYKKIFKA+F  PPWFS+SAKKLI RI
Sbjct: 200 GYDGAKADLWSCGVILFVLMAGYLPFEESNLMALYKKIFKAEFTCPPWFSSSAKKLIKRI 259

Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE- 310
           LDPNP+TRIT+AEVIENEWFKKGYKPP+FEQ  + LDDV+SIFNES D ++LVVERRE  
Sbjct: 260 LDPNPLTRITIAEVIENEWFKKGYKPPTFEQAEVSLDDVNSIFNESGDCQDLVVERREAP 319

Query: 311 -GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
            GPVAP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 320 IGPVAPITMNAFELISTSQGLNLSSLFEKQMGL 352

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740758|emb|CBI30940.3| unnamed protein product [Vitis vinifera]

 Score =  624 bits (1608), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 300/337 (89%), Positives = 317/337 (94%), Gaps = 1/337 (0%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           MASR+    RTRVGKYELGRTLGEG+FAKVKFARN ETGENVAIKILDKEKVLKHKMIGQ
Sbjct: 1   MASRSS-TGRTRVGKYELGRTLGEGTFAKVKFARNVETGENVAIKILDKEKVLKHKMIGQ 59

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           IKREISTMKLIRHPNVIRM+EVMASKTKIYIVLEFVTGGELFDKIAS+GRLKEDEARKYF
Sbjct: 60  IKREISTMKLIRHPNVIRMHEVMASKTKIYIVLEFVTGGELFDKIASKGRLKEDEARKYF 119

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           QQLINAVDYCHSR V HRDLKPENLLLDANGVLKVSDFGLSALPQQVR+DGLLHTTCGTP
Sbjct: 120 QQLINAVDYCHSRCVFHRDLKPENLLLDANGVLKVSDFGLSALPQQVREDGLLHTTCGTP 179

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           NYVAPEVINNKGYDGAKADLWSCGVIL+VLMAGYLPFEESNLMALYKKIFKADF  PPW 
Sbjct: 180 NYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEESNLMALYKKIFKADFTFPPWL 239

Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDS 300
           S+SAKKLI RILDPNP TRIT+AEVIENEWFKKGYKPPSFEQ ++ LDDVD+IF+ES DS
Sbjct: 240 SSSAKKLIKRILDPNPETRITIAEVIENEWFKKGYKPPSFEQADVSLDDVDAIFDESGDS 299

Query: 301 RNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLK 337
           +NLVVERREE P  P+T+NAFELISTSQGLNL +L +
Sbjct: 300 QNLVVERREERPTTPVTLNAFELISTSQGLNLGTLFE 336

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483902|ref|XP_002279222.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 23 [Vitis vinifera] gi|310913178|emb|CBW30552.1| CBL-interacting protein kinase 04 [Vitis vinifera]

 Score =  623 bits (1606), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 300/337 (89%), Positives = 317/337 (94%), Gaps = 1/337 (0%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           MASR+    RTRVGKYELGRTLGEG+FAKVKFARN ETGENVAIKILDKEKVLKHKMIGQ
Sbjct: 1   MASRSS-TGRTRVGKYELGRTLGEGTFAKVKFARNVETGENVAIKILDKEKVLKHKMIGQ 59

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           IKREISTMKLIRHPNVIRM+EVMASKTKIYIVLEFVTGGELFDKIAS+GRLKEDEARKYF
Sbjct: 60  IKREISTMKLIRHPNVIRMHEVMASKTKIYIVLEFVTGGELFDKIASKGRLKEDEARKYF 119

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           QQLINAVDYCHSR V HRDLKPENLLLDANGVLKVSDFGLSALPQQVR+DGLLHTTCGTP
Sbjct: 120 QQLINAVDYCHSRCVFHRDLKPENLLLDANGVLKVSDFGLSALPQQVREDGLLHTTCGTP 179

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           NYVAPEVINNKGYDGAKADLWSCGVIL+VLMAGYLPFEESNLMALYKKIFKADF  PPW 
Sbjct: 180 NYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEESNLMALYKKIFKADFTFPPWL 239

Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDS 300
           S+SAKKLI RILDPNP TRIT+AEVIENEWFKKGYKPPSFEQ ++ LDDVD+IF+ES DS
Sbjct: 240 SSSAKKLIKRILDPNPETRITIAEVIENEWFKKGYKPPSFEQADVSLDDVDAIFDESGDS 299

Query: 301 RNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLK 337
           +NLVVERREE P  P+T+NAFELISTSQGLNL +L +
Sbjct: 300 QNLVVERREERPTTPVTLNAFELISTSQGLNLGTLFE 336

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116265966|gb|ABJ91231.1| CBL-interacting protein kinase 25 [Populus trichocarpa]

 Score =  622 bits (1605), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 296/336 (88%), Positives = 318/336 (94%), Gaps = 3/336 (0%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +TRVG+YELGRTLGEG+FAKVKFARN ET ENVAIKILDKE VLKHKMIGQIKREISTMK
Sbjct: 20  KTRVGRYELGRTLGEGNFAKVKFARNVETKENVAIKILDKENVLKHKMIGQIKREISTMK 79

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           LIRHPNV+RMYEVMASKTKIYIVL+FVTGGELFDKIAS+GRLKEDEARKYFQQLI AVDY
Sbjct: 80  LIRHPNVVRMYEVMASKTKIYIVLQFVTGGELFDKIASKGRLKEDEARKYFQQLICAVDY 139

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           CHSRGV HRDLKPENLL+DANG+LKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVIN
Sbjct: 140 CHSRGVYHRDLKPENLLMDANGILKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 199

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           NKGYDGAKADLWSCGVIL+VLMAGYLPFEE+NLMALYKKIFKADF  PPWFS+SAKKLI 
Sbjct: 200 NKGYDGAKADLWSCGVILFVLMAGYLPFEEANLMALYKKIFKADFTCPPWFSSSAKKLIK 259

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERRE 309
           RILDPNP TRIT+AE+IENEWFKKGYKPP+FEQ N+ LDDV+SIFNES+DSRNLVVERRE
Sbjct: 260 RILDPNPSTRITIAELIENEWFKKGYKPPAFEQANVSLDDVNSIFNESVDSRNLVVERRE 319

Query: 310 E---GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
           E   GP+AP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 320 EGFIGPMAPVTMNAFELISTSQGLNLSSLFEKQMGL 355

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224993592|gb|ACN76475.1| CBL-interacting protein kinase 25 [Populus euphratica]

 Score =  612 bits (1579), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 290/336 (86%), Positives = 317/336 (94%), Gaps = 3/336 (0%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +TRVG+YELGRTLGEG+FAKVKFARN +T ENVAIKILDKE VLKHKMIGQIKREISTMK
Sbjct: 17  KTRVGRYELGRTLGEGNFAKVKFARNVKTKENVAIKILDKENVLKHKMIGQIKREISTMK 76

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           LIRHPNV+RMYEVMASKTKIYIVL+FVTGGELFDK+AS+GRLKEDEARKYFQQLI AVDY
Sbjct: 77  LIRHPNVVRMYEVMASKTKIYIVLQFVTGGELFDKLASKGRLKEDEARKYFQQLICAVDY 136

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           CHSRGV HRDLKPENLL+DA+G+LKVSDFGLSALPQQVR+DGLLHTTCGTPNYVAPEVIN
Sbjct: 137 CHSRGVYHRDLKPENLLMDADGILKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 196

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           NK YDGAKADLWSCGVIL+VLMAGYLPFEE+NLMALYKKIFKADF  PPWFS+SAKKLI 
Sbjct: 197 NKDYDGAKADLWSCGVILFVLMAGYLPFEEANLMALYKKIFKADFTCPPWFSSSAKKLIK 256

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERRE 309
           RILDPNP TRIT+AE+IENEWFKKGYKPP+FEQ N+ LDDV+S+FNES+DS+NLVVERRE
Sbjct: 257 RILDPNPSTRITIAELIENEWFKKGYKPPAFEQANVSLDDVNSVFNESVDSQNLVVERRE 316

Query: 310 E---GPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
           E   GP+AP+TMNAFELISTSQGLNLSSL + +  L
Sbjct: 317 EGFIGPMAPVTMNAFELISTSQGLNLSSLFEKQMGL 352

Source: Populus euphratica

Species: Populus euphratica

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454969|ref|XP_004145226.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 23-like [Cucumis sativus] gi|449527537|ref|XP_004170767.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 23-like [Cucumis sativus]

 Score =  610 bits (1573), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 291/338 (86%), Positives = 313/338 (92%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
           A+ +    RTRVGKYELG+TLGEG+FAKVKFARN+ETGENVAIKILDKEKVLKHKMI QI
Sbjct: 10  AASSSNGGRTRVGKYELGKTLGEGNFAKVKFARNSETGENVAIKILDKEKVLKHKMISQI 69

Query: 62  KREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
           KREISTMKLIRHPNVIRM EVMASKTKIYIVLEFVTGGELFDKI SRGR+KEDE RKYFQ
Sbjct: 70  KREISTMKLIRHPNVIRMIEVMASKTKIYIVLEFVTGGELFDKIVSRGRMKEDETRKYFQ 129

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           QLINAVDYCHSRGV HRDLKPENLLLDANGVLKVSDFGLSALPQQVR+DGLLHTTCGTPN
Sbjct: 130 QLINAVDYCHSRGVFHRDLKPENLLLDANGVLKVSDFGLSALPQQVREDGLLHTTCGTPN 189

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           YVAPEVINNKGYDGAKADLWSCGVIL+VLMAGYLPFE+SNL+ALYKKI KADF  PPWFS
Sbjct: 190 YVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLVALYKKIHKADFTCPPWFS 249

Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSR 301
           T+AKKLI RILDPNP TRIT+ EVIENEWF+KGYKPP+FEQ +I LDDVD+IFNE+ DS 
Sbjct: 250 TNAKKLIKRILDPNPSTRITIPEVIENEWFRKGYKPPTFEQADISLDDVDAIFNETGDSG 309

Query: 302 NLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSK 339
           +LVVER+EEG  +PLTMNAFELIS SQGLNLSSL + +
Sbjct: 310 SLVVERKEEGSKSPLTMNAFELISKSQGLNLSSLFEKQ 347

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	342
TAIR|locus:2009812	482	CIPK23 "CBL-interacting protei	0.988	0.701	0.838	4.1e-152
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.938	0.711	0.721	1.4e-128
TAIR|locus:1005716172	439	CIPK26 "calcineurin B-like pro	0.944	0.735	0.708	2.4e-122
TAIR|locus:2135962	445	CIPK8 "CBL-interacting protein	0.932	0.716	0.643	2.9e-110
TAIR|locus:2155233	446	SOS2 "SALT OVERLY SENSITIVE 2"	0.947	0.726	0.621	6.1e-110
TAIR|locus:1005716169	831	AT5G21222 [Arabidopsis thalian	0.853	0.351	0.668	1.7e-105
TAIR|locus:2152380	439	CIPK20 "CBL-interacting protei	0.915	0.712	0.616	2.3e-103
TAIR|locus:2124072	489	CIPK12 "CBL-interacting protei	0.941	0.658	0.572	1e-100
TAIR|locus:2152370	483	CIPK19 "CBL-interacting protei	0.941	0.666	0.568	9.1e-100
TAIR|locus:2183720	445	CIPK5 "CBL-interacting protein	0.956	0.734	0.581	1.9e-99

TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 1484 (527.5 bits), Expect = 4.1e-152, P = 4.1e-152
 Identities = 285/340 (83%), Positives = 309/340 (90%)

Query:     3 SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
             S +GG  RTRVGKYELGRTLGEG+FAKVKFARN E G+NVAIK++DKEKVLK+KMI QIK
Sbjct:    20 SSSGG--RTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIK 77

Query:    63 REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
             REISTMKLI+HPNVIRM+EVMASKTKIY VLEFVTGGELFDKI+S GRLKEDEARKYFQQ
Sbjct:    78 REISTMKLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQ 137

Query:   123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
             LINAVDYCHSRGV HRDLKPENLLLDANG LKVSDFGLSALPQQVR+DGLLHTTCGTPNY
Sbjct:   138 LINAVDYCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNY 197

Query:   183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
             VAPEVINNKGYDGAKADLWSCGVIL+VLMAGYLPFE+SNL +LYKKIFKA+F  PPWFS 
Sbjct:   198 VAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSA 257

Query:   243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
             SAKKLI RILDPNP TRIT AEVIENEWFKKGYK P FE  ++ LDDVD+IF++S +S+N
Sbjct:   258 SAKKLIKRILDPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKN 317

Query:   303 LVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKWDL 342
             LVVERREEG   P+TMNAFELISTSQGLNL SL + +  L
Sbjct:   318 LVVERREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGL 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IPI

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0010107 "potassium ion import" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007584 "response to nutrient" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA;IMP

GO:0009536 "plastid" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
 Identities = 236/327 (72%), Positives = 286/327 (87%)

Query:    10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
             + RVGKYE+GRT+GEG+FAKVKFARN+ETGE VA+KILDKEKVLKHKM  QI+REI+TMK
Sbjct:    18 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMK 77

Query:    70 LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             LI+HPNV+++YEVMASKTKI+I+LE+VTGGELFDKI + GR+KEDEAR+YFQQLI+AVDY
Sbjct:    78 LIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDY 137

Query:   130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
             CHSRGV HRDLKPENLLLD+ G LK+SDFGLSAL QQVRDDGLLHT+CGTPNYVAPEV+N
Sbjct:   138 CHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLN 197

Query:   190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
             ++GYDGA AD+WSCGV+LYVL+AGYLPF++SNLM LYKKI   +F  PPW S  A KLI+
Sbjct:   198 DRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLIT 257

Query:   250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ-PNIDLDDVDSIFNESMDSRNLVVERR 308
             RILDPNP+TR+T  EV E+EWFKK YKPP FE+  + ++DD+D++F +S +  +LV E+R
Sbjct:   258 RILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEE--HLVTEKR 315

Query:   309 EEGPVAPLTMNAFELISTSQGLNLSSL 335
             EE P A   +NAFE+IS S+GLNL +L
Sbjct:   316 EEQPAA---INAFEIISMSRGLNLENL 339

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 1203 (428.5 bits), Expect = 2.4e-122, P = 2.4e-122
 Identities = 233/329 (70%), Positives = 271/329 (82%)

Query:    12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
             RVGKYE+G+TLG+G+FAKV+ A NTETGE VA+KILDKEKVLKHKM  QI+REI TMKLI
Sbjct:     9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68

Query:    72 RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
              HPNV+R+YEV+ASKTKIYIVLEF TGGELFDKI   GRLKE+ ARKYFQQLINAVDYCH
Sbjct:    69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128

Query:   132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
             SRGV HRDLKPENLLLDA G LKVSDFGLSAL +QVR DGLLHT CGTPNY APEV+N++
Sbjct:   129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188

Query:   192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
             GYDGA ADLWSCGVIL+VL+AGYLPFE+SNLM LYKKI   ++  PPW S  AK LI RI
Sbjct:   189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248

Query:   252 LDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN-IDLDDVDSIFNESMDSRNLVVERREE 310
             LDPNP+TRIT+ EV+ + WFKK YKP  FE+    +LDDVD++F +S +    V E++EE
Sbjct:   249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHH--VTEKKEE 306

Query:   311 GPVAPLTMNAFELISTSQGLNLSSLLKSK 339
              P +   MNAFELIS S+ L+L +L + +
Sbjct:   307 QPTS---MNAFELISMSRALDLGNLFEEE 332

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
 Identities = 209/325 (64%), Positives = 262/325 (80%)

Query:    12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
             +VGKYELGRT+GEG+FAKVKFA+NTETGE+VA+KI+D+  ++K KM+ QIKREIS MKL+
Sbjct:     5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64

Query:    72 RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
             RHP V+R+YEV+AS+TKIYI+LE++TGGELFDKI   GRL E EARKYF QLI+ VDYCH
Sbjct:    65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124

Query:   132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
             S+GV HRDLKPENLLLD+ G LK+SDFGLSALP+Q     +L TTCGTPNYVAPEV+++K
Sbjct:   125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQ--GVTILKTTCGTPNYVAPEVLSHK 182

Query:   192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
             GY+GA AD+WSCGVILYVLMAGYLPF+E +L  LY KI KA+F  P +F+  AK LI+RI
Sbjct:   183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRI 242

Query:   252 LDPNPVTRITMAEVIENEWFKKGYKPPSF-EQPNIDLDDVDSIFNESMDSRNLVVERREE 310
             LDPNP TRIT+AE+ ++EWF K Y P    +  +++LDDV + F++  +        R+ 
Sbjct:   243 LDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDT 302

Query:   311 GPVAPLTMNAFELISTSQGLNLSSL 335
             GP   LT+NAF+LI  SQGLNL++L
Sbjct:   303 GP---LTLNAFDLIILSQGLNLATL 324

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=TAS

GO:0010167 "response to nitrate" evidence=IEP;IMP

GO:0048364 "root development" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
 Identities = 207/333 (62%), Positives = 267/333 (80%)

Query:    12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
             RVGKYE+GRT+GEG+FAKVKFARNT+TG+NVAIKI+ K  +LK++M+ QIKREIS MK++
Sbjct:     7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66

Query:    72 RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
             RHPN++R+YEV+AS +KIYIVLEFVTGGELFD+I  +GRL+E E+RKYFQQL++AV +CH
Sbjct:    67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126

Query:   132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
              +GV HRDLKPENLLLD NG LKVSDFGLSALPQ+  +  LL TTCGTPNYVAPEV++ +
Sbjct:   127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184

Query:   192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
             GYDG+ AD+WSCGVIL+V++AGYLPF E++L  LY+KI  A+F  PPWFS   K LI RI
Sbjct:   185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244

Query:   252 LDPNPVTRITMAEVIENEWFKKGYKP-PSFEQPNIDLDDVDSIFNESMDSRNLV--VERR 308
             LDPNP TRI +  + ++ WF+  Y P  + E+  ++LDD+ ++F + ++   +   VER 
Sbjct:   245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVF-DGIEGSYVAENVERN 303

Query:   309 EEGPVAPLTMNAFELISTSQGLNLSSLLKSKWD 341
             +EGP   L MNAFE+I+ SQGLNLS+L   + D
Sbjct:   304 DEGP---LMMNAFEMITLSQGLNLSALFDRRQD 333

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042802 "identical protein binding" evidence=IPI

GO:0009705 "plant-type vacuole membrane" evidence=IDA

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)]

 Score = 1044 (372.6 bits), Expect = 1.7e-105, P = 1.7e-105
 Identities = 196/293 (66%), Positives = 239/293 (81%)

Query:    10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
             R  VGKYE+GR +GE +F K++ A +TETG+ VA+ ILDK+KVLKHKM  QIKREIS MK
Sbjct:     7 RRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKREISIMK 66

Query:    70 LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             LI HPNV+++YEV+ASK KIYIVLEF++GG+LFDKI + GR+ EDEA++YFQQLINAVDY
Sbjct:    67 LINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQLINAVDY 126

Query:   130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
             CHSRGV HRDLKPENLLLDA   LKV++FGL AL QQ   DGL HT CG P+Y APEV+N
Sbjct:   127 CHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYAAPEVLN 186

Query:   190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
             ++GYDGAKADLWSCGVIL+VL+AGYLPFE+S+L  LYKKI  ADF  PPW S+  K LI 
Sbjct:   187 DQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSGVKNLIV 246

Query:   250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN-IDLDDVDSIFNESMDSR 301
             RILDPNP+TRIT+ E++E+ WFKK YKP  FE+    +L DV+++F +S + R
Sbjct:   247 RILDPNPMTRITIPEILEDVWFKKDYKPAVFEEKKEANLADVEAVFKDSEEGR 299

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
 Identities = 201/326 (61%), Positives = 252/326 (77%)

Query:    15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
             KYELGR LG+G+FAKV  ARN +TGE+VAIK++DK+KV K  +I QIKREIS M+L+RHP
Sbjct:    11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70

Query:    75 NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
             +V+ ++EVMASKTKIY  +E+V GGELFDK+ S+G+LKE+ ARKYFQQLI A+DYCHSRG
Sbjct:    71 HVVFLHEVMASKTKIYFAMEYVKGGELFDKV-SKGKLKENIARKYFQQLIGAIDYCHSRG 129

Query:   135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
             V HRDLKPENLLLD NG LK+SDFGLSAL +  + DGLLHTTCGTP YVAPEVI  KGYD
Sbjct:   130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189

Query:   195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             GAKAD+WSCGV+LYVL+AG+LPF E NL+ +Y+KI K +FK P WF    KKL+SRILDP
Sbjct:   190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249

Query:   255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVA 314
             NP +RI + +++EN WF+KG+K    E P        S  +  +DS  L+ +      V 
Sbjct:   250 NPNSRIKIEKIMENSWFQKGFK--KIETPK-------SPESHQIDS--LISDVHAAFSVK 298

Query:   315 PLTMNAFELIST-SQGLNLSSLLKSK 339
             P++ NAF+LIS+ SQG +LS L + +
Sbjct:   299 PMSYNAFDLISSLSQGFDLSGLFEKE 324

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 999 (356.7 bits), Expect = 1.0e-100, P = 1.0e-100
 Identities = 193/337 (57%), Positives = 255/337 (75%)

Query:    13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
             +G+YE+G+ LG G+FAKV  ARN +T E+VAIK++DKEKVLK  +I  IKREIS ++ +R
Sbjct:    23 LGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRRVR 82

Query:    73 HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
             HPN+++++EVMA+K KIY V+E+V GGELF+K+A +GRLKE+ ARKYFQQLI+AV +CH+
Sbjct:    83 HPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVA-KGRLKEEVARKYFQQLISAVTFCHA 141

Query:   133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
             RGV HRDLKPENLLLD NG LKVSDFGLSA+  Q+R DGL HT CGTP YVAPEV+  KG
Sbjct:   142 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 201

Query:   193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
             YD AK D+WSCGVIL+VLMAGYLPF + N+MA+YKKI++ +F+ P WFST   +L+S++L
Sbjct:   202 YDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKLL 261

Query:   253 DPNPVTRITMAEVIENEWFKKGYKPPSF--EQPNI-DLDDVDSIFNESMDS-RN------ 302
             + NP  R T  E++EN WFKKG+K   F  E   + ++ D D + ++S++S R+      
Sbjct:   262 ETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAASES 321

Query:   303 ----LVVERREEGPVAPLTMNAFELISTSQGLNLSSL 335
                 L   RR  G   P ++NAF++IS SQG +LS L
Sbjct:   322 EIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGL 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 990 (353.6 bits), Expect = 9.1e-100, P = 9.1e-100
 Identities = 195/343 (56%), Positives = 254/343 (74%)

Query:    13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
             +GKYE+GR LG G+FAKV  ARN ++GE+VAIK++DKEKVLK  +I  IKREIS ++ +R
Sbjct:    25 LGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRRVR 84

Query:    73 HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
             HPN+++++EVMA+K+KIY V+E+V GGELF+K+A +GRLKE+ ARKYFQQLI+AV +CH 
Sbjct:    85 HPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVA-KGRLKEEMARKYFQQLISAVSFCHF 143

Query:   133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
             RGV HRDLKPENLLLD NG LKVSDFGLSA+  Q+R DGL HT CGTP YVAPEV+  KG
Sbjct:   144 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 203

Query:   193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
             YDGAK D+WSCGVIL+VLMAG+LPF + N+MA+YKKI++ DF+ P WF     +L+ R+L
Sbjct:   204 YDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRML 263

Query:   253 DPNPVTRITMAEVIENEWFKKGYKPPSF--EQP----NI-DLDDVDSIFNESMDSRNLVV 305
             +  P  R TM +++E  WFKKG+K   F  E      N+ D D+++SI  ES+  R+  V
Sbjct:   264 ETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESI--ESVSGRSSTV 321

Query:   306 E----------RREEGPVA-PLTMNAFELISTSQGLNLSSLLK 337
                        RR  G +  P ++NAF+LIS S G +LS L +
Sbjct:   322 SEPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLSGLFE 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
 Identities = 193/332 (58%), Positives = 251/332 (75%)

Query:    10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-MIGQIKREISTM 68
             R   GKYE+GR LG+G+FAKV + +    GE VAIK+++K++V+K   M+ QIKREIS M
Sbjct:     6 RVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKREISIM 65

Query:    69 KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
             KL+RHPN++ + EVMA+KTKI+ V+EFV GGELF KI S+G+L ED AR+YFQQLI+AVD
Sbjct:    66 KLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKI-SKGKLHEDAARRYFQQLISAVD 124

Query:   129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
             YCHSRGV HRDLKPENLLLD NG LK+SDFGLSALP+Q+  DGLLHT CGTP YVAPEV+
Sbjct:   125 YCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVL 184

Query:   189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
               KGYDGAKAD+WSCGV+LYVL+AG LPF++ NLM +Y+KIF+ADF+ PPWFS  A++LI
Sbjct:   185 KKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLI 244

Query:   249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERR 308
             S++L  +P  RI++  ++   W +K + PP   + +  +    S  NE  +  +   E +
Sbjct:   245 SKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEE-EEEDGDCENQ 303

Query:   309 EEGPVAPLTMNAFELIST-SQGLNLSSLLKSK 339
              E P++P   NAFE IS+ S G +LSSL +SK
Sbjct:   304 TE-PISPKFFNAFEFISSMSSGFDLSSLFESK 334

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q93VD3	CIPKN_ARATH	2, ., 7, ., 1, 1, ., 1	0.8454	0.9649	0.6846	yes	no
Q6ZLP5	CIPKN_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8308	0.9707	0.7377	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: CIPK24 SubName- Full=CBL-interacting protein kinase 24; (443 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	342
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-113
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-97
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-85
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-81
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-75
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-73
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-72
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-69
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-69
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-68
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-65
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-60
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-59
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-57
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-53
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-52
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-51
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-51
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-51
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-50
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-50
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-50
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-49
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-48
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-48
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-48
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-47
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-47
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-47
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-47
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-47
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-47
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-46
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-46
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-46
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-45
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-45
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-45
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-45
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-44
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-44
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-44
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-44
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-44
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-44
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-43
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-42
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-42
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-42
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-41
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-41
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-41
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-41
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-41
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-41
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-41
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-41
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-41
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-40
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-40
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-40
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-40
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-40
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-40
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-39
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-39
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-38
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-38
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-38
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-38
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-37
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-37
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-37
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-37
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-37
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-37
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-37
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-37
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-37
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-36
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-36
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-36
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-36
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-36
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-36
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-35
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-35
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-35
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-35
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-35
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-35
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-35
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-35
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-35
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-35
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-34
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-34
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-33
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-33
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-33
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-33
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-32
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-32
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-32
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-32
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-32
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-32
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-32
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-31
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-31
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-31
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-31
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-31
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-31
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-31
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-31
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-31
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-30
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-30
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-30
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-30
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-30
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-30
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-29
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-29
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-28
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-28
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-27
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-27
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-27
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-26
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-26
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-25
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-25
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-25
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-25
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-25
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-24
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-24
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-24
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-24
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-24
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-23
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-23
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-23
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-23
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-22
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-22
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-22
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-21
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-21
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-20
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-20
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-20
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-19
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-19
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-18
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-17
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-17
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-15
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-05
pfam03822	58	pfam03822, NAF, NAF domain	5e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
cd12195	116	cd12195, CIPK_C, C-terminal regulatory domain of C	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  328 bits (843), Expect = e-113
 Identities = 119/260 (45%), Positives = 173/260 (66%), Gaps = 10/260 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YE+   LGEGSF KV  AR+ +TG+ VAIK++ K+K+ K +   +I REI  +K ++HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE--RILREIKILKKLKHPN 58

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y+V   + K+Y+V+E+  GG+LFD +  RGRL EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRDLKPEN+LLD +G +K++DFGL+    Q+     L T  GTP Y+APEV+  KGY  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 196 AKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFKADFKSPPW---FSTSAKKLISRI 251
              D+WS GVILY L+ G  PF  +  L+ L+KKI K     PP     S  AK LI ++
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 252 LDPNPVTRITMAEVIENEWF 271
           L  +P  R+T  E +++ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  288 bits (740), Expect = 2e-97
 Identities = 106/263 (40%), Positives = 156/263 (59%), Gaps = 10/263 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YEL R LG GSF  V  A++  TG+ VA+KIL K    K K     +REI  ++ + HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+ +    K  +Y+V+E+  GG+LFD ++  G L EDEA+K   Q++  ++Y HS G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRDLKPEN+LLD NGV+K++DFGL+   + ++    L T  GTP Y+APEV+      G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 196 AKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKADFKSPPWFSTS----AKKLI 248
            K D+WS GVILY L+ G  PF      + + L ++I     +      +S    AK LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 249 SRILDPNPVTRITMAEVIENEWF 271
            + L+ +P  R T  E++++ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  258 bits (662), Expect = 3e-85
 Identities = 100/262 (38%), Positives = 158/262 (60%), Gaps = 11/262 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E  +TLG GSF +V   R+  +G+  A+KIL K K++K K +  +  E   ++ IRHP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ +Y      + +Y+V+E+V GGELF  +   GR  E  AR Y  Q++ A++Y HS  +
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPENLLLD++G +K++DFG +      R  G  +T CGTP Y+APE+I +KGY  
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGYGK 177

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           A  D W+ G+++Y ++AGY PF + N + +Y+KI +   + P +FS  AK LI  +L  +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236

Query: 256 PVTRI-----TMAEVIENEWFK 272
              R+      + ++  + WF 
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 5e-81
 Identities = 98/253 (38%), Positives = 155/253 (61%), Gaps = 6/253 (2%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+GSF KV   R  +TG+  A+K+L K+K++K K +     E + +  I HP +++++ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
              ++ K+Y+VLE+  GGELF  ++  GR  E+ AR Y  +++ A++Y HS G+ +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
           PEN+LLDA+G +K++DFGL+   +   +    +T CGTP Y+APEV+  KGY  A  D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWW 177

Query: 202 SCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRIT 261
           S GV+LY ++ G  PF   +   +Y+KI K   + P + S  A+ LIS +L  +P  R+ 
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237

Query: 262 ---MAEVIENEWF 271
                E+  + +F
Sbjct: 238 SGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  230 bits (590), Expect = 2e-75
 Identities = 96/249 (38%), Positives = 139/249 (55%), Gaps = 37/249 (14%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LGEG F  V  AR+ +TG+ VAIKI+ KE      ++ ++ REI  +K + HPN++++Y 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
           V   +  +Y+V+E+  GG L D +    G+L EDE  +   Q++  ++Y HS G+ HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 141 KPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           KPEN+LLD+ NG +K++DFGLS L     D  LL T  GTP Y+APEV+  KGY   K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
           +WS GVILY L                                  K LI ++L  +P  R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205

Query: 260 ITMAEVIEN 268
            +  E++E+
Sbjct: 206 PSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  226 bits (579), Expect = 5e-73
 Identities = 93/265 (35%), Positives = 148/265 (55%), Gaps = 21/265 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILD------KEKVLKHKMIGQIKREISTM 68
           KYE+ + +G+GSF KV   R    G+   +K +D      KE+            E+  +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-------DALNEVKIL 53

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLI 124
           K + HPN+I+ YE    K K+ IV+E+  GG+L  KI  + +      E++   +F QL 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
            A+ Y HSR + HRD+KP+N+ L +NG++K+ DFG+S +     D  L  T  GTP Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLS 171

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTS 243
           PE+  NK Y+  K+D+WS G +LY L     PFE  NL+ L  KI K  +   P  +S+ 
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230

Query: 244 AKKLISRILDPNPVTRITMAEVIEN 268
            + L+S +L  +P  R ++A+++++
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  224 bits (574), Expect = 4e-72
 Identities = 95/272 (34%), Positives = 150/272 (55%), Gaps = 20/272 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           ++ G+ +GEGSF+ V  A+  ET +  AIKILDK +++K K +  +K E   + +L  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            +I++Y     +  +Y VLE+   GEL   I   G L E   R Y  +++ A++Y HS+G
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLS------ALPQQVRDDGLLHTT------------ 176
           + HRDLKPEN+LLD +  +K++DFG +      + P+  + D     +            
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS 236
            GT  YV+PE++N K   G  +DLW+ G I+Y ++ G  PF  SN    ++KI K ++  
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241

Query: 237 PPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
           PP F   AK LI ++L  +P  R+ + E  + 
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  216 bits (553), Expect = 4e-69
 Identities = 87/264 (32%), Positives = 140/264 (53%), Gaps = 11/264 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           ++  G  LG GSF  V  A + +TGE +A+K ++       + +  ++REI  +  ++HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59

Query: 75  NVIRMY--EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           N++R Y  E    K  + I LE+V+GG L   +   G+L E   RKY +Q++  + Y HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+K  N+L+D++GV+K++DFG +     +       +  GTP ++APEVI  + 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPP----WFSTSAKKL 247
           Y G  AD+WS G  +  +  G  P+ E  N MA   KI       PP      S  AK  
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEPPEIPEHLSEEAKDF 236

Query: 248 ISRILDPNPVTRITMAEVIENEWF 271
           + + L  +P  R T  E++++ + 
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  216 bits (552), Expect = 5e-69
 Identities = 92/259 (35%), Positives = 144/259 (55%), Gaps = 13/259 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G F +V+  +        A+K + K  +++      I  E   ++   HP ++++Y 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
               K  IY+++E+  GGEL+  +  RG   E  AR Y   ++ A +Y H+RG+ +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
           PENLLLD+NG +K+ DFG +   ++++      T CGTP YVAPE+I NKGYD +  D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176

Query: 202 SCGVILYVLMAGYLPFEESNL--MALYKKIFKADFK--SPPWFSTSAKKLISRILDPNPV 257
           S G++LY L+ G  PF E +   M +Y  I K + K   P +   +AK LI ++L  NP 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236

Query: 258 TRITM-----AEVIENEWF 271
            R+        ++ +++WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  217 bits (554), Expect = 2e-68
 Identities = 102/253 (40%), Positives = 150/253 (59%), Gaps = 6/253 (2%)

Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
            S  ++  +E+G TLG GSF +V+ A++  TGE  AIK L K ++LK K +  + +E S 
Sbjct: 12  TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71

Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           +  + HP ++ M      + ++Y +LEFV GGELF  +   GR   D A+ Y  +L+ A 
Sbjct: 72  LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +Y HS+ + +RDLKPENLLLD  G +KV+DFG +   ++V D     T CGTP Y+APEV
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDR--TFTLCGTPEYLAPEV 186

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I +KG+  A  D W+ GV+LY  +AGY PF +     +Y+KI     K P WF   A+ L
Sbjct: 187 IQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL 245

Query: 248 ISRILDPNPVTRI 260
           +  +L  +   R+
Sbjct: 246 VKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  206 bits (527), Expect = 3e-65
 Identities = 87/259 (33%), Positives = 141/259 (54%), Gaps = 12/259 (4%)

Query: 25  GSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA 84
           G++ +V  A+   TG+  AIK++ K  +++   + Q+  E   +   + P V+++Y    
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 85  SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPEN 144
            K  +Y+V+E++ GG+L   + + G L ED AR Y  +++ A++Y HS G+ HRDLKP+N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 145 LLLDANGVLKVSDFGLSALPQQVRDDGLL------HTTCGTPNYVAPEVINNKGYDGAKA 198
           +L+D+NG LK++DFGLS +    R   L           GTP+Y+APEVI  +G+     
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS--AKKLISRILDPNP 256
           D WS G ILY  + G  PF       +++ I     + P     S  A  LIS++L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242

Query: 257 VTRITMA---EVIENEWFK 272
             R+      E+  + +FK
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  194 bits (495), Expect = 3e-60
 Identities = 91/280 (32%), Positives = 154/280 (55%), Gaps = 22/280 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
            E  +T+G G+F +V   R+  +    A+K++   +V++ K    +  E   +K + HP 
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +IR++     +  +Y+++E+V GGELF  + + GR        Y  +++ A++Y HS+ +
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPEN+LLD  G +K++DFG +   +++RD     T CGTP Y+APEVI +KG++ 
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           A  D W+ G+++Y ++ GY PF + N   +Y+KI     + P      AK LI ++L  +
Sbjct: 178 A-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236

Query: 256 PVTRI-TM----AEVIENEWFKKGYKPPSFEQPNIDLDDV 290
              R+  M     +V  + WFK            +D DDV
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKS-----------VDWDDV 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  191 bits (488), Expect = 1e-59
 Identities = 92/261 (35%), Positives = 146/261 (55%), Gaps = 13/261 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E+   +G+G F +V  AR+  TG+ VAIK++  E   K + I     EI  +K  +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---NEIQILKKCKHP 57

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSR 133
           N+++ Y     K +++IV+EF +GG L D + S  + L E +     ++L+  ++Y HS 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ HRD+K  N+LL ++G +K+ DFGLSA   Q+ D    +T  GTP ++APEVIN K Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 194 DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLIS 249
           D  KAD+WS G I  + +A G  P+ E   M    KI        ++P  +S   K  + 
Sbjct: 175 DY-KADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 250 RILDPNPVTRITMAEVIENEW 270
           + L  NP  R T  +++++ +
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  191 bits (484), Expect = 1e-57
 Identities = 100/350 (28%), Positives = 166/350 (47%), Gaps = 27/350 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y + R LGEGSF +V  AR+ +    VA+K+L K+   K K + +  REI  +  + HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 75  -NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYC 130
            N++++Y+    +  +Y+V+E+V GG L D +   GR   L E EA     Q+++A++Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 131 HSRGVCHRDLKPENLLLDANG-VLKVSDFGLSAL----PQQVRDDGLLHTTCGTPNYVAP 185
           HS+G+ HRD+KPEN+LLD +G V+K+ DFGL+ L            L  T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 186 EVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFE----ESNLMALYKKIFKADFKS--- 236
           EV+   +  Y  + +D+WS G+ LY L+ G  PFE     S      K I +    S   
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 237 ------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDV 290
                 P   S +A  L+ ++L  +P  R++ +  + ++         S     +  DD 
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 291 DSIFNESMDSRNLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSKW 340
             +      S   ++       ++   +   +   + +            
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHN 347

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  174 bits (444), Expect = 8e-53
 Identities = 88/270 (32%), Positives = 143/270 (52%), Gaps = 21/270 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +++ G  +G G+F KV  A N +TGE +A+K +  +     K I +I  E+  ++L++HP
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHP 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA--RKYFQQLINAVDYCHS 132
           N+++ Y V   + K+YI +E+ +GG L + +   GR+  DE   R Y  QL+  + Y HS
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHS 117

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNYVAPEVI-- 188
            G+ HRD+KP N+ LD NGV+K+ DFG +             + +  GTP Y+APEVI  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 189 -NNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPWFSTSA-- 244
              KG+  A AD+WS G ++  +  G  P+ E  N   +   +F       P    S   
Sbjct: 178 GKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQI---MFHVGAGHKPPIPDSLQL 233

Query: 245 ----KKLISRILDPNPVTRITMAEVIENEW 270
               K  + R L+ +P  R T +E++++ +
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  171 bits (436), Expect = 8e-52
 Identities = 72/261 (27%), Positives = 146/261 (55%), Gaps = 9/261 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +EL R +G+G+F KV   +  +T +  A+K ++K+K ++   +  +  E   ++ + HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ ++     +  +Y+V++ + GG+L   ++ + +  E++ + +  +++ A++Y HS+G+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KP+N+LLD  G + ++DF ++    +V  D L  +T GTP Y+APEV+  +GY  
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177

Query: 196 AKADLWSCGVILYVLMAGYLPFE--ESNLMALYKKIFK-ADFKSPPWFSTSAKKLISRIL 252
              D WS GV  Y  + G  P+      +    +   + AD   P  +ST A   I+++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237

Query: 253 DPNPVTRI--TMAEVIENEWF 271
           + +P  R+   + ++  + +F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  171 bits (436), Expect = 1e-51
 Identities = 85/256 (33%), Positives = 134/256 (52%), Gaps = 15/256 (5%)

Query: 25  GSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNVIRMYEVM 83
           G+F  V  A+   TG+  AIK+L K  ++    +  +K E + M +    P V ++Y   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 84  ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPE 143
            SK  +Y+V+E++ GG+    I + G L ED A++Y  +++  V+  H RG+ HRD+KPE
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 144 NLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSC 203
           NLL+D  G LK++DFGLS    + +         GTP+Y+APE I   G D   +D WS 
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKM-SDWWSL 179

Query: 204 GVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSAKKLISRILDPNPVTR 259
           G +++  + GY PF      A++  I       P     + S  A  LI+R+L  +P  R
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Query: 260 I---TMAEVIENEWFK 272
           +      E+  + +FK
Sbjct: 240 LGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  170 bits (434), Expect = 3e-51
 Identities = 86/266 (32%), Positives = 144/266 (54%), Gaps = 16/266 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            YE+  T+G+GSF  V+  R    G+ +  K +D   + + +   Q+  E++ ++ ++HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ-QLVSEVNILRELKHP 59

Query: 75  NVIRMY--EVMASKTKIYIVLEFVTGGELFDKI----ASRGRLKEDEARKYFQQLINAVD 128
           N++R Y   +  S   +YIV+E+  GG+L   I      R  ++E+   +   QL+ A+ 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 129 YCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
            CH+R      V HRDLKP N+ LDAN  +K+ DFGL+ +     D     T  GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177

Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFST 242
           +PE +N+  YD  K+D+WS G ++Y L A   PF   N + L  KI +  F+  P  +S+
Sbjct: 178 SPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236

Query: 243 SAKKLISRILDPNPVTRITMAEVIEN 268
              ++I  +L+ +P  R +  E+++ 
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  170 bits (433), Expect = 3e-51
 Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 11/261 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y+LG  +G G+F  V    N ETG+ VAIK +  EK+ +  +   I +EI  +K ++HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHP 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+++    + +   +YI+LE+   G L   I   G   E     Y  Q++  + Y H +G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-GTPNYVAPEVINNKGY 193
           V HRD+K  N+L   +GV+K++DFG++    ++ D      +  GTP ++APEVI   G 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW---FSTSAKKLISR 250
               +D+WS G  +  L+ G  P+ + N MA   +I + D   PP     S   K  + +
Sbjct: 177 S-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPPLPEGISPELKDFLMQ 233

Query: 251 ILDPNPVTRITMAEVIENEWF 271
               +P  R T  +++++ W 
Sbjct: 234 CFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  169 bits (430), Expect = 3e-50
 Identities = 92/294 (31%), Positives = 156/294 (53%), Gaps = 24/294 (8%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIR 78
           + LG+GSF KV  A    T E  A+K+L K+ +L+   +     E   + L  +HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +K +++ V+E+V GG+L   I   GR  E  AR Y  +++  + + H RG+ +R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLD+ G +K++DFG+    + +       T CGTP+Y+APE+++ + Y G   
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W+ GV+LY ++AG  PFE  +   L++ I + + + P W S  AK ++   L  NP  
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237

Query: 259 RI-----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDVDSIF 294
           R+        ++  + +F+         K  KPP   +P I    D+ + D  F
Sbjct: 238 RLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPF--KPKIKGRFDVSNFDDEF 289

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 4e-50
 Identities = 89/290 (30%), Positives = 148/290 (51%), Gaps = 34/290 (11%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   R+ +TG+  A+K+L K  ++K   I  ++ E   +     P 
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++++Y     +  +Y+V+E++ GG+L + +  +    E+ AR Y  +L+ A+D  H  G 
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA---------------LPQQVRDDGLLH------ 174
            HRD+KP+N+L+DA+G +K++DFGL                      RD+ L+       
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 175 ------TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
                 +T GTP+Y+APEV+    Y   + D WS GVILY ++ G+ PF    L   Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 229 I--FKADFKSPP--WFSTSAKKLISRILDPNPVTRITMAE-VIENEWFKK 273
           I  +K   + PP    S  A  LI R+L   P  R+   E +  + +FK 
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  168 bits (428), Expect = 7e-50
 Identities = 84/241 (34%), Positives = 133/241 (55%), Gaps = 3/241 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   TG+  A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+ Y HS  V +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           LK ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ +  Y G   D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +P  R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 260 I 260
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  166 bits (422), Expect = 5e-49
 Identities = 88/241 (36%), Positives = 135/241 (56%), Gaps = 3/241 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   +G+  A+KIL KE ++    +     E   +K  RHP +  +
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +K ++  V+E+V GGELF  ++      ED  R Y  ++++A+DY HS  + +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           LK ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ +  Y G   D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   D K P   S  AK L+S +L  +P  R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237

Query: 260 I 260
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  165 bits (418), Expect = 2e-48
 Identities = 87/257 (33%), Positives = 141/257 (54%), Gaps = 8/257 (3%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y HSR V +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           +K ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ +  Y G   D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +P  R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 260 I-----TMAEVIENEWF 271
           +        EV+E+ +F
Sbjct: 238 LGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  165 bits (418), Expect = 2e-48
 Identities = 83/242 (34%), Positives = 133/242 (54%), Gaps = 4/242 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIR 78
           R LG+GSF KV  AR  E+G   A+K+L K+ +L+   +     E   + L R HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           +Y    +  +++ V+EFV GG+L   I    R  E  AR Y  ++ +A+ + H +G+ +R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLD  G  K++DFG+    + + +     T CGTP+Y+APE++    Y G   
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W+ GV+LY ++ G+ PFE  N   L++ I   +   P W S  A  ++   +  NP  
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237

Query: 259 RI 260
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 3e-48
 Identities = 87/286 (30%), Positives = 145/286 (50%), Gaps = 29/286 (10%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+G + +V  A+  +TGE VA+K + K  + K   +  +  E   +   +   ++++  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +Y+ +E+V GG+    + + G L ED AR Y  ++  AVD  H  G  HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLL---HTTCGTPNYVAPEVINNKGYDGAKA 198
           PEN L+DA+G +K++DFGLS         G++   ++  G+P+Y+APEV+  KGYD    
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPW------FSTSAKKLISR 250
           D WS G +LY  + G+ PF  S     ++ +  +K   + P +       S  A  LI++
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239

Query: 251 ILDPNPVTRITMAEVIENEWFKKG--------YKPPSFEQPNIDLD 288
           +++ +P  R    E I+N  F K          KPP   +   ++D
Sbjct: 240 LIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELESEID 284

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  163 bits (415), Expect = 6e-48
 Identities = 94/295 (31%), Positives = 148/295 (50%), Gaps = 23/295 (7%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIR 78
           + +G+GSF KV  A++   G+  A+K+L K+ +LK K    I  E + + K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +  K+Y VL++V GGELF  +       E  AR Y  ++ +A+ Y HS  + +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLKPEN+LLD+ G + ++DFGL    + +       T CGTP Y+APEV+  + YD    
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W  G +LY ++ G  PF   +   +Y  I     +  P  S SA+ L+  +L  +   
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237

Query: 259 RI----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDVDSIFNE 296
           R+       E+  + +F          K   PP    PN+    DL   D  F E
Sbjct: 238 RLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPF--NPNVSGPMDLKHFDPEFTE 290

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 1e-47
 Identities = 93/309 (30%), Positives = 142/309 (45%), Gaps = 80/309 (25%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIK----REISTMK 69
           YE    LGEG++  V  AR+ +TGE VA+K   LD E+       G I     REIS +K
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE------G-IPSTALREISLLK 53

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGE-----LFDKIASRGRLKEDEARKYFQQLI 124
            ++HPN++++ +V+ ++ K+Y+V E+    +       DK    G L  +  +    QL+
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKR--PGPLSPNLIKSIMYQLL 108

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN--- 181
             + YCHS  + HRDLKP+N+L++ +GVLK++DFGL+                G P    
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTY 155

Query: 182 --------YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAG------------------Y 214
                   Y APE++  +K Y  A  D+WS G I   ++ G                   
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214

Query: 215 L--PFEES--NLMAL--YKKIFKADFKSPPWFST------SAKKLISRILDPNPVTRITM 262
           L  P EES   +  L  YK  F   F                  L+S++L  NP  RI+ 
Sbjct: 215 LGTPTEESWPGVTKLPDYKPTFPK-FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273

Query: 263 AEVIENEWF 271
            E +++ +F
Sbjct: 274 KEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  162 bits (410), Expect = 2e-47
 Identities = 98/304 (32%), Positives = 153/304 (50%), Gaps = 26/304 (8%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF KV   R  +T    A+K + K  ++    +     E + +  +  P ++ +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
              S  K+Y+VL F+ GGELF  +   GR     AR Y  +L+ A++  H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
           PEN+LLD  G + + DFGL  L   ++DD   +T CGTP Y+APE++   GY  A  D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177

Query: 202 SCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRIT 261
           + GV+LY ++ G  PF + N+  +Y+KI +   + P  F   AK L+  +L  +P  R+ 
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237

Query: 262 M--AEVIENEWF----------KKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERRE 309
              A+ I+N  F           KG +PP   +P +           ++D+ N   E   
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPPF--KPAVS---------SAIDTSNFDEEFTR 286

Query: 310 EGPV 313
           E P+
Sbjct: 287 EKPI 290

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  159 bits (405), Expect = 4e-47
 Identities = 89/268 (33%), Positives = 141/268 (52%), Gaps = 21/268 (7%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR-----EIST 67
           +G +++ + +G+G F+ V  A     G  VA+K     KV   +M+    R     EI  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDL 55

Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL---FDKIASRGRL-KEDEARKYFQQL 123
           +K + HPNVI+         ++ IVLE    G+L         + RL  E    KYF QL
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
            +A+++ HS+ + HRD+KP N+ + A GV+K+ D GL             H+  GTP Y+
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYM 173

Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKADFKSPP--W 239
           +PE I+  GY+  K+D+WS G +LY + A   PF  ++ NL +L KKI K D+   P   
Sbjct: 174 SPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADH 232

Query: 240 FSTSAKKLISRILDPNPVTRITMAEVIE 267
           +S   + L+SR ++P+P  R  ++ V++
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  161 bits (409), Expect = 5e-47
 Identities = 98/321 (30%), Positives = 171/321 (53%), Gaps = 28/321 (8%)

Query: 20  RTLGEGSFAKVKFARN---TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + LG+GSF KV   R     + G+  A+K+L K+  LK +   + K E   +  + HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           ++++    ++ K+Y++L+F+ GG+LF +++      E++ + Y  +L  A+D+ HS G+ 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           +RDLKPEN+LLD  G +K++DFGLS   + +  +   ++ CGT  Y+APEV+N +G+  +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNP 256
            AD WS GV+++ ++ G LPF+  +       I KA    P + S  A+ L+  +   NP
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237

Query: 257 VTRITM----AEVIE----------NEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
             R+       E I+          N+ +++  KPP   +P +   D    F+    SR 
Sbjct: 238 ANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPF--KPAVGRPDDTFYFDPEFTSRT 295

Query: 303 LVVERREEGPVAPLTMNAFEL 323
                 ++ P  P + NA +L
Sbjct: 296 -----PKDSPGIPPSANAHQL 311

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  161 bits (409), Expect = 5e-47
 Identities = 82/245 (33%), Positives = 141/245 (57%), Gaps = 7/245 (2%)

Query: 20  RTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKH-KMIGQIKREISTMKLIRHPN 75
           + LG+G + KV   R     +TG+  A+K+L K  ++++ K     K E + ++ ++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ +     +  K+Y++LE+++GGELF  +   G   ED A  Y  ++  A+++ H +G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPEN+LLDA G +K++DFGL    + + +  + HT CGT  Y+APE++   G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
              D WS G ++Y ++ G  PF   N      KI K     PP+ +  A+ L+ ++L  N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238

Query: 256 PVTRI 260
           P +R+
Sbjct: 239 PSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  160 bits (406), Expect = 6e-47
 Identities = 88/275 (32%), Positives = 151/275 (54%), Gaps = 21/275 (7%)

Query: 16  YELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLI 71
           +EL R LG G++ KV   R     + G+  A+K+L K  ++ K K     + E   ++ +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 72  RH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           R  P ++ ++    + TK++++L++V GGELF  +  R    E E R Y  +++ A+D+ 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL---PQQVRDDGLLHTTCGTPNYVAPEV 187
           H  G+ +RD+K EN+LLD+ G + ++DFGLS      ++ R     ++ CGT  Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEV 177

Query: 188 INNK--GYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFS 241
           I     G+D A  D WS GV+ + L+ G  PF    E+++   + ++I K+    P   S
Sbjct: 178 IRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236

Query: 242 TSAKKLISRILDPNPVTRITM--AEVIENEWFKKG 274
             A+  I ++L+ +P  R+    A+ I+N  F +G
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 1e-46
 Identities = 76/261 (29%), Positives = 137/261 (52%), Gaps = 6/261 (2%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH--KMIGQIKREISTMKLIRH 73
           +  G+ LG+G+F +V    + +TG  +A+K +  +       K +  ++ EI  +K ++H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
             +++ Y  +     + I +E++ GG + D++ + G L E   RKY +Q++  V+Y HS 
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKG 192
            + HRD+K  N+L D+ G +K+ DFG S   Q +   G  + +  GTP +++PEVI+ +G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK--ADFKSPPWFSTSAKKLISR 250
           Y G KAD+WS G  +  ++    P+ E   MA   KI     + + P   S  A+  + R
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Query: 251 ILDPNPVTRITMAEVIENEWF 271
               N   R +  E++ + + 
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  160 bits (405), Expect = 3e-46
 Identities = 99/305 (32%), Positives = 149/305 (48%), Gaps = 33/305 (10%)

Query: 20  RTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           RTLG GSF +V  A    E    VAIK  +K K++K K +  +  E   +  I HP  + 
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           +Y     ++ +Y+VLEFV GGE F  +    R   D    Y  Q++   +Y  S  + +R
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLKPENLLLD +G +K++DFG + +      D   +T CGTP Y+APE++ N G+ G  A
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKAA 209

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W+ G+ +Y ++ G  PF  +  + +Y+KI +     P +   + K L+ ++L  +   
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTK 269

Query: 259 RI-----TMAEVIENEWFKK-------------GYKP--------PSFEQPNIDLDDVDS 292
           R          V E+ WF                YKP         +FE+   DL   D 
Sbjct: 270 RYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQEDLTIADK 329

Query: 293 IFNES 297
           I NE+
Sbjct: 330 ITNEN 334

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  159 bits (403), Expect = 4e-46
 Identities = 93/307 (30%), Positives = 160/307 (52%), Gaps = 20/307 (6%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   +   TG   A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHR 138
                +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+DY HS + V +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK ENL+LD +G +K++DFGL    + ++D   + T CGTP Y+APEV+ +  Y G   
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L+S +L  +P  
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237

Query: 259 RI-----TMAEVIENEWF---------KKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLV 304
           R+        E++++++F         +K   PP   +P +  +     F+E   ++ + 
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPF--KPQVTSETDTRYFDEEFTAQMIT 295

Query: 305 VERREEG 311
           +   ++ 
Sbjct: 296 ITPPDQD 302

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  155 bits (393), Expect = 2e-45
 Identities = 82/257 (31%), Positives = 133/257 (51%), Gaps = 7/257 (2%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKLIR 72
           ++  G  LG GSF  V    N + G+  A+K   L  +     + + Q+++EI+ +  ++
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN+++       +  +YI LE V GG L   +   G   E   R Y +Q++  ++Y H 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R   HRD+K  N+L+D NGV+K++DFG++   +QV +     +  G+P ++APEVI  +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTSAKKLISR 250
             G  AD+WS G  +  +  G  P+ +   +A   KI   K     P   S  AK  I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 251 ILDPNPVTRITMAEVIE 267
            L  +P  R T AE++E
Sbjct: 238 CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  155 bits (393), Expect = 6e-45
 Identities = 83/273 (30%), Positives = 142/273 (52%), Gaps = 17/273 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y+    +GEG+  +V  A +  TG+ VAIK   K ++ K      I  EI  MK  +HP
Sbjct: 20  LYKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQNKEL-IINEILIMKDCKHP 75

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSR 133
           N++  Y+      ++++V+E++ GG L D I  +  R+ E +     ++++  ++Y HS+
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSAL---PQQVRDDGLLHTTCGTPNYVAPEVINN 190
            V HRD+K +N+LL  +G +K++DFG +A     +  R     ++  GTP ++APEVI  
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-----NSVVGTPYWMAPEVIKR 190

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFKA--DFKSPPWFSTSAKKL 247
           K Y   K D+WS G++   +  G  P   E  L AL+    K     K+P  +S   K  
Sbjct: 191 KDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSF 280
           +++ L  +P  R +  E++++ + KK      F
Sbjct: 250 LNKCLVKDPEKRPSAEELLQHPFLKKACPKEEF 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 7e-45
 Identities = 92/301 (30%), Positives = 144/301 (47%), Gaps = 59/301 (19%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIG---QIKREISTMKL 70
           YE    +GEG++ +V  ARN +TGE VA+K   ++ EK       G      REI  ++ 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE------GFPITAIREIKLLQK 54

Query: 71  IRHPNVIRMYEVMASKTK--IYIVLEFV----TGGELFDKIASRGRLK--EDEARKYFQQ 122
           +RHPN++R+ E++ SK K  IY+V E++    TG      +     +K  E + + Y +Q
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQ 108

Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           L+  + Y HS G+ HRD+K  N+L++ +GVLK++DFGL A P   R+         T  Y
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWY 167

Query: 183 VAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--------- 232
             PE++     Y     D+WS G IL  L  G   F+ S  +   +KIF+          
Sbjct: 168 RPPELLLGATRYGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226

Query: 233 -DFKSPPWF---------------------STSAKKLISRILDPNPVTRITMAEVIENEW 270
                 PWF                       SA  L+ ++L  +P  RI+  + +++E+
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Query: 271 F 271
           F
Sbjct: 287 F 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  155 bits (393), Expect = 9e-45
 Identities = 87/268 (32%), Positives = 140/268 (52%), Gaps = 4/268 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIR 78
           + LG+GSF KV  A    T E  AIK L K+ VL+   +     E   + L   HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +K  ++ V+E++ GG+L   I S GR  E  AR Y  ++I  + + H +G+ +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLD +G +K++DFG+    + +  +G   T CGTP+Y+APE++  + Y+    
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D WS GV+LY ++ G  PF   +   L+  I       P W S  AK  +S++ + +P  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237

Query: 259 RITMAEVIENEWFKKGYKPPSFEQPNID 286
           R+ +   I    F +G      E+  I 
Sbjct: 238 RLGVDGDIRQHPFFRGIDWERLEKREIP 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  155 bits (392), Expect = 1e-44
 Identities = 93/302 (30%), Positives = 152/302 (50%), Gaps = 23/302 (7%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIR 78
           + +G+GSF KV  A+    G   A+K+L K+ +LK K    I  E + + K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +  K+Y VL++V GGELF  +       E  AR Y  ++ +A+ Y HS  + +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLKPEN+LLD+ G + ++DFGL    + V  +    T CGTP Y+APEV+  + YD    
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W  G +LY ++ G  PF   ++  +Y  I     + P   + +A  L+  +L  +   
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237

Query: 259 RI-TMAEVIE------------NEWFKKGYKPPSFEQPNI----DLDDVDSIFNESMDSR 301
           R+   A+ +E            ++ + K   PP    PN+    DL   D  F +   S 
Sbjct: 238 RLGAKADFLEIKNHVFFSPINWDDLYHKRITPPY--NPNVAGPADLRHFDPEFTQEAVSS 295

Query: 302 NL 303
           ++
Sbjct: 296 SV 297

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  155 bits (392), Expect = 1e-44
 Identities = 82/242 (33%), Positives = 130/242 (53%), Gaps = 4/242 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIR 78
           + LG+GSF KV  A    T E  AIK+L K+ +L+   +     E   + L   HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +K +++ V+E+V GG+L  +I    +  E  +R Y  ++  A+ + H  GV +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLDA G  K++DFG+    + + +     T CGTP+Y+APE++    Y G   
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W+ GV++Y +MAG  PFE  N   L++ I   D   P W S  A  ++   +  NP  
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237

Query: 259 RI 260
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  153 bits (388), Expect = 2e-44
 Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 15/268 (5%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YEL   +G G+ A V  A      E VAIK +D EK      + ++++E+  M    HPN
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPN 60

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS---RGRLKEDEARKYFQQLINAVDYCHS 132
           V++ Y       ++++V+ +++GG L D + S   RG L E       ++++  ++Y HS
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD--GLLHTTCGTPNYVAPEVINN 190
            G  HRD+K  N+LL  +G +K++DFG+SA      D    +  T  GTP ++APEV+  
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 191 K-GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW------FSTS 243
             GYD  KAD+WS G+    L  G  P+ +   M +     + D  S         +S S
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWF 271
            +K+IS  L  +P  R T  E++++++F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  154 bits (391), Expect = 2e-44
 Identities = 95/294 (32%), Positives = 151/294 (51%), Gaps = 21/294 (7%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIR 78
           + +G+GSF KV  A+    G+  A+K+L K+ VL  K    I  E + + K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +  K+Y VL+FV GGELF  +       E  AR Y  ++ +A+ Y HS  + +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLKPEN+LLD+ G + ++DFGL        D     T CGTP Y+APEVI  + YD    
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYDNT-V 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W  G +LY ++ G  PF   ++  +Y  I        P  S +A  ++  +L+ +   
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237

Query: 259 RI----TMAEVIENEWFK--------KGYKPPSFEQPNI----DLDDVDSIFNE 296
           R+       E+ E+ +F+        +   PP F  PN+    D+ + D++F E
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPF-NPNVEGPDDISNFDAVFTE 290

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  152 bits (387), Expect = 6e-44
 Identities = 97/314 (30%), Positives = 146/314 (46%), Gaps = 64/314 (20%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-I-LDKEKVLKHKMIGQIKREISTMKLIR 72
           +YE G+ LGEG++A V  AR+ ETG  VAIK I L + K  K  +     REI  ++ ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTG---GELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           HPN+I + +V   K+ I +V EF+       + DK      L   + + Y    +  ++Y
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEY 117

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN-------- 181
            HS  + HRDLKP NLL+ ++GVLK++DFGL+              + G+PN        
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVV 164

Query: 182 ---YVAPEVINNKGYDGAKADLWSCGVILYVLMAG--YLPFEESNLMALYKKIFKA---- 232
              Y APE++    + G   D+WS G I   L+    +LP  +S++  L  KIF+A    
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTP 222

Query: 233 ------DFKSPPWF------------------STSAKKLISRILDPNPVTRITMAEVIEN 268
                    S P +                  S  A  L+ R+L  NP  RIT  + +E+
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Query: 269 EWFKKGYKPPSFEQ 282
            +F     P    Q
Sbjct: 283 PYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  152 bits (386), Expect = 9e-44
 Identities = 82/242 (33%), Positives = 134/242 (55%), Gaps = 4/242 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIR 78
           + +G+GSF KV  AR+    +  A+K+L K+ +LK K    I  E + + K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    +  K+Y VL+++ GGELF  +       E  AR Y  ++ +A+ Y HS  + +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLKPEN+LLD+ G + ++DFGL    + +  +G   T CGTP Y+APEV++ + YD    
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D W  G +LY ++ G  PF   N   +Y  I     +  P  + SA+ L+  +L  +   
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237

Query: 259 RI 260
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  150 bits (382), Expect = 1e-43
 Identities = 82/268 (30%), Positives = 135/268 (50%), Gaps = 21/268 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIK---ILDKEKVLKHKMIGQIKREISTMKLIRH 73
           E  + LG+GS   V   R+  TG+  A+K   +   E+  K     Q+ RE+ T++    
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS- 132
           P V++ Y     + +I IVLE++ GG L D +   G++ E       +Q++  +DY H+ 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R + HRD+KP NLL+++ G +K++DFG+S + +   D    +T  GT  Y++PE I  + 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGE- 175

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIFKADFKSPPW----FSTSAK 245
                AD+WS G+ L     G  PF    + +   L + I   D   P      FS   +
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI--CDGPPPSLPAEEFSPEFR 233

Query: 246 KLISRILDPNPVTRITMAEVIENEWFKK 273
             IS  L  +P  R + AE++++ + KK
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 2e-42
 Identities = 86/277 (31%), Positives = 137/277 (49%), Gaps = 41/277 (14%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E  + +G G+F +V+  +  +TG   A+K L K ++L+ + +  ++ E   +    +P 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           V+++Y     +  +Y+++E++ GG++   +  +    E+E R Y  + I A+D  H  G 
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLS-----------------ALPQQVRDD-------- 170
            HRD+KP+NLLLDA G +K+SDFGL                  ALP    D         
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 171 -----------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
                       L ++T GTP+Y+APEV    GY   + D WS GVI+Y ++ GY PF  
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 220 SNLMALYKKI--FKADFKSPP--WFSTSAKKLISRIL 252
            N    Y+KI  +K   + P     S  AK LI R+ 
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  147 bits (372), Expect = 3e-42
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 11/256 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++ + LG+GS+  V   +     +  A+K +D   + + +    +  EI  +  + HPN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK----EDEARKYFQQLINAVDYCH 131
           +I   E      K+ IV+E+   G+L   I+ R + +    E E  + F QL+  +   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + + HRDLK  N+LL AN ++K+ D G+S + ++     +  T  GTP+Y+APEV   +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISR 250
            Y   K+D+WS G +LY +     PFE  ++  L  K+ +  +   PP +S   +  I  
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235

Query: 251 ILDPNPVTRITMAEVI 266
           +L   P  R    +++
Sbjct: 236 MLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  147 bits (373), Expect = 6e-42
 Identities = 90/285 (31%), Positives = 148/285 (51%), Gaps = 38/285 (13%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI--KREISTMKLIRH 73
           +E  + +  G++  V   R+ ET +  A+K ++K+ ++    I Q+  +R+I T     +
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--EN 60

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           P V+ M+    +K  + +V+E+V GG+    + + G L  D AR YF + + A++Y H+ 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT----------------- 176
           G+ HRDLKP+NLL+ + G +K++DFGLS +       GL+  T                 
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLD 173

Query: 177 ---CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD 233
              CGTP Y+APEVI  +GY G   D W+ G+ILY  + G +PF       L+ ++   D
Sbjct: 174 KQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232

Query: 234 FKSPPW---FSTSAKKLISRILDPNPVTRI---TMAEVIENEWFK 272
            + P         A+ LISR+L  NP+ R+      EV ++ +F 
Sbjct: 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 1e-41
 Identities = 89/307 (28%), Positives = 151/307 (49%), Gaps = 43/307 (14%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G   +V   R   TG+  A+K+LDK++++K   + ++  E   +  + HP +  +
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 80  YEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           Y    ++T + +V+++  GGELF   +      L E+ AR Y  +++ A++Y H  G+ +
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 138 RDLKPENLLLDANGVLKVSDFGLSAL----PQQVRDDGL-----------LHTT------ 176
           RDLKPEN+LL  +G + +SDF LS      P  V                   T      
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186

Query: 177 ------CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF 230
                  GT  Y+APEVI+  G+  A  D W+ G++LY ++ G  PF+ SN    +  I 
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245

Query: 231 KADFKSP--PWFSTSAKKLISRILDPNPVTRI----TMAEVIENEWFK-------KGYKP 277
           K +   P  P  S+SA+ LI ++L  +P  R+      AE+ ++ +F+       +   P
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTP 305

Query: 278 PSFEQPN 284
           P   +P+
Sbjct: 306 PIIPRPD 312

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  147 bits (373), Expect = 1e-41
 Identities = 86/274 (31%), Positives = 151/274 (55%), Gaps = 18/274 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEK-VLKHKMIGQIKREISTMKLI 71
           +EL + LG G++ KV   R     +TG+  A+K+L K   V K K +   + E + ++ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 72  RH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           R  P ++ ++    ++ K++++L++V+GGE+F  +  R    EDE R Y  ++I A+++ 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVI 188
           H  G+ +RD+K EN+LLD+ G + ++DFGLS   L ++       ++ CGT  Y+APE+I
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSA 244
             KG  G   D WS G++++ L+ G  PF    E +    + ++I K D   P +    A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 245 KKLISRILDPNPVTRITM----AEVIENEWFKKG 274
           + L+ ++L  +P  R+      A  I+   F KG
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  147 bits (372), Expect = 2e-41
 Identities = 88/306 (28%), Positives = 160/306 (52%), Gaps = 34/306 (11%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIR 78
           R +G GS+AKV      +T    A+K++ KE V   + I  ++ E    +    HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    ++++++ V+EFV+GG+L   +  + +L E+ AR Y  ++  A+++ H RG+ +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLDA G +K++D+G+    + +R      T CGTPNY+APE++  + Y G   
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177

Query: 199 DLWSCGVILYVLMAGYLPF---------EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           D W+ GV+++ +MAG  PF         +++    L++ I +   + P   S  A  ++ 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237

Query: 250 RILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDV 290
             L+ +P  R+         ++  + +F+         K   PP   +PNI    DLD+ 
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPY--KPNIESDRDLDNF 295

Query: 291 DSIFNE 296
           D  F +
Sbjct: 296 DPQFTD 301

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  144 bits (365), Expect = 2e-41
 Identities = 84/256 (32%), Positives = 138/256 (53%), Gaps = 9/256 (3%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KYE  R +G G+F  V   R     + V IK +  E++ K + +   + E   +KL+ HP
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHP 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHS 132
           N+I  YE       + IV+E+  GG L + I  R    L ED    +F Q++ A+ + H+
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 133 RGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + + HRDLK +N+LLD +  V+K+ DFG+S   + +      +T  GTP Y++PE+   K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGIS---KILSSKSKAYTVVGTPCYISPELCEGK 176

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISR 250
            Y+  K+D+W+ G +LY L +    FE +NL AL  KI    F      +S   ++LI  
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235

Query: 251 ILDPNPVTRITMAEVI 266
           +L+ +P  R  +++++
Sbjct: 236 MLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  145 bits (368), Expect = 2e-41
 Identities = 85/292 (29%), Positives = 136/292 (46%), Gaps = 42/292 (14%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK----REISTMKL 70
           +Y++   +GEG+   V  A++ ETGE VA+K     KV   ++ G I     REI  ++ 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALK-----KVALRRLEGGIPNQALREIKALQA 55

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDY 129
            +HP V+++ +V    +   +V+E++    L + +    R L E + + Y + L+  V Y
Sbjct: 56  CQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            H+ G+ HRDLKP NLL+ A+GVLK++DFGL A      +  L      T  Y APE++ 
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGL-ARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMAL----------------------- 225
                    DLW+ G I   L+ G   F  E+++  L                       
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233

Query: 226 YKKIFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
           Y KI   + K  P        S  A  L+  +L  +P  R++ AE + + +F
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 3e-41
 Identities = 86/281 (30%), Positives = 142/281 (50%), Gaps = 17/281 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            + L   +G+GSF +V  A +  T + VAIK++D E+      I  I++EI  +   R P
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            + + Y      +K++I++E+  GG   D +   G+L E       ++++  ++Y H  G
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL-LHTTCGTPNYVAPEVINNKGY 193
             HRD+K  N+LL   G +K++DFG+S    Q+       +T  GTP ++APEVI   GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-----WFSTSAKKLI 248
           D  KAD+WS G+    L  G  P  + + M +   I K    +PP      FS   K  +
Sbjct: 176 DE-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---NNPPSLEGNKFSKPFKDFV 231

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDD 289
           S  L+ +P  R +  E++++++ KK  K  S+    I+   
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKK-AKKTSYLTLLIERIK 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  144 bits (364), Expect = 4e-41
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 12/259 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREISTMKLIRH 73
           +YE+ + +GEGSF K+  A+     E+  IK +D  K+ +K K     K+E+  +  ++H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKH 58

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRL-KEDEARKYFQQLINAVDYCH 131
           PN++  +       +++IV+E+  GG+L  +I   RG L  ED+   +F Q+   + + H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 132 SRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHTTC-GTPNYVAPEVIN 189
            R + HRD+K +N+ L  NG V K+ DFG++   +Q+ D   L  TC GTP Y++PE+  
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLI 248
           N+ Y+  K D+WS G +LY L     PFE +NL  L  KI +  F    P FS   + LI
Sbjct: 176 NRPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234

Query: 249 SRILDPNPVTRITMAEVIE 267
           S++   +P  R ++  +++
Sbjct: 235 SQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  143 bits (363), Expect = 7e-41
 Identities = 80/251 (31%), Positives = 127/251 (50%), Gaps = 18/251 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++   LGEGS+  V  A + ETG+ VAIK++  E+ L+     +I +EIS +K    P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRG 134
           +++ Y      T ++IV+E+   G + D +    + L E+E      Q +  ++Y HS  
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
             HRD+K  N+LL+  G  K++DFG+S   Q        +T  GTP ++APEVI   GY+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK------KLI 248
             KAD+WS G+    +  G  P+ + + M   + IF    K PP  S   K        +
Sbjct: 178 -NKADIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPPPTLSDPEKWSPEFNDFV 233

Query: 249 SRILDPNPVTR 259
            + L  +P  R
Sbjct: 234 KKCLVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  143 bits (362), Expect = 8e-41
 Identities = 78/256 (30%), Positives = 141/256 (55%), Gaps = 7/256 (2%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY   + +GEGSF K    ++ E G+   IK ++  K +  K   + ++E++ +  ++HP
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRL-KEDEARKYFQQLINAVDYCHS 132
           N+++  E       +YIV+++  GG+L+ KI A RG L  ED+   +F Q+  A+ + H 
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R + HRD+K +N+ L  +G +K+ DFG++ +     +  L  T  GTP Y++PE+  N+ 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISRI 251
           Y+  K+D+W+ G +LY +      FE  N+  L  KI +  +      +S   + L+S++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236

Query: 252 LDPNPVTRITMAEVIE 267
              NP  R ++  ++E
Sbjct: 237 FKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  145 bits (366), Expect = 1e-40
 Identities = 90/300 (30%), Positives = 157/300 (52%), Gaps = 23/300 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI--KREISTMKLIRH-PNVIR 78
           +G+G+F +V   R  +T    A+K+L K++++  K +     +R I    L+   P ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           +     + + +Y+V ++++GGELF  +   GR  ED A+ Y  +L+ A+++ H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV-INNKGYDGAK 197
           DLKPEN+LLDA G + + DFGLS     + D+   +T CGT  Y+APEV ++ KGY    
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177

Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-WFSTSAKKLISRILDPNP 256
            D WS GV+++ +  G+ PF   +   +Y+ I     + P    S   ++ +  +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237

Query: 257 VTRI----TMAEVIENEWF---------KKGYKPPSFEQPNIDLDDVDSIFNESMDSRNL 303
             R+       E+ E+ +F         KK   PP   +P +D D+  S F+    + +L
Sbjct: 238 QHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPF--KPIVDSDEDVSNFDPEFTNSSL 295

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 2e-40
 Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 10/204 (4%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIK---ILDKEKVLKHKMIGQIKREISTMKL 70
            KYE+   +GEG++  V   RN  TGE VAIK     + ++ +K        RE+  ++ 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQ 56

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +RH N++ + E    K ++Y+V E+V    L    AS G L  D  R Y  QL+ A+ YC
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS  + HRD+KPEN+L+  +GVLK+ DFG + AL  +      L     T  Y APE++ 
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELLV 174

Query: 190 NKGYDGAKADLWSCGVILYVLMAG 213
                G   D+W+ G I+  L+ G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  142 bits (359), Expect = 4e-40
 Identities = 80/268 (29%), Positives = 143/268 (53%), Gaps = 18/268 (6%)

Query: 19  GRTLGEGSFAKVKFARNTETGENVAIK-------ILDKEKVLKHKMIGQIKREISTMKLI 71
           G  +G+G++ +V  A N  TGE +A+K       I  +    +  M+  ++ EI T+K +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            H N+++      ++  + I LE+V GG +   + + GR +E   R + +Q++  + Y H
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN- 190
           S+G+ HRDLK +NLL+DA+G+ K+SDFG+S     + D+    +  G+  ++APEVI++ 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 191 -KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW-------FST 242
            +GY  AK D+WS G ++  + AG  P+ +   +A   K+      +PP         S 
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNLSP 243

Query: 243 SAKKLISRILDPNPVTRITMAEVIENEW 270
            A   ++     NP  R T  E++++ +
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 8e-40
 Identities = 88/261 (33%), Positives = 139/261 (53%), Gaps = 19/261 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LG+G+F KV  A++ ETG   A KI+    E+ L+  M+     EI  +   +HPN++ +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKHPNIVGL 67

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHR 138
           YE    + K++I++EF  GG L   +    R L E + R   +Q++ A+++ HS  V HR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN-----NKGY 193
           DLK  N+LL  +G +K++DFG+SA  +         T  GTP ++APEV+      +  Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISR 250
           D  KAD+WS G+ L  L     P  E N M +  KI K++      P  +S+S    +  
Sbjct: 186 D-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244

Query: 251 ILDPNPVTRITMAEVIENEWF 271
            L  +P  R T AE++++ + 
Sbjct: 245 CLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  141 bits (357), Expect = 8e-40
 Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 15/267 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A +  TG  VA+K +D  K  + +++     E+  M+  +HPN++ MY 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQHPNIVEMYS 83

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+ + H++GV HRD+K
Sbjct: 84  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
            +++LL ++G +K+SDFG  A   QV  +     +  GTP ++APEVI+   Y G + D+
Sbjct: 143 SDSILLTSDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDI 198

Query: 201 WSCGVILYVLMAGYLP-FEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILDPNP 256
           WS G+++  ++ G  P F E  L A+ K+I        K+    S   +  + R+L  +P
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257

Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQP 283
             R T AE++ + +  K   PPS   P
Sbjct: 258 AQRATAAELLNHPFLAKA-GPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  141 bits (357), Expect = 9e-40
 Identities = 83/258 (32%), Positives = 153/258 (59%), Gaps = 17/258 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLI 71
           +EL + LG G++ KV   R     ++G+  A+K+L K  ++ K K     + E   ++ I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 72  RH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           R  P ++ ++    + TK++++L+++ GGELF  ++ R R KE E + Y  +++ A+++ 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL--LHTTCGTPNYVAPEVI 188
           H  G+ +RD+K EN+LLD+NG + ++DFGLS   ++  +D +   ++ CGT  Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 189 --NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFST 242
              + G+D A  D WS GV++Y L+ G  PF    E+++   + ++I K++   P   S 
Sbjct: 179 RGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237

Query: 243 SAKKLISRILDPNPVTRI 260
            AK +I R+L  +P  R+
Sbjct: 238 LAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  140 bits (354), Expect = 1e-39
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 21/263 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD----KEKVLKHKMIGQIKREISTMKLI 71
           Y   R LG+G+F +    R TE    V  K ++     EK  +  +      EI  + L+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLL 56

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDY 129
           +HPN+I  Y        + I +E+  GG L+DKI  +     +E+    Y  Q+++AV Y
Sbjct: 57  QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-GTPNYVAPEVI 188
            H  G+ HRD+K  N+ L   G++K+ DFG+S   + +  +  +  T  GTP Y++PE+ 
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSPELC 173

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---ADFKSPPWFSTSAK 245
               Y+  K+D+W+ G +LY L+     F+ +N + L  KI +       S   +S+   
Sbjct: 174 QGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV--YSSELI 230

Query: 246 KLISRILDPNPVTRITMAEVIEN 268
            L+  +L  +P  R T  EV++ 
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  141 bits (358), Expect = 2e-39
 Identities = 78/240 (32%), Positives = 130/240 (54%), Gaps = 4/240 (1%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-VIRMY 80
           LG+GSF KV  A    T E  AIKIL K+ +++   +     E   + L   P  + +++
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
               +  ++Y V+E+V GG+L   I   G+ KE  A  Y  ++   + + HS+G+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           K +N++LDA G +K++DFG+    + +       T CGTP+Y+APE+I  + Y G   D 
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           W+ GV+LY ++AG  PF+  +   L++ I + +   P   S  A  +   +L  +P  R+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  139 bits (352), Expect = 8e-39
 Identities = 80/240 (33%), Positives = 133/240 (55%), Gaps = 4/240 (1%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMY 80
           LG+GSF KV  A    T E  AIKIL K+ V++   +     E   + L  + P + +++
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
               +  ++Y V+E+V GG+L  +I   GR KE  A  Y  ++   + + HS+G+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           K +N++LD+ G +K++DFG+    + + D     T CGTP+Y+APE+I  + Y G   D 
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           W+ GV+LY ++AG  PFE  +   L++ I + +   P   S  A  +   ++  +P  R+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 2e-38
 Identities = 72/201 (35%), Positives = 105/201 (52%), Gaps = 9/201 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           Y+    +GEG++  V  AR+  TGE VAIK I  + +           REI  +K + HP
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL--REIKLLKELNHP 58

Query: 75  NVIRMYEVMASKTKIYIVLEFV-TGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           N+I++ +V   K  +Y+V EF+ T      K   RG L E   + Y  QL+  + +CHS 
Sbjct: 59  NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH 117

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKG 192
           G+ HRDLKPENLL++  GVLK++DFGL+   +        +T    T  Y APE++    
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLA---RSFGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 193 YDGAKADLWSCGVILYVLMAG 213
                 D+WS G I   L++ 
Sbjct: 175 GYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  136 bits (345), Expect = 3e-38
 Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 11/258 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+   +G+GSF  V            A+K +D  K +  +   +   E   +  +    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSR 133
           +IR YE    K K+ IV+E+   G+L   +   RGR L ED+  ++F Q++  + + HS+
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + HRD+K  NL LDA   +K+ D G++ L            +T  GTP Y++PE+  +K
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN----FANTIVGTPYYLSPELCEDK 176

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISR 250
            Y+  K+D+W+ GV+LY    G  PF+ +N  AL  KI +  F      +S    +LI +
Sbjct: 177 PYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235

Query: 251 ILDPNPVTRITMAEVIEN 268
            L  +   R    +++ N
Sbjct: 236 CLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  138 bits (348), Expect = 3e-38
 Identities = 78/240 (32%), Positives = 132/240 (55%), Gaps = 4/240 (1%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMY 80
           LG+GSF KV  A    T E  AIKIL K+ V++   +     E   + L  + P + +++
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
               +  ++Y V+E+V GG+L   I   G+ KE +A  Y  ++   + + H RG+ +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           K +N++LD+ G +K++DFG+    + + D     T CGTP+Y+APE+I  + Y G   D 
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           W+ GV+LY ++AG  PF+  +   L++ I + +   P   S  A  +   ++  +P  R+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  137 bits (346), Expect = 7e-38
 Identities = 88/304 (28%), Positives = 160/304 (52%), Gaps = 34/304 (11%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIR 78
           R +G GS+AKV   R  +T    A+K++ KE V   + I  ++ E     +   HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    ++++++ V+E+V GG+L   +  + +L E+ AR Y  ++  A++Y H RG+ +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLD+ G +K++D+G+    + +R      T CGTPNY+APE++  + Y G   
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177

Query: 199 DLWSCGVILYVLMAGYLPF---------EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           D W+ GV+++ +MAG  PF         +++    L++ I +   + P   S  A  ++ 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237

Query: 250 RILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSFEQPNID----LDDV 290
             L+ +P  R+        A++  + +F+         K   PP   +PNI     LD+ 
Sbjct: 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPF--KPNISGEFGLDNF 295

Query: 291 DSIF 294
           D+ F
Sbjct: 296 DAQF 299

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  137 bits (346), Expect = 8e-38
 Identities = 87/301 (28%), Positives = 147/301 (48%), Gaps = 27/301 (8%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++   +G G F +V+  R   TG+  A+K++ K  +L  + +   + E   + +   P 
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSR 133
           + ++      K  +Y+V+E+  GG+L   + +R   +  ED A+ Y  +L+ A+   H  
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI--- 188
           G  HRD+KPEN+L+D  G +K++DFG +A   ++  + ++++    GTP+Y+APEV+   
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 189 --NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSP--PWFST 242
             + KG  G + D WS GVI Y ++ G  PF E      Y  I  F+   K P  P  S+
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238

Query: 243 SAKKLISRILDPNPVTRITMAEVIEN-------EWFKKGYKPPSFEQPNIDLDDVDSIFN 295
               LI  +L      R+   E +         +W       P F  P +  DD  S F+
Sbjct: 239 DFLDLIQSLL-CGQKERLGY-EGLCCHPFFSKIDWNNIRNSLPPF-VPTLKSDDDTSNFD 295

Query: 296 E 296
           E
Sbjct: 296 E 296

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (340), Expect = 1e-37
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 17/261 (6%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            LG+ LGEG+F +V   +      +    VA+K L ++   +     +  RE   M+ + 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE--EFLREARIMRKLD 59

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           HPNV+++  V   +  +YIV+E++ GG+L   +  +R +L   +   +  Q+   ++Y  
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT-P-NYVAPEVIN 189
           S+   HRDL   N L+  N V+K+SDFGLS   + + DD       G  P  ++APE + 
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 190 NKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK--K 246
              +  +K+D+WS GV+L+ +   G  P+   +   + + + K  ++ P   +   +   
Sbjct: 177 EGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-KNGYRLPQPPNCPPELYD 234

Query: 247 LISRILDPNPVTRITMAEVIE 267
           L+ +    +P  R T +E++E
Sbjct: 235 LMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (340), Expect = 2e-37
 Identities = 69/262 (26%), Positives = 125/262 (47%), Gaps = 18/262 (6%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            LG+ LGEG+F +V               VA+K L ++   +     +  RE   M+ + 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE--EFLREARIMRKLD 59

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGEL--FDKIASRGRLKEDEARKYFQQLINAVDYC 130
           HPN++++  V   +  + IV+E++ GG+L  + +      L   +   +  Q+   ++Y 
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT-P-NYVAPEVI 188
            S+   HRDL   N L+  N V+K+SDFGLS   + + DD       G  P  ++APE +
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 189 NNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK-- 245
               +  +K+D+WS GV+L+ +   G  P+   +   + + + K      P  +   +  
Sbjct: 177 KEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP-PNCPPELY 234

Query: 246 KLISRILDPNPVTRITMAEVIE 267
           KL+ +    +P  R T +E++E
Sbjct: 235 KLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  136 bits (343), Expect = 2e-37
 Identities = 77/242 (31%), Positives = 127/242 (52%), Gaps = 4/242 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIR 78
           + LG+GSF KV  A    T +  AIK L K+ VL    +     E   + L   HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           +Y    +K  ++ V+E++ GG+L   I S  +     A  Y  ++I  + + HS+G+ +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLD +G +K++DFG+    + +  D    T CGTP+Y+APE++  + Y     
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D WS GV+LY ++ G  PF   +   L++ I   +   P W +  AK ++ ++    P  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237

Query: 259 RI 260
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  137 bits (346), Expect = 2e-37
 Identities = 78/259 (30%), Positives = 135/259 (52%), Gaps = 13/259 (5%)

Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
             R +   +++ + +G G+F +V+  R+  + +  A+K+L K +++K         E   
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           M       +++++        +Y+V+E++ GG+L + + S   + E  AR Y  +++ A+
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLAL 155

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAP 185
           D  HS G  HRD+KP+N+LLD +G LK++DFG      ++  +G++   T  GTP+Y++P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISP 212

Query: 186 EVINNKGYD---GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF----KADFKSPP 238
           EV+ ++G D   G + D WS GV LY ++ G  PF   +L+  Y KI        F    
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272

Query: 239 WFSTSAKKLISRILDPNPV 257
             S  AK LI   L    V
Sbjct: 273 EISKQAKDLICAFLTDREV 291

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  134 bits (339), Expect = 2e-37
 Identities = 83/255 (32%), Positives = 134/255 (52%), Gaps = 11/255 (4%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  + + + +G G F++V  A     G  VA+K +    ++  K      +EI  +K + 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI----ASRGRLKEDEARKYFQQLINAVD 128
           HPNVI+ Y       ++ IVLE    G+L   I      +  + E    KYF QL +A++
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + HSR V HRD+KP N+ + A GV+K+ D GL             H+  GTP Y++PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKADFKSPP--WFSTSA 244
           +  GY+  K+D+WS G +LY + A   PF  ++ NL +L KKI + D+   P   +S   
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237

Query: 245 KKLISRILDPNPVTR 259
           ++L++  ++P+P  R
Sbjct: 238 RQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  136 bits (344), Expect = 3e-37
 Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 38/272 (13%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E  + +G G+F +V+  +  +TG   A+KIL K  +L+ + +  I+ E   +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           V++M+     K  +Y+++EF+ GG++   +  +  L E+  + Y  + + A+D  H  G 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGL-SALPQQVRDD------------------------ 170
            HRD+KP+NLLLDA G +K+SDFGL + L +  R +                        
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 171 --------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL 222
                    L ++T GTP+Y+APEV    GY+    D WS GVI+Y ++ GY PF     
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 223 MALYKKI--FKADFKSPPW--FSTSAKKLISR 250
              Y+K+  +K     PP    S  AK LI R
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  136 bits (344), Expect = 3e-37
 Identities = 86/272 (31%), Positives = 135/272 (49%), Gaps = 38/272 (13%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E  + +G G+F +V+  +  +TG   A+KIL K  +L+ + +G I+ E   +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           V++M+     K  +Y+++EF+ GG++   +  +  L E+E + Y  + + A+D  H  G 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGL-SALPQQVRDD------------------------ 170
            HRD+KP+NLLLD+ G +K+SDFGL + L +  R +                        
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 171 --------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL 222
                    L  +T GTP+Y+APEV    GY+    D WS GVI+Y ++ GY PF     
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 223 MALYKKI--FKADFKSPPW--FSTSAKKLISR 250
              YKK+  +K     PP    S  AK LI R
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  135 bits (341), Expect = 3e-37
 Identities = 81/268 (30%), Positives = 138/268 (51%), Gaps = 4/268 (1%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIR 78
           + LG+GSF KV  A     GE  A+K L K+ VL    +     E   + L   +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           +Y    +K  ++ V+EF+ GG+L   I  +GR     A  Y  +++  + + HS+G+ +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N++LD +G +K++DFG+    + V  D    T CGTP+Y+APE++    Y  +  
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           D WS GV+LY ++ G  PF   +   L++ I       P W +  +K ++ ++ + +P  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237

Query: 259 RITMAEVIENEWFKKGYKPPSFEQPNID 286
           R+ +   I    F K     + E+  +D
Sbjct: 238 RLGVVGNIRGHPFFKTINWTALEKRELD 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  136 bits (343), Expect = 5e-37
 Identities = 87/274 (31%), Positives = 144/274 (52%), Gaps = 15/274 (5%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   YE+ + +G G+F +V+  R+  T +  A+K+L K +++K         E   M 
Sbjct: 39  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
               P V++++        +Y+V+E++ GG+L + + S   + E  AR Y  +++ A+D 
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDA 157

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAPEV 187
            HS G  HRD+KP+N+LLD +G LK++DFG      ++  +G++   T  GTP+Y++PEV
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEV 214

Query: 188 INNK---GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWF 240
           + ++   GY G + D WS GV LY ++ G  PF   +L+  Y KI        F      
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 274

Query: 241 STSAKKLISRILDPNPVT--RITMAEVIENEWFK 272
           S  AK LI   L    V   R  + E+  + +FK
Sbjct: 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  136 bits (344), Expect = 5e-37
 Identities = 70/239 (29%), Positives = 110/239 (46%), Gaps = 42/239 (17%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +T+G G+F +V   R  +T    A+K L K  VL       +K E   +    +  V+++
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           Y     K  +Y V++++ GG++   +   G  +ED AR Y  +L  A++  H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 140 LKPENLLLDANGVLKVSDFGLSA-----------------------LPQQVRDDG----- 171
           +KP+N+L+D +G +K++DFGL                           ++  +       
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 172 -------------LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
                        L H+  GTPNY+APEV+   GY     D WS GVILY ++ G  PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  132 bits (333), Expect = 1e-36
 Identities = 78/263 (29%), Positives = 135/263 (51%), Gaps = 11/263 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LKHKMIGQIKREISTMKLIR 72
           +Y L + LG+GSF  V   ++ +      +K+L +  V  L      Q  +E   +  + 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLINAVD 128
           HP +++ +     +    I+ E+  G +L  K+     +   L E++  ++F QL+  V 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y H R + HRDLK +N+ L  N +LK+ DFG+S L     D  L  T  GTP Y++PE +
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKL 247
            ++GYD +K+D+WS G ILY +      FE  N +++  +I +    S P  +S     +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236

Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           +  +L+ +P  R + AE++ N +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  133 bits (336), Expect = 2e-36
 Identities = 73/249 (29%), Positives = 140/249 (56%), Gaps = 11/249 (4%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIR 78
           R +G GS+AKV   R  +  +  A+K++ KE V   + I  ++ E    +    +P ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    + +++++V+E+V GG+L   +  + +L E+ AR Y  ++  A+++ H RG+ +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLK +N+LLDA+G +K++D+G+    + +       T CGTPNY+APE++  + Y G   
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177

Query: 199 DLWSCGVILYVLMAGYLPF-------EESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
           D W+ GV+++ +MAG  PF       + +    L++ I +   + P + S  A  ++   
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237

Query: 252 LDPNPVTRI 260
           L+ +P  R+
Sbjct: 238 LNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  133 bits (336), Expect = 2e-36
 Identities = 77/251 (30%), Positives = 120/251 (47%), Gaps = 17/251 (6%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI---KREISTMKLIRHPNVIR 78
           LG G F KV  A   +TGE  AIK L K  ++    +  +   KR   T    RHP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++    ++  +  V+E+  GG+L   I       E  A  Y   ++  + Y H   + +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH-----TTCGTPNYVAPEVINNKGY 193
           DLK +NLLLD  G +K++DFGL         +G+       T CGTP ++APEV+    Y
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
             A  D W  GV++Y ++ G  PF   +   ++  I   + + P + S  A  ++ R+L 
Sbjct: 179 TRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237

Query: 254 PNPVTRITMAE 264
            NP  R+   E
Sbjct: 238 RNPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  131 bits (331), Expect = 3e-36
 Identities = 71/262 (27%), Positives = 125/262 (47%), Gaps = 18/262 (6%)

Query: 17  ELGRTLGEGSFAKVK----FARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           ELG+ LGEG+F +V           T   VA+K L +      +   +   E S MK + 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS--EEEREEFLEEASIMKKLS 59

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           HPN++R+  V      +YIV E++ GG+L D +     +L   +  +   Q+   ++Y  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVI 188
           S+   HRDL   N L+  N V+K+SDFGLS   + + +D       G      ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS---RDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF--KSPPWFSTSAK 245
            +  +  +K+D+WS GV+L+ +   G  P+   +   + + + +  +    P        
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELY 234

Query: 246 KLISRILDPNPVTRITMAEVIE 267
           +L+ +    +P  R T +E++E
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVE 256

Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  131 bits (330), Expect = 4e-36
 Identities = 82/255 (32%), Positives = 135/255 (52%), Gaps = 11/255 (4%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  +++ + +G G F++V  A      + VA+K +   +++  K      +EI  +K + 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI----ASRGRLKEDEARKYFQQLINAVD 128
           HPNVI+  +      ++ IVLE    G+L   I      +  + E    KYF QL +AV+
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + HSR V HRD+KP N+ + A GV+K+ D GL             H+  GTP Y++PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKADFKSPP--WFSTSA 244
           +  GY+  K+D+WS G +LY + A   PF  ++ NL +L +KI + D+   P   +S   
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237

Query: 245 KKLISRILDPNPVTR 259
           ++L+S  + P+P  R
Sbjct: 238 RELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  132 bits (335), Expect = 4e-36
 Identities = 91/326 (27%), Positives = 144/326 (44%), Gaps = 61/326 (18%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +YEL + +G G++  V  A +  TG  VAIK +    V    +  + I REI  ++ +RH
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 74  PNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
            N+I + +++   +      +YIV E +   +L   I S   L +D  + +  Q++  + 
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS--ALPQQVRDDGLLHTTCGTPNYV--- 183
           Y HS  V HRDLKP N+L+++N  LK+ DFGL+    P +     L         YV   
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTR 170

Query: 184 ---APEVI-NNKGYDGAKADLWSCGVILYVLMAG--------YL------------PFEE 219
              APE++ ++  Y  A  D+WS G I   L+          Y+            P EE
Sbjct: 171 WYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229

Query: 220 -----SNLMAL-YKKIFKADFKSP-----PWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
                ++  A  Y K      K P     P  S  A  L+ ++L  +P  RIT  E + +
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289

Query: 269 EWFKKGYKP---PSFEQPNIDLDDVD 291
            +  + + P   P  + P  D D  D
Sbjct: 290 PYLAQLHDPEDEPVAKPP-FDFDFFD 314

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  133 bits (335), Expect = 8e-36
 Identities = 82/268 (30%), Positives = 145/268 (54%), Gaps = 15/268 (5%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y++ + +G G+F +V+  R+  + +  A+K+L K +++K         E   M     P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           V++++        +Y+V+E++ GG+L + + S   + E  A+ Y  +++ A+D  HS G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAPEVINNK-- 191
            HRD+KP+N+LLD +G LK++DFG      ++ + G++   T  GTP+Y++PEV+ ++  
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 192 -GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF----KADFKSPPWFSTSAKK 246
            GY G + D WS GV L+ ++ G  PF   +L+  Y KI       +F      S  AK 
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280

Query: 247 LISRILDPNPVT--RITMAEVIENEWFK 272
           LI   L    V   R  + E+ ++ +FK
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 1e-35
 Identities = 80/229 (34%), Positives = 125/229 (54%), Gaps = 14/229 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            YEL + +G G++  V  AR+  TGE VAIK++   K+        I++EIS +K  RHP
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSR 133
           N++  +     + K++IV+E+  GG L D    +RG L E +     ++ +  + Y H  
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-- 191
           G  HRD+K  N+LL  +G +K++DFG+SA  Q         +  GTP ++APEV   +  
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 192 -GYDGAKADLWSCGVILYVLMAGYLP--FEESNLMALYKKIFKADFKSP 237
            GYDG K D+W+ G I  + +A   P  F+   + AL+  I K++F  P
Sbjct: 179 GGYDG-KCDIWALG-ITAIELAELQPPMFDLHPMRALF-LISKSNFPPP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-35
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--------REI-S 66
           Y++ + LG+G+F  V  ARN ETGE VAIK          KM  +          RE+ S
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIK----------KMKKKFYSWEECMNLREVKS 50

Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLI 124
             KL  HPN++++ EV     ++Y V E++ G  L+  +  R      E   R    Q++
Sbjct: 51  LRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
             + + H  G  HRDLKPENLL+    V+K++DFGL+   +++R          T  Y A
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA---REIRSRPPYTDYVSTRWYRA 166

Query: 185 PEVINNKGYDGAKADLWSCGVI---LYVL 210
           PE++       +  D+W+ G I   LY L
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTL 195

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 1e-35
 Identities = 90/288 (31%), Positives = 137/288 (47%), Gaps = 49/288 (17%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKIL----DKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           +GEG++  V  AR+  TGE VA+K +    + E V    +     REIS +K + HPN++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----REISLLKELNHPNIV 61

Query: 78  RMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           R+ +V+ S+ K+Y+V EF+     +  D     G L     + Y  QL+  + YCHS  V
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
            HRDLKP+NLL+D  G LK++DFGL+ A    VR     H    T  Y APE++      
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQY 177

Query: 195 GAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKA----------------DFKS 236
               D+WS G I +  M    P    +S +  L+ +IF+                 D+K 
Sbjct: 178 STPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDYKP 235

Query: 237 --PPWFSTSAKK-----------LISRILDPNPVTRITMAEVIENEWF 271
             P W      K           L+S++L  +P  RI+    +++ +F
Sbjct: 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  129 bits (326), Expect = 2e-35
 Identities = 82/266 (30%), Positives = 140/266 (52%), Gaps = 20/266 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGEN-VAIK-------ILDKEKVLKHKMIGQIKREIST 67
           Y +   LG G+F  V   R    G+N +A+K          K+K  + K IG I  E++ 
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 68  MK-LIRHPNVIRMYEVMASKTKIYIVLEFVTG---GELFDKIASRG-RLKEDEARKYFQQ 122
           +K  +RHPN++R Y+      ++YIV++ + G   GE F+ +  +  R  E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 123 LINAVDYCH-SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           ++ A+ Y H  + + HRDL P N++L  +  + ++DFGL+   +Q + +  L +  GT  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTSVVGTIL 178

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--W 239
           Y  PE++ N+ Y G KAD+W+ G ILY +     PF  +N+++L  KI +A ++  P   
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 240 FSTSAKKLISRILDPNPVTRITMAEV 265
           +S     +I+  L P+   R  + +V
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 2e-35
 Identities = 71/219 (32%), Positives = 122/219 (55%), Gaps = 6/219 (2%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKIL--DKEKVLKHKMIGQIKREISTMKLIRH 73
           + LG+ LG G+F +V    + +TG  +A+K +  D +     K +  ++ EI  +K +RH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 74  PNVIRMYEVMASKT--KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
             +++ Y  +      K+ I +E++ GG + D++ + G L E+  R+Y +Q++  V Y H
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL-LHTTCGTPNYVAPEVINN 190
           S  + HRD+K  N+L D+ G +K+ DFG S   Q +   G  + +  GTP +++PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI 229
           +GY G KAD+WS    +  ++    P+ E   MA   KI
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  129 bits (326), Expect = 3e-35
 Identities = 88/293 (30%), Positives = 143/293 (48%), Gaps = 44/293 (15%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKI-LDKEKVLKHKMIGQIK-REISTMKLIR 72
           KYE    +GEGS+  V   ++ ETG+ VAIK  L+ E     KM+ +I  REI  +K +R
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H N++ + EV   K ++Y+V EFV    L D       L E   RKY  Q++  +++CHS
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
             + HRD+KPEN+L+  +GV+K+ DFG +   A P +V  D +      T  Y APE++ 
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173

Query: 190 NKGYDGAKADLWSCGVILYVLMAG--YLPFEES------------NLMALYKKIFK---- 231
                G   D+W+ G ++  ++ G    P +              NL+  +++IF+    
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 232 ------ADFKSP-------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
                  + K         P  S     L  + L  +P  R + ++++ +E+F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  129 bits (326), Expect = 3e-35
 Identities = 86/287 (29%), Positives = 134/287 (46%), Gaps = 47/287 (16%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LGEG++A V   RN  TGE VA+K   LD E+      I    REIS MK ++H N++R+
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI----REISLMKELKHENIVRL 63

Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           ++V+ ++ K+ +V E++     +  D    RG L  +  + +  QL+  + +CH   V H
Sbjct: 64  HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123

Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG----TPNYVAPEVINNKGY 193
           RDLKP+NLL++  G LK++DFGL+      R  G+   T      T  Y AP+V+     
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---------------------- 231
                D+WS G I+  ++ G   F  +N      KIF+                      
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237

Query: 232 ------ADFKS-PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
                  D +   P        L+ R+L  NP  RI+  + +++ WF
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  128 bits (324), Expect = 3e-35
 Identities = 78/244 (31%), Positives = 130/244 (53%), Gaps = 8/244 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKIL--DKEKVLKHKMIGQIKREISTMKLIRH 73
           + LG+ LG+G+F +V    + +TG  +A+K +  D E     K +  ++ EI  +K + H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 74  PNVIRMYEVM--ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
             +++ Y  +    +  + I +E + GG + D++ S G L E+  RKY +Q++  V Y H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL-LHTTCGTPNYVAPEVINN 190
           S  + HRD+K  N+L D+ G +K+ DFG S   Q +   G  + +  GTP +++PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK--ADFKSPPWFSTSAKKLI 248
           +GY G KAD+WS G  +  ++    P+ E   MA   KI     +   PP  S   +  +
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242

Query: 249 SRIL 252
            RI 
Sbjct: 243 KRIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 4e-35
 Identities = 92/278 (33%), Positives = 140/278 (50%), Gaps = 28/278 (10%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLI 71
            G +EL   +GEG++ KV  AR+ +TG+ VAIKI+D    +      +IK E + + K  
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60

Query: 72  RHPNVIRMYEVMASKT------KIYIVLEFVTGG---ELFDKIASRG-RLKEDEARKYFQ 121
            HPN+   Y     K       ++++V+E   GG   +L   +  +G RLKE+      +
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           + +  + Y H   V HRD+K +N+LL  N  +K+ DFG+SA  Q     G  +T  GTP 
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178

Query: 182 YVAPEVINNK-----GYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD-- 233
           ++APEVI         YD A++D+WS G+    L  G  P  + + M AL+ KI +    
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPP 236

Query: 234 -FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEW 270
             KSP  +S      IS  L  N   R  M E++E+ +
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  128 bits (322), Expect = 6e-35
 Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 24/265 (9%)

Query: 19  GRTLGEGSFAKVKFARNTETGENVAIK------ILDKEKVLKHKMIGQIKREISTMKLIR 72
           G  +G GSF  V    N  +GE +A+K      +    K  K  M+  + REI+ +K ++
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H N+++          + I LE+V GG +   + + G  +E   R + +Q++  ++Y H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-------GTPNYVAP 185
           RG+ HRD+K  N+L+D  G +K+SDFG+S   +++  + L   T        G+  ++AP
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGIS---KKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF----S 241
           EV+    Y   KAD+WS G ++  ++ G  PF +   +   + IFK    + P      S
Sbjct: 182 EVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGENASPEIPSNIS 237

Query: 242 TSAKKLISRILDPNPVTRITMAEVI 266
           + A   + +  + +   R T AE++
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 1e-34
 Identities = 78/274 (28%), Positives = 138/274 (50%), Gaps = 21/274 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH- 73
           + EL   +G G++  V   ++  TG  VA+KI++ +       +  I+RE++ +  +R  
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQS 59

Query: 74  --PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
             PN+ + Y       +++I++E+  GG +   +   G + E       ++++ A+ Y H
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI-NN 190
             GV HRD+K  N+L+   G +K+ DFG++AL  Q        T  GTP ++APEVI   
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEG 176

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-----WFSTSAK 245
           K YD  KAD+WS G+ +Y +  G  P+ + +       I K     PP      +S   +
Sbjct: 177 KYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SKPPRLEDNGYSKLLR 232

Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           + ++  LD  P  R++  E+++++W K   K P 
Sbjct: 233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  126 bits (318), Expect = 4e-34
 Identities = 87/273 (31%), Positives = 143/273 (52%), Gaps = 27/273 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ETG   A K+++   E+ L+  M+     EI  +    H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNH 68

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIA---SRGRLKEDEARKYFQQLINAVDYC 130
           P ++++        K++I++EF  GG + D I     RG L E + +   +Q++ A+ Y 
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYL 126

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVI 188
           HS  + HRDLK  N+LL  +G +K++DFG+SA  +    R D  +    GTP ++APEV+
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVV 182

Query: 189 -----NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWF 240
                 +  YD  KAD+WS G+ L  +     P  E N M +  KI K++      P  +
Sbjct: 183 MCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW 241

Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
           S   +  +   LD +P TR + A+++E+ +   
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  127 bits (321), Expect = 1e-33
 Identities = 79/243 (32%), Positives = 114/243 (46%), Gaps = 46/243 (18%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +TLG G+F +V  AR  +T    A+K L K+ VL    +  +K E   +    +  V+R+
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           Y     K  +Y V++++ GG++   +   G   ED AR Y  +L  AV+  H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 140 LKPENLLLDANGVLKVSDFGL---------SALPQ---QVRDDG---------------- 171
           +KP+N+L+D +G +K++DFGL         S   Q    VR D                 
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 172 -----------------LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY 214
                            L H+  GTPNY+APEV+   GY     D WS GVILY ++ G 
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245

Query: 215 LPF 217
            PF
Sbjct: 246 PPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  125 bits (315), Expect = 1e-33
 Identities = 83/255 (32%), Positives = 142/255 (55%), Gaps = 20/255 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  AR   +G  VA+K++D  K  + +++     E+  M+  +H NV+ MY+
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++++EF+ GG L D I S+ RL E++     + ++ A+ Y HS+GV HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  +D     +  GTP ++APEVI+   Y G + D+W
Sbjct: 145 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201

Query: 202 SCGVILYVLMAGYLP-FEESNLMALYKKIFKADFKSPPWFSTSAKKL-------ISRILD 253
           S G+++  ++ G  P F +S + A+     K    SPP    +A K+       + R+L 
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 254 PNPVTRITMAEVIEN 268
             P  R T  E++++
Sbjct: 257 REPQERATAQELLDH 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  124 bits (312), Expect = 1e-33
 Identities = 70/216 (32%), Positives = 121/216 (56%), Gaps = 6/216 (2%)

Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKIL--DKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           G+ LG+G+F +V    + +TG  +A K +  D E     K +  ++ EI  +K ++H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 77  IRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++ Y  +  + +  + I +E++ GG + D++ + G L E   RKY +Q++  + Y HS  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL-LHTTCGTPNYVAPEVINNKGY 193
           + HRD+K  N+L D+ G +K+ DFG S   Q +   G  + +  GTP +++PEVI+ +GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI 229
            G KAD+WS G  +  ++    P+ E   MA   KI
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  125 bits (316), Expect = 2e-33
 Identities = 76/249 (30%), Positives = 136/249 (54%), Gaps = 15/249 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +     +  A+KIL+K ++LK       + E   +    +  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++     +  +Y+V+++  GG+L   ++    RL ED AR Y  +++ A+D  H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI---- 188
             HRD+KP+N+L+D NG ++++DFG S L  ++ +DG + ++   GTP+Y++PE++    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF--KADFKSPPW---FSTS 243
           + KG  G + D WS GV +Y ++ G  PF   +L+  Y KI   K  F+ P      S  
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239

Query: 244 AKKLISRIL 252
           AK LI R++
Sbjct: 240 AKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  123 bits (309), Expect = 3e-33
 Identities = 79/254 (31%), Positives = 129/254 (50%), Gaps = 20/254 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y + R +GEGSF +    ++  + +  A+K +   K      +   ++E   +  ++HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRL-KEDEARKYFQQLINAVDYCHS 132
           N++   E   +   +YIV+E+  GG+L  KI   RG+L  ED   ++F Q+   V + H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH------TTCGTPNYVAPE 186
           + V HRD+K +N+ L  NG +K+ DFG + L        L        T  GTP YV PE
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSPGAYACTYVGTPYYVPPE 170

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAK 245
           +  N  Y+  K+D+WS G ILY L     PF+ ++   L  K+ +  +K  P  +S   +
Sbjct: 171 IWENMPYNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229

Query: 246 KLISRILDPNPVTR 259
            LI ++   NP +R
Sbjct: 230 SLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  122 bits (308), Expect = 1e-32
 Identities = 84/284 (29%), Positives = 136/284 (47%), Gaps = 41/284 (14%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 64

Query: 80  YEVMASKTKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            +V+ ++ K+Y+V EF+    + F   +    +     + Y  QL+  + +CHS  V HR
Sbjct: 65  LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124

Query: 139 DLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           DLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y    
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTA 181

Query: 198 ADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFKA----------------DFKS--PP 238
            D+WS G I   ++     F  +S +  L+ +IF+                 D+K   P 
Sbjct: 182 VDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240

Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
           W                + L+S++L  +P  RI+    + + +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  121 bits (307), Expect = 1e-32
 Identities = 67/266 (25%), Positives = 124/266 (46%), Gaps = 25/266 (9%)

Query: 20  RTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + LGEG+F +V   +          VA+K L ++   + +      +E   MK + HPNV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERK--DFLKEARVMKKLGHPNV 58

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLI-------NAV 127
           +R+  V   +  +Y+VLE++ GG+L D +     +     +     + L+         +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---A 184
           +Y  S+   HRDL   N L+  + V+K+SDFGLS   + V DD       G    +   A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS---RDVYDDDYYRKKTGGKLPIRWMA 175

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE + +  +  +K+D+WS GV+L+ +   G  P+   +   + + + +  ++   P +  
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCP 233

Query: 242 TSAKKLISRILDPNPVTRITMAEVIE 267
               +L+      +P  R T +E++E
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVE 259

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  123 bits (309), Expect = 2e-32
 Identities = 75/249 (30%), Positives = 133/249 (53%), Gaps = 15/249 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +   T    A+KIL+K ++LK       + E + +       
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++     +  +Y+V+++  GG+L   ++    RL ED AR Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI---- 188
             HRD+KP+N+LLD NG ++++DFG S L  ++  DG + ++   GTP+Y++PE++    
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWF---STS 243
           +  G  G + D WS GV +Y ++ G  PF   +L+  Y KI   +  F+ P      S  
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 244 AKKLISRIL 252
           AK LI R++
Sbjct: 240 AKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  123 bits (311), Expect = 2e-32
 Identities = 73/243 (30%), Positives = 112/243 (46%), Gaps = 46/243 (18%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +TLG G+F +V  A   +T    A+K L K+ VL    +  +K E   +    +  V+++
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           Y     K  +Y V++++ GG++   +       E  AR Y  +L  A++  H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 140 LKPENLLLDANGVLKVSDFGL----------------------SALPQQVRDD------- 170
           +KP+N+L+D +G +K++DFGL                      S  P  + DD       
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 171 ----------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY 214
                            L H+  GTPNY+APEV+  KGY     D WS GVIL+ ++ G 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245

Query: 215 LPF 217
            PF
Sbjct: 246 PPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  121 bits (305), Expect = 5e-32
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 49/288 (17%)

Query: 24  EGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM 83
           EG++  V  AR+ +TGE VA+K L  EK  +   I  + REI+ +  ++HPN++ + EV+
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVKEVV 73

Query: 84  ASKT--KIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
                 KIY+V+E+V   +L   + + +    + E +    QL++ V + H   + HRDL
Sbjct: 74  VGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDL 132

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN-----YVAPEVINNKGYDG 195
           K  NLLL+  G+LK+ DFGL+                 T       Y APE++       
Sbjct: 133 KTSNLLLNNRGILKICDFGLAREYGSPLKP-------YTQLVVTLWYRAPELLLGAKEYS 185

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---------------------DF 234
              D+WS G I   L+     F   + +    KIFK                       F
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTF 245

Query: 235 KSPPW-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
              P+            S +   L++R+L  +P  RI+  + +++ +F
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  122 bits (308), Expect = 5e-32
 Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 24/278 (8%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKIL---DKEKVLKHKMI 58
           AS +  ++   + + E    +G G+   V    +  TG   A+K++    ++ V +    
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR---- 117

Query: 59  GQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFD-KIASRGRLKEDEAR 117
            QI REI  ++ + HPNV++ +++     +I ++LEF+ GG L    IA    L  D AR
Sbjct: 118 -QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-DVAR 175

Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
               Q+++ + Y H R + HRD+KP NLL+++   +K++DFG+S +  Q  D    +++ 
Sbjct: 176 ----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSV 229

Query: 178 GTPNYVAPEVIN---NKG-YDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIF 230
           GT  Y++PE IN   N G YDG   D+WS GV +     G  PF    + +  +L   I 
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC 289

Query: 231 KADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            +   ++P   S   +  IS  L   P  R +  ++++
Sbjct: 290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  120 bits (303), Expect = 6e-32
 Identities = 89/295 (30%), Positives = 143/295 (48%), Gaps = 49/295 (16%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKIL----DKEKVLKHKMIGQIKREISTMKL 70
           KYE    +GEG++  V  A+N ET E VA+K +    D E V    +     REI  +K 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVD 128
           ++H N++R+Y+V+ S  K+ +V E+      + FD  +  G +  +  + +  QL+  + 
Sbjct: 56  LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLA 113

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CHS  V HRDLKP+NLL++ NG LK++DFGL+ A    VR          T  Y  P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDV 170

Query: 188 I-NNKGYDGAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFK-------------- 231
           +   K Y     D+WS G I   L     P F  +++    K+IF+              
Sbjct: 171 LFGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229

Query: 232 --ADFKSPPWF-------------STSAKKLISRILDPNPVTRITMAEVIENEWF 271
              D+K  P +             +++ + L+  +L  NPV RI+  E +++ +F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 7e-32
 Identities = 93/311 (29%), Positives = 158/311 (50%), Gaps = 31/311 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +   TG+  A+KIL+K ++LK       + E   +       
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++     +  +Y+V+++  GG+L   ++    RL ED AR Y  +++ A+D  H  G
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI---- 188
             HRD+KP+N+LLD NG ++++DFG S L  ++  DG + +    GTP+Y++PE++    
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPW---FSTS 243
           + KG  G + D WS GV +Y ++ G  PF   +L+  Y KI   K  F+ PP     S  
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239

Query: 244 AKKLISRILDP--NPVTRITMAEVIENEWF--------KKGYKP--PSFEQP----NIDL 287
           AK LI R++      + R  + +  ++ +F        +    P  P    P    N D+
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDV 299

Query: 288 DDVDSIFNESM 298
           DD D    ES+
Sbjct: 300 DDDDLRNTESL 310

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  120 bits (302), Expect = 9e-32
 Identities = 81/276 (29%), Positives = 147/276 (53%), Gaps = 15/276 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAIK ++ ++  K ++I     EI  M+  +HP
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHP 76

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +      T  GTP ++APEV+  K 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKA 191

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALY--KKIFKADFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 192 Y-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R L+ +   R +  E++++ + K   KP S   P I
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLKIA-KPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  119 bits (300), Expect = 1e-31
 Identities = 84/264 (31%), Positives = 137/264 (51%), Gaps = 15/264 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T E VAIKI+D E+      I  I++EI+ +     P + R Y 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D +   G L+E       ++++  +DY HS    HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL   G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD  KAD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184

Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFSTSAKKLISRILDPNP 256
           WS G+    L  G  P  + + M   + +F     SPP     +S   K+ +   L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPM---RVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241

Query: 257 VTRITMAEVIENEWFKKGYKPPSF 280
             R T  E++++++  +  K  SF
Sbjct: 242 RFRPTAKELLKHKFITRYTKKTSF 265

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  119 bits (300), Expect = 1e-31
 Identities = 85/270 (31%), Positives = 140/270 (51%), Gaps = 15/270 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+      I  I++EI+ +     P V + Y 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D +   G L E +     ++++  +DY HS    HRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL  +G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD +KAD+
Sbjct: 129 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 184

Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----FSTSAKKLISRILDPNP 256
           WS G+    L  G  P  E + M   K +F     +PP     +S   K+ +   L+  P
Sbjct: 185 WSLGITAIELAKGEPPHSELHPM---KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241

Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             R T  E++++++  +  K  S+    ID
Sbjct: 242 SFRPTAKELLKHKFIVRFAKKTSYLTELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  123 bits (309), Expect = 2e-31
 Identities = 92/311 (29%), Positives = 154/311 (49%), Gaps = 19/311 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY + R LG G+   V  A+    GE  A+K++D E  +      + + E+  +      
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFF 91

Query: 75  NVIRMYEVMASKTK--------IYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQ 122
           ++++ +E  A K          I +VL++   G+L  +I SR +     +E EA   F Q
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           ++ AV + HS+ + HRD+K  N+LL +NG++K+ DFG S +      D +  T CGTP Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFS 241
           VAPE+   K Y   KAD++S GV+LY L+    PF+  N+  +  K     +   PP  S
Sbjct: 212 VAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270

Query: 242 TSAKKLISRILDPNPVTRITMAEVIEN---EWFKKGYKPPSFEQPNIDLDDVDSIFNESM 298
              +++++ +L  +P  R + ++++     + F  G       QP       D+I  +  
Sbjct: 271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQ 330

Query: 299 DS-RNLVVERR 308
            + + L VERR
Sbjct: 331 QTKQLLQVERR 341

Length = 496

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  119 bits (298), Expect = 2e-31
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 13/269 (4%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+      I  I++EI+ +     P V + Y 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D + + G   E +     ++++  +DY HS    HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL   G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD +KAD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184

Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW---FSTSAKKLISRILDPNPV 257
           WS G+    L  G  P  + + M +   I K     P     FS   K+ I   L+ +P 
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPS 242

Query: 258 TRITMAEVIENEWFKKGYKPPSFEQPNID 286
            R T  E++++++  K  K  S+    ID
Sbjct: 243 FRPTAKELLKHKFIVKNAKKTSYLTELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  118 bits (298), Expect = 3e-31
 Identities = 79/263 (30%), Positives = 132/263 (50%), Gaps = 15/263 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V   +   TG+  A K LDK+++ K K       E   ++ +    ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAVDYCHSRGVCHRD 139
              +K  + +V+  + GG+L   I + G     EAR  F   Q+I  +++ H R + +RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           LKPEN+LLD +G +++SD GL+    +++    +    GTP Y+APEV+  + YD    D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176

Query: 200 LWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            ++ G  LY ++AG  PF    E+     L ++  +   + P  FS  AK L   +L  +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 256 PVTRI-----TMAEVIENEWFKK 273
           P  R+     +  EV E+  FK 
Sbjct: 237 PEKRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 3e-31
 Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 54/284 (19%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G+G+F +V+  +  +TG+  A+K L K ++ K   +  +K E   +     P V+ +
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           Y        +Y+++EF+ GG+L   +       ED  R Y  + + A++  H  G  HRD
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDG---------------------------- 171
           +KP+N+L+D  G +K+SDFGLS    +  D                              
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186

Query: 172 -----------------LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY 214
                            + ++T GTP+Y+APE+   +GY G + D WS G I++  + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245

Query: 215 LPFEESNLMALYKKIFKADFKSPPWF------STSAKKLISRIL 252
            PF   N    Y+KI   +++   +F      S  A+ LI R++
Sbjct: 246 PPFCSENSHETYRKII--NWRETLYFPDDIHLSVEAEDLIRRLI 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  118 bits (298), Expect = 3e-31
 Identities = 80/261 (30%), Positives = 138/261 (52%), Gaps = 11/261 (4%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    TG+ VA+K +D  K  + +++     E+  M+   H NV+ MY 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+ Y H++GV HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL ++G +K+SDFG  A  Q  ++     +  GTP ++APEVI+   Y G + D+W
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIW 202

Query: 202 SCGVILYVLMAGYLP-FEESNLMAL--YKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L A+   +       K     S+  +  +  +L   P  
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262

Query: 259 RITMAEVIENEWFKKGYKPPS 279
           R T  E++++ + K    PPS
Sbjct: 263 RATAQELLQHPFLKLA-GPPS 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  117 bits (296), Expect = 4e-31
 Identities = 78/267 (29%), Positives = 124/267 (46%), Gaps = 24/267 (8%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
             LG G+   V    +  TG+ +A+K +  E  +   +  QI RE+  +     P ++  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHS-RGVC 136
           Y    +   I I +E++ GG L DKI     GR+ E    K    ++  + Y H    + 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123

Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           HRD+KP N+L+++ G +K+ DFG+S   Q V  + L  T  GT +Y+APE I    Y   
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG--QLV--NSLAKTFVGTSSYMAPERIQGNDY-SV 178

Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMA-----LYKKIFKADFKSPP-----WFSTSAKK 246
           K+D+WS G+ L  L  G  P+   N        L + I       PP      FS   + 
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQD 235

Query: 247 LISRILDPNPVTRITMAEVIENEWFKK 273
            ++  L  +P  R +  E++E+ + KK
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  122 bits (306), Expect = 4e-31
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 20/255 (7%)

Query: 34  RNTETGENVAIKILD-KEKVL-KHKMIGQIKR------EISTMKLIRHPNVIRMYEVMAS 85
           RN  T   VA +  D KEKV+ K  M+   ++      E+  +    H  +++ ++   S
Sbjct: 77  RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136

Query: 86  KTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
             K+ +++E+ +GG+L  +I  R +     +E E    F Q++ A+D  HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLL---HTTCGTPNYVAPEVINNKGYDGAKA 198
             N+ L   G++K+ DFG S   +Q  D   L    + CGTP Y+APE+   K Y   KA
Sbjct: 197 SANIFLMPTGIIKLGDFGFS---KQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKA 252

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW-FSTSAKKLISRILDPNPV 257
           D+WS GVILY L+  + PF+  +   + +++    +   P   S+  K L+  +L  NP 
Sbjct: 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPA 312

Query: 258 TRITMAEVIENEWFK 272
            R T  +++  E+ K
Sbjct: 313 LRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 6e-31
 Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 71/307 (23%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIK----ILDKEKVLKHKMIGQIKREISTMKLI 71
           YE    +GEG++  V  AR+  TG  VA+K     L +E +     +    REI+ +K +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI-PLSTL----REIALLKQL 55

Query: 72  R---HPNVIRMYEV-----MASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQ 121
               HPN++R+ +V        + K+ +V E V         K    G L  +  +   +
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-GTP 180
           QL+  VD+ HS  + HRDLKP+N+L+ ++G +K++DFGL+    ++    +  T+   T 
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALTSVVVTL 170

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY---------KKIFK 231
            Y APEV+    Y     D+WS G I           E      L+          KIF 
Sbjct: 171 WYRAPEVLLQSSY-ATPVDMWSVGCIFA---------ELFRRRPLFRGTSEADQLDKIFD 220

Query: 232 --------------------------ADFKSP-PWFSTSAKKLISRILDPNPVTRITMAE 264
                                       FKS  P        L+ ++L  NP  RI+  E
Sbjct: 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280

Query: 265 VIENEWF 271
            +++ +F
Sbjct: 281 ALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  119 bits (300), Expect = 6e-31
 Identities = 87/331 (26%), Positives = 148/331 (44%), Gaps = 57/331 (17%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++ +V  A +T+TG  VAIK L +  +  +  K   +  RE+  +K + 
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK---RTYRELRLLKHMD 72

Query: 73  HPNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V    +       +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRG 130

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS G+ HRDLKP N+ ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---------------- 230
           ++ N  +     D+WS G I+  L+ G   F  S+ +   K+I                 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 231 --------------KADFKSP-PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY 275
                         K DFK      +  A  L+ ++L  +P  RIT AE + + +  + Y
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE-Y 304

Query: 276 KPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
             P  E        V   +++S +SR+L V+
Sbjct: 305 HDPEDEP-------VAPPYDQSFESRDLTVD 328

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  117 bits (294), Expect = 7e-31
 Identities = 76/270 (28%), Positives = 134/270 (49%), Gaps = 22/270 (8%)

Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKIL--------DKEKVLKHKMIGQIKREISTMKL 70
           G+ LG G+F+    AR+ +TG  +A+K +        ++E+V++      +++EI  M  
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-----ALRKEIRLMAR 59

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           + HP++IRM       +   + +E++ GG +   ++  G  KE     Y +QL+  + Y 
Sbjct: 60  LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119

Query: 131 HSRGVCHRDLKPENLLLDANG-VLKVSDFGLSA-LPQQVRDDGLLH-TTCGTPNYVAPEV 187
           H   + HRD+K  NLL+D+ G  L+++DFG +A L  +    G       GT  ++APEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIFKADFKS--PPWFST 242
           +  + Y G   D+WS G ++  +     P+   + SN +AL  KI  A      P   S 
Sbjct: 180 LRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK 272
             + +  R L+  P  R    E++++  F+
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  117 bits (295), Expect = 9e-31
 Identities = 81/261 (31%), Positives = 141/261 (54%), Gaps = 11/261 (4%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++     +  GTP ++APE+I+   Y G + D+W
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIW 200

Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260

Query: 259 RITMAEVIENEWFKKGYKPPS 279
           R T AE++++ +  K   PPS
Sbjct: 261 RATAAELLKHPFLAKA-GPPS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  117 bits (294), Expect = 1e-30
 Identities = 81/276 (29%), Positives = 147/276 (53%), Gaps = 15/276 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAIK ++ ++  K ++I     EI  M+  ++P
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKNP 76

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+D+ HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +      T  GTP ++APEV+  K 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKA 191

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 192 Y-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R L+ +   R +  E++++ + K   KP S   P I
Sbjct: 251 RCLEMDVDRRGSAKELLQHPFLKLA-KPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  117 bits (294), Expect = 1e-30
 Identities = 79/276 (28%), Positives = 149/276 (53%), Gaps = 15/276 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 77

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +   ++    GTP ++APEV+  K 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKA 192

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 193 Y-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R LD +   R +  E++++++ K   KP S   P I
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIA-KPLSSLTPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  116 bits (293), Expect = 2e-30
 Identities = 81/290 (27%), Positives = 146/290 (50%), Gaps = 52/290 (17%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKIL----DKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           +GEG++  V   RN +TG+ VA+K +    ++E V    +     REIS +K ++HPN++
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-----REISLLKELQHPNIV 62

Query: 78  RMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            + +V+  ++++Y++ EF++    +  D +     +  +  + Y  Q++  + +CHSR V
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKP+NLL+D  GV+K++DFGL+    +P +V    ++     T  Y APEV+    
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVLLGSP 177

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKA----------------DF 234
                 D+WS G I +  MA   P    +S +  L+ +IF+                 D+
Sbjct: 178 RYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLPDY 235

Query: 235 KS--PPWFSTSAKK-----------LISRILDPNPVTRITMAEVIENEWF 271
           K+  P W   S +            L+ ++L  +P  RI+  + + + +F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  116 bits (291), Expect = 2e-30
 Identities = 69/213 (32%), Positives = 113/213 (53%), Gaps = 9/213 (4%)

Query: 19  GRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLK-HKMIGQIKREISTMKLIRHPN 75
           G  LG+G++  V +   T  G+ +A+K   LD   VL   K   +++ E+  +K ++H N
Sbjct: 5   GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++          I I +EFV GG +   +   G L E    KY +Q+++ V Y H+  V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRD+K  N++L  NG++K+ DFG    L+ +        +L +  GTP ++APEVIN  
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMA 224
           GY G K+D+WS G  ++ +  G  P    + +A
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLA 215

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  116 bits (291), Expect = 3e-30
 Identities = 82/266 (30%), Positives = 140/266 (52%), Gaps = 23/266 (8%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ETG   A K++D   E+ L+  M+     EI  +    H
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-----EIDILASCDH 61

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHS 132
           PN++++ +    +  ++I++EF  GG +   +    R L E + R   +Q + A++Y H 
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV--RDDGLLHTTCGTPNYVAPEVI-- 188
             + HRDLK  N+L   +G +K++DFG+SA   +   R D  +    GTP ++APEV+  
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177

Query: 189 ---NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFST 242
               ++ YD  KAD+WS G+ L  +     P  E N M +  KI K++      P  +S+
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236

Query: 243 SAKKLISRILDPNPVTRITMAEVIEN 268
             K  + + L+ N   R T  +++++
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  115 bits (291), Expect = 4e-30
 Identities = 78/300 (26%), Positives = 141/300 (47%), Gaps = 62/300 (20%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--REISTMK-LIR 72
           Y++   +GEG+F++V  A++ +TG+  AIK + K      K + Q+   REI  ++ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56

Query: 73  HPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDY 129
           HPN++R+ EV+  +   ++ +V E +    L++ I  R R L E   + Y  QL+ ++D+
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV------ 183
            H  G+ HRD+KPEN+L+  + +LK++DFG S                  P Y       
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFG-SC-----------RGIYSKPPYTEYISTR 162

Query: 184 ---APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN------------------L 222
              APE +   GY G K D+W+ G + + +++ +  F  +N                  +
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222

Query: 223 MALYKKIFKADFKSP-----------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
           +  ++K    ++  P           P  S     L+ ++L  +P  RIT  + + + +F
Sbjct: 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  116 bits (292), Expect = 4e-30
 Identities = 94/319 (29%), Positives = 146/319 (45%), Gaps = 68/319 (21%)

Query: 7   GASRTRVGKYE-LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G  R+ V ++E L R +GEG++  V  AR+T +GE VA+K +  +       I  + REI
Sbjct: 1   GRCRS-VTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REI 57

Query: 66  STMKLIRHPNVIRMYEVMASK--TKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQ 121
           + +  +RHPN++ + EV+  K    I++V+E+       L D + +     E + +    
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLML 115

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCG 178
           QL+  + Y H   + HRDLK  NLLL   G LK++DFGL+    LP +            
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM---------- 165

Query: 179 TPN-----YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAG--YLP----FEESNLMA-- 224
           TP      Y APE++     Y  A  D+W+ G IL  L+A    LP     E+ +L+   
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224

Query: 225 ----------------LYKKI---------FKADFKSPPWFSTSAKKLISRILDPNPVTR 259
                           L  K           K  F   PW S +  +L++ +L  +P  R
Sbjct: 225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF---PWLSEAGLRLLNFLLMYDPKKR 281

Query: 260 ITMAEVIENEWFKKGYKPP 278
            T  E +E+ +FK+  KP 
Sbjct: 282 ATAEEALESSYFKE--KPL 298

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  115 bits (288), Expect = 8e-30
 Identities = 81/276 (29%), Positives = 148/276 (53%), Gaps = 15/276 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAIK ++ +K  K ++I     EI  MK +++P
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKNP 76

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ H+  
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +      T  GTP ++APEV+  K 
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKA 191

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 192 Y-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R L+ +   R +  E++++ + K   KP S   P I
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLKLA-KPLSSLTPLI 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  113 bits (284), Expect = 4e-29
 Identities = 89/293 (30%), Positives = 144/293 (49%), Gaps = 42/293 (14%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YE    +GEG++  V  AR+  T E +A+K +  E+  +      I REIS +K ++H 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE--ARKYFQQLINAVDYCHS 132
           N++R+ +V+ S+ ++Y+V E++   +L   + S     ++    + Y  Q++  + YCHS
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 133 RGVCHRDLKPENLLLD-ANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
             V HRDLKP+NLL+D     LK++DFGL+ A    VR     H    T  Y APE++  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVV-TLWYRAPEILLG 177

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFK----------------A 232
             +     D+WS G I +  M    P    +S +  L+ KIF+                 
Sbjct: 178 SRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGVTSLP 235

Query: 233 DFKS--PPWFST-----------SAKKLISRILDPNPVTRITMAEVIENEWFK 272
           D+KS  P W              +   L+S++L  +P  RIT    +E+E+FK
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Length = 294

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  113 bits (284), Expect = 5e-29
 Identities = 79/308 (25%), Positives = 134/308 (43%), Gaps = 57/308 (18%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKL 70
           V KYE    +G+G+F +V  AR+ +T + VA+K  +++ EK  +   I  + REI  ++L
Sbjct: 11  VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITAL-REIKILQL 67

Query: 71  IRHPNVIRMYEVMASKTK--------IYIVLEFVT---GGELFDKIASRGRLKEDEARKY 119
           ++H NV+ + E+  +K           Y+V EF      G L +K     +    E +K 
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKV 124

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTT-C 177
            + L+N + Y H   + HRD+K  N+L+  +G+LK++DFGL+ A           +T   
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVIL------YVLMAG------------------ 213
            T  Y  PE++  +   G   D+W  G I+        +M G                  
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 214 ---------YLPFEESNLMALYKKIFKADFKSPPWFST-SAKKLISRILDPNPVTRITMA 263
                       F++  L    K+  K   K  P+     A  LI ++L  +P  RI   
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDAD 302

Query: 264 EVIENEWF 271
             + +++F
Sbjct: 303 TALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  111 bits (279), Expect = 1e-28
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 12/260 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +EL + +G G++  V  ARN  TGE  AIK++   K+   +    +++EI  MK  +H N
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++  +     + K++I +EF  GG L D     G L E +     ++ +  + Y HS+G 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV--INNKGY 193
            HRD+K  N+LL  NG +K++DFG+SA  Q         +  GTP ++APEV  +  KG 
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW-----FSTSAKKLI 248
                D+W+ G+    L     P  + + M     + K++F+ P       +S S    +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245

Query: 249 SRILDPNPVTRITMAEVIEN 268
              L  NP  R T  +++++
Sbjct: 246 KMALTKNPKKRPTAEKLLQH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  109 bits (273), Expect = 9e-28
 Identities = 79/279 (28%), Positives = 138/279 (49%), Gaps = 28/279 (10%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREI--STMKLIRHPNVIR 78
           +G G F +V   R  +TG+  A+K LDK+++ +K      +   I  S +     P ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           M     +  K+  +L+ + GG+L   ++  G   E E R Y  ++I  +++ H+R V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG--YDGA 196
           DLKP N+LLD +G +++SD GL+    + +     H + GT  Y+APEV+  KG  YD +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVL-QKGVAYD-S 175

Query: 197 KADLWSCGVILYVLMAGYLPFEE---SNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
            AD +S G +L+ L+ G+ PF +    +   + +       + P  FS   + L+  +L 
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 254 PNPVTRI-----TMAEVIENEWFK---------KGYKPP 278
            +   R+        EV E+ +F+         + Y PP
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  109 bits (274), Expect = 9e-28
 Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 40/291 (13%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIKREISTMKLIRH 73
           KYE    +GEGS+  V   RN ETG+ VAIK  ++ E     K I    REI  +K ++H
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL--REIRMLKQLKH 59

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           PN++ + EV   K K+++V E+     L +   +   + E   +K   Q + AV++CH  
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-GTPNYVAPEVINNKG 192
              HRD+KPEN+L+   G +K+ DFG + +     DD   +T    T  Y APE++    
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVGDT 176

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF--EESNLMALY-------------KKIFKAD--FK 235
             G   D+W+ G +   L+ G  P    +S++  LY             ++IF  +  FK
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 236 -----SP----------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
                 P          P  S+ A   +   L  +P  R++  E++E+ +F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 1e-27
 Identities = 98/339 (28%), Positives = 150/339 (44%), Gaps = 64/339 (18%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHP 74
           Y+    +GEG++  V  A +  TG  VAIK   K    +H+   Q   REI  ++  +H 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 75  NVIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           N+I + +++   +      +YIV E +   +L+  I ++  L  D  + +  Q++  + Y
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGL--SALPQQVRDDGLLHTTCGTPNYVAPEV 187
            HS  V HRDLKP NLLL+ N  LK+ DFGL   A P+     G L     T  Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-HTGFLTEYVATRWYRAPEI 180

Query: 188 -INNKGYDGAKADLWSCGVILYVLMAG--------YLPFEESNL---------MALYKKI 229
            +N+KGY  A  D+WS G IL  +++         YL   + NL               I
Sbjct: 181 MLNSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLNCI 237

Query: 230 F----KADFKSPPWFST------------SAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                +   KS P+                A  L+ ++L  NP  RIT+ E + + + ++
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297

Query: 274 GYKP---PSFEQP-NIDLDDVDS---------IFNESMD 299
            + P   P  E+P   D +  D          IF E M 
Sbjct: 298 YHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIMR 336

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  109 bits (273), Expect = 1e-27
 Identities = 86/276 (31%), Positives = 128/276 (46%), Gaps = 30/276 (10%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           EL R LGEG+   V   R   TG   A+K I         K   QI RE+   K  + P 
Sbjct: 5   ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCKSPY 60

Query: 76  VIRMYE--VMASKTKIYIVLEFVTGGEL---FDKIASRG-RLKEDEARKYFQQLINAVDY 129
           +++ Y   +  S + I I +E+  GG L   + K+  RG R+ E    K  + ++  + Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            HSR + HRD+KP N+LL   G +K+ DFG+S   + V  + L  T  GT  Y+APE I 
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--NSLAGTFTGTSFYMAPERIQ 176

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEES--------NLMALYKKIFKADFKSPP--- 238
            K Y    +D+WS G+ L  +     PF            L++    +   + K  P   
Sbjct: 177 GKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235

Query: 239 --WFSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
             W S   K  I + L+ +P  R T  +++E+ W K
Sbjct: 236 IKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  108 bits (271), Expect = 2e-27
 Identities = 80/259 (30%), Positives = 133/259 (51%), Gaps = 17/259 (6%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           LG+G++  V  AR+  T   +AIK    E   +     Q +  EI+    ++H N+++  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIK----EIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEA--RKYFQQLINAVDYCHSRGVCH 137
              +      I +E V GG L   + S+ G LK++E     Y +Q++  + Y H   + H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 138 RDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYD 194
           RD+K +N+L++  +GV+K+SDFG S   +    +    T  GT  Y+APEVI+   +GY 
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKGPRGY- 188

Query: 195 GAKADLWSCGVILYVLMAGYLPFEE--SNLMALYK-KIFKADFKSPPWFSTSAKKLISRI 251
           GA AD+WS G  +  +  G  PF E      A++K  +FK   + P   S  AK  I R 
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248

Query: 252 LDPNPVTRITMAEVIENEW 270
            +P+P  R +  +++++ +
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  109 bits (274), Expect = 2e-27
 Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 58/314 (18%)

Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK--------MIGQIK------R 63
            G  LGEG++ KV+ A +T TG+ VAIK   K K+++          ++G         R
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIK---KVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           E+  M  I+H N++ + +V      I +V++ +   +L   +  + RL E + +    Q+
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTP 180
           +N ++  H     HRDL P N+ +++ G+ K++DFGL+     P          T     
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 181 N---------YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF- 230
                     Y APE++          D+WS G I   L+ G   F   N +    +IF 
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248

Query: 231 --------------------------KADFKSP-PWFSTSAKKLISRILDPNPVTRITMA 263
                                       D K+  P  S  A  L+  +L  NP+ RI+  
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308

Query: 264 EVIENEWFKKGYKP 277
           E +++E+FK    P
Sbjct: 309 EALKHEYFKSDPLP 322

Length = 335

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  112 bits (282), Expect = 3e-27
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 11/213 (5%)

Query: 37  ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY-EVMASKTKIYIVLEF 95
            TG  VAIK+L  +   +     + +RE +    + HPN++ +     A    ++ V E+
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 96  VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV--- 152
           V G  L + +A+ G L   E  +   Q+++A+   H++G+ HRDLKP+N+++   GV   
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 153 LKVSDFGLSALPQQVRDDGLLHTT-----CGTPNYVAPEVINNKGYDGAKADLWSCGVIL 207
            KV DFG+  L   VRD  +   T      GTP Y APE +  +      +DL++ G+I 
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179

Query: 208 YVLMAGYLPFE-ESNLMALYKKIFKADFKSPPW 239
              + G    +  S    LY+++   D   PPW
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPW 212

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  107 bits (268), Expect = 4e-27
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 15/262 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH---PNVIR 78
           +G G F +V   R  +TG+  A+K LDK+++   +       E   + L+     P ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           M     +  K+  +L+ + GG+L   ++  G   E E R Y  ++I  +++ H+R V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKA 198
           DLKP N+LLD +G +++SD GL+    + +     H + GT  Y+APEV+       + A
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177

Query: 199 DLWSCGVILYVLMAGYLPFEE---SNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           D +S G +L+ L+ G+ PF +    +   + +     + + P  FS   K L+  +L  +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237

Query: 256 PVTRI-----TMAEVIENEWFK 272
              R+        EV E+ +FK
Sbjct: 238 VSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  106 bits (265), Expect = 8e-27
 Identities = 73/264 (27%), Positives = 138/264 (52%), Gaps = 18/264 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK---REISTMKLIR 72
           Y   R +G+GS+ +V   R+   G+   IK L+    L++    + K   +E   +  ++
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN----LRNASRRERKAAEQEAQLLSQLK 57

Query: 73  HPNVIRMYEVMASKT-KIYIVLEFVTGGELFDKIA-SRGRL-KEDEARKYFQQLINAVDY 129
           HPN++   E    +   +YIV+ F  GG+L+ K+   +G+L  E++  ++F Q+  A+ Y
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            H + + HRDLK +N+ L    ++KV D G++ + +   D  +  T  GTP Y++PE+ +
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFS 175

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW---FSTSAKK 246
           NK Y+  K+D+W+ G  +Y +      F   ++ +L  +I +   K PP    +S    +
Sbjct: 176 NKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLPPMPKDYSPELGE 232

Query: 247 LISRILDPNPVTRITMAEVIENEW 270
           LI+ +L   P  R ++  ++   +
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (265), Expect = 1e-26
 Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 12/218 (5%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + L R LG G F +V      +    VAIKIL  + +LK +     ++E+  +K +RH +
Sbjct: 8   FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRHKH 63

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQ-QLINAVDYCHSR 133
           +I ++ V +    +YI+ E +  G L   + S  G++    +      Q+   + Y   +
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRDL   N+L+  + V KV+DFGL+ L   +++D  L +    P  + APE  ++  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180

Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI 229
           +   K+D+WS G++LY +   G +P+   N   +Y +I
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 1e-26
 Identities = 70/265 (26%), Positives = 128/265 (48%), Gaps = 15/265 (5%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    V+ +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAVDYCHSRGVCH 137
                +K  + +VL  + GG+L   I + G    DE R  F   ++   ++  H   + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           RDLKPEN+LLD  G +++SD GL+    ++ +   +    GT  Y+APEV+ N+ Y    
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181

Query: 198 ADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
            D W  G ++Y ++ G  PF    E+     + +++ +   +    FS +A+ +  ++L 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 254 PNPVTRI-----TMAEVIENEWFKK 273
            +P  R+        EV  + +F+ 
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 3e-26
 Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 18/256 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +LG T+G+G F  V        G+ VA+K L  +             E S M  +RHPN+
Sbjct: 9   KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRG 134
           +++  V+     +YIV E++  G L D + SRGR  +   +   +   +   ++Y   + 
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+L+  + V KVSDFGL+    Q +D G L      P  + APE +  K +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEALREKKF 176

Query: 194 DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISRI 251
              K+D+WS G++L+ + + G +P+    L  +   + K    ++P        K++   
Sbjct: 177 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235

Query: 252 LDPNPVTRITMAEVIE 267
            + +P  R T  ++ E
Sbjct: 236 WELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  106 bits (266), Expect = 4e-26
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK----ILDKEKVLKHKMIGQIKREISTMKL 70
           +Y+    +G G++  V  A +T +G+ VAIK      D   + K  +     RE+  ++ 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKILRH 60

Query: 71  IRHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
            +H N+I + +++         +Y+V++ +   +L   I S   L E+  R +  QL+  
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVA 184
           + Y HS  V HRDLKP NLL++ +  L++ DFG++        +     T    T  Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 185 PEVI-NNKGYDGAKADLWSCGVIL 207
           PE++ +   Y  A  D+WS G I 
Sbjct: 180 PELLLSLPEYTTA-IDMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  104 bits (262), Expect = 6e-26
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 35/276 (12%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILD---KEKVLKHKMIGQIKREISTMKLIRHPNV 76
           R +G GSF  V FAR+  T E VAIK +    K+   K +    I +E+  ++ +RHPN 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLRHPNT 77

Query: 77  IRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           I        +   ++V+E+  G   ++ +    +  L+E E        +  + Y HS  
Sbjct: 78  IEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHE 135

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNYVAPEVI---N 189
             HRD+K  N+LL   G +K++DFG ++L  P          +  GTP ++APEVI   +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--------SFVGTPYWMAPEVILAMD 187

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKSPPWFSTSA---- 244
              YDG K D+WS G+    L     P    N M ALY  I + D    P  S++     
Sbjct: 188 EGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQND---SPTLSSNDWSDY 242

Query: 245 -KKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
            +  +   L   P  R +  E++++ +  +  +PP+
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRE-RPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  104 bits (260), Expect = 7e-26
 Identities = 69/251 (27%), Positives = 123/251 (49%), Gaps = 10/251 (3%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    V+ +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCH 137
                +K  + +VL  + GG+L   I + G    +E+ A  Y  +++  ++  H     +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           RDLKPEN+LLD  G +++SD GL+    ++ +   +    GT  Y+APEV+NN+ Y    
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181

Query: 198 ADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
            D W  G ++Y ++ G  PF    E+     + +++ + +      FS  AK +   +L 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 254 PNPVTRITMAE 264
            +P  R+   E
Sbjct: 242 KDPKQRLGCQE 252

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  107 bits (269), Expect = 1e-25
 Identities = 73/243 (30%), Positives = 127/243 (52%), Gaps = 37/243 (15%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           +R+ +YE+ + +G G F +V   ++  T E    K +   + LK +   Q+  E++ M+ 
Sbjct: 10  SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMRE 68

Query: 71  IRHPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLI 124
           ++H N++R  +   +K   K+YI++EF   G+L   I       G+++E       +QL+
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 125 NAVDYCHS-------RGVCHRDLKPENLLL---------------DANG--VLKVSDFGL 160
           +A+ YCH+         V HRDLKP+N+ L               + NG  + K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 161 SALPQQVRDDGLLHTTCGTPNYVAPEVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFE 218
           S   + +  + + H+  GTP Y +PE++    K YD  K+D+W+ G I+Y L +G  PF 
Sbjct: 189 S---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFH 244

Query: 219 ESN 221
           ++N
Sbjct: 245 KAN 247

Length = 1021

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  104 bits (260), Expect = 1e-25
 Identities = 82/304 (26%), Positives = 138/304 (45%), Gaps = 54/304 (17%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKL 70
           V K+++   +GEG++ +V  AR+ +TGE VA+K   LD EK  +   I  I REI  ++ 
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAI-REIKILRQ 62

Query: 71  IRHPNVIRMYEVMASKTK----------IYIVLEFVTG---GELFDKIASRGRLKEDEAR 117
           + H N++ + E++  K             Y+V E++     G L   +       ED  +
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIK 119

Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT- 176
            + +QL+  ++YCH +   HRD+K  N+LL+  G +K++DFGL+ L     ++   +T  
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTNK 177

Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK----- 231
             T  Y  PE++  +   G   D+WSCG IL  L      F+ +  +A  + I +     
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237

Query: 232 -----ADFKSPPWFSTSAKK--------------------LISRILDPNPVTRITMAEVI 266
                 D    P+F+T   K                    L+  +L  +P  R T  E +
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297

Query: 267 ENEW 270
            + W
Sbjct: 298 NSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  103 bits (257), Expect = 1e-25
 Identities = 77/263 (29%), Positives = 129/263 (49%), Gaps = 14/263 (5%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YEL + +G G++  V  ARN  TGE  A+KI+  E      +I Q   EI  +K  +H N
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCN 67

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++  +    S+ K++I +E+  GG L D     G L E +     ++ +  + Y HS+G 
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---NNKG 192
            HRD+K  N+LL  NG +K++DFG++A  +         +  GTP ++APEV     N G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW-----FSTSAKKL 247
           Y+    D+W+ G+    L     P  + + M     + K++F+ P       +S++    
Sbjct: 186 YNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244

Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           +   L  NP  R T   ++ + +
Sbjct: 245 VKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  103 bits (258), Expect = 1e-25
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 25/270 (9%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    V+ +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAVDYCHSRGVCH 137
                +K  + +VL  + GG+L   I   G    +E R  F   ++   ++  H   + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           RDLKPEN+LLD +G +++SD GL+     V +   +    GT  Y+APEV+ N+ Y  + 
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181

Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---------PPWFSTSAKKLI 248
            D W+ G +LY ++AG  PF++       KKI + + +             FS  A+ L 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARSLC 236

Query: 249 SRILDPNPVTRI-----TMAEVIENEWFKK 273
             +L  +P  R+        EV E+  FK+
Sbjct: 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  103 bits (260), Expect = 2e-25
 Identities = 90/340 (26%), Positives = 146/340 (42%), Gaps = 68/340 (20%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK--------ILDKEKVLKHKMIGQIKREIS 66
           KY   + +G G++  V  A+N+ET E VAIK         +D ++ L         REI 
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---------REIK 56

Query: 67  TMKLIRHPNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
            ++ + H NVI + ++M    +     +YIV E +   +L   I S   L +D  + +  
Sbjct: 57  LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           QL+  + Y HS  V HRDLKP NLLL+AN  LK+ DFGL+    +      +     T  
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRW 173

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-------------------EESNL 222
           Y APE++ N        D+WS G I   L+     F                    E +L
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 223 MALYKKIFKADFKSPPWF------------STSAKKLISRILDPNPVTRITMAEVIENEW 270
             +  +  +   +S P+             +  A  L+ ++L  +P  RIT+ E + + +
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 271 FKKGYKP---PS--------FEQPNIDLDDV-DSIFNESM 298
               + P   P         FE+  +  +D+ + I+NE +
Sbjct: 294 LASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELIYNEML 333

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  105 bits (264), Expect = 5e-25
 Identities = 45/137 (32%), Positives = 80/137 (58%)

Query: 25  GSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA 84
           G+F KV   R     +  A+K++ K  ++   M+ Q++ E   + L + P ++ +Y  + 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 85  SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPEN 144
           S   +Y+V+E++ GG++   +   G   E+ A KY  ++  A+DY H  G+ HRDLKP+N
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134

Query: 145 LLLDANGVLKVSDFGLS 161
           +L+   G +K++DFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  100 bits (251), Expect = 1e-24
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 7/201 (3%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           K+E+   +GEG++  V   R+ ET E VAIK   K+     ++     RE+  ++ ++  
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           N++ + E    + K+Y+V E+V     EL +++ +   +  ++ R Y  QLI A+ +CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
             + HRD+KPENLL+  N VLK+ DFG +    +  +         T  Y +PE++    
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177

Query: 193 YDGAKADLWSCGVILYVLMAG 213
           Y G   D+WS G IL  L  G
Sbjct: 178 Y-GKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  101 bits (253), Expect = 2e-24
 Identities = 80/283 (28%), Positives = 129/283 (45%), Gaps = 31/283 (10%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDK---EKVLKHKMIGQIKREISTMKLIRHPNV 76
           + +G G+F  V  AR+  TG+NVAIK + K     VL  +      RE+  +K +RH N+
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY----RELKLLKHLRHENI 71

Query: 77  IRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           I + ++  S    IY V E +  G    ++ +   L++   + +  Q++  + Y HS GV
Sbjct: 72  ISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGV 129

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRDLKP N+L++ N  LK+ DFGL A  Q  +  G + T      Y APE++       
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQKYD 184

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            + D+WS G I   ++ G   F   + +  +  I      +PP        +I+ I   N
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL-LGTPP------DDVINTICSEN 237

Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESM 298
            +  +           K+   P S +  N D   +D +  E M
Sbjct: 238 TLRFVQSLP-------KREPVPFSEKFKNADPSAIDLL--EKM 271

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  101 bits (253), Expect = 2e-24
 Identities = 88/340 (25%), Positives = 150/340 (44%), Gaps = 59/340 (17%)

Query: 16  YELGRTLGEGSFAKVKFARNTET--GENVAIK----ILDKEKVLKHKMIGQIKREISTMK 69
           YEL + LG+G++  V  ARN ET   E VAIK    +  K+ + K  +     RE+  ++
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56

Query: 70  LIR-HPNVIRMYE---VMASK-TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
             R H N+  +Y+   V      ++Y+  E +   +L   I S   L +   + +  Q++
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNY 182
             + Y HS  V HRDLKP NLL++A+  LK+ DFGL+         + G +     T  Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 183 VAPEV-INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---------- 231
            APE+ ++ + Y  A  D+WS G IL  L+     F+  + +    +I +          
Sbjct: 176 RAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234

Query: 232 ADFKSP---------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEW 270
           +   SP                     P  +  A  L+ ++L  +P  RI++ E +E+ +
Sbjct: 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Query: 271 FKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
               + P   ++P          F+ S +S + + E R+ 
Sbjct: 295 LAIWHDPD--DEPV-----CQKPFDFSFESEDSMEELRDM 327

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 60/305 (19%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKI----LDKEKVLKHKMIGQIKREISTMKL 70
            YE    +GEG++ KV  AR+  TG+ VA+K     +D+E +    +     REIS +++
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQM 56

Query: 71  IRH-PNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGR-----LKEDEARKY 119
           +     ++R+ +V   + K     +Y+V E++   +L   + S GR     L     + +
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLKVSDFGLS---ALPQQVRDDGLLHT 175
             QL+  V +CH  GV HRDLKP+NLL+D   G+LK++D GL    ++P +     ++  
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-- 173

Query: 176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFK--- 231
              T  Y APEV+    +     D+WS G I   +      F  +S L  L   IFK   
Sbjct: 174 ---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLG 229

Query: 232 ----------ADFKS----PPW-----------FSTSAKKLISRILDPNPVTRITMAEVI 266
                     +  +     P W            S     L+ ++L  +P  RI+    +
Sbjct: 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289

Query: 267 ENEWF 271
            + +F
Sbjct: 290 THPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  100 bits (249), Expect = 2e-24
 Identities = 78/260 (30%), Positives = 132/260 (50%), Gaps = 26/260 (10%)

Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           A R   G +EL   +G G++ +V   R+ +TG+  AIK++D  +  +     +IK EI+ 
Sbjct: 10  ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE----EIKLEINM 65

Query: 68  MK-LIRHPNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIA-SRGR-LKEDEARK 118
           +K    H N+   Y     K+      ++++V+EF   G + D +  ++G  LKED    
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
             ++++  + + H+  V HRD+K +N+LL  N  +K+ DFG+SA  Q  R  G  +T  G
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIG 183

Query: 179 TPNYVAPEVIN-----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD 233
           TP ++APEVI      +  YD  ++D+WS G+    +  G  P  + + M   + +F   
Sbjct: 184 TPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFLIP 239

Query: 234 FKSPPWFSTS--AKKLISRI 251
              PP   +   +KK I  I
Sbjct: 240 RNPPPKLKSKKWSKKFIDFI 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  100 bits (251), Expect = 4e-24
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 31/234 (13%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           R LG GS   V  A +++  + VA+K  +L   + +KH +     REI  ++ + H N++
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRLDHDNIV 65

Query: 78  RMYEVMASKTK--------------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           ++YEV+                   +YIV E++        +  +G L E+ AR +  QL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLS-ALPQQVRDDGLLHTTCGTPN 181
           +  + Y HS  V HRDLKP N+ ++    VLK+ DFGL+  +       G L     T  
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 182 YVAPEVI---NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA 232
           Y +P ++   NN  Y  A  D+W+ G I   ++ G   F  ++ +   + I ++
Sbjct: 184 YRSPRLLLSPNN--YTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 99.7 bits (248), Expect = 4e-24
 Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 31/276 (11%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRHP 74
           +E+  T+G+G++ KV    N + G   A+KILD      H +  +I+ E + +K L  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75

Query: 75  NVIRMYEVMASKT-----KIYIVLEFVTGGELFDKIA---SRG-RLKEDEARKYFQQLIN 125
           NV++ Y +   K      ++++VLE   GG + D +     RG R++E        + + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
            + + H     HRD+K  N+LL   G +K+ DFG+SA     R     +T+ GTP ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAP 193

Query: 186 EVIN-----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-- 238
           EVI      +  YD A+ D+WS G+    L  G  P  + + M   + +FK     PP  
Sbjct: 194 EVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPM---RALFKIPRNPPPTL 249

Query: 239 ----WFSTSAKKLISRILDPNPVTRITMAEVIENEW 270
                +S      I + L  +   R T+++++++ +
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 27/207 (13%)

Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LGEG F KV+  R       TGE VA+K L+     +H      +REI  ++ + H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHEN 67

Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR--KYFQQLINAVDYCH 131
           +++   V        + +++E++  G L D +  R R + +  R   +  Q+   +DY  
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ------VRDDGLLHTTCGTP-NYVA 184
           S+   HRDL   N+L+++  ++K+SDFGL+ +  +      V++ G        P  + A
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES------PIFWYA 180

Query: 185 PEVIN-NKGYDGAKADLWSCGVILYVL 210
           PE +  +K    + +D+WS GV LY L
Sbjct: 181 PECLRTSKFS--SASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 98.1 bits (244), Expect = 1e-23
 Identities = 72/247 (29%), Positives = 120/247 (48%), Gaps = 10/247 (4%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    V+ +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAVDYCHSRGVCH 137
                +K  + +VL  + GG+L   I + G    DE R  F   +L   ++      + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           RDLKPEN+LLD  G +++SD GL+    Q+ +   +    GT  Y+APEVINN+ Y  + 
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181

Query: 198 ADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
            D W  G ++Y ++ G  PF    E      + +++ +   +    FS  AK +   +L 
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 254 PNPVTRI 260
            NP  R+
Sbjct: 242 KNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 78/318 (24%), Positives = 139/318 (43%), Gaps = 68/318 (21%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH--KMIGQIK--REIS 66
           +++  YE+   LGEG+F +V  AR  +TG  VA+K     K+L H  K    I   REI 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIK 59

Query: 67  TMKLIRHPNVIRMYEVMASKTK--------IYIVLEFVT---GGELFDKIASRGRLKEDE 115
            +K ++HPNV+ + ++   +          +Y+V  ++     G L +      +L E +
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQ 116

Query: 116 ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL----PQQVRDDG 171
            + Y  QL+  ++Y H   + HRD+K  N+L+D  G+LK++DFGL+      P   +  G
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 172 LLHTTCGTPN-----YVAPE-VINNKGYDGAKADLWSCGVILYVLMAG------------ 213
              T   T       Y  PE ++  + Y  A  D+W  G +   +               
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 214 -----YL---PFEESNLMALYKKI--FKADFKSPPWFSTSAKK----------LISRILD 253
                 L   P EE+     ++ +   +       +  T  ++          L+S++L 
Sbjct: 236 LHLIFKLCGTPTEET--WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293

Query: 254 PNPVTRITMAEVIENEWF 271
            +P  R+T ++ +E+ +F
Sbjct: 294 LDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 94/342 (27%), Positives = 155/342 (45%), Gaps = 64/342 (18%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH-KMIGQIKREISTMKLIRH 73
           +Y++   +G+GS+  V  A +T TGE VAIK ++   V +H     +I REI  ++L+RH
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58

Query: 74  PNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           P+++ +  +M   ++     IY+V E +   +L   I +   L  +  + +  QL+ A+ 
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEV 187
           Y H+  V HRDLKP+N+L +A+  LK+ DFGL+ +        +  T    T  Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 188 INN--KGYDGAKADLWSCGVILYVLMAGYLPFEESN------------------------ 221
             +    Y  A  D+WS G I   ++ G   F   N                        
Sbjct: 178 CGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236

Query: 222 -------LMALYKKI---FKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
                  L ++ KK    F   F   P     A +L+ R+L  +P  R T  E + + +F
Sbjct: 237 NEKARRYLSSMRKKQPVPFSQKF---PNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 272 K---KGYKPPS----------FEQPNIDLDDV-DSIFNESMD 299
           K   K  + PS          FE+  +  +DV + I+ E ++
Sbjct: 294 KGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILE 335

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 95.8 bits (238), Expect = 7e-23
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 27/254 (10%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLK---HKMIGQIKREISTMKLIRHPNVIR 78
           LG+G F +V   +   TG+  A K LDK+++ K    KM   +++EI  ++ +  P ++ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEI--LEKVNSPFIVN 57

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR--KYFQQLINAVDYCHSRGVC 136
           +     SKT + +V+  + GG+L   I + G    +  R   Y  Q+   + + HS  + 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           +RD+KPEN+LLD  G  ++SD GL+    +++D   +    GT  Y+APE++  + Y   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-Y 173

Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----------FSTSAKK 246
             D ++ G  +Y ++AG  PF++       +K+ K + K              F+  +K 
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHK-----EKVAKEELKRRTLEDEVKFEHQNFTEESKD 228

Query: 247 LISRILDPNPVTRI 260
           +    L   P  R+
Sbjct: 229 ICRLFLAKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 96.2 bits (239), Expect = 7e-23
 Identities = 74/240 (30%), Positives = 115/240 (47%), Gaps = 25/240 (10%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIR 72
             +E+  T+G+G++ KV    N + G   A+KILD        +  +I+ E + ++ L  
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77

Query: 73  HPNVIRMYEVMASKTK-----IYIVLEFVTGG---ELFDKIASRG-RLKEDEARKYFQQL 123
           HPNV++ Y +     K     +++VLE   GG   EL   +   G RL E          
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           +  + + H+  + HRD+K  N+LL   G +K+ DFG+SA     R     +T+ GTP ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 195

Query: 184 APEVIN-----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP 238
           APEVI      +  YD A+ D+WS G+    L  G  P  +   M   K +FK     PP
Sbjct: 196 APEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFD---MHPVKTLFKIPRNPPP 251

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 96.6 bits (240), Expect = 8e-23
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 15/263 (5%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G GSF  V FA N+ T E VA+K +       ++    I +E+  ++ ++HPN I    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
               +   ++V+E+  G         +  L+E E        +  + Y HS  + HRD+K
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---NNKGYDGAKA 198
             N+LL   G +K++DFG ++           ++  GTP ++APEVI   +   YDG K 
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDG-KV 201

Query: 199 DLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILDPN 255
           D+WS G+    L     P    N M+    I + D    +S  W + S +  +   L   
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQKI 260

Query: 256 PVTRITMAEVIENEWFKKGYKPP 278
           P  R   AE++ +++ ++  +P 
Sbjct: 261 PQERPASAELLRHDFVRRD-RPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 92/328 (28%), Positives = 151/328 (46%), Gaps = 68/328 (20%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK---------REI 65
           KYE+ + LG+G++  V  A +  T E VA+K          K+    +         REI
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREI 57

Query: 66  STMK-LIRHPNVIRMYEVMASK--TKIYIVLEFV-TGGELFDKIASRGRLKEDEARKYFQ 121
             ++ L  HPN++++  V+ ++    IY+V E++ T  +L   I     L++   R    
Sbjct: 58  MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET--DLHAVI-RANILEDVHKRYIMY 114

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCG 178
           QL+ A+ Y HS  V HRDLKP N+LL+++  +K++DFGL+   +  ++  ++ +L     
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 179 TPNYVAPEV-INNKGYDGAKA-DLWSCGVILYVLMAGYLPFEESNLMALYKKIF------ 230
           T  Y APE+ + +  Y   K  D+WS G IL  ++ G   F  ++ +   +KI       
Sbjct: 175 TRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232

Query: 231 -KAD---FKSP---------------------PWFSTSAKKLISRILDPNPVTRITMAEV 265
              D    KSP                     P  S  A  L+ ++L  NP  R+T  E 
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292

Query: 266 IENEWFKKGYKP---PSFEQP-NIDLDD 289
           +E+ +  + + P   P    P  I LDD
Sbjct: 293 LEHPYVAQFHNPSDEPVLPYPITIPLDD 320

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 15/249 (6%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V   +   TG+  A K L+K+++ K K       E   +  +    ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLINAVDYCHSRGVCH 137
              +KT + +V+  + GG+L   I +         E  A  Y  Q+I+ +++ H R + +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 138 RDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           RDLKPEN+LLD +G +++SD GL+      Q +  G      GTP ++APE++  + YD 
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYDF 176

Query: 196 AKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
           +  D ++ GV LY ++A   PF    E+     L ++I       P  FS ++K     +
Sbjct: 177 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 252 LDPNPVTRI 260
           L  +P  R+
Sbjct: 236 LAKDPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 42/220 (19%)

Query: 18  LGRTLGEGSFAKVKFAR-NTETGENVAIKIL-----DKEKVLKHKMIGQIKREISTMKLI 71
           L R LG G F +V     N  T   VA+K L       E  L+         E   MK +
Sbjct: 10  LERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQ---------EAQIMKKL 58

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK-YFQQLI------ 124
           RH  ++++Y V + +  IYIV E+++ G L D       LK  E +K    QL+      
Sbjct: 59  RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQI 112

Query: 125 -NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-GTP-- 180
              + Y  SR   HRDL   N+L+  N V K++DFGL+ L   + DD   +T   G    
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFP 167

Query: 181 -NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFE 218
             + APE  N  G    K+D+WS G++L  ++  G +P+ 
Sbjct: 168 IKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 95.2 bits (236), Expect = 1e-22
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 21/222 (9%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R   G +EL   +G G++ +V   R+ +TG+  AIK++D    +      +IK+EI+ +K
Sbjct: 2   RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLK 57

Query: 70  -LIRHPNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYF- 120
               H N+   Y     K       ++++V+EF   G + D I  ++G   ++E   Y  
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           ++++  + + H   V HRD+K +N+LL  N  +K+ DFG+SA  Q  R  G  +T  GTP
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTP 175

Query: 181 NYVAPEVIN-----NKGYDGAKADLWSCGVILYVLMAGYLPF 217
            ++APEVI      +  YD  K+DLWS G+    +  G  P 
Sbjct: 176 YWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 83/324 (25%), Positives = 141/324 (43%), Gaps = 52/324 (16%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y   + +G G++  V  A +  TG  VAIK L +  +  L  K   +  RE+  +K ++
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMK 72

Query: 73  HPNVIRMYEVMASKTKI------YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V      +      Y+V+ F+  G    K+    +L ED  +    Q++  
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y H+ G+ HRDLKP NL ++ +  LK+ DFGL+      + D  +     T  Y APE
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPE 185

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPF----------------------------- 217
           VI N  +     D+WS G I+  ++ G   F                             
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245

Query: 218 -EESNLMALYKKIFKADFKSP-PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY 275
            +  N +    +  K DF+S  P  +  A  ++ ++L  +  +RIT AE + + +F++ +
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305

Query: 276 KP---PSFEQPNIDLDDVDSIFNE 296
            P         +   D+VD    E
Sbjct: 306 DPEDETEAPPYDDSFDEVDQSLEE 329

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 67/227 (29%), Positives = 115/227 (50%), Gaps = 17/227 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           K  LG  +GEG F  V   +   TG+ VA+K + K  V     +     E + M  + H 
Sbjct: 7   KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNI-KCDVTAQAFL----EETAVMTKLHHK 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR--KYFQQLINAVDYCHS 132
           N++R+  V+     +YIV+E ++ G L + + +RGR      +  ++   +   ++Y  S
Sbjct: 60  NLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           + + HRDL   N+L+  +GV KVSDFGL+ +     D+  L        + APE + +K 
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173

Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPP 238
           +  +K+D+WS GV+L+ V   G  P+ + +L  + + + K     PP
Sbjct: 174 FS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 94.5 bits (235), Expect = 2e-22
 Identities = 68/265 (25%), Positives = 125/265 (47%), Gaps = 19/265 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G++  V    +  TG  +A+K +  E  L      QI  E+  +     P ++  Y 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 82  VMASKTKIYIVLEFVTGG---ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCH 137
               +  +Y+ +E++  G   +L+    +   + ED  R+    ++  + +      + H
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126

Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA- 196
           RD+KP N+L++ NG +K+ DFG+S     V    L  T  G  +Y+APE I + G +   
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKTNIGCQSYMAPERIKSGGPNQNP 182

Query: 197 ----KADLWSCGVILYVLMAG---YLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLI 248
               ++D+WS G+ +  +  G   Y P   +N+ A    I   D  + P  +S  A+  +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242

Query: 249 SRILDPNPVTRITMAEVIENEWFKK 273
           ++ L+  P  R T A+++E+ W  K
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 28/236 (11%)

Query: 51  KVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG 109
           K++K K    I  E    +L++ +PN I++Y  + +     ++++++  G+LFD +   G
Sbjct: 47  KIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104

Query: 110 RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLKVSDFGLSALPQQVR 168
           +L E E +K  +QL+ A++  H   + H D+K EN+L D A   + + D+GL     ++ 
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC----KII 160

Query: 169 DDGLLHTTC--GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN----- 221
                  +C  GT +Y +PE I    YD    D W+ GV+ Y L+ G  PF+E       
Sbjct: 161 G----TPSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215

Query: 222 ---LMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR-ITMAEVIENEWFKK 273
              L+   +K            S +A   +  +L  N   R     E+I++ + K 
Sbjct: 216 LESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 80/331 (24%), Positives = 145/331 (43%), Gaps = 57/331 (17%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 74

Query: 73  HPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 75  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 187

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF-----S 241
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +              S
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247

Query: 242 TSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKGY 275
            SA+  I  +            +  NP+               RIT A+ + + +F + +
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307

Query: 276 KPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
            P        D + V   +++S +SR+L+++
Sbjct: 308 DP--------DDEPVADPYDQSFESRDLLID 330

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 16/198 (8%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LGEGS+A V   R+  TG+ VA+K   L+ E+      I    RE S +K ++H N++ +
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REASLLKDLKHANIVTL 68

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++++ +K  + +V E++   +L   +   G  L     R +  QL+  + YCH R V HR
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127

Query: 139 DLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           DLKP+NLL+   G LK++DFGL+   ++P +   + ++     T  Y  P+V+       
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYRPPDVLLGSTEYS 182

Query: 196 AKADLWSCGVILYVLMAG 213
              D+W  G I Y +  G
Sbjct: 183 TSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.7 bits (228), Expect = 2e-21
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 46/211 (21%)

Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +T  G+   VA+K L  +K+    ++    +E + M  + H N+IR
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR--------KYFQQLINAVDYC 130
           +Y V+ +   + +V E    G L D      RL++D            Y  Q+ N + Y 
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYV------ 183
            S+   HRDL   N+LL ++  +K+ DFGL  ALPQ               +YV      
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLK 161

Query: 184 ------APEVINNKGYDGAKADLWSCGVILY 208
                 APE +  + +  A +D+W  GV L+
Sbjct: 162 VPFAWCAPESLRTRTFSHA-SDVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.5 bits (227), Expect = 2e-21
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  V   +       VAIK +++  + +   I     E   M  + HP ++++
Sbjct: 10  KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFI----EEAKVMMKLSHPKLVQL 64

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  +YIV EF+  G L + +  R G+L +D      Q +   ++Y       HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+ + GV+KVSDFG++   + V DD    ++ G      +  PEV N   Y  
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179

Query: 196 AKADLWSCGVILY-VLMAGYLPFE-ESNL 222
           +K+D+WS GV+++ V   G +PFE +SN 
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 91.7 bits (227), Expect = 3e-21
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 18/213 (8%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMK 69
           +   YE    LGEGS+A V   ++   G+ VA+K+  L +E+      I    RE S +K
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLK 58

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAV 127
            ++H N++ +++++ +K  + +V E+V     +  DK    G L  +  + +  QL+  +
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGL 116

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVA 184
            Y H R + HRDLKP+NLL+   G LK++DFGL+   ++P     + ++     T  Y  
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRP 171

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           P+V+          D+W  G I   ++ G   F
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.1 bits (228), Expect = 4e-21
 Identities = 72/255 (28%), Positives = 117/255 (45%), Gaps = 14/255 (5%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R +G GSF  V FAR+  T E VAIK +       ++    I +E+  ++ I+HPN I  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                 +   ++V+E+  G         +  L+E E        +  + Y HS  + HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---NNKGYDGA 196
           +K  N+LL   G +K++DFG +++          ++  GTP ++APEVI   +   YDG 
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG- 203

Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILD 253
           K D+WS G+    L     P    N M+    I + +    +S  W S   +  +   L 
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW-SDYFRNFVDSCLQ 262

Query: 254 PNPVTRITMAEVIEN 268
             P  R T  E++++
Sbjct: 263 KIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 16/216 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--REISTMKLIRHPNVIRM 79
           LGEG++A V   R+  T   VA+K    E  L+H+        RE+S +K ++H N++ +
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ-QLINAVDYCHSRGVCHR 138
           ++++ ++  + +V E++   +L   + + G L      K F  QL+  + YCH R + HR
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 139 DLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           DLKP+NLL++  G LK++DFGL+   ++P +   + ++     T  Y  P+V+       
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSTEYS 182

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
              D+W  G ILY +  G   F  S +      IF+
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 4e-21
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 27/201 (13%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKIL-------DKEKVLKHKMIGQIKREISTMKLIR 72
             +G+G+F  V +    +    VA+K          K K L+         E   +K   
Sbjct: 1   EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ---------EAEILKQYD 50

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           HPN++++  V   K  IYIV+E V GG L   +   + RL   +  +        ++Y  
Sbjct: 51  HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN----YVAPEV 187
           S+   HRDL   N L+  N VLK+SDFG+S    +  + G+   + G       + APE 
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 188 INNKGYDGAKADLWSCGVILY 208
           +N   Y  +++D+WS G++L+
Sbjct: 167 LNYGRYT-SESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.7 bits (222), Expect = 8e-21
 Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 12/192 (6%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G G+F +V   R       VA+K     + L   +  +  +E   +K   HPN++R+  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
           V   K  IYIV+E V GG+    + + G RLK  E  +  +     ++Y  S+   HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN----YVAPEVINNKGYDGA 196
              N L+    VLK+SDFG+S    +  +DG+  +T G       + APE +N   Y  +
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175

Query: 197 KADLWSCGVILY 208
           ++D+WS G++L+
Sbjct: 176 ESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 15/264 (5%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R +G GSF  V FAR+    E VAIK +       ++    I +E+  ++ +RHPN I+ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                 +   ++V+E+  G         +  L+E E        +  + Y HS  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---NNKGYDGA 196
           +K  N+LL   G++K+ DFG +++          +   GTP ++APEVI   +   YDG 
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG- 193

Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILD 253
           K D+WS G+    L     P    N M+    I + +    +S  W S   +  +   L 
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQ 252

Query: 254 PNPVTRITMAEVIENEWFKKGYKP 277
             P  R T +EV+    F    +P
Sbjct: 253 KIPQDRPT-SEVLLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 18  LGRTLGEGSFAKVKFA--RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
             + LG G F  V     R      +VAIK++ +  + +   I     E   M  + HPN
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKI---DVAIKMIREGAMSEDDFI----EEAKVMMKLSHPN 60

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++++Y V   +  I+IV E++  G L + +   +G+L  +        +  A++Y  S G
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNK 191
             HRDL   N L+  + V+KVSDFGL+   + V DD    +  GT     +  PEV +  
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVFDYS 176

Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPFE 218
            +  +K+D+WS GV+++ V   G +P+E
Sbjct: 177 RFS-SKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.1 bits (221), Expect = 1e-20
 Identities = 70/267 (26%), Positives = 125/267 (46%), Gaps = 23/267 (8%)

Query: 16  YELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
           +E+ RT       LG G + +V      +    VA+K L ++ +   + +    +E + M
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVM 56

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLINA 126
           K I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +A
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAP 185
           ++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + AP
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAP 174

Query: 186 EVINNKGYDGAKADLWSCGVILYVL----MAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           E +    +   K+D+W+ GV+L+ +    M+ Y   + S +  L +K ++ +   P    
Sbjct: 175 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME--RPEGCP 231

Query: 242 TSAKKLISRILDPNPVTRITMAEVIEN 268
               +L+      NP  R + AE+ + 
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEIHQA 258

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.4 bits (219), Expect = 3e-20
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 15/207 (7%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I     E   M  + H  ++++
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI----EEAKVMMKLSHEKLVQL 64

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  IYIV E+++ G L + +   G R +  +  +  + +   + Y  S+   HR
Sbjct: 65  YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+D  G +KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS- 179

Query: 196 AKADLWSCGVILY-VLMAGYLPFEESN 221
           +K+D+W+ GV+++ V   G +P+E  N
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFN 206

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 88/348 (25%), Positives = 150/348 (43%), Gaps = 69/348 (19%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+  + +G G+   V  A +T TG+NVAIK L +  + V   K   +  RE+  MKL+ 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKLVN 73

Query: 73  HPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYF-QQLIN 125
           H N+I +  V   +        +Y+V+E +    L   I       + E   Y   Q++ 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MDLDHERMSYLLYQMLC 129

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
            + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++     T  Y AP
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAP 186

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI---------------- 229
           EVI   GY     D+WS G I+  ++ G + F  ++ +  + KI                
Sbjct: 187 EVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245

Query: 230 --------------------------FKADFKSPPWFSTS-AKKLISRILDPNPVTRITM 262
                                     F  D +S      S A+ L+S++L  +P  RI++
Sbjct: 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305

Query: 263 AEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
            + +++ +    Y P   E P        + ++ S+D R   VE  +E
Sbjct: 306 DDALQHPYINVWYDPSEVEAPP------PAPYDHSIDEREHTVEEWKE 347

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.1 bits (218), Expect = 3e-20
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPN 75
           +L +T+G+G F  V        G  VA+K       +K+    Q    E S M  +RH N
Sbjct: 9   KLLQTIGKGEFGDVMLGDYR--GNKVAVK------CIKNDATAQAFLAEASVMTQLRHSN 60

Query: 76  VIRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHS 132
           ++++  V+   K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y  +
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
               HRDL   N+L+  + V KVSDFGL+      +D G L        + APE +  K 
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKK 175

Query: 193 YDGAKADLWSCGVILYVLMA-GYLPF 217
           +   K+D+WS G++L+ + + G +P+
Sbjct: 176 FS-TKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM-IGQIKREISTMKLIRHPN 75
           E  R +G G+F  V    +   G+ VA+K +    V ++ +   ++ RE+  +   +H N
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDN 60

Query: 76  VIRMYEVMASK-----TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           V+   +++         +IY+V E +   +L   I S   L  D  + +  Q++  + Y 
Sbjct: 61  VLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI 188
           HS G+ HRD+KP NLL+++N VLK+ DFGL+ + +    D   H T    T  Y APE++
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP---DESKHMTQEVVTQYYRAPEIL 176

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
               +  +  D+WS G I   L+   + F+  +
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 87.2 bits (216), Expect = 5e-20
 Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 24/243 (9%)

Query: 25  GSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH--PNVIRMYEV 82
           G   KV    +T T +   +K L K          + +  I     I H  PN++ +++ 
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-----IPHCVPNMVCLHKY 53

Query: 83  MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKP 142
           + S+  +++VL+   GG+L+  I+    + E+  +++  +++ A+D  H  G+  RDL P
Sbjct: 54  IVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113

Query: 143 ENLLLDANGVLKVSDFG-LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            N+LLD  G ++++ F   S +      + + +  C      APEV      +    D W
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV-GGISEETEACDWW 166

Query: 202 SCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRIT 261
           S G IL+ L+ G     E +   +           P W S  A+ L+ ++L  NP  R+ 
Sbjct: 167 SLGAILFELLTG-KTLVECHPSGINT---HTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222

Query: 262 MAE 264
              
Sbjct: 223 AGV 225

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 16/224 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRH 73
           +Y+    +G G++  V  A +T   + VA+K L +  + L H    +  RE+  +K ++H
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHAR--RTYRELRLLKHMKH 73

Query: 74  PNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            NVI + +V    T      ++Y+V   +  G   + I    +L ++  +    QL+  +
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
            Y HS G+ HRDLKP N+ ++ +  L++ DFGL+   +Q  D+  +     T  Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDE--MTGYVATRWYRAPEI 186

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           + N  +     D+WS G I+  L+ G   F  ++ +   K+I +
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 16/216 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--REISTMKLIRHPNVIRM 79
           LGEG++A V   R+  T   VA+K    E  L+H+        RE+S +K ++H N++ +
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ-QLINAVDYCHSRGVCHR 138
           ++++ ++  + +V E++   +L   +   G        K F  QL+  ++YCH R V HR
Sbjct: 70  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 139 DLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           DLKP+NLL++  G LK++DFGL+   ++P +   + ++     T  Y  P+++       
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYS 183

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
            + D+W  G I Y +  G   F  S +      IF+
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.6 bits (217), Expect = 8e-20
 Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 25/206 (12%)

Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV        N  TGE VA+K L +E   ++      K+EI+ +K + H N
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67

Query: 76  VIRMYEVMASK---TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +++ Y+   S+     + +++E+V  G L D +  + +L   +   + QQ+   + Y HS
Sbjct: 68  IVK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNY-VAP 185
           +   HRDL   N+LLD + ++K+ DFGL+ A+P+     +VR+DG       +P +  A 
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179

Query: 186 EVINNKGYDGAKADLWSCGVILYVLM 211
           E +    +  A +D+WS GV LY L+
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.3 bits (216), Expect = 9e-20
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 35/277 (12%)

Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV+  R       TGE VA+K L  E    H  I  +K+EI  ++ + H N
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67

Query: 76  VIRMYEVMASK---TKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCH 131
           +++ Y+ + ++     I +++EF+  G L + +  ++ ++   +  KY  Q+   +DY  
Sbjct: 68  IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPE-VIN 189
           SR   HRDL   N+L+++   +K+ DFGL+   +  ++   +     +P +  APE +I 
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF------------------K 231
           +K Y    +D+WS GV LY L+  Y    ES+ M L+ K+                    
Sbjct: 187 SKFY--IASDVWSFGVTLYELLT-YCD-SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242

Query: 232 ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
                PP       +L+ +  +  P  R T   +IE 
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 71/239 (29%), Positives = 116/239 (48%), Gaps = 39/239 (16%)

Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKIL-----DKEKVLKHKMIGQIKREISTMKLI 71
           + +G G F +V   R    G+    VAIK L     DK+++           E S M   
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIMGQF 62

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN------ 125
            HPN+IR+  V+     + I+ E++  G L DK      L+E++ +    QL+       
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116

Query: 126 -AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG--TP-N 181
             + Y       HRDL   N+L+++N V KVSDFGLS   +++ D    +TT G   P  
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIR 173

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEE-SNLMALYKKIFKADFKSPP 238
           + APE I  + +  A +D+WS G++++ +M+ G  P+ + SN   + K +    ++ PP
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVED-GYRLPP 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 80/357 (22%), Positives = 154/357 (43%), Gaps = 66/357 (18%)

Query: 4   RTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR 63
           +   ++ T + +Y+  + +G G+   V  A +T  G NVA+K L +          +  R
Sbjct: 11  QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYR 69

Query: 64  EISTMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEAR 117
           E+  +K + H N+I +  V   +        +Y+V+E +        +     ++ D  R
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-----NLCQVIHMELDHER 124

Query: 118 KYF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT 175
             +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +    + ++  
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTP 181

Query: 176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---- 231
              T  Y APEVI   GY     D+WS G I+  L+ G + F+ ++ +  + K+ +    
Sbjct: 182 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240

Query: 232 --ADFKS-------------------------PPWF-----------STSAKKLISRILD 253
             A+F +                         P W            ++ A+ L+S++L 
Sbjct: 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300

Query: 254 PNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
            +P  RI++ E + + +    Y P   E P         I++  ++ R   +E  +E
Sbjct: 301 IDPDKRISVDEALRHPYITVWYDPAEAEAPP------PQIYDAQLEEREHAIEEWKE 351

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 16/216 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--REISTMKLIRHPNVIRM 79
           LGEG++A V   R+  T   VA+K    E  L+H+        RE+S +K ++H N++ +
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF-QQLINAVDYCHSRGVCHR 138
           ++++ +   + +V E++   +L   +   G +      K F  Q++  + YCH R V HR
Sbjct: 70  HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 139 DLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           DLKP+NLL++  G LK++DFGL+   ++P +   + ++     T  Y  P+V+       
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSSEYS 183

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
            + D+W  G I + + +G   F  S +      IF+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
           +YE    +GEG++ KV  AR+ + G   VA+K + + +  +  M     RE++ ++ +  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60

Query: 73  --HPNVIRMYEVMA-----SKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQL 123
             HPNV+R+++V        +TK+ +V E V        DK+   G +  +  +    QL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           +  +D+ HS  V HRDLKP+N+L+ ++G +K++DFGL+ +         L +   T  Y 
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 176

Query: 184 APEVINNKGYDGAKADLWSCGVIL 207
           APEV+    Y     DLWS G I 
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIF 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 25/268 (9%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
             LG G+   V   ++  TG  +A K++      K  +  QI RE+  M   R P ++  
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSF 68

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSR-GVCH 137
           Y    ++  I + +EF+  G L D+I  + G +  +   K    ++  + Y ++   + H
Sbjct: 69  YGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127

Query: 138 RDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RD+KP N+L+++ G +K+ DFG+S  L   + D     T  GT  Y++PE I    Y   
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKYT-V 181

Query: 197 KADLWSCGVILYVLMAGYLPFEESNL--------MALYKKIFKADFKSPP-----WFSTS 243
           K+D+WS G+ +  L  G  PF  SN+        M +   + +   + PP      F   
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWF 271
            +  +   L  +P  R T  ++     F
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 86.5 bits (214), Expect = 4e-19
 Identities = 88/326 (26%), Positives = 139/326 (42%), Gaps = 59/326 (18%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK----EKVLKHKMIGQIKREISTMKL 70
           +Y   + +G G++  V  A +  TGE VAIK L +    E   K        RE++ +K 
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-----RELTLLKH 70

Query: 71  IRHPNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
           ++H NVI + +V  S          Y+V+ ++       KI     L ED+ +    Q++
Sbjct: 71  MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQML 127

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
             + Y HS G+ HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y A
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRA 182

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA------DF---- 234
           PEVI N  +     D+WS G I+  ++ G   F+  + +    +I K       +F    
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242

Query: 235 -------------KSP--------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                        K P        P  S  A  L+ ++L+ +   R+T  E +E+ +F  
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Query: 274 GYKPPSF-EQPNIDLDDVDSIFNESM 298
                   EQ   D    DS+ NE +
Sbjct: 303 FRDADEETEQQPYD----DSLENEKL 324

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 85.0 bits (210), Expect = 8e-19
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK---ILDKEKVLKHKMIGQIKREISTMKLI 71
           +YE    +G G++  V  AR+  +G  VA+K   +   E  L    +    RE++ +K +
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV----REVALLKRL 56

Query: 72  R---HPNVIRMYEVMAS-----KTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQ 121
               HPN++R+ +V A+     +TK+ +V E V        DK+   G L  +  +   +
Sbjct: 57  EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMR 115

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ-QVRDDGLLHTTCGTP 180
           Q +  +D+ H+  + HRDLKPEN+L+ + G +K++DFGL+ +   Q+    ++ T     
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW--- 172

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVIL 207
            Y APEV+    Y     D+WS G I 
Sbjct: 173 -YRAPEVLLQSTY-ATPVDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 85.0 bits (210), Expect = 8e-19
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 47/288 (16%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LGEGS+A V    +   G+ VA+K+  +  E+ +    I    RE S +K ++H N++ +
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLL 68

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           ++++ +K  +  V E++        I   G L     R +  QL+  + Y H + + HRD
Sbjct: 69  HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128

Query: 140 LKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           LKP+NLL+   G LK++DFGL+   ++P Q     ++     T  Y  P+V+       +
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATDYSS 183

Query: 197 KADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIF---------------KADFKSPPWF 240
             D+W  G I   ++ G   F   S++    +KI+               K     P WF
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 241 STS-----------------AKKLISRILDPNPVTRITMAEVIENEWF 271
                               A+ L S++L   P  RI+  + + + +F
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 44/222 (19%)

Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    A+    GE    VAIK +++   ++ ++  +   E S MK
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKY----FQQLIN 125
                +V+R+  V+++     +V+E +  G+L   + SR R + +          Q+ I 
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123

Query: 126 -------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--------- 169
                   + Y  ++   HRDL   N ++  +  +K+ DFG++      RD         
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT------RDIYETDYYRK 177

Query: 170 --DGLLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILY 208
              GLL      P  ++APE + + G    K+D+WS GV+L+
Sbjct: 178 GGKGLL------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 84.8 bits (209), Expect = 2e-18
 Identities = 79/355 (22%), Positives = 148/355 (41%), Gaps = 66/355 (18%)

Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 9   GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYREL 67

Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R  
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMS 122

Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 179

Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+        
Sbjct: 180 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           P  RI++ E +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 299 PAKRISVDEALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 347

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 28/239 (11%)

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCH 131
           P +++ Y    + + ++I +E +      DK+  R  G + ED   K    ++ A+ Y  
Sbjct: 74  PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 132 SR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT-TCGTPNYVAPEVIN 189
            + GV HRD+KP N+LLDA+G +K+ DFG+S   + V  D    T + G   Y+APE I+
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERID 187

Query: 190 ----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPPW---FS 241
               N  YD  +AD+WS G+ L  L  G  P++       +  KI + +  S P    FS
Sbjct: 188 PPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDS 300
                 +   L  +   R    E++++ + ++ Y+            DV   F + M  
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR-YETAEV--------DVAGWFQDVMAE 296

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 82.7 bits (204), Expect = 3e-18
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 26/198 (13%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G+F +V F    +    VA+K   ++  L  ++  +   E   +K   HPN++++  
Sbjct: 3   LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-AVD------YCHSRG 134
           V   +  IYIV+E V GG+    +    R K+DE +   +QL+  A+D      Y  S+ 
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELKT--KQLVKFALDAAAGMAYLESKN 113

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN----YVAPEVINN 190
             HRDL   N L+  N VLK+SDFG+S      ++D  ++++ G       + APE +N 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNY 168

Query: 191 KGYDGAKADLWSCGVILY 208
             Y  +++D+WS G++L+
Sbjct: 169 GRYS-SESDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y + +TL  GS  +V  A      + V +KI  K   L   M+         ++ + HP+
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAML---------LQNVNHPS 118

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRG 134
           VIRM + + S     +VL   +  +L+  +  R   L  D+A    +Q++  + Y H++ 
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEVINNKGY 193
           + HRD+K EN+ ++    + + D G +  P       GL     GT    APEV+    Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233

Query: 194 DGAKADLWSCGVILYVLMA 212
           + +KAD+WS G++L+ ++A
Sbjct: 234 N-SKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 4e-18
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKIL-----DKEKVLKHKMIGQIKREISTMKLI 71
           +L R LG G F +V       T   VA+K L     D +  L          E   MK +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFL---------AEAQIMKKL 58

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDY 129
           RHP +I++Y V   +  IYIV E +  G L + +       LK  +      Q+ + + Y
Sbjct: 59  RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
             ++   HRDL   N+L+  N + KV+DFGL+    +V  + +     G      + APE
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAKFPIKWTAPE 174

Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPF 217
                 +   K+D+WS G++L  ++  G +P+
Sbjct: 175 AALYNRFS-IKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)

Query: 7   GASRTRVGKYELGRTLGEGSFAKV-KFARNTETGE--NVAIKIL-------DKEKVLKHK 56
              R  +    LGR +GEG F  V +    +   E   VA+K          +EK L+  
Sbjct: 2   EIQREDI---TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-- 56

Query: 57  MIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDE 115
                  E   M+   HP+++++  V+ ++  ++IV+E    GEL   +  ++  L    
Sbjct: 57  -------EAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLAS 108

Query: 116 ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT 175
              Y  QL  A+ Y  S+   HRD+   N+L+ +   +K+ DFGLS     + D+     
Sbjct: 109 LILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKA 165

Query: 176 TCGT-P-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           + G  P  ++APE IN + +  A +D+W  GV ++ +LM G  PF
Sbjct: 166 SKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.5 bits (201), Expect = 7e-18
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 15/202 (7%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G G F  V      E  + VAIK + +E  +  +       E   M  + HP ++++Y 
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTI-REGAMSEE---DFIEEAQVMMKLSHPKLVQLYG 66

Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
           V   ++ I +V EF+  G L D + A RG+  ++        +   + Y  S  V HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDGAK 197
              N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  +K
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF---VLDDQYTSST-GTKFPVKWSSPEVFSFSKYS-SK 181

Query: 198 ADLWSCGVILY-VLMAGYLPFE 218
           +D+WS GV+++ V   G  P+E
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 39/226 (17%)

Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  LG+ LGEG+F +V  A      N      VA+K+L K+   +  +   +  E+  MK
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70

Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ------- 121
           +I +H N+I +  V   +  +Y+V+E+   G L D + +R R   + A            
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129

Query: 122 ----------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-- 169
                     Q+   +++  S+   HRDL   N+L+  + V+K++DFGL+      RD  
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIH 183

Query: 170 --DGLLHTTCG-TP-NYVAPEVINNKGYDGAKADLWSCGVILYVLM 211
             D    TT G  P  ++APE + ++ Y   ++D+WS GV+L+ + 
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 80/355 (22%), Positives = 148/355 (41%), Gaps = 66/355 (18%)

Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74

Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-----NLCQVIQMELDHERMS 129

Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 186

Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245

Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305

Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 54/226 (23%), Positives = 108/226 (47%), Gaps = 21/226 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
             +G+   +     V  A++  T   VA+K ++ +     + +  +++EI T + ++HPN
Sbjct: 4   TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHS 132
           ++         +++Y+V   +  G   D + +    G L E       + ++NA+DY HS
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-------NYVAP 185
           +G  HR +K  ++LL  +G + +S  GL      ++           P        +++P
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 186 EVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFEE--SNLMALYK 227
           EV+  N +GY+  K+D++S G+    L  G++PF++  +  M L K
Sbjct: 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 69/317 (21%), Positives = 137/317 (43%), Gaps = 73/317 (23%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKE----KVLKHKMIGQIKREISTM 68
           + +Y++ R +G+G   +V  A +      VA+K + ++     +LK + +    RE    
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL----REAKIA 56

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTG---GELFDKIASRGRLKEDEARK------- 118
             + HP ++ +Y + +    +Y  + ++ G     L   +  +  L ++ A K       
Sbjct: 57  ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 119 -YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD------- 170
             F ++   ++Y HS+GV HRDLKP+N+LL   G + + D+G +   +   +D       
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 171 --GLLHTT-------CGTPNYVAPEVINNKGYDGA-KADLWSCGVILYVLMAGYLPF--- 217
              + +++        GTP+Y+APE +   G   +   D+++ GVILY ++    P+   
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 218 -----------EESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRIT----M 262
                           +A Y++I       PP+ S    ++  + L  +P  R +    +
Sbjct: 235 KGRKISYRDVILSPIEVAPYREI-------PPFLS----QIAMKALAVDPAERYSSVQEL 283

Query: 263 AEVIEN------EWFKK 273
            + +E       EW  K
Sbjct: 284 KQDLEPHLQGSPEWTVK 300

Length = 932

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 17  ELGRTLGEGSFAKVKFA-RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V     N  T   VA+K L    +     +     E + MK ++H  
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNNST--KVAVKTLKPGTMSVQAFL----EEANLMKTLQHDK 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSR 133
           ++R+Y V+  +  IYI+ E++  G L D + S   G++   +   +  Q+   + Y   +
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINN 190
              HRDL+  N+L+  + + K++DFGL+    +V +D       G      + APE IN 
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINF 178

Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPF 217
             +   K+D+WS G++LY ++  G +P+
Sbjct: 179 GSFT-IKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 25/214 (11%)

Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + +G G F +V   R    G+    VAIK L      K +       E S M    HPN+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR--DFLSEASIMGQFDHPNI 67

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAVDY 129
           I +  V+     + IV E++  G L D       L++ + +    QL+       + + Y
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSL-DAF-----LRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
               G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + APE
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPE 179

Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPFEE 219
            I  + +  A +D+WS G++++ +M+ G  P+ E
Sbjct: 180 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 92/329 (27%), Positives = 142/329 (43%), Gaps = 55/329 (16%)

Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK-REIST 67
           +R+    Y+LG  +G GSF  V  A   +T E VAIK     KVL+     Q K RE+  
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDP---QYKNRELLI 112

Query: 68  MKLIRHPNVIRMYE------VMASKTKIY--IVLEFVTGG-ELFDKIASRGR--LKEDEA 116
           MK + H N+I + +         ++  I+  +V+EF+      + K  +R    L     
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172

Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHT 175
           + Y  QL  A+ Y HS+ +CHRDLKP+NLL+D N   LK+ DFG  +    +     +  
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSY 230

Query: 176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---- 231
            C +  Y APE++          DLWS G I+  ++ GY  F   + +    +I +    
Sbjct: 231 IC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289

Query: 232 -------------ADFKSPPWFSTSAKK------------LISRILDPNPVTRITMAEVI 266
                        AD K P       KK             IS+ L   P+ R+   E +
Sbjct: 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349

Query: 267 ENEWFKKGYKPPSFEQPNIDLDDVDSIFN 295
            + +F    + P  + P   +D +  +FN
Sbjct: 350 ADPFFDD-LRDPCIKLPKY-IDKLPDLFN 376

Length = 440

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMK 69
            + E  + LG G+F  V        GE     VAIK+L +E     K   +I  E   M 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVD 128
            + HP+V+R+  +  S   + ++ + +  G L D + + +  +       +  Q+   + 
Sbjct: 65  SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPE 186
           Y   + + HRDL   N+L+     +K++DFGL+ L     D+   H   G  P  ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181

Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPFE 218
            I ++ Y   K+D+WS GV ++ LM  G  P+E
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 22  LGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N++
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIV 68

Query: 78  RMYEVM--ASKTKIYIVLEFVTGGELFDK-IASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +   V   A +  + +V+E++  G L D     R RL   +   Y  Q+   ++Y  S+ 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNKGY 193
             HRDL   N+L+++   +K+ DFGL+ +  Q ++   +     +P +  APE +    +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188

Query: 194 DGAKADLWSCGVILYVL 210
             A +D+WS GV+LY L
Sbjct: 189 SVA-SDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 8/196 (4%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V   ++  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDL 140
              S  +I I +E + GG L   +    R+ E+   K    ++  + Y   +  + HRD+
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185

Query: 201 WSCGVILYVLMAGYLP 216
           WS G+ L  L  G  P
Sbjct: 186 WSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 24/231 (10%)

Query: 22  LGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           +G G F +V   R    G+    VAIK L      K +       E S M    HPN+I 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAVDYCH 131
           +  V+     + I+ EF+  G L D       L++++ +    QL+         + Y  
Sbjct: 70  LEGVVTKSRPVMIITEFMENGAL-DSF-----LRQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVI 188
                HRDL   N+L+++N V KVSDFGLS   +    D    ++ G      + APE I
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
             + +  A +D+WS G++++ +M+ G  P+ + +   +   I + D++ PP
Sbjct: 184 AYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPP 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
            LG G+   V  A +  T   +A+K++  +  ++  +  QI  E+  +     P +I  Y
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65

Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL 140
                + +I I  EF+ GG L        ++ E    +    ++  + Y  S  + HRD+
Sbjct: 66  GAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L++  G +K+ DFG+S   Q V  + +  T  GT  Y+APE I+ + Y G  +D+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVST--QLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176

Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+    L  G  P+
Sbjct: 177 WSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 8/196 (4%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130

Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185

Query: 201 WSCGVILYVLMAGYLP 216
           WS G+ L  +  G  P
Sbjct: 186 WSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)

Query: 20  RTLGEGSFAKVK---FARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + LG G+F  V    +   +     VA+K L +E +   K   +  RE S M  + HP +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           +R+  V   +  + +V+E    G L   +  R  +   + ++   Q+   + Y  S+   
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 137 HRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGT-P-NYVAPEVINNKGY 193
           HRDL   N+LL      K+SDFG+S AL      D    TT G  P  + APE IN   +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 194 DGAKADLWSCGVILY-VLMAGYLPFEE 219
             +K+D+WS GV L+     G  P+ E
Sbjct: 176 S-SKSDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.2 bits (182), Expect = 3e-15
 Identities = 70/265 (26%), Positives = 122/265 (46%), Gaps = 27/265 (10%)

Query: 16  YELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           + LGR LG+G F  V+ A+      + + VA+K+L K  +     I +  RE + MK   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 73  HPNVIRMYEV-MASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-- 124
           HPNVI++  V + S+ K       ++L F+  G+L   +    R+ E+      Q L+  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPFTLPLQTLVRF 118

Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
                + ++Y  S+   HRDL   N +L+ N  + V+DFGLS   +++         C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175

Query: 180 P---NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-F 234
                ++A E + +  Y    +D+W+ GV ++ +M  G  P+       +Y  + K +  
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234

Query: 235 KSPPWFSTSAKKLISRILDPNPVTR 259
           K PP       +L+ +   P P  R
Sbjct: 235 KQPPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 17/216 (7%)

Query: 17  ELGRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           EL   +G G      V  AR   TGE V ++ ++ E    ++M+  ++ E+   KL  HP
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHP 59

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHS 132
           N++       +  ++++V  F+  G   D I +     + E       Q ++ A+DY H 
Sbjct: 60  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-------VAP 185
            G  HR +K  ++L+  +G  KV   GL +    +     L      P Y       ++P
Sbjct: 120 MGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177

Query: 186 EVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
           EV+  N +GYD AK+D++S G+    L  G++PF++
Sbjct: 178 EVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 72/276 (26%), Positives = 131/276 (47%), Gaps = 38/276 (13%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIK-----ILDKEKVLKHKMIGQIKREISTMKLIRHP 74
             LG G++  V   R+  TG  +A+K     +  +E+    +++  +  +IS M+ +  P
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDL--DIS-MRSVDCP 60

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRG-RLKEDEARKYFQQLINAVDYCH 131
             +  Y  +  +  ++I +E +     + + K+  +G  + ED   K    ++ A++Y H
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 132 SR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN- 189
           S+  V HRD+KP N+L++ NG +K+ DFG+S     + D        G   Y+APE IN 
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINP 177

Query: 190 ---NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---KADFKSPP----- 238
               KGYD  K+D+WS G+ +  L  G  P++       +K  F   K   + P      
Sbjct: 178 ELNQKGYD-VKSDVWSLGITMIELATGRFPYDS------WKTPFQQLKQVVEEPSPQLPA 230

Query: 239 -WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             FS   +  +++ L  N   R    E++++ +F+ 
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 47/248 (18%)

Query: 15  KYELGRTLGEGSFAKVKFAR--NTETGENVAIKILDKEKVLKHKMIG---QIKREISTMK 69
           KYE+   +G G++ +V  A+  N + G+  AIK   K K  K +  G      REI+ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLR 57

Query: 70  LIRHPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKI-----ASRGRLKEDEARKYFQQ 122
            ++H NV+ + EV        +Y++ ++    +L+  I     A R  +     +    Q
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 123 LINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGL-----SALPQQVRDDGLL 173
           ++N V Y HS  V HRDLKP N+L+       GV+K+ D GL     + L      D ++
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 174 HTTCGTPNYVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK- 231
            T      Y APE++   + Y  A  D+W+ G I          F E  L+ L + IFK 
Sbjct: 177 VTIW----YRAPELLLGARHYTKA-IDIWAIGCI----------FAE--LLTL-EPIFKG 218

Query: 232 --ADFKSP 237
             A  K  
Sbjct: 219 REAKIKKS 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 31/217 (14%)

Query: 18  LGRTLGEGSFAKVKFAR-------NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG F +V  A          +    VA+K+L        K +  +  E+  MKL
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKL 73

Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKED---------EARKYF 120
           I +H N+I +  V   +  +Y+++E+   G L + + +R     D         E +  F
Sbjct: 74  IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 121 QQLINAV-------DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
           + L++         +Y  SR   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191

Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY 208
            T+ G     ++APE + ++ Y   ++D+WS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 27/212 (12%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V  A  N  T   VA+K +    +     +     E + MK ++H  
Sbjct: 9   KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDK 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--------YFQQLINAV 127
           +++++ V+ +K  IYI+ EF+  G L D       LK DE  K        +  Q+   +
Sbjct: 63  LVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGM 115

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPE 186
            +   R   HRDL+  N+L+ A+ V K++DFGL+ + +   ++         P  + APE
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE 173

Query: 187 VINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
            IN   +   K+D+WS G++L  ++  G +P+
Sbjct: 174 AINFGSFT-IKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 74/288 (25%), Positives = 132/288 (45%), Gaps = 36/288 (12%)

Query: 9   SRTRVGKYELGRTLGEGSFAKVKFAR-------NTETGENVAIKILDKEKVLKHKMIGQI 61
           SRTR+    LG+ LGEG F +V  A               VA+K+L  +     K +  +
Sbjct: 10  SRTRL---TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDL 64

Query: 62  KREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR---------GRL 111
             E+  MK+I +H N+I +         +Y+++E+ + G L + + +R            
Sbjct: 65  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124

Query: 112 KEDEARKYFQQLIN-------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP 164
           K  E +  F+ L++        ++Y  S+   HRDL   N+L+  + V+K++DFGL+   
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 165 QQVRDDGLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESN 221
             +  D    TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    
Sbjct: 185 HNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241

Query: 222 LMALYKKIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +  L+K + +      P   T    +I R      P  R T  +++E+
Sbjct: 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 61/240 (25%), Positives = 114/240 (47%), Gaps = 32/240 (13%)

Query: 15  KYELGRTLGEGSFAKVKFAR-------NTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG F +V  A          +    VA+K+L  +     K +  +  E+  
Sbjct: 16  KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 73

Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKED---------EAR 117
           MK+I +H N+I +         +Y+++E+ + G L + + +R     +         + +
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 118 KYFQQLIN-------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
             F+ L++        ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--D 191

Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI-STMKLIRHPNVIRMY 80
           +G G+F  V    +  +G  +A+K + +  V + +   ++  ++   M+    P +++ Y
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQK-RLLMDLDVVMRSSDCPYIVKFY 69

Query: 81  EVMASKTKIYIVLEFV-TGGELFDKIA---SRGRLKEDEARKYFQQLINAVDYCHSR-GV 135
             +  +   +I +E +    + F K      +  + E+   K     + A++Y      +
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQ----QVRDDGLLHTTCGTPNYVAPEVIN-- 189
            HRD+KP N+LLD NG +K+ DFG+S        + RD G     C  P Y+APE I+  
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG-----C-RP-YMAPERIDPS 182

Query: 190 -NKGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
              GYD  ++D+WS G+ LY +  G  P+ + N
Sbjct: 183 ARDGYD-VRSDVWSLGITLYEVATGKFPYPKWN 214

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 30/210 (14%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           ELG   G G   KV    +  +G  +A K++  E  +K  +  QI RE+  +     P +
Sbjct: 8   ELGAGNG-GVVTKV---LHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYI 61

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGV 135
           +  Y    S  +I I +E + GG L D++  + GR+ E+        ++  +     RG+
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEN--------ILGKISIAVLRGL 112

Query: 136 C---------HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
                     HRD+KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPE 168

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLP 216
            +    Y   ++D+WS G+ L  +  G  P
Sbjct: 169 RLQGTHY-TVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 20/159 (12%)

Query: 60  QIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE--------FVTGGELFDKIASRGRL 111
           Q++ EI  +  + H N++++ E++ S+   Y++ +        F+       K   R  L
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK--DRPLL 266

Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL---PQQVR 168
           K+   R   +QL+ AV+Y H + + HRD+K EN+ L+ +G + + DFG +      ++  
Sbjct: 267 KQ--TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVIL 207
           D G +    GT    +PE++   GY     D+WSCG+IL
Sbjct: 325 DYGWV----GTVATNSPEILAGDGY-CEITDIWSCGLIL 358

Length = 501

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 17  ELGRTLGEGSFAKV--KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +L + LG G F +V   +         VAIK L K+  +          E + MK ++HP
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNGHT---KVAIKSL-KQGSMS---PEAFLAEANLMKQLQHP 61

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHS 132
            ++R+Y V+ ++  IYI+ E++  G L D  K     +L  ++      Q+   + +   
Sbjct: 62  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNK 191
           +   HRDL+  N+L+      K++DFGL+ L +   ++         P  + APE I N 
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NY 177

Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPF 217
           G    K+D+WS G++L  ++  G +P+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 32/237 (13%)

Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG F +V  A      +        VA+K+L  +     K +  +  E+  MK+
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 79

Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 197

Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 27/271 (9%)

Query: 18  LGRTLGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           LG+ LGEG F  V   + + + G    VA+K + K  +  +  I +   E + MK   HP
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 75  NVIRMYEV---MASKTKI---YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-AV 127
           NV+++  V    +S  KI    ++L F+  G+L   +    RL     +   Q L+   V
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMV 120

Query: 128 D------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP- 180
           D      Y  +R   HRDL   N +L  +  + V+DFGLS   +++              
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKM 177

Query: 181 --NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKS 236
              ++A E + ++ Y  +K+D+W+ GV ++ +   G  P+       +Y  +   +  K 
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 237 PPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
           P         L+      +P  R T  ++ E
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.8 bits (165), Expect = 6e-13
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 22  LGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG+G F +V     T  G   VAIK L    +     +    +E   MK +RH  ++++Y
Sbjct: 14  LGQGCFGEV--WMGTWNGTTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLY 67

Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ S+  IYIV E+++ G L D  K      L+  +      Q+ + + Y       HR
Sbjct: 68  AVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126

Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA-LYGRFTIK 183

Query: 198 ADLWSCGVILYVLMA-GYLPF 217
           +D+WS G++L  L   G +P+
Sbjct: 184 SDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 12/193 (6%)

Query: 22  LGEGSFAKVK--FARNTETGENVAIKIL---DKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           LG G+F  VK    +  ++ + VA+KIL   + +  LK +++    RE + M+ + +P +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL----REANVMQQLDNPYI 58

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           +RM  +  +++ + +V+E    G L   +     + E    +   Q+   + Y       
Sbjct: 59  VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           HRDL   N+LL      K+SDFGLS       +     T    P  + APE +N   +  
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176

Query: 196 AKADLWSCGVILY 208
           +K+D+WS GV+++
Sbjct: 177 SKSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T + VAIK L    ++    +    +E   MK +RH  ++ +Y 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFL----QEAQIMKKLRHDKLVPLYA 68

Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV EF+  G L D  K      LK  +      Q+ + + Y       HRD
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V K++DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 184

Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L+  G +P+
Sbjct: 185 DVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 42/286 (14%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETG-----ENVAIKILDKEKVLKHKMIGQIKREISTMK 69
              LG+TLGEG F KV  A             VA+K+L +           +  E + +K
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLK 58

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL----------------FDKIASRGRLKE 113
            + HP+VI++Y   +    + +++E+   G L                 D   +   L  
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 114 DEAR--------KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ 165
            + R         +  Q+   + Y     + HRDL   N+L+     +K+SDFGLS    
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--D 176

Query: 166 QVRDDGLLHTTCG-TP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPF---EE 219
              +D  +  + G  P  ++A E + +  Y   ++D+WS GV+L+ ++  G  P+     
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 220 SNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEV 265
             L  L K  ++ +   P   S     L+       P  R T A++
Sbjct: 236 ERLFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 24/208 (11%)

Query: 22  LGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           LGEG+F KV            +  +VAIK L +    K +   + ++E   M  ++HPN+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYF 120
           + +  V   +    ++ E++  G+L + +                     L   +     
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
            Q+   ++Y  S    HRDL   N L+     +K+SDFGLS          +   +    
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILY 208
            ++ PE I   G    ++D+WS GV+L+
Sbjct: 191 RWMPPEAILY-GKFTTESDIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 19/215 (8%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           E+GR  G  +   V  AR+T TG  V ++I D E   +  +   ++ E+      RHPN+
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61

Query: 77  IRMYEVMASKTKIYIVLEFVTGG---ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +  + V  + + ++++  F+  G    L       G + E          +  ++Y H  
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-------VAPE 186
           G  HR++K  ++L+  +G++ +S  GLS L   VR+          P +       ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 187 VINNK--GYDGAKADLWSCGVILYVLMAGYLPFEE 219
           ++     GY+  K+D++S G+    L  G +PF++
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 23/264 (8%)

Query: 21  TLGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           TLG G F +V  A+     E      V +K L K K     +  + +RE+   + + H N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKN 69

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           V+R+  +       Y++LE+   G+L   + A++ + ++ +      +   A+    + G
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 135 V--------CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAP 185
           +         HRDL   N L+ +   +KVS   LS        +         P  ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAP 187

Query: 186 EVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           E +    +   K+D+WS GV+++ V   G LPF   +   +  ++     + P      +
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246

Query: 245 K--KLISRILDPNPVTRITMAEVI 266
           +  KL++R    NP  R + +E++
Sbjct: 247 RLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 29/226 (12%)

Query: 20  RTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + +G G F +V     K     E    VAIK L      K +       E S M    H 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVA--VAIKTLKPGYTEKQRQ--DFLSEASIMGQFSHH 66

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-------AV 127
           N+IR+  V+       I+ E++  G L DK      L++ +      QL+         +
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y       HRDL   N+L+++N   KVSDFGLS + +   D    +TT G      + A
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTA 178

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI 229
           PE I  + +  A +D+WS G++++ +M+ G  P+ + +   + K I
Sbjct: 179 PEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 15/210 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V     T  G   VA+K L    +     +     E   MK +RH  
Sbjct: 9   QLIKKLGNGQFGEV--WMGTWNGNTKVAVKTLKPGTMSPESFL----EEAQIMKKLRHDK 62

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGR-LKEDEARKYFQQLINAVDYCHSR 133
           ++++Y V+ S+  IYIV E+++ G L D +    GR LK         Q+   + Y    
Sbjct: 63  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRDL+  N+L+    V K++DFGL+ L +   ++         P  + APE     G
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAA-LYG 178

Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFEESN 221
               K+D+WS G++L  L+  G +P+   N
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMN 208

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 17/219 (7%)

Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S +  AS  R+ +Y +  +L  GS  +V     T+ G+    K++ K  V   K  G   
Sbjct: 82  SSSDPASVVRM-QYNILSSLTPGSEGEVFVC--TKHGDEQRKKVIVK-AVTGGKTPG--- 134

Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           REI  +K I H  +I +      K+ + +V+      +LF  +   G L  ++A    ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCG 178
           L+ A+ Y H RG+ HRD+K EN+ LD      + DFG    L A P   +  G      G
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW----SG 249

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           T    +PE++    Y  AK D+WS G++L+ +    +  
Sbjct: 250 TLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.2 bits (153), Expect = 2e-11
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 30/230 (13%)

Query: 22  LGEGSFAKVKFARNTETG--ENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIR 78
           +GEG+F +V  AR  + G   + AIK + KE   K         E+  + KL  HPN+I 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDH-RDFAGELEVLCKLGHHPNIIN 60

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA----------------RKYFQQ 122
           +      +  +Y+ +E+   G L D +     L+ D A                  +   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG--TP 180
           +   +DY   +   HRDL   N+L+  N V K++DFGLS        +  +  T G    
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPV 175

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI 229
            ++A E +N   Y    +D+WS GV+L+ +++ G  P+       LY+K+
Sbjct: 176 RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 34/232 (14%)

Query: 22  LGEGSFAKVKFARNTETGE--NVAIKILDKEKVLK--HKMIGQIKREISTM-KLIRHPNV 76
           +GEG+F +V  A   + G   N AIK+L KE   +  H+       E+  + KL  HPN+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHR---DFAGELEVLCKLGHHPNI 65

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA--RKY-------FQQLI--- 124
           I +     ++  +YI +E+   G L D +     L+ D A  +++        QQL+   
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 125 ----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-- 178
                 + Y   +   HRDL   N+L+  N   K++DFGLS       ++  +  T G  
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRL 180

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI 229
              ++A E +N   Y   K+D+WS GV+L+ +++ G  P+       LY+K+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 43/281 (15%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIRMY 80
           +GEG+F +V  AR  + G  +   I   ++            E+  + KL  HPN+I + 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF---------QQLIN------ 125
                +  +Y+ +E+   G L D +     L+ D A             QQL++      
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 126 -AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG--TPNY 182
             +DY   +   HRDL   N+L+  N V K++DFGLS   Q+V     +  T G     +
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGRLPVRW 189

Query: 183 VAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           +A E +N   Y    +D+WS GV+L+ ++  G  P+       LY+K+       P  + 
Sbjct: 190 MAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGYR 241

Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
                 + + L+ +      + +++   W +K Y+ PSF Q
Sbjct: 242 ------LEKPLNCDD----EVYDLMRQCWREKPYERPSFAQ 272

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 46/236 (19%)

Query: 18  LGRTLGEGSFAKVKFA--RNTETGEN---VAIKILDKEKVLK--HKMIGQIKREISTMKL 70
           L R LGEG+F KV      + E   +   VA+K L KE       K     +RE   +  
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARK---DFEREAELLTN 64

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG--------------RLKEDEA 116
            +H N+++ Y V        +V E++  G+L   + S G               L   + 
Sbjct: 65  FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q+ + + Y  S+   HRDL   N L+  + V+K+ DFG+S      RD   ++TT
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTT 175

Query: 177 -----CGTP----NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLP-FEESN 221
                 G       ++ PE I  + +   ++D+WS GV+L+ +   G  P +  SN
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSN 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.5 bits (149), Expect = 7e-11
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 18/196 (9%)

Query: 22  LGEGSFAKVK--FARNTETGENVAIKIL--DKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LG G+F  VK    +  +   +VAIK+L  + EK ++ +M+    RE   M  + +P ++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM----REAEIMHQLDNPYIV 58

Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           RM  V  ++  + +V+E  +GG L   ++  +  +      +   Q+   + Y   +   
Sbjct: 59  RMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117

Query: 137 HRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTP---NYVAPEVINNKG 192
           HRDL   N+LL      K+SDFGLS AL     DD              + APE IN + 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 193 YDGAKADLWSCGVILY 208
           +  +++D+WS G+ ++
Sbjct: 175 FS-SRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.8 bits (150), Expect = 8e-11
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 42/228 (18%)

Query: 14  GKYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
              E  R +G+G+F +V  AR       E    VA+K+L +E     +     +RE + M
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALM 62

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQ 121
               HPN++++  V A    + ++ E++  G+L + +  R              ARK   
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 122 ---------QLINAVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                    QL  A        Y   R   HRDL   N L+  N V+K++DFGLS     
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----- 177

Query: 167 VRDDGLLHTTCGTPN------YVAPEVINNKGYDGAKADLWSCGVILY 208
            R+         + N      ++ PE I    Y   ++D+W+ GV+L+
Sbjct: 178 -RNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 10/205 (4%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           R+  +  + T + ++ + +  G L D +   +  +       +  Q+   ++Y   R + 
Sbjct: 73  RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV 131

Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNKGYD 194
           HRDL   N+L+     +K++DFGL+ L     D+   H   G  P  ++A E I ++ Y 
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 195 GAKADLWSCGVILYVLMA-GYLPFE 218
             ++D+WS GV ++ LM  G  P++
Sbjct: 190 -HQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 58/248 (23%), Positives = 110/248 (44%), Gaps = 37/248 (14%)

Query: 17  ELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KL 70
             G+TLG G+F KV  A       ++    VA+K+L        +    +  E+  M  L
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE--ALMSELKIMSHL 95

Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVD 128
             H N++ +         I ++ E+   G+L + +  +    L  ++   +  Q+   + 
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV----- 183
           +  S+   HRDL   N+LL    ++K+ DFGL+      RD  +++ +    NYV     
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----NYVVKGNA 203

Query: 184 -------APEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK 235
                  APE I N  Y   ++D+WS G++L+ + + G  P+    + + + K+ K  ++
Sbjct: 204 RLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262

Query: 236 -SPPWFST 242
            + P  + 
Sbjct: 263 MAQPEHAP 270

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 31/215 (14%)

Query: 18  LGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           L R LGEG+F KV  A       T+    VA+K L    +   K     +RE   +  ++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQ 65

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELF----------------DKIASRGRLKEDEA 116
           H ++++ Y V      + +V E++  G+L                     ++G L   + 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA---LPQQVRDDGLL 173
                Q+ + + Y  S+   HRDL   N L+ AN ++K+ DFG+S         R  G  
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183

Query: 174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
           HT      ++ PE I  + +   ++D+WS GVIL+
Sbjct: 184 HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 41/181 (22%), Positives = 84/181 (46%), Gaps = 14/181 (7%)

Query: 35  NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL- 93
           + +T E+V IK   +         G    E   ++ I HP++I++           ++L 
Sbjct: 113 DNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163

Query: 94  EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVL 153
            + T  +L+  +A++  +   +     + ++ A+ Y H   + HRD+K EN+ ++  G +
Sbjct: 164 RYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221

Query: 154 KVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG 213
            + DFG +  P  +  +   +   GT    APE++    Y G   D+WS G++L+ +   
Sbjct: 222 CLGDFGAACFPVDINANK-YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279

Query: 214 Y 214
           +
Sbjct: 280 H 280

Length = 391

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 1/88 (1%)

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           +QL++A+DY H  G+ HRD+K EN+L++    + + DFG +   +        +   GT 
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILY 208
           +  APEV+    Y     D+WS G++++
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 66/289 (22%), Positives = 109/289 (37%), Gaps = 62/289 (21%)

Query: 17  ELGRTLGEGSFAKVKFA-----RNTETGENVAIKIL-------DKEKVLKHKMIGQIKRE 64
            L R LG G+F +V                VA+K L       D+   L   +I      
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI------ 62

Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK------ 118
              M    H N++R+  V   +   +I+LE + GG+L      +  L+E+  R       
Sbjct: 63  ---MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSL 113

Query: 119 YFQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLS-----AL 163
             + L+  A D      Y       HRD+   N LL   G   V K++DFG++     A 
Sbjct: 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173

Query: 164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG---AKADLWSCGVILYVLMA-GYLPFE- 218
             +     +L        ++ PE       DG   +K D+WS GV+L+ + + GY+P+  
Sbjct: 174 YYRKGGRAMLPI-----KWMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Query: 219 ESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            +N   +           P        ++++      P  R   A ++E
Sbjct: 225 RTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 18  LGRTLGEGSFAKVKFAR--NTETGENVAIKILDKEKVLKHKMIGQIK---REISTMKLIR 72
           L R LGEG+F KV  A   N    ++   KIL   K LK       K   RE   +  ++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQD---KILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------------RLKEDEARKY 119
           H ++++ Y V      + +V E++  G+L   + + G              L + +    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA---LPQQVRDDGLLHTT 176
            QQ+   + Y  S+   HRDL   N L+  N ++K+ DFG+S         R  G  HT 
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTM 183

Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                ++ PE I  + +   ++D+WS GV+L+
Sbjct: 184 LPI-RWMPPESIMYRKFT-TESDVWSLGVVLW 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 24/270 (8%)

Query: 18  LGRTLGEGSFAKVKFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           LG+TLGEG F  V   +  +      VA+K + K  +     +     E   MK   HPN
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 76  VIRMYEV--MASKTKIY----IVLEFVTGGEL-----FDKIASRGR-LKEDEARKYFQQL 123
           V+R+  V     +++ Y    ++L F+  G+L     + ++    + L      K+   +
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--TCGTP- 180
            + ++Y  S+   HRDL   N +L+ N  + V+DFGLS   +++ +            P 
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS---KKIYNGDYYRQGRIAKMPV 178

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKAD-FKSPP 238
            ++A E + ++ Y   K+D+WS GV ++ +   G  P+       +Y  + + +  K PP
Sbjct: 179 KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIEN 268
                   L+S     NP  R +   +   
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK----REISTMKL 70
           +YE G  +G G++  V  A+  +  +       +KE  LK      I     REI+ ++ 
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGISMSACREIALLRE 54

Query: 71  IRHPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKI----ASRG-----RLKEDEARKY 119
           ++HPNVI + +V  S +  K++++ ++    +L+  I    AS+      +L     +  
Sbjct: 55  LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLSAL---PQQVRDDGL 172
             Q+++ + Y H+  V HRDLKP N+L+       G +K++D G + L   P +   D  
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-- 171

Query: 173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM 211
           L     T  Y APE++    +     D+W+ G I   L+
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 55/237 (23%), Positives = 103/237 (43%), Gaps = 38/237 (16%)

Query: 22  LGEGSFAKVK----FARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LGE +F K+     +    +  + VAIK L      +    G+ ++E S M  + HPN++
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70

Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASR-------------GRLKEDEARKYFQ--- 121
            +  V+  +  + ++ E++  G+L + +  R             G +K       F    
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 122 -QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL-----SALPQQVRDDGLLHT 175
            Q+   ++Y  S    H+DL   N+L+     +K+SD GL     SA   +V+   LL  
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVL----MAGYLPFEESNLMALYKK 228
                 ++ PE I    +  + +D+WS GV+L+ +    +  Y  F    ++ + +K
Sbjct: 191 -----RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK----REISTMKL 70
           +YE G  +G G++  V  A+  +  +       D++  LK      I     REI+ ++ 
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54

Query: 71  IRHPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKI----ASRG-----RLKEDEARKY 119
           ++HPNVI + +V  S    K++++ ++    +L+  I    AS+      +L     +  
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLSAL---PQQVRDDGL 172
             Q+++ + Y H+  V HRDLKP N+L+       G +K++D G + L   P +   D  
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-- 171

Query: 173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM 211
           L     T  Y APE++    +     D+W+ G I   L+
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            ++++   LGEG+F KV  A + +  E  A+KI+    V K+    +I  EI  M+ +R 
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKI--EIQFMEKVRQ 184

Query: 74  PNVIRMYEVMASKTKIY---------IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
            +    + +M  K + Y         IV+    G  L D I   G        +   Q  
Sbjct: 185 ADPADRFPLM--KIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSHRHLAQIIFQTG 241

Query: 125 NAVDYCHSR-GVCHRDLKPENLLLDAN--GVLKVSDFGLSALPQQVR--------DDGLL 173
            A+DY H+   + H DLKPEN+L++ +   V  V++  L   P +VR        D+   
Sbjct: 242 VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS 301

Query: 174 HTT-CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE 218
            T    T +Y +PEV+   G+     D+WS G I+Y L  G L ++
Sbjct: 302 RTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYD 346

Length = 467

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)

Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI----STMKLIRHPN 75
           + LG G+F  V        GENV I +    KVL+     +  +EI      M  +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPV--AIKVLRENTSPKANKEILDEAYVMAGVGSPY 70

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           V R+  +  + T + +V + +  G L D +  ++ R+   +   +  Q+   + Y     
Sbjct: 71  VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNKG 192
           + HRDL   N+L+ +   +K++DFGL+ L     D+   H   G  P  ++A E I ++ 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRR 187

Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFE 218
           +   ++D+WS GV ++ LM  G  P++
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 23/234 (9%)

Query: 22  LGEGSFAKVKFARNTETGENVA---IKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           +G G F KV        G + A   +K L        ++     +E+   + + HPNV++
Sbjct: 3   IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQ 59

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQL----INAVDYCHSR 133
                       +VLEF   G+L + + S RG + +   +   Q++     + + + H  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC-GTP-NYVAPEVINNK 191
              H DL   N  L A+  +K+ D+GL+   +Q  +D  +   C   P  ++APE++  +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 192 GYD------GAKADLWSCGVILYVLM-AGYLPFEE-SNLMALYKKIFKADFKSP 237
           G D        K+++WS GV ++ L  A   P+ + S+   L + + + D K P
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 18/259 (6%)

Query: 20  RTLGEGSFAKV---KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           R +G+G F  V       +     + A+K L++   L+   + Q  +E   MK   HPNV
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58

Query: 77  IRMYEVMASKTKI-YIVLEFVTGGELFDKIASRGRLKEDEARKYFQ-QLINAVDYCHSRG 134
           + +  +         +VL ++  G+L + I S       +    F  Q+   ++Y  S+ 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL----HTTCGTP-NYVAPEVIN 189
             HRDL   N +LD +  +KV+DFGL+   + + D        HT    P  ++A E + 
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLA---RDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 190 NKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL 247
            + +   K+D+WS GV+L+ LM  G  P+ + +   +   + +      P +      ++
Sbjct: 176 TQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234

Query: 248 ISRILDPNPVTRITMAEVI 266
           +     P P  R T +E++
Sbjct: 235 MLSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 14/207 (6%)

Query: 20  RTLGEGSFAKVKFARNTETGENV----AIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG G+F  V        GE V    AIKIL++    K  +  +   E   M  + HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++R+  V  S T I +V + +  G L D +   +  +       +  Q+   + Y   R 
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP--NYVAPEVINNKG 192
           + HRDL   N+L+ +   +K++DFGL+ L +   D+   +   G     ++A E I+ + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKWMALECIHYRK 187

Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFE 218
           +   ++D+WS GV ++ LM  G  P++
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 40/220 (18%)

Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 7   KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS--------RGRLKE--DEARKY 119
                +V+R+  V++      +V+E +  G+L   + S         GR      E  + 
Sbjct: 65  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD---------- 169
             ++ + + Y +++   HRDL   N ++  +  +K+ DFG++      RD          
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYETDYYRKG 178

Query: 170 -DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
             GLL        ++APE + + G     +D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 35/170 (20%)

Query: 22  LGEGSFAKV---------KFARNTETGEN-------VAIKIL--DKEKVLKHKMIGQIKR 63
           LGEG F +V         KF     + +        VA+K+L  D  K  ++  +    +
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL----K 68

Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA------- 116
           EI  M  ++ PN+IR+  V  +   + ++ E++  G+L ++  SR   +E          
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTI 127

Query: 117 -----RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS 161
                     Q+ + + Y  S    HRDL   N L+  N  +K++DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 12/160 (7%)

Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQ 121
           E  T+    H N++R+  V+     + IV E+++ G L D    +  G+L   +      
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLP 114

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
            L + + Y    G  H+ L    +L++++ V K+S F       Q      ++TT    +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKS 170

Query: 182 YV---APEVINNKGYDGAKADLWSCGVILYVLMA-GYLPF 217
            V   APE I    +  A +D+WS G++++ +M+ G  P+
Sbjct: 171 PVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 44/228 (19%)

Query: 20  RTLGEGSFAKVKFARNTE-----TGE-NVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             LG G+F +V     T+     +G   VA+K L K    + K   +  +E   M    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD----- 128
           PN++++  V       YI++E + GG+L         L++    ++   L+   +     
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLS------YLRDARVERFGPPLLTLKELLDIC 112

Query: 129 --------YCHSRGVCHRDLKPENLLL-----DANGVLKVSDFGL-----SALPQQVRDD 170
                   Y       HRDL   N L+     DA+ V+K+ DFGL      +   +   +
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           GLL        ++APE + + G    ++D+WS GV+++ +L  G  P+
Sbjct: 173 GLLPV-----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 40/220 (18%)

Query: 15  KYELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  + R LG+GSF  V     K     E    VAIK +++   ++ ++  +   E S MK
Sbjct: 7   KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEA------RKYFQ- 121
                +V+R+  V++      +++E +T G+L   + S R  ++ +        +K  Q 
Sbjct: 65  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124

Query: 122 --QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD---------- 169
             ++ + + Y ++    HRDL   N ++  +  +K+ DFG++      RD          
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 178

Query: 170 -DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
             GLL        +++PE + + G     +D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS----TMKLIRHP 74
            + LG G F  V        G+++ I +    K ++ +   Q  +EI+     M  + H 
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPV--AIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSR 133
            ++R+  +      + +V +    G L D +   R  L       +  Q+   + Y    
Sbjct: 70  YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTP-NYVAPEVINN 190
            + HR+L   N+LL ++ +++++DFG++ L  P    D    ++   TP  ++A E I  
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKTPIKWMALESILF 185

Query: 191 KGYDGAKADLWSCGVILYVLMA 212
             Y   ++D+WS GV ++ +M+
Sbjct: 186 GRYT-HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-----DGLL 173
           Y  Q+   +++  SR   HRDL   N+LL  N V+K+ DFGL+      RD     D + 
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVR 232

Query: 174 HTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFK 231
             +   P  ++APE I +K Y   ++D+WS GV+L+ + + G  P+    +   + +  K
Sbjct: 233 KGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291

Query: 232 --ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
                ++P   +    +++      +P  R T + ++E
Sbjct: 292 DGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 27/152 (17%)

Query: 164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM 223
              V  + +L    GTP+Y+APE++  K +  A  D W+ GV L+  + G  PF +    
Sbjct: 532 AAPVEGERIL----GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQ 586

Query: 224 ALYKKIFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIEN------EWF 271
            +++ I   D    PW       S +A+  I  +L  +P  R  + E+ ++      +W 
Sbjct: 587 QVFQNILNRDI---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWE 643

Query: 272 KKGYKPPSF-EQPNIDLDDVDSIFNESMDSRN 302
               +   F  QP+   D+ D+ +    ++RN
Sbjct: 644 NLQNQTMPFIPQPD---DETDTSY---FEARN 669

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 14/105 (13%)

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+   + Y H RGV H+D+   N ++D    +K++D  LS      RD   +   C   N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS------RDLFPMDYHCLGDN 178

Query: 182 ------YVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEE 219
                 ++A E + NK Y  A +D+WS GV+L+ LM  G  P+ E
Sbjct: 179 ENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALPQQVRD-DGLL 173
           Y  Q+   +++  SR   HRDL   N+LL  N V+K+ DFGL+      P  VR  D  L
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                   ++APE I +K Y   ++D+WS GV+L+
Sbjct: 238 PL-----KWMAPESIFDKVYT-TQSDVWSFGVLLW 266

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 44/178 (24%)

Query: 18  LGRTLGEGSFAKVKFAR------------NTETGEN--VAIKIL--DKEKVLKHKMIGQI 61
           L   LGEG F +V                    G+   VA+K+L  D  K  ++  +   
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL--- 65

Query: 62  KREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
            +EI  M  +++PN+IR+  V  S   + ++ E++  G+L   ++ R      E    F 
Sbjct: 66  -KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR------EIESTFT 118

Query: 122 ------------------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS 161
                             Q+ + + Y  S    HRDL   N L+  +  +K++DFG+S
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 14/158 (8%)

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALPQQVRD-DGLL 173
           Y  Q+   +++  SR   HRDL   N+LL  N V+K+ DFGL+      P  VR  D  L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFK- 231
                   ++APE I ++ Y   ++D+WS GV+L+ + + G  P+    +   + +  K 
Sbjct: 244 PL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297

Query: 232 -ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
               ++P + +    + +       P  R T +E++E+
Sbjct: 298 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 26/226 (11%)

Query: 22  LGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           LGEG+F KV  A             VA+K L KE     +     +RE   + +++H ++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTVLQHQHI 69

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELF---------------DKIASRGRLKEDEARKYFQ 121
           +R Y V      + +V E++  G+L                 +  + G+L   +      
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+ + + Y  S    HRDL   N L+    V+K+ DFG+S          +   T     
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLP-FEESNLMAL 225
           ++ PE I  + +   ++D+WS GV+L+ +   G  P ++ SN  A+
Sbjct: 190 WMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 29/220 (13%)

Query: 22  LGEGSFAKVKFAR--NTETGENV-AIKILDKEKVLKHKMIGQIKREISTMKLIR----HP 74
           LGE  F KV       T  GE   A+ I    K LK K  G ++ E     ++R    HP
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAI----KTLKDKAEGPLREEFKHEAMMRSRLQHP 68

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR------GRLKEDEARK---------- 118
           N++ +  V+  +  + ++  + +  +L + +  R      G   +D+  K          
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
              Q+   +++  S  V H+DL   N+L+     +K+SD GL           L+  +  
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
              +++PE I   G     +D+WS GV+L+ V   G  P+
Sbjct: 189 PIRWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 28/161 (17%)

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   + +R+D          N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDS---------N 269

Query: 182 YV------------APEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKK 228
           YV            APE I N  Y   ++D+WS G++L+ + + G  P+    + + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328

Query: 229 IFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
           + K  ++  SP    +    ++    D +P+ R T  ++++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 21/135 (15%)

Query: 36  TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-----PNVIRMYEVMASKTKIY 90
               E+  +KI    +          +RE++ ++L+       P V+   E   S    Y
Sbjct: 18  GTKDEDYVLKINPSREKGAD-----REREVAILQLLARKGLPVPKVLASGE---SDGWSY 69

Query: 91  IVLEFVTGGELFDKIASRGRLKEDEARKYFQQL--INAVDYCHSRGVCHRDLKPENLLLD 148
           +++E++ G  L +        KED A +  + L  ++ +       +CH DL P N+L+D
Sbjct: 70  LLMEWIEGETLDE---VSEEEKEDIAEQLAELLAKLHQLP---LLVLCHGDLHPGNILVD 123

Query: 149 ANGVLKVSDFGLSAL 163
              +L + D+  +  
Sbjct: 124 DGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 43/178 (24%)

Query: 22  LGEGSFAKV--------------KFARNTETGEN--VAIKIL--DKEKVLKHKMIGQIKR 63
           LGEG F +V              +F  N   G    VA+KIL  D  K  ++  +    +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL----K 68

Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ-- 121
           E+  +  ++ PN+IR+  V   +  + ++ E++  G+L   ++S   L + E        
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVP 127

Query: 122 ------------------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS 161
                             Q+ + + Y  S    HRDL   N L+  N  +K++DFG+S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 48/245 (19%), Positives = 99/245 (40%), Gaps = 27/245 (11%)

Query: 39  GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY----EVMASKTKIYIVLE 94
            + V I+   K       +I   + EI  ++ I   N++++Y    +++    ++ ++LE
Sbjct: 43  NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102

Query: 95  FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC-------HSRGVCHRDLKPENLLL 147
           + T G L      R  L +++   +  +L  A+D C             +++L   + L+
Sbjct: 103 YCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGV 205
             N  LK+   GL  +                  Y + +++N+    Y   K D++S GV
Sbjct: 157 TENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYT-IKDDIYSLGV 210

Query: 206 ILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMA 263
           +L+ +  G +PFE      +Y  I   +   K P       K ++      + + R  + 
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270

Query: 264 EVIEN 268
           E++ N
Sbjct: 271 EILYN 275

Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 29/175 (16%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGEN----------------VAIKILDKEKVLKHKM 57
                   LGEG F +V         +                 VA+K+L +     +  
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63

Query: 58  IGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL----FDKIASRGRLKE 113
              +K E+  +  +  PN+ R+  V      + +++E++  G+L       +A    L  
Sbjct: 64  EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 114 DEARKYFQQLIN-------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS 161
           +     F  L+         + Y  S    HRDL   N L+  N  +K++DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 26/120 (21%)

Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR---KYFQQLINAVDYCHSRGV 135
           + ++M SK   Y V  +     L  K+    +  E E +      +Q++ A+D  HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276

Query: 136 CHRDLKPENLLLD-ANGVLKVSDFGLSA--------LPQQVRDDGLLHTTCGTPNYVAPE 186
            HRD+KP+N++    +G  K+ D G +A        +P++   D         P Y APE
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD---------PRYAAPE 327

Length = 566

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 41/272 (15%)

Query: 21  TLGEGSFAKVKFARNTETGE-------NVAIKILDKEKVLKHKMIGQIKRE-ISTMKLIR 72
           +LG+G+F K+      E G+        V +K+LDK     H+   +   E  S M  + 
Sbjct: 2   SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK----SHRNYSESFFEAASMMSQLS 57

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKY--FQQLINAVDYC 130
           H +++  Y V     +  +V E+V  G L D    + +   + + K    +QL  A+ + 
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFL 116

Query: 131 HSRGVCHRDLKPENLLL-----DANG---VLKVSDFGLS--ALPQQVRDDGLLHTTCGTP 180
             +G+ H ++  +N+LL        G    +K+SD G+S   LP+++  + +        
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI-------- 168

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKAD---FKS 236
            +V PE I N       AD WS G  L+ +   G  P   S L +  K  F  D     +
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL--SALDSQKKLQFYEDRHQLPA 226

Query: 237 PPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
           P W  T    LI++ +D  P  R +   +I +
Sbjct: 227 PKW--TELANLINQCMDYEPDFRPSFRAIIRD 256

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 20/66 (30%), Positives = 36/66 (54%)

Query: 94  EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVL 153
           EF+  G+       + +   +  +   +Q++  +   H  G+ HRD+KPENLL+  +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348

Query: 154 KVSDFG 159
           K+ DFG
Sbjct: 349 KIIDFG 354

Length = 507

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 6/101 (5%)

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGT 179
           Q+ N +++  S+   HRDL   N+L+    ++K+ DFGL+     +RD   +   +T   
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLP 304

Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEE 219
             ++APE I N  Y    +D+WS G++L+ +   G  P+ E
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|217748 pfam03822, NAF, NAF domain

 Score = 40.2 bits (95), Expect = 5e-05
 Identities = 12/18 (66%), Positives = 15/18 (83%)

Query: 318 MNAFELISTSQGLNLSSL 335
           +NAF+LIS S GL+LS L
Sbjct: 1   LNAFDLISLSSGLDLSGL 18

Length = 58

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 42.8 bits (101), Expect = 6e-05
 Identities = 44/139 (31%), Positives = 61/139 (43%), Gaps = 26/139 (18%)

Query: 99  GELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRG----VCHRDLKPENLLLDANGVL 153
             L D +  RGR L E+E        I AV  C          HR  K  N+LL  +G+L
Sbjct: 1   VSLADILEVRGRPLNEEE--------IWAV--CLQCLGALRELHRQAKSGNILLTWDGLL 50

Query: 154 KVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG 213
           K+        P+Q R           P ++APEVI  + Y   KAD++S G+ LY  +  
Sbjct: 51  KLDGSVAFKTPEQSR---------PDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDY 100

Query: 214 YLP-FEESNLMALYKKIFK 231
            LP  EE  L A+ + +  
Sbjct: 101 ELPYNEERELSAILEILLN 119

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           EI+ M  ++HPN++++  +  S+   Y++ E++ G  L + + +   L  +  RK    +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGI 789

Query: 124 INAVDYCH---SRGVCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLHTTCG 178
             A+ + H   S  V   +L PE +++D      L++S      LP  +  D    T C 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS------LPGLLCTD----TKCF 839

Query: 179 TPN-YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLP 216
             + YVAPE    K     K+D++  G+IL  L+ G  P
Sbjct: 840 ISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 62/269 (23%), Positives = 106/269 (39%), Gaps = 50/269 (18%)

Query: 20  RTLGEGSFAKVKFA--RNTETGEN--------VAIKILDKEKVLKHKMIGQIKREISTMK 69
             LG+G+F  +     R     +         V +K+L       H+         S M 
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAV 127
            + H +++++Y V      I +V E+V  G L D    R +       K    +QL +A+
Sbjct: 57  QLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASAL 114

Query: 128 DYCHSRGVCHRDLKPENLLLDANGV-------LKVSDFG--LSALPQQVRDDGLLHTTCG 178
            Y   + + H ++  +N+L+   G+       +K+SD G  ++ L ++ R + +      
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI------ 168

Query: 179 TPNYVAPEVINNKGYDGAK----ADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKAD 233
            P ++APE I N     A     AD WS G  L  +   G  P   S L +  K+ F  D
Sbjct: 169 -P-WIAPECIRN---GQASLTIAADKWSFGTTLLEICSNGEEPL--STLSSSEKERFYQD 221

Query: 234 ---FKSPPWFSTSAKKLISRILDPNPVTR 259
                 P     +   LI++    +P  R
Sbjct: 222 QHRLPMPDCAELAN--LINQCWTYDPTKR 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 34/229 (14%)

Query: 4   RTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR 63
           R  G       + E    L EG         N      V +K+LD      H+ I     
Sbjct: 17  RVEGGGEPEEDEMEDEDPLVEG--------NNNGRELRVVLKVLDPS----HRDIALAFF 64

Query: 64  EI-STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF-- 120
           E  S M  + H ++  ++ V    ++  +V EFV  G L D    + + +   A K    
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVA 123

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGV-------LKVSDFGLS--ALPQQVRDDG 171
           QQL +A+ Y   + + H ++  +N+LL   G+       +K+SD G+S  AL ++ R + 
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183

Query: 172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCG-VILYVLMAGYLPFEE 219
           +         ++APE +         AD WS G  +L +   G +P +E
Sbjct: 184 I--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 26/216 (12%)

Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKY--FQQL 123
           S M+ + H +++ +Y V     +  +V EFV  G L D    R         K+   +QL
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQL 114

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGV-------LKVSDFG--LSALPQQVRDDGLLH 174
            +A+ Y   + + H ++  +N+LL   G+       +K+SD G  ++ L +Q   + +  
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-- 172

Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKAD 233
                  ++APE + +       AD WS G  L+ +   G +P ++  L A  ++ ++  
Sbjct: 173 ------PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERFYEGQ 225

Query: 234 FKSPPWFSTSAKKLISRIL--DPN--PVTRITMAEV 265
                        L++  +  DPN  P  R  M ++
Sbjct: 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 25/99 (25%)

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+   +++  S+   HRDL   N+LL    ++K+ DFGL+      RD  ++H +    N
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA------RD--IMHDS----N 292

Query: 182 YV------------APEVINNKGYDGAKADLWSCGVILY 208
           YV            APE I +  Y    +D+WS G++L+
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLW 330

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases

 Score = 38.7 bits (91), Expect = 7e-04
 Identities = 12/21 (57%), Positives = 16/21 (76%)

Query: 319 NAFELISTSQGLNLSSLLKSK 339
           NAF+LIS S GL+LS L + +
Sbjct: 1   NAFDLISLSSGLDLSGLFEEE 21

CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 25/99 (25%)

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+   +D+  S+   HRD+   N+LL    V K+ DFGL+   + + +D          N
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA---RDIMNDS---------N 267

Query: 182 YV------------APEVINNKGYDGAKADLWSCGVILY 208
           YV            APE I +  Y   ++D+WS G++L+
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 305

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 20  RTLGEGSFAKVKFAR-NTE-TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           + +G G F KV     N+  T   V +K L     ++ +M  +   E    + ++H N++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLL 58

Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA------RKYFQQLINAVDYCH 131
           +        T   +V+EF   G+L   + S  R  E         ++   ++   + + H
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN-------YVA 184
                H DL   N LL A+  +K+ D+GLS    + ++D  +     TP+       ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIA 170

Query: 185 PEVI-----NNKGYDGAK-ADLWSCGVILYVL 210
           PE++     N    D  K +++WS GV ++ L
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	342
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
PRK10345	210	hypothetical protein; Provisional	99.88
smart00090	237	RIO RIO-like kinase.	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
KOG1243	690	consensus Protein kinase [General function predict	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.7
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.52
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.46
KOG3087	229	consensus Serine/threonine protein kinase [General	99.41
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.34
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.21
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.2
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.07
PRK09902	216	hypothetical protein; Provisional	98.96
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.91
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.79
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.75
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.73
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.62
PF01636	239	APH: Phosphotransferase enzyme family This family	98.61
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.5
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.4
PLN02876	822	acyl-CoA dehydrogenase	98.37
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.32
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.3
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.24
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.04
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.03
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.85
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.81
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.75
KOG2270	520	consensus Serine/threonine protein kinase involved	97.72
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.7
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.69
PRK05231	319	homoserine kinase; Provisional	97.55
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.45
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.38
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.3
PLN02236	344	choline kinase	97.18
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.07
PRK10593	297	hypothetical protein; Provisional	97.01
PLN02756	418	S-methyl-5-thioribose kinase	96.99
PRK12396	409	5-methylribose kinase; Reviewed	96.77
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.59
PTZ00384	383	choline kinase; Provisional	96.44
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	96.37
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.33
PRK11768	325	serine/threonine protein kinase; Provisional	96.22
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.16
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.98
PTZ00296	442	choline kinase; Provisional	95.48
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.2
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.09
PRK06148	1013	hypothetical protein; Provisional	94.96
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.88

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-62  Score=447.81  Aligned_cols=264  Identities=38%  Similarity=0.717  Sum_probs=250.1

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+....+....+.+.+|+++.+.|+|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999988888888999999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |+|..++|..+++++++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.....  .....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999986543  23445


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      .+.||||.|.|||++...++ +..+||||+||++|.|++|++||...+..+.+..|...++..|..++.++++||.+||+
T Consensus       176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~  254 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR  254 (592)
T ss_pred             ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence            78999999999999998776 49999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHhcCcccccCCCCCCC
Q 019360          254 PNPVTRITMAEVIENEWFKKGYKPPSF  280 (342)
Q Consensus       254 ~dP~~Rps~~e~l~h~~~~~~~~~~~~  280 (342)
                      +||.+|||++++|.|+||..++.|...
T Consensus       255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~l  281 (592)
T KOG0575|consen  255 PNPSERPSLDEVLDHPFFKSGFTPARL  281 (592)
T ss_pred             CCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence            999999999999999999887777543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-63  Score=434.14  Aligned_cols=263  Identities=39%  Similarity=0.715  Sum_probs=234.0

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh----HHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK----MIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .....+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.......    .....++|+++|++|+|||||+++++|+
T Consensus       167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            344556799999999999999999999999999999999876554322    2335679999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC---CCeeEcccccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN---GVLKVSDFGLS  161 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~---~~~kl~Dfg~~  161 (342)
                      ..+..|+||||++||+|.+.+-.++.+.+...+.+++|++.|+.|||++||+||||||+|||++.+   ..+||+|||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999999999999999999999999999999999999999999999999999766   68999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCC--CCcccchhhhhHHHHHHHhCCCCCCCCcHHH-HHHHHHhcCCCCC-
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY--DGAKADLWSCGVILYVLMAGYLPFEESNLMA-LYKKIFKADFKSP-  237 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~-  237 (342)
                      +...   ..+...+.||||.|.|||++.+.+.  ++.++|+|||||++|-+++|.+||++..... ..+.|.++.+.+. 
T Consensus       327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            9643   5667789999999999999986554  3457899999999999999999998876555 8888888887764 


Q ss_pred             ---CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          238 ---PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       238 ---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                         ..++.++.+||++||..||++|||++|+|+||||+..
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence               3489999999999999999999999999999999853

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-60  Score=411.51  Aligned_cols=261  Identities=37%  Similarity=0.731  Sum_probs=243.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....+.|++++.||+|+||.||+++.+++++.||+|++.+..+......+....|..+|..++||.||+++..|++.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45688999999999999999999999999999999999998888888889999999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+|+||+.||.|...|++.+.+++..++.++..|+.||.|||++|||||||||+|||++.+|+++|+|||+++....  .
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~  178 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--D  178 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--C
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999985332  3


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC-CCCHHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-WFSTSAKKLI  248 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li  248 (342)
                      .....+.|||+.|||||++.+.+|+ ..+|+||||+++|+|++|.+||.+.+......+|.+.....++ .++.++++|+
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence            3345668999999999999998886 8899999999999999999999999999999999999955544 4999999999


Q ss_pred             HHhcCCCCCCCC----CHHHHhcCccccc
Q 019360          249 SRILDPNPVTRI----TMAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rp----s~~e~l~h~~~~~  273 (342)
                      +++|+.||++|.    ++.++-+||||..
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            999999999995    6899999999973

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-59  Score=404.23  Aligned_cols=254  Identities=29%  Similarity=0.506  Sum_probs=229.9

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-KIYIV   92 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv   92 (342)
                      ...+.++.||+|+.|+||+++++.+++.+|+|++..  ..+....+++.+|+++++..+||+||++|+.|.... .++++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            467889999999999999999999999999999943  234566788999999999999999999999999988 49999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||++|+|..++...+.++|..+..|+.++++||.|||+ .+||||||||+|||++..|.|||||||.+....    ++
T Consensus       157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv----nS  232 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV----NS  232 (364)
T ss_pred             hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh----hh
Confidence            9999999999999988999999999999999999999995 999999999999999999999999999998532    23


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC-----cHHHHHHHHHhcCCCC-CCC-CCHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES-----NLMALYKKIFKADFKS-PPW-FSTSA  244 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~-~~~-~~~~~  244 (342)
                      ...+..||..|||||.+.+..|. .++||||||++++|+++|+.||...     +..++...|+....+. |.. +|+++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            56788999999999999998775 8899999999999999999999875     7788888888865543 444 99999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ++||..||++||.+|||+.|+++|||+++.
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            999999999999999999999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-59  Score=390.38  Aligned_cols=259  Identities=39%  Similarity=0.767  Sum_probs=247.0

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      +....++|++++.||.|+||.|.+++++.+|..+|+|++.+..+.+....+...+|.++|+.+.||+++++++.+.+.+.
T Consensus        39 ~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   39 NPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             CCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            33788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||.+||.|.+++++.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||.|+..    
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v----  194 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV----  194 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999853    


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                       .+...+.||||.|+|||++..+++. .++|.|||||++|||+.|.+||...+...++++|+.+...+|+.+++++++||
T Consensus       195 -~~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl  272 (355)
T KOG0616|consen  195 -SGRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLL  272 (355)
T ss_pred             -cCcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHH
Confidence             3346889999999999999998886 89999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          249 SRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +++|+.|-.+|.     ..+++..||||+.
T Consensus       273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            999999999994     5789999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-58  Score=419.06  Aligned_cols=262  Identities=61%  Similarity=1.070  Sum_probs=244.4

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh-h-hhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-K-HKMIGQIKREISTMKLIR-HPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~   86 (342)
                      ....++|.+.+.||+|+||.|+.|.+..+|..||+|++.+.... . ....+.+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            46788999999999999999999999999999999987765332 1 134567789999999999 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~~~~  165 (342)
                      ..+|+||||+.||+|.+++.+.+++.+.+++.+++|++.|++|+|++||+||||||+|||++.+ +++||+|||++....
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999 999999999998654


Q ss_pred             cccCCCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCC-CHH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF-STS  243 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~  243 (342)
                        .......+.|||+.|+|||++.+.. |.+.++||||+||++|.|++|+.||...+...+...+.++.+..+..+ +++
T Consensus       173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE  250 (370)
T ss_pred             --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence              3456778899999999999999988 889999999999999999999999999999999999999999999999 999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +++|+.+||..||.+|+|+.++++||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-57  Score=411.49  Aligned_cols=263  Identities=35%  Similarity=0.687  Sum_probs=244.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCe
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTK   88 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~   88 (342)
                      .....+|.+++.||.|+|++|++|.++.+++.||||++.+..+..+...+.+.+|-.+|.+| .||.|++|+..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            55677899999999999999999999999999999999998888888888899999999999 69999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+|+||+++|+|.+++.+.+.|++.-.+.++.+|+.||+|||++|||||||||+|||++.+++++|+|||.++......
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998643321


Q ss_pred             CC-----------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC
Q 019360          169 DD-----------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP  237 (342)
Q Consensus       169 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  237 (342)
                      ..           ....+.+||..|.+||++..... +..+|+|+|||++|.|+.|.+||.+.+...++++|+...+.++
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            11           11245789999999999987655 5899999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +.+++.+++||+++|..||.+|+|+++|.+||||..
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            999999999999999999999999999999999974

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-57  Score=395.43  Aligned_cols=263  Identities=40%  Similarity=0.707  Sum_probs=238.1

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      .......++|.+.+.||+|+||+||+|+++.++..||||.+.+... ..+..+.+..|+.+|+.++|||||.+++++..+
T Consensus         3 ~~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    3 GGSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD   81 (429)
T ss_pred             CCcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence            3455678999999999999999999999999999999999987654 345567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC------CCeeEccccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN------GVLKVSDFGL  160 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~------~~~kl~Dfg~  160 (342)
                      +.+|+|||||.||+|..++++++.+++..++.++.||+.||++||+++||||||||.|||++..      ..+||+|||+
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            9999999999999999999999999999999999999999999999999999999999999765      5689999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---C
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---P  237 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---~  237 (342)
                      |+...   ......+.||++.|||||++....|+ .|+|+||+|+++|+|++|+.||...+..+++..+.++....   +
T Consensus       162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~  237 (429)
T KOG0595|consen  162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP  237 (429)
T ss_pred             hhhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence            99755   45567789999999999999888886 99999999999999999999999999999998777664432   3


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ..+++.+.+|+...|+.+|..|.+..+-+.|+++...
T Consensus       238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            4577888999999999999999999999999998754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-57  Score=419.61  Aligned_cols=268  Identities=44%  Similarity=0.856  Sum_probs=252.5

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      +....+|-|++++.||.|+-|.|-+|++..+|+..|||++.+...........+.+|+-+|+.+.|||+++++++|++..
T Consensus         6 ~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen    6 SHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            45667899999999999999999999999999999999998875555566678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ++|+|.||++||.|++++..++++++.+..++++||+.|+.|+|..+|+|||+||+|+|++..+.+||+|||+|.+.   
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---  162 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---  162 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999863   


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                      ..+....+.||+|.|.|||++.+..|++.++||||.||++|.|++|++||++.+...++.++..+.+..|..+++++++|
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL  242 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL  242 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence            34667889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                      |.+||..||++|.|.+||+.|||+......+
T Consensus       243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             HHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence            9999999999999999999999998655443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.4e-56  Score=400.37  Aligned_cols=262  Identities=35%  Similarity=0.658  Sum_probs=236.8

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...+.|++++.||+|+||.||+|+.+.+|..+|+|++.+........++.+..|-++|....+++||+++..|++.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45678999999999999999999999999999999999999888888899999999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc---
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ---  166 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---  166 (342)
                      ||||||++||++..+|.+.+.|+++.++.++.+++.|+..||+.|+|||||||+|+|||..|++||+|||+|.....   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999852111   


Q ss_pred             ------------c----c----C----------------------CCceecccCCcccCChhhhccCCCCCcccchhhhh
Q 019360          167 ------------V----R----D----------------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCG  204 (342)
Q Consensus       167 ------------~----~----~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG  204 (342)
                                  .    .    .                      .....+..|||-|||||++.+.+|. ..+|+||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHH
Confidence                        0    0    0                      0012235799999999999999875 899999999


Q ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHhcC--C--CCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 019360          205 VILYVLMAGYLPFEESNLMALYKKIFKAD--F--KSPPWFSTSAKKLISRILDPNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       205 ~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~--~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      |++|||+.|.+||.+.++.+.+.+|.+-.  +  +....+++++.|||.+||. ||++|..   ++||.+||||+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            99999999999999999999999998754  3  3345688999999999998 9999995   899999999985

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.5e-57  Score=381.10  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=222.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|+.+.++|+|+||+||+++++.+|+.||||.+..+ ..+....+-..+|+++|++|+|+|+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            46899999999999999999999999999999999643 23345556788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      +|||+. ++.+-++. ...++.+.+..+++|++.|+.|+|+++++||||||+||||+.+|.+||||||.|+....  ...
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd  156 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD  156 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence            999977 44455554 35689999999999999999999999999999999999999999999999999996543  344


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---------------  236 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------------  236 (342)
                      ..+.+..|.+|+|||.+.+...++..+||||+||++.||++|.+.|.+.+..+....|.+.....               
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            45677889999999999997777899999999999999999999999998888776665421111               


Q ss_pred             ----------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          237 ----------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       237 ----------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                      .+.++.-+.+|++.||+.||.+|++.+++|.|+||..
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                            0235677899999999999999999999999999953

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-56  Score=395.38  Aligned_cols=261  Identities=31%  Similarity=0.510  Sum_probs=227.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCC-e
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKT-K   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~-~   88 (342)
                      ...+||+++++||.|.||.||+|+.+.+|+.||||.+.+.... -+. ..-.||+..|++|+ ||||+++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            4568999999999999999999999999999999999754332 221 23458999999999 999999999998877 8


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      +|+|||||+ ..|+++++.+ ..+++..++.|++||++||+|+|++|+.|||+||+||||+....+||+|||+|+...  
T Consensus        85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--  161 (538)
T KOG0661|consen   85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--  161 (538)
T ss_pred             EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence            999999995 5999999875 569999999999999999999999999999999999999999999999999999533  


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-------------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------  234 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------  234 (342)
                       .....+.++.|.+|+|||++....+++.+.|+||+||+++|+.+-++.|.|.+..+.+.+|+.-..             
T Consensus       162 -SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 -SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             -cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence             344567788999999999999988889999999999999999999999999999988888864211             


Q ss_pred             ------CCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          235 ------KSP-----------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       235 ------~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                            .++           +..+.++.+||.+||++||.+||||.|+|+||||+.....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                  111           2367899999999999999999999999999999865443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-55  Score=378.20  Aligned_cols=269  Identities=29%  Similarity=0.441  Sum_probs=232.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----   85 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----   85 (342)
                      .....+|..++.||.|+||.|+.+.++.+|+.||+|.+.. .....-..++..+|+++|+.++|+||+.+.+++..    
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            3445667778999999999999999999999999999964 34455667889999999999999999999999865    


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           86 -KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        86 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                       -..+|+|+|+| +.+|.+.++++..++++++..+++|++.||+|+|+.+|+||||||+|++++.+..+||||||+|+..
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence             34699999999 6699999999888999999999999999999999999999999999999999999999999999976


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--------  236 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  236 (342)
                      .........+.+..|.+|+|||++.....++.+.||||+||++.||++|++.|.|.+..+.++.|+.....+        
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            543345556777889999999999877767799999999999999999999999988777766665322111        


Q ss_pred             -----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCC
Q 019360          237 -----------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSF  280 (342)
Q Consensus       237 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~~~  280 (342)
                                             .+..++.+.+|+.+||..||.+|+|++|+|+|||+.....+...
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE  322 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE  322 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence                                   13568899999999999999999999999999999987776543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-56  Score=371.12  Aligned_cols=249  Identities=35%  Similarity=0.608  Sum_probs=222.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEE-EEEeCCe
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE-VMASKTK   88 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~-~~~~~~~   88 (342)
                      ......|+++++||+|+||.||++++..+|..+|.|.+.-. ..+.+..+.+..|+.+|++|+|||||++++ .|..+..
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            34455699999999999999999999999999999999743 345566778899999999999999999998 4444444


Q ss_pred             -EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeecCCCCcEEecCCCCeeEcccc
Q 019360           89 -IYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHS--RG--VCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        89 -~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~--~g--iiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                       +++|||||.+|+|.+.++.    +..+++..++.++.|++.||..+|+  ..  |+||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             8999999999999998864    4569999999999999999999999  44  9999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-C-
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-P-  237 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~-  237 (342)
                      +++....  ......+..|||.||+||.+.+.+|+ .++||||+||++|||+.-++||.+.+...+..+|.++++++ | 
T Consensus       174 L~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  174 LGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            9997543  34556778999999999999999986 99999999999999999999999999999999999999874 3 


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCH
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITM  262 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~  262 (342)
                      ..+|.++..||..|+..||..||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            4689999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-54  Score=380.34  Aligned_cols=260  Identities=33%  Similarity=0.567  Sum_probs=221.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--eEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--KIY   90 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~   90 (342)
                      ..+|...+.||+|+||.||++.+..+|..+|||.+......   ..+.+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            56699999999999999999999999999999999765221   1567899999999999999999999754444  689


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCcc-c
Q 019360           91 IVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQ-V  167 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~-~  167 (342)
                      ++|||+++|+|.+++.+.+ .+++..++.+.+|+++||+|||++||+|+||||+|||++. ++.+||+|||+++.... .
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999876 7999999999999999999999999999999999999999 79999999999886543 1


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHhcC--CCCCCCCCHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKAD--FKSPPWFSTSA  244 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~  244 (342)
                      ..........||+.|||||++........++|||||||++.||+||+.||.. .......-.+....  ...+..++.++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence            1223344578999999999998633333589999999999999999999987 44444444444333  45577899999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      ++||.+|++.||++||||+++|+|||.+...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            9999999999999999999999999997644

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-55  Score=355.86  Aligned_cols=260  Identities=40%  Similarity=0.722  Sum_probs=245.5

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..-.+++|++.+.||+|.||.||+|+.+.++-.||+|++.++++.......++.+|+++...|+||||++++++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            45567899999999999999999999999999999999999998888888899999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           89 IYIVLEFVTGGELFDKIA--SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +|+++||.+.|+|...+.  ...++++...+.+++|++.||.|+|.++|+||||||+|+|++..+.+|++|||.+...+ 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999999998  45679999999999999999999999999999999999999999999999999987533 


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK  246 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (342)
                         .+...+.|||..|.|||+..+..++ ..+|+|++|++.||++.|.+||...+..+.+++|.+.++..|+.++.+++|
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d  251 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD  251 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence               4456788999999999999998876 889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ||.+||..+|.+|.+..|++.|||+..
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999999864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.5e-55  Score=394.00  Aligned_cols=256  Identities=34%  Similarity=0.633  Sum_probs=240.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. ..++.++.+.+|+++++.++||||+.++++|+...++++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            468999999999999999999999999999999998754 3455678899999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      +||+.| +|..++...+.++|+.++.++.+++.||.|||+.+|+|||+||.|||+..++++|+||||+++....  ....
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v  156 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV  156 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence            999977 9999999999999999999999999999999999999999999999999999999999999986443  4556


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  252 (342)
                      .....|||.|||||.+.+..|+ ..+|.|||||++||+++|++||-..+...+...|.....+.|+..+..+..|+..+|
T Consensus       157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL  235 (808)
T ss_pred             eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence            6778899999999999988876 889999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccc
Q 019360          253 DPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+||.+|.|..+++.|||.+.
T Consensus       236 ~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  236 IKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             hcChhhcccHHHHhcChHHhh
Confidence            999999999999999999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-54  Score=397.18  Aligned_cols=261  Identities=30%  Similarity=0.597  Sum_probs=242.0

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~   87 (342)
                      .....+.|+++++||+|+||.|+++..+.+++.||||++++..+......+..+.|.+++...+ ||.++.++..|+..+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3566789999999999999999999999999999999999999998899999999999998886 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ++|+||||+.||++..+ ...+.+++..++.|+..++.||.|||++||||||||.+|||+|.+|++||+|||+++-.  .
T Consensus       443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m  519 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--M  519 (694)
T ss_pred             eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--C
Confidence            99999999999995443 33467999999999999999999999999999999999999999999999999999842  3


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                      .......+.||||.|||||++.+..|. .++|.|||||++|||+.|+.||.+.+.++++..|+..+...|.+++.++.++
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAI  598 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence            345567889999999999999998875 9999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          248 ISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      ++++|..||++|..     +++|..||||+.
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            99999999999996     589999999974

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-53  Score=385.87  Aligned_cols=261  Identities=39%  Similarity=0.744  Sum_probs=236.8

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      .......+.|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++++++||||+++++++...
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            44566788999999999999999999999999999999999766554455567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +.+|+||||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999875322


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK  246 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (342)
                           .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+..++..+++
T Consensus       171 -----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  244 (329)
T PTZ00263        171 -----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD  244 (329)
T ss_pred             -----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHH
Confidence                 1234578999999999987766 4899999999999999999999999888888888888888888889999999


Q ss_pred             HHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          247 LISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       247 li~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      ||.+||+.||.+|++     ++++++||||.+
T Consensus       245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            999999999999997     799999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-53  Score=354.26  Aligned_cols=258  Identities=32%  Similarity=0.495  Sum_probs=225.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|...++||+|.||+||+|++..+|+.||||.+...... ........+|++.|+.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            5899999999999999999999999999999999765433 223346779999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||++. +|...++.. ..++..+++.++.++++||+|+|++.|+||||||+|+|++.+|.+||+|||+++........  
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--  157 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--  157 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence            99965 999988764 56899999999999999999999999999999999999999999999999999975543222  


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC---------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP---------------  237 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  237 (342)
                      ......|.+|+|||.+.+...++..+|+||.||++.||+.|.+.|.+.+..+....|+..-..+.               
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            23336799999999999988888999999999999999999999999999888888875322111               


Q ss_pred             -------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          238 -------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       238 -------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                   +..++++.||+.+||..||.+|+|+.|+|+|+||....
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                         22467889999999999999999999999999998643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-53  Score=382.65  Aligned_cols=261  Identities=33%  Similarity=0.533  Sum_probs=228.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--C
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--T   87 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~   87 (342)
                      ....+.|+.+++||+|.||.||+|++..+|+.||+|.+..+.. ++....-+.+||.+|++|+||||+++.++....  +
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            3455679999999999999999999999999999999986543 345556788999999999999999999998766  6


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      .+|+|+|||+. +|.-++... -.|++.+++.+++||++||.|+|++||+|||||.+||||+.+|.+||+|||+|++...
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            89999999976 888888764 4699999999999999999999999999999999999999999999999999997554


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC---------
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP---------  237 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---------  237 (342)
                      .. ....+..+.|.+|+|||.+.+...++.++|+||.|||+.||++|++.|.+.+..+....|++.-..+.         
T Consensus       271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            32 22356667799999999999988888999999999999999999999999999999998876322111         


Q ss_pred             --------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          238 --------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       238 --------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                          ..++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                                135788999999999999999999999999999954

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-53  Score=378.37  Aligned_cols=254  Identities=33%  Similarity=0.655  Sum_probs=230.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997654444445567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....     ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999875322     12


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ...+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..++..+++||++||+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  234 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV  234 (291)
T ss_pred             ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence            34578999999999987665 48899999999999999999999999988888888888888888889999999999999


Q ss_pred             CCCCCCCC-----HHHHhcCccccc
Q 019360          254 PNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      .||.+|++     ++++++||||+.
T Consensus       235 ~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         235 VDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCHHHccCCccCCHHHHhcCccccC
Confidence            99999995     999999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=378.07  Aligned_cols=273  Identities=36%  Similarity=0.658  Sum_probs=234.2

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh-----------HHHHHHHHHHHHhcCCC
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-----------MIGQIKREISTMKLIRH   73 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h   73 (342)
                      .....+..++.|++++.||+|.||.|-+|++..+++.||||++.+.......           .++...+||.+|+++.|
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            3445677889999999999999999999999999999999999764433221           24678999999999999


Q ss_pred             CcceeEEEEEEeC--CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 019360           74 PNVIRMYEVMASK--TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG  151 (342)
Q Consensus        74 ~~iv~l~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~  151 (342)
                      +|||+|+++..+.  +.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+||+||||||+|+|++.+|
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            9999999998654  67999999999888754333323389999999999999999999999999999999999999999


Q ss_pred             CeeEcccccccCCccc---cCCCceecccCCcccCChhhhcc---CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHH
Q 019360          152 VLKVSDFGLSALPQQV---RDDGLLHTTCGTPNYVAPEVINN---KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL  225 (342)
Q Consensus       152 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~  225 (342)
                      ++||+|||.+......   ..........|||.|+|||.+.+   ..+.+.+.||||+||++|.|+.|+.||-+....++
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998754221   12223445789999999999876   44567899999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          226 YKKIFKADFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       226 ~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      +.+|.+..+.+|..  +..++++||.+||.+||++|++..++..|||.......
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            99999988777654  78999999999999999999999999999999865443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-52  Score=379.94  Aligned_cols=251  Identities=35%  Similarity=0.649  Sum_probs=226.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++|+||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998655444555667889999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCC
Q 019360          100 ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT  179 (342)
Q Consensus       100 ~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  179 (342)
                      +|..++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....  ........+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence            9999998888899999999999999999999999999999999999999999999999999874221  12223456799


Q ss_pred             cccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019360          180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR  259 (342)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (342)
                      +.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.......+..+++++.+||++||+.||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            99999999987666 48999999999999999999999998888888888888888888899999999999999999999


Q ss_pred             C-----CHHHHhcCccccc
Q 019360          260 I-----TMAEVIENEWFKK  273 (342)
Q Consensus       260 p-----s~~e~l~h~~~~~  273 (342)
                      |     ++.++++||||..
T Consensus       238 ~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         238 LGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            9     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-54  Score=355.79  Aligned_cols=258  Identities=37%  Similarity=0.715  Sum_probs=232.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      -.+.|++-+.||+|+|+.|+++.+..+|+.+|+|++....... ...+.+.+|+++-+.|+||||+++.+.+...+..|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3467999999999999999999999999999999997655443 366889999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcccccccCCcccc
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+|+++|++|..-+-.+..+++..+..+++||++||.|+|.+||+|||+||+|+++..   ..-+||+|||++.-..   
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---  164 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---  164 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence            9999999999887777777899999999999999999999999999999999999943   3469999999997433   


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----CCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~  244 (342)
                      .........|||.|||||++...++. ..+|||+-||++|-|+.|++||.+.+...+++.|..+.+..++    .+++++
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            45566778899999999999987764 8899999999999999999999999999999999998776544    589999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ++||++||..||.+|+|+.|+|+|||+.+.
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999999999753

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.9e-52  Score=378.25  Aligned_cols=259  Identities=33%  Similarity=0.641  Sum_probs=233.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCC-cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .....++|++.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++...+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            4456678999999999999999999876655 689999997655545555678889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||+++++|.+++..+..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999875322 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                          ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+..+++.+.++
T Consensus       184 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  258 (340)
T PTZ00426        184 ----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL  258 (340)
T ss_pred             ----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence                1234679999999999987665 48999999999999999999999999888888889888888888899999999


Q ss_pred             HHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          248 ISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      |++||+.||++|+     +++++++||||.+
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            9999999999995     8999999999975

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=363.36  Aligned_cols=262  Identities=34%  Similarity=0.564  Sum_probs=228.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      .....|++.+.||.|..++||+|+....++.||||++..+.....  .+.+.+|+..|+.++||||++++..|..+..+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            345679999999999999999999999999999999987665433  678999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||.||.+|++.+++...  ..++|..+..|++++++||.|||.+|-||||||+.||||+.+|.|||+|||.+......+
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999999874  459999999999999999999999999999999999999999999999999876443322


Q ss_pred             CCC--ceecccCCcccCChhhhc-c-CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC-------
Q 019360          169 DDG--LLHTTCGTPNYVAPEVIN-N-KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP-------  237 (342)
Q Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------  237 (342)
                      ...  ...+..||+.|||||++. . .+| +.|+||||||++..||.+|..||....++..+..-+++.++.+       
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            111  114568999999999953 3 345 4899999999999999999999999999988877777766532       


Q ss_pred             ---CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          238 ---PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       238 ---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                         ..++..++.+|..||++||.+|||++++|.|+||+...
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence               23677899999999999999999999999999998643

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-51  Score=372.51  Aligned_cols=250  Identities=34%  Similarity=0.634  Sum_probs=224.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999765544555567788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcc
Q 019360          102 FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN  181 (342)
Q Consensus       102 ~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  181 (342)
                      .+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....  ........+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence            99998888899999999999999999999999999999999999999999999999999874322  1222344678999


Q ss_pred             cCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 019360          182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI-  260 (342)
Q Consensus       182 y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-  260 (342)
                      |+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..+++++.+||.+||+.||++|| 
T Consensus       159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            999999987666 488999999999999999999999988888888888888888888999999999999999999997 


Q ss_pred             --CHHHHhcCcccccC
Q 019360          261 --TMAEVIENEWFKKG  274 (342)
Q Consensus       261 --s~~e~l~h~~~~~~  274 (342)
                        ++.+++.||||.+.
T Consensus       238 ~~~~~e~l~hp~~~~~  253 (312)
T cd05585         238 YNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              57999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-53  Score=367.35  Aligned_cols=262  Identities=42%  Similarity=0.781  Sum_probs=246.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ...||++.+.||+|.||.|-+|.+...|+.||||.+.+..+.+++..-++.+|+++|..|+||||+.++++|++.+.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            34589999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||..+|.|++++.+++.+++.+.+++++||..|+.|+|+++++|||||.+|||++.++++||+|||++.+..   ...
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~k  207 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKK  207 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---ccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999997643   466


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      ...+.||+|.|.+||++++.+|.++.+|.|||||++|.|+.|..||++.+...+...|..+.+.-|+ -+.++.-||+.|
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwm  286 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWM  286 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHH
Confidence            7889999999999999999999999999999999999999999999999999999999988877655 467799999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          252 LDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      |-.||++|.|++++..|=|++=++..
T Consensus       287 LmVNP~RRATieDiAsHWWvNwgy~~  312 (668)
T KOG0611|consen  287 LMVNPERRATIEDIASHWWVNWGYNM  312 (668)
T ss_pred             HhcCcccchhHHHHhhhheeeccccc
Confidence            99999999999999999998755443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-52  Score=356.84  Aligned_cols=263  Identities=30%  Similarity=0.407  Sum_probs=225.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCe
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KTK   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~   88 (342)
                      ..++.|+.++.|++|+||+||+|+|+.+++.||+|.++.+.. .....=.-.+||.+|.+++|||||.+-++...  -+.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            346679999999999999999999999999999999976542 22222245699999999999999999998753  456


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      +|+|||||+. +|..++.+-+ ++...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.....
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999999976 9999998864 7999999999999999999999999999999999999999999999999999964432


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----------  237 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------  237 (342)
                        ....+...-|.+|+|||.+.+...++.+.|+||+||++.||+++++.|.+.+..+...+|++....+.          
T Consensus       231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence              22345566799999999999988778999999999999999999999999999998888875321110          


Q ss_pred             --------------------C--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          238 --------------------P--WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       238 --------------------~--~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                          .  .++....+|++.+|..||.+|.||+|+|.|.||.+...+
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                                0  145788999999999999999999999999999985544

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.9e-51  Score=372.58  Aligned_cols=251  Identities=36%  Similarity=0.655  Sum_probs=225.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +.||+|+||.||++.++.+|+.||+|++.+...........+.+|+++++.++|+||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765544555678889999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCC
Q 019360          100 ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT  179 (342)
Q Consensus       100 ~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  179 (342)
                      +|..++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ........+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence            9999998888899999999999999999999999999999999999999999999999999874221  12223446799


Q ss_pred             cccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019360          180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR  259 (342)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (342)
                      +.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.......+..+++++.+||++||+.||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            99999999987665 48999999999999999999999998888888888877788888899999999999999999999


Q ss_pred             C-----CHHHHhcCccccc
Q 019360          260 I-----TMAEVIENEWFKK  273 (342)
Q Consensus       260 p-----s~~e~l~h~~~~~  273 (342)
                      +     ++.++++||||..
T Consensus       238 ~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         238 LGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCCCHHHHhcCCCcCC
Confidence            7     8999999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-52  Score=362.40  Aligned_cols=265  Identities=30%  Similarity=0.501  Sum_probs=237.3

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....+.|++++.||.|.-|+||+++.+.++..+|+|++.++.....+...+++-|.++|..+.||.+..+|..|+.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            44456789999999999999999999999999999999999988888888999999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           89 IYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      .|++||||+||+|..+++++  +.++++.++.++..++.||+|||..|||+|||||+||||-++|++.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999998875  5699999999999999999999999999999999999999999999999998742110


Q ss_pred             ----c----------------------------c-C---------------------CCceecccCCcccCChhhhccCC
Q 019360          167 ----V----------------------------R-D---------------------DGLLHTTCGTPNYVAPEVINNKG  192 (342)
Q Consensus       167 ----~----------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~  192 (342)
                          .                            . .                     .....+.+||-.|+|||++.+.+
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                0                            0 0                     00112346899999999999988


Q ss_pred             CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC--CCCHHHHHHHHHhcCCCCCCCCC----HHHHh
Q 019360          193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--WFSTSAKKLISRILDPNPVTRIT----MAEVI  266 (342)
Q Consensus       193 ~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps----~~e~l  266 (342)
                      .. .++|+|+|||++|||+.|..||.+.+..+.+.+|+.....++.  .++..++|||+++|.+||++|..    |+||-
T Consensus       312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            75 8999999999999999999999999999999999988777654  57889999999999999999998    99999


Q ss_pred             cCcccccC
Q 019360          267 ENEWFKKG  274 (342)
Q Consensus       267 ~h~~~~~~  274 (342)
                      +||||..-
T Consensus       391 ~HpFF~gV  398 (459)
T KOG0610|consen  391 RHPFFEGV  398 (459)
T ss_pred             cCccccCC
Confidence            99999853

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8e-51  Score=375.65  Aligned_cols=258  Identities=33%  Similarity=0.594  Sum_probs=222.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765555555678889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD----  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~----  169 (342)
                      ||++|++|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999874321100    


Q ss_pred             -----------------------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          170 -----------------------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       170 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                                                   .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                         0011345799999999999877665 8999999999999999999999998


Q ss_pred             cHHHHHHHHHhcC--CCCC--CCCCHHHHHHHHHhcCCCCC---CCCCHHHHhcCccccc
Q 019360          221 NLMALYKKIFKAD--FKSP--PWFSTSAKKLISRILDPNPV---TRITMAEVIENEWFKK  273 (342)
Q Consensus       221 ~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~L~~dP~---~Rps~~e~l~h~~~~~  273 (342)
                      +..+....+....  ...+  ..+++++++||.+|+. +|.   .||+++|+++||||+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence            8888888777532  2223  3478999999999875 444   4689999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.2e-51  Score=371.66  Aligned_cols=251  Identities=35%  Similarity=0.655  Sum_probs=225.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +.||+|+||.||+++++.+|+.||+|++.+...........+.+|+++++.++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444555667789999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCC
Q 019360          100 ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT  179 (342)
Q Consensus       100 ~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  179 (342)
                      +|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  .........||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence            9999998888899999999999999999999999999999999999999999999999999864211  11222345789


Q ss_pred             cccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019360          180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR  259 (342)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (342)
                      +.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.......+..+++++.+||.+||+.||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            99999999987666 48999999999999999999999998888888888887778888899999999999999999999


Q ss_pred             C-----CHHHHhcCccccc
Q 019360          260 I-----TMAEVIENEWFKK  273 (342)
Q Consensus       260 p-----s~~e~l~h~~~~~  273 (342)
                      +     ++.++++||||..
T Consensus       238 ~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         238 LGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            8     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=370.54  Aligned_cols=255  Identities=29%  Similarity=0.556  Sum_probs=225.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....     ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999875332     23


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC------CCCCHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP------PWFSTSAK  245 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~------~~~~~~~~  245 (342)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+....  ...+      ..+++++.
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            45678999999999987765 489999999999999999999999988877766665422  1111      14589999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +||.+||+.+|.+||+++++++||||...
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-52  Score=378.40  Aligned_cols=258  Identities=29%  Similarity=0.525  Sum_probs=228.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+.-..+|+..++||+|+-|.||.|....+++.||+|.+........   +-+.+|+.+|+..+|+|||.+++.|.-.+.
T Consensus       268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~de  344 (550)
T KOG0578|consen  268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDE  344 (550)
T ss_pred             CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence            34456689999999999999999999999999999999986554433   468899999999999999999999998899


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +++||||++||+|.+.+.. ..++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||.+.....  
T Consensus       345 LWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~--  421 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE--  421 (550)
T ss_pred             eEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc--
Confidence            9999999999999888876 4489999999999999999999999999999999999999999999999999875433  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc---CCCCCCCCCHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---DFKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~  245 (342)
                      ......+..|||.|||||++....|. ++.||||||++++||+-|++||-..++......|...   .+..+..+|+.++
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~k  500 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELK  500 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHH
Confidence            23355678899999999999988874 9999999999999999999999877766665555543   3445778999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +|+.+||+.||++|+++.|+|+||||+.
T Consensus       501 dFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  501 DFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999999999953

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.8e-51  Score=369.41  Aligned_cols=251  Identities=33%  Similarity=0.648  Sum_probs=223.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|..++..+ +|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999765544444556777888888776 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  .........|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence            99999998888899999999999999999999999999999999999999999999999999864221  1222344578


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..++.++.+||++||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999987665 4889999999999999999999999999888899988888888889999999999999999999


Q ss_pred             CCCH------HHHhcCccccc
Q 019360          259 RITM------AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~------~e~l~h~~~~~  273 (342)
                      ||++      +++++||||..
T Consensus       238 R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         238 RLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCCCHHHHHcCCCcCC
Confidence            9998      99999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-50  Score=367.17  Aligned_cols=254  Identities=29%  Similarity=0.558  Sum_probs=224.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHH---hcCCCCcceeEEEEEEeCCeEEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM---KLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      |++++.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|++++   +.++|+||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999765544444556777777665   566799999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |||+++++|...+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....  ....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence            999999999888764 5699999999999999999999999999999999999999999999999999864221  1222


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  252 (342)
                      ....+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......+..++.++.++|.+||
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence            345678999999999987665 4889999999999999999999999988888888888888788889999999999999


Q ss_pred             CCCCCCCC-----CHHHHhcCccccc
Q 019360          253 DPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       253 ~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +.||.+||     ++.++++||||.+
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            99999999     6999999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=370.65  Aligned_cols=260  Identities=39%  Similarity=0.713  Sum_probs=235.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCe
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTK   88 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~   88 (342)
                      ......|++.+.||+|.||.||.++++.+|+.+|+|++.+...........+.+|+.+|++++ ||||+.+.++|++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            344557999999999999999999999999999999998877655555678999999999999 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC----CCeeEcccccccCC
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN----GVLKVSDFGLSALP  164 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~----~~~kl~Dfg~~~~~  164 (342)
                      +++|||+|.||.|.+.+... .+++..+..++.|++.|++|||+.||+||||||+|+|+...    +.+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999999877 49999999999999999999999999999999999999543    47999999999865


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC----CCCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----PPWF  240 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~  240 (342)
                      ..   .......+||+.|+|||++....|. ..+||||+|+++|.|++|.+||.+.+.......+..+.+.+    .+.+
T Consensus       190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  190 KP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             cC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            43   4567889999999999999877764 89999999999999999999999999999999999887754    3457


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +..++++|.+||..||.+|+|+.++|+|||++..
T Consensus       266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999999864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-50  Score=367.59  Aligned_cols=256  Identities=31%  Similarity=0.582  Sum_probs=228.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC-cceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP-NVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~   93 (342)
                      .|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|++++..++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999876544445566788899999999865 5888999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence            9999999999998888899999999999999999999999999999999999999999999999999863211  12223


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......+..++.++.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            45679999999999987666 48899999999999999999999999988888888888888788899999999999999


Q ss_pred             CCCCCCCCH-----HHHhcCccccc
Q 019360          254 PNPVTRITM-----AEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rps~-----~e~l~h~~~~~  273 (342)
                      .||.+|+++     +++++||||..
T Consensus       238 ~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         238 KHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999986     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-50  Score=374.65  Aligned_cols=258  Identities=33%  Similarity=0.623  Sum_probs=223.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++++.||.|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997655444555667889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC---
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD---  170 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---  170 (342)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.........   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998643211000   


Q ss_pred             ---------------------------------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC
Q 019360          171 ---------------------------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF  217 (342)
Q Consensus       171 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf  217 (342)
                                                       ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence                                             011234689999999999877664 8999999999999999999999


Q ss_pred             CCCcHHHHHHHHHhcC--CCC--CCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 019360          218 EESNLMALYKKIFKAD--FKS--PPWFSTSAKKLISRILDPNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       218 ~~~~~~~~~~~i~~~~--~~~--~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      ...+.......+....  ...  ...+++++.+||.+||. +|.+|++   ++++++||||..
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9988877777666432  222  23478999999999996 9999998   999999999975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-50  Score=374.71  Aligned_cols=258  Identities=29%  Similarity=0.517  Sum_probs=220.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999987655555666789999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC-----
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-----  169 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----  169 (342)
                      |+++++|.+++.+...+++..++.++.|++.||.|||+.||+||||||+|||++.++++||+|||++........     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999998753210000     


Q ss_pred             ----------------------------------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHH
Q 019360          170 ----------------------------------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYV  209 (342)
Q Consensus       170 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~  209 (342)
                                                              .......+||+.|+|||++.+..+. .++|||||||++||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e  240 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE  240 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence                                                    0011235799999999999877664 88999999999999


Q ss_pred             HHhCCCCCCCCcHHHHHHHHHhc--CC--CCCCCCCHHHHHHHHHhc--CCCCCCCCCHHHHhcCccccc
Q 019360          210 LMAGYLPFEESNLMALYKKIFKA--DF--KSPPWFSTSAKKLISRIL--DPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       210 l~~g~~pf~~~~~~~~~~~i~~~--~~--~~~~~~~~~~~~li~~~L--~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      |++|..||...+.......+...  ..  +....+++++.+||.+|+  ..+|..|++++++++||||+.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            99999999888776666555532  22  223358999999999965  445556999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-50  Score=362.15  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=213.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++|+||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            46789999999999999999999999999999999864322  2223467789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||+++ +|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....  .
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~  157 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T  157 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence            9999975 8988887644 5789999999999999999999999999999999999999999999999998743221  1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---------------  235 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------------  235 (342)
                      .......+++.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+..+....+......               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            12234567899999999876544468999999999999999999999887766655444321100               


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 ---------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 ---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                     ..+.++.++.+||++||+.||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                           012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.8e-51  Score=369.94  Aligned_cols=251  Identities=35%  Similarity=0.654  Sum_probs=224.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +.||+|+||.||++.+..+|+.||+|++.+...........+.+|+++++.++|+||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765544455567788999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360          100 ELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus       100 ~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      +|..++.....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++....  .........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence            999999888889999999999999999999997 7999999999999999999999999999864221  1222334579


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+..+++++.+||.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            999999999987666 4899999999999999999999999888888888888888888889999999999999999999


Q ss_pred             CC-----CHHHHhcCccccc
Q 019360          259 RI-----TMAEVIENEWFKK  273 (342)
Q Consensus       259 Rp-----s~~e~l~h~~~~~  273 (342)
                      |+     ++.++++||||..
T Consensus       238 R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         238 RLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             hCCCCCCCHHHHhcCCCcCC
Confidence            97     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=373.03  Aligned_cols=258  Identities=33%  Similarity=0.668  Sum_probs=226.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.++..++|+||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765544455678889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc-----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----  168 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----  168 (342)
                      ||+++++|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999987543221     


Q ss_pred             ----------------------CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH
Q 019360          169 ----------------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY  226 (342)
Q Consensus       169 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~  226 (342)
                                            .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                  0012234568999999999988765 48999999999999999999999998887777


Q ss_pred             HHHHh--cCCCCC--CCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 019360          227 KKIFK--ADFKSP--PWFSTSAKKLISRILDPNPVTRIT-MAEVIENEWFKK  273 (342)
Q Consensus       227 ~~i~~--~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps-~~e~l~h~~~~~  273 (342)
                      ..+..  .....+  ..+++++.+||.+||. ||.+|++ ++++++||||..
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            77766  333333  3469999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-50  Score=361.01  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=217.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999876554433444567899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|...+...  ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.....   ...
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence            99999998877543  4689999999999999999999999999999999999999999999999999875322   122


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH----HHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM----ALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                      .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+..    .....+.......+..++.++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            2345789999999999876664 8899999999999999999999875432    2333333444455667899999999


Q ss_pred             HHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          249 SRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      ++||+.||++||+     ++++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            9999999999997     899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-50  Score=375.15  Aligned_cols=258  Identities=31%  Similarity=0.590  Sum_probs=220.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+++++.++|+||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999997655545555678899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD----  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~----  169 (342)
                      ||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999853211000    


Q ss_pred             ---------C--------------------------------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHH
Q 019360          170 ---------D--------------------------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY  208 (342)
Q Consensus       170 ---------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~  208 (342)
                               .                                ......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence                     0                                00012468999999999987766 48899999999999


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhc--CCCCC--CCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 019360          209 VLMAGYLPFEESNLMALYKKIFKA--DFKSP--PWFSTSAKKLISRILDPNPVTR---ITMAEVIENEWFKK  273 (342)
Q Consensus       209 ~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~R---ps~~e~l~h~~~~~  273 (342)
                      ||++|..||.+.+..+....+...  ....+  ..++.++.+||.+||. +|.+|   +++.++++||||..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            999999999988877777766642  22222  3478999999999997 67665   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-50  Score=375.14  Aligned_cols=258  Identities=33%  Similarity=0.568  Sum_probs=222.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++++++|+||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999998655545556678899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc-----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----  168 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----  168 (342)
                      ||+++|+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999975221000     


Q ss_pred             ----------------------------------------CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHH
Q 019360          169 ----------------------------------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY  208 (342)
Q Consensus       169 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~  208 (342)
                                                              ........+||+.|+|||++.+..+. .++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence                                                    00011234689999999999887765 8999999999999


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhcC----CCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 019360          209 VLMAGYLPFEESNLMALYKKIFKAD----FKSPPWFSTSAKKLISRILDPNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       209 ~l~~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      ||++|+.||.+.+..+....+....    .+....+++++.++|.+|+ .+|++|++   ++++++||||..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            9999999999888777666665422    2223458999999999987 59999997   999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.8e-50  Score=364.31  Aligned_cols=251  Identities=31%  Similarity=0.605  Sum_probs=220.1

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc-CCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL-IRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.++.+|+.||+|++.+.........+....|..++.. ++|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999976544333344566778888865 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++..+..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++....  ........+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence            99999998888899999999999999999999999999999999999999999999999999863211  1223345678


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+..++.++++||.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999987666 4889999999999999999999999888888888877777777789999999999999999999


Q ss_pred             CCCH-HHHhcCccccc
Q 019360          259 RITM-AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~-~e~l~h~~~~~  273 (342)
                      |+++ +++++||||..
T Consensus       238 R~~~~~~~~~h~~f~~  253 (316)
T cd05620         238 RLGVVGNIRGHPFFKT  253 (316)
T ss_pred             cCCChHHHHcCCCcCC
Confidence            9997 58999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-50  Score=366.55  Aligned_cols=251  Identities=33%  Similarity=0.610  Sum_probs=224.1

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.++.+++.||+|++.+.........+.+..|.+++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999775544455556777899998866 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|...+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  1222344578


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.......+..++.++.+||.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            999999999987666 4889999999999999999999999999999999988888888889999999999999999999


Q ss_pred             CC-------CHHHHhcCccccc
Q 019360          259 RI-------TMAEVIENEWFKK  273 (342)
Q Consensus       259 Rp-------s~~e~l~h~~~~~  273 (342)
                      |+       +++++++||||..
T Consensus       238 R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         238 RLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             cCCCCCCCCCHHHHhcCCccCC
Confidence            99       8999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-53  Score=371.10  Aligned_cols=255  Identities=33%  Similarity=0.504  Sum_probs=227.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ..|+.++.||+|+||.||+|++..+++.||+|++..+..  ...++.+++|+.+|.+++++||.++|+.+..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            468889999999999999999999999999999986543  445678999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |||.||++.+.++....+++..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++......  ....
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr  168 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRR  168 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhcc
Confidence            99999999999998887899999999999999999999999999999999999999999999999998754332  2233


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHhc
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISRIL  252 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L  252 (342)
                      .+..|||.|||||++.+..|+ .++||||||++.+||++|.+|+...+++.....|-+...+. ...+++.+++||..||
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence            778999999999999987876 89999999999999999999999988866555554433332 2357899999999999


Q ss_pred             CCCCCCCCCHHHHhcCccccc
Q 019360          253 DPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++||+.||+|.++|.|+|++.
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHh
Confidence            999999999999999999986

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-50  Score=364.98  Aligned_cols=251  Identities=33%  Similarity=0.648  Sum_probs=224.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+.+|..+++.+ +|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544455556778899999887 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|...+.+...+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence            99999998888899999999999999999999999999999999999999999999999999864211  1222334578


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      ++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.......+..++.++.+||++||+.||++
T Consensus       159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            9999999999877664 889999999999999999999999888888888888777777889999999999999999999


Q ss_pred             CCCH-----HHHhcCccccc
Q 019360          259 RITM-----AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~-----~e~l~h~~~~~  273 (342)
                      ||++     .++++||||..
T Consensus       238 R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         238 RLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             cCCCCCCCHHHHhcCCCcCC
Confidence            9999     99999999976

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.9e-50  Score=372.84  Aligned_cols=258  Identities=31%  Similarity=0.545  Sum_probs=221.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+++|+.++|+||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997655444455677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc-----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----  168 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----  168 (342)
                      ||+++++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999974211000     


Q ss_pred             ------------------------------------CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh
Q 019360          169 ------------------------------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA  212 (342)
Q Consensus       169 ------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~  212 (342)
                                                          ........+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence                                                0001123479999999999987766 489999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHhcC----CCCCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 019360          213 GYLPFEESNLMALYKKIFKAD----FKSPPWFSTSAKKLISRILDPNPVTRI---TMAEVIENEWFKK  273 (342)
Q Consensus       213 g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~h~~~~~  273 (342)
                      |+.||.+.+..+....+....    .+....+++++.++|.+|+ .+|.+|+   ++.++++||||+.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999888777666654322    2223457899999999987 5999999   9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.2e-50  Score=362.85  Aligned_cols=251  Identities=31%  Similarity=0.593  Sum_probs=219.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc-CCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL-IRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|++..+++.||+|++................|..++.. ++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976543333344566678888875 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....  .........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence            99999998878899999999999999999999999999999999999999999999999999863211  1122345678


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+..++.++.+||.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence            999999999987666 4899999999999999999999999888888877776666667778999999999999999999


Q ss_pred             CCCHH-HHhcCccccc
Q 019360          259 RITMA-EVIENEWFKK  273 (342)
Q Consensus       259 Rps~~-e~l~h~~~~~  273 (342)
                      ||++. ++++||||..
T Consensus       238 R~~~~~~l~~h~~~~~  253 (316)
T cd05619         238 RLGVKGDIRQHPFFRE  253 (316)
T ss_pred             cCCChHHHHcCcccCC
Confidence            99996 9999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-51  Score=353.64  Aligned_cols=259  Identities=31%  Similarity=0.480  Sum_probs=220.2

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-   86 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-   86 (342)
                      ..++..-+|.-.+.+|+|+||+||+|....+++.||||.+-.+....       .+|+.+|+.+.|||||++..+|... 
T Consensus        18 ~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   18 DGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSST   90 (364)
T ss_pred             CCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecC
Confidence            34456667999999999999999999999999999999986544332       3799999999999999999888532 


Q ss_pred             --C--eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcc
Q 019360           87 --T--KIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSD  157 (342)
Q Consensus        87 --~--~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~D  157 (342)
                        +  ...+||||++. +|.+.++.    +..++...++-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||
T Consensus        91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicD  169 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICD  169 (364)
T ss_pred             CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEecc
Confidence              2  34589999965 89888874    5678999999999999999999999999999999999999876 8999999


Q ss_pred             cccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC--
Q 019360          158 FGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK--  235 (342)
Q Consensus       158 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~--  235 (342)
                      ||.|+....   +....++.+|..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+....|.+.-..  
T Consensus       170 FGSAK~L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  170 FGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             CCcceeecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence            999986443   333467788999999999999888889999999999999999999999999888877766542111  


Q ss_pred             ---------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          236 ---------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       236 ---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                                 .....++++.+|+.++|+.+|.+|.++.|++.||||..-..+
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                                       113468899999999999999999999999999999876655

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.8e-50  Score=362.23  Aligned_cols=258  Identities=27%  Similarity=0.452  Sum_probs=209.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.....  ......+.+|+.+++.++|+||+++++++......++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            45789999999999999999999999999999999865332  1222356789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||++ ++|.+++..+ +.++++.+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......  .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  157 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S  157 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence            999996 5777777654 56899999999999999999999999999999999999999999999999998643221  1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH-HHHHHHHHhcC----------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKAD----------------  233 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~----------------  233 (342)
                      .......+++.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+....                
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            2223456889999999987655455889999999999999999999987532 22222221100                


Q ss_pred             CC-------C---------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          234 FK-------S---------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       234 ~~-------~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +.       .         ...+++++.+|+.+||+.||++|||++|+++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            00       0         01245678999999999999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-51  Score=366.32  Aligned_cols=273  Identities=40%  Similarity=0.728  Sum_probs=248.7

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      ++..-+...+-|.+.+.||+|-|++|-+|++-.+|+.||||++.+.... .-....+.+|++.|+.++|||||++|++..
T Consensus         9 g~i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViD   87 (864)
T KOG4717|consen    9 GHIYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVID   87 (864)
T ss_pred             ccccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence            3445667778899999999999999999999999999999999886543 334468889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe-cCCCCeeEccccccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL-DANGVLKVSDFGLSA  162 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli-~~~~~~kl~Dfg~~~  162 (342)
                      .+..+|+|+|+-++|+|++++.++ ..+.++..++++.||+.|+.|+|+..+|||||||+||++ ..-|-|||.|||.+.
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence            999999999999999999999876 569999999999999999999999999999999999887 567899999999986


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCH
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST  242 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  242 (342)
                      ...   ......+.||+..|-|||++.+..|+.+++|||||||++|.|++|++||...+..+.+..|+...+..|..++.
T Consensus       168 kf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~  244 (864)
T KOG4717|consen  168 KFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSK  244 (864)
T ss_pred             cCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhH
Confidence            433   34556789999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCCC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFE  281 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~~~~  281 (342)
                      ++++||.+||..||++|.+.+||..|+|++....+++..
T Consensus       245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~  283 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA  283 (864)
T ss_pred             HHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence            999999999999999999999999999999877665543

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.3e-50  Score=363.73  Aligned_cols=251  Identities=30%  Similarity=0.592  Sum_probs=218.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876555555567788999999888 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....  ........+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999863211  1223345679


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---------cHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---------NLMALYKKIFKADFKSPPWFSTSAKKLIS  249 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (342)
                      |+.|+|||++.+..+. .++|+|||||++|+|++|+.||...         ......+.+.......+..++.++.++|+
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  237 (329)
T cd05588         159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK  237 (329)
T ss_pred             CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999876654 8899999999999999999999631         22334555666667777889999999999


Q ss_pred             HhcCCCCCCCCC------HHHHhcCccccc
Q 019360          250 RILDPNPVTRIT------MAEVIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rps------~~e~l~h~~~~~  273 (342)
                      +||+.||.+|++      ++++++||||..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999997      789999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-50  Score=359.56  Aligned_cols=255  Identities=28%  Similarity=0.442  Sum_probs=212.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            479999999999999999999999999999999865432 2334467789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  158 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY  158 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence            999987776655555679999999999999999999999999999999999999999999999999987543211 1122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------------  234 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------------  234 (342)
                      ....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.....                   
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            34568999999999987665 4899999999999999999999987665443333221100                   


Q ss_pred             --CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 --KS-----------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 --~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                        +.           ...++.++.+||.+||+.||++|||++++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              00           11267889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.7e-50  Score=363.45  Aligned_cols=256  Identities=32%  Similarity=0.568  Sum_probs=227.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .|++.+.||+|+||.||+|+++.+++.||+|++.+.........+....|..++..+. |++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4899999999999999999999999999999998755444444556777888887774 889999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|...+...+.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874221  12223


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.......+..++.++.+|+.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence            456789999999999877664 8999999999999999999999999988888888888888888899999999999999


Q ss_pred             CCCCCCCCH-----HHHhcCccccc
Q 019360          254 PNPVTRITM-----AEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rps~-----~e~l~h~~~~~  273 (342)
                      .||.+|++.     .++++||||+.
T Consensus       238 ~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         238 KHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999984     89999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.1e-50  Score=365.72  Aligned_cols=258  Identities=29%  Similarity=0.545  Sum_probs=223.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765544555677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ...
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence            999999999999876 679999999999999999999999999999999999999999999999999987543211 112


Q ss_pred             eecccCCcccCChhhhcc-----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC----CCCCCCCCHH
Q 019360          173 LHTTCGTPNYVAPEVINN-----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWFSTS  243 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~  243 (342)
                      .....||+.|+|||++..     ....+.++|||||||++|+|++|+.||...+.......+....    ++..+.++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            233568999999999863     2233578999999999999999999999888777777766532    2333457899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +.+||.+||+ ||.+|||++++++||||..
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            9999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.1e-50  Score=361.81  Aligned_cols=251  Identities=33%  Similarity=0.652  Sum_probs=219.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc-CCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL-IRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+....|..++.. .+|+||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999976554444444556667777764 4799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....  ........+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874321  1123345678


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..++.++.+||.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999987665 4889999999999999999999999888888888877777777789999999999999999999


Q ss_pred             CCCH-HHHhcCccccc
Q 019360          259 RITM-AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~-~e~l~h~~~~~  273 (342)
                      ||++ .++++||||..
T Consensus       238 R~~~~~~l~~h~~~~~  253 (316)
T cd05592         238 RLGVDGDIRQHPFFRG  253 (316)
T ss_pred             cCCChHHHHcCcccCC
Confidence            9986 58889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.9e-50  Score=369.60  Aligned_cols=263  Identities=30%  Similarity=0.539  Sum_probs=225.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.....
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            34456789999999999999999999999999999999976544444455667899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999999988754 58999999999999999999999999999999999999999999999999987532211


Q ss_pred             CCCceecccCCcccCChhhhccCC---CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC--CCCC
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKG---YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP--PWFS  241 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~  241 (342)
                       .......+||+.|+|||++.+..   ..+.++|||||||++|+|++|+.||.+.+....+..+....  ...+  ..++
T Consensus       197 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             -cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence             11223457999999999987532   24588999999999999999999999988888888876543  2223  3579


Q ss_pred             HHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      .++.+||.+||+.+|.+  |+|++++++||||+.
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            99999999999999988  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.7e-50  Score=363.78  Aligned_cols=252  Identities=34%  Similarity=0.662  Sum_probs=222.6

Q ss_pred             eeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           19 GRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      ++.||+|+||.||++.+.   .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999874   46889999999764432 22334567899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      |+++++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999863221  122233


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (342)
                      ...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.......++.+++++.+||.+||+.
T Consensus       159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence            4578999999999987665 488999999999999999999999998888888888888888888999999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccc
Q 019360          255 NPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       255 dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ||++||     +++++++||||..
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCC
Confidence            999999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6e-50  Score=364.16  Aligned_cols=251  Identities=33%  Similarity=0.613  Sum_probs=220.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||+||+|.++.+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999997654443444445555655 46889999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999864221  1222344578


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+.......++.++..+.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            999999999987665 4889999999999999999999999888888888888877777889999999999999999999


Q ss_pred             CCCH----HHHhcCccccc
Q 019360          259 RITM----AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~----~e~l~h~~~~~  273 (342)
                      ||++    .++++||||..
T Consensus       238 R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         238 RLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            9997    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-49  Score=362.89  Aligned_cols=258  Identities=32%  Similarity=0.602  Sum_probs=220.3

Q ss_pred             CeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeE
Q 019360           15 KYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~   89 (342)
                      +|++++.||+|+||.||++++.   .+++.||+|++.+.... .....+.+.+|+.+++.++ |+||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999874   47899999999754332 2334467789999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ++||||+++++|.+++..+..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987532211 


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                      .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||...    ........+.......+..+++.+.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ  239 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            122234579999999999986554468899999999999999999999642    3344555566666666777999999


Q ss_pred             HHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +++.+||+.||++||     +++++++||||++
T Consensus       240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999999999     8889999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-50  Score=361.92  Aligned_cols=248  Identities=28%  Similarity=0.504  Sum_probs=213.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcE-EEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-KIYI   91 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~l   91 (342)
                      ....+.+.||+|+||+||+|...  |+. ||+|++......... .+.+.+|+.+|.+++|||||+++|++.... ..++
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            34566777999999999999885  555 999999765544333 779999999999999999999999998877 7999


Q ss_pred             EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCcEEecCCC-CeeEcccccccCCccc
Q 019360           92 VLEFVTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDLKPENLLLDANG-VLKVSDFGLSALPQQV  167 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~g-iiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~  167 (342)
                      ||||+++|+|.+++..  ...++...+..++.+|+.||.|||+++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999999988  578999999999999999999999999 99999999999999997 9999999999854432


Q ss_pred             cCCCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTS  243 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~  243 (342)
                      .  .......||+.|||||++.+  ..+ +.++||||||+++|||+||+.||.+.........+....  ...+..+++.
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            1  22334689999999999994  455 599999999999999999999999998877666665333  2335558999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +..|+.+||..||++||++.+++.
T Consensus       275 l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999885

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7e-50  Score=369.03  Aligned_cols=258  Identities=33%  Similarity=0.611  Sum_probs=223.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..++|+||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997655555556678889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD----  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~----  169 (342)
                      ||++|++|.+++.+...+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999864321100    


Q ss_pred             -----------------------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          170 -----------------------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       170 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                                                   .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence                                         0011235799999999999887765 8899999999999999999999998


Q ss_pred             cHHHHHHHHHhcC--CCCC--CCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 019360          221 NLMALYKKIFKAD--FKSP--PWFSTSAKKLISRILDPNPVTRI---TMAEVIENEWFKK  273 (342)
Q Consensus       221 ~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~h~~~~~  273 (342)
                      +.......+....  ...+  ..++.++++||.+|+. ||.+|+   +++++++||||..
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            8888777776532  2222  3478999999999875 999998   4899999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-50  Score=349.43  Aligned_cols=260  Identities=30%  Similarity=0.461  Sum_probs=222.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCC----
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-VIRMYEVMASKT----   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~----   87 (342)
                      ...|+.+++||+|+||+||+|+++.+|+.||+|++..+... +.......+|+.+|+.|+|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            66789999999999999999999999999999999754321 223346679999999999999 999999998776    


Q ss_pred             --eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           88 --KIYIVLEFVTGGELFDKIASRG----RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        88 --~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                        .+++|+||+. .+|..++....    .++...++.+++||+.||+|||+++|+||||||.||||+..|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              8999999995 49999998754    4778899999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----  236 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----  236 (342)
                      +....  .........+|.+|+|||++.+...++...||||+||+++||+++++.|.+.+..+....|......+     
T Consensus       168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            85332  22235667789999999999998777789999999999999999999999999888887776432111     


Q ss_pred             -------------C------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 -------------P------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 -------------~------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                   +            +..+++..+++.+||+.+|.+|.|++.+|.||||+....
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                         0            112458899999999999999999999999999987544

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-49  Score=361.68  Aligned_cols=251  Identities=34%  Similarity=0.601  Sum_probs=219.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.++.+|+.+|+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654444444455556655 46789999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999864221  1222345678


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......++..+..+.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence            9999999999877664 889999999999999999999999988888888888777777789999999999999999999


Q ss_pred             CCCH----HHHhcCccccc
Q 019360          259 RITM----AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~----~e~l~h~~~~~  273 (342)
                      ||++    .+++.||||..
T Consensus       238 R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         238 RLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             cCCCCCCHHHHhcCCCcCC
Confidence            9986    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.9e-49  Score=359.59  Aligned_cols=256  Identities=31%  Similarity=0.582  Sum_probs=226.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .|+..+.||+|+||.||+|+++.+|+.||+|++.+.........+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999998655444445567788999998886 577888999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874221  11223


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..++.++.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence            34568999999999987665 48899999999999999999999999888888888888888888899999999999999


Q ss_pred             CCCCCCCC-----HHHHhcCccccc
Q 019360          254 PNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      .||.+|++     .+++++||||..
T Consensus       238 ~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         238 KHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             cCHhhCCCCCCCCHHHHhcCcccCC
Confidence            99999997     479999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.9e-49  Score=361.63  Aligned_cols=251  Identities=31%  Similarity=0.609  Sum_probs=217.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876555555566788899988776 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  1222344678


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC---------CcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE---------SNLMALYKKIFKADFKSPPWFSTSAKKLIS  249 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||..         .........+.......+..++..+.+||+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~  237 (329)
T cd05618         159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK  237 (329)
T ss_pred             CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            999999999987666 4889999999999999999999952         122334555666667777889999999999


Q ss_pred             HhcCCCCCCCCC------HHHHhcCccccc
Q 019360          250 RILDPNPVTRIT------MAEVIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rps------~~e~l~h~~~~~  273 (342)
                      +||+.||++||+      ++++++||||+.
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999998      589999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-49  Score=366.43  Aligned_cols=261  Identities=31%  Similarity=0.574  Sum_probs=222.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.++.+++.+|+|++.+.........+.+.+|+.+++.++||||+++++++..++.+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999999999999999997654444445567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~  197 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence            999999999999998754 58999999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CceecccCCcccCChhhhccCC---CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC--CCCCHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKG---YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP--PWFSTS  243 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~  243 (342)
                      ......+||+.|+|||++.+..   ..+.++|||||||++|+|++|+.||.+.+.......+....  ...+  ..++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence            1223567999999999997543   24578999999999999999999999988888777776533  2223  346899


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      +++++..||+.+|.+  |++++|+++||||+.
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            999999999866654  899999999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-49  Score=361.54  Aligned_cols=258  Identities=29%  Similarity=0.467  Sum_probs=209.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-----TKI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~   89 (342)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+.... ........+.+|+++++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            6999999999999999999999999999999986432 1223345678999999999999999999987543     358


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+. ++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 68999998888899999999999999999999999999999999999999999999999999874322111


Q ss_pred             -CCceecccCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc---------------
Q 019360          170 -DGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---------------  232 (342)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~---------------  232 (342)
                       ........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+...               
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence             1122345789999999998652 23358899999999999999999999876543322211110               


Q ss_pred             -----------CCC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          233 -----------DFK-----SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       233 -----------~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                 ..+     ..+.+++.+.+++.+||+.||++|||++|+++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                       000     012467889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-49  Score=360.76  Aligned_cols=250  Identities=30%  Similarity=0.580  Sum_probs=216.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC---CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI---RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      ||+|+||+||+|+++.+++.||+|++.+..............|..++..+   .||||+++++++.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999765544444445556677777655   699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence            99999998888899999999999999999999999999999999999999999999999999864221  1222345679


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhcCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-WFSTSAKKLISRILDPNPV  257 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li~~~L~~dP~  257 (342)
                      |+.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+.......+. .+++++.+||++||+.||+
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence            999999999976544468899999999999999999999998888888888776665553 4789999999999999999


Q ss_pred             CCC----CHHHHhcCccccc
Q 019360          258 TRI----TMAEVIENEWFKK  273 (342)
Q Consensus       258 ~Rp----s~~e~l~h~~~~~  273 (342)
                      +||    +++++++||||..
T Consensus       239 ~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         239 HRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             HCCCCCCCHHHHhcCccccC
Confidence            998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.3e-49  Score=358.62  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=217.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||++++..+|..+|+|++....  .....+.+.+|+++|++++|+||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999987532  233456789999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.....    .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~  157 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S  157 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence            99999999999999888899999999999999999999986 699999999999999999999999999874322    1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHh--------------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK--------------------  231 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~--------------------  231 (342)
                      ......|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+..                    
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence            2234568999999999987665 4899999999999999999999977655443322111                    


Q ss_pred             --------------------------cCCC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          232 --------------------------ADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       232 --------------------------~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                                ...+  ....+++++++||.+||+.||++|||++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                      0000  112367899999999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.6e-49  Score=356.99  Aligned_cols=251  Identities=33%  Similarity=0.595  Sum_probs=219.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++|+||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999997655444444455556655 57889999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|...+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  1222344578


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......++..+.++.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            9999999999876654 889999999999999999999999988888888888777777788999999999999999999


Q ss_pred             CCCH----HHHhcCccccc
Q 019360          259 RITM----AEVIENEWFKK  273 (342)
Q Consensus       259 Rps~----~e~l~h~~~~~  273 (342)
                      |+++    .++++|+||..
T Consensus       238 R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         238 RLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCCCCCHHHHhCCCCcCC
Confidence            9975    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-51  Score=347.68  Aligned_cols=262  Identities=34%  Similarity=0.646  Sum_probs=245.5

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ....++.|..++.||+|.||.|.+++.+.+++.||+|+++++.+......+.-..|-++|+..+||.+..+...|+..++
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            44578899999999999999999999999999999999999888888888888899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||..||.|.-.+.....+++...+.+...|+.||.|||+++||+||+|.+|.|++.+|++||+|||+++-  ...
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~  320 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIK  320 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--ccc
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999974  233


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                      ......+.||||.|+|||++....| +.++|.|.+||++|||++|+.||...+...++.-|+..+..+|..++++++.|+
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL  399 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL  399 (516)
T ss_pred             ccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence            4556678999999999999998776 589999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          249 SRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ..+|.+||++|.     .+.|+.+|+||..
T Consensus       400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999998     4899999999974

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-48  Score=356.39  Aligned_cols=251  Identities=33%  Similarity=0.624  Sum_probs=218.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999997654433333344445544 56889999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  1222345679


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.......++.++..+.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence            9999999999876664 889999999999999999999999888888888887777777789999999999999999999


Q ss_pred             CCCHH----HHhcCccccc
Q 019360          259 RITMA----EVIENEWFKK  273 (342)
Q Consensus       259 Rps~~----e~l~h~~~~~  273 (342)
                      |+++.    ++++|+||..
T Consensus       238 R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         238 RLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCCHHHHhcCcccCC
Confidence            99875    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-49  Score=359.31  Aligned_cols=251  Identities=33%  Similarity=0.620  Sum_probs=221.7

Q ss_pred             eeeecccCceEEEEEEEc---CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           19 GRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      ++.||+|+||.||++.+.   .+|+.||+|++.+.... ......+.+|++++++++|+||+++++++...+.+|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            368999999999999863   57899999999764432 23345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceec
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT  175 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (342)
                      +++++|.+++.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......  ......
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~  157 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYS  157 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceec
Confidence            999999999988888999999999999999999999999999999999999999999999999998753221  122345


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN  255 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  255 (342)
                      ..|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+.......+..+++++.+||++||+.|
T Consensus       158 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             ccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            678999999999987665 4889999999999999999999999988888888888888888889999999999999999


Q ss_pred             CCCCCC-----HHHHhcCccccc
Q 019360          256 PVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       256 P~~Rps-----~~e~l~h~~~~~  273 (342)
                      |++||+     +++++.||||..
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCC
Confidence            999999     778999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-48  Score=361.50  Aligned_cols=262  Identities=32%  Similarity=0.575  Sum_probs=223.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++.+.||+|+||.||+|.++.+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+...+.+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            34457999999999999999999999999999999999765444444556788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-  196 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-  196 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence            9999999999999988754 58999999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCceecccCCcccCChhhhccCC---CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC----CCCCCCCCH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKG---YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWFST  242 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~  242 (342)
                      .......+||+.|+|||++.+..   ..+.++|||||||++|+|++|..||...+.......+....    ++....++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence            11223567999999999987543   24588999999999999999999999988888888877543    223346899


Q ss_pred             HHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          243 SAKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      .+++||..||+.++.+  |++++++++|+||.+
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            9999999999854443  789999999999976

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.5e-49  Score=349.52  Aligned_cols=249  Identities=28%  Similarity=0.459  Sum_probs=212.0

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||+|+||+||++.++.+++.||+|.+.+.........+.+..|+++++.++|+||+++.+++......|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999765544444456778899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceeccc
Q 019360          102 FDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC  177 (342)
Q Consensus       102 ~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  177 (342)
                      ...+..    ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......  ........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence            887743    356899999999999999999999999999999999999999999999999998643321  11223457


Q ss_pred             CCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH----HHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL----MALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ||+.|+|||++.+..++ .++|||||||++|+|++|+.||.....    ......+.......+..++.++.+++.+||+
T Consensus       159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            89999999999877664 889999999999999999999976532    2333444444445566789999999999999


Q ss_pred             CCCCCCC-----CHHHHhcCccccc
Q 019360          254 PNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      .||++||     +++++++||||+.
T Consensus       238 ~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhcChhhhc
Confidence            9999999     8899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-50  Score=337.35  Aligned_cols=259  Identities=36%  Similarity=0.629  Sum_probs=228.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchh-----hhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEK-----VLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMA   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~   84 (342)
                      .-..+|...+.||+|..++|-++.++.+|+.+|+|++....     .......+.-.+|+.+|+++. ||+|+++.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567889999999999999999999999999999985311     112334556678999999986 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ++..+++|+|.|+.|.|.+++.+.-.+++.+.++|++|+++|+.|||.++|+||||||+|||++++-++||+|||.+...
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999854


Q ss_pred             ccccCCCceecccCCcccCChhhhccC-----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC--
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNK-----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP--  237 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--  237 (342)
                      .   ........||||+|+|||.+...     +-++...|+|++||++|.++.|.+||-....+-+...|+.+.+.+.  
T Consensus       174 ~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  174 E---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             C---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence            3   34456778999999999998642     1235789999999999999999999999988999999999887663  


Q ss_pred             --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          238 --PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       238 --~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                        ..++...++||.+||+.||.+|.|++|+|+||||.
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence              34889999999999999999999999999999994

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-48  Score=360.33  Aligned_cols=262  Identities=27%  Similarity=0.461  Sum_probs=213.4

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-   87 (342)
                      .....++|++.+.||+|+||.||++.+..+|+.||+|++.... ........+.+|+.+++.++|+||+++++++...+ 
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          16 TFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            3456789999999999999999999999999999999986542 22334457789999999999999999999986443 


Q ss_pred             -----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           88 -----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        88 -----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                           .+|+||||+++ +|...+.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence                 57999999965 5666654  348899999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--------  234 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--------  234 (342)
                      ....   ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+.....        
T Consensus       172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            4321   2223445789999999999877664 789999999999999999999987765444332221100        


Q ss_pred             --------------C--------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          235 --------------K--------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       235 --------------~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                                    .                    .....++++++||.+||+.||++|||+.|+|+||||..++.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence                          0                    0012357789999999999999999999999999998766654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-48  Score=355.56  Aligned_cols=251  Identities=29%  Similarity=0.605  Sum_probs=218.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++ .|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876555555667788999999888 599999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360           99 GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus        99 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      ++|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  1223345679


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC-------cHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES-------NLMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|..||...       ........+.......+..++..+.++|.+|
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            999999999987666 48999999999999999999999532       2334455566666667778899999999999


Q ss_pred             cCCCCCCCCC------HHHHhcCccccc
Q 019360          252 LDPNPVTRIT------MAEVIENEWFKK  273 (342)
Q Consensus       252 L~~dP~~Rps------~~e~l~h~~~~~  273 (342)
                      |+.||++|++      ++++++||||..
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            9999999998      579999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-48  Score=348.35  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=217.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999976544434444567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|...+...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....   ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence            99999999887643  4589999999999999999999999999999999999999999999999999875322   112


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH----HHHHhcCCCCCCCCCHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY----KKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~li  248 (342)
                      .....|++.|+|||.+.+..+ +.++||||+||++|++++|+.||.+.+.....    ..+.......+..++..+.+|+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            234578999999999987655 48899999999999999999999876553332    2333333444566899999999


Q ss_pred             HHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          249 SRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      .+||+.||++||     +++++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     8999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-48  Score=360.70  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=214.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-----KI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~   89 (342)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+++.+|+.+++.++|+||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4789999999999999999999999999999986432 22233467889999999999999999999998776     78


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+. ++|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~  157 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E  157 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence            99999996 588888888788999999999999999999999999999999999999999999999999998753321 1


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc-----------------
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA-----------------  232 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~-----------------  232 (342)
                      ........+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...                 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            112233467899999999987554568899999999999999999999887766555444321                 


Q ss_pred             ------CC---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          233 ------DF---------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       233 ------~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                            ..         ......++++.+||.+||+.||++|||+.|+|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                  11         1123357889999999999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-50  Score=360.05  Aligned_cols=257  Identities=28%  Similarity=0.504  Sum_probs=234.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe-EE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK-IY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~   90 (342)
                      ..+.|..++.+|+|+||.+++++++.++..+++|.+........ ..+...+|+.+++++.|||||.+.+.|..++. ++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            35789999999999999999999999999999999987654433 34477899999999999999999999998888 99


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||+||+||+|.+.+.+.  ..++++.+..++.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+..... 
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-  159 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-  159 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence            999999999999999764  45899999999999999999999999999999999999999999999999999975442 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                       .....+..||+.||+||++.+.+|. .++|||||||++|||++-+.+|.+.+...+..+|.+.. .+.+..++.+++.+
T Consensus       160 -~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 -DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             -hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence             2356778999999999999998886 99999999999999999999999999999999999988 55677899999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      |+.||..+|..||++.++|.+|..+
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhh
Confidence            9999999999999999999998876

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-48  Score=353.20  Aligned_cols=259  Identities=30%  Similarity=0.548  Sum_probs=218.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997655444555667889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence            99999999999976 4579999999999999999999999999999999999999999999999999986432211 111


Q ss_pred             eecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC---CCCCHH
Q 019360          173 LHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP---PWFSTS  243 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~  243 (342)
                      .....||+.|+|||++..    ....+.++|||||||++|+|++|+.||.+.+..+....+....  +..+   ..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence            223468999999999863    2334578999999999999999999999888777777765432  2222   347899


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      +++||++||..++++  |++++++++||||..
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            999999999765544  889999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.8e-48  Score=350.98  Aligned_cols=260  Identities=25%  Similarity=0.444  Sum_probs=215.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++.++|+||+++++++..++..+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            456789999999999999999999999999999999865332  122335678999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......  
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--  157 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--  157 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--
Confidence            99999975 788877654 45899999999999999999999999999999999999999999999999998743221  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC----------------
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----------------  233 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~----------------  233 (342)
                      ........+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            1122334678999999998765545689999999999999999999998877655544443210                


Q ss_pred             -----CC---------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          234 -----FK---------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       234 -----~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                           .+         ..+.++.++.+||.+||+.||.+|||++|+++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                 00         1124678999999999999999999999999999998644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-48  Score=368.34  Aligned_cols=253  Identities=29%  Similarity=0.416  Sum_probs=206.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-----   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----   86 (342)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+|+.++|+||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3468999999999999999999999999999999885432       1234799999999999999999887432     


Q ss_pred             ---CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEccc
Q 019360           87 ---TKIYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDF  158 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Df  158 (342)
                         ..+++||||+++ +|..++.    ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               246799999975 6766654    346689999999999999999999999999999999999998665 7999999


Q ss_pred             ccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-----
Q 019360          159 GLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD-----  233 (342)
Q Consensus       159 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~-----  233 (342)
                      |+++....   ........||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+....     
T Consensus       216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99975332   1222345789999999998765445689999999999999999999999877655554443211     


Q ss_pred             --------------CC----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          234 --------------FK----------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       234 --------------~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                    ++          .+...++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                          00          1224678999999999999999999999999999998643

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-48  Score=361.33  Aligned_cols=253  Identities=20%  Similarity=0.333  Sum_probs=207.3

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|++++++++||||+++++++......+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            344689999999999999999999999999999997532         24568999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +|+|++. ++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~  237 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NA  237 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cc
Confidence            9999995 689888888788999999999999999999999999999999999999999999999999998643221 11


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-------HHHHHHHHHh------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-------LMALYKKIFK------------  231 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-------~~~~~~~i~~------------  231 (342)
                      .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+       .......+..            
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            22344679999999999987665 489999999999999999998764321       1111111110            


Q ss_pred             --------------cCCCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          232 --------------ADFKSP---------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       232 --------------~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                    .....+         ..++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                          000000         12456899999999999999999999999999998743

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-48  Score=358.19  Aligned_cols=263  Identities=27%  Similarity=0.447  Sum_probs=215.6

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-   86 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-   86 (342)
                      ......++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++++... 
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~   96 (364)
T cd07875          18 STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   96 (364)
T ss_pred             chhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence            34456789999999999999999999999999999999986532 2233445778999999999999999999987543 


Q ss_pred             -----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           87 -----TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        87 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                           ..+|+||||+++ +|...+..  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence                 357999999965 67776653  4788999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----  236 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----  236 (342)
                      +....   ........+|+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+......+     
T Consensus       174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cccCC---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            75322   2222345789999999999877664 88999999999999999999998877666655554311100     


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          237 -------------------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       237 -------------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                                                           ....+.++++||.+||+.||.+|||+.++|+||||..++.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence                                                 011246789999999999999999999999999998765543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.3e-48  Score=345.18  Aligned_cols=254  Identities=39%  Similarity=0.763  Sum_probs=229.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|.||++.+..+++.+|+|++.+.........+.+.+|+++++++.|+||+++++++......|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997665555555678899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......     .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence            99999999999998888999999999999999999999999999999999999999999999999998754321     2


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ....+++.|+|||.+.+... +.++||||||+++|+|++|..||...+.......+.......+..++..+.++|.+||+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  234 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ  234 (290)
T ss_pred             CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence            34568899999999876654 48899999999999999999999888877777777777777777889999999999999


Q ss_pred             CCCCCCC-----CHHHHhcCccccc
Q 019360          254 PNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      .||.+|+     +++++++||||..
T Consensus       235 ~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             CCHHHccCcccCCHHHHHcCccccc
Confidence            9999999     8999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3e-48  Score=357.21  Aligned_cols=260  Identities=27%  Similarity=0.454  Sum_probs=213.0

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....+.|+.++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+++++.++|+||+++++++...+.+
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            334678999999999999999999999999999999986432  233446788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+++++|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            999999999988543    335778889999999999999999999999999999999999999999999987543211 


Q ss_pred             CCceecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcH---HHHHHHHH-hcCCCCCCCCC
Q 019360          170 DGLLHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNL---MALYKKIF-KADFKSPPWFS  241 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~---~~~~~~i~-~~~~~~~~~~~  241 (342)
                       .......||..|+|||++..    ..+.+.++|||||||++|+|++|+.||.....   ......+. ......+..++
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence             12234578999999998753    23345689999999999999999999974332   22222222 22233455688


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      .++.+||.+||+.||++|||+.|+++||||.....+
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            999999999999999999999999999999876544

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.6e-48  Score=357.01  Aligned_cols=265  Identities=26%  Similarity=0.457  Sum_probs=215.2

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      |.+.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874           9 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             CchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            3444567899999999999999999999999999999999986532 223344677889999999999999999998864


Q ss_pred             C------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           86 K------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        86 ~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      .      ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence            3      357999999965 66666653  48899999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-----
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-----  234 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-----  234 (342)
                      +++....   ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+.....     
T Consensus       165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             ccccCCC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9975322   2223445789999999999877664 889999999999999999999988765554433321100     


Q ss_pred             -------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          235 -------------------------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       235 -------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                                           ......+.++++||.+||+.||++|||+.|+|+||||+..+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                                                 0011235678999999999999999999999999999876654


Q ss_pred             C
Q 019360          278 P  278 (342)
Q Consensus       278 ~  278 (342)
                      .
T Consensus       321 ~  321 (355)
T cd07874         321 A  321 (355)
T ss_pred             h
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-47  Score=350.27  Aligned_cols=259  Identities=28%  Similarity=0.507  Sum_probs=219.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444445567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||++|++|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence            99999999999987 4678999999999999999999999999999999999999999999999999986432211 111


Q ss_pred             eecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC---CCCCHH
Q 019360          173 LHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP---PWFSTS  243 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~  243 (342)
                      ....+||+.|+|||++.+.    ...+.++|||||||++|+|++|+.||...+..+....+....  ++.+   ..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            2235689999999998752    223578999999999999999999999888877777776543  2222   236899


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      +++||.+||..++++  |++++++++||||+.
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            999999999876654  568999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.1e-48  Score=367.17  Aligned_cols=257  Identities=28%  Similarity=0.487  Sum_probs=222.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCC-CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ....|.+.+.||+|++|.||+|.+..+ ++.||+|.+....   ......+.+|+.+|+.++||||+++++++...+..|
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            345599999999999999999999877 7889999774332   333456788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           91 IVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +||||+++++|.+++..    ..++++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999887753    45689999999999999999999999999999999999999999999999999975433


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAK  245 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~  245 (342)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+..+... .+..++.++.
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  300 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK  300 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence            222223345679999999999987665 48899999999999999999999998888888887766554 3456889999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +||.+||+.||++||++++++.|+|++
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHhCHHHH
Confidence            999999999999999999999999985

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.9e-48  Score=345.15  Aligned_cols=252  Identities=29%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcC-CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC---CCCcceeEEEEEE-----
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTE-TGENVAIKILDKEKVLKHKMIGQIKREISTMKLI---RHPNVIRMYEVMA-----   84 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~-----   84 (342)
                      .+|++.+.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 4688999998653322 22223455677777655   6999999999885     


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ....+++||||++ ++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999996 5898888753  458999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-------  235 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------  235 (342)
                      ....   ........|++.|+|||.+.+..+ +.++|||||||++|+|++|++||.+.+..+....+......       
T Consensus       159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            5332   122344568999999999987665 47899999999999999999999988777666665432110       


Q ss_pred             --------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 --------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                          ..+.++..+.+|+.+||+.||++|||+.|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                012467788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-47  Score=350.13  Aligned_cols=259  Identities=27%  Similarity=0.508  Sum_probs=219.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+++++.+++.+|+|++.+...........+.+|+.++..++|++|+++++.+...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444445566889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++|+|.+++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence            99999999999986 467899999999999999999999999999999999999999999999999998643211 1111


Q ss_pred             eecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--CCC---CCCCHH
Q 019360          173 LHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--KSP---PWFSTS  243 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~---~~~~~~  243 (342)
                      ....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||...+..+....+.....  ..+   ..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            233578999999999863    23345789999999999999999999999888888877765432  222   347899


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      +++|+++||..+|.+  |++++++++||||..
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            999999999765554  789999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.6e-48  Score=368.31  Aligned_cols=262  Identities=31%  Similarity=0.526  Sum_probs=225.0

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--   87 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--   87 (342)
                      ....++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+..+..++|+||+++++.+...+  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3455799999999999999999999999999999999975433 2344567889999999999999999988775332  


Q ss_pred             ------eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcc
Q 019360           88 ------KIYIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSD  157 (342)
Q Consensus        88 ------~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~D  157 (342)
                            .+++||||+++|+|.+++..+    ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                  378999999999999988653    4689999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-C
Q 019360          158 FGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-S  236 (342)
Q Consensus       158 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~  236 (342)
                      ||+++..............+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+...... .
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            9998754332223333456799999999999876664 8999999999999999999999998888877777765543 4


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++.+++++.+|+.+||+.||.+||++.++++|||++.
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            5678999999999999999999999999999999864

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-48  Score=341.05  Aligned_cols=253  Identities=38%  Similarity=0.687  Sum_probs=213.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      |++++.||+|+||+||++.+..+++.||+|++......... .....+|+.++++++|+||+++++++......++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999876543332 33445699999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceec
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT  175 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (342)
                      +++++|.+++.....+++..+..++.|+++||.+||++|++|+||||+||+++.++.++|+|||.+...  .........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~  157 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP  157 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence            999999999997788999999999999999999999999999999999999999999999999998642  122333455


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHHhcCCCC----CCCCCHHHHHHH
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKADFKS----PPWFSTSAKKLI  248 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~----~~~~~~~~~~li  248 (342)
                      ..++..|+|||++......+.++||||||+++|+|++|..||...   +...............    ....+..+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            678999999999982333458999999999999999999999887   3333333333322211    111248899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCccc
Q 019360          249 SRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-47  Score=349.41  Aligned_cols=255  Identities=24%  Similarity=0.424  Sum_probs=214.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.++||.|+||.||++.+..++..+|+|.+....  .......+.+|+++++.++|+||+++++++...+.+++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            478999999999999999999999999999999986532  233345788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....    .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S  157 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----h
Confidence            99999999999999888899999999999999999999975 799999999999999999999999999864322    1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHH----------------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI----------------------  229 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i----------------------  229 (342)
                      ......|+..|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+                      
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence            1233568999999999987655 48899999999999999999999765443322111                      


Q ss_pred             ----------------------HhcCCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          230 ----------------------FKADFKS--PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       230 ----------------------~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                            .....+.  ...++.++++||.+||+.||++|||++|++.||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                  1110000  11357889999999999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-48  Score=357.65  Aligned_cols=251  Identities=33%  Similarity=0.492  Sum_probs=214.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-C-----CcceeEEEEEEe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-H-----PNVIRMYEVMAS   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~l~~~~~~   85 (342)
                      ...||.+++.||+|+||.|.+|.+..+++.||||+++...    ....+...|+++|..|+ |     -|+|+++++|..
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            3448999999999999999999999999999999997543    34456778999999997 3     489999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC--CCeeEcccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN--GVLKVSDFGLS  161 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~--~~~kl~Dfg~~  161 (342)
                      .++.|+|+|.+ +.+|+++++.+  ..++...++.++.||+.||.+||+.||||+||||+|||+...  ..+||+|||.|
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999999 56999999876  458999999999999999999999999999999999999654  37999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----  237 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----  237 (342)
                      .....     ...+++-+..|+|||++.+.+|+ .+.|||||||+++||++|.+.|.+.+..+.+..|......++    
T Consensus       339 c~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  339 CFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            85332     23367778999999999999886 889999999999999999999999988888776653111100    


Q ss_pred             -----------------------------------------------C------------CCCHHHHHHHHHhcCCCCCC
Q 019360          238 -----------------------------------------------P------------WFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       238 -----------------------------------------------~------------~~~~~~~~li~~~L~~dP~~  258 (342)
                                                                     +            .-...+.+||++||++||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                                                           0            01235789999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 019360          259 RITMAEVIENEWFKK  273 (342)
Q Consensus       259 Rps~~e~l~h~~~~~  273 (342)
                      |+|+.++|+||||..
T Consensus       493 R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  493 RITPAQALNHPFLTG  507 (586)
T ss_pred             cCCHHHHhcCccccc
Confidence            999999999999984

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-47  Score=335.45  Aligned_cols=257  Identities=30%  Similarity=0.550  Sum_probs=218.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh--hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL--KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      +.|++.+.||+|++|.||.|.+..+++.+|+|.+......  .....+.+.+|+.++++++|+||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4699999999999999999999999999999998643221  12234678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |+||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987433211111


Q ss_pred             -ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--CCCCCCCCCHHHHHHH
Q 019360          172 -LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li  248 (342)
                       ......++..|+|||.+.+..+ +.++||||||+++|++++|+.||...+.......+...  ....+..++..+.++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence             1123457889999999987664 58999999999999999999999876665554444333  2334556889999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCccc
Q 019360          249 SRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .+||..+|++|||+.++++||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-47  Score=351.28  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=212.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC----
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK----   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----   86 (342)
                      ...++|++++.||.|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            456799999999999999999999999999999999865432 223345677899999999999999999987533    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           87 --TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        87 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                        ...|++++++ +++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              3478999998 7789877754 56999999999999999999999999999999999999999999999999998753


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--------  236 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  236 (342)
                      ..     ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.......        
T Consensus       169 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             CC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            22     22345789999999999775445689999999999999999999998776555444433211000        


Q ss_pred             -----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 -----------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                             ....++.+.+||.+||+.||++|||+.|+|+||||.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                                   0124667899999999999999999999999999987544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.8e-47  Score=363.04  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=202.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC------CCcceeEEEEEEeC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR------HPNVIRMYEVMASK   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~~~   86 (342)
                      .++|++++.||+|+||+||+|.+..+++.||||++.....    .......|+.+++.++      |.+++++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            4789999999999999999999999999999999864221    1234455666666664      45688999988754


Q ss_pred             -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCC-------------
Q 019360           87 -TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANG-------------  151 (342)
Q Consensus        87 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~-------------  151 (342)
                       ..+|+|||++ |++|.+++.+++.+++..+..|+.|++.||.|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 77899999888889999999999999999999998 5999999999999998665             


Q ss_pred             ---CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH
Q 019360          152 ---VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK  228 (342)
Q Consensus       152 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~  228 (342)
                         .+||+|||.+....     ......+||+.|+|||++.+..+. .++|||||||++|||++|+.||.+.+..+....
T Consensus       283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence               49999999875321     122456789999999999887764 889999999999999999999988766554433


Q ss_pred             HHhcCCCCC------------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 019360          229 IFKADFKSP------------------------------------------PWFSTSAKKLISRILDPNPVTRITMAEVI  266 (342)
Q Consensus       229 i~~~~~~~~------------------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l  266 (342)
                      +.......+                                          ...++.+.+||.+||+.||++|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            322110000                                          00135578999999999999999999999


Q ss_pred             cCcccccCC
Q 019360          267 ENEWFKKGY  275 (342)
Q Consensus       267 ~h~~~~~~~  275 (342)
                      +||||++.+
T Consensus       437 ~Hp~~~~~~  445 (467)
T PTZ00284        437 THPYVLKYY  445 (467)
T ss_pred             cCccccccC
Confidence            999998644

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.6e-47  Score=339.87  Aligned_cols=255  Identities=28%  Similarity=0.456  Sum_probs=213.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++|++++.+++.+...+..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999876544434444567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|..++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....   ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence            99999999888643  3589999999999999999999999999999999999999999999999999864322   112


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH---HHHHHHH-hcCCCCCCCCCHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM---ALYKKIF-KADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~---~~~~~i~-~~~~~~~~~~~~~~~~li  248 (342)
                      .....|+..|+|||.+.+..+ +.++||||+||++|+|++|+.||......   ....... ......+..+++++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            233468999999999987665 48899999999999999999999864321   1122221 112233456889999999


Q ss_pred             HHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          249 SRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      .+||+.||++|||     ++|+++||||..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            9999999999999     999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.5e-47  Score=341.88  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=214.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||.|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++.++|+||+++++++...+..+
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            356789999999999999999999999999999999864332  222345678999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......  
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--  157 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--  157 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--
Confidence            9999997 4888887653 56899999999999999999999999999999999999999999999999998743221  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---------------
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---------------  234 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---------------  234 (342)
                      ........+++.|+|||++.+....+.++|||||||++|+|++|+.||...+..+....+.....               
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            11122345688999999987655456889999999999999999999988776555444332100               


Q ss_pred             ----C-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          235 ----K-----------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       235 ----~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                          .           ....+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                0           01246788999999999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-47  Score=339.94  Aligned_cols=251  Identities=28%  Similarity=0.453  Sum_probs=204.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC---CCCcceeEEEEEEe-----C
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI---RHPNVIRMYEVMAS-----K   86 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~-----~   86 (342)
                      +|++.+.||+|+||+||+|.++.+|+.||+|.+...... ........+|+.+++.+   +|+||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            699999999999999999999999999999998653221 11223445677776655   69999999998854     3


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ..++++|||+++ +|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            458999999975 888888763  34899999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC----------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF----------  234 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~----------  234 (342)
                      ..   ........++..|+|||++.+..+ +.++|||||||++|+|++|.+||.+........++.....          
T Consensus       159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            32   112234567899999999987665 4899999999999999999999988776655555433110          


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 -----------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 -----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                       ...+.++..+.+||.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                             0113467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.5e-47  Score=336.86  Aligned_cols=248  Identities=27%  Similarity=0.441  Sum_probs=206.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||+|+||.||++.++.+|+.||+|.+.............+..|+++++.++||||+++++++..+...|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999764443333334566799999999999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCC
Q 019360          102 FDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT  179 (342)
Q Consensus       102 ~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  179 (342)
                      ...+...  ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....   ........|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence            8887653  3588999999999999999999999999999999999999999999999999875332   1222345689


Q ss_pred             cccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH----HHHHHHHHhcCCCC-CCCCCHHHHHHHHHhcCC
Q 019360          180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL----MALYKKIFKADFKS-PPWFSTSAKKLISRILDP  254 (342)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~~  254 (342)
                      ..|+|||++.+..+ +.++|||||||++|+|++|+.||.....    .............. ...+++++.+|+.+||+.
T Consensus       158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            99999999987665 4899999999999999999999976432    23333333333322 235789999999999999


Q ss_pred             CCCCCCCH----HHHhcCccccc
Q 019360          255 NPVTRITM----AEVIENEWFKK  273 (342)
Q Consensus       255 dP~~Rps~----~e~l~h~~~~~  273 (342)
                      ||++||++    ++++.||||+.
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    67889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.7e-47  Score=337.11  Aligned_cols=255  Identities=27%  Similarity=0.457  Sum_probs=217.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|+..+.||.|+||+||+|.+..+++.+|+|.+.............+.+|+++++.++|+||+.+.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999976544444444567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|...+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....   ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence            99999998887643  4699999999999999999999999999999999999999999999999998864322   112


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHH----HHHhcCCCCCCCCCHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK----KIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~li  248 (342)
                      .....|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||..........    .+.......+..++.++.+|+
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            234568999999999987665 488999999999999999999998765543332    233333444566889999999


Q ss_pred             HHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          249 SRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      .+||+.||++||+     +.++++|+||+.
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence            9999999999999     889999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-48  Score=354.72  Aligned_cols=264  Identities=41%  Similarity=0.791  Sum_probs=246.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ...++-|.+.+.||+|.|+.|.+|.+..++..||+|.+++..... ...+.+.+|+++|+.|+|||||+++.+.+....+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            346788999999999999999999999999999999998876543 3445588999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+.+|.+++++.+++...+..+..++.|+..|++|+|+++|+|||||++|||++.+-++||+|||++....   .
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~  207 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y  207 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998644   4


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS  249 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (342)
                      .....+.||++.|.|||++.+..|+++.+|+||+|+++|.|+.|.+||++.+...+....+.+.+..+-.++.++.+||+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr  287 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR  287 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence            55678899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      ++|..+|.+|++.++++.|+|...++..
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999998765544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=347.55  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=211.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      +++++.||+|.||.||.|.... ...||+|.+.......    ..+.+|+.+|++|+|++||++++++..++.+||||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            5668899999999999999853 3479999986543222    3567999999999999999999999998899999999


Q ss_pred             cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           96 VTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        96 ~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |+.|+|.++|+.  +..+...+...++.||++|++||+++++|||||...|||++.+..+||+|||+|+..... .....
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~  361 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS  361 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence            999999999997  466999999999999999999999999999999999999999999999999999943221 11112


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHh
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~  251 (342)
                      ....-+..|.|||.+....++ .++|||||||+|||++| |+.||.+.+..+..+.+.++ ..+.|+.+++++.+++..|
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            222235679999999987765 89999999999999999 99999999999999998876 4566788999999999999


Q ss_pred             cCCCCCCCCCHHHHh
Q 019360          252 LDPNPVTRITMAEVI  266 (342)
Q Consensus       252 L~~dP~~Rps~~e~l  266 (342)
                      |..+|++|||++.+.
T Consensus       441 W~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLR  455 (468)
T ss_pred             hhCCcccCCCHHHHH
Confidence            999999999999665

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=328.30  Aligned_cols=258  Identities=33%  Similarity=0.621  Sum_probs=221.5

Q ss_pred             Ceee-eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEE
Q 019360           15 KYEL-GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        15 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv   92 (342)
                      -|++ .+.||+|+++.|--+....+|..||||++.+..   .....++.+|++++.+.+ |+||++++++|++++.+|+|
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            3554 457899999999999999999999999998763   344568899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---eeEcccccccCCccc--
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV---LKVSDFGLSALPQQV--  167 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~---~kl~Dfg~~~~~~~~--  167 (342)
                      ||.|.||+|...++++..+++.++.+++++|+.||.+||++||.|||+||+|||+.....   +|||||.+..-....  
T Consensus       155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            999999999999999999999999999999999999999999999999999999976654   799999987532221  


Q ss_pred             ---cCCCceecccCCcccCChhhhc----cCCCCCcccchhhhhHHHHHHHhCCCCCCCC---------------cHHHH
Q 019360          168 ---RDDGLLHTTCGTPNYVAPEVIN----NKGYDGAKADLWSCGVILYVLMAGYLPFEES---------------NLMAL  225 (342)
Q Consensus       168 ---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---------------~~~~~  225 (342)
                         .......+.+|+..|||||++.    ...++..++|.|||||++|.|++|++||.+.               -...+
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence               1222345678889999999874    2334458899999999999999999999653               24567


Q ss_pred             HHHHHhcCCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          226 YKKIFKADFKSPP----WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       226 ~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +..|..+.+.+|.    .+|.++++||+.+|..|+.+|.++.++++|||++.-.
T Consensus       315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            7788888888775    4899999999999999999999999999999998543

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-46  Score=327.17  Aligned_cols=253  Identities=29%  Similarity=0.478  Sum_probs=220.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            488999999999999999999999999999998654322 3445678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~  157 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF  157 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence            99999999999764  56899999999999999999999999999999999999999999999999988754321  112


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHh
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP-PWFSTSAKKLISRI  251 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~  251 (342)
                      .....+++.|+|||++.+..+ +.++|+|||||++++|++|+.||...+.......+.....+.. ..++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            234567889999999987665 4889999999999999999999998887777777766655443 36889999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccc
Q 019360          252 LDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~  271 (342)
                      |+.+|++||++.++++|||+
T Consensus       237 l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         237 LTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-47  Score=345.93  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.++..+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            468999999999999999999752     345789999986432  223345788999999999 899999999988654


Q ss_pred             -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 019360           87 -TKIYIVLEFVTGGELFDKIASR---------------------------------------------------------  108 (342)
Q Consensus        87 -~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  108 (342)
                       ..+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999988752                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccC
Q 019360          109 -----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV  183 (342)
Q Consensus       109 -----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  183 (342)
                           ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence                 237788899999999999999999999999999999999999999999999987532211111112234567899


Q ss_pred             ChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHH-HHHHhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 019360          184 APEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALY-KKIFKA-DFKSPPWFSTSAKKLISRILDPNPVTRI  260 (342)
Q Consensus       184 aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~-~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rp  260 (342)
                      |||++.+..+ +.++|||||||++|||++ |..||.+....... ..+..+ ....+..+++++.+|+.+||+.||++||
T Consensus       244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            9999987665 489999999999999997 99999876543333 333322 2334556789999999999999999999


Q ss_pred             CHHHHhc
Q 019360          261 TMAEVIE  267 (342)
Q Consensus       261 s~~e~l~  267 (342)
                      |+.++++
T Consensus       323 s~~el~~  329 (338)
T cd05102         323 TFSALVE  329 (338)
T ss_pred             CHHHHHH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.8e-46  Score=336.50  Aligned_cols=259  Identities=33%  Similarity=0.624  Sum_probs=222.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.|++.+.||.|+||.||++.+..+++.|++|.+...........+.+.+|+++++.++|+||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999987654434445567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC----
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD----  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~----  169 (342)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999998863211000    


Q ss_pred             ---------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC---
Q 019360          170 ---------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP---  237 (342)
Q Consensus       170 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---  237 (342)
                               ........++..|+|||.+.+..+ +.++|+|||||++|++++|..||.+.+..+....+.......+   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                     001112357889999999877655 5889999999999999999999998888777777766543322   


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 019360          238 PWFSTSAKKLISRILDPNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      ..++.++.++|.+||+.||++||+   +.++|+||||..
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            257899999999999999999998   799999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=338.12  Aligned_cols=260  Identities=32%  Similarity=0.561  Sum_probs=224.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|++.+.||.|++|.||+|.+..+++.+|+|.+...........+.+.+|+.+++.++|+||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998765544445678899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC-
Q 019360           94 EFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-  170 (342)
Q Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-  170 (342)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998764  56899999999999999999999999999999999999999999999999987643221100 


Q ss_pred             --------------------------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH
Q 019360          171 --------------------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA  224 (342)
Q Consensus       171 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~  224 (342)
                                                .......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                      01112357889999999987665 588999999999999999999999888777


Q ss_pred             HHHHHHhcCCCCCCC--CCHHHHHHHHHhcCCCCCCCCC----HHHHhcCcccccC
Q 019360          225 LYKKIFKADFKSPPW--FSTSAKKLISRILDPNPVTRIT----MAEVIENEWFKKG  274 (342)
Q Consensus       225 ~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps----~~e~l~h~~~~~~  274 (342)
                      .+..+.......+..  ++..+.++|.+||+.||++|||    ++++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            777776555444433  6899999999999999999999    9999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-46  Score=330.35  Aligned_cols=256  Identities=29%  Similarity=0.528  Sum_probs=217.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh------hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL------KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+......      .....+.+.+|+.++++++|+||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999999989999999988643221      22345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987543211


Q ss_pred             C----CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHH
Q 019360          169 D----DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA-DFKSPPWFSTS  243 (342)
Q Consensus       169 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (342)
                      .    ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+... ....+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence            1    111123457889999999987655 47899999999999999999999887665544444333 22344568899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +.++|++||+.||.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.1e-46  Score=327.00  Aligned_cols=253  Identities=26%  Similarity=0.540  Sum_probs=216.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-KTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~   93 (342)
                      +|++.+.||.|++|.||++.++.+++.+|+|.+..... .....+.+.+|+.++++++|+|++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            59999999999999999999999999999999865332 23345578899999999999999999998764 44689999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           94 EFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||+++++|.+++...  ..+++.++..++.+++.||.+||+.|++||||+|+||+++.++.++|+|||++......  ..
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~  157 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD  157 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence            999999999988763  45899999999999999999999999999999999999999999999999998754321  12


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLISR  250 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~  250 (342)
                      ......+++.|+|||.+.+..+. .++|+|||||+++++++|+.||...+.......+..... ..+..+++++.+++.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            23345688999999999876654 789999999999999999999988777666666655544 3345688999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCccc
Q 019360          251 ILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ||+.||++||++.++++||||
T Consensus       237 ~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-46  Score=336.51  Aligned_cols=263  Identities=33%  Similarity=0.483  Sum_probs=219.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh--hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL--KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+......  .......+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999754432  122345677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+ +++|.+++.... .+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence            9999 889999998765 79999999999999999999999999999999999999999999999999987543321  1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----------------  235 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------  235 (342)
                      ......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+..+....+......                
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2223356788999999866544568899999999999999999999877766555554321100                


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCC
Q 019360          236 ------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSF  280 (342)
Q Consensus       236 ------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~~~  280 (342)
                                  .....+.++.++|.+||++||++|||+.|++.|+||++...+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~  294 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP  294 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence                        012346789999999999999999999999999999987776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.3e-46  Score=336.63  Aligned_cols=254  Identities=25%  Similarity=0.427  Sum_probs=213.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....  .......+.+|++++++++|+||+++++++..++.+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            46999999999999999999999999999999986432  2334457889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++.+.+.+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++.....    ..
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence            999999999999888889999999999999999999997 6999999999999999999999999998864322    12


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--------------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--------------------  232 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--------------------  232 (342)
                      .....++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+...                    
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            234568899999999876655 48899999999999999999999765533332211110                    


Q ss_pred             ----------------CCC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          233 ----------------DFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       233 ----------------~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                      ..+  +...++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                            000  011267789999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.1e-46  Score=333.46  Aligned_cols=253  Identities=28%  Similarity=0.493  Sum_probs=208.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58999999999999999999999999999999865322 22334567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           95 FVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        95 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |++ ++|.+++...   ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~  156 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR  156 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence            997 5888887642   46899999999999999999999999999999999999999999999999998743221  11


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD------------------  233 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~------------------  233 (342)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+....                  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            22234568899999998765544588999999999999999999998765443332221100                  


Q ss_pred             --C---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 --F---------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 --~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                        .         .....+++++.++|.+||+.||.+|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence              0         0123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-46  Score=331.49  Aligned_cols=253  Identities=28%  Similarity=0.575  Sum_probs=222.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987655454566789999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      |++|++|..++.....+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||.+......   ....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence            9999999999988778999999999999999999999999999999999999999999999999998754321   1223


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      ...|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+   ...............+..++.++.++|.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence            4567889999999987664 588999999999999999999998766   344444433345556677889999999999


Q ss_pred             cCCCCCCCCCH--HHHhcCccc
Q 019360          252 LDPNPVTRITM--AEVIENEWF  271 (342)
Q Consensus       252 L~~dP~~Rps~--~e~l~h~~~  271 (342)
                      |+.||.+||++  .|+++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.5e-46  Score=332.47  Aligned_cols=255  Identities=29%  Similarity=0.449  Sum_probs=212.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++|+|++++++++......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            579999999999999999999999999999999864322 1222346789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|..++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........  ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  157 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY  157 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence            9999988888877767799999999999999999999999999999999999999999999999999875433211  12


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--------------------  233 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--------------------  233 (342)
                      ....++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+..+....+....                    
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            234578899999998764444588999999999999999999998776544433322100                    


Q ss_pred             -CCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 -FKS----------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 -~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                       .+.          .+.++..+.+|+.+||+.||++||++.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence             000          12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-46  Score=332.93  Aligned_cols=257  Identities=33%  Similarity=0.490  Sum_probs=219.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||.|++|.||+|.+..+++.+|+|++...   .....+.+.+|+.+++.++|+||+++++++..+...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            46799999999999999999999889999999998643   233346788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|..++.+. ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......  ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            9999999999998764 56999999999999999999999999999999999999999999999999987643221  11


Q ss_pred             ceecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---CCCCCCCHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---KSPPWFSTSA  244 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~  244 (342)
                      ......+++.|+|||.+...    ...+.++|+|||||++|+|++|+.||...+.......+.....   ..+..++.++
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            22345688999999998532    2234689999999999999999999988877776666655433   2345678999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .++|.+||+.||.+||+++++++||||.+.
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-46  Score=335.05  Aligned_cols=253  Identities=31%  Similarity=0.529  Sum_probs=207.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|+||.||+|.++.+|+.+|+|.+..... .......+.+|+.+++.++|+||+++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            69999999999999999999999999999999865322 22233467789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |+++ +|.+++.+ ...+++..++.++.|+++||.|||+.||+||||||+||+++.++.++|+|||++......  ....
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~  156 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY  156 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence            9965 78777765 567999999999999999999999999999999999999999999999999998743221  1112


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC-CCCcHHHHHHHHHhcC-------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKAD-------------------  233 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf-~~~~~~~~~~~i~~~~-------------------  233 (342)
                      ....++..|+|||.+.+....+.++|||||||++|+|++|..|+ .+.+.......+....                   
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            33456889999999877554468899999999999999998885 4444444333332110                   


Q ss_pred             C----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 F----------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 ~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .          ...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0          0112467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-46  Score=351.64  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+++|++++|+||+++++++...+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4479999999999999999999999999999996421         2345899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||++. ++|..++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99995 5888887654 569999999999999999999999999999999999999999999999999987543322222


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-C-------cHHHHHHHHHhcCCC--------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-S-------NLMALYKKIFKADFK--------  235 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~-------~~~~~~~~i~~~~~~--------  235 (342)
                      ......||+.|+|||++.+..+ +.++|||||||++|||++|..|+-. .       ....+.+.+......        
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2234579999999999987766 4899999999999999998765422 1       122222222211110        


Q ss_pred             ---------------------CC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          236 ---------------------SP-----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       236 ---------------------~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                           .+     ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                 00     124568999999999999999999999999999974

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.9e-46  Score=330.62  Aligned_cols=256  Identities=30%  Similarity=0.460  Sum_probs=213.4

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++|+||+++++.+...+..
T Consensus         5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            344568999999999999999999999999999999986532   22334678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+++++|.+++...+.+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998643221  


Q ss_pred             CCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----CCCCCH
Q 019360          170 DGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFST  242 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~  242 (342)
                      ........|+..|+|||.+..  ....+.++|+|||||++|+|++|..||...................     ...++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            112234568999999999742  2223478999999999999999999997655443333332222222     124678


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      .+.++|.+||+.||++|||++++++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9e-46  Score=327.00  Aligned_cols=256  Identities=32%  Similarity=0.531  Sum_probs=218.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|+||+|....++..+|+|++.......  ..+.+.+|+..++.++|+|++++++.+...+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998899999999986543222  4568899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           94 EFVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |++++++|.+++...   ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   45899999999999999999999999999999999999999999999999998654332211


Q ss_pred             --CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC------CCCCH
Q 019360          171 --GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWFST  242 (342)
Q Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------~~~~~  242 (342)
                        .......|+..|+|||++......+.++|+|||||++|+|++|+.||...+................      ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence              1223446889999999987663446899999999999999999999988777666666555432211      24678


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .+.+++.+||+.||++|||+++++.||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            89999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.7e-46  Score=327.81  Aligned_cols=248  Identities=36%  Similarity=0.700  Sum_probs=217.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||.|++|.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.++|+||+++++++..+...|+++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999765554445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcc
Q 019360          102 FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN  181 (342)
Q Consensus       102 ~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  181 (342)
                      .+++.+...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......   ......+++.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE  157 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence            9999888789999999999999999999999999999999999999999999999999987543221   2233467889


Q ss_pred             cCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc--HHHHHHHHH--hcCCCCCCCCCHHHHHHHHHhcCCCCC
Q 019360          182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN--LMALYKKIF--KADFKSPPWFSTSAKKLISRILDPNPV  257 (342)
Q Consensus       182 y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~--~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~  257 (342)
                      |+|||.+.+..+ +.++|+||||+++|++++|..||....  .......+.  ......+...++++.++|.+||+.||+
T Consensus       158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  236 (262)
T cd05572         158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE  236 (262)
T ss_pred             ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            999999876655 488999999999999999999998776  666666666  344455566789999999999999999


Q ss_pred             CCCC-----HHHHhcCccccc
Q 019360          258 TRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       258 ~Rps-----~~e~l~h~~~~~  273 (342)
                      +||+     ++|+++||||.+
T Consensus       237 ~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         237 ERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hCcCCcccCHHHHhcChhhhC
Confidence            9999     999999999975

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=337.94  Aligned_cols=258  Identities=31%  Similarity=0.495  Sum_probs=231.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..+.|+..+.||+|+||.||.++.+.+|+.||.|.+.+..+..........+|-.+|.+++.+.||.+-..|++.+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            45678899999999999999999999999999999988877777777778899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+..|+||+|.-.+.+.+  .++++.+..++.+|+.||.+||+.+||+||+||+|||+|+.|+++|+|+|+|.-..   .
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~---~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP---E  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC---C
Confidence            999999999998887765  79999999999999999999999999999999999999999999999999997433   3


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc----HHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN----LMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                      ........||.+|||||++.+..|+ .+.|.|||||++|||+.|+.||....    .+++-+.+.......+..+|++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak  418 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK  418 (591)
T ss_pred             CCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence            4445566899999999999987764 89999999999999999999997643    345556666667777888999999


Q ss_pred             HHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +|.+.+|++||++|.     .++++.+||||++
T Consensus       419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            999999999999998     4789999999985

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-46  Score=348.19  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=205.8

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ..+|++++.||.|+||.||++...  ..+..||+|.+....        ...+|+++|+.++|+||+++++++......|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            357999999999999999999764  356789999885432        3457999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ++||++. ++|..++.....+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999995 588888877788999999999999999999999999999999999999999999999999998754332222


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH---HHHHHHHHhc---------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL---MALYKKIFKA---------------  232 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~---~~~~~~i~~~---------------  232 (342)
                      .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+...   ......+...               
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            223345789999999999877664 889999999999999999999965431   1111111110               


Q ss_pred             --------------CCCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          233 --------------DFKSP-----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       233 --------------~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                    .+..+     ..++.++.++|.+||..||++|||+.|+|+||||.+.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                          00111     1246688999999999999999999999999999763

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-45  Score=332.23  Aligned_cols=259  Identities=27%  Similarity=0.479  Sum_probs=218.6

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      +.+....+|++.+.||+|++|.||+|.+..+++.+|+|.+......   ..+.+.+|+.+++.+.|+|++++++.+....
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            3445567999999999999999999999999999999998754322   2356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999999998865 45899999999999999999999999999999999999999999999999988743221


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSA  244 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~  244 (342)
                        ........+++.|+|||.+.+... +.++|||||||++|+|++|+.||...+.......+....   ...+..++..+
T Consensus       170 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (296)
T cd06654         170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF  246 (296)
T ss_pred             --ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence              111233468899999999987655 489999999999999999999998776544433333222   12244578899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+++.+||+.||++||++.++++||||..
T Consensus       247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             HHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            99999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.4e-46  Score=340.98  Aligned_cols=269  Identities=28%  Similarity=0.479  Sum_probs=217.9

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      |.+.....++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.++|+||+++++++..
T Consensus         8 ~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850           8 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             cchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            3344456789999999999999999999999999999999986432 223334567789999999999999999998864


Q ss_pred             C------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           86 K------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        86 ~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      .      ...|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          87 QKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            3      357999999964 888877654  8999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---  236 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---  236 (342)
                      +++....   ........++..|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+..+......+   
T Consensus       164 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         164 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             cceeCCC---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9875332   1122334678899999999877664 88999999999999999999998776555444443211000   


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 ----------------------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 ----------------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                                              ....+..+.+||.+||+.||++|||+.|+|.||||+.++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                                                    1123557899999999999999999999999999998777


Q ss_pred             CCCCCC
Q 019360          277 PPSFEQ  282 (342)
Q Consensus       277 ~~~~~~  282 (342)
                      +.+...
T Consensus       320 ~~~~~~  325 (353)
T cd07850         320 PSEVEA  325 (353)
T ss_pred             CccCCC
Confidence            654443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.6e-46  Score=338.32  Aligned_cols=247  Identities=24%  Similarity=0.429  Sum_probs=192.5

Q ss_pred             eeeecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeEEEEEe
Q 019360           19 GRTLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KTKIYIVLE   94 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e   94 (342)
                      .++||+|+||+||+|.++  .+++.||+|.+.....     ...+.+|+.++++++||||+++++++..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999976  4678899999864322     1346789999999999999999999854  456899999


Q ss_pred             ccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCeeEcccccc
Q 019360           95 FVTGGELFDKIASR---------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLS  161 (342)
Q Consensus        95 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli----~~~~~~kl~Dfg~~  161 (342)
                      |+. ++|..++...         ..+++..++.++.|++.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            995 4887777532         248999999999999999999999999999999999999    45678999999999


Q ss_pred             cCCcccc-CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH---------HHHHHHHHh
Q 019360          162 ALPQQVR-DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL---------MALYKKIFK  231 (342)
Q Consensus       162 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~---------~~~~~~i~~  231 (342)
                      +...... .........||+.|+|||++.+....+.++||||+||++|+|++|++||.....         ......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            7543221 111223457899999999998755556889999999999999999999964321         111111111


Q ss_pred             cC----------------------------CC----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          232 AD----------------------------FK----------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       232 ~~----------------------------~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ..                            ..          .....+.++.+||.+||+.||++|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00                            00          001235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.4e-46  Score=329.42  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=212.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...++|++.+.||+|+||.||+|.++.+++.||+|++....   ......+.+|+.++++++|+||+++++++...+..
T Consensus         5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            345568999999999999999999999999999999986432   22234678999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......  
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--  159 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998754221  


Q ss_pred             CCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----CCCCCH
Q 019360          170 DGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFST  242 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~  242 (342)
                      ........+++.|+|||.+..  ....+.++|+||+||++|+|++|+.||...........+....+..     ...++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            111233467889999998853  2223478999999999999999999997655443332222222221     234678


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      .+.+||++||+.||++|||++++++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.9e-46  Score=339.00  Aligned_cols=255  Identities=22%  Similarity=0.400  Sum_probs=205.1

Q ss_pred             eeeeeccc--CceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           18 LGRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        18 ~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      ++++||+|  +|++||++.++.+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            57889999  789999999999999999999865432 233456788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC----
Q 019360           96 VTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD----  169 (342)
Q Consensus        96 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~----  169 (342)
                      +++++|.+++..+  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++||+..........    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999998753  4589999999999999999999999999999999999999999999999986432211100    


Q ss_pred             -CCceecccCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC------------
Q 019360          170 -DGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK------------  235 (342)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------  235 (342)
                       ........++..|+|||++.+. ...+.++|||||||++|+|++|+.||.................+            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence             0111223467789999998753 22358899999999999999999999765544333222221110            


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          236 ----------------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       236 ----------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                                        ....+++++.+||.+||+.||++|||++++++||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                              01124678999999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.4e-46  Score=330.71  Aligned_cols=255  Identities=30%  Similarity=0.506  Sum_probs=214.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++|+||+++++++..+...|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            699999999999999999999999999999998754322 3334678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |+ +++|.+++.. ...+++.+++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY  157 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence            99 9999998865 45689999999999999999999999999999999999999999999999999875433221 122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK------------------  235 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------------  235 (342)
                      ....++..|+|||.+.+....+.++||||+||++|+|++|.+||.+.........+......                  
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            34568899999999876555568999999999999999999999877665554444321100                  


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          236 ------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       236 ------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                                  ..+..+..+.+||.+||+.||++|||++++++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                        0124578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-46  Score=333.57  Aligned_cols=255  Identities=30%  Similarity=0.473  Sum_probs=213.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+++++.++|+||+++++++..++..|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            4799999999999999999999989999999998653322 233456789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|..+......+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~  157 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY  157 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence            999998888877766679999999999999999999999999999999999999999999999999987533211  222


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------------  234 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------------  234 (342)
                      ....++..|+|||++.+....+.++||||||+++|+|++|++||...+..+....+.....                   
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            3345788999999987655456789999999999999999999987665444333321100                   


Q ss_pred             ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 ------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                  ...+.++..+.+|+.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                        0123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=354.12  Aligned_cols=254  Identities=30%  Similarity=0.481  Sum_probs=225.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -|.|++.||.|+||.||+|..+.++-..|.|++.   ....+.++.+.-||.+|..+.||+|+++++.|.-++.++++.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            4789999999999999999999988888999885   3456667888999999999999999999999988999999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||.||-+..++-. ...+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.....  .....
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR  187 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR  187 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence            9999998887765 46699999999999999999999999999999999999999999999999999863222  22234


Q ss_pred             ecccCCcccCChhhhcc-----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---CCCCCHHHH
Q 019360          174 HTTCGTPNYVAPEVINN-----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---PPWFSTSAK  245 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~  245 (342)
                      .+.+|||+|||||++..     .+|+ .++||||||+++.||..+.+|....+++..+-+|.+...+.   |..++..+.
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence            56789999999999753     4454 89999999999999999999999999999999998877654   677899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      |++++||.+||..||+++++|+||||++.
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            99999999999999999999999999853

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-45  Score=325.44  Aligned_cols=255  Identities=28%  Similarity=0.508  Sum_probs=214.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh---hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV---LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      +|++.+.||.|+||.||+|.+ .+|+.+|+|.+.....   ........+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999987 4788999998864321   123344678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc---
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR---  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---  168 (342)
                      ++||+++++|.+++.+...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||.+.......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999887889999999999999999999999999999999999999999999999999886432111   


Q ss_pred             -CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc---CCCCCCCCCHHH
Q 019360          169 -DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---DFKSPPWFSTSA  244 (342)
Q Consensus       169 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~  244 (342)
                       .........++..|+|||.+.+..+ +.++|+|||||++|++++|..||...+.......+...   ....+..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence             1112234568899999999987665 48899999999999999999999876655544443332   123455688999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .++|.+||+.+|.+||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-45  Score=323.22  Aligned_cols=253  Identities=29%  Similarity=0.599  Sum_probs=219.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|+||.||++.+..+|+.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            699999999999999999999999999999998654322 3334578899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|.+.+...  ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  157 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL  157 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence            99999999988764  357899999999999999999999999999999999999999999999999987533211  11


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHHh
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISRI  251 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~  251 (342)
                      .....|++.|+|||.+.+... +.++|+|||||+++++++|..||...+..+....+...... .+..++.++.++|.+|
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence            123457889999999877654 47899999999999999999999888877777777665543 3456789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccc
Q 019360          252 LDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~  271 (342)
                      |+.+|.+||++.++++||||
T Consensus       237 l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         237 FKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-45  Score=328.35  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=215.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -|++.+.||.|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.++|+|++++++++..++..|+|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            3788999999999999999999999999999986432   3345678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |+++++|..++.+ ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......  ....
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~  160 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  160 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence            9999999887765 467899999999999999999999999999999999999999999999999998643221  1122


Q ss_pred             ecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---CCCCCCCHHHHH
Q 019360          174 HTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---KSPPWFSTSAKK  246 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~  246 (342)
                      ....+++.|+|||.+..    ....+.++|+|||||++|+|++|..||...+.......+.....   ..+..++.++.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            34568899999999842    12224689999999999999999999988776666555554332   234457899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ||.+||+.||.+||+++++++||||...
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            9999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-45  Score=330.01  Aligned_cols=240  Identities=18%  Similarity=0.275  Sum_probs=207.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeEEEEEec
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----KTKIYIVLEF   95 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~e~   95 (342)
                      ..||+|++|.||+|..  +|+.||+|.+.+.........+.+.+|+.+|++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6789999999999987  689999999976554444445788899999999999999999999876    3568999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      +++|+|.+++.++..+++.....++.+++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....     ..
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~  178 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF  178 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence            9999999999988889999999999999999999998 49999999999999999999999999998743221     12


Q ss_pred             cccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHHHHHH
Q 019360          175 TTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKLISR  250 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~  250 (342)
                      ...++..|+|||++.+  ..+ +.++|||||||++|||++|+.||.+.+..+....+....  ...+..+++.+.+|+.+
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~  257 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA  257 (283)
T ss_pred             cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence            3467899999999975  344 589999999999999999999999988887777775443  33444688999999999


Q ss_pred             hcCCCCCCCCCHHHHhc
Q 019360          251 ILDPNPVTRITMAEVIE  267 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~  267 (342)
                      ||+.||++|||++++++
T Consensus       258 cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        258 CTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HhcCCcccCcCHHHHHH
Confidence            99999999999999985

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-45  Score=331.95  Aligned_cols=258  Identities=27%  Similarity=0.489  Sum_probs=219.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +....+|++.+.||.|++|.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++...+.+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            3445679999999999999999999999999999999864332   2245778999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+|+||+++++|..++.. ..+++.++..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--  168 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--  168 (296)
T ss_pred             EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--
Confidence            999999999999998875 45899999999999999999999999999999999999999999999999988743221  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKK  246 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~  246 (342)
                      ........++..|+|||.+.+..+ +.++|+|||||++|++++|+.||...+.......+....   ...+..+++.+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD  247 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence            111233467889999999987665 488999999999999999999998877655554444332   2234567899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ||.+||..||++||++.+++.||||+..
T Consensus       248 li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         248 FLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            9999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-45  Score=329.40  Aligned_cols=249  Identities=29%  Similarity=0.466  Sum_probs=203.4

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHH---hcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           21 TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM---KLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..++   ....|+||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998764433222222334444443   34479999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceeccc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC  177 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  177 (342)
                      +++|..++..++.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......    ......
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence            9999999988888999999999999999999999999999999999999999999999999998643221    122346


Q ss_pred             CCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 019360          178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKADFKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (342)
                      |+..|+|||.+......+.++||||+||++|+|++|..||....   ...............++.++.++.++|.+||+.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence            89999999998643334588999999999999999999996532   222223333334445667899999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccc
Q 019360          255 NPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       255 dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ||.+|+     |++++++||||+.
T Consensus       237 ~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         237 DVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             CHHHhcCCCCCCHHHHHhCccccC
Confidence            999999     6999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.8e-46  Score=330.04  Aligned_cols=257  Identities=36%  Similarity=0.686  Sum_probs=227.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++.+...........+.+|+.+++++. |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999997755544555567889999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC---
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD---  169 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~---  169 (342)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........   
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999875432211   


Q ss_pred             ---------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          170 ---------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       170 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                                     ........++..|+|||.+..... +.++|+||||++++++++|..||...+.......+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence                           012233457889999999876554 4889999999999999999999998887777777777777


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRITM----AEVIENEWF  271 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~----~e~l~h~~~  271 (342)
                      ..+..+++.+.+||.+||+.||.+||++    +++++||||
T Consensus       240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            7788889999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-45  Score=325.51  Aligned_cols=257  Identities=30%  Similarity=0.525  Sum_probs=213.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh-------hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-------KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+......       .....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            689999999999999999999989999999988542211       1123456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998754322


Q ss_pred             cCCCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC----CCC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP----PWF  240 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~----~~~  240 (342)
                      ..........++..|+|||.+.... ..+.++|+||||+++|++++|..||...+.......+....  ...+    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            2222223456788999999987644 23588999999999999999999997665544443332221  1111    245


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +.++.++|.+||..||.+|||++++++|||+
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-45  Score=324.60  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=212.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh--hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KTKI   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~   89 (342)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+.....  ........+.+|+.+++.++|+||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            468999999999999999999999999999999864321  122345678899999999999999999998865  3678


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc-
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  168 (342)
                      ++++||+++++|.+++.....+++..++.++.|++.||+|||++||+||||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            9999999999999999887789999999999999999999999999999999999999999999999999987432211 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--CCCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~  246 (342)
                      .........++..|+|||.+.+..+ +.++|+||+||++|++++|+.||...+...........  ....+..+++.+++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence            1111233457889999999987655 48899999999999999999999876655544443322  22234457888999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      ++ +||..+|++||+++|+++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=328.27  Aligned_cols=255  Identities=31%  Similarity=0.516  Sum_probs=219.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+.+++.++|+||+++++++..+...|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            47999999999999999999999999999999986543  2233456789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++......  ...
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~  155 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR  155 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence            999999999998875 78999999999999999999999999999999999999999999999999987543321  122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCC-CCHHHHHHHHHh
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPW-FSTSAKKLISRI  251 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~-~~~~~~~li~~~  251 (342)
                      ....+++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+.....+. +.. ++.++.+++.+|
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            34567889999999987665 489999999999999999999998877666555555443322 223 788999999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccccC
Q 019360          252 LDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      |..||++|||++++++||||++.
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-45  Score=329.07  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=216.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+.|++++.||.|+||.||+|.+..+++.+++|.+...   .....+.+.+|+.+++.++|+||+++++.+..++..|+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            46799999999999999999999999999999998653   233456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....  ...
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~  165 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQ  165 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccc
Confidence            999999999887754 45689999999999999999999999999999999999999999999999998764221  111


Q ss_pred             ceecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---CCCCCCCHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---KSPPWFSTSA  244 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~  244 (342)
                      ......+++.|+|||.+.+.    ...+.++|+|||||++|+|++|..||...+.......+.....   ..+..++.++
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence            22345678899999998532    1224789999999999999999999988776655555544332   2244578899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .++|.+||+.||++||+++++++||||...
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            999999999999999999999999999753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=368.74  Aligned_cols=262  Identities=31%  Similarity=0.544  Sum_probs=233.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...++|.+++.||+|+||.|..++++.+++.||+|++.+-.........-|..|-.+|..-+.+.|+.++..|.++.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            34567899999999999999999999999999999999876655556667889999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||++||+|..++.+..+++++.++.++..|..||..||+.|.|||||||+|||++..|++||+|||.+-.....+ 
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999886544322 


Q ss_pred             CCceecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--CCCCC--CCCC
Q 019360          170 DGLLHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSP--PWFS  241 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~  241 (342)
                      .-.....+|||-|.+||++..    .+.++..+|+||+||++|||+.|..||...+..+.+.+|++-  .+.+|  ..+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            112345679999999999863    245679999999999999999999999999999999999875  45555  5689


Q ss_pred             HHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      .++++||.+++ .+|+.|..   ++++..||||.+
T Consensus       310 eeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  310 EEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             HHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence            99999999998 67899998   999999999975

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-45  Score=332.25  Aligned_cols=261  Identities=27%  Similarity=0.472  Sum_probs=218.5

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      +.+....+|++.+.||.|++|.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++...+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345556899999999999999999999999999999999865332   22356789999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999998865 45899999999999999999999999999999999999999999999999988643221


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSA  244 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~  244 (342)
                        ........+++.|+|||.+.+..+ +.++|+|||||++|++++|+.||...+.......+....   ...+..++..+
T Consensus       169 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (297)
T cd06656         169 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF  245 (297)
T ss_pred             --ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHH
Confidence              112233467889999999987665 488999999999999999999998765543332222221   12344578889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .+|+.+||+.||++||+++++++||||....
T Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            9999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-45  Score=364.19  Aligned_cols=262  Identities=28%  Similarity=0.494  Sum_probs=214.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--C
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--K   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~   86 (342)
                      .....++|++++.||.|+||+||+|.+..++..+|+|++..... .......+.+|+.+++.|+||||++++++|..  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            45567899999999999999999999999999999999865432 23345678899999999999999999998854  4


Q ss_pred             CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeecCCCCcEEecC------
Q 019360           87 TKIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSR-------GVCHRDLKPENLLLDA------  149 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~-------giiH~dlkp~NIli~~------  149 (342)
                      ..+|+||||+++++|..++..    ...+++..++.|+.||+.||.|||+.       +|+||||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            568999999999999998875    35699999999999999999999985       4999999999999954      


Q ss_pred             -----------CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCC
Q 019360          150 -----------NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPF  217 (342)
Q Consensus       150 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf  217 (342)
                                 .+.+||+|||++.....   ........||+.|+|||++.+. ...+.++|||||||++|+|++|..||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                       23589999999875432   2223445789999999998643 23358899999999999999999999


Q ss_pred             CCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          218 EESNLMALYKKIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       218 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ...+........+.... ......+.++.+||..||+.+|.+||++.++|.|+|+...
T Consensus       244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            76654443333333322 2234578999999999999999999999999999999753

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-45  Score=327.57  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=208.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36889999999999999999999999999999986532  2233457889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....    ...
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence            99999988654    3478899999999999999999999999999999999999999999999999874322    122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH-------HHHHHHHHhcCCC--CCCCCCHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-------MALYKKIFKADFK--SPPWFSTSA  244 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~--~~~~~~~~~  244 (342)
                      ....++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.....       ......+......  ....+++++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            34578999999999987665 4899999999999999999999965321       1222222222222  123478899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+++.+||+.||++||+++++++||||+..
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.8e-45  Score=332.59  Aligned_cols=263  Identities=29%  Similarity=0.424  Sum_probs=215.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--Ce
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TK   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~   88 (342)
                      ...++|++.+.||.|+||.||+|.+..+|+.||+|++...... ........+|+.++++++|+||+++++++...  +.
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            4578899999999999999999999999999999998653322 22223456899999999999999999998754  56


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      +++||||+.+ +|.+++.. ...+++.++..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||.+......
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            8999999965 88888775 366899999999999999999999999999999999999999999999999998754322


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-------------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------  234 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------  234 (342)
                      .  .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+.....             
T Consensus       162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 A--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             c--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            1  1122334578899999987655456889999999999999999999998887776665544210             


Q ss_pred             ------CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          235 ------KS-----------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       235 ------~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                            ..           ....++++.+||.+||+.||++|||++++++||||++..-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                  00           01257889999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-45  Score=322.53  Aligned_cols=251  Identities=31%  Similarity=0.500  Sum_probs=215.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|+||.||+|.+..+++.+++|++.....   ...+.+.+|+.+++.++|+||+++++++.....+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            689999999999999999999999999999999975432   24567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++... ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  157 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK  157 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence            999999999998876 789999999999999999999999999999999999999999999999999987533211  12


Q ss_pred             eecccCCcccCChhhhccC---CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----CCCCCHHH
Q 019360          173 LHTTCGTPNYVAPEVINNK---GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFSTSA  244 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~  244 (342)
                      .....++..|+|||.+.+.   .+ +.++|+|||||++|+|++|+.||...+.......+....+..     ...++.++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             cccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            2334678899999998765   44 478999999999999999999998877655555444442222     23457889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      .+++.+||..||.+|||+.+++.|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-45  Score=321.89  Aligned_cols=254  Identities=31%  Similarity=0.523  Sum_probs=216.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh--hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +|+..+.||+|++|.||+|.+..+++.|++|.+.....  ......+.+.+|+.+++.++|+||+++++++......|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            68889999999999999999998999999999865321  1233456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      +||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......   .
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987543221   2


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHh--cCCCCCCCCCHHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK--ADFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~  250 (342)
                      .....++..|+|||.+......+.++|+|||||++|++++|..||...........+..  .....+..+++++.+++.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK  237 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence            23456888999999987655235889999999999999999999987665444444433  1223345678999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCccc
Q 019360          251 ILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ||+.+|.+||++.+++.|||+
T Consensus       238 ~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         238 CLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.5e-45  Score=319.88  Aligned_cols=253  Identities=30%  Similarity=0.554  Sum_probs=220.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++++.||.|+||.||.+.+..+++.+++|.+...... ......+.+|+.++++++|+||+++++++...+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            699999999999999999999999999999998654322 3345578899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|.+++...  ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~  157 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM  157 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence            99999999999765  458999999999999999999999999999999999999999999999999987543221  12


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHh
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISRI  251 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~  251 (342)
                      .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+....... +..++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            334568999999999987665 478999999999999999999999888877777776655543 345789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccc
Q 019360          252 LDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~  271 (342)
                      |..||.+||++.++++|+|+
T Consensus       237 l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         237 LQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCcccCCCHHHHhhCcCC
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-45  Score=325.51  Aligned_cols=257  Identities=26%  Similarity=0.486  Sum_probs=213.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh---hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV---LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      +|+..+.||+|++|.||+|.+..+++.+|+|++.....   ......+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            48889999999999999999999999999999864321   122345688999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCCccccC-
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRD-  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~~~-  169 (342)
                      |+||+++++|.+++...+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........ 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 599999999865432211 


Q ss_pred             -CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHH---HHHh--cCCCCCCCCCHH
Q 019360          170 -DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK---KIFK--ADFKSPPWFSTS  243 (342)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~---~i~~--~~~~~~~~~~~~  243 (342)
                       ........++..|+|||.+.+..+ +.++|+||||+++|++++|..||..........   .+..  .....+..++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence             111223467889999999877655 488999999999999999999997544322222   2211  122334567899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +.+++.+||+.||.+||++.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-45  Score=327.12  Aligned_cols=248  Identities=31%  Similarity=0.492  Sum_probs=210.5

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++|+||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999765443344445667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCC
Q 019360          102 FDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT  179 (342)
Q Consensus       102 ~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  179 (342)
                      .+++.+..  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.....   ........++
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence            99987755  689999999999999999999999999999999999999999999999998875332   1122334578


Q ss_pred             cccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH----HHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Q 019360          180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL----MALYKKIFKADFKSPPWFSTSAKKLISRILDPN  255 (342)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  255 (342)
                      ..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.....    ......+.......+..+++.+.++|.+||+.|
T Consensus       158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            89999999877664 4889999999999999999999976543    333333333344455668999999999999999


Q ss_pred             CCCCC-----CHHHHhcCccccc
Q 019360          256 PVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       256 P~~Rp-----s~~e~l~h~~~~~  273 (342)
                      |.+||     ++.++++||||.+
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8888999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-45  Score=325.18  Aligned_cols=255  Identities=29%  Similarity=0.437  Sum_probs=210.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC---
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK---   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~---   86 (342)
                      ...++|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+ +|+||+++++++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            34578999999999999999999999999999999986432    1224677899999988 699999999998642   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           87 ---TKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                         ..+|++|||+++++|.+++...  ..+++..+..++.|++.||+|||++||+|+||+|+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence               4689999999999999998863  45899999999999999999999999999999999999999999999999998


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC--
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK--  235 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~--  235 (342)
                      ......  ........|+..|+|||++.+.    ...+.++|+||+||++|+|++|..||...........+......  
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            753321  1223345688999999998632    12347899999999999999999999776655544444332221  


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ....++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            223578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-45  Score=329.83  Aligned_cols=252  Identities=20%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC----------------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE----------------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV   76 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   76 (342)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++++++|+||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4689999999999999999998632                34579999986532  23334678899999999999999


Q ss_pred             eeEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 019360           77 IRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------------------RLKEDEARKYFQQLINAVDYCHSRGVCH  137 (342)
Q Consensus        77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH  137 (342)
                      +++++++...+..++||||+++++|.+++....                   .+++..+..++.|++.||.|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999886531                   3677889999999999999999999999


Q ss_pred             ecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh--CCC
Q 019360          138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA--GYL  215 (342)
Q Consensus       138 ~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~  215 (342)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++  +..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999874322111111223345778999999877665 489999999999999986  677


Q ss_pred             CCCCCcHHHHHHHHHh--------cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          216 PFEESNLMALYKKIFK--------ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       216 pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ||...+..+....+..        .....++.++..+.+|+.+||+.||++|||++++.+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            8877665554443321        112234567899999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.7e-45  Score=321.21  Aligned_cols=257  Identities=30%  Similarity=0.543  Sum_probs=213.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh--hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TKI   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~   89 (342)
                      ..|++.+.||+|+||.||.|.+..+|+.||+|.+.....  ......+.+.+|+.+++.+.|+||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999998854221  1223456888999999999999999999988653  468


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc-
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  168 (342)
                      +++|||+++++|.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999999887788999999999999999999999999999999999999999999999999987533211 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~  246 (342)
                      .........++..|+|||.+.+... +.++|||||||++|+|++|+.||...+.......+....  ...+..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence            1111233458889999999987655 488999999999999999999998765555444443322  2234457788999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +|.+|+. +|++||+++++++|||+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-45  Score=340.27  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=198.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..+|++++.||+|+||.||+|.+..+++.||+|+....         ....|+.++++++|+||+++++++......++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34699999999999999999999999999999985432         224689999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||++. ++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....   ..
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence            99995 578887765 46789999999999999999999999999999999999999999999999999874322   11


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC-CCCcH---------HHHHHHHHhc-C-----CC
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-EESNL---------MALYKKIFKA-D-----FK  235 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf-~~~~~---------~~~~~~i~~~-~-----~~  235 (342)
                      ......||+.|+|||++.+..+ +.++|||||||++|||+++..|+ .....         ......+... .     ++
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            2234568999999999987766 48999999999999999855443 32110         0111111110 0     00


Q ss_pred             ----------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          236 ----------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       236 ----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                                  ....++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                        00134667888999999999999999999999999975

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.4e-45  Score=327.45  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=214.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCC-----cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETG-----ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|++.+.||+|+||.||+|.+...+     ..+|+|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            3568999999999999999999986554     679999986432  233445788999999999999999999999988


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                      ...+++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999764                457888999999999999999999999999999999999999


Q ss_pred             CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 019360          151 GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI  229 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i  229 (342)
                      +.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.+.+..+....+
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999874322211122233456788999999877665 489999999999999998 99999988887777776


Q ss_pred             HhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          230 FKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       230 ~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..... ..+..+++++.+|+.+||+.||++||++.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            65543 3355689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.3e-45  Score=319.34  Aligned_cols=252  Identities=33%  Similarity=0.556  Sum_probs=217.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+.+|+.+++.++|+|++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            69999999999999999999999999999999875433 23345688899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcccccccCCccccCCC
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |+++++|.+++...  ..+++..+..++.+++.||+|||++|++|+||+|+||+++.+ +.++|+|||.+......   .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence            99999999999764  358999999999999999999999999999999999999755 46899999998754321   1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISR  250 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~  250 (342)
                      ......++..|+|||.+.+... +.++||||||+++|+|++|..||...+.......+...... .+..++.++.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            2233567889999999987654 48899999999999999999999988877777666655443 345688999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCccc
Q 019360          251 ILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ||+.||.+|||+.++++||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4e-45  Score=325.56  Aligned_cols=249  Identities=29%  Similarity=0.460  Sum_probs=206.2

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHH---HHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           21 TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI---STMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|.   ..++...|++|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998764333222122233343   34455679999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceeccc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC  177 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  177 (342)
                      |++|..++...+.+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++......    ......
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence            9999999988888999999999999999999999999999999999999999999999999998643221    123456


Q ss_pred             CCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 019360          178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKADFKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (342)
                      |+..|+|||.+.+....+.++||||+||++|+|++|+.||...   ................+..++.++.+++.+||..
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  236 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR  236 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence            8999999999875433458899999999999999999999776   3344444444444555666799999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccc
Q 019360          255 NPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       255 dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ||.+||     ++.++++||||..
T Consensus       237 ~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         237 DVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             CHHhccCCCCCCHHHHHhCccccC
Confidence            999999     9999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=330.17  Aligned_cols=252  Identities=30%  Similarity=0.505  Sum_probs=220.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -|.++++||+|+||.||+|.++.+|+.+|+|.+..+     ..++.+..|+.+|++++.+++|++|+.|-....+++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            388999999999999999999999999999998643     345678899999999999999999999988889999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||..|++.+.+.. ++++++.++..+++..+.||+|||...-+|||||..|||++.+|++||+|||.+.....  .....
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR  186 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR  186 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence            9999999999875 57899999999999999999999999999999999999999999999999999863222  22234


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc---CCCCCCCCCHHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---DFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~  250 (342)
                      .+..|||.|||||++..-+|+ .++||||||++..||..|++||..-.++...-.|-..   .+..|..+++++.|+|++
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence            567899999999999988887 7899999999999999999999887776544333322   223345678999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcccccC
Q 019360          251 ILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ||.++|++|-|+.++++|||.++.
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCC
Confidence            999999999999999999999753

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-45  Score=329.47  Aligned_cols=256  Identities=31%  Similarity=0.444  Sum_probs=212.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TKI   89 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~   89 (342)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++|+||+++++++...  ...
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            356899999999999999999999999999999999654322 23334567899999999999999999998877  889


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+||||+++ +|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999999975 898888764 458999999999999999999999999999999999999999999999999987543321


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--------------
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--------------  234 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--------------  234 (342)
                        .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+......++.....              
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              1223345788999999987655446889999999999999999999988776665554432110              


Q ss_pred             -----------------CCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 -----------------KSPPW-FSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 -----------------~~~~~-~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                       ..+.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                             01111 47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-45  Score=327.73  Aligned_cols=256  Identities=25%  Similarity=0.465  Sum_probs=214.1

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++++.||+|+||.||+|.+..++..||+|.+....  .....+.+.+|+.++++++|+||+++++.+...+..|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999999999999999886432  2333467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           94 EFVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||+++++|..++...   ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.++|+|||++.....   
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  155 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---  155 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence            999999999888763   368999999999999999999996 5999999999999999999999999999864321   


Q ss_pred             CCceecccCCcccCChhhhccCCC-----CCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH---HHhcC-CCCCCCC
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGY-----DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK---IFKAD-FKSPPWF  240 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~---i~~~~-~~~~~~~  240 (342)
                       .......+++.|+|||.+.+...     .+.++|+|||||++|+|++|+.||...........   +.... ...++.+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence             12234467889999999864332     25789999999999999999999976554443332   22222 2344558


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +.++.+||.+||+.+|.+||+++++++||||....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            89999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-45  Score=326.10  Aligned_cols=255  Identities=30%  Similarity=0.491  Sum_probs=206.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||.|++|.||+|.++.+++.||+|.+......  .....+.+|+.+++.++|+||+++++++...+..|+
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            468899999999999999999999999999999998653321  112345689999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||+++ +|.+++... ..+++..++.++.|+++||.|||+.||+||||+|+||+++.++.++|+|||+++......  
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9999975 898888764 468999999999999999999999999999999999999999999999999987432211  


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC----------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKAD----------------  233 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~----------------  233 (342)
                      .......++..|+|||.+.+....+.++||||+|+++|+|++|+.||.... ..+....+....                
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            111223467889999998764444588999999999999999999997654 222222221100                


Q ss_pred             -----CCC---------CCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 -----FKS---------PPWFS--TSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 -----~~~---------~~~~~--~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                           ...         .+.++  .++.+++.+||+.||++|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                 000         01233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-47  Score=343.65  Aligned_cols=252  Identities=27%  Similarity=0.436  Sum_probs=224.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|.-++.||.|+||.||.|++..+.+.||||.+.-......+..+++..|++.|++++|||++.+-++|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            47778999999999999999999999999999987666667777899999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||- |+-.+++.-+ +++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.+.+.      ...
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------~PA  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------APA  179 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc------Cch
Confidence            995 5888888754 67999999999999999999999999999999999999999999999999988753      334


Q ss_pred             ecccCCcccCChhhhc---cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAKKLI  248 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li  248 (342)
                      .+.+|||.|||||++.   ...|+ -++||||||+++.||.-.++|+-+.+.+..+..|-..+.+.  ...++..++.||
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            6789999999999975   34454 68999999999999999999999888888777777665443  345789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ..||++-|.+|||.+++|.|+|....
T Consensus       259 d~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhcchhccC
Confidence            99999999999999999999998753

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.3e-45  Score=320.20  Aligned_cols=250  Identities=30%  Similarity=0.506  Sum_probs=214.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+.....     .+.+.+|+++++.++|+||+++++++......|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            679999999999999999999998899999999865322     467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~  155 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK  155 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence            99999999999875 4568999999999999999999999999999999999999999999999999987543221  12


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLIS  249 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~  249 (342)
                      .....++..|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+....   ...+..++.++.++|.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            233457889999999987665 488999999999999999999998776555443333221   2223457789999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccc
Q 019360          250 RILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +||+.||++|||+.++|.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-44  Score=324.52  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=212.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK-   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-   86 (342)
                      .....++|++.+.||+|+||.||+|.+..+++.+|+|++.....    ....+.+|+.+++++ +|+|++++++++... 
T Consensus        17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            34457889999999999999999999999999999999864321    224567899999988 799999999998643 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccc
Q 019360           87 ----TKIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDF  158 (342)
Q Consensus        87 ----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Df  158 (342)
                          +..|+||||+++++|.+++..    ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence                358999999999999988753    356899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccCCCceecccCCcccCChhhhccCC----CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          159 GLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG----YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       159 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      |++........  ......++..|+|||.+....    ..+.++|||||||++|+|++|+.||...+.......+.....
T Consensus       173 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         173 GVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            99875332111  112346788999999986432    125789999999999999999999987766555444443322


Q ss_pred             ---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          235 ---KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       235 ---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                         ..+..++..+.+||.+||+.||++||++.++++||||+
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence               22345678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-45  Score=323.03  Aligned_cols=251  Identities=34%  Similarity=0.661  Sum_probs=219.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||.|+||.||++.+..+|+.+++|++...........+.+.+|++++++++|+||+++++.+......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999989999999999765554445667889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC------CCceec
Q 019360          102 FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------DGLLHT  175 (342)
Q Consensus       102 ~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~  175 (342)
                      .+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........      ......
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            99998877899999999999999999999999999999999999999999999999999874322211      112233


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhcC
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF--STSAKKLISRILD  253 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~li~~~L~  253 (342)
                      ..++..|+|||....... +.++|+||||+++|++++|..||...........+.......+...  +..+.+++.+||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            457889999999877654 5889999999999999999999998888888777776665555544  8999999999999


Q ss_pred             CCCCCCCCH---HHHhcCccccc
Q 019360          254 PNPVTRITM---AEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rps~---~e~l~h~~~~~  273 (342)
                      .+|.+|||+   .++|+||||.+
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccC
Confidence            999999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3e-45  Score=327.03  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=208.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++++.||.|++|.||+|.++.+|+.||+|.+..... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            48999999999999999999999999999999864332 22233578899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+. ++|..++..  ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~  156 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT  156 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence            996 588888865  356899999999999999999999999999999999999999999999999998743221  111


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-----------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-----------------  235 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------  235 (342)
                      .....+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+......                 
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            223456889999999876555467899999999999999999999876654443333221000                 


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 ------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 ------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                  ..+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=326.56  Aligned_cols=256  Identities=32%  Similarity=0.520  Sum_probs=213.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|.||+|.++.+++.||+|++..... .....+.+.+|+++++.++|+||+++++++...+..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999865332 2334467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||++++.+..+..+...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL  158 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence            9999877776666667799999999999999999999999999999999999999999999999999875443221 122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--------------------  233 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--------------------  233 (342)
                      ....++..|+|||++.+....+.++|+||||+++|+|++|+.||.+....+....+....                    
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            345678899999999876344689999999999999999999998765544333222100                    


Q ss_pred             -C-----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 -F-----------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 -~-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                       .           ..+..++.++.+||.+||..||++|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             0           0122347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.3e-45  Score=340.36  Aligned_cols=253  Identities=22%  Similarity=0.402  Sum_probs=204.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARN-----TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            45799999999999999999974     34567899999864322  22345788999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG---------------------------------------------------------  109 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  109 (342)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886421                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360          110 ------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus       110 ------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                                        .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                              36788899999999999999999999999999999999999999999999987543221111


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKLI  248 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li  248 (342)
                      ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||................  ...+...+.++.+|+
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            1122334567999999987665 489999999999999998 899998765443333333332  223445688999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcC
Q 019360          249 SRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+||+.||++|||+.++++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-45  Score=340.46  Aligned_cols=253  Identities=21%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~   85 (342)
                      ..++|++.+.||+|+||.||+|++...     +..||+|++.....  ......+.+|+.+++.+ +|+||+++++++..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            345799999999999999999986443     35799999965432  22345788999999999 79999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR---------------------------------------------------------  108 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  108 (342)
                      .+.+++||||+++|+|.+++...                                                         
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            99999999999999999988542                                                         


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceec
Q 019360          109 -------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT  175 (342)
Q Consensus       109 -------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (342)
                                   .++++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.............
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                         2367888999999999999999999999999999999999999999999999874332111111112


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHHHHHHhc
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L  252 (342)
                      ..++..|+|||++.+..+ +.++|||||||++|+|++ |+.||................  ...+..+++++.+++.+||
T Consensus       274 ~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  352 (374)
T cd05106         274 ARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW  352 (374)
T ss_pred             CCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence            234567999999977665 589999999999999997 999998765544444444332  2334557899999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q 019360          253 DPNPVTRITMAEVIE  267 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~  267 (342)
                      +.||++|||+.++++
T Consensus       353 ~~dp~~RPs~~~l~~  367 (374)
T cd05106         353 NLEPTERPTFSQISQ  367 (374)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-45  Score=324.47  Aligned_cols=249  Identities=29%  Similarity=0.516  Sum_probs=204.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeC--CeEEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASK--TKIYIV   92 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv   92 (342)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+...... .. .....+|+.+++++. |+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-ch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            78899999999999999999999999999998653221 11 123457888898885 99999999999877  889999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++ +|.+.+.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||++......   .
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence            999975 77777765 356899999999999999999999999999999999999999 99999999998754321   1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD------------------  233 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~------------------  233 (342)
                      ......++..|+|||.+......+.++|||||||++|+|++|..||.+.+..+....+....                  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            12234578899999987665555689999999999999999999998877655444433211                  


Q ss_pred             CCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 FKS-----------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 ~~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +..           .+.++.++.++|.+||++||++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            001           12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.8e-45  Score=328.56  Aligned_cols=261  Identities=26%  Similarity=0.407  Sum_probs=207.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-   87 (342)
                      ....+++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++...+ 
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            34567889999999999999999999999999999999864322 1222335568999999999999999999986543 


Q ss_pred             -------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           88 -------KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        88 -------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                             ..++||||+.+ +|...+... ..+++.+++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                   45999999964 788777654 368999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCC--CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---
Q 019360          160 LSALPQQVRDD--GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---  234 (342)
Q Consensus       160 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---  234 (342)
                      ++.........  .......++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+.......+.....   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98754322111  1222345678899999987654445789999999999999999999987765444332222100   


Q ss_pred             ----------------CC-------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 ----------------KS-------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ----------------~~-------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                      ..             +...+..+.+||.+||..||.+|||++++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                            00             01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-45  Score=322.18  Aligned_cols=255  Identities=33%  Similarity=0.490  Sum_probs=211.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC--
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT--   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~--   87 (342)
                      ...++|++.+.||.|++|.||+|.++.+++.+++|++.....    ..+.+.+|+.+++++ .|+||+++++++....  
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            356899999999999999999999998999999999865432    235788999999998 6999999999996544  


Q ss_pred             ----eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           88 ----KIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        88 ----~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                          .+|+||||+++++|.+++..    +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence                48999999999999988765    3578999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK  235 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  235 (342)
                      .+......  ........++..|+|||.+...    ...+.++|||||||++|+|++|+.||...........+......
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            88643221  1222345688899999988532    22347899999999999999999999876655555555443222


Q ss_pred             ---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 ---SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                         .+..++.++.+||.+||..||++|||+.++++|||+
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence               223367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-45  Score=323.42  Aligned_cols=253  Identities=28%  Similarity=0.473  Sum_probs=214.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|.||+|.++.+++.+|+|.+.....  ......+.+|+.+++.++|+||+++++++......++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            468899999999999999999999999999999875432  234467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           94 EFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            999999999999876 779999999999999999999999 999999999999999999999999999886432211   


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC-----cHHHHHHHHHhcCCC-CCCC-CCHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES-----NLMALYKKIFKADFK-SPPW-FSTSA  244 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~-~~~~-~~~~~  244 (342)
                       .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||...     ...+....+.....+ .+.. ++.++
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         156 -AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             -hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence             112567889999999987655 48899999999999999999999654     233333444333222 2222 78899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .++|.+||..||++|||+.+++.||||+.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            99999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-45  Score=323.56  Aligned_cols=256  Identities=28%  Similarity=0.539  Sum_probs=215.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR---HPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~l   91 (342)
                      .|++.+.||.|+||.||+|.+..+++.+|+|.+....  .....+.+.+|+.+++.++   |+|++++++++......|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5888999999999999999999999999999986432  2233457888999999886   9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  .
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S  156 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence            9999999999998876 478999999999999999999999999999999999999999999999999987543321  2


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CC-CCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PP-WFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~-~~~~~~~~li~  249 (342)
                      ......|+..|+|||.+.+....+.++|+|||||++|+|++|..||.+.+.......+.....+. +. .++.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            22334688899999998764444689999999999999999999998876655444333322211 12 27789999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +||+.||++||++.+++.|+||++..
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999998654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-44  Score=320.12  Aligned_cols=251  Identities=19%  Similarity=0.280  Sum_probs=209.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.+....  .......+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            457999999999999999999875   345789999987532  223345788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999998764 578999999999999999999999999999999999999999999999999876422111


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~  246 (342)
                       ........++..|+|||.+.+..+ +.++|||||||++|++++ |..||...+..+....+.... .+.+..++..+.+
T Consensus       162 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         162 -IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             -hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence             111112234678999999987665 489999999999999775 999998887777666665442 3445668899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhc
Q 019360          247 LISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++.+||+.+|.+||+++++++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-45  Score=324.43  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=216.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||+||++.+..+|+.||+|++....  .....+.+.+|+++++.++|+||+++++++...+.+++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3568999999999999999999999999999999986432  23345678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||+++++|..++.+.+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....    
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----  156 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----  156 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence            99999999999999888889999999999999999999997 6999999999999999999999999998764321    


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-----------HHHHHHHhcCCC-CCC
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-----------ALYKKIFKADFK-SPP  238 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-----------~~~~~i~~~~~~-~~~  238 (342)
                      .......|+..|+|||++.+..+ +.++|+|||||++|++++|..||......           +....+.....+ .+.
T Consensus       157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence            11223568999999999876655 47899999999999999999999765431           223333322222 122


Q ss_pred             -CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          239 -WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       239 -~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                       .++.++.+|+.+||+.||.+|||+.|+++|+||.+...
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence             26788999999999999999999999999999976443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=346.00  Aligned_cols=250  Identities=30%  Similarity=0.530  Sum_probs=215.3

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCc
Q 019360           21 TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGE  100 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~  100 (342)
                      +||+|.||+||.|+|..+....|||.+...   .....+.+..|+.+.++|+|.|||+++|.+..++.+-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            799999999999999999999999999643   34456788999999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCccccCCCceecc
Q 019360          101 LFDKIASR-GRL--KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTT  176 (342)
Q Consensus       101 L~~~l~~~-~~l--~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~  176 (342)
                      |..++.+. +++  .+..+-.+.+||++||.|||++.|||||||-+||||+. .|.+||+|||-++....  -+....+.
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            99999876 667  78889999999999999999999999999999999965 78999999998875432  34455677


Q ss_pred             cCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCCCCCc--HHHHHH-HHHhcCCCCCCCCCHHHHHHHHHhc
Q 019360          177 CGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPFEESN--LMALYK-KIFKADFKSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf~~~~--~~~~~~-~i~~~~~~~~~~~~~~~~~li~~~L  252 (342)
                      .||..|||||++... .-++.++|||||||++.||.||++||-...  ...+++ ..++...+.|..++.+++.+|.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            899999999999743 234689999999999999999999996432  222222 2345556677788999999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccCC
Q 019360          253 DPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .+||.+||++.++|..||++...
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             CCCcccCccHHHhccCcccccCC
Confidence            99999999999999999998763

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=315.96  Aligned_cols=254  Identities=37%  Similarity=0.652  Sum_probs=216.4

Q ss_pred             eecCeeee-eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe----
Q 019360           12 RVGKYELG-RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS----   85 (342)
Q Consensus        12 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----   85 (342)
                      ..++|++- ++||-|-.|.|-.+.++.+|+.+|+|++....        ...+|+++.-.. .|+|||.++++|++    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45677774 57899999999999999999999999985432        345788876444 59999999999864    


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGL  160 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg~  160 (342)
                      ...+.+|||.|+||.|++.++.++.  ++|.++..|++||..|+.|||+.+|.||||||+|+|++.   +..+||+|||.
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            4568899999999999999998765  999999999999999999999999999999999999965   45799999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc----HHHHHHHHHhcCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN----LMALYKKIFKADFKS  236 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~  236 (342)
                      ++...   ......+.|.||.|.|||++....|+ ..+|+||+||++|.|++|.+||-...    ......+|..+.+.+
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            98533   24556788999999999999877765 88999999999999999999996543    345567777777766


Q ss_pred             CC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 PP----WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      |.    .+|.+++++|+.+|..+|.+|.|++++++|||+......
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v  331 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV  331 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence            53    378999999999999999999999999999999865443

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-46  Score=352.49  Aligned_cols=250  Identities=33%  Similarity=0.551  Sum_probs=207.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEE-EEEe------C
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYE-VMAS------K   86 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~-~~~~------~   86 (342)
                      +++|.+.|.+|||+.||+|++...|..||+|.+...   ++..++.+.+|+++|++|+ |+|||.+++ ....      .
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            578899999999999999999888899999998543   5677889999999999998 999999999 3321      1


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCeeEccccccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      -.++|+||||+||.|.+++.++  ..|++.++++|++++++|+++||.++  |||||||-+||||+.+++.||||||.+.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            2478999999999999999854  45999999999999999999999998  9999999999999999999999999886


Q ss_pred             CCccccCC-C---c---eecccCCcccCChhhhc---cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc
Q 019360          163 LPQQVRDD-G---L---LHTTCGTPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA  232 (342)
Q Consensus       163 ~~~~~~~~-~---~---~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~  232 (342)
                      -.-..... .   .   --....|+.|+|||++.   +... +.|+|||+|||+||.|+....||+.....    .|+++
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng  269 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG  269 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence            32211100 0   0   01123689999999975   3333 58999999999999999999999887443    45666


Q ss_pred             CCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          233 DFKSP--PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       233 ~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      .+.+|  +.++..+.+||+.||+.||.+||++.+++.+-+--
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence            66555  46999999999999999999999999999765543

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=331.45  Aligned_cols=261  Identities=29%  Similarity=0.479  Sum_probs=210.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----C
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-----T   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~   87 (342)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            478999999999999999999999999999999985321  223345677899999999999999999887543     3


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+++||+.+ +|...+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999964 88777754 56899999999999999999999999999999999999999999999999998753321


Q ss_pred             cC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-------------
Q 019360          168 RD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD-------------  233 (342)
Q Consensus       168 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  233 (342)
                      .. ........|++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            11 1122335678999999987654444688999999999999999999997765433322221100             


Q ss_pred             ---------CC---------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          234 ---------FK---------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       234 ---------~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                               .+         ..+.+++++.+++.+||+.||++|||+.++++||||.....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                     00         013457889999999999999999999999999999977655

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-46  Score=342.75  Aligned_cols=257  Identities=25%  Similarity=0.478  Sum_probs=219.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      +..+..||  ...||+|+|-+||+|.|..+|-.||.-.+..... ......+++..|+.+|+.|+|+||++++++|.+..
T Consensus        37 p~gRy~k~--~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   37 PTGRYLKF--DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             CCCceeeh--hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            33444444  5789999999999999999999999776654333 34556789999999999999999999999998766


Q ss_pred             e--EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeecCCCCcEEecC-CCCeeEccccccc
Q 019360           88 K--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR--GVCHRDLKPENLLLDA-NGVLKVSDFGLSA  162 (342)
Q Consensus        88 ~--~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~--giiH~dlkp~NIli~~-~~~~kl~Dfg~~~  162 (342)
                      .  +-+|+|.+..|+|+.|+++++.++...++.|++||+.||.|||++  -|+|||||.+||+|+. .|.|||+|+|+|+
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence            5  889999999999999999999999999999999999999999998  4999999999999976 5899999999998


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHhcCCCC--CCC
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKS--PPW  239 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~--~~~  239 (342)
                      ....    .......|||.|||||++. ..|+ ..+||||||++++||+|+..||.. .+..+++.++..+..+.  ..-
T Consensus       195 l~r~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  195 LLRK----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             Hhhc----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc
Confidence            6433    3445578999999999998 4565 899999999999999999999976 56677777776654432  122


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      -++++++||.+||.. .+.|+|+.|+|.||||+..
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            478999999999999 9999999999999999864

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-44  Score=317.01  Aligned_cols=249  Identities=30%  Similarity=0.564  Sum_probs=214.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|+||.||++.++.+++.+|+|.+.....  ....+.+.+|+.+++.++|+||+++++.+...+.+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999864322  2334678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++++|||.+......  ...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~  156 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY  156 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence            99999999988653  45899999999999999999999999999999999999999999999999998754321  112


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHHh
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISRI  251 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~  251 (342)
                      .....+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+..++..+.+||.+|
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            233568889999999987665 48899999999999999999999988877777776665543 3456889999999999


Q ss_pred             cCCCCCCCCCHHHHhcC
Q 019360          252 LDPNPVTRITMAEVIEN  268 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h  268 (342)
                      |+.||++|||+.+++.-
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.3e-44  Score=317.61  Aligned_cols=256  Identities=32%  Similarity=0.579  Sum_probs=214.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      ||++.+.||+|+||.||+|.+..+++.|++|++...... ....+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            699999999999999999999989999999998765432 3456789999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC-c-
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-L-  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~-  172 (342)
                      |+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......... . 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            99999999999887778999999999999999999999999999999999999999999999999987543321111 0 


Q ss_pred             eecccCCcccCChhhhccCC--CCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhc-CCCCCC--CCCHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKG--YDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKA-DFKSPP--WFSTSAKK  246 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~-~~~~~~--~~~~~~~~  246 (342)
                      .....++..|+|||.+.+..  ..+.++||||||+++|++++|+.||...+ .......+... ....+.  .++..+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            12346788999999987654  13588999999999999999999997653 22222222222 122233  34889999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          247 LISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +|.+||+.||.+|||+++++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-44  Score=317.94  Aligned_cols=253  Identities=33%  Similarity=0.596  Sum_probs=217.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KTKIYIV   92 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv   92 (342)
                      +|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+.+|+.+++.++|+||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            58999999999999999999999999999999865433 23445678899999999999999999998753  4568999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           93 LEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCH-----SRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH-----~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999998875    357899999999999999999999     89999999999999999999999999999875


Q ss_pred             CccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCH
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFST  242 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~  242 (342)
                      .....  .......+++.|+|||.+.+..+ +.++|+||||+++++|++|..||...+.......+...... .+..++.
T Consensus       160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence            43321  11234568999999999987654 48899999999999999999999988877766666665543 3456889


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .+.+++.+||+.+|++||++.++++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-44  Score=324.61  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=207.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCe----
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTK----   88 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~----   88 (342)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. |+||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999865322 2223356778999999996 6999999999876665    


Q ss_pred             -EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccc
Q 019360           89 -IYIVLEFVTGGELFDKIASR-----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLS  161 (342)
Q Consensus        89 -~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~  161 (342)
                       .|+||||+++ +|.+++...     ..+++..++.++.|++.||.|||+.||+||||+|+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999976 788877642     35799999999999999999999999999999999999998 889999999998


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-------
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------  234 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-------  234 (342)
                      ......  ........+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+.....       
T Consensus       159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            743221  11112235678899999987644446899999999999999999999988766655544432110       


Q ss_pred             ---------------C------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          235 ---------------K------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       235 ---------------~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                                     .      ..+.++.++.+||.+||+.||.+||++++++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                           0      0134788899999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-44  Score=323.36  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=203.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999865332  12223567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++......  .
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~  158 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--Q  158 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--C
Confidence            99996 567666554 4567888999999999999999999999999999999999999999999999987432211  1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcC-----------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD-----------------  233 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~-----------------  233 (342)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+.. +....+....                 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            1223456889999999876443457899999999999999999999765432 2222111100                 


Q ss_pred             ----CC--CC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 ----FK--SP---------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 ----~~--~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                          ..  .+         -..+.++.+++.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                00  00         0125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-44  Score=323.77  Aligned_cols=258  Identities=30%  Similarity=0.472  Sum_probs=210.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||.|++|+||+|.++.+|+.||+|.+..... .....+.+.+|+++++.++|+||+++++++......|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999865432 223345678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCccccC
Q 019360           93 LEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |||++ ++|.+.+.....  +++..+..++.|++.||+|||++|++|+||+|+||+++. ++.+||+|||++......  
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence            99996 478777765433  578889999999999999999999999999999999985 557999999998743221  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---------------
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---------------  234 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---------------  234 (342)
                      ........+++.|+|||.+.+....+.++|||||||++|+|++|..||...+..+...++.....               
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            11122345688999999987654445889999999999999999999987766555544432100               


Q ss_pred             --------C------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          235 --------K------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       235 --------~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                              .      ..+.+++++.+++.+||+.||++||++.++++||||.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                    0      023467889999999999999999999999999999864

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.9e-45  Score=332.89  Aligned_cols=264  Identities=26%  Similarity=0.433  Sum_probs=214.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCe
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----KTK   88 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~   88 (342)
                      .++|++.+.||.|++|.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++|+||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3789999999999999999999999999999999865322 22345677889999999999999999988753    356


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||+. ++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            899999995 5899999877789999999999999999999999999999999999999999999999999986432211


Q ss_pred             --CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--------------
Q 019360          169 --DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--------------  232 (342)
Q Consensus       169 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--------------  232 (342)
                        .........++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...              
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence              1112234568889999999876444468999999999999999999999876544333222110              


Q ss_pred             --------CCC----C-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          233 --------DFK----S-----PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       233 --------~~~----~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                              .+.    .     .+..+.++.++|.+||+.||.+|||+++++.||||.....+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                    000    0     133678999999999999999999999999999998765544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=318.17  Aligned_cols=248  Identities=33%  Similarity=0.601  Sum_probs=209.8

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHH-hcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      ++.||.|++|.||+|.+..+|+.||+|++.+...........+..|..++ ...+|+|++++++++...+..|+|+||++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            36799999999999999999999999999764433333333444555444 55689999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceeccc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC  177 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  177 (342)
                      +++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....      .....
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~  154 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFV  154 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCC
Confidence            999999998888899999999999999999999999999999999999999999999999998874322      22345


Q ss_pred             CCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC----CCCCCHHHHHHHHHhcC
Q 019360          178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----PPWFSTSAKKLISRILD  253 (342)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~L~  253 (342)
                      ++..|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......    ...+++++.+++.+||+
T Consensus       155 ~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         155 GTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            7889999999987664 589999999999999999999999888877777766544332    23478999999999999


Q ss_pred             CCCCCCCC---HHHHhcCccccc
Q 019360          254 PNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       254 ~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      .||++||+   ++|++.||||.+
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhc
Confidence            99999995   589999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.1e-44  Score=325.43  Aligned_cols=257  Identities=27%  Similarity=0.417  Sum_probs=214.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+..|
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            34467999999999999999999999999999999986543333444567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +|+||++| ++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....   
T Consensus        92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---  167 (307)
T cd06607          92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---  167 (307)
T ss_pred             EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence            99999975 67666654 45689999999999999999999999999999999999999999999999998874322   


Q ss_pred             CCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAK  245 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~  245 (342)
                         .....++..|+|||++.+  ....+.++||||||+++|+|++|+.||...+.......+.....+.  +..++..+.
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence               123457889999998752  2223578999999999999999999998877666554444332222  234678999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ++|.+||+.||++||++.+++.||||...
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            99999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-44  Score=318.68  Aligned_cols=253  Identities=32%  Similarity=0.548  Sum_probs=211.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+.............+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            36899999999999999999999999999999988654444445556788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           93 LEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988753    3458999999999999999999999999999999999999999999999999887543211


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc--HHHHHHHHHhcCCCC--CCCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN--LMALYKKIFKADFKS--PPWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~--~~~~~~~~  244 (342)
                        .......+++.|+|||.+.+.... .++|+||+|+++|+|++|..||....  .......+.....+.  ...++..+
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             --HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence              112234678899999999876654 88999999999999999999996543  334444444333322  23477889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          245 KKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+++.+||+.+|++||+++++++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.5e-45  Score=330.00  Aligned_cols=247  Identities=24%  Similarity=0.425  Sum_probs=191.0

Q ss_pred             eeeecccCceEEEEEEEcC--CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE--eCCeEEEEEe
Q 019360           19 GRTLGEGSFAKVKFARNTE--TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA--SKTKIYIVLE   94 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~~lv~e   94 (342)
                      ..+||+|+||.||+|.++.  ++..||+|.+.....     ...+.+|+.+++.++|+||+++++++.  .+..+++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999999754  568899999865322     235678999999999999999999885  3567899999


Q ss_pred             ccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCeeEcccccc
Q 019360           95 FVTGGELFDKIASR---------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLS  161 (342)
Q Consensus        95 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli----~~~~~~kl~Dfg~~  161 (342)
                      |+++ +|.+++...         ..+++..+..++.|++.||.|||+.||+||||||+||++    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9965 777776421         248899999999999999999999999999999999999    45679999999999


Q ss_pred             cCCccccC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH---------HHHHHHHh
Q 019360          162 ALPQQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM---------ALYKKIFK  231 (342)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~---------~~~~~i~~  231 (342)
                      +....... ........+|+.|+|||++.+....+.++|||||||++|+|++|++||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            75432211 112234567899999999977554568899999999999999999999653211         00000000


Q ss_pred             c----------------------------CC----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          232 A----------------------------DF----------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       232 ~----------------------------~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .                            ..          ......+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0                            00          0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-44  Score=322.63  Aligned_cols=252  Identities=31%  Similarity=0.509  Sum_probs=210.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++.....  ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            58999999999999999999999999999999865432  2223466789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           95 FVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        95 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......  .
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~  155 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N  155 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence            9975 888887654   358999999999999999999999999999999999999999999999999987433211  1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-----------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-----------------  234 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-----------------  234 (342)
                      ......++..|+|||.+.+....+.++|+|||||++|++++|+.||.+.+..+....+.....                 
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            122345688999999987655556889999999999999999999988776655554432110                 


Q ss_pred             ---C---------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 ---K---------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ---~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                         +         ..+.++..+.+++.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence               0         012357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-44  Score=331.14  Aligned_cols=260  Identities=30%  Similarity=0.430  Sum_probs=212.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----C
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-----T   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~   87 (342)
                      ..+|++.+.||.|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            4689999999999999999999999999999999865322 222345677899999999999999999987644     3


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            4899999995 689999988888999999999999999999999999999999999999999999999999998754322


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc---------------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---------------  232 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~---------------  232 (342)
                      .  .......++..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+...               
T Consensus       162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            1  22234567889999999875433458999999999999999999999876543322222110               


Q ss_pred             --------C-----C---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          233 --------D-----F---KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       233 --------~-----~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                              .     .   ...+.+++++.+||.+||+.||++|||++++++||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                    0     0   012357889999999999999999999999999999976443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=327.93  Aligned_cols=256  Identities=27%  Similarity=0.447  Sum_probs=204.2

Q ss_pred             CeeeeeeecccCceEEEEEEEcC--CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTE--TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TKIY   90 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~   90 (342)
                      +|++.+.||+|++|.||+|.+..  +++.||+|.+.............+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            68999999999999999999988  8999999999764322233345677899999999999999999999887  7899


Q ss_pred             EEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC----CCCeeEcccccc
Q 019360           91 IVLEFVTGGELFDKIASR-----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA----NGVLKVSDFGLS  161 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~----~~~~kl~Dfg~~  161 (342)
                      +||||+++ +|.+.+...     ..+++..++.++.|++.||.|||+.||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 676666432     36899999999999999999999999999999999999999    899999999998


Q ss_pred             cCCccccC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH---------HHHHHHh
Q 019360          162 ALPQQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA---------LYKKIFK  231 (342)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~---------~~~~i~~  231 (342)
                      ........ ........++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.....         ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            75433221 1122334678899999998765444588999999999999999999997544321         0000000


Q ss_pred             -------------------------cCCCCCC------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          232 -------------------------ADFKSPP------------WFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       232 -------------------------~~~~~~~------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                               ......+            ..+.++.+++.+||+.||++|||+.|+++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                     0000011            456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-45  Score=326.32  Aligned_cols=257  Identities=28%  Similarity=0.499  Sum_probs=216.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.|.....||.|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            45666788999999999999999999999999986432   233456889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......  ....
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~  175 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKR  175 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccC
Confidence            99999999988754 56899999999999999999999999999999999999999999999999998643221  1122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc---CCCCCCCCCHHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---DFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~  250 (342)
                      ....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+...   .......++..+.+++.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            34568899999999977665 47899999999999999999999887766555444332   222233578899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          251 ILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      ||..||++|||++++++||||.....+
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCCc
Confidence            999999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9e-46  Score=291.36  Aligned_cols=257  Identities=31%  Similarity=0.502  Sum_probs=219.8

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|.-.++||+|.||+||+|++..+++.||+|.++... .++.......+|+-+|+.++|+|||+++++...+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            46788899999999999999999999999999997543 23333456789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |||.. +|..+..+ ++.++.+.++.++.|++.||.+.|++++.|||+||.|.+|+.+|.+|++|||+++.....  -..
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrc  157 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC  157 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence            99954 88888876 577999999999999999999999999999999999999999999999999999854321  112


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCCCC--------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP--------------  237 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~--------------  237 (342)
                      .....-|.+|++|.++.+...++.+.|+||.||++.|+.. |++.|.+.+..+....|+.....+.              
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            3344568999999999998877899999999999999986 8888999999988888875321110              


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          238 ---------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       238 ---------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                     +.++..-++|+.++|..+|.+|.+++++++||||.+.
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                           2234567899999999999999999999999999763

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=326.74  Aligned_cols=264  Identities=31%  Similarity=0.572  Sum_probs=239.6

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEe
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMAS   85 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~   85 (342)
                      .........|..+.+||+|+||.|-+|..+.+.+.||||++.+..+......+--..|-++|.... -|.+++++..|+.
T Consensus       342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence            334566778999999999999999999999999999999998877766666666667888888774 7889999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      -+.+|+||||+.||+|-..+++-+.+.+..+..++..|+-||-+||++||++||||.+|||++.+|++||+|||+++-  
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--  499 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--  499 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999873  


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                      .........+.||||.|+|||++...+| +.++|.||+||++|||+.|++||++.+..++++.|+......|..+|.++.
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv  578 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV  578 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence            2233445678899999999999988776 589999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 019360          246 KLISRILDPNPVTRITM-----AEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~-----~e~l~h~~~~~  273 (342)
                      ++++.+|.+.|.+|...     .++-.||||+.
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            99999999999999864     78999999974

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.7e-44  Score=316.13  Aligned_cols=255  Identities=31%  Similarity=0.525  Sum_probs=218.9

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.|++.+.||.|++|.||+|.+..+++.|++|++......  .....+.+|+..+..++|+|++++++++......++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            3689999999999999999999999999999998754321  34567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~  156 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--Q  156 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--c
Confidence            999999999999988889999999999999999999999 9999999999999999999999999999875432211  1


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHHhcCCC-CCCC-CCHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKADFK-SPPW-FSTSAKKL  247 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~~~~~~-~~~~-~~~~~~~l  247 (342)
                      .....++..|+|||.+....+ +.++|+||||+++|+|++|..||...   ...+....+...... .+.. ++..+.++
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence            124467889999999887654 58899999999999999999999776   444555555443322 2334 78899999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      |.+||..+|++||++.++++|||++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-44  Score=321.32  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=208.8

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE----
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA----   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~----   84 (342)
                      ....++|++.+.||+|+||.||+|.++.+++.+|+|++.....    ....+.+|+.+++.+ +|+||+++++++.    
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            3466799999999999999999999999999999998854221    124577899999999 6999999999873    


Q ss_pred             -eCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           85 -SKTKIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                       .++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             34578999999999999987753    3568899999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--  233 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--  233 (342)
                      ++......  ........|++.|+|||++...    ...+.++|||||||++|+|++|+.||...+.......+....  
T Consensus       170 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         170 VSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             ceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            98743221  1122334688999999998532    223578999999999999999999998776544443332221  


Q ss_pred             -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          234 -FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       234 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                       ...+..++..+.+|+.+||+.||++|||+.|+++|+||
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             11234467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-45  Score=332.67  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=210.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..|+++++||+||-+.||++.... .+.||+|.+.. ...+.+.+.-+.+|+..|.+|+ |.+|+++++|-..++.+|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            459999999999999999998754 45566666543 2345667788999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||- ..+|..+|.+... ++.-.++.+.+|++.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|.........-
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccce
Confidence            9986 4599999988654 3435788999999999999999999999999999999 77899999999998777666666


Q ss_pred             ceecccCCcccCChhhhccCCC----------CCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCC--CCCC
Q 019360          172 LLHTTCGTPNYVAPEVINNKGY----------DGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKADF--KSPP  238 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~----------~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~--~~~~  238 (342)
                      ...+.+||+.||+||.+.....          .+.++|||||||++|+|+.|++||.... ...-+..|.....  .++.
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~  596 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD  596 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence            6778899999999999864322          2578999999999999999999996643 3333444444422  3332


Q ss_pred             CCC-HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          239 WFS-TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~-~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .-+ .++.++++.||+.||++|||+.++|+|||++-
T Consensus       597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            222 33999999999999999999999999999975

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=322.34  Aligned_cols=252  Identities=32%  Similarity=0.501  Sum_probs=209.4

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      |++.+.||.|++|.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++|+|++++++++...+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            6889999999999999999999999999999865432 222335677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           96 VTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        96 ~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ++ ++|.+++....  .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++......  ....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~  156 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY  156 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence            95 58999888765  6899999999999999999999999999999999999999999999999998743221  1112


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-------------------
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------------  234 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------------  234 (342)
                      ....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+.....                   
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            2235688999999887654445789999999999999999999987765544433322100                   


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 ----------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                ...+.++..+.++|.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                      0123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.3e-44  Score=318.95  Aligned_cols=255  Identities=29%  Similarity=0.500  Sum_probs=216.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ..|...+.||.|++|.||++.++.+++.+++|++....   ....+.+.+|+.+++.++|+||+++++++...+..++++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            35666789999999999999999999999999985432   223356789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+......  ....
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~  172 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR  172 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence            99999999999887 66899999999999999999999999999999999999999999999999987643221  1122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---CCCCCHHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---PPWFSTSAKKLISR  250 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~  250 (342)
                      ....|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+.......   +..++..+.+++.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             ccccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            33568899999999877655 488999999999999999999998877766666655443222   22377899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcccccCC
Q 019360          251 ILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      ||+.+|++|||+.++++||||.+..
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccCC
Confidence            9999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-44  Score=321.17  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=209.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe---
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS---   85 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---   85 (342)
                      ....++|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++ +|+||+++++++..   
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            456689999999999999999999999999999999986432    2234677899999888 69999999999852   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           86 ---KTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        86 ---~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                         ...+|++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence               45789999999999999988753  4588889999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-  235 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-  235 (342)
                      +......  ........|++.|+|||.+...    ...+.++|+|||||++|+|++|..||...........+...... 
T Consensus       168 ~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         168 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             hhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence            8743221  1122345688999999997531    22347899999999999999999999776654444433332221 


Q ss_pred             -CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 -SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 -~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                       ....++.++.+||.+||+.||.+|||+.|+++||||
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             123478899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.9e-44  Score=320.73  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=210.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      -..|.+.+.||+|+||.||++.+.     .++..+|+|.+....   ....+.+.+|+.++++++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            357999999999999999999863     345679999886432   334457889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           88 KIYIVLEFVTGGELFDKIASRG-------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      ..++||||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999999987543             389999999999999999999999999999999999999999999


Q ss_pred             EcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC
Q 019360          155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD  233 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~  233 (342)
                      |+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999874332211111223345678999999987665 489999999999999998 999998888777777777655


Q ss_pred             CC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          234 FK-SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       234 ~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .. .+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            43 34457899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-44  Score=321.42  Aligned_cols=252  Identities=24%  Similarity=0.364  Sum_probs=212.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .++|.+.+.||+|+||.||+|.+..     +++.||+|.+.....  ....+.+.+|+++++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4679999999999999999998753     357899999865322  223468889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCe
Q 019360           88 KIYIVLEFVTGGELFDKIASRG--------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVL  153 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~  153 (342)
                      ..++||||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999997542              37888999999999999999999999999999999999999999


Q ss_pred             eEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 019360          154 KVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA  232 (342)
Q Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~  232 (342)
                      +|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999874322111111223345778999999987665 488999999999999998 99999888777777777665


Q ss_pred             CCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          233 DFKS-PPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       233 ~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .... +..++..+.+++.+||+.||++||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5433 4568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-44  Score=328.45  Aligned_cols=261  Identities=28%  Similarity=0.421  Sum_probs=215.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-   87 (342)
                      .-...++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.++|+||+++++++.... 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            3446789999999999999999999999999999999986432 22333456789999999999999999999987553 


Q ss_pred             -----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           88 -----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        88 -----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                           .+++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence                 468999999 7788887764 568999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-------  235 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------  235 (342)
                      ....     ......+++.|+|||.+.+....+.++|+|||||++|++++|..||.+.+.......+.+....       
T Consensus       167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         167 QTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            5322     1223457889999999876444468899999999999999999999877665554444332111       


Q ss_pred             ------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          236 ------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       236 ------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                              ..+.+++++.++|.+||+.||++|||+.+++.||||+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                                    113467889999999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-44  Score=328.47  Aligned_cols=268  Identities=28%  Similarity=0.402  Sum_probs=217.0

Q ss_pred             CCceeecCeee-eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh-----------HHHHHHHHHHHHhcCCCCc
Q 019360            8 ASRTRVGKYEL-GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-----------MIGQIKREISTMKLIRHPN   75 (342)
Q Consensus         8 ~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~   75 (342)
                      +.....+||.. .+.||.|+||+||+|.++.+++.||+|++.........           ....+.+|+++++.++|+|
T Consensus         2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            34456678875 47799999999999999999999999998653322110           1124678999999999999


Q ss_pred             ceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeE
Q 019360           76 VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV  155 (342)
Q Consensus        76 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl  155 (342)
                      |+++++++...+..++||||+. ++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence            9999999999999999999996 589999988888999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccc------------cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH
Q 019360          156 SDFGLSALPQQV------------RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM  223 (342)
Q Consensus       156 ~Dfg~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~  223 (342)
                      +|||.+......            ..........+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998753310            00111223346788999999876554568999999999999999999999887766


Q ss_pred             HHHHHHHhcCCC----------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          224 ALYKKIFKADFK----------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       224 ~~~~~i~~~~~~----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +....+......                            .....+.++.++|.+||+.||++|||++++|.||||+...
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            655544321100                            0123477899999999999999999999999999998654


Q ss_pred             C
Q 019360          276 K  276 (342)
Q Consensus       276 ~  276 (342)
                      .
T Consensus       321 ~  321 (335)
T PTZ00024        321 L  321 (335)
T ss_pred             C
Confidence            3

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-44  Score=320.29  Aligned_cols=255  Identities=30%  Similarity=0.487  Sum_probs=215.9

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ..|+..+.||.|+||.||+|.+..+++.+|+|++.....  ......+.+|+.+++.+.|+||+++++++......|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468899999999999999999999999999999865332  233568889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++.. .++++.++..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~  158 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR  158 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence            99999999998875 56899999999999999999999999999999999999999999999999998643321  1112


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhc
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L  252 (342)
                      ....++..|+|||.+.+... +.++|+|||||++|+|++|..||...+.......+..... ..+..++..+.+++.+||
T Consensus       159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            23457889999999877655 4889999999999999999999987766555444433222 223346788999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccC
Q 019360          253 DPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +.+|++||++++++.|+||...
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhc
Confidence            9999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-44  Score=320.13  Aligned_cols=259  Identities=21%  Similarity=0.317  Sum_probs=212.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+.....  ......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            35789999999999999999997652     345799998864322  22234677899999999999999999999988


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR----------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~  156 (342)
                      ...|+||||+++++|.+++...          ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999999752          234667889999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-  234 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-  234 (342)
                      |||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+..+....+..... 
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999875332211111122334678999999887665 489999999999999998 7999988887777776665433 


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------Cccccc
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRITMAEVIE------NEWFKK  273 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------h~~~~~  273 (342)
                      ..+...++.+.+++.+||+.||++|||+.++++      ||||+.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            334556889999999999999999999999987      888864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=314.68  Aligned_cols=247  Identities=40%  Similarity=0.742  Sum_probs=220.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||.|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++|+||+++++.+..+...|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999876655555667889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcc
Q 019360          102 FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN  181 (342)
Q Consensus       102 ~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  181 (342)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.......  .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence            9999988789999999999999999999999999999999999999999999999999987543211  12334567889


Q ss_pred             cCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 019360          182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRIT  261 (342)
Q Consensus       182 y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  261 (342)
                      |+|||...+... +.++|+||||+++|++++|..||...+.......+.......+...+..+.+++++||..||++||+
T Consensus       159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999977654 4789999999999999999999988887777777777777777788999999999999999999999


Q ss_pred             H---HHHhcCccc
Q 019360          262 M---AEVIENEWF  271 (342)
Q Consensus       262 ~---~e~l~h~~~  271 (342)
                      +   +++++||||
T Consensus       238 ~~~~~~l~~~~~f  250 (250)
T cd05123         238 SGGAEEIKAHPFF  250 (250)
T ss_pred             cccHHHHHhCCCC
Confidence            9   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.9e-44  Score=312.49  Aligned_cols=255  Identities=33%  Similarity=0.571  Sum_probs=217.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TKIYIV   92 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv   92 (342)
                      +|++.+.||+|++|.||+|.+..+++.+++|++...... ....+.+.+|+..+++++|+||+++++.+...  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999989999999998654332 34457888999999999999999999999888  889999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      +||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998877899999999999999999999999999999999999999999999999999875443222111


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHh--cCCCCCCCCCHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFK--ADFKSPPWFSTSAKKLIS  249 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~--~~~~~~~~~~~~~~~li~  249 (342)
                      .....++..|+|||.+.+... +.++||||||+++|+|++|..||...+ .......+..  .....+..++..+.++|.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            334567889999999877654 589999999999999999999998765 2333333321  223345567899999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccc
Q 019360          250 RILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +||+.||.+||++.+++.||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.2e-44  Score=312.40  Aligned_cols=253  Identities=36%  Similarity=0.666  Sum_probs=220.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|++|.||++.+..+++.+++|++..... .......+.+|+++++.++|+|++++.+.+...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            68999999999999999999999999999999865432 23445678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           95 FVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        95 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |+++++|.+.+...    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999998764    679999999999999999999999999999999999999999999999999987543321  


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCCCCHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLIS  249 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~  249 (342)
                      .......|++.|+|||.+.+... +.++|+||+|+++++|++|..||...+............... +..++..+.+++.
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            12334568889999999877665 488999999999999999999998888777777666554433 4468899999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccc
Q 019360          250 RILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +||..+|.+|||+.++|+||||
T Consensus       237 ~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         237 SLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.1e-44  Score=329.09  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=208.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC------
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK------   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------   86 (342)
                      .++|++.+.||.|+||.||+|.++.+|+.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            4799999999999999999999999999999999865432   3345778999999999999999999776543      


Q ss_pred             --------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcc
Q 019360           87 --------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSD  157 (342)
Q Consensus        87 --------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~D  157 (342)
                              ...|+||||++ ++|.+.+.. ..+++..++.++.|+++||.|||+.||+||||||+||+++. ++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    35799999996 588887764 46899999999999999999999999999999999999974 55789999


Q ss_pred             cccccCCccccC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--
Q 019360          158 FGLSALPQQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--  234 (342)
Q Consensus       158 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--  234 (342)
                      ||.+........ ........++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.....  
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999875322111 11122345788999999876544455889999999999999999999987665554443332110  


Q ss_pred             ---------------------C-------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          235 ---------------------K-------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       235 ---------------------~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                           .       ..+.++.++.+||.+||+.||++|||+.+++.||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence                                 0       01246788999999999999999999999999999986433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.7e-44  Score=314.36  Aligned_cols=253  Identities=32%  Similarity=0.605  Sum_probs=215.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|+||.||+|.++.+|..+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+...+..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            68999999999999999999999999999999865432 22334577899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCCccccCCC
Q 019360           95 FVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence            999999999987643  479999999999999999999999999999999999998876 4699999988754321  11


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISR  250 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~  250 (342)
                      ......|++.|+|||.+.+..+ +.++|+||||++++++++|..||...+.......+...... ..+.++.++.++|.+
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ  236 (257)
T ss_pred             cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence            2233458889999999876655 48899999999999999999999887776666665554433 345578899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCccc
Q 019360          251 ILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ||+.+|++|||+.+++.||||
T Consensus       237 ~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         237 LFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-46  Score=336.62  Aligned_cols=237  Identities=26%  Similarity=0.457  Sum_probs=209.4

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEecc
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      ..++-||+|+.|.||+|+.  .++.||||++..-+          ..+|+-|++|+|+||+.+.++|.....+|+|||||
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            4467799999999999987  47899999885321          24788899999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecc
Q 019360           97 TGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT  176 (342)
Q Consensus        97 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  176 (342)
                      ..|.|.++|+.+..++......+.++|+.|+.|||.++|||||||.-||||+.+..|||+|||-++...   ........
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS---DKSTKMSF  271 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---hhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999999887433   23445678


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHHHHHHhcCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~  254 (342)
                      +||..|||||++...+.. .|+|||||||+||||+||..||.+.+...++-.+-...  ++.|..+++.++-||+.||+-
T Consensus       272 aGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence            999999999999988775 99999999999999999999999887776655554433  345677899999999999999


Q ss_pred             CCCCCCCHHHHhcCc
Q 019360          255 NPVTRITMAEVIENE  269 (342)
Q Consensus       255 dP~~Rps~~e~l~h~  269 (342)
                      .|..||++.++|.|-
T Consensus       351 KpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHL  365 (904)
T ss_pred             CCCCCccHHHHHHHH
Confidence            999999999999984

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.5e-44  Score=318.42  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=208.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+.....  ......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45689999999999999999998642     356799999854321  22345688999999999999999999999998


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG----------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~  156 (342)
                      ...++||||+++++|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999987532          35678899999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-  234 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-  234 (342)
                      |||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..... 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999874322111111112345678999999987665 488999999999999998 7999988877776666655443 


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3455678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-44  Score=322.05  Aligned_cols=260  Identities=27%  Similarity=0.480  Sum_probs=216.8

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+...++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.++|||++++++++...+.
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            3445689999999999999999999999899999999985432   2223567899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .|+|+||+++++|.+++.+. .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-  168 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  168 (293)
T ss_pred             EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-
Confidence            99999999999999988754 5789999999999999999999999999999999999999999999999987643221 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~  245 (342)
                       ........+++.|+|||.+....+ +.++|+|||||++|++++|+.||...+.......+....   +..+..++..+.
T Consensus       169 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (293)
T cd06647         169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  246 (293)
T ss_pred             -ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence             112233467889999999877655 488999999999999999999998766544333332221   222334678899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      ++|.+||+.+|++||++++++.|+||+...
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.2e-44  Score=313.51  Aligned_cols=245  Identities=26%  Similarity=0.433  Sum_probs=202.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +.||+|+||.||+|.++.+++.+|+|.+....  .......+.+|+++++.++|+||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46999999999999999999999999886432  2333457889999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360          100 ELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus       100 ~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      +|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.................
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            999998764 4589999999999999999999999999999999999999999999999999874322111100111123


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP  256 (342)
                      +..|+|||.+.+..+ +.++|||||||++|++++ |..||...........+... ....+..++..+.+|+.+||+.||
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999877665 488999999999999997 99999877666555555443 234455678999999999999999


Q ss_pred             CCCCCHHHHhc
Q 019360          257 VTRITMAEVIE  267 (342)
Q Consensus       257 ~~Rps~~e~l~  267 (342)
                      ++|||+.++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4e-44  Score=322.99  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=208.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcE--EEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGEN--VAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      ....+.|++.+.||+|+||.||+|.++.++..  +|+|.+...  ........+.+|+.++.++ +|+||+++++++...
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            45577899999999999999999999877765  466665432  2233446788999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                      +..|+||||+++++|.+++....                .+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999987532                47899999999999999999999999999999999999999


Q ss_pred             CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 019360          151 GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI  229 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i  229 (342)
                      +.+||+|||++........   .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  236 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  236 (303)
T ss_pred             CcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            9999999999863221111   111223567999999876654 588999999999999998 99999887776666555


Q ss_pred             HhcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          230 FKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       230 ~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      .... ...+..+++++.+|+.+||+.+|++||++++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            4332 223445788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-44  Score=352.28  Aligned_cols=255  Identities=21%  Similarity=0.388  Sum_probs=207.8

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|++.++||+|+||.||+|.+..+|+.||+|++...........+++.+|+++++.++||||+++++++...+..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            47999999999999999999999999999999999764433344556789999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           93 LEFVTGGELFDKIASR-----------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      |||++|++|.+++...           ...+...+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988641           23456778899999999999999999999999999999999999999999998


Q ss_pred             cCCccccC----------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHH
Q 019360          162 ALPQQVRD----------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL  225 (342)
Q Consensus       162 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~  225 (342)
                      ........                ........||+.|+|||.+.+..+ +.++|||||||++|+|++|..||...+....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            75421100                001122468999999999987665 5899999999999999999999987654433


Q ss_pred             HHHHHhcC---CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          226 YKKIFKAD---FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       226 ~~~i~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ........   ......+++.+.+++.+||+.||++|++..+.+.+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22211111   11223578899999999999999999887665543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-44  Score=328.64  Aligned_cols=261  Identities=28%  Similarity=0.425  Sum_probs=216.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++|+|++++.+++...+.
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            3345678999999999999999999999999999999986532 222334567789999999999999999988765554


Q ss_pred             ------EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           89 ------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        89 ------~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                            .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence                  89999999 6699888875 568999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS------  236 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------  236 (342)
                      .....     .....++..|+|||.+.+....+.++|||||||++|++++|+.||.+.+.......+.......      
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            53221     2334678899999998754444689999999999999999999998877665555443321100      


Q ss_pred             -------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 -------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 -------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                               ...++.++.+||.+||+.||++|||+.++++||||++...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                                     12358899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.9e-44  Score=317.31  Aligned_cols=254  Identities=30%  Similarity=0.493  Sum_probs=216.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -|++.+.||.|+||.||+|.+..+++.+|+|++.....  ....+.+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47889999999999999999998999999999864332  2334678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      |+++++|..++.. ..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......  .....
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~  159 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN  159 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence            9999999998875 46899999999999999999999999999999999999999999999999988643321  11122


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHHhcC
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISRILD  253 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~  253 (342)
                      ...++..|+|||.+.+... +.++|+|||||++|+|++|..||...........+.....+ ....++.++.+++.+||+
T Consensus       160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            3467889999999876555 47899999999999999999999877766555555433322 344578899999999999


Q ss_pred             CCCCCCCCHHHHhcCcccccC
Q 019360          254 PNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       254 ~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+|.+||++.++++||||.+.
T Consensus       239 ~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         239 KEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             CChhhCcCHHHHHhCHHHhhh
Confidence            999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.9e-44  Score=317.33  Aligned_cols=245  Identities=27%  Similarity=0.467  Sum_probs=202.6

Q ss_pred             ecCeeeeeee--cccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTL--GEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~   89 (342)
                      .++|++.+.+  |.|+||.||++.++.++..+|+|++.......        .|+.....+ +|+||+++++.+...+..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            4577777777  99999999999999999999999986543221        122222222 699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~~  168 (342)
                      |+||||+++++|.+++..+..+++.++..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....  
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--  162 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--  162 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence            99999999999999998877899999999999999999999999999999999999999988 999999998874322  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHH----HHHHHhcCCCCCCCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL----YKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  244 (342)
                          .....++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||........    ...........+..+++.+
T Consensus       163 ----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T PHA03390        163 ----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA  237 (267)
T ss_pred             ----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence                123457899999999987665 4889999999999999999999975543221    1122233334455689999


Q ss_pred             HHHHHHhcCCCCCCCCC-HHHHhcCcccc
Q 019360          245 KKLISRILDPNPVTRIT-MAEVIENEWFK  272 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps-~~e~l~h~~~~  272 (342)
                      .+||.+||+.||.+||+ ++++|+||||.
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            99999999999999996 69999999996

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-43  Score=314.52  Aligned_cols=251  Identities=29%  Similarity=0.497  Sum_probs=205.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      +.....||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            344568999999999999999999999999986533   22345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCccccCCC
Q 019360           96 VTGGELFDKIASR-GRL--KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        96 ~~~~~L~~~l~~~-~~l--~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      +++++|..++... ..+  ++..+..++.|++.||+|||+.||+||||||+||+++. ++.++|+|||.+......  ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~  164 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NP  164 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CC
Confidence            9999999998764 445  88889999999999999999999999999999999976 679999999998643221  11


Q ss_pred             ceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCcHHH--HHHH-HHhcCCCCCCCCCHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESNLMA--LYKK-IFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~l  247 (342)
                      ......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.......  .... ........+..+++++.++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence            223345788999999986533 23578999999999999999999997543221  1111 1222333455688999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCccc
Q 019360          248 ISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +.+||+.+|.+|||+.+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.8e-44  Score=324.39  Aligned_cols=253  Identities=22%  Similarity=0.348  Sum_probs=208.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...+|++.+.||+|+||.||+|.+..+++.    ||+|++....  .....+.+.+|+.+++.++|+||+++++++... 
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            456799999999999999999998766654    8999986422  233456788999999999999999999998764 


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++++||+++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            577999999999999999874 4588999999999999999999999999999999999999999999999999985433


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (342)
                      ...........++..|+|||.+.+..+ +.++|||||||++|||++ |..||.+....+....+... ..+.++.++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            221111122234668999999987665 489999999999999997 99999887766654444333 234456678999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          245 KKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+++.+||..||.+||++.+++.+
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=310.23  Aligned_cols=253  Identities=31%  Similarity=0.556  Sum_probs=219.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|++++++++|+|++++++++......+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            689999999999999999999999999999999765432 2445688999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      |+++++|.+++.....+++..+..++.|++.||.+||+.||+||||+|+||+++.++.++|+|||.+........  ...
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~  157 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA  157 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999875433221  123


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHH-hcCCCCCCCCCHHHHHHHHHhcC
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF-KADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ...++..|+|||...+... +.++|+||+|+++|+|++|..||...+......... ......+..++..+.+++.+||.
T Consensus       158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  236 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ  236 (254)
T ss_pred             ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence            3567889999999877664 588999999999999999999998766544444433 33334456688999999999999


Q ss_pred             CCCCCCCCHHHHhcCccc
Q 019360          254 PNPVTRITMAEVIENEWF  271 (342)
Q Consensus       254 ~dP~~Rps~~e~l~h~~~  271 (342)
                      .+|++|||+.+++.||||
T Consensus       237 ~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         237 KDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-43  Score=313.81  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=211.1

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ...|++.+.||+|++|.||+|.++.+++.+|+|.+....    .....+.+|+++++.++|+||+++++++...+.++++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            456999999999999999999999999999999986432    2235678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++...  ..+++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999999998753  35899999999999999999999999999999999999999999999999998754321111


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                       ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....+..++.++.+++
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence             1111223567999999877665 478999999999999998 99999988877776666553 3344566889999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.||++|||+.++++
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.8e-44  Score=317.87  Aligned_cols=253  Identities=21%  Similarity=0.349  Sum_probs=209.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ...|++.+.||+|+||.||+|...    .++..+|+|.+....  .....+.+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            467999999999999999999853    456789999986432  23344678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 019360           89 IYIVLEFVTGGELFDKIASR-----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG  151 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~  151 (342)
                      .|+||||+++++|.+++..+                 ..+++.++..++.|++.||+|||++|++||||||+||+++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            99999999999999988532                 2378889999999999999999999999999999999999999


Q ss_pred             CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 019360          152 VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIF  230 (342)
Q Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~  230 (342)
                      .+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999875432211112233345678999999977655 489999999999999998 999998877666655555


Q ss_pred             hcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          231 KAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       231 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ... ...+..+++.+.+++.+||+.||++||++.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            433 33455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.9e-45  Score=311.72  Aligned_cols=264  Identities=28%  Similarity=0.423  Sum_probs=209.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-CC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGE----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-KT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~   87 (342)
                      ...|++.+.||+|.||.||+|..+.++.    .+|+|.+..+... ...-...-+|+.+++.++|+|++.+..+|.. +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3469999999999999999997665442    6899998654221 1122355689999999999999999999977 78


Q ss_pred             eEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC----CCeeEccc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN----GVLKVSDF  158 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~----~~~kl~Df  158 (342)
                      .+++++||.+. +|.+.++-+     ..++...++.|++||+.|+.|||++=|+||||||.|||+..+    |.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999976 888888643     458999999999999999999999999999999999999877    89999999


Q ss_pred             ccccCCccccCCC-ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---------HHHHHHH
Q 019360          159 GLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---------LMALYKK  228 (342)
Q Consensus       159 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---------~~~~~~~  228 (342)
                      |++++....-..- ......-|.+|+|||.+.+...++.+.||||+||++.||+|-++.|.+..         ..+....
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999754432211 22344568999999999998888899999999999999999888885532         1222333


Q ss_pred             HHhcCCCC-----------C--------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          229 IFKADFKS-----------P--------------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       229 i~~~~~~~-----------~--------------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      |+.....+           |                          ..-++...+|+.+||+.||.+|.|++++|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            33211100           0                          0124558899999999999999999999999999


Q ss_pred             ccCCCCC
Q 019360          272 KKGYKPP  278 (342)
Q Consensus       272 ~~~~~~~  278 (342)
                      .....|+
T Consensus       341 ~~d~lpp  347 (438)
T KOG0666|consen  341 TEDPLPP  347 (438)
T ss_pred             ccCCCCC
Confidence            9876664

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-43  Score=313.85  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=211.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .++|++.+.||+|+||.||+|.++.+   ...||+|.+....  .......+.+|+.+++.++|+||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            46799999999999999999998654   4579999986432  233345788899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +++|||+++++|.+++... +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999998764 468999999999999999999999999999999999999999999999999998653211


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (342)
                      .........++..|+|||.+.+..+ +.++||||||+++|++++ |..||...........+... ..+.+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1111112234578999999987665 488999999999999998 99999887777766666554 23445567899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcC
Q 019360          247 LISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.+||+.+|++||++++++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.6e-44  Score=317.04  Aligned_cols=254  Identities=21%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|++.+.||+|++|.||+|.+..     .+..||+|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34679999999999999999999987     67889999886432  222335688899999999999999999999888


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CeeEc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVS  156 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~---~~kl~  156 (342)
                      +..++||||+++++|.+++....       .+++..+..++.|++.||+|||++|++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            89999999999999999987643       488999999999999999999999999999999999998654   69999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CC
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DF  234 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~  234 (342)
                      |||+++................+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999875422111111112223567999999987665 489999999999999997 99999988777666555443 33


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+..++..+.+++.+||+.||++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4456688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=311.78  Aligned_cols=256  Identities=29%  Similarity=0.517  Sum_probs=214.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchh--hhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEK--VLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TKI   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~   89 (342)
                      .+|++.+.||+|+||.||+|.+..+++.+|+|.+....  .........+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875321  12234456888999999999999999999998654  468


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ++++||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            89999999999999998877899999999999999999999999999999999999999999999999999875432111


Q ss_pred             -CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHH
Q 019360          170 -DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKK  246 (342)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~  246 (342)
                       ........++..|+|||.+.+... +.++|+|||||++|++++|+.||...........+....  ...+..+++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence             111233467889999999987655 488999999999999999999998776655555544332  2346668899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          247 LISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ++.+||+ +|.+||++.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-44  Score=327.97  Aligned_cols=261  Identities=30%  Similarity=0.449  Sum_probs=218.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-----KI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~   89 (342)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++|+||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            6999999999999999999999899999999986532 22334467889999999999999999999987765     78


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |++|||++ ++|.+++.....+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 48999998877899999999999999999999999999999999999999999999999999875433211


Q ss_pred             -CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC------------
Q 019360          170 -DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS------------  236 (342)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------  236 (342)
                       ........++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+....+.......            
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence             0122344678899999999876344689999999999999999999998887766655554321110            


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 -------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 -------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                         .+.++.++.++|.+||+.||.+||++++++.||||+....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                               12357889999999999999999999999999999875554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-44  Score=321.88  Aligned_cols=255  Identities=30%  Similarity=0.480  Sum_probs=214.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ..|+..+.||.|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.+++.++|+||+++++++......|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            458889999999999999999999999999999864322  234467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~  158 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR  158 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence            99999999988865 56899999999999999999999999999999999999999999999999998753321  1112


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhc
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L  252 (342)
                      ....++..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+..... .....++.++.++|.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            23457889999999987665 4889999999999999999999977655554444333222 223347788999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccC
Q 019360          253 DPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +.+|.+||++.++++||||...
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHH
Confidence            9999999999999999999764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-43  Score=312.43  Aligned_cols=246  Identities=26%  Similarity=0.437  Sum_probs=212.6

Q ss_pred             eeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEecc
Q 019360           20 RTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      +.||+|+||.||+|.+...   +..+++|.+.......  ..+.+.+|++.++.++|+||+++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4799999999999999866   8999999997643322  4568889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           97 TGGELFDKIASR---------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        97 ~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ++++|.+++...         ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999999865432


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      ..........++..|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+.... ...+..++.++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            22122334557889999999887654 589999999999999999 699999988877777776533 344566789999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcC
Q 019360          246 KLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +++.+||+.||.+|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-43  Score=316.53  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=208.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KTKIYI   91 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~l   91 (342)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++.++|+||+++++++..  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            579999999999999999999999999999999875322  2334678899999999999999999998854  347899


Q ss_pred             EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           92 VLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    345899999999999999999999999999999999999999999999999998643221


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC-----cHHHHHHHHHhcCCC-CC----
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES-----NLMALYKKIFKADFK-SP----  237 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~-~~----  237 (342)
                          ......++..|+|||.+.+..+ +.++|||||||++|+|++|..||...     ...+....+...... .+    
T Consensus       159 ----~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         159 ----LAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ----ccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence                1123457889999999987665 48899999999999999999999765     223333333331111 11    


Q ss_pred             --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          238 --PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       238 --~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                        ..+++.+.+++.+||+.||.+|||+.|++.||||.+.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence              1246789999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-44  Score=327.84  Aligned_cols=264  Identities=29%  Similarity=0.437  Sum_probs=213.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC--
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK--   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~--   86 (342)
                      .+..++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++ +|+||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            4567899999999999999999999998999999998864321 222335677899999999 999999999988643  


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ...|+||||++ ++|..++... .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            46899999996 4998888765 788999999999999999999999999999999999999999999999999875433


Q ss_pred             ccCC---CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---------
Q 019360          167 VRDD---GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---------  234 (342)
Q Consensus       167 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---------  234 (342)
                      ....   .......|+..|+|||.+.+....+.++||||||+++|+|++|+.||.+.........+.....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211   2223456788999999887655456889999999999999999999987665444333222110         


Q ss_pred             ----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          235 ----------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       235 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                            ...+.++.++.++|.+||+.||++|||+.++++|||++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                  011236889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=302.73  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=210.2

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      .+.......||++.+.||.|||+-||+++...+++.||+|.+....   .+..+...+|++..++++|||+++++++...
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            3445556789999999999999999999999999999999997654   3445688999999999999999999987643


Q ss_pred             C-----CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCee
Q 019360           86 K-----TKIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        86 ~-----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~~k  154 (342)
                      +     ...|++++|...|+|.+.++.    +..+++.++.+|+.++++||++||+..  .+||||||.|||+++++.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            3     349999999999999998875    346999999999999999999999998  99999999999999999999


Q ss_pred             EcccccccCCccccCCC-------ceecccCCcccCChhhhccCCC--CCcccchhhhhHHHHHHHhCCCCCCCCcH--H
Q 019360          155 VSDFGLSALPQQVRDDG-------LLHTTCGTPNYVAPEVINNKGY--DGAKADLWSCGVILYVLMAGYLPFEESNL--M  223 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~pf~~~~~--~  223 (342)
                      +.|||.++..+..-.+.       ......+|..|+|||.+.-+..  -+.++|||||||++|+|+.|..||+..-.  .
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            99999887543322111       1122357899999999864333  25899999999999999999999953211  1


Q ss_pred             HHHHHHHhcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          224 ALYKKIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       224 ~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+.-.+.++.  ++....++..+.+||+.||+.||.+||++.+++.+
T Consensus       250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111222222  33345599999999999999999999999999875

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.5e-44  Score=315.47  Aligned_cols=252  Identities=32%  Similarity=0.571  Sum_probs=210.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||.|++|.||+|+++.+++.+|+|.+.............+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            36799999999999999999999999999999988764444445556888999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           93 LEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-  159 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-  159 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence            999999999998863    345899999999999999999999999999999999999999999999999988754321 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH--HHHHHHHHhcCCCC--CCCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL--MALYKKIFKADFKS--PPWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~--~~~~~~~~  244 (342)
                       ........++..|+|||.+.+... +.++|+||||+++|+|++|..||.+...  ......+.....+.  ...++..+
T Consensus       160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence             112234568899999999977665 4789999999999999999999965432  33333333333222  23478899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+++.+||+.||++|||+.++++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.9e-44  Score=319.01  Aligned_cols=255  Identities=25%  Similarity=0.453  Sum_probs=211.3

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      ...++|++.+.||+|+||.||++.+...     ...+|+|.+....  .......+.+|+.+++.+ +|+||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3456899999999999999999988643     3789999986532  223345788999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                      ..+.++++|||+++++|..++..+                ..+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999998642                3588999999999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+....+...
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999875433211111122234568999999877665 488999999999999997 999999887777766


Q ss_pred             HHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          228 KIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       228 ~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+..... ..+...+.++.+|+.+||..||++|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6655432 3455678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=335.88  Aligned_cols=250  Identities=23%  Similarity=0.400  Sum_probs=212.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+...+...||+|.||+||+|.+-   ..||||++....... +..+.|++|+.++++-+|.||+-+.|++..++. .+|
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             HHHhhccceeccccccceeecccc---cceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            345678999999999999999884   349999998766554 478899999999999999999999999988776 899


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      +-+|+|.+|+.+++-. ..|.....+.|+.|+++|+.|||.++|||||||..||++.++++|||+|||++..........
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            9999999999998753 568889999999999999999999999999999999999999999999999998655554455


Q ss_pred             ceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----CCCCCHHH
Q 019360          172 LLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFSTSA  244 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~  244 (342)
                      ......|...|||||++..  ...++..+|||||||++|||++|..||.......++-.+-++...+     ...++.++
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m  625 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM  625 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence            5566678889999999864  2334688999999999999999999999766666555554443322     23467799


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++|+..||..+|++||.+.+||.
T Consensus       626 k~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  626 KRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHhcCcccCccHHHHHH
Confidence            99999999999999999999986

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-44  Score=317.73  Aligned_cols=253  Identities=33%  Similarity=0.537  Sum_probs=210.7

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeEEEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TKIYIVL   93 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~   93 (342)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|+|++++++++...  +..++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            788999999999999999999999999999997653 2233345678899999999999999999999887  8899999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++ +|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence            99975 888888765 5799999999999999999999999999999999999999999999999999875433221 11


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC----------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----------------  236 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----------------  236 (342)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.......                
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            2334567889999988765445689999999999999999999998877666555544311000                


Q ss_pred             ---------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          237 ---------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       237 ---------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                     ...++..+.+++.+||+.||.+||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                           01137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-43  Score=314.74  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=211.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|++.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            346899999999999999999998644     3789999986432  223345678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR----------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~  156 (342)
                      ...++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            9999999999999999998653          236788999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-C
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-F  234 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~  234 (342)
                      |||+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.......+.... .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999875332221112233446788999999876655 588999999999999998 999998888777766666443 3


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..+..++.++.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            445668899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.9e-43  Score=311.09  Aligned_cols=251  Identities=33%  Similarity=0.588  Sum_probs=210.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+...........+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999986544444444568889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           94 EFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||+++++|..++..    ...+++.++..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++......  
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~--  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence            99999999998864    345899999999999999999999999999999999999999999999999998743221  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc--HHHHHHHHHhcCCCC-CC-CCCHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN--LMALYKKIFKADFKS-PP-WFSTSAK  245 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~-~~-~~~~~~~  245 (342)
                      ........++..|+|||.+.+..+. .++|+|||||++|+|++|+.||....  .......+....... +. .++..+.
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR  238 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence            1122334678899999999876654 78999999999999999999996543  233333433333322 22 5778999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q 019360          246 KLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++|.+||..+|++|||+.++++
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.3e-44  Score=320.84  Aligned_cols=259  Identities=28%  Similarity=0.507  Sum_probs=210.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--   87 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--   87 (342)
                      .+..++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++|+||+++++++....  
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            3456889999999999999999999999999999999865332 2223346778999999999999999999986654  


Q ss_pred             --------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccc
Q 019360           88 --------KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDF  158 (342)
Q Consensus        88 --------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Df  158 (342)
                              .+++|+||+++ ++...+.+. ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    78999999976 676766654 46899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---
Q 019360          159 GLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---  235 (342)
Q Consensus       159 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---  235 (342)
                      |++........ .......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+......   
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99875433221 11122345778999999875544468899999999999999999999877655544443331100   


Q ss_pred             ---------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 ---------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 ---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                                 ....++..+.+++.+||+.||.+||+++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                       112367899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.3e-44  Score=318.41  Aligned_cols=253  Identities=20%  Similarity=0.320  Sum_probs=212.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ..+|++.+.||.|+||.||+|.+..+     ++.||+|++....  .....+.+.+|+.++..++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            45789999999999999999987543     5789999986432  2334467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 019360           88 KIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG  151 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~  151 (342)
                      ..++++||+++++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            999999999999999988532                2478888999999999999999999999999999999999999


Q ss_pred             CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 019360          152 VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIF  230 (342)
Q Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~  230 (342)
                      .+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.+....+....+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999875432222222223345778999999876665 488999999999999998 899999888888877777


Q ss_pred             hcCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          231 KADFK-SPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       231 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..... .+..++..+.+|+..||+.+|.+||++++++..
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            66543 356688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.4e-44  Score=320.79  Aligned_cols=256  Identities=29%  Similarity=0.512  Sum_probs=214.8

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .-|.....||.|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.+.|+||+++++++..++..|+|+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            345566789999999999999999999999999864322   22356789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      ||+++++|..++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......  ....
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~  174 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKR  174 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccc
Confidence            99999999887754 56899999999999999999999999999999999999999999999999988643221  1122


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISR  250 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~  250 (342)
                      ....++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+....   ......++..+.++|.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            34568899999999987665 489999999999999999999998776655555443322   12234578899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          251 ILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ||+.+|++||+++++++||||.+...
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhccCCC
Confidence            99999999999999999999987544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-43  Score=324.76  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=210.5

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC----
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK----   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----   86 (342)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ......+.+.+|+.++++++|+||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   92 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence            34589999999999999999999999999999999986532 2222345678899999999999999999988543    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           87 --TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        87 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                        ...|++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence              3478888887 7799887765 46899999999999999999999999999999999999999999999999998753


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC----------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF----------  234 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~----------  234 (342)
                      ..     ......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+.....          
T Consensus       171 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         171 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             cc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            22     123356788999999987644345889999999999999999999987665444333322110          


Q ss_pred             -------------CC--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          235 -------------KS--------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       235 -------------~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                   ..        ....++++.++|.+||+.||.+||++.++++||||++...+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                         00        11247789999999999999999999999999999975554

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-43  Score=318.92  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=213.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.|...+.||.|+||+||+|.+..+++.+++|++.............+.+|+.+++.++|+|++++++++......|+||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            34777889999999999999999999999999987544444445567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+.+ ++.+.+.. ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....      .
T Consensus       101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~  173 (313)
T cd06633         101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P  173 (313)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence            99965 77776654 4568999999999999999999999999999999999999999999999999876321      1


Q ss_pred             eecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAKKLI  248 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li  248 (342)
                      .....|+..|+|||.+..  ....+.++|||||||++|+|++|..||...+.......+.....+.  ...++..+.+|+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            223567889999999852  2223578999999999999999999998877666555554433322  234678899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||+.+|.+||++.+++.||||+..
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         254 DYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-43  Score=318.09  Aligned_cols=253  Identities=20%  Similarity=0.287  Sum_probs=209.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCC----------------cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETG----------------ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN   75 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   75 (342)
                      ..++|++++.||+|+||.||+|.+...+                ..||+|.+.....  ....+.+.+|++++++++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3568999999999999999999876543                5589999865432  234567889999999999999


Q ss_pred             ceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCc
Q 019360           76 VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-----------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPEN  144 (342)
Q Consensus        76 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~N  144 (342)
                      |+++++++..++..+++||++++++|.+++....           .+++..++.++.|++.||+|||++|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999899999999999999999997755           68999999999999999999999999999999999


Q ss_pred             EEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh--CCCCCCCCcH
Q 019360          145 LLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA--GYLPFEESNL  222 (342)
Q Consensus       145 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~pf~~~~~  222 (342)
                      |+++.++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++  |..||...+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999875332222222233456778999999877555 589999999999999998  7889987766


Q ss_pred             HHHHHHHHhc--------CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          223 MALYKKIFKA--------DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       223 ~~~~~~i~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ...+..+...        ....+..++.++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            6655554332        12234456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=331.74  Aligned_cols=249  Identities=29%  Similarity=0.467  Sum_probs=213.7

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCc---E-EEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGE---N-VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      -.+.++||+|+||.||+|..+..+.   . ||+|...............+.+|+++|++++|+||++++|+......+|+
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3456899999999999999875432   3 89999875444556677899999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+|+||+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++........
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~  318 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK  318 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence            999999999999999876 4999999999999999999999999999999999999999999999999999854321111


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCC--CCCCCCHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK--SPPWFSTSAKKL  247 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~l  247 (342)
                      .  ....-+..|+|||.+....+ +.++|||||||++||+++ |..||.+....+....+....++  .+...+.++..+
T Consensus       319 ~--~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~  395 (474)
T KOG0194|consen  319 K--FLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV  395 (474)
T ss_pred             c--ccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence            1  01124578999999998755 599999999999999998 89999999999999999665443  345677889999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+|+..||++||++.++.+
T Consensus       396 ~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  396 MKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHhccCChhhccCHHHHHH
Confidence            99999999999999999875

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-44  Score=322.01  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=206.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC------
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK------   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------   86 (342)
                      .++|++.+.||.|++|.||+|.++.+++.+|+|++...... ......+.+|+.+++.++|+||+++++++...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            78999999999999999999999999999999998653322 22223567899999999999999999887443      


Q ss_pred             --CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           87 --TKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        87 --~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                        ..+++||||+.+ +|...+.. ...+++..+..++.|+++||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              347999999965 67666654 45799999999999999999999999999999999999999999999999999875


Q ss_pred             CccccCC---------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          164 PQQVRDD---------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       164 ~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      .......         .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            3322111         1112335678899999987654445889999999999999999999988777665554432111


Q ss_pred             CC------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 KS------------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ~~------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ..                              ...+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            00                              01244678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-43  Score=316.77  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=210.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|.+.+.||+|+||.||+|.+.     .++..+++|.+....   ....+.+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            3567999999999999999999864     345669999886433   23335688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                      +..++||||+++++|.+++..+.                .+++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997542                37899999999999999999999999999999999999999


Q ss_pred             CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 019360          151 GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI  229 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i  229 (342)
                      +.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999874332211112223446788999999987665 478999999999999998 99999888777777666


Q ss_pred             HhcCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          230 FKADFK-SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       230 ~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ...... .+..++..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            655443 34457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=330.24  Aligned_cols=247  Identities=31%  Similarity=0.609  Sum_probs=214.9

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      .+.||+|.||+||-|+++.+|+.||||++.+......+ ...+.+|+.+|+++.||+||.+...|+..+.+++|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            47899999999999999999999999999886655433 36899999999999999999999999999999999999965


Q ss_pred             CchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcccccccCCccccCCCce
Q 019360           99 GELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        99 ~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                       ++.+.+-+  .+++++...+.++.||+.||+|||-++|+|+||||+|||+..   -..+||||||.+++..   ..+..
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---EksFR  723 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKSFR  723 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---hhhhh
Confidence             66665543  478999999999999999999999999999999999999954   3489999999999754   45566


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC----CCCCCHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----PPWFSTSAKKLIS  249 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~  249 (342)
                      .+..|||.|+|||++..++|+ .+.|+||+||++|.-++|..||...  +++...|.+..+..    ...+++++.|||.
T Consensus       724 rsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             hhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence            778999999999999999997 8899999999999999999999654  33444455544433    3458999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccccc
Q 019360          250 RILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+|+..-.+|.|++..|.|||+++
T Consensus       801 ~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHHHHHHHHhcchHhhccchhhhc
Confidence            999999999999999999999985

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.1e-43  Score=314.86  Aligned_cols=255  Identities=24%  Similarity=0.409  Sum_probs=203.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHH-HhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+....... . ...+..|+.. ++.+.|+||+++++++...+..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47999999999999999999999999999999987543221 1 2344456554 6777899999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           93 LEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      |||++ ++|.+++..    ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99996 578777654    34689999999999999999999997 9999999999999999999999999998753221


Q ss_pred             cCCCceecccCCcccCChhhhccC---CCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC-CCC-CCCCC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNK---GYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKAD-FKS-PPWFS  241 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~-~~~-~~~~~  241 (342)
                         .......++..|+|||.+.+.   ...+.++|+|||||++|+|++|+.||.... ..+....+.... ... ...++
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd06617         158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS  234 (283)
T ss_pred             ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence               112234578899999988642   122578999999999999999999996532 222233333322 222 23478


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .++.++|.+||+.+|.+||+++++++||||...
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            999999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-44  Score=326.43  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe-
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS-   85 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-   85 (342)
                      .++|++.+.||.|+||.||+|.+..     +++.||+|++.....  ....+.+.+|+.+++++ +|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3589999999999999999997543     457899999864322  22345678899999999 79999999998764 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR---------------------------------------------------------  108 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  108 (342)
                      +..++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45788999999999999888542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCC
Q 019360          109 ----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA  184 (342)
Q Consensus       109 ----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  184 (342)
                          ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++................++..|+|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                2578899999999999999999999999999999999999999999999999875432111111223345678999


Q ss_pred             hhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc--CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 019360          185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA--DFKSPPWFSTSAKKLISRILDPNPVTRIT  261 (342)
Q Consensus       185 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps  261 (342)
                      ||++.+..+. .++|||||||++|+|++ |..||.+....+........  ....+...++++.+++.+||+.+|++||+
T Consensus       244 PE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         244 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             cHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            9999877664 88999999999999998 99999875443333333222  22234457889999999999999999999


Q ss_pred             HHHHhcC
Q 019360          262 MAEVIEN  268 (342)
Q Consensus       262 ~~e~l~h  268 (342)
                      ++|+++|
T Consensus       323 ~~ell~~  329 (337)
T cd05054         323 FSELVEI  329 (337)
T ss_pred             HHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-43  Score=310.35  Aligned_cols=248  Identities=26%  Similarity=0.447  Sum_probs=208.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..+|++.+.||+|+||.||++..+ .+..+|+|.+......    .+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            357999999999999999999875 4568999987643322    24678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|.+++... +.+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.++....... .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence            9999999999998753 5689999999999999999999999999999999999999999999999998874322111 1


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~  249 (342)
                      ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...+..+....+...... .+...+..+.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             ccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            1112234568999999987665 488999999999999999 99999988887777777665432 34457888999999


Q ss_pred             HhcCCCCCCCCCHHHHhc
Q 019360          250 RILDPNPVTRITMAEVIE  267 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~  267 (342)
                      +||+.||.+||+++++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5e-43  Score=306.17  Aligned_cols=249  Identities=35%  Similarity=0.587  Sum_probs=213.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|++.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+..++.++|+|++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            48899999999999999999998999999999975432   344678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |+++++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+........   .
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999998876 5799999999999999999999999999999999999999999999999999875433211   2


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---CCCCCCHHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---SPPWFSTSAKKLISR  250 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~  250 (342)
                      ....++..|+|||.+.+... +.++|+||||+++|+|++|..||...+..............   ....++..+.++|.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            34567889999999986654 58899999999999999999999887554444443332221   122347899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcc
Q 019360          251 ILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~  270 (342)
                      ||+.||++|||+.++++|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-44  Score=315.66  Aligned_cols=248  Identities=29%  Similarity=0.506  Sum_probs=203.1

Q ss_pred             eeeeeecccCceEEEEEEEc----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           17 ELGRTLGEGSFAKVKFARNT----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...  ......+.+.+|++.+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            56889999999999999987    44577999999542  2333467889999999999999999999999988889999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +||+++++|.+++...  ..+++..+..|+.|++.||.|||+++++|++|+++||+++.++.+||+|||++.........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999986  67999999999999999999999999999999999999999999999999998754211111


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li  248 (342)
                      .......+...|+|||.+....+ +.++||||||+++||+++ |+.||...+..+....+..... ..+..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            11223346778999999987665 589999999999999999 7899998888887777755443 34556899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..||..||++|||+.++++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-43  Score=319.17  Aligned_cols=254  Identities=24%  Similarity=0.445  Sum_probs=209.1

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcC-------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTE-------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVM   83 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~   83 (342)
                      ..++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+ +|+||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34789999999999999999998643       23569999987532  233345788899999999 799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL  147 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli  147 (342)
                      ...+..|+||||+++++|.+++..+.                .+++.++..++.|++.||+|||+.|++||||||+||++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997642                47889999999999999999999999999999999999


Q ss_pred             cCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHH
Q 019360          148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALY  226 (342)
Q Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~  226 (342)
                      +.++.++|+|||.++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+..
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            9999999999999875432111111112234568999999987655 488999999999999998 89999887776666


Q ss_pred             HHHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          227 KKIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       227 ~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+..... ..+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            66554432 3455678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-43  Score=329.65  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=204.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMA   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~   84 (342)
                      ...++|++++.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3456889999999999999999987433     3469999986532  2333467889999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc--------------------------------------------------------
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR--------------------------------------------------------  108 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------  108 (342)
                      ..+.+|+|||||++|+|.+++...                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999887542                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360          109 ----------------------------------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus       109 ----------------------------------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                                                              ..+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367788899999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||..........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999875332211112223346778999999987665 489999999999999997 999998754433333


Q ss_pred             HHHhcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          228 KIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       228 ~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ......  ...+..++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333322  3334568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.7e-43  Score=315.44  Aligned_cols=259  Identities=31%  Similarity=0.569  Sum_probs=216.4

Q ss_pred             CeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeE
Q 019360           15 KYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~   89 (342)
                      .|++.+.||.|+||.||.|.+.   .+|+.||+|++...... .....+.+.+|+++++.+ .|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   47899999998654322 223345778899999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  244 (342)
                      ........|+..|+|||.+.... ..+.++||||||+++|+|++|..||...    ........+.....+.+..+++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA  239 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence            11223456889999999986532 2357899999999999999999999643    334444555555555666788999


Q ss_pred             HHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRI-----TMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~~  274 (342)
                      .+++.+||+.||++||     ++++++.||||+..
T Consensus       240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            9999999999999997     89999999999763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-43  Score=313.51  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=204.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCc--EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC------C
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK------T   87 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~   87 (342)
                      |.+.+.||+|+||.||+|++..++.  .+|+|.+.... ......+.+.+|+.+++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578899999999999999987765  69999886532 2334456788999999999999999999976422      2


Q ss_pred             eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           88 KIYIVLEFVTGGELFDKIAS------RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      ..+++|||+++++|..++..      ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            46899999999999888742      234789999999999999999999999999999999999999999999999998


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCC
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPW  239 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~  239 (342)
                      +...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.........+..... ..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            75432111111122345678999999987665 489999999999999999 8999988777777666665433 44566


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++..+.++|.+||+.||++|||+++++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.1e-43  Score=314.50  Aligned_cols=257  Identities=30%  Similarity=0.512  Sum_probs=219.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....+.|++.+.||.|++|.||+|.+..+++.+++|++.....    ....+.+|++.++.++|+|++++++.+...+..
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            3456679999999999999999999998899999999965432    345678999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999999999876 89999999999999999999999999999999999999999999999999876432211


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---CCCCCCHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---SPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~  245 (342)
                        .......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+......   ....++.++.
T Consensus       171 --~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         171 --SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             --hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence              11233457889999999887665 48899999999999999999999887766555554433322   2233788999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++|.+||+.+|.+|||+.++++|+||..
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            9999999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.8e-43  Score=321.51  Aligned_cols=261  Identities=29%  Similarity=0.441  Sum_probs=209.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCC--CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe----CC
Q 019360           15 KYELGRTLGEGSFAKVKFARNTET--GENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS----KT   87 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----~~   87 (342)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+.... ......+.+.+|+.+++++ +|+||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  8999999986432 2222345677899999999 49999999987532    24


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|++++++. ++|...+.....+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5789999985 689999988888999999999999999999999999999999999999999999999999998743321


Q ss_pred             cC--CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC------------
Q 019360          168 RD--DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD------------  233 (342)
Q Consensus       168 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~------------  233 (342)
                      ..  ........|++.|+|||.+.+....+.++||||+||++|++++|..||...+.......+....            
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            11  1112335689999999988664334588999999999999999999998766444333222110            


Q ss_pred             -------------C------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          234 -------------F------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       234 -------------~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                   .      ...+..+..+.+|+.+||+.||++|||+.+++.|||++++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                         0      0112357889999999999999999999999999999876654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.5e-43  Score=318.15  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=214.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|+..+.||+|+||.||+|.+..++..+|+|++.............+.+|+++++.++|+|++++++++......++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            48899999999999999999999999999999875444444455678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |++| +|.+.+.. ...+++.++..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++.....      .
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~  178 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A  178 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence            9975 77776654 45689999999999999999999999999999999999999999999999998864321      2


Q ss_pred             ecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAKKLIS  249 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~  249 (342)
                      ....+++.|+|||.+..  ....+.++|||||||++|+|++|+.||...+.......+.......  ...+++.+.+++.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  258 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  258 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence            23467889999999742  2223578999999999999999999998877666666655544332  3347888999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +||+.+|.+||++.++++|+|+...
T Consensus       259 ~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         259 SCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HHccCCcccCcCHHHHHhChhhhcc
Confidence            9999999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-43  Score=312.35  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=206.4

Q ss_pred             eeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe----
Q 019360           16 YELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK----   88 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----   88 (342)
                      |++.+.||+|+||.||.|.+..+   +..||+|.+..... .......+.+|+..++.++|+||+++++++...+.    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67899999999999999987654   47899999865332 23345678899999999999999999998765443    


Q ss_pred             --EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           89 --IYIVLEFVTGGELFDKIASR------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        89 --~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                        .++++||+++++|..++...      ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888542      3589999999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPP  238 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~  238 (342)
                      ++...............++..|+|||.+.+..+ +.++|||||||++|||++ |..||.+.+..+....+.... ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            875432211111122334678999999876555 489999999999999999 999998887777766665543 33456


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .++.++.+++.+||+.||++|||+.+++.+
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.3e-43  Score=309.99  Aligned_cols=249  Identities=22%  Similarity=0.391  Sum_probs=208.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|+++++||+|++|.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            3568999999999999999999875 567899998764322    23578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +|||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999998753  5588999999999999999999999999999999999999999999999999975432111


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                       .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+.... .+....++.++.++
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence             11122335678999999877655 478999999999999998 999998877777666665432 23344578999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+||..||++||+++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.1e-43  Score=308.86  Aligned_cols=251  Identities=29%  Similarity=0.507  Sum_probs=218.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      +|++.+.||.|++|.||++.++.+++.+|+|.+...... ......+.+|+.+++.++|+||+++++++......|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            589999999999999999999999999999998754432 2334577889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           95 FVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        95 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |+++++|..++..    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999998866    356899999999999999999999999999999999999999999999999998754332   


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLIS  249 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~  249 (342)
                       ......+++.|+|||.+.+..+ +.++|+||||+++|++++|+.||...+.......+....++ .+..++.++.+++.
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence             2233457889999999987665 47899999999999999999999988877776666665543 33457889999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccc
Q 019360          250 RILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +||+.+|++||++.++++||++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-43  Score=316.51  Aligned_cols=256  Identities=29%  Similarity=0.486  Sum_probs=214.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      |+...+||+|+||.||++..+.+++.||+|++....   ......+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            444578999999999999999999999999985322   23345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceec
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT  175 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (342)
                      +++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+......  ......
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~  175 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKS  175 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccc
Confidence            999999987754 46899999999999999999999999999999999999999999999999987643221  112233


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHHHHHHHhc
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~L  252 (342)
                      ..+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.+.......+....   ......++..+.+++.+||
T Consensus       176 ~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         176 LVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             cccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            567889999999876554 488999999999999999999998876665544443222   2223457889999999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          253 DPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                      +.||.+||++.++++||||.+...+.
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccCCCc
Confidence            99999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.9e-43  Score=312.74  Aligned_cols=252  Identities=22%  Similarity=0.353  Sum_probs=207.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGE----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...+|++.+.||.|+||+||+|.+..+++    .||+|++....  .....+.+.+|+.+++.++|+||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            45689999999999999999999877776    48999986432  233346788999999999999999999998754 


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++++||+++|+|.+.+..+ +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            578999999999999999764 5689999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  244 (342)
                      ...........++..|+|||.+.+..+ +.++|||||||++|||++ |..||...........+.... .+.+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence            211111112234678999999987665 488999999999999998 999998776666555554432 33455688999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+++.+||+.||++||++.+++.
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-43  Score=310.27  Aligned_cols=248  Identities=24%  Similarity=0.442  Sum_probs=206.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++.+....    ...+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            46899999999999999999886 4678999998643322    235678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+++++|.+++..+ ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++...... ...
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTS  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccc
Confidence            999999999998764 468999999999999999999999999999999999999999999999999987432211 001


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~  250 (342)
                      .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||...+..+....+... ....+..++.++.+++.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            111123457999999987665 478999999999999998 89999887777766666544 234455689999999999


Q ss_pred             hcCCCCCCCCCHHHHhcC
Q 019360          251 ILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h  268 (342)
                      ||..+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-43  Score=311.85  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=211.1

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ...|++.+.||.|+||.||+|.++. ++.+|+|++.....   ...+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4579999999999999999999987 89999999865432   2245688999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+.......  
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--  158 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--  158 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence            9999999999999753  458999999999999999999999999999999999999999999999999987543211  


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                      .......++..|+|||.+....+ +.++||||||+++|+|++ |+.||...+..+....+... ..+.+..+++.+.+++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence            11123345678999999877655 488999999999999998 89999888777776666543 2344567889999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.||.+|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         238 LECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-43  Score=309.07  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=207.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++...+..|++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            357999999999999999999975 457899999865332    134678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++....  .+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999999997654  6899999999999999999999999999999999999999999999999998754321111


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                       .......+..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+.... ...+..++..+.+++
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence             1111222457999999876655 488999999999999999 999998887777666665432 234456789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.||++||++.+++.
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.5e-43  Score=317.62  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=213.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ...+|+..+.||.|+||.||+|+++.+++.+|+|.+............++.+|+++++.++|+|++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            44568889999999999999999999999999999865333334445678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||+. +++...+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....    
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----  167 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence            999996 477776654 45689999999999999999999999999999999999999999999999998864321    


Q ss_pred             CceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAKK  246 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~  246 (342)
                        .....+++.|+|||.+.+  ....+.++|||||||++|+|++|..||...+.......+.....+.  ...++..+.+
T Consensus       168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence              123457889999999753  2223578999999999999999999998766555555444443322  3357889999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ||++||+.+|++||+++++++|||+...
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-43  Score=322.79  Aligned_cols=255  Identities=29%  Similarity=0.441  Sum_probs=208.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-----   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----   86 (342)
                      ..++|.+.+.||.|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.+++.++|+||+++++++...     
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            4579999999999999999999999999999999986532 2223345678999999999999999999998654     


Q ss_pred             -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 -TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                       ..+|+|+||+.. +|..+.  ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++...
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             CceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence             346999999954 676654  2458999999999999999999999999999999999999999999999999987532


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-----------
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-----------  234 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-----------  234 (342)
                      .     ......++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.....           
T Consensus       169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            2     122345788999999987644445889999999999999999999988776555444332100           


Q ss_pred             --------------CC------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          235 --------------KS------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       235 --------------~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                    ..      .+..+.++.+||.+||+.||++||++++++.||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                          00      123677899999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.6e-43  Score=345.76  Aligned_cols=150  Identities=30%  Similarity=0.645  Sum_probs=140.1

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|+++++||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            67999999999999999999999999999999999765555555567888999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      |||+.|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999887889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5e-43  Score=308.24  Aligned_cols=249  Identities=23%  Similarity=0.394  Sum_probs=207.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||.|.+.. +..+|+|.+......    ...+.+|+.+++.++||||+++++++...+..++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            4579999999999999999998753 456999988643321    24678999999999999999999999988889999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||.++....... .
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            9999999999998764 4689999999999999999999999999999999999999999999999998874322111 0


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~  249 (342)
                      ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+...... .+...+..+.+++.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            1112234567999999986655 478999999999999998 99999887777666666654333 34457889999999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q 019360          250 RILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h  268 (342)
                      +||+.||.+||++.+++.+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4e-43  Score=315.56  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=206.8

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCc--EEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~   90 (342)
                      ++|++.+.||.|+||.||+|.++.++.  .+++|.+...  ......+.+.+|+.++.++ +||||+++++++...+..|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            579999999999999999999987765  4688877532  1223345788999999999 6999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           91 IVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      +++||+++++|.+++.+..                .+++..+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999987532                478899999999999999999999999999999999999999999


Q ss_pred             EcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC
Q 019360          155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD  233 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~  233 (342)
                      |+|||++........   ......+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+....
T Consensus       160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             ECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            999999863221111   111223457999999877665 489999999999999997 999999888777777665543


Q ss_pred             -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          234 -FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       234 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ...+..++.++.+|+.+||+.||.+|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             23445688999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=330.08  Aligned_cols=260  Identities=33%  Similarity=0.613  Sum_probs=240.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ......++++..||-|+||.|-++........+|+|++++..+.+....+++..|-++|..+..+.||++|..|.+...+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            34456778899999999999999998776667999999988888888888999999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |++||-|-||.|...+..++.+++...+.++..+++|+.|||++|||+|||||+|.+++.+|-+||.|||.++..   ..
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki---~~  572 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI---GS  572 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh---cc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999854   34


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~l  247 (342)
                      ....++.||||.|.|||++.+++.+ .++|.||||+++|||++|.+||.+.+++..++.|+++.  +.+|..++..+.+|
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence            5667889999999999999998887 89999999999999999999999999999999999874  45678899999999


Q ss_pred             HHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          248 ISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      |+++...+|.+|..     +.++-.|.||..
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            99999999999986     899999999964

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.7e-43  Score=316.20  Aligned_cols=252  Identities=25%  Similarity=0.458  Sum_probs=207.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-------ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      .++|.+.+.||+|+||.||+|.+.       .....+|+|.+....  .......+.+|+.+++.+ .|+||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            468999999999999999999863       234579999986432  233356788999999999 5999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                      ..+.+|++|||+++++|.+++...                ..+++.++..++.|++.||.|||++|++||||||+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            889999999999999999999753                2478889999999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999975432211111122234567999999987655 488999999999999999 899998887777776


Q ss_pred             HHHhcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          228 KIFKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       228 ~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+.... ...+..++.++.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            665543 2345567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-43  Score=311.03  Aligned_cols=252  Identities=19%  Similarity=0.328  Sum_probs=205.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ..++|++.+.||.|+||+||+|.+..+++.    +++|.+...  ........+..|+..++.++|+||+++++++. ..
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence            457899999999999999999999877764    677776432  12233457778888999999999999999875 45


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++++||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            578999999999999999764 5689999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~  244 (342)
                      ...........++..|+|||.+.+..+ +.++|||||||++||+++ |..||.+.........+..... ..+..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            221112223456778999999987665 489999999999999998 9999988776655444444333 2344567889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+++.+|+..||++|||+.|+++
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.5e-43  Score=312.57  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=208.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ..+|+..++||+|+||.||++...     .++..+|+|.+....   ....+.+.+|+++++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            357889999999999999999753     346789999876432   334467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC
Q 019360           88 KIYIVLEFVTGGELFDKIASRG---------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV  152 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~  152 (342)
                      ..+++|||+++++|.+++....               .+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            9999999999999999987643               4788999999999999999999999999999999999999999


Q ss_pred             eeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 019360          153 LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFK  231 (342)
Q Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  231 (342)
                      ++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            99999999864322111111122334678999999987665 488999999999999998 9999987776666666555


Q ss_pred             cC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          232 AD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       232 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .. ...+..+++.+.+|+.+||+.||++||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            43 3345568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-43  Score=322.04  Aligned_cols=255  Identities=20%  Similarity=0.374  Sum_probs=202.3

Q ss_pred             eeeeccc--CceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEecc
Q 019360           19 GRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        19 ~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      ...||.|  +||+||++.+..+|+.||+|++...... ....+.+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            3456666  9999999999999999999998754322 234578899999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC---
Q 019360           97 TGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG---  171 (342)
Q Consensus        97 ~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---  171 (342)
                      .+++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+..........   
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999999988764  348999999999999999999999999999999999999999999999998653221111000   


Q ss_pred             --ceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--------------
Q 019360          172 --LLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--------------  234 (342)
Q Consensus       172 --~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--------------  234 (342)
                        ......++..|+|||++.+.. ..+.++|||||||++|+|++|..||.................              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence              001123456799999987532 235889999999999999999999987654443333222110              


Q ss_pred             ---------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          235 ---------------------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       235 ---------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                                       +....+++.+.+|+++||+.||++|||++|+|+||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                             0112256779999999999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6e-43  Score=307.81  Aligned_cols=245  Identities=23%  Similarity=0.334  Sum_probs=203.3

Q ss_pred             eeecccCceEEEEEEE--cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARN--TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      +.||+|+||.||+|.+  +.++..+|+|++.... ......+.+.+|+.+++.+.|+||+++++++. .+..++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            3689999999999965  4567899999986432 23344567889999999999999999999885 456789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC-Cceecc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTT  176 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  176 (342)
                      +++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......... ......
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            9999999988788999999999999999999999999999999999999999999999999998754322111 011122


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhcCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~  254 (342)
                      .++..|+|||.+....+ +.++|+|||||++|||++ |..||...+.......+..... ..+..+++++.++|.+||+.
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence            34578999999876554 478999999999999998 9999988877777776665433 44566899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 019360          255 NPVTRITMAEVIE  267 (342)
Q Consensus       255 dP~~Rps~~e~l~  267 (342)
                      ||++||+++++..
T Consensus       238 ~p~~Rp~~~~i~~  250 (257)
T cd05116         238 GVDERPGFAVVEL  250 (257)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.8e-43  Score=314.82  Aligned_cols=254  Identities=22%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      ...++|++.+.||.|+||.||++.+.     .++..+|+|.+.....  ....+.+.+|+.+++++ +|+||+++++++.
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            44568999999999999999999752     3456899999865322  23346788999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ..+..|++|||+++++|.+++....  .+++.++..++.|++.||.|||++||+|+||||+||+++.++.++++|||+++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999999987543  38999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC--CCCCC
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF--KSPPW  239 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~  239 (342)
                      ...............++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.................  ..+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            4432211111122345678999999987665 488999999999999998 9999987665554444443322  23445


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .++++.+++.+||+.+|++|||+.++++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-43  Score=314.99  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=203.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC--------------CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCccee
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET--------------GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR   78 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   78 (342)
                      .++|++.+.||+|+||.||++.+...              ...||+|.+....  .....+.+.+|++++++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            36899999999999999999987543              2358999986532  2334457889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019360           79 MYEVMASKTKIYIVLEFVTGGELFDKIASRG------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLL  146 (342)
Q Consensus        79 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIl  146 (342)
                      +++++...+..++||||+++++|.+++....            .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886532            3678899999999999999999999999999999999


Q ss_pred             ecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh--CCCCCCCCcHHH
Q 019360          147 LDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA--GYLPFEESNLMA  224 (342)
Q Consensus       147 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~pf~~~~~~~  224 (342)
                      ++.++.+||+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++  |..||...+..+
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999874322111111122334678999999877665 589999999999999988  678888766655


Q ss_pred             HHHHHHh--------cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          225 LYKKIFK--------ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       225 ~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ....+..        .....++.+++.+.+|+.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5444322        112234457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.6e-43  Score=315.20  Aligned_cols=254  Identities=23%  Similarity=0.358  Sum_probs=204.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +.|+..+.||+|+||.||++.+..+++.+|+|.+......  .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            4677889999999999999999999999999998754322  33457889999999996 99999999999988899999


Q ss_pred             EeccCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           93 LEFVTGGELFDKI---A--SRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        93 ~e~~~~~~L~~~l---~--~~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      |||+.+ ++.++.   .  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999854 554432   2  235689999999999999999999974 999999999999999999999999999864322


Q ss_pred             ccCCCceecccCCcccCChhhhccC--CCCCcccchhhhhHHHHHHHhCCCCCCCCcH-HHHHHHHHhcCCCC-----CC
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNK--GYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKS-----PP  238 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~-----~~  238 (342)
                         ........|+..|+|||.+.+.  ...+.++|||||||++|+|++|+.||..... .+....+.....+.     +.
T Consensus       161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence               1112334678899999999765  2345889999999999999999999976542 12222222222111     12


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .++.++.+|+.+||+.||++|||+++++.||||+.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            37889999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-43  Score=338.50  Aligned_cols=260  Identities=22%  Similarity=0.366  Sum_probs=194.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCC-cEEEEE--------------EecchhhhhhhHHHHHHHHHHHHhcCCCCcc
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETG-ENVAIK--------------ILDKEKVLKHKMIGQIKREISTMKLIRHPNV   76 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   76 (342)
                      ..++|++++.||+|+||.||++..+... ...+.|              .+.+...........+.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998765332 222222              1111111122334568899999999999999


Q ss_pred             eeEEEEEEeCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 019360           77 IRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG  151 (342)
Q Consensus        77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~  151 (342)
                      +++++++...+..|+|++++. ++|..++...     ......++..++.|++.||.|||++||+||||||+|||++.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999995 4777766432     2244667889999999999999999999999999999999999


Q ss_pred             CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCC-CCCC--cHHHHHHH
Q 019360          152 VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLP-FEES--NLMALYKK  228 (342)
Q Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~p-f~~~--~~~~~~~~  228 (342)
                      .+||+|||+++...... ........||..|+|||++.+..+. .++|||||||++|||++|..+ +...  ........
T Consensus       305 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        305 KIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999997543211 1122345789999999999887664 889999999999999998754 4322  11122111


Q ss_pred             HHhc------CCCC--------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          229 IFKA------DFKS--------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       229 i~~~------~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +...      .++.                          ...++.++.++|.+||+.||++|||+.|+|+||||...
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1110      0000                          01245678889999999999999999999999999764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-42  Score=316.96  Aligned_cols=260  Identities=29%  Similarity=0.442  Sum_probs=211.0

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-KTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~   89 (342)
                      ...++|++.+.||.|+||.||+|.++.+++.||+|++.+.. ......+.+.+|+.+++.++||||+++.+++.. ....
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            35678999999999999999999999999999999886432 222334567889999999999999999999865 5678


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+++||+ +++|..++.. ..+++..+..++.|+++||+|||+.||+||||+|+||+++.++.++|+|||.+.....   
T Consensus        86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---  160 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---  160 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence            9999998 5688887764 4578889999999999999999999999999999999999999999999999874321   


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc-----------------
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA-----------------  232 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~-----------------  232 (342)
                        ......++..|+|||.+.+....+.++|+|||||++|+|++|+.||...........+.+.                 
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence              1233457889999998866344458999999999999999999999876543322211110                 


Q ss_pred             ---------CCC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          233 ---------DFK-----SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       233 ---------~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                               ...     ..+.++..+.++|.+||+.+|++|||+++++.||||.....++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence                     000     0124678999999999999999999999999999998766554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.2e-43  Score=312.78  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=206.4

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+.....  ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     235688888864322  23346788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019360           90 YIVLEFVTGGELFDKIASR------------------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENL  145 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NI  145 (342)
                      ++++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2478889999999999999999999999999999999


Q ss_pred             EecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHH
Q 019360          146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMA  224 (342)
Q Consensus       146 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~  224 (342)
                      +++.++.+||+|||+++...............++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999874322211111222345678999999876655 488999999999999998 999999888777


Q ss_pred             HHHHHHhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          225 LYKKIFKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..+.+... ....+..++.++.+++.+||+.||++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            66655443 23345568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-43  Score=314.44  Aligned_cols=257  Identities=24%  Similarity=0.439  Sum_probs=212.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNT-------ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMY   80 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~   80 (342)
                      .....++|++.+.||+|+||.||+|++.       ..+..+|+|.+....  .......+.+|+.+++.+ +|+||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            3455678999999999999999999753       234579999986432  233356788999999999 799999999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCc
Q 019360           81 EVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPEN  144 (342)
Q Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~N  144 (342)
                      +++......|+||||+++++|.+++...                ..++...+..++.|++.||.|||++|++||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9999999999999999999999998763                236788899999999999999999999999999999


Q ss_pred             EEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHH
Q 019360          145 LLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLM  223 (342)
Q Consensus       145 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~  223 (342)
                      |+++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|++++ |..||.+.+..
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999875433222212223345678999999987655 488999999999999998 88999888887


Q ss_pred             HHHHHHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          224 ALYKKIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       224 ~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +....+..... ..+..++.++.+|+.+||..+|.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            77776654432 3345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-42  Score=308.06  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=209.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .+.|++.+.||+|+||.||+|.++.+++   .||+|.+....  .....+.+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4579999999999999999999987765   59999986432  234456889999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||+++++|.+++... +.+++.++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998763 568999999999999999999999999999999999999999999999999987543221


Q ss_pred             CCCceeccc---CCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHH
Q 019360          169 DDGLLHTTC---GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTS  243 (342)
Q Consensus       169 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (342)
                      .........   .+..|+|||.+.+..+ +.++|||||||++||+++ |..||...+.......+... ..+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            111111111   2357999999987665 478999999999999886 99999887777666666433 23344567889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+++.+||+.+|.+||++++++.
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-43  Score=313.15  Aligned_cols=252  Identities=32%  Similarity=0.546  Sum_probs=211.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      |++.+.||+|++|.||+|.+..+++.+|+|++.... ......+.+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999997643 2233345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           96 VTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        96 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      ++ ++|.+++.+. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+.......  ....
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~  156 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT  156 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence            97 5899999876 579999999999999999999999999999999999999999999999999987543211  1222


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--------------------C
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--------------------F  234 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--------------------~  234 (342)
                      ...++..|+|||.+.+....+.++|+|||||++|++++|..||...+.......+....                    +
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            34457789999998766445688999999999999999999998877665554443210                    0


Q ss_pred             C---------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 K---------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +         ..+.++..+.++|.+||+.||++||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0         012347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=313.52  Aligned_cols=252  Identities=33%  Similarity=0.509  Sum_probs=210.4

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      |++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            6788999999999999999999999999999865432 223456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           96 VTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        96 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      +++ +|.+.+.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~  156 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT  156 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence            975 88877766 3578999999999999999999999999999999999999999999999999887543321  1122


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-------------------
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-------------------  235 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------------------  235 (342)
                      ...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+......                   
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            3457788999999877634468999999999999999999999887766555444321100                   


Q ss_pred             -----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 -----------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 -----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                 ..+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                       012357889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.9e-43  Score=312.15  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=209.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .++|++.+.||.|+||.||+|.+..     ++..+|+|++....  .......+.+|+.+++.+.|+||+++++++..+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            4679999999999999999998753     57889999986532  2233457889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019360           88 KIYIVLEFVTGGELFDKIASRG----------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENL  145 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NI  145 (342)
                      ..+++|||+++++|.+++....                      .+++..++.++.|++.||.|||++|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999987432                      367888999999999999999999999999999999


Q ss_pred             EecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHH
Q 019360          146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMA  224 (342)
Q Consensus       146 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~  224 (342)
                      +++.++.++|+|||.+.................+..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999864322211111122334667999999887665 489999999999999997 889998877777


Q ss_pred             HHHHHHhcCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          225 LYKKIFKADFK-SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       225 ~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ....+...... .+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77766655443 34567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=305.40  Aligned_cols=244  Identities=25%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             eeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEecc
Q 019360           20 RTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      ++||+|+||.||+|.+...+   ..+|+|.+......  ...+.+.+|+.+++.++|+||+++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876554   78999998754432  34467889999999999999999999876 45689999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC-ceec
Q 019360           97 TGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHT  175 (342)
Q Consensus        97 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~  175 (342)
                      ++++|.+++.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||+++......... ....
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            999999999887889999999999999999999999999999999999999999999999999987543211110 0111


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhcC
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~  253 (342)
                      ..++..|+|||.+.+..+ +.++|||||||++|++++ |..||...+..+....+..... ..+..++..+.+++.+||+
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            123467999999977665 489999999999999998 9999988877666666554432 3455688999999999999


Q ss_pred             CCCCCCCCHHHHhc
Q 019360          254 PNPVTRITMAEVIE  267 (342)
Q Consensus       254 ~dP~~Rps~~e~l~  267 (342)
                      .||++||++.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1e-42  Score=311.40  Aligned_cols=259  Identities=31%  Similarity=0.558  Sum_probs=215.0

Q ss_pred             CeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeE
Q 019360           15 KYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~   89 (342)
                      .|++.+.||.|++|.||++.+.   .+++.||+|++.+.... .....+.+.+|+.++.++ .|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   46788999998754332 233446788999999999 499999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ++||||+++++|...+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++...... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence            9999999999999999877789999999999999999999999999999999999999999999999999987533221 


Q ss_pred             CCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  244 (342)
                      ........|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...    ........+.......+..++..+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA  239 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence            11122346788999999986543 2347899999999999999999999643    233444555555566666789999


Q ss_pred             HHHHHHhcCCCCCCCCC---HHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRIT---MAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps---~~e~l~h~~~~~~  274 (342)
                      .+++.+||+.||++|||   +.++|+||||+..
T Consensus       240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            99999999999999998   5778999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-42  Score=307.39  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=204.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.++||+|+||.||+|.+..+ ..||+|.+......    .+.+.+|+.+++.++|+||+++++.+. ....++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence            46799999999999999999988655 46999998753321    246788999999999999999999875 4568999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.++....... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            9999999999999763  3578999999999999999999999999999999999999999999999999875432211 


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                      .......++..|+|||...+..+ +.++|||||||++|++++ |..||.+.........+.... ...+..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  236 (262)
T ss_pred             ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            11122345678999999876665 488999999999999999 899998877666666654432 333456889999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.||++||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=298.59  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=212.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~   89 (342)
                      +.++..+.+..||+|+.|+||+++.+.+|...|||.+.+..  +.+..+++...++++.... +|+||+.+|+|..+..+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            34455677889999999999999999999999999997643  3444567888888876655 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ++.||.| +.-+..++.. .++++|..+-.+...++.||.||.. +||+|||+||+|||+|..|++||||||++...-. 
T Consensus       167 ~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-  244 (391)
T KOG0983|consen  167 FICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-  244 (391)
T ss_pred             HHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec-
Confidence            9999998 4345555543 4679999999999999999999995 5899999999999999999999999999875322 


Q ss_pred             cCCCceecccCCcccCChhhhccC--CCCCcccchhhhhHHHHHHHhCCCCCCCC-cHHHHHHHHHhcCCCCC---CCCC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNK--GYDGAKADLWSCGVILYVLMAGYLPFEES-NLMALYKKIFKADFKSP---PWFS  241 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~---~~~~  241 (342)
                        ....+...|.+.|||||.+.-.  ..+...+||||||++++||.||+.||.+. ...+...++++...+..   ..+|
T Consensus       245 --SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  245 --SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             --ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence              2233456789999999998642  22247899999999999999999999884 56677778887655432   2389


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +++++|+..||.+|+.+||...++|+|||+..
T Consensus       323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             HHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence            99999999999999999999999999999874

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-42  Score=308.12  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=210.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGE----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ..++|++.+.||+|+||.||+|.++.+|+    .+|+|.......  ......+.+|+.+++.++|+||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            34689999999999999999999877665    589998765432  3344678899999999999999999999987 7


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            889999999999999998874 4689999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  244 (342)
                      ...........++..|+|||.+....+ +.++|+||||+++|++++ |..||.+....+....+.... .+.+...+.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            211111111223567999999876555 488999999999999998 999999888777777666543 34455678899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+++.+||..||++||++.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=310.19  Aligned_cols=250  Identities=30%  Similarity=0.474  Sum_probs=205.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC---CCCcceeEEEEEEeCCe----
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI---RHPNVIRMYEVMASKTK----   88 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~----   88 (342)
                      |++.+.||.|+||.||+|.++.+++.+|+|.+..... .......+.+|+.+++++   +|+|++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7899999999999999999998899999999964332 222233556777777655   59999999999987776    


Q ss_pred             -EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           89 -IYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 -~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                       ++++|||+++ +|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999975 8888887643  58999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----------
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----------  235 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------  235 (342)
                      ..   .......++..|+|||.+.+..+ +.++|+|||||++|+|++|.+||...+..+....+......          
T Consensus       159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            21   12223457889999999987665 48899999999999999999999988777666655432100          


Q ss_pred             --------C---------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 --------S---------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 --------~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                              .         .+.++..+.++|.+||+.||.+||++++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                    0         01245778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-42  Score=311.85  Aligned_cols=251  Identities=20%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcC----------------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTE----------------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI   77 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   77 (342)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|++....  .....+.+.+|+.+++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986432                34579999986432  233446788999999999999999


Q ss_pred             eEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019360           78 RMYEVMASKTKIYIVLEFVTGGELFDKIASRG-----------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLL  146 (342)
Q Consensus        78 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIl  146 (342)
                      ++++++...+..++||||+++++|.+++....           .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999987642           3667789999999999999999999999999999999


Q ss_pred             ecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh--CCCCCCCCcHHH
Q 019360          147 LDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA--GYLPFEESNLMA  224 (342)
Q Consensus       147 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~pf~~~~~~~  224 (342)
                      ++.++.++|+|||+++...............++..|+|||...+..+ +.++|||||||++|||++  |..||...+..+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999874322111111122234578999998876655 589999999999999998  789997766555


Q ss_pred             HHHHHHh--------cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          225 LYKKIFK--------ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       225 ~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .......        ...+.+..+++.+.+|+.+||+.||++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4433211        122334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-42  Score=317.50  Aligned_cols=254  Identities=24%  Similarity=0.442  Sum_probs=209.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC-------CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET-------GENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      ..+|++.+.||+|+||.||+|++...       +..+|+|.+....  .....+.+.+|+.+++++ +|+||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            34799999999999999999986432       2368999886432  233456788999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                      ..+..++++||+++++|.+++.+..                .++...+..++.|++.||.|||++|++||||||+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            9999999999999999999987532                367788999999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++.+||+|||+++...............++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999998754322111111222345679999999876654 78999999999999998 899999888777777


Q ss_pred             HHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          228 KIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       228 ~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      .+..... ..+..++.++.+|+.+||+.+|++|||+.+++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            6655433 34556788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-42  Score=303.96  Aligned_cols=243  Identities=27%  Similarity=0.502  Sum_probs=208.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+.|++.+.||.|++|.||+|...  |+.||+|.+.....    ..+++.+|+.+++.++|+||+++++++...+..++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            467999999999999999999874  78999999965432    346788999999999999999999999988999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999999998765  68999999999999999999999999999999999999999999999999987542211  


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                         .....+..|+|||.+....+ +.++||||||+++|++++ |..||...........+... ....+..+++++.++|
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence               12334567999999876555 478999999999999997 99999888777766655443 2233456789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.+|++|||+.++++
T Consensus       233 ~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         233 KDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHhccChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-43  Score=310.98  Aligned_cols=250  Identities=30%  Similarity=0.462  Sum_probs=206.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEEe
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      |++.+.||.|++|+||+|.+..+++.|++|.+......  .......+|+..+++++ |+|++++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            78899999999999999999989999999998653221  11223457999999999 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           95 FVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |+ +++|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......   ..
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence            99 779988887754  7899999999999999999999999999999999999999999999999998753321   12


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-----------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-----------------  235 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------  235 (342)
                      .....++..|+|||++......+.++|+||||+++++|++|+.||...+..+....+......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            233457889999999865544468999999999999999999999877655544433221000                 


Q ss_pred             -------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          236 -------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       236 -------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                                   ..+..+.++.++|.+||+.||++|||++|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                         011235789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-42  Score=305.99  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=208.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .++|++.+.||+|+||.||+|.++.++.   .+|+|.+....  .....+.+.+|+.++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4689999999999999999999875543   69999886432  223356788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+||||+++++|.+++... +.+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999765 468999999999999999999999999999999999999999999999999987543221


Q ss_pred             CCCc-eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          169 DDGL-LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      .... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||...+..+....+.... .+.+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            1110 111223567999999987665 489999999999999886 999998877666666655432 233445788999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q 019360          246 KLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-42  Score=305.84  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=204.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.++++++|+|++++++++. ....|++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            468999999999999999999875 5677999998654322    246789999999999999999999885 4568999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++...  ..+++..+..++.+++.||+|||+.|++||||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence            9999999999998763  3589999999999999999999999999999999999999999999999999875332111 


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                      .......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.+..+....+... ..+.+...+..+.+|+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM  236 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            11112234567999999876555 488999999999999999 99999887777766666543 2334556789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.||.+|||++++++
T Consensus       237 ~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHcccCcccCcCHHHHHH
Confidence            9999999999999999873

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=304.04  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=208.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||+|.+. +++.+|+|.+......    .+.+.+|+.+++.++|+||+++++++......++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            468999999999999999999975 5578999998754322    34678999999999999999999999988899999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++...  ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            9999999999999764  368999999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                      .......++..|+|||.+.+... +.++|+||||+++|++++ |+.||.+.+.......+... ....+...+.++.+++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11112234568999999986655 588999999999999998 99999888777777666554 2334555788999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.+|++||+++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHcccCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=359.30  Aligned_cols=263  Identities=31%  Similarity=0.535  Sum_probs=224.5

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...-||+...+||.|.||.||-|.+..+|+..|+|.+...... ......+.+|..++..++|||+|+++++-...+.++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3445788899999999999999999999999999998654433 556678899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc--c
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV--R  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~  168 (342)
                      +.||||++|+|.+.++..+..++.....+..|++.|++|||++|||||||||+||+++.+|.+|++|||.|......  .
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            99999999999999998777888888899999999999999999999999999999999999999999998754322  2


Q ss_pred             CCCceecccCCcccCChhhhccCCC--CCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHh-cCCCCCCCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGY--DGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFK-ADFKSPPWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~~~~  244 (342)
                      .........||+.|||||++.+...  .+-+.|||||||++.||+||+.||...+.. .+...+-. .....|..++++.
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence            2344566789999999999976432  246899999999999999999999875433 23333332 3455677799999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ++||..||+.||++|+++.|+++|.|-...
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            999999999999999999999999987654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-43  Score=336.84  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=213.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .-+..+.||+|+||.||+|+-..     ....||||.++...  +.+..++|++|++++..|+|||||+++|++..++.+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            45678899999999999998642     34569999986533  344567999999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeE
Q 019360           90 YIVLEFVTGGELFDKIASRG--------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV  155 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl  155 (342)
                      |+|+|||..|||.++|..+.              +++..+.+.|+.||+.|+.||-++.+|||||-+.|+||.++..|||
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence            99999999999999996432              2788899999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC
Q 019360          156 SDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      +|||+++-.-............-..+|||||.+....+. .++||||+||++||+++ |+.||.+.+..+.++.+..+..
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l  723 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL  723 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence            999999843322222222222336799999999887764 89999999999999998 9999999999999999988765


Q ss_pred             -CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 019360          235 -KSPPWFSTSAKKLISRILDPNPVTRITMAEVI  266 (342)
Q Consensus       235 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  266 (342)
                       +.|..++.++.+|+..||+.+|++||++.||-
T Consensus       724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence             45778999999999999999999999999985

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.3e-43  Score=307.28  Aligned_cols=253  Identities=30%  Similarity=0.541  Sum_probs=210.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh--hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL--KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ||.+.+.||+|+||.||++.+...+..+++|++......  .......+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            799999999999999999999887777777776542221  122234567899999999999999999999988899999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           93 LEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||+++++|..++..    ...+++.+++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~-  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS-  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence            999999999988753    356899999999999999999999999999999999999964 67999999988753221 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCCCCHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKL  247 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l  247 (342)
                       ........+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.....+. +..++.++.++
T Consensus       159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (260)
T cd08222         159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI  236 (260)
T ss_pred             -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence             1222344578899999998766654 78999999999999999999998877766666665544333 44578899999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCccc
Q 019360          248 ISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      |.+||..||++||++.++++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         237 MQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-44  Score=304.58  Aligned_cols=263  Identities=29%  Similarity=0.580  Sum_probs=239.3

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS   85 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~   85 (342)
                      ++.....+.|+++.+||+|+|+.|.+++.+.+.+.||+|+++++-+.+.+.+.-.+.|-.+..+. +||.+|.++.+|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            45666778999999999999999999999999999999999998888888888888898888766 59999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      +..+++|.||++||+|--.++++..++++.++.+...|..||.|||++||++||||.+|||++..|++||+|+|.++.  
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--  400 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--  400 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--
Confidence            999999999999999998898888999999999999999999999999999999999999999999999999999874  


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC--------CcHHHHHHHHHhcCCCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE--------SNLMALYKKIFKADFKSP  237 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~--------~~~~~~~~~i~~~~~~~~  237 (342)
                      .........+.||||.|.|||++.+..| +.++|.|+|||+++||+.|+.||+-        .+...+++-|+......|
T Consensus       401 ~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip  479 (593)
T KOG0695|consen  401 GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP  479 (593)
T ss_pred             CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence            2334556678999999999999998776 5999999999999999999999952        345667888899999999


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCcccc
Q 019360          238 PWFSTSAKKLISRILDPNPVTRIT------MAEVIENEWFK  272 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps------~~e~l~h~~~~  272 (342)
                      ..++-.+..+++..|++||.+|..      ++++-.|+||+
T Consensus       480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence            999999999999999999999974      68999999997

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-42  Score=303.35  Aligned_cols=247  Identities=26%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+++++.++|+|++++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            46799999999999999999988654 4699998764332    2246788999999999999999999885 4568899


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence            9999999999999764  347899999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                      .......++..|+|||...+... +.++||||||+++|+|++ |..||.+.........+.... ...+..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            11122335678999998876554 488999999999999999 999998877776666655432 233456789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++||+.||++||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-42  Score=302.78  Aligned_cols=244  Identities=27%  Similarity=0.442  Sum_probs=203.9

Q ss_pred             eeecccCceEEEEEEEcC-CCc--EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEecc
Q 019360           20 RTLGEGSFAKVKFARNTE-TGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      +.||+|++|.||+|.+.. .++  .+|+|.+......  ...+.+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 333  6999999765432  456788999999999999999999999988 8899999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC-Cce
Q 019360           97 TGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLL  173 (342)
Q Consensus        97 ~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~  173 (342)
                      ++++|.+++....  .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++......... ...
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999998754  6899999999999999999999999999999999999999999999999998754331111 111


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc--CCCCCCCCCHHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA--DFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~  250 (342)
                      ....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+...  ....+..++..+.+++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            12446778999999887665 478999999999999998 99999887777766665532  222344578899999999


Q ss_pred             hcCCCCCCCCCHHHHhc
Q 019360          251 ILDPNPVTRITMAEVIE  267 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~  267 (342)
                      ||+.+|++|||+.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.5e-42  Score=303.42  Aligned_cols=247  Identities=23%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      -++|+++++||+|+||.||+|... +++.||+|.+......    ...+.+|+.++++++|+||+++++++. .+..+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            467999999999999999999875 5788999998654322    246788999999999999999999874 4568999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++...  ..+++.++..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence            9999999999988753  468999999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                      .......++..|+|||.+....+ +.++||||||+++|++++ |+.||.+.+.......+... ..+.+...+.++.+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11122335678999999876655 488999999999999998 99999887776666655443 2233455788999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.+|++||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.3e-42  Score=303.48  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=208.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .+.|+..+.||+|+||.||+|.++.+++   .+|+|.+....  .....+.+.+|+++++.++|+|++++.+++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            4578999999999999999999876665   69999886432  223346788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+||||+++++|..++... +.+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999998764 578999999999999999999999999999999999999999999999999987543221


Q ss_pred             CCCce-ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          169 DDGLL-HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      ..... .....+..|+|||.+....+ +.++|||||||++|++++ |..||...+.......+.... .+.+..++.++.
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            11111 11123457999999987665 488999999999999997 999998877777666665432 233345788999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q 019360          246 KLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +++.+||+.+|++||++.++++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.3e-42  Score=302.50  Aligned_cols=243  Identities=24%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             eecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           21 TLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.++++++|+||+++++++.. +..++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999775  445679999986532  23344678899999999999999999998864 568999999999


Q ss_pred             CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC-ceecc
Q 019360           99 GELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTT  176 (342)
Q Consensus        99 ~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~  176 (342)
                      ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999875 4568999999999999999999999999999999999999999999999999987433221111 11112


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~  254 (342)
                      .++..|+|||.+....+ +.++|||||||++|++++ |..||...........+..+. ...++..++++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            23568999999886655 478999999999999996 999998887777666665543 344566789999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 019360          255 NPVTRITMAEVIE  267 (342)
Q Consensus       255 dP~~Rps~~e~l~  267 (342)
                      ||++||++.++++
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-42  Score=318.83  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=201.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe-
Q 019360           13 VGKYELGRTLGEGSFAKVKFARN-----TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS-   85 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-   85 (342)
                      -++|++.+.||.|+||.||+|.+     ..+++.||+|.+.....  ....+.+.+|+.++.++ +|+||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            36899999999999999999984     34678899999865322  23345788999999999 58999999998764 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR---------------------------------------------------------  108 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  108 (342)
                      +..++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45688999999999999988642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360          109 ----------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus       109 ----------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                                ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++................+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                      1367788899999999999999999999999999999999999999999999875322111111122335


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHH-hc-CCCCCCCCCHHHHHHHHHhcCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIF-KA-DFKSPPWFSTSAKKLISRILDPN  255 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~-~~-~~~~~~~~~~~~~~li~~~L~~d  255 (342)
                      +..|+|||.+.+..+ +.++||||||+++|+|++ |..||............. .. ....+...++++.+++..||+.|
T Consensus       244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            677999999977665 488999999999999997 999997754333222222 22 22334557889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 019360          256 PVTRITMAEVIEN  268 (342)
Q Consensus       256 P~~Rps~~e~l~h  268 (342)
                      |++|||+.++++|
T Consensus       323 p~~Rps~~eil~~  335 (343)
T cd05103         323 PSQRPTFSELVEH  335 (343)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-42  Score=301.27  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=203.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      ++||.|++|.||++.+.. ++.||+|.+......  .....+.+|++++++++|+||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999977 999999998654332  34467889999999999999999999999999999999999999


Q ss_pred             chHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360          100 ELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus       100 ~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      +|.+++.. ...+++..+..++.+++.||.|||++|++||||+|+||+++.++.++|+|||.+................+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99999865 35689999999999999999999999999999999999999999999999999874331111111111233


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhcCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP  256 (342)
                      +..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....+...+.++.+++.+||+.+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            567999999877655 589999999999999999 89999887766666655443 233455678999999999999999


Q ss_pred             CCCCCHHHHhc
Q 019360          257 VTRITMAEVIE  267 (342)
Q Consensus       257 ~~Rps~~e~l~  267 (342)
                      ++|||+.|+++
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-42  Score=321.81  Aligned_cols=255  Identities=23%  Similarity=0.371  Sum_probs=206.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMA   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~   84 (342)
                      ...++|.+.++||+|+||.||+|.+.     ..++.||+|++.....  ....+.+.+|+++|.++. |+||+++++++.
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34456889999999999999999864     3456899999975322  223456889999999998 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC-------------------------------------------------------
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRG-------------------------------------------------------  109 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------  109 (342)
                      ..+..++||||+++|+|.+++....                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999886431                                                       


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019360          110 -------------------------------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLL  146 (342)
Q Consensus       110 -------------------------------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIl  146 (342)
                                                                 .+++..+..++.|++.||.|||+.|++||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2566778899999999999999999999999999999


Q ss_pred             ecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHH
Q 019360          147 LDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMAL  225 (342)
Q Consensus       147 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~  225 (342)
                      ++.++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|||++ |..||......+.
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            99999999999999875322111111123356788999999987655 488999999999999998 8999987655444


Q ss_pred             HHHHHhcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          226 YKKIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       226 ~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ........  ...+..++.++.+|+.+||..+|.+||+++++++.
T Consensus       351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43433332  23455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.1e-42  Score=306.24  Aligned_cols=253  Identities=19%  Similarity=0.308  Sum_probs=207.9

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcC----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-C
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTE----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-K   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~   86 (342)
                      ..++|++.+.||+|+||.||+|.+..    .+..|++|.+...  ......+.+.+|+.+++.++|+||+++++++.. .
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            35789999999999999999999875    3578999987642  234445678899999999999999999998765 5


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR--------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDF  158 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Df  158 (342)
                      ...+++++|+++++|..++...        ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            6788999999999999998753        35889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCC
Q 019360          159 GLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKS  236 (342)
Q Consensus       159 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~  236 (342)
                      |+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |+.||...+..+....+.... ...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            99874322111111112345678999999977665 488999999999999998 999998887777665554432 233


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +..+++++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-42  Score=302.32  Aligned_cols=242  Identities=27%  Similarity=0.485  Sum_probs=203.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE-EeCCeEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM-ASKTKIYI   91 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~~l   91 (342)
                      ..+|++.+.||+|+||.||++...  |..+|+|.+....     ..+.+.+|+.++++++|+|++++++++ ...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            457999999999999999999764  7889999985432     234678999999999999999999975 45567899


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +|||+++++|.+++.+..  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--  155 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  155 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence            999999999999987643  4789999999999999999999999999999999999999999999999998743221  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                         .....++..|+|||++.+..+ +.++|||||||++|+|++ |+.||...+.......+.... ...++.+++.+.++
T Consensus       156 ---~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (256)
T cd05082         156 ---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV  231 (256)
T ss_pred             ---CCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence               122334568999999987665 488999999999999997 999998887777666665442 23345688999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+||+.||++|||+.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-43  Score=317.79  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=197.9

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-KIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~   90 (342)
                      .++.|.....||+|+||.||+|... +|..||||.+.......   ...|.+|+.++.+++|+|+|+++|||.+.+ ..+
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence            3457788899999999999999885 45899999876543221   345999999999999999999999999888 599


Q ss_pred             EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           91 IVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSR---GVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~---giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      +|+||++.|+|.+.+....  .++|.++..|+.+++.||+|||..   .|+|||||++|||+|.+.++||+|||+|+..+
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence            9999999999999998754  899999999999999999999985   39999999999999999999999999997544


Q ss_pred             cccCCCceecc-cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc------HHHHHHHHHhc-C----
Q 019360          166 QVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN------LMALYKKIFKA-D----  233 (342)
Q Consensus       166 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~------~~~~~~~i~~~-~----  233 (342)
                      ..  ....... .||.+|+|||++..... +.++|||||||++.|++||+.+.+...      ..+........ .    
T Consensus       229 ~~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  229 EG--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             cc--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            31  2222222 89999999999987444 589999999999999999998876432      12221112111 1    


Q ss_pred             --CCCC-CCCC--HH---HHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          234 --FKSP-PWFS--TS---AKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       234 --~~~~-~~~~--~~---~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                        .... ..++  ..   +..+..+|++.+|++||++.|+++.
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence              1111 2223  22   5577789999999999999998653

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.9e-43  Score=307.28  Aligned_cols=239  Identities=23%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             eeecccCceEEEEEEEcCCCc-------EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           20 RTLGEGSFAKVKFARNTETGE-------NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +.||.|+||.||+|.+...+.       .+|+|.+....   ....+.+.+|+.+++.+.|+||+++++++...+..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999999865544       38888875432   33445788899999999999999999999998899999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--------eeEcccccccC
Q 019360           93 LEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV--------LKVSDFGLSAL  163 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~--------~kl~Dfg~~~~  163 (342)
                      |||+++++|..++..++ .+++..+..++.|++.||+|||++||+||||||+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997654 5899999999999999999999999999999999999987664        69999998764


Q ss_pred             CccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCCCCCCCCCH
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKADFKSPPWFST  242 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  242 (342)
                      ...      .....++..|+|||.+.+....+.++|||||||++|+|++| ..||...+...... ........+...+.
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT  230 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence            221      12345788999999998654445889999999999999998 56776655544332 33444555556778


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.+|+.+||+.||++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.3e-42  Score=301.20  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=209.9

Q ss_pred             eeeeeeecccCceEEEEEEEcCCC----cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETG----ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      +++.+.||.|+||.||++.+...+    ..+|+|.+.....  ....+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467899999999999999998766    8899999865432  2245688899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +|||+++++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976544  89999999999999999999999999999999999999999999999999875433211


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~l  247 (342)
                      ... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+...... .+..++.++.++
T Consensus       159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            111 12236789999999866554 589999999999999998 89999888877777776654433 345578999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+||+.||++|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6e-42  Score=301.02  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=208.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..+|++.+.||.|+||.||+|.+. .+..+|+|.+......    ...+.+|++++++++|+|++++++++......++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468999999999999999999885 4778999998654322    23577899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++++|.+++... +.++++.+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence            9999999999998764 568999999999999999999999999999999999999999999999999886432211 11


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~  249 (342)
                      ......++..|+|||.+.+..+ +.++||||||+++|++++ |..||...........+..... ..+...+..+.+|+.
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            1112234568999999987665 478999999999999998 9999988887777776655422 234457899999999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q 019360          250 RILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h  268 (342)
                      +||+.+|++|||+.+++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=340.91  Aligned_cols=249  Identities=23%  Similarity=0.437  Sum_probs=213.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCc-----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGE-----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..-++...||+|+||.||.|.......     .||+|.+.+  ..+.+....|.+|+.+|+.++|||||+++|++.+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            456788999999999999998764333     388888865  3456667899999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           89 IYIVLEFVTGGELFDKIASR-------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      .++++|||+||+|..+|++.       ..++..++..++.+|+.|+.||+++++|||||..+|+|++....|||+|||+|
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999999874       34889999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCceecc--cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHh-cCCCCC
Q 019360          162 ALPQQVRDDGLLHTT--CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFK-ADFKSP  237 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~-~~~~~~  237 (342)
                      +-...  ........  .-...|||||.+....+ +.++|||||||++||++| |..||.+.+..++....+. +....|
T Consensus       850 rDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  850 RDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             Hhhhh--chheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            82211  11111111  22458999999998655 589999999999999998 9999999999998885554 567778


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..++..+.+++..||+.+|++||++..+++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            889999999999999999999999999997

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6e-42  Score=303.70  Aligned_cols=242  Identities=24%  Similarity=0.413  Sum_probs=199.1

Q ss_pred             eeecccCceEEEEEEEcCCCc--EEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEecc
Q 019360           20 RTLGEGSFAKVKFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      +.||+|+||.||+|.++.++.  .+++|.+....  .....+.+.+|+.++.++ .||||+++++++...+..|++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            468999999999999988775  46888875321  223345788999999999 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           97 TGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        97 ~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      ++++|.+++....                .+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999987532                478899999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPP  238 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~  238 (342)
                      +.......   .......+..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+.......+.... ...+.
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            86322111   1111233567999999876655 489999999999999997 999998877776666654432 23344


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .++.++.+|+.+||+.||.+|||+++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            57889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.6e-42  Score=304.46  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=209.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+|++...||+|+||.||+|+.+.     ..+.+++|.+....  .....+.+.+|++++++++|+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            679999999999999999999753     34679999886432  22345678899999999999999999999998889


Q ss_pred             EEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRG---------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      .++||||+++++|.+++....         .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999999998655         68999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC--CC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF--KS  236 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~--~~  236 (342)
                      ++...... .........++..|+|||.+.+... +.++||||||+++|++++ |..||...........+.....  ..
T Consensus       163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            88643211 1111223345678999999876655 488999999999999998 8899987766666666654443  33


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +..++..+.+++.+||+.||.+|||+.+++.+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            45688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.7e-42  Score=312.47  Aligned_cols=249  Identities=20%  Similarity=0.372  Sum_probs=197.0

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCchHHHH
Q 019360           26 SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI  105 (342)
Q Consensus        26 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l  105 (342)
                      ++|.||.+++..+++.||+|++.... ......+.+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            45666777777789999999997542 23345678999999999999999999999999999999999999999999998


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC-----CCceecccC
Q 019360          106 ASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-----DGLLHTTCG  178 (342)
Q Consensus       106 ~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g  178 (342)
                      ...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+........     ........+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            763  4589999999999999999999999999999999999999999999999998763321111     111223456


Q ss_pred             CcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----------------------
Q 019360          179 TPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----------------------  235 (342)
Q Consensus       179 t~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------------  235 (342)
                      +..|+|||++... ...+.++|+||+||++|+|++|..||..............+...                      
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            7789999998753 12347899999999999999999999876543332221111100                      


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          236 ------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       236 ------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                  ....++.++.+|+.+||+.||++|||++++|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                        0112346788999999999999999999999999998644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.3e-42  Score=301.92  Aligned_cols=239  Identities=20%  Similarity=0.312  Sum_probs=193.2

Q ss_pred             eeecccCceEEEEEEEcC------------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           20 RTLGEGSFAKVKFARNTE------------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      +.||+|+||.||+|....            ....+++|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999998532            22358888875432   233457788999999999999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-------eeEcccc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV-------LKVSDFG  159 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~-------~kl~Dfg  159 (342)
                      ..++||||+++++|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            899999999999998888753 56899999999999999999999999999999999999976654       8999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHH-hCCCCCCCCcHHHHHHHHHhcCCCCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM-AGYLPFEESNLMALYKKIFKADFKSPP  238 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~  238 (342)
                      ++.....      .....++..|+|||.+......+.++|||||||++|+|+ +|..||......+.. ...........
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~  230 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT  230 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence            8864321      123457888999999874444468899999999999997 589998776544432 23333334444


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+.++.+|+.+||+.||++||++.+++++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-43  Score=321.64  Aligned_cols=257  Identities=32%  Similarity=0.546  Sum_probs=224.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -|..++.||-|+||.|.++...++...||+|.+.+..+...........|-.+|..-..+.||+|+..|.+.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            38889999999999999999999999999999999888888888999999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC-----
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-----  169 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----  169 (342)
                      |++||++-.+|-+-+-|.|+.++.++..+..|+++.|+-|+|||||||+|||||.+|++||+|||+++-.....+     
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            999999999999989999999999999999999999999999999999999999999999999999863211100     


Q ss_pred             -----------------------------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCC
Q 019360          170 -----------------------------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY  214 (342)
Q Consensus       170 -----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~  214 (342)
                                                         ........||+.|+|||++...++. ..+|.||.||+||||+.|+
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence                                               0012335699999999999988875 8899999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHh----cCCCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 019360          215 LPFEESNLMALYKKIFK----ADFKSPPWFSTSAKKLISRILDPNPVTRIT---MAEVIENEWFKK  273 (342)
Q Consensus       215 ~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~h~~~~~  273 (342)
                      .||-..+..+...++.+    ..++....++.++.++|.+++ .+++.|..   ++++..||||+.
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            99988776665555432    234455678999999999877 56788884   678999999973

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6e-42  Score=304.47  Aligned_cols=238  Identities=23%  Similarity=0.313  Sum_probs=192.3

Q ss_pred             eecccCceEEEEEEEcCC------------------------CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc
Q 019360           21 TLGEGSFAKVKFARNTET------------------------GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV   76 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   76 (342)
                      .||+|+||.||+|....+                        ...|++|++....   ......+.+|+.+++.++|+||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            699999999999975321                        2358888886432   2334567889999999999999


Q ss_pred             eeEEEEEEeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----
Q 019360           77 IRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG----  151 (342)
Q Consensus        77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~----  151 (342)
                      +++++++......++||||+++++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999998865 46789999999999999999999999999999999999997643    


Q ss_pred             ---CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHH-HhCCCCCCCCcHHHHHH
Q 019360          152 ---VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVL-MAGYLPFEESNLMALYK  227 (342)
Q Consensus       152 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l-~~g~~pf~~~~~~~~~~  227 (342)
                         .++++|||.+.....      .....++..|+|||.+.+....+.++|||||||++||+ ++|..||..........
T Consensus       159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               489999998753211      12235678899999987644446899999999999998 47999998766544433


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          228 KIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       228 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ........+...++.+.++|.+||+.+|++|||+++++++
T Consensus       233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             2333334444567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-41  Score=296.47  Aligned_cols=243  Identities=26%  Similarity=0.424  Sum_probs=201.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +.||.|+||.||+|... +++.+|+|.+....  .......+.+|+++++.++|+||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46899999999999864 68899999986533  2233346889999999999999999999999999999999999999


Q ss_pred             chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360          100 ELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus       100 ~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                      +|.+++... ..+++..+..++.+++.||.|||++|++||||+|+||+++.++.++|+|||++....... ........+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            999988753 468999999999999999999999999999999999999999999999999986432211 111112234


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP  256 (342)
                      +..|+|||++.+..+ +.++||||||+++|++++ |..||...........+.... ...+..++..+.+++.+||+.+|
T Consensus       157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (250)
T cd05085         157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP  235 (250)
T ss_pred             cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence            567999999976655 488999999999999998 999998877766666655442 23455688999999999999999


Q ss_pred             CCCCCHHHHhc
Q 019360          257 VTRITMAEVIE  267 (342)
Q Consensus       257 ~~Rps~~e~l~  267 (342)
                      ++||++.++++
T Consensus       236 ~~Rp~~~~l~~  246 (250)
T cd05085         236 ENRPKFSELQK  246 (250)
T ss_pred             ccCCCHHHHHH
Confidence            99999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-41  Score=300.92  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ..+|++.+.||.|+||.||+|.+...   ...+|+|.+.....  ....+.+.+|+.+++.++|+||+++++++.. +..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            45799999999999999999987644   35699998864321  3344678899999999999999999998875 457


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+||||+++++|.+++.+. ..+++..+..++.+++.||+|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            8999999999999999864 358999999999999999999999999999999999999999999999999987533221


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~  246 (342)
                      .. ......++..|+|||.+....+ +.++||||||+++|++++ |..||...+..+....+.+.. ...+..++..+.+
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         162 YY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             ce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            11 1112234567999999876655 488999999999999886 999998887766666655443 3445678899999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcC
Q 019360          247 LISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.+|+..+|.+|||+.+++..
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-41  Score=303.74  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=197.2

Q ss_pred             cCe-eeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--
Q 019360           14 GKY-ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--   86 (342)
Q Consensus        14 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--   86 (342)
                      +|| ++++.||+|+||+||++.    ...+++.||+|.+.....  ......+.+|+++++.++|+||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            456 999999999999998765    335678999999865322  22345678899999999999999999987653  


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++++|||+++++|.+++... .+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999998764 589999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCC-ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH--HH------------HHHHH-
Q 019360          167 VRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM--AL------------YKKIF-  230 (342)
Q Consensus       167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~--~~------------~~~i~-  230 (342)
                      ..... ......++..|+|||.+.+..+ +.++||||||+++|+|++|..||......  +.            ..... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            21111 1122345667999999876655 48999999999999999999998643211  00            00011 


Q ss_pred             h-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          231 K-ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       231 ~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      . ...+.+..++.++.+++..||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1 112224557889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=321.89  Aligned_cols=244  Identities=35%  Similarity=0.615  Sum_probs=209.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~   90 (342)
                      ..+.|.+...+|.|+|+.|..+.+..+++.+++|++.+...       ...+|+.++... +|+||+++.+.+.+..+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            46789999999999999999999999999999999977522       234677665544 6999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe-cCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL-DANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli-~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +|||.+.|+.+.+.+.....+. .++..|+++|+.|+.|||++|++||||||+|||+ +..++++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999888887765555 7788899999999999999999999999999999 68899999999988743322  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                         ..+.|-|..|.|||++....++ .++||||||+++|+|++|+.||...... ++...+..+.+.  ..+|.++++||
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl  543 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL  543 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence               3445668899999999977775 9999999999999999999999765444 555555544444  77999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCccc
Q 019360          249 SRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +.||+.||.+|+++.+++.||||
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-41  Score=305.56  Aligned_cols=260  Identities=23%  Similarity=0.400  Sum_probs=208.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~   87 (342)
                      .....+.|++.+.||+|++|.||+|.+..+++.||+|.+.+....  .....+.+|+.++.... |+||+++++++....
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            455678899999999999999999999988999999998654321  22345566777666554 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           88 KIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      ..|++|||+.+ ++..++.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99999999854 77766655 4578999999999999999999997 699999999999999999999999999986432


Q ss_pred             cccCCCceecccCCcccCChhhhccCC---CCCcccchhhhhHHHHHHHhCCCCCCCCcH-HHHHHHHHhcCCC---CCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKG---YDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFK---SPP  238 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~~~~~~i~~~~~~---~~~  238 (342)
                      ..   .......++..|+|||.+.+..   ..+.++||||||+++|+|++|+.||..... .+....+......   ...
T Consensus       167 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06618         167 DS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE  243 (296)
T ss_pred             CC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence            21   1112335778999999987542   234789999999999999999999976332 3334444433322   122


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .++.++.+|+.+||..||++||+++++++||||+..
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            468899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-41  Score=306.65  Aligned_cols=253  Identities=23%  Similarity=0.353  Sum_probs=205.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGE----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ..++|++.+.||+|+||.||+|.+..+|.    .+|+|.+.....  ......+.+|+.+++.++|+||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            45679999999999999999999987776    468888754322  22334678999999999999999999998654 


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++++||+++|+|.+++..+. .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            4679999999999999987654 589999999999999999999999999999999999999999999999999975432


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  244 (342)
                      ...........++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.........+.... .+.++.++..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            221111222345678999999877665 488999999999999997 999998766555444443322 33345578899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          245 KKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+++.+|+..+|++||+++++++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=300.15  Aligned_cols=268  Identities=28%  Similarity=0.451  Sum_probs=225.9

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      +++.++...||.-+..+|.|+. .|..|.|...+++||+|.+... .......++..+|..++..++|+||++++.+|..
T Consensus         9 ~~s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP   86 (369)
T KOG0665|consen    9 DSSTFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP   86 (369)
T ss_pred             CCcceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence            4478899999999999999999 8889999999999999998765 3334445788999999999999999999999965


Q ss_pred             CC------eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           86 KT------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        86 ~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      ..      .+|+|||+|. .+|.+.+.  -.++-+.+..|+.|++.|++|||+.||+||||||+||++..++.+||.|||
T Consensus        87 ~~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   87 QKTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             cccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccch
Confidence            43      4899999994 58888877  347888999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC--
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP--  237 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--  237 (342)
                      +++..+.   .-..+.+..|..|+|||++.+.++. ..+||||+||++.||++|...|.+.+..+.+.++......+.  
T Consensus       164 ~ar~e~~---~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  164 LARTEDT---DFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             hhcccCc---ccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            9985433   2355677889999999999998864 889999999999999999999999888777776653211110  


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          238 ----------------------------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       238 ----------------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                                              +.-+..+++|+.+||..||++|.|++++|+|||++-|+.+
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~  319 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP  319 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence                                                    1123568999999999999999999999999999977665


Q ss_pred             CCCCC
Q 019360          278 PSFEQ  282 (342)
Q Consensus       278 ~~~~~  282 (342)
                      .....
T Consensus       320 ~ev~a  324 (369)
T KOG0665|consen  320 DEVEA  324 (369)
T ss_pred             ccccC
Confidence            54433

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.2e-41  Score=297.30  Aligned_cols=248  Identities=23%  Similarity=0.397  Sum_probs=204.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||++.+. .+..+|+|.+.....    ....+.+|+.+++.++|+||+++++++.. ...++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            3578999999999999999999865 456799998864321    23567889999999999999999999877 77899


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +|||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  156 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  156 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence            99999999999999763  457888999999999999999999999999999999999999999999999886432211 


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                      ........++..|+|||.+....+ +.++|+|||||++|++++ |..||...+.......+.... ...+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            111112234567999999976554 478999999999999998 999998877766666554432 23345678899999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+||+.||++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-41  Score=302.87  Aligned_cols=251  Identities=26%  Similarity=0.440  Sum_probs=199.4

Q ss_pred             CeeeeeeecccCceEEEEEEE----cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--Ce
Q 019360           15 KYELGRTLGEGSFAKVKFARN----TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--TK   88 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~   88 (342)
                      -|++++.||+|+||.||++..    +.++..||+|.+....  .....+.+.+|+.+++.++|+|++++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            378999999999999999974    4568899999986432  233456789999999999999999999998765  56


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .++||||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            89999999999999998764 45899999999999999999999999999999999999999999999999998754322


Q ss_pred             cCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---------------HHHHHHHHHh
Q 019360          168 RDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---------------LMALYKKIFK  231 (342)
Q Consensus       168 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---------------~~~~~~~i~~  231 (342)
                      ... .......++..|+|||.+.+..+ +.++|||||||++|+|+++..|+....               .......+..
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            111 11123446678999999876655 488999999999999999876643211               0111111111


Q ss_pred             -cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          232 -ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       232 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ...+.+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             1223345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2e-41  Score=300.08  Aligned_cols=245  Identities=20%  Similarity=0.242  Sum_probs=192.4

Q ss_pred             eeecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      +.||+|+||.||+|.+.  .++..+|+|.+.....  ......+.+|+.+++.++|+||+++++++......++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999864  3456799998865432  2233468889999999999999999999998889999999999


Q ss_pred             CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           98 GGELFDKIASRG-----RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        98 ~~~L~~~l~~~~-----~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      +++|.+++....     .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+...........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999987532     356778889999999999999999999999999999999999999999999864322111111


Q ss_pred             eecccCCcccCChhhhccCC------CCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCC-----CCC
Q 019360          173 LHTTCGTPNYVAPEVINNKG------YDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKS-----PPW  239 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~-----~~~  239 (342)
                      .....++..|+|||++.+..      ..+.++|+||||+++|+|++ |..||......+........ ....     ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            22345678899999986421      12578999999999999996 99999876655544333222 1111     123


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .++.+.+++..|+ .+|++|||+++++.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999998 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2e-41  Score=300.09  Aligned_cols=245  Identities=21%  Similarity=0.289  Sum_probs=192.4

Q ss_pred             eeecccCceEEEEEEEcC--CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARNTE--TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++|+||+++++.+......|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999996532  34568888775432  23334567889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           98 GGELFDKIASRG-----RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        98 ~~~L~~~l~~~~-----~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      +++|.+++....     ..++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999987643     246778899999999999999999999999999999999999999999999864322111111


Q ss_pred             eecccCCcccCChhhhccC------CCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-C-----CCCC
Q 019360          173 LHTTCGTPNYVAPEVINNK------GYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-K-----SPPW  239 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~-----~~~~  239 (342)
                      .....++..|+|||++...      ...+.++|||||||++|+|++ |..||......+....+..... .     .+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            1223456789999997531      223578999999999999999 8899988766655555443321 1     1235


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++..+.+++..|+ .||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            7788999999998 59999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-41  Score=301.14  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=198.1

Q ss_pred             cCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CC
Q 019360           14 GKYELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KT   87 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~   87 (342)
                      .+|++.+.||+|+||.||++.    +..++..||+|.+....   ....+.+.+|+++++.++|+||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            479999999999999999997    44578899999986432   3345678899999999999999999998643  34


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      .+++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999998764 5689999999999999999999999999999999999999999999999999885432


Q ss_pred             ccCCC-ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHH---------------HHHHH
Q 019360          167 VRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL---------------YKKIF  230 (342)
Q Consensus       167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~---------------~~~i~  230 (342)
                      ..... ......++..|+|||.+.+..+ +.++|||||||++|||++|..|+........               .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            21111 0111223456999999987655 4889999999999999998777543321100               11111


Q ss_pred             hc--CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          231 KA--DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       231 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..  ..+.+..++.++.+|+.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11  22334567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-41  Score=300.94  Aligned_cols=245  Identities=23%  Similarity=0.375  Sum_probs=200.7

Q ss_pred             eeecccCceEEEEEEEcCCC------cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           20 RTLGEGSFAKVKFARNTETG------ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.||.|+||.||+|.++...      +.+|+|.+.+..  .......+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46899999999999986543      679999885432  1233457889999999999999999999999889999999


Q ss_pred             eccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-----CeeEcccccc
Q 019360           94 EFVTGGELFDKIASR-------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-----VLKVSDFGLS  161 (342)
Q Consensus        94 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-----~~kl~Dfg~~  161 (342)
                      ||+++++|.+++...       ..+++.++..++.|++.||+|||+.+++|+||+|+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       3378899999999999999999999999999999999998877     8999999998


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCC
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPW  239 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  239 (342)
                      ................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+... ....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            74322111111122345678999999987665 589999999999999998 99999887766665555433 3344566


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++..+.+++.+||+.+|.+||+++++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-44  Score=297.58  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=214.8

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe------
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS------   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------   85 (342)
                      ..+.|.-..+||+|.||.||+|+.+.+|+.||+|++..+.. ....-....+|+++|..|+|+|++.++++|..      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            35678889999999999999999999999999998754322 23333456799999999999999999887742      


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           86 --KTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                        ...+|+|+.+|+. +|.-++... -.++..++..++.+++.||.|+|...|+|||+|++|+||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              2458999999976 888888765 569999999999999999999999999999999999999999999999999997


Q ss_pred             CCccccC--CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--CCCC--
Q 019360          163 LPQQVRD--DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKS--  236 (342)
Q Consensus       163 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~--  236 (342)
                      .......  ....+...-|.+|++||.+.+...++++.|||+.||++.||.++.+.+.+.+.......|...  ....  
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            5433211  112233455899999999999887889999999999999999999999988776665554321  1000  


Q ss_pred             ---------------C----------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 ---------------P----------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ---------------~----------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                     +                -.-++++.+|+..||..||.+|++++++++|.||.....|
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                           0                0014578899999999999999999999999999876543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.9e-42  Score=298.06  Aligned_cols=229  Identities=26%  Similarity=0.426  Sum_probs=191.4

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCchHHH
Q 019360           25 GSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDK  104 (342)
Q Consensus        25 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~  104 (342)
                      |.+|.||+++++.+++.||+|.+.+...        ..+|...+....||||+++++++...+..++||||+++++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999975431        22455555566799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCC
Q 019360          105 IASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA  184 (342)
Q Consensus       105 l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  184 (342)
                      +.+...+++..+..++.|+++||.|||+.||+||||||+||+++.++.++++|||.+......     .....++..|+|
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a  150 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA  150 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence            988778999999999999999999999999999999999999999999999999987543221     123345778999


Q ss_pred             hhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH--
Q 019360          185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITM--  262 (342)
Q Consensus       185 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--  262 (342)
                      ||.+.+..+ +.++|+||+|+++|+|++|+.|+.......  .  .......+..+++.++++|.+||+.||++||++  
T Consensus       151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            999876555 478999999999999999998875432110  0  011233456789999999999999999999986  


Q ss_pred             ---HHHhcCccc
Q 019360          263 ---AEVIENEWF  271 (342)
Q Consensus       263 ---~e~l~h~~~  271 (342)
                         +++++||||
T Consensus       226 ~~~~~~~~h~~~  237 (237)
T cd05576         226 AGVEDIKSHPFF  237 (237)
T ss_pred             cchHHHHcCCCC
Confidence               999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.9e-41  Score=298.08  Aligned_cols=250  Identities=30%  Similarity=0.573  Sum_probs=209.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcC-CCcEEEEEEecchhh-------hhhhHHHHHHHHHHHHhc-CCCCcceeEEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTE-TGENVAIKILDKEKV-------LKHKMIGQIKREISTMKL-IRHPNVIRMYEVMAS   85 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~   85 (342)
                      .|++.+.||+|+||.||+|.+.. .++.+|+|.+.....       ........+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 678999998753221       223344567788888864 789999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      .+..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3568999999999999999999996 7899999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC--C
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP--P  238 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--~  238 (342)
                      +.......   ......++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+......+.  .
T Consensus       161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            87543221   3344568889999999987655 5899999999999999999999988877776666665544332  2


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+++.+.++|.+||+.||++||++.|+.++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            578999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.8e-41  Score=295.78  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=196.9

Q ss_pred             eeecccCceEEEEEEEcC---CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE-eCCeEEEEEec
Q 019360           20 RTLGEGSFAKVKFARNTE---TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA-SKTKIYIVLEF   95 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~   95 (342)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .....+.+.+|+.+++.++|+||+++++++. .++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998753   34579999875322  2334567889999999999999999999765 45568899999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC--CCc
Q 019360           96 VTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGL  172 (342)
Q Consensus        96 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~  172 (342)
                      +.+++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.......  ...
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999999764 4467788899999999999999999999999999999999999999999999874322110  011


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISR  250 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~  250 (342)
                      .....++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+...... .+..+++.+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            112345678999999877665 489999999999999999 57778777776666666554333 244578899999999


Q ss_pred             hcCCCCCCCCCHHHHhcC
Q 019360          251 ILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h  268 (342)
                      ||+.+|++||++.+++..
T Consensus       238 cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         238 CWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HcCCChhhCCCHHHHHHH
Confidence            999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.1e-41  Score=298.55  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             eeeeeeecccCceEEEEEEEcC---CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----
Q 019360           16 YELGRTLGEGSFAKVKFARNTE---TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-----   87 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----   87 (342)
                      |++.+.||+|+||.||+|.++.   +++.+|+|++.... ......+.+.+|+++++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998653   57889999986533 23344567889999999999999999999885432     


Q ss_pred             -eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           88 -KIYIVLEFVTGGELFDKIASR------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        88 -~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                       ..++++||+++++|..++...      ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247889999999998876431      2478899999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPP  238 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~  238 (342)
                      ++...............+++.|++||.+....+ +.++|||||||++|+|++ |+.||.+.+..+....+.... ...++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            875432111111122334678999999877655 478999999999999999 899998887776666655443 33345


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+..+.+++.+||+.+|.+|||+.+++++
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.5e-41  Score=295.27  Aligned_cols=241  Identities=27%  Similarity=0.492  Sum_probs=202.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||++..  +++.+|+|.+....     ....+.+|+.+++.++|+|++++++++... ..+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            46799999999999999999864  67889999986432     124678999999999999999999998654 47999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+......   
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999999997643  4789999999999999999999999999999999999999999999999998743221   


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                        ......+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+.... ...+..++..+.+++
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  230 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM  230 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence              112234567999999876555 488999999999999997 999998888777666665442 223455789999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.+|++||++++++.
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         231 TSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=304.28  Aligned_cols=253  Identities=30%  Similarity=0.469  Sum_probs=205.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC--C----cceeEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH--P----NVIRMYEVM   83 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~iv~l~~~~   83 (342)
                      +...+||.++..+|+|.||.|..+.+..++..||+|+++.-.    ...+...-|+++|.++.+  |    -++.+.+||
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            344779999999999999999999999999999999986432    223345679999999952  2    378888999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC------------
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA------------  149 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~------------  149 (342)
                      .-.++.|+|+|.+ |.++.+++.++  .+++..+++.+.+|+++++++||+.+++|.||||+|||+..            
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999999998 77999999875  46899999999999999999999999999999999999932            


Q ss_pred             --------CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc
Q 019360          150 --------NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN  221 (342)
Q Consensus       150 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~  221 (342)
                              +..++|+|||.|+.....     ..+...|..|+|||++.+-+++ .++||||+||+++|+.+|...|...+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCC
Confidence                    235899999999854332     2556789999999999999986 88999999999999999999997765


Q ss_pred             HHH---HHHHHHhcC------------------CC---------------CC----------CCCCHHHHHHHHHhcCCC
Q 019360          222 LMA---LYKKIFKAD------------------FK---------------SP----------PWFSTSAKKLISRILDPN  255 (342)
Q Consensus       222 ~~~---~~~~i~~~~------------------~~---------------~~----------~~~~~~~~~li~~~L~~d  255 (342)
                      ..+   +.+.|+...                  +.               .+          +..-.++.||+++||..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            433   333333210                  00               00          001235889999999999


Q ss_pred             CCCCCCHHHHhcCccccc
Q 019360          256 PVTRITMAEVIENEWFKK  273 (342)
Q Consensus       256 P~~Rps~~e~l~h~~~~~  273 (342)
                      |.+|+|+.|+|.||||..
T Consensus       394 P~~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  394 PARRITLREALSHPFFAR  411 (415)
T ss_pred             ccccccHHHHhcCHHhhc
Confidence            999999999999999975

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-41  Score=296.05  Aligned_cols=236  Identities=20%  Similarity=0.260  Sum_probs=192.3

Q ss_pred             eeecccCceEEEEEEEcCCC----------cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           20 RTLGEGSFAKVKFARNTETG----------ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +.||+|+||.||+|.+..++          ..+++|++......    ...+.+|+.+++.++|+||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999998766          34788876543211    4578899999999999999999999887 778


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-------CeeEcccccc
Q 019360           90 YIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-------VLKVSDFGLS  161 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-------~~kl~Dfg~~  161 (342)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++       .++|+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 789999999999999999999999999999999999998887       7999999998


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCCCCCC
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPW  239 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  239 (342)
                      .....      .....++..|+|||.+.+. ...+.++|||||||++|++++ |..||...+......... .....+..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~  228 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP  228 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence            74322      1234467789999998765 234588999999999999999 688887765433333322 22222222


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ....+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            3478999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.2e-41  Score=299.34  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--C
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--K   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~   86 (342)
                      ...|++.+.||+|+||.||+|....    +++.+|+|++......  ...+.+.+|+++++.++|+||+++++++..  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            3578899999999999999998643    4789999999754332  345688999999999999999999999876  5


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      ...+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            57899999999999999997654 58999999999999999999999999999999999999999999999999987644


Q ss_pred             cccCCC-ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH--------------HHHHHH
Q 019360          166 QVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA--------------LYKKIF  230 (342)
Q Consensus       166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~--------------~~~~i~  230 (342)
                      ...... ......++..|+|||.+.+..+ +.++||||||+++|+|++|..|+.......              ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            211111 1112234567999999876655 488999999999999999999986532211              111122


Q ss_pred             hc--CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          231 KA--DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       231 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..  ..+.+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22  22334457789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-40  Score=294.57  Aligned_cols=245  Identities=18%  Similarity=0.273  Sum_probs=192.4

Q ss_pred             eeecccCceEEEEEEEcCC--CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARNTET--GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      +.||+|+||.||++.....  ...+++|.+.....  ....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3699999999999975433  24566777654321  2334678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           98 GGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        98 ~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      +++|.+++.+.    ...++..+..++.|++.||+|||+.+++||||||+|||++.++.++|+|||++............
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999998753    33567788899999999999999999999999999999999999999999987632211111112


Q ss_pred             ecccCCcccCChhhhccCC------CCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC------CCCCCC
Q 019360          174 HTTCGTPNYVAPEVINNKG------YDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF------KSPPWF  240 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~------~~~~~~  240 (342)
                      ....++..|+|||++....      ..+.++|||||||++|+|++ |..||...+..+....+.+...      .....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3456788999999885321      12478999999999999996 5789987777666665544321      122347


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++.+.+++..|+ .+|.+||+++++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            888999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.9e-42  Score=333.56  Aligned_cols=255  Identities=31%  Similarity=0.546  Sum_probs=205.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-------
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-------   85 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-------   85 (342)
                      ...|+.++.||+||||.||+++++-+|+.||||.+....  .......+.+|+.+|.+|+|||||+++..|..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            456889999999999999999999999999999997543  44556688899999999999999998844311       


Q ss_pred             --------------------------------------------------------------------------------
Q 019360           86 --------------------------------------------------------------------------------   85 (342)
Q Consensus        86 --------------------------------------------------------------------------------   85 (342)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 019360           86 ------------------------K--------TKIYIVLEFVTGGELFDKIASRGRL-KEDEARKYFQQLINAVDYCHS  132 (342)
Q Consensus        86 ------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~~l~~~L~~LH~  132 (342)
                                              +        ..+|+-||||+..++++++..+... .....++++++|++||+|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1268999999988888877765544 477899999999999999999


Q ss_pred             CCceeecCCCCcEEecCCCCeeEcccccccCCc----c------------ccCCCceecccCCcccCChhhhccCC--CC
Q 019360          133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ----Q------------VRDDGLLHTTCGTPNYVAPEVINNKG--YD  194 (342)
Q Consensus       133 ~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  194 (342)
                      .|||||||||.||+++.++.|||+|||+++...    .            .......+..+||..|+|||++.+..  .+
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999997511    0            01122445678999999999998655  34


Q ss_pred             CcccchhhhhHHHHHHHhCCCCCCCC-cHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          195 GAKADLWSCGVILYVLMAGYLPFEES-NLMALYKKIFKADFKSPPWF----STSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       195 ~~~~DiwslG~ll~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      +.|+|+||||++++||+   .||... .....+..+.++.++.++.+    -+.-..+|++||+.||.+||||.|+|++.
T Consensus       796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~  872 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE  872 (1351)
T ss_pred             cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence            59999999999999997   456543 34445555555555555222    24567999999999999999999999999


Q ss_pred             ccc
Q 019360          270 WFK  272 (342)
Q Consensus       270 ~~~  272 (342)
                      ||.
T Consensus       873 llp  875 (1351)
T KOG1035|consen  873 LLP  875 (1351)
T ss_pred             CCC
Confidence            986

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.9e-40  Score=295.77  Aligned_cols=253  Identities=16%  Similarity=0.195  Sum_probs=190.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhh--hhh------HHHHHHHHHHHHhcCCCCcceeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVL--KHK------MIGQIKREISTMKLIRHPNVIRMY   80 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~--~~~------~~~~~~~E~~~l~~l~h~~iv~l~   80 (342)
                      ..++|++.+.||+|+||.||+|.+..+   +..+|+|+.......  .+.      .......+...+..+.|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999998877   667788764321110  000      001122344556677899999999


Q ss_pred             EEEEeCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEc
Q 019360           81 EVMASKT----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        81 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~  156 (342)
                      +.+....    ..+++++++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence            8765443    3578888874 4676777665557889999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccC-----CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH-HH------
Q 019360          157 DFGLSALPQQVRD-----DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MA------  224 (342)
Q Consensus       157 Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~~------  224 (342)
                      |||+++.......     ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ..      
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            9999875422111     111223468999999999987665 5899999999999999999999987632 21      


Q ss_pred             --HHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          225 --LYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       225 --~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                        ....+...... .+..+.++.+++..|++.+|++||+++++++
T Consensus       248 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              12223322222 2346789999999999999999999999975

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=303.54  Aligned_cols=266  Identities=29%  Similarity=0.438  Sum_probs=222.4

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh----hHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH----KMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .++..+||-+++.||+|+|+.||+|.|....++||+|+-.....+..    .+.+..-+|.++-+.|.||.||++|++|.
T Consensus       458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            45677899999999999999999999999999999998654333333    34567789999999999999999999996


Q ss_pred             -eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeecCCCCcEEec---CCCCeeEccc
Q 019360           85 -SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR--GVCHRDLKPENLLLD---ANGVLKVSDF  158 (342)
Q Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~--giiH~dlkp~NIli~---~~~~~kl~Df  158 (342)
                       +.+.+|-|+|||+|.+|.-+++.+..+++.+++.|+.||+.||.||...  .|||-||||.|||+-   .-|.+||+||
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence             4567899999999999999999999999999999999999999999976  599999999999993   4578999999


Q ss_pred             ccccCCccccCC-----CceecccCCcccCChhhhcc---CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHH--H
Q 019360          159 GLSALPQQVRDD-----GLLHTTCGTPNYVAPEVINN---KGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALY--K  227 (342)
Q Consensus       159 g~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~--~  227 (342)
                      |++++.+....+     .......||.+|+|||.+.-   .+..+.++||||+||++|.++.|+.||...... +++  +
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            999987654333     23445679999999998752   334468999999999999999999999765332 222  2


Q ss_pred             HHHh---cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          228 KIFK---ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       228 ~i~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .|++   ..++..+-+++++++||++||++--++|..+.++..||||...
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            2332   2456667799999999999999999999999999999999753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=313.90  Aligned_cols=248  Identities=31%  Similarity=0.513  Sum_probs=199.2

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...+..+-|..-+.||.|+||.||+++++.+|+.||||.+.+..  .....++.-+|+++|++++|+|||+++++-+...
T Consensus         7 l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~   84 (732)
T KOG4250|consen    7 LTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKF   84 (732)
T ss_pred             cccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence            34445577888999999999999999999999999999997643  3344567889999999999999999999865443


Q ss_pred             ------eEEEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec--CCC--Cee
Q 019360           88 ------KIYIVLEFVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD--ANG--VLK  154 (342)
Q Consensus        88 ------~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~--~~~--~~k  154 (342)
                            ...+|||||.||||+..+++.   ..+++.++..++.++..||.|||++||+||||||.||++-  .+|  ..|
T Consensus        85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence                  467999999999999999863   4599999999999999999999999999999999999993  223  579


Q ss_pred             EcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc----HHHHHHHHH
Q 019360          155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN----LMALYKKIF  230 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~----~~~~~~~i~  230 (342)
                      |+|||.|+-.+   ++....+..||+.|.+||.+....+++..+|.|||||++|+++||..||....    ..+....+.
T Consensus       165 LtDfG~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~  241 (732)
T KOG4250|consen  165 LTDFGAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII  241 (732)
T ss_pred             eecccccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence            99999998543   45577889999999999999965666789999999999999999999995321    122222222


Q ss_pred             hc---------------------CCCCCCCCCH----HHHHHHHHhcCCCCCCCC
Q 019360          231 KA---------------------DFKSPPWFST----SAKKLISRILDPNPVTRI  260 (342)
Q Consensus       231 ~~---------------------~~~~~~~~~~----~~~~li~~~L~~dP~~Rp  260 (342)
                      ..                     .++.+..+++    .+...+..+|..+|++|.
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            11                     1222222333    345778899999999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.2e-39  Score=310.62  Aligned_cols=256  Identities=18%  Similarity=0.276  Sum_probs=177.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCC----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEE---
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTET----GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEV---   82 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~---   82 (342)
                      ....++|++.+.||+|+||.||+|.+..+    +..||+|.+.......     ...++  .++...+.++..+...   
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhc
Confidence            34667899999999999999999999988    8999999875422111     11111  1122222222222111   


Q ss_pred             ---EEeCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 019360           83 ---MASKTKIYIVLEFVTGGELFDKIASRGR--------------------LKEDEARKYFQQLINAVDYCHSRGVCHRD  139 (342)
Q Consensus        83 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~~l~~~L~~LH~~giiH~d  139 (342)
                         .......++|+||+++++|.+++.....                    .....+..++.|++.||.|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2355679999999999999998875421                    12344678999999999999999999999


Q ss_pred             CCCCcEEecC-CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCC---------------------Ccc
Q 019360          140 LKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD---------------------GAK  197 (342)
Q Consensus       140 lkp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~  197 (342)
                      |||+|||++. ++.+||+|||+++..... .........+++.|+|||.+......                     +.+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999985 579999999999743221 12223456789999999976432211                     235


Q ss_pred             cchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---------------------CCCCCCCHHHHHHHHHhcCCCC
Q 019360          198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---------------------KSPPWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       198 ~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---------------------~~~~~~~~~~~~li~~~L~~dP  256 (342)
                      +|||||||++|||+++..++.... ......+.....                     ......+....+||.+||+.||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            699999999999999776654321 111111111100                     0001122345689999999999


Q ss_pred             CCCCCHHHHhcCcccccC
Q 019360          257 VTRITMAEVIENEWFKKG  274 (342)
Q Consensus       257 ~~Rps~~e~l~h~~~~~~  274 (342)
                      ++|||++++|+||||+..
T Consensus       439 ~kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        439 RQRISAKAALAHPYFDRE  456 (566)
T ss_pred             ccCCCHHHHhCCcCcCCC
Confidence            999999999999999863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.8e-39  Score=278.50  Aligned_cols=240  Identities=48%  Similarity=0.827  Sum_probs=205.7

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCchHHHH
Q 019360           26 SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI  105 (342)
Q Consensus        26 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l  105 (342)
                      +||.||+|.+..+|+.+|+|++........  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999998899999999975443221  468889999999999999999999999989999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCCh
Q 019360          106 ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP  185 (342)
Q Consensus       106 ~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  185 (342)
                      .....++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ......++..|+||
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p  155 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP  155 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence            876668999999999999999999999999999999999999999999999999987543321   23445678899999


Q ss_pred             hhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHhcCCCCCCCCC
Q 019360          186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW---FSTSAKKLISRILDPNPVTRIT  261 (342)
Q Consensus       186 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rps  261 (342)
                      |.+...... .++||||||++++++++|..||.. .+.......+..........   ++.++.+++.+||..+|++||+
T Consensus       156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            999866654 799999999999999999999987 55555555554444443332   7889999999999999999999


Q ss_pred             HHHHhcCccc
Q 019360          262 MAEVIENEWF  271 (342)
Q Consensus       262 ~~e~l~h~~~  271 (342)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=298.81  Aligned_cols=250  Identities=19%  Similarity=0.318  Sum_probs=207.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+..+.++||+|.||.|.+++.. .+..||+|.++....  ....+.|.+|+++|.+|+||||++++++|..++.+++|+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            34678999999999999999874 478999999976442  333578999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           94 EFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||++.|+|.+++.++.  .+..+...+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++-.-......
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999999999873  34566778899999999999999999999999999999999999999999998432211111


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHH--hCCCCCCCCcHHHHHHHHHhc--------CCCCCCCCC
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM--AGYLPFEESNLMALYKKIFKA--------DFKSPPWFS  241 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~--~g~~pf~~~~~~~~~~~i~~~--------~~~~~~~~~  241 (342)
                      ......-+.+|||||.+....+ +.++|+|+||+++||++  +.+.||+..+.++...+....        ....|+-++
T Consensus       695 vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence            1122234679999999887666 48999999999999865  588999988877766654321        233466789


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..+.+|+.+|+..|-++|||++++..
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            99999999999999999999999853

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=307.91  Aligned_cols=259  Identities=29%  Similarity=0.448  Sum_probs=219.9

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEE--
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMA--   84 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~--   84 (342)
                      ......+.|.+.+.||.|.+|.||++..+.+++..|+|+.......    .+.++.|.++|+..+ |||++.++++|.  
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3455677899999999999999999999999999999998654322    246778999998886 999999999985  


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           85 ---SKTKIYIVLEFVTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        85 ---~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                         .++.++||||||.||+.-++++.  ...+.|+.+..|++.++.||.+||++.++|||||-.|||++.++.|||+|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence               35789999999999999998875  4568999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhcc-----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINN-----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      ++.-..  .......+..|||.|||||++..     ..| +..+|+||||++..||.-|.+|+....++..+-.|-....
T Consensus       169 vSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP  245 (953)
T KOG0587|consen  169 VSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP  245 (953)
T ss_pred             eeeeee--cccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence            987433  23444567889999999999864     223 4789999999999999999999999888766555544322


Q ss_pred             C---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          235 K---SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       235 ~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +   .+..++.++.++|..||.+|-++||++.++|+|||+..
T Consensus       246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            2   23457889999999999999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=282.16  Aligned_cols=260  Identities=25%  Similarity=0.457  Sum_probs=214.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT----   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----   87 (342)
                      ...+.+.-+.||.|+||+||.+.|..+|+.||+|.+..- ...-...+++.+|+.+|..++|.|++..+++.....    
T Consensus        51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF  129 (449)
T KOG0664|consen   51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF  129 (449)
T ss_pred             ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence            344566778999999999999999999999999998642 233334568889999999999999999998876543    


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 -KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                       .+|+++|.| ..+|...+-+...++.+.++-+++||+.||+|||+.+|.||||||.|.|++.+..+||||||+++....
T Consensus       130 qEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  130 QELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence             478899999 458999998888899999999999999999999999999999999999999999999999999996543


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHh---------------
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---------------  231 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~---------------  231 (342)
                      .. ....+...-|..|+|||++.+...++.+.||||+||++.|++..+..|...++.+..+.|..               
T Consensus       209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            22 22334456688999999999988788999999999999999999999987776665554432               


Q ss_pred             --------cCCCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          232 --------ADFKSPP-----------WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       232 --------~~~~~~~-----------~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                              ...+.|+           .-..+..+++..+|..||.+|.+.++++.|++..++
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                    1111111           123467899999999999999999999999998653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.2e-41  Score=299.99  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=212.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC------CCcceeEEEEEEeC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR------HPNVIRMYEVMASK   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~~~   86 (342)
                      -++|.+....|.|-||+|..|.+...|+.||||++....+..    +.-..|+++|++|+      -.|+++++..|...
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            358999999999999999999999999999999997654433    34568999999996      24899999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEccccccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG---RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSA  162 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~  162 (342)
                      +++|||+|-+ ...|.++|++.+   .+....+..++.|++.||..|.++||+|.||||+|||++.. ..+||||||.|.
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999999988 569999998754   37888999999999999999999999999999999999875 468999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----  238 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----  238 (342)
                      ...    .+..+.+.-+..|+|||++.+..|+ ...|+||+||+||||.||+..|++.+...++.-.+....++|.    
T Consensus       586 ~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  586 FAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            533    3344556667889999999999887 8899999999999999999999998877776655433322220    


Q ss_pred             -------------------------------------------------CC-------CHHHHHHHHHhcCCCCCCCCCH
Q 019360          239 -------------------------------------------------WF-------STSAKKLISRILDPNPVTRITM  262 (342)
Q Consensus       239 -------------------------------------------------~~-------~~~~~~li~~~L~~dP~~Rps~  262 (342)
                                                                       .+       -..+++|+.+||..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence                                                             01       1358899999999999999999


Q ss_pred             HHHhcCccccc
Q 019360          263 AEVIENEWFKK  273 (342)
Q Consensus       263 ~e~l~h~~~~~  273 (342)
                      .++|.||||+.
T Consensus       741 nqAL~HpFi~~  751 (752)
T KOG0670|consen  741 NQALKHPFITE  751 (752)
T ss_pred             HHHhcCCcccC
Confidence            99999999974

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=280.67  Aligned_cols=253  Identities=23%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHh-cCCCCcceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ..+-++.||.|+||+|++-.++.+|+..|||.+.....  +...+++..|.+... .-+.||||+++|..-.++..++.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            34557789999999999999999999999999986554  344467888888754 446999999999988889999999


Q ss_pred             eccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           94 EFVTGGELFDKIA-----SRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        94 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      |+|. .+|..+-+     ....++|+.+-.|......||.||.. .+|||||+||+|||++..|.+||||||++....  
T Consensus       143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--  219 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--  219 (361)
T ss_pred             HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence            9994 46644322     34569999999999999999999985 589999999999999999999999999986322  


Q ss_pred             cCCCceecccCCcccCChhhhccCCC-CCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCCCCC------CC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGY-DGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKADFKSP------PW  239 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~------~~  239 (342)
                       ..-..+.-.|...|||||.+..... +..++|+||||+++||+.||..||.+-+ ..+....+..+.++..      -.
T Consensus       220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence             1122234568899999999874332 2488999999999999999999998754 4455555566655432      13


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++..+..+|..||.+|-..||...+++.+||++.
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            7889999999999999999999999999999975

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-40  Score=299.20  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCC--Cc--EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTET--GE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      .++.+.||.|.||.||+|....-  |+  .||||..+....  ....+.|..|+.+|+++.||||++++|++.. ...++
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            45567899999999999986532  33  488888765433  3336789999999999999999999999965 45899


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||.++.|.|+.+++.+ ..++...+..+++||+.||+|||+..+|||||...|||+.....|||+|||+++........
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            99999999999999876 46899999999999999999999999999999999999999999999999999976543222


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                      .. ....-+..|||||.++-..+ +.++|||-|||++||++. |..||.+....+.+-.+-++ ..+.|+.+++.+..|+
T Consensus       548 ka-S~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm  625 (974)
T KOG4257|consen  548 KA-SRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM  625 (974)
T ss_pred             hc-cccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence            11 12223567999999987666 488999999999999765 99999998877777666665 4567889999999999


Q ss_pred             HHhcCCCCCCCCCHHHHh
Q 019360          249 SRILDPNPVTRITMAEVI  266 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l  266 (342)
                      .+||+.+|.+||.+.++.
T Consensus       626 skcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  626 SKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHhccCcccCCcHHHHH
Confidence            999999999999987765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=289.15  Aligned_cols=130  Identities=28%  Similarity=0.498  Sum_probs=113.8

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC--------CCcceeEEEEEE-
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR--------HPNVIRMYEVMA-   84 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~~~~-   84 (342)
                      +||.+.++||.|-|++||++.|.++.+.||+|+++....    +.+....||++|++++        ..+||+|++.|. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            799999999999999999999999999999999965443    3456678999999884        247999999995 


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEec
Q 019360           85 ---SKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLD  148 (342)
Q Consensus        85 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~  148 (342)
                         .+.++|||+|++ |..|..++...  ..++...++.|++|++.||.|||. +||||.||||+|||+.
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence               456899999999 77898888763  569999999999999999999995 6999999999999994

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-40  Score=302.23  Aligned_cols=254  Identities=27%  Similarity=0.443  Sum_probs=215.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ++.++.++||+|+||+|++|.++..+   -.||||.+.......  ....|.+|+.+|.+|+|+|++++||+..+ ..+.
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            35677899999999999999887543   349999997544332  45789999999999999999999999987 6688


Q ss_pred             EEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+|+++.|+|.+.|.+  ...|....+..++.||+.||.||.++++|||||-..|+|+.....|||||||+.+......
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999999987  3568888999999999999999999999999999999999999999999999998655433


Q ss_pred             CCCceecc-cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          169 DDGLLHTT-CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      ........ .-...|+|||.+....+. .++|||++||++|||++ |+.||.+.....+++.+-.++ ++.+..++.++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY  345 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY  345 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence            33222211 124579999999987775 89999999999999998 899999999999998887554 456778999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ++++.||..+|++|||+..|.+.-+.
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHH
Confidence            99999999999999999988755444

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-38  Score=297.33  Aligned_cols=265  Identities=19%  Similarity=0.263  Sum_probs=190.3

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEc----------------CCCcEEEEEEecchhhhhhh-----------HHHH
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNT----------------ETGENVAIKILDKEKVLKHK-----------MIGQ   60 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~-----------~~~~   60 (342)
                      ..+...++|++.++||+|+||+||+|.+.                ..++.||||.+.........           ..+.
T Consensus       139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~  218 (507)
T PLN03224        139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET  218 (507)
T ss_pred             CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence            34566789999999999999999999752                34567999998542211100           0112


Q ss_pred             HHHHHHHHhcCCCCcc-----eeEEEEEEe--------CCeEEEEEeccCCCchHHHHHhc-------------------
Q 019360           61 IKREISTMKLIRHPNV-----IRMYEVMAS--------KTKIYIVLEFVTGGELFDKIASR-------------------  108 (342)
Q Consensus        61 ~~~E~~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-------------------  108 (342)
                      ...|+.++.+++|.++     +++++++..        .+..++||||+++++|.+++...                   
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            3357777777766554     667776643        35689999999999999888642                   


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccC
Q 019360          109 -----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV  183 (342)
Q Consensus       109 -----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  183 (342)
                           ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++........ .......+++.|+
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~  377 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYS  377 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCccee
Confidence                 1235667889999999999999999999999999999999999999999999864322111 1111223478999


Q ss_pred             ChhhhccCCC--------------------C-CcccchhhhhHHHHHHHhCCC-CCCCCcHH-----------HHHHHHH
Q 019360          184 APEVINNKGY--------------------D-GAKADLWSCGVILYVLMAGYL-PFEESNLM-----------ALYKKIF  230 (342)
Q Consensus       184 aPE~~~~~~~--------------------~-~~~~DiwslG~ll~~l~~g~~-pf~~~~~~-----------~~~~~i~  230 (342)
                      |||.+.....                    . ..+.||||+||++|+|++|.. ||......           ..+..+.
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            9999854221                    0 124799999999999999875 77542211           1111121


Q ss_pred             hc--CCCCCCCCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCccccc
Q 019360          231 KA--DFKSPPWFSTSAKKLISRILDPNP---VTRITMAEVIENEWFKK  273 (342)
Q Consensus       231 ~~--~~~~~~~~~~~~~~li~~~L~~dP---~~Rps~~e~l~h~~~~~  273 (342)
                      ..  .+......++..++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            12  233344578999999999999876   68999999999999964

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8e-40  Score=306.10  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=218.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ...|.+.||.|-||.|++|+.+..|   ..||||.++..  ..++....|..|+.+|-++.||||++|.|+......+.+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            4578999999999999999998766   45999999643  345666789999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |+|||+.|+|..+|..+ ++++..++..+++.|+.|++||-+.|.|||||...|||++.+-.+|++|||+++...... .
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~  786 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-E  786 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-C
Confidence            99999999999999875 779999999999999999999999999999999999999999999999999999764433 1


Q ss_pred             CceecccC--CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHH
Q 019360          171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKK  246 (342)
Q Consensus       171 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (342)
                      ...++..|  +.+|.|||.+....+ +.++||||+|+++||.++ |..||-+.+..+.++.|..+ .+++|..++..+.+
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q  865 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ  865 (996)
T ss_pred             ccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence            12222223  468999999987766 488999999999998766 99999999999999888765 56677789999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcC
Q 019360          247 LISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      |+..||++|-++||.+.+|+.+
T Consensus       866 LMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.2e-39  Score=264.17  Aligned_cols=250  Identities=26%  Similarity=0.480  Sum_probs=202.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCC--e
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKT--K   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~--~   88 (342)
                      ..++|++.+++|+|.++.||.|....+++.++||++..-.      .+.+.+|+.+|..|. ||||++++++..+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            5678999999999999999999999999999999986432      246789999999998 999999999986553  4


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~  167 (342)
                      ..+|+||++..+...+-..   ++.-.++.++.+++.||.|+|+.||+|||+||.|++|+.. ..++|+|+|+|.+....
T Consensus       110 paLiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            6799999988877766544   8889999999999999999999999999999999999864 57999999999764332


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC-CCCcHHHHHHHHHh-------------cC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFK-------------AD  233 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf-~~~~~~~~~~~i~~-------------~~  233 (342)
                      .   .......+..|--||.+.....+..+.|+|||||++..|+..+.|| .+.+..+..-+|.+             ..
T Consensus       187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            2   2233445677889999987666668999999999999999998887 34443333332221             00


Q ss_pred             CCC------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          234 FKS------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       234 ~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ...                        ....++++.||+.++|..|..+|+|+.|++.||||..
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            000                        1125789999999999999999999999999999974

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=290.68  Aligned_cols=243  Identities=26%  Similarity=0.444  Sum_probs=209.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      ....++||.|.||.||.|.++...-.||||.++...    -..+.|..|+.+|+.++|||+|+++++|..+..+|+|+||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            456789999999999999999999999999985432    2356789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           96 VTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        96 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |..|.|.++|.+.  ..++...+..++.||..|+.||..+++|||||...|+|+.++..||++|||++++.....    .
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT----Y  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT----Y  420 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc----e
Confidence            9999999999864  346777888999999999999999999999999999999999999999999999754322    1


Q ss_pred             ecccC---CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHHH
Q 019360          174 HTTCG---TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLI  248 (342)
Q Consensus       174 ~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li  248 (342)
                      +...|   ...|.|||.+....+. .++|||+|||++||+.| |-.||.+-+..+.+.-+-++ ...-+..+++.+.+|+
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM  499 (1157)
T ss_pred             ecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence            22233   4579999999766654 89999999999999998 89999999887776655543 3345778999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.||+++|.+||+++|+-+
T Consensus       500 raCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHhcCCcccCccHHHHHH
Confidence            9999999999999998853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=304.91  Aligned_cols=255  Identities=31%  Similarity=0.436  Sum_probs=199.9

Q ss_pred             eeeeeeecccCceE-EEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEE
Q 019360           16 YELGRTLGEGSFAK-VKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        16 y~~~~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      |.-.+.+|.|+.|+ ||+|..  .|+.||||.+..+.      ....++|+..|+.-. ||||+++++.-.++...|+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            44466789999985 788976  57899999875433      346779999998885 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---C--CCeeEcccccccCC
Q 019360           94 EFVTGGELFDKIASRG----RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---N--GVLKVSDFGLSALP  164 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~--~~~kl~Dfg~~~~~  164 (342)
                      |.|. .+|.++++...    .......+.++.|+++||++||+.+|+||||||.||||+.   +  ..++|+|||+++..
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9994 59999998741    1122456788999999999999999999999999999976   3  47899999999864


Q ss_pred             ccc-cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCCCC---CCC
Q 019360          165 QQV-RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKADFKS---PPW  239 (342)
Q Consensus       165 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~---~~~  239 (342)
                      ... ..-.......||.+|+|||++..... +.++|||||||++|+.++| ..||...-.  ...+|+++....   .+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccC
Confidence            432 12223456679999999999987654 4789999999999998885 999976533  233555554432   122


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCCCC
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ  282 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~~~~~  282 (342)
                      ...++.+||.+|+++||..||+|.++|.||+|....+...|.+
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~  781 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLR  781 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHH
Confidence            2228999999999999999999999999999987655544433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=318.47  Aligned_cols=237  Identities=19%  Similarity=0.337  Sum_probs=186.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ..|+..+.||+|+||.||+|+++.++..||+|.+......       ...|++.+++++||||+++++++...+..|+||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3466778999999999999999999999999998643211       125688899999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH---SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH---~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||+++++|.+++..   +++.++..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.......    
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999999964   889999999999999999999   6699999999999999998888775 555432111    


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-----HHHHHHHHH---------hcCCCC
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-----LMALYKKIF---------KADFKS  236 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-----~~~~~~~i~---------~~~~~~  236 (342)
                        .....+++.|+|||++.+..+ +.++|||||||++|||++|+.||....     .........         ......
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence              122357899999999987665 489999999999999999999985321     111111111         000100


Q ss_pred             C----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          237 P----PWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       237 ~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .    .....++.+++.+||+.||++|||++|+++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0    0112356789999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=289.12  Aligned_cols=258  Identities=28%  Similarity=0.480  Sum_probs=223.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +.-.++|.++..+|+|.+|.||+++++.+++..|+|+++.+.   .....-+++|+-+++..+|+||+.+++.+...+.+
T Consensus        11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            344568999999999999999999999999999999997544   33456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ++.||||.||+|.+.-.--+++++.++..+++..++||+|||+.|-+|||||-.||++++.|.+|+.|||.+.-....  
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--
Confidence            999999999999998877789999999999999999999999999999999999999999999999999987532221  


Q ss_pred             CCceecccCCcccCChhhhc---cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC-----CCCC
Q 019360          170 DGLLHTTCGTPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP-----PWFS  241 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~  241 (342)
                      -.......||+.|||||+..   ..+|. ..+|||++|+...|+---++|.....++....-..+..+.++     ...+
T Consensus       166 i~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            12235678999999999853   34454 899999999999999888888877777776666666655554     3478


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +.+.+|++.+|.++|++||+++.+|.|||...
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            88999999999999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-36  Score=266.48  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=193.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc--CCCCcceeEEEEEEeCC-
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL--IRHPNVIRMYEVMASKT-   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~-   87 (342)
                      ......++.+.||+|.||.||+|+..  ++.||||++....      .+.+++|-++.+.  ++|+||+++++.-.... 
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            34556788999999999999999874  5999999996433      3466677777654  47999999998876554 


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeecCCCCcEEecCCCCeeE
Q 019360           88 ---KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR---------GVCHRDLKPENLLLDANGVLKV  155 (342)
Q Consensus        88 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~---------giiH~dlkp~NIli~~~~~~kl  155 (342)
                         .+++|++|.+.|+|.++|..+ .+++....+|+..++.||+|||+.         .|+|||||..|||+..|++..|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               789999999999999999975 489999999999999999999963         5999999999999999999999


Q ss_pred             cccccccCCccccCCCceecccCCcccCChhhhccCCCCC-----cccchhhhhHHHHHHHhCCC------------CCC
Q 019360          156 SDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG-----AKADLWSCGVILYVLMAGYL------------PFE  218 (342)
Q Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~ll~~l~~g~~------------pf~  218 (342)
                      +|||+|.........+......||.+|||||++.+.-...     .+.||||+|.++||+++...            ||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999998766555555556689999999999998633221     35899999999999998543            332


Q ss_pred             -----CCcHHHHHHHHHhcCCC--CCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          219 -----ESNLMALYKKIFKADFK--SPPW-----FSTSAKKLISRILDPNPVTRITMAEV  265 (342)
Q Consensus       219 -----~~~~~~~~~~i~~~~~~--~~~~-----~~~~~~~li~~~L~~dP~~Rps~~e~  265 (342)
                           ..+..+++..+......  .+..     ....+++.+..||+.||+.|.|+.=+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                 13344454444443322  2221     23568899999999999999998543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=285.67  Aligned_cols=247  Identities=25%  Similarity=0.455  Sum_probs=203.8

Q ss_pred             eeeeeecccCceEEEEEEEc---C----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCe
Q 019360           17 ELGRTLGEGSFAKVKFARNT---E----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTK   88 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~---~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~   88 (342)
                      .+.+.||+|+||.|++|.-.   .    ....||||.+......  ...+.+..|+++|+.+. |+||+.+++.+...+.
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            56679999999999999743   1    1456999998654332  55678999999999885 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC
Q 019360           89 IYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV  152 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~  152 (342)
                      +++|+||+..|+|.+++....                .++..++..++.||+.|++||++.+++||||-..|||++.+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence            999999999999999998755                3888999999999999999999999999999999999999999


Q ss_pred             eeEcccccccCCccccCCCceecccC--CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCc-HHHHHHH
Q 019360          153 LKVSDFGLSALPQQVRDDGLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESN-LMALYKK  228 (342)
Q Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~-~~~~~~~  228 (342)
                      +||+|||+++........ ......+  ...|||||.+....+ +.++||||+|+++||+++ |..||.+.. ..++.+.
T Consensus       457 ~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             EEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            999999999843221111 1111222  346999999998554 589999999999999998 999998855 5556555


Q ss_pred             HHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          229 IFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       229 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +..+.. ..|..+++++.++++.||+.+|++||++.++.+
T Consensus       535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            555443 556778999999999999999999999999884

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=281.82  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=209.1

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCc----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGE----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      .+..++||+|+||+||+|.+...|+    +||+|++.....  .+....+.+|+-+|..+.|+|++++++++.... +.+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4557899999999999999876564    488888764332  333467889999999999999999999997655 789


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |++|+++|.|.++++.+ ..+-.+..+.|+.||++||.|||.+.++||||-..|||+....++|+.|||+++........
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999999864 67889999999999999999999999999999999999999999999999999976554433


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                      .......-.+.|||-|.+....+ +.++||||+||++||++| |..|+.+....++-..+.+++ ++-|+.++.++..++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            33333334567999999887666 589999999999999888 999999988877766665543 556778999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||-.|++.||+++++..
T Consensus       934 vkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHhccCcccCccHHHHHH
Confidence            9999999999999998875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=275.97  Aligned_cols=203  Identities=32%  Similarity=0.620  Sum_probs=184.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhH-----HHHHHHHHHHHhcCC---CCcceeEEEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM-----IGQIKREISTMKLIR---HPNVIRMYEVM   83 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~---h~~iv~l~~~~   83 (342)
                      .+..|..++.+|.|+||.|++|.++.+...|++|.+.++++.-...     +..+-.|+.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4556999999999999999999999999999999998877755443     335668999999998   99999999999


Q ss_pred             EeCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           84 ASKTKIYIVLEF-VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        84 ~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ++++++|++||- -+|.+|.++++.++.++|.+...|++|++.|+++||++||+|||||-+||.++.+|.+||+|||.+.
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence            999999999996 4677999999999999999999999999999999999999999999999999999999999999886


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCC
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE  218 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~  218 (342)
                      .    ...+......||..|.|||++.+..|-+..-|||+||+++|.++....||-
T Consensus       719 ~----~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 Y----TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             h----hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            3    345667788999999999999999999999999999999999998888874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=3.3e-36  Score=265.29  Aligned_cols=255  Identities=27%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcC---CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTE---TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASK   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~   86 (342)
                      .....|..+++||.|.|++||++.+..   ..+.||+|.+.....     ..++.+|+++|..+. +.||+++.+.+..+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            344578999999999999999999887   678999999864322     247889999999986 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~  165 (342)
                      +.+.+|+||++..+..++...   ++..++..+++.++.||+++|.+|||||||||+|+|.+. .+.-.|+|||++...+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999999888888766   778999999999999999999999999999999999975 4678999999985110


Q ss_pred             ccc------------------------------------------CCCceecccCCcccCChhhhccCCCCCcccchhhh
Q 019360          166 QVR------------------------------------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSC  203 (342)
Q Consensus       166 ~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  203 (342)
                      ...                                          .........||++|+|||++...+..++++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            000                                          00011224699999999999988777899999999


Q ss_pred             hHHHHHHHhCCCCCCCCc-HHHHHHHH---------------------------------------------HhcCC---
Q 019360          204 GVILYVLMAGYLPFEESN-LMALYKKI---------------------------------------------FKADF---  234 (342)
Q Consensus       204 G~ll~~l~~g~~pf~~~~-~~~~~~~i---------------------------------------------~~~~~---  234 (342)
                      |+++.-++++..||-... .......+                                             .+...   
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999984311 00000000                                             00000   


Q ss_pred             ---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          235 ---KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       235 ---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                         .....++..+.+|+.+||..||.+|.|++++|.||||..
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               001124557899999999999999999999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=235.23  Aligned_cols=208  Identities=26%  Similarity=0.488  Sum_probs=170.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEEe
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      ..-+..||+|++|.|-+.++..+|...|+|.+.....  .+..+++.+|+++..+. .+|.+|.+++.+-....+++.||
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            3446789999999999999999999999999965432  33446777888886544 69999999999888999999999


Q ss_pred             ccCCCchHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           95 FVTGGELFD----KIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        95 ~~~~~~L~~----~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      .|. .+|..    .+...+.++|..+-+|+..+..||.|||++ .++|||+||+||||+.+|++|+||||++....    
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~----  200 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV----  200 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh----
Confidence            994 47654    345567899999999999999999999976 89999999999999999999999999987432    


Q ss_pred             CCceec-ccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHh
Q 019360          170 DGLLHT-TCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFK  231 (342)
Q Consensus       170 ~~~~~~-~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~  231 (342)
                      ++...+ ..|...|||||.+..    .+| +-++||||||++++||.+++.||+. .++.+.+..+..
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            222333 568889999999863    345 4899999999999999999999975 355555555554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=256.65  Aligned_cols=248  Identities=25%  Similarity=0.444  Sum_probs=192.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHh--cCCCCcceeEEEEEEeC-
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK--LIRHPNVIRMYEVMASK-   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~~iv~l~~~~~~~-   86 (342)
                      +|.....++.+.||+|-||.||+|.+  .|+.||||++....      .+.+.+|.++.+  .|+|+||+.+++.-..+ 
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            45667799999999999999999988  48999999995322      235667888875  56999999999876433 


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEecCCCCeeE
Q 019360           87 ---TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR--------GVCHRDLKPENLLLDANGVLKV  155 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~--------giiH~dlkp~NIli~~~~~~kl  155 (342)
                         .++++|++|.+.|+|+++|.+ ..++.+...+++..++.||++||..        .|.|||||..|||+..++.+.|
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence               369999999999999999997 6689999999999999999999953        4999999999999999999999


Q ss_pred             cccccccCCcccc--CCCceecccCCcccCChhhhccCC----CCC-cccchhhhhHHHHHHHhC----------CCCCC
Q 019360          156 SDFGLSALPQQVR--DDGLLHTTCGTPNYVAPEVINNKG----YDG-AKADLWSCGVILYVLMAG----------YLPFE  218 (342)
Q Consensus       156 ~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~~~-~~~DiwslG~ll~~l~~g----------~~pf~  218 (342)
                      +|+|+|.......  -+-.....+||.+|||||++...-    +.+ ..+||||||.++||++..          ++||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999997544332  122345678999999999986421    111 359999999999999762          56774


Q ss_pred             C-----CcHHHHHHHHHhcCCCC--CCCC-C----HHHHHHHHHhcCCCCCCCCCHHHHh
Q 019360          219 E-----SNLMALYKKIFKADFKS--PPWF-S----TSAKKLISRILDPNPVTRITMAEVI  266 (342)
Q Consensus       219 ~-----~~~~~~~~~i~~~~~~~--~~~~-~----~~~~~li~~~L~~dP~~Rps~~e~l  266 (342)
                      +     .+.+++..-+......+  +... +    ..+..+++.||..||.-|.|+-.+-
T Consensus       438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            3     44555555444443333  2222 2    2466889999999999999986654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.2e-33  Score=237.74  Aligned_cols=213  Identities=45%  Similarity=0.815  Sum_probs=185.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      ||.|++|.||++.+..+++.+++|++.......  ....+.+|+..++.++|++++++++++......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999997543321  345788999999999999999999999998999999999998999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCccccCCCceecccCC
Q 019360          102 FDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGT  179 (342)
Q Consensus       102 ~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  179 (342)
                      .+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........  ......+.
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT  156 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence            9999876 57899999999999999999999999999999999999999 89999999999875432211  12334578


Q ss_pred             cccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019360          180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR  259 (342)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (342)
                      ..|++||........+.++|+|++|++++++                               ..+.+++..|++.||.+|
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R  205 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR  205 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence            8999999997653445889999999999998                               679999999999999999


Q ss_pred             CCHHHHhcCc
Q 019360          260 ITMAEVIENE  269 (342)
Q Consensus       260 ps~~e~l~h~  269 (342)
                      |+++++++|+
T Consensus       206 ~~~~~l~~~~  215 (215)
T cd00180         206 PSAKEILEHL  215 (215)
T ss_pred             cCHHHHhhCC
Confidence            9999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=242.10  Aligned_cols=250  Identities=26%  Similarity=0.461  Sum_probs=195.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEE-EEeCCeEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEV-MASKTKIY   90 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~-~~~~~~~~   90 (342)
                      .+.|.|.+.||+|.||.+-++.++.++..+++|.+.+....    .+.|.+|..---.|. |.||+.-+++ |+..+.+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            45799999999999999999999999999999999765433    457889988777776 8999988875 67777888


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec--CCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD--ANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~--~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +++||++-|+|.+.+... .+-|.....++.|+++|+.|+|++++||||||.+||||-  +..++||||||+++....  
T Consensus        99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--  175 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--  175 (378)
T ss_pred             EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence            999999999999988764 478999999999999999999999999999999999993  344899999999874322  


Q ss_pred             CCCceecccCCcccCChhhhccCC----CCCcccchhhhhHHHHHHHhCCCCCCCCcHHH----HHHHHHhcC----CCC
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKG----YDGAKADLWSCGVILYVLMAGYLPFEESNLMA----LYKKIFKAD----FKS  236 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~----~~~~i~~~~----~~~  236 (342)
                         .....--+..|.|||......    .-.+.+|+|+||+++|.++||+.||.....++    .+..-.+..    ...
T Consensus       176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~  252 (378)
T KOG1345|consen  176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK  252 (378)
T ss_pred             ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence               112222356789999875321    11367999999999999999999997533211    122222221    112


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCcccc
Q 019360          237 PPWFSTSAKKLISRILDPNPVTR---ITMAEVIENEWFK  272 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~R---ps~~e~l~h~~~~  272 (342)
                      ...+++.+..+.++-|..+|++|   .++.......|..
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            23478999999999999999999   6666666666754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-32  Score=233.62  Aligned_cols=216  Identities=45%  Similarity=0.788  Sum_probs=181.5

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+......  ...+.+.+|+..++.++|+|++++++++......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999988999999999764432  2456888999999999999999999999988999999999


Q ss_pred             cCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           96 VTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      +++++|.+++..... +++..+..++.+++.++.+||+++++|+|++|.||+++.++.++|+|||.+........ ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~  157 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK  157 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence            999999999988666 89999999999999999999999999999999999999999999999998875433210 1223


Q ss_pred             cccCCcccCChhhh-ccCCCCCcccchhhhhHHHHHHHhCCCCCCC-Cc-HHHHHHHHHhcCCC
Q 019360          175 TTCGTPNYVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SN-LMALYKKIFKADFK  235 (342)
Q Consensus       175 ~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~-~~~~~~~i~~~~~~  235 (342)
                      ...++..|++||.+ ....+ +.++|+|+||+++++|++|+.||.. .+ ...+.+.+..+...
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            45678889999998 44344 4689999999999999999999977 34 44555555554433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1.3e-32  Score=277.53  Aligned_cols=201  Identities=17%  Similarity=0.238  Sum_probs=146.5

Q ss_pred             cCCC-CcceeEEEEE-------EeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 019360           70 LIRH-PNVIRMYEVM-------ASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDL  140 (342)
Q Consensus        70 ~l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dl  140 (342)
                      .++| +||..++++|       .....+++++|++ +++|.+++... ..+++.+++.+++||++||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3345 4777777776       2234577889988 56999999753 55899999999999999999999999999999


Q ss_pred             CCCcEEecCC-------------------CCeeEcccccccCCccccC--------------CCceecccCCcccCChhh
Q 019360          141 KPENLLLDAN-------------------GVLKVSDFGLSALPQQVRD--------------DGLLHTTCGTPNYVAPEV  187 (342)
Q Consensus       141 kp~NIli~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~  187 (342)
                      ||+|||++..                   +.+|++|||+++.......              ........||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999654                   4556666666653211000              000112457889999999


Q ss_pred             hccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 019360          188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISRILDPNPVTRITMAEVI  266 (342)
Q Consensus       188 ~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  266 (342)
                      +.+..+ +.++|||||||++|||++|..|+.....  ....+.....+. .....+...+++.+||++||.+||++.|++
T Consensus       187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence            988776 5899999999999999999988754321  111221111111 111245678999999999999999999999


Q ss_pred             cCcccccC
Q 019360          267 ENEWFKKG  274 (342)
Q Consensus       267 ~h~~~~~~  274 (342)
                      +||||...
T Consensus       264 ~h~~~~~~  271 (793)
T PLN00181        264 QSEFINEP  271 (793)
T ss_pred             hchhhhhh
Confidence            99999763

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=233.22  Aligned_cols=251  Identities=19%  Similarity=0.261  Sum_probs=203.8

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCC-----cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-CC
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETG-----ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-KT   87 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~   87 (342)
                      .|++....+-+|.||.||.|++.+..     +.|-+|.+...  .++-....+..|...+..+.|+|+..+.++... ..
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            46788888999999999999775432     33555655321  233445678899999999999999999998754 45


Q ss_pred             eEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           88 KIYIVLEFVTGGELFDKIASR--------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      ..++++.++.-|.|..++...        ..++..++..++.|++.|++|||++|+||.||...|.+|++.-.+||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            678889999889999998721        237778899999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSP  237 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~  237 (342)
                      +++-.-...........-.+..||+||.+....++ .++|+|||||++|||+| |+.|+..-++.++..-+.++. ..-|
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            98743222222222223346689999999988775 88999999999999988 999999999999888887764 3445


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      -.+++++..++.-||..+|++||+++|+..
T Consensus       521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            679999999999999999999999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.4e-32  Score=260.29  Aligned_cols=262  Identities=29%  Similarity=0.525  Sum_probs=210.1

Q ss_pred             ecCe-eeeeeecccCceEEEEEEEcCCCcEEEEEEecch---hhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           13 VGKY-ELGRTLGEGSFAKVKFARNTETGENVAIKILDKE---KVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        13 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..+| ...+.+|.|++|.|+.+......+.++.|.+...   ..........+..|+-+-..++|+|++..+..+.....
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            4456 4577899999998888888777777777765421   11222222336677777888999999887777666665


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .+..||||++ +|...+.+.+.+...++..+++|++.|++|+|+.||.|||+|++|++++.+|.+||+|||.+.......
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            6666999999 999999988789999999999999999999999999999999999999999999999999988665544


Q ss_pred             CC--CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH--HHHHh-------cCCCCC
Q 019360          169 DD--GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY--KKIFK-------ADFKSP  237 (342)
Q Consensus       169 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~--~~i~~-------~~~~~~  237 (342)
                      ..  ......+|+..|+|||++.+..|+....||||.|+++..|.+|+.||......+..  .....       +.....
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence            44  55667789999999999999999989999999999999999999999765544332  11111       111122


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      ..++.+.+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            34678899999999999999999999999999998643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=5.3e-30  Score=212.46  Aligned_cols=158  Identities=25%  Similarity=0.324  Sum_probs=127.3

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceeccc
Q 019360           99 GELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC  177 (342)
Q Consensus        99 ~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  177 (342)
                      |+|.+++..+ ..+++.+++.++.|++.||.|||+++      ||+||+++.++.+++  ||.+......       ...
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence            5899999874 56999999999999999999999999      999999999999999  9988753321       126


Q ss_pred             CCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcCCCC-------CCCCCH--HHHHH
Q 019360          178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKS-------PPWFST--SAKKL  247 (342)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~-------~~~~~~--~~~~l  247 (342)
                      ||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .....+.......       +..++.  ++.++
T Consensus        66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            88999999999887764 8999999999999999999999765432 2223332221111       112333  69999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +.+||+.||.+||++.++++|+|+.
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHH
Confidence            9999999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=5.2e-27  Score=211.72  Aligned_cols=255  Identities=36%  Similarity=0.653  Sum_probs=210.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC-cceeEEEEEEeCCeEEEEEe
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP-NVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e   94 (342)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+.+++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999987   78999999765554433567889999999999988 79999999987777899999


Q ss_pred             ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCCccccCC
Q 019360           95 FVTGGELFDKIASRG---RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ++.++++...+....   .++......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777664   799999999999999999999999999999999999999988 7999999998743332211


Q ss_pred             C----ceecccCCcccCChhhhccC--CCCCcccchhhhhHHHHHHHhCCCCCCCCcH----HHHHHHHHhcCCC-CCCC
Q 019360          171 G----LLHTTCGTPNYVAPEVINNK--GYDGAKADLWSCGVILYVLMAGYLPFEESNL----MALYKKIFKADFK-SPPW  239 (342)
Q Consensus       171 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~----~~~~~~i~~~~~~-~~~~  239 (342)
                      .    ......|+..|+|||.+.+.  ...+...|+|++|++++++++|..||.....    ......+.....+ ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence            1    34667899999999999874  3455889999999999999999999877763    4444444444433 2211


Q ss_pred             CC--------HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          240 FS--------TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       240 ~~--------~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ..        ..+.+++..++..+|..|.+..+...+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            11        47899999999999999999999998877654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.9e-28  Score=221.22  Aligned_cols=173  Identities=21%  Similarity=0.233  Sum_probs=134.0

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcC-CCcEEEEEEecchhh--hhhhHHHHHHHHHHHHhcCCCCccee-EEE
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTE-TGENVAIKILDKEKV--LKHKMIGQIKREISTMKLIRHPNVIR-MYE   81 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-l~~   81 (342)
                      |+.-+...++|++.+.||+|+||+||+|+++. +++.+|||++.....  ........+.+|+++|++++|+|++. +++
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            44456677889999999999999999999876 678889998753211  12233457899999999999999985 443


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCcEEecCCCCeeEccccc
Q 019360           82 VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL-KPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dl-kp~NIli~~~~~~kl~Dfg~  160 (342)
                          .+..|+||||++|++|.. ...   ..   ...++.++++||.|||++||+|||| ||+|||++.++.++|+|||+
T Consensus        90 ----~~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         90 ----TGKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             ----cCCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence                245799999999999963 211   11   2467899999999999999999999 99999999999999999999


Q ss_pred             ccCCccccCCCc------eecccCCcccCChhhhc
Q 019360          161 SALPQQVRDDGL------LHTTCGTPNYVAPEVIN  189 (342)
Q Consensus       161 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~  189 (342)
                      ++..........      .....+++.|+|||.+.
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            985443221111      23456788899999885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-29  Score=230.09  Aligned_cols=239  Identities=33%  Similarity=0.610  Sum_probs=207.1

Q ss_pred             eecccCceEEEEEEE---cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEEecc
Q 019360           21 TLGEGSFAKVKFARN---TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~   96 (342)
                      .+|.|+||.|+++..   ...|.-+|+|+..+......... +-..|..++...+ |+.++++...++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999997753   34577799999876443322222 4556778888887 999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecc
Q 019360           97 TGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT  176 (342)
Q Consensus        97 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  176 (342)
                      .|++|...+.....+.+.....+...++-++.++|+.||+|||+|++||+++.+|++++.|||+++..-...      ..
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence            999999999888889999999999999999999999999999999999999999999999999998533221      12


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP  256 (342)
                      |||..|||||+++  +. ...+|.||+|+++++|++|..||.+    ++...|++..+..|...+..+++++..++..+|
T Consensus       154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence            8999999999998  23 3789999999999999999999988    788889999999999999999999999999999


Q ss_pred             CCCCC-----HHHHhcCccccc
Q 019360          257 VTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       257 ~~Rps-----~~e~l~h~~~~~  273 (342)
                      .+|.-     +.|+++|+||+.
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             HHHhccCcchhHHHhccchhee
Confidence            99985     489999999974

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-26  Score=207.75  Aligned_cols=249  Identities=25%  Similarity=0.325  Sum_probs=192.1

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCC-cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC----CCcceeEEEEE-EeCCe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR----HPNVIRMYEVM-ASKTK   88 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~iv~l~~~~-~~~~~   88 (342)
                      +|++.++||+|+||.||.|.+..++ ..+|+|+.........   ..+..|+.++..+.    ..++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998775 6789998765322211   15667888888886    36899999998 47778


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-----CCeeEcccccc
Q 019360           89 IYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-----GVLKVSDFGLS  161 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-----~~~kl~Dfg~~  161 (342)
                      -|+||+.+ |.+|.++....  +.++...+..|+.|++.+|++||+.|++||||||+|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            89999998 88999988654  579999999999999999999999999999999999999754     46999999999


Q ss_pred             cCCccccCC--------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHH---
Q 019360          162 ALPQQVRDD--------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---  230 (342)
Q Consensus       162 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~---  230 (342)
                      +........        .......||..|.++....+... +.+.|+||++.++.+++.|..||.+...........   
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            832211111        10123459999999999987665 589999999999999999999997655322222221   


Q ss_pred             hcCC-C-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          231 KADF-K-SPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       231 ~~~~-~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .... . .....+.++.++...+-..+...+|....+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            1111 1 223345678888888888899999998777654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=9.6e-26  Score=191.05  Aligned_cols=174  Identities=14%  Similarity=0.210  Sum_probs=135.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHH------HHHHHHHHhcCCCCcceeEEEEEEe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ------IKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      ..++|++.+.||.|+||.||++.+  ++..+|+|++.......+....+      +.+|+..+.++.|++|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999755  46789999997655444444444      5799999999999999999988653


Q ss_pred             C--------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcc
Q 019360           86 K--------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSD  157 (342)
Q Consensus        86 ~--------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~D  157 (342)
                      .        +..+++|||++|.+|.+...    +++    ....+++.+|..+|+.|++|||++|+||+++.++ ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3        35789999999999977632    333    2456999999999999999999999999999888 99999


Q ss_pred             cccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHH
Q 019360          158 FGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM  211 (342)
Q Consensus       158 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~  211 (342)
                      ||.+.........              ...+....+. .++|+|+||+++..+.
T Consensus       178 fg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence            9987643211100              1133444565 7899999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=1.7e-25  Score=195.02  Aligned_cols=237  Identities=26%  Similarity=0.335  Sum_probs=155.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC----------CcceeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH----------PNVIRMYEV   82 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~iv~l~~~   82 (342)
                      .......+.||.|+++.||.+.+..+|+.+|+|++...........+.+.+|.-....+.+          -.++-.++.
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            3456788999999999999999999999999999865544444556777777766655432          122222232


Q ss_pred             EE---------eC---C-----eEEEEEeccCCCchHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHhCCceee
Q 019360           83 MA---------SK---T-----KIYIVLEFVTGGELFDKIA---SRGRL----KEDEARKYFQQLINAVDYCHSRGVCHR  138 (342)
Q Consensus        83 ~~---------~~---~-----~~~lv~e~~~~~~L~~~l~---~~~~l----~~~~~~~i~~~l~~~L~~LH~~giiH~  138 (342)
                      ..         ..   .     +.+++|+-+ .++|...+.   .....    .......+..|+++.+++||..|++|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            21         11   1     246788887 458877654   22222    222345556899999999999999999


Q ss_pred             cCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccC-------CCCCcccchhhhhHHHHHHH
Q 019360          139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-------GYDGAKADLWSCGVILYVLM  211 (342)
Q Consensus       139 dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~ll~~l~  211 (342)
                      ||+|+|++++.+|.+.|+||+.......     .......+..|.|||.....       ...+.+.|.|+||+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999987653222     11213445789999987542       12357899999999999999


Q ss_pred             hCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019360          212 AGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR  259 (342)
Q Consensus       212 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (342)
                      +|..||...........    .+.....+++.+++||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999986543221111    333333688999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=8.5e-27  Score=226.19  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=183.6

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .|...+.||++-|=.|.+|++.. |. |++|++-+... ..-....+...|++ ....++||++++.-+...+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            68889999999999999998853 44 99999865431 12222233334555 56678999999988887888889999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC--CC
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DG  171 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~  171 (342)
                      +|... +|++.+..++.+..-+.+.|+.|++.||..+|+.||+|||||.+||||+..+.+.|+||..-+..-...+  ..
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99965 9999999999999999999999999999999999999999999999999999999999985432111111  11


Q ss_pred             ---ceecccCCcccCChhhhccCC---------C-CCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHH-HHhcCCCC
Q 019360          172 ---LLHTTCGTPNYVAPEVINNKG---------Y-DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKK-IFKADFKS  236 (342)
Q Consensus       172 ---~~~~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~-i~~~~~~~  236 (342)
                         ...+...-..|.|||.+....         . -+++.||||+||+++|+++ |++||.-......... ....+...
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L  259 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL  259 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence               111222334799999886421         1 2468999999999999988 7888854332222111 00000000


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..--+..++.||..|++.||.+|.++++.|+.
T Consensus       260 e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  260 EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            01124579999999999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=2e-25  Score=186.62  Aligned_cols=141  Identities=23%  Similarity=0.292  Sum_probs=111.4

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh-----------------------HHHHHHHHHHHHhcCCCCc
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-----------------------MIGQIKREISTMKLIRHPN   75 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~   75 (342)
                      .+.||+|++|.||+|.+. +|+.||+|++.........                       ......+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999997 8999999999754221111                       0123346999999998877


Q ss_pred             ceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEEecCCCCee
Q 019360           76 VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC-HSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        76 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~L-H~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      +.....+.. .. .++||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+||+++ ++.++
T Consensus        81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            644333322 22 389999999887765544456789999999999999999999 799999999999999998 57899


Q ss_pred             EcccccccC
Q 019360          155 VSDFGLSAL  163 (342)
Q Consensus       155 l~Dfg~~~~  163 (342)
                      |+|||+|..
T Consensus       158 LiDFG~a~~  166 (190)
T cd05147         158 IIDVSQSVE  166 (190)
T ss_pred             EEEcccccc
Confidence            999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-24  Score=178.85  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=188.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCe
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNVIRMYEVMASKTK   88 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~   88 (342)
                      ....++|+++++||+|+||.+|.|....+|+.||+|+-.... ...    ++..|.++.+.|++ ..|..+..++.+...
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCc----chhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            356789999999999999999999999999999999865422 222    46689999999974 577777777778888


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC---CCeeEcccccccCC
Q 019360           89 IYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN---GVLKVSDFGLSALP  164 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~---~~~kl~Dfg~~~~~  164 (342)
                      -.+||+.. |.+|.+++.- ...++..++.-++-|++.-++|+|.++++||||||+|+|..-+   ..+.++|||+|+..
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            88999998 8899888764 3558999999999999999999999999999999999999543   46899999999754


Q ss_pred             ccccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH---HHHHHHHHhcCCCC
Q 019360          165 QQVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL---MALYKKIFKADFKS  236 (342)
Q Consensus       165 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~  236 (342)
                      ......     ..-....||.+|.+--...+.. .+...|+=|+|.++.++.-|..||.+-..   .+-+++|.......
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST  243 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence            332211     1123346888898877665533 34779999999999999999999987543   33444454444333


Q ss_pred             C-----CCCCHHHHHHHHHhcCCCCCCCCCH
Q 019360          237 P-----PWFSTSAKKLISRILDPNPVTRITM  262 (342)
Q Consensus       237 ~-----~~~~~~~~~li~~~L~~dP~~Rps~  262 (342)
                      +     ..++.++.-.+.-|-..-=++-|..
T Consensus       244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            2     3467788888877766655666653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.9e-24  Score=183.87  Aligned_cols=212  Identities=24%  Similarity=0.393  Sum_probs=173.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~   90 (342)
                      ..-.|+++++||+|+||+.+.|.+.-++++||||.-.....     .-++..|.+..+.|. .++|..++.+...+-+-.
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            34479999999999999999999999999999997543221     226778999998886 789999998888888888


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-----CeeEcccccccCC
Q 019360           91 IVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-----VLKVSDFGLSALP  164 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-----~~kl~Dfg~~~~~  164 (342)
                      +|+|++ |.+|.++..-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+     .+.++|||+++..
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999998 88999988764 5699999999999999999999999999999999999996543     5899999999754


Q ss_pred             ccccC-----CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHH
Q 019360          165 QQVRD-----DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIF  230 (342)
Q Consensus       165 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~  230 (342)
                      .....     .....+..||.+||+--...+... +..-|+=|||-++++++-|.+||.+.   +..+-+++|-
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            33221     123345679999999988887654 48899999999999999999999774   3444444443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=1.9e-25  Score=216.57  Aligned_cols=225  Identities=32%  Similarity=0.601  Sum_probs=174.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ....-..|..++.|..|++|.||.++++.+.+++|+|+ .++...       +.+   ++.....|.             
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-------lRn---ilt~a~npf-------------  133 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-------LRN---ILTFAGNPF-------------  133 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-------hhc---cccccCCcc-------------
Confidence            33445679999999999999999999999999999944 332211       111   222222332             


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                        .|      |+=...++.-++++.+.        +.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++..-...
T Consensus       134 --vv------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  134 --VV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             --ee------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence              33      34445555556666654        778999999999999999999999999999999999986421110


Q ss_pred             C-------------CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC
Q 019360          169 D-------------DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK  235 (342)
Q Consensus       169 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  235 (342)
                      .             .-.-...|||+.|+|||++...+| +..+|+|++|+++|+++-|+.||.+.+.++++..+......
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            0             011234589999999999998887 48899999999999999999999999999999988876655


Q ss_pred             CC---CCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCcccccC
Q 019360          236 SP---PWFSTSAKKLISRILDPNPVTRI---TMAEVIENEWFKKG  274 (342)
Q Consensus       236 ~~---~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~h~~~~~~  274 (342)
                      .+   ..++++++++|..+|+.+|..|.   .+-++.+|+||+..
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            44   34789999999999999999997   46788899999853

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=4.7e-24  Score=178.92  Aligned_cols=143  Identities=21%  Similarity=0.284  Sum_probs=113.5

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh-----------------------hhHHHHHHHHHHHHhcCCCC
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK-----------------------HKMIGQIKREISTMKLIRHP   74 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~   74 (342)
                      +.+.||+|++|.||+|.+. +|+.||+|++.......                       ......+.+|.+.+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3678999999999999987 89999999987542110                       00122346899999999999


Q ss_pred             cceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCe
Q 019360           75 NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVL  153 (342)
Q Consensus        75 ~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~  153 (342)
                      ++.....+....  .|+||||++|+++.........++......++.|++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            875544443332  48999999987654443344668889999999999999999999 9999999999999998 8999


Q ss_pred             eEcccccccCC
Q 019360          154 KVSDFGLSALP  164 (342)
Q Consensus       154 kl~Dfg~~~~~  164 (342)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.2e-25  Score=184.15  Aligned_cols=244  Identities=20%  Similarity=0.369  Sum_probs=194.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ++...++-+|.....|..|+|++.  |..+++|++..... ....-+.|..|.-.|+-+.||||+.+++.+....++.++
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            344566778889999999999884  55677788754333 333446788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           93 LEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ..||+.|+|++.+.....  .+..++.+++.+++.|++|||+..  |----|....|+|+++-+.+|. .+-+++..+  
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq--  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ--  342 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee--
Confidence            999999999999987643  577889999999999999999874  4444788899999999887764 111111111  


Q ss_pred             CCCceecccCCcccCChhhhccCCCC--CcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--CCCCCCCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYD--GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~  244 (342)
                      .    ....-.|.||+||.+..++.+  -.++|+|||++++||+.|...||..-++++.-.++.-.  ....|+.++..+
T Consensus       343 e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  343 E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence            0    112236899999999875543  35799999999999999999999999888876665433  456788999999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHh
Q 019360          245 KKLISRILDPNPVTRITMAEVI  266 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l  266 (342)
                      ..|++-|++.||.+||.++.++
T Consensus       419 ~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999988775

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-24  Score=189.24  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=175.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCc-----------------------------------EEEEEEecchhh-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGE-----------------------------------NVAIKILDKEKV-   52 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----------------------------------~vavK~~~~~~~-   52 (342)
                      ++.+++.|++.+.||+|+...||.+....+|.                                   +.|+|.+-.-.. 
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            45677889999999999999999987654211                                   244554321111 


Q ss_pred             -hhhhHHHHHHHHHH-------H-------Hhc--------CCCCcceeEEEEEEe------------------------
Q 019360           53 -LKHKMIGQIKREIS-------T-------MKL--------IRHPNVIRMYEVMAS------------------------   85 (342)
Q Consensus        53 -~~~~~~~~~~~E~~-------~-------l~~--------l~h~~iv~l~~~~~~------------------------   85 (342)
                       .+...++.+.+|.-       .       .+.        -+|||||++.++|.+                        
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence             11222333333321       1       111        259999999987633                        


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec--CCC--CeeEccc
Q 019360           86 ---KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD--ANG--VLKVSDF  158 (342)
Q Consensus        86 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~--~~~--~~kl~Df  158 (342)
                         ...+|+||..++. +|++++-.+. .+.....-++.|+++|+.|||++||.|||+|.+|||+.  +++  .+.|+||
T Consensus       312 ~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             cCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence               2358999998854 9999998754 46667788999999999999999999999999999993  333  5789999


Q ss_pred             ccccCCcccc----CCCceecccCCcccCChhhhccCCC-----CCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHH
Q 019360          159 GLSALPQQVR----DDGLLHTTCGTPNYVAPEVINNKGY-----DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI  229 (342)
Q Consensus       159 g~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i  229 (342)
                      |.+-..+..+    ..+......|.-.-||||+....+-     +-.++|.|+.|.+.||+++...||-+...+.+-..-
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~  469 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT  469 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence            9864221100    0111122346677899999863221     125799999999999999999999774433222111


Q ss_pred             H--hcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 019360          230 F--KADFKSPPWFSTSAKKLISRILDPNPVTRITMA  263 (342)
Q Consensus       230 ~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  263 (342)
                      .  ......++.+++.+++|+..+|+.||++|+++.
T Consensus       470 Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  470 YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            1  223345677999999999999999999999954

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1e-22  Score=169.13  Aligned_cols=191  Identities=16%  Similarity=0.211  Sum_probs=141.3

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhH-HHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM-IGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.+...|++|+||+||.+..  .+.+++.+.+.......... ...+.+|+++|++|. |+++.+++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            35678999999999997765  67888877776544432222 225789999999996 5789999886    3469999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCcEEecCCCCeeEcccccccCCccccCC--
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL-KPENLLLDANGVLKVSDFGLSALPQQVRDD--  170 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dl-kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~--  170 (342)
                      ||+.|.+|......       ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++.........  
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888654321       12357889999999999999999999 799999999999999999999743321110  


Q ss_pred             --Cc-------eecccCCcccCChhhhccCCCCC-cccchhhhhHHHHHHHhCCCCCCC
Q 019360          171 --GL-------LHTTCGTPNYVAPEVINNKGYDG-AKADLWSCGVILYVLMAGYLPFEE  219 (342)
Q Consensus       171 --~~-------~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~ll~~l~~g~~pf~~  219 (342)
                        ..       ..-...++.|+.|+....-...+ ...+.++.|+-+|.++|+..++-+
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence              00       00112577888888754322222 567899999999999999988643

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=1.1e-21  Score=165.82  Aligned_cols=136  Identities=21%  Similarity=0.290  Sum_probs=107.8

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-----CCCcceeEEEEEEeCC---e
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-----RHPNVIRMYEVMASKT---K   88 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~---~   88 (342)
                      .-.+.||+|+||.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+     .||||++++++++++.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3457899999999995  7777665 6998865322   2235788999999999     5799999999998763   4


Q ss_pred             EE-EEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeecCCCCcEEecC----CCCeeEccccc
Q 019360           89 IY-IVLEF--VTGGELFDKIASRGRLKEDEARKYFQQLINAV-DYCHSRGVCHRDLKPENLLLDA----NGVLKVSDFGL  160 (342)
Q Consensus        89 ~~-lv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L-~~LH~~giiH~dlkp~NIli~~----~~~~kl~Dfg~  160 (342)
                      ++ +|+||  +++++|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||||+|||++.    ++.++|+||+.
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            44 78999  5579999999764 46665  46678888777 9999999999999999999974    34799999554


Q ss_pred             c
Q 019360          161 S  161 (342)
Q Consensus       161 ~  161 (342)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=7e-22  Score=170.79  Aligned_cols=144  Identities=19%  Similarity=0.245  Sum_probs=114.5

Q ss_pred             CeeeeeeecccCceEEEEEE-EcCCCcEEEEEEecchhhhh---------------------hhHHHHHHHHHHHHhcCC
Q 019360           15 KYELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLK---------------------HKMIGQIKREISTMKLIR   72 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~   72 (342)
                      -|++.+.||.|++|.||+|. +..+|+.||+|++.......                     ......+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47899999999999999999 66789999999987532100                     011234678999999997


Q ss_pred             CCc--ceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCcEEecC
Q 019360           73 HPN--VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDLKPENLLLDA  149 (342)
Q Consensus        73 h~~--iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~g-iiH~dlkp~NIli~~  149 (342)
                      +.+  +.+++++    ...++||||++|.+|.........+...++..++.|++.++++||+.| ++||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3444442    235899999999888766544455677778899999999999999999 99999999999998 


Q ss_pred             CCCeeEcccccccC
Q 019360          150 NGVLKVSDFGLSAL  163 (342)
Q Consensus       150 ~~~~kl~Dfg~~~~  163 (342)
                      ++.++|+|||.+..
T Consensus       184 ~~~i~LiDFg~a~~  197 (237)
T smart00090      184 DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCCEEEEEChhhhc
Confidence            88999999998763

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=6.2e-22  Score=195.40  Aligned_cols=197  Identities=21%  Similarity=0.334  Sum_probs=159.3

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR---HPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~   87 (342)
                      ....+|.|.+.||.|+||.||.|.+.. |+.||+|+-.....+.-..-      ..++.+|+   -+.|..+...+.-.+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccCC
Confidence            345679999999999999999999976 99999999766555533222      22333444   234555555545556


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-------CCCeeEccccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-------NGVLKVSDFGL  160 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-------~~~~kl~Dfg~  160 (342)
                      .-++|+||.+.|+|.+++...+.+++..+..++.|++..+..||..|||||||||+|.|+..       ..-++|+|||.
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            67899999999999999998888999999999999999999999999999999999999942       34689999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYL  215 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~  215 (342)
                      +.-.............++|..+-.+|+..+..+. ..+|.|.|+.+++.|+.|+.
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence            8644333444566777889999999999999985 99999999999999999863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.9e-23  Score=199.56  Aligned_cols=260  Identities=30%  Similarity=0.533  Sum_probs=214.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC-CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~   90 (342)
                      ...|.+.+.||.|+|+.|-.+....+ ...+|+|.+.... .......++..|..+-+.++ |.|++.+++.....+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            66799999999999999988877433 3456666664332 23344556677888888887 999999999999999999


Q ss_pred             EEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEecCCC-CeeEcccccccCCcc
Q 019360           91 IVLEFVTGGELFDKI-ASRG-RLKEDEARKYFQQLINAVDYCH-SRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQ  166 (342)
Q Consensus        91 lv~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~~l~~~L~~LH-~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~  166 (342)
                      +++++..|+++...+ .... ..+......++.|+..++.|+| ..++.|+|+||+|.+++..+ ..++.|||+|.....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999888 5554 5778889999999999999999 99999999999999999999 999999999986655


Q ss_pred             -ccCCCceecccC-CcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH-HHhc----CCCCCCC
Q 019360          167 -VRDDGLLHTTCG-TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK-IFKA----DFKSPPW  239 (342)
Q Consensus       167 -~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~-i~~~----~~~~~~~  239 (342)
                       .+........+| ++.|+|||...+..+.+...|+||.|+++..+++|..|+........... ....    ...+...
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             445555667788 99999999999877778999999999999999999999976554332211 1111    2344556


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++....+++.+++..+|..|.+.+++-.++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=3.2e-20  Score=158.38  Aligned_cols=138  Identities=25%  Similarity=0.325  Sum_probs=115.0

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhh-----hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++.||+|++|.||+|..  .|..+++|+.......     ......++.+|++++..+.|+++.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  6778999986532211     1112346789999999999999887777776777889999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      ||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.||+++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998876432    8889999999999999999999999999999998 78999999998874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=2.5e-20  Score=172.72  Aligned_cols=200  Identities=21%  Similarity=0.355  Sum_probs=158.3

Q ss_pred             HhcCCCCcceeEEEEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-eeecCCCCcE
Q 019360           68 MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGV-CHRDLKPENL  145 (342)
Q Consensus        68 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~gi-iH~dlkp~NI  145 (342)
                      |+.+.|.|+.++++.+.++...+.|.+||.-|+|.+.+... -.++..-...++++++.||.|||+..| .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999873 457888888999999999999998876 9999999999


Q ss_pred             EecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCC------CCcccchhhhhHHHHHHHhCCCCCCC
Q 019360          146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY------DGAKADLWSCGVILYVLMAGYLPFEE  219 (342)
Q Consensus       146 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~ll~~l~~g~~pf~~  219 (342)
                      +++....+||+|||+.................-...|.|||.+.....      -+.+.||||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876543111111222223457999999976321      24679999999999999999999975


Q ss_pred             C----cHHHHHHHHHh-cCCCCCC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          220 S----NLMALYKKIFK-ADFKSPP------WFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       220 ~----~~~~~~~~i~~-~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .    +..++...+.+ ....+.+      ...+++..+++.||..+|.+||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    33445555555 2222222      23457999999999999999999988864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=1.3e-21  Score=178.26  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=173.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEE----
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE----   81 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~----   81 (342)
                      .......+.+.+..+..+++.+...+-..+   .+.++-+.....   +........+++-.+....|.+..-+.+    
T Consensus       239 ~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s  315 (516)
T KOG1033|consen  239 RHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPS  315 (516)
T ss_pred             cccccccccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCc
Confidence            334445566777777777777776554433   233444433221   1122234445666665555544433333    


Q ss_pred             ---EEE-----eCCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           82 ---VMA-----SKTKIYIVLEFVTGGELFDKIASRG---RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        82 ---~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                         .+.     ...++|+.|++|...+|.+++..+.   ..+...+..++.|++.|+.|   +|.+|+|+||.||+...+
T Consensus       316 ~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d  392 (516)
T KOG1033|consen  316 LFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD  392 (516)
T ss_pred             hhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc
Confidence               111     1235889999999999999997543   36777899999999999999   999999999999999999


Q ss_pred             CCeeEcccccccCCcccc----CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHH
Q 019360          151 GVLKVSDFGLSALPQQVR----DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMAL  225 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~  225 (342)
                      ..+||.|||+........    .....+...||..||+||.+.+..|. .++||||||++++|++. -..+|   .....
T Consensus       393 ~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~---er~~t  468 (516)
T KOG1033|consen  393 DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQF---ERIAT  468 (516)
T ss_pred             hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHH---HHHHh
Confidence            999999999987543332    12234556799999999999998875 99999999999999986 22222   12222


Q ss_pred             HHHHHhcCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          226 YKKIFKADFKSPPW-FSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       226 ~~~i~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ...+-.+.+++... -.++-.+|+.+||.+.|.+||++.+.-.|+|.
T Consensus       469 ~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  469 LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            33333344432111 12456799999999999999988888777775

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1.1e-19  Score=153.55  Aligned_cols=133  Identities=20%  Similarity=0.262  Sum_probs=107.3

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEecchhhh-----hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           21 TLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      .||+|++|.||+|..  +|..+++|+.......     ......++.+|++++..+.|+++....-++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  5788999986432211     112235778999999999988765555455556667899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988765321       7899999999999999999999999999998 89999999998874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=9.2e-20  Score=153.98  Aligned_cols=137  Identities=19%  Similarity=0.300  Sum_probs=107.9

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh-------------------hhHHHHHHHHHHHHhcCCCCc-
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK-------------------HKMIGQIKREISTMKLIRHPN-   75 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~h~~-   75 (342)
                      |.+.+.||.|+||.||++... +|+.||||++.......                   ........+|+.++..+.|.+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999875 79999999875422000                   001123678899998887774 


Q ss_pred             -ceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           76 -VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        76 -iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                       +...++    ....++||||++|++|......      .....++.+++.++.++|+.|++||||+|+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2345899999999988765331      34567889999999999999999999999999999999999


Q ss_pred             EcccccccC
Q 019360          155 VSDFGLSAL  163 (342)
Q Consensus       155 l~Dfg~~~~  163 (342)
                      |+|||.+..
T Consensus       166 liDfg~~~~  174 (198)
T cd05144         166 IIDWPQMVS  174 (198)
T ss_pred             EEECCcccc
Confidence            999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=3.3e-19  Score=172.48  Aligned_cols=139  Identities=19%  Similarity=0.249  Sum_probs=112.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchh-----hhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEK-----VLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..|...+.||+|+||+||++....  ..+++|+.....     .......+++.+|+++++.++|++++....++.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345668899999999999998753  344444432111     1111234578899999999999999888777777777


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      .++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999998875        356789999999999999999999999999999 678999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=1.1e-18  Score=145.93  Aligned_cols=137  Identities=23%  Similarity=0.373  Sum_probs=98.8

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHH---------------------HHHHHHHHHhcCCCCc--
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG---------------------QIKREISTMKLIRHPN--   75 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~h~~--   75 (342)
                      .+.||+|+||+||+|.+. +|+.||+|++............                     ....|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999986 8999999998653221111111                     1135666666665432  


Q ss_pred             ceeEEEEEEeCCeEEEEEeccCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCe
Q 019360           76 VIRMYEVMASKTKIYIVLEFVTGGELFD-KIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVL  153 (342)
Q Consensus        76 iv~l~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~  153 (342)
                      +.+.++.    ...++||||++++.+.. .+.... .. .+...++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4444443    23589999999854321 121111 11 6788999999999999999 9999999999999999 8999


Q ss_pred             eEcccccccC
Q 019360          154 KVSDFGLSAL  163 (342)
Q Consensus       154 kl~Dfg~~~~  163 (342)
                      +|+|||.+..
T Consensus       154 ~liDfg~a~~  163 (187)
T cd05119         154 YIIDVPQAVE  163 (187)
T ss_pred             EEEECccccc
Confidence            9999998863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=1.2e-17  Score=144.72  Aligned_cols=137  Identities=20%  Similarity=0.313  Sum_probs=105.0

Q ss_pred             eeec-ccCceEEEEEEEcCCCcEEEEEEecchhh----------hhhhHHHHHHHHHHHHhcCCCCcc--eeEEEEEEeC
Q 019360           20 RTLG-EGSFAKVKFARNTETGENVAIKILDKEKV----------LKHKMIGQIKREISTMKLIRHPNV--IRMYEVMASK   86 (342)
Q Consensus        20 ~~lG-~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~   86 (342)
                      ..|| .|+.|+||.+...  +..+++|.+.....          .......++.+|++++..|.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 8888899988774  78899998853211          111223567899999999998875  6677664332


Q ss_pred             -Ce---EEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           87 -TK---IYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        87 -~~---~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                       ..   .++|||+++| .+|.+++.. ..+++..    +.+++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             22   3599999997 688888765 3456543    568999999999999999999999999999899999999987


Q ss_pred             cC
Q 019360          162 AL  163 (342)
Q Consensus       162 ~~  163 (342)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            63

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=8.6e-18  Score=134.93  Aligned_cols=132  Identities=23%  Similarity=0.358  Sum_probs=112.0

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC--CcceeEEEEEEeCCeEEEEEec
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH--PNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      +++.||.|.++.||++....  ..+++|.......     ...+.+|+..++.+++  .++.+++.+....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999999853  7899999865432     3467889999999986  5889999888877889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR---GVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~---giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      ++|..+...       +......++.+++++++++|..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            988777544       5567778899999999999985   799999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=4.5e-18  Score=165.84  Aligned_cols=264  Identities=26%  Similarity=0.443  Sum_probs=207.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +..++.+.+.+.+-+|+++.++.+.-..+|...+.|+............+.+..+-.++-...+|-++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45778899999999999999999988777866777765432222121122233333333333456666555455667889


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc--
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV--  167 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  167 (342)
                      +++++|..+++|...++.-+..+.+-.+..+..+.+++++||+..+.|+|++|.|+++..+++.++.|||........  
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            999999999999999998888888888899999999999999999999999999999999999999999843211000  


Q ss_pred             --c-------------------------CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          168 --R-------------------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       168 --~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                        .                         .........||+.|.+||...+... +..+|+|++|+++++.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence              0                         0011233568999999999988766 47899999999999999999999999


Q ss_pred             cHHHHHHHHHhcCCCCC---CCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCcccccC
Q 019360          221 NLMALYKKIFKADFKSP---PWFSTSAKKLISRILDPNPVTRITMA---EVIENEWFKKG  274 (342)
Q Consensus       221 ~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~---e~l~h~~~~~~  274 (342)
                      .....+..+.+...+.+   ...+.++++++..+|..+|.+|..+.   ++-.|+||+..
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            99999999988877654   34788999999999999999999987   88999999853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.71  E-value=1.9e-16  Score=148.61  Aligned_cols=234  Identities=17%  Similarity=0.284  Sum_probs=164.9

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -|.+ ...+-++.+..-.|..+.++.+|.|.++.....   .......+.+.-|+.++||||+++++.++..+.+|+|+|
T Consensus        14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence            3666 555555555333577788999999999875443   344567788999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH-SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH-~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      .+.  .|..++++   +....+...++||+.||.||| +++++|++|+-+.|+++..|..||++|.++........  ..
T Consensus        90 rV~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~  162 (690)
T KOG1243|consen   90 RVR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PA  162 (690)
T ss_pred             ccc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cc
Confidence            983  67777776   347788889999999999997 67899999999999999999999999998764433221  11


Q ss_pred             ecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Q 019360          174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD  253 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (342)
                      ....---.|..|+.+....   ...|.|.|||++++++.|..+  ...           .......++.....+..+-+-
T Consensus       163 ~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~--~~~-----------~~~~~~~ipk~~~~~~~k~~~  226 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLL--TKT-----------DLSNTGKIPKALIELYCKKLG  226 (690)
T ss_pred             ccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccC--cch-----------hhhccCccchhHHHHHHHHhc
Confidence            2222233577777664332   458999999999999998322  111           111222234444445444444


Q ss_pred             CCCCCCCCHH-----HHhcCcccccCC
Q 019360          254 PNPVTRITMA-----EVIENEWFKKGY  275 (342)
Q Consensus       254 ~dP~~Rps~~-----e~l~h~~~~~~~  275 (342)
                      -.+..||...     -.+-|.||++.+
T Consensus       227 ~~~~~r~n~~~~~~~~~~~~gff~n~f  253 (690)
T KOG1243|consen  227 ATELKRPNKLRFILECRLLGGFFRNDF  253 (690)
T ss_pred             cccccccchhhHHHHHHhccccccchH
Confidence            5566666532     223388887643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.6e-17  Score=154.38  Aligned_cols=253  Identities=20%  Similarity=0.230  Sum_probs=192.5

Q ss_pred             cCeeeeeeecc--cCceEEEEEEE--cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCe
Q 019360           14 GKYELGRTLGE--GSFAKVKFARN--TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTK   88 (342)
Q Consensus        14 ~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~   88 (342)
                      .+|.+.+.+|.  |.+|.||.+..  ..++..+|+|.-.. .......-.+-.+|+...+.+. |++.++.+..++..+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            35778889999  99999999998  88999999998322 1111222233456777777775 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeecCCCCcEEecCC-CCeeEccccccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLIN----AVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSA  162 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~----~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~  162 (342)
                      .|+-+|+| +.+|..+...... +++..++.++.+..+    ||.++|+.+++|-|+||.||+...+ ...+++|||+..
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            99999999 5688888876544 889999999999999    9999999999999999999999998 889999999876


Q ss_pred             CCccccCCC---ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHHhcCCCC
Q 019360          163 LPQQVRDDG---LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKADFKS  236 (342)
Q Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~  236 (342)
                      ......-..   ......|...|++||..++.  .+...|+|++|.++.+..++..+....   ......+..  .....
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~  347 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEF  347 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchhh
Confidence            443322111   11222567789999999764  357899999999999988876665433   111111111  11111


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      ....+.++...+..|++.+|..|++++.+++|++..
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            223466777799999999999999999999999876

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=4.6e-17  Score=140.49  Aligned_cols=203  Identities=15%  Similarity=0.274  Sum_probs=144.6

Q ss_pred             HHHHhcCCCCcceeEEEEEEeC-----CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 019360           65 ISTMKLIRHPNVIRMYEVMASK-----TKIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSR--  133 (342)
Q Consensus        65 ~~~l~~l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~--  133 (342)
                      ...|-++-|.|+++++.|+.+.     ....++.|||..|++.++|++    +..+......+++-||+.||.|||++  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3445566799999999998543     458899999999999999975    34578889999999999999999988  


Q ss_pred             CceeecCCCCcEEecCCCCeeEcccccccCCccccC--CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHH
Q 019360          134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM  211 (342)
Q Consensus       134 giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~  211 (342)
                      -|+|+++..+.|++..+|-+|+.--.-.........  ........+-++|.+||.-...+.. .++|||++|....+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~-~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTT-GASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccc-cchhhhhhhHHHHHHH
Confidence            499999999999999999888863322211111100  0111223456889999976654443 6799999999999998


Q ss_pred             hCCCCC-CCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          212 AGYLPF-EESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       212 ~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      .+..-- ...+.......+.+..+..   -...-++++.+||+..|+.||++.+++.||..
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            876542 2222222222222211111   12335688999999999999999999999975

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.62  E-value=4.5e-16  Score=147.98  Aligned_cols=147  Identities=22%  Similarity=0.391  Sum_probs=98.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh-------------------------------hhHH
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK-------------------------------HKMI   58 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~   58 (342)
                      ...+..|+. +.||+|++|.||+|+.+.+|+.||||+..+.....                               .+..
T Consensus       116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            344566776 89999999999999998889999999997431100                               0111


Q ss_pred             HH------HHHHHHHHhcCC----CCcceeEEEEEEe-CCeEEEEEeccCCCchHHH--HHhcC----CCCHHHHHHHHH
Q 019360           59 GQ------IKREISTMKLIR----HPNVIRMYEVMAS-KTKIYIVLEFVTGGELFDK--IASRG----RLKEDEARKYFQ  121 (342)
Q Consensus        59 ~~------~~~E~~~l~~l~----h~~iv~l~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~  121 (342)
                      +.      +.+|+..+.++.    +...+.+-.++.+ .+..++||||++|+.+.+.  +...+    .+.+..+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            22      344444444442    3333333333322 3456799999999999764  33332    133333444444


Q ss_pred             HHHHHHHHHHhCCceeecCCCCcEEecCCC----CeeEcccccccCC
Q 019360          122 QLINAVDYCHSRGVCHRDLKPENLLLDANG----VLKVSDFGLSALP  164 (342)
Q Consensus       122 ~l~~~L~~LH~~giiH~dlkp~NIli~~~~----~~kl~Dfg~~~~~  164 (342)
                      |+       ...|++|+|+||.||+++.++    .++++|||++...
T Consensus       275 Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        275 QV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            44       468999999999999999887    9999999998643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=9.2e-15  Score=137.34  Aligned_cols=146  Identities=23%  Similarity=0.324  Sum_probs=99.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh-------------------------------hHH----
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH-------------------------------KMI----   58 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------~~~----   58 (342)
                      ..|. .+.||+|++|.||+|..+ +|+.||||+........-                               +..    
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~  195 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR  195 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence            3344 368999999999999875 789999999854211000                               000    


Q ss_pred             --HHHHHHHHHHhcCC----CCcceeEEEEE-EeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHH
Q 019360           59 --GQIKREISTMKLIR----HPNVIRMYEVM-ASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLIN-AVDY  129 (342)
Q Consensus        59 --~~~~~E~~~l~~l~----h~~iv~l~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~-~L~~  129 (342)
                        -++.+|++.+.++.    +.+-+.+-.++ ...+..++||||++|++|.+..... ...+   ...++..++. .+..
T Consensus       196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQ  272 (437)
T ss_pred             HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence              02455666665553    32223322222 2234568999999999998876532 1222   3445556555 4788


Q ss_pred             HHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360          130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus       130 LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      +|..|++|+|++|.||+++.++.++++|||++...
T Consensus       273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            99999999999999999999999999999998643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.6e-15  Score=141.11  Aligned_cols=253  Identities=20%  Similarity=0.192  Sum_probs=187.5

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc-CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCe
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT-ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTK   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~   88 (342)
                      ...++|..+..||.|.|+.|+.+... .++..|++|...+........+.. ..|+-+...+ .|.+++.....|....+
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence            45678999999999999999987755 677889999886544433333322 2455555555 48888888887777777


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~  167 (342)
                      .|+--|||.++++.........+++...+++..|++.++.++|+..++|+|++|+||++..+ +..++.|||..+.... 
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-  419 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-  419 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence            88999999998887666544557888999999999999999999999999999999999876 7889999998753111 


Q ss_pred             cCCCceecccCCcccCC-hhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVA-PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK  246 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (342)
                          .........++.| +|++........++|+++||..+.+.+++...-..   ...+..+..+..+..+....++..
T Consensus       420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQV  492 (524)
T ss_pred             ----ecccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhh
Confidence                0111223344452 55554444445899999999999999988654222   122344555555555556688999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          247 LISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +.+.++.+++..|+.+.++..|.-|-
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhh
Confidence            99999999999999999999887654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.57  E-value=3.5e-14  Score=118.00  Aligned_cols=140  Identities=16%  Similarity=0.219  Sum_probs=101.2

Q ss_pred             eeeecccCceEEEEEEEcC------CCcEEEEEEecchhh---------------h----hhhHHH----HHHHHHHHHh
Q 019360           19 GRTLGEGSFAKVKFARNTE------TGENVAIKILDKEKV---------------L----KHKMIG----QIKREISTMK   69 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~---------------~----~~~~~~----~~~~E~~~l~   69 (342)
                      ...||.|.-+.||.|....      .+..+|||+......               .    .....+    ...+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998653      357899998742110               0    001122    2348999999


Q ss_pred             cCCC--CcceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEE
Q 019360           70 LIRH--PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC-HSRGVCHRDLKPENLL  146 (342)
Q Consensus        70 ~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~L-H~~giiH~dlkp~NIl  146 (342)
                      ++..  -++..++++    ..-++||||+.+..+..-..+...+++++...+..+++.+|..| |+.|++||||++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8864  355566654    34579999997654432222233456677788899999999999 8999999999999999


Q ss_pred             ecCCCCeeEcccccccC
Q 019360          147 LDANGVLKVSDFGLSAL  163 (342)
Q Consensus       147 i~~~~~~kl~Dfg~~~~  163 (342)
                      ++ ++.+.|+|||.+..
T Consensus       158 ~~-~~~v~iIDF~qav~  173 (197)
T cd05146         158 WH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             EE-CCcEEEEECCCcee
Confidence            96 57899999998763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.52  E-value=4.8e-14  Score=115.86  Aligned_cols=127  Identities=21%  Similarity=0.331  Sum_probs=95.8

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce-eEEEEEEeCCeEEEEEeccC
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI-RMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~lv~e~~~   97 (342)
                      ++.|+.|.++.||++...  ++.|++|+......    ....+.+|+.+++.+.+.+++ +++.+..  +..++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999874  78899999754321    112456899999888755544 4554432  33579999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeecCCCCcEEecCCCCeeEccccccc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV-----CHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~gi-----iH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      |.++...        ......++.+++++|+.||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887543        01123456899999999999985     9999999999998 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1.1e-12  Score=105.71  Aligned_cols=135  Identities=19%  Similarity=0.256  Sum_probs=100.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh-----HHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-----MIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      ..+++|+-+.+|.+..  -|..+++|.=.+.....+.     -..+-.+|++++.++.--.|.-..=++.+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4678999999999865  3455777753221111111     23466789999998876555544445556667789999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      |++|..|.+.+...       ...++..+-.-+.-||..||+||||.++||+++.++ +.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99999898888875       256677777888999999999999999999996654 999999998753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.41  E-value=6.7e-12  Score=100.75  Aligned_cols=145  Identities=21%  Similarity=0.230  Sum_probs=107.3

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecc-----hhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDK-----EKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+..|-+|+-+.|+.+..  .|+.+.||.-..     ......-..++..+|++.|.++.--.|.-..=++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678889999999999976  588888886322     1122222346778999999888755555444455555566799


Q ss_pred             EeccCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CeeEcccccccCC
Q 019360           93 LEFVTG-GELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALP  164 (342)
Q Consensus        93 ~e~~~~-~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~---~~kl~Dfg~~~~~  164 (342)
                      |||++| .++.+++.+..  ....+....++..+-+.+.-||..+||||||.++||++..++   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999977 46777776542  233334478899999999999999999999999999996654   4589999998753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=6.8e-12  Score=107.53  Aligned_cols=141  Identities=21%  Similarity=0.311  Sum_probs=106.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC--cceeEEEEEEeC---CeEEEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP--NVIRMYEVMASK---TKIYIVL   93 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~---~~~~lv~   93 (342)
                      .+.|+.|..+.||++... +|+.+++|........  .....+.+|+.+++.+.+.  .+.+++.+....   +..++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            367899999999999874 3688999997653321  1234678999999999764  456777776553   3578999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-----------------------------------------  132 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-----------------------------------------  132 (342)
                      ||++|.++...+.. ..+++++...++.+++++|..||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999888665432 346777777777788888877773                                         


Q ss_pred             ---------------CCceeecCCCCcEEecC--CCCeeEcccccccC
Q 019360          133 ---------------RGVCHRDLKPENLLLDA--NGVLKVSDFGLSAL  163 (342)
Q Consensus       133 ---------------~giiH~dlkp~NIli~~--~~~~kl~Dfg~~~~  163 (342)
                                     ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23699999999999988  56789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.34  E-value=3.6e-11  Score=110.37  Aligned_cols=212  Identities=17%  Similarity=0.251  Sum_probs=154.6

Q ss_pred             ceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeEEEEEeccCC-Cch
Q 019360           27 FAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----KTKIYIVLEFVTG-GEL  101 (342)
Q Consensus        27 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~e~~~~-~~L  101 (342)
                      -.+.|++....+|..|++|.++..+....   +....-++.++++.|.|+|++.++|..    +..+++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            36789999999999999999954332222   122345778999999999999999873    3468999999876 456


Q ss_pred             HHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360          102 FDKIA---------------SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus       102 ~~~l~---------------~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      .++--               ++...++..+|.++.|+..||.++|+.|+..+-|.|.+|+++.+.+++|...|+..+...
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            55431               122468899999999999999999999999999999999999988999988777654332


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC-CCCcHHHH-HHHHHhcCCCCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-EESNLMAL-YKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf-~~~~~~~~-~~~i~~~~~~~~~~~~~~~  244 (342)
                      ..              .  |.+.+.    .+-|.=.||.+++.|.||..-- ........ ...|       ...++.++
T Consensus       446 d~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~  498 (655)
T KOG3741|consen  446 DP--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDL  498 (655)
T ss_pred             CC--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHH
Confidence            11              0  112221    3578899999999999996442 11111111 1111       23378899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      +++|.-+...++++ -++.+++.|-
T Consensus       499 rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  499 RNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHHHHHHhcCccc-ccHHHHHHHH
Confidence            99999999999987 7788888653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.21  E-value=3.6e-10  Score=99.20  Aligned_cols=135  Identities=16%  Similarity=0.100  Sum_probs=95.6

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecchhhhh---h-----hHHHHHHHHHHHHhcCCCCcc--eeEEEEEEe-----CCeEE
Q 019360           26 SFAKVKFARNTETGENVAIKILDKEKVLK---H-----KMIGQIKREISTMKLIRHPNV--IRMYEVMAS-----KTKIY   90 (342)
Q Consensus        26 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~-----~~~~~   90 (342)
                      ....|+.+..  .|+.|.||.........   .     .-...+.+|.+.+..|...+|  ..++.+++.     ....+
T Consensus        34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            3444556543  57789999764322110   0     001136789999888854333  344555543     23578


Q ss_pred             EEEeccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-------CCCeeEccccc
Q 019360           91 IVLEFVTGG-ELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-------NGVLKVSDFGL  160 (342)
Q Consensus        91 lv~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-------~~~~kl~Dfg~  160 (342)
                      +|||++++. +|.+++..  ....+......++.+++..+.-||+.||+|+|+++.|||++.       +..+.++||+.
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            999999886 78888764  244567788899999999999999999999999999999975       46899999997


Q ss_pred             cc
Q 019360          161 SA  162 (342)
Q Consensus       161 ~~  162 (342)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            75

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.20  E-value=2.2e-10  Score=94.98  Aligned_cols=126  Identities=25%  Similarity=0.390  Sum_probs=83.2

Q ss_pred             EEEEEEEcCCCcEEEEEEecchh-----------------------hhhhhHHHHHHHHHHHHhcCCCC--cceeEEEEE
Q 019360           29 KVKFARNTETGENVAIKILDKEK-----------------------VLKHKMIGQIKREISTMKLIRHP--NVIRMYEVM   83 (342)
Q Consensus        29 ~V~~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~   83 (342)
                      .||.|.. .+|..+|+|+.....                       ...........+|++.|.++...  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888987 467899999874310                       01111234678999999999866  456666542


Q ss_pred             EeCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           84 ASKTKIYIVLEFVT--GGELFDKIASRGRLKEDEARKYFQQLINAVDY-CHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        84 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~-LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                          .-.+||||++  |..+..+....  ++.+....++.+++..+.. +|..||+|||+++.||+++.+ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2359999998  65665443322  1245567788888885555 579999999999999999877 999999998


Q ss_pred             cc
Q 019360          161 SA  162 (342)
Q Consensus       161 ~~  162 (342)
                      +.
T Consensus       153 av  154 (188)
T PF01163_consen  153 AV  154 (188)
T ss_dssp             EE
T ss_pred             ce
Confidence            76

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=1.2e-11  Score=117.27  Aligned_cols=153  Identities=18%  Similarity=0.325  Sum_probs=111.2

Q ss_pred             HHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCcccc-----CCC--ceecccCCcccCChhhhccCCC
Q 019360          122 QLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----DDG--LLHTTCGTPNYVAPEVINNKGY  193 (342)
Q Consensus       122 ~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~--~~~~~~gt~~y~aPE~~~~~~~  193 (342)
                      +++.|+.|+|. .++||++|.|++|.++..+.+||+.|+.+.......     ...  ..........|.|||++.... 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence            33489999996 589999999999999999999999999875433211     111  111112346799999998744 


Q ss_pred             CCcccchhhhhHHHHHHH-hCCCCCCCCcHHHHHHHHH----hcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          194 DGAKADLWSCGVILYVLM-AGYLPFEESNLMALYKKIF----KADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       194 ~~~~~DiwslG~ll~~l~-~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+.++|+||+||++|.+. .|+.-+...........-.    ...+.....+++++++=+.++|..++..||++.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            468999999999999888 4555554432222211111    11223345688999999999999999999999999999


Q ss_pred             cccccCC
Q 019360          269 EWFKKGY  275 (342)
Q Consensus       269 ~~~~~~~  275 (342)
                      |||++..
T Consensus       266 ~ff~D~~  272 (700)
T KOG2137|consen  266 PFFSDPG  272 (700)
T ss_pred             cccCCch
Confidence            9998643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=1.2e-09  Score=98.29  Aligned_cols=235  Identities=17%  Similarity=0.215  Sum_probs=151.3

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEE------EEeCC-e
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEV------MASKT-K   88 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~------~~~~~-~   88 (342)
                      .....||+|+-+.+|-.-.-   ...+.|++.........      +.+..|... .||-+-.-+.|      ..+++ .
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            34678999999999965332   22455888765432221      223334333 45533321211      12223 3


Q ss_pred             EEEEEeccCCCchHHHH-------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           89 IYIVLEFVTGGELFDKI-------ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l-------~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      +.++|+.+.|..--..+       ++...+.+.-..+..+.++.+.+.||+.|-+-||++++|+|+++++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            77999988775322222       12234778899999999999999999999999999999999999999999875422


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCC----CCCcccchhhhhHHHHHHHhC-CCCCCCCc-------HH--HHHH
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKG----YDGAKADLWSCGVILYVLMAG-YLPFEESN-------LM--ALYK  227 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~ll~~l~~g-~~pf~~~~-------~~--~~~~  227 (342)
                      .+   ...........|...|.+||.-.-..    ..+...|.|.||+++++++.| +.||.+-.       ..  .+..
T Consensus       165 qi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         165 QI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             ee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            21   12333445567889999999754111    124679999999999998876 99997621       11  1111


Q ss_pred             HHH------hcCCCC-C-----CCCCHHHHHHHHHhcCC--CCCCCCCHH
Q 019360          228 KIF------KADFKS-P-----PWFSTSAKKLISRILDP--NPVTRITMA  263 (342)
Q Consensus       228 ~i~------~~~~~~-~-----~~~~~~~~~li~~~L~~--dP~~Rps~~  263 (342)
                      ..+      .....+ |     .-+++++..|+.+|+..  ++.-|||++
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            111      011111 1     23678999999999965  356899975

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.11  E-value=4e-10  Score=96.28  Aligned_cols=137  Identities=21%  Similarity=0.325  Sum_probs=103.8

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchh-------h------------hhhhHHHHHHHHHHHHhcCCCC--
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEK-------V------------LKHKMIGQIKREISTMKLIRHP--   74 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~------------~~~~~~~~~~~E~~~l~~l~h~--   74 (342)
                      +.+..+||-|.-|.||.|.+. .|.++|+|.=....       .            +-.-.....++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356789999999999999986 78999999521100       0            0011234568999999999755  


Q ss_pred             cceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           75 NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        75 ~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      .+.+.+++    +.-.+|||+++|..|...-     ++.+....++..|++-+..+-..|++|||+++-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            67777654    4567999999997765432     24556667777788777777799999999999999999999999


Q ss_pred             Eccccccc
Q 019360          155 VSDFGLSA  162 (342)
Q Consensus       155 l~Dfg~~~  162 (342)
                      ++||-.+.
T Consensus       243 vIDwPQ~v  250 (304)
T COG0478         243 VIDWPQAV  250 (304)
T ss_pred             EEeCcccc
Confidence            99998665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=2e-09  Score=91.24  Aligned_cols=105  Identities=21%  Similarity=0.381  Sum_probs=84.4

Q ss_pred             HHHHHHHHHHhcCCCCc--ceeEEEEEEeC----CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019360           59 GQIKREISTMKLIRHPN--VIRMYEVMASK----TKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAVDYCH  131 (342)
Q Consensus        59 ~~~~~E~~~l~~l~h~~--iv~l~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH  131 (342)
                      .+..+|.+.+..|...+  +.+.+++.+..    ...++|+|++++. +|.+++......+......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            35778888887775333  34556665542    2458999999884 79998887555777888999999999999999


Q ss_pred             hCCceeecCCCCcEEecCCC---CeeEcccccccC
Q 019360          132 SRGVCHRDLKPENLLLDANG---VLKVSDFGLSAL  163 (342)
Q Consensus       132 ~~giiH~dlkp~NIli~~~~---~~kl~Dfg~~~~  163 (342)
                      ..||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999998877   899999997763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.96  E-value=1.1e-08  Score=85.52  Aligned_cols=138  Identities=14%  Similarity=0.145  Sum_probs=99.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEecchhhhh---hhHHHHHHHHHHHHhcCCCCc--ceeEEEEEE---e--CCeEEE
Q 019360           22 LGEGSFAKVKFARNTETGENVAIKILDKEKVLK---HKMIGQIKREISTMKLIRHPN--VIRMYEVMA---S--KTKIYI   91 (342)
Q Consensus        22 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~---~--~~~~~l   91 (342)
                      -|+||.+.|+....  .|+.+-+|.-.......   +.....+.+|+..|.+|...+  +.++. ++.   .  .-..+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            36699999998765  34468888754111100   122357889999998886332  44444 332   1  123679


Q ss_pred             EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--eeEccccccc
Q 019360           92 VLEFVTG-GELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV--LKVSDFGLSA  162 (342)
Q Consensus        92 v~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~--~kl~Dfg~~~  162 (342)
                      |+|-++| .+|.+++.+.  .+.+......++.+++..++-||+.|+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9997754 5788887653  34678888999999999999999999999999999999986666  9999998765

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.91  E-value=2.1e-08  Score=84.12  Aligned_cols=139  Identities=19%  Similarity=0.275  Sum_probs=90.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHH------HHHHHHHHhcCC---CCcceeEEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ------IKREISTMKLIR---HPNVIRMYEVM   83 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~---h~~iv~l~~~~   83 (342)
                      .+.|.+.+.+-.....-|.+..-  +|+.+++|...............      ..+++..+..+.   -.....++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            35678888887777776766644  67899999986543332222221      233444343333   22333333332


Q ss_pred             E-----eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccc
Q 019360           84 A-----SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDF  158 (342)
Q Consensus        84 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Df  158 (342)
                      +     -....+++|||++|..|.+...    +++    .+...+.+++.-||+.|+.|||.+|.|++++.+ .++++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence            2     1234568999999988866532    333    244567788999999999999999999999854 5999999


Q ss_pred             cccc
Q 019360          159 GLSA  162 (342)
Q Consensus       159 g~~~  162 (342)
                      +..+
T Consensus       179 ~~k~  182 (229)
T PF06176_consen  179 QGKR  182 (229)
T ss_pred             cccc
Confidence            8654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=4.7e-08  Score=92.94  Aligned_cols=141  Identities=21%  Similarity=0.302  Sum_probs=92.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh-------------------------------hH------HHHHH
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH-------------------------------KM------IGQIK   62 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------~~------~~~~~   62 (342)
                      +.|+.++-|.||+|+.+ +|+.||||+.+..-...-                               +.      .-++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            78899999999999986 499999999754110000                               00      01244


Q ss_pred             HHHHHHhcCC-----CCcceeEEEEEEeCCeEEEEEeccCCCchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019360           63 REISTMKLIR-----HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI--ASRGRLKEDEARKYFQQLINAVDYCHSRGV  135 (342)
Q Consensus        63 ~E~~~l~~l~-----h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~~l~~~L~~LH~~gi  135 (342)
                      +|+..+.+++     .+++.-..=+++-.+.-.++|||++|..+.+..  ++ ..++...+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            5666665553     233322222223345567999999999888774  44 3455444333332221  333345899


Q ss_pred             eeecCCCCcEEecCCCCeeEcccccccCC
Q 019360          136 CHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus       136 iH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      +|.|.+|.||+++.+|++.+.|||+....
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecC
Confidence            99999999999999999999999987643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.75  E-value=9.8e-08  Score=81.02  Aligned_cols=138  Identities=20%  Similarity=0.265  Sum_probs=96.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh---------------------HHHHHHHHHHHHhcCC--CCc
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK---------------------MIGQIKREISTMKLIR--HPN   75 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~~~~~E~~~l~~l~--h~~   75 (342)
                      ...|+.|.-+.||+|.. .++..+|+|++......-..                     ...-..+|++.|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            45788899999999976 56899999998543221111                     0122357888888775  344


Q ss_pred             ceeEEEEEEeCCeEEEEEeccCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCe
Q 019360           76 VIRMYEVMASKTKIYIVLEFVTGGEL-FDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVL  153 (342)
Q Consensus        76 iv~l~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~  153 (342)
                      +.+.+.+.    .-.+|||++..... .-.|.. -++..++...+..++++.+.-|-. .++||+||+.=|||+. ++.+
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            45555544    34599999854311 111211 223344678888899999998887 8999999999999998 8899


Q ss_pred             eEcccccccC
Q 019360          154 KVSDFGLSAL  163 (342)
Q Consensus       154 kl~Dfg~~~~  163 (342)
                      .++|||.+..
T Consensus       206 ~iID~~QaV~  215 (268)
T COG1718         206 YIIDVSQAVT  215 (268)
T ss_pred             EEEECccccc
Confidence            9999998763

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.73  E-value=2.1e-07  Score=79.99  Aligned_cols=133  Identities=15%  Similarity=0.175  Sum_probs=83.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc--ceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN--VIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      ..||.|..+.||+.    .|..+++|......     ....+.+|.++++.+..-+  +.+.+++....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999973    25568889876422     1235678999998886443  4677777777777889999999


Q ss_pred             CCc-hHHH--------------H-------Hhc--CCCCHHHH-HHHHH----------HHHH-HHHHHH----hCCcee
Q 019360           98 GGE-LFDK--------------I-------ASR--GRLKEDEA-RKYFQ----------QLIN-AVDYCH----SRGVCH  137 (342)
Q Consensus        98 ~~~-L~~~--------------l-------~~~--~~l~~~~~-~~i~~----------~l~~-~L~~LH----~~giiH  137 (342)
                      |.+ +...              +       ++-  ...+.... ..+-.          .+.. ...+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 1111              1       110  01111110 01100          0111 112222    124789


Q ss_pred             ecCCCCcEEecCCCCeeEccccccc
Q 019360          138 RDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       138 ~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      +|+.|.||+++.++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.73  E-value=1.9e-07  Score=93.78  Aligned_cols=207  Identities=19%  Similarity=0.241  Sum_probs=146.2

Q ss_pred             HHHHHHHHHHHhcCCCCcceeEEEEEEeCCe----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019360           58 IGQIKREISTMKLIRHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR  133 (342)
Q Consensus        58 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~  133 (342)
                      +....-|+..+.++.|+|++.++.|-.....    ..+..++|...++...++.-+.++....+.+..++++||.|+|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            3445567788889999999999988754432    235567898999999999888899999999999999999999999


Q ss_pred             CceeecCCCC---cEEecCCCCeeEc--ccccccCCccccCCCceecccCCcccCChhhhccCCCC-CcccchhhhhHHH
Q 019360          134 GVCHRDLKPE---NLLLDANGVLKVS--DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD-GAKADLWSCGVIL  207 (342)
Q Consensus       134 giiH~dlkp~---NIli~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DiwslG~ll  207 (342)
                      ...|.-+..+   +-..+..+.+..+  ||+.+......   ........+..+.+||........ ....|+|++|.+.
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~---~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN---EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCc---ccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            7666666555   4444556666666  88877643322   122233446678888887654443 2347999999999


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          208 YVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       208 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ..+..|..+-.....   ...++..      .......+++.+|+..++++|+++.+++.|+|......
T Consensus       383 ~~~~~~~~i~~~~~~---~~~~l~~------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV---PVSLLDV------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             hhhhhcCcccccccc---hhhhhcc------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            998887655322111   1111110      01126889999999999999999999999999875433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.62  E-value=7.4e-09  Score=97.70  Aligned_cols=237  Identities=21%  Similarity=0.204  Sum_probs=163.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-VIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~   93 (342)
                      .|...+-+++|+++.+++.+...+...+ .+.+...        ....-++++|.+++||| .+..++-+..++..++.+
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            3667788899999999999887654444 6665432        13346888999999999 677777777778889999


Q ss_pred             eccCCC-c-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           94 EFVTGG-E-LFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        94 e~~~~~-~-L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      +++.++ + ....-.....+.+-+...+++.-+++++++|+.-=+|+|    ||+.+. +..+..||+...-...   ..
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TM  385 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---cc
Confidence            999776 1 111111122244455666777788999999998778888    777644 7889999998753322   22


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCC-----CCCHHH-
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPP-----WFSTSA-  244 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~-----~~~~~~-  244 (342)
                      ...+..+++.++|||+.....+. ...|.|++|+-..++.-|.+|-...-  .....+  +..+ .+.     ..++.. 
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~--g~~p~s~~L~~~~aw~~~~~  460 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMI--GNGPNSPMLTDKSAWSPVFH  460 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCC--CCCCCccccchhhhcCcccc
Confidence            34566789999999998887776 78999999998788887877754411  000000  0000 000     011111 


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .++...|+..-|..|+...+++-|.+|..
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            24778899999999999999999999874

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.61  E-value=7.3e-07  Score=76.75  Aligned_cols=137  Identities=19%  Similarity=0.311  Sum_probs=81.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC--cceeEEEEEE---eCCeEEEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP--NVIRMYEVMA---SKTKIYIVL   93 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~---~~~~~~lv~   93 (342)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.+...  .+.+++....   .....+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999998854  58999997653     2234677888888887633  3456665432   334578999


Q ss_pred             eccCCCchHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 019360           94 EFVTGGELFD----------------KIA---SR----GRLKEDE---------ARKY------------FQQLIN-AVD  128 (342)
Q Consensus        94 e~~~~~~L~~----------------~l~---~~----~~l~~~~---------~~~i------------~~~l~~-~L~  128 (342)
                      ++++|..+..                .+.   ..    ..+....         ....            ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    0111000         0000            111222 233


Q ss_pred             HHH-------hCCceeecCCCCcEEec-CCCCeeEccccccc
Q 019360          129 YCH-------SRGVCHRDLKPENLLLD-ANGVLKVSDFGLSA  162 (342)
Q Consensus       129 ~LH-------~~giiH~dlkp~NIli~-~~~~~kl~Dfg~~~  162 (342)
                      .++       ...++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            333       24699999999999999 56667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.50  E-value=1.3e-06  Score=76.01  Aligned_cols=134  Identities=13%  Similarity=0.111  Sum_probs=82.5

Q ss_pred             eecccCc-eEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEEeccCC
Q 019360           21 TLGEGSF-AKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        21 ~lG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      .|..|.. ..||++...  +..+.+|......      ...+.+|+++++.+. +--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            4555555 788988653  4678888875432      224567888888875 44456778777766678899999999


Q ss_pred             CchHHHH-------------------HhcC----CCCH---HHHHHH---HH----------------HHHHHHHHHH--
Q 019360           99 GELFDKI-------------------ASRG----RLKE---DEARKY---FQ----------------QLINAVDYCH--  131 (342)
Q Consensus        99 ~~L~~~l-------------------~~~~----~l~~---~~~~~i---~~----------------~l~~~L~~LH--  131 (342)
                      .++....                   +.-.    ++..   ......   +.                .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            7765331                   1000    0110   000000   00                0111122221  


Q ss_pred             -----hCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          132 -----SRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       132 -----~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                           ...++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 2348999999999999988778899999765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.40  E-value=4.9e-06  Score=69.15  Aligned_cols=128  Identities=22%  Similarity=0.279  Sum_probs=91.3

Q ss_pred             cCeeeeeeecccCc-eEEEEEEEcCCCcEEEEEEecc----------hhhhh--------hhHHHHHHHHHHHHhcCC--
Q 019360           14 GKYELGRTLGEGSF-AKVKFARNTETGENVAIKILDK----------EKVLK--------HKMIGQIKREISTMKLIR--   72 (342)
Q Consensus        14 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vavK~~~~----------~~~~~--------~~~~~~~~~E~~~l~~l~--   72 (342)
                      ..++.++.||.|.. |.||+++.  .|+.||+|++..          +....        ......+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 99999987  578999999321          00000        023346788999887775  


Q ss_pred             -CCcc--eeEEEEEEeC------------------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019360           73 -HPNV--IRMYEVMASK------------------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH  131 (342)
Q Consensus        73 -h~~i--v~l~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH  131 (342)
                       +.++  ++.+||..-.                  ....+|.||.+...         .++...    +.++.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence             4455  8999987321                  12457888776543         223333    456667788899


Q ss_pred             hCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360          132 SRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus       132 ~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      ..||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     4589999853

>PLN02876 acyl-CoA dehydrogenase

Probab=98.37  E-value=5.8e-06  Score=84.43  Aligned_cols=81  Identities=15%  Similarity=0.305  Sum_probs=56.9

Q ss_pred             eeeeecccCceEEEEEEEcCCC--cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcc--eeEEEEEEeC---CeE
Q 019360           18 LGRTLGEGSFAKVKFARNTETG--ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNV--IRMYEVMASK---TKI   89 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~l~~~~~~~---~~~   89 (342)
                      .+..++.|....+|+......+  ..+++|+........  ....+.+|+++|+.+. |.++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3677899999999998765432  467888764322111  1236779999999995 6654  7777777654   467


Q ss_pred             EEEEeccCCCc
Q 019360           90 YIVLEFVTGGE  100 (342)
Q Consensus        90 ~lv~e~~~~~~  100 (342)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999998864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.32  E-value=4.9e-06  Score=79.18  Aligned_cols=139  Identities=24%  Similarity=0.351  Sum_probs=87.6

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh----------------------------hhHHH------HHHHH
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK----------------------------HKMIG------QIKRE   64 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~~------~~~~E   64 (342)
                      -+.||.-+.|.||+|+.+. |+.||||+-+..-...                            .+..+      ++.+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4689999999999999875 9999999865411100                            00011      23344


Q ss_pred             HHHHhcC----CCCc------ceeEEEEEEeCCeEEEEEeccCCCchHH--HHHhcCCCCHHHHHHHHHHHHHHHH-HHH
Q 019360           65 ISTMKLI----RHPN------VIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVD-YCH  131 (342)
Q Consensus        65 ~~~l~~l----~h~~------iv~l~~~~~~~~~~~lv~e~~~~~~L~~--~l~~~~~l~~~~~~~i~~~l~~~L~-~LH  131 (342)
                      ++...+.    +|-+      |.+++-.  -.....++||||+|..+.+  .+.+++ ++...+..   .+.++.. -+=
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~---~l~~~~~~qIf  318 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILN---KLVEAYLEQIF  318 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHH---HHHHHHHHHHH
Confidence            4443333    3444      3333322  2345679999999987654  445544 55554333   3333322 233


Q ss_pred             hCCceeecCCCCcEEecC----CCCeeEcccccccCC
Q 019360          132 SRGVCHRDLKPENLLLDA----NGVLKVSDFGLSALP  164 (342)
Q Consensus       132 ~~giiH~dlkp~NIli~~----~~~~kl~Dfg~~~~~  164 (342)
                      ..|++|+|-+|.||++..    ++.+.+-|||+....
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            578999999999999984    668999999997643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.30  E-value=3.9e-06  Score=72.72  Aligned_cols=73  Identities=11%  Similarity=0.139  Sum_probs=45.8

Q ss_pred             eeeecccCce-EEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC---cceeEEEEEEeC---CeEEE
Q 019360           19 GRTLGEGSFA-KVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP---NVIRMYEVMASK---TKIYI   91 (342)
Q Consensus        19 ~~~lG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~~~---~~~~l   91 (342)
                      ++.|+.|+.. .||+.     +..+++|......     ....+.+|+++++.+...   .+.++++.....   ...++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            4567777776 48875     2357788764321     123678899999887632   344444443322   23588


Q ss_pred             EEeccCCCch
Q 019360           92 VLEFVTGGEL  101 (342)
Q Consensus        92 v~e~~~~~~L  101 (342)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=9.1e-06  Score=65.56  Aligned_cols=129  Identities=17%  Similarity=0.264  Sum_probs=91.5

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCccee-EEEEEEeCCeEEEEEec
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR-MYEVMASKTKIYIVLEF   95 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~~~~~~~~lv~e~   95 (342)
                      +..+.||+|.+|.||++...  |..+|+|+-..+.     ....++.|+++|..++-.++.+ ++.+..    .++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            45678999999999999874  6689999865432     2347889999999998777654 444332    3355999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC-CcEEecCCCCeeEcccccccC
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKP-ENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp-~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      +.|-.|.......   +    .+-+..++++---|-..||-|+.|+- ..+++-.++.+.|+||.-|+.
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9998886654421   2    23334556665567788999999974 444444556999999998773

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=4.6e-05  Score=63.81  Aligned_cols=131  Identities=21%  Similarity=0.308  Sum_probs=90.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhh-------------hhhhHHHHHHHHHHHHhcCC------CCcceeE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-------------LKHKMIGQIKREISTMKLIR------HPNVIRM   79 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~------h~~iv~l   79 (342)
                      ...||+|+.-.||.-  . .....+||+......             ......+...+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457899999999854  3 344578899876540             00111244556666665555      7889999


Q ss_pred             EEEEEeCCeEEEEEeccCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC--
Q 019360           80 YEVMASKTKIYIVLEFVTG------GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG--  151 (342)
Q Consensus        80 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~--  151 (342)
                      +|+.++..-..+|+|.+..      .+|.+++.. +.+++    .+...+-+-..||-+.+|+.+|++|.||++....  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999998888999987532      357777754 44555    3344455666788899999999999999995432  


Q ss_pred             --CeeEcc
Q 019360          152 --VLKVSD  157 (342)
Q Consensus       152 --~~kl~D  157 (342)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=5.3e-05  Score=63.08  Aligned_cols=98  Identities=17%  Similarity=0.260  Sum_probs=77.8

Q ss_pred             HHHHHHHhcCCC-CcceeEEEEEEeCCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 019360           62 KREISTMKLIRH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDK---IASRGRLKEDEARKYFQQLINAVDYCHS---RG  134 (342)
Q Consensus        62 ~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~~l~~~L~~LH~---~g  134 (342)
                      .+|.-+|+.+.+ +++.+++|+|-   + +++.||...+++...   +..-...++..+..|+.++++.+.+++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            368888888875 69999999883   2 568899876655321   1122235899999999999999999997   34


Q ss_pred             ceeecCCCCcEEecCCCCeeEcccccccC
Q 019360          135 VCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus       135 iiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      +.-.|++++|+-++.++++|++|......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            77799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.04  E-value=5.5e-05  Score=65.39  Aligned_cols=75  Identities=20%  Similarity=0.338  Sum_probs=48.1

Q ss_pred             eeeecccCceEEEEEEEcC-CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeEEEEEecc
Q 019360           19 GRTLGEGSFAKVKFARNTE-TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~   96 (342)
                      ++.|..|-...+|++.... .++.|++|+......   . .-...+|+.+++.+...++ .+++..+.  +  .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4677788888999987543 357899998753211   1 1123478888888864333 44444332  2  3799999


Q ss_pred             CCCch
Q 019360           97 TGGEL  101 (342)
Q Consensus        97 ~~~~L  101 (342)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.03  E-value=3.8e-06  Score=74.08  Aligned_cols=136  Identities=16%  Similarity=0.264  Sum_probs=96.0

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-----hhh--------------hHHHHHHHHHHHHhcCCC-C-
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-----LKH--------------KMIGQIKREISTMKLIRH-P-   74 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~--------------~~~~~~~~E~~~l~~l~h-~-   74 (342)
                      +.+++.||-|.-+.||.+-+. .|++.++|.=.....     ...              -..-...+|...|+.|.. . 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567899999999999999884 688899985321110     000              001134578888888853 2 


Q ss_pred             cceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           75 NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        75 ~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      -+.+.++    .+.-++|||++.|-.|.+.-+-      .....+...+..-+.-|-++|+||+|+.--||++.+++.++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            2344444    3456899999999887654321      22334555666677788899999999999999999999999


Q ss_pred             Eccccccc
Q 019360          155 VSDFGLSA  162 (342)
Q Consensus       155 l~Dfg~~~  162 (342)
                      ++||-...
T Consensus       243 vIDFPQmv  250 (465)
T KOG2268|consen  243 VIDFPQMV  250 (465)
T ss_pred             EeechHhh
Confidence            99998654

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.92  E-value=0.00032  Score=65.07  Aligned_cols=80  Identities=19%  Similarity=0.216  Sum_probs=54.4

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhh--hh--hhHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LK--HKMIGQIKREISTMKLIR---HPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~--~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~l   91 (342)
                      .+.||.|.+..||++.+...++.++||.-.....  ..  .-..++...|.+.|+.+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999864446899998532110  00  112356777888888763   3456777766  3455789


Q ss_pred             EEeccCCCc
Q 019360           92 VLEFVTGGE  100 (342)
Q Consensus        92 v~e~~~~~~  100 (342)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.85  E-value=9.2e-05  Score=64.97  Aligned_cols=133  Identities=17%  Similarity=0.179  Sum_probs=76.1

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeEEEEEeccCCC
Q 019360           21 TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      .+..|-...+|+..  .+++.+++|........   ..-...+|..+++.+...++ .+++...  .  -++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            34567777889886  35678889876432111   00124678888988864434 3444433  2  26899999986


Q ss_pred             chHH--------------HH---Hhc----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeecC
Q 019360          100 ELFD--------------KI---ASR----GRLKE-DEARKYFQQL---------INAVDYCHS--------RGVCHRDL  140 (342)
Q Consensus       100 ~L~~--------------~l---~~~----~~l~~-~~~~~i~~~l---------~~~L~~LH~--------~giiH~dl  140 (342)
                      .+..              .+   ++-    .+++. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6431              11   111    11121 1122221111         111222211        24899999


Q ss_pred             CCCcEEecCCCCeeEcccccccC
Q 019360          141 KPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus       141 kp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      .|.||+++.++ +.|+||+.+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999998877 78999998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.84  E-value=0.00013  Score=65.52  Aligned_cols=138  Identities=17%  Similarity=0.170  Sum_probs=82.6

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc--ceeEEEE------EEeCCe
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN--VIRMYEV------MASKTK   88 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~------~~~~~~   88 (342)
                      .-.+.|..|....+|++..  .+..+++|+....   .   ...+..|++++..+.+.+  +.+++..      ....+.
T Consensus        17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             hheecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            3366787888889998864  3457999987531   1   235667888887775332  3444331      233456


Q ss_pred             EEEEEeccCCCchHH-----------HH---Hhc-CCC----------CHHH--H--------HHHHHHHHHHHHHHHh-
Q 019360           89 IYIVLEFVTGGELFD-----------KI---ASR-GRL----------KEDE--A--------RKYFQQLINAVDYCHS-  132 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~-----------~l---~~~-~~l----------~~~~--~--------~~i~~~l~~~L~~LH~-  132 (342)
                      .++|+++++|..+..           .+   +.. ..+          .+..  .        ......+..++.++.+ 
T Consensus        89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  168 (296)
T cd05153          89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF  168 (296)
T ss_pred             eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence            789999998866421           00   100 000          0000  0        0011122334444443 


Q ss_pred             ------CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          133 ------RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       133 ------~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                            .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                  479999999999999988778899999765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.81  E-value=2.6e-06  Score=88.00  Aligned_cols=213  Identities=17%  Similarity=0.075  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHhcCCCCcceeEEEEEEe--CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 019360           59 GQIKREISTMKLIRHPNVIRMYEVMAS--KTKIYIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHS  132 (342)
Q Consensus        59 ~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~  132 (342)
                      +....|.+.++...|+++.....-...  ....|..++|+.+|.+.+.+-++    ..+...-+.....+......-.|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            344455556666788888776654433  23468899999999999988653    234444444444444677777665


Q ss_pred             C-----CceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHH
Q 019360          133 R-----GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVIL  207 (342)
Q Consensus       133 ~-----giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll  207 (342)
                      .     -.+|+++|+-|.+|..+..+++.++|+.++...  .........+++.|++|++.+.-.+. .++|+|..|+.+
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSL 1430 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHH
Confidence            4     268999999999999999999999999983222  22333455678889999998876654 569999999999


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          208 YVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       208 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      |....|..+|-..........+.+..+. .+...+.++-.....+|-..-..||.-...+.-+.|..+
T Consensus      1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred             HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence            9998888777332222222222222222 222234555555555666666789998888887777643

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.75  E-value=0.00014  Score=68.16  Aligned_cols=161  Identities=21%  Similarity=0.279  Sum_probs=107.2

Q ss_pred             HHHHHHHHHhcCCCCcceeEEEEEEe-CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 019360           60 QIKREISTMKLIRHPNVIRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR  138 (342)
Q Consensus        60 ~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~  138 (342)
                      .+.-....++.+.|+|....+++... .....+|||++ +.+|.+.+..+. +-.....                  .||
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~~   87 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AHG   87 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------ccc
Confidence            34456778899999999999987753 34578999999 669999887754 3222211                  222


Q ss_pred             cCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCC
Q 019360          139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE  218 (342)
Q Consensus       139 dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~  218 (342)
                      -+ +-||+       +.+| -...       .           |        ....++++|||++|.++.++..|...+.
T Consensus        88 ~~-~~~~~-------~~td-~~~t-------~-----------~--------~~~~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   88 VL-HLNII-------YITD-HFLT-------K-----------Y--------PSPIGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             cc-eehhh-------hccc-cccc-------c-----------C--------CCCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence            11 11222       2222 0000       0           0        0111248999999999999999988877


Q ss_pred             CCcHHHHHHHHHhcCCCCCC------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          219 ESNLMALYKKIFKADFKSPP------------WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       219 ~~~~~~~~~~i~~~~~~~~~------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .....+....+.+.......            ..+....++..+|+-..|..||...++..++-|.+..
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            66666666665554433322            2456678899999999999999999999999987653

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.72  E-value=0.0003  Score=63.42  Aligned_cols=142  Identities=23%  Similarity=0.306  Sum_probs=95.3

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh----------------------hhhhHHH-HHHHHHHHHhcCCC
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV----------------------LKHKMIG-QIKREISTMKLIRH   73 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~-~~~~E~~~l~~l~h   73 (342)
                      .+-..|..|.-+.||.|.. .+|..+|||++.-+-.                      .....++ ....|++.|+++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3456788899999999976 4788899998742100                      0111111 34678899988876


Q ss_pred             CcceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEecCCCC
Q 019360           74 PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH-SRGVCHRDLKPENLLLDANGV  152 (342)
Q Consensus        74 ~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH-~~giiH~dlkp~NIli~~~~~  152 (342)
                      ..|...--+...  .-.|||+++....-..-..+...++...+..+-.+++.-+.-|- .+++||.||+--|+|+ .+|.
T Consensus       226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            554432222211  23589999843222111122345777778888788888877764 6799999999999999 6789


Q ss_pred             eeEccccccc
Q 019360          153 LKVSDFGLSA  162 (342)
Q Consensus       153 ~kl~Dfg~~~  162 (342)
                      +.++|.+.+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999998775

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.70  E-value=0.00031  Score=63.24  Aligned_cols=76  Identities=13%  Similarity=0.216  Sum_probs=47.8

Q ss_pred             eeeecccCceEEEEEEEcC------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeEEE
Q 019360           19 GRTLGEGSFAKVKFARNTE------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKIYI   91 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~l   91 (342)
                      ++.|..|-...+|++....      .++.+++|+......    ......+|.++++.+...++ .+++.++. +   ..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            3556666667889887543      257899999754321    11245688888888864333 34555543 2   25


Q ss_pred             EEeccCCCchH
Q 019360           92 VLEFVTGGELF  102 (342)
Q Consensus        92 v~e~~~~~~L~  102 (342)
                      |+||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89998887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.69  E-value=0.00037  Score=62.93  Aligned_cols=139  Identities=19%  Similarity=0.236  Sum_probs=80.0

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc--ceeEEEE------EEeCCe
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN--VIRMYEV------MASKTK   88 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~------~~~~~~   88 (342)
                      ..++.++.|....+|++.. . +..+++|+.....  .   .+.+..|.+++..|...+  +.+++..      ....+.
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             eeccccCCccccceEEEEe-C-CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            3466777887789998864 3 3468889875421  1   123446677776664322  3343331      122456


Q ss_pred             EEEEEeccCCCchH-----------HHH---Hh-cCCC--------CHHH---H--H----------HHHHHHHHHHHHH
Q 019360           89 IYIVLEFVTGGELF-----------DKI---AS-RGRL--------KEDE---A--R----------KYFQQLINAVDYC  130 (342)
Q Consensus        89 ~~lv~e~~~~~~L~-----------~~l---~~-~~~l--------~~~~---~--~----------~i~~~l~~~L~~L  130 (342)
                      .+++++|++|..+.           ..+   +. ...+        ....   .  .          .....+...+.++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            78999999885431           011   11 0000        0000   0  0          0011223345555


Q ss_pred             Hh-------CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          131 HS-------RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       131 H~-------~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ..       .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            42       589999999999999988777899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0024  Score=57.93  Aligned_cols=30  Identities=33%  Similarity=0.561  Sum_probs=25.9

Q ss_pred             CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          133 RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       133 ~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      .|+||+|++|.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            389999999999999866666899999765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.45  E-value=0.0011  Score=59.55  Aligned_cols=145  Identities=17%  Similarity=0.257  Sum_probs=80.1

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC--CcceeEEEEEEeCC--eEEEE
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH--PNVIRMYEVMASKT--KIYIV   92 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~--~~~lv   92 (342)
                      .+++.+..|.--.+|...+.  ++.+++. ... ............+|..+++.+.-  --+...++++..+.  ..|.|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            34444433333445555443  7888888 321 11112223466788888887753  23344555565554  67999


Q ss_pred             EeccCCCchHHH------------------HHh-c----------C---CCCHHHHHHHHHHH--------------HHH
Q 019360           93 LEFVTGGELFDK------------------IAS-R----------G---RLKEDEARKYFQQL--------------INA  126 (342)
Q Consensus        93 ~e~~~~~~L~~~------------------l~~-~----------~---~l~~~~~~~i~~~l--------------~~~  126 (342)
                      |+|++|..+.+.                  |.. +          +   .....++..+..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999988432111                  100 0          0   00011111111111              122


Q ss_pred             HHHHHhC--------CceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360          127 VDYCHSR--------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus       127 L~~LH~~--------giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      ..+|+.+        .++|||+++.|++++.++-+-|.||+.+...+
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            3334332        48999999999999998889999999987533

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.38  E-value=0.0029  Score=57.70  Aligned_cols=76  Identities=16%  Similarity=0.150  Sum_probs=48.9

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEecchhhh-h---hhHHHHHHHHHHHHhcCC--CC-cceeEEEEEEeCCeEEEEE
Q 019360           21 TLGEGSFAKVKFARNTETGENVAIKILDKEKVL-K---HKMIGQIKREISTMKLIR--HP-NVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        21 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~---~~~~~~~~~E~~~l~~l~--h~-~iv~l~~~~~~~~~~~lv~   93 (342)
                      .||.|....||++.+...++.++||.-...... .   .-...+..-|...|+...  .| .+.+++.+  +++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999998644468999975321110 0   223456667888887664  34 45555543  445566999


Q ss_pred             eccCC
Q 019360           94 EFVTG   98 (342)
Q Consensus        94 e~~~~   98 (342)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.30  E-value=0.0027  Score=56.34  Aligned_cols=30  Identities=23%  Similarity=0.449  Sum_probs=25.1

Q ss_pred             CceeecCCCCcEEecCCCC-eeEcccccccC
Q 019360          134 GVCHRDLKPENLLLDANGV-LKVSDFGLSAL  163 (342)
Q Consensus       134 giiH~dlkp~NIli~~~~~-~kl~Dfg~~~~  163 (342)
                      .++|+|++|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.18  E-value=0.003  Score=57.92  Aligned_cols=136  Identities=18%  Similarity=0.282  Sum_probs=80.1

Q ss_pred             eeeecccCceEEEEEEEcC----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce-eEEEEEEeCCeEEEEE
Q 019360           19 GRTLGEGSFAKVKFARNTE----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI-RMYEVMASKTKIYIVL   93 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~lv~   93 (342)
                      +..|-.|-.-.+|++....    .++.|++|+.....   ...+.+ .+|..+++.+...++. ++++.+..+    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            4455557778899986532    24679999875432   222333 5799999888754444 566665332    578


Q ss_pred             eccCCCchHHH--------------H---HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 019360           94 EFVTGGELFDK--------------I---ASRG------RLKEDEARKYFQQL-----------------INAVDYC---  130 (342)
Q Consensus        94 e~~~~~~L~~~--------------l---~~~~------~l~~~~~~~i~~~l-----------------~~~L~~L---  130 (342)
                      +|+++.++...              +   ++-.      ....+++..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            88887665311              1   1100      01122232332211                 1111112   


Q ss_pred             -H----hCCceeecCCCCcEEecC-CCCeeEccccccc
Q 019360          131 -H----SRGVCHRDLKPENLLLDA-NGVLKVSDFGLSA  162 (342)
Q Consensus       131 -H----~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~  162 (342)
                       .    ...++|+|+++.||+++. ++.+.++||..+.
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             1    235899999999999976 4689999999775

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.07  E-value=0.0044  Score=56.55  Aligned_cols=136  Identities=17%  Similarity=0.258  Sum_probs=77.3

Q ss_pred             eeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce-eEEEEEEeCCeEEEEEe
Q 019360           19 GRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI-RMYEVMASKTKIYIVLE   94 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~lv~e   94 (342)
                      ++.|..|=.-.+|++.....   +..|++|+.....   ...+ .-.+|..+++.+...++. ++++++. .+   +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            34454466677888865432   2478999875422   1112 235788888888755554 5565553 22   5889


Q ss_pred             ccCCCchHH----------HH-------HhcC-C----C-CHHHHHHHHHHH----------------------HHHHHH
Q 019360           95 FVTGGELFD----------KI-------ASRG-R----L-KEDEARKYFQQL----------------------INAVDY  129 (342)
Q Consensus        95 ~~~~~~L~~----------~l-------~~~~-~----l-~~~~~~~i~~~l----------------------~~~L~~  129 (342)
                      |++|..|..          .+       ++.. +    . ....+..+..++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            988765421          11       1111 0    1 122222222221                      111111


Q ss_pred             ---HH-hC----CceeecCCCCcEEecC-CCCeeEccccccc
Q 019360          130 ---CH-SR----GVCHRDLKPENLLLDA-NGVLKVSDFGLSA  162 (342)
Q Consensus       130 ---LH-~~----giiH~dlkp~NIli~~-~~~~kl~Dfg~~~  162 (342)
                         +. ..    -++|+|+.+.||++++ ++.++++||..|.
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence               11 11    2799999999999975 5789999999875

>PRK10593 hypothetical protein; Provisional

Probab=97.01  E-value=0.007  Score=54.31  Aligned_cols=106  Identities=13%  Similarity=0.123  Sum_probs=73.9

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC---CcceeEEEEEEe---CCeE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH---PNVIRMYEVMAS---KTKI   89 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~l~~~~~~---~~~~   89 (342)
                      -.-.+.||.|..+.||..... ++ .+.+|.... ..    ....+..|+..|+.+..   -.+.++++++..   .+..
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARS-FS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-CC-CEEEEEecc-cc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            344678999999999998653 23 467777432 10    11367789999988853   357788877654   3668


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR  133 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~  133 (342)
                      ++|||+++|.++.+.     ..+......+..+++++|+.||+.
T Consensus        89 ~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         89 VLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999877651     123445566777888999999974

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.99  E-value=0.011  Score=54.96  Aligned_cols=77  Identities=13%  Similarity=0.100  Sum_probs=51.9

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-hhh---hHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeEE
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKH---KMIGQIKREISTMKLIR---HPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~   90 (342)
                      ..+.||.|....||++.+.  ++.++||.-..... ...   ....+...|++.|+.+.   ...+.+++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4778899999999999873  45699997642111 001   12345556777776664   347778888776  4456


Q ss_pred             EEEeccCC
Q 019360           91 IVLEFVTG   98 (342)
Q Consensus        91 lv~e~~~~   98 (342)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999976

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.77  E-value=0.013  Score=54.12  Aligned_cols=78  Identities=17%  Similarity=0.228  Sum_probs=51.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh---hhHHHHHHHHHHHHhcCC--CC-cceeEEEEEEeCCeEEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK---HKMIGQIKREISTMKLIR--HP-NVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--h~-~iv~l~~~~~~~~~~~lv   92 (342)
                      .+.||.|.-..||++.+...++.++||.-.......   .-...+..-|.+.|+...  .| .+.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            678999999999999985445779999743211111   123456777888888764  34 45556544  44556688


Q ss_pred             EeccCC
Q 019360           93 LEFVTG   98 (342)
Q Consensus        93 ~e~~~~   98 (342)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.59  E-value=0.024  Score=50.43  Aligned_cols=75  Identities=13%  Similarity=0.166  Sum_probs=47.5

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeEEEEE
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR---HPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +-.+.++.|....+|...  .+++.+.+|+-....      ...+..|+.-|+.|.   .-.+.+++.+....+.-|+||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            446788889999999886  577889999875211      135677888888773   445778888887777779999


Q ss_pred             eccCCC
Q 019360           94 EFVTGG   99 (342)
Q Consensus        94 e~~~~~   99 (342)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=96.44  E-value=0.019  Score=53.41  Aligned_cols=76  Identities=17%  Similarity=0.229  Sum_probs=44.8

Q ss_pred             eeeeecccCceEEEEEEEcCC-CcE-----EEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce-eEEEEEEeCCeEE
Q 019360           18 LGRTLGEGSFAKVKFARNTET-GEN-----VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI-RMYEVMASKTKIY   90 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~   90 (342)
                      .++.|..|-...+|++..... +..     |.+++...   .....+ .-.+|+++++.+...++. ++++.+..    +
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            345665688888999875432 222     44443211   111111 235789999999755554 56666542    5


Q ss_pred             EEEeccCCCch
Q 019360           91 IVLEFVTGGEL  101 (342)
Q Consensus        91 lv~e~~~~~~L  101 (342)
                      +|.||++|.+|
T Consensus       126 ~l~efIeGr~l  136 (383)
T PTZ00384        126 TIQEWVEGNTM  136 (383)
T ss_pred             EEEEEeccccC
Confidence            89999988765

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=96.37  E-value=0.0011  Score=43.93  Aligned_cols=27  Identities=44%  Similarity=0.730  Sum_probs=20.9

Q ss_pred             CCCCChHHHHhhCCCCCCCCCCCcCCC
Q 019360          315 PLTMNAFELISTSQGLNLSSLLKSKWD  341 (342)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (342)
                      |..||+|++|+.++|+|||++.+.+.+
T Consensus         2 p~~lNAFdiIS~S~G~DLSgLFe~~~~   28 (63)
T PF03822_consen    2 PKSLNAFDIISLSSGFDLSGLFEEKDK   28 (63)
T ss_dssp             -EE--HHHHHCTSTTTSCGGGGGCG-S
T ss_pred             CccccHHHHHHhccCCChHHhcCcccc
Confidence            668999999999999999999977653

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.33  E-value=0.01  Score=53.71  Aligned_cols=102  Identities=21%  Similarity=0.339  Sum_probs=69.2

Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      .+.|++|++- |+.+.. +.   ....+++..++++.+..+.-+... ..-|||+.-.||||+ +|.+.|+||-+++...
T Consensus       299 ~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             eEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            4567888875 555532 22   245688899999999888888754 789999999999998 9999999999998422


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhh
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSC  203 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  203 (342)
                      .  ..     ...-...--|-.+.|..  +...+||-+
T Consensus       373 ~--q~-----~isy~rldhp~lF~G~d--d~QFeIYrl  401 (488)
T COG5072         373 S--QG-----IISYNRLDHPDLFNGVD--DYQFEIYRL  401 (488)
T ss_pred             C--Cc-----eeeccccCchhhhcCcc--ceeeeHHHH
Confidence            1  11     11112233455555433  366777763

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.22  E-value=0.11  Score=47.36  Aligned_cols=28  Identities=21%  Similarity=0.177  Sum_probs=23.9

Q ss_pred             CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          133 RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       133 ~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      .++||+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4789999999999995 4 57899999765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.16  E-value=0.18  Score=45.53  Aligned_cols=29  Identities=17%  Similarity=0.168  Sum_probs=27.0

Q ss_pred             CceeecCCCCcEEecCCCCeeEccccccc
Q 019360          134 GVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       134 giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ++||+|+.+.||+++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.98  E-value=0.052  Score=46.18  Aligned_cols=68  Identities=22%  Similarity=0.365  Sum_probs=45.7

Q ss_pred             eEEEEEEEcCCC-cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeEEEEEeccCCCch
Q 019360           28 AKVKFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR---HPNVIRMYEVMASKTKIYIVLEFVTGGEL  101 (342)
Q Consensus        28 g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~e~~~~~~L  101 (342)
                      |.|..|....+| .++-+|+-..      .....+..|+.-|+.+.   .-.+.+++.+....++.|+||||++.+.+
T Consensus        27 G~inea~~v~dg~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccccceeEeecCCcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            344444444344 6688887433      22345666777666664   45678889999999999999999987654

>PTZ00296 choline kinase; Provisional

Probab=95.48  E-value=0.14  Score=48.66  Aligned_cols=76  Identities=13%  Similarity=0.144  Sum_probs=46.8

Q ss_pred             eeeeecccCceEEEEEEEcCC--------CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce-eEEEEEEeCCe
Q 019360           18 LGRTLGEGSFAKVKFARNTET--------GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI-RMYEVMASKTK   88 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~   88 (342)
                      -++.|..|-.-.+|++.....        ++.|.+++.....   ...+ .-.+|..+++.+...+|. ++++.+. +  
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g--  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G--  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C--
Confidence            456666666677888875421        5679999875422   2222 234688888877655554 4555553 2  


Q ss_pred             EEEEEeccCCCch
Q 019360           89 IYIVLEFVTGGEL  101 (342)
Q Consensus        89 ~~lv~e~~~~~~L  101 (342)
                       +.|.+|++|.+|
T Consensus       182 -g~I~efi~g~~l  193 (442)
T PTZ00296        182 -GRIEEWLYGDPL  193 (442)
T ss_pred             -CEEEEeeCCccC
Confidence             357899987644

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.20  E-value=0.077  Score=49.00  Aligned_cols=59  Identities=20%  Similarity=0.251  Sum_probs=43.3

Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEEec
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC-HSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~L-H~~giiH~dlkp~NIli~  148 (342)
                      ..++-+|..|.++..++...+ .+++.+..++.-...|+--+ --.+++|.|++|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            456777888988888887644 46666667776666665443 346899999999999994

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.09  E-value=0.089  Score=44.59  Aligned_cols=102  Identities=17%  Similarity=0.168  Sum_probs=63.6

Q ss_pred             cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHH
Q 019360           40 ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKY  119 (342)
Q Consensus        40 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i  119 (342)
                      .+..+|++......-.  ..-+.++.+++.++  ..|+++..-  ..-.+.++.|+|-....             ....+
T Consensus        86 G~L~lKKi~slp~~~~--~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~  146 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCIN--DALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI-------------NFSNF  146 (308)
T ss_pred             chhhhhhccCCCcccc--hhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc-------------chhHH
Confidence            3455565543322211  12456777777654  357777632  33456799999843211             11122


Q ss_pred             HHHHHHHHHHHHh--CCceeecCCCCcEEecCCCCeeEccccc
Q 019360          120 FQQLINAVDYCHS--RGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus       120 ~~~l~~~L~~LH~--~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      +..=+.+|.-.|+  .+.+|||-.|+||+.+..|-+||.|=+.
T Consensus       147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            2223566777884  4799999999999999999999999763

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=94.96  E-value=0.69  Score=48.78  Aligned_cols=31  Identities=32%  Similarity=0.463  Sum_probs=25.9

Q ss_pred             CCceeecCCCCcEEecCCC--Ce-eEcccccccC
Q 019360          133 RGVCHRDLKPENLLLDANG--VL-KVSDFGLSAL  163 (342)
Q Consensus       133 ~giiH~dlkp~NIli~~~~--~~-kl~Dfg~~~~  163 (342)
                      .++||+|+++.||+++.++  .+ -|+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999998775  45 4999998753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.88  E-value=0.053  Score=48.82  Aligned_cols=29  Identities=38%  Similarity=0.679  Sum_probs=25.3

Q ss_pred             CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          133 RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       133 ~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      .+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	342
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-75
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-74
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-74
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-74
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-74
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-74
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-73
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-70
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-68
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-68
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-67
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-65
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-65
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-65
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-64
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-64
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-63
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-63
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-62
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-57
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-57
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-56
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-56
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-54
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-54
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-53
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-53
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-52
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-52
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-52
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-52
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-52
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-52
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-51
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-51
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-51
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-51
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-51
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-51
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-51
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-51
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-51
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-51
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-51
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-51
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-51
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-51
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-51
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-51
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-51
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-51
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-51
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-50
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-50
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-50
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-50
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-50
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-50
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-50
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-50
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-50
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-50
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-50
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-50
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-49
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-49
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-48
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-48
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-48
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-47
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-47
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-47
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-47
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-47
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-47
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-47
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-47
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-47
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-47
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-47
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-47
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-47
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-46
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-46
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-46
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-46
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-46
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-46
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-46
3soa_A	444	Full-Length Human Camkii Length = 444		2e-46
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-46
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-46
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-46
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-46
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-46
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-46
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-46
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-46
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-46
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-46
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-46
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-46
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-46
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-46
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-46
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-46
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-46
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-46
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-46
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-46
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-46
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-46
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-45
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-45
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-45
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-45
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-45
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-45
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-45
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-45
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-45
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-45
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-45
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-45
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-45
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-45
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-45
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-45
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-45
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-45
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-45
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-45
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-45
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-45
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-45
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-45
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-45
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-45
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-45
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-45
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-45
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-45
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-45
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-45
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-45
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-45
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-45
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-45
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-45
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-45
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-45
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-45
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-45
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-45
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-45
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-44
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-44
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-44
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-44
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-44
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-44
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-44
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-44
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-44
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-44
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-44
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-43
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-43
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-43
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-42
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-42
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-42
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-42
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-42
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-42
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-42
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-42
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-42
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-42
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-42
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-42
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-42
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-42
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-42
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-42
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-42
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-42
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-42
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-41
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-41
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-41
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-41
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-41
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-41
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-41
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-41
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-41
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-41
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-41
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-40
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-40
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-40
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-40
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-40
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-40
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-40
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-40
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-40
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-40
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-40
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-40
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-40
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-40
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-40
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-40
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-40
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-40
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-40
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-40
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-40
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-40
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-40
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-40
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-40
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-40
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-40
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-40
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-40
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-40
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-40
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-39
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-39
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-39
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-39
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-39
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-39
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-39
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-39
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-39
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-39
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-39
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-39
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-39
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-39
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-39
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-39
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-39
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-39
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-39
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-39
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-39
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-39
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-39
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-39
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-38
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-37
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-37
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-37
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-37
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-37
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-37
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-36
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-36
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-35
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-35
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-34
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-34
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-34
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-34
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-34
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-34
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-34
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-34
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-34
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-34
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-34
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-34
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-34
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-34
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-34
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-34
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-34
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-33
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-33
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-33
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-33
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-33
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-33
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-33
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-33
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-33
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-32
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-32
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-31
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-31
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-31
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-31
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-31
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-31
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-30
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-30
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-30
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-30
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-30
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-29
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-29
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-29
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-29
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-29
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-29
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-28
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-28
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-28
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-28
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-28
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-28
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-28
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-28
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-28
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-27
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-27
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-27
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-27
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-27
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-27
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-27
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-27
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-27
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-27
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-27
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-27
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-27
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-27
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-27
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-27
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-27
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-27
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-27
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-27
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-27
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-27
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-27
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-27
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-27
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-27
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-27
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-27
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-27
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-27
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-27
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-27
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-27
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-27
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-27
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-26
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-26
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-26
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-26
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-26
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-26
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-26
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-26
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-26
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-26
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-26
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-26
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-26
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-26
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-26
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-26
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-25
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-25
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-25
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-25
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-25
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-25
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-25
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-24
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-24
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-24
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-24
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-24
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-24
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-24
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-23
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-23
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-23
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-23
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-23
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-23
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-23
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-23
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-23
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-23
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-23
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-23
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-23
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-23
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-23
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-23
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-23
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-23
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-23
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-23
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-23
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-23
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-23
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-23
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-23
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-23
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-22
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-22
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-22
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-22
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-22
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-21
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-21
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-21
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-21
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-21
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-21
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-20
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-20
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-20
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-20
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-19
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-19
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-19
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-19
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-19
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-19
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-19
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-19
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-19
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-19
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-19
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-19
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-19
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-19
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-19
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-19
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-19
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-19
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-19
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-19
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-19
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-19
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-19
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-19
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-19
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-19
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-19
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-18
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-18
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-18
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-18
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-18
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-18
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-18
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-18
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-18
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-18
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-18
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-18
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-18
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-18
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-18
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-18
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-18
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-18
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-18
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-18
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-18
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-18
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-18
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-18
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-18
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-18
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-18
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-18
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-18
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-18
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-18
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-18
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-18
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-18
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-18
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-18
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-18
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-18
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-18
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-18
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-18
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-18
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-18
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-18
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-18
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-18
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-18
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-17
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-17
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-17
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-17
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-17
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-17
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-17
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-17
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-17
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-17
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-17
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-17
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-17
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-16
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-16
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-16
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-16
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-16
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-16
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-16
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-16
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-16
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-16
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-14
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-14
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		8e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		9e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		5e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-10
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-09
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-09
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-09
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-09
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-09
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-09
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-09
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-09
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-09
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-09

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 129/275 (46%), Positives = 191/275 (69%), Gaps = 5/275 (1%)
Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
            R ++G Y LG TLG G+F KVK   +  TG  VA+KIL+++K+    ++G+IKREI  +
Sbjct: 6   GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           KL RHP++I++Y+V+++ T  ++V+E+V+GGELFD I   GR++E EAR+ FQQ+++AVD
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCH   V HRDLKPEN+LLDA+   K++DFGLS +   + D   L T+CG+PNY APEVI
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI 182
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           + + Y G + D+WSCGVILY L+ G LPF++ ++  L+KKI    F  P + + S   L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242
Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
             +L  +P+ R T+ ++ E+EWFK+    PS+  P
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDL--PSYLFP 275

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 128/275 (46%), Positives = 190/275 (69%), Gaps = 5/275 (1%)
Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
            R ++G Y LG TLG G+F KVK   +  TG  VA+KIL+++K+    ++G+IKREI  +
Sbjct: 6   GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           KL RHP++I++Y+V+++ T  ++V+E+V+GGELFD I   GR++E EAR+ FQQ+++AVD
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCH   V HRDLKPEN+LLDA+   K++DFGLS +   + D   L  +CG+PNY APEVI
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDSCGSPNYAAPEVI 182
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           + + Y G + D+WSCGVILY L+ G LPF++ ++  L+KKI    F  P + + S   L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242
Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
             +L  +P+ R T+ ++ E+EWFK+    PS+  P
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDL--PSYLFP 275

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  275 bits (703), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 128/272 (47%), Positives = 193/272 (70%), Gaps = 4/272 (1%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           M  ++  A    +G Y++ +TLGEGSF KVK A +T TG+ VA+KI++K+ + K  M G+
Sbjct: 1   MNPKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR 60
Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           I+REIS ++L+RHP++I++Y+V+ SK +I +V+E+  G ELFD I  R ++ E EAR++F
Sbjct: 61  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFF 119
Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           QQ+I+AV+YCH   + HRDLKPENLLLD +  +K++DFGLS +   + D   L T+CG+P
Sbjct: 120 QQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSP 176
Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           NY APEVI+ K Y G + D+WSCGVILYV++   LPF++ ++  L+K I    +  P + 
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL 236
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFK 272
           S  A  LI R+L  NP+ RI++ E+++++WFK
Sbjct: 237 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  274 bits (701), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 124/273 (45%), Positives = 189/273 (69%), Gaps = 3/273 (1%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           MA +     R ++G Y LG TLG G+F KVK  ++  TG  VA+KIL+++K+    ++G+
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           I+REI  +KL RHP++I++Y+V+++ + I++V+E+V+GGELFD I   GRL E E+R+ F
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           QQ+++ VDYCH   V HRDLKPEN+LLDA+   K++DFGLS +   + D   L  +CG+P
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRXSCGSP 179
Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           NY APEVI+ + Y G + D+WS GVILY L+ G LPF++ ++  L+KKI    F +P + 
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
           + S   L+  +L  +P+ R T+ ++ E+EWFK+
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  273 bits (699), Expect = 8e-74,   Method: Compositional matrix adjust.
 Identities = 127/269 (47%), Positives = 192/269 (71%), Gaps = 4/269 (1%)
Query: 4   RTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR 63
           ++  A    +G Y++ +TLGEGSF KVK A +T TG+ VA+KI++K+ + K  M G+I+R
Sbjct: 3   KSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER 62
Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           EIS ++L+RHP++I++Y+V+ SK +I +V+E+  G ELFD I  R ++ E EAR++FQQ+
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 121
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           I+AV+YCH   + HRDLKPENLLLD +  +K++DFGLS +   + D   L T+CG+PNY 
Sbjct: 122 ISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYA 178
Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
           APEVI+ K Y G + D+WSCGVILYV++   LPF++ ++  L+K I    +  P + S  
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPG 238
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           A  LI R+L  NP+ RI++ E+++++WFK
Sbjct: 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  273 bits (698), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 127/265 (47%), Positives = 190/265 (71%), Gaps = 4/265 (1%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           A    +G Y++ +TLGEGSF KVK A +T TG+ VA+KI++K+ + K  M G+I+REIS 
Sbjct: 2   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 61
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           ++L+RHP++I++Y+V+ SK +I +V+E+  G ELFD I  R ++ E EAR++FQQ+I+AV
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +YCH   + HRDLKPENLLLD +  +K++DFGLS +   + D   L T+CG+PNY APEV
Sbjct: 121 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEV 177
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I+ K Y G + D+WSCGVILYV++   LPF++ ++  L+K I    +  P + S  A  L
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 237
Query: 248 ISRILDPNPVTRITMAEVIENEWFK 272
           I R+L  NP+ RI++ E+++++WFK
Sbjct: 238 IKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  272 bits (696), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 126/262 (48%), Positives = 189/262 (72%), Gaps = 4/262 (1%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             +G Y++ +TLGEGSF KVK A +T TG+ VA+KI++K+ + K  M G+I+REIS ++L
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 60
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +RHP++I++Y+V+ SK +I +V+E+  G ELFD I  R ++ E EAR++FQQ+I+AV+YC
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 119
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           H   + HRDLKPENLLLD +  +K++DFGLS +   + D   L T+CG+PNY APEVI+ 
Sbjct: 120 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVISG 176
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           K Y G + D+WSCGVILYV++   LPF++ ++  L+K I    +  P + S  A  LI R
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR 236
Query: 251 ILDPNPVTRITMAEVIENEWFK 272
           +L  NP+ RI++ E+++++WFK
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFK 258

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  261 bits (666), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 120/263 (45%), Positives = 182/263 (69%), Gaps = 4/263 (1%)
Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
           S+  +G Y +  TLGEGSF KVK A + +T + VA+K + ++ + K  M  +++REIS +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           KL+RHP++I++Y+V+ + T I +V+E+  GGELFD I  + R+ EDE R++FQQ+I A++
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCH   + HRDLKPENLLLD N  +K++DFGLS +   + D   L T+CG+PNY APEVI
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 179
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           N K Y G + D+WSCG++LYV++ G LPF++  +  L+KK+    +  P + S  A+ LI
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239
Query: 249 SRILDPNPVTRITMAEVIENEWF 271
            R++  +P+ RIT+ E+  + WF
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWF 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  255 bits (652), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 118/291 (40%), Positives = 190/291 (65%), Gaps = 7/291 (2%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G   +  +G Y L +T+G+G+FAKVK AR+  TG  VAIKI+DK + L    + ++ RE+
Sbjct: 4   GSDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREV 62
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             MK++ HPN+++++EV+ ++  +Y+++E+ +GGE+FD + + GR+KE EAR  F+Q+++
Sbjct: 63  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +    G L T CG+P Y AP
Sbjct: 123 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFCGSPPYAAP 179
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST  +
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 239
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPS---FEQPNIDLDDVDSI 293
            L+ R L  NP+ R T+ +++++ W   G++      F +P +D+ D   I
Sbjct: 240 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRI 290

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  251 bits (642), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 116/285 (40%), Positives = 186/285 (65%), Gaps = 7/285 (2%)
Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            +G Y L +T+G+G+FAKVK AR+  TG  VAIKI+DK + L    + ++ RE+  MK++
Sbjct: 13  HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKIL 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            HPN+++++EV+ ++  +Y+++E+ +GGE+FD + + GR+KE EAR  F+Q+++AV YCH
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + + HRDLK ENLLLDA+  +K++DFG S    +    G L   CG P Y APE+   K
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
            YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST  + L+ R 
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPS---FEQPNIDLDDVDSI 293
           L  NP+ R T+ +++++ W   G++      F +P +D+ D   I
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRI 293

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  245 bits (626), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 112/274 (40%), Positives = 182/274 (66%), Gaps = 4/274 (1%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S T    +  +G Y L +T+G+G+FAKVK AR+  TG+ VA+KI+DK + L    + ++ 
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-LNSSSLQKLF 61
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+  MK++ HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + GR+KE EAR  F+Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +      L T CG+P Y
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPY 178
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
            APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK 276
             + L+ + L  NP  R T+ +++++ W   G++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  245 bits (626), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 112/274 (40%), Positives = 182/274 (66%), Gaps = 4/274 (1%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S T    +  +G Y L +T+G+G+FAKVK AR+  TG+ VA+KI+DK + L    + ++ 
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-LNSSSLQKLF 61
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+  MK++ HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + GR+KE EAR  F+Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +      L T CG+P Y
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPY 178
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
            APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK 276
             + L+ + L  NP  R T+ +++++ W   G++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  244 bits (624), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 111/274 (40%), Positives = 182/274 (66%), Gaps = 4/274 (1%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S T    +  +G Y L +T+G+G+FAKVK AR+  TG+ VA++I+DK + L    + ++ 
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQ-LNSSSLQKLF 61
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+  MK++ HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + GR+KE EAR  F+Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +      L T CG+P Y
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPY 178
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
            APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK 276
             + L+ + L  NP  R T+ +++++ W   G++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 111/274 (40%), Positives = 180/274 (65%), Gaps = 4/274 (1%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S T    +  +G Y L +T+G+G+FAKVK AR+  TG+ VA+KI+DK + L    + ++ 
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-LNSSSLQKLF 61
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+  MK++ HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + GR+KE EAR  F+Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +      L   CG P Y
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDAFCGAPPY 178
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
            APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK 276
             + L+ + L  NP  R T+ +++++ W   G++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  242 bits (618), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 110/274 (40%), Positives = 181/274 (66%), Gaps = 4/274 (1%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S T    +  +G Y L +T+G+G+FAKVK AR+  TG+ VA++I+DK + L    + ++ 
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQ-LNSSSLQKLF 61
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+  MK++ HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + GR+KE EAR  F+Q
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +      L   CG+P Y
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDEFCGSPPY 178
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
            APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 238
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK 276
             + L+ + L  NP  R T+ +++++ W   G++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 109/265 (41%), Positives = 178/265 (67%), Gaps = 4/265 (1%)
Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            +G Y L +T+G+G+FAKVK AR+  TG+ VA+KI+DK + L    + ++ RE+  MK++
Sbjct: 5   HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-LNSSSLQKLFREVRIMKVL 63
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + G +KE EAR  F+Q+++AV YCH
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH 123
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + + HRDLK ENLLLDA+  +K++DFG S    +      L T CG+P Y APE+   K
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAPELFQGK 180
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
            YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST  + L+ + 
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKF 240
Query: 252 LDPNPVTRITMAEVIENEWFKKGYK 276
           L  NP  R T+ +++++ W   G++
Sbjct: 241 LILNPSKRGTLEQIMKDRWMNVGHE 265

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  237 bits (605), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 112/285 (39%), Positives = 187/285 (65%), Gaps = 7/285 (2%)
Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            +G Y L +T+G+G+FAKVK AR+  TG  VA+KI+DK + L    + ++ RE+  MK++
Sbjct: 13  HIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQ-LNPTSLQKLFREVRIMKIL 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            HPN+++++EV+ ++  +Y+V+E+ +GGE+FD + + GR+KE EAR  F+Q+++AV YCH
Sbjct: 72  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + + HRDLK ENLLLD +  +K++DFG S    +      L T CG+P Y APE+   K
Sbjct: 132 QKYIVHRDLKAENLLLDGDMNIKIADFGFS---NEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
            YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST  + L+ ++
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKL 248
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPS---FEQPNIDLDDVDSI 293
           L  NP+ R ++ +++++ W   G++      + +P+ D +D   I
Sbjct: 249 LVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPDPDFNDTKRI 293

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 110/274 (40%), Positives = 176/274 (64%), Gaps = 4/274 (1%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S T    +  +G Y L +T+G+G+FAKVK AR+  TG+ VA+KI+DK + L    + ++ 
Sbjct: 3   SATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-LNSSSLQKLF 61
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+   K++ HPN+++++EV+ ++  +Y+V E+ +GGE+FD + + GR KE EAR  F+Q
Sbjct: 62  REVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ 121
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +      L   CG P Y
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFS---NEFTFGNKLDAFCGAPPY 178
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
            APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + ST
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXST 238
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK 276
             + L+ + L  NP  R T+ ++ ++ W   G++
Sbjct: 239 DCENLLKKFLILNPSKRGTLEQIXKDRWXNVGHE 272

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  219 bits (559), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 113/271 (41%), Positives = 163/271 (60%), Gaps = 23/271 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YEL + +G G+F   +  R+ ++ E VA+K +++ +    K+   +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHP 75
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R  EV+ + T + IV+E+ +GGELF++I + GR  EDEAR +FQQLI+ V YCH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLH----TTCGTPNYVAPEVI 188
           VCHRDLK EN LLD +    LK+ DFG S          +LH    +T GTP Y+APEV+
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIFKADFKSPPW--FST 242
             K YDG  AD+WSCGV LYV++ G  PFE+     N      +I    +  P +   S 
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             + LISRI   +P  RI++ E+  +EWF K
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  218 bits (554), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 113/271 (41%), Positives = 163/271 (60%), Gaps = 23/271 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YEL + +G G+F   +  R+ ++ E VA+K +++ +    K+   +KREI   + +RHP
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 74
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R  EV+ + T + IV+E+ +GGELF++I + GR  EDEAR +FQQLI+ V YCH+  
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLH----TTCGTPNYVAPEVI 188
           VCHRDLK EN LLD +    LK+ DFG S          +LH    +T GTP Y+APEV+
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 187
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIFKADFKSPPW--FST 242
             K YDG  AD+WSCGV LYV++ G  PFE+     N      +I    +  P +   S 
Sbjct: 188 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 247
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             + LISRI   +P  RI++ E+  +EWF K
Sbjct: 248 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 278

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 113/270 (41%), Positives = 162/270 (60%), Gaps = 21/270 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YEL + +G G+F   +  R+ ++ E VA+K +++ +    K+   +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R  EV+ + T + IV+E+ +GGELF++I + GR  EDEAR +FQQLI+ V YCH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGL---SALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           VCHRDLK EN LLD +    LK+  FG    S L  Q +D      T GTP Y+APEV+ 
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD------TVGTPAYIAPEVLL 189
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIFKADFKSPPW--FSTS 243
            K YDG  AD+WSCGV LYV++ G  PFE+     N      +I    +  P +   S  
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPE 249
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKK 273
            + LISRI   +P  RI++ E+  +EWF K
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/271 (41%), Positives = 162/271 (59%), Gaps = 23/271 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YEL + +G G+F   +  R+ ++ E VA+K +++ +    K+   +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R  EV+ + T + IV+E+ +GGELF++I + GR  EDEAR +FQQLI+ V YCH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLH----TTCGTPNYVAPEVI 188
           VCHRDLK EN LLD +    LK+  FG S          +LH    +T GTP Y+APEV+
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIFKADFKSPPW--FST 242
             K YDG  AD+WSCGV LYV++ G  PFE+     N      +I    +  P +   S 
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             + LISRI   +P  RI++ E+  +EWF K
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  208 bits (529), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 160/271 (59%), Gaps = 23/271 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YEL + +G G+F   +  R+ +  E VA+K +++ +    K+   +KREI   + +RHP
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R  EV+ + T + IV+E+ +GGELF++I + GR  EDEAR +FQQLI+ V Y H+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLH----TTCGTPNYVAPEVI 188
           V HRDLK EN LLD +    LK++DFG S          +LH    +  GTP Y+APEV+
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKA-------SVLHSQPKSAVGTPAYIAPEVL 188
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIFKADFKSPPW--FST 242
             K YDG  AD+WSCGV LYV++ G  PFE+     N      +I    +  P +   S 
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             + LISRI   +P  RI++ E+  +EWF K
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 279

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  208 bits (529), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 155/264 (58%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    R  E     Y  +L NA+ YCHS+ V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL +NG LK++DFG S      R D    T CGT +Y+ PE+I  + +D 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPEMIEGRMHD- 188
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE       Y++I + +F  P + +  A+ LISR+L  N
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
              R+T+AEV+E+ W K     PS
Sbjct: 249 ASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  206 bits (525), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 115/307 (37%), Positives = 170/307 (55%), Gaps = 35/307 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  + +G G+F   +  R+  T E VA+K +++   +       ++REI   + +RHP
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHP 76
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R  EV+ + T + I++E+ +GGEL+++I + GR  EDEAR +FQQL++ V YCHS  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLH----TTCGTPNYVAPEVI 188
           +CHRDLK EN LLD +    LK+ DFG S          +LH    +T GTP Y+APEV+
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 189
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK----IFKADFKSPP--WFST 242
             + YDG  AD+WSCGV LYV++ G  PFE+      Y+K    I    +  P     S 
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKK------------GYKPPSFEQPNIDLDDV 290
               LISRI   +P TRI++ E+  + WF K            G +    EQP   LD +
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTI 309
Query: 291 DSIFNES 297
             I +E+
Sbjct: 310 MQIISEA 316

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 154/264 (58%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    R  E     Y  +L NA+ YCHS+ V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL +NG LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 188
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE       Y++I + +F  P + +  A+ LISR+L  N
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
              R+T+AEV+E+ W K     PS
Sbjct: 249 ASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 157/272 (57%), Gaps = 8/272 (2%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  +++GR LG+G F  V  AR  +    +A+K+L K ++ K  +  Q++REI     +R
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN++RMY     + +IY++LEF   GEL+ ++   GR  E  +  + ++L +A+ YCH 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V HRD+KPENLL+   G LK++DFG S     +R   +    CGT +Y+ PE+I  K 
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM----CGTLDYLPPEMIEGKT 189
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
           +D  K DLW  GV+ Y  + G  PF+  +    +++I   D K PP+ S  +K LIS++L
Sbjct: 190 HD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 248
Query: 253 DPNPVTRITMAEVIENEWFKKGYK---PPSFE 281
             +P  R+ +  V+E+ W K   +   PP ++
Sbjct: 249 RYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 280

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  201 bits (511), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 152/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   GE++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 189
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 250 PSQRPMLREVLEHPWITANSSKPS 273

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  201 bits (511), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 101/274 (36%), Positives = 157/274 (57%), Gaps = 7/274 (2%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS 66
           G+ +  +  +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+ 
Sbjct: 4   GSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
               +RHPN++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAP 185
           + YCHS+ V HRD+KPENLLL + G LK++DFG S   P   RDD      CGT +Y+ P
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDYLPP 178
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E+I  + +D  K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+
Sbjct: 179 EMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
            LISR+L  NP  R  + EV+E+ W       PS
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  201 bits (510), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 152/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R D    T CGT +Y+ PE+I  + +D 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPEMIEGRMHD- 185
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 246 PSQRPMLREVLEHPWITANSSKPS 269

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  200 bits (509), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 7/265 (2%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
            HRD+KPENLLL + G LK++DFG S   P   RDD      CGT +Y+ PE+I  + +D
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDYLPPEMIEGRMHD 210
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  
Sbjct: 211 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 269
Query: 255 NPVTRITMAEVIENEWFKKGYKPPS 279
           NP  R  + EV+E+ W       PS
Sbjct: 270 NPSQRPMLREVLEHPWITANSSKPS 294

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  198 bits (504), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 155/273 (56%), Gaps = 5/273 (1%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS 66
           G+ +  +  +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+ 
Sbjct: 4   GSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
               +RHPN++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + YCHS+ V HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPE 179
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK 246
           +I  + +D  K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ 
Sbjct: 180 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 247 LISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           LISR+L  NP  R  + EV+E+ W       PS
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  198 bits (504), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 156/272 (57%), Gaps = 8/272 (2%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  +++ R LG+G F  V  AR  +    +A+K+L K ++ K  +  Q++REI     +R
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN++RMY     + +IY++LEF   GEL+ ++   GR  E  +  + ++L +A+ YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V HRD+KPENLL+   G LK++DFG S     +R   +    CGT +Y+ PE+I  K 
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM----CGTLDYLPPEMIEGKT 188
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
           +D  K DLW  GV+ Y  + G  PF+  +    +++I   D K PP+ S  +K LIS++L
Sbjct: 189 HD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247
Query: 253 DPNPVTRITMAEVIENEWFKKGYK---PPSFE 281
             +P  R+ +  V+E+ W K   +   PP ++
Sbjct: 248 RYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 146
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 201
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 261
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 262 PSQRPMLREVLEHPWITANSSKPS 285

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 187
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 248 PSQRPMLREVLEHPWITANSSKPS 271

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 189
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 250 PSQRPMLREVLEHPWITANSSKPS 273

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 210
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 270
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 271 PSQRPMLREVLEHPWITANSSKPS 294

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 184
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPS 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 183
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 243
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 244 PSQRPMLREVLEHPWITANSSKPS 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 188
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 249 PSQRPMLREVLEHPWITANSSKPS 272

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 150/264 (56%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE I  + +D 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEXIEGRXHD- 189
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 250 PSQRPXLREVLEHPWITANSSKPS 273

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHD- 184
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPS 268

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  197 bits (502), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 152/265 (57%), Gaps = 7/265 (2%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
            HRD+KPENLLL + G LK++DFG S   P   R D      CGT +Y+ PE+I  + +D
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 184
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  
Sbjct: 185 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 243
Query: 255 NPVTRITMAEVIENEWFKKGYKPPS 279
           NP  R  + EV+E+ W       PS
Sbjct: 244 NPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  197 bits (502), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 152/265 (57%), Gaps = 7/265 (2%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
            HRD+KPENLLL + G LK++DFG S   P   R D      CGT +Y+ PE+I  + +D
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 189
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  
Sbjct: 190 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 248
Query: 255 NPVTRITMAEVIENEWFKKGYKPPS 279
           NP  R  + EV+E+ W       PS
Sbjct: 249 NPSQRPMLREVLEHPWITANSSKPS 273

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  197 bits (502), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 152/265 (57%), Gaps = 7/265 (2%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
            HRD+KPENLLL + G LK++DFG S   P   R D      CGT +Y+ PE+I  + +D
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 185
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  
Sbjct: 186 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 244
Query: 255 NPVTRITMAEVIENEWFKKGYKPPS 279
           NP  R  + EV+E+ W       PS
Sbjct: 245 NPSQRPMLREVLEHPWITANSSKPS 269

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  197 bits (502), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 152/265 (57%), Gaps = 7/265 (2%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
            HRD+KPENLLL + G LK++DFG S   P   R D      CGT +Y+ PE+I  + +D
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 184
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  
Sbjct: 185 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 243
Query: 255 NPVTRITMAEVIENEWFKKGYKPPS 279
           NP  R  + EV+E+ W       PS
Sbjct: 244 NPSQRPMLREVLEHPWITANSSKPS 268

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  197 bits (502), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 132 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLPPEMIEGRMHD- 186
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 246
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 247 PSQRPMLREVLEHPWITANSSKPS 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  197 bits (501), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL----CGTLDYLPPEMIEGRMHD- 184
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPS 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  197 bits (501), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL----CGTLDYLPPEMIEGRMHD- 184
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPS 268

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  197 bits (501), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLPPEMIEGRMHD- 184
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPS 268

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 150/264 (56%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR   +   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHD- 184
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPS 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   GE++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L     GT +Y+ PE+I  + +D 
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GTLDYLPPEMIEGRMHD- 189
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 249
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 250 PSQRPMLREVLEHPWITANSSKPS 273

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK+++FG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 132 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 186
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 246
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 247 PSQRPMLREVLEHPWITANSSKPS 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 151/264 (57%), Gaps = 5/264 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK+++FG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 133 IHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 187
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PVTRITMAEVIENEWFKKGYKPPS 279
           P  R  + EV+E+ W       PS
Sbjct: 248 PSQRPMLREVLEHPWITANSSKPS 271

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 96/255 (37%), Positives = 149/255 (58%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 187
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PVTRITMAEVIENEW 270
           P  R  + EV+E+ W
Sbjct: 248 PSQRPMLREVLEHPW 262

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 96/255 (37%), Positives = 149/255 (58%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R   L    CGT +Y+ PE+I  + +D 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLPPEMIEGRMHD- 187
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PVTRITMAEVIENEW 270
           P  R  + EV+E+ W
Sbjct: 248 PSQRPMLREVLEHPW 262

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 160/263 (60%), Gaps = 15/263 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+    LG G+F++V  A +  T + VAIK + KE +   +  G ++ EI+ +  I+HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ + ++  S   +Y++++ V+GGELFD+I  +G   E +A +   Q+++AV Y H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 CHRDLKPENLL---LDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNK 191
            HRDLKPENLL   LD +  + +SDFGLS    ++ D G +L T CGTP YVAPEV+  K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLS----KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y  A  D WS GVI Y+L+ GY PF + N   L+++I KA  +F SP W   S SAK  
Sbjct: 194 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           I  +++ +P  R T  + +++ W
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 160/263 (60%), Gaps = 15/263 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+    LG G+F++V  A +  T + VAIK + KE +   +  G ++ EI+ +  I+HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ + ++  S   +Y++++ V+GGELFD+I  +G   E +A +   Q+++AV Y H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 CHRDLKPENLL---LDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNK 191
            HRDLKPENLL   LD +  + +SDFGLS    ++ D G +L T CGTP YVAPEV+  K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLS----KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y  A  D WS GVI Y+L+ GY PF + N   L+++I KA  +F SP W   S SAK  
Sbjct: 194 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           I  +++ +P  R T  + +++ W
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 160/263 (60%), Gaps = 15/263 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+    LG G+F++V  A +  T + VAIK + KE +   +  G ++ EI+ +  I+HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ + ++  S   +Y++++ V+GGELFD+I  +G   E +A +   Q+++AV Y H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 CHRDLKPENLL---LDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNK 191
            HRDLKPENLL   LD +  + +SDFGLS    ++ D G +L T CGTP YVAPEV+  K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLS----KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y  A  D WS GVI Y+L+ GY PF + N   L+++I KA  +F SP W   S SAK  
Sbjct: 194 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           I  +++ +P  R T  + +++ W
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  195 bits (495), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 96/255 (37%), Positives = 148/255 (58%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  +    +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T CGT +Y+ PE+I  + +D 
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHD- 181
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 241
Query: 256 PVTRITMAEVIENEW 270
           P  R  + EV+E+ W
Sbjct: 242 PSQRPMLREVLEHPW 256

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 151/267 (56%), Gaps = 5/267 (1%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+KPENLLL + G LK++DFG S      R      T  GT +Y+ PE+I  + +D 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT----TLSGTLDYLPPEMIEGRMHD- 185
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
            K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  N
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQ 282
           P  R  + EV+E+ W       PS  Q
Sbjct: 246 PSQRPMLREVLEHPWITANSSKPSNSQ 272

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  194 bits (494), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 161/263 (61%), Gaps = 15/263 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+    LG G+F++V  A +  T + VAIK + K K L+ K  G ++ EI+ +  I+HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKE-GSMENEIAVLHKIKHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ + ++  S   +Y++++ V+GGELFD+I  +G   E +A +   Q+++AV Y H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 CHRDLKPENLL---LDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNK 191
            HRDLKPENLL   LD +  + +SDFGLS    ++ D G +L T CGTP YVAPEV+  K
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLS----KMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y  A  D WS GVI Y+L+ GY PF + N   L+++I KA  +F SP W   S SAK  
Sbjct: 194 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           I  +++ +P  R T  + +++ W
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 156/263 (59%), Gaps = 11/263 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++ RTLG GSF +V   R+   G   A+K+L KE V++ K +     E   + ++ HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +IRM+       +I+++++++ GGELF  +    R     A+ Y  ++  A++Y HS+ +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPEN+LLD NG +K++DFG +     V      +  CGTP+Y+APEV++ K Y+ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YXLCGTPDYIAPEVVSTKPYNK 182
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           +  D WS G+++Y ++AGY PF +SN M  Y+KI  A+ + PP+F+   K L+SR++  +
Sbjct: 183 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 256 PVTRI-----TMAEVIENEWFKK 273
              R+        +V  + WFK+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  190 bits (483), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 160/264 (60%), Gaps = 11/264 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+L   LG+G+F+ V+      TG+  A KI++ +K L  +   +++RE    +L++HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKK-LSARDHQKLEREARICRLLKHP 63
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++ ++ +   Y+V + VTGGELF+ I +R    E +A    QQ++ +V++CH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 135 VCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLLL +      +K++DFGL+   Q   D        GTP Y++PEV+   
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKD 181
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y G   D+W+CGVILY+L+ GY PF + +   LY++I     DF SP W   +  AK L
Sbjct: 182 PY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 248 ISRILDPNPVTRITMAEVIENEWF 271
           I+++L  NP  RIT +E +++ W 
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 160/264 (60%), Gaps = 11/264 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+L   LG+G+F+ V+      TG+  A KI++ +K L  +   +++RE    +L++HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKK-LSARDHQKLEREARICRLLKHP 63
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++ ++ +   Y+V + VTGGELF+ I +R    E +A    QQ++ +V++CH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 135 VCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLLL +      +K++DFGL+   Q   D        GTP Y++PEV+   
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKD 181
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y G   D+W+CGVILY+L+ GY PF + +   LY++I     DF SP W   +  AK L
Sbjct: 182 PY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 248 ISRILDPNPVTRITMAEVIENEWF 271
           I+++L  NP  RIT +E +++ W 
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 101/258 (39%), Positives = 151/258 (58%), Gaps = 15/258 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
             LG G+F++V   +   TG+  A+K + K    +      ++ EI+ +K I+H N++ +
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTL 71
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
            ++  S T  Y+V++ V+GGELFD+I  RG   E +A    QQ+++AV Y H  G+ HRD
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 140 LKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           LKPENLL    + N  + ++DFGLS + Q    +G++ T CGTP YVAPEV+  K Y  A
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKLISRIL 252
             D WS GVI Y+L+ GY PF E     L++KI +   +F+SP W   S SAK  I  +L
Sbjct: 188 -VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246
Query: 253 DPNPVTRITMAEVIENEW 270
           + +P  R T  + + + W
Sbjct: 247 EKDPNERYTCEKALSHPW 264

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 154/262 (58%), Gaps = 13/262 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E   TLG G+F++V  A    TG+  A+K + K K LK K    I+ EI+ ++ I+H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPK-KALKGKE-SSIENEIAVLRKIKHEN 81
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ + ++  S   +Y+V++ V+GGELFD+I  +G   E +A    +Q+++AV Y H  G+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 136 CHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPENLL    D    + +SDFGLS +  +     ++ T CGTP YVAPEV+  K 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK---GDVMSTACGTPGYVAPEVLAQKP 198
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKLI 248
           Y  A  D WS GVI Y+L+ GY PF + N   L+++I KA  +F SP W   S SAK  I
Sbjct: 199 YSKA-VDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFI 257
Query: 249 SRILDPNPVTRITMAEVIENEW 270
             +++ +P  R T  +   + W
Sbjct: 258 RNLMEKDPNKRYTCEQAARHPW 279

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 100/263 (38%), Positives = 158/263 (60%), Gaps = 11/263 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+L   LG+G+F+ V+       G+  A KI++ +K L  +   +++RE    +L++HPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKK-LSARDHQKLEREARICRLLKHPN 82
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+++ ++ +   Y++ + VTGGELF+ I +R    E +A    QQ++ AV +CH  GV
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPENLLL +      +K++DFGL+   +   +        GTP Y++PEV+    
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS--AKKLI 248
           Y G   DLW+CGVILY+L+ GY PF + +   LY++I     DF SP W + +  AK LI
Sbjct: 201 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 259
Query: 249 SRILDPNPVTRITMAEVIENEWF 271
           +++L  NP  RIT AE +++ W 
Sbjct: 260 NKMLTINPSKRITAAEALKHPWI 282

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 100/263 (38%), Positives = 158/263 (60%), Gaps = 11/263 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+L   +G+G+F+ V+      TG   A KI++ +K L  +   +++RE    +L++H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKK-LSARDHQKLEREARICRLLKHS 63
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++ ++ +   Y+V + VTGGELF+ I +R    E +A    QQ++ AV +CH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 135 VCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           V HRDLKPENLLL +      +K++DFGL+   Q   D        GTP Y++PEV+  +
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKE 181
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS--AKKL 247
            Y G   D+W+CGVILY+L+ GY PF + +   LY++I     DF SP W + +  AK L
Sbjct: 182 AY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           I+++L  NP  RIT  E +++ W
Sbjct: 241 INQMLTINPAKRITAHEALKHPW 263

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  184 bits (468), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 104/290 (35%), Positives = 163/290 (56%), Gaps = 24/290 (8%)
Query: 1   MASRTGG------------ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILD 48
           MAS TGG            AS      Y++   LG+G+F+ V+   +  TG   A KI++
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 49  KEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR 108
            +K L  +   +++RE    + ++HPN++R+++ +  ++  Y+V + VTGGELF+ I +R
Sbjct: 64  TKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 109 GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQ 165
               E +A    QQ++ ++ YCHS G+ HR+LKPENLLL +      +K++DFGL+    
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 179
Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL 225
           +V D    H   GTP Y++PEV+    Y     D+W+CGVILY+L+ GY PF + +   L
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRL 238
Query: 226 YKKIFKA--DFKSPPWFSTS--AKKLISRILDPNPVTRITMAEVIENEWF 271
           Y +I     D+ SP W + +  AK LI  +L  NP  RIT  + ++  W 
Sbjct: 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  184 bits (467), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  184 bits (467), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  184 bits (467), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 274

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 160/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 169/291 (58%), Gaps = 21/291 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  R LG+GSF +V   ++  TG+  A+K++ K +V +      + RE+  +K + HP
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V E  TGGELFD+I SR R  E +A +  +Q+++ + Y H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 135 VCHRDLKPENLLL-----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           + HRDLKPENLLL     DAN  +++ DFGLS   +  +    +    GT  Y+APEV++
Sbjct: 170 IVHRDLKPENLLLESKSKDAN--IRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLH 224
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAK 245
              YD  K D+WS GVILY+L++G  PF  +N   + KK+ K    F+ P W   S SAK
Sbjct: 225 GT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 282
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVD-SIFN 295
            LI ++L   P  RI+  + +++EW +   K    EQ ++D+  +D +I N
Sbjct: 283 DLIRKMLTYVPSMRISARDALDHEWIQTYTK----EQISVDVPSLDNAILN 329

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 109/291 (37%), Positives = 169/291 (58%), Gaps = 21/291 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  R LG+GSF +V   ++  TG+  A+K++ K +V +      + RE+  +K + HP
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V E  TGGELFD+I SR R  E +A +  +Q+++ + Y H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 135 VCHRDLKPENLLL-----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           + HRDLKPENLLL     DAN  +++ DFGLS   +  +    +    GT  Y+APEV++
Sbjct: 171 IVHRDLKPENLLLESKSKDAN--IRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLH 225
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAK 245
              YD  K D+WS GVILY+L++G  PF  +N   + KK+ K    F+ P W   S SAK
Sbjct: 226 GT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 283
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVD-SIFN 295
            LI ++L   P  RI+  + +++EW +   K    EQ ++D+  +D +I N
Sbjct: 284 DLIRKMLTYVPSMRISARDALDHEWIQTYTK----EQISVDVPSLDNAILN 330

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 156/264 (59%), Gaps = 5/264 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWFKK 273
           +IL  NP  RIT+ ++ ++ W+ K
Sbjct: 244 KILVENPSARITIPDIKKDRWYNK 267

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 156/264 (59%), Gaps = 5/264 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWFKK 273
           +IL  NP  RIT+ ++ ++ W+ K
Sbjct: 243 KILVENPSARITIPDIKKDRWYNK 266

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 167/287 (58%), Gaps = 20/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  R LG+GSF +V   ++  TG+  A+K++ K +V +      + RE+  +K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V E  TGGELFD+I SR R  E +A +  +Q+++ + Y H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 135 VCHRDLKPENLLL-----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           + HRDLKPENLLL     DAN  +++ DFGLS   +  +    +    GT  Y+APEV++
Sbjct: 147 IVHRDLKPENLLLESKSKDAN--IRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLH 201
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAK 245
              YD  K D+WS GVILY+L++G  PF  +N   + KK+ K    F+ P W   S SAK
Sbjct: 202 GT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDS 292
            LI ++L   P  RI+  + +++EW +   K    EQ ++D+  +D+
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTK----EQISVDVPSLDN 302

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 157/263 (59%), Gaps = 11/263 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+L   LG+G+F+ V+       G+  A  I++ +K L  +   +++RE    +L++HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHP 70
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++ ++ +   Y++ + VTGGELF+ I +R    E +A    QQ++ AV +CH  G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 135 VCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           V HR+LKPENLLL +      +K++DFGL+   +  +         GTP Y++PEV+   
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSPEVLRKD 188
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y G   DLW+CGVILY+L+ GY PF + +   LY++I     DF SP W   +  AK L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           I+++L  NP  RIT AE +++ W
Sbjct: 248 INKMLTINPSKRITAAEALKHPW 270

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 151/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G   T CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 151/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G   T CGTP Y+APE+I +
Sbjct: 144 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEIILS 198
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 199 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 257
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 258 LLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 159/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG+  +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 155/262 (59%), Gaps = 12/262 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y++   LG+G+F+ V+   +  TG   A KI++ +K L  +   +++RE    + ++HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPN 66
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+++ +  ++  Y+V + VTGGELF+ I +R    E +A    QQ++ ++ YCHS G+
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HR+LKPENLLL +      +K++DFGL+    +V D    H   GTP Y++PEV+    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS--AKKLI 248
           Y     D+W+CGVILY+L+ GY PF + +   LY +I     D+ SP W + +  AK LI
Sbjct: 184 Y-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 249 SRILDPNPVTRITMAEVIENEW 270
             +L  NP  RIT  + ++  W
Sbjct: 243 DSMLTVNPKKRITADQALKVPW 264

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/265 (38%), Positives = 152/265 (57%), Gaps = 15/265 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y L  T+G GS+ +VK A    T    A K + K  V   + + + K+EI  MK + HPN
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 84
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +IR+YE     T IY+V+E  TGGELF+++  +   +E +A +  + +++AV YCH   V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 136 CHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPEN L      +  LK+ DFGL+A   + +   ++ T  GTP YV+P+V+  +G
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL--EG 199
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--WFSTS--AKKLI 248
             G + D WS GV++YVL+ GY PF       +  KI +  F  P   W + S  A+ LI
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 259
Query: 249 SRILDPNPVTRITMAEVIENEWFKK 273
            R+L  +P  RIT  + +E+EWF+K
Sbjct: 260 RRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 156/267 (58%), Gaps = 5/267 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI    ++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINAMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 154/262 (58%), Gaps = 12/262 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y++   LG+G+F+ V+   +  TG   A KI++ +K L  +   +++RE    + ++HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPN 66
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+++ +  ++  Y+V + VTGGELF+ I +R    E +A    QQ++ ++ YCHS G+
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HR+LKPENLLL +      +K++DFGL+    +V D    H   GTP Y++PEV+    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKLI 248
           Y     D+W+CGVILY+L+ GY PF + +   LY +I     D+ SP W   +  AK LI
Sbjct: 184 Y-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 249 SRILDPNPVTRITMAEVIENEW 270
             +L  NP  RIT  + ++  W
Sbjct: 243 DSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 155/262 (59%), Gaps = 12/262 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y++   LG+G+F+ V+   +  TG   A KI++ +K L  +   +++RE    + ++HPN
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPN 65
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+++ +  ++  Y+V + VTGGELF+ I +R    E +A    QQ++ ++ YCHS G+
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 125
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HR+LKPENLLL +      +K++DFGL+    +V D    H   GTP Y++PEV+    
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS--AKKLI 248
           Y     D+W+CGVILY+L+ GY PF + +   LY +I     D+ SP W + +  AK LI
Sbjct: 183 Y-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 249 SRILDPNPVTRITMAEVIENEW 270
             +L  NP  RIT  + ++  W
Sbjct: 242 DSMLTVNPKKRITADQALKVPW 263

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 103/265 (38%), Positives = 152/265 (57%), Gaps = 15/265 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y L  T+G GS+ +VK A    T    A K + K  V   + + + K+EI  MK + HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 67
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +IR+YE     T IY+V+E  TGGELF+++  +   +E +A +  + +++AV YCH   V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 136 CHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPEN L      +  LK+ DFGL+A   + +   ++ T  GTP YV+P+V+  +G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--WFSTS--AKKLI 248
             G + D WS GV++YVL+ GY PF       +  KI +  F  P   W + S  A+ LI
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 242
Query: 249 SRILDPNPVTRITMAEVIENEWFKK 273
            R+L  +P  RIT  + +E+EWF+K
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 154/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 53  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G   T CGTP Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLA 227
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 228 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 287 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 96/266 (36%), Positives = 148/266 (55%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  RTLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E    + 
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+VLE+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 154/266 (57%), Gaps = 10/266 (3%)
Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           ++  +++G  LG+GSFA V  A +  TG  VAIK++DK+ + K  M+ +++ E+     +
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYC 130
           +HP+++ +Y        +Y+VLE    GE+   + +R +   E+EAR +  Q+I  + Y 
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA---LPQQVRDDGLLHTTCGTPNYVAPEV 187
           HS G+ HRDL   NLLL  N  +K++DFGL+    +P +       +T CGTPNY++PE+
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-----YTLCGTPNYISPEI 183
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
                + G ++D+WS G + Y L+ G  PF+   +     K+  AD++ P + S  AK L
Sbjct: 184 ATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242
Query: 248 ISRILDPNPVTRITMAEVIENEWFKK 273
           I ++L  NP  R++++ V+++ +  +
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 205
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 206 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 264
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 265 LLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +T+G GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 150
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 205
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 206 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 264
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 265 LLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 233
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 234 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 292
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 293 LLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 159/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+   GT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 159/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+   GT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/267 (38%), Positives = 157/267 (58%), Gaps = 16/267 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  R LG+GSF +V   ++  TG+  A+K++ K +V +      + RE+  +K + HP
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V E  TGGELFD+I SR R  E +A +  +Q+++ + Y H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 135 VCHRDLKPENLLL-----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           + HRDLKPENLLL     DAN  +++ DFGLS   +  +    +    GT  Y+APEV++
Sbjct: 153 IVHRDLKPENLLLESKSKDAN--IRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLH 207
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAK 245
              YD  K D+WS GVILY+L++G  PF  +N   + KK+ K    F+ P W   S SAK
Sbjct: 208 GT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 265
Query: 246 KLISRILDPNPVTRITMAEVIENEWFK 272
            LI ++L   P  RI+  + +++EW +
Sbjct: 266 DLIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 159/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+   GT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 154/273 (56%), Gaps = 8/273 (2%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  +E+GR LG+G F  V  AR  ++   VA+K+L K ++ K  +  Q++REI     + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN++R+Y     + +IY++LE+   GEL+ ++       E       ++L +A+ YCH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           + V HRD+KPENLLL   G LK++DFG S     +R      T CGT +Y+ PE+I  + 
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK----TMCGTLDYLPPEMIEGRM 197
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
           ++  K DLW  GV+ Y L+ G  PFE ++    Y++I K D K P    T A+ LIS++L
Sbjct: 198 HN-EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLL 256
Query: 253 DPNPVTRITMAEVIENEWFKKGYK---PPSFEQ 282
             NP  R+ +A+V  + W +   +   PPS  Q
Sbjct: 257 RHNPSERLPLAQVSAHPWVRANSRRVLPPSALQ 289

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 159/273 (58%), Gaps = 9/273 (3%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 63
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+   GT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 RILDPNPVTRITMAEVIENEWF----KKGYKPP 278
           +IL  NP  RIT+ ++ ++ W+    KKG K P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFGL+      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 164/287 (57%), Gaps = 20/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  R LG+GSF +V   ++  TG+  A+K++ K +V +      + RE+  +K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+ ++YE    K   Y+V E  TGGELFD+I SR R  E +A +  +Q+++ + Y H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 135 VCHRDLKPENLLL-----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           + HRDLKPENLLL     DAN  +++ DFGLS   +  +         GT  Y+APEV++
Sbjct: 147 IVHRDLKPENLLLESKSKDAN--IRIIDFGLSTHFEASKK---XKDKIGTAYYIAPEVLH 201
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAK 245
              YD  K D+WS GVILY+L++G  PF  +N   + KK+ K    F+ P W   S SAK
Sbjct: 202 GT-YD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDS 292
            LI + L   P  RI+  + +++EW +   K    EQ ++D+  +D+
Sbjct: 260 DLIRKXLTYVPSXRISARDALDHEWIQTYTK----EQISVDVPSLDN 302

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 156/267 (58%), Gaps = 5/267 (1%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+   GT  YVAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 243 KILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 27  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 146
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 201
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 202 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 260
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 261 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 33  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 208 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 267 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 149/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 149/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 149/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 19  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 138
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 193
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 194 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 252
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 253 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 53  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 172
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 227
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 228 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 287 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G ++V+DFGL+      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 153/272 (56%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENL++D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIIISKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 90/248 (36%), Positives = 144/248 (58%), Gaps = 6/248 (2%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRIL 252
           K L+  +L
Sbjct: 266 KDLLRNLL 273

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 149/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G ++V+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 148/266 (55%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P + ++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +T+G GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E++ GG++F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 148/266 (55%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P + ++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 148/266 (55%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +TLG GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P + ++       + +Y+V+E+  GGE+F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENL++D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 213
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 214 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
             + ++E  +T+G GSF +V   ++ ETG + A+KILDK+KV+K K I     E   ++ 
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +  P ++++       + +Y+V+E++ GG++F  +   GR  E  AR Y  Q++   +Y 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + +RDLKPENLL+D  G +KV+DFG +      R  G     CGTP Y+APE+I +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILS 212
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
           KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  
Sbjct: 213 KGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 251 ILDPNPVTRI-----TMAEVIENEWF 271
           +L  +   R       + ++  ++WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  177 bits (449), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 106/290 (36%), Positives = 164/290 (56%), Gaps = 18/290 (6%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           T   +Y +   LG+GSF +V   ++  T +  A+K+++K    K+K    I RE+  +K 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKK 77
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           + HPN+++++E++   +  YIV E  TGGELFD+I  R R  E +A +  +Q+ + + Y 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 131 HSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           H   + HRDLKPEN+LL++   +  +K+ DFGLS   QQ   +  +    GT  Y+APEV
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEV 194
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPW--FSTS 243
           +  +G    K D+WS GVILY+L++G  PF   N   + K++   K  F  P W   S  
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI-DLDDVDS 292
           AK LI ++L  +P  RIT  + +E+ W +K     S E P I DL  ++S
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK----YSSETPTISDLPSLES 298

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 152/272 (55%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           P +I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PAIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 147/266 (55%), Gaps = 12/266 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  + LG G++ +V   ++  TG   AIKI+ K  V      G +  E++ +K + HP
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V+E   GGELFD+I  R +  E +A    +Q+++   Y H   
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 135 VCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLLL++   + ++K+ DFGLSA        G +    GT  Y+APEV+  K
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            YD  K D+WSCGVILY+L+ GY PF       + K++ K    F  P W   S  AK+L
Sbjct: 182 -YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 248 ISRILDPNPVTRITMAEVIENEWFKK 273
           +  +L   P  RI+  E + + W  K
Sbjct: 240 VKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 156/268 (58%), Gaps = 15/268 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           YE+G  LG G FA V+  R   TG+  A K + K ++   +      +I+RE++ ++ IR
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN+I ++++  +KT + ++LE V+GGELFD +A +  L EDEA ++ +Q+++ V Y HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 133 RGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN++L    V    +K+ DFG++    ++          GTP +VAPE++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTS--A 244
           N +   G +AD+WS GVI Y+L++G  PF           I     DF    + +TS  A
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242
Query: 245 KKLISRILDPNPVTRITMAEVIENEWFK 272
           K  I R+L  +P  R+T+A+ +E+ W K
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 147/266 (55%), Gaps = 12/266 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  + LG G++ +V   ++  TG   AIKI+ K  V      G +  E++ +K + HP
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V+E   GGELFD+I  R +  E +A    +Q+++   Y H   
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 141
Query: 135 VCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLLL++   + ++K+ DFGLSA        G +    GT  Y+APEV+  K
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKK 198
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS--AKKL 247
            YD  K D+WSCGVILY+L+ GY PF       + K++ K    F  P W   S  AK+L
Sbjct: 199 -YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 256
Query: 248 ISRILDPNPVTRITMAEVIENEWFKK 273
           +  +L   P  RI+  E + + W  K
Sbjct: 257 VKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 152/272 (55%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G      GTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 152/272 (55%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G     CGTP  +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 155/270 (57%), Gaps = 13/270 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           T   +Y +   LG+GSF +V   ++  T +  A+K+++K    K+K    I RE+  +K 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKK 77
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           + HPN+++++E++   +  YIV E  TGGELFD+I  R R  E +A +  +Q+ + + Y 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 131 HSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           H   + HRDLKPEN+LL++   +  +K+ DFGLS   QQ   +  +    GT  Y+APEV
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEV 194
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPW--FSTS 243
           +  +G    K D+WS GVILY+L++G  PF   N   + K++   K  F  P W   S  
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKK 273
           AK LI ++L  +P  RIT  + +E+ W +K
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 155/270 (57%), Gaps = 13/270 (4%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           T   +Y +   LG+GSF +V   ++  T +  A+K+++K    K+K    I RE+  +K 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKK 77
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           + HPN+++++E++   +  YIV E  TGGELFD+I  R R  E +A +  +Q+ + + Y 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 131 HSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           H   + HRDLKPEN+LL++   +  +K+ DFGLS   QQ   +  +    GT  Y+APEV
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEV 194
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPW--FSTS 243
           +  +G    K D+WS GVILY+L++G  PF   N   + K++   K  F  P W   S  
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKK 273
           AK LI ++L  +P  RIT  + +E+ W +K
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 155/268 (57%), Gaps = 15/268 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           YE+G  LG G FA V+  R   TG+  A K + K ++   +      +I+RE++ ++ IR
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN+I ++++  +KT + ++LE V+GGELFD +A +  L EDEA ++ +Q+++ V Y HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 133 RGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN++L    V    +K+ DFG++    ++          GTP +VAPE++
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTS--A 244
           N +   G +AD+WS GVI Y+L++G  PF           I     DF    + +TS  A
Sbjct: 205 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 263
Query: 245 KKLISRILDPNPVTRITMAEVIENEWFK 272
           K  I R+L  +P  R+ +A+ +E+ W K
Sbjct: 264 KDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 96/268 (35%), Positives = 155/268 (57%), Gaps = 15/268 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           YE+G  LG G FA V+  R   TG+  A K + K ++   +      +I+RE++ ++ IR
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN+I ++++  +KT + ++LE V+GGELFD +A +  L EDEA ++ +Q+++ V Y HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 133 RGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN++L    V    +K+ DFG++    ++          GTP +VAPE++
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTS--A 244
           N +   G +AD+WS GVI Y+L++G  PF           I     DF    + +TS  A
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 249
Query: 245 KKLISRILDPNPVTRITMAEVIENEWFK 272
           K  I R+L  +P  R+ +A+ +E+ W K
Sbjct: 250 KDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 152/272 (55%), Gaps = 11/272 (4%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
           T   +  ++ +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              ++ +  P ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
              +Y HS  + +RDLKPENLL+D  G ++V+DFG +      R  G      GTP Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLA 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PE+I +KGY+ A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF 271
           K L+  +L  +   R       + ++  ++WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 154/262 (58%), Gaps = 11/262 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+L   LG+G+F+ V+        +  A KI++ +K L  +   +++RE    +L++HPN
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKK-LSARDHQKLEREARICRLLKHPN 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++R+++ ++ +   Y+V + VTGGELF+ I +R    E +A     Q++ +V++ H   +
Sbjct: 92  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDI 151
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPENLLL +      +K++DFGL+   Q   +        GTP Y++PEV+    
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--EQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS--AKKLI 248
           Y G   D+W+CGVILY+L+ GY PF + +   LY++I     DF SP W + +  AK LI
Sbjct: 210 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 249 SRILDPNPVTRITMAEVIENEW 270
           +++L  NP  RIT  + +++ W
Sbjct: 269 NQMLTINPAKRITADQALKHPW 290

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 154/263 (58%), Gaps = 17/263 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+   LG G+ + V   +   T +  A+K+L  +K +  K++   + EI  +  + HPN
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIV---RTEIGVLLRLSHPN 109
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +I++ E+  + T+I +VLE VTGGELFD+I  +G   E +A    +Q++ AV Y H  G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPENLL      +  LK++DFGLS +   V    L+ T CGTP Y APE++    
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKAD--FKSPPW--FSTSAKKL 247
           Y G + D+WS G+I Y+L+ G+ PF +E     ++++I   +  F SP W   S +AK L
Sbjct: 227 Y-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285
Query: 248 ISRILDPNPVTRITMAEVIENEW 270
           + +++  +P  R+T  + +++ W
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 156/270 (57%), Gaps = 24/270 (8%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIR 78
           + LGEGSF+  +   + ++ +  A+KI+ K      +M    ++EI+ +KL   HPN+++
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           ++EV   +   ++V+E + GGELF++I  +    E EA    ++L++AV + H  GV HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 139 DLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           DLKPENLL    + N  +K+ DFG + L  +  D+  L T C T +Y APE++N  GYD 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 196 AKADLWSCGVILYVLMAGYLPFEE-------SNLMALYKKIFKAD--FKSPPW--FSTSA 244
           +  DLWS GVILY +++G +PF+        ++ + + KKI K D  F+   W   S  A
Sbjct: 189 S-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA 247
Query: 245 KKLISRILDPNPVTRITMAEVIENEWFKKG 274
           K LI  +L  +P  R+ M+ +  NEW + G
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 157/279 (56%), Gaps = 15/279 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+  + LG G++ +V   R+  T    AIKI+ K  V       ++  E++ +KL+ HPN
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDHPN 97
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++++Y+    K   Y+V+E   GGELFD+I  R +  E +A    +Q+++ V Y H   +
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 136 CHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            HRDLKPENLLL++   + ++K+ DFGLSA+ +  +    +    GT  Y+APEV+  K 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRKK- 213
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAKKLI 248
           YD  K D+WS GVIL++L+AGY PF       + +K+ K    F SP W   S  AK LI
Sbjct: 214 YD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272
Query: 249 SRILDPNPVTRITMAEVIENEWFKK--GYKPPSFEQPNI 285
            ++L  +   RI+  + +E+ W K+    K    E P++
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL 311

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 157/272 (57%), Gaps = 19/272 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG--QIKREISTMKLIRH 73
           YEL   +G+G+F+ V+   N ETG+  A+KI+D  K      +    +KRE S   +++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLINAVDY 129
           P+++ + E  +S   +Y+V EF+ G +L  +I  R        E  A  Y +Q++ A+ Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 CHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLH-TTCGTPNYVAP 185
           CH   + HRD+KPEN+LL   + +  +K+ DFG++    Q+ + GL+     GTP+++AP
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAI---QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--W--FS 241
           EV+  + Y G   D+W CGVIL++L++G LPF  +    L++ I K  +K  P  W   S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            SAK L+ R+L  +P  RIT+ E + + W K+
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 70
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 188 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPAFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 70
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 188 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---------IKREI 65
           +Y + +TLG G+  +VK A   +T + VAIKI+ K K      IG          ++ EI
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKF----AIGSAREADPALNVETEI 66
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 67  EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 183 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---------IKREI 65
           +Y + +TLG G+  +VK A   +T + VAIKI+ K K      IG          ++ EI
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKF----AIGSAREADPALNVETEI 72
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 73  EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 188
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 189 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 247
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 248 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 151/269 (56%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---------IKREI 65
           +Y + +TLG G+  +VK A   +T + VAIKI+ K K      IG          ++ EI
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKF----AIGSAREADPALNVETEI 65
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 66  EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 181
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 182 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 240
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 241 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---------IKREI 65
           +Y + +TLG G+  +VK A   +T + VAIKI+ K K      IG          ++ EI
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKF----AIGSAREADPALNVETEI 66
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 67  EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 183 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 102/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---------IKREI 65
           +Y + +TLG G+  +VK A   +T + VAIKI+ K K      IG          ++ EI
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKF----AIGSAREADPALNVETEI 66
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 67  EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 183 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG---------QIKREI 65
           +Y + +TLG G+  +VK A   +T + VAI+I+ K K      IG          ++ EI
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKF----AIGSAREADPALNVETEI 205
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 206 EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 321
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 322 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 380
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 381 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 146/268 (54%), Gaps = 8/268 (2%)
Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
           ++  +  ++  + LG+G+F KV   R   TG   A+KIL KE ++    +     E   +
Sbjct: 3   AKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           +  RHP +  +     +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 122
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y HSR V +RD+K ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+
Sbjct: 123 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 180
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
            +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L+
Sbjct: 181 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 239
Query: 249 SRILDPNPVTRI-----TMAEVIENEWF 271
           + +L  +P  R+        EV+E+ +F
Sbjct: 240 AGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 154/278 (55%), Gaps = 29/278 (10%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG---------QIKREI 65
           +Y + +TLG G+  +VK A   +T + VAI+I+ K K      IG          ++ EI
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKF----AIGSAREADPALNVETEI 191
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             +K + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ 
Sbjct: 192 EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 126 AVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           AV Y H  G+ HRDLKPEN+LL +   + ++K++DFG S +   + +  L+ T CGTP Y
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 307
Query: 183 VAPEV---INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKSPP 238
           +APEV   +   GY+ A  D WS GVIL++ ++GY PF E    ++L  +I    +   P
Sbjct: 308 LAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 239 --WFSTSAKK--LISRILDPNPVTRITMAEVIENEWFK 272
             W   S K   L+ ++L  +P  R T  E + + W +
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 98/269 (36%), Positives = 150/269 (55%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----QIKREISTMKLI 71
           Y+ G  LG G FA VK  R   TG   A K + K +  K    G     I+RE+S +K I
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEI 71
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++ E V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTS--- 243
           +N +   G +AD+WS GVI Y+L++G  PF           +   +++    +FS +   
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK 272
           AK  I R+L  +P  R+T+ + +++ W K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 144/264 (54%), Gaps = 5/264 (1%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y  GR LG+G FAK     + +T E  A K++ K  +LK     ++  EI+  K + +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +V+  +        +Y+VLE      L +    R  + E EAR + +Q I  V Y H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGY 193
           V HRDLK  NL L+ +  +K+ DFGL+    ++  DG    T CGTPNY+APEV+  KG+
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT---KIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
              + D+WS G ILY L+ G  PFE S L   Y +I K ++  P   +  A  LI R+L 
Sbjct: 220 -SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 278
Query: 254 PNPVTRITMAEVIENEWFKKGYKP 277
            +P  R ++AE++ +E+F  GY P
Sbjct: 279 ADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 141/257 (54%), Gaps = 8/257 (3%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y HSR V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           +K ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +P  R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 I-----TMAEVIENEWF 271
           +        EV+E+ +F
Sbjct: 248 LGGGPSDAKEVMEHRFF 264

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 140/254 (55%), Gaps = 4/254 (1%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           ++R  +  +E  R LG+GSF KV  AR  ETG+  A+K+L K+ +L+   +     E   
Sbjct: 17  SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI 76
Query: 68  MKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           + L R HP + +++    +  +++ V+EFV GG+L   I    R  E  AR Y  ++I+A
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA 136
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + + H +G+ +RDLK +N+LLD  G  K++DFG+    + + +     T CGTP+Y+APE
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK 246
           ++    Y G   D W+ GV+LY ++ G+ PFE  N   L++ I   +   P W    A  
Sbjct: 195 ILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG 253
Query: 247 LISRILDPNPVTRI 260
           ++   +  NP  R+
Sbjct: 254 ILKSFMTKNPTMRL 267

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 141/257 (54%), Gaps = 8/257 (3%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y HSR V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           +K ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +P  R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 I-----TMAEVIENEWF 271
           +        EV+E+ +F
Sbjct: 248 LGGGPSDAKEVMEHRFF 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 165/299 (55%), Gaps = 24/299 (8%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKHKMIGQIK 62
            G+ +     +EL + LG+GSF KV   R     ++G   A+K+L K+  LK +   + K
Sbjct: 20  AGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL-KKATLKVRDRVRTK 78
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
            E   +  + HP V++++    ++ K+Y++L+F+ GG+LF +++      E++ + Y  +
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           L   +D+ HS G+ +RDLKPEN+LLD  G +K++DFGLS   + +  +   ++ CGT  Y
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEY 196
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
           +APEV+N +G+  + AD WS GV+++ ++ G LPF+  +       I KA    P + ST
Sbjct: 197 MAPEVVNRQGHSHS-ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLST 255
Query: 243 SAKKLISRILDPNPVTRITM----AEVIE----------NEWFKKGYKP---PSFEQPN 284
            A+ L+  +   NP  R+      AE I+          N+ +++  KP   P+  QP+
Sbjct: 256 EAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVAQPD 314

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 95/292 (32%), Positives = 157/292 (53%), Gaps = 32/292 (10%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-------------- 56
            ++ +Y L   +G+GS+  VK A N       A+K+L K+K+++                
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 57  ---------MIGQIKREISTMKLIRHPNVIRMYEVM--ASKTKIYIVLEFVTGGELFDKI 105
                     I Q+ +EI+ +K + HPNV+++ EV+   ++  +Y+V E V  G + + +
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-V 128
Query: 106 ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ 165
            +   L ED+AR YFQ LI  ++Y H + + HRD+KP NLL+  +G +K++DFG+S   +
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN--E 186
Query: 166 QVRDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLM 223
               D LL  T GTP ++APE ++   K + G   D+W+ GV LY  + G  PF +  +M
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 224 ALYKKIFKA--DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            L+ KI     +F   P  +   K LI+R+LD NP +RI + E+  + W  +
Sbjct: 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 162/315 (51%), Gaps = 20/315 (6%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G  +R  + ++E  + LG+G+F KV   +   TG   A+KIL KE ++    +     E 
Sbjct: 1   GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 60
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
             ++  RHP +  +     +  ++  V+E+  GGELF  ++      ED AR Y  ++++
Sbjct: 61  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 120
Query: 126 AVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
           A+DY HS + V +RDLK ENL+LD +G +K++DFGL    + ++D   +   CGTP Y+A
Sbjct: 121 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 178
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
           PEV+ +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P      A
Sbjct: 179 PEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 237
Query: 245 KKLISRILDPNPVTRI-----TMAEVIENEWF---------KKGYKPPSFEQPNIDLDDV 290
           K L+S +L  +P  R+        E++++ +F         +K   PP   +P +  +  
Sbjct: 238 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPF--KPQVTSETD 295
Query: 291 DSIFNESMDSRNLVV 305
              F+E   ++ + +
Sbjct: 296 TRYFDEEFTAQMITI 310

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 143/264 (54%), Gaps = 5/264 (1%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y  GR LG+G FAK     + +T E  A K++ K  +LK     ++  EI+  K + +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +V+  +        +Y+VLE      L +    R  + E EAR + +Q I  V Y H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGY 193
           V HRDLK  NL L+ +  +K+ DFGL+    ++  DG      CGTPNY+APEV+  KG+
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT---KIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
              + D+WS G ILY L+ G  PFE S L   Y +I K ++  P   +  A  LI R+L 
Sbjct: 220 -SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 278
Query: 254 PNPVTRITMAEVIENEWFKKGYKP 277
            +P  R ++AE++ +E+F  GY P
Sbjct: 279 ADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 143/264 (54%), Gaps = 5/264 (1%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y  GR LG+G FAK     + +T E  A K++ K  +LK     ++  EI+  K + +P
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 86
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +V+  +        +Y+VLE      L +    R  + E EAR + +Q I  V Y H+  
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGY 193
           V HRDLK  NL L+ +  +K+ DFGL+    ++  DG      CGTPNY+APEV+  KG+
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLAT---KIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
              + D+WS G ILY L+ G  PFE S L   Y +I K ++  P   +  A  LI R+L 
Sbjct: 204 -SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 262
Query: 254 PNPVTRITMAEVIENEWFKKGYKP 277
            +P  R ++AE++ +E+F  GY P
Sbjct: 263 ADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 143/264 (54%), Gaps = 5/264 (1%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y  GR LG+G FAK     + +T E  A K++ K  +LK     ++  EI+  K + +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +V+  +        +Y+VLE      L +    R  + E EAR + +Q I  V Y H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGY 193
           V HRDLK  NL L+ +  +K+ DFGL+    ++  DG      CGTPNY+APEV+  KG+
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT---KIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
              + D+WS G ILY L+ G  PFE S L   Y +I K ++  P   +  A  LI R+L 
Sbjct: 220 -SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLH 278
Query: 254 PNPVTRITMAEVIENEWFKKGYKP 277
            +P  R ++AE++ +E+F  GY P
Sbjct: 279 ADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 140/257 (54%), Gaps = 8/257 (3%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y HSR V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           +K ENL+LD +G +K++DFGL    + + D   +   CGTP Y+APEV+ +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +P  R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 I-----TMAEVIENEWF 271
           +        EV+E+ +F
Sbjct: 248 LGGGPSDAKEVMEHRFF 264

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 161/313 (51%), Gaps = 20/313 (6%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
            SR  + ++E  + LG+G+F KV   +   TG   A+KIL KE ++    +     E   
Sbjct: 2   GSRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 61
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           ++  RHP +  +     +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 121
Query: 128 DYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           DY HS + V +RDLK ENL+LD +G +K++DFGL    + ++D   +   CGTP Y+APE
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPE 179
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK 246
           V+ +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P      AK 
Sbjct: 180 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 238
Query: 247 LISRILDPNPVTRI-----TMAEVIENEWF---------KKGYKPPSFEQPNIDLDDVDS 292
           L+S +L  +P  R+        E++++ +F         +K   PP   +P +  +    
Sbjct: 239 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPF--KPQVTSETDTR 296
Query: 293 IFNESMDSRNLVV 305
            F+E   ++ + +
Sbjct: 297 YFDEEFTAQMITI 309

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 144/267 (53%), Gaps = 8/267 (2%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  +  ++  + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             RHP +  +     +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            HSR V +RD+K ENL+LD +G +K++DFGL    + + D   +   CGTP Y+APEV+ 
Sbjct: 126 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLE 183
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++
Sbjct: 184 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 242
Query: 250 RILDPNPVTRI-----TMAEVIENEWF 271
            +L  +P  R+        EV+E+ +F
Sbjct: 243 GLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 140/257 (54%), Gaps = 8/257 (3%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++  RHP +  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y HSR V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKAD 199
           +K ENL+LD +G +K++DFGL    + + D   +   CGTP Y+APEV+ +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 LWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTR 259
            W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +P  R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 I-----TMAEVIENEWF 271
           +        EV+E+ +F
Sbjct: 248 LGGGPSDAKEVMEHRFF 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 144/267 (53%), Gaps = 8/267 (2%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  +  ++  + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             RHP +  +     +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            HSR V +RD+K ENL+LD +G +K++DFGL    + + D   +   CGTP Y+APEV+ 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLE 178
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 250 RILDPNPVTRI-----TMAEVIENEWF 271
            +L  +P  R+        EV+E+ +F
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 142/271 (52%), Gaps = 22/271 (8%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK----------HKMIGQIKREISTMK 69
           R LG G++ +V   +        AIK++ K +  K           K   +I  EIS +K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HPN+I++++V   K   Y+V EF  GGELF++I +R +  E +A    +Q+++ + Y
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 130 CHSRGVCHRDLKPENLLLDANGVL---KVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
            H   + HRD+KPEN+LL+    L   K+ DFGLS+   +   D  L    GT  Y+APE
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPE 218
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----DFKSPPWFST 242
           V+  K     K D+WSCGVI+Y+L+ GY PF   N   + KK+ K     DF      S 
Sbjct: 219 VLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            AK+LI  +L  +   R T  E + + W KK
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 86/252 (34%), Positives = 139/252 (55%), Gaps = 4/252 (1%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R  + ++E  + LG+G+F KV   +   TG   A+KIL KE ++    +     E   ++
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             RHP +  +     +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+DY
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 130 CHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
            HS + V +RDLK ENL+LD +G +K++DFGL    + ++D   + T CGTP Y+APEV+
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 321
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
            +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P      AK L+
Sbjct: 322 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380
Query: 249 SRILDPNPVTRI 260
           S +L  +P  R+
Sbjct: 381 SGLLKKDPKQRL 392

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 86/252 (34%), Positives = 139/252 (55%), Gaps = 4/252 (1%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R  + ++E  + LG+G+F KV   +   TG   A+KIL KE ++    +     E   ++
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             RHP +  +     +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+DY
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 266
Query: 130 CHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
            HS + V +RDLK ENL+LD +G +K++DFGL    + ++D   + T CGTP Y+APEV+
Sbjct: 267 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 324
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
            +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P      AK L+
Sbjct: 325 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 383
Query: 249 SRILDPNPVTRI 260
           S +L  +P  R+
Sbjct: 384 SGLLKKDPKQRL 395

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 149/266 (56%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK---MIGQIKREISTMKLIR 72
           Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           HPN+I +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H+
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 RGVCHRDLKPEN-LLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN +LLD N     +K+ DFGL+    ++ D        GTP +VAPE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTS--A 244
           N +   G +AD+WS GVI Y+L++G  PF           I     DF    +  TS  A
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 245 KKLISRILDPNPVTRITMAEVIENEW 270
           K  I ++L      R+T+ E + + W
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 153/272 (56%), Gaps = 19/272 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG--QIKREISTMKLIRH 73
           YEL   +G+G F+ V+   N ETG+  A+KI+D  K      +    +KRE S   +++H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLINAVDY 129
           P+++ + E  +S   +Y+V EF+ G +L  +I  R        E  A  Y +Q++ A+ Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 130 CHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLH-TTCGTPNYVAP 185
           CH   + HRD+KP  +LL   + +  +K+  FG++    Q+ + GL+     GTP+++AP
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAP 204
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--W--FS 241
           EV+  + Y G   D+W CGVIL++L++G LPF  +    L++ I K  +K  P  W   S
Sbjct: 205 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 262
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            SAK L+ R+L  +P  RIT+ E + + W K+
Sbjct: 263 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 145/258 (56%), Gaps = 7/258 (2%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKH-KMIGQIK 62
           G  + R   +EL R LG+G + KV   R      TG+  A+K+L K  ++++ K     K
Sbjct: 10  GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
            E + ++ ++HP ++ +     +  K+Y++LE+++GGELF ++   G   ED A  Y  +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +  A+ + H +G+ +RDLKPEN++L+  G +K++DFGL    + + D  + HT CGT  Y
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEY 187
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
           +APE++   G++ A  D WS G ++Y ++ G  PF   N      KI K     PP+ + 
Sbjct: 188 MAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246
Query: 243 SAKKLISRILDPNPVTRI 260
            A+ L+ ++L  N  +R+
Sbjct: 247 EARDLLKKLLKRNAASRL 264

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTEK 206
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 265
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 266 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 292

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV----GTAQYVSPELLTEK 207
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 267 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 293

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 153/272 (56%), Gaps = 19/272 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG--QIKREISTMKLIRH 73
           YEL   +G+G F+ V+   N ETG+  A+KI+D  K      +    +KRE S   +++H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLINAVDY 129
           P+++ + E  +S   +Y+V EF+ G +L  +I  R        E  A  Y +Q++ A+ Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 CHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLH-TTCGTPNYVAP 185
           CH   + HRD+KP  +LL   + +  +K+  FG++    Q+ + GL+     GTP+++AP
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--W--FS 241
           EV+  + Y G   D+W CGVIL++L++G LPF  +    L++ I K  +K  P  W   S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            SAK L+ R+L  +P  RIT+ E + + W K+
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 93/311 (29%), Positives = 160/311 (51%), Gaps = 20/311 (6%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R  + ++E  + LG+G+F KV   +   TG   A+KIL KE ++    +     E   ++
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             RHP +  +     +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+DY
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 130 CHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
            HS + V +RDLK ENL+LD +G +K++DFGL    + ++D   +   CGTP Y+APEV+
Sbjct: 126 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVL 183
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
            +  Y G   D W  GV++Y +M G LPF   +   L++ I   + + P      AK L+
Sbjct: 184 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 242
Query: 249 SRILDPNPVTRI-----TMAEVIENEWF---------KKGYKPPSFEQPNIDLDDVDSIF 294
           S +L  +P  R+        E++++ +F         +K   PP   +P +  +     F
Sbjct: 243 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPF--KPQVTSETDTRYF 300
Query: 295 NESMDSRNLVV 305
           +E   ++ + +
Sbjct: 301 DEEFTAQMITI 311

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTEK 210
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 269
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 270 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 296

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 212
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 213 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKL 271
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 272 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 298

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 206
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 265
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 266 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 292

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 146/280 (52%), Gaps = 20/280 (7%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + R   ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP  +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 122
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAP 185
            H +G+ HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+P
Sbjct: 123 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSP 178
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E++  K      +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+
Sbjct: 179 ELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 237
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
            L+ ++L  +   R+   E+       +GY P    P FE
Sbjct: 238 DLVEKLLVLDATKRLGCEEM-------EGYGPLKAHPFFE 270

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 146/280 (52%), Gaps = 20/280 (7%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + R   ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP  +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAP 185
            H +G+ HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+P
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSP 179
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E++  K      +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+
Sbjct: 180 ELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
            L+ ++L  +   R+   E+       +GY P    P FE
Sbjct: 239 DLVEKLLVLDATKRLGCEEM-------EGYGPLKAHPFFE 271

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 191
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 192 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 250
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 251 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 277

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 146/280 (52%), Gaps = 20/280 (7%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + R   ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP  +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 124
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAP 185
            H +G+ HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+P
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSP 180
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E++  K      +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+
Sbjct: 181 ELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 239
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
            L+ ++L  +   R+   E+       +GY P    P FE
Sbjct: 240 DLVEKLLVLDATKRLGCEEM-------EGYGPLKAHPFFE 272

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 209
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 268
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 269 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 295

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  160 bits (405), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 209
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 268
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 269 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 295

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  160 bits (405), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 146/280 (52%), Gaps = 20/280 (7%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + R   ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP  +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 125
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAP 185
            H +G+ HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+P
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSP 181
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E++  K      +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+
Sbjct: 182 ELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 240
Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
            L+ ++L  +   R+   E+       +GY P    P FE
Sbjct: 241 DLVEKLLVLDATKRLGCEEM-------EGYGPLKAHPFFE 273

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 207
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 267 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 293

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 98/282 (34%), Positives = 146/282 (51%), Gaps = 5/282 (1%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + + H +V+  + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +++VLE      L +    R  L E EAR Y +Q++    Y H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADL 200
             NL L+ +  +K+ DFGL+    +V  DG    T CGTPNY+APEV++ KG+   + D+
Sbjct: 145 LGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDV 200
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++L  +P  R 
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 260
Query: 261 TMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           T+ E++ +E+F  GY P       + +    SI   S+D  N
Sbjct: 261 TINELLNDEFFTSGYIPARLPITCLTIPPXFSIAPSSLDPSN 302

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 210
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 269
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 270 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 296

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 207
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 267 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 293

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 209
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 268
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 269 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 295

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 153/271 (56%), Gaps = 7/271 (2%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH-KMIGQIKREISTMKLI 71
           +GKY +G  LGEGS+ KVK   ++ET    A+KIL K+K+ +       +K+EI  ++ +
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 72  RHPNVIRMYEVMAS--KTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAV 127
           RH NVI++ +V+ +  K K+Y+V+E+   G  E+ D +  + R    +A  YF QLI+ +
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGL 122
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +Y HS+G+ H+D+KP NLLL   G LK+S  G++        D    T+ G+P +  PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 188 INN-KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK 246
            N    + G K D+WS GV LY +  G  PFE  N+  L++ I K  +  P         
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 247 LISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           L+  +L+  P  R ++ ++ ++ WF+K + P
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 214
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 215 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 273
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 274 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 300

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 98/282 (34%), Positives = 146/282 (51%), Gaps = 5/282 (1%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + + H +V+  + 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +++VLE      L +    R  L E EAR Y +Q++    Y H   V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADL 200
             NL L+ +  +K+ DFGL+    +V  DG    T CGTPNY+APEV++ KG+   + D+
Sbjct: 149 LGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDV 204
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++L  +P  R 
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 264
Query: 261 TMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           T+ E++ +E+F  GY P       + +    SI   S+D  N
Sbjct: 265 TINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 306

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 98/282 (34%), Positives = 146/282 (51%), Gaps = 5/282 (1%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + + H +V+  + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +++VLE      L +    R  L E EAR Y +Q++    Y H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADL 200
             NL L+ +  +K+ DFGL+    +V  DG    T CGTPNY+APEV++ KG+   + D+
Sbjct: 145 LGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDV 200
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++L  +P  R 
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 260
Query: 261 TMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           T+ E++ +E+F  GY P       + +    SI   S+D  N
Sbjct: 261 TINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 302

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 149/257 (57%), Gaps = 7/257 (2%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKR 63
           G  +    ++EL + LG+GSF KV   +    ++  +  A+K+L K+  LK +   + K 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKM 75
Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           E   +  + HP +++++    ++ K+Y++L+F+ GG+LF +++      E++ + Y  +L
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
             A+D+ HS G+ +RDLKPEN+LLD  G +K++DFGLS   + +  +   ++ CGT  Y+
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 193
Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
           APEV+N +G+  + AD WS GV+++ ++ G LPF+  +       I KA    P + S  
Sbjct: 194 APEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 244 AKKLISRILDPNPVTRI 260
           A+ L+  +   NP  R+
Sbjct: 253 AQSLLRMLFKRNPANRL 269

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 144/258 (55%), Gaps = 7/258 (2%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKH-KMIGQIK 62
           G  + R   +EL R LG+G + KV   R      TG+  A+K+L K  ++++ K     K
Sbjct: 10  GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
            E + ++ ++HP ++ +     +  K+Y++LE+++GGELF ++   G   ED A  Y  +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           +  A+ + H +G+ +RDLKPEN++L+  G +K++DFGL    + + D  + H  CGT  Y
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEY 187
Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST 242
           +APE++   G++ A  D WS G ++Y ++ G  PF   N      KI K     PP+ + 
Sbjct: 188 MAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246
Query: 243 SAKKLISRILDPNPVTRI 260
            A+ L+ ++L  N  +R+
Sbjct: 247 EARDLLKKLLKRNAASRL 264

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 149/257 (57%), Gaps = 7/257 (2%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKR 63
           G  +    ++EL + LG+GSF KV   +    ++  +  A+K+L K+  LK +   + K 
Sbjct: 18  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKM 76
Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           E   +  + HP +++++    ++ K+Y++L+F+ GG+LF +++      E++ + Y  +L
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 136
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
             A+D+ HS G+ +RDLKPEN+LLD  G +K++DFGLS   + +  +   ++ CGT  Y+
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 194
Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
           APEV+N +G+  + AD WS GV+++ ++ G LPF+  +       I KA    P + S  
Sbjct: 195 APEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 253
Query: 244 AKKLISRILDPNPVTRI 260
           A+ L+  +   NP  R+
Sbjct: 254 AQSLLRMLFKRNPANRL 270

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 149/257 (57%), Gaps = 7/257 (2%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKR 63
           G  +    ++EL + LG+GSF KV   +    ++  +  A+K+L K+  LK +   + K 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKM 75
Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           E   +  + HP +++++    ++ K+Y++L+F+ GG+LF +++      E++ + Y  +L
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
             A+D+ HS G+ +RDLKPEN+LLD  G +K++DFGLS   + +  +   ++ CGT  Y+
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 193
Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
           APEV+N +G+  + AD WS GV+++ ++ G LPF+  +       I KA    P + S  
Sbjct: 194 APEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 244 AKKLISRILDPNPVTRI 260
           A+ L+  +   NP  R+
Sbjct: 253 AQSLLRMLFKRNPANRL 269

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 209
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
               + +DLW+ G I+Y L+AG  PF   N   ++ KI K ++  P  F   A+ L+ ++
Sbjct: 210 SAXKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 269 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 295

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 143/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+    AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 207
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 267 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 293

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 143/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTEK 209
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
                 +DLW+ G I+Y L+AG  PF   N   ++ KI K ++  P  F   A+ L+ ++
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 269 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 295

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 150/266 (56%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NVI +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 RGVCHRDLKPEN-LLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN +LLD N     +K+ DFGL+    ++ D        GTP +VAPE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSA 244
           N +   G +AD+WS GVI Y+L++G  PF    ++  L  +    +  D +     S  A
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 245 KKLISRILDPNPVTRITMAEVIENEW 270
           K  I ++L      R+T+ E + + W
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 154/271 (56%), Gaps = 25/271 (9%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NVI +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 RGVCHRDLKPEN-LLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN +LLD N     +K+ DFGL+    ++ D        GTP +VAPE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF-----EES--NLMALYKKIFKADFKSPPWFS 241
           N +   G +AD+WS GVI Y+L++G  PF     +E+  N+ A+       DF    +  
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-----SYDFDEEFFSQ 244
Query: 242 TS--AKKLISRILDPNPVTRITMAEVIENEW 270
           TS  AK  I ++L      R+T+ E + + W
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 150/266 (56%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NVI +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 RGVCHRDLKPEN-LLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN +LLD N     +K+ DFGL+    ++ D        GTP +VAPE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSA 244
           N +   G +AD+WS GVI Y+L++G  PF    ++  L  +    +  D +     S  A
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 245 KKLISRILDPNPVTRITMAEVIENEW 270
           K  I ++L      R+T+ E + + W
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 155/283 (54%), Gaps = 20/283 (7%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILD-KEKVLKHKMIGQIK--- 62
            A++    KY+    +G G  + V+   +  TG   A+KI++   + L  + + +++   
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 63  -REISTMKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
            RE   ++ +  HP++I + +   S + +++V + +  GELFD +  +  L E E R   
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206
Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           + L+ AV + H+  + HRDLKPEN+LLD N  +++SDFG S     +     L   CGTP
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTP 263
Query: 181 NYVAPEVI------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA-- 232
            Y+APE++       + GY G + DLW+CGVIL+ L+AG  PF     + + + I +   
Sbjct: 264 GYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322
Query: 233 DFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            F SP W   S++ K LISR+L  +P  R+T  + +++ +F++
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 144/274 (52%), Gaps = 20/274 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   G L   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFG----LSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            HRDLKPEN+LL+ +  ++++DFG    LS   +Q R +  +    GT  YV+PE++  K
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTEK 209
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
               + +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++
Sbjct: 210 SASKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 268
Query: 252 LDPNPVTRITMAEVIENEWFKKGYKP----PSFE 281
           L  +   R+   E+       +GY P    P FE
Sbjct: 269 LVLDATKRLGCEEM-------EGYGPLKAHPFFE 295

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 148/266 (55%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NVI +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 RGVCHRDLKPEN-LLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN +LLD N     +K+ DFGL+    ++ D        GTP +VAPE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTS--A 244
           N +   G +AD+WS GVI Y+L++G  PF           I     DF    +  TS  A
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 245 KKLISRILDPNPVTRITMAEVIENEW 270
           K  I ++L      R+T+ E + + W
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 150/266 (56%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLIR 72
           Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NVI +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 RGVCHRDLKPEN-LLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + + H DLKPEN +LLD N     +K+ DFGL+    ++ D        GTP +VAPE++
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSA 244
           N +   G +AD+WS GVI Y+L++G  PF    ++  L  +    +  D +     S  A
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 245 KKLISRILDPNPVTRITMAEVIENEW 270
           K  I ++L      R+T+ E + + W
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 101/299 (33%), Positives = 159/299 (53%), Gaps = 22/299 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y +  T+G GS+++ K   +  T    A+K++DK K    + I     EI  ++  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI-----EI-LLRYGQHPN 82
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +I + +V      +Y+V E + GGEL DKI  +    E EA      +   V+Y HS+GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 136 CHRDLKPENLL-LDANG---VLKVSDFGLSALPQQVR-DDGLLHTTCGTPNYVAPEVINN 190
            HRDLKP N+L +D +G    L++ DFG +   +Q+R ++GLL T C T N+VAPEV+  
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFA---KQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFE-------ESNLMALYKKIFKADFKSPPWFSTS 243
           +GYD    D+WS G++LY ++AGY PF        E  L  +    F     +    S +
Sbjct: 200 QGYDEG-CDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           AK L+S++L  +P  R+T  +V+++ W  +  K P  +  + DL  V      +  + N
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 97/282 (34%), Positives = 145/282 (51%), Gaps = 5/282 (1%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + + H +V+  + 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +++VLE      L +    R  L E EAR Y +Q++    Y H   V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADL 200
             NL L+ +  +K+ DFGL+    +V  DG      CGTPNY+APEV++ KG+   + D+
Sbjct: 169 LGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDV 224
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++L  +P  R 
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 284
Query: 261 TMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           T+ E++ +E+F  GY P       + +    SI   S+D  N
Sbjct: 285 TINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 326

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 97/282 (34%), Positives = 145/282 (51%), Gaps = 5/282 (1%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + + H +V+  + 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +++VLE      L +    R  L E EAR Y +Q++    Y H   V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADL 200
             NL L+ +  +K+ DFGL+    +V  DG      CGTPNY+APEV++ KG+   + D+
Sbjct: 167 LGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDV 222
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++L  +P  R 
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 282
Query: 261 TMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           T+ E++ +E+F  GY P       + +    SI   S+D  N
Sbjct: 283 TINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 324

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 101/299 (33%), Positives = 159/299 (53%), Gaps = 22/299 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y +  T+G GS+++ K   +  T    A+K++DK K    + I     EI  ++  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI-----EI-LLRYGQHPN 82
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +I + +V      +Y+V E + GGEL DKI  +    E EA      +   V+Y HS+GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 136 CHRDLKPENLL-LDANG---VLKVSDFGLSALPQQVR-DDGLLHTTCGTPNYVAPEVINN 190
            HRDLKP N+L +D +G    L++ DFG +   +Q+R ++GLL T C T N+VAPEV+  
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFA---KQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFE-------ESNLMALYKKIFKADFKSPPWFSTS 243
           +GYD    D+WS G++LY ++AGY PF        E  L  +    F     +    S +
Sbjct: 200 QGYDEG-CDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           AK L+S++L  +P  R+T  +V+++ W  +  K P  +  + DL  V      +  + N
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 92/257 (35%), Positives = 137/257 (53%), Gaps = 5/257 (1%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + + H +V+  + 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                  +++VLE      L +    R  L E EAR Y +Q++    Y H   V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADL 200
             NL L+ +  +K+ DFGL+    +V  DG      CGTPNY+APEV++ KG+   + D+
Sbjct: 143 LGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDV 198
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++L  +P  R 
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP 258
Query: 261 TMAEVIENEWFKKGYKP 277
           T+ E++ +E+F  GY P
Sbjct: 259 TINELLNDEFFTSGYIP 275

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 102/313 (32%), Positives = 164/313 (52%), Gaps = 25/313 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YE+   +G GS++  K   +  T    A+KI+DK K    + I     EI  ++  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI-----EI-LLRYGQHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +I + +V      +Y+V E + GGEL DKI  +    E EA      +   V+Y H++GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 136 CHRDLKPENLL-LDANG---VLKVSDFGLSALPQQVR-DDGLLHTTCGTPNYVAPEVINN 190
            HRDLKP N+L +D +G    +++ DFG +   +Q+R ++GLL T C T N+VAPEV+  
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFA---KQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFE---ESNLMALYKKIFKADF--KSPPWFSTS-- 243
           +GYD A  D+WS GV+LY ++ GY PF    +     +  +I    F      W S S  
Sbjct: 195 QGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNL 303
           AK L+S++L  +P  R+T A V+ + W     + P ++   ++  D   +   +M +   
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ---LNRQDAPHLVKGAMAATYS 310
Query: 304 VVERREEGPVAPL 316
            + R +   + P+
Sbjct: 311 ALNRNQSPVLEPV 323

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 134/252 (53%), Gaps = 4/252 (1%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM- 68
             +   +   + +G+GSF KV  AR+       A+K+L K+ +LK K    I  E + + 
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           K ++HP ++ ++    +  K+Y VL+++ GGELF  +       E  AR Y  ++ +A+ 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y HS  + +RDLKPEN+LLD+ G + ++DFGL    + +  +    T CGTP Y+APEV+
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           + + YD    D W  G +LY ++ G  PF   N   +Y  I     +  P  + SA+ L+
Sbjct: 212 HKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270
Query: 249 SRILDPNPVTRI 260
             +L  +   R+
Sbjct: 271 EGLLQKDRTKRL 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 93/289 (32%), Positives = 166/289 (57%), Gaps = 20/289 (6%)
Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKM 57
           A+ TG A +  +  +EL + LG G++ KV   R     +TG+  A+K+L K  ++ K K 
Sbjct: 42  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 101
Query: 58  IGQIKREISTMKLIRH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA 116
               + E   ++ IR  P ++ ++    ++TK++++L+++ GGELF  ++ R R  E E 
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 161
Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHT 175
           + Y  +++ A+++ H  G+ +RD+K EN+LLD+NG + ++DFGLS   + V D+    + 
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYD 219
Query: 176 TCGTPNYVAPEVI--NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKI 229
            CGT  Y+AP+++   + G+D A  D WS GV++Y L+ G  PF    E+++   + ++I
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
Query: 230 FKADFKSPPWFSTSAKKLISRILDPNPVTRITMA-----EVIENEWFKK 273
            K++   P   S  AK LI R+L  +P  R+        E+ E+ +F+K
Sbjct: 279 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 145/268 (54%), Gaps = 23/268 (8%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG G+F  V       +G    IK ++K++      + QI+ EI  +K + HPN+I++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS---RGR-LKEDEARKYFQQLINAVDYCHSRGV 135
           +EV      +YIV+E   GGEL ++I S   RG+ L E    +  +Q++NA+ Y HS+ V
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 136 CHRDLKPENLLLD---ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            H+DLKPEN+L      +  +K+ DFGL+ L    + D       GT  Y+APEV     
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW------FSTSAKK 246
               K D+WS GV++Y L+ G LPF  ++L  + +   KA +K P +       +  A  
Sbjct: 203 --TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ---KATYKEPNYAVECRPLTPQAVD 257
Query: 247 LISRILDPNPVTRITMAEVIENEWFKKG 274
           L+ ++L  +P  R + A+V+ +EWFK+ 
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 98/278 (35%), Positives = 148/278 (53%), Gaps = 22/278 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YE+   +G GS++  K   +  T    A+KI+DK K    + I     EI  ++  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEI-----EI-LLRYGQHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +I + +V      +Y+V E   GGEL DKI  +    E EA      +   V+Y H++GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 136 CHRDLKPENLL-LDANG---VLKVSDFGLSALPQQVR-DDGLLHTTCGTPNYVAPEVINN 190
            HRDLKP N+L +D +G    +++ DFG +   +Q+R ++GLL T C T N+VAPEV+  
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFA---KQLRAENGLLXTPCYTANFVAPEVLER 194
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFE---ESNLMALYKKIFKADF--KSPPWFSTS-- 243
           +GYD A  D+WS GV+LY  + GY PF    +     +  +I    F      W S S  
Sbjct: 195 QGYDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFE 281
           AK L+S+ L  +P  R+T A V+ + W     + P ++
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 147/277 (53%), Gaps = 25/277 (9%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--------KEKVLKHKMIGQIKREIST 67
           YE    LG G  + V+   +  T +  A+KI+D         E+V   ++     +E+  
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV--QELREATLKEVDI 76
Query: 68  MKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           ++ +  HPN+I++ +   + T  ++V + +  GELFD +  +  L E E RK  + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           +   H   + HRDLKPEN+LLD +  +K++DFG S    Q+     L + CGTP+Y+APE
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLRSVCGTPSYLAPE 193
Query: 187 VI------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPP 238
           +I      N+ GY G + D+WS GVI+Y L+AG  PF     M + + I   +  F SP 
Sbjct: 194 IIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 239 W--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
           W  +S + K L+SR L   P  R T  E + + +F++
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 146/277 (52%), Gaps = 25/277 (9%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--------KEKVLKHKMIGQIKREIST 67
           YE    LG G  + V+   +  T +  A+KI+D         E+V   ++     +E+  
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV--QELREATLKEVDI 76
Query: 68  MKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           ++ +  HPN+I++ +   + T  ++V + +  GELFD +  +  L E E RK  + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           +   H   + HRDLKPEN+LLD +  +K++DFG S    Q+     L   CGTP+Y+APE
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPE 193
Query: 187 VI------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPP 238
           +I      N+ GY G + D+WS GVI+Y L+AG  PF     M + + I   +  F SP 
Sbjct: 194 IIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 239 W--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
           W  +S + K L+SR L   P  R T  E + + +F++
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 146/277 (52%), Gaps = 25/277 (9%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--------KEKVLKHKMIGQIKREIST 67
           YE    LG G  + V+   +  T +  A+KI+D         E+V   ++     +E+  
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV--QELREATLKEVDI 63
Query: 68  MKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           ++ +  HPN+I++ +   + T  ++V + +  GELFD +  +  L E E RK  + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           +   H   + HRDLKPEN+LLD +  +K++DFG S    Q+     L   CGTP+Y+APE
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPE 180
Query: 187 VI------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPP 238
           +I      N+ GY G + D+WS GVI+Y L+AG  PF     M + + I   +  F SP 
Sbjct: 181 IIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 239
Query: 239 W--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
           W  +S + K L+SR L   P  R T  E + + +F++
Sbjct: 240 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 105/365 (28%), Positives = 192/365 (52%), Gaps = 46/365 (12%)
Query: 1   MASRTGGASRTRVG--KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI 58
           M +R  G + + +G   ++L R +G GS+AKV   R  +T    A++++ KE V   + I
Sbjct: 37  MNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDI 96
Query: 59  GQIKREISTM-KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR 117
             ++ E     +   HP ++ ++    ++++++ V+E+V GG+L   +  + +L E+ AR
Sbjct: 97  DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 156
Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
            Y  ++  A++Y H RG+ +RDLK +N+LLD+ G +K++D+G+    + +R      T C
Sbjct: 157 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFC 214
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF---------EESNLMALYKK 228
           GTPNY+APE++  + Y G   D W+ GV+++ +MAG  PF         +++    L++ 
Sbjct: 215 GTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
Query: 229 IFKADFKSPPWFSTSAKKLISRILDPNPVTRI------TMAEVIENEWFK---------K 273
           I +   + P   S  A  ++   L+ +P  R+        A++  + +F+         K
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQK 333
Query: 274 GYKPPSFEQPNID----LDDVDSIF-NESM----DSRNLV--VERRE-EG--PVAPLTMN 319
              PP   +PNI     LD+ DS F NE +    D  ++V  +++ E EG   + PL M+
Sbjct: 334 QVVPPF--KPNISGEFGLDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINPLLMS 391
Query: 320 AFELI 324
           A E +
Sbjct: 392 AEECV 396

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 105/365 (28%), Positives = 191/365 (52%), Gaps = 46/365 (12%)
Query: 1   MASRTGGASRTRVG--KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI 58
           M +R  G + + +G   ++L R +G GS+AKV   R  +T    A+K++ KE V   + I
Sbjct: 5   MNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI 64
Query: 59  GQIKREISTM-KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR 117
             ++ E     +   HP ++ ++    ++++++ V+E+V GG+L   +  + +L E+ AR
Sbjct: 65  DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 124
Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
            Y  ++  A++Y H RG+ +RDLK +N+LLD+ G +K++D+G+    + +R        C
Sbjct: 125 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 182
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF---------EESNLMALYKK 228
           GTPNY+APE++  + Y G   D W+ GV+++ +MAG  PF         +++    L++ 
Sbjct: 183 GTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 241
Query: 229 IFKADFKSPPWFSTSAKKLISRILDPNPVTRI------TMAEVIENEWFK---------K 273
           I +   + P   S  A  ++   L+ +P  R+        A++  + +F+         K
Sbjct: 242 ILEKQIRIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQK 301
Query: 274 GYKPPSFEQPNID----LDDVDSIF-NESM----DSRNLV--VERRE-EG--PVAPLTMN 319
              PP   +PNI     LD+ DS F NE +    D  ++V  +++ E EG   + PL M+
Sbjct: 302 QVVPPF--KPNISGEFGLDNFDSQFTNERVQLXPDDDDIVRKIDQSEFEGFEYINPLLMS 359
Query: 320 AFELI 324
           A E +
Sbjct: 360 AEECV 364

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 100/320 (31%), Positives = 157/320 (49%), Gaps = 53/320 (16%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LKHKMIGQIKR 63
           GG+      KY L   +G+GS+  V+ A   +T    AIKI++K K+  +  K + +IK 
Sbjct: 18  GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-----SRGRLKED---- 114
           E+  MK + HPN+ R+YEV   +  I +V+E   GG L DK+      S G+   D    
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 115 ---------------------EARKYFQ----------QLINAVDYCHSRGVCHRDLKPE 143
                                E+  + Q          Q+ +A+ Y H++G+CHRD+KPE
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 144 NLLLDANGV--LKVSDFGLSALPQQVRDDGL--LHTTCGTPNYVAPEVIN--NKGYDGAK 197
           N L   N    +K+ DFGLS    ++ +     + T  GTP +VAPEV+N  N+ Y G K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPK 256
Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIF--KADFKSPPW--FSTSAKKLISRILD 253
            D WS GV+L++L+ G +PF   N      ++   K  F++P +   S  A+ L+S +L+
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316
Query: 254 PNPVTRITMAEVIENEWFKK 273
            N   R      +++ W  +
Sbjct: 317 RNVDERFDAMRALQHPWISQ 336

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 144/271 (53%), Gaps = 9/271 (3%)
Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
            R ++  +     LG+GSF KV  A    T E  AIKIL K+ V++   +     E   +
Sbjct: 14  DRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVL 73
Query: 69  KLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            L+ + P + +++    +  ++Y V+E+V GG+L   I   G+ KE +A  Y  ++   +
Sbjct: 74  ALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGL 133
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
            + H RG+ +RDLK +N++LD+ G +K++DFG+    + + D       CGTP+Y+APE+
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEI 191
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I  + Y G   D W+ GV+LY ++AG  PF+  +   L++ I + +   P   S  A  +
Sbjct: 192 IAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI 250
Query: 248 ISRILDPNPVTRITMA-----EVIENEWFKK 273
              ++  +P  R+        +V E+ +F++
Sbjct: 251 CKGLMTKHPAKRLGCGPEGERDVREHAFFRR 281

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 79/252 (31%), Positives = 134/252 (53%), Gaps = 4/252 (1%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + ++  +EL + LG+GSF KV  A   +T +  AIK L K+ VL    +     E   + 
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 73
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           L   HP +  M+    +K  ++ V+E++ GG+L   I S  +     A  Y  ++I  + 
Sbjct: 74  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + HS+G+ +RDLK +N+LLD +G +K++DFG+    + +  D   +  CGTP+Y+APE++
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
             + Y+ +  D WS GV+LY ++ G  PF   +   L+  I   +   P W    AK L+
Sbjct: 192 LGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 250
Query: 249 SRILDPNPVTRI 260
            ++    P  R+
Sbjct: 251 VKLFVREPEKRL 262

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 144/264 (54%), Gaps = 11/264 (4%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY   + +GEGSF K    ++TE G    IK ++  + +  K   + +RE++ +  ++HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRL-KEDEARKYFQQLINAVDYCHS 132
           N+++  E       +YIV+++  GG+LF +I A +G L +ED+   +F Q+  A+ + H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R + HRD+K +N+ L  +G +++ DFG++ +     +  L     GTP Y++PE+  NK 
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKP 201
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP---WFSTSAKKLIS 249
           Y+  K+D+W+ G +LY L      FE  ++  L  KI    F  PP    +S   + L+S
Sbjct: 202 YNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVS 258
Query: 250 RILDPNPVTRITMAEVIENEWFKK 273
           ++   NP  R ++  ++E  +  K
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAK 282

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 124
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 125 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 241
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 242 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 339

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 118
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 235
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 236 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 140/277 (50%), Gaps = 30/277 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKIL------DKEKVLKHKMIGQIKREISTMK 69
           Y++   LG G+F  V       TG N A K +      DKE V         ++EI TM 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV---------RKEIQTMS 103
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVD 128
           ++RHP ++ +++      ++ ++ EF++GGELF+K+A    ++ EDEA +Y +Q+   + 
Sbjct: 104 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 163
Query: 129 YCHSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNYVA 184
           + H     H DLKPEN++     +  LK+ DFGL+A   P+Q      +  T GT  + A
Sbjct: 164 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-----VKVTTGTAEFAA 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----SPPWF 240
           PEV   K   G   D+WS GV+ Y+L++G  PF   N     + +   D+     +    
Sbjct: 219 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 277
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           S   K  I ++L  +P TR+T+ + +E+ W   G  P
Sbjct: 278 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 314

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 189
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 190 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 287

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 79
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 80  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 140 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 196
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 197 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 294

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 73
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 74  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 191 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 288

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 162/308 (52%), Gaps = 34/308 (11%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           ++L R +G GS+AKV   R  +T    A+K++ KE V   + I  ++ E     +   HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++ ++    ++++++ V+E+V GG+L   +  + +L E+ AR Y  ++  A++Y H RG
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + +RDLK +N+LLD+ G +K++D+G+    + +R        CGTPNY+APE++  + Y 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDY- 183
Query: 195 GAKADLWSCGVILYVLMAGYLPF---------EESNLMALYKKIFKADFKSPPWFSTSAK 245
           G   D W+ GV+++ +MAG  PF         +++    L++ I +   + P   S  A 
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 243
Query: 246 KLISRILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSFEQPNID---- 286
            ++   L+ +P  R+        A++  + +F+         K   PP   +PNI     
Sbjct: 244 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF--KPNISGEFG 301
Query: 287 LDDVDSIF 294
           LD+ DS F
Sbjct: 302 LDNFDSQF 309

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 78
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 79  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 195
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 196 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 293

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 140/277 (50%), Gaps = 30/277 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKIL------DKEKVLKHKMIGQIKREISTMK 69
           Y++   LG G+F  V       TG N A K +      DKE V         ++EI TM 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV---------RKEIQTMS 209
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVD 128
           ++RHP ++ +++      ++ ++ EF++GGELF+K+A    ++ EDEA +Y +Q+   + 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 129 YCHSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNYVA 184
           + H     H DLKPEN++     +  LK+ DFGL+A   P+Q      +  T GT  + A
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-----VKVTTGTAEFAA 324
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----SPPWF 240
           PEV   K   G   D+WS GV+ Y+L++G  PF   N     + +   D+     +    
Sbjct: 325 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 383
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           S   K  I ++L  +P TR+T+ + +E+ W   G  P
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 144/278 (51%), Gaps = 30/278 (10%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVIR 78
           + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++R
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVR 89
Query: 79  MYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHS 132
           + +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y HS
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 133 RGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
             + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+ 
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLG 206
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--FS 241
            + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   S
Sbjct: 207 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 265
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
              K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 266 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 303

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 80
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 81  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 197
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 198 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 295

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 191
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 192 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 289

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 144/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 191
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 192 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 289

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 162/308 (52%), Gaps = 34/308 (11%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           ++L R +G GS+AKV   R  +T    A+K++ KE V   + I  ++ E     +   HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++ ++    ++++++ V+E+V GG+L   +  + +L E+ AR Y  ++  A++Y H RG
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + +RDLK +N+LLD+ G +K++D+G+    + +R        CGTPNY+APE++  + Y 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDY- 187
Query: 195 GAKADLWSCGVILYVLMAGYLPF---------EESNLMALYKKIFKADFKSPPWFSTSAK 245
           G   D W+ GV+++ +MAG  PF         +++    L++ I +   + P   S  A 
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247
Query: 246 KLISRILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSFEQPNID---- 286
            ++   L+ +P  R+        A++  + +F+         K   PP   +PNI     
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF--KPNISGEFG 305
Query: 287 LDDVDSIF 294
           LD+ DS F
Sbjct: 306 LDNFDSQF 313

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 135/252 (53%), Gaps = 13/252 (5%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   YE+ + +G G+F +V+  R+  T +  A+K+L K +++K         E   M 
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
               P V++++        +Y+V+E++ GG+L + + S   + E  AR Y  +++ A+D 
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDA 188
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAPEV 187
            HS G  HRD+KP+N+LLD +G LK++DFG      ++  +G++   T  GTP+Y++PEV
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 188 INNK---GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWF 240
           + ++   GY G + D WS GV LY ++ G  PF   +L+  Y KI        F      
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 305
Query: 241 STSAKKLISRIL 252
           S  AK LI   L
Sbjct: 306 SKEAKNLICAFL 317

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 135/252 (53%), Gaps = 13/252 (5%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   YE+ + +G G+F +V+  R+  T +  A+K+L K +++K         E   M 
Sbjct: 65  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
               P V++++        +Y+V+E++ GG+L + + S   + E  AR Y  +++ A+D 
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDA 183
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAPEV 187
            HS G  HRD+KP+N+LLD +G LK++DFG      ++  +G++   T  GTP+Y++PEV
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 188 INNK---GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWF 240
           + ++   GY G + D WS GV LY ++ G  PF   +L+  Y KI        F      
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300
Query: 241 STSAKKLISRIL 252
           S  AK LI   L
Sbjct: 301 SKEAKNLICAFL 312

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 135/252 (53%), Gaps = 13/252 (5%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   YE+ + +G G+F +V+  R+  T +  A+K+L K +++K         E   M 
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
               P V++++        +Y+V+E++ GG+L + + S   + E  AR Y  +++ A+D 
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDA 188
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAPEV 187
            HS G  HRD+KP+N+LLD +G LK++DFG      ++  +G++   T  GTP+Y++PEV
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 188 INNK---GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWF 240
           + ++   GY G + D WS GV LY ++ G  PF   +L+  Y KI        F      
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 305
Query: 241 STSAKKLISRIL 252
           S  AK LI   L
Sbjct: 306 SKEAKNLICAFL 317

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 135/257 (52%), Gaps = 4/257 (1%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G   R ++  +     LG+GSF KV  +    T E  A+KIL K+ V++   +     E
Sbjct: 11  NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 65  ISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
              + L  + P + +++    +  ++Y V+E+V GG+L   I   GR KE  A  Y  ++
Sbjct: 71  KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
              + +  S+G+ +RDLK +N++LD+ G +K++DFG+    + + D       CGTP+Y+
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYI 188
Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
           APE+I  + Y G   D W+ GV+LY ++AG  PFE  +   L++ I + +   P   S  
Sbjct: 189 APEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247
Query: 244 AKKLISRILDPNPVTRI 260
           A  +   ++  +P  R+
Sbjct: 248 AVAICKGLMTKHPGKRL 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 133/252 (52%), Gaps = 4/252 (1%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + ++  + L + LG+GSF KV  A   +T +  AIK L K+ VL    +     E   + 
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           L   HP +  M+    +K  ++ V+E++ GG+L   I S  +     A  Y  ++I  + 
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + HS+G+ +RDLK +N+LLD +G +K++DFG+    + +  D   +  CGTP+Y+APE++
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
             + Y+ +  D WS GV+LY ++ G  PF   +   L+  I   +   P W    AK L+
Sbjct: 191 LGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249
Query: 249 SRILDPNPVTRI 260
            ++    P  R+
Sbjct: 250 VKLFVREPEKRL 261

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 143/279 (51%), Gaps = 30/279 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L   C TP YVAPEV+
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTEPCYTPYYVAPEVL 189
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 190 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 287

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 135/257 (52%), Gaps = 4/257 (1%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G   R ++  +     LG+GSF KV  +    T E  A+KIL K+ V++   +     E
Sbjct: 332 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 65  ISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
              + L  + P + +++    +  ++Y V+E+V GG+L   I   GR KE  A  Y  ++
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
              + +  S+G+ +RDLK +N++LD+ G +K++DFG+    + + D       CGTP+Y+
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYI 509
Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
           APE+I  + Y G   D W+ GV+LY ++AG  PFE  +   L++ I + +   P   S  
Sbjct: 510 APEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 568
Query: 244 AKKLISRILDPNPVTRI 260
           A  +   ++  +P  R+
Sbjct: 569 AVAICKGLMTKHPGKRL 585

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 147/274 (53%), Gaps = 15/274 (5%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +   Y++ + +G G+F +V+  R+  + +  A+K+L K +++K         E   M 
Sbjct: 71  QMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
               P V++++        +Y+V+E++ GG+L + + S   + E  A+ Y  +++ A+D 
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH--TTCGTPNYVAPEV 187
            HS G+ HRD+KP+N+LLD +G LK++DFG      ++ + G++H  T  GTP+Y++PEV
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVHCDTAVGTPDYISPEV 246
Query: 188 INNK---GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD----FKSPPWF 240
           + ++   GY G + D WS GV L+ ++ G  PF   +L+  Y KI        F      
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI 306
Query: 241 STSAKKLISRILDPNPVT--RITMAEVIENEWFK 272
           S  AK LI   L    V   R  + E+ ++ +FK
Sbjct: 307 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 340

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 135/267 (50%), Gaps = 19/267 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---IKREISTMKLI 71
           +Y LG  LG+G F  V           VAIK++ + +VL    +        E++ +  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 72  R----HPNVIRMYEVMASKTKIYIVLEF-VTGGELFDKIASRGRLKEDEARKYFQQLINA 126
                HP VIR+ +   ++    +VLE  +   +LFD I  +G L E  +R +F Q++ A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 127 VDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           + +CHSRGV HRD+K EN+L+D   G  K+ DFG  AL   + D+       GT  Y  P
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-GTRVYSPP 207
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           E I+   Y    A +WS G++LY ++ G +PFE        ++I +A+   P   S    
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCC 261
Query: 246 KLISRILDPNPVTRITMAEVIENEWFK 272
            LI R L P P +R ++ E++ + W +
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 84/255 (32%), Positives = 134/255 (52%), Gaps = 11/255 (4%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  + + + +G G F++V  A     G  VA+K +    ++  K      +EI  +K + 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK----EDEARKYFQQLINAVD 128
           HPNVI+ Y       ++ IVLE    G+L   I    + K    E    KYF QL +A++
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + HSR V HRD+KP N+ + A GV+K+ D GL             H+  GTP Y++PE I
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 208
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKADFKSPP--WFSTSA 244
           +  GY+  K+D+WS G +LY + A   PF  ++ NL +L KKI + D+   P   +S   
Sbjct: 209 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 245 KKLISRILDPNPVTR 259
           ++L++  ++P+P  R
Sbjct: 268 RQLVNMCINPDPEKR 282

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 140/265 (52%), Gaps = 15/265 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI-----GQIKREISTMK 69
           KY     LG G+F  V  A + E  + V +K + KEKVL+   I     G++  EI+ + 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLE-FVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
            + H N+I++ ++  ++    +V+E   +G +LF  I    RL E  A   F+QL++AV 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y   + + HRD+K EN+++  +  +K+ DFG +A  ++ +   L +T CGT  Y APEV+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVL 201
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
               Y G + ++WS GV LY L+     FEE+    L + + +A    P   S     L+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLV-----FEENPFCELEETV-EAAIHPPYLVSKELMSLV 255
Query: 249 SRILDPNPVTRITMAEVIENEWFKK 273
           S +L P P  R T+ +++ + W  +
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 145/271 (53%), Gaps = 28/271 (10%)
Query: 16  YELGRT--LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           Y + +T  LG G F +V     T TG  +A KI+ K + +K K   ++K EIS M  + H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDK--EEVKNEISVMNQLDH 145
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
            N+I++Y+   SK  I +V+E+V GGELFD+I      L E +   + +Q+   + + H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 133 RGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
             + H DLKPEN+L    DA  + K+ DFGL+   ++ +    L    GTP ++APEV+N
Sbjct: 206 MYILHLDLKPENILCVNRDAKQI-KIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 190 NKGYDGAK--ADLWSCGVILYVLMAGYLPF-------EESNLMALYKKIFKADFKSPPWF 240
              YD      D+WS GVI Y+L++G  PF         +N++A    +   +F+     
Sbjct: 262 ---YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD---I 315
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWF 271
           S  AK+ IS++L      RI+ +E +++ W 
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHPNVI 77
            + LG G   KV    N  T E  A+K L            + +RE+    +  + P+++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKXLQD--------CPKARREVELHWRASQCPHIV 118
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 119 RIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C TP YVAPEV+
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 235
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D WS GVI Y+L+ GY PF  ++ +A+        +  + +F +P W   
Sbjct: 236 GPEKYDKS-CDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP 278
           S   K LI  +L   P  R T+ E   + W  +  K P
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVP 332

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 155/306 (50%), Gaps = 46/306 (15%)
Query: 7   GASRTRVGKYE-----LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
           G++ +  GK+E         LGEG++AKV+ A + + G+  A+KI++K+    H    ++
Sbjct: 1   GSTDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA--GHSR-SRV 57
Query: 62  KREISTMKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
            RE+ T+   + + N++ + E     T+ Y+V E + GG +   I  +    E EA +  
Sbjct: 58  FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVV 117
Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDAN---GVLKVSDFGL--------SALPQQVRD 169
           + +  A+D+ H++G+ HRDLKPEN+L ++      +K+ DF L        S  P    +
Sbjct: 118 RDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 170 DGLLHTTCGTPNYVAPEVI----NNKGYDGAKADLWSCGVILYVLMAGYLPF-------- 217
              L T CG+  Y+APEV+    +   +   + DLWS GV+LY++++GY PF        
Sbjct: 178 ---LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADC 234
Query: 218 ---EESNLMALYKKIF------KADFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVI 266
                        K+F      K +F    W   S+ AK LIS++L  +   R++ A+V+
Sbjct: 235 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVL 294
Query: 267 ENEWFK 272
           ++ W +
Sbjct: 295 QHPWVQ 300

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 141/270 (52%), Gaps = 16/270 (5%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           +R   YE+  T+G GS+ + +  R    G+ +  K LD   + + +    +  E++ ++ 
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRE 61
Query: 71  IRHPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLI 124
           ++HPN++R Y+ +  +T   +YIV+E+  GG+L   I      R  L E+   +   QL 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 125 NAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
            A+  CH R      V HRDLKP N+ LD    +K+ DFGL+ +     D     T  GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGT 179
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW 239
           P Y++PE +N   Y+  K+D+WS G +LY L A   PF   +   L  KI +  F+  P+
Sbjct: 180 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 240 -FSTSAKKLISRILDPNPVTRITMAEVIEN 268
            +S    ++I+R+L+     R ++ E++EN
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 135/264 (51%), Gaps = 14/264 (5%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y++   LG G+F  V       TG     K ++    L    +   K EIS M  + HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHPK 109
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRG 134
           +I +++    K ++ ++LEF++GGELFD+IA+   ++ E E   Y +Q    + + H   
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 135 VCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           + H D+KPEN++ +      +K+ DFGL+    ++  D ++  T  T  + APE+++ + 
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPWFSTS--AKKLI 248
             G   D+W+ GV+ YVL++G  PF   + +   + + + D  F    + S S  AK  I
Sbjct: 227 V-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285
Query: 249 SRILDPNPVTRITMAEVIENEWFK 272
             +L   P  R+T+ + +E+ W K
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 142/260 (54%), Gaps = 12/260 (4%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ R +G+GSF KV   +  +T +  A+K ++K+K ++   +  + +E+  M+ + HP 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ ++     +  +++V++ + GG+L   +      KE+  + +  +L+ A+DY  ++ +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVINNK--- 191
            HRD+KP+N+LLD +G + ++DF ++A LP++ +    + T  GT  Y+APE+ +++   
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ----ITTMAGTKPYMAPEMFSSRKGA 192
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFE---ESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           GY  A  D WS GV  Y L+ G  P+     ++   +           P  +S     L+
Sbjct: 193 GYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251
Query: 249 SRILDPNPVTRITMAEVIEN 268
            ++L+PNP  R +    ++N
Sbjct: 252 KKLLEPNPDQRFSQLSDVQN 271

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 24/279 (8%)
Query: 16  YELGR-TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           Y+L +  LG G   KV    +  TG+  A+K+L      + ++    +       +    
Sbjct: 30  YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC--- 86
Query: 75  NVIRMYEVMA-SKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
            ++ +YE M   K  + I++E + GGELF +I  RG     E EA +  + +  A+ + H
Sbjct: 87  -ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 132 SRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL    + + VLK++DFG +    Q      L T C TP YVAPEV+
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVL 201
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ G+ PF  +   A+        ++ +  F +P W   
Sbjct: 202 GPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S  AK+LI  +L  +P  R+T+ + + + W  +    P 
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 141/270 (52%), Gaps = 16/270 (5%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           +R   YE+  T+G GS+ + +  R    G+ +  K LD   + + +    +  E++ ++ 
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRE 61
Query: 71  IRHPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLI 124
           ++HPN++R Y+ +  +T   +YIV+E+  GG+L   I      R  L E+   +   QL 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 125 NAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
            A+  CH R      V HRDLKP N+ LD    +K+ DFGL+ +     D+       GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DEDFAKEFVGT 179
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW 239
           P Y++PE +N   Y+  K+D+WS G +LY L A   PF   +   L  KI +  F+  P+
Sbjct: 180 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 240 -FSTSAKKLISRILDPNPVTRITMAEVIEN 268
            +S    ++I+R+L+     R ++ E++EN
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 24/279 (8%)
Query: 16  YELGR-TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           Y+L +  LG G   KV    +  TG+  A+K+L      + ++    +       +    
Sbjct: 11  YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC--- 67
Query: 75  NVIRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
            ++ +YE M   K  + I++E + GGELF +I  RG     E EA +  + +  A+ + H
Sbjct: 68  -ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 132 SRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL    + + VLK++DFG +    Q      L T C TP YVAPEV+
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVL 182
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             + YD +  D+WS GVI+Y+L+ G+ PF  +   A+        ++ +  F +P W   
Sbjct: 183 GPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 241
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S  AK+LI  +L  +P  R+T+ + + + W  +    P 
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 280

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 16/270 (5%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           +R   YE+  T+G GS+ + +  R    G+ +  K LD   + + +    +  E++ ++ 
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRE 61
Query: 71  IRHPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLI 124
           ++HPN++R Y+ +  +T   +YIV+E+  GG+L   I      R  L E+   +   QL 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 125 NAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
            A+  CH R      V HRDLKP N+ LD    +K+ DFGL+ +     D        GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGT 179
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW 239
           P Y++PE +N   Y+  K+D+WS G +LY L A   PF   +   L  KI +  F+  P+
Sbjct: 180 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 240 -FSTSAKKLISRILDPNPVTRITMAEVIEN 268
            +S    ++I+R+L+     R ++ E++EN
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YEL   +G G+ A V+ A      E VAIK ++ EK      + ++ +EI  M    HPN
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 74
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS--------RGRLKEDEARKYFQQLINAV 127
           ++  Y     K ++++V++ ++GG + D I           G L E       ++++  +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD---DGLLHTTCGTPNYVA 184
           +Y H  G  HRD+K  N+LL  +G ++++DFG+SA      D   + +  T  GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 185 PEVINN-KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST- 242
           PEV+   +GYD  KAD+WS G+    L  G  P+ +   M +     + D   PP   T 
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---PPSLETG 250
Query: 243 ------------SAKKLISRILDPNPVTRITMAEVIENEWFKKG 274
                       S +K+IS  L  +P  R T AE++ +++F+K 
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YEL   +G G+ A V+ A      E VAIK ++ EK      + ++ +EI  M    HPN
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 69
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS--------RGRLKEDEARKYFQQLINAV 127
           ++  Y     K ++++V++ ++GG + D I           G L E       ++++  +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD---DGLLHTTCGTPNYVA 184
           +Y H  G  HRD+K  N+LL  +G ++++DFG+SA      D   + +  T  GTP ++A
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 185 PEVINN-KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST- 242
           PEV+   +GYD  KAD+WS G+    L  G  P+ +   M +     + D   PP   T 
Sbjct: 190 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---PPSLETG 245
Query: 243 ------------SAKKLISRILDPNPVTRITMAEVIENEWFKKG 274
                       S +K+IS  L  +P  R T AE++ +++F+K 
Sbjct: 246 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 146/284 (51%), Gaps = 35/284 (12%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRM 79
            LGEG+ A+V+   N  T +  A+KI++K+      +  ++ RE+  +   + H NV+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
            E    + + Y+V E + GG +   I  R    E EA    Q + +A+D+ H++G+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 140 LKPENLLLD-ANGV--LKVSDFGLSALPQQVRDDGL-----LHTTCGTPNYVAPEVINNK 191
           LKPEN+L +  N V  +K+ DFGL +  +   D        L T CG+  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 192 GYDGA----KADLWSCGVILYVLMAGYLPF-----------------EESNLMALYKKIF 230
             + +    + DLWS GVILY+L++GY PF                    N++    +  
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 231 KADFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
           K +F    W   S +AK LIS++L  +   R++ A+V+++ W +
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 134/249 (53%), Gaps = 15/249 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +   T    A+KIL+K ++LK       + E   +       
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++     +  +Y+V+++  GG+L   ++    +L ED AR Y  +++ A+D  H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI---- 188
             HRD+KP+N+LLD NG ++++DFG S L  ++ DDG + ++   GTP+Y++PE++    
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFG-SCL--KMNDDGTVQSSVAVGTPDYISPEILQAME 268
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW---FSTS 243
           +  G  G + D WS GV +Y ++ G  PF   +L+  Y KI   +  F+ P      S  
Sbjct: 269 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEE 328
Query: 244 AKKLISRIL 252
           AK LI R++
Sbjct: 329 AKDLIQRLI 337

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 134/249 (53%), Gaps = 15/249 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +   T    A+KIL+K ++LK       + E   +       
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++     +  +Y+V+++  GG+L   ++    +L ED AR Y  +++ A+D  H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVI---- 188
             HRD+KP+N+LLD NG ++++DFG S L  ++ DDG + ++   GTP+Y++PE++    
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFG-SCL--KMNDDGTVQSSVAVGTPDYISPEILQAME 252
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW---FSTS 243
           +  G  G + D WS GV +Y ++ G  PF   +L+  Y KI   +  F+ P      S  
Sbjct: 253 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEE 312
Query: 244 AKKLISRIL 252
           AK LI R++
Sbjct: 313 AKDLIQRLI 321

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 139/256 (54%), Gaps = 16/256 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  AR   +G  VA+K++D  K  + +++     E+  M+  +H NV+ MY+
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHFNVVEMYK 109
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++++EF+ GG L D I S+ RL E++     + ++ A+ Y H++GV HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  +D        GTP ++APEVI+   Y   + D+W
Sbjct: 169 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKXLVGTPYWMAPEVISRSLY-ATEVDIW 225
Query: 202 SCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK------KLISRILDPN 255
           S G+++  ++ G  P+   + +   K++  +    PP    S K        + R+L  +
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPKLKNSHKVSPVLRDFLERMLVRD 282
Query: 256 PVTRITMAEVIENEWF 271
           P  R T  E++++ + 
Sbjct: 283 PQERATAQELLDHPFL 298

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 134/249 (53%), Gaps = 15/249 (6%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +     +  A+KIL+K ++LK       + E   +       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++        +Y+V+++  GG+L   ++    RL E+ AR Y  +++ A+D  H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEVIN--- 189
             HRD+KP+N+L+D NG ++++DFG S L  ++ +DG + ++   GTP+Y++PE++    
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 190 -NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF--KADFKSPPW---FSTS 243
             KG  G + D WS GV +Y ++ G  PF   +L+  Y KI   K  F+ P      S +
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312
Query: 244 AKKLISRIL 252
           AK LI R++
Sbjct: 313 AKDLIRRLI 321

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 145/284 (51%), Gaps = 35/284 (12%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRM 79
            LGEG+ A+V+   N  T +  A+KI++K+      +  ++ RE+  +   + H NV+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
            E    + + Y+V E + GG +   I  R    E EA    Q + +A+D+ H++G+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 140 LKPENLLLD-ANGV--LKVSDFGLSALPQQVRDDGL-----LHTTCGTPNYVAPEVINNK 191
           LKPEN+L +  N V  +K+ DF L +  +   D        L T CG+  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 192 GYDGA----KADLWSCGVILYVLMAGYLPF-----------------EESNLMALYKKIF 230
             + +    + DLWS GVILY+L++GY PF                    N++    +  
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 231 KADFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
           K +F    W   S +AK LIS++L  +   R++ A+V+++ W +
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 95
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++        GTP ++APE+I+   Y G + D+W
Sbjct: 155 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 211
Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 271
Query: 259 RITMAEVIENEWFKKGYKPPSF 280
           R T AE++++ +  K   P S 
Sbjct: 272 RATAAELLKHPFLAKAGPPASI 293

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 88
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++        GTP ++APE+I+   Y G + D+W
Sbjct: 148 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 204
Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 264
Query: 259 RITMAEVIENEWFKKGYKPPSF 280
           R T AE++++ +  K   P S 
Sbjct: 265 RATAAELLKHPFLAKAGPPASI 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 93
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++        GTP ++APE+I+   Y G + D+W
Sbjct: 153 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 209
Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 269
Query: 259 RITMAEVIENEWFKKGYKPPSF 280
           R T AE++++ +  K   P S 
Sbjct: 270 RATAAELLKHPFLAKAGPPASI 291

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 138
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++        GTP ++APE+I+   Y G + D+W
Sbjct: 198 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 254
Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314
Query: 259 RITMAEVIENEWFKKGYKPPSF 280
           R T AE++++ +  K   P S 
Sbjct: 315 RATAAELLKHPFLAKAGPPASI 336

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 215
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++        GTP ++APE+I+   Y G + D+W
Sbjct: 275 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 331
Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391
Query: 259 RITMAEVIENEWFKKGYKPPSF 280
           R T AE++++ +  K   P S 
Sbjct: 392 RATAAELLKHPFLAKAGPPASI 413

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 10/262 (3%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    +G+ VA+K +D  K  + +++     E+  M+  +H NV+ MY 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+   H++GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL  +G +K+SDFG  A  Q  ++        GTP ++APE+I+   Y G + D+W
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 202 SCGVILYVLMAGYLP-FEESNL--MALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L  M + +       K+    S S K  + R+L  +P  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 259 RITMAEVIENEWFKKGYKPPSF 280
           R T AE++++ +  K   P S 
Sbjct: 261 RATAAELLKHPFLAKAGPPASI 282

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 148/276 (53%), Gaps = 15/276 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 77
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +      T  GTP ++APEV+  K 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKA 192
Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 193 Y-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R LD +   R +  E++++++ K   KP S   P I
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIA-KPLSSLTPLI 286

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE +    +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 184
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 238
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 149/276 (53%), Gaps = 15/276 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 77
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +   ++    GTP ++APEV+  K 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV----GTPYWMAPEVVTRKA 192
Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 193 Y-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R LD +   R +  E++++++ K   KP S   P I
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIA-KPLSSLTPLI 286

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 144/301 (47%), Gaps = 48/301 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKIL----DKEKVLKHKMIGQIKREISTMKL 70
           KYE    +GEG++  V  A+N ET E VA+K +    D E V    +     REI  +K 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 57
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVD 128
           ++H N++R+++V+ S  K+ +V EF      + FD  +  G L  +  + +  QL+  + 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CHSR V HRDLKP+NLL++ NG LK++DFGL+ A    VR          T  Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDV 172
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFK--------------- 231
           +          D+WS G I   L     P F  +++    K+IF+               
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 232 -ADFKSPPWF-------------STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
             D+K  P +             + + + L+  +L  NPV RI+  E +++ +F   + P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291
Query: 278 P 278
           P
Sbjct: 292 P 292

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 149/276 (53%), Gaps = 15/276 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 78
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +   ++    GTP ++APEV+  K 
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKA 193
Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 194 Y-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 252
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R L+ +   R +  E+I++++ K   KP S   P I
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFLKIA-KPLSSLTPLI 287

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 139/283 (49%), Gaps = 32/283 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIK-REISTMKLIR 72
           KYE    +GEGS+  V   RN +TG  VAIK  L+ +     KM+ +I  REI  +K +R
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLR 82
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H N++ + EV   K + Y+V EFV    L D       L     +KY  Q+IN + +CHS
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
             + HRD+KPEN+L+  +GV+K+ DFG +   A P +V DD +      T  Y APE++ 
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-----ATRWYRAPELLV 197
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
                G   D+W+ G ++  +  G   F  +S++  LY                    LI
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH------------IMMCLGNLI 245
Query: 249 SR---ILDPNPV-TRITMAEVIENEWFKKGYKPPSFEQPNIDL 287
            R   + + NPV   + + E+ E E  ++ Y  P   +  IDL
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRY--PKLSEVVIDL 286

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 138/270 (51%), Gaps = 15/270 (5%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+        Q  +EI+ +     P V + Y 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 92
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D +   G L E +     ++++  +DY HS    HRD+K
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL  +G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD +KAD+
Sbjct: 152 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 207
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----FSTSAKKLISRILDPNP 256
           WS G+    L  G  P  E + M   K +F     +PP     +S   K+ +   L+  P
Sbjct: 208 WSLGITAIELARGEPPHSELHPM---KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 264
Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             R T  E++++++  +  K  S+    ID
Sbjct: 265 SFRPTAKELLKHKFILRNAKKTSYLTELID 294

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 138/270 (51%), Gaps = 15/270 (5%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+        Q  +EI+ +     P V + Y 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D +   G L E +     ++++  +DY HS    HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL  +G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD +KAD+
Sbjct: 132 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 187
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----FSTSAKKLISRILDPNP 256
           WS G+    L  G  P  E + M   K +F     +PP     +S   K+ +   L+  P
Sbjct: 188 WSLGITAIELARGEPPHSELHPM---KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             R T  E++++++  +  K  S+    ID
Sbjct: 245 SFRPTAKELLKHKFILRNAKKTSYLTELID 274

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 239
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 137/265 (51%), Gaps = 11/265 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +GEGS   V  A    TG+ VA+K +D  K  + +++     E+  M+   H NV+ MY 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHDNVVDMYS 109
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                 ++++V+EF+ GG L D I +  R+ E++       ++ A+ Y H++GV HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
            +++LL ++G +K+SDFG  A  Q  ++        GTP ++APEVI+   Y G + D+W
Sbjct: 169 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIW 225
Query: 202 SCGVILYVLMAGYLP-FEESNLMAL--YKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
           S G+++  ++ G  P F E  L A+   +       K     S+  +  +  +L   P  
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQ 285
Query: 259 RITMAEVIENEWFKKGYKPPSFEQP 283
           R T  E++ + + K    PPS   P
Sbjct: 286 RATAQELLGHPFLKLA-GPPSCIVP 309

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 239
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 184
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 238
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 199
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 253
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 183
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 237
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 238 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 267

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 234
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 234
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 239
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 144/268 (53%), Gaps = 27/268 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ETG   A K+++   E+ L+  ++     EI  +    H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-----EIEILATCDH 67
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIA---SRGRLKEDEARKYFQQLINAVDYC 130
           P ++++        K++I++EF  GG + D I     RG L E + +   +Q++ A+++ 
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFL 125
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVI 188
           HS+ + HRDLK  N+L+   G ++++DFG+SA  L    + D  +    GTP ++APEV+
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVV 181
Query: 189 -----NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWF 240
                 +  YD  KAD+WS G+ L  +     P  E N M +  KI K+D     +P  +
Sbjct: 182 MCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 240
Query: 241 STSAKKLISRILDPNPVTRITMAEVIEN 268
           S   +  +   LD NP TR + A+++E+
Sbjct: 241 SVEFRDFLKIALDKNPETRPSAAQLLEH 268

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 200
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 254
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 144/268 (53%), Gaps = 27/268 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ETG   A K+++   E+ L+  ++     EI  +    H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-----EIEILATCDH 75
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIA---SRGRLKEDEARKYFQQLINAVDYC 130
           P ++++        K++I++EF  GG + D I     RG L E + +   +Q++ A+++ 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFL 133
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVI 188
           HS+ + HRDLK  N+L+   G ++++DFG+SA  L    + D  +    GTP ++APEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVV 189
Query: 189 -----NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWF 240
                 +  YD  KAD+WS G+ L  +     P  E N M +  KI K+D     +P  +
Sbjct: 190 MCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248
Query: 241 STSAKKLISRILDPNPVTRITMAEVIEN 268
           S   +  +   LD NP TR + A+++E+
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEH 276

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 266
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 219
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 273
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 149/276 (53%), Gaps = 15/276 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 77
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HRD+K +N+LL  +G +K++DFG  A   P+Q +   ++    GTP ++APEV+  K 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKA 192
Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 193 Y-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R L+ +   R +  E++++++ K   KP S   P I
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLKIA-KPLSSLTPLI 286

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSSECQHL 234
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 148/276 (53%), Gaps = 15/276 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNP 78
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           V HR++K +N+LL  +G +K++DFG  A   P+Q +      T  GTP ++APEV+  K 
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKA 193
Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWFSTSAKKLIS 249
           Y G K D+WS G++   ++ G  P+  E+ L ALY        + ++P   S   +  ++
Sbjct: 194 Y-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 252
Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           R L+ +   R +  E+I++++ K   KP S   P I
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFLKIA-KPLSSLTPLI 287

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 227
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHL 281
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSSECQHL 266
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 141/264 (53%), Gaps = 19/264 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ET    A K++D   E+ L+  M+     EI  +    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-----EIDILASCDH 93
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHS 132
           PN++++ +    +  ++I++EF  GG +   +    R L E + +   +Q ++A++Y H 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---- 188
             + HRDLK  N+L   +G +K++DFG+SA  +  R      +  GTP ++APEV+    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 189 -NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSA 244
             ++ YD  KAD+WS G+ L  +     P  E N M +  KI K++      P  +S++ 
Sbjct: 212 SKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 270
Query: 245 KKLISRILDPNPVTRITMAEVIEN 268
           K  + + L+ N   R T ++++++
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQH 294

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 141/264 (53%), Gaps = 19/264 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ET    A K++D   E+ L+  M+     EI  +    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-----EIDILASCDH 93
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHS 132
           PN++++ +    +  ++I++EF  GG +   +    R L E + +   +Q ++A++Y H 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---- 188
             + HRDLK  N+L   +G +K++DFG+SA  +  R      +  GTP ++APEV+    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 189 -NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSA 244
             ++ YD  KAD+WS G+ L  +     P  E N M +  KI K++      P  +S++ 
Sbjct: 212 SKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 270
Query: 245 KKLISRILDPNPVTRITMAEVIEN 268
           K  + + L+ N   R T ++++++
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQH 294

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSSECQHL 266
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSSECQHL 267
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S+  + L
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSSECQHL 267
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 200
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 254
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 255 IRWCLALRPXDRPTFEEIQNHPWMQDVLLP 284

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 227
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 281
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 207
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 261
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 262 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 291

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 199
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 253
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  R--HPNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 200
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 254
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 48/301 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKIL----DKEKVLKHKMIGQIKREISTMKL 70
           KYE    +GEG++  V  A+N ET E VA+K +    D E V    +     REI  +K 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 57
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVD 128
           ++H N++R+++V+ S  K+ +V EF      + FD  +  G L  +  + +  QL+  + 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CHSR V HRDLKP+NLL++ NG LK+++FGL+ A    VR          T  Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDV 172
Query: 188 INNKGYDGAKADLWSCGVILYVLM-AGYLPFEESNLMALYKKIFK--------------- 231
           +          D+WS G I   L  AG   F  +++    K+IF+               
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 232 -ADFKSPPWF-------------STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
             D+K  P +             + + + L+  +L  NPV RI+  E +++ +F   + P
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD-FCP 291
Query: 278 P 278
           P
Sbjct: 292 P 292

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 150/306 (49%), Gaps = 32/306 (10%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++   LGEGS+  V  A + ETG+ VAIK +  E  L+     +I +EIS M+    P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEISIMQQCDSPH 85
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRG 134
           V++ Y      T ++IV+E+   G + D I  R + L EDE     Q  +  ++Y H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEVINNKGY 193
             HRD+K  N+LL+  G  K++DFG++    Q+ D     +   GTP ++APEVI   GY
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF------STSAKKL 247
           +   AD+WS G+    +  G  P+ + + M   + IF      PP F      S +    
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTNPPPTFRKPELWSDNFTDF 258
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDS--RNLVV 305
           + + L  +P  R T  +++++  F +  K  S          +  + NE+MD   +    
Sbjct: 259 VKQCLVKSPEQRATATQLLQHP-FVRSAKGVSI---------LRDLINEAMDVKLKRQES 308
Query: 306 ERREEG 311
           ++REEG
Sbjct: 309 QQREEG 314

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 232
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHL 286
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 287 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 316

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSXECQHL 267
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 140/264 (53%), Gaps = 19/264 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIRH 73
           +E+   LG+G+F KV  A+N ET    A K++D   E+ L+  M+     EI  +    H
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-----EIDILASCDH 93
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHS 132
           PN++++ +    +  ++I++EF  GG +   +    R L E + +   +Q ++A++Y H 
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---- 188
             + HRDLK  N+L   +G +K++DFG+SA  +  R         GTP ++APEV+    
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 189 -NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSA 244
             ++ YD  KAD+WS G+ L  +     P  E N M +  KI K++      P  +S++ 
Sbjct: 212 SKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 270
Query: 245 KKLISRILDPNPVTRITMAEVIEN 268
           K  + + L+ N   R T ++++++
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQH 294

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSXECQHL 267
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 17/270 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI---GQIKREISTMKLI 71
           +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  RH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVD 128
                 VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +     GT  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
           I    Y G  A +WS G++LY ++ G +PFE    +   +  F+         S   + L
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSXECQHL 266
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           I   L   P  R T  E+  + W +    P
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 15/270 (5%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+        Q  +EI+ +     P V + Y 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D +   G L E +     ++++  +DY HS    HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL  +G +K++DFG++    Q+ D  +      GTP ++APEVI    YD +KAD+
Sbjct: 132 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADI 187
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----FSTSAKKLISRILDPNP 256
           WS G+    L  G  P  E + M   K +F     +PP     +S   K+ +   L+  P
Sbjct: 188 WSLGITAIELARGEPPHSELHPM---KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             R T  E++++++  +  K  S+    ID
Sbjct: 245 SFRPTAKELLKHKFILRNAKKTSYLTELID 274

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 15/270 (5%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+        Q  +EI+ +     P V + Y 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 87
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                TK++I++E++ GG   D +   G L E +     ++++  +DY HS    HRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL  +G +K++DFG++    Q+ D  +      GTP ++APEVI    YD +KAD+
Sbjct: 147 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADI 202
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----FSTSAKKLISRILDPNP 256
           WS G+    L  G  P  E + M   K +F     +PP     +S   K+ +   L+  P
Sbjct: 203 WSLGITAIELARGEPPHSELHPM---KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             R T  E++++++  +  K  S+    ID
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTELID 289

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 19/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
            ++ +Y+   ++T      YIV+E+V G  L D + + G +    A +       A+++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTC--GTPNYVAPE 186
           H  G+ HRD+KP N+L+ A   +KV DFG++   + + D G  +  T    GT  Y++PE
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIA---RAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFST 242
                  D A++D++S G +LY ++ G  PF   + +++  +  + D   P       S 
Sbjct: 190 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK-KGYKPPSFEQPNIDLD 288
               ++ + L  NP  R   A  +  +  +    +PP  E P +  D
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP--EAPKVLTD 293

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 137/265 (51%), Gaps = 18/265 (6%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   +E+ + +G G+F++V   +  +TG+  A+KI++K  +LK   +   + E   + 
Sbjct: 57  RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVD 128
                 + +++     +  +Y+V+E+  GG+L   ++  G R+  + AR Y  +++ A+D
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--TCGTPNYVAPE 186
             H  G  HRD+KP+N+LLD  G ++++DFG S L  ++R DG + +    GTP+Y++PE
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFG-SCL--KLRADGTVRSLVAVGTPDYLSPE 233
Query: 187 VIN------NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSP- 237
           ++         G  G + D W+ GV  Y +  G  PF   +    Y KI  +K     P 
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293
Query: 238 --PWFSTSAKKLISRILDPNPVTRI 260
                   A+  I R+L P P TR+
Sbjct: 294 VDEGVPEEARDFIQRLLCP-PETRL 317

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 136/287 (47%), Gaps = 19/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
            ++ +Y+   ++T      YIV+E+V G  L D + + G +    A +       A+++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTC--GTPNYVAPE 186
           H  G+ HRD+KP N+++ A   +KV DFG++   + + D G  +  T    GT  Y++PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIA---RAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFST 242
                  D A++D++S G +LY ++ G  PF   + +++  +  + D   P       S 
Sbjct: 190 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK-KGYKPPSFEQPNIDLD 288
               ++ + L  NP  R   A  +  +  +    +PP  E P +  D
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP--EAPKVLTD 293

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 136/287 (47%), Gaps = 19/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
            ++ +Y+   ++T      YIV+E+V G  L D + + G +    A +       A+++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTC--GTPNYVAPE 186
           H  G+ HRD+KP N+++ A   +KV DFG++   + + D G  +  T    GT  Y++PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIA---RAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFST 242
                  D A++D++S G +LY ++ G  PF   + +++  +  + D   P       S 
Sbjct: 190 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK-KGYKPPSFEQPNIDLD 288
               ++ + L  NP  R   A  +  +  +    +PP  E P +  D
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP--EAPKVLTD 293

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 146/295 (49%), Gaps = 19/295 (6%)
Query: 1   MASRTGGASR-TRVGKYELGRTL---GEGSFAKVKFARNTETGENVAIKILDKEKVLKHK 56
           MA   G A++ +RV   EL   L   G+GSF +V    +  T E VAIKI+D E+     
Sbjct: 2   MAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEI 61
Query: 57  MIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA 116
              Q  +EI+ +     P + R +      TK++I++E++ GG   D +   G L+E   
Sbjct: 62  EDIQ--QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYI 118
Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
               ++++  +DY HS    HRD+K  N+LL   G +K++DFG++    Q+ D  +    
Sbjct: 119 ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNX 175
Query: 177 -CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK 235
             GTP ++APEVI    YD  KAD+WS G+    L  G  P  + + M +   +F     
Sbjct: 176 FVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIPKN 231
Query: 236 SPPWF----STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
           SPP      S   K+ +   L+ +P  R T  E++++++  +  K  SF    ID
Sbjct: 232 SPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELID 286

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNVI 77
            + LG G FA V+   +  TG+  A K L K +        +I  EI+ ++L +  P VI
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGV 135
            ++EV  + ++I ++LE+  GGE+F          + E++  +  +Q++  V Y H   +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 136 CHRDLKPENLLLDAN---GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            H DLKP+N+LL +    G +K+ DFG+S   +++     L    GTP Y+APE++N   
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEILN--- 206
Query: 193 YD--GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPWFSTS--AKK 246
           YD      D+W+ G+I Y+L+    PF   +    Y  I     D+    + S S  A  
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266
Query: 247 LISRILDPNPVTRITMAEVIENEWFKK 273
            I  +L  NP  R T    + + W ++
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + HP
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 89
Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
            ++ +Y+   ++T      YIV+E+V G  L D + + G +    A +       A+++ 
Sbjct: 90  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 149
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTC--GTPNYVAPE 186
           H  G+ HRD+KP N+++ A   +KV DFG++   + + D G  +  T    GT  Y++PE
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIA---RAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFST 242
                  D A++D++S G +LY ++ G  PF   + +++  +  + D   P       S 
Sbjct: 207 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 265
Query: 243 SAKKLISRILDPNPVTRITMA 263
               ++ + L  NP  R   A
Sbjct: 266 DLDAVVLKALAKNPENRYQTA 286

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 135/287 (47%), Gaps = 19/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
            ++ +Y    ++T      YIV+E+V G  L D + + G +    A +       A+++ 
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTC--GTPNYVAPE 186
           H  G+ HRD+KP N+++ A   +KV DFG++   + + D G  +  T    GT  Y++PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIA---RAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFST 242
                  D A++D++S G +LY ++ G  PF   + +++  +  + D   P       S 
Sbjct: 190 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK-KGYKPPSFEQPNIDLD 288
               ++ + L  NP  R   A  +  +  +    +PP  E P +  D
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP--EAPKVLTD 293

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 138/270 (51%), Gaps = 15/270 (5%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G+GSF +V    +  T + VAIKI+D E+        Q  +EI+ +       V + Y 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
                +K++I++E++ GG   D + + G   E +     ++++  +DY HS    HRD+K
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYDGAKADL 200
             N+LL   G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD +KAD+
Sbjct: 148 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 203
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW----FSTSAKKLISRILDPNP 256
           WS G+    L  G  P  + + M +   +F     +PP     F+ S K+ I   L+ +P
Sbjct: 204 WSLGITAIELAKGEPPNSDMHPMRV---LFLIPKNNPPTLVGDFTKSFKEFIDACLNKDP 260
Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             R T  E++++++  K  K  S+    ID
Sbjct: 261 SFRPTAKELLKHKFIVKNSKKTSYLTELID 290

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 135/287 (47%), Gaps = 19/287 (6%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
            ++ +Y+   ++T      YIV+E+V G  L D + + G +    A +       A+++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTC--GTPNYVAPE 186
           H  G+ HRD+KP N+++ A   +KV DFG++   + + D G  +  T    GT  Y++PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIA---RAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFST 242
                  D A++D++S G +LY ++ G  PF   +  ++  +  + D   P       S 
Sbjct: 190 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSA 248
Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK-KGYKPPSFEQPNIDLD 288
               ++ + L  NP  R   A  +  +  +    +PP  E P +  D
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP--EAPKVLTD 293

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 144/291 (49%), Gaps = 39/291 (13%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +GEG++  V  A+N   GE  A+K +  EK     +     REIS +K ++H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHS 60
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           N++++Y+V+ +K ++ +V E +     +L D     G L+   A+ +  QL+N + YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           R V HRDLKP+NLL++  G LK++DFGL+ A    VR     H    T  Y AP+V+   
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVV-TLWYRAPDVLMGS 175
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYK--------------KIFKAD 233
                  D+WS G I   ++ G   F    E   LM +++              ++ K D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 234 -----FKSPPWFS------TSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                ++  PW S       S   L+S++L  +P  RIT  + +E+ +FK+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 144/291 (49%), Gaps = 39/291 (13%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +GEG++  V  A+N   GE  A+K +  EK     +     REIS +K ++H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHS 60
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           N++++Y+V+ +K ++ +V E +     +L D     G L+   A+ +  QL+N + YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           R V HRDLKP+NLL++  G LK++DFGL+ A    VR     H    T  Y AP+V+   
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVV-TLWYRAPDVLMGS 175
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYK--------------KIFKAD 233
                  D+WS G I   ++ G   F    E   LM +++              ++ K D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 234 -----FKSPPWFS------TSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                ++  PW S       S   L+S++L  +P  RIT  + +E+ +FK+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 144/291 (49%), Gaps = 39/291 (13%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +GEG++  V  A+N   GE  A+K +  EK     +     REIS +K ++H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHS 60
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           N++++Y+V+ +K ++ +V E +     +L D     G L+   A+ +  QL+N + YCH 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           R V HRDLKP+NLL++  G LK++DFGL+ A    VR     H    T  Y AP+V+   
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIV-TLWYRAPDVLMGS 175
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYK--------------KIFKAD 233
                  D+WS G I   ++ G   F    E   LM +++              ++ K D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 234 -----FKSPPWFS------TSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                ++  PW S       S   L+S++L  +P  RIT  + +E+ +FK+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 133/269 (49%), Gaps = 21/269 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVA---IKILDKEKVLKHKMIGQIKREISTMKLI 71
           KY +   LG G F  V     T + +      +K+   ++VL       +K+EIS + + 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-------VKKEISILNIA 58
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYC 130
           RH N++ ++E   S  ++ ++ EF++G ++F++I  S   L E E   Y  Q+  A+ + 
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 131 HSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           HS  + H D++PEN++     +  +K+ +FG +   +Q++           P Y APEV 
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF----KSPPWFSTSA 244
            +     A  D+WS G ++YVL++G  PF       + + I  A++    ++    S  A
Sbjct: 176 QHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 245 KKLISRILDPNPVTRITMAEVIENEWFKK 273
              + R+L     +R+T +E +++ W K+
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 131/279 (46%), Gaps = 51/279 (18%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVI 77
            + LG G   KV    N  T E  A+K+L            + +RE+    +  + P+++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RMYEVM----ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCH 131
           R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 SRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           S  + HRD+KPENLL  +   N +LK++DFG                        A E  
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AKETT 171
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK------KIFKADFKSPPW--F 240
             K YD +  D+WS GVI+Y+L+ GY PF  ++ +A+        ++ + +F +P W   
Sbjct: 172 GEK-YDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 68
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF++    +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 69  LDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKPENLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 184
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 244
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 245 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 70
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF++    +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 71  LDVIHTENKLYLVFEFLSMDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKPENLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 130 RDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 186
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 246
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 247 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 128/254 (50%), Gaps = 20/254 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKIL-----DKEKVLKHKMIGQIKREISTMK 69
           +Y++   LG G  + V  A +T     VAIK +     +KE+ LK     + +RE+    
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLK-----RFEREVHNSS 66
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + H N++ M +V       Y+V+E++ G  L + I S G L  D A  +  Q+++ + +
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--TCGTPNYVAPEV 187
            H   + HRD+KP+N+L+D+N  LK+ DFG++   + + +  L  T    GT  Y +PE 
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA---KALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
              +  D    D++S G++LY ++ G  PF     +++  K  +    S P  +T  +K 
Sbjct: 184 AKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ---DSVPNVTTDVRKD 239
Query: 248 ISRILDPNPVTRIT 261
           I + L  N + R T
Sbjct: 240 IPQSL-SNVILRAT 252

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKPENLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 69
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF++    +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 70  LDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 185
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 245
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 246 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 70
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF++    +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 71  LDVIHTENKLYLVFEFLSMDLKDFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 186
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 246
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 247 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 68
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 69  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKPENLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 184
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 244
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 245 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 69
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 70  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKPENLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 129 RDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 185
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 245
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 246 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGXKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 74
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 75  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 133
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGXKYYST 190
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 191 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 250
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 251 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLSFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 71
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 72  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 130
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 187
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 188 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 247
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 248 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 182
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 68
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 69  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 184
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 244
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 245 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 68
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 69  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 184
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 244
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 245 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 182
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 70
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 71  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 186
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 246
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 247 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 68
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 69  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 184
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 185 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 244
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 245 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 69
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 70  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 185
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 245
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 246 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 71
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 72  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 130
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 187
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 188 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 247
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 248 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 182
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 182
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 70
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 71  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 186
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 246
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 247 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 69
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 70  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 185
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 186 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 245
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 246 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 74
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 75  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 133
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 190
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 191 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 250
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 251 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 137/289 (47%), Gaps = 39/289 (13%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 70
Query: 80  YEVMASKTKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            +V+ ++ K+Y+V EF+    + F   ++   +     + Y  QL+  + +CHS  V HR
Sbjct: 71  LDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 139 DLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           DLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y    
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYSTA 187
Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PPW 239
            D+WS G I   ++     F   + +    +IF+                 D+K   P W
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 240 -----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                           + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAI-KI-LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+ KI LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 184 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 243
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAI-KI-LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+ KI LD E      +     REIS +K + HPN++++
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 182
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 70
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V E V     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 71  LDVIHTENKLYLVFEHVDQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 186
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PP 238
             D+WS G I   ++     F   + +    +IF+                 D+K   P 
Sbjct: 187 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 246
Query: 239 W-----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
           W                + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 247 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 22  LGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LG G++A V    N  TG  VA+K   LD E+      I    REIS MK ++H N++R+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIVRL 68
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRG-----RLKEDEARKYFQ-QLINAVDYCHSR 133
           Y+V+ ++ K+ +V EF+   +L   + SR      R  E    KYFQ QL+  + +CH  
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
            + HRDLKP+NLL++  G LK+ DFGL+    +P          +   T  Y AP+V+  
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-----FSSEVVTLWYRAPDVLMG 182
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF 230
                   D+WSCG IL  ++ G   F  +N     K IF
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/191 (36%), Positives = 104/191 (54%), Gaps = 12/191 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  YEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
            +V+ ++ K+Y+V EF+     +  D  A  G +     + Y  QL+  + +CHS  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y   
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVV-TLWYRAPEILLGCKYYST 183
Query: 197 KADLWSCGVIL 207
             D+WS G I 
Sbjct: 184 AVDIWSLGCIF 194

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 39/289 (13%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +GEG++  V  ARN  TGE VA+K   LD E      +     REIS +K + HPN++++
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  YEVMASKTKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            +V+ ++ K+Y+V E V    + F   ++   +     + Y  QL+  + +CHS  V HR
Sbjct: 67  LDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 139 DLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           DLKP+NLL++  G +K++DFGL+ A    VR     H    T  Y APE++    Y    
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTA 183
Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----------------DFKS--PPW 239
            D+WS G I   ++     F   + +    +IF+                 D+K   P W
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 240 -----------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                           + L+S++L  +P  RI+    + + +F+   KP
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 120/243 (49%), Gaps = 17/243 (6%)
Query: 42  VAIKILDKEKVLKHKMI---GQIKREISTMKLIR--HPNVIRMYEVMASKTKIYIVLEFV 96
           VAIK ++K+++     +    ++  E+  +K +      VIR+ +         ++LE  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 97  TG-GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLK 154
               +LFD I  RG L+E+ AR +F Q++ AV +CH+ GV HRD+K EN+L+D N G LK
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 198
Query: 155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY 214
           + DFG  AL +    D +     GT  Y  PE I    Y G  A +WS G++LY ++ G 
Sbjct: 199 LIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 215 LPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG 274
           +PFE    +   +  F+         S+  + LI   L   P  R T  E+  + W +  
Sbjct: 255 IPFEHDEEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 308
Query: 275 YKP 277
             P
Sbjct: 309 LLP 311

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREI--STMKLIR 72
           + + R +G G F +V   R  +TG+  A+K LDK+++ +K      +   I  S +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
            P ++ M     +  K+  +L+ + GG+L   ++  G   E + R Y  ++I  +++ H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V +RDLKP N+LLD +G +++SD GL+    + +     H + GT  Y+APEV+    
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV 366
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
              + AD +S G +L+ L+ G+ PF +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREI--STMKLIR 72
           + + R +G G F +V   R  +TG+  A+K LDK+++ +K      +   I  S +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
            P ++ M     +  K+  +L+ + GG+L   ++  G   E + R Y  ++I  +++ H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V +RDLKP N+LLD +G +++SD GL+    + +     H + GT  Y+APEV+    
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV 366
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
              + AD +S G +L+ L+ G+ PF +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREI--STMKLIR 72
           + + R +G G F +V   R  +TG+  A+K LDK+++ +K      +   I  S +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
            P ++ M     +  K+  +L+ + GG+L   ++  G   E + R Y  ++I  +++ H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V +RDLKP N+LLD +G +++SD GL+    + +     H + GT  Y+APEV+    
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV 366
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
              + AD +S G +L+ L+ G+ PF +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREI--STMKLIR 72
           + + R +G G F +V   R  +TG+  A+K LDK+++ +K      +   I  S +    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
            P ++ M     +  K+  +L+ + GG+L   ++  G   E + R Y  ++I  +++ H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V +RDLKP N+LLD +G +++SD GL+    + +     H + GT  Y+APEV+    
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV 365
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
              + AD +S G +L+ L+ G+ PF +
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQ 392

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 44/285 (15%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
            LG+G+F +V  ARN       AIK +   +    + +  I  E+  +  + H  V+R Y
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYY 68
Query: 81  EV-------------MASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINA 126
                          +  K+ ++I +E+   G L+D I S     + DE  + F+Q++ A
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------------DGLLH 174
           + Y HS+G+ HRDLKP N+ +D +  +K+ DFGL+    +  D               L 
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIF 230
           +  GT  YVA EV++  G+   K D++S G+I + ++    PF    E  N++   KK+ 
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNIL---KKLR 242
Query: 231 KADFKSPPWFSTS----AKKLISRILDPNPVTRITMAEVIENEWF 271
               + PP F  +     KK+I  ++D +P  R     ++ + W 
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 100/349 (28%), Positives = 152/349 (43%), Gaps = 63/349 (18%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREIST 67
           ++R  +YE    LGEG FA V  AR+  T + VAIK   L      K  +     REI  
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFV-TGGELFDKIASRGRLKEDEARKYFQQLINA 126
           ++ + HPN+I + +    K+ I +V +F+ T  E+  K  S   L     + Y    +  
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-VLTPSHIKAYMLMTLQG 124
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN----- 181
           ++Y H   + HRDLKP NLLLD NGVLK++DFGL+              + G+PN     
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNRAYXH 171
Query: 182 ------YVAPEVINNKGYDGAKADLWSCGVIL--YVLMAGYLPFEESNLMALYKKIFKA- 232
                 Y APE++      G   D+W+ G IL   +L   +LP  +S+L  L  +IF+  
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQL-TRIFETL 229
Query: 233 ------------------DFKSPP------WFSTSAK---KLISRILDPNPVTRITMAEV 265
                              FKS P       FS +      LI  +   NP  RIT  + 
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 266 IENEWFKKGYKPP---SFEQPNIDLDDVDSIFNESMDSRNLVVERREEG 311
           ++ ++F     P       +PN  ++ +    N ++  +    E  E+G
Sbjct: 290 LKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQG 338

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 41  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 95
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 96  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 151
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 209
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 210 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 329 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 361

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 117
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 175
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 176 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 295 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 11  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 65
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 66  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 121
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 122 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 179
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 180 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 299 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 331

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 26  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 80
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 81  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 136
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 137 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 194
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 195 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 253
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 254 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 313
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 314 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 346

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 19  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 73
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 74  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 129
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 130 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 187
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 188 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 247 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 307 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 339

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 8   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 62
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 63  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 118
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 119 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 176
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 177 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 235
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 236 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 295
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 296 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 328

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 15  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 69
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 70  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 125
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 126 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 183
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 184 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 242
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 243 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 302
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 303 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 335

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 19  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 73
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 74  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 129
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 130 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 187
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 188 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 247 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 307 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 339

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 117
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 175
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 176 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 295 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIKREISTMKLIRH 73
           KYE    +GEGS+  V   RN +TG+ VAIK  L+ E     K I    REI  +K ++H
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           PN++ + EV   K ++++V E+     L +    +  + E   +    Q + AV++CH  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSAL---PQQVRDDGLLHTTCGTPNYVAPEVINN 190
              HRD+KPEN+L+  + V+K+ DFG + L   P    DD +      T  Y +PE++  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-----ATRWYRSPELLVG 176
Query: 191 KGYDGAKADLWSCGVILYVLMAG 213
               G   D+W+ G +   L++G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 20  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 74
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 75  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 130
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 131 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 188
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 189 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 247
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 248 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 307
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 308 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 340

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 12  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 66
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 67  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 122
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 123 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 180
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 181 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 240 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 300 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 332

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 33/267 (12%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G GSF  V   R    G +VA+KIL  E+    + + +  RE++ MK +RHPN++    
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 82  VMASKTKIYIVLEFVTGGELF---DKIASRGRLKEDEARKYFQQLINAVDYCHSRG--VC 136
            +     + IV E+++ G L+    K  +R +L E         +   ++Y H+R   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--TCGTPNYVAPEVINNKGYD 194
           HRDLK  NLL+D    +KV DFGLS L    +    L +    GTP ++APEV+ ++  +
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL----KASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL-ISRILD 253
             K+D++S GVIL+ L     P+   N   +   +    FK         K+L I R L+
Sbjct: 218 -EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFK--------CKRLEIPRNLN 265
Query: 254 PNPVTRITMAEVIENEWFKKGYKPPSF 280
           P       +A +IE  W  + +K PSF
Sbjct: 266 PQ------VAAIIEGCWTNEPWKRPSF 286

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 86  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 140
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 141 --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 196
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 197 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 254
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 255 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 313
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 314 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 373
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 374 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 406

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 45  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 99
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 100 --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 155
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 156 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 213
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 214 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 272
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 273 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 332
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 333 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 365

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 41  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 95
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 96  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 151
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 209
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 210 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 329 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 361

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 43  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 97
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 98  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 153
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 154 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 211
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 212 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 270
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 271 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 330
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 331 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 363

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 35  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 89
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 90  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 145
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 146 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 203
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 204 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 262
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 263 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 322
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 323 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 355

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 15/261 (5%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
            LG+G++  V   R+      +AIK + +      +    +  EI+  K ++H N+++  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARK--YFQQLINAVDYCHSRGVCH 137
              +    I I +E V GG L   + S+ G LK++E     Y +Q++  + Y H   + H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 138 RDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYD 194
           RD+K +N+L++  +GVLK+SDFG S     +  +    T  GT  Y+APE+I+   +GY 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGY- 202
Query: 195 GAKADLWSCGVILYVLMAGYLPFEE--SNLMALYK-KIFKADFKSPPWFSTSAKKLISRI 251
           G  AD+WS G  +  +  G  PF E      A++K  +FK   + P   S  AK  I + 
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262
Query: 252 LDPNPVTRITMAEVIENEWFK 272
            +P+P  R    +++ +E+ K
Sbjct: 263 FEPDPDKRACANDLLVDEFLK 283

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 154/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 117
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 175
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 176 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 295 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 153/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + + K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 117
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 175
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 176 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 295 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 15/261 (5%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
            LG+G++  V   R+      +AIK + +      +    +  EI+  K ++H N+++  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARK--YFQQLINAVDYCHSRGVCH 137
              +    I I +E V GG L   + S+ G LK++E     Y +Q++  + Y H   + H
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 138 RDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYD 194
           RD+K +N+L++  +GVLK+SDFG S     +  +    T  GT  Y+APE+I+   +GY 
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGY- 188
Query: 195 GAKADLWSCGVILYVLMAGYLPFEE--SNLMALYK-KIFKADFKSPPWFSTSAKKLISRI 251
           G  AD+WS G  +  +  G  PF E      A++K  +FK   + P   S  AK  I + 
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 248
Query: 252 LDPNPVTRITMAEVIENEWFK 272
            +P+P  R    +++ +E+ K
Sbjct: 249 FEPDPDKRACANDLLVDEFLK 269

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 99/339 (29%), Positives = 153/339 (45%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K  +Y+  VL++V   E   ++A   SR + 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQ 117
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 175
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F   + +    +
Sbjct: 176 GEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 229 IFK-----------------ADFKSP-----PWFST-------SAKKLISRILDPNPVTR 259
           I K                  +FK P     PW           A  L SR+L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 295 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 130/265 (49%), Gaps = 29/265 (10%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G GSF  V   R    G +VA+KIL  E+    + + +  RE++ MK +RHPN++    
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 82  VMASKTKIYIVLEFVTGGELF---DKIASRGRLKEDEARKYFQQLINAVDYCHSRG--VC 136
            +     + IV E+++ G L+    K  +R +L E         +   ++Y H+R   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           HR+LK  NLL+D    +KV DFGLS L           +  GTP ++APEV+ ++  +  
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSN-E 218
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL-ISRILDPN 255
           K+D++S GVIL+ L     P+   N   +   +    FK         K+L I R L+P 
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFK--------CKRLEIPRNLNPQ 267
Query: 256 PVTRITMAEVIENEWFKKGYKPPSF 280
                 +A +IE  W  + +K PSF
Sbjct: 268 ------VAAIIEGCWTNEPWKRPSF 286

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 98/339 (28%), Positives = 152/339 (44%), Gaps = 62/339 (18%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + + K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIA---SRGR- 110
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V   E   ++A   SR + 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQ 117
Query: 111 -LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVR 168
            L     + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVR 175
Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMAL-- 225
            +  +   C    Y APE+I       +  D+WS G +L  L+ G   F  +S +  L  
Sbjct: 176 GEPNVSYICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 226 -------------------YKKIFKADFKSPPWFST-------SAKKLISRILDPNPVTR 259
                              Y +      K+ PW           A  L SR+L+  P  R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 260 ITMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           +T  E   + +F +         PN+ L    D  ++FN
Sbjct: 295 LTPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 95/338 (28%), Positives = 149/338 (44%), Gaps = 60/338 (17%)
Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + + K  K+     
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN----- 61
Query: 61  IKREISTMKLIRHPNVIRM----YEVMASKTKIYI--VLEFVTGGELFDKIASRGRLKED 114
             RE+  M+ + H N++R+    Y     K ++Y+  VL++V    ++       R K+ 
Sbjct: 62  --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQT 118
Query: 115 ----EARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRD 169
                 + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   Q VR 
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRG 176
Query: 170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMAL--- 225
           +  +   C    Y APE+I       +  D+WS G +L  L+ G   F  +S +  L   
Sbjct: 177 EPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 226 ------------------YKKIFKADFKSPPWFST-------SAKKLISRILDPNPVTRI 260
                             Y +      K+ PW           A  L SR+L+  P  R+
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 261 TMAEVIENEWFKKGYKPPSFEQPNIDLD---DVDSIFN 295
           T  E   + +F +         PN+ L    D  ++FN
Sbjct: 296 TPLEACAHSFFDE------LRDPNVKLPNGRDTPALFN 327

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 44/285 (15%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
            LG+G+F +V  ARN       AIK +   +    + +  I  E+  +  + H  V+R Y
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYY 68
Query: 81  EV-------------MASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINA 126
                          +  K+ ++I +E+     L+D I S     + DE  + F+Q++ A
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------------DGLLH 174
           + Y HS+G+ HRDLKP N+ +D +  +K+ DFGL+    +  D               L 
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIF 230
           +  GT  YVA EV++  G+   K D++S G+I + ++    PF    E  N++   KK+ 
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNIL---KKLR 242
Query: 231 KADFKSPPWFSTSA----KKLISRILDPNPVTRITMAEVIENEWF 271
               + PP F  +     KK+I  ++D +P  R     ++ + W 
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 100/343 (29%), Positives = 159/343 (46%), Gaps = 57/343 (16%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +Y   + +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIK---KISPFEHQTYCQRTLREIQILLRFRH 100
Query: 74  PNVIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
            NVI + +++ + T      +YIV + +   +L+  + S+ +L  D    +  Q++  + 
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQ-QLSNDHICYFLYQILRGLK 158
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV 187
           Y HS  V HRDLKP NLL++    LK+ DFGL+ +     D  G L     T  Y APE+
Sbjct: 159 YIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 188 -INNKGYDGAKADLWSCGVILYVLMAG--------YL------------PFEE------- 219
            +N+KGY  +  D+WS G IL  +++         YL            P +E       
Sbjct: 219 MLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 220 ----SNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY 275
               + L +L  K   A  K  P   + A  L+ R+L  NP  RIT+ E + + + ++ Y
Sbjct: 278 MKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYY 337
Query: 276 KP---PSFEQP---NIDLDDV------DSIFNESMDSRNLVVE 306
            P   P  E+P    ++LDD+      + IF E+   +  V+E
Sbjct: 338 DPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLE 380

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 129/278 (46%), Gaps = 38/278 (13%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRHPNVIR 78
           R L EG FA V  A++  +G   A+K L   +  K++ I Q   E+  MK L  HPN+++
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHPNIVQ 90
Query: 79  MYEVMA--------SKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVD 128
                +         + +  ++ E   G   E   K+ SRG L  D   K F Q   AV 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 129 YCHSRG--VCHRDLKPENLLLDANGVLKVSDFG------------LSALPQQVRDDGLLH 174
           + H +   + HRDLK ENLLL   G +K+ DFG             SA  + + ++ +  
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 175 TTCGTPNYVAPEVIN--NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA 232
            T  TP Y  PE+I+  +    G K D+W+ G ILY+L     PFE+   +    +I   
Sbjct: 211 NT--TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNG 264
Query: 233 DFKSPPWFS--TSAKKLISRILDPNPVTRITMAEVIEN 268
            +  PP  +  T    LI  +L  NP  R+++AEV+  
Sbjct: 265 KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 142/293 (48%), Gaps = 44/293 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIR 72
           KY+    +GEG++  V  A++++ G  VA+K   LD E      +     REIS +K + 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAED---EGIPSTAIREISLLKELH 77
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           HPN++ + +V+ S+  + +V EF+     ++ D+  ++  L++ + + Y  QL+  V +C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           H   + HRDLKP+NLL++++G LK++DFGL+ A    VR     H    T  Y AP+V+ 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVV-TLWYRAPDVLM 192
Query: 190 NKGYDGAKADLWSCGVILYVLMAG-----------YLP-------------FEESNLMAL 225
                    D+WS G I   ++ G            LP             + +   + L
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 226 YKKIFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
           +K+     F+  PW      F      L+S +L  +P  RI+  + + + +FK
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 142/293 (48%), Gaps = 44/293 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKI--LDKEKVLKHKMIGQIKREISTMKLIR 72
           KY+    +GEG++  V  A++++ G  VA+K   LD E      +     REIS +K + 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAED---EGIPSTAIREISLLKELH 77
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           HPN++ + +V+ S+  + +V EF+     ++ D+  ++  L++ + + Y  QL+  V +C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           H   + HRDLKP+NLL++++G LK++DFGL+ A    VR     H    T  Y AP+V+ 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVV-TLWYRAPDVLM 192
Query: 190 NKGYDGAKADLWSCGVILYVLMAG-----------YLP-------------FEESNLMAL 225
                    D+WS G I   ++ G            LP             + +   + L
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 226 YKKIFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
           +K+     F+  PW      F      L+S +L  +P  RI+  + + + +FK
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 134/307 (43%), Gaps = 49/307 (15%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++L   LGEG++  V  A +  TGE VAIK +  E   K     +  REI  +K  +H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 76  VIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +I ++ +    +     ++YI+ E +       ++ S   L +D  + +  Q + AV   
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--------TCGTPNY 182
           H   V HRDLKP NLL+++N  LKV DFGL+ +  +   D    T           T  Y
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 183 VAPEVINNKGYDGAKADLWSCGVIL------------------YVLMAGYL--PFEESNL 222
            APEV+          D+WSCG IL                   +L+ G +  P  +++L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 223 MALYKKIFKADFKSPPWFSTSAKK------------LISRILDPNPVTRITMAEVIENEW 270
             +     +   KS P +  +  +            L+ R+L  +P  RIT  E +E+ +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 271 FKKGYKP 277
            +  + P
Sbjct: 309 LQTYHDP 315

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 135/307 (43%), Gaps = 49/307 (15%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++L   LGEG++  V  A +  TGE VAIK +  E   K     +  REI  +K  +H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 76  VIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +I ++ +    +     ++YI+ E +       ++ S   L +D  + +  Q + AV   
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--TCGTPNYV----- 183
           H   V HRDLKP NLL+++N  LKV DFGL+ +  +   D    T    G   YV     
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 184 -APEVINNKGYDGAKADLWSCGVIL------------------YVLMAGYL--PFEESNL 222
            APEV+          D+WSCG IL                   +L+ G +  P  +++L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 223 MALYKKIFKADFKSPPWFSTSAKK------------LISRILDPNPVTRITMAEVIENEW 270
             +     +   KS P +  +  +            L+ R+L  +P  RIT  E +E+ +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 271 FKKGYKP 277
            +  + P
Sbjct: 309 LQTYHDP 315

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 134/307 (43%), Gaps = 49/307 (15%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++L   LGEG++  V  A +  TGE VAIK +  E   K     +  REI  +K  +H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 76  VIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           +I ++ +    +     ++YI+ E +       ++ S   L +D  + +  Q + AV   
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--------TCGTPNY 182
           H   V HRDLKP NLL+++N  LKV DFGL+ +  +   D    T           T  Y
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 183 VAPEVINNKGYDGAKADLWSCGVIL------------------YVLMAGYL--PFEESNL 222
            APEV+          D+WSCG IL                   +L+ G +  P  +++L
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 223 MALYKKIFKADFKSPPWFSTSAKK------------LISRILDPNPVTRITMAEVIENEW 270
             +     +   KS P +  +  +            L+ R+L  +P  RIT  E +E+ +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 271 FKKGYKP 277
            +  + P
Sbjct: 309 LQTYHDP 315

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 44/285 (15%)
Query: 21  TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
            LG+G+F +V  ARN       AIK +   +    + +  I  E+  +  + H  V+R Y
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVXLLASLNHQYVVRYY 68
Query: 81  EV-------------MASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINA 126
                          +  K+ ++I  E+     L+D I S     + DE  + F+Q++ A
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------------DGLLH 174
           + Y HS+G+ HR+LKP N+ +D +  +K+ DFGL+    +  D               L 
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIF 230
           +  GT  YVA EV++  G+   K D +S G+I +  +    PF    E  N++   KK+ 
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNIL---KKLR 242
Query: 231 KADFKSPPWFSTSA----KKLISRILDPNPVTRITMAEVIENEWF 271
               + PP F  +     KK+I  ++D +P  R     ++ + W 
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 135/293 (46%), Gaps = 51/293 (17%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKI-------LDKEKVLKHKMIGQIKREISTM 68
           +E  + LG G F  V  A+N     N AIK        L +EKV+         RE+  +
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM---------REVKAL 57
Query: 69  KLIRHPNVIRMY------------EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE- 115
             + HP ++R +            +  + K  +YI ++      L D +  R  ++E E 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 116 --ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGL 172
                 F Q+  AV++ HS+G+ HRDLKP N+    + V+KV DFGL +A+ Q   +  +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 173 L--------HT-TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM 223
           L        HT   GT  Y++PE I+   Y   K D++S G+IL+ L+    PF  S  M
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL---YPF--STQM 231
Query: 224 ALYKKIFKA-DFKSPPWFST---SAKKLISRILDPNPVTRITMAEVIENEWFK 272
              + +    + K PP F+        ++  +L P+P+ R     +IEN  F+
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 143/299 (47%), Gaps = 28/299 (9%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           A R   G +EL   +G G++ +V   R+ +TG+  AIK++D    +      +IK+EI+ 
Sbjct: 18  ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINM 73
Query: 68  MK-LIRHPNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIA-SRGR-LKEDEARK 118
           +K    H N+   Y     K       ++++V+EF   G + D I  ++G  LKE+    
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
             ++++  + + H   V HRD+K +N+LL  N  +K+ DFG+SA  Q  R  G  +T  G
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIG 191
Query: 179 TPNYVAPEVIN-----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA---LYKKIF 230
           TP ++APEVI      +  YD  K+DLWS G+    +  G  P  + + M    L  +  
Sbjct: 192 TPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250
Query: 231 KADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDD 289
               KS  W S   +  I   L  N   R    +++++ + +     P+  Q  I L D
Sbjct: 251 APRLKSKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIR---DQPNERQVRIQLKD 305

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 91/320 (28%), Positives = 142/320 (44%), Gaps = 80/320 (25%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G     R   Y   + +G GSF  V  A+  E+ E VAIK + ++K  K+       RE+
Sbjct: 32  GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------REL 83
Query: 66  STMKLIRHPNVIRMYEVMAS----KTKIYI--VLEFVTGGELFDKIASRGRLKEDEA--- 116
             M++++HPNV+ +     S    K ++++  VLE+V    ++       +LK+      
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLL 142
Query: 117 -RKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLKVSDFGLSALPQQVRDDGLLH 174
            + Y  QL+ ++ Y HS G+CHRD+KP+NLLLD  +GVLK+ DFG + +           
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------- 191
Query: 175 TTCGTPN--------YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMAL 225
              G PN        Y APE+I          D+WS G ++  LM G   F  ES +  L
Sbjct: 192 LIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251
Query: 226 ----------------------------------YKKIFKADFKSPPWFSTSAKKLISRI 251
                                             + K+F+   ++PP     A  LISR+
Sbjct: 252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRP--RTPP----DAIDLISRL 305
Query: 252 LDPNPVTRITMAEVIENEWF 271
           L+  P  R+T  E + + +F
Sbjct: 306 LEYTPSARLTAIEALCHPFF 325

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 133/265 (50%), Gaps = 15/265 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    V+ +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAVDYCHSRGVCH 137
                +K  + +VL  + GG+L   I   G+    EAR  F   ++   ++  H   + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           RDLKPEN+LLD +G +++SD GL+     V +   +    GT  Y+APEV+ N+ Y  + 
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 365
Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSAKKLISRILD 253
            D W+ G +LY ++AG  PF++       +++ +   + P      FS  A+ L S++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 254 PNPVTRI-----TMAEVIENEWFKK 273
            +P  R+     +  EV E+  FKK
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 133/265 (50%), Gaps = 15/265 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    V+ +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF--QQLINAVDYCHSRGVCH 137
                +K  + +VL  + GG+L   I   G+    EAR  F   ++   ++  H   + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           RDLKPEN+LLD +G +++SD GL+     V +   +    GT  Y+APEV+ N+ Y  + 
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 365
Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSAKKLISRILD 253
            D W+ G +LY ++AG  PF++       +++ +   + P      FS  A+ L S++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 254 PNPVTRI-----TMAEVIENEWFKK 273
            +P  R+     +  EV E+  FKK
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 11/210 (5%)
Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           S +   S T + +Y     LGEG++ +V  A +T T E VAIK +  E   +  + G   
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAI 81
Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
           RE+S +K ++H N+I +  V+    +++++ E+    +L   +     +     + +  Q
Sbjct: 82  REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANG-----VLKVSDFGLS-ALPQQVRDDGLLHTT 176
           LIN V++CHSR   HRDLKP+NLLL  +      VLK+ DFGL+ A    +R     H  
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVI 206
             T  Y  PE++    +     D+WS   I
Sbjct: 199 I-TLWYRPPEILLGSRHYSTSVDIWSIACI 227

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 15/266 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R +G GSF  V FAR+    E VAIK +       ++    I +E+  ++ +RHPN I+ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                 +   ++V+E+  G         +  L+E E        +  + Y HS  + HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---NNKGYDGA 196
           +K  N+LL   G++K+ DFG +++          +   GTP ++APEVI   +   YDG 
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG- 232
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILD 253
           K D+WS G+    L     P    N M+    I + +    +S  W S   +  +   L 
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQ 291
Query: 254 PNPVTRITMAEVIENEWFKKGYKPPS 279
             P  R T +EV+    F    +PP+
Sbjct: 292 KIPQDRPT-SEVLLKHRFVLRERPPT 316

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 15/266 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R +G GSF  V FAR+    E VAIK +       ++    I +E+  ++ +RHPN I+ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
                 +   ++V+E+  G         +  L+E E        +  + Y HS  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI---NNKGYDGA 196
           +K  N+LL   G++K+ DFG +++          +   GTP ++APEVI   +   YDG 
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG- 193
Query: 197 KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILD 253
           K D+WS G+    L     P    N M+    I + +    +S  W S   +  +   L 
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQ 252
Query: 254 PNPVTRITMAEVIENEWFKKGYKPPS 279
             P  R T +EV+    F    +PP+
Sbjct: 253 KIPQDRPT-SEVLLKHRFVLRERPPT 277

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 137/316 (43%), Gaps = 50/316 (15%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +G G++  V  A +  TG  VAIK L   +  + ++  +   RE+  +K +RH NVI + 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 81  EVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +V          T  Y+V+ F+  G    K+    +L ED  +    Q++  + Y H+ G
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRDLKP NL ++ +  LK+ DFGL+      + D  +     T  Y APEVI N    
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF-------------- 240
               D+WS G I+  ++ G   F+ S+ +   K+I K     P  F              
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 241 -----------------STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PSF 280
                            S  A  L+ ++L  +   R+T  E + + +F+  +     P  
Sbjct: 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV 323
Query: 281 EQPNIDLDDVDSIFNE 296
           ++ +   DDVD   +E
Sbjct: 324 QKYDDSFDDVDRTLDE 339

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +Y+V   + G +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLM-GADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 226 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 285 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 344
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 345 AEAPFKFDMELDDL 358

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 144/340 (42%), Gaps = 50/340 (14%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIKREISTMKLIRH 73
           +YE+  T+G G++  V  AR   TG+ VAIK I +   V+ +    +  RE+  +K  +H
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELKILKHFKH 112
Query: 74  PNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            N+I + +++           +Y+VL+ +   +L   I S   L  +  R +  QL+  +
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS--ALPQQVRDDGLLHTTCGTPNYVAP 185
            Y HS  V HRDLKP NLL++ N  LK+ DFG++             +     T  Y AP
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-------------------LMALY 226
           E++ +        DLWS G I   ++A    F   N                   + A+ 
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291
Query: 227 KKIFKADFKS------PPWFST------SAKKLISRILDPNPVTRITMAEVIENEWFKKG 274
            +  +A  +S       PW +        A  L+ R+L   P  RI+ A  + + +  K 
Sbjct: 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVA 314
           + P        D  D    F+ + D   L  ER +E  VA
Sbjct: 352 HDPD-------DEPDCAPPFDFAFDREALTRERIKEAIVA 384

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/356 (22%), Positives = 154/356 (43%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
              ++ T + +Y+  + +G G+   V  A +T  G NVA+K L +          +  RE
Sbjct: 15  VADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  +K + H N+I +  V   +        +Y+V+E +        +     ++ D  R 
Sbjct: 74  LVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHERM 128
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +    + ++   
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPY 185
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK----- 231
             T  Y APEVI   GY  A  D+WS G I+  L+ G + F+ ++ +  + K+ +     
Sbjct: 186 VVTRYYRAPEVILGMGY-AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTP 244
Query: 232 -ADFKS-------------------------PPWF-----------STSAKKLISRILDP 254
            A+F +                         P W            ++ A+ L+S++L  
Sbjct: 245 SAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVI 304
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ E + + +    Y P   E P         I++  ++ R   +E  +E
Sbjct: 305 DPDKRISVDEALRHPYITVWYDPAEAEAPP------PQIYDAQLEEREHAIEEWKE 354

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            G +E+   LG G F  V    + +TGE VAIK   +E   K++    +  EI  MK + 
Sbjct: 14  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLN 71
Query: 73  HPNVIRMYEV------MASKTKIYIVLEFVTGGEL---FDKIASRGRLKEDEARKYFQQL 123
           HPNV+   EV      +A      + +E+  GG+L    ++  +   LKE   R     +
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQQVRDDGLLHTT-CGT 179
            +A+ Y H   + HRDLKPEN++L       + K+ D G +    +  D G L T   GT
Sbjct: 132 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA----KELDQGELCTEFVGT 187
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
             Y+APE++  K Y     D WS G + +  + G+ PF
Sbjct: 188 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 224

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 144/340 (42%), Gaps = 50/340 (14%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQIKREISTMKLIRH 73
           +YE+  T+G G++  V  AR   TG+ VAIK I +   V+ +    +  RE+  +K  +H
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA--KRTLRELKILKHFKH 113
Query: 74  PNVIRMYEVMASKT------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            N+I + +++           +Y+VL+ +   +L   I S   L  +  R +  QL+  +
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS--ALPQQVRDDGLLHTTCGTPNYVAP 185
            Y HS  V HRDLKP NLL++ N  LK+ DFG++             +     T  Y AP
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-------------------LMALY 226
           E++ +        DLWS G I   ++A    F   N                   + A+ 
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 292
Query: 227 KKIFKADFKS------PPWFST------SAKKLISRILDPNPVTRITMAEVIENEWFKKG 274
            +  +A  +S       PW +        A  L+ R+L   P  RI+ A  + + +  K 
Sbjct: 293 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVA 314
           + P        D  D    F+ + D   L  ER +E  VA
Sbjct: 353 HDPD-------DEPDCAPPFDFAFDREALTRERIKEAIVA 385

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            G +E+   LG G F  V    + +TGE VAIK   +E   K++    +  EI  MK + 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLN 70
Query: 73  HPNVIRMYEV------MASKTKIYIVLEFVTGGEL---FDKIASRGRLKEDEARKYFQQL 123
           HPNV+   EV      +A      + +E+  GG+L    ++  +   LKE   R     +
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQQVRDDGLLHTT-CGT 179
            +A+ Y H   + HRDLKPEN++L       + K+ D G +    +  D G L T   GT
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA----KELDQGELCTEFVGT 186
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
             Y+APE++  K Y     D WS G + +  + G+ PF
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 223

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 209
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 210 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 329 AEAPFKFDMELDDL 342

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 210
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 211 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 269
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 270 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 329
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 330 AEAPFKFDMELDDL 343

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 208 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYL 266
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + +  + Y P   P 
Sbjct: 267 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPI 326
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 327 AEAPFKFDMELDDL 340

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 213
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 214 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 272
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 273 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 332
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 333 AEAPFKFDMELDDL 346

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 206 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 265 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 324
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 325 AEAPFKFDMELDDL 338

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 206 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 265 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 324
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 325 AEAPFKFDMELDDL 338

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 208 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 267 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 326
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 327 AEAPFKFDMELDDL 340

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 206 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYL 264
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 265 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 324
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 325 AEAPFKFDMELDDL 338

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 208 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + +  + Y P   P 
Sbjct: 267 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPI 326
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 327 AEAPFKFDMELDDL 340

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 206 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 265 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 324
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 325 AEAPFKFDMELDDL 338

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 226 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 285 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 344
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 345 AEAPFKFDMELDDL 358

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 206 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYL 264
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 265 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 324
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 325 AEAPFKFDMELDDL 338

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 210 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 329 AEAPFKFDMELDDL 342

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 210 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 329 AEAPFKFDMELDDL 342

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 204 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 262
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 263 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 322
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 323 AEAPFKFDMELDDL 336

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 210
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 211 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 269
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 270 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 329
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 330 AEAPFKFDMELDDL 343

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 211
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 212 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 270
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 271 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 330
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 331 AEAPFKFDMELDDL 344

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 202
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 203 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 261
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 262 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 321
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 322 AEAPFKFDMELDDL 335

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 210 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 329 AEAPFKFDMELDDL 342

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 63
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI++EF+T G L D +    R + +     +   Q+ +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTXTAHAGAKFPIKWTA 181
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 182 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 239
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 21/272 (7%)
Query: 7   GASRTRVGKYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG 59
           GA      K+E+ RT       LG G + +V      +    VA+K L KE  ++   + 
Sbjct: 1   GAMDPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VE 56
Query: 60  QIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
           +  +E + MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 116
Query: 120 FQ--QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q+ +A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H   
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGA 174
Query: 178 GTP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK 235
             P  + APE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++
Sbjct: 175 KFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYR 232
Query: 236 --SPPWFSTSAKKLISRILDPNPVTRITMAEV 265
              P        +L+      NP  R + AE+
Sbjct: 233 MERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 67
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI++EF+T G L D +    R + +     +   Q+ +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 185
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 186 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 243
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/357 (22%), Positives = 154/357 (43%), Gaps = 66/357 (18%)
Query: 4   RTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR 63
           +   ++ T + +Y+  + +G G+   V  A +T  G NVA+K L +          +  R
Sbjct: 12  QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYR 70
Query: 64  EISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEAR 117
           E+  +K + H N+I +  V   +        +Y+V+E +        +     ++ D  R
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIHMELDHER 125
Query: 118 KYF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT 175
             +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +    + ++  
Sbjct: 126 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTP 182
Query: 176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK---- 231
              T  Y APEVI   GY     D+WS G I+  L+ G + F+ ++ +  + K+ +    
Sbjct: 183 YVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 241
Query: 232 --ADFKS-------------------------PPWF-----------STSAKKLISRILD 253
             A+F +                         P W            ++ A+ L+S++L 
Sbjct: 242 PSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLV 301
Query: 254 PNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
            +P  RI++ E + + +    Y P   E P         I++  ++ R   +E  +E
Sbjct: 302 IDPDKRISVDEALRHPYITVWYDPAEAEAPP------PQIYDAQLEEREHAIEEWKE 352

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 204 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYL 262
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 263 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 322
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 323 AEAPFKFDMELDDL 336

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 210 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 329 AEAPFKFDMELDDL 342

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L +T+G+G F  V        G  VA+K +  +   +  +      E S M  +RH N+
Sbjct: 24  KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNL 76
Query: 77  IRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++  V+   K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
              HRDL   N+L+  + V KVSDFGL+      +D G L        + APE +  K +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF 191
Query: 194 DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
              K+D+WS G++L+ + + G +P+    L  +  ++ K      P              
Sbjct: 192 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-------------- 236
Query: 253 DPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDS 292
           D  P     + EV++N W       PSF Q    L+ + +
Sbjct: 237 DGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRHPNVIRMY 80
           +GEG++  V  A +      VAI+   K    +H+   Q   REI  +   RH N+I + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIR---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 81  EVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +++ + T      +YIV + +   +L+ K+     L  D    +  Q++  + Y HS  V
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD-GLLHTTCGTPNYVAPEV-INNKGY 193
            HRDLKP NLLL+    LK+ DFGL+ +     D  G L     T  Y APE+ +N+KGY
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 194 DGAKADLWSCGVILYVLMAG--------YL------------PFEES-----NLMALYKK 228
             +  D+WS G IL  +++         YL            P +E      NL A    
Sbjct: 210 TKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 229 IFKADFKSPPW------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PS 279
           +        PW        + A  L+ ++L  NP  RI + + + + + ++ Y P   P 
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
Query: 280 FEQP---NIDLDDV 290
            E P   +++LDD+
Sbjct: 329 AEAPFKFDMELDDL 342

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 62
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI++EF+T G L D +    R +       +   Q+ +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 181 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 238
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 12  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 67
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  + AS  + +  +     +Q    +DY H+
Sbjct: 68  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI  + 
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 193 YD--GAKADLWSCGVILYVLMAGYLPFEESN 221
            +    ++D+++ G++LY LM G LP+   N
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L +T+G+G F  V        G  VA+K +  +   +  +      E S M  +RH N+
Sbjct: 9   KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNL 61
Query: 77  IRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++  V+   K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y    
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
              HRDL   N+L+  + V KVSDFGL+      +D G L        + APE +  K +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF 176
Query: 194 DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
              K+D+WS G++L+ + + G +P+    L  +  ++ K      P              
Sbjct: 177 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-------------- 221
Query: 253 DPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDS 292
           D  P     + EV++N W       PSF Q    L+ + +
Sbjct: 222 DGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 258

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 67
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTXTAHAGAKFPIKWTA 185
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 186 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 243
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 62
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI++EF+T G L D +    R +       +   Q+ +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 181 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 238
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGXVATRWYRAPE 212
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 271
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 332 HDP--------DDEPVADPYDQSFESRDLLID 355

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 135/314 (42%), Gaps = 74/314 (23%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--------------EKVLKHKMI 58
           +  Y + RTL +G F K+      +  +  A+K  +K              +K+      
Sbjct: 30  INDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 59  GQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
              K E+  +  I++   +    ++ +  ++YI+ E++    +         LK DE   
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI---------LKFDE--- 135
Query: 119 YF--------------------QQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSD 157
           YF                    + ++N+  Y H+ + +CHRD+KP N+L+D NG +K+SD
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 158 FGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLP 216
           FG S    +   D  +  + GT  ++ PE  +N+  Y+GAK D+WS G+ LYV+    +P
Sbjct: 196 FGES----EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
Query: 217 FE-ESNLMALYKKIFKADFKSP-------------------PWFSTSAKKLISRILDPNP 256
           F  + +L+ L+  I   + + P                    + S      +   L  NP
Sbjct: 252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311
Query: 257 VTRITMAEVIENEW 270
             RIT  + +++EW
Sbjct: 312 AERITSEDALKHEW 325

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 188
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 247
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 308 HDP--------DDEPVADPYDQSFESRDLLID 331

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 66
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 184
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 185 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 242
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL         D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S++SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSLESRDLLID 335

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 67
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 185
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 186 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 243
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G F +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 5   KWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 60
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R +       +   Q+ +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTXTAHAGAKFPIKWTA 178
Query: 185 PEVINNKGYDGAKADLWSCGVILYVL----MAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           PE +    +   K+D+W+ GV+L+ +    M+ Y   + S +  L +K ++ +   P   
Sbjct: 179 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRME--RPEGC 235
Query: 241 STSAKKLISRILDPNPVTRITMAEV 265
                +L+      NP  R + AE+
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 67
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 185
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 186 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 243
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 212
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 271
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 332 HDP--------DDEPVADPYDQSFESRDLLID 355

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/332 (25%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   F++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPFDQSFESRDLLID 335

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 23/265 (8%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 60
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI++EF+T G L D +    R +       +   Q+ +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTXTAHAGAKFPIKWTA 178
Query: 185 PEVINNKGYDGAKADLWSCGVILYVL----MAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           PE +    +   K+D+W+ GV+L+ +    M+ Y   + S +  L +K ++ +   P   
Sbjct: 179 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRME--RPEGC 235
Query: 241 STSAKKLISRILDPNPVTRITMAEV 265
                +L+      NP  R + AE+
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 98
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 211
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 270
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 271 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 331 HDP--------DDEPVADPYDQSFESRDLLID 354

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 75
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 193
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 194 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 251
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 252 EKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 62
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 181 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 238
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 64
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 182
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 183 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 240
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L +T+G+G F  V        G  VA+K +  +   +  +      E S M  +RH N+
Sbjct: 15  KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNL 67
Query: 77  IRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++  V+   K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y    
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
              HRDL   N+L+  + V KVSDFGL+      +D G L        + APE +    +
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREAAF 182
Query: 194 DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
              K+D+WS G++L+ + + G +P+    L  +  ++ K      P              
Sbjct: 183 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-------------- 227
Query: 253 DPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDS 292
           D  P     + EV++N W       PSF Q    L+ + +
Sbjct: 228 DGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 62
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 181 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 238
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L +T+G+G F  V        G  VA+K +  +   +  +      E S M  +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNL 248
Query: 77  IRMYEVMAS-KTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++  V+   K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y    
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
              HRDL   N+L+  + V KVSDFGL+      +D G L        + APE +  K +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF 363
Query: 194 DGAKADLWSCGVILYVLMA-GYLPF 217
              K+D+WS G++L+ + + G +P+
Sbjct: 364 S-TKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 62
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R +       +   Q+ +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 181 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 238
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 188
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 247
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 308 HDP--------DDEPVADPYDQSFESRDLLID 331

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L K  + ++  K   +  RE+  +K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAK---RTYRELRLLKHMK 91
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 204
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 263
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 324 HDP--------DDEPVADPYDQSFESRDLLID 347

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 67
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R +       +   Q+ +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 185
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 186 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 243
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 118/254 (46%), Gaps = 22/254 (8%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG GSF +V    + +TG   A+K +  E V +         E+     +  P ++ +Y 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLE-VFR-------AEELMACAGLTSPRIVPLYG 152
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
            +     + I +E + GG L   +  +G L ED A  Y  Q +  ++Y HSR + H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 142 PENLLLDANGV-LKVSDFGLSALPQQVRDDGLLHTTC------GTPNYVAPEVINNKGYD 194
            +N+LL ++G    + DFG +     ++ DGL  +        GT  ++APEV+  +  D
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVC---LQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRI 251
            AK D+WS   ++  ++ G  P+ +     L  KI        + PP  +    + I   
Sbjct: 270 -AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG 328
Query: 252 LDPNPVTRITMAEV 265
           L   P+ R++ AE+
Sbjct: 329 LRKEPIHRVSAAEL 342

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 89
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 147
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 202
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 261
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 322 HDP--------DDEPVADPYDQSFESRDLLID 345

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYRAPE 188
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 247
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 308 HDP--------DDEPVADPYDQSFESRDLLID 331

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 62
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R +       +   Q+ +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 181 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 238
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 198
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 257
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 318 HDP--------DDEPVADPYDQSFESRDLLID 341

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 194
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 253
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 314 HDP--------DDEPVADPYDQSFESRDLLID 337

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 198
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 257
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 318 HDP--------DDEPVADPYDQSFESRDLLID 341

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 24  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 79
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  + AS  + +  +     +Q    +DY H+
Sbjct: 80  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           + + HRDLK  N+ L  +  +K+ DFGL+    +           G+  ++APEVI  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 193 YD--GAKADLWSCGVILYVLMAGYLPFEESN 221
            +    ++D+++ G++LY LM G LP+   N
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 16/216 (7%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--REISTMKLIRHPNVIRM 79
           LGEG++A V   ++  T   VA+K    E  L+H+        RE+S +K ++H N++ +
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ-QLINAVDYCHSRGVCHR 138
           ++++ ++  + +V E++   +L   +   G +      K F  QL+  + YCH + V HR
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 139 DLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
           DLKP+NLL++  G LK++DFGL+   ++P +  D+ ++     T  Y  P+++       
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPPDILLGSTDYS 179
Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
            + D+W  G I Y +  G   F  S +      IF+
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           E+   +G G+F  V  A+     ++VAIK ++ E   K  ++     E+  +  + HPN+
Sbjct: 11  EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIV-----ELRQLSRVNHPNI 63
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK---EDEARKYFQQLINAVDYCHS- 132
           +++Y   A    + +V+E+  GG L++ +     L       A  +  Q    V Y HS 
Sbjct: 64  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 --RGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHTTC--GTPNYVAPEV 187
             + + HRDLKP NLLL A G VLK+ DFG +        D   H T   G+  ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------DIQTHMTNNKGSAAWMAPEV 174
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK-- 245
                Y   K D++S G+IL+ ++    PF+E    A        +   PP      K  
Sbjct: 175 FEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 246 -KLISRILDPNPVTRITMAEVIE 267
             L++R    +P  R +M E+++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           E+   +G G+F  V  A+     ++VAIK ++ E   K  ++     E+  +  + HPN+
Sbjct: 12  EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIV-----ELRQLSRVNHPNI 64
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK---EDEARKYFQQLINAVDYCHS- 132
           +++Y   A    + +V+E+  GG L++ +     L       A  +  Q    V Y HS 
Sbjct: 65  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 133 --RGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHTTC--GTPNYVAPEV 187
             + + HRDLKP NLLL A G VLK+ DFG +        D   H T   G+  ++APEV
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------DIQTHMTNNKGSAAWMAPEV 175
Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK-- 245
                Y   K D++S G+IL+ ++    PF+E    A        +   PP      K  
Sbjct: 176 FEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 246 -KLISRILDPNPVTRITMAEVIE 267
             L++R    +P  R +M E+++
Sbjct: 235 ESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 126/259 (48%), Gaps = 14/259 (5%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 150
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 151 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 205
Query: 201 WSCGVILYVLMAGYLPF-EESNLMALYKKIFKADFKSPP-----WFSTSAKKLISRILDP 254
           WS G+ L  +  G  P    S  MA+++ +     + PP      FS   +  +++ L  
Sbjct: 206 WSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 265
Query: 255 NPVTRITMAEVIENEWFKK 273
           NP  R  + +++ + + K+
Sbjct: 266 NPAERADLKQLMVHAFIKR 284

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 102
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGYVATRWYRAPE 215
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 274
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 335 HDP--------DDEPVADPYDQSFESRDLLID 358

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LG  +G G+F +V   R       VA+K     + L   +  +  +E   +K   HPN++
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVC 136
           R+  V   K  IYIV+E V GG+    + + G RL+     +        ++Y  S+   
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN----YVAPEVINNKG 192
           HRDL   N L+    VLK+SDFG+S    +   DG+   + G       + APE +N   
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 193 YDGAKADLWSCGVILY 208
           Y  +++D+WS G++L+
Sbjct: 292 YS-SESDVWSFGILLW 306

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 36/286 (12%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG GSF +V    + +TG   A+K +  E V +         E+     +  P ++ +Y 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLE-VFR-------AEELMACAGLTSPRIVPLYG 133
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
            +     + I +E + GG L   +  +G L ED A  Y  Q +  ++Y HSR + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 142 PENLLLDANGV-LKVSDFGLSALPQQVRDDGL---LHT---TCGTPNYVAPEVINNKGYD 194
            +N+LL ++G    + DFG +     ++ DGL   L T     GT  ++APEV+  +  D
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVC---LQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRI 251
            AK D+WS   ++  ++ G  P+ +     L  KI        + PP  +    + I   
Sbjct: 251 -AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEG 309
Query: 252 LDPNPVTRITMAEV-------------IENEWFKKGYKPPSFEQPN 284
           L   P+ R++ AE+             +++ W +  YK P    PN
Sbjct: 310 LRKEPIHRVSAAELGGKVNRALQQVGGLKSPW-RGEYKEPRHPPPN 354

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 102
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 215
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 274
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 335 HDP--------DDEPVADPYDQSFESRDLLID 358

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LG  +G G+F +V   R       VA+K     + L   +  +  +E   +K   HPN++
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVC 136
           R+  V   K  IYIV+E V GG+    + + G RL+     +        ++Y  S+   
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN----YVAPEVINNKG 192
           HRDL   N L+    VLK+SDFG+S    +   DG+   + G       + APE +N   
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMS----REEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 193 YDGAKADLWSCGVILY 208
           Y  +++D+WS G++L+
Sbjct: 292 YS-SESDVWSFGILLW 306

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 98
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 211
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 270
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 271 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 331 HDP--------DDEPVADPYDQSFESRDLLID 354

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 212
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 271
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 272 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 332 HDP--------DDEPVADPYDQSFESRDLLID 355

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 194
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 253
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 314 HDP--------DDEPVADPYDQSFESRDLLID 337

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 197
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 256
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 317 HDP--------DDEPVADPYDQSFESRDLLID 340

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 91
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 204
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 263
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 324 HDP--------DDEPVADPYDQSFESRDLLID 347

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 91
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 204
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 263
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 324 HDP--------DDEPVADPYDQSFESRDLLID 347

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 194
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 253
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 314 HDP--------DDEPVADPYDQSFESRDLLID 337

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 90
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 203
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 262
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 323 HDP--------DDEPVADPYDQSFESRDLLID 346

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 197
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 256
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 317 HDP--------DDEPVADPYDQSFESRDLLID 340

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 194
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 253
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 314 HDP--------DDEPVADPYDQSFESRDLLID 337

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 90
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 203
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 262
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 323 HDP--------DDEPVADPYDQSFESRDLLID 346

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 77
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 190
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 249
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 310 HDP--------DDEPVADPYDQSFESRDLLID 333

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 199
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 258
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 319 HDP--------DDEPVADPYDQSFESRDLLID 342

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 198
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 257
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 318 HDP--------DDEPVADPYDQSFESRDLLID 341

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 19  GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           G  LG+G F +     + ETGE + +K L +      +      +E+  M+ + HPNV++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF-QQLINAVDYCHSRGVCH 137
              V+    ++  + E++ GG L   I S         R  F + + + + Y HS  + H
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 138 RDLKPENLLLDANGVLKVSDFGLSAL-------PQQVR-----DDGLLHTTCGTPNYVAP 185
           RDL   N L+  N  + V+DFGL+ L       P+ +R     D    +T  G P ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 186 EVINNKGYDGAKADLWSCGVIL 207
           E+IN + YD  K D++S G++L
Sbjct: 192 EMINGRSYD-EKVDVFSFGIVL 212

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 197
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 256
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 317 HDP--------DDEPVADPYDQSFESRDLLID 340

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 78
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 191
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 250
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 311 HDP--------DDEPVADPYDQSFESRDLLID 334

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 197
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 256
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 317 HDP--------DDEPVADPYDQSFESRDLLID 340

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 127/266 (47%), Gaps = 24/266 (9%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKIL--DKEKVLKHKMIGQIKREISTMKLIRHPN 75
           L   +G G F KV   R    G+ VA+K    D ++ +  + I  +++E     +++HPN
Sbjct: 11  LEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPN 67
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +I +  V   +  + +V+EF  GG L +++ S  R+  D    +  Q+   ++Y H   +
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 136 C---HRDLKPENLLL--------DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
               HRDLK  N+L+         +N +LK++DFGL+    +        +  G   ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMA 182
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF--KADFKSPPWFST 242
           PEVI    +    +D+WS GV+L+ L+ G +PF   + +A+   +   K     P     
Sbjct: 183 PEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241
Query: 243 SAKKLISRILDPNPVTRITMAEVIEN 268
              KL+    +P+P +R +   +++ 
Sbjct: 242 PFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 44/296 (14%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
           +YE    +GEG++ KV  AR+ + G   VA+K + + +  +  M     RE++ ++ +  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 70
Query: 73  --HPNVIRMYEVMA-----SKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQL 123
             HPNV+R+++V        +TK+ +V E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           +  +D+ HS  V HRDLKP+N+L+ ++G +K++DFGL+ +         L +   T  Y 
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 186
Query: 184 APEVINNKGYDGAKADLWSCGVILY--------------------VLMAGYLPFEES--N 221
           APEV+    Y     DLWS G I                      +L    LP EE    
Sbjct: 187 APEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 222 LMALYKKIFKADFKSP-PWFSTS----AKKLISRILDPNPVTRITMAEVIENEWFK 272
            +AL ++ F +    P   F T      K L+ + L  NP  RI+    + + +F+
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 198
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 257
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 318 HDP--------DDEPVADPYDQSFESRDLLID 341

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 188
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 247
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 308 HDP--------DDEPVADPYDQSFESRDLLID 331

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 150/332 (45%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+   +   D+  +     T  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 258
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S++SR+L+++
Sbjct: 319 HDP--------DDEPVADPYDQSLESRDLLID 342

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 60
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R +       +   Q+ +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTFTAHAGAKFPIKWTA 178
Query: 185 PEVINNKGYDGAKADLWSCGVILYVL----MAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           PE +    +   K+D+W+ GV+L+ +    M+ Y   + S +  L +K ++ +   P   
Sbjct: 179 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRME--RPEGC 235
Query: 241 STSAKKLISRILDPNPVTRITMAEV 265
                +L+      NP  R + AE+
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 76
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 248
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 309 HDP--------DDEPVADPYDQSFESRDLLID 332

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 76
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 248
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 309 HDP--------DDEPVADPYDQSFESRDLLID 332

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 308
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HR+L   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 426
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 427 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 484
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 485 EKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 44/296 (14%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
           +YE    +GEG++ KV  AR+ + G   VA+K + + +  +  M     RE++ ++ +  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 70
Query: 73  --HPNVIRMYEVMA-----SKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQL 123
             HPNV+R+++V        +TK+ +V E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           +  +D+ HS  V HRDLKP+N+L+ ++G +K++DFGL+ +         L +   T  Y 
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 186
Query: 184 APEVINNKGYDGAKADLWSCGVILY--------------------VLMAGYLPFEES--N 221
           APEV+    Y     DLWS G I                      +L    LP EE    
Sbjct: 187 APEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 222 LMALYKKIFKADFKSP-PWFSTS----AKKLISRILDPNPVTRITMAEVIENEWFK 272
            +AL ++ F +    P   F T      K L+ + L  NP  RI+    + + +F+
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 44/296 (14%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
           +YE    +GEG++ KV  AR+ + G   VA+K + + +  +  M     RE++ ++ +  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 70
Query: 73  --HPNVIRMYEVMA-----SKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQL 123
             HPNV+R+++V        +TK+ +V E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           +  +D+ HS  V HRDLKP+N+L+ ++G +K++DFGL+ +         L +   T  Y 
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 186
Query: 184 APEVINNKGYDGAKADLWSCGVILY--------------------VLMAGYLPFEES--N 221
           APEV+    Y     DLWS G I                      +L    LP EE    
Sbjct: 187 APEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 222 LMALYKKIFKADFKSP-PWFSTS----AKKLISRILDPNPVTRITMAEVIENEWFK 272
            +AL ++ F +    P   F T      K L+ + L  NP  RI+    + + +F+
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 269
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R +       +   Q+ +
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HR+L   N L+  N ++KV+DFGLS L     D    H     P  + A
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 387
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 388 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 445
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 30  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 87
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 194 DGAKA----------DLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                          D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 266 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPNVIR 78
           R +G G++  V  A +    + VA+K L +  + L H    +  RE+  +K ++H NVI 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR--RTYRELRLLKHLKHENVIG 91
Query: 79  MYEVMASKTKI------YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           + +V    T I      Y+V   + G +L + + S+  L ++  +    QL+  + Y HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIHS 149
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRDLKP N+ ++ +  L++ DFGL+      + D  +     T  Y APE++ N  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           +     D+WS G I+  L+ G   F  S+ +   K+I +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 115
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 175 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 194 D----------GAKADLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                        K+D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 294 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+   +   D+  +     T  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 258
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 319 HDP--------DDEPVADPYDQSFESRDLLID 342

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 13/219 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV+  R       TGE VA+K L  E    H  I  +K+EI  ++ + H N
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 84
Query: 76  VIRMYEVMASK--TKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   +        I +++EF+  G L + +  ++ ++   +  KY  Q+   +DY  S
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           R   HRDL   N+L+++   +K+ DFGL+   +  ++   +     +P +  APE +   
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF 230
            +  A +D+WS GV L+ L+  Y    +S+ MAL+ K+ 
Sbjct: 205 KFYIA-SDVWSFGVTLHELLT-YCD-SDSSPMALFLKMI 240

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 30  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 87
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 194 DGAKA----------DLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                          D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 266 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 13/218 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV+  R       TGE VA+K L  E    H  I  +K+EI  ++ + H N
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 72
Query: 76  VIRMYEVMASK--TKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   +        I +++EF+  G L + +  ++ ++   +  KY  Q+   +DY  S
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           R   HRDL   N+L+++   +K+ DFGL+   +  ++   +     +P +  APE +   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI 229
            +  A +D+WS GV L+ L+  Y    +S+ MAL+ K+
Sbjct: 193 KFYIA-SDVWSFGVTLHELLT-YCD-SDSSPMALFLKM 227

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/355 (22%), Positives = 151/355 (42%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK++ H N+I +  V   +        +YIV+E +        ++   +++ D  R  
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS GVI+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/355 (22%), Positives = 151/355 (42%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK++ H N+I +  V   +        +YIV+E +        ++   +++ D  R  
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS GVI+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 14  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 71
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 131 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 194 D----------GAKADLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                        K+D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 249
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 250 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 286

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 147/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ D+GL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 10  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 67
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 127 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 194 D----------GAKADLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                        K+D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 245
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 246 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 282

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V KYE    +G+G+F +V  AR+ +TG+ VA+K +  E   +   I  + REI  ++L++
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLK 74
Query: 73  HPNVIRMYEVMASKTK--------IYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQ 122
           H NV+ + E+  +K          IY+V +F       L   +  +  L   E ++  Q 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQM 132
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGT 179
           L+N + Y H   + HRD+K  N+L+  +GVLK++DFGL+   +L +  + +   +    T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 191
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVIL 207
             Y  PE++  +   G   DLW  G I+
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIM 219

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V KYE    +G+G+F +V  AR+ +TG+ VA+K +  E   +   I  + REI  ++L++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLK 75
Query: 73  HPNVIRMYEVMASKTK--------IYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQ 122
           H NV+ + E+  +K          IY+V +F       L   +  +  L   E ++  Q 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQM 133
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGT 179
           L+N + Y H   + HRD+K  N+L+  +GVLK++DFGL+   +L +  + +   +    T
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVIL 207
             Y  PE++  +   G   DLW  G I+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 115
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 175 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 194 D----------GAKADLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                        K+D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 294 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 24  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 79
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++  ++ IV ++  G  L+  + AS  + +  +     +Q    +DY H+
Sbjct: 80  VNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           + + HRDLK  N+ L  +  +K+ DFGL+    +           G+  ++APEVI  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 193 YD--GAKADLWSCGVILYVLMAGYLPFEESN 221
            +    ++D+++ G++LY LM G LP+   N
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/354 (22%), Positives = 146/354 (41%), Gaps = 62/354 (17%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 8   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 66
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +    L   I  +  L  +    
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI--QMELDHERMSY 123
Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
              Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++     
Sbjct: 124 LLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVV 180
Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--------- 229
           T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+         
Sbjct: 181 TRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 230 ---------------------------------FKADFKSPPWFSTSAKKLISRILDPNP 256
                                            F AD +     ++ A+ L+S++L  +P
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 257 VTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
             RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 347

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 126/251 (50%), Gaps = 15/251 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG G F +V   +   TG+  A K L+K+++ K K       E   +  +    ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  YEVMASKTKIYIVLEFVTGGEL----FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
                +KT + +V+  + GG++    ++        +E  A  Y  Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQ--QVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            +RDLKPEN+LLD +G +++SD GL+   +  Q +  G      GTP ++APE++  + Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLGEEY 366
Query: 194 DGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           D +  D ++ GV LY ++A   PF    E+     L +++ +     P  FS ++K    
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 RILDPNPVTRI 260
            +L  +P  R+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 9   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 67
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 68  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 122
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 123 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 179
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 180 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 238
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 239 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 298
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 299 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 348

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 126/251 (50%), Gaps = 15/251 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG G F +V   +   TG+  A K L+K+++ K K       E   +  +    ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  YEVMASKTKIYIVLEFVTGGEL----FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
                +KT + +V+  + GG++    ++        +E  A  Y  Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQ--QVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            +RDLKPEN+LLD +G +++SD GL+   +  Q +  G      GTP ++APE++  + Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLGEEY 366
Query: 194 DGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           D +  D ++ GV LY ++A   PF    E+     L +++ +     P  FS ++K    
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 RILDPNPVTRI 260
            +L  +P  R+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 11  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 68
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +   
Sbjct: 128 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 194 D----------GAKADLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                        K+D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 247 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 8   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 66
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 121
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 178
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 179 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 347

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 9   VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 67
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 68  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 122
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 123 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 179
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 180 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 238
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 239 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 298
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 299 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 348

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V KYE    +G+G+F +V  AR+ +TG+ VA+K +  E   +   I  + REI  ++L++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLK 75
Query: 73  HPNVIRMYEVMASKTK--------IYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQ 122
           H NV+ + E+  +K          IY+V +F       L   +  +  L   E ++  Q 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQM 133
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGT 179
           L+N + Y H   + HRD+K  N+L+  +GVLK++DFGL+   +L +  + +   +    T
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVIL 207
             Y  PE++  +   G   DLW  G I+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 126/251 (50%), Gaps = 15/251 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG G F +V   +   TG+  A K L+K+++ K K       E   +  +    ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  YEVMASKTKIYIVLEFVTGGEL----FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
                +KT + +V+  + GG++    ++        +E  A  Y  Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQ--QVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            +RDLKPEN+LLD +G +++SD GL+   +  Q +  G      GTP ++APE++  + Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLGEEY 366
Query: 194 DGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           D +  D ++ GV LY ++A   PF    E+     L +++ +     P  FS ++K    
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 RILDPNPVTRI 260
            +L  +P  R+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 15  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 128
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 185
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 186 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 305 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 354

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 149/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+   +   D+  +     T  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 258
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 319 HDP--------DDEPVADPYDQSSESRDLLID 342

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V KYE    +G+G+F +V  AR+ +TG+ VA+K +  E   +   I  + REI  ++L++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLK 75
Query: 73  HPNVIRMYEVMASKTK--------IYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQ 122
           H NV+ + E+  +K          IY+V +F       L   +  +  L   E ++  Q 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQM 133
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGT 179
           L+N + Y H   + HRD+K  N+L+  +GVLK++DFGL+   +L +  + +   +    T
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVIL 207
             Y  PE++  +   G   DLW  G I+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 15  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERM 128
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 129 SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPY 185
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 186 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 305 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 354

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 16  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 74
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 75  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 129
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 186
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 187 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 245
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 246 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 306 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 355

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 14  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 72
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 73  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 127
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 128 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 184
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 185 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 243
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 244 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 303
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 304 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 353

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 15  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 128
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 185
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 186 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 305 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 354

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 16  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 74
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 75  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 129
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 186
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 187 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 245
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 246 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 306 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 355

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 15  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LXQVIQMELDHERM 128
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 129 SYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPY 185
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 186 VVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 305 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 354

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 53  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 111
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 166
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 223
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 224 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 343 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 392

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/331 (22%), Positives = 144/331 (43%), Gaps = 57/331 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  + + ++G  +A+K L +  + ++  K   +  RE+  +K ++
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 108
Query: 73  HPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V    T       +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APE
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 221
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF-----S 241
           ++ N  +     D+WS G I+  L+ G   F  ++ +   ++I +     P        S
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPS 281
Query: 242 TSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKGY 275
             A+  I+ +            +  NP+               RIT +E + + +F + +
Sbjct: 282 HEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYH 341
Query: 276 KPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
            P        D +     +++S +SR L +E
Sbjct: 342 DP--------DDEPESEPYDQSFESRQLEIE 364

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 126/251 (50%), Gaps = 15/251 (5%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           R LG G F +V   +   TG+  A K L+K+++ K K       E   +  +    ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  YEVMASKTKIYIVLEFVTGGEL----FDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
                +KT + +V+  + GG++    ++        +E  A  Y  Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQ--QVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            +RDLKPEN+LLD +G +++SD GL+   +  Q +  G      GTP ++APE++  + Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLGEEY 366
Query: 194 DGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           D +  D ++ GV LY ++A   PF    E+     L +++ +     P  FS ++K    
Sbjct: 367 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 RILDPNPVTRI 260
            +L  +P  R+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/332 (24%), Positives = 148/332 (44%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   + G +L + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ DF L+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 126/265 (47%), Gaps = 20/265 (7%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILYVLMAGYLPFEESNL-------MALYKKIFKADFKSPP-----WFSTSAKKLI 248
           WS G+ L  +  G  P    +        MA+++ +     + PP      FS   +  +
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 246
Query: 249 SRILDPNPVTRITMAEVIENEWFKK 273
           ++ L  NP  R  + +++ + + K+
Sbjct: 247 NKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/356 (21%), Positives = 148/356 (41%), Gaps = 66/356 (18%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 53  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 111
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 166
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPY 223
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI------- 229
             T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+       
Sbjct: 224 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 230 -----------------------------------FKADFKSPPWFSTSAKKLISRILDP 254
                                              F AD +     ++ A+ L+S++L  
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 255 NPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           +P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 343 DPAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 392

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/368 (22%), Positives = 155/368 (42%), Gaps = 62/368 (16%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPEV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDD--VDSIFNESMDSRNLVVERREEGPV 313
              RI++ E +++ +    Y P   E P   + D  +D   +   + + L+ +   + P 
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLPK 365
Query: 314 APLTMNAF 321
            P T+N F
Sbjct: 366 RPTTLNLF 373

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 63
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D          P  + A
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAPAGAKFPIKWTA 181
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 182 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 239
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEI 263

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 23/228 (10%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS 66
           G+  T    + L   LG+G+ A V   R+ +TG+  AIK+ +    L+   +    RE  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 67  TMKLIRHPNVIRMYEVMASKTKIY--IVLEFVTGGELF---DKIASRGRLKEDEARKYFQ 121
            +K + H N+++++ +    T  +  +++EF   G L+   ++ ++   L E E     +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
            ++  +++    G+ HR++KP N++     D   V K++DFG +   +++ DD    +  
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVSLY 176
Query: 178 GTPNYVAPEVI--------NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           GT  Y+ P++         + K Y GA  DLWS GV  Y    G LPF
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPF 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 16/219 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPNVIR 78
           R +G G++  V  A +    + VA+K L +  + L H    +  RE+  +K ++H NVI 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR--RTYRELRLLKHLKHENVIG 91
Query: 79  MYEVMASKTKI------YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           + +V    T I      Y+V   +  G   + I     L ++  +    QL+  + Y HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRDLKP N+ ++ +  L++ DFGL+      + D  +     T  Y APE++ N  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           +     D+WS G I+  L+ G   F  S+ +   K+I +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 64
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YI+ EF+T G L D +    R + +     +   Q+ +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N ++KV+DFGLS L     D          P  + A
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAPAGAKFPIKWTA 182
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFS 241
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y ++ + D++   P    
Sbjct: 183 PESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCP 240
Query: 242 TSAKKLISRILDPNPVTRITMAEV 265
               +L+      NP  R + AE+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 146/332 (43%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+  FGL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK---ILDKEKVLKHKMIGQIKREISTMKLI 71
           +YE    +G G++  V  AR+  +G  VA+K   + + E+ L    + ++   +  ++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAF 63
Query: 72  RHPNVIRMYEVMAS-----KTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLI 124
            HPNV+R+ +V A+     + K+ +V E V        DK    G L  +  +   +Q +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFL 122
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL-PQQVRDDGLLHTTCGTPNYV 183
             +D+ H+  + HRDLKPEN+L+ + G +K++DFGL+ +   Q+  D ++ T      Y 
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLW----YR 178
Query: 184 APEVINNKGYDGAKADLWSCGVIL 207
           APEV+    Y     D+WS G I 
Sbjct: 179 APEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 125/258 (48%), Gaps = 16/258 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 134
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S    Q+ D+ + +   GT +Y++PE +    Y   ++D+
Sbjct: 135 KPSNILVNSRGEIKLCDFGVSG---QLIDE-MANEFVGTRSYMSPERLQGTHYS-VQSDI 189
Query: 201 WSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP-----WFSTSAKKLISRILDPN 255
           WS G+ L  +  G  P      MA+++ +     + PP      FS   +  +++ L  N
Sbjct: 190 WSMGLSLVEMAVGRYPRPP---MAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKN 246
Query: 256 PVTRITMAEVIENEWFKK 273
           P  R  + +++ + + K+
Sbjct: 247 PAERADLKQLMVHAFIKR 264

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 150/355 (42%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK++ H N+I +  V   +        +YIV+E +        ++   +++ D  R  
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 23/205 (11%)
Query: 20  RTLGEGSFAKVKF----ARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV        N  TGE VA+K L  +   +H+     K+EI  ++ + H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEH 94
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +I+       A    + +V+E+V  G L D +  R  +   +   + QQ+   + Y H++
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNY-VAPE 186
              HRDL   N+LLD + ++K+ DFGL+ A+P+     +VR+DG       +P +  APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG------DSPVFWYAPE 207
Query: 187 VINNKGYDGAKADLWSCGVILYVLM 211
            +    +  A +D+WS GV LY L+
Sbjct: 208 CLKEYKFYYA-SDVWSFGVTLYELL 231

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V      +   +VA+K+L+       ++    K E+  ++  RH
Sbjct: 13  GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 68
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 69  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V      +   +VA+K+L+       ++    K E+  ++  RH
Sbjct: 10  GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 65
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 66  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 35  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 90
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 91  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V      +   +VA+K+L+       ++    K E+  ++  RH
Sbjct: 13  GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 68
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 69  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 146/332 (43%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ D GL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 16/219 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPNVIR 78
           R +G G++  V  A +    + VA+K L +  + L H    +  RE+  +K ++H NVI 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR--RTYRELRLLKHLKHENVIG 83
Query: 79  MYEVMASKTKI------YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           + +V    T I      Y+V   +  G   + I     L ++  +    QL+  + Y HS
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRDLKP N+ ++ +  L++ DFGL+      + D  +     T  Y APE++ N  
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWM 196
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK 231
           +     D+WS G I+  L+ G   F  S+ +   K+I +
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 235

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
           Y + + +G G  +KV F    E  +  AIK ++ E+   ++ +   + EI+ + KL +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 115
Query: 75  N-VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           + +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  G  NY+ PE I +   
Sbjct: 175 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 194 D----------GAKADLWSCGVILYVLMAGYLPFEE-----SNLMALYKKIFKADFKSPP 238
                        K+D+WS G ILY +  G  PF++     S L A+     + +F   P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                 + ++   L  +P  RI++ E++ + + +    P
Sbjct: 294 --EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V      +   +VA+K+L+       ++    K E+  ++  RH
Sbjct: 8   GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 63
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 64  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 150/355 (42%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK++ H N+I +  V   +        +YIV+E +        ++   +++ D  R  
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 36  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 91
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 92  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 23/228 (10%)
Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS 66
           G+  T    + L   LG+G+ A V   R+ +TG+  AIK+ +    L+   +    RE  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 67  TMKLIRHPNVIRMYEVMASKTKIY--IVLEFVTGGELF---DKIASRGRLKEDEARKYFQ 121
            +K + H N+++++ +    T  +  +++EF   G L+   ++ ++   L E E     +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
            ++  +++    G+ HR++KP N++     D   V K++DFG +   +++ DD       
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVXLY 176
Query: 178 GTPNYVAPEVI--------NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           GT  Y+ P++         + K Y GA  DLWS GV  Y    G LPF
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPF 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 149/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        ++   +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 146/332 (43%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ D GL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 146/332 (43%), Gaps = 59/332 (17%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +Y+    +G G++  V  A +T+TG  VA+K L +  + ++  K   +  RE+  +K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 73  HPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           H NVI + +V            +Y+V   +  G   + I    +L +D  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS  + HRDLKP NL ++ +  LK+ D GL+        D  +     T  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGYVATRWYRAPE 192
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWF 240
           ++ N  +     D+WS G I+  L+ G   F  ++ +   K I +    +P         
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKIS 251
Query: 241 STSAKKLISRI------------LDPNPVT--------------RITMAEVIENEWFKKG 274
           S SA+  I  +            +  NP+               RIT A+ + + +F + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 275 YKPPSFEQPNIDLDDVDSIFNESMDSRNLVVE 306
           + P        D + V   +++S +SR+L+++
Sbjct: 312 HDP--------DDEPVADPYDQSFESRDLLID 335

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 24/263 (9%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YE+ + +G+GSF +V  A + +  ++VA+K++  EK   H+   Q   EI  ++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-HR---QAAEEIRILEHLRKQ 153
Query: 75  ------NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
                 NVI M E    +  I +  E ++    EL  K   +G       RK+   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
           +D  H   + H DLKPEN+LL   G   +KV DFG S    Q      ++T   +  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTXIQSRFYRA 267
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGY--LPFE-ESNLMALYKKIFKADFKSPPWFS 241
           PEVI    Y G   D+WS G IL  L+ GY  LP E E + +A   ++     +     S
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
Query: 242 TSAKKLISRILDPNPVTRITMAE 264
             AK  +S    P   T  T+++
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSD 349

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 24/263 (9%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YE+ + +G+GSF +V  A + +  ++VA+K++  EK   H+   Q   EI  ++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-HR---QAAEEIRILEHLRKQ 153
Query: 75  ------NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
                 NVI M E    +  I +  E ++    EL  K   +G       RK+   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
           +D  H   + H DLKPEN+LL   G   +KV DFG S    Q      ++T   +  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTXIQSRFYRA 267
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGY--LPFE-ESNLMALYKKIFKADFKSPPWFS 241
           PEVI    Y G   D+WS G IL  L+ GY  LP E E + +A   ++     +     S
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
Query: 242 TSAKKLISRILDPNPVTRITMAE 264
             AK  +S    P   T  T+++
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSD 349

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK---ILDKEKVLKHKMIGQIKREISTMKLI 71
           +YE    +G G++  V  AR+  +G  VA+K   + + E+ L    + ++   +  ++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAF 63
Query: 72  RHPNVIRMYEVMAS-----KTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLI 124
            HPNV+R+ +V A+     + K+ +V E V        DK    G L  +  +   +Q +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFL 122
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
             +D+ H+  + HRDLKPEN+L+ + G +K++DFGL+ +         L     T  Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVTLWYRA 179
Query: 185 PEVINNKGYDGAKADLWSCGVIL 207
           PEV+    Y     D+WS G I 
Sbjct: 180 PEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 42/262 (16%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKIL--------DKEKVLKHKM 57
           G   R  + KYEL + LG+G++  V  + +  TGE VA+K +        D ++  +  M
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM 60
Query: 58  IGQIKREISTMKLIRHPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDE 115
           I          +L  H N++ +  V+ +     +Y+V +++   E       R  + E  
Sbjct: 61  I--------LTELSGHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPV 109
Query: 116 ARKYF-QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR------ 168
            ++Y   QLI  + Y HS G+ HRD+KP N+LL+A   +KV+DFGLS     +R      
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 169 -------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYL 215
                        D  +L     T  Y APE++          D+WS G IL  ++ G  
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 216 PFEESNLMALYKKIFKA-DFKS 236
            F  S+ M   ++I    DF S
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPS 251

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK---ILDKEKVLKHKMIGQIKREISTMKLI 71
           +YE    +G G++  V  AR+  +G  VA+K   + + E+ L    + ++   +  ++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAF 63
Query: 72  RHPNVIRMYEVMAS-----KTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLI 124
            HPNV+R+ +V A+     + K+ +V E V        DK    G L  +  +   +Q +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFL 122
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
             +D+ H+  + HRDLKPEN+L+ + G +K++DFGL+ +         L     T  Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVTLWYRA 179
Query: 185 PEVINNKGYDGAKADLWSCGVIL 207
           PEV+    Y     D+WS G I 
Sbjct: 180 PEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 149/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        ++   +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LSQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 148/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 17  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 75
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 130
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 187
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 188 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 307 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 355

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 95/186 (51%), Gaps = 13/186 (6%)
Query: 85  SKTK-IYIVLEFVTGGELFDKIASRGRLKEDE--ARKYFQQLINAVDYCHSRGVCHRDLK 141
           SKTK ++I +EF   G L   I  R   K D+  A + F+Q+   VDY HS+ + HRDLK
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLK 163
Query: 142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLW 201
           P N+ L     +K+ DFGL      +++DG    + GT  Y++PE I+++ Y G + DL+
Sbjct: 164 PSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLY 219
Query: 202 SCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRI 260
           + G+IL  +L      FE S      +    +D      F    K L+ ++L   P  R 
Sbjct: 220 ALGLILAELLHVCDTAFETSKFFTDLRDGIISDI-----FDKKEKTLLQKLLSKKPEDRP 274
Query: 261 TMAEVI 266
             +E++
Sbjct: 275 NTSEIL 280

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 148/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPS 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 148/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 19/262 (7%)
Query: 15  KYELGRT-------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST 67
           K+E+ RT       LG G + +V      +    VA+K L KE  ++   + +  +E + 
Sbjct: 26  KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAV 81
Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ--QLIN 125
           MK I+HPN++++  V   +   YIV E++  G L D +    R +       +   Q+ +
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVA 184
           A++Y   +   HRDL   N L+  N V+KV+DFGLS L     D    H     P  + A
Sbjct: 142 AMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA 199
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKA-DFKSPPWFST 242
           PE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y  + K    + P     
Sbjct: 200 PESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPP 258
Query: 243 SAKKLISRILDPNPVTRITMAE 264
              +L+      +P  R + AE
Sbjct: 259 KVYELMRACWKWSPADRPSFAE 280

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 36  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 91
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 92  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+    +           G+  ++APEVI   +
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK--REISTMKLIR 72
           +YE    +G G++  V  AR+  +G  VA+K +             I   RE++ ++ + 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 73  ---HPNVIRMYEVMAS-----KTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQ 122
              HPNV+R+ +V A+     + K+ +V E V        DK    G L  +  +   +Q
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQ 128
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
            +  +D+ H+  + HRDLKPEN+L+ + G +K++DFGL+ +         L     T  Y
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVTLWY 185
Query: 183 VAPEVINNKGYDGAKADLWSCGVIL 207
            APEV+    Y     D+WS G I 
Sbjct: 186 RAPEVLLQSTY-ATPVDMWSVGCIF 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V      +   +VA+K+L+       ++    K E+  ++  RH
Sbjct: 8   GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 63
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDK---IASRGRLKE--DEARKYFQQLINAVD 128
            N++ ++   ++K ++ IV ++  G  L+     I ++  + +  D AR    Q    +D
Sbjct: 64  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR----QTAQGMD 118
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y H++ + HRDLK  N+ L  +  +K+ DFGL+    +           G+  ++APEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 189 --NNKGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
              +K     ++D+++ G++LY LM G LP+   N
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG GSF +V   ++ +TG   A+K +  E V +         E+     +  P ++ +Y 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFR-------VEELVACAGLSSPRIVPLYG 131
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
            +     + I +E + GG L   I   G L ED A  Y  Q +  ++Y H+R + H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 142 PENLLLDANGV-LKVSDFGLSALPQQVRDDGLLHTTC------GTPNYVAPEVINNKGYD 194
            +N+LL ++G    + DFG +     ++ DGL  +        GT  ++APEV+  K  D
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 195 GAKADLWSCGVILYVLMAGYLPFEE 219
            AK D+WS   ++  ++ G  P+ +
Sbjct: 249 -AKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       ++    K E+  ++  RH
Sbjct: 28  GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 83
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++K ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 84  VNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+    +           G+  ++APEVI   +
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 4   RTGGASRTRVGK--YELGRT------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKH 55
           R  G  +  V K  +EL +T      +G G++  V  A +  +GE VAIK L +      
Sbjct: 6   RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSE 64
Query: 56  KMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI------YIVLEFVTGGELFDKIASRG 109
               +  RE+  +K ++H NVI + +V    + +      Y+V+ F+       KI    
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL- 121
Query: 110 RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD 169
           +  E++ +    Q++  + Y HS GV HRDLKP NL ++ +  LK+ DFGL+        
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HA 176
Query: 170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI 229
           D  +     T  Y APEVI +  +     D+WS G I+  ++ G   F+  + +    +I
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
Query: 230 FK 231
            K
Sbjct: 237 LK 238

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V      +   +VA+K+L+       ++    K E+  ++  RH
Sbjct: 8   GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRH 63
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHS 132
            N++ ++   ++  ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 64  VNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NN 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
           K     ++D+++ G++LY LM G LP+   N
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 146/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMEPEV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     DLWS G I+  ++   + F   + +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           L + LG G F  VK  +  +   +VA+K++ +  + + +      +E  TM  + HP ++
Sbjct: 12  LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFF----QEAQTMMKLSHPKLV 66
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVC 136
           + Y V + +  IYIV E+++ G L + + S G+ L+  +  +    +   + +  S    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGY 193
           HRDL   N L+D +  +KVSDFG++   + V DD  + ++ GT     + APEV +   Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMT---RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKY 182
Query: 194 DGAKADLWSCGVILY-VLMAGYLPFE 218
             +K+D+W+ G++++ V   G +P++
Sbjct: 183 -SSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 148/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 18  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 76
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 77  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 131
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 132 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMVPFV 188
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++ G + F  ++ +  + K+        
Sbjct: 189 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 247
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 248 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 307
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 308 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 356

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 39/266 (14%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKIL--DKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           +G G F +V  A++   G+   IK +  + EK          +RE+  +  + H N++  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA---------EREVKALAKLDHVNIVHY 69
Query: 80  --------YE-------VMASKTK-IYIVLEFVTGGELFDKIASRGRLKEDE--ARKYFQ 121
                   Y+          SKTK ++I +EF   G L   I  R   K D+  A + F+
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+   VDY HS+ + +RDLKP N+ L     +K+ DFGL      +++DG    + GT  
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRXRSKGTLR 186
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           Y++PE I+++ Y G + DL++ G+IL  +L      FE S      +    +D      F
Sbjct: 187 YMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI-----F 240
Query: 241 STSAKKLISRILDPNPVTRITMAEVI 266
               K L+ ++L   P  R   +E++
Sbjct: 241 DKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + E+G  +G+G F +V   R    GE VAI+++D E+      +   KRE+   +  RH 
Sbjct: 34  QLEIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERD-NEDQLKAFKREVMAYRQTRHE 89
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSR 133
           NV+       S   + I+     G  L+  +  ++  L  ++ R+  Q+++  + Y H++
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGL---SALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           G+ H+DLK +N+  D NG + ++DFGL   S + Q  R +  L    G   ++APE+I  
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 191 KGYD--------GAKADLWSCGVILYVLMAGYLPFE 218
              D           +D+++ G I Y L A   PF+
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 146/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 10  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 68
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 69  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 123
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 180
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     DLWS G I+  ++   + F   + +  + K+        
Sbjct: 181 VTRYYRAPEVILGMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 240 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 299
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 300 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 348

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/355 (22%), Positives = 146/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 21  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 79
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 80  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 134
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 135 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYV 191
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     DLWS G I+  ++   + F   + +  + K+        
Sbjct: 192 VTRYYRAPEVILGMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 250
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 251 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 310
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 311 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 359

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 23/242 (9%)
Query: 4   RTGGASRTRVGK--YELGRT------LGEGSFAKVKFARNTETGENVAIKILDKEKVLKH 55
           R  G  +  V K  +EL +T      +G G++  V  A +  +GE VAIK L +      
Sbjct: 24  RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSE 82
Query: 56  KMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI------YIVLEFVTGGELFDKIASRG 109
               +  RE+  +K ++H NVI + +V    + +      Y+V+ F+       KI    
Sbjct: 83  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM- 139
Query: 110 RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD 169
              E++ +    Q++  + Y HS GV HRDLKP NL ++ +  LK+ DFGL+        
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HA 194
Query: 170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI 229
           D  +     T  Y APEVI +  +     D+WS G I+  ++ G   F+  + +    +I
Sbjct: 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254
Query: 230 FK 231
            K
Sbjct: 255 LK 256

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/355 (22%), Positives = 146/355 (41%), Gaps = 66/355 (18%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE+
Sbjct: 16  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYREL 74
Query: 66  STMKLIRHPNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
             MK + H N+I +  V   +        +YIV+E +        +    +++ D  R  
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMS 129
Query: 120 F--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++    
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMEPEV 186
Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI-------- 229
            T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+        
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 230 ----------------------------------FKADFKSPPWFSTSAKKLISRILDPN 255
                                             F AD +     ++ A+ L+S++L  +
Sbjct: 246 PAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
              RI++ E +++ +    Y P   E P   + D      + +D R   +E  +E
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPD------KQLDEREHTIEEWKE 354

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGSFAKVKF----ARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV        N  TGE VA+K L  +   +H+     K+EI  ++ + H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEH 77
Query: 76  VIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +I+       + +  + +V+E+V  G L D +  R  +   +   + QQ+   + Y HS+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNY-VAPE 186
              HR+L   N+LLD + ++K+ DFGL+ A+P+     +VR+DG       +P +  APE
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 190
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA 212
            +    +  A +D+WS GV LY L+ 
Sbjct: 191 CLKEYKFYYA-SDVWSFGVTLYELLT 215

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G    V  A + +  + VAIK  +L   + +KH +     REI  ++ + H N++
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-----REIKIIRRLDHDNIV 71
Query: 78  RMYEVMASK--------------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           +++E++                   +YIV E++        +  +G L E+ AR +  QL
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQL 129
Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLS-ALPQQVRDDGLLHTTCGTPN 181
           +  + Y HS  V HRDLKP NL ++    VLK+ DFGL+  +       G L     T  
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----------------------EE 219
           Y +P ++ +        D+W+ G I   ++ G   F                      + 
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 220 SNLMALYKKIFKADFKSP--------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
             L+++     + D   P        P  S  A   + +IL  +P+ R+T  E + + + 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G GSF +V   ++ +TG   A+K +  E V +         E+     +  P ++ +Y 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFR-------VEELVACAGLSSPRIVPLYG 117
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
            +     + I +E + GG L   I   G L ED A  Y  Q +  ++Y H+R + H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 142 PENLLLDANGV-LKVSDFGLSALPQQVRDDGLLHTTC------GTPNYVAPEVINNKGYD 194
            +N+LL ++G    + DFG +     ++ DGL  +        GT  ++APEV+  K  D
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 195 GAKADLWSCGVILYVLMAGYLPFEE 219
            AK D+WS   ++  ++ G  P+ +
Sbjct: 235 -AKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G GSF +V   ++ +TG   A+K +  E       + +++  ++   L   P ++ +Y 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------VFRVEELVACAGL-SSPRIVPLYG 133
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK 141
            +     + I +E + GG L   I   G L ED A  Y  Q +  ++Y H+R + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 142 PENLLLDANGV-LKVSDFGLSALPQQVRDDGLLHTTC------GTPNYVAPEVINNKGYD 194
            +N+LL ++G    + DFG +     ++ DGL  +        GT  ++APEV+  K  D
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 195 GAKADLWSCGVILYVLMAGYLPFEE 219
            AK D+WS   ++  ++ G  P+ +
Sbjct: 251 -AKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 14  GKYELGRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           G YEL   +G+G      V  AR   TGE V ++ ++ E    ++M+  ++ E+   KL 
Sbjct: 9   GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF 67
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDY 129
            HPN++       +  ++++V  F+  G   D I +     + E       Q ++ A+DY
Sbjct: 68  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 127
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDF--GLSALP----QQVRDDGLLHTTCGTPNYV 183
            H  G  HR +K  ++L+  +G + +S     LS +     Q+V  D   ++    P ++
Sbjct: 128 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WL 186
Query: 184 APEVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
           +PEV+  N +GYD AK+D++S G+    L  G++PF++
Sbjct: 187 SPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 223

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 15/218 (6%)
Query: 14  GKYELGRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           G YEL   +G+G      V  AR   TGE V ++ ++ E    ++M+  ++ E+   KL 
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF 83
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDY 129
            HPN++       +  ++++V  F+  G   D I +     + E       Q ++ A+DY
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDF--GLSALP----QQVRDDGLLHTTCGTPNYV 183
            H  G  HR +K  ++L+  +G + +S     LS +     Q+V  D   ++    P ++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-WL 202
Query: 184 APEVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
           +PEV+  N +GYD AK+D++S G+    L  G++PF++
Sbjct: 203 SPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 239

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--YFQQLINAVDYCH 131
           P+++++  V+ ++  ++I++E  T GEL   +  R +   D A    Y  QL  A+ Y  
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE 128
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVIN 189
           S+   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 190 NKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
            + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 186 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGSFAKVKF----ARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV        N  TGE VA+K L  +   +H+     K+EI  ++ + H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEH 77
Query: 76  VIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +I+       + +  + +V+E+V  G L D +  R  +   +   + QQ+   + Y H++
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNY-VAPE 186
              HR+L   N+LLD + ++K+ DFGL+ A+P+     +VR+DG       +P +  APE
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 190
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA 212
            +    +  A +D+WS GV LY L+ 
Sbjct: 191 CLKEYKFYYA-SDVWSFGVTLYELLT 215

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 24/263 (9%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +YE+ + +G+G F +V  A + +  ++VA+K++  EK   H+   Q   EI  ++ +R  
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRF-HR---QAAEEIRILEHLRKQ 153
Query: 75  ------NVIRMYEVMASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
                 NVI M E    +  I +  E ++    EL  K   +G       RK+   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
           +D  H   + H DLKPEN+LL   G   +KV DFG S    Q      ++    +  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYXXIQSRFYRA 267
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGY--LPFE-ESNLMALYKKIFKADFKSPPWFS 241
           PEVI    Y G   D+WS G IL  L+ GY  LP E E + +A   ++     +     S
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDAS 326
Query: 242 TSAKKLISRILDPNPVTRITMAE 264
             AK  +S    P   T  T+++
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSD 349

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I + K     M  + H  ++++
Sbjct: 14  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 68
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L++  GV+KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 183
Query: 196 AKADLWSCGVILYVLMA-GYLPFE 218
           +K+D+W+ GV+++ + + G +P+E
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G++  V+  R+  +G+ +A+K +      + +    +  +IS M+ +  P  +  Y 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPFTVTFYG 73
Query: 82  VMASKTKIYIVLEFVTGG--ELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSR-GVCH 137
            +  +  ++I +E +     + + ++  +G+ + ED   K    ++ A+++ HS+  V H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133
Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI----NNKGY 193
           RD+KP N+L++A G +K+ DFG+S     + DD       G   Y+APE I    N KGY
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEE--SNLMALYKKIFKADFKSPP-WFSTSAKKLISR 250
              K+D+WS G+ +  L     P++   +    L + + +   + P   FS       S+
Sbjct: 191 -SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 249
Query: 251 ILDPNPVTRITMAEVIENEWF 271
            L  N   R T  E++++ +F
Sbjct: 250 CLKKNSKERPTYPELMQHPFF 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I     E   M  + H  ++++
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEKLVQL 84
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L++  GV+KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 199
Query: 196 AKADLWSCGVILYVLMA-GYLPFE 218
           +K+D+W+ GV+++ + + G +P+E
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 98
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 99  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 215 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 242

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I + K     M  + H  ++++
Sbjct: 15  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 69
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L++  GV+KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 184
Query: 196 AKADLWSCGVILYVLMA-GYLPFE 218
           +K+D+W+ GV+++ + + G +P+E
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 187 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 192 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 187 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 111/225 (49%), Gaps = 19/225 (8%)
Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVK---FARNTETGENVAIKILDKEKVLKHKMI 58
           ++R     R R+   ELGR +GEG F  V    +         VAIK    +      + 
Sbjct: 381 STRDYEIQRERI---ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVR 435
Query: 59  GQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
            +  +E  TM+   HP+++++  V+ ++  ++I++E  T GEL   +  R +   D A  
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-KFSLDLASL 493
Query: 119 --YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
             Y  QL  A+ Y  S+   HRD+   N+L+ +N  +K+ DFGLS   + + D      +
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKAS 550
Query: 177 CGT--PNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
            G     ++APE IN + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 551 KGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 211

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I + K     M  + H  ++++
Sbjct: 21  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 75
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L++  GV+KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 190
Query: 196 AKADLWSCGVILYVLMA-GYLPFE 218
           +K+D+W+ GV+++ + + G +P+E
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I + K     M  + H  ++++
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 64
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L++  GV+KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 179
Query: 196 AKADLWSCGVILYVLMA-GYLPFE 218
           +K+D+W+ GV+++ + + G +P+E
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 73
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 74  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 190 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 10/209 (4%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 72
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           P+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y  S
Sbjct: 73  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINN 190
           +   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G     ++APE IN 
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 189 RRFTSA-SDVWMFGVCMWEILMHGVKPFQ 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           + ELGR +GEG F  V +    +     +A+ I   +      +  +  +E  TM+   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--YFQQLINAVDYCH 131
           P+++++  V+ ++  ++I++E  T GEL   +  R +   D A    Y  QL  A+ Y  
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE 128
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVIN 189
           S+   HRD+   N+L+ A   +K+ DFGLS   + + D      + G     ++APE IN
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 190 NKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
            + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 186 FRRFTSA-SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-P 74
           Y+L R LG G +++V  A N    E V +KIL   K        +IKREI  ++ +R  P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------NKIKREIKILENLRGGP 92
Query: 75  NVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           N+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYCH
Sbjct: 93  NIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 132 SRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           S G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVD 205
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPF 217
                   D+WS G +L  ++    PF
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 23/280 (8%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G ++  R  K+++   +G GSF  V    +TET   VA   L   K+ K +   + K E 
Sbjct: 20  GXSNDGRFLKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEA 76
Query: 66  STMKLIRHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
             +K ++HPN++R Y+   S  K    I +V E  T G L   +      K    R + +
Sbjct: 77  EXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCR 136
Query: 122 QLINAVDYCHSRG--VCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
           Q++  + + H+R   + HRDLK +N+ +    G +K+ D GL+ L +            G
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIG 192
Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSP 237
           TP + APE    K YD +  D+++ G           P+ E  N   +Y+++       P
Sbjct: 193 TPEFXAPEXYEEK-YDES-VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG--VKP 248
Query: 238 PWFSTSA----KKLISRILDPNPVTRITMAEVIENEWFKK 273
             F   A    K++I   +  N   R ++ +++ + +F++
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I     E   M  + H  ++++
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEKLVQL 84
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L++  GV+KVSDFGLS   + V DD    ++ G+     +  PEV+    +  
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEET-SSVGSKFPVRWSPPEVLMYSKF-S 199
Query: 196 AKADLWSCGVILYVLMA-GYLPFE 218
           +K+D+W+ GV+++ + + G +P+E
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE---ARKYFQQLINAVDYCH 131
           N +   +  + K  +YI ++      L D +  R  L++ E       F Q+  AV++ H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHT---------TCGTPN 181
           S+G+ HRDLKP N+    + V+KV DFGL +A+ Q   +  +L             GT  
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKL 241
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA-DFKSPPWF 240
           Y++PE I+   Y   K D++S G+IL+ L+  +     S  M   + I    + K P  F
Sbjct: 242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSF-----STQMERVRIITDVRNLKFPLLF 295
Query: 241 STSAKK---LISRILDPNPVTRITMAEVIENEWFK 272
           +    +   ++  +L P+P  R    ++IEN  F+
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 134 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 193
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 194 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 248
Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+ L  +  G  P 
Sbjct: 249 WSMGLSLVEMAVGRYPI 265

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + LG G F  VK+ +      +VAIK++ +  + + + I + K     M  + H  ++++
Sbjct: 15  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 69
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEVINNKGYDGA 196
           DL   N L++  GV+KVSDFGLS   + V DD    +        +  PEV+    +  +
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSRGSKFPVRWSPPEVLMYSKF-SS 185
Query: 197 KADLWSCGVILYVLMA-GYLPFE 218
           K+D+W+ GV+++ + + G +P+E
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 15  KYELGRTLGEGSFAKVK---FARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           + ELGR +GEG F  V    +         VAIK    +      +  +  +E  TM+  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF 448
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--YFQQLINAVDY 129
            HP+++++  V+ ++  ++I++E  T GEL   +  R +   D A    Y  QL  A+ Y
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAY 506
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--PNYVAPEV 187
             S+   HRD+   N+L+ A   +K+ DFGLS   + + D      + G     ++APE 
Sbjct: 507 LESKRFVHRDIAARNVLVSATDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPES 563
Query: 188 INNKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           IN + +  A +D+W  GV ++ +LM G  PF+
Sbjct: 564 INFRRFTSA-SDVWMFGVCMWEILMHGVKPFQ 594

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+ L  +  G  P 
Sbjct: 187 WSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+ L  +  G  P 
Sbjct: 187 WSMGLSLVEMAVGRYPI 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E    LG G+   V   ++  +G  +A K++  E  +K  +  QI RE+  +     P 
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 75
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG- 134
           ++  Y    S  +I I +E + GG L   +    R+ E+   K    ++  + Y   +  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRD+KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y+APE +    Y 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMAPERLQGTHYS 191
Query: 195 GAKADLWSCGVILYVLMAGYLPF 217
             ++D+WS G+ L  L  G  P 
Sbjct: 192 -VQSDIWSMGLSLVELAVGRYPI 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL--KHKMIGQIKREISTMKLIRHPN 75
           L   +G GSF  V   +      +VA+KIL   KV+    +     + E++ ++  RH N
Sbjct: 40  LSTRIGSGSFGTVYKGK---WHGDVAVKIL---KVVDPTPEQFQAFRNEVAVLRKTRHVN 93
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++     M +K  + IV ++  G  L+  +     + +  +     +Q    +DY H++ 
Sbjct: 94  ILLFMGYM-TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRD+K  N+ L     +K+ DFGL+ +  +      +    G+  ++APEVI  +  +
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 195 --GAKADLWSCGVILYVLMAGYLPFEESN 221
               ++D++S G++LY LM G LP+   N
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++EF+  G L + +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 196 KFSVA-SDVWSFGVVLYELFT 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 213
Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+ L  +  G  P 
Sbjct: 214 WSMGLSLVEMAVGRYPI 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+ L  +  G  P 
Sbjct: 187 WSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P ++  Y 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-VCHRDL 140
              S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL 200
           KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y   ++D+
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILYVLMAGYLPF 217
           WS G+ L  +  G  P 
Sbjct: 187 WSMGLSLVEMAVGRYPI 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---IKREISTMKLIRHPNVIR 78
           LG+G+F  V+  R    G+N    +  K+  L+H    Q    +REI  +K + H + I 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL-HSDFIV 71
Query: 79  MYEVMA---SKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRG 134
            Y  ++    + ++ +V+E++  G L D +   R RL       Y  Q+   ++Y  SR 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNKGY 193
             HRDL   N+L+++   +K++DFGL+ L    +D  ++     +P +  APE +++  +
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 194 DGAKADLWSCGVILYVLM 211
              ++D+WS GV+LY L 
Sbjct: 192 -SRQSDVWSFGVVLYELF 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D + +   R+   +  +Y  Q+   ++Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 196 KFSVA-SDVWSFGVVLYELFT 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 127/261 (48%), Gaps = 16/261 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G++  V+  R+  +G+ +A+K +      + +    +  +IS M+ +  P  +  Y 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPFTVTFYG 117
Query: 82  VMASKTKIYIVLEFVTGG--ELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSR-GVCH 137
            +  +  ++I +E +     + + ++  +G+ + ED   K    ++ A+++ HS+  V H
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 177
Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI----NNKGY 193
           RD+KP N+L++A G +K+ DFG+S     + D        G   Y+APE I    N KGY
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGY---LVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEE--SNLMALYKKIFKADFKSPP-WFSTSAKKLISR 250
              K+D+WS G+ +  L     P++   +    L + + +   + P   FS       S+
Sbjct: 235 -SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 293
Query: 251 ILDPNPVTRITMAEVIENEWF 271
            L  N   R T  E++++ +F
Sbjct: 294 CLKKNSKERPTYPELMQHPFF 314

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/321 (22%), Positives = 133/321 (41%), Gaps = 56/321 (17%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 15  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +    L   I  +  L  +    
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVI--QMELDHERMSY 130
Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
              Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++     
Sbjct: 131 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVV 187
Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--------- 229
           T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+         
Sbjct: 188 TRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 230 ---------------------------------FKADFKSPPWFSTSAKKLISRILDPNP 256
                                            F AD +     ++ A+ L+S++L  +P
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 257 VTRITMAEVIENEWFKKGYKP 277
             RI++ + +++ +    Y P
Sbjct: 307 AKRISVDDALQHPYINVWYDP 327

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 132/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
              +TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 76
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 197 KFSVA-SDVWSFGVVLYELFT 216

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 14/240 (5%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKRE 64
           A    V   ++   +G G F +V   R    G+    VAIK L      + +   +   E
Sbjct: 8   AKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSE 65
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL--FDKIASRGRLKEDEARKYFQQ 122
            S M    HPN+IR+  V+ +   + I+ EF+  G L  F ++ + G+    +     + 
Sbjct: 66  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRG 124
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-- 180
           + + + Y       HRDL   N+L+++N V KVSDFGLS   ++   D    ++ G    
Sbjct: 125 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 181 -NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
             + APE I  + +  A +D WS G++++ +M+ G  P+ + +   +   I + D++ PP
Sbjct: 185 IRWTAPEAIAFRKFTSA-SDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI-EQDYRLPP 242

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 103
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 224 KFSVA-SDVWSFGVVLYELFT 243

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 193 KFSVA-SDVWSFGVVLYELFT 212

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 5   TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE 64
            G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  RE
Sbjct: 15  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE 73
Query: 65  ISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
           +  MK + H N+I +  V   +        +Y+V+E +        +    +++ D  R 
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERM 128
Query: 119 YF--QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
            +   Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++   
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPY 185
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVIL 207
             T  Y APEVI   GY     D+WS G I+
Sbjct: 186 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIM 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 71
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 192 KFSVA-SDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 70
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 191 KFSVA-SDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 79
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 200 KFSVA-SDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 193 KFSVA-SDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 77
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 198 KFSVA-SDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 78
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 199 KFSVA-SDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 196 KFSVA-SDVWSFGVVLYELFT 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 90
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 211 KFSVA-SDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 90
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 211 KFSVA-SDVWSFGVVLYELFT 230

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 115/253 (45%), Gaps = 22/253 (8%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKIL------DKEKVLKHKMIGQIKREISTMKLIRHPN 75
           LG GS+ +V   R+ E G   A+K         K++  K   +G      S  K+ +HP 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG------SHEKVGQHPC 118
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRG 134
            +R+ +       +Y+  E + G  L     + G  L E +   Y +  + A+ + HS+G
Sbjct: 119 CVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + H D+KP N+ L   G  K+ DFGL     ++   G      G P Y+APE++  +G  
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL--QGSY 232
Query: 195 GAKADLWSCGV-ILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
           G  AD++S G+ IL V     LP        L +     +F +    S+  + ++  +L+
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSVLVMMLE 290
Query: 254 PNPVTRITMAEVI 266
           P+P  R T   ++
Sbjct: 291 PDPKLRATAEALL 303

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---IKREISTMKLIRHPNVIR 78
           LG+G+F  V+  R    G+N    +  K+  L+H    Q    +REI  +K + H + I 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL-HSDFIV 74
Query: 79  MYEVMA---SKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRG 134
            Y  ++    +  + +V+E++  G L D +   R RL       Y  Q+   ++Y  SR 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNKGY 193
             HRDL   N+L+++   +K++DFGL+ L    +D  ++     +P +  APE +++  +
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 194 DGAKADLWSCGVILYVLM 211
              ++D+WS GV+LY L 
Sbjct: 195 -SRQSDVWSFGVVLYELF 211

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 85
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 203
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 263 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 304

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 82
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 200
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 260 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 301

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 80
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNI--D 198
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 258 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 299

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 139
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 257
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V++++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---IKREISTMKLIRHPNVIR 78
           LG+G+F  V+  R    G+N    +  K+  L+H    Q    +REI  +K + H + I 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL-HSDFIV 75
Query: 79  MYEVMA---SKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRG 134
            Y  ++    +  + +V+E++  G L D +   R RL       Y  Q+   ++Y  SR 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNKGY 193
             HRDL   N+L+++   +K++DFGL+ L    +D  ++     +P +  APE +++  +
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 194 DGAKADLWSCGVILYVLM 211
              ++D+WS GV+LY L 
Sbjct: 196 S-RQSDVWSFGVVLYELF 212

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 38/294 (12%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKRE 64
           A    V   ++   +G G F +V   R    G+    VAIK L      + +   +   E
Sbjct: 10  AKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSE 67
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGEL--FDKIASRGRLKEDEARKYFQQ 122
            S M    HPN+IR+  V+ +   + I+ EF+  G L  F ++ + G+    +     + 
Sbjct: 68  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRG 126
Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-- 180
           + + + Y       HRDL   N+L+++N V KVSDFGLS   ++   D    ++ G    
Sbjct: 127 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 181 -NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW 239
             + APE I  + +  A +D WS G++++ +M+                     F   P+
Sbjct: 187 IRWTAPEAIAFRKFTSA-SDAWSYGIVMWEVMS---------------------FGERPY 224
Query: 240 FSTSAKKLISRI-----LDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLD 288
           +  S + +I+ I     L P P    ++ +++ + W K     P F Q    LD
Sbjct: 225 WDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 86  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 204 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ---IKREISTMKLIRHPNVIR 78
           LG+G+F  V+  R    G+N    +  K+  L+H    Q    +REI  +K + H + I 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 79  MYEVMA---SKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRG 134
            Y  ++    +  + +V+E++  G L D +   R RL       Y  Q+   ++Y  SR 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNKGY 193
             HRDL   N+L+++   +K++DFGL+ L    +D  ++     +P +  APE +++  +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 194 DGAKADLWSCGVILYVLM 211
              ++D+WS GV+LY L 
Sbjct: 208 S-RQSDVWSFGVVLYELF 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L + LG G F +V       + + VA+K L    +     +     E + MK ++H  +
Sbjct: 16  KLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFL----EEANLMKTLQHDKL 70
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRG 134
           +R+Y V+  +  IYI+ E++  G L D + S   G++   +   +  Q+   + Y   + 
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNK 191
             HRDL+  N+L+  + + K++DFGL+    +V +D       G      + APE IN  
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINF- 185
Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPF 217
           G    K+D+WS G++LY ++  G +P+
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HRDL   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 193 KFSVA-SDVWSFGVVLYELFT 212

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 115/231 (49%), Gaps = 30/231 (12%)
Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
           SR  + ++++ R  G+G+F  V+  +   TG +VAIK + ++   +++ + QI ++++  
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLA-- 74
Query: 69  KLIRHPNVIRMYEVMAS-----KTKIY--IVLEFVTGGELFDKI--ASRGRLKEDEA--- 116
            ++ HPN++++     +     +  IY  +V+E+V      D +    R   +   A   
Sbjct: 75  -VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPP 128
Query: 117 ---RKYFQQLINAVDYCH--SRGVCHRDLKPENLLL-DANGVLKVSDFGLSALPQQVRDD 170
              + +  QLI ++   H  S  VCHRD+KP N+L+ +A+G LK+ DFG SA      + 
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEP 187
Query: 171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN 221
            + +    +  Y APE+I    +     D+WS G I   +M G   F   N
Sbjct: 188 NVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 198 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 44/278 (15%)
Query: 20  RTLGEGSFAKVKFARNTETGE-NVAIKILDKEKVLKHKMIGQIKR----EISTMKLIRHP 74
           R +G G F +V   R    G+ +VA+ I    K LK     + +R    E S M    HP
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAI----KTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHS 132
           NV+ +  V+     + IV+EF+  G L D    +  G+    +     + +   + Y   
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVIN 189
            G  HRDL   N+L+++N V KVSDFGLS + +   D   ++TT G      + APE I 
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED--DPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
            + +  A +D+WS G++++ +M+                     +   P++  S + +I 
Sbjct: 222 YRKFTSA-SDVWSYGIVMWEVMS---------------------YGERPYWDMSNQDVIK 259
Query: 250 RILD----PNPV-TRITMAEVIENEWFKKGYKPPSFEQ 282
            I +    P P+     + +++ + W K+  + P FEQ
Sbjct: 260 AIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQ 297

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     + +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EEDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++E+ + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G G F  V         + VAIK + +  + +   I     E   M  + HP ++++
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI----EEAEVMMKLSHPKLVQL 67
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I +V EF+  G L D +   RG    +        +   + Y     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSST-GTKFPVKWASPEVFSFSRYS- 182
Query: 196 AKADLWSCGVILY-VLMAGYLPFE 218
           +K+D+WS GV+++ V   G +P+E
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V  A  N  T   VA+K +    +     +     E + MK ++H  
Sbjct: 18  KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDK 71
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--------YFQQLINAV 127
           +++++ V+ +K  IYI+ EF+  G L D       LK DE  K        +  Q+   +
Sbjct: 72  LVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGM 124
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            +   R   HRDL+  N+L+ A+ V K++DFGL+    +V +D       G      + A
Sbjct: 125 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTA 180
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           PE IN   +   K+D+WS G++L  ++  G +P+
Sbjct: 181 PEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPY 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L + LG G F +V       + + VA+K L    +     +     E + MK ++H  +
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFL----EEANLMKTLQHDKL 69
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRG 134
           +R+Y V+  +  IYI+ EF+  G L D + S   G++   +   +  Q+   + Y   + 
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNK 191
             HRDL+  N+L+  + + K++DFGL+    +V +D       G      + APE IN  
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINF- 184
Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPF 217
           G    K+++WS G++LY ++  G +P+
Sbjct: 185 GCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 110/245 (44%), Gaps = 52/245 (21%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           T   KY LG+TLG GSF  V    + E+G+  A+K + ++   K+       RE+  MK+
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-------RELDIMKV 56
Query: 71  IRHPNVIRMYE-------------------------------------VMASKTK-IYIV 92
           + H N+I++ +                                     V  S+ K + ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 93  LEFV--TGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA 149
           +E+V  T  ++       GR +  +    Y  QL  AV + HS G+CHRD+KP+NLL+++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 150 -NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
            +  LK+ DFG +   + +  +  +   C    Y APE++          DLWS G +  
Sbjct: 177 KDNTLKLCDFGSAK--KLIPSEPSVAXICSR-FYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 209 VLMAG 213
            L+ G
Sbjct: 234 ELILG 238

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 86  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 204 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V  A  N  T   VA+K +    +     +     E + MK ++H  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDK 244
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--------YFQQLINAV 127
           +++++ V+ +K  IYI+ EF+  G L D       LK DE  K        +  Q+   +
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            +   R   HRDL+  N+L+ A+ V K++DFGL+    +V +D       G      + A
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTA 353
Query: 185 PEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           PE IN   +   K+D+WS G++L  ++  G +P+
Sbjct: 354 PEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPY 386

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 124/266 (46%), Gaps = 23/266 (8%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G G+  +V   R  +TG  +A+K + +    +      +  ++  +K    P +++ + 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFG 91
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSR-GVCHR 138
              + T ++I +E +  G   +K+  R  G + E    K    ++ A+ Y   + GV HR
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN-----NKGY 193
           D+KP N+LLD  G +K+ DFG+S    ++ DD     + G   Y+APE I+        Y
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW------FSTSAKKL 247
           D  +AD+WS G+ L  L  G  P++  N    ++ + K   + PP       FS   +  
Sbjct: 207 D-IRADVWSLGISLVELATGQFPYK--NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 248 ISRILDPNPVTRITMAEVIENEWFKK 273
           +   L  +   R    +++E+ + K+
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKR 289

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 80  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 198 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G G F  V         + VAIK + +  + +   I     E   M  + HP ++++
Sbjct: 16  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI----EEAEVMMKLSHPKLVQL 70
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I +V EF+  G L D +   RG    +        +   + Y     V HR
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSST-GTKFPVKWASPEVFSFSRYS- 185
Query: 196 AKADLWSCGVILY-VLMAGYLPFE 218
           +K+D+WS GV+++ V   G +P+E
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYE 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 22  LGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           LG+GSF  V+    +  +G+  +VA+K L  + + + + +    RE++ M  + H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  MYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           +Y V+ +   + +V E    G L D++   +G        +Y  Q+   + Y  S+   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKPENLLLDANGVLKVSDFGL-SALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDG 195
           RDL   NLLL    ++K+ DFGL  ALPQ   D  ++      P  + APE +  + +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 AKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSP 237
           A +D W  GV L+ +   G  P+   N   +  KI K   + P
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G G F  V         + VAIK + +  + +   I     E   M  + HP ++++
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI----EEAEVMMKLSHPKLVQL 67
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I +V EF+  G L D +   RG    +        +   + Y     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSST-GTKFPVKWASPEVFSFSRYS- 182
Query: 196 AKADLWSCGVILY-VLMAGYLPFE 218
           +K+D+WS GV+++ V   G +P+E
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 89
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DXXK 207
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 267 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G G F  V         + VAIK + +  + +   I     E   M  + HP ++++
Sbjct: 11  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI----EEAEVMMKLSHPKLVQL 65
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I +V EF+  G L D +   RG    +        +   + Y     V HR
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSST-GTKFPVKWASPEVFSFSRY-S 180
Query: 196 AKADLWSCGVILY-VLMAGYLPFE 218
           +K+D+WS GV+++ V   G +P+E
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYE 204

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 77
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 189
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 190 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 242

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 20  RTLGEGSFAKVKF----ARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV        N  TGE VA+K L KE        G  +REI  ++ + H +
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KEGCGPQLRSG-WQREIEILRTLYHEH 72
Query: 76  VIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +++       + +  + +V+E+V  G L D +  R  +   +   + QQ+   + Y H++
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNY-VAPE 186
              HR L   N+LLD + ++K+ DFGL+ A+P+     +VR+DG       +P +  APE
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 185
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA 212
            +    +  A +D+WS GV LY L+ 
Sbjct: 186 CLKECKFYYA-SDVWSFGVTLYELLT 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G G F  V         + VAIK + +  + +   I     E   M  + HP ++++
Sbjct: 33  QEIGSGQFGLVHLGYWLNK-DKVAIKTIKEGSMSEDDFI----EEAEVMMKLSHPKLVQL 87
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I +V EF+  G L D +   RG    +        +   + Y     V HR
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSST-GTKFPVKWASPEVFSFSRYS- 202
Query: 196 AKADLWSCGVILY-VLMAGYLPFE 218
           +K+D+WS GV+++ V   G +P+E
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYE 226

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 20  RTLGEGSFAKVKF----ARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           R LGEG F KV        N  TGE VA+K L KE        G  +REI  ++ + H +
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KEGCGPQLRSG-WQREIEILRTLYHEH 71
Query: 76  VIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +++       + +  + +V+E+V  G L D +  R  +   +   + QQ+   + Y H++
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNY-VAPE 186
              HR L   N+LLD + ++K+ DFGL+ A+P+     +VR+DG       +P +  APE
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 184
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA 212
            +    +  A +D+WS GV LY L+ 
Sbjct: 185 CLKECKFYYA-SDVWSFGVTLYELLT 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++ + + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 94
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 149 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 206
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 207 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 259

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 24/245 (9%)
Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKRE 64
           A    +   ++ + +G G F +V        G+    VAIK L      K +       E
Sbjct: 27  AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSE 84
Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
            S M    HPNVI +  V+   T + I+ EF+  G L         L++++ +    QL+
Sbjct: 85  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLV 138
Query: 125 N-------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
                    + Y       HRDL   N+L+++N V KVSDFGLS   +    D    +  
Sbjct: 139 GMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 198
Query: 178 GTP---NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD 233
           G      + APE I  + +  A +D+WS G++++ +M+ G  P+ +     +   I + D
Sbjct: 199 GGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQD 256
Query: 234 FKSPP 238
           ++ PP
Sbjct: 257 YRLPP 261

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 30/221 (13%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKIL-------DKEKVLKHKMIGQIKREISTMK 69
           E  + +G+G F  V   R  +    VAIK L       + E + K +   + +RE+  M 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ---EFQREVFIMS 78
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVD 128
            + HPN++++Y +M +  +  +V+EFV  G+L+ ++  +   +K     +    +   ++
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 129 YCHSRG--VCHRDLKPENLL---LDANGVL--KVSDFGLSALPQQVRD-DGLLHTTCGTP 180
           Y  ++   + HRDL+  N+    LD N  +  KV+DFGLS   Q V    GLL    G  
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLL----GNF 190
Query: 181 NYVAPEVIN--NKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
            ++APE I    + Y   KAD +S  +ILY ++ G  PF+E
Sbjct: 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 81
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 82  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 199
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 258
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 259 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 297

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 104
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 159 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 216
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 217 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 269

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 89
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG----------------RLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 207
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 267 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 89
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 207
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 267 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 78
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 196
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 255
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 256 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 294

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           + +G G F  V         + VAIK + +  + +   I     E   M  + HP ++++
Sbjct: 14  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFI----EEAEVMMKLSHPKLVQL 68
Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
           Y V   +  I +V EF+  G L D +   RG    +        +   + Y     V HR
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVINNKGYDG 195
           DL   N L+  N V+KVSDFG++     V DD    +T GT     + +PEV +   Y  
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSST-GTKFPVKWASPEVFSFSRYS- 183
Query: 196 AKADLWSCGVILY-VLMAGYLPFE 218
           +K+D+WS GV+++ V   G +P+E
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYE 207

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 82
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 83  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 200
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 259
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 260 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 298

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 89
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 207
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 267 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 305

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 74
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 192
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           K  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 93
Query: 68  MKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-----------GRLKEDE 115
           MK+I +H N+I +         +Y+++ + + G L + + +R            R+ E++
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 116 AR-----KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
                      QL   ++Y  S+   HRDL   N+L+  N V+K++DFGL+     +  D
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--D 211
Query: 171 GLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYK 227
               TT G     ++APE + ++ Y   ++D+WS GV+++ +   G  P+    +  L+K
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 228 KIFKADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
            + +      P   T+   ++ R      P  R T  +++E+
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 18  LGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMKL 70
           LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  MK+
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 130
Query: 71  I-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----------------GRLKE 113
           I +H N+I +         +Y+++E+ + G L + + +R                 +L  
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +  D   
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYK 248
Query: 174 HTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIF 230
            TT G     ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K + 
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307
Query: 231 KADFKSPPWFSTSAKKLISR-ILDPNPVTRITMAEVIEN 268
           +      P   T+   ++ R      P  R T  +++E+
Sbjct: 308 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 31/269 (11%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG--QIKREISTMKLIR 72
            Y   + LGEG F+ V        G   A+K     ++L H+     + +RE    +L  
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALK-----RILCHEQQDREEAQREADMHRLFN 84
Query: 73  HPNVIRMYEVM----ASKTKIYIVLEFVTGGELFDKIA---SRGR-LKEDEARKYFQQLI 124
           HPN++R+         +K + +++L F   G L+++I     +G  L ED+       + 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG--------LSALPQQVRDDGLLHTT 176
             ++  H++G  HRDLKP N+LL   G   + D G        +    Q +         
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 177 CGTPNYVAPEVINNKGYD--GAKADLWSCGVILYVLMAGYLP----FEESNLMALYKKIF 230
           C T +Y APE+ + + +     + D+WS G +LY +M G  P    F++ + +AL  +  
Sbjct: 205 C-TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-N 262
Query: 231 KADFKSPPWFSTSAKKLISRILDPNPVTR 259
           +      P  S++  +L++ ++  +P  R
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIRH 73
           Y +   +G GS+  V  A +  T +NVAIK +++  E ++  K   +I REI+ +  ++ 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLKS 84
Query: 74  PNVIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
             +IR+Y+++         ++YIVLE +   +L     +   L E+  +     L+   +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL---------------- 172
           + H  G+ HRDLKP N LL+ +  +KV DFGL+      +D  +                
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 173 ----LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM 211
               L +   T  Y APE+I  +       D+WS G I   L+
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 20  RTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + LG+G+F  V+  R       TGE VA+K L        + +   +REI  +K ++H N
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 73
Query: 76  VIRMYEVM--ASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHS 132
           +++   V   A +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y  +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY-VAPEVINNK 191
           +   HR+L   N+L++    +K+ DFGL+ +  Q ++   +     +P +  APE +   
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 192 GYDGAKADLWSCGVILYVLMA 212
            +  A +D+WS GV+LY L  
Sbjct: 194 KFSVA-SDVWSFGVVLYELFT 213

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 7   GASRTR---VGKYELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQ 60
           G S TR     +  + + +G G   +V + R    G+    VAIK L      + +    
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--D 96
Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
              E S M    HPN+IR+  V+       IV E++  G L D       L+  + +   
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTF-----LRTHDGQFTI 150
Query: 121 QQLIN-------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            QL+         + Y    G  HRDL   N+L+D+N V KVSDFGLS + +   D    
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 174 HTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
            T    P  + APE I  + +  A +D+WS GV+++ VL  G  P+
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPY 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 7   GASRTR---VGKYELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQ 60
           G S TR     +  + + +G G   +V + R    G+    VAIK L      + +    
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--D 96
Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
              E S M    HPN+IR+  V+       IV E++  G L D       L+  + +   
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTF-----LRTHDGQFTI 150
Query: 121 QQLIN-------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
            QL+         + Y    G  HRDL   N+L+D+N V KVSDFGLS + +   D    
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 174 HTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
            T    P  + APE I  + +  A +D+WS GV+++ VL  G  P+
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPY 255

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 19  GRTLGEGSFAKV--KFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPN 75
           G  +GEG F  V   +  NT     VA+K L     +   ++  Q  +EI  M   +H N
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHS 132
           ++ +    +    + +V  ++  G L D+++       L      K  Q   N +++ H 
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
               HRD+K  N+LLD     K+SDFGL+   ++     +     GT  Y+APE +  +G
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RG 209
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
               K+D++S GV+L  ++ G    +E
Sbjct: 210 EITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 19  GRTLGEGSFAKV--KFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPN 75
           G  +GEG F  V   +  NT     VA+K L     +   ++  Q  +EI  M   +H N
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHS 132
           ++ +    +    + +V  ++  G L D+++       L      K  Q   N +++ H 
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
               HRD+K  N+LLD     K+SDFGL+   ++     +     GT  Y+APE +  +G
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RG 209
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
               K+D++S GV+L  ++ G    +E
Sbjct: 210 EITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 35/211 (16%)
Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V  A  N  T   VA+K +    +     +     E + MK ++H  
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDK 238
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK--------YFQQLINAV 127
           +++++ V+ +K  IYI+ EF+  G L D       LK DE  K        +  Q+   +
Sbjct: 239 LVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGM 291
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
            +   R   HRDL+  N+L+ A+ V K++DFGL+ +  +               + APE 
Sbjct: 292 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEA 340
Query: 188 INNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           IN   +   K+D+WS G++L  ++  G +P+
Sbjct: 341 INFGSFT-IKSDVWSFGILLMEIVTYGRIPY 370

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 19  GRTLGEGSFAKV--KFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPN 75
           G  +GEG F  V   +  NT     VA+K L     +   ++  Q  +EI  M   +H N
Sbjct: 30  GNKMGEGGFGVVYKGYVNNT----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 85
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHS 132
           ++ +    +    + +V  ++  G L D+++       L      K  Q   N +++ H 
Sbjct: 86  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
               HRD+K  N+LLD     K+SDFGL+   ++     +     GT  Y+APE +  +G
Sbjct: 146 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RG 203
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
               K+D++S GV+L  ++ G    +E
Sbjct: 204 EITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGL+ + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 112/235 (47%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E +  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 112/235 (47%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 77
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E +  G L         L++ +A+    QL+       + +
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 189
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 190 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 242

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E++  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGL  + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKIL-------DKEKVLKHKMIGQIKREISTMK 69
           E  + +G+G F  V   R  +    VAIK L       + E + K +   + +RE+  M 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ---EFQREVFIMS 78
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVD 128
            + HPN++++Y +M +  +  +V+EFV  G+L+ ++  +   +K     +    +   ++
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 129 YCHSRG--VCHRDLKPENLL---LDANGVL--KVSDFGLSALPQQVRD-DGLLHTTCGTP 180
           Y  ++   + HRDL+  N+    LD N  +  KV+DFG S   Q V    GLL    G  
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLL----GNF 190
Query: 181 NYVAPEVIN--NKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
            ++APE I    + Y   KAD +S  +ILY ++ G  PF+E
Sbjct: 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 14  GKYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            +YE+  TLGEG+F KV +   +   G +VA+KI+        +     + EI  ++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 73  --HPN----VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRL--KEDEARKYFQQLI 124
              PN     ++M E       I IV E + G   +D I   G L  + D  RK   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDA-------------------NGVLKVSDFGLSALPQ 165
            +V++ HS  + H DLKPEN+L                      N  +KV DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
              DD    T   T +Y APEVI   G+     D+WS G IL     G+  F
Sbjct: 187 ---DDEHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 112/235 (47%), Gaps = 26/235 (11%)
Query: 18  LGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R    ++   +VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAV 127
           N+IR+  V+     + IV E +  G L         L++ +A+    QL+       + +
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVA 184
            Y    G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + +
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTS 218
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
           PE I  + +  A +D+WS G++L+ +M+ G  P+ E +   + K + +  ++ PP
Sbjct: 219 PEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKIL-------DKEKVLKHKMIGQIKREISTMK 69
           E  + +G+G F  V   R  +    VAIK L       + E + K +   + +RE+  M 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ---EFQREVFIMS 78
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVD 128
            + HPN++++Y +M +  +  +V+EFV  G+L+ ++  +   +K     +    +   ++
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 129 YCHSRG--VCHRDLKPENLLL-----DANGVLKVSDFGLSALPQQVRD-DGLLHTTCGTP 180
           Y  ++   + HRDL+  N+ L     +A    KV+DF LS   Q V    GLL    G  
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLL----GNF 190
Query: 181 NYVAPEVIN--NKGYDGAKADLWSCGVILYVLMAGYLPFEE 219
            ++APE I    + Y   KAD +S  +ILY ++ G  PF+E
Sbjct: 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           R +G G F +V   R    G+    VAIK L      K +       E S M    HPN+
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNI 85
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-------AVDY 129
           I +  V+     + IV E++  G L D       LK+++ +    QL+         + Y
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSL-DTF-----LKKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
               G  HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + APE
Sbjct: 140 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPE 197
Query: 187 VINNKGYDGAKADLWSCGVILY-VLMAGYLPFEE 219
            I  + +  A +D+WS G++++ V+  G  P+ E
Sbjct: 198 AIAFRKFTSA-SDVWSYGIVMWEVVSYGERPYWE 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + +G G F +V        G+    VAIK L      K +       E S M    HPNV
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNV 70
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-------AVDY 129
           I +  V+   T + I+ EF+  G L         L++++ +    QL+         + Y
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSL------DSFLRQNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
                  HR L   N+L+++N V KVSDFGLS   +    D    +  G      + APE
Sbjct: 125 LADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
            I  + +  A +D+WS G++++ +M+ G  P+ +     +   I + D++ PP
Sbjct: 185 AIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPP 235

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 118/261 (45%), Gaps = 16/261 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G++  V+  R+  +G+  A+K + +  V   +    +     + + +  P  +  Y 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 82  VMASKTKIYIVLEF--VTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSR-GVCH 137
            +  +  ++I  E    +  + + ++  +G+ + ED   K    ++ A+++ HS+  V H
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 160
Query: 138 RDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI----NNKGY 193
           RD+KP N+L++A G +K  DFG+S     + DD       G   Y APE I    N KGY
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGISGY---LVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 194 DGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLISR 250
              K+D+WS G+    L     P++         K++ +      P   FS       S+
Sbjct: 218 -SVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 276
Query: 251 ILDPNPVTRITMAEVIENEWF 271
            L  N   R T  E+ ++ +F
Sbjct: 277 CLKKNSKERPTYPELXQHPFF 297

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + +G G F +V   R    G+    VAIK L      K +       E S M    HPN+
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNI 92
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAVDY 129
           I +  V+     + I+ E++  G L         L++++ R    QL+       + + Y
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
                  HRDL   N+L+++N V KVSDFG+S + +   D    +TT G      + APE
Sbjct: 147 LSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPE 204
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
            I  + +  A +D+WS G++++ +M+ G  P+ + +   + K I +  ++ PP
Sbjct: 205 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPP 255

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 20  RTLGEGSFAKV-KFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + +G G F +V K    T +G+    VAIK L      K ++      E   M    H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHN 107
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-------AVD 128
           +IR+  V++    + I+ E++  G L DK      L+E +      QL+         + 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAP 185
           Y  +    HRDL   N+L+++N V KVSDFGLS + +   D    +TT G      + AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAP 219
Query: 186 EVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEE 219
           E I+ + +  A +D+WS G++++ V+  G  P+ E
Sbjct: 220 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 114/240 (47%), Gaps = 22/240 (9%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVIRMY 80
           +G G++  V    +  +G+ +A+K +     +  K   Q+  ++   M+    P +++ Y
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 81  EVMASKTKIYIVLEFVTGGELFDKIASR------GRLKEDEARKYFQQLINAVDYCHSR- 133
             +  +   +I +E ++    FDK            + E+   K     + A+++     
Sbjct: 88  GALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN---- 189
            + HRD+KP N+LLD +G +K+ DFG+S    Q+ D        G   Y+APE I+    
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
            +GYD  ++D+WS G+ LY L  G  P+ + N  +++ ++ +     PP  S S ++  S
Sbjct: 203 RQGYD-VRSDVWSLGITLYELATGRFPYPKWN--SVFDQLTQVVKGDPPQLSNSEEREFS 259

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIRH 73
           YE+   +G GS+  V  A +    +NVAIK +++  E ++  K   +I REI+ +  ++ 
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCK---RILREITILNRLKS 86
Query: 74  PNVIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
             +IR+++++  +      ++YIVLE +   +L     +   L E   +     L+    
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEK 145
Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL---------------- 172
           + H  G+ HRDLKP N LL+ +  +K+ DFGL+      +D  +                
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 173 -------LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLM 211
                  L +   T  Y APE+I  +       D+WS G I   L+
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + +G G F +V   R    G+    VAIK L      K +       E S M    HPN+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNI 71
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAVDY 129
           I +  V+     + I+ E++  G L         L++++ R    QL+       + + Y
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
                  HRDL   N+L+++N V KVSDFG+S + +   D    +TT G      + APE
Sbjct: 126 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPE 183
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
            I  + +  A +D+WS G++++ +M+ G  P+ + +   + K I +  ++ PP
Sbjct: 184 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPP 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 38/230 (16%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIR 72
           +YE+   +G GS+  V  A +      VAIK + +  E ++  K   +I REI+ +  + 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK---RILREIAILNRLN 110
Query: 73  HPNVIRMYEVMASKT-----KIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINA 126
           H +V+++ +++  K      ++Y+VLE       F K+  +   L E   +     L+  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL-----------SALPQQVRDDGL-LH 174
           V Y HS G+ HRDLKP N L++ +  +KV DFGL           S LP   R+D + L 
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 175 TTCGTPN-------------YVAPEVINNKGYDGAKADLWSCGVILYVLM 211
           T   T N             Y APE+I  +       D+WS G I   L+
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 26/233 (11%)
Query: 20  RTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           + +G G F +V   R    G+    VAIK L      K +       E S M    HPN+
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNI 77
Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI-------NAVDY 129
           I +  V+     + I+ E++  G L         L++++ R    QL+       + + Y
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPE 186
                  HRDL   N+L+++N V KVSDFG+S + +   D    +TT G      + APE
Sbjct: 132 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPE 189
Query: 187 VINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPP 238
            I  + +  A +D+WS G++++ +M+ G  P+ + +   + K I +  ++ PP
Sbjct: 190 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EEGYRLPP 240

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 14  GKYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            +YE+  TLGEG+F KV +   +   G +VA+KI+        +     + EI  ++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 73  --HPN----VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRL--KEDEARKYFQQLI 124
              PN     ++M E       I IV E + G   +D I   G L  + D  RK   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 NAVDYCHSRGVCHRDLKPENLLLDA-------------------NGVLKVSDFGLSALPQ 165
            +V++ HS  + H DLKPEN+L                      N  +KV DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF 217
              DD    T     +Y APEVI   G+     D+WS G IL     G+  F
Sbjct: 187 ---DDEHHSTLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF 234

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 125/261 (47%), Gaps = 23/261 (8%)
Query: 18  LGRTLGEGSFAKV-KFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           L R LGEG F +V +       GE  NVA+K   K+  L +K   +   E   MK + HP
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 85
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSR 133
           +++++  ++  +   +I++E    GEL   +  ++  LK      Y  Q+  A+ Y  S 
Sbjct: 86  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRD+   N+L+ +   +K+ DFGLS   +   +D    +    P  +++PE IN + 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKWMSPESINFRR 202
Query: 193 YDGAKADLWSCGVILY-VLMAGYLPF---EESNLMALYKK---IFKADFKSPPWFSTSAK 245
           +  A +D+W   V ++ +L  G  PF   E  +++ + +K   + K D   PP   T   
Sbjct: 203 FTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL-CPPVLYT--- 257
Query: 246 KLISRILDPNPVTRITMAEVI 266
            L++R  D +P  R    E++
Sbjct: 258 -LMTRCWDYDPSDRPRFTELV 277

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 125/261 (47%), Gaps = 23/261 (8%)
Query: 18  LGRTLGEGSFAKV-KFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           L R LGEG F +V +       GE  NVA+K   K+  L +K   +   E   MK + HP
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 73
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSR 133
           +++++  ++  +   +I++E    GEL   +  ++  LK      Y  Q+  A+ Y  S 
Sbjct: 74  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRD+   N+L+ +   +K+ DFGLS   +   +D    +    P  +++PE IN + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKWMSPESINFRR 190
Query: 193 YDGAKADLWSCGVILY-VLMAGYLPF---EESNLMALYKK---IFKADFKSPPWFSTSAK 245
           +  A +D+W   V ++ +L  G  PF   E  +++ + +K   + K D   PP   T   
Sbjct: 191 FTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL-CPPVLYT--- 245
Query: 246 KLISRILDPNPVTRITMAEVI 266
            L++R  D +P  R    E++
Sbjct: 246 -LMTRCWDYDPSDRPRFTELV 265

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RH 73
           +YE+   +G+GSF +V  A +    E VAIKI+  +K      + Q + E+  ++L+ +H
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKH 110
Query: 74  PNVIRMYEVMASKTKIY-----IVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
              ++ Y V   +  ++     +V E ++    +L      RG +  +  RK+ QQ+  A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTA 169
Query: 127 VDYCHS--RGVCHRDLKPENLLL--DANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPN 181
           + +  +    + H DLKPEN+LL       +K+ DFG S  L Q++      +    +  
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI------YQXIQSRF 223
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           Y +PEV+    YD A  D+WS G IL  +  G   F  +N +    KI +     PP   
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPP--- 278
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEW-------FKKGYKPP 278
                  + ILD  P  R    ++ +  W        K+ YKPP
Sbjct: 279 -------AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 125/261 (47%), Gaps = 23/261 (8%)
Query: 18  LGRTLGEGSFAKV-KFARNTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           L R LGEG F +V +       GE  NVA+K   K+  L +K   +   E   MK + HP
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 69
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSR 133
           +++++  ++  +   +I++E    GEL   +  ++  LK      Y  Q+  A+ Y  S 
Sbjct: 70  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRD+   N+L+ +   +K+ DFGLS   +   +D    +    P  +++PE IN + 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKWMSPESINFRR 186
Query: 193 YDGAKADLWSCGVILY-VLMAGYLPF---EESNLMALYKK---IFKADFKSPPWFSTSAK 245
           +  A +D+W   V ++ +L  G  PF   E  +++ + +K   + K D   PP   T   
Sbjct: 187 FTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL-CPPVLYT--- 241
Query: 246 KLISRILDPNPVTRITMAEVI 266
            L++R  D +P  R    E++
Sbjct: 242 -LMTRCWDYDPSDRPRFTELV 261

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RH 73
           +YE+   +G+GSF +V  A +    E VAIKI+  +K      + Q + E+  ++L+ +H
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKH 91
Query: 74  PNVIRMYEVMASKTKIY-----IVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
              ++ Y V   +  ++     +V E ++    +L      RG +  +  RK+ QQ+  A
Sbjct: 92  DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTA 150
Query: 127 VDYCHS--RGVCHRDLKPENLLL--DANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPN 181
           + +  +    + H DLKPEN+LL       +K+ DFG S  L Q++      +    +  
Sbjct: 151 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI------YQXIQSRF 204
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           Y +PEV+    YD A  D+WS G IL  +  G   F  +N +    KI +     PP   
Sbjct: 205 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPP--- 259
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEW-------FKKGYKPP 278
                  + ILD  P  R    ++ +  W        K+ YKPP
Sbjct: 260 -------AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 296

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RH 73
           +YE+   +G+GSF +V  A +    E VAIKI+  +K      + Q + E+  ++L+ +H
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKH 110
Query: 74  PNVIRMYEVMASKTKIY-----IVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
              ++ Y V   +  ++     +V E ++    +L      RG +  +  RK+ QQ+  A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTA 169
Query: 127 VDYCHS--RGVCHRDLKPENLLL--DANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPN 181
           + +  +    + H DLKPEN+LL       +K+ DFG S  L Q++      +    +  
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRI------YQXIQSRF 223
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           Y +PEV+    YD A  D+WS G IL  +  G   F  +N +    KI +     PP   
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGIPP--- 278
Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEW-------FKKGYKPP 278
                  + ILD  P  R    ++ +  W        K+ YKPP
Sbjct: 279 -------AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/317 (24%), Positives = 138/317 (43%), Gaps = 48/317 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-NTETGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           ++ LGR LG+G F  V+ A+   E G    VA+K+L K  ++    I +  RE + MK  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 72  RHPNVIRMYEV-MASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
            HP+V ++  V + S+ K       ++L F+  G+L   + +  R+ E+      Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQTLVR 141
Query: 126 -------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
                   ++Y  SR   HRDL   N +L  +  + V+DFGLS   +++         C 
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS---RKIYSGDYYRQGCA 198
Query: 179 TP---NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD- 233
           +     ++A E + +  Y    +D+W+ GV ++ +M  G  P+       +Y  +   + 
Sbjct: 199 SKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257
Query: 234 FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDV--- 290
            K PP        L+ +    +P  R                  PSF    ++L+++   
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQR------------------PSFTCLRMELENILGH 299
Query: 291 DSIFNESMDSRNLVVER 307
            S+ + S D   + +ER
Sbjct: 300 LSVLSTSQDPLYINIER 316

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV+E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 30  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 83
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 84  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 199
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 200 SDVWSFGILLTEIVTHGRIPY 220

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 29  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 82
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 83  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 198
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 199 SDVWSFGILLTEIVTHGRIPY 219

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 27  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 80
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 196
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 197 SDVWSFGILLTEIVTHGRIPY 217

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 74
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 191 SDVWSFGILLTEIVTHGRIPY 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 74
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 191 SDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 23  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 76
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 77  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 192
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 193 SDVWSFGILLTEIVTHGRIPY 213

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 12/207 (5%)
Query: 19  GRTLGEGSFAKV--KFARNTETGENVAIKILDKE-KVLKHKMIGQIKREISTMKLIRHPN 75
           G   GEG F  V   +  NT     VA+K L     +   ++  Q  +EI      +H N
Sbjct: 27  GNKXGEGGFGVVYKGYVNNT----TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHEN 82
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHS 132
           ++ +    +    + +V  +   G L D+++       L      K  Q   N +++ H 
Sbjct: 83  LVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHE 142
Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
               HRD+K  N+LLD     K+SDFGL+   ++           GT  Y APE +  +G
Sbjct: 143 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RG 200
Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE 219
               K+D++S GV+L  ++ G    +E
Sbjct: 201 EITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 22  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 75
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 76  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIK 191
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 192 SDVWSFGILLTEIVTHGRIPY 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK IRH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKIRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV+E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 329
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 445
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 446 DVWSFGILLTELTTKGRVPY 465

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 26  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 79
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 80  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIK 195
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 196 SDVWSFGILLTEIVTHGRIPY 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 27  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 80
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIK 196
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 197 SDVWSFGILLTEIVTHGRIPY 217

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 246
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 362
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 363 DVWSFGILLTELTTKGRVPY 382

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 74
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 191 SDVWSFGILLTEIVTHGRIPY 211

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 246
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 362
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 363 DVWSFGILLTELTTKGRVPY 382

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 31  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 84
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 85  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIK 200
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 201 SDVWSFGILLTEIVTHGRIPY 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 77
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E++  G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 78  VV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED--NEWTARQGAKFPIKWTAPEAALY-GRFTIKS 193
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 194 DVWSFGILLTELTTKGRVPY 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 73
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 74  VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 189
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 190 DVWSFGILLTELTTKGRVPY 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 71
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 72  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 187
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 188 DVWSFGILLTELTTKGRVPY 207

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 16  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 69
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 70  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           DL+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIK 185
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 186 SDVWSFGILLTEIVTHGRIPY 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 69
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 70  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 185
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 186 DVWSFGILLTELTTKGRVPY 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV+E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 77
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E++  G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 78  VV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 193
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 194 DVWSFGILLTELTTKGRVPY 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 246
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 247 VV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 362
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 363 DVWSFGILLTELTTKGRVPY 382

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEAFL----QEAQVMKKLRHEKLVQLYA 247
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASR-GR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 248 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL  L +   ++         P  + APE     G    K+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIED--NEYTARQGAKFPIKWTAPEAA-LYGRFTIKS 363
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 364 DVWSFGILLTELTTKGRVPY 383

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L   N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 117/260 (45%), Gaps = 31/260 (11%)
Query: 14  GKYELGRTLGEGSFAKVKFA--RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           G+YE+   +  G    +  A  RN   G  V +K L      + + +   +R+   +  +
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQF--LAEV 136
Query: 72  RHPNVIRMYEVMASKTKI-----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
            HP++++++  +    +      YIV+E+V G  L  K +   +L   EA  Y  +++ A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPA 194
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + Y HS G+ + DLKPEN++L     LK+ D G  +   ++   G L+   GTP + APE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS---RINSFGYLY---GTPGFQAPE 247
Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFST--SA 244
           ++          D+++ G  L  L          +L     +      +  P   T  S 
Sbjct: 248 IVRTG--PTVATDIYTVGRTLAALTL--------DLPTRNGRYVDGLPEDDPVLKTYDSY 297
Query: 245 KKLISRILDPNPVTRITMAE 264
            +L+ R +DP+P  R T AE
Sbjct: 298 GRLLRRAIDPDPRQRFTTAE 317

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 80
Query: 82  VMASKTKIYIVLEFVTGGELFDKI-ASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  IYIV E+++ G L D +    G+ L+  +      Q+ + + Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALY-GRFTIKS 196
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 197 DVWSFGILLTELTTKGRVPY 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 22  LGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY 80
           LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  ++R+Y
Sbjct: 17  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLY 70
Query: 81  EVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
            V+ ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R   HR
Sbjct: 71  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAK 197
           +L+  N+L+      K++DFGL+ L +   ++         P  + APE I N G    K
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIK 186
Query: 198 ADLWSCGVILY-VLMAGYLPF 217
           +D+WS G++L  ++  G +P+
Sbjct: 187 SDVWSFGILLTEIVTHGRIPY 207

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 8/158 (5%)
Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQ 121
           E + MK ++H  ++R+Y V+ ++  IYI+ E++  G L D  K  S  +L  ++      
Sbjct: 58  EANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP- 180
           Q+   + +   R   HRDL+  N+L+      K++DFGL+ L +              P 
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA--REGAKFPI 174
Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
            + APE I N G    K+D+WS G++L  ++  G +P+
Sbjct: 175 KWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 39/232 (16%)
Query: 15  KYELGRTLGEGSFAKV-KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           +YE+  TLGEG+F +V +   +   G  VA+KI+  + V K+K   ++  EI+ ++ I  
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII--KNVEKYKEAARL--EINVLEKINE 89
Query: 74  PN------VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKE--DEARKYFQQLIN 125
            +       ++M++       + I  E + G   FD +     L     + R    QL  
Sbjct: 90  KDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 126 AVDYCHSRGVCHRDLKPENLLL---------------DANGV----LKVSDFGLSALPQQ 166
           AV + H   + H DLKPEN+L                D   V    ++V DFG +    +
Sbjct: 149 AVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHE 208
Query: 167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE 218
                   T   T +Y APEVI   G+     D+WS G I++    G+  F+
Sbjct: 209 HHS-----TIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQ 254

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG+G F +V       T   VAIK L    +     +    +E   MK +RH  ++++Y 
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 70
Query: 82  VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRD 139
           V+ S+  I IV E+++ G L D  K  +   L+  +      Q+ + + Y       HRD
Sbjct: 71  VV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGYDGAKA 198
           L+  N+L+  N V KV+DFGL+ L +   ++         P  + APE     G    K+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEAALY-GRFTIKS 186
Query: 199 DLWSCGVILYVLMA-GYLPF 217
           D+WS G++L  L   G +P+
Sbjct: 187 DVWSFGILLTELTTKGRVPY 206

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 21  TLGEGSFAKVKFARNTETG--ENVAIKILDKEKVLK--HK-MIGQIKREISTMKLIRHPN 75
            +GEG+F +V  AR  + G   + AIK + KE   K  H+   G+++      KL  HPN
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELE---VLCKLGHHPN 87
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF---------QQLIN- 125
           +I +      +  +Y+ +E+   G L D +     L+ D A             QQL++ 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 126 ------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
                  +DY   +   HRDL   N+L+  N V K++DFGLS   Q+V     +  T G 
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGR 202
Query: 180 --PNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFK 235
               ++A E +N   Y    +D+WS GV+L+ +++ G  P+       LY+K+ +    +
Sbjct: 203 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261
Query: 236 SPPWFSTSAKKLISRILDPNPVTRITMAEVI 266
            P         L+ +     P  R + A+++
Sbjct: 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 21  TLGEGSFAKVKFARNTETG--ENVAIKILDKEKVLK--HK-MIGQIKREISTMKLIRHPN 75
            +GEG+F +V  AR  + G   + AIK + KE   K  H+   G+++      KL  HPN
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELE---VLCKLGHHPN 77
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF---------QQLIN- 125
           +I +      +  +Y+ +E+   G L D +     L+ D A             QQL++ 
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 126 ------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
                  +DY   +   HRDL   N+L+  N V K++DFGLS   Q+V     +  T G 
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGR 192
Query: 180 --PNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFK 235
               ++A E +N   Y    +D+WS GV+L+ +++ G  P+       LY+K+ +    +
Sbjct: 193 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 251
Query: 236 SPPWFSTSAKKLISRILDPNPVTRITMAEVI 266
            P         L+ +     P  R + A+++
Sbjct: 252 KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 32/225 (14%)
Query: 12  RVG-KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           RVG K+ LGR +G GSF ++    N +T E VAIK+ + +   KH    Q+  E    ++
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHP---QLLYESKIYRI 58
Query: 71  IRH----PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           ++     PNV R + V      + + L   +  +LF+  + +  LK         Q+IN 
Sbjct: 59  LQGGTGIPNV-RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINR 115
Query: 127 VDYCHSRGVCHRDLKPENLLLD----ANGVLKVSDFGLSALPQQVRDDGLLH-------- 174
           V++ HS+   HRD+KP+N L+     AN V  + DFGL+   ++ RD             
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLA---KKYRDTSTHQHIPYRENK 171
Query: 175 TTCGTPNYVAPEVINNKGYDGAKA-DLWSCGVILYVLMAGYLPFE 218
              GT  Y +  V  + G + ++  DL S G +L   + G LP++
Sbjct: 172 NLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 115/265 (43%), Gaps = 38/265 (14%)
Query: 17  ELGRTLGEGSFAKVKFA-----RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           E G+ LG G+F KV  A       T     VA+K+L KEK    +    +       +L 
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLG 106
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK------------ 118
            H N++ +         IY++ E+   G+L + + S R +  EDE               
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 119 ----------YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR 168
                     +  Q+   +++   +   HRDL   N+L+    V+K+ DFGL+   + + 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA---RDIM 223
Query: 169 DDG--LLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMA 224
            D   ++      P  ++APE +  +G    K+D+WS G++L+ +   G  P+    + A
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 225 LYKKIFKADFK-SPPWFSTSAKKLI 248
            + K+ +  FK   P+++T    +I
Sbjct: 283 NFYKLIQNGFKMDQPFYATEEIYII 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G F KV   R  + G  VA+K L +E+    ++  Q + E+  + +  H N++R+  
Sbjct: 46  LGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRG 102
Query: 82  VMASKTKIYIVLEFVTGGELFDKI------------ASRGRLKEDEARKYFQQLINAVDY 129
              + T+  +V  ++  G +   +              R R+    AR     L    D+
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG----LAYLHDH 158
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           C  + + HRD+K  N+LLD      V DFGL+ L    +D  +     GT  ++APE ++
Sbjct: 159 CDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRGTIGHIAPEYLS 216
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNL 222
             G    K D++  GV+L  L+ G   F+ + L
Sbjct: 217 T-GKSSEKTDVFGYGVMLLELITGQRAFDLARL 248

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G G F KV +      G  VA+K    E     + I + + EI T+   RHP+++ +  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL------INAVDYCHSRGV 135
               + ++ ++ +++  G L  K    G      +  + Q+L         + Y H+R +
Sbjct: 103 FCDERNEMILIYKYMENGNL--KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+K  N+LLD N V K++DFG+S    ++    L     GT  Y+ PE    KG   
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF-IKGRLT 219
Query: 196 AKADLWSCGVILYVLMAG------YLPFEESNL 222
            K+D++S GV+L+ ++         LP E  NL
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G G F KV +      G  VA+K    E     + I + + EI T+   RHP+++ +  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 82  VMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL------INAVDYCHSRGV 135
               + ++ ++ +++  G L  K    G      +  + Q+L         + Y H+R +
Sbjct: 103 FCDERNEMILIYKYMENGNL--KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRD+K  N+LLD N V K++DFG+S    ++    L     GT  Y+ PE    KG   
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF-IKGRLT 219
Query: 196 AKADLWSCGVILYVLMAG------YLPFEESNL 222
            K+D++S GV+L+ ++         LP E  NL
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 21  TLGEGSFAKVKFARNTETG--ENVAIKILDKEKVLK--HK-MIGQIKREISTMKLIRHPN 75
            +GEG+F +V  AR  + G   + AIK + KE   K  H+   G+++      KL  HPN
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELE---VLCKLGHHPN 84
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF---------QQLIN- 125
           +I +      +  +Y+ +E+   G L D +     L+ D A             QQL++ 
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 126 ------AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
                  +DY   +   HR+L   N+L+  N V K++DFGLS   Q+V     +  T G 
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGR 199
Query: 180 --PNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFK 235
               ++A E +N   Y    +D+WS GV+L+ +++ G  P+       LY+K+ +    +
Sbjct: 200 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 258
Query: 236 SPPWFSTSAKKLISRILDPNPVTRITMAEVI 266
            P         L+ +     P  R + A+++
Sbjct: 259 KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI----STMKLIRHPN 75
           + LG G+F  V        GENV I +    KVL+     +  +EI      M  +  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPV--AIKVLRENTSPKANKEILDEAYVMAGVGSPY 80
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           V R+  +  + T + +V + +  G L D +  +RGRL   +   +  Q+   + Y     
Sbjct: 81  VSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNKG 192
           + HRDL   N+L+ +   +K++DFGL+ L     D+   H   G  P  ++A E I  + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILRRR 197
Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFE 218
           +   ++D+WS GV ++ LM  G  P++
Sbjct: 198 FT-HQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL----IRHPN 75
           + LG G F  V        GE++ I +  K  V++ K   Q  + ++   L    + H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++R+   +   + + +V +++  G L D +   RG L       +  Q+   + Y    G
Sbjct: 95  IVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
           + HR+L   N+LL +   ++V+DFG++  LP    D  LL++   TP  ++A E I+   
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHFGK 211
Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI--- 248
           Y   ++D+WS GV ++ LM  G  P+    L  +   + K +  + P   T    ++   
Sbjct: 212 YT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVK 270
Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSF 280
             ++D N   R T  E + NE+ +    PP +
Sbjct: 271 CWMIDEN--IRPTFKE-LANEFTRMARDPPRY 299

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL----IRHPN 75
           + LG G F  V        GE++ I +  K  V++ K   Q  + ++   L    + H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++R+   +   + + +V +++  G L D +   RG L       +  Q+   + Y    G
Sbjct: 77  IVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
           + HR+L   N+LL +   ++V+DFG++  LP    D  LL++   TP  ++A E I+   
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHFGK 193
Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI--- 248
           Y   ++D+WS GV ++ LM  G  P+    L  +   + K +  + P   T    ++   
Sbjct: 194 YT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVK 252
Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSF 280
             ++D N   R T  E + NE+ +    PP +
Sbjct: 253 CWMIDEN--IRPTFKE-LANEFTRMARDPPRY 281

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 121/259 (46%), Gaps = 19/259 (7%)
Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKI----LDKEKVLKHKMIGQIKREIS 66
           T+ G Y L R +G G    V  A +T     VA+K+    L  + V + +     +RE  
Sbjct: 31  TQFGPYRLRRLVGRGGXGDVYEAEDTVRERIVALKLXSETLSSDPVFRTRX----QREAR 86
Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
           T   ++ P+V+ +++      ++Y+    + G +L   +  +G L    A    +Q+ +A
Sbjct: 87  TAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSA 146
Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL--LHTTCGTPNYVA 184
           +D  H+ G  HRD+KPEN+L+ A+    + DFG+++      D+ L  L  T GT  Y A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYXA 203
Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWF 240
           PE   ++ +   +AD+++   +LY  + G  P++   L      I +A    P    P  
Sbjct: 204 PERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQA-IPRPSTVRPGI 261
Query: 241 STSAKKLISRILDPNPVTR 259
             +   +I+R    NP  R
Sbjct: 262 PVAFDAVIARGXAKNPEDR 280

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 59/293 (20%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR----HPN 75
           + LG GS   V F + +  G  VA+K +         +I      +  +KL+     HPN
Sbjct: 39  KILGYGSSGTVVF-QGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 88
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINAVD 128
           VIR Y    +   +YI LE +    L D + S+          KE       +Q+ + V 
Sbjct: 89  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 129 YCHSRGVCHRDLKPENLLLDA-------------NGVLKVSDFGLSALPQQVRDDGL--- 172
           + HS  + HRDLKP+N+L+               N  + +SDFGL     +  D G    
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC----KKLDSGQXXF 203
Query: 173 ---LHTTCGTPNYVAPEVI--NNKGYDGAKADLWSCGVIL-YVLMAGYLPF-----EESN 221
              L+   GT  + APE++  + K       D++S G +  Y+L  G  PF      ESN
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 222 LMALYKKIFKAD---FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
           ++   + IF  D             A  LIS+++D +P+ R T  +V+ +  F
Sbjct: 264 II---RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 59/293 (20%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR----HPN 75
           + LG GS   V F + +  G  VA+K +         +I      +  +KL+     HPN
Sbjct: 39  KILGYGSSGTVVF-QGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 88
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINAVD 128
           VIR Y    +   +YI LE +    L D + S+          KE       +Q+ + V 
Sbjct: 89  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 129 YCHSRGVCHRDLKPENLLLDA-------------NGVLKVSDFGLSALPQQVRDDGL--- 172
           + HS  + HRDLKP+N+L+               N  + +SDFGL     +  D G    
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC----KKLDSGQXXF 203
Query: 173 ---LHTTCGTPNYVAPEVI--NNKGYDGAKADLWSCGVIL-YVLMAGYLPF-----EESN 221
              L+   GT  + APE++  + K       D++S G +  Y+L  G  PF      ESN
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 222 LMALYKKIFKAD---FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
           ++   + IF  D             A  LIS+++D +P+ R T  +V+ +  F
Sbjct: 264 II---RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 22  LGEGSFAKVK--FARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LG G+F  V+    R  +   +VAIK+L +  EK    +M+    RE   M  + +P ++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM----REAQIMHQLDNPYIV 73
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFD-KIASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           R+  V  ++  + +V+E   GG L    +  R  +      +   Q+   + Y   +   
Sbjct: 74  RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP----NYVAPEVINNKG 192
           HRDL   N+LL      K+SDFGLS   + +  D   +T          + APE IN + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS---KALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEE 219
           +  +++D+WS GV ++  L  G  P+++
Sbjct: 190 FS-SRSDVWSYGVTMWEALSYGQKPYKK 216

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+L R LG G +++V  A N    E VA+KIL   K  K K   +I   +        PN
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRGG-----PN 93
Query: 76  VIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYCHS
Sbjct: 94  IITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 149
Query: 133 RGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            G+ HRD+KP N+L+D  +  L++ D+GL+      ++    +    +  +  PE++ + 
Sbjct: 150 MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY 206
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF 217
                  D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 41/232 (17%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK----------- 62
            +Y L R LG G F+ V  A++     +VA+KI+  +KV       +IK           
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 63  REIS-----TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGE----LFDKIASRGRLKE 113
           +E S      +KL+ H N             +++V+ F   GE    L  K   RG +  
Sbjct: 79  KEDSMGANHILKLLDHFN-------HKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPL 130
Query: 114 DEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLD-----ANGV-LKVSDFGLSALPQQ 166
              ++  +QL+  +DY H R G+ H D+KPEN+L++      N + +K++D G +     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-- 188
Query: 167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE 218
              D     +  T  Y +PEV+    + G  AD+WS   +++ L+ G   FE
Sbjct: 189 ---DEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE 236

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G F KV   R  + G  VA+K L +E+    ++  Q + E+  + +  H N++R+  
Sbjct: 38  LGRGGFGKVYKGRLAD-GXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 82  VMASKTKIYIVLEFVTGGELFDKI------------ASRGRLKEDEARKYFQQLINAVDY 129
              + T+  +V  ++  G +   +              R R+    AR     L    D+
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG----LAYLHDH 150
Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           C  + + HRD+K  N+LLD      V DFGL+ L    +D  +     G   ++APE ++
Sbjct: 151 CDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRGXIGHIAPEYLS 208
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNL 222
             G    K D++  GV+L  L+ G   F+ + L
Sbjct: 209 T-GKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 18  LGRTLGEGSFAKVKFARN-----TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           L R LGEG+F KV  A       T+    VA+K L    +   K     +RE   +  ++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQ 75
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI----------------ASRGRLKEDEA 116
           H ++++ Y V      + +V E++  G+L   +                 ++G L   + 
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
                Q+ + + Y  S+   HRDL   N L+ AN ++K+ DFG+S          +   T
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLP-FEESN 221
                ++ PE I  + +   ++D+WS GVIL+ +   G  P F+ SN
Sbjct: 196 MLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSN 241

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 41/232 (17%)
Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK----------- 62
            +Y L R LG G F+ V  A++     +VA+KI+  +KV       +IK           
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 63  REIS-----TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGE----LFDKIASRGRLKE 113
           +E S      +KL+ H N             +++V+ F   GE    L  K   RG +  
Sbjct: 79  KEDSMGANHILKLLDHFN-------HKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPL 130
Query: 114 DEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLD-----ANGV-LKVSDFGLSALPQQ 166
              ++  +QL+  +DY H R G+ H D+KPEN+L++      N + +K++D G +     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-- 188
Query: 167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE 218
              D     +  T  Y +PEV+    + G  AD+WS   +++ L+ G   FE
Sbjct: 189 ---DEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE 236

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 66/306 (21%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKIL---DKEKVLKHKMIGQIKREIS 66
           RT   +  L   +G+G + +V   R +  GENVA+KI    D++   +       + E+ 
Sbjct: 4   RTVAHQITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDEKSWFR-------ETELY 54
Query: 67  TMKLIRHPNVIRM----YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
              ++RH N++           S T+++++  +   G L+D +     L      +    
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLS 113
Query: 123 LINAVDYCH-----SRG---VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGL 172
           + + + + H     ++G   + HRDLK +N+L+  NG   ++D GL+ +  Q  +  D  
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 173 LHTTCGTPNYVAPEVINNK----GYDGAK-ADLWSCGVILYV---------LMAGYLP-- 216
            +   GT  Y+APEV++       +D  K  D+W+ G++L+          ++  Y P  
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 217 ---------FEESNLMALYKKIFKADFKSPP----WFS----TSAKKLISRILDPNPVTR 259
                    FE+       +K+   D + P     WFS    TS  KL+      NP  R
Sbjct: 234 YDVVPNDPSFED------MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287
Query: 260 ITMAEV 265
           +T   +
Sbjct: 288 LTALRI 293

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 63/297 (21%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR----HPN 75
           + LG GS   V F + +  G  VA+K +         +I      +  +KL+     HPN
Sbjct: 21  KILGYGSSGTVVF-QGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 70
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINAVD 128
           VIR Y    +   +YI LE +    L D + S+          KE       +Q+ + V 
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 129 YCHSRGVCHRDLKPENLLLDA-------------NGVLKVSDFGLSALPQQVRDDGL--- 172
           + HS  + HRDLKP+N+L+               N  + +SDFGL     +  D G    
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC----KKLDSGQXXF 185
Query: 173 ---LHTTCGTPNYVAPEVINNKGYDGAK------ADLWSCGVIL-YVLMAGYLPF----- 217
              L+   GT  + APE++        K       D++S G +  Y+L  G  PF     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 218 EESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
            ESN++   + IF  D             A  LIS+++D +P+ R T  +V+ +  F
Sbjct: 246 RESNII---RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V     T  G   VAIK L    +     +     E   MK ++H  
Sbjct: 12  QLIKRLGNGQFGEVWMG--TWNGNTKVAIKTLKPGTMSPESFL----EEAQIMKKLKHDK 65
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGR-LKEDEARKYFQQLINAVDYCHSR 133
           ++++Y V+ S+  IYIV E++  G L D +    GR LK         Q+   + Y    
Sbjct: 66  LVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRDL+  N+L+    + K++DFGL+ L +   ++         P  + APE     G
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIED--NEXTARQGAKFPIKWTAPEAA-LYG 181
Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFEESN 221
               K+D+WS G++L  L+  G +P+   N
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 63/297 (21%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR----HPN 75
           + LG GS   V F + +  G  VA+K +         +I      +  +KL+     HPN
Sbjct: 21  KILGYGSSGTVVF-QGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 70
Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINAVD 128
           VIR Y    +   +YI LE +    L D + S+          KE       +Q+ + V 
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 129 YCHSRGVCHRDLKPENLLLDA-------------NGVLKVSDFGLSALPQQVRDDGL--- 172
           + HS  + HRDLKP+N+L+               N  + +SDFGL     +  D G    
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC----KKLDSGQSSF 185
Query: 173 ---LHTTCGTPNYVAPEVINNKGYDGAK------ADLWSCGVIL-YVLMAGYLPF----- 217
              L+   GT  + APE++        K       D++S G +  Y+L  G  PF     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 218 EESNLMALYKKIFKAD---FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF 271
            ESN++   + IF  D             A  LIS+++D +P+ R T  +V+ +  F
Sbjct: 246 RESNII---RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/258 (22%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 20  RTLGEGSFAKVKFARNTETGEN-VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR 78
           R +G+G F  V      +  +N +   I    ++ + + +    RE   M+ + HPNV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 79  MYEVMASKTKI-YIVLEFVTGGELFDKIASRGRLKE-DEARKYFQQLINAVDYCHSRGVC 136
           +  +M     + +++L ++  G+L   I S  R     +   +  Q+   ++Y   +   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL----HTTCGTP-NYVAPEVINNK 191
           HRDL   N +LD +  +KV+DFGL+   + + D        H     P  + A E +   
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLA---RDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 192 GYDGAKADLWSCGVILYVLMA-------GYLPFEESNLMALYKKIFKADFKSPPWFSTSA 244
            +   K+D+WS GV+L+ L+           PF+ ++ +A  +++       P +   S 
Sbjct: 204 RFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-----PQPEYCPDSL 257
Query: 245 KKLISRILDPNPVTRITM 262
            +++ +  + +P  R T 
Sbjct: 258 YQVMQQCWEADPAVRPTF 275

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 66/306 (21%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKIL---DKEKVLKHKMIGQIKREIS 66
           RT   +  L   +G+G + +V   R +  GENVA+KI    D++   +       + E+ 
Sbjct: 33  RTVARQITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDEKSWFR-------ETELY 83
Query: 67  TMKLIRHPNVIRM----YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
              ++RH N++           S T+++++  +   G L+D +     L      +    
Sbjct: 84  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLS 142
Query: 123 LINAVDYCH-----SRG---VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGL 172
           + + + + H     ++G   + HRDLK +N+L+  NG   ++D GL+ +  Q  +  D  
Sbjct: 143 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 202
Query: 173 LHTTCGTPNYVAPEVINNK----GYDGAK-ADLWSCGVILYV---------LMAGYLP-- 216
            +   GT  Y+APEV++       +D  K  D+W+ G++L+          ++  Y P  
Sbjct: 203 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 262
Query: 217 ---------FEESNLMALYKKIFKADFKSPP----WFS----TSAKKLISRILDPNPVTR 259
                    FE+       +K+   D + P     WFS    TS  KL+      NP  R
Sbjct: 263 YDVVPNDPSFED------MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 316
Query: 260 ITMAEV 265
           +T   +
Sbjct: 317 LTALRI 322

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 79/344 (22%), Positives = 135/344 (39%), Gaps = 63/344 (18%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIK-----ILDKEKV---LKHKMIGQIKREIST 67
           Y + R +  GS+  V    ++E G  VAIK     + D   V       +  ++ REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 68  MKLIRHPNVIRMYEVMA-----SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ- 121
           +    HPN++ + ++       +  K+Y+V E +   +L   I  +  +   +  +YF  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
            ++  +   H  GV HRDL P N+LL  N  + + DF L+   +   D    H       
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRW- 198
Query: 182 YVAPE-VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD------- 233
           Y APE V+  KG+     D+WS G ++  +      F  S       KI +         
Sbjct: 199 YRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 234 ---FKSP----------------------PWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              F SP                      P     A  LI+++L+ NP  RI+  + + +
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 269 EWFKKGYKPP----------SFEQPNIDLDDVDSIFNESMDSRN 302
            +F+  + P            F++   D+ D+  IF   ++  N
Sbjct: 318 PYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 79/344 (22%), Positives = 135/344 (39%), Gaps = 63/344 (18%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIK-----ILDKEKV---LKHKMIGQIKREIST 67
           Y + R +  GS+  V    ++E G  VAIK     + D   V       +  ++ REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 68  MKLIRHPNVIRMYEVMA-----SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ- 121
           +    HPN++ + ++       +  K+Y+V E +   +L   I  +  +   +  +YF  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
            ++  +   H  GV HRDL P N+LL  N  + + DF L+   +   D    H       
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRW- 198
Query: 182 YVAPE-VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD------- 233
           Y APE V+  KG+     D+WS G ++  +      F  S       KI +         
Sbjct: 199 YRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 234 ---FKSP----------------------PWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              F SP                      P     A  LI+++L+ NP  RI+  + + +
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 269 EWFKKGYKPP----------SFEQPNIDLDDVDSIFNESMDSRN 302
            +F+  + P            F++   D+ D+  IF   ++  N
Sbjct: 318 PYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 17  ELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           E  R +GEG+F +V  AR       E    VA+K+L +E      M    +RE + M   
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF 107
Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGEL----------------FDKIASRGR----- 110
            +PN++++  V A    + ++ E++  G+L                   +++R R     
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 111 ---LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALP 164
              L   E     +Q+   + Y   R   HRDL   N L+  N V+K++DFGLS      
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
              + DG          ++ PE I    Y   ++D+W+ GV+L+ +   G  P+
Sbjct: 228 DYYKADG---NDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPY 277

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +   G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  + 
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 104
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE------------- 115
            +  H N++ +           ++ E+   G+L + +    R K D              
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRDSFICSKTSPAIMED 160
Query: 116 ---------ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                       +  Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   + 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RH 217
Query: 167 VRDDG--LLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL 222
           +++D   ++      P  ++APE I N  Y   ++D+WS G+ L+ L + G  P+    +
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 276
Query: 223 MALYKKIFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            + + K+ K  F+  SP         ++    D +P+ R T  ++++
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +   G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  + 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE------------- 115
            +  H N++ +           ++ E+   G+L + +    R K D              
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRDSFICSKTSPAIMED 137
Query: 116 ---------ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                       +  Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   + 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RD 194
Query: 167 VRDDG--LLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL 222
           +++D   ++      P  ++APE I N  Y   ++D+WS G+ L+ L + G  P+    +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 223 MALYKKIFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            + + K+ K  F+  SP         ++    D +P+ R T  ++++
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +   G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  + 
Sbjct: 40  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 97
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE------------- 115
            +  H N++ +           ++ E+   G+L + +    R K D              
Sbjct: 98  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRDSFICSKTSPAIMED 153
Query: 116 ---------ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                       +  Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   + 
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RD 210
Query: 167 VRDDG--LLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL 222
           +++D   ++      P  ++APE I N  Y   ++D+WS G+ L+ L + G  P+    +
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 269
Query: 223 MALYKKIFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            + + K+ K  F+  SP         ++    D +P+ R T  ++++
Sbjct: 270 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 130/306 (42%), Gaps = 66/306 (21%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKIL---DKEKVLKHKMIGQIKREIS 66
           RT      L   +G+G + +V   R +  GENVA+KI    D++   +       + E+ 
Sbjct: 4   RTVARDITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDEKSWFR-------ETELY 54
Query: 67  TMKLIRHPNVIRM----YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQ 122
              ++RH N++           S T+++++  +   G L+D +     L      +    
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLS 113
Query: 123 LINAVDYCH-----SRG---VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGL 172
           + + + + H     ++G   + HRDLK +N+L+  NG   ++D GL+ +  Q  +  D  
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 173 LHTTCGTPNYVAPEVINNK----GYDGAK-ADLWSCGVILYV---------LMAGYLP-- 216
            +   GT  Y+APEV++       +D  K  D+W+ G++L+          ++  Y P  
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 217 ---------FEESNLMALYKKIFKADFKSPP----WFS----TSAKKLISRILDPNPVTR 259
                    FE+       +K+   D + P     WFS    TS  KL+      NP  R
Sbjct: 234 YDVVPNDPSFED------MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287
Query: 260 ITMAEV 265
           +T   +
Sbjct: 288 LTALRI 293

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +   G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  + 
Sbjct: 42  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 99
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE------------- 115
            +  H N++ +           ++ E+   G+L + +    R K D              
Sbjct: 100 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRDSFICSKTSPAIMED 155
Query: 116 ---------ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                       +  Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   + 
Sbjct: 156 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RD 212
Query: 167 VRDDG--LLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL 222
           +++D   ++      P  ++APE I N  Y   ++D+WS G+ L+ L + G  P+    +
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 271
Query: 223 MALYKKIFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            + + K+ K  F+  SP         ++    D +P+ R T  ++++
Sbjct: 272 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIG----QIKREISTMKL 70
           +++   +GEG+F+ V  A          +++  +EK+ LKH +      +I  E+  + +
Sbjct: 23  FKIEDKIGEGTFSSVYLA-------TAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTV 75
Query: 71  IR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
                NV+ +         + I + ++      D + S   L   E R+Y   L  A+  
Sbjct: 76  AGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS---LSFQEVREYMLNLFKALKR 132
Query: 130 CHSRGVCHRDLKPENLLLDANGVLK---VSDFGLS---------------ALPQQVRDDG 171
            H  G+ HRD+KP N L   N  LK   + DFGL+               +  QQ R   
Sbjct: 133 IHQFGIVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQ 190
Query: 172 LLHTTC-----------GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES 220
              + C           GTP + APEV+          D+WS GVI   L++G  PF ++
Sbjct: 191 NKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250
Query: 221 N 221
           +
Sbjct: 251 S 251

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +   G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  + 
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 104
Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE------------- 115
            +  H N++ +           ++ E+   G+L + +    R K D              
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRDSFICSKTSPAIMED 160
Query: 116 ---------ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                       +  Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   + 
Sbjct: 161 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RD 217
Query: 167 VRDDG--LLHTTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL 222
           +++D   ++      P  ++APE I N  Y   ++D+WS G+ L+ L + G  P+    +
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPV 276
Query: 223 MALYKKIFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            + + K+ K  F+  SP         ++    D +P+ R T  ++++
Sbjct: 277 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 22  LGEGSFAKVK--FARNTETGENVAIKILDK--EKVLKHKMIGQIKREISTMKLIRHPNVI 77
           LG G+F  V+    R  +   +VAIK+L +  EK    +M+    RE   M  + +P ++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM----REAQIMHQLDNPYIV 399
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFD-KIASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           R+  V  ++  + +V+E   GG L    +  R  +      +   Q+   + Y   +   
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP----NYVAPEVINNKG 192
           HR+L   N+LL      K+SDFGLS   + +  D   +T          + APE IN + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLS---KALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEE 219
           +  +++D+WS GV ++  L  G  P+++
Sbjct: 516 FS-SRSDVWSYGVTMWEALSYGQKPYKK 542

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGAT--HSEHRALMSELKILI 85
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR------------LK 112
            I  H NV+ +   + + TK    + +++EF   G L   + S+              L 
Sbjct: 86  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 113 EDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALPQQVR 168
            +    Y  Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P  VR
Sbjct: 143 LEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 169 D-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALY 226
             D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +   +
Sbjct: 203 KGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 256
Query: 227 KKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
            +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 257 XRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 29  RLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 86
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRG------RLKEDEARK 118
            I  H NV+ +   + + TK    + +++EF   G L   + S+       +  ED  + 
Sbjct: 87  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD 143
Query: 119 YFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALPQ 165
           +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P 
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 166 QVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLM 223
            VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    + 
Sbjct: 204 XVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 224 ALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
             + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 75  NVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           N+I++ + +    SKT   +V E++   + F ++     L + + R Y  +L+ A+DYCH
Sbjct: 94  NIIKLIDTVKDPVSKTPA-LVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCH 149
Query: 132 SRGVCHRDLKPENLLLD-ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           S+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE++ +
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE---YNVRVASRYFKGPELLVD 206
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPF 217
                   D+WS G +L  ++    PF
Sbjct: 207 YQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 43/286 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGAT--HSEHRALMSELKILI 87
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------------- 110
            I  H NV+ +   + + TK    + +++EF   G L   + S+                
Sbjct: 88  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF 144
Query: 111 LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALPQQ 166
           L  +    Y  Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 167 VRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMA 224
           VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +  
Sbjct: 205 VRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 225 LYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
            + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKIL-DKEKVLKHKMIGQIKREISTM 68
           RT   + ++ + +G+G + +V   +    GE VA+K+    E+    +     + EI   
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFR-----ETEIYQT 85
Query: 69  KLIRHPNVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
            L+RH N++           S T++Y++ ++   G L+D + S   L      K     +
Sbjct: 86  VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSV 144
Query: 125 NAVDYCHSR--------GVCHRDLKPENLLLDANGVLKVSDFGLSA--LPQQVRDDGLLH 174
           + + + H+          + HRDLK +N+L+  NG   ++D GL+   +      D   +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 175 TTCGTPNYVAPEVIN-----NKGYDGAKADLWSCGVILY 208
           T  GT  Y+ PEV++     N       AD++S G+IL+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 75  NVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           N+I++ + +    SKT   +V E++   + F ++     L + + R Y  +L+ A+DYCH
Sbjct: 99  NIIKLIDTVKDPVSKTPA-LVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCH 154
Query: 132 SRGVCHRDLKPENLLLD-ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           S+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE++ +
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE---YNVRVASRYFKGPELLVD 211
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPF 217
                   D+WS G +L  ++    PF
Sbjct: 212 YQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 37/275 (13%)
Query: 73  HPNVIRMYEVMASKTKIYIVLEFV--TGGELFDK--IASRGRLKEDEARKYFQQLINAVD 128
           HPNVIR +     +   YI +E    T  E  ++   A  G     E     QQ  + + 
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL----EPITLLQQTTSGLA 132
Query: 129 YCHSRGVCHRDLKPENLLL---DANGVLK--VSDFGLS---ALPQQ--VRDDGLLHTTCG 178
           + HS  + HRDLKP N+L+   +A+G +K  +SDFGL    A+ +    R  G+     G
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP----G 188
Query: 179 TPNYVAPEVINNKGYDGA--KADLWSCGVIL-YVLMAGYLPFEESNLMALYKKIFKA--- 232
           T  ++APE+++    +      D++S G +  YV+  G  PF +S L      +  A   
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-LQRQANILLGACSL 247
Query: 233 DFKSPPWFS-TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVD 291
           D   P       A++LI +++  +P  R +   V+++ +F    K   F Q     D  D
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQ-----DVSD 302
Query: 292 SIFNESMDSRNLVVERREEGPVAPLTMNAFELIST 326
            I  ES+D    +V++ E G  A + M+  E I+ 
Sbjct: 303 RIEKESLDGP--IVKQLERGGRAVVKMDWRENITV 335

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 72
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 73  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 192 -SSKSDVWSFGVLMW 205

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++  R  L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 18  LGRTLGEGSFAKV----KFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           LG+TLGEG F KV     F      G   VA+K+L KE     ++   +  E + +K + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSEL-RDLLSEFNVLKQVN 84
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKE------------------- 113
           HP+VI++Y   +    + +++E+   G L      RG L+E                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 114 ----DEAR-------KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA 162
               DE          +  Q+   + Y     + HRDL   N+L+     +K+SDFGLS 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 163 LPQQVRDDGLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                 +D  +  + G     ++A E + +  Y   ++D+WS GV+L+
Sbjct: 199 --DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++++ +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 82  RLLGICLTST-VQLIMQLMPFGXLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 196 IYT-HQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 87
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASR-------GRLKEDEAR 117
            I  H NV+ +   + + TK    + +++EF   G L   + S+           ED  +
Sbjct: 88  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK 144
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 145 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ + + G  P+    +
Sbjct: 205 DYVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 258
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 259 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 86
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 87  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 206 -SSKSDVWSFGVLMW 219

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 88
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 89  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 208 -SSKSDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 88
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 89  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 208 -SSKSDVWSFGVLMW 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGAT--HSEHRALMSELKILI 85
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR------------LK 112
            I  H NV+ +   + + TK    + +++EF   G L   + S+              L 
Sbjct: 86  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 113 EDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALPQQVR 168
            +    Y  Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P  VR
Sbjct: 143 LEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 169 D-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALY 226
             D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +   +
Sbjct: 203 KGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 256
Query: 227 KKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
            +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 257 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 18  LGRTLGEGSFAKV----KFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           LG+TLGEG F KV     F      G   VA+K+L KE     ++   +  E + +K + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSEL-RDLLSEFNVLKQVN 84
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKE------------------- 113
           HP+VI++Y   +    + +++E+   G L      RG L+E                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 114 ----DEAR-------KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA 162
               DE          +  Q+   + Y     + HRDL   N+L+     +K+SDFGLS 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 163 LPQQVRDDGLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                 +D  +  + G     ++A E + +  Y   ++D+WS GV+L+
Sbjct: 199 --DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK---REISTMKLIRHP 74
           L R LGEG+F KV  A           KIL   K LK       K   RE   +  ++H 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPE-QDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 75
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------------RLKEDEARKYFQ 121
           ++++ Y V      + +V E++  G+L   + + G              L + +     Q
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+   + Y  S+   HRDL   N L+  N ++K+ DFG+S          +   T     
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 182 YVAPEVINNKGYDGAKADLWSCGVILY 208
           ++ PE I  + +   ++D+WS GV+L+
Sbjct: 196 WMPPESIMYRKFT-TESDVWSLGVVLW 221

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 72
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 73  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 192 -SSKSDVWSFGVLMW 205

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 78
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 79  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 198 -SSKSDVWSFGVLMW 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 85
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + +++EF   G L   + S+           ED  +
Sbjct: 86  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 203 DXVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 76
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + +++EF   G L   + S+           ED  +
Sbjct: 77  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 194 DXVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/275 (21%), Positives = 118/275 (42%), Gaps = 32/275 (11%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTM-KL 70
           + G+TLG G+F KV  A     G+      VA+K+L        K    +  E+  M  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE--ALMSELKIMSHL 106
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR------------- 117
            +H N++ +         + ++ E+   G+L + +  + R+ E +               
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 118 -KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLH 174
             +  Q+   + +  S+   HRD+   N+LL    V K+ DFGL+   + + +D   ++ 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVK 223
Query: 175 TTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKA 232
                P  ++APE I +  Y   ++D+WS G++L+ +   G  P+    + + + K+ K 
Sbjct: 224 GNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 233 DFK--SPPWFSTSAKKLISRILDPNPVTRITMAEV 265
            ++   P +   +   ++       P  R T  ++
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 68
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 69  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 188 -SSKSDVWSFGVLMW 201

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/275 (21%), Positives = 118/275 (42%), Gaps = 32/275 (11%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTM-KL 70
           + G+TLG G+F KV  A     G+      VA+K+L        K    +  E+  M  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE--ALMSELKIMSHL 106
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEAR------------- 117
            +H N++ +         + ++ E+   G+L + +  + R+ E +               
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 118 -KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLH 174
             +  Q+   + +  S+   HRD+   N+LL    V K+ DFGL+   + + +D   ++ 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVK 223
Query: 175 TTCGTP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKA 232
                P  ++APE I +  Y   ++D+WS G++L+ +   G  P+    + + + K+ K 
Sbjct: 224 GNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 233 DFK--SPPWFSTSAKKLISRILDPNPVTRITMAEV 265
            ++   P +   +   ++       P  R T  ++
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 66
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 67  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 186 -SSKSDVWSFGVLMW 199

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 18  LGRTLGEGSFAKV----KFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           LG+TLGEG F KV     F      G   VA+K+L KE     ++   +  E + +K + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSEL-RDLLSEFNVLKQVN 84
Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKE------------------- 113
           HP+VI++Y   +    + +++E+   G L      RG L+E                   
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 114 ----DEAR-------KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA 162
               DE          +  Q+   + Y     + HRDL   N+L+     +K+SDFGLS 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 163 LPQQVRDDGLLHTTCG--TPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                 +D  +  + G     ++A E + +  Y   ++D+WS GV+L+
Sbjct: 199 --DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTM-KL 70
           + G+TLG G+F KV  A     G+      VA+K+L        K    +  E+  M  L
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE--ALMSELKIMSHL 98
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGEL--FDKIASRGRLKEDEAR--------KYF 120
            +H N++ +         + ++ E+   G+L  F +  +   L +++ R         + 
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTCG 178
            Q+   + +  S+   HRD+   N+LL    V K+ DFGL+   + + +D   ++     
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVKGNAR 215
Query: 179 TP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK- 235
            P  ++APE I +  Y   ++D+WS G++L+ +   G  P+    + + + K+ K  ++ 
Sbjct: 216 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 236 -SPPWFSTSAKKLISRILDPNPVTRITMAEV 265
             P +   +   ++       P  R T  ++
Sbjct: 275 AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 85
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + +++EF   G L   + S+           ED  +
Sbjct: 86  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 203 DXVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 75
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK--YFQQLI-- 124
                +V+R+  V++      +V+E +  G+L   + S R   + +  R     Q++I  
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----DDGLLH 174
                + + Y +++   HRDL   N ++  +  +K+ DFG++    +         GLL 
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                  ++APE + + G     +D+WS GV+L+
Sbjct: 196 V-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 75
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK--YFQQLI-- 124
                +V+R+  V++      +V+E +  G+L   + S R   + +  R     Q++I  
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----DDGLLH 174
                + + Y +++   HRDL   N ++  +  +K+ DFG++    +         GLL 
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                  ++APE + + G     +D+WS GV+L+
Sbjct: 196 V-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 15  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 72
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK--YFQQLI-- 124
                +V+R+  V++      +V+E +  G+L   + S R   + +  R     Q++I  
Sbjct: 73  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 132
Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----DDGLLH 174
                + + Y +++   HRDL   N ++  +  +K+ DFG++    +         GLL 
Sbjct: 133 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                  ++APE + + G     +D+WS GV+L+
Sbjct: 193 V-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 220

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 85
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + +++EF   G L   + S+           ED  +
Sbjct: 86  HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 203 DYVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 65  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 122
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + +++EF   G L   + S+           ED  +
Sbjct: 123 HIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 240 DYVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 293
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++++ +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 85  RLLGICLTST-VQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 199 IYT-HQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTM-KL 70
           + G+TLG G+F KV  A     G+      VA+K+L        K    +  E+  M  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE--ALMSELKIMSHL 106
Query: 71  IRHPNVIRMYEVMASKTKIYIVLEFVTGGEL--FDKIASRGRLKEDEAR--------KYF 120
            +H N++ +         + ++ E+   G+L  F +  +   L +++ R         + 
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG--LLHTTCG 178
            Q+   + +  S+   HRD+   N+LL    V K+ DFGL+   + + +D   ++     
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVKGNAR 223
Query: 179 TP-NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK- 235
            P  ++APE I +  Y   ++D+WS G++L+ +   G  P+    + + + K+ K  ++ 
Sbjct: 224 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 236 -SPPWFSTSAKKLISRILDPNPVTRITMAEV 265
             P +   +   ++       P  R T  ++
Sbjct: 283 AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 7   GASRTRVG-KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G+   RVG KY LGR +G GSF  +    N  +GE VAIK+    + +K K   Q+  E 
Sbjct: 1   GSMELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKL----ECVKTKH-PQLHIES 55
Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG---GELFDKIASRGRLKEDEARKYFQQ 122
              K+++    I   +   ++    +++  + G    +LF+  + +  LK         Q
Sbjct: 56  KFYKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKT--VLLLADQ 113
Query: 123 LINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLL-----H 174
           +I+ ++Y HS+   HRD+KP+N L+       ++ + DFGL+   +  R    +      
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 175 TTCGTPNYVAPEVINNKGYDGAKA-DLWSCGVILYVLMAGYLPFE 218
              GT  Y +  +  + G + ++  DL S G +L     G LP++
Sbjct: 174 NLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++++ +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 84  RLLGICLTST-VQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 198 IYT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YE+ R +G G +++V    N    E         + +   K     +       L+  PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLMGGPN 87
Query: 76  VIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           ++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYCHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYCHS 143
Query: 133 RGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VINN 190
           +G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE +++ 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 200
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPF 217
           + YD +  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++++ +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 82  RLLGICLTST-VQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 196 IYT-HQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 430
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 431 YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 550 S-SKSDVWSFGVLMW 563

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++++ +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 83  RLLGICLTST-VQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 197 IYT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++++ +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 81  RLLGICLTST-VQLIMQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 195 IYT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 17  ELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
                +G G F  V      +  G+ +   +    ++     + Q   E   MK   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 76  VIRMYEV-MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK---YFQQLINAVDYCH 131
           V+ +  + + S+    +VL ++  G+L + I  R        +    +  Q+   + Y  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVI 188
           S+   HRDL   N +LD    +KV+DFGL A     ++   +H   G      ++A E +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
             + +   K+D+WS GV+L+ LM  G  P+ + N   +   + +             ++L
Sbjct: 209 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRL 255
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
           +     P+P     + EV+   W  K    PSF +
Sbjct: 256 LQPEYCPDP-----LYEVMLKCWHPKAEMRPSFSE 285

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           L  ++G+G F +V   R    GE VA+KI       + +     + EI    ++RH N++
Sbjct: 46  LQESIGKGRFGEV--WRGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENIL 99
Query: 78  RMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
                      + T++++V ++   G LFD + +R  +  +   K      + + + H  
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 134 --------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNYV 183
                    + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 184 APEV----INNKGYDGAK-ADLWSCGVILY 208
           APEV    IN K ++  K AD+++ G++ +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 20  RTLGEGSFAKVK--FARNTETGENVAIKILDKEK---VLKHKMIGQIKREISTMKLIRHP 74
           + LG G+F  VK  + +  +  + VA+KIL  E     LK +++     E + M+ + +P
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----EANVMQQLDNP 431
Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++RM  +  +++ + +V+E    G L   +     +K+    +   Q+   + Y     
Sbjct: 432 YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKGY 193
             HRDL   N+LL      K+SDFGLS   +   +     T    P  + APE IN   +
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 194 DGAKADLWSCGVILY 208
             +K+D+WS GV+++
Sbjct: 551 S-SKSDVWSFGVLMW 564

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 75
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK--YFQQLI-- 124
                +V+R+  V++      +V+E +  G+L   + S R   + +  R     Q++I  
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----DDGLLH 174
                + + Y +++   HRDL   N ++  +  +K+ DFG++    +         GLL 
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                  ++APE + + G     +D+WS GV+L+
Sbjct: 196 V-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 40/220 (18%)
Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 75
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK--YFQQLI-- 124
                +V+R+  V++      +V+E +  G+L   + S R   + +  R     Q++I  
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD---------- 169
                + + Y +++   HRDL   N ++  +  +K+ DFG++      RD          
Sbjct: 136 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYETDYYRKG 189
Query: 170 -DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
             GLL        ++APE + + G     +D+WS GV+L+
Sbjct: 190 GKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           L  ++G+G F +V   R    GE VA+KI       + +     + EI    ++RH N++
Sbjct: 13  LQESIGKGRFGEV--WRGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENIL 66
Query: 78  RMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
                      + T++++V ++   G LFD + +R  +  +   K      + + + H  
Sbjct: 67  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 134 --------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNYV 183
                    + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT  Y+
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 184 APEV----INNKGYDGAK-ADLWSCGVILY 208
           APEV    IN K ++  K AD+++ G++ +
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           L  ++G+G F +V   R    GE VA+KI       + +     + EI    ++RH N++
Sbjct: 33  LQESIGKGRFGEV--WRGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENIL 86
Query: 78  RMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
                      + T++++V ++   G LFD + +R  +  +   K      + + + H  
Sbjct: 87  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 134 --------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNYV 183
                    + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT  Y+
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 184 APEV----INNKGYDGAK-ADLWSCGVILY 208
           APEV    IN K ++  K AD+++ G++ +
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           L  ++G+G F +V   R    GE VA+KI       + +     + EI    ++RH N++
Sbjct: 7   LQESIGKGRFGEV--WRGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENIL 60
Query: 78  RMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
                      + T++++V ++   G LFD + +R  +  +   K      + + + H  
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 134 --------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNYV 183
                    + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT  Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 184 APEV----INNKGYDGAK-ADLWSCGVILY 208
           APEV    IN K ++  K AD+++ G++ +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 76
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + ++ EF   G L   + S+           ED  +
Sbjct: 77  HIGHHLNVVNL---LGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 194 DXVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 18  LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           L  ++G+G F +V   R    GE VA+KI       + +     + EI    ++RH N++
Sbjct: 8   LQESIGKGRFGEV--WRGKWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENIL 61
Query: 78  RMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
                      + T++++V ++   G LFD + +R  +  +   K      + + + H  
Sbjct: 62  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 134 --------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNYV 183
                    + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT  Y+
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 184 APEV----INNKGYDGAK-ADLWSCGVILY 208
           APEV    IN K ++  K AD+++ G++ +
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G  +RT V    L  ++G+G F +V   R    GE VA+KI       + +     + EI
Sbjct: 2   GTIARTIV----LQESIGKGRFGEV--WRGKWRGEEVAVKIFSS----REERSWFREAEI 51
Query: 66  STMKLIRHPNVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
               ++RH N++           + T++++V ++   G LFD + +R  +  +   K   
Sbjct: 52  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLAL 110
Query: 122 QLINAVDYCHSR--------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DG 171
              + + + H           + HRDLK +N+L+  NG   ++D GL+       D  D 
Sbjct: 111 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 170
Query: 172 LLHTTCGTPNYVAPEV----INNKGYDGAK-ADLWSCGVILY 208
             +   GT  Y+APEV    IN K ++  K AD+++ G++ +
Sbjct: 171 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 63  REISTMKLIRHPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKI----ASRG-----RL 111
           REI+ ++ ++HPNVI + +V  S    K++++ ++    +L+  I    AS+      +L
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLSAL---P 164
                +    Q+++ + Y H+  V HRDLKP N+L+       G +K++D G + L   P
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG 213
            +   D  L     T  Y APE++    +     D+W+ G I   L+  
Sbjct: 186 LKPLAD--LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 81  RLLGICLTST-VQLITQLMPFGXLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 195 IYT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 141
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 198
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 199 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 87  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 142
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 199
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 200 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 15  KYELGRTLGEGSFAKV--KFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  L R LG+GSF  V    AR+   GE    VA+K +++   L+ ++  +   E S MK
Sbjct: 17  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 74
Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARK--YFQQLI-- 124
                +V+R+  V++      +V+E +  G+L   + S R   + +  R     Q++I  
Sbjct: 75  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 134
Query: 125 -----NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR-----DDGLLH 174
                + + Y +++   HRDL   N ++  +  +K+ DFG++    +         GLL 
Sbjct: 135 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY 208
                  ++APE + + G     +D+WS GV+L+
Sbjct: 195 V-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 222

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 141
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 198
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 199 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 141
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 198
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 199 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 76
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + ++ EF   G L   + S+           ED  +
Sbjct: 77  HIGHHLNVVNL---LGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 194 DYVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 107 PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 162
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 219
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 220 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 247

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 146
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +     H     +  E+  + 
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 76
Query: 70  LI-RHPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGR-------LKEDEAR 117
            I  H NV+ +   + + TK    + ++ EF   G L   + S+           ED  +
Sbjct: 77  HIGHHLNVVNL---LGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 118 KYFQ---------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS----ALP 164
            +           Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      P
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 165 QQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNL 222
             VR  D  L        ++APE I ++ Y   ++D+WS GV+L+ +   G  P+    +
Sbjct: 194 DYVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 223 MALYKKIFK--ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
              + +  K     ++P + +    + +       P  R T +E++E+
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 88  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 143
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 200
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 201 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 228

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+L R LG G +++V  A N    E V +KIL   K  K K   +I   +        PN
Sbjct: 44  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGG-----PN 98
Query: 76  VIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYCHS
Sbjct: 99  IITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 154
Query: 133 RGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ + 
Sbjct: 155 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY 211
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF 217
                  D+WS G +L  ++    PF
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+L R LG G +++V  A N    E V +KIL   K  K K   +I   +        PN
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGG-----PN 93
Query: 76  VIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYCHS
Sbjct: 94  IITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 149
Query: 133 RGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ + 
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY 206
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF 217
                  D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 147
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 204
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YE+ R +G G +++V    N    E         + +   K     +       L   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQNLCGGPN 87
Query: 76  VIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           ++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYCHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYCHS 143
Query: 133 RGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VINN 190
           +G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE +++ 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 200
Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPF 217
           + YD +  D+WS G +   ++    PF
Sbjct: 201 QDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           Y+L R LG G +++V  A N    E V +KIL   K  K K   +I   +        PN
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGG-----PN 92
Query: 76  VIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYCHS
Sbjct: 93  IITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 148
Query: 133 RGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ + 
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDY 205
Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF 217
                  D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 87  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 142
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 199
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 200 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +V E V   + F ++     L + + R Y  +++ A+DYC
Sbjct: 90  PNIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYC 145
Query: 131 HSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 202
Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF 217
           +        D+WS G +L  ++    PF
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 81/149 (54%), Gaps = 13/149 (8%)
Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN++++ +++    SKT   ++ E+V   +   K+     L + + R Y  +L+ A+DYC
Sbjct: 86  PNIVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLY-PTLTDYDIRYYIYELLKALDYC 141
Query: 131 HSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE-VI 188
           HS+G+ HRD+KP N+++D     L++ D+GL+      ++    +    +  +  PE ++
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLV 198
Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +   ++    PF
Sbjct: 199 DLQDYDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 17  ELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
                +G G F  V      +  G+ +   +    ++     + Q   E   MK   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VIRMYEV-MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK---YFQQLINAVDYCH 131
           V+ +  + + S+    +VL ++  G+L + I  R        +    +  Q+   + Y  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVI 188
           S+   HRDL   N +LD    +KV+DFGL A     ++   +H   G      ++A E +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
             + +   K+D+WS GV+L+ LM  G  P+ + N   +   + +             ++L
Sbjct: 210 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRL 256
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
           +     P+P     + EV+   W  K    PSF +
Sbjct: 257 LQPEYCPDP-----LYEVMLKCWHPKAEMRPSFSE 286

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 17  ELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
                +G G F  V      +  G+ +   +    ++     + Q   E   MK   HPN
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 76  VIRMYEV-MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK---YFQQLINAVDYCH 131
           V+ +  + + S+    +VL ++  G+L + I  R        +    +  Q+   + Y  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVI 188
           S+   HRDL   N +LD    +KV+DFGL A     ++   +H   G      ++A E +
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
             + +   K+D+WS GV+L+ LM  G  P+ + N   +   + +             ++L
Sbjct: 228 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRL 274
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
           +     P+P     + EV+   W  K    PSF +
Sbjct: 275 LQPEYCPDP-----LYEVMLKCWHPKAEMRPSFSE 304

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 83  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 197 IYT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 88  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 201
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 202 IYT-HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 91  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 204
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 205 IYT-HQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 87  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 200
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 201 IYT-HQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 17  ELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
                +G G F  V      +  G+ +   +    ++     + Q   E   MK   HPN
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 76  VIRMYEV-MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK---YFQQLINAVDYCH 131
           V+ +  + + S+    +VL ++  G+L + I  R        +    +  Q+   + Y  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP---NYVAPEVI 188
           S+   HRDL   N +LD    +KV+DFGL A     ++   +H   G      ++A E +
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL 247
             + +   K+D+WS GV+L+ LM  G  P+ + N   +   + +             ++L
Sbjct: 202 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRL 248
Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
           +     P+P     + EV+   W  K    PSF +
Sbjct: 249 LQPEYCPDP-----LYEVMLKCWHPKAEMRPSFSE 278

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 106 RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 219
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 220 IYT-HQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 195 IYT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 84  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 198 IYT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 84  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 198 IYT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 75  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 188
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 189 IYT-HQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 20  RTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ----QLINAVDYCHSR 133
           R+  +  + T + ++ + +  G L D +      K++   +Y      Q+   ++Y   R
Sbjct: 78  RLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVINNK 191
            + HRDL   N+L+     +K++DFGL+ L     ++   H   G  P  ++A E I ++
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHR 191
Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFE 218
            Y   ++D+WS GV ++ LM  G  P++
Sbjct: 192 IYT-HQSDVWSYGVTVWELMTFGSKPYD 218
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	342
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	0.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	0.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	0.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	0.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	0.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	0.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-179
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-175
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-175
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-175
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-169
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-168
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-167
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-165
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-162
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-157
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-156
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-147
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-121
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-119
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-116
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-115
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-115
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-114
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-113
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-113
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-113
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-112
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-112
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-112
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-109
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-108
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-108
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-108
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-108
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-107
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-107
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-106
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-106
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-106
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-106
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-106
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-105
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-104
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-104
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-104
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-104
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-103
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-102
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-101
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-100
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-100
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-99
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-99
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-98
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-93
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-91
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-90
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-89
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-87
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-85
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-85
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-84
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-84
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-84
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-83
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-82
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-81
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-80
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-78
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-78
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-71
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-71
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-71
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-71
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-71
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-70
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-70
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-69
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-69
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-69
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-68
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-68
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-67
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-67
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-67
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-66
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-65
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-64
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-64
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-62
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-62
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-60
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-55
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-54
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-52
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-52
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-52
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-51
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-51
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-51
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-50
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-50
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-50
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-49
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-49
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-49
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-48
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-48
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-48
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-48
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-48
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-47
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-47
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-47
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-46
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-46
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-46
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-46
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-46
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-43
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-43
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-42
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-41
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-41
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-40
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-40
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-40
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-40
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-40
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-40
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-40
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-38
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-38
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-38
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-37
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-37
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-36
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-33
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-29
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-28
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-27
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-27
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-20
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	1e-05
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	2e-05
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	5e-05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	2e-04

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  515 bits (1328), Expect = 0.0
 Identities = 127/274 (46%), Positives = 188/274 (68%), Gaps = 3/274 (1%)

Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
            R ++G Y LG TLG G+F KVK   +  TG  VA+KIL+++K+    ++G+IKREI  +
Sbjct: 6   GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           KL RHP++I++Y+V+++ T  ++V+E+V+GGELFD I   GR++E EAR+ FQQ+++AVD
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCH   V HRDLKPEN+LLDA+   K++DFGLS +     D   L T+CG+PNY APEVI
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAPEVI 182

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           + + Y G + D+WSCGVILY L+ G LPF++ ++  L+KKI    F  P + + S   L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
             +L  +P+ R T+ ++ E+EWFK+      F +
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  519 bits (1339), Expect = 0.0
 Identities = 133/330 (40%), Positives = 204/330 (61%), Gaps = 9/330 (2%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           MA +     R ++G Y LG TLG G+F KVK  ++  TG  VA+KIL+++K+    ++G+
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           I+REI  +KL RHP++I++Y+V+++ + I++V+E+V+GGELFD I   GRL E E+R+ F
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           QQ+++ VDYCH   V HRDLKPEN+LLDA+   K++DFGLS +     D   L T+CG+P
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSP 179

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           NY APEVI+ + Y G + D+WS GVILY L+ G LPF++ ++  L+KKI    F +P + 
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP------NIDLDDVDSIF 294
           + S   L+  +L  +P+ R T+ ++ E+EWFK+      F +        ID + +  + 
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVC 299

Query: 295 NESMDSRNLVVERREEGPVAPLTMNAFELI 324
            +   S   V+              A+ LI
Sbjct: 300 EKFECSEEEVLSCLYNRNHQDPLAVAYHLI 329

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  511 bits (1317), Expect = 0.0
 Identities = 101/293 (34%), Positives = 167/293 (56%), Gaps = 7/293 (2%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFE--QPNIDLDDVDSIFNESMDS 300
           +IL  NP  RIT+ ++ ++ W+ K  K  +      +  + +  S F++ + S
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQS 296

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  507 bits (1308), Expect = 0.0
 Identities = 98/267 (36%), Positives = 157/267 (58%), Gaps = 5/267 (1%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+++ S+    Y    +      PW    ++   L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLK 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  506 bits (1304), Expect = 0.0
 Identities = 129/325 (39%), Positives = 200/325 (61%), Gaps = 10/325 (3%)

Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
           S+  +G Y +  TLGEGSF KVK A + +T + VA+K + ++ + K  M  +++REIS +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           KL+RHP++I++Y+V+ + T I +V+E+  GGELFD I  + R+ EDE R++FQQ+I A++
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCH   + HRDLKPENLLLD N  +K++DFGLS +     D   L T+CG+PNY APEVI
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVI 179

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           N K Y G + D+WSCG++LYV++ G LPF++  +  L+KK+    +  P + S  A+ LI
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDS-IFNESMD----SRNL 303
            R++  +P+ RIT+ E+  + WF             +     DS I ++  +    S + 
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDY 299

Query: 304 VVERREEGPVAPLTMNAFELISTSQ 328
           +VE         +   A+ L+  +Q
Sbjct: 300 IVEALRSDENNEVK-EAYNLLHENQ 323

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  502 bits (1294), Expect = 0.0
 Identities = 96/286 (33%), Positives = 153/286 (53%), Gaps = 7/286 (2%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK-MIGQIKREISTMKL 70
            +GKY +G  LGEGS+ KVK   ++ET    A+KIL K+K+ +       +K+EI  ++ 
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 71  IRHPNVIRMYEVM--ASKTKIYIVLEFVTGG--ELFDKIASRGRLKEDEARKYFQQLINA 126
           +RH NVI++ +V+    K K+Y+V+E+   G  E+ D +    R    +A  YF QLI+ 
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           ++Y HS+G+ H+D+KP NLLL   G LK+S  G++        D    T+ G+P +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 187 VINN-KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           + N    + G K D+WS GV LY +  G  PFE  N+  L++ I K  +  P        
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241

Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVD 291
            L+  +L+  P  R ++ ++ ++ WF+K + P     P     D  
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  499 bits (1288), Expect = e-179
 Identities = 110/338 (32%), Positives = 168/338 (49%), Gaps = 22/338 (6%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
              +Y+  + +G G+F   +  R+  T E VA+K +++   +       ++REI   + +
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSL 73

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           RHPN++R  EV+ + T + I++E+ +GGEL+++I + GR  EDEAR +FQQL++ V YCH
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 132 SRGVCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           S  +CHRDLK EN LLD +    LK+ DFG S             +T GTP Y+APEV+ 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEVLL 190

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK----IFKADFKSPP--WFSTS 243
            + YDG  AD+WSCGV LYV++ G  PFE+      Y+K    I    +  P     S  
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI--DLDDVDSIFNESMDSR 301
              LISRI   +P TRI++ E+  + WF K        + N      + +          
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310

Query: 302 NLVVERREEGPVAPLTMNAFELISTSQGLNLSSLLKSK 339
            ++ E            N       +  L+L   +   
Sbjct: 311 QIISEATIPAV-----RNRCLDDFMTDNLDLDDDMDDF 343

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  488 bits (1259), Expect = e-175
 Identities = 98/291 (33%), Positives = 147/291 (50%), Gaps = 3/291 (1%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
              +Y  GR LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + +
Sbjct: 39  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            H +V+  +        +++VLE      L +    R  L E EAR Y +Q++    Y H
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
              V HRDLK  NL L+ +  +K+ DFGL+   +   D       CGTPNY+APEV++ K
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKK 216

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
           G+   + D+WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++
Sbjct: 217 GHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275

Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
           L  +P  R T+ E++ +E+F  GY P       + +    SI   S+D  N
Sbjct: 276 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSN 326

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  486 bits (1254), Expect = e-175
 Identities = 93/272 (34%), Positives = 139/272 (51%), Gaps = 3/272 (1%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
              +Y  GR LG+G FAK     + +T E  A KI+ K  +LK     ++  EIS  + +
Sbjct: 13  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            H +V+  +        +++VLE      L +    R  L E EAR Y +Q++    Y H
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
              V HRDLK  NL L+ +  +K+ DFGL+   +   D       CGTPNY+APEV++ K
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKK 190

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI 251
           G+   + D+WS G I+Y L+ G  PFE S L   Y +I K ++  P   +  A  LI ++
Sbjct: 191 GHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249

Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
           L  +P  R T+ E++ +E+F  GY P      
Sbjct: 250 LQTDPTARPTINELLNDEFFTSGYIPARLPIT 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  485 bits (1250), Expect = e-175
 Identities = 88/274 (32%), Positives = 154/274 (56%), Gaps = 4/274 (1%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
             ++  +++G  LG+GSFA V  A +  TG  VAIK++DK+ + K  M+ +++ E+    
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVD 128
            ++HP+++ +Y        +Y+VLE    GE+   + +R     E+EAR +  Q+I  + 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y HS G+ HRDL   NLLL  N  +K++DFGL+   +        +T CGTPNY++PE+ 
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
               + G ++D+WS G + Y L+ G  PF+   +     K+  AD++ P + S  AK LI
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
            ++L  NP  R++++ V+++ +  +     S ++
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  470 bits (1213), Expect = e-169
 Identities = 96/301 (31%), Positives = 158/301 (52%), Gaps = 32/301 (10%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK----- 56
            S        ++ +Y L   +G+GS+  VK A N       A+K+L K+K+++       
Sbjct: 1   GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60

Query: 57  ------------------MIGQIKREISTMKLIRHPNVIRMYEVM--ASKTKIYIVLEFV 96
                              I Q+ +EI+ +K + HPNV+++ EV+   ++  +Y+V E V
Sbjct: 61  PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV 120

Query: 97  TGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS 156
             G + + + +   L ED+AR YFQ LI  ++Y H + + HRD+KP NLL+  +G +K++
Sbjct: 121 NQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179

Query: 157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGY 214
           DFG+S   +    D LL  T GTP ++APE ++   K + G   D+W+ GV LY  + G 
Sbjct: 180 DFGVSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

Query: 215 LPFEESNLMALYKKIFKADFKSP--PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
            PF +  +M L+ KI     + P  P  +   K LI+R+LD NP +RI + E+  + W  
Sbjct: 238 CPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

Query: 273 K 273
           +
Sbjct: 298 R 298

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  468 bits (1208), Expect = e-168
 Identities = 99/277 (35%), Positives = 158/277 (57%), Gaps = 8/277 (2%)

Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
            +  +  +++GR LG+G F  V  AR  +    +A+K+L K ++ K  +  Q++REI   
Sbjct: 9   RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
             +RHPN++RMY     + +IY++LEF   GEL+ ++   GR  E  +  + ++L +A+ 
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCH R V HRD+KPENLL+   G LK++DFG S     +R      T CGT +Y+ PE+I
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMI 184

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
             K +D  K DLW  GV+ Y  + G  PF+  +    +++I   D K PP+ S  +K LI
Sbjct: 185 EGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYK---PPSFEQ 282
           S++L  +P  R+ +  V+E+ W K   +   PP ++ 
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  468 bits (1206), Expect = e-167
 Identities = 111/282 (39%), Positives = 182/282 (64%), Gaps = 4/282 (1%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
           +  +    +  +G Y L +T+G+G+FAKVK AR+  TG  VAIKI+DK + L    + ++
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKL 61

Query: 62  KREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
            RE+  MK++ HPN+++++EV+ ++  +Y+++E+ +GGE+FD + + GR+KE EAR  F+
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           Q+++AV YCH + + HRDLK ENLLLDA+  +K++DFG S    +    G L   CG P 
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPP 178

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFS 241
           Y APE+   K YDG + D+WS GVILY L++G LPF+  NL  L +++ +  ++ P + S
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
           T  + L+ R L  NP+ R T+ +++++ W   G++    +  
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPF 280

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  460 bits (1187), Expect = e-165
 Identities = 98/275 (35%), Positives = 153/275 (55%), Gaps = 5/275 (1%)

Query: 9   SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
            +  +  +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+   
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
             +RHPN++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           YCHS+ V HRD+KPENLLL + G LK++DFG S      R        CGT +Y+ PE+I
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMI 179

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
             + +D  K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LI
Sbjct: 180 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
           SR+L  NP  R  + EV+E+ W       PS  Q 
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  454 bits (1170), Expect = e-162
 Identities = 88/310 (28%), Positives = 149/310 (48%), Gaps = 17/310 (5%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI-----GQIKREIS 66
              KY     LG G+F  V  A + E  + V +K + KEKVL+   I     G++  EI+
Sbjct: 22  YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81

Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEF-VTGGELFDKIASRGRLKEDEARKYFQQLIN 125
            +  + H N+I++ ++  ++    +V+E   +G +LF  I    RL E  A   F+QL++
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           AV Y   + + HRD+K EN+++  +  +K+ DFG +A         L +T CGT  Y AP
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAP 198

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK 245
           EV+    Y G + ++WS GV LY L+    PF E       ++  +A    P   S    
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELM 252

Query: 246 KLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVV 305
            L+S +L P P  R T+ +++ + W  +      +     ++  V+   +  + + +L +
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE--EVFRVNKPESGVLSAASLEM 310

Query: 306 ERREEGPVAP 315
             R    VA 
Sbjct: 311 GNRSLSDVAQ 320

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  441 bits (1137), Expect = e-157
 Identities = 87/289 (30%), Positives = 135/289 (46%), Gaps = 19/289 (6%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI--- 58
               G        +Y LG  LG+G F  V           VAIK++ + +VL    +   
Sbjct: 19  PPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDS 78

Query: 59  GQIKREISTMKLIR----HPNVIRMYEVMASKTKIYIVLEF-VTGGELFDKIASRGRLKE 113
                E++ +  +     HP VIR+ +   ++    +VLE  +   +LFD I  +G L E
Sbjct: 79  VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE 138

Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGL 172
             +R +F Q++ A+ +CHSRGV HRD+K EN+L+D   G  K+ DFG  AL      D  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEP 194

Query: 173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA 232
                GT  Y  PE I+   Y    A +WS G++LY ++ G +PFE        ++I +A
Sbjct: 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEA 248

Query: 233 DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFE 281
           +   P   S     LI R L P P +R ++ E++ + W +   +     
Sbjct: 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  439 bits (1130), Expect = e-156
 Identities = 85/292 (29%), Positives = 134/292 (45%), Gaps = 17/292 (5%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMI--- 58
               G        +Y++G  LG G F  V           VAIK ++K+++     +   
Sbjct: 31  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 90

Query: 59  GQIKREISTMKLIRH--PNVIRMYEVMASKTKIYIVLEFVTG-GELFDKIASRGRLKEDE 115
            ++  E+  +K +      VIR+ +         ++LE      +LFD I  RG L+E+ 
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150

Query: 116 ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLH 174
           AR +F Q++ AV +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL +    D +  
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYT 206

Query: 175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF 234
              GT  Y  PE I    Y G  A +WS G++LY ++ G +PFE        ++I +   
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV 260

Query: 235 KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
                 S+  + LI   L   P  R T  E+  + W +    P    + ++ 
Sbjct: 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  417 bits (1075), Expect = e-147
 Identities = 71/322 (22%), Positives = 134/322 (41%), Gaps = 51/322 (15%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK------------- 56
              +  Y + RTL +G F K+      +  +  A+K  +K  + K +             
Sbjct: 27  DKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIK 84

Query: 57  -MIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK--- 112
                 K E+  +  I++   +    ++ +  ++YI+ E++    +         L    
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 113 -----EDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ 166
                    +   + ++N+  Y H+ + +CHRD+KP N+L+D NG +K+SDFG S     
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--- 201

Query: 167 VRDDGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFE-ESNLMA 224
              D  +  + GT  ++ PE  +N+  Y+GAK D+WS G+ LYV+    +PF  + +L+ 
Sbjct: 202 -MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

Query: 225 LYKKIFKADFKSP-------------------PWFSTSAKKLISRILDPNPVTRITMAEV 265
           L+  I   + + P                    + S      +   L  NP  RIT  + 
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 266 IENEWFKKGYKPPSFEQPNIDL 287
           +++EW           + + +L
Sbjct: 321 LKHEWLAD-TNIEDLREFSKEL 341

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  350 bits (899), Expect = e-121
 Identities = 75/298 (25%), Positives = 134/298 (44%), Gaps = 36/298 (12%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E    LG+G+F +V  ARN       AIK +   +    + +  I  E+  +  + H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQ 62

Query: 75  NVIRMYEV-------------MASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYF 120
            V+R Y               +  K+ ++I +E+   G L+D I S     + DE  + F
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ------------VR 168
           +Q++ A+ Y HS+G+ HRDLKP N+ +D +  +K+ DFGL+    +              
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK 228
               L +  GT  YVA EV++  G+   K D++S G+I + ++  Y        + + KK
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK 240

Query: 229 IFKADFKSPPWF----STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
           +     + PP F        KK+I  ++D +P  R     ++ + W    ++    ++
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  346 bits (890), Expect = e-119
 Identities = 104/315 (33%), Positives = 161/315 (51%), Gaps = 22/315 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMK 69
           +Y + +TLG G+  +VK A   +T + VAIKI+ K K       +      ++ EI  +K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ AV Y
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 130 CHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
            H  G+ HRDLKPEN+LL   + + ++K++DFG S +   + +  L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186

Query: 187 VINNKGYD--GAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWF- 240
           V+ + G        D WS GVIL++ ++GY PF E    ++L  +I     +F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246

Query: 241 -STSAKKLISRILDPNPVTRITMAEVIENEWFKKG---YKPPSFEQPNIDLDDVDSIFNE 296
            S  A  L+ ++L  +P  R T  E + + W +      K         +   +  +  +
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQ 306

Query: 297 SMDSRNLVVERREEG 311
              SR    E   EG
Sbjct: 307 PSTSRKRPREGEAEG 321

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  336 bits (865), Expect = e-116
 Identities = 97/272 (35%), Positives = 155/272 (56%), Gaps = 12/272 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y++   LG+G+F+ V+   +  TG   A KI++ +K L  +   +++RE    + ++HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++ +  ++  Y+V + VTGGELF+ I +R    E +A    QQ++ ++ YCHS G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HR+LKPENLLL        +K++DFGL+    +V D    H   GTP Y++PEV+   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKD 182

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y     D+W+CGVILY+L+ GY PF + +   LY +I     D+ SP W   +  AK L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           I  +L  NP  RIT  + ++  W     +  S
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVAS 273

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  339 bits (871), Expect = e-115
 Identities = 98/283 (34%), Positives = 153/283 (54%), Gaps = 19/283 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMK 69
           +Y + +TLG G+  +VK A   +T + VAI+I+ K K       +      ++ EI  +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP +I++     ++   YIVLE + GGELFDK+    RLKE   + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 130 CHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
            H  G+ HRDLKPEN+LL   + + ++K++DFG S +   + +  L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311

Query: 187 VINNKGYD--GAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPWF- 240
           V+ + G        D WS GVIL++ ++GY PF E    ++L  +I     +F    W  
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371

Query: 241 -STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
            S  A  L+ ++L  +P  R T  E + + W +       F+ 
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  336 bits (863), Expect = e-115
 Identities = 88/275 (32%), Positives = 148/275 (53%), Gaps = 20/275 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-----LKHKMIGQIKREISTMK 69
           KY+    +G G  + V+   +  TG   A+KI++            ++    +RE   ++
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 70  -LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
            +  HP++I + +   S + +++V + +  GELFD +  +  L E E R   + L+ AV 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           + H+  + HRDLKPEN+LLD N  +++SDFG S     +     L   CGTP Y+APE++
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271

Query: 189 ------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW- 239
                  + GY G + DLW+CGVIL+ L+AG  PF     + + + I +    F SP W 
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330

Query: 240 -FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             S++ K LISR+L  +P  R+T  + +++ +F++
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  332 bits (853), Expect = e-114
 Identities = 102/271 (37%), Positives = 148/271 (54%), Gaps = 15/271 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y L  T+G GS+ +VK A    T    A K + K  V   + + + K+EI  MK + HP
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+IR+YE     T IY+V+E  TGGELF+++  +   +E +A +  + +++AV YCH   
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           V HRDLKPEN L      +  LK+ DFGL+A     +   ++ T  GTP YV+P+V+   
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVL-EG 182

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y G + D WS GV++YVL+ GY PF       +  KI +    F    W   S  A+ L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPP 278
           I R+L  +P  RIT  + +E+EWF+K     
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  330 bits (849), Expect = e-113
 Identities = 100/278 (35%), Positives = 154/278 (55%), Gaps = 15/278 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +     LG G+F++V   +   TG+  A+K + K    +   +   + EI+ +K I+H 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL---ENEIAVLKKIKHE 66

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++ + ++  S T  Y+V++ V+GGELFD+I  RG   E +A    QQ+++AV Y H  G
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLL    + N  + ++DFGLS    ++  +G++ T CGTP YVAPEV+  K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y     D WS GVI Y+L+ GY PF E     L++KI +   +F+SP W   S SAK  
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           I  +L+ +P  R T  + + + W            P++
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSV 279

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  329 bits (847), Expect = e-113
 Identities = 90/276 (32%), Positives = 142/276 (51%), Gaps = 21/276 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK------HKMIGQIKREISTM 68
            YE    LG G  + V+   +  T +  A+KI+D             ++     +E+  +
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 69  K-LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           + +  HPN+I++ +   + T  ++V + +  GELFD +  +  L E E RK  + L+  +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
              H   + HRDLKPEN+LLD +  +K++DFG S    Q+     L   CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEI 194

Query: 188 I------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW 239
           I      N+ GY G + D+WS GVI+Y L+AG  PF     M + + I      F SP W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 240 --FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             +S + K L+SR L   P  R T  E + + +F++
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  328 bits (843), Expect = e-113
 Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 17/270 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +   R LG G+F  V       +G    IK ++K++      + QI+ EI  +K + HP
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHP 80

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYC 130
           N+I+++EV      +YIV+E   GGEL ++I S       L E    +  +Q++NA+ Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 131 HSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           HS+ V H+DLKPEN+L      +  +K+ DFGL+ L    + D       GT  Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWF-STSA 244
              +     K D+WS GV++Y L+ G LPF  ++L  + +K      ++       +  A
Sbjct: 198 F-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255

Query: 245 KKLISRILDPNPVTRITMAEVIENEWFKKG 274
             L+ ++L  +P  R + A+V+ +EWFK+ 
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  330 bits (849), Expect = e-112
 Identities = 105/307 (34%), Positives = 164/307 (53%), Gaps = 24/307 (7%)

Query: 1   MASRTGGASRTRVG------------KYELGRTLGEGSFAKVKFARNTETGENVAIKILD 48
           MAS TGG    R               Y++   LG+G+F+ V+   +  TG   A KI++
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 49  KEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR 108
            +K L  +   +++RE    + ++HPN++R+++ +  ++  Y+V + VTGGELF+ I +R
Sbjct: 64  TKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122

Query: 109 GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQ 165
               E +A    QQ++ ++ YCHS G+ HR+LKPENLLL        +K++DFGL+    
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 179

Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL 225
           +V D    H   GTP Y++PEV+    Y     D+W+CGVILY+L+ GY PF + +   L
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRL 238

Query: 226 YKKIFKA--DFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFE 281
           Y +I     D+ SP W   +  AK LI  +L  NP  RIT  + ++  W     +  S  
Sbjct: 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

Query: 282 QPNIDLD 288
                +D
Sbjct: 299 HRQDTVD 305

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  326 bits (839), Expect = e-112
 Identities = 95/266 (35%), Positives = 150/266 (56%), Gaps = 13/266 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y +   LG+GSF +V   ++  T +  A+K+++K    K+K    I RE+  +K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+++++E++   +  YIV E  TGGELFD+I  R R  E +A +  +Q+ + + Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPEN+LL   + +  +K+ DFGLS      + +  +    GT  Y+APEV+   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RG 197

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y   K D+WS GVILY+L++G  PF   N   + K++      F  P W   S  AK L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 248 ISRILDPNPVTRITMAEVIENEWFKK 273
           I ++L  +P  RIT  + +E+ W +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  327 bits (841), Expect = e-112
 Identities = 68/280 (24%), Positives = 133/280 (47%), Gaps = 19/280 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y + + +G G  +KV    N E  +  AIK ++ E+   ++ +   + EI+ +  ++  
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 86

Query: 75  N--VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +  +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +  
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 193 YD----------GAKADLWSCGVILYVLMAGYLPFEE--SNLMALYKKI-FKADFKSPPW 239
                         K+D+WS G ILY +  G  PF++  + +  L+  I    + + P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
                + ++   L  +P  RI++ E++ + + +    P +
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  321 bits (825), Expect = e-109
 Identities = 68/302 (22%), Positives = 140/302 (46%), Gaps = 20/302 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y + + +G G  +KV    N E  +  AIK ++ E+   ++ +   + EI+ +  ++  
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67

Query: 75  N--VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +  +IR+Y+   +   IY+V+E     +L   +  +  +   E + Y++ ++ AV   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  GT NY+ PE I +  
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 193 YD----------GAKADLWSCGVILYVLMAGYLPFEE--SNLMALYKKI-FKADFKSPPW 239
                         K+D+WS G ILY +  G  PF++  + +  L+  I    + + P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMD 299
                + ++   L  +P  RI++ E++ + + +    P + +      +++  +  + + 
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN-QMAKGTTEEMKYVLGQLVG 304

Query: 300 SR 301
             
Sbjct: 305 LN 306

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  323 bits (830), Expect = e-108
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 13/273 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+L   LG+G+F+ V+       G+  A  I++ +K+       +++RE    +L++HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++ ++ +   Y++ + VTGGELF+ I +R    E +A    QQ++ AV +CH  G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVAPEVINN 190
           V HR+LKPENLLL        +K++DFGL+    +V  +        GTP Y++PEV+  
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKK 246
             Y G   DLW+CGVILY+L+ GY PF + +   LY++I     DF SP W   +  AK 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 247 LISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           LI+++L  NP  RIT AE +++ W        S
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVAS 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  319 bits (818), Expect = e-108
 Identities = 66/308 (21%), Positives = 117/308 (37%), Gaps = 52/308 (16%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + L   LG+G+ A V   R+ +TG+  AIK+ +    L+   +    RE   +K + H N
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68

Query: 76  VIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYC 130
           +++++ +    T     +++EF   G L+  +        L E E     + ++  +++ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 131 HSRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
              G+ HR++KP N++     D   V K++DFG +    ++ DD    +  GT  Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185

Query: 187 VI--------NNKGYDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKI----- 229
           +         + K Y GA  DLWS GV  Y    G LPF           +  KI     
Sbjct: 186 MYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 230 --------------FKADFKSPPWFSTS------AKKLISRILDPNPVTRITMAEVIENE 269
                                P   S S         +++ IL+ +        +     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

Query: 270 WFKKGYKP 277
                   
Sbjct: 305 SDILHRGN 312

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  321 bits (824), Expect = e-108
 Identities = 68/316 (21%), Positives = 142/316 (44%), Gaps = 20/316 (6%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
            +S        +   Y + + +G G  +KV    N E  +  AIK ++ E+   ++ +  
Sbjct: 43  ASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDS 100

Query: 61  IKREISTMKLIRHPN--VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
            + EI+ +  ++  +  +IR+Y+   +   IY+V+E     +L   +  +  +   E + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 159

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
           Y++ ++ AV   H  G+ H DLKP N L+  +G+LK+ DFG++   Q      +  +  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 179 TPNYVAPEVINNKGYD----------GAKADLWSCGVILYVLMAGYLPFEE--SNLMALY 226
             NY+ PE I +                K+D+WS G ILY +  G  PF++  + +  L+
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 227 KKI-FKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
             I    + + P       + ++   L  +P  RI++ E++ + + +    P + +    
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN-QMAKG 337

Query: 286 DLDDVDSIFNESMDSR 301
             +++  +  + +   
Sbjct: 338 TTEEMKYVLGQLVGLN 353

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  330 bits (847), Expect = e-108
 Identities = 74/339 (21%), Positives = 127/339 (37%), Gaps = 42/339 (12%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
             R+        G +E+   LG G F  V    + +TGE VAIK   +E  L  K   + 
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERW 59

Query: 62  KREISTMKLIRHPNVIRMYEVMASKTKI------YIVLEFVTGGELFDKIASRGR---LK 112
             EI  MK + HPNV+   EV     K+       + +E+  GG+L   +        LK
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119

Query: 113 EDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQQVRD 169
           E   R     + +A+ Y H   + HRDLKPEN++L       + K+ D G +   +++  
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQ 176

Query: 170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKK 228
             L     GT  Y+APE++  K Y     D WS G + +  + G+ PF      +  + K
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

Query: 229 IFKADFKSPPWFSTS-----------------------AKKLISRILDPNPVTRITMAEV 265
           + +   +    +                           ++ +  +L  +   R T  + 
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295

Query: 266 IENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLV 304
                F+      S +  ++       +    +     +
Sbjct: 296 PNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENL 334

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  321 bits (825), Expect = e-107
 Identities = 95/282 (33%), Positives = 154/282 (54%), Gaps = 14/282 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y +   LG+GSF +V   ++  T +  A+K+++K    K+K    I RE+  +K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+++++E++   +  YIV E  TGGELFD+I  R R  E +A +  +Q+ + + Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPEN+LL   + +  +K+ DFGLS      + +  +    GT  Y+APEV+   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RG 197

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y   K D+WS GVILY+L++G  PF   N   + K++      F  P W   S  AK L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDD 289
           I ++L  +P  RIT  + +E+ W  + Y   +    ++   +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWI-QKYSSETPTISDLPSLE 297

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  316 bits (811), Expect = e-107
 Identities = 95/267 (35%), Positives = 150/267 (56%), Gaps = 17/267 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E+   LG G+ + V   +   T +  A+K+L K    K      ++ EI  +  + HP
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVLLRLSHP 108

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+I++ E+  + T+I +VLE VTGGELFD+I  +G   E +A    +Q++ AV Y H  G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLL      +  LK++DFGLS   + V    L+ T CGTP Y APE++   
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGC 225

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKA--DFKSPPW--FSTSAKK 246
            Y G + D+WS G+I Y+L+ G+ PF +E     ++++I      F SP W   S +AK 
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 247 LISRILDPNPVTRITMAEVIENEWFKK 273
           L+ +++  +P  R+T  + +++ W   
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTG 311

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  314 bits (806), Expect = e-106
 Identities = 90/310 (29%), Positives = 144/310 (46%), Gaps = 51/310 (16%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--LKHKMIGQIKREISTMKLIR 72
           KY L   +G+GS+  V+ A   +T    AIKI++K K+  +  K + +IK E+  MK + 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---------------------- 110
           HPN+ R+YEV   +  I +V+E   GG L DK+                           
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 111 ------------------LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL--DAN 150
                              +E       +Q+ +A+ Y H++G+CHRD+KPEN L   + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 151 GVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNYVAPEVINNKGYD-GAKADLWSCGVIL 207
             +K+ DFGLS         +   + T  GTP +VAPEV+N      G K D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 208 YVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKLISRILDPNPVTRITMA 263
           ++L+ G +PF   N      ++      F++P +   S  A+ L+S +L+ N   R    
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326

Query: 264 EVIENEWFKK 273
             +++ W  +
Sbjct: 327 RALQHPWISQ 336

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  313 bits (805), Expect = e-106
 Identities = 91/279 (32%), Positives = 150/279 (53%), Gaps = 19/279 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ--IKREISTMKLIR 72
            YEL   +G+G F+ V+   N ETG+  A+KI+D  K      +    +KRE S   +++
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK----EDEARKYFQQLINAVD 128
           HP+++ + E  +S   +Y+V EF+ G +L  +I  R        E  A  Y +Q++ A+ 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 129 YCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYVA 184
           YCH   + HRD+KP  +LL   + +  +K+  FG++    Q+ + G +     GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--F 240
           PEV+  + Y G   D+W CGVIL++L++G LPF  +    L++ I K         W   
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259

Query: 241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           S SAK L+ R+L  +P  RIT+ E + + W K+  +   
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  311 bits (799), Expect = e-106
 Identities = 96/270 (35%), Positives = 154/270 (57%), Gaps = 15/270 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLI 71
            YE+G  LG G FA V+  R   TG+  A K + K ++   +      +I+RE++ ++ I
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           RHPN+I ++++  +KT + ++LE V+GGELFD +A +  L EDEA ++ +Q+++ V Y H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 132 SRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S+ + H DLKPEN++L      N  +K+ DFG++    ++          GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEI 182

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTS 243
           +N +   G +AD+WS GVI Y+L++G  PF           I     DF    +   S  
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKK 273
           AK  I R+L  +P  R+T+A+ +E+ W K 
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  312 bits (802), Expect = e-106
 Identities = 92/277 (33%), Positives = 139/277 (50%), Gaps = 22/277 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRH 73
            YE+   +G GS++  K   +  T    A+KI+DK K            EI  + +  +H
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           PN+I + +V      +Y+V E + GGEL DKI  +    E EA      +   V+Y H++
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135

Query: 134 GVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
           GV HRDLKP N+L          +++ DFG +   Q   ++GLL T C T N+VAPEV+ 
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLE 193

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIFKA--DFKSPPW--FST 242
            +GYD A  D+WS GV+LY ++ GY PF    +     +  +I           W   S 
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252

Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           +AK L+S++L  +P  R+T A V+ + W     + P 
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  317 bits (814), Expect = e-106
 Identities = 100/282 (35%), Positives = 156/282 (55%), Gaps = 14/282 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+  R LG+GSF +V   ++  TG+  A+K++ K +V +      + RE+  +K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++YE    K   Y+V E  TGGELFD+I SR R  E +A +  +Q+++ + Y H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLLL     +  +++ DFGLS           +    GT  Y+APEV+ + 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HG 202

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y   K D+WS GVILY+L++G  PF  +N   + KK+ K    F+ P W   S SAK L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDD 289
           I ++L   P  RI+  + +++EW +   K       ++   D
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTK--EQISVDVPSLD 301

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  314 bits (805), Expect = e-105
 Identities = 63/307 (20%), Positives = 114/307 (37%), Gaps = 52/307 (16%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           + L   LG+G+ A V   R+ +TG+  AIK+ +    L+   +    RE   +K + H N
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68

Query: 76  VIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYC 130
           +++++ +    T     +++EF   G L+  +        L E E     + ++  +++ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 131 HSRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
              G+ HR++KP N++     D   V K++DFG +    ++ DD    +  GT  Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185

Query: 187 VI--------NNKGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIFKADF 234
           +         + K Y GA  DLWS GV  Y    G LPF           +  KI     
Sbjct: 186 MYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 235 KS-------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENE 269
                                                +++ IL+ +        +     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

Query: 270 WFKKGYK 276
                  
Sbjct: 305 SDILHRM 311

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  314 bits (807), Expect = e-104
 Identities = 96/283 (33%), Positives = 151/283 (53%), Gaps = 13/283 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y+  + LG G++ +V   R+  T    AIKI+ K   +      ++  E++ +KL+ HP
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++Y+    K   Y+V+E   GGELFD+I  R +  E +A    +Q+++ V Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLLL   + + ++K+ DFGLSA+     +   +    GT  Y+APEV+  K
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVL-RK 212

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
            Y   K D+WS GVIL++L+AGY PF       + +K+ K    F SP W   S  AK L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDV 290
           I ++L  +   RI+  + +E+ W K+             L + 
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  307 bits (789), Expect = e-104
 Identities = 96/276 (34%), Positives = 148/276 (53%), Gaps = 15/276 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM---IGQIKREISTMKLI 71
            Y+ G  LG G FA VK  R   TG   A K + K +    +       I+RE+S +K I
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 132 SRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L         +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTS 243
           +N +   G +AD+WS GVI Y+L++G  PF           +     +F+   +   S  
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           AK  I R+L  +P  R+T+ + +++ W K      +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  313 bits (804), Expect = e-104
 Identities = 96/296 (32%), Positives = 147/296 (49%), Gaps = 22/296 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG----------QIKRE 64
            Y   R LG G++ +V   +        AIK++ K +  K +             +I  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
           IS +K + HPN+I++++V   K   Y+V EF  GGELF++I +R +  E +A    +Q++
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 125 NAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           + + Y H   + HRD+KPEN+LL   ++   +K+ DFGLS        D  L    GT  
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW 239
           Y+APEV+  K Y   K D+WSCGVI+Y+L+ GY PF   N   + KK+ K    F    W
Sbjct: 214 YIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271

Query: 240 --FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSI 293
              S  AK+LI  +L  +   R T  E + + W KK     +          + ++
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  306 bits (787), Expect = e-104
 Identities = 90/280 (32%), Positives = 147/280 (52%), Gaps = 15/280 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG---QIKREISTMKLI 71
            Y++G  LG G FA VK  R   TG   A K + K +    +      +I+RE+S ++ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            H NVI +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 132 SRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           ++ + H DLKPEN++L         +K+ DFGL+    ++ D        GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTS 243
           +N +   G +AD+WS GVI Y+L++G  PF           I     DF    +   S  
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
           AK  I ++L      R+T+ E + + W        +  + 
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  306 bits (785), Expect = e-103
 Identities = 98/283 (34%), Positives = 152/283 (53%), Gaps = 27/283 (9%)

Query: 15  KYELG---RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            Y+L    + LGEGSF+  +   + ++ +  A+KI+ K            ++EI+ +KL 
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN------TQKEITALKLC 62

Query: 72  R-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
             HPN+++++EV   +   ++V+E + GGELF++I  +    E EA    ++L++AV + 
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 131 HSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           H  GV HRDLKPENLL    + N  +K+ DFG + L     D+  L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIFKA------DFKSPP 238
           +N  GYD    DLWS GVILY +++G +PF   + S       +I K        F+   
Sbjct: 181 LNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

Query: 239 W--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           W   S  AK LI  +L  +P  R+ M+ +  NEW + G +  S
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  305 bits (782), Expect = e-102
 Identities = 91/280 (32%), Positives = 148/280 (52%), Gaps = 15/280 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK---HKMIGQIKREISTMKLI 71
            Y++G  LG G FA VK  R   TG   A K + K +           +I+RE+S ++ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            HPN+I +++V  ++T + ++LE V+GGELFD +A +  L E+EA  + +Q+++ V+Y H
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 132 SRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           ++ + H DLKPEN++L         +K+ DFGL+    ++ D        GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPWFSTS-- 243
           +N +   G +AD+WS GVI Y+L++G  PF           I     DF    +  TS  
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
           AK  I ++L      R+T+ E + + W        +  + 
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  299 bits (767), Expect = e-101
 Identities = 69/272 (25%), Positives = 129/272 (47%), Gaps = 15/272 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY +   LG G F  V     T + +    K +  +   +      +K+EIS + + RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARHR 61

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSR 133
           N++ ++E   S  ++ ++ EF++G ++F++I +    L E E   Y  Q+  A+ + HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 134 GVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + H D++PEN++     +  +K+ +FG +   +Q++           P Y APEV  + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
                  D+WS G ++YVL++G  PF       + + I  A   F    +   S  A   
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           + R+L     +R+T +E +++ W K+  +  S
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  299 bits (767), Expect = e-100
 Identities = 89/305 (29%), Positives = 146/305 (47%), Gaps = 35/305 (11%)

Query: 15  KYELGR-TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIR 72
            Y+L +  LG G   KV    +  TG+  A+K+L            + ++E+    +   
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80

Query: 73  HPNVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLK--EDEARKYFQQLINA 126
            P+++ + +V       K  + I++E + GGELF +I  RG     E EA +  + +  A
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 127 VDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
           + + HS  + HRD+KPENLL    + + VLK++DFG +           L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYV 196

Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKA--DFKSP 237
           APEV+  + YD    D+WS GVI+Y+L+ G+ PF     ++    + ++I      F +P
Sbjct: 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 238 PW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFN 295
            W   S  AK+LI  +L  +P  R+T+ + + + W  +    P   Q  +    V     
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP---QTPLHTARVLQEDK 312

Query: 296 ESMDS 300
           +  D 
Sbjct: 313 DHWDE 317

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  297 bits (762), Expect = e-100
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 16/277 (5%)

Query: 15  KYEL-GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            Y L  + LG G FA V+   +  TG+  A K L K +        +I  EI+ ++L + 
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87

Query: 74  -PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYC 130
            P VI ++EV  + ++I ++LE+  GGE+F          + E++  +  +Q++  V Y 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 131 HSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           H   + H DLKP+N+LL      G +K+ DFG+S   +++     L    GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTS 243
           +N         D+W+ G+I Y+L+    PF   +    Y  I +   D+    +   S  
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSF 280
           A   I  +L  NP  R T    + + W ++      F
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  298 bits (766), Expect = 1e-99
 Identities = 91/282 (32%), Positives = 139/282 (49%), Gaps = 30/282 (10%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRHP 74
               + LG G   KV    N  T E  A+K+L            + +RE+       + P
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCP 115

Query: 75  NVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLK--EDEARKYFQQLINAVD 128
           +++R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 129 YCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           Y HS  + HRD+KPENLL      N +LK++DFG +   ++      L T C TP YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAP 232

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA------DFKSPPW 239
           EV+  + YD    D+WS GVI+Y+L+ GY PF  ++ +A+   +         +F +P W
Sbjct: 233 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291

Query: 240 --FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
              S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  295 bits (757), Expect = 2e-99
 Identities = 88/294 (29%), Positives = 144/294 (48%), Gaps = 38/294 (12%)

Query: 15  KYELGR-TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIR 72
            Y+L    LGEG+ A+V+   N  T +  A+KI++K+      +  ++ RE+  +     
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV+ + E    + + Y+V E + GG +   I  R    E EA    Q + +A+D+ H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 133 RGVCHRDLKPENLLL---DANGVLKVSDFGLSAL-----PQQVRDDGLLHTTCGTPNYVA 184
           +G+ HRDLKPEN+L    +    +K+ DF L +               L T CG+  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 185 PEVIN-----NKGYDGAKADLWSCGVILYVLMAGYLPF---------------EESNLMA 224
           PEV+         YD  + DLWS GVILY+L++GY PF                 +    
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 225 LYKKIFKA--DFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG 274
           L++ I +   +F    W   S +AK LIS++L  +   R++ A+V+++ W +  
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  295 bits (756), Expect = 3e-98
 Identities = 76/280 (27%), Positives = 137/280 (48%), Gaps = 14/280 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y++   LG G+F  V       TG     K ++    L    +   K EIS M  + HP
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHP 108

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSR 133
            +I +++    K ++ ++LEF++GGELFD+IA+   ++ E E   Y +Q    + + H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 134 GVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + H D+KPEN++        +K+ DFGL+    ++  D ++  T  T  + APE+++ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDRE 225

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
              G   D+W+ GV+ YVL++G  PF   + +   + + +   +F    +   S  AK  
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDL 287
           I  +L   P  R+T+ + +E+ W K  +   +   P+   
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 324

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  289 bits (742), Expect = 2e-96
 Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 16/268 (5%)

Query: 15  KYELGRT--LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            Y + +T  LG G F +V     T TG  +A KI+    +   + +   K EIS M  + 
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV---KNEISVMNQLD 144

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCH 131
           H N+I++Y+   SK  I +V+E+V GGELFD+I      L E +   + +Q+   + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 132 SRGVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
              + H DLKPEN+L        +K+ DFGL+   ++ +    L    GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAK 245
                    D+WS GVI Y+L++G  PF   N       I     D +   +   S  AK
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320

Query: 246 KLISRILDPNPVTRITMAEVIENEWFKK 273
           + IS++L      RI+ +E +++ W   
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSD 348

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  288 bits (739), Expect = 5e-96
 Identities = 51/316 (16%), Positives = 103/316 (32%), Gaps = 57/316 (18%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           + S  G   RT       G  LG+        A + ETGE+  + +    +      I Q
Sbjct: 64  VESELGERPRT----LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQ 119

Query: 61  IKREISTMKLIR-------------------------HPNVIRMYEVMASKTKIYIVLEF 95
           +K E+  ++L+R                            +IR+         +     +
Sbjct: 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179

Query: 96  --------VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL 147
                     G  L    ++   L      +   Q+I  +   H  G+ H  L+P +++L
Sbjct: 180 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 239

Query: 148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI----------NNKGYDGAK 197
           D  G + ++ F           DG    +  +  +  PE+           + +      
Sbjct: 240 DQRGGVFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPV 257
            D W+ G+++Y +    LP  +   +   + I    F+S        + L+   L     
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKE 349

Query: 258 TRITMAEVIENEWFKK 273
            R+   + +E   +++
Sbjct: 350 DRLLPLQAMETPEYEQ 365

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  287 bits (735), Expect = 8e-96
 Identities = 87/314 (27%), Positives = 137/314 (43%), Gaps = 34/314 (10%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRH 73
           +  + R L EG FA V  A++  +G   A+K L   +    +    I +E+  MK L  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGH 85

Query: 74  PNVIRMY-------EVMASKTKIYIVLEFVTGGELFDKI---ASRGRLKEDEARKYFQQL 123
           PN+++         E   +    +++L  +  G+L + +    SRG L  D   K F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 124 INAVDYCHSRG--VCHRDLKPENLLLDANGVLKVSDFGLSALP----------QQVRDDG 171
             AV + H +   + HRDLK ENLLL   G +K+ DFG +             Q+     
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 172 LLHTTCGTPNYVAPEVIN--NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI 229
              T   TP Y  PE+I+  +    G K D+W+ G ILY+L     PFE+   +     I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----I 261

Query: 230 FKADFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDL 287
               +  PP     T    LI  +L  NP  R+++AEV+         +  + + P  +L
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321

Query: 288 DDVDSIFNESMDSR 301
            + +  +  +  SR
Sbjct: 322 LEQNGGYGSATLSR 335

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  294 bits (754), Expect = 9e-96
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 14/272 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y++   LG G+F  V       TG N A K +             +++EI TM ++RHP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHP 214

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSR 133
            ++ +++      ++ ++ EF++GGELF+K+     ++ EDEA +Y +Q+   + + H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 134 GVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
              H DLKPEN++     +  LK+ DFGL+     +     +  T GT  + APEV   K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGK 331

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSPPW--FSTSAKKL 247
              G   D+WS GV+ Y+L++G  PF   N     + +     +     +   S   K  
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           I ++L  +P TR+T+ + +E+ W   G  P  
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  278 bits (713), Expect = 8e-93
 Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 23/285 (8%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y   + LGEG F+ V        G   A+K +   +    +   + +RE    +L  HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHP 86

Query: 75  NVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINA 126
           N++R+         +K + +++L F   G L+++I         L ED+       +   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP-------QQVRDDGLLHTTCGT 179
           ++  H++G  HRDLKP N+LL   G   + D G            +Q            T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 180 PNYVAPEVINNKGYD--GAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFKADFKS 236
            +Y APE+ + + +     + D+WS G +LY +M G  P++             +     
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 237 PPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           P     S++  +L++ ++  +P  R  +  ++      +   P  
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  274 bits (703), Expect = 3e-91
 Identities = 81/264 (30%), Positives = 138/264 (52%), Gaps = 7/264 (2%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
            +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y H +G+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            HRDLKPEN+LL+ +  ++++DFG + +          ++  GT  YV+PE++  K    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           + +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ ++L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270

Query: 256 PVTRIT------MAEVIENEWFKK 273
              R+          +  + +F+ 
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  271 bits (696), Expect = 1e-90
 Identities = 84/275 (30%), Positives = 139/275 (50%), Gaps = 16/275 (5%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           +R   YE+  T+G GS+ + +  R    G+ +  K LD    +       +  E++ ++ 
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE 61

Query: 71  IRHPNVIRMYE--VMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLI 124
           ++HPN++R Y+  +  + T +YIV+E+  GG+L   I    +    L E+   +   QL 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 125 NAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
            A+  CH R      V HRDLKP N+ LD    +K+ DFGL+ +     D     T  GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGT 179

Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PP 238
           P Y++PE +N   Y+  K+D+WS G +LY L A   PF   +   L  KI +  F+  P 
Sbjct: 180 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238

Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            +S    ++I+R+L+     R ++ E++EN    +
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  270 bits (693), Expect = 3e-89
 Identities = 76/262 (29%), Positives = 137/262 (52%), Gaps = 7/262 (2%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY   + +GEGSF K    ++TE G    IK ++  + +  K   + +RE++ +  ++HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI--ASRGRLKEDEARKYFQQLINAVDYCHS 132
           N+++  E       +YIV+++  GG+LF +I        +ED+   +F Q+  A+ + H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R + HRD+K +N+ L  +G +++ DFG++ +        L     GTP Y++PE+  NK 
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISRI 251
           Y+  K+D+W+ G +LY L      FE  ++  L  KI    F      +S   + L+S++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260

Query: 252 LDPNPVTRITMAEVIENEWFKK 273
              NP  R ++  ++E  +  K
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  273 bits (700), Expect = 3e-89
 Identities = 80/335 (23%), Positives = 128/335 (38%), Gaps = 54/335 (16%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRH 73
                + LG GS   V F   +  G  VA+K +  +             EI  + +   H
Sbjct: 16  LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINA 126
           PNVIR Y    +   +YI LE      L D + S+          KE       +Q+ + 
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 127 VDYCHSRGVCHRDLKPENLLLD-------------ANGVLKVSDFGLSAL--PQQVRDDG 171
           V + HS  + HRDLKP+N+L+               N  + +SDFGL       Q     
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 172 LLHTTCGTPNYVAPEVINNKGYD------GAKADLWSCGVILYVLM-AGYLPFEESNLMA 224
            L+   GT  + APE++                D++S G + Y ++  G  PF +     
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246

Query: 225 LYKKIFKA-----DFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
               I +      + K          A  LIS+++D +P+ R T  +V+ +  F    K 
Sbjct: 247 -ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305

Query: 278 PSFEQPNIDLDDV-DSIFNESMDSRNLVVERREEG 311
             F      L  V D +  E+ D  + ++ + + G
Sbjct: 306 LEF------LLKVSDRLEIENRDPPSALLMKFDAG 334

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  264 bits (677), Expect = 2e-87
 Identities = 82/282 (29%), Positives = 127/282 (45%), Gaps = 51/282 (18%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
               + LG G   KV    N  T E  A+K+L            + +RE+    +  + P
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCP 71

Query: 75  NVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLK--EDEARKYFQQLINAVD 128
           +++R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  + +  A+ 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 129 YCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           Y HS  + HRD+KPENLL      N +LK++DFG                        A 
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA------DFKSPPW 239
           E    + YD    D+WS GVI+Y+L+ GY PF  ++ +A+   +         +F +P W
Sbjct: 169 ETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 240 --FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
              S   K LI  +L   P  R+T+ E + + W  +  K P 
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  262 bits (672), Expect = 3e-85
 Identities = 72/309 (23%), Positives = 121/309 (39%), Gaps = 31/309 (10%)

Query: 9   SRTRVGK--YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS 66
           S   VGK  +     LG G+   + + R      +VA+K +  E            RE+ 
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADREVQ 69

Query: 67  TMK-LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLI 124
            ++    HPNVIR +     +   YI +E      L + +  +       E     QQ  
Sbjct: 70  LLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTT 128

Query: 125 NAVDYCHSRGVCHRDLKPENLLL-----DANGVLKVSDFGLSA-LPQQVRDDGLLHTTCG 178
           + + + HS  + HRDLKP N+L+            +SDFGL   L              G
Sbjct: 129 SGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 179 TPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF 234
           T  ++APE+++    +       D++S G + Y +++ G  PF +S        +     
Sbjct: 189 TEGWIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247

Query: 235 KSPPWF---STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVD 291
                       A++LI +++  +P  R +   V+++ +F    K   F Q     D  D
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQ-----DVSD 302

Query: 292 SIFNESMDS 300
            I  ES+D 
Sbjct: 303 RIEKESLDG 311

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  256 bits (657), Expect = 9e-85
 Identities = 64/276 (23%), Positives = 118/276 (42%), Gaps = 33/276 (11%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++    +G G F +V  A++   G+   IK +            + +RE+  +  + H N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDHVN 65

Query: 76  VIRMYE----------------VMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEAR 117
           ++                      +    ++I +EF   G L   I  R   +L +  A 
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
           + F+Q+   VDY HS+ + +RDLKP N+ L     +K+ DFGL      +++DG    + 
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSK 182

Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP 237
           GT  Y++PE I+++ Y   + DL++ G+IL  L+       E++    +  +        
Sbjct: 183 GTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII--S 237

Query: 238 PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             F    K L+ ++L   P  R   +E++      K
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  256 bits (656), Expect = 3e-84
 Identities = 86/288 (29%), Positives = 140/288 (48%), Gaps = 11/288 (3%)

Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK 62
           +         +  + + + +G G F++V  A     G  VA+K +    ++  K      
Sbjct: 21  ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80

Query: 63  REISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARK 118
           +EI  +K + HPNVI+ Y       ++ IVLE    G+L   I    +    + E    K
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
           YF QL +A+++ HSR V HRD+KP N+ + A GV+K+ D GL             H+  G
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVG 198

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKADFKS 236
           TP Y++PE I+  GY+  K+D+WS G +LY + A   PF  ++ NL +L KKI + D+  
Sbjct: 199 TPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257

Query: 237 PPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ 282
            P   +S   ++L++  ++P+P  R  +  V +           S E 
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  257 bits (660), Expect = 3e-84
 Identities = 93/277 (33%), Positives = 151/277 (54%), Gaps = 20/277 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E   ++ +  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y HS  +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPENLL+D  G ++V+DFG +      R  G   T CGTP  +APE+I +KGY+ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNK 217

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           A  D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  +L  +
Sbjct: 218 A-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

Query: 256 PVTRI-----TMAEVIENEWFK---------KGYKPP 278
              R       + ++  ++WF          +  + P
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  255 bits (655), Expect = 6e-84
 Identities = 98/290 (33%), Positives = 164/290 (56%), Gaps = 22/290 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++ RTLG GSF +V   R+   G   A+K+L KE V++ K +     E   + ++ HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +IRM+       +I+++++++ GGELF  +    R     A+ Y  ++  A++Y HS+ +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPEN+LLD NG +K++DFG +          + +T CGTP+Y+APEV++ K Y+ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           +  D WS G+++Y ++AGY PF +SN M  Y+KI  A+ + PP+F+   K L+SR++  +
Sbjct: 183 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241

Query: 256 PVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNIDLDDVD 291
              R+        +V  + WFK         +  + P +E P I     D
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP-YE-PPIQQGQGD 289

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  254 bits (651), Expect = 9e-83
 Identities = 46/315 (14%), Positives = 88/315 (27%), Gaps = 51/315 (16%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           + S      R      +L   L  G  + V   R+ E  E+ A+K+           + +
Sbjct: 53  VDSLLSQGERK----LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108

Query: 61  IKREISTMKLIRHPNVIRMYEVM--------------------------ASKTKIYIVLE 94
           +         +   +     +                             +     +++ 
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 95  FVTG-----GELFDKIASRGRLKEDEARKYF-QQLINAVDYCHSRGVCHRDLKPENLLLD 148
             +          D +      +   A      QLI       S+G+ H    P+NL + 
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM 228

Query: 149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD-GAKADLWSCGVIL 207
            +G L + D          +       +     Y   E +N          + W  G+ +
Sbjct: 229 PDGRLMLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283

Query: 208 YVLMAGYLPFEESN--LMALYKKIFKA-------DFKSPPWFSTSAKKLISRILDPNPVT 258
           Y +   +LPF      +   +K+            F S        K LI R L+ +   
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343

Query: 259 RITMAEVIENEWFKK 273
           R+   E +E   F +
Sbjct: 344 RLLPLEAMETPEFLQ 358

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  250 bits (641), Expect = 5e-82
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 10/261 (3%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            ++    LG GS+ +V   R+ E G   A+K              ++    S  K+ +HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSR 133
             +R+ +       +Y+  E   G  L     + G  L E +   Y +  + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ H D+KP N+ L   G  K+ DFGL     ++   G      G P Y+APE++    Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232

Query: 194 DGAKADLWSCGVILYVLMAGY-LPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL 252
               AD++S G+ +  +     LP        L +     +F      S+  + ++  +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289

Query: 253 DPNPVTRITMAEVIENEWFKK 273
           +P+P  R T   ++     ++
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  247 bits (633), Expect = 6e-81
 Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 33/292 (11%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E  + LG G F  V  A+N     N AIK +        +   ++ RE+  +  + HP
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHP 63

Query: 75  NVIRMYEV------------MASKTKIYIVLEFVTGGELFDKIASRGRLK---EDEARKY 119
            ++R +               + K  +YI ++      L D +  R  ++          
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL----------PQQVRD 169
           F Q+  AV++ HS+G+ HRDLKP N+    + V+KV DFGL                +  
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKK 228
                   GT  Y++PE I+   Y   K D++S G+IL+ L+    PF  +   +     
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239

Query: 229 IFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           +    F             ++  +L P+P+ R     +IEN  F+    P  
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  250 bits (639), Expect = 1e-80
 Identities = 54/326 (16%), Positives = 107/326 (32%), Gaps = 46/326 (14%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           + S  G   RT       G  LG+        A + ETGE+  + +    +      I Q
Sbjct: 69  VESELGERPRT----LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQ 124

Query: 61  IKREISTMKLIR----------------------HPNVIRMYEVMASKTKIYIVLEFVT- 97
           +K E+  ++L+R                       P   +M  V   +  ++++  F   
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 98  ----------GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL 147
                     G  L    ++   L      +   Q+I  +   H  G+ H  L+P +++L
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244

Query: 148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK----ADLWSC 203
           D  G + ++ F    +         +      P   A  ++    +         D W+ 
Sbjct: 245 DQRGGVFLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303

Query: 204 GVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMA 263
           G+ +Y +    LP  +   +   + IF++    P       + L+   L      R+   
Sbjct: 304 GLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP----VRALLEGFLRYPKEDRLLPL 359

Query: 264 EVIENEWFKKGYKPPSFEQPNIDLDD 289
           + +E   +++     S   P    D 
Sbjct: 360 QAMETPEYEQLRTELSAALPLYQTDG 385

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  243 bits (622), Expect = 2e-78
 Identities = 42/287 (14%), Positives = 103/287 (35%), Gaps = 34/287 (11%)

Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
              +   LGEG+FA+V  A      + +  +   +K+       +  +     + +  +K
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQLMERLK 122

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-----LKEDEARKYFQQLI 124
                  ++ Y     +    +V E  + G L + I          + +     +  +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 125 NAVDYCHSRGVCHRDLKPENLLL-----------DANGVLKVSDFGLSALPQQVRDDGLL 173
             ++  H   + H D+KP+N +L           D +  L + D G S   +      + 
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 174 HTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKA 232
              C T  +   E+++NK ++  + D +     +Y ++ G Y+  +        + +F+ 
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 233 DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE---NEWFKKGYK 276
                 W      +    +L+      +   +++     + F++ Y 
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  242 bits (620), Expect = 6e-78
 Identities = 77/299 (25%), Positives = 149/299 (49%), Gaps = 23/299 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           E+ R +G+GSF KV   +  +T +  A+K ++K+K ++   +  + +E+  M+ + HP +
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVC 136
           + ++     +  +++V++ + GG+L   +      KE+  + +  +L+ A+DY  ++ + 
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137

Query: 137 HRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK---GY 193
           HRD+KP+N+LLD +G + ++DF ++A    +  +  + T  GT  Y+APE+ +++   GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 194 DGAKADLWSCGVILYVLMAGYLPFE---ESNLMALYKKIFKADFKSPPWFSTSAKKLISR 250
             A  D WS GV  Y L+ G  P+     ++   +           P  +S     L+ +
Sbjct: 195 SFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253

Query: 251 ILDPNPVTRI-TMAEVIENEWFK---------KGYKPPSFEQPNIDLDDVDSIF-NESM 298
           +L+PNP  R   +++V    +           K   P  F  PN    + D  F  E M
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPG-FI-PNKGRLNCDPTFELEEM 310

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  224 bits (574), Expect = 2e-71
 Identities = 95/297 (31%), Positives = 153/297 (51%), Gaps = 23/297 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           ++  + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++  RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +  +     +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y HSR V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RD+K ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ +  Y  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
           A  D W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++ +L  +
Sbjct: 185 A-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243

Query: 256 PVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDVDSIF 294
           P  R+        EV+E+ +F          K   PP F +P +    D    D  F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP-F-KPQVTSEVDTRYFDDEF 298

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  226 bits (578), Expect = 3e-71
 Identities = 88/290 (30%), Positives = 147/290 (50%), Gaps = 26/290 (8%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   YE+ + +G G+F +V+  R+  T +  A+K+L K +++K         E   M 
Sbjct: 65  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
               P V++++        +Y+V+E++ GG+L   + S   + E  AR Y  +++ A+D 
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL--HTTCGTPNYVAPEV 187
            HS G  HRD+KP+N+LLD +G LK++DFG      ++  +G++   T  GTP+Y++PEV
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEV 240

Query: 188 INNKGYD---GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSP--PWF 240
           + ++G D   G + D WS GV LY ++ G  PF   +L+  Y KI   K     P     
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300

Query: 241 STSAKKLISRILDPNPVTRIT---MAEVIENEWFK---------KGYKPP 278
           S  AK LI   L  +   R+    + E+  + +FK         +    P
Sbjct: 301 SKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAP 349

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  223 bits (571), Expect = 3e-71
 Identities = 97/314 (30%), Positives = 164/314 (52%), Gaps = 27/314 (8%)

Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMI 58
           S   G  + R   +EL R LG+G + KV   R      TG+  A+K+L K  ++   K  
Sbjct: 6   SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65

Query: 59  GQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARK 118
              K E + ++ ++HP ++ +     +  K+Y++LE+++GGELF ++   G   ED A  
Sbjct: 66  AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF 125

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
           Y  ++  A+ + H +G+ +RDLKPEN++L+  G +K++DFGL    + + D  + HT CG
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCG 183

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP 238
           T  Y+APE++   G++ A  D WS G ++Y ++ G  PF   N      KI K     PP
Sbjct: 184 TIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP 242

Query: 239 WFSTSAKKLISRILDPNPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPN 284
           + +  A+ L+ ++L  N  +R+        EV  + +F+         +  +PP F +P 
Sbjct: 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP-F-KPL 300

Query: 285 I-DLDDV---DSIF 294
           +   +DV   DS F
Sbjct: 301 LQSEEDVSQFDSKF 314

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  222 bits (568), Expect = 7e-71
 Identities = 89/299 (29%), Positives = 158/299 (52%), Gaps = 27/299 (9%)

Query: 17  ELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           EL + LG+GSF KV   +    ++  +  A+K+L K  +     + + K E   +  + H
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVEVNH 85

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           P +++++    ++ K+Y++L+F+ GG+LF +++      E++ + Y  +L  A+D+ HS 
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           G+ +RDLKPEN+LLD  G +K++DFGLS   + +  +   ++ CGT  Y+APEV+N +G+
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILD 253
             + AD WS GV+++ ++ G LPF+  +       I KA    P + S  A+ L+  +  
Sbjct: 204 TQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 262

Query: 254 PNPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDVDSIF 294
            NP  R+      + E+  + +F          +   PP F +P      D    D  F
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP-F-KPATGRPEDTFYFDPEF 319

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  224 bits (572), Expect = 9e-71
 Identities = 93/296 (31%), Positives = 148/296 (50%), Gaps = 23/296 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPN 75
              + +G+GSF KV  AR+       A+K+L K+ +LK K    I  E + + K ++HP 
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++ ++    +  K+Y VL+++ GGELF  +       E  AR Y  ++ +A+ Y HS  +
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPEN+LLD+ G + ++DFGL    + +  +    T CGTP Y+APEV++ + YD 
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
              D W  G +LY ++ G  PF   N   +Y  I     +  P  + SA+ L+  +L  +
Sbjct: 219 T-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277

Query: 256 PVTRI----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDVDSIF 294
              R+       E+  + +F          K   PP F  PN+    DL   D  F
Sbjct: 278 RTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPP-F-NPNVSGPNDLRHFDPEF 331

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  222 bits (569), Expect = 1e-70
 Identities = 89/294 (30%), Positives = 146/294 (49%), Gaps = 20/294 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL-IRHP 74
           + L + LG+GSF KV  A   +T +  AIK L K+ VL    +     E   + L   HP
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            +  M+    +K  ++ V+E++ GG+L   I S  +     A  Y  ++I  + + HS+G
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + +RDLK +N+LLD +G +K++DFG+    + +  D   +T CGTP+Y+APE++  + Y+
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
            +  D WS GV+LY ++ G  PF   +   L+  I   +   P W    AK L+ ++   
Sbjct: 197 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255

Query: 255 NPVTRITMAEVIEN-EWFK---------KGYKPPSFEQPNI----DLDDVDSIF 294
            P  R+ +   I     F+         K   PP F +P +    D  + D  F
Sbjct: 256 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPP-F-RPKVKSPFDCSNFDKEF 307

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  221 bits (566), Expect = 3e-70
 Identities = 86/311 (27%), Positives = 153/311 (49%), Gaps = 23/311 (7%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
               G   R ++  +     LG+GSF KV  +    T E  A+KIL K+ V++   +   
Sbjct: 8   FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 67

Query: 62  KREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
             E   + L  + P + +++    +  ++Y V+E+V GG+L   I   GR KE  A  Y 
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
            ++   + +  S+G+ +RDLK +N++LD+ G +K++DFG+    + + D     T CGTP
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTP 185

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           +Y+APE+I  + Y  +  D W+ GV+LY ++AG  PFE  +   L++ I + +   P   
Sbjct: 186 DYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244

Query: 241 STSAKKLISRILDPNPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNID 286
           S  A  +   ++  +P  R+        ++ E+ +F+         K  +PP + +P   
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP-Y-KPKAC 302

Query: 287 LDDV---DSIF 294
             +    D  F
Sbjct: 303 GRNAENFDRFF 313

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  220 bits (562), Expect = 1e-69
 Identities = 91/318 (28%), Positives = 164/318 (51%), Gaps = 34/318 (10%)

Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G      +  ++L R +G GS+AKV   R  +T    A+K++ KE V   + I  ++ E 
Sbjct: 1   GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60

Query: 66  STMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI 124
              +    HP ++ ++    ++++++ V+E+V GG+L   +  + +L E+ AR Y  ++ 
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
            A++Y H RG+ +RDLK +N+LLD+ G +K++D+G+    + +R      T CGTPNY+A
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 178

Query: 185 PEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA---------LYKKIFKADFK 235
           PE++  + Y  +  D W+ GV+++ +MAG  PF+               L++ I +   +
Sbjct: 179 PEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237

Query: 236 SPPWFSTSAKKLISRILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSF 280
            P   S  A  ++   L+ +P  R+        A++  + +F+         K   PP F
Sbjct: 238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP-F 296

Query: 281 EQPNI----DLDDVDSIF 294
            +PNI     LD+ DS F
Sbjct: 297 -KPNISGEFGLDNFDSQF 313

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  219 bits (559), Expect = 4e-69
 Identities = 94/313 (30%), Positives = 158/313 (50%), Gaps = 25/313 (7%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
                 ++R  +  +E  R LG+GSF KV  AR  ETG+  A+K+L K+ +L+   +   
Sbjct: 11  GIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT 70

Query: 62  KREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
             E   + L   HP + +++    +  +++ V+EFV GG+L   I    R  E  AR Y 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
            ++I+A+ + H +G+ +RDLK +N+LLD  G  K++DFG+    + + +     T CGTP
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTP 188

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           +Y+APE++    Y  A  D W+ GV+LY ++ G+ PFE  N   L++ I   +   P W 
Sbjct: 189 DYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247

Query: 241 STSAKKLISRILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSFEQPNI 285
              A  ++   +  NP  R+          ++ + +FK         +  +PP F +P I
Sbjct: 248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP-F-RPRI 305

Query: 286 ----DLDDVDSIF 294
               D+ + D  F
Sbjct: 306 KSREDVSNFDPDF 318

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  221 bits (564), Expect = 7e-69
 Identities = 95/298 (31%), Positives = 153/298 (51%), Gaps = 24/298 (8%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E  + LG+G+F KV   +   TG   A+KIL KE ++    +     E   ++  RHP 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RG 134
           +  +     +  ++  V+E+  GGELF  ++      ED AR Y  ++++A+DY HS + 
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V +RDLK ENL+LD +G +K++DFGL    + ++D   + T CGTP Y+APEV+ +  Y 
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
            A  D W  GV++Y +M G LPF   +   L++ I   + + P      AK L+S +L  
Sbjct: 328 RA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 386

Query: 255 NPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDVDSIF 294
           +P  R+        E++++ +F          K   PP F +P +    D    D  F
Sbjct: 387 DPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP-F-KPQVTSETDTRYFDEEF 442

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  218 bits (558), Expect = 4e-68
 Identities = 75/286 (26%), Positives = 140/286 (48%), Gaps = 28/286 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+ + +G G+F +V   +     +  A+KIL+K ++LK       + E   +       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +  ++        +Y+V+++  GG+L   ++    RL E+ AR Y  +++ A+D  H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL--HTTCGTPNYVAPEVIN--- 189
             HRD+KP+N+L+D NG ++++DFG      ++ +DG +      GTP+Y++PE++    
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252

Query: 190 --NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSPPW---FST 242
                Y G + D WS GV +Y ++ G  PF   +L+  Y KI   K  F+ P      S 
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311

Query: 243 SAKKLISRILDPNPVTRIT---MAEVIENEWFK-------KGYKPP 278
           +AK LI R++      R+    + +  ++ +F        +  + P
Sbjct: 312 NAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAP 356

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  224 bits (572), Expect = 6e-68
 Identities = 86/311 (27%), Positives = 153/311 (49%), Gaps = 23/311 (7%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI 61
               G   R ++  +     LG+GSF KV  +    T E  A+KIL K+ V++   +   
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388

Query: 62  KREISTMKLI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
             E   + L  + P + +++    +  ++Y V+E+V GG+L   I   GR KE  A  Y 
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
            ++   + +  S+G+ +RDLK +N++LD+ G +K++DFG+    + + D     T CGTP
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTP 506

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
           +Y+APE+I  + Y  +  D W+ GV+LY ++AG  PFE  +   L++ I + +   P   
Sbjct: 507 DYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565

Query: 241 STSAKKLISRILDPNPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNID 286
           S  A  +   ++  +P  R+        ++ E+ +F+         K  +PP + +P   
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP-Y-KPKAS 623

Query: 287 LDDV---DSIF 294
             +    D  F
Sbjct: 624 GRNAENFDRFF 634

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  216 bits (551), Expect = 2e-67
 Identities = 89/308 (28%), Positives = 162/308 (52%), Gaps = 34/308 (11%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHP 74
           ++L R +G GS+AKV   R  +T    A++++ KE V   + I  ++ E    +    HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++ ++    ++++++ V+E+V GG+L   +  + +L E+ AR Y  ++  A++Y H RG
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + +RDLK +N+LLD+ G +K++D+G+    + +R      T CGTPNY+APE++  + Y 
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMA---------LYKKIFKADFKSPPWFSTSAK 245
            +  D W+ GV+++ +MAG  PF+               L++ I +   + P   S  A 
Sbjct: 232 FS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290

Query: 246 KLISRILDPNPVTRI------TMAEVIENEWFK---------KGYKPPSFEQPNI----D 286
            ++   L+ +P  R+        A++  + +F+         K   PP F +PNI     
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP-F-KPNISGEFG 348

Query: 287 LDDVDSIF 294
           LD+ DS F
Sbjct: 349 LDNFDSQF 356

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  214 bits (546), Expect = 4e-67
 Identities = 94/303 (31%), Positives = 167/303 (55%), Gaps = 29/303 (9%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKM 57
           A+ TG A +  +  +EL + LG G++ KV   R     +TG+  A+K+L K  ++ K K 
Sbjct: 42  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 101

Query: 58  IGQIKREISTMKLIRH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA 116
               + E   ++ IR  P ++ ++    ++TK++++L+++ GGELF  ++ R R  E E 
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 161

Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL-HT 175
           + Y  +++ A+++ H  G+ +RD+K EN+LLD+NG + ++DFGLS   + V D+    + 
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYD 219

Query: 176 TCGTPNYVAPEVI--NNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKI 229
            CGT  Y+AP+++   + G+D A  D WS GV++Y L+ G  PF    E+++   + ++I
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

Query: 230 FKADFKSPPWFSTSAKKLISRILDPNPVTRI-----TMAEVIENEWFK---------KGY 275
            K++   P   S  AK LI R+L  +P  R+        E+ E+ +F+         K  
Sbjct: 279 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 338

Query: 276 KPP 278
             P
Sbjct: 339 PAP 341

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  215 bits (550), Expect = 5e-67
 Identities = 77/293 (26%), Positives = 140/293 (47%), Gaps = 28/293 (9%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           R +   +E+ + +G G+F++V   +  +TG+  A+KI++K  +LK   +   + E   + 
Sbjct: 57  RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVD 128
                 + +++     +  +Y+V+E+  GG+L   ++  G R+  + AR Y  +++ A+D
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL--HTTCGTPNYVAPE 186
             H  G  HRD+KP+N+LLD  G ++++DFG      ++R DG +      GTP+Y++PE
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPE 233

Query: 187 VINNKGYD------GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI--FKADFKSP- 237
           ++   G        G + D W+ GV  Y +  G  PF   +    Y KI  +K     P 
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293

Query: 238 --PWFSTSAKKLISRILDPNPVTRIT---MAEVIENEWFK-------KGYKPP 278
                   A+  I R+L   P TR+      +   + +F        +   PP
Sbjct: 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPP 345

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  217 bits (555), Expect = 1e-66
 Identities = 71/304 (23%), Positives = 134/304 (44%), Gaps = 29/304 (9%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
              R LG G F +V   +   TG+  A K L+K+++ K K       E   +  +    +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELF----DKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           + +     +KT + +V+  + GG++     +        +E  A  Y  Q+++ +++ H 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R + +RDLKPEN+LLD +G +++SD GL+   +            GTP ++APE++  + 
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEE 365

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKADFKSPPWFSTSAKKLI 248
           YD +  D ++ GV LY ++A   PF    E+     L +++ +     P  FS ++K   
Sbjct: 366 YDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFC 424

Query: 249 SRILDPNPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNI----DLDDV 290
             +L  +P  R+     +   +  +  F+             PP           ++ DV
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDV 484

Query: 291 DSIF 294
            +  
Sbjct: 485 GAFS 488

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  215 bits (549), Expect = 2e-65
 Identities = 80/303 (26%), Positives = 140/303 (46%), Gaps = 28/303 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +   R LG+G F +V   +   TG+  A K L+K+++ K K       E   ++ +    
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           V+ +     +K  + +VL  + GG+L   I   G+    E  A  Y  ++   ++  H  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            + +RDLKPEN+LLD +G +++SD GL+     V +   +    GT  Y+APEV+ N+ Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----DFKSPPWFSTSAKKLIS 249
             +  D W+ G +LY ++AG  PF++       +++ +       +    FS  A+ L S
Sbjct: 363 TFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421

Query: 250 RILDPNPVTRI-----TMAEVIENEWFKK-------------GYKPPSFEQPNIDLDDVD 291
           ++L  +P  R+     +  EV E+  FKK              +KP        D+ D++
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIE 481

Query: 292 SIF 294
              
Sbjct: 482 QFS 484

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  204 bits (522), Expect = 2e-64
 Identities = 53/284 (18%), Positives = 97/284 (34%), Gaps = 35/284 (12%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           ++     +G G F  V        G   AIK   K           ++   +   L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----LKEDEARKYFQQLINAVDYC 130
           +V+R +   A    + I  E+  GG L D I+   R     KE E +    Q+   + Y 
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 131 HSRGVCHRDLKPENLLLDANGVL-------------------KVSDFGLSALPQQVRDDG 171
           HS  + H D+KP N+ +    +                    K+ D G       V    
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185

Query: 172 LLHTTCGTPNYVAPEVIN-NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF 230
                 G   ++A EV+  N  +   KAD+++  + +             +      +I 
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241

Query: 231 KADFKS-PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
           +      P   S    +L+  ++ P+P  R +   ++++     
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  214 bits (547), Expect = 3e-64
 Identities = 76/283 (26%), Positives = 135/283 (47%), Gaps = 26/283 (9%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKRE---ISTMKLIRH 73
            + R +G G F +V   R  +TG+  A+K LDK+++   +       E   +S +     
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           P ++ M     +  K+  +L+ + GG+L   ++  G   E + R Y  ++I  +++ H+R
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN-NKG 192
            V +RDLKP N+LLD +G +++SD GL+            H + GT  Y+APEV+     
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVA 367

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           YD + AD +S G +L+ L+ G+ PF   +  +   + +       + P  FS   + L+ 
Sbjct: 368 YDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426

Query: 250 RILDPNPVTRI-----TMAEVIENEWFK---------KGYKPP 278
            +L  +   R+        EV E+ +F+         + Y PP
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP 469

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  201 bits (512), Expect = 2e-62
 Identities = 73/335 (21%), Positives = 121/335 (36%), Gaps = 73/335 (21%)

Query: 8   ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILD-------KEKVLK------ 54
           ASR     +E  + +G G F  V  A+N     N AIK +        +EKV++      
Sbjct: 1   ASRYL-TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 59

Query: 55  ------------------------------------------HKMIGQIKREISTMKLIR 72
                                                        +     +I  M    
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDE---ARKYFQQLINAVDY 129
             N +   +  + K  +YI ++      L D +  R  L++ E       F Q+  AV++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA----------LPQQVRDDGLLHTTCGT 179
            HS+G+ HRDLKP N+    + V+KV DFGL            +   +          GT
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-KSPP 238
             Y++PE I+   Y   K D++S G+IL+ L+  Y    +   + +   +    F     
Sbjct: 240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFT 296

Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                   ++  +L P+P  R    ++IEN  F+ 
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  200 bits (510), Expect = 5e-62
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 23/287 (8%)

Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS 66
              R  V        +G GSF +V   ++ +TG   A+K +  E             E+ 
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELV 102

Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINA 126
               +  P ++ +Y  +     + I +E + GG L   I   G L ED A  Y  Q +  
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEG 162

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVL-KVSDFGLSALPQQVRDDGLLHTTC------GT 179
           ++Y H+R + H D+K +N+LL ++G    + DFG +     ++ DGL  +        GT
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGT 219

Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKS 236
             ++APEV+  K  D AK D+WS   ++  ++ G  P+ +     L  KI        + 
Sbjct: 220 ETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278

Query: 237 PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
           PP  +    + I   L   PV R +  E+          +    + P
Sbjct: 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ-EVGGLKSP 324

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  193 bits (493), Expect = 5e-60
 Identities = 85/295 (28%), Positives = 136/295 (46%), Gaps = 29/295 (9%)

Query: 9   SRTRVGKYEL-----GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR 63
           S      YE         LG+G++  V   R+      +AIK + +      +    +  
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHE 68

Query: 64  EISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEA--RKYF 120
           EI+  K ++H N+++     +    I I +E V GG L   + S+ G LK++E     Y 
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTC-G 178
           +Q++  + Y H   + HRD+K +N+L++  +GVLK+SDFG S    ++        T  G
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTG 185

Query: 179 TPNYVAPEVIN--NKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFK-ADF 234
           T  Y+APE+I+   +GY G  AD+WS G    + MA G  PF    L      +FK   F
Sbjct: 186 TLQYMAPEIIDKGPRGY-GKAADIWSLG-CTIIEMATGKPPF--YELGEPQAAMFKVGMF 241

Query: 235 KSPP----WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           K  P      S  AK  I +  +P+P  R    +++ +E+ K         QP +
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS-SKKKKTQPKL 295

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  180 bits (459), Expect = 6e-55
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 24/274 (8%)

Query: 14  GKYE-LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           G++      +G GSF  V    +TET   VA   L   K+ K     + K E   +K ++
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83

Query: 73  HPNVIRMY----EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           HPN++R Y      +  K  I +V E +T G L   +     +K    R + +Q++  + 
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 129 YCHSRG--VCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           + H+R   + HRDLK +N+ +    G +K+ D GL+ L +            GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKADFKSPPW----- 239
           E+     YD    D+++ G+ +  +     P+ E  N   +Y+++        P      
Sbjct: 200 EMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---GVKPASFDKV 254

Query: 240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                K++I   +  N   R ++ +++ + +F++
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  179 bits (455), Expect = 4e-54
 Identities = 86/277 (31%), Positives = 142/277 (51%), Gaps = 17/277 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +     +G+GSF +V    +  T + VAIKI+D E+      I  I++EI+ +     P 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           V + Y      TK++I++E++ GG   D +   G L E +     ++++  +DY HS   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVINNKGYD 194
            HRD+K  N+LL  +G +K++DFG++    Q+ D  +   T  GTP ++APEVI    YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKSPPW----FSTSAKKLIS 249
            +KAD+WS G+    L  G  P  E + M  L+  I K +   PP     +S   K+ + 
Sbjct: 198 -SKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNN---PPTLEGNYSKPLKEFVE 252

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
             L+  P  R T  E++++++  +  K  S+    ID
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELID 289

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  177 bits (452), Expect = 3e-53
 Identities = 90/355 (25%), Positives = 147/355 (41%), Gaps = 67/355 (18%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREIST 67
           ++R  +YE    LGEG FA V  AR+  T + VAIK   L      K  +     REI  
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 68  MKLIRHPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLIN 125
           ++ + HPN+I + +    K+ I +V +F+      +     +   L     + Y    + 
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN---- 181
            ++Y H   + HRDLKP NLLLD NGVLK++DFGL+              + G+PN    
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNRAYT 170

Query: 182 -------YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAG--YLPFEESNLMALYKKIFK 231
                  Y APE++   + Y     D+W+ G IL  L+    +LP  +S+L  L  +IF+
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRVPFLP-GDSDLDQLT-RIFE 227

Query: 232 A----------------DFKS-PPW-----------FSTSAKKLISRILDPNPVTRITMA 263
                            D+ +   +                  LI  +   NP  RIT  
Sbjct: 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287

Query: 264 EVIENEWFK---KGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREEGPVAP 315
           + ++ ++F             +PN  ++ +    N ++  +    E  E+G +  
Sbjct: 288 QALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  174 bits (444), Expect = 2e-52
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 29/263 (11%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           E+   +G G+F  V  A+     ++VAIK ++ E   K         E+  +  + HPN+
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLI---NAVDYCHSR 133
           +++Y   A    + +V+E+  GG L++ +     L    A       +     V Y HS 
Sbjct: 64  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 134 ---GVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
               + HRDLKP NLLL A G VLK+ DFG +   Q       +    G+  ++APEV  
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFSTSA 244
              Y   K D++S G+IL+ ++    PF+E    A   +I  A                 
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLPKPI 233

Query: 245 KKLISRILDPNPVTRITMAEVIE 267
           + L++R    +P  R +M E+++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVK 256

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  173 bits (442), Expect = 4e-52
 Identities = 76/315 (24%), Positives = 136/315 (43%), Gaps = 62/315 (19%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKLIR 72
           KYE    +GEGS+  V   RN +TG+ VAIK  +  ++  +  K+     REI  +K ++
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA---LREIRMLKQLK 60

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           HPN++ + EV   K ++++V E+         D+   +  + E   +    Q + AV++C
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYV------ 183
           H     HRD+KPEN+L+  + V+K+ DFG +  L          +      + V      
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRWYR 169

Query: 184 APEVI-NNKGYDGAKADLWSCGVILYVLMAG--YLPFEESNLMALYKKIFKA-------- 232
           +PE++  +  Y G   D+W+ G +   L++G    P  +S++  LY  I K         
Sbjct: 170 SPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLY-LIRKTLGDLIPRH 226

Query: 233 -----------DFKSPPW------------FSTSAKKLISRILDPNPVTRITMAEVIENE 269
                        K P               S  A  L+   L  +P  R+T  +++ + 
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286

Query: 270 WFKKGYKPPSFEQPN 284
           +F+   +     + +
Sbjct: 287 YFENIREIEDLAKEH 301

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  173 bits (440), Expect = 6e-52
 Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 19/261 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
            +   +G GSF  V   R    G +VA+KIL ++     + + +  RE++ MK +RHPN+
Sbjct: 40  NIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNI 96

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFD---KIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           +     +     + IV E+++ G L+    K  +R +L E         +   ++Y H+R
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 134 G--VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
              + HR+LK  NLL+D    +KV DFGLS L  +        +  GTP ++APEV+ ++
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFSTSAKK 246
             +  K+D++S GVIL+ L     P+   N   +   +    FK      P   +     
Sbjct: 215 PSN-EKSDVYSFGVILWELATLQQPWGNLNPAQV---VAAVGFKCKRLEIPRNLNPQVAA 270

Query: 247 LISRILDPNPVTRITMAEVIE 267
           +I       P  R + A +++
Sbjct: 271 IIEGCWTNEPWKRPSFATIMD 291

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  172 bits (438), Expect = 8e-52
 Identities = 78/276 (28%), Positives = 144/276 (52%), Gaps = 13/276 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K ++I     EI  M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNP 77

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V HRD+K +N+LL  +G +K++DFG  A  Q   +     T  GTP ++APEV+  K Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 195 GAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISR 250
             K D+WS G++   ++ G  P   E+ L ALY  I        ++P   S   +  ++R
Sbjct: 195 P-KVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
            L+ +   R +  E++++++ K   KP S   P I 
Sbjct: 253 CLEMDVEKRGSAKELLQHQFLKIA-KPLSSLTPLIA 287

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  172 bits (437), Expect = 2e-51
 Identities = 80/276 (28%), Positives = 147/276 (53%), Gaps = 13/276 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
             +    +GEGS   V  AR   +G  VA+K++D  K  + +++     E+  M+  +H 
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHF 102

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           NV+ MY+      ++++++EF+ GG L D I S+ RL E++     + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V HRD+K +++LL  +G +K+SDFG  A  Q  +D     +  GTP ++APEVI+   Y 
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 195 GAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFKAD---FKSPPWFSTSAKKLISR 250
             + D+WS G+++  ++ G  P F +S + A+  ++  +     K+    S   +  + R
Sbjct: 220 -TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLER 277

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
           +L  +P  R T  E++++ +  +    P    P I 
Sbjct: 278 MLVRDPQERATAQELLDHPFLLQT-GLPECLVPLIQ 312

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  172 bits (437), Expect = 3e-51
 Identities = 85/316 (26%), Positives = 135/316 (42%), Gaps = 64/316 (20%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIK-REISTMK 69
           + KYE    +GEGS+  V   RN +TG  VAIK  +   +     KM+ +I  REI  +K
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLK 79

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLINAV 127
            +RH N++ + EV   K + Y+V EFV     +  +       L     +KY  Q+IN +
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGI 137

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYV--- 183
            +CHS  + HRD+KPEN+L+  +GV+K+ DFG +  L          +      + V   
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----DEVATR 188

Query: 184 ---APEVI-NNKGYDGAKADLWSCGVILYVLMAG--YLPFEESNLMALYKKIFKA----- 232
              APE++  +  Y  A  D+W+ G ++  +  G    P  +S++  LY  I        
Sbjct: 189 WYRAPELLVGDVKYGKA-VDVWAIGCLVTEMFMGEPLFP-GDSDIDQLY-HIMMCLGNLI 245

Query: 233 -----------DFKS---PPW------------FSTSAKKLISRILDPNPVTRITMAEVI 266
                       F     P               S     L  + L  +P  R   AE++
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

Query: 267 ENEWFKKGYKPPSFEQ 282
            +++F+       F Q
Sbjct: 306 HHDFFQMDGFAERFSQ 321

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  170 bits (433), Expect = 5e-51
 Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 26/287 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           YEL   +G G+ A V+ A      E VAIK ++ EK      + ++ +EI  M    HPN
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 74

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFD--------KIASRGRLKEDEARKYFQQLINAV 127
           ++  Y     K ++++V++ ++GG + D             G L E       ++++  +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL---HTTCGTPNYVA 184
           +Y H  G  HRD+K  N+LL  +G ++++DFG+SA      D        T  GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194

Query: 185 PEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYK---------KIFKAD 233
           PEV+   +GYD  KAD+WS G+    L  G  P+ +   M  L           +    D
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253

Query: 234 FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSF 280
            +    +  S +K+IS  L  +P  R T AE++ +++F+K  K   F
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK-AKNKEF 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (431), Expect = 7e-51
 Identities = 58/261 (22%), Positives = 118/261 (45%), Gaps = 16/261 (6%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
            +G+ +G GSF  V   + + +    VA+K+L        + +   K E+  ++  RH N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD----VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++       +  ++ IV ++  G  L+  + AS  + +  +     +Q    +DY H++ 
Sbjct: 82  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRDLK  N+ L  +  +K+ DFGL+    +           G+  ++APEVI  +  +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 195 --GAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFK-----ADFKSPPWFSTSAKK 246
               ++D+++ G++LY LM G LP+   +N   + + + +        K         K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260

Query: 247 LISRILDPNPVTRITMAEVIE 267
           L++  L      R +   ++ 
Sbjct: 261 LMAECLKKKRDERPSFPRILA 281

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  168 bits (427), Expect = 4e-50
 Identities = 88/305 (28%), Positives = 139/305 (45%), Gaps = 67/305 (21%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEK------VLKHKMIGQIKREIS 66
           KYE    +GEG++  V  A+N ET E VA+K   LD +        L         REI 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL---------REIC 53

Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLI 124
            +K ++H N++R+++V+ S  K+ +V EF      + FD     G L  +  + +  QL+
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLL 111

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN--- 181
             + +CHSR V HRDLKP+NLL++ NG LK+++FGL+      R  G +   C +     
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------RAFG-IPVRCYSAEVVT 164

Query: 182 --YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPF--EESNLMALYKKIFKA---- 232
             Y  P+V+   K Y  +  D+WS G I   L     P          L  +IF+     
Sbjct: 165 LWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTP 222

Query: 233 ------------DFKS-PPW------------FSTSAKKLISRILDPNPVTRITMAEVIE 267
                       D+K  P +             + + + L+  +L  NPV RI+  E ++
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

Query: 268 NEWFK 272
           + +F 
Sbjct: 283 HPYFS 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  168 bits (428), Expect = 4e-50
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 22/280 (7%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           E+G  +G+G F +V   R + E    VAI+++D E+      +   KRE+   +  RH N
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRG 134
           V+       S   + I+     G  L+  +      L  ++ R+  Q+++  + Y H++G
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + H+DLK +N+  D NG + ++DFGL     + Q  R +  L    G   ++APE+I   
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 192 GYDGA--------KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS 243
             D           +D+++ G I Y L A   PF+     A+  ++      +       
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269

Query: 244 A--KKLISRILDPNPVTRITMAEVIEN-EWFKKGYKPPSF 280
                ++          R T  ++++  E   K  +  S 
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  168 bits (428), Expect = 5e-50
 Identities = 79/323 (24%), Positives = 135/323 (41%), Gaps = 73/323 (22%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTM 68
           +   +++    LG G++A V    N  TG  VA+K   LD E+      I    REIS M
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLM 57

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGG-----ELFDKIASRGRLKEDEARKYFQQL 123
           K ++H N++R+Y+V+ ++ K+ +V EF+        +      +   L+ +  + +  QL
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN-- 181
           +  + +CH   + HRDLKP+NLL++  G LK+ DFGL+      R         G P   
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGIPVNT 164

Query: 182 ---------YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIF 230
                    Y AP+V+  ++ Y  +  D+WSCG IL  ++ G   F   ++   L   IF
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGKPLFPGTNDEEQLK-LIF 222

Query: 231 KA----------------DFK------------------SPPWFSTSAKKLISRILDPNP 256
                              +                   +      +    +  +L  NP
Sbjct: 223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282

Query: 257 VTRITMAEVIENEWFKKGYKPPS 279
             R++  + + + WF + Y   S
Sbjct: 283 DMRLSAKQALHHPWFAEYYHHAS 305

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  168 bits (428), Expect = 7e-50
 Identities = 83/332 (25%), Positives = 139/332 (41%), Gaps = 81/332 (24%)

Query: 3   SRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEK------VLK 54
           S +   S T + +Y     LGEG++ +V  A +T T E VAIK   L+ E+       + 
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI- 81

Query: 55  HKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKED 114
                   RE+S +K ++H N+I +  V+    +++++ E+    +L   +     +   
Sbjct: 82  --------REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR 132

Query: 115 EARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-----GVLKVSDFGLSALPQQVRD 169
             + +  QLIN V++CHSR   HRDLKP+NLLL  +      VLK+ DFGL+      R 
Sbjct: 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R- 185

Query: 170 DGLLHTTCGTPN-----------YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
                   G P            Y  PE++  ++ Y  +  D+WS   I   ++     F
Sbjct: 186 ------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKTPLF 238

Query: 218 E-ESNLMALYKKIFKA----------------DFKS--------------PPWFSTSAKK 246
             +S +  L+ KIF+                 D+K                         
Sbjct: 239 PGDSEIDQLF-KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLD 297

Query: 247 LISRILDPNPVTRITMAEVIENEWFKKGYKPP 278
           L++ +L+ +PV RI+    +E+ +F      P
Sbjct: 298 LLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  167 bits (424), Expect = 1e-49
 Identities = 78/282 (27%), Positives = 141/282 (50%), Gaps = 18/282 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E+   LG+G+F KV  A+N ETG   A K+++ +   +   +     EI  +    HP
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSR 133
            ++++        K++I++EF  GG +   +      L E + +   +Q++ A+++ HS+
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI----- 188
            + HRDLK  N+L+   G ++++DFG+SA  + ++      +  GTP ++APEV+     
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD---FKSPPWFSTSA 244
            +  YD  KAD+WS G+ L  +     P  E N M  L  KI K+D     +P  +S   
Sbjct: 195 KDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252

Query: 245 KKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
           +  +   LD NP TR + A+++E+ +           +  + 
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSI-TSNKALRELVA 293

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  166 bits (422), Expect = 4e-49
 Identities = 83/277 (29%), Positives = 139/277 (50%), Gaps = 15/277 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +++   LGEGS+  V  A + ETG+ VAIK +  E  L+     +I +EIS M+    P
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEISIMQQCDSP 84

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSR 133
           +V++ Y      T ++IV+E+   G + D I  R   L EDE     Q  +  ++Y H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
              HRD+K  N+LL+  G  K++DFG++   Q        +T  GTP ++APEVI   GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD---FKSPPWFSTSAKKLIS 249
           +   AD+WS G+    +  G  P+ + + M A++  I       F+ P  +S +    + 
Sbjct: 203 NC-VADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
           + L  +P  R T  +++++ + +   K  S  +  I+
Sbjct: 261 QCLVKSPEQRATATQLLQHPFVRSA-KGVSILRDLIN 296

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  166 bits (421), Expect = 5e-49
 Identities = 64/269 (23%), Positives = 118/269 (43%), Gaps = 17/269 (6%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHP 74
            E    +G G+  +V   R  +TG  +A+K + +      +   +I  ++   +K    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-R 133
            +++ +    + T ++I +E +       K   +G + E    K    ++ A+ Y     
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI----- 188
           GV HRD+KP N+LLD  G +K+ DFG+S    ++ DD     + G   Y+APE I     
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKAD---FKSPPWFSTSA 244
               YD  +AD+WS G+ L  L  G  P++       +  K+ + +         FS   
Sbjct: 202 TKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260

Query: 245 KKLISRILDPNPVTRITMAEVIENEWFKK 273
           +  +   L  +   R    +++E+ + K+
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  164 bits (418), Expect = 1e-48
 Identities = 83/325 (25%), Positives = 143/325 (44%), Gaps = 82/325 (25%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEK------VL 53
           + R     +  + KY+    +GEG++  V  A+++  G  VA+K   LD E        +
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI 67

Query: 54  KHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRL 111
                    REIS +K + HPN++ + +V+ S+  + +V EF+     ++ D+   +  L
Sbjct: 68  ---------REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGL 116

Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG 171
           ++ + + Y  QL+  V +CH   + HRDLKP+NLL++++G LK++DFGL+      R   
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R--- 167

Query: 172 LLHTTCGTPN-----------YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAG--YLPF 217
                 G P            Y AP+V+  +K Y  +  D+WS G I   ++ G    P 
Sbjct: 168 ----AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGKPLFP- 221

Query: 218 EESNLMALYKKIFKA----------------DFKSP--------------PWFSTSAKKL 247
             ++   L  KIF                   +K                P F      L
Sbjct: 222 GVTDDDQLP-KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDL 280

Query: 248 ISRILDPNPVTRITMAEVIENEWFK 272
           +S +L  +P  RI+  + + + +FK
Sbjct: 281 LSNMLCFDPNKRISARDAMNHPYFK 305

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  167 bits (424), Expect = 2e-48
 Identities = 92/333 (27%), Positives = 140/333 (42%), Gaps = 70/333 (21%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK     KVL+ K    
Sbjct: 41  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRF-- 93

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKT------KIYIVLEFVTG---GELFDKIASRGRL 111
             RE+  M+ + H N++R+     S         + +VL++V             ++  L
Sbjct: 94  KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153

Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDD 170
                + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +         
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA--------- 204

Query: 171 GLLHTTCGTPN--YV------APEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFE-ES 220
                  G PN  Y+      APE+I     Y  +  D+WS G +L  L+ G   F  +S
Sbjct: 205 --KQLVRGEPNVSYICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPGDS 261

Query: 221 NLMALYKKIFK-----------------ADFKSPPW------------FSTSAKKLISRI 251
            +  L  +I K                  +FK P                  A  L SR+
Sbjct: 262 GVDQLV-EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 320

Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN 284
           L+  P  R+T  E   + +F    + P+ + PN
Sbjct: 321 LEYTPTARLTPLEACAHSFF-DELRDPNVKLPN 352

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  162 bits (413), Expect = 2e-48
 Identities = 46/270 (17%), Positives = 98/270 (36%), Gaps = 38/270 (14%)

Query: 17  ELGRTLGEGSFAKVKFA--RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
                L E    ++     +  +    + +K+L        +       E   +++  HP
Sbjct: 13  NFLTKLNENHSGELWKGRWQGND----IVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHP 67

Query: 75  NVIRMYEVMAS--KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD---- 128
           NV+ +     S       ++  ++  G L++ +        D++    Q +  A+D    
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS----QAVKFALDMARG 123

Query: 129 --YCHSRG--VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
             + H+    +    L   ++++D +   ++S   +    Q              P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVA 176

Query: 185 PEVINNKGYDGA--KADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----P 237
           PE +  K  D     AD+WS  V+L+ L+   +PF + + M +     K   +      P
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GMKVALEGLRPTIP 233

Query: 238 PWFSTSAKKLISRILDPNPVTRITMAEVIE 267
           P  S    KL+   ++ +P  R     ++ 
Sbjct: 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  163 bits (414), Expect = 3e-48
 Identities = 87/304 (28%), Positives = 138/304 (45%), Gaps = 67/304 (22%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEK------VLKHKMIGQIKREIS 66
           KY     +GEG++  V  A+N   GE  A+K   L+KE        +         REIS
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTI---------REIS 52

Query: 67  TMKLIRHPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLI 124
            +K ++H N++++Y+V+ +K ++ +V E +     +L D     G L+   A+ +  QL+
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLL 110

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN--- 181
           N + YCH R V HRDLKP+NLL++  G LK++DFGL+      R  G +     T     
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------RAFG-IPVRKYTHEIVT 163

Query: 182 --YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFKA----- 232
             Y AP+V+  +K Y     D+WS G I   ++ G   F   S    L  +IF+      
Sbjct: 164 LWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGTPLFPGVSEADQLM-RIFRILGTPN 221

Query: 233 -----------DFKSP-------------PWFSTSAKKLISRILDPNPVTRITMAEVIEN 268
                       +                     S   L+S++L  +P  RIT  + +E+
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281

Query: 269 EWFK 272
            +FK
Sbjct: 282 AYFK 285

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  165 bits (419), Expect = 4e-48
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 20/231 (8%)

Query: 14  GKYELGRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           G YEL   +G+G      V  AR   TGE V ++ ++ E     +M+  ++ E+   KL 
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDY 129
            HPN++       +  ++++V  F+  G   D         + E       Q ++ A+DY
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC--------GTPN 181
            H  G  HR +K  ++L+  +G + +S    +     +   G                  
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200

Query: 182 YVAPEVI--NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKI 229
           +++PEV+  N +GYD AK+D++S G+    L  G++PF++      L +K+
Sbjct: 201 WLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  161 bits (410), Expect = 7e-48
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 26/267 (9%)

Query: 17  ELGRTLGEGSFAKVKFA--RNTETGENVAIKILDKEKV-LKHKMIGQIKREISTMKLIRH 73
            L   +G G F KV  A     E    VA+K    +      + I  +++E     +++H
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDE----VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           PN+I +  V   +  + +V+EF  GG L   ++ + R+  D    +  Q+   ++Y H  
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDE 124

Query: 134 G---VCHRDLKPENLLLD--------ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
               + HRDLK  N+L+         +N +LK++DFGL+    +        +  G   +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAW 180

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKAD-FKSPPWF 240
           +APEVI    +    +D+WS GV+L+ L+ G +PF     L   Y           P   
Sbjct: 181 MAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239

Query: 241 STSAKKLISRILDPNPVTRITMAEVIE 267
                KL+    +P+P +R +   +++
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILD 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  162 bits (411), Expect = 7e-48
 Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 28/270 (10%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKIL----DKEKVLKHKMIGQIKREISTMKLIR 72
           E  + +G+G F  V   R  +    VAIK L     + +    +   + +RE+  M  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCH 131
           HPN++++Y          +V+EFV  G+L+ ++  +   +K     +    +   ++Y  
Sbjct: 82  HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 132 SRG--VCHRDLKPENLLLDANG-----VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
           ++   + HRDL+  N+ L +         KV+DFGLS           +    G   ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMA 194

Query: 185 PEVIN--NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----P 237
           PE I    + Y   KAD +S  +ILY ++ G  PF+E +   + K I     +      P
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREEGLRPTIP 252

Query: 238 PWFSTSAKKLISRILDPNPVTRITMAEVIE 267
                  + +I      +P  R   + +++
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  163 bits (414), Expect = 7e-48
 Identities = 74/328 (22%), Positives = 134/328 (40%), Gaps = 76/328 (23%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKLIR 72
            Y     LGEG++A V   ++  T   VA+K   L+ E+      I    RE+S +K ++
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           H N++ +++++ ++  + +V E++     +  D       +     + +  QL+  + YC
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN--------- 181
           H + V HRDLKP+NLL++  G LK++DFGL+      R           P          
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEVVT 163

Query: 182 --YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAG--YLPFEESNLMALYKKIFKA---- 232
             Y  P+++  +  Y     D+W  G I Y +  G    P   +    L+  IF+     
Sbjct: 164 LWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGRPLFP-GSTVEEQLH-FIFRILGTP 220

Query: 233 ------------DFKSP--------------PWFSTSAKKLISRILDPNPVTRITMAEVI 266
                       +FK+               P   +    L++++L      RI+  + +
Sbjct: 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280

Query: 267 ENEWFKKGYKPPSFEQPNIDLDDVDSIF 294
           ++ +F       S  +    L D  SIF
Sbjct: 281 KHPFFL------SLGERIHKLPDTTSIF 302

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  161 bits (409), Expect = 3e-47
 Identities = 74/317 (23%), Positives = 120/317 (37%), Gaps = 68/317 (21%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEKVLKHKMIGQIKREISTMKL 70
             +YE    +G G++  V  AR+  +G  VA+K   +         +     RE++ ++ 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 71  IR---HPNVIRMYEVMASK-----TKIYIVLEFVTG--GELFDKIASRGRLKEDEARKYF 120
           +    HPNV+R+ +V A+       K+ +V E V        DK    G L  +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           +Q +  +D+ H+  + HRDLKPEN+L+ + G +K++DFGL+      R            
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQ 173

Query: 181 N----------YVAPEVINNKGYDGAKADLWSCGVILYVLMAG--YLPFEESNLMALYKK 228
                      Y APEV+    Y     D+WS G I   +           S    L  K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFC-GNSEADQLG-K 230

Query: 229 IFKA----------------DFKSPPW-----------FSTSAKKLISRILDPNPVTRIT 261
           IF                      PP               S  +L+  +L  NP  RI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290

Query: 262 MAEVIENEWFKKGYKPP 278
               +++ +  K    P
Sbjct: 291 AFRALQHSYLHKDEGNP 307

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  160 bits (408), Expect = 3e-47
 Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 29/301 (9%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
             G  LG+G F +     + ETGE + +K L +      +      +E+  M+ + HPNV
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGV 135
           ++   V+    ++  + E++ GG L   I S        +   + + + + + Y HS  +
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSAL------------PQQVRDDGLLHTTCGTPNYV 183
            HRDL   N L+  N  + V+DFGL+ L              +  D    +T  G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS------P 237
           APE+IN + YD  K D++S G++L  ++       +          F  + +       P
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPD---YLPRTMDFGLNVRGFLDRYCP 245

Query: 238 PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID-LDDVDSIFNE 296
           P    S   +  R  D +P  R +  ++    W +      +   P    L+ +D  F E
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLE--HWLETLRMHLAGHLPLGPQLEQLDRGFWE 303

Query: 297 S 297
           +
Sbjct: 304 T 304

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  162 bits (411), Expect = 9e-47
 Identities = 95/347 (27%), Positives = 149/347 (42%), Gaps = 59/347 (17%)

Query: 6   GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G     R   Y   + +G GSF  V  A+  E+ E VAIK     KVL+ K      RE+
Sbjct: 32  GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-----KVLQDKRF--KNREL 83

Query: 66  STMKLIRHPNVIRMYEVMAS------KTKIYIVLEFVTGGELFDKIASRGRLK----EDE 115
             M++++HPNV+ +     S      +  + +VLE+V    ++       +LK       
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLL 142

Query: 116 ARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLH 174
            + Y  QL+ ++ Y HS G+CHRD+KP+NLLLD   GVLK+ DFG +     +  +  + 
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEPNVS 200

Query: 175 TTCGTPNYVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFK- 231
             C +  Y APE+I     Y     D+WS G ++  LM G   F  ES +  L  +I K 
Sbjct: 201 YIC-SRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLV-EIIKV 257

Query: 232 ----------------ADFKSPPW------------FSTSAKKLISRILDPNPVTRITMA 263
                            + K P                  A  LISR+L+  P  R+T  
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317

Query: 264 EVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           E + + +F    +      PN    ++  +FN + +  ++  +    
Sbjct: 318 EALCHPFF-DELRTGEARMPN--GRELPPLFNWTKEELSVRPDLISR 361

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  159 bits (405), Expect = 1e-46
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 27/292 (9%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIR 72
           G +EL   +G G++ +V   R+ +TG+  AIK++D    +      +IK+EI+ +K    
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 73  HPNVIRMYE------VMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLI 124
           H N+   Y             ++++V+EF   G + D  K      LKE+      ++++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVA 184
             + + H   V HRD+K +N+LL  N  +K+ DFG+SA  Q  R  G  +T  GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197

Query: 185 PEVINNK-----GYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD---FK 235
           PEVI         YD  K+DLWS G+    +  G  P  + + M AL+  I +      K
Sbjct: 198 PEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 255

Query: 236 SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDL 287
           S  W S   +  I   L  N   R    +++++ + +             D 
Sbjct: 256 SKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDH 306

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  160 bits (406), Expect = 2e-46
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 17/279 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +   R +G GSF  V FAR+    E VAIK +       ++    I +E+  ++ +RHP
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N I+       +   ++V+E+  G         +  L+E E        +  + Y HS  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN---K 191
           + HRD+K  N+LL   G++K+ DFG ++       +    +  GTP ++APEVI      
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPAN----SFVGTPYWMAPEVILAMDEG 228

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD---FKSPPWFSTSAKKL 247
            YDG K D+WS G+    L     P    N M ALY  I + +    +S  W S   +  
Sbjct: 229 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRNF 285

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
           +   L   P  R T   ++++ +  +  +PP+     I 
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRE-RPPTVIMDLIQ 323

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  157 bits (400), Expect = 4e-46
 Identities = 68/253 (26%), Positives = 120/253 (47%), Gaps = 11/253 (4%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +Y++   LG G  + V  A +T     VAIK +      K + + + +RE+     + H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
            N++ M +V       Y+V+E++ G  L + I S G L  D A  +  Q+++ + + H  
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC--GTPNYVAPEVINNK 191
            + HRD+KP+N+L+D+N  LK+ DFG++   + + +  L  T    GT  Y +PE    +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIA---KALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFKADFKSP----PWFSTSAKK 246
             D    D++S G++LY ++ G  PF  E+ +    K I  +              S   
Sbjct: 188 ATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246

Query: 247 LISRILDPNPVTR 259
           +I R  + +   R
Sbjct: 247 VILRATEKDKANR 259

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  159 bits (404), Expect = 4e-46
 Identities = 78/323 (24%), Positives = 135/323 (41%), Gaps = 83/323 (25%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIK--ILDKEK------VLKHKMIGQIKR 63
            V KYE    +G+G+F +V  AR+ +TG+ VA+K  +++ EK       L         R
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL---------R 65

Query: 64  EISTMKLIRHPNVIRMYEVMASK--------TKIYIVLEFV----TGGELFDKIASRGRL 111
           EI  ++L++H NV+ + E+  +K          IY+V +F      G  L   +    + 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKF 121

Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS---ALPQQVR 168
              E ++  Q L+N + Y H   + HRD+K  N+L+  +GVLK++DFGL+   +L +  +
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 169 DDGLLHTTCGTPN-----YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAG--------- 213
            +        T       Y  PE++   + Y G   DLW  G I+  +            
Sbjct: 182 PNRY------TNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTE 234

Query: 214 -----------------------YLP-FEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
                                      +E+  L+   K+  K   K+       A  LI 
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLID 293

Query: 250 RILDPNPVTRITMAEVIENEWFK 272
           ++L  +P  RI   + + +++F 
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFW 316

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  157 bits (400), Expect = 6e-46
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 6/229 (2%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           M         T+ G Y L R +G G    V  A +T     VA+K++ +          +
Sbjct: 21  MDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR 80

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
           ++RE  T   ++ P+V+ +++      ++Y+ +  + G +L   +  +G L    A    
Sbjct: 81  MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIV 140

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT--TCG 178
           +Q+ +A+D  H+ G  HRD+KPEN+L+ A+    + DFG++       D+ L     T G
Sbjct: 141 RQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVG 197

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK 227
           T  Y+APE  +       +AD+++   +LY  + G  P++   L  +  
Sbjct: 198 TLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGA 245

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  158 bits (400), Expect = 1e-45
 Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 8/249 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E    LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG- 134
           ++  Y    S  +I I +E + GG L   +   GR+ E    K    +I  + Y   +  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRD+KP N+L+++ G +K+ DFG+S   Q +  D + ++  GT +Y++PE +    Y 
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS 208

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             ++D+WS G+ L  +  G  P    +   L                   +     +   
Sbjct: 209 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 255 NPVTRITMA 263
              +R  MA
Sbjct: 268 GMDSRPPMA 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  154 bits (391), Expect = 2e-44
 Identities = 63/276 (22%), Positives = 122/276 (44%), Gaps = 26/276 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHP 74
            +    +G G++  V    +  +G+ +A+K +     +  K   Q+  ++   M+    P
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI------ASRGRLKEDEARKYFQQLINAVD 128
            +++ Y  +  +   +I +E ++    FDK            + E+   K     + A++
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 129 YCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           +      + HRD+KP N+LLD +G +K+ DFG+S    Q+ D        G   Y+APE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196

Query: 188 I----NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKAD---FKSPPW 239
           I    + +GYD  ++D+WS G+ LY L  G  P+ + N +     ++ K D     +   
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255

Query: 240 --FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
             FS S    ++  L  +   R    E++++ +   
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  152 bits (386), Expect = 4e-44
 Identities = 71/299 (23%), Positives = 128/299 (42%), Gaps = 35/299 (11%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHP 74
            E    LG G++  V+  R+  +G+ +A+K +     +  +   ++  ++  +M+ +  P
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-----ASRGRLKEDEARKYFQQLINAVDY 129
             +  Y  +  +  ++I +E +      DK           + ED   K    ++ A+++
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 130 CHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
            HS   V HRD+KP N+L++A G +K+ DFG+S     + DD       G   Y+APE I
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181

Query: 189 ----NNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKSPP----- 238
               N KGY   K+D+WS G+ +  L     P++         K++ +      P     
Sbjct: 182 NPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPAD 237

Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDD-VDSIFNE 296
            FS       S+ L  N   R T  E++++ +F         E    D+   V  I  +
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL------HESKGTDVASFVKLILGD 290

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  152 bits (386), Expect = 1e-43
 Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 85/335 (25%)

Query: 7   GASRTRVGKYELGRTLGEGSFAKVKFARNT-ETGENVAIK--ILDKEK------VLKHKM 57
           G  R    +YE    +GEG++ KV  AR+    G  VA+K   +   +       +    
Sbjct: 5   GLCRA-DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI---- 59

Query: 58  IGQIKREISTMKLIR---HPNVIRMYEV-----MASKTKIYIVLEFVTG--GELFDKIAS 107
                RE++ ++ +    HPNV+R+++V        +TK+ +V E V        DK+  
Sbjct: 60  -----REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 114

Query: 108 RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV 167
            G +  +  +    QL+  +D+ HS  V HRDLKP+N+L+ ++G +K++DFGL+      
Sbjct: 115 PG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------ 167

Query: 168 RDDGLLHTTCGTPN----------YVAPEVINNKGYDGAKADLWSCGVILYVLMAG--YL 215
           R                       Y APEV+    Y     DLWS G I   +       
Sbjct: 168 R-------IYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLF 219

Query: 216 PFEESNLMALYKKIFKA----------------DFKSPPW-----------FSTSAKKLI 248
               S++  L  KI                                          K L+
Sbjct: 220 R-GSSDVDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQP 283
            + L  NP  RI+    + + +F+   +       
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYFQDLERCKENLDS 312

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  151 bits (383), Expect = 2e-43
 Identities = 69/256 (26%), Positives = 120/256 (46%), Gaps = 12/256 (4%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 74  PNVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           P ++ +Y+       +    YIV+E+V G  L D + + G +    A +       A+++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVI 188
            H  G+ HRD+KP N+++ A   +KV DFG++ A+              GT  Y++PE  
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESNLMALYKKIFKADFKSP----PWFSTS 243
                D A++D++S G +LY ++ G  PF  +S +   Y+ + + D   P       S  
Sbjct: 192 RGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSAD 249

Query: 244 AKKLISRILDPNPVTR 259
              ++ + L  NP  R
Sbjct: 250 LDAVVLKALAKNPENR 265

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  151 bits (384), Expect = 4e-43
 Identities = 85/335 (25%), Positives = 144/335 (42%), Gaps = 65/335 (19%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
            A+     SR  + ++++ R  G+G+F  V+  +   TG +VAIK     KV++      
Sbjct: 10  AAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR- 63

Query: 61  IKREISTMKLIR---HPNVIRMYEVMASKTK-------IYIVLEFVTGGELFDKIASRGR 110
             RE+  M+ +    HPN++++     +  +       + +V+E+V    L     +  R
Sbjct: 64  -NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYR 121

Query: 111 LK---EDEARKYFQ-QLINAVDYCH--SRGVCHRDLKPENLLLD-ANGVLKVSDFGLSAL 163
            +        K F  QLI ++   H  S  VCHRD+KP N+L++ A+G LK+ DFG +  
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK- 180

Query: 164 PQQVRDDGLLHTTCGTPNYVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFE-ESN 221
            +    +  +   C +  Y APE+I  N+ Y  A  D+WS G I   +M G   F  +++
Sbjct: 181 -KLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTA-VDIWSVGCIFAEMMLGEPIFRGDNS 237

Query: 222 LMALYKKIFK-----------------ADFKSP-----PW---FSTSAKK-------LIS 249
              L  +I +                  D         PW   FS  + K       L+S
Sbjct: 238 AGQL-HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN 284
            +L   P  R+   E + + +F      P+ + PN
Sbjct: 297 ALLQYLPEERMKPYEALCHPYF-DELHDPATKLPN 330

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  147 bits (374), Expect = 2e-41
 Identities = 81/361 (22%), Positives = 141/361 (39%), Gaps = 93/361 (25%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY LG+TLG GSF  V    + E+G+  A+K     KVL+        RE+  MK++ H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRY--KNRELDIMKVLDHV 60

Query: 75  NVIRMYEVMASKTK--------------------------------------IYIVLEFV 96
           N+I++ +   +                                         + +++E+V
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 97  TGGELFDKI----ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-G 151
               L   +     S   +  +    Y  QL  AV + HS G+CHRD+KP+NLL+++   
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 152 VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI-NNKGYDGAKADLWSCGVILYVL 210
            LK+ DFG +   + +  +  +   C +  Y APE++     Y  +  DLWS G +   L
Sbjct: 180 TLKLCDFGSAK--KLIPSEPSVAYIC-SRFYRAPELMLGATEYTPS-IDLWSIGCVFGEL 235

Query: 211 MAGYLPFE-ESNLMALYKKIFK-----------------ADFKSPPWFSTSAKK------ 246
           + G   F  E+++  L  +I +                  + + P   +   +K      
Sbjct: 236 ILGKPLFSGETSIDQL-VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294

Query: 247 ------LISRILDPNPVTRITMAEVIENEWFKKGYKP------PSFEQPNIDLDDVDSIF 294
                 L+ +IL   P  RI   E + + +F             +   P+    ++  +F
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLF 354

Query: 295 N 295
           N
Sbjct: 355 N 355

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  146 bits (370), Expect = 4e-41
 Identities = 88/358 (24%), Positives = 144/358 (40%), Gaps = 72/358 (20%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
            Y   + +G G++  V  A +  TG  VAIK L   +  + ++  +   RE+  +K +RH
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRH 83

Query: 74  PNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            NVI + +V             Y+V+ F+ G +L  K+    +L ED  +    Q++  +
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---- 183
            Y H+ G+ HRDLKP NL ++ +  LK+ DFGL+      R      T      YV    
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTRW 190

Query: 184 --APEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---------- 230
             APEVI N   Y     D+WS G I+  ++ G   F+ S+ +   K+I           
Sbjct: 191 YRAPEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 231 --------------------KADFKSP-PWFSTSAKKLISRILDPNPVTRITMAEVIENE 269
                               K DF S     S  A  L+ ++L  +   R+T  E + + 
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

Query: 270 WFKKGYKP----------PSFEQPNIDLDDV-DSIFNESMDSRNLVVERREEGPVAPL 316
           +F+  +             SF+  +  LD+     + E +  +             PL
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  145 bits (367), Expect = 1e-40
 Identities = 88/346 (25%), Positives = 136/346 (39%), Gaps = 68/346 (19%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
            ++L   LGEG++  V  A +  TGE VAIK   K +     +      REI  +K  +H
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68

Query: 74  PNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
            N+I ++ +    +      +YI+ E +   +L  ++ S   L +D  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVK 126

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGL--SALPQQVRDDGLLHTTCGTPNYV--- 183
             H   V HRDLKP NLL+++N  LKV DFGL          +        G   +V   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186

Query: 184 ---APEVI-NNKGYDGAKADLWSCGVILYVLMAG--------YL------------PFEE 219
              APEV+  +  Y  A  D+WSCG IL  L           Y             P  +
Sbjct: 187 WYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 220 SNL--------------MALYKKI-FKADFKSPPWFSTSAKKLISRILDPNPVTRITMAE 264
           ++L              + +Y     +  F   P  +     L+ R+L  +P  RIT  E
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMF---PRVNPKGIDLLQRMLVFDPAKRITAKE 302

Query: 265 VIENEWFKKGYKP---PSFEQPNIDLDDVDSIFNESMDSRNLVVER 307
            +E+ + +  + P   P  E          S F        L  + 
Sbjct: 303 ALEHPYLQTYHDPNDEPEGEPI------PPSFFEFDHYKEALTTKD 342

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  150 bits (379), Expect = 1e-40
 Identities = 64/264 (24%), Positives = 104/264 (39%), Gaps = 39/264 (14%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTE-TGENVAIKIL----DKEKVLKHKMIGQIKREISTM 68
           G+YE+   +  G    +  A +    G  V +K L    D E             E   +
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMAMAERQFL 133

Query: 69  KLIRHPNVIRMYEV-----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
             + HP++++++              YIV+E+V G  L        +L   EA  Y  ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR---DDGLLHTTCGTP 180
           + A+ Y HS G+ + DLKPEN++L    + K+ D G       V      G L    GTP
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGA------VSRINSFGYL---YGTP 241

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF 240
            + APE++  +       D+++ G  L  L           +  L       +       
Sbjct: 242 GFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKT 293

Query: 241 STSAKKLISRILDPNPVTRITMAE 264
             S  +L+ R +DP+P  R T AE
Sbjct: 294 YDSYGRLLRRAIDPDPRQRFTTAE 317

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  143 bits (362), Expect = 1e-40
 Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 48/292 (16%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
            L   +G+G + +V        GENVA+KI               + E+    ++RH N+
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFR----ETELYNTVMLRHENI 64

Query: 77  IRMY----EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +           S T+++++  +   G L+D +     L      +    + + + + H 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 133 R--------GVCHRDLKPENLLLDANGVLKVSDFGLSAL--PQQVRDDGLLHTTCGTPNY 182
                     + HRDLK +N+L+  NG   ++D GL+ +      + D   +   GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 183 VAPEVINNKGYDGA-----KADLWSCGVILYVLMAGY----------LPFEESN-LMALY 226
           +APEV++            + D+W+ G++L+ +               PF +       +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 227 KKIFKA---DFKSPP----WFSTSAKKLISRIL----DPNPVTRITMAEVIE 267
           + + K    D + P     WFS      +++++      NP  R+T   + +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  143 bits (363), Expect = 4e-40
 Identities = 80/342 (23%), Positives = 142/342 (41%), Gaps = 74/342 (21%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
            Y     +G G++  V  A +  +GE VAIK L   +  + ++  +   RE+  +K ++H
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 74  PNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            NVI + +V    +        Y+V+ F+   +L   +    +  E++ +    Q++  +
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---- 183
            Y HS GV HRDLKP NL ++ +  LK+ DFGL+      R      T      YV    
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188

Query: 184 --APEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---------- 230
             APEVI +   Y+    D+WS G I+  ++ G   F+  + +    +I           
Sbjct: 189 YRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 231 --------------------KADFKSP-PWFSTSAKKLISRILDPNPVTRITMAEVIENE 269
                               + DF    P  S  A  L+ ++L+ +   R+T A+ + + 
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307

Query: 270 WFKKGYKP-----------PSFEQPNIDLDDV-DSIFNESMD 299
           +F+    P            S E   + +D+    I+ E ++
Sbjct: 308 FFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVN 349

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  142 bits (361), Expect = 4e-40
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 20/209 (9%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-H 73
            Y+L R LG G +++V  A N    E V +KIL   K  K      IKREI  ++ +R  
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGG 90

Query: 74  PNVIRMYEVM---ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           PN+I + +++    S+T   +  E V   +      +   L + + R Y  +++ A+DYC
Sbjct: 91  PNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146

Query: 131 HSRGVCHRDLKPENLLLD-ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI- 188
           HS G+ HRD+KP N+++D  +  L++ D+GL+      ++    +    +  +  PE++ 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPF 217
           + + YD +  D+WS G +L  ++    PF
Sbjct: 204 DYQMYDYS-LDMWSLGCMLASMIFRKEPF 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  145 bits (368), Expect = 5e-40
 Identities = 79/384 (20%), Positives = 153/384 (39%), Gaps = 73/384 (19%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +Y+  + +G G+   V  A +     NVAIK L   +  +++   +   RE+  MK + H
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 74  PNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            N+I +  V   +        +Y+V+E +    L   I  +  L  +       Q++  +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
            + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++     T  Y APEV
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV 234

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF----------------- 230
           I   GY     D+WS G I+  ++   + F   + +  + K+                  
Sbjct: 235 ILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293

Query: 231 ------------KADFKS-------------PPWFSTSAKKLISRILDPNPVTRITMAEV 265
                          F                   ++ A+ L+S++L  +P  RI++ + 
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 266 IENEWFKKGYKP------------PSFEQPNIDLDDV-DSIFNESMDSRNLVVERREEGP 312
           +++ +    Y P               ++    +++  + I+ E M+S         +G 
Sbjct: 354 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQ 413

Query: 313 VAPLT--MNAFELISTSQGLNLSS 334
            +P    +N+ E +  S  +N  S
Sbjct: 414 PSPSGAAVNSSESLPPSSSVNDIS 437

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  143 bits (362), Expect = 6e-40
 Identities = 77/341 (22%), Positives = 145/341 (42%), Gaps = 72/341 (21%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +Y+    +G G++  V  A +T+TG  VA+K L   +  +  +  +   RE+  +K ++H
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 74  PNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            NVI + +V            +Y+V   + G +L + +  + +L +D  +    Q++  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGL 145

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---- 183
            Y HS  + HRDLKP NL ++ +  LK+ DFGL+    +   D +         YV    
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM-------TGYVATRW 194

Query: 184 --APEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---------- 230
             APE++ N   Y+    D+WS G I+  L+ G   F  ++ +   K I           
Sbjct: 195 YRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 231 --------------------KADFKSP-PWFSTSAKKLISRILDPNPVTRITMAEVIENE 269
                               K +F +     +  A  L+ ++L  +   RIT A+ + + 
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313

Query: 270 WFKKGYKP----------PSFEQPNIDLDDV-DSIFNESMD 299
           +F + + P           S E  ++ +D+     ++E + 
Sbjct: 314 YFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEVIS 354

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  143 bits (362), Expect = 7e-40
 Identities = 74/347 (21%), Positives = 141/347 (40%), Gaps = 71/347 (20%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +Y+  + +G G+   V  A +     NVAIK L   +  +++   +   RE+  MK + H
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 74  PNVIRMYEVMASKTK------IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
            N+I +  V   +        +YIV+E +    L   I  +  L  +       Q++  +
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 140

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
            + HS G+ HRDLKP N+++ ++  LK+ DFGL+   +      ++     T  Y APEV
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV 197

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF----------------- 230
           I   GY     D+WS G I+  ++ G + F  ++ +  + K+                  
Sbjct: 198 ILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 231 ------------KADFKS-------------PPWFSTSAKKLISRILDPNPVTRITMAEV 265
                          F+                  ++ A+ L+S++L  +   RI++ E 
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 266 IENEWFKKGYKP------------PSFEQPNIDLDDV-DSIFNESMD 299
           +++ +    Y P               ++    +++  + I+ E MD
Sbjct: 317 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD 363

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  142 bits (361), Expect = 8e-40
 Identities = 86/344 (25%), Positives = 144/344 (41%), Gaps = 73/344 (21%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +Y     +GEG++  V  A +      VAIK   K    +H+   Q   REI  +   RH
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRH 84

Query: 74  PNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
            N+I + +++ + T      +YIV + +   +L+  + ++  L  D    +  Q++  + 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV----- 183
           Y HS  V HRDLKP NLLL+    LK+ DFGL+ +     D     T      YV     
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197

Query: 184 -APEVI-NNKGYDGAKADLWSCGVILYVLMAG--------YL------------PFEE-- 219
            APE++ N+KGY  +  D+WS G IL  +++         YL            P +E  
Sbjct: 198 RAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256

Query: 220 ------------SNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
                        +L    K  +   F   P   + A  L+ ++L  NP  RI + + + 
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLF---PNADSKALDLLDKMLTFNPHKRIEVEQALA 313

Query: 268 NEWFKKGYKPP-----------SFEQPNIDLDDV-DSIFNESMD 299
           + + ++ Y P              E  ++  + + + IF E+  
Sbjct: 314 HPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETAR 357

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  140 bits (354), Expect = 2e-38
 Identities = 73/354 (20%), Positives = 132/354 (37%), Gaps = 89/354 (25%)

Query: 8   ASRTRVG-KYE-LGRTLGEGSFAKVKFARN--TETGENVAIKILDKEKVLKHKMIGQIKR 63
           + R RV   +E  G  +G G++  V  A+    +  ++ A+K ++   +          R
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----R 67

Query: 64  EISTMKLIRHPNVIRMYEVMASKT--KIYIVLEFV--------TGGELFDKIASRGRLKE 113
           EI+ ++ ++HPNVI + +V  S    K++++ ++                      +L  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA----NGVLKVSDFGLS---ALPQQ 166
              +    Q+++ + Y H+  V HRDLKP N+L+       G +K++D G +     P +
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 167 VRDDGLLHTTCGTPN-----YVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPF--- 217
                        P      Y APE++   + Y  A  D+W+ G I   L+     F   
Sbjct: 188 PL-------ADLDPVVVTFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSEPIFHCR 239

Query: 218 -EESNLMALYK-----KIFKA----------DFKSPPWFSTSAKK--------------- 246
            E+      Y      +IF            D K  P  ST  K                
Sbjct: 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 299

Query: 247 -------------LISRILDPNPVTRITMAEVIENEWFKKGYKP--PSFEQPNI 285
                        L+ ++L  +P+ RIT  + +++ +F +   P    F    I
Sbjct: 300 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQI 353

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  141 bits (357), Expect = 2e-38
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 42/228 (18%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK----ILDKEKVLKHKMIGQIKREISTMKL 70
           +YE+   +G GS+  V  A +      VAIK    + +     K      I REI+ +  
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-----ILREIAILNR 108

Query: 71  IRHPNVIRMYEVMASKT-----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
           + H +V+++ +++  K      ++Y+VLE     +      +   L E   +     L+ 
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLV 167

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPN--- 181
            V Y HS G+ HRDLKP N L++ +  +KV DFGL+  +      +  L  +    +   
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 182 ---------------YV------APEVI-NNKGYDGAKADLWSCGVIL 207
                          +V      APE+I   + Y  A  D+WS G I 
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIGCIF 274

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  138 bits (351), Expect = 3e-38
 Identities = 69/346 (19%), Positives = 127/346 (36%), Gaps = 64/346 (18%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQ-------IKREIS 66
            Y + R +  GS+  V    ++  G  VAIK + +     +   I         + REI 
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 67  TMKLIRHPNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ 121
            +    HPN++ + ++     +     +Y+V E +   +L   I  +  +   +  +YF 
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140

Query: 122 -QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
             ++  +   H  GV HRDL P N+LL  N  + + DF L+   ++   D          
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTHR 197

Query: 181 NYVAPEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF--------- 230
            Y APE++   KG+     D+WS G ++  +      F  S       KI          
Sbjct: 198 WYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256

Query: 231 ----------------------KADFKSP-PWFSTSAKKLISRILDPNPVTRITMAEVIE 267
                                    + +  P     A  LI+++L+ NP  RI+  + + 
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316

Query: 268 NEWFKKGYKPP----------SFEQPNIDLDDV-DSIFNESMDSRN 302
           + +F+  + P            F++   D+ D+      E     +
Sbjct: 317 HPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVERFND 362

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  136 bits (345), Expect = 7e-38
 Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 50/295 (16%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
             +L      G F  V   +     E VA+KI   +     K   Q + E+ ++  ++H 
Sbjct: 25  PLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHE 78

Query: 75  NVIRMY----EVMASKTKIYIVLEFVTGGELFD-------KIASRGRLKEDEAR--KYFQ 121
           N+++         +    ++++  F   G L D              + E  AR   Y  
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           + I  +   H   + HRD+K +N+LL  N    ++DFGL+   +  +  G  H   GT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 182 YVAPEV----INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP 237
           Y+APEV    IN +     + D+++ G++L+ L +     +       Y   F+ +    
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV--DEYMLPFEEEIGQH 256

Query: 238 P---------------------WFSTSAKKLISRIL----DPNPVTRITMAEVIE 267
           P                     W   +   ++   +    D +   R++   V E
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  135 bits (342), Expect = 3e-37
 Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 48/292 (16%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
            L  ++G+G F +V   +    GE VA+KI         +     + EI    ++RH N+
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98

Query: 77  IRMY----EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           +       +   + T++++V ++   G LFD + +R  +  +   K      + + + H 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 133 R--------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGTPNY 182
                     + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 183 VAPEVINNKGYDGA-----KADLWSCGVILYVLMAGYLPFEESNLMAL-YKKIFKADFK- 235
           +APEV+++           +AD+++ G++ + +              L Y  +  +D   
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 236 ----------------SPPWFSTSAKKLISRIL----DPNPVTRITMAEVIE 267
                              W S  A +++++I+      N   R+T   + +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  134 bits (338), Expect = 3e-37
 Identities = 41/259 (15%), Positives = 82/259 (31%), Gaps = 39/259 (15%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+Y L    G     +   A +T     VA+  +D + VL   ++ +       +  I  
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           P V R+ +V+ ++    +V E++ GG L +            A +  Q L  A D  H  
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
           GV      P  + +  +G + ++                          +          
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK-------K 246
              + D+   G  LY L+    P  E+ + +      +     P   +   +        
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238

Query: 247 LISRILDPNPVTRITMAEV 265
           + +R +  +   R     +
Sbjct: 239 VAARSVQGDGGIRSASTLL 257

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  135 bits (341), Expect = 4e-37
 Identities = 66/300 (22%), Positives = 121/300 (40%), Gaps = 50/300 (16%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           RT   + ++ + +G+G + +V   +    GE VA+K+    +          + EI    
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFR----ETEIYQTV 86

Query: 70  LIRHPNVIRMY----EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN 125
           L+RH N++       +   S T++Y++ ++   G L+D + S   L      K     ++
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVS 145

Query: 126 AVDYCHSR--------GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHT 175
            + + H+          + HRDLK +N+L+  NG   ++D GL+       +  D   +T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 176 TCGTPNYVAPEVI------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL-YKK 228
             GT  Y+ PEV+      N+       AD++S G+IL+ +    +         L Y  
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264

Query: 229 IFKADFKS-------------PP----WFSTSA----KKLISRILDPNPVTRITMAEVIE 267
           +  +D                P     W S        KL++     NP +R+T   V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  135 bits (342), Expect = 2e-36
 Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 33/263 (12%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
            Y +   +G GS+  V  A +  T +NVAIK +   ++ +  +  + I REI+ +  ++ 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS 84

Query: 74  PNVIRMYEVMASKTK-----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
             +IR+Y+++          +YIVLE     +L     +   L E+  +     L+   +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-----------ALPQQVRDDGLLHTTC 177
           + H  G+ HRDLKP N LL+ +  +KV DFGL+               +  ++   H   
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 178 GTP---NYV------APEVI-NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK 227
                 ++V      APE+I   + Y  +  D+WS G I   L+         N      
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWSTGCIFAELLNM--LQSHINDPTNRF 260

Query: 228 KIFKADFKSPPWFSTSAKKLISR 250
            +F      P     ++KK+  +
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEK 283

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  132 bits (334), Expect = 1e-35
 Identities = 80/383 (20%), Positives = 147/383 (38%), Gaps = 93/383 (24%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIK-ILDKEKVLKHKMIGQ-IKREISTMKLIR 72
           KYEL + LG+G++  V  + +  TGE VA+K I D     ++    Q   REI  +  + 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILTELS 66

Query: 73  -HPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQ-QLINAVD 128
            H N++ +  V+ +     +Y+V +++   +L   I  R  + E   ++Y   QLI  + 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI--RANILEPVHKQYVVYQLIKVIK 123

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-------ALPQQVRDDGLLHTTCGTPN 181
           Y HS G+ HRD+KP N+LL+A   +KV+DFGLS        +   +      +T     +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 182 ------YV------APEVI-NNKGYDGAKADLWSCGVILYVLMAG--------------- 213
                 YV      APE++  +  Y     D+WS G IL  ++ G               
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKG-IDMWSLGCILGEILCGKPIFPGSSTMNQLER 242

Query: 214 -----------------------YL---------PFEESNLMALYKKIFKADFKSPPWFS 241
                                   +                +    K            +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

Query: 242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PSFEQP-NIDLDDVDS----- 292
             A  L+ ++L  NP  RI+  + +++ +    + P   P+ +    I ++D        
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD 362

Query: 293 ----IFNESMDSRNLVVERREEG 311
               +++E    +  ++  + + 
Sbjct: 363 YRNLVYSEISRRKRELISNKHQN 385

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  129 bits (327), Expect = 3e-35
 Identities = 73/319 (22%), Positives = 124/319 (38%), Gaps = 71/319 (22%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ-IKREISTMKLIRH 73
           +Y   + LG G    V  A + +  + VAIK +    VL      +   REI  ++ + H
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDH 67

Query: 74  PNVIRMYEVMASKTK--------------IYIVLEFVTGGELFDKIASRGRLKEDEARKY 119
            N+++++E++                   +YIV E++   +L   +  +G L E+ AR +
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLF 125

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
             QL+  + Y HS  V HRDLKP NL ++  + VLK+ DFGL+ +           +   
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS--- 182

Query: 179 TPNYV------APEVI-NNKGYDGAKADLWSCGVILYVLMAG--------YL-------- 215
               +      +P ++ +   Y  A  D+W+ G I   ++ G         L        
Sbjct: 183 --EGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

Query: 216 ----PFEE-------------SNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVT 258
                 EE              N M    K         P  S  A   + +IL  +P+ 
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL---PGISREAVDFLEQILTFSPMD 296

Query: 259 RITMAEVIENEWFKKGYKP 277
           R+T  E + + +      P
Sbjct: 297 RLTAEEALSHPYMSIYSFP 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  125 bits (316), Expect = 2e-33
 Identities = 55/288 (19%), Positives = 108/288 (37%), Gaps = 41/288 (14%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L   +G G +  V   + +     VA+K+        ++     ++ I  + L+ H N+
Sbjct: 16  KLLELIGRGRYGAVY--KGSLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69

Query: 77  IRMY-----EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
            R            + +  +V+E+   G L   + S        + +    +   + Y H
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 132 S---------RGVCHRDLKPENLLLDANGVLKVSDFGLS------ALPQQVRDDGLLHTT 176
           +           + HRDL   N+L+  +G   +SDFGLS       L +   +D    + 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 177 CGTPNYVAPEVI------NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF 230
            GT  Y+APEV+       +      + D+++ G+I + +            +  Y+  F
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 231 KADFKSPPWFST-----SAKKL---ISRILDPNPVTRITMAEVIENEW 270
           + +  + P F       S +K           N +   ++ E IE+ W
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  125 bits (317), Expect = 3e-33
 Identities = 64/259 (24%), Positives = 114/259 (44%), Gaps = 16/259 (6%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
            LG  +G G+F +V   R       VA+K   +E +    +  +  +E   +K   HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPP-DLKAKFLQEARILKQYSHPNI 174

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGV 135
           +R+  V   K  IYIV+E V GG+    + + G  L+     +        ++Y  S+  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY----VAPEVINNK 191
            HRDL   N L+    VLK+SDFG+S    +   DG+   + G         APE +N  
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290

Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKADFK--SPPWFSTSAKKLI 248
            Y  +++D+WS G++L+     G  P+   +     + + +   +   P     +  +L+
Sbjct: 291 RYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLM 348

Query: 249 SRILDPNPVTRITMAEVIE 267
            +     P  R + + + +
Sbjct: 349 EQCWAYEPGQRPSFSTIYQ 367

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  120 bits (302), Expect = 1e-30
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 13/218 (5%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
            +   LG G + +V      +    VA+K L ++ +   + +    +E + MK I+HPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNL 278

Query: 77  IRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           +++  V   +   YI+ EF+T G L D  +  +R  +          Q+ +A++Y   + 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY--VAPEVINNKG 192
             HR+L   N L+  N ++KV+DFGLS   + +  D               APE +    
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
           +   K+D+W+ GV+L+ +   G  P+   +L  +Y+ +
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  114 bits (287), Expect = 9e-30
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGEN--VAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            L   LG+GSF  V+    +  +G+   VA+K L  + + + + +    RE++ M  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-AVD---- 128
            N+IR+Y V      + +V E    G L D      RL++ +       L   AV     
Sbjct: 81  RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 129 --YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYV-- 183
             Y  S+   HRDL   NLLL    ++K+ DFGL  ALPQ   +D               
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190

Query: 184 -APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEE 219
            APE +  + +    +D W  GV L+ +   G  P+  
Sbjct: 191 CAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIG 227

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (286), Expect = 1e-29
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 31/227 (13%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKIL-----DKEKVLKHKMIGQIKREISTMKLI 71
            +   LG G + +V      +    VA+K L     + E+ LK         E + MK I
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 66

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDY 129
           +HPN++++  V   +   YI+ EF+T G L D  +  +R  +          Q+ +A++Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG------TPNYV 183
              +   HRDL   N L+  N ++KV+DFGLS   + +  D              T    
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWT---- 179

Query: 184 APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
           APE +    +   K+D+W+ GV+L+ +   G  P+   +L  +Y+ +
Sbjct: 180 APESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  114 bits (288), Expect = 2e-29
 Identities = 63/343 (18%), Positives = 120/343 (34%), Gaps = 83/343 (24%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
            +Y L R LG G F+ V  A++     +VA+KI+  +K          + EI  ++ +  
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74

Query: 73  ----------HPNVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEA 116
                       +++++ +       +   + +V E V G  L   I       +     
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133

Query: 117 RKYFQQLINAVDYCHSR-GVCHRDLKPENLLLD------ANGVLKVSDFGLSALPQQVRD 169
           ++  +QL+  +DY H R G+ H D+KPEN+L++          +K++D G +        
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188

Query: 170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFE---------ES 220
           D     +  T  Y +PEV+    +    AD+WS   +++ L+ G   FE         + 
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

Query: 221 NLMALY------------------KKIFKADFKSPPWFSTSAKKL--------------- 247
           + +A                    +  F +              L               
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307

Query: 248 ------ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN 284
                 +S +L  +P  R     ++ + W K          P+
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  111 bits (280), Expect = 6e-29
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 23/220 (10%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L +T+G+G F  V        G  VA+K + K        +     E S M  +RH N+
Sbjct: 24  KLLQTIGKGEFGDVMLG--DYRGNKVAVKCI-KNDATAQAFL----AEASVMTQLRHSNL 76

Query: 77  IRMYEV-MASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++  V +  K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---APEVINN 190
              HRDL   N+L+  + V KVSDFGL+      ++      T   P  V   APE +  
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLP--VKWTAPEALRE 188

Query: 191 KGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
           K +   K+D+WS G++L+ +   G +P+    L  +  ++
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  111 bits (281), Expect = 7e-29
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 11/208 (5%)

Query: 18  LGRTLGEGSFAKVKFA--RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
             + LG G+F  VK    +  +  + VA+KIL K +     +  ++  E + M+ + +P 
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           ++RM  +        +V+E    G L   +     +K+    +   Q+   + Y      
Sbjct: 80  IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--P-NYVAPEVINNKG 192
            HRDL   N+LL      K+SDFGLS   +   D+           P  + APE IN   
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196

Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEE 219
           +  +K+D+WS GV+++     G  P+  
Sbjct: 197 FS-SKSDVWSFGVLMWEAFSYGQKPYRG 223

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (286), Expect = 1e-28
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 17/219 (7%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
            L   LG+G F +V     N  T   VAIK L    +     +    +E   MK +RH  
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 240

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           ++++Y V  S+  IYIV E+++ G L D +       L+  +      Q+ + + Y    
Sbjct: 241 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT-P-NYVAPEVINNK 191
              HRDL+  N+L+  N V KV+DFGL+   + + D+          P  + APE     
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
            +   K+D+WS G++L  +   G +P+       +  ++
Sbjct: 357 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  110 bits (278), Expect = 1e-28
 Identities = 59/237 (24%), Positives = 111/237 (46%), Gaps = 40/237 (16%)

Query: 14  GKYE-------LGRTLGEGSFAKVKFAR-NTETGENVAIKIL-----DKEKVLKHKMIGQ 60
           G  E       L + LG G F  VK  +   +   +VA+K++      +++  +      
Sbjct: 1   GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFFQ------ 52

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKY 119
              E  TM  + HP +++ Y V + +  IYIV E+++ G L + + S G+ L+  +  + 
Sbjct: 53  ---EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG- 178
              +   + +  S    HRDL   N L+D +  +KVSDFG++   + V DD  + +    
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT---RYVLDDQYVSSVGTK 166

Query: 179 -----TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
                +    APEV +   Y  +K+D+W+ G++++ V   G +P++      +  K+
Sbjct: 167 FPVKWS----APEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  114 bits (287), Expect = 2e-28
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 17/219 (7%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
            L   LG+G F +V     N  T   VAIK L    +     +    +E   MK +RH  
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 323

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           ++++Y V  S+  IYIV E+++ G L D +       L+  +      Q+ + + Y    
Sbjct: 324 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT-P-NYVAPEVINNK 191
              HRDL+  N+L+  N V KV+DFGL+   + + D+          P  + APE     
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 192 GYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
            +   K+D+WS G++L  +   G +P+       +  ++
Sbjct: 440 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (276), Expect = 3e-28
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 42/238 (17%)

Query: 14  GKYE-------LGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           GK+          + +G G F  V       +    VAIK + +  + +   I     E 
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTIREGAMSEEDFI----EEA 54

Query: 66  STMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLI 124
             M  + HP ++++Y V   +  I +V EF+  G L D +   RG    +        + 
Sbjct: 55  EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV- 183
             + Y     V HRDL   N L+  N V+KVSDFG++   + V DD           Y  
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT---RFVLDD----------QYTS 161

Query: 184 -----------APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
                      +PEV +   Y  +K+D+WS GV+++ V   G +P+E  +   + + I
Sbjct: 162 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (279), Expect = 3e-28
 Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 16/222 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  + LG G+F  V        GE     VAIK L +    K     +I  E   M  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASVD 75

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           +P+V R+  +    + + ++ + +  G L D +   +  +       +  Q+   ++Y  
Sbjct: 76  NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--P-NYVAPEVI 188
            R + HRDL   N+L+     +K++DFGL+ L   +  +   +   G   P  ++A E I
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESI 191

Query: 189 NNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
            ++ Y   ++D+WS GV ++ ++  G  P++      +   +
Sbjct: 192 LHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  112 bits (282), Expect = 4e-28
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 24/230 (10%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +YE+ + +G+GSF +V  A + +  ++VA+K++  EK    +   Q   EI  ++ +R 
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRK 152

Query: 74  ------PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLIN 125
                  NVI M E    +  I +  E +    L++ I             RK+   ++ 
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANG--VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV 183
            +D  H   + H DLKPEN+LL   G   +KV DFG S       +   ++T   +  Y 
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYTYIQSRFYR 266

Query: 184 APEVINNKGYDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIF 230
           APEVI    Y     D+WS G IL  L+ GY      +E + +A   ++ 
Sbjct: 267 APEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  110 bits (276), Expect = 4e-28
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 24/209 (11%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  + LG+G+F  V+  R       TGE VA+K L +    +H      +REI  +K ++
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQ 69

Query: 73  HPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDY 129
           H N+++   V  S  +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTP-NY 182
             ++   HRDL   N+L++    +K+ DFGL+  LPQ     +V++ G        P  +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------PIFW 183

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLM 211
            APE +    +    +D+WS GV+LY L 
Sbjct: 184 YAPESLTESKFS-VASDVWSFGVVLYELF 211

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (276), Expect = 4e-28
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  R LGEG F KV+  R       TGE VA+K L  E    H     +K+EI  ++ + 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLY 81

Query: 73  HPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDY 129
           H N+++   +        I +++EF+  G L + +  ++ ++   +  KY  Q+   +DY
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTP-NY 182
             SR   HRDL   N+L+++   +K+ DFGL+ A+        V+DD         P  +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFW 195

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLM 211
            APE +    +    +D+WS GV L+ L+
Sbjct: 196 YAPECLMQSKFY-IASDVWSFGVTLHELL 223

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  109 bits (274), Expect = 6e-28
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L   LG G F +V     N  T   VA+K L +  +     +     E + MK ++H  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           ++R+Y V  ++  IYI+ E++  G L D  K  S  +L  ++      Q+   + +   R
Sbjct: 70  LVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG------TPNYVAPEV 187
              HRDL+  N+L+      K++DFGL+   + + D+              T    APE 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDNEYTAREGAKFPIKWT----APEA 181

Query: 188 INNKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           IN   +   K+D+WS G++L  ++  G +P+ 
Sbjct: 182 INYGTFT-IKSDVWSFGILLTEIVTHGRIPYP 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 7e-28
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 24/209 (11%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  + LG+G+F  V+  R       TGE VA+K L +    +H      +REI  +K ++
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQ 100

Query: 73  HPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDY 129
           H N+++   V  S  +  + +++E++  G L D +   + R+   +  +Y  Q+   ++Y
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTP-NY 182
             ++   HRDL   N+L++    +K+ DFGL+  LPQ     +V++ G        P  +
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIFW 214

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLM 211
            APE +    +    +D+WS GV+LY L 
Sbjct: 215 YAPESLTESKFS-VASDVWSFGVVLYELF 242

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  109 bits (275), Expect = 8e-28
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 13/210 (6%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            + + +G G   +V + R    G+    VAIK L      + +       E S M    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMGQFDH 109

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
           PN+IR+  V+       IV E++  G L   +    G+    +     + +   + Y   
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---APEVIN 189
            G  HRDL   N+L+D+N V KVSDFGLS + +   D    +TT G    +   APE I 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 190 NKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
            + +  + +D+WS GV+++ VL  G  P+ 
Sbjct: 228 FRTFS-SASDVWSFGVVMWEVLAYGERPYW 256

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (274), Expect = 1e-27
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 27/210 (12%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  R LGEG F KV        N  TGE VA+K L  +   +H+     K+EI  ++ + 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS--GWKQEIDILRTLY 91

Query: 73  HPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           H ++I+            + +V+E+V  G L D +     +   +   + QQ+   + Y 
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYL 150

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQ-----QVRDDGLLHTTCGTPNYV- 183
           H++   HRDL   N+LLD + ++K+ DFGL+ A+P+     +VR+DG        P  V 
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202

Query: 184 --APEVINNKGYDGAKADLWSCGVILYVLM 211
             APE +    +    +D+WS GV LY L+
Sbjct: 203 WYAPECLKEYKFY-YASDVWSFGVTLYELL 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  109 bits (274), Expect = 2e-27
 Identities = 83/336 (24%), Positives = 129/336 (38%), Gaps = 83/336 (24%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            +YE+  TLGEG+F KV    + + G  +VA+KI+        +     + EI  ++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69

Query: 73  HP------NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLI 124
                     ++M E       I IV E + G   +D I   G    + D  RK   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGV-------------------LKVSDFGLSALPQ 165
            +V++ HS  + H DLKPEN+L   +                     +KV DFG SA   
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SA--- 184

Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF---EESNL 222
              DD    T   T +Y APEVI   G+     D+WS G IL     G+  F   +    
Sbjct: 185 -TYDDEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEH 242

Query: 223 MAL-----------------YKKIFKADFKSPPWFSTSAKK------------------- 246
           +A+                  +K F  D       S++ +                    
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302

Query: 247 -----LISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                LI ++L+ +P  RIT+ E +++ +F    K 
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  109 bits (274), Expect = 2e-27
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 15/210 (7%)

Query: 18  LGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + + +G G F +V   R     +    VAIK L      K +       E S M    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSR 133
           N+IR+  V+     + IV E++  G L   +     +    +     + + + + Y    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG-LLHTTCGTPNYV---APEVIN 189
           G  HRDL   N+L+++N V KVSDFGL    + + DD    +TT G    +   +PE I 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLG---RVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 190 NKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
            + +  + +D+WS G++L+ V+  G  P+ 
Sbjct: 224 YRKFT-SASDVWSYGIVLWEVMSYGERPYW 252

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  110 bits (276), Expect = 4e-27
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 19/218 (8%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV 76
           +L +T+G+G F  V        G  VA+K + K        +     E S M  +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCI-KNDATAQAFL----AEASVMTQLRHSNL 248

Query: 77  IRMYEV-MASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++  V +  K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y    
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP-NYVAPEVINNKG 192
              HRDL   N+L+  + V KVSDFGL+      ++      T   P  + APE +  K 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKK 362

Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
           +   K+D+WS G++L+ +   G +P+    L  +  ++
Sbjct: 363 FS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (271), Expect = 4e-27
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 30/212 (14%)

Query: 17  ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIK---REISTMK 69
           +    LG+G+F  V+  R       TG  VA+K       L+H    Q +   REI  +K
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILK 79

Query: 70  LIRHPNVIRMYEVMASKTK--IYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINA 126
            +    +++   V     +  + +V+E++  G L D +   R RL       Y  Q+   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS-ALPQQ-----VRDDGLLHTTCGTP 180
           ++Y  SR   HRDL   N+L+++   +K++DFGL+  LP       VR+ G        P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193

Query: 181 -NYVAPEVINNKGYDGAKADLWSCGVILYVLM 211
             + APE +++  +   ++D+WS GV+LY L 
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVLYELF 224

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  109 bits (273), Expect = 4e-27
 Identities = 68/296 (22%), Positives = 125/296 (42%), Gaps = 39/296 (13%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +YE+   +G+GSF +V  A +    E VAIKI+  +K      + Q + E+  ++L+  
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNK 109

Query: 74  P------NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLIN 125
                   ++ +      +  + +V E +    L+D + +     +  +  RK+ QQ+  
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 126 AVDYCHSR--GVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN 181
           A+ +  +    + H DLKPEN+LL       +K+ DFG S+     +    ++    +  
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SS----CQLGQRIYQYIQSRF 223

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF---EESNLMALYKKIFKADFKSPP 238
           Y +PEV+    YD A  D+WS G IL  +  G   F    E + M    ++       P 
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG---IPPA 279

Query: 239 WF---STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVD 291
                +  A+K   ++ D     +       + +  K+ YKPP   + +  L    
Sbjct: 280 HILDQAPKARKFFEKLPDGTWNLK-------KTKDGKREYKPPGTRKLHNILGVET 328

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (268), Expect = 4e-27
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 35/228 (15%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
              + LG G F  VK+ +   +   +VAIK++ +  + + + I     E   M  + H  
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQY--DVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 80

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++++Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+ 
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV----------- 183
             HRDL   N L++  GV+KVSDFGLS   + V DD           Y            
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDD----------EYTSSVGSKFPVRW 187

Query: 184 -APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
             PEV+    +  +K+D+W+ GV+++ +   G +P+E        + I
Sbjct: 188 SPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  108 bits (271), Expect = 6e-27
 Identities = 65/337 (19%), Positives = 127/337 (37%), Gaps = 89/337 (26%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             + + R +G+G+F +V   ++ +  +  A+K++   K    K     K E   +K I++
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQN 90

Query: 74  -----PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINA 126
                 N+++ +        + ++ E   G  L++ I          ++ + Y  +++ A
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 127 VDYCHSRGVCHRDLKPENLLLDANGV-------------------------LKVSDFGLS 161
           ++Y     + H DLKPEN+LLD                             +K+ DFG  
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208

Query: 162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF---E 218
           A            +   T  Y APEVI N G+D + +D+WS G +L  L  G L F   E
Sbjct: 209 A----TFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263

Query: 219 ESNLMAL---------YKKIFKADFKSPPWF------------STSAKK----------- 246
               +A+            +++A   +   +            + S+             
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323

Query: 247 -----------LISRILDPNPVTRITMAEVIENEWFK 272
                       +  IL  +P  R + AE++++++ +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  107 bits (269), Expect = 6e-27
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 14/210 (6%)

Query: 18  LGRTLGEGSFAKVKFAR-NTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             + +G G F +V      T +G+    VAIK L      K ++      E   M    H
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSH 105

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
            N+IR+  V++    + I+ E++  G L   +    G     +     + +   + Y  +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYV---APEVIN 189
               HRDL   N+L+++N V KVSDFGLS + +   D    +TT G    +   APE I+
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAIS 223

Query: 190 NKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
            + +  + +D+WS G++++ V+  G  P+ 
Sbjct: 224 YRKFT-SASDVWSFGIVMWEVMTYGERPYW 252

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  107 bits (269), Expect = 6e-27
 Identities = 50/222 (22%), Positives = 98/222 (44%), Gaps = 16/222 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           +  + LG G+F  V        GE     VAIK L +    K     +I  E   M  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASVD 75

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           +P+V R+  +    + + ++ + +  G L D +   +  +       +  Q+   ++Y  
Sbjct: 76  NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--P-NYVAPEVI 188
            R + HRDL   N+L+     +K++DFGL+ L   +  +   +   G   P  ++A E I
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESI 191

Query: 189 NNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
            ++ Y   ++D+WS GV ++ ++  G  P++      +   +
Sbjct: 192 LHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (264), Expect = 2e-26
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)

Query: 15  KYELGRT--------LGEGSFAKVKFAR-NTETGE-NVAIKILDKEKVLKHKMIGQIKRE 64
           K  L R         LG G+F  V+         + +VAIK+L +          ++ RE
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMRE 60

Query: 65  ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQL 123
              M  + +P ++R+  V  ++  + +V+E   GG L   +   R  +      +   Q+
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--P- 180
              + Y   +   HRDL   N+LL      K+SDFGLS       DD           P 
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPL 177

Query: 181 NYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEE 219
            + APE IN + +  +++D+WS GV ++  L  G  P+++
Sbjct: 178 KWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKK 216

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  105 bits (263), Expect = 2e-26
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 33/232 (14%)

Query: 7   GASRTRVGKYE-------LGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLK 54
           GA  +    YE       LGR +GEG F  V         N      VAIK         
Sbjct: 1   GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDS 58

Query: 55  HKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKE 113
            +   +  +E  TM+   HP+++++  V  ++  ++I++E  T GEL   +   +  L  
Sbjct: 59  VRE--KFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL 115

Query: 114 DEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
                Y  QL  A+ Y  S+   HRD+   N+L+ +N  +K+ DFGLS   + + D    
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYY 172

Query: 174 HTTCG------TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
             + G           APE IN + +  + +D+W  GV ++ +LM G  PF+
Sbjct: 173 KASKGKLPIKWM----APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQ 219

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  105 bits (265), Expect = 2e-26
 Identities = 48/222 (21%), Positives = 98/222 (44%), Gaps = 16/222 (7%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
              + LG G F  V        GE+    V IK++ ++K  + +    +   +  +  + 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGR-QSFQAVTDHMLAIGSLD 73

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           H +++R+  +    + + +V +++  G L D +   RG L       +  Q+   + Y  
Sbjct: 74  HAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT--P-NYVAPEVI 188
             G+ HR+L   N+LL +   ++V+DFG++ L   +  D           P  ++A E I
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMALESI 189

Query: 189 NNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
           +   Y   ++D+WS GV ++ ++  G  P+    L  +   +
Sbjct: 190 HFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (269), Expect = 3e-26
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)

Query: 17  ELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +L + LG G F +V  A  N  T   VA+K +    +     +     E + MK ++H  
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFL----AEANVMKTLQHDK 244

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSR 133
           +++++ V  +K  IYI+ EF+  G L D + S         +   +  Q+   + +   R
Sbjct: 245 LVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG------TPNYVAPEV 187
              HRDL+  N+L+ A+ V K++DFGL+   + + D+              T    APE 
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWT----APEA 356

Query: 188 INNKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           IN   +   K+D+WS G++L  ++  G +P+ 
Sbjct: 357 INFGSFT-IKSDVWSFGILLMEIVTYGRIPYP 387

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  106 bits (266), Expect = 3e-26
 Identities = 75/349 (21%), Positives = 118/349 (33%), Gaps = 95/349 (27%)

Query: 14  GKYELGRTLGEGSFAKVKFAR-NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            +YE+   LGEG+F KV     +      VA+KI+        K     + EI+ +K I+
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIK 74

Query: 73  HP------NVIRMYEVMASKTKIYIVLEFVTGGELFD--KIASRGRLKEDEARKYFQQLI 124
                     + M +       + I  E + G   F+  K  +         R    QL 
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 125 NAVDYCHSRGVCHRDLKPENLLLDANGV-------------------LKVSDFGLSALPQ 165
           +A+ + H   + H DLKPEN+L   +                     ++V+DFG SA   
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT-- 190

Query: 166 QVRDDGLLHTTCGTPNYV------APEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-- 217
               D   HTT      V       PEVI   G+     D+WS G IL+    G+  F  
Sbjct: 191 ---FDHEHHTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQT 241

Query: 218 -EESNLMA------------LYKKIFKADF---KSPPWFSTSAKK--------------- 246
            E    +             +  +  K  +       W   S+                 
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301

Query: 247 -----------LISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN 284
                      L+ R+L+ +P  RIT+AE + + +F            +
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTS 350

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  108 bits (270), Expect = 5e-26
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           ELGR +GEG F  V         N      VAIK          +   +  +E  TM+  
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVRE--KFLQEALTMRQF 448

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYC 130
            HP+++++  V  ++  ++I++E  T GEL   +   +  L       Y  QL  A+ Y 
Sbjct: 449 DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG-TP-NYVAPEVI 188
            S+   HRD+   N+L+ +N  +K+ DFGLS   + + D      + G  P  ++APE I
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESI 564

Query: 189 NNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           N + +  + +D+W  GV ++ +LM G  PF
Sbjct: 565 NFRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  103 bits (260), Expect = 7e-26
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 17  ELGRTLGEGSFAKV---KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            L R LGEG F +V    +  +     NVA+K   K+  L +K   +   E   MK + H
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDH 72

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
           P+++++  ++  +   +I++E    GEL   +  ++  LK      Y  Q+  A+ Y  S
Sbjct: 73  PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG------TPNYVAPE 186
               HRD+   N+L+ +   +K+ DFGLS   + + D+     +             +PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWM----SPE 184

Query: 187 VINNKGYDGAKADLWSCGVILY-VLMAGYLPFEE 219
            IN + +    +D+W   V ++ +L  G  PF  
Sbjct: 185 SINFRRFT-TASDVWMFAVCMWEILSFGKQPFFW 217

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (264), Expect = 3e-25
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)

Query: 22  LGEGSFAKVKFAR-NTETGE-NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LG G+F  V+         + +VAIK+L +          ++ RE   M  + +P ++R+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRL 401

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
             V  ++  + +V+E   GG L   +   R  +      +   Q+   + Y   +   HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460

Query: 139 DLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYV---APEVINNKGYD 194
           +L   N+LL      K+SDFGLS AL     DD            +   APE IN + + 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 195 GAKADLWSCGVILY-VLMAGYLPFE 218
            +++D+WS GV ++  L  G  P++
Sbjct: 518 -SRSDVWSYGVTMWEALSYGQKPYK 541

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  102 bits (256), Expect = 3e-25
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)

Query: 17  ELGRTLGEGSFAKV---KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            LGR LG+G F  V   +  +   +   VA+K+L K  ++    I +  RE + MK   H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84

Query: 74  PNVIRMYEV------MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-A 126
           P+V ++  V              ++L F+  G+L   + +  R+ E+      Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143

Query: 127 VD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           VD      Y  SR   HRDL   N +L  +  + V+DFGLS      R    +++     
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK---IYSG---- 190

Query: 181 NY-------------VAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           +Y             +A E + +  Y    +D+W+ GV ++ ++  G  P+
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  100 bits (251), Expect = 1e-24
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 27/217 (12%)

Query: 17  ELGRTLGEGSFAKV---KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
                +G G F  V       N     + A+K L++   +      Q   E   MK   H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 85

Query: 74  PNVIRMYEVMA-SKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           PNV+ +  +   S+    +VL ++  G+L + I          +   +  Q+   + Y  
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSAL-------PQQVRDDGLLHTTCGTPNYV- 183
           S+   HRDL   N +LD    +KV+DFGL+             +    L      P  V 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P--VK 197

Query: 184 --APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
             A E +  + +   K+D+WS GV+L+ ++  G  P+
Sbjct: 198 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 27/217 (12%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
                +G G F  V      +        A+K L++   +      Q   E   MK   H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 149

Query: 74  PNVIRMYEVMA-SKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           PNV+ +  +   S+    +VL ++  G+L + I          +   +  Q+   + +  
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLS-------ALPQQVRDDGLLHTTCGTPNYV- 183
           S+   HRDL   N +LD    +KV+DFGL+             +    L      P  V 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------P--VK 261

Query: 184 --APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
             A E +  + +   K+D+WS GV+L+ ++  G  P+
Sbjct: 262 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 297

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 40/226 (17%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREISTMK 69
               +LG+G+F K+      E G+        V +K+LDK      +         S M 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE---SFFEAASMMS 67

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVD 128
            + H +++  Y V     +  +V EFV  G L   +  ++  +      +  +QL  A+ 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 129 YCHSRGVCHRDLKPENLLLDA--------NGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
           +     + H ++  +N+LL             +K+SD G+S     V             
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---ITVLPK---------- 174

Query: 181 NY-------VAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFE 218
           +        V PE I N        D WS G  L+ +   G  P  
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 97.0 bits (242), Expect = 2e-23
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 27/217 (12%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
              R +G+G F  V      +  +N    AIK L +   ++        RE   M+ + H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE--AFLREGLLMRGLNH 81

Query: 74  PNVIRMYEV-MASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCH 131
           PNV+ +  + +  +   +++L ++  G+L   I + +      +   +  Q+   ++Y  
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSAL-------PQQVRDDGLLHTTCGTPNYV- 183
            +   HRDL   N +LD +  +KV+DFGL+           Q      L      P  V 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P--VK 193

Query: 184 --APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
             A E +    +   K+D+WS GV+L+ +L  G  P+
Sbjct: 194 WTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPY 229

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 47/231 (20%)

Query: 17  ELGRTLGEGSFAKV---KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            LG+ LGEG F  V      +   T   VA+K + K      + I +   E + MK   H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95

Query: 74  PNVIRMYEV-----MASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-AV 127
           PNVIR+  V          K  ++L F+  G+L   +    RL+        Q L+   V
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154

Query: 128 D------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-----------D 170
           D      Y  +R   HRDL   N +L  +  + V+DFGLS      +             
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208

Query: 171 GLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
             +      P  V   A E + ++ Y  +K+D+W+ GV ++ +   G  P+
Sbjct: 209 AKM------P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPY 250

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.5 bits (241), Expect = 5e-23
 Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 51/228 (22%)

Query: 17  ELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
             G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  +  +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLSYL 83

Query: 72  -RHPNVIRMYEVMASKTKIYIVLEFVTGGEL-----------FDKIASRGRLKEDEARKY 119
             H N++ +           ++ E+   G+L                S   +++DE    
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 120 FQQLI-------NAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL 172
            + L+         + +  S+   HRDL   N+LL    + K+ DFGL+   + +++D  
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKNDS- 199

Query: 173 LHTTCGTPNYV------------APEVINNKGYDGAKADLWSCGVILY 208
                   NYV            APE I N  Y   ++D+WS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 47/231 (20%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            + R LG+GSF  V     K     E    VAIK +++   ++ ++  +   E S MK  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKY--FQQLIN-AV 127
              +V+R+  V++      +++E +T G+L   + + R  +  +         ++I  A 
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 128 D------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-----------D 170
           +      Y ++    HRDL   N ++  +  +K+ DFG++      RD            
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGK 199

Query: 171 GLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
           GLL      P  V   +PE + +  +    +D+WS GV+L+ +      P+
Sbjct: 200 GLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPY 241

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 35/215 (16%)

Query: 18  LGRTLGEGSFAKVKFAR--NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHP 74
               +GEG+F +V  AR        + AIK + KE             E+  +  +  HP
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYA-SKDDHRDFAGELEVLCKLGHHP 86

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKYFQQLIN 125
           N+I +      +  +Y+ +E+   G L D            +        +    QQL++
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 126 -AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
            A D      Y   +   HRDL   N+L+  N V K++DFGLS      R   +      
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTM 200

Query: 179 T--PNYV---APEVINNKGYDGAKADLWSCGVILY 208
              P  V   A E +N   Y    +D+WS GV+L+
Sbjct: 201 GRLP--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 54/237 (22%)

Query: 17  ELGRTLGEGSFAKV--KFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            L R LGEG+F KV      N    ++   VA+K L K+  L  +     +RE   +  +
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARK--DFQREAELLTNL 74

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKYFQQ 122
           +H ++++ Y V      + +V E++  G+L            I   G+ ++ +      Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 123 LIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------ 169
           +++ A        Y  S+   HRDL   N L+ AN ++K+ DFG+S      RD      
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDY 188

Query: 170 -----DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
                  +L      P  +    PE I  + +   ++D+WS GVIL+ +   G  P+
Sbjct: 189 YRVGGHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPW 236

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 47/224 (20%)

Query: 17  ELGRTLGEGSFAKVKFA-----RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           + G+TLG G+F KV  A        +    VA+K+L K           +  E+  M  +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTA-HADEKEALMSELKIMSHL 106

Query: 72  -RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKY-------FQQL 123
            +H N++ +         + ++ E+   G+L + +  + R+ E +            + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 124 IN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
           ++ +        +  S+   HRD+   N+LL    V K+ DFGL+      RD       
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD------I 214

Query: 177 CGTPNYV------------APEVINNKGYDGAKADLWSCGVILY 208
               NY+            APE I +  Y   ++D+WS G++L+
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 91.1 bits (227), Expect = 4e-21
 Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 56/233 (24%)

Query: 17  ELGRTLGEGSF-----AKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            LG+TLGEG F     A     +       VA+K+L KE       +  +  E + +K +
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENA-SPSELRDLLSEFNVLKQV 83

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGEL-----------------FDKIASRGRLKED 114
            HP+VI++Y   +    + +++E+   G L                      S      D
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 115 EARKYFQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV 167
           E       LI+ A        Y     + HRDL   N+L+     +K+SDFGLS      
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------ 197

Query: 168 RDDGLLHTTCGTPNYV------------APEVINNKGYDGAKADLWSCGVILY 208
           RD   ++      +YV            A E + +  Y   ++D+WS GV+L+
Sbjct: 198 RD---VYE---EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 90.3 bits (225), Expect = 5e-21
 Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 53/237 (22%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
                LGE  F KV           E  + VAIK L K+K        + + E      +
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLRE-EFRHEAMLRARL 69

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKYFQQ 122
           +HPNV+ +  V+     + ++  + + G+L +          + S    +  ++      
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 123 LIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------ 169
            ++          Y  S  V H+DL   N+L+     +K+SD GL       R+      
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183

Query: 170 -----DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
                + LL      P  +   APE I    +    +D+WS GV+L+ V   G  P+
Sbjct: 184 YKLLGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPY 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.8 bits (226), Expect = 6e-21
 Identities = 56/236 (23%), Positives = 90/236 (38%), Gaps = 53/236 (22%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            L   LGEG+F KV           +    VA+K L KE     +     +RE   + ++
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGEL--------FDKIASRGRLKEDEARKYFQQL 123
           +H +++R + V      + +V E++  G+L         D     G            QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 124 IN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD------- 169
           +  A        Y       HRDL   N L+    V+K+ DFG+S      RD       
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYY 214

Query: 170 ----DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY-VLMAGYLPF 217
                 +L      P  +    PE I  + +   ++D+WS GV+L+ +   G  P+
Sbjct: 215 RVGGRTML------P--IRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPW 261

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 47/231 (20%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            L R LG G+F +V         N  +   VA+K L +    + ++      E   +   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-AVD-- 128
            H N++R   V       +I++E + GG+L   +          +      L++ A D  
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 129 ----YCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQQVRD-----------D 170
               Y       HRD+   N LL   G   V K+ DFG++      RD            
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGGC 204

Query: 171 GLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILYVLMA-GYLPF 217
            +L      P  V    PE      +  +K D WS GV+L+ + + GY+P+
Sbjct: 205 AML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPY 246

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 55/230 (23%)

Query: 17  ELGRTLGEGSFAKVKFAR-------NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
            LG+ LGEG+F +V  A          +    VA+K+L K+     K +  +  E+  MK
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDA-TEKDLSDLVSEMEMMK 95

Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKY 119
           +I +H N+I +         +Y+++E+ + G L +            S    +  E +  
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 120 FQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--- 169
           F+ L++          Y  S+   HRDL   N+L+  N V+K++DFGL+      RD   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 209

Query: 170 --------DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY 208
                   +G L      P  V   APE + ++ Y   ++D+WS GV+++
Sbjct: 210 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 56/231 (24%), Positives = 88/231 (38%), Gaps = 47/231 (20%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            L R LG G+F +V         N  +   VA+K L +    + ++      E   +   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 131

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLIN-AVD-- 128
            H N++R   V       +I+LE + GG+L   +          +      L++ A D  
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 129 ----YCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQQVRD-----------D 170
               Y       HRD+   N LL   G   V K+ DFG++      RD            
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGC 245

Query: 171 GLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILYVLMA-GYLPF 217
            +L      P  V    PE      +  +K D WS GV+L+ + + GY+P+
Sbjct: 246 AML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPY 287

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 50/227 (22%)

Query: 17  ELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           +LG+ LG G+F +V  A       T T   VA+K+L KE    H     +  E+  +  I
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGA-THSEHRALMSELKILIHI 87

Query: 72  -RHPNVIRMYEV-MASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKYF 120
             H NV+ +          + +++EF   G L                      +     
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 121 QQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL 173
           + LI  +        +  SR   HRDL   N+LL    V+K+ DFGL+      RD   +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD---I 198

Query: 174 HTTCGTPNYV------------APEVINNKGYDGAKADLWSCGVILY 208
           +     P+YV            APE I ++ Y   ++D+WS GV+L+
Sbjct: 199 YK---DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 55/230 (23%)

Query: 17  ELGRTLGEGSFAKVKFAR-------NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
            LG+ LGEG+F +V  A               VA+K+L K    +  +   I  E+  MK
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMK 129

Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKY 119
           +I +H N+I +         +Y+++E+ + G L +            S       E +  
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 120 FQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--- 169
            + L++ A        Y  S+   HRDL   N+L+  + V+K++DFGL+      RD   
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------RDIHH 243

Query: 170 --------DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY 208
                   +G L      P  V   APE + ++ Y   ++D+WS GV+L+
Sbjct: 244 IDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 59/233 (25%), Positives = 92/233 (39%), Gaps = 56/233 (24%)

Query: 17  ELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           E G+ LG G+F KV  A       T     VA+K+L KEK         +  E+  M  +
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKA-DSSEREALMSELKMMTQL 105

Query: 72  -RHPNVIRMYEVMASKTKIYIVLEFVTGGEL----------------FDKIASRGRLKED 114
             H N++ +         IY++ E+   G+L                  +   R   +ED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 115 EARKYFQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV 167
                F+ L+  A        +   +   HRDL   N+L+    V+K+ DFGL+      
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219

Query: 168 RDDGLLHTTCGTPNYV------------APEVINNKGYDGAKADLWSCGVILY 208
           RD   + +     NYV            APE +    Y   K+D+WS G++L+
Sbjct: 220 RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 55/230 (23%)

Query: 17  ELGRTLGEGSFAKVKFAR-------NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
            LG+ LGEG F +V  A          +    VA+K+L K+     K +  +  E+  MK
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDA-TEKDLSDLVSEMEMMK 141

Query: 70  LI-RHPNVIRMYEVMASKTKIYIVLEFVTGGELFD---------KIASRGRLKEDEARKY 119
           +I +H N+I +         +Y+++E+ + G L +            S    +  E +  
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 120 FQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--- 169
           F+ L++          Y  S+   HRDL   N+L+  N V+K++DFGL+      RD   
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 255

Query: 170 --------DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY 208
                   +G L      P  V   APE + ++ Y   ++D+WS GV+++
Sbjct: 256 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 87.8 bits (218), Expect = 8e-20
 Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 60/235 (25%)

Query: 17  ELGRTLGEGSFAKV-----KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           E  R +GEG+F +V           E    VA+K+L KE+     M    +RE + M   
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASA-DMQADFQREAALMAEF 107

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGEL-----------------FDKIASRGRLKED 114
            +PN++++  V A    + ++ E++  G+L                  D           
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 115 EARKYFQQLIN-AVD------YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV 167
                  + +  A        Y   R   HRDL   N L+  N V+K++DFGLS      
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221

Query: 168 RD-----------DGLLHTTCGTPNYV---APEVINNKGYDGAKADLWSCGVILY 208
           R+           +  +      P  +    PE I    Y   ++D+W+ GV+L+
Sbjct: 222 RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLW 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 36/240 (15%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             + +G+ +G G+F +++  +N  T E VAIK+   E +       Q+  E    K +  
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--QLHLEYRFYKQLGS 63

Query: 74  -PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDY 129
              + ++Y          +VLE   G  L D      R   LK         QLI+ ++Y
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLCDRTFSLKT--VLMIAIQLISRMEY 120

Query: 130 CHSRGVCHRDLKPENLLLDANG-----VLKVSDFGLSALPQQVRD-DGLLH-------TT 176
            HS+ + +RD+KPEN L+   G     V+ + DF L+   ++  D +   H       + 
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA---KEYIDPETKKHIPYREHKSL 177

Query: 177 CGTPNYVAPEVINN-KGYD-GAKADLWSCGVILYVLMAGYLP---FEESNLMALYKKIFK 231
            GT  Y++   IN   G +   + DL + G +    + G LP    +   L   Y+KI  
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 70/372 (18%), Positives = 115/372 (30%), Gaps = 125/372 (33%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
           G+Y + R LG G F+ V  + + +  + VA+K++                EI  +K +R 
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRN 92

Query: 73  ----HPN---VIRMY---EVMASKTK-IYIVLEFVTGGELFDKIAS--RGRLKEDEARKY 119
                PN   V+++    ++       I +V E V G  L   I       L     +K 
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 120 FQQLINAVDYCHSR-GVCHRDLKPENLLL------------------------------- 147
            QQ++  +DY H++  + H D+KPEN+LL                               
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 148 ------------------DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPN-YVAPEVI 188
                                  +K++D G +    +        T       Y + EV+
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY---------------------- 226
              GY+   AD+WS   + + L  G   FE  +                           
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324

Query: 227 -----KKIF------KADFKSPPWFS---------------TSAKKLISRILDPNPVTRI 260
                K+ F      K   K  PW                       +  +L+  P  R 
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

Query: 261 TMAEVIENEWFK 272
           T AE + + W  
Sbjct: 385 TAAECLRHPWLN 396

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 34/238 (14%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR- 72
            K+ LGR +G GSF ++    N +T E VAIK+   E V       Q+  E    ++++ 
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP--QLLYESKIYRILQG 61

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTG---GELFDKIASRGRLKEDEARKYFQQLINAVDY 129
              +  +           +V++ + G    +LF+  + +  LK         Q+IN V++
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEF 118

Query: 130 CHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQQVRD-DGLLHTT-------CG 178
            HS+   HRD+KP+N L+        + + DFGL+   ++ RD     H          G
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA---KKYRDTSTHQHIPYRENKNLTG 175

Query: 179 TPNYVAPEVINN-KGYD-GAKADLWSCGVILYVLMAGYLP---FEESNLMALYKKIFK 231
           T  Y +   +N   G +   + DL S G +L   + G LP    +       Y+KI +
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.0 bits (203), Expect = 5e-18
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 37/247 (14%)

Query: 7   GASRTRVG-KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREI 65
           G+   RVG +Y LGR +G GSF  +    +   GE VAIK+   E V       Q+  E 
Sbjct: 1   GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHP--QLHIES 55

Query: 66  STMKLIRH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQ 121
              K+++    +  +    A      +V+E + G  L D      R   LK         
Sbjct: 56  KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKT--VLLLAD 112

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLSALPQQVRDD-GLLHTT 176
           Q+I+ ++Y HS+   HRD+KP+N L+      N V  + DFGL+   ++ RD     H  
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY-IIDFGLA---KKYRDARTHQHIP 168

Query: 177 -------CGTPNYVAPEVINN-KGYD-GAKADLWSCGVILYVLMAGYLP---FEESNLMA 224
                   GT  Y +   IN   G +   + DL S G +L     G LP    + +    
Sbjct: 169 YRENKNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225

Query: 225 LYKKIFK 231
            Y++I +
Sbjct: 226 KYERISE 232

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 36/240 (15%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             Y++GR +GEGSF  +    N    + VAIK    E         Q++ E  T KL+  
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP--QLRDEYRTYKLLAG 64

Query: 74  -PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDY 129
              +  +Y          +V++   G  L D +   GR   +K        +Q++  V  
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKT--VAMAAKQMLARVQS 121

Query: 130 CHSRGVCHRDLKPENLLLDANG-----VLKVSDFGLSALPQQVRD-DGLLH-------TT 176
            H + + +RD+KP+N L+         ++ V DFG+    +  RD     H         
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV---KFYRDPVTKQHIPYREKKNL 178

Query: 177 CGTPNYVAPEVINN-KGYD-GAKADLWSCGVILYVLMAGYLP---FEESNLMALYKKIFK 231
            GT  Y++   IN   G +   + DL + G +    + G LP    + +     Y++I +
Sbjct: 179 SGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 45/236 (19%), Positives = 88/236 (37%), Gaps = 46/236 (19%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            ++ LG+ +G G F  +  A  T   E  A  +    KV   +  G +  E+   + +  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV---VKVEYQEN-GPLFSELKFYQRVAK 92

Query: 74  PNVIRMYEVMASKTKI-------------------YIVLEFVTGGELFDKIASRGRLKED 114
            + I+ +        +                   ++V+E + G +L       G  K+ 
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151

Query: 115 EARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV--SDFGLSALPQQVRDDGL 172
              +   ++++ ++Y H     H D+K  NLLL      +V  +D+GLS    +   +G 
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNGN 208

Query: 173 L----------HTTCGTPNYVAPEVINN-KGYD-GAKADLWSCGVILYVLMAGYLP 216
                      H   GT  + +   ++  KG     ++D+   G  +   + G LP
Sbjct: 209 HKQYQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 65/280 (23%), Positives = 116/280 (41%), Gaps = 50/280 (17%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           +G G F KV +      G  VA+K    E     +   + + EI T+   RHP+++ +  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102

Query: 82  VMASKTKIYIVLEFVTGGE----LFDKIASRG------RLK--EDEARKYFQQLINAVDY 129
               + ++ ++ +++  G     L+             RL+     AR         + Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT---CGTPNYVAPE 186
            H+R + HRD+K  N+LLD N V K++DFG+S       +    H +    GT  Y+ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE 211

Query: 187 -VINNKGYDGAKADLWSCGVILYVLMAG------YLPFEESNL----MALYKK--IFK-A 232
             I  +  +  K+D++S GV+L+ ++         LP E  NL    +  +    + +  
Sbjct: 212 YFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269

Query: 233 DFKSPPWFST-SAKKLI---SRILDPNPVTRITMAEVIEN 268
           D          S +K      + L  +   R +M +V+  
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 78.0 bits (191), Expect = 2e-16
 Identities = 38/192 (19%), Positives = 60/192 (31%), Gaps = 48/192 (25%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKIL-----DKEKVLKHKMIGQIKREISTMK 69
           K +    +GEG F +V           VAIKI+     D       K   +I  EI   K
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 70  LI---------RHPNVIRMYEV------------------------------MASKTKIY 90
            +         R    I +  V                                   +++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 91  IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDA 149
           IVLEF  GG   +++ ++       A+    QL  ++    +     HRDL   N+LL  
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 150 NGVLKVSDFGLS 161
             + K+      
Sbjct: 198 TSLKKLHYTLNG 209

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 77.2 bits (191), Expect = 3e-16
 Identities = 64/288 (22%), Positives = 105/288 (36%), Gaps = 69/288 (23%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR----EISTMKLIRHPNVI 77
           +GEG F  V   +       VA+K L     +      ++K+    EI  M   +H N++
Sbjct: 39  MGEGGFGVV--YKGYVNNTTVAVKKLAAMVDIT---TEELKQQFDQEIKVMAKCQHENLV 93

Query: 78  RM-------------YEVMASKTKIYIVLEFVTGGELFDKIASRG-----RLK--EDEAR 117
            +             Y  M + +     L       L     +       R K  +  A 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGS-----LLDR----LSCLDGTPPLSWHMRCKIAQGAAN 144

Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT- 176
                    +++ H     HRD+K  N+LLD     K+SDFGL+              T 
Sbjct: 145 --------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTS 193

Query: 177 --CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIF 230
              GT  Y+APE +  +G    K+D++S GV+L  ++ G        E   L+ + ++I 
Sbjct: 194 RIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251

Query: 231 K--------ADFKSPPWFSTSAKKLI---SRILDPNPVTRITMAEVIE 267
                     D K     STS + +    S+ L      R  + +V +
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 36/220 (16%)

Query: 22  LGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYE 81
           LG G F KV   R    G  VA+K L +E+    ++  Q + E+  + +  H N++R+  
Sbjct: 38  LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94

Query: 82  VMASKTKIYIVLEFVTGG----ELFDKIASRGRLKED-EARK-----------YFQQLIN 125
              + T+  +V  ++  G     L ++  S+  L  D   R+           Y      
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPL--DWPKRQRIALGSARGLAYLH---- 148

Query: 126 AVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT---CGTPNY 182
             D+C  + + HRD+K  N+LLD      V DFGL+ L     D    H T    GT  +
Sbjct: 149 --DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGTIGH 201

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL 222
           +APE ++  G    K D++  GV+L  L+ G   F+ + L
Sbjct: 202 IAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 44/250 (17%), Positives = 93/250 (37%), Gaps = 42/250 (16%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             +++G  +G+G F  + +  +  + E+V        KV      G +  E+   +    
Sbjct: 35  AAWKVGLPIGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-------GR----LKEDEARKYFQ- 121
           P  I+ +        + +   + +G    +  + R       G     + E  A+++ + 
Sbjct: 93  PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRK 152

Query: 122 -------QLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV--SDFGLSALPQQVRDDGL 172
                  ++++ ++Y H     H D+K  NLLL+     +V   D+GL+    +   +G+
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA---YRYCPEGV 209

Query: 173 L--------HTTCGTPNYVAPEVINN-KGYD-GAKADLWSCGVILYVLMAGYLPFEE--- 219
                        GT  + +   I+   G     + DL   G  +   + G+LP+E+   
Sbjct: 210 HKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266

Query: 220 SNLMALYKKI 229
                   KI
Sbjct: 267 DPKYVRDSKI 276

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 36/266 (13%), Positives = 89/266 (33%), Gaps = 74/266 (27%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETG--------ENVAIKILDKEKVLKHKMIGQIKREI 65
            +++L       +   +  A  T T         +  ++K+ D +        G++  E 
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-DAKD-------GRLFNEQ 93

Query: 66  STMKLIRHPNVIRMYEVMASKTKI----------------YIVLEFVTGGELFDKIASRG 109
           +  +    P  +  ++ + S   +                ++VL  + G  L        
Sbjct: 94  NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS------ 146

Query: 110 RLKEDEARKYF---------QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV--SDF 158
              +   +             +L++A+++ H     H ++  EN+ +D     +V  + +
Sbjct: 147 -ALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGY 205

Query: 159 GLSALPQQVRDDG----------LLHTTCGTPNYVAPEVINN-KGYDGA-KADLWSCGVI 206
           G +    +    G            H   G   +++   ++  KG   + ++DL S G  
Sbjct: 206 GFA---FRYCPSGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYC 257

Query: 207 LYVLMAGYLP---FEESNLMALYKKI 229
           +   + G+LP      +    + +K 
Sbjct: 258 MLKWLYGFLPWTNCLPNTEDIMKQKQ 283

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 43/175 (24%), Positives = 69/175 (39%), Gaps = 26/175 (14%)

Query: 55  HKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKED 114
               G+       + L R  + I   +  AS   +          E   +   +  L  +
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLE 193

Query: 115 EARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH 174
               Y  Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+      RD     
Sbjct: 194 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD----- 242

Query: 175 TTCGTPNYV------------APEVINNKGYDGAKADLWSCGVILYVLMA-GYLP 216
                P+YV            APE I ++ Y   ++D+WS GV+L+ + + G  P
Sbjct: 243 -IYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 36/152 (23%), Positives = 57/152 (37%), Gaps = 13/152 (8%)

Query: 17  ELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           +LG+ LG G+F +V  A       T T   VA+K+L KE    H     +  E+  +  I
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEG-ATHSEHRALMSELKILIHI 82

Query: 72  -RHPNVIRMYEVM-ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             H NV+ +          + +++EF   G L   +    R K +E   Y  +       
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLS 161
               G    DLK     + ++     S F   
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 3e-08
 Identities = 52/355 (14%), Positives = 105/355 (29%), Gaps = 116/355 (32%)

Query: 6   GGASRTRV--GKYELGRTLGEGS--FAKVKFARNTETGENVAIKILDKEKV----LKHKM 57
             A+ T +    + +  T  E      K           +   + L +E +     +  +
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYL---------DCRPQDLPREVLTTNPRRLSI 332

Query: 58  IGQIKRE-ISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA 116
           I +  R+ ++T    +H N  ++  ++ S       L                 L+  E 
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEPAEY 371

Query: 117 RKYFQQL--------I------------------NAVDYCHSRGVCHRDLKPE-----NL 145
           RK F +L        I                    V+  H   +  +  K       ++
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431

Query: 146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGV 205
            L+              L  ++ ++  LH +    +Y  P+  ++        D +    
Sbjct: 432 YLE--------------LKVKLENEYALHRSI-VDHYNIPKTFDSDDLIPPYLDQYFYSH 476

Query: 206 ILYVLMAGYLPFEESNLMALYKKIFKADFK---------SPPWFSTSA--------KKLI 248
           I + L       E    M L++ +F  DF+         S  W ++ +        K   
Sbjct: 477 IGHHLKNI----EHPERMTLFRMVF-LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYK 531

Query: 249 SRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDL------DDVDSIFNES 297
             I D +P     +   I +  F    +         DL       + ++IF E+
Sbjct: 532 PYICDNDP-KYERLVNAILD--FLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 2e-06
 Identities = 60/330 (18%), Positives = 104/330 (31%), Gaps = 92/330 (27%)

Query: 46  ILDKEK-VLKHKMIGQIKREISTMKLIRHPNVI----RMYEVMASKTKIYIVLEFVTGGE 100
           + D  K +L        K EI    +I   + +    R++  + SK +  +V +FV    
Sbjct: 38  VQDMPKSILS-------KEEID--HIIMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVL 87

Query: 101 ------LFDKIASRGRLKEDEARKYFQQ---LINAVD----YCHSRGVCHRDLKPENLL- 146
                 L   I +  R      R Y +Q   L N       Y  SR   +  L+ + LL 
Sbjct: 88  RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-QALLE 146

Query: 147 LDANGVLKV---SDFGLSALPQQV-RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWS 202
           L     + +      G + +   V     +               ++ K +       W 
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ------------CKMDFKIF-------W- 186

Query: 203 CGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTS--AKKLISRILDPNPVTRI 260
                  L        E+ L  L K +++ D   P W S S  +  +  RI       R 
Sbjct: 187 -------LNLKNCNSPETVLEMLQKLLYQID---PNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 261 TMAEVIENEWFKKGYKPPSFEQPN--IDLDDV-DSIFNESMD--SRNLVVERREE--GPV 313
            +          K Y        N  + L +V ++    + +   + L+  R ++    +
Sbjct: 237 LLKS--------KPY-------ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFL 281

Query: 314 APLTMNAFELISTSQGLNLS---SLLKSKW 340
           +  T     L   S  L      SLL  K+
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLL-LKY 310

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 24/159 (15%), Positives = 56/159 (35%), Gaps = 28/159 (17%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQI-------------- 61
             +G+ +GEG  + V     +E      +K          K+  +               
Sbjct: 92  DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 62  -KREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
            + E   ++ ++   V ++Y          +++E +   EL+        ++ +   +  
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYR-------VRVENPDEVL 199

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG 159
             ++  V   + RG+ H DL   N+L+     + + DF 
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123

 Score = 42.2 bits (99), Expect = 2e-05
 Identities = 12/24 (50%), Positives = 15/24 (62%)

Query: 313 VAPLTMNAFELISTSQGLNLSSLL 336
           +    MNAF++IS S G NLS L 
Sbjct: 1   MGARRMNAFDIISGSPGFNLSGLF 24

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score = 41.9 bits (98), Expect = 5e-05
 Identities = 17/27 (62%), Positives = 21/27 (77%)

Query: 315 PLTMNAFELISTSQGLNLSSLLKSKWD 341
           PL MNAFE+I+ SQGLNLS+L   + D
Sbjct: 4   PLMMNAFEMITLSQGLNLSALFDRRQD 30

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 33/168 (19%), Positives = 56/168 (33%), Gaps = 26/168 (15%)

Query: 16  YELGRTLGEGSFAKVKFARN--TETGENVAIKI-------LDKEKVLKHKMIGQIKREIS 66
             +G  +  G  A V +A          +A+KI        DK     +       R IS
Sbjct: 49  TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108

Query: 67  TMKLIR------HPNVIRMYEVMASKTKIY------IVLEFVTGGEL--FDKIASRGRLK 112
             + +         N+ R  E   S  + Y      +++EF+   EL     +     LK
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168

Query: 113 EDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFG 159
           E +    F  ++  V   +    + H DL   N++      +   D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	342
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.29
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.23
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.0
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.85
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.84
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.51
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.43
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.09
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.07
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.07
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.92
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.69
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.66
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.61
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.57
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.47
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.01
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.03
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.98
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.49
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.22

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.3e-70  Score=486.15  Aligned_cols=263  Identities=32%  Similarity=0.610  Sum_probs=243.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++|++++||||++++++|++++.+
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34567799999999999999999999999999999999877666666678899999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999986544444


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS  249 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (342)
                      .....+.+||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+..++...+.+..+..+..+++++++||.
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence            4455678999999999999988775 899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCHHH------HhcCccccc
Q 019360          250 RILDPNPVTRITMAE------VIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e------~l~h~~~~~  273 (342)
                      +||+.||++|||++|      +++||||+.
T Consensus       267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            999999999999988      588999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-69  Score=477.28  Aligned_cols=261  Identities=48%  Similarity=0.916  Sum_probs=222.8

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .++.+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+++.+|+++|++++||||+++++++.+.+.
T Consensus         8 ~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   87 (275)
T 3hyh_A            8 DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE   87 (275)
T ss_dssp             ------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            45678999999999999999999999999999999999987665555566789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||| +|+|.+++.+++.+++.+++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|+....  
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  164 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--  164 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence            99999999 679999999999999999999999999999999999999999999999999999999999999975432  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                       .....+.+||+.|||||++.+..+++.++|||||||++|+|++|+.||.+.+...+...+.+.....+..+++++++||
T Consensus       165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  243 (275)
T 3hyh_A          165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI  243 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence             2334567899999999999988877789999999999999999999999999999999999999998999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCccccc
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+||+.||++|||++|+++||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-67  Score=475.87  Aligned_cols=259  Identities=29%  Similarity=0.579  Sum_probs=227.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|++|+|||||++++++.+++.+|+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            457999999999999999999999999999999999765443 3446789999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |||||+||+|.+++..+  ..+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            99999999999999754  35799999999999999999999999999999999999999999999999999864321  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCCCCHHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPWFSTSAKKLI  248 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li  248 (342)
                      .....+.+||+.|||||++.+..|+ .++|||||||++|||++|+.||.+.+..++...+....++ .+..+++++++||
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence            1123456899999999999987775 8999999999999999999999999999999999888764 4567899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||+.||++|||++|+|+||||++.
T Consensus       258 ~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-66  Score=470.92  Aligned_cols=256  Identities=28%  Similarity=0.455  Sum_probs=228.8

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ...|+++++||+|+||+||+|+++.+|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357999999999999999999999999999999997544322   34678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....  ....
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~  226 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR  226 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence            999999999998876 5699999999999999999999999999999999999999999999999999985432  2233


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---CCCCCCHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---SPPWFSTSAKKLIS  249 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~  249 (342)
                      ..+.+||+.|||||++.+..|+ .++|||||||++|||++|+.||.+.+..+....+......   .+..+++++++||.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            4567999999999999887774 8999999999999999999999999988888888765432   33458999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +||+.||++|||++|+|+||||++..
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.8e-67  Score=465.19  Aligned_cols=259  Identities=32%  Similarity=0.605  Sum_probs=227.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...++|++++.||+|+||+||+|++.   .+++.||+|++.+...... ...++.+|+++|++++||||+++++++.+++
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            34578999999999999999999984   4678999999976543222 2236788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|+|||||+||+|.+++.+.+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.... 
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-
Confidence            9999999999999999999989999999999999999999999999999999999999999999999999999975332 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                       ......+.+||+.|||||++.+..++ .++|||||||++|||++|+.||.+.+..++...+.+.....+..+|+++++|
T Consensus       179 -~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          179 -HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL  256 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence             22334567899999999999988775 8999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          248 ISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      |.+||+.||++|||     ++|+++||||+.
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            99999999999998     489999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.4e-65  Score=471.20  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=229.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..+|+++++||+|+||.||+|+++.+|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            467999999999999999999999999999999997544322   34678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  ....
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~  303 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR  303 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCC
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcc
Confidence            999999999998875 5699999999999999999999999999999999999999999999999999975432  2234


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---CCCCCCCHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---KSPPWFSTSAKKLIS  249 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~  249 (342)
                      ..+.+||+.|||||++.+..|+ .++|||||||++|||++|+.||.+.+..+....+.....   ..+..+++++++||.
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            4567899999999999887774 899999999999999999999999998888888876533   334568999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +||+.||++|||++|+|+||||++..
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999998743

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-65  Score=450.95  Aligned_cols=254  Identities=25%  Similarity=0.472  Sum_probs=218.9

Q ss_pred             ecCe-eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----CC
Q 019360           13 VGKY-ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----KT   87 (342)
Q Consensus        13 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~   87 (342)
                      .+|| ++.++||+|+||+||+|.++.++..||+|++..... .....+.+.+|+++|++++|||||+++++|..    +.
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            3566 778899999999999999999999999999976543 33445789999999999999999999999865    35


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecC-CCCeeEcccccccCC
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDA-NGVLKVSDFGLSALP  164 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~  164 (342)
                      .+|+|||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|  |+||||||+|||++. ++.+||+|||+|+..
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            68999999999999999999899999999999999999999999998  999999999999974 789999999999743


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCCC--CCCCCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKADFK--SPPWFS  241 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~~--~~~~~~  241 (342)
                      .    .....+.+||+.|||||++.+ .+ +.++|||||||++|||+||+.||.+.+ ...+...+.....+  .+...+
T Consensus       183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (290)
T 3fpq_A          183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence            2    334567799999999999875 45 589999999999999999999997654 44455555544332  244578


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +++++||.+||+.||++|||++|+|+||||++
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-64  Score=456.30  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=223.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+.|++.++||+|+||.||+|+++.+|+.||||++..+..        ..+|+.+|+.++|||||++++++.+++.+|+|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4568999999999999999999999999999999976432        23799999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+||+|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+|||++.++ ++||+|||+|+.........
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999999999999988999999999999999999999999999999999999999887 69999999998643322111


Q ss_pred             ---ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---CCCCCCHHHH
Q 019360          172 ---LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---SPPWFSTSAK  245 (342)
Q Consensus       172 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~  245 (342)
                         .....+||+.|||||++.+..++ .++|||||||++|||++|+.||.+.+...+...+.....+   .++.+++++.
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence               12345799999999999987775 8999999999999999999999988777777777766543   4667999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHH-------------hcCcccccCCCC
Q 019360          246 KLISRILDPNPVTRITMAEV-------------IENEWFKKGYKP  277 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~-------------l~h~~~~~~~~~  277 (342)
                      +||.+||+.||++|||+.|+             |+|||+.+...|
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            99999999999999999997             579999765443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-63  Score=457.00  Aligned_cols=263  Identities=29%  Similarity=0.420  Sum_probs=227.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe------C
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS------K   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~   86 (342)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+++|+.++||||+++++++..      .
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            4689999999999999999999999999999999975432 33445678899999999999999999999754      3


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +.+|+|||||+ |+|.+++.+++.+++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            67999999995 68999999889999999999999999999999999999999999999999999999999999985432


Q ss_pred             c--cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC-------
Q 019360          167 V--RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP-------  237 (342)
Q Consensus       167 ~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------  237 (342)
                      .  .......+.+||+.|||||++.+..+++.++||||+||++|||++|++||.+.+..+....|......++       
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence            2  2233445679999999999998877667999999999999999999999999998888887765322211       


Q ss_pred             ------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          238 ------------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       238 ------------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                              +.+++++.+||.+||+.||++|||++|+|+||||++...+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence                                    2468899999999999999999999999999999976554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.3e-61  Score=462.89  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=229.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHH---HHHHHhcCCCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR---EISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ...+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+   ++.+++.++|||||+++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            345789999999999999999999999999999999998765544333333334   46677788999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +.+|+|||||+||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999999989999999999999999999999999999999999999999999999999999975332


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHHhcCCCCCCCCCHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKADFKSPPWFSTS  243 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  243 (342)
                          ....+.+||+.|||||++.+...++.++|||||||++|||++|++||.+.   +...+...+.......+..++++
T Consensus       345 ----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~  420 (689)
T 3v5w_A          345 ----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  420 (689)
T ss_dssp             ----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence                23456799999999999975433458999999999999999999999764   44566777888888888999999


Q ss_pred             HHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      +++||.+||+.||++|++     ++|+++||||+.
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            999999999999999998     799999999974

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.1e-61  Score=429.29  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=219.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .++|.+.+.||+|+||+||+|++.     .++..||||++....   ....+.+.+|+++|++++|||||++++++.+.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            357999999999999999999875     357889999996532   344568999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           88 KIYIVLEFVTGGELFDKIASR-------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      .+|+|||||++|+|.+++.++             ..+++.++..|+.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999999764             3599999999999999999999999999999999999999999999


Q ss_pred             EcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC
Q 019360          155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD  233 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~  233 (342)
                      |+|||+|+...............||+.|||||++.+..++ .++|||||||++|||+| |+.||.+.+..++...+..+.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~  247 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  247 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999754332222222335689999999999987775 89999999999999998 899999999999888888765


Q ss_pred             C-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          234 F-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       234 ~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      . +.|..+++++.+|+.+||+.||++|||+++++  +|+++
T Consensus       248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            4 45677999999999999999999999999994  56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.4e-61  Score=429.62  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=202.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-----   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----   87 (342)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+++|++++|||||+++++|...+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            356999999999999999999999999999999997543  2334567899999999999999999999986543     


Q ss_pred             -------eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcc
Q 019360           88 -------KIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSD  157 (342)
Q Consensus        88 -------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~D  157 (342)
                             .+|+|||||+||+|.+++..+..   .++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   37999999999999999987654   34566889999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCC----------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH-HHHH
Q 019360          158 FGLSALPQQVRDD----------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALY  226 (342)
Q Consensus       158 fg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~~~~  226 (342)
                      ||+|+........          ....+.+||+.|||||++.+..++ .++|||||||++|||++   ||..... ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            9999864432111          122446899999999999987775 89999999999999996   7865432 2333


Q ss_pred             HHHHhcCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          227 KKIFKADFKS-PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       227 ~~i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ..+....++. ....++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            3344333321 12346778999999999999999999999999999753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.3e-60  Score=428.97  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=212.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ..+|.+.++||+|+||+||+|++.     .+++.||||++...   .....+.+.+|+++|++++|||||++++++.+.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            356889999999999999999864     36789999999653   2344568999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC
Q 019360           88 KIYIVLEFVTGGELFDKIASR---------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV  152 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~  152 (342)
                      .+|+|||||++|+|.+++.++               +++++.++..|+.|++.||+|||+++|+||||||+|||++.++.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence            999999999999999999753               35899999999999999999999999999999999999999999


Q ss_pred             eeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHh
Q 019360          153 LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFK  231 (342)
Q Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~  231 (342)
                      +||+|||+|+..............+||+.|||||++.+..++ .++|||||||++|||+| |+.||.+.+..+....+..
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  275 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ  275 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999865433333334456799999999999987764 89999999999999999 9999999998888888877


Q ss_pred             cC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          232 AD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       232 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +. .+.+..+++++.+|+.+||+.||++|||++|++++
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            54 55677899999999999999999999999999865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.2e-60  Score=433.51  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=208.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~   87 (342)
                      ..++|++.++||+|+||+||+|+++   .+++.||+|++.+..     ...++.+|+++|+.+ +||||++++++|.+.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            4578999999999999999999875   457889999986532     124677999999988 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~  166 (342)
                      .+|+|||||+|++|.+++.   .+++.+++.+++|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus        94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            9999999999999999884   49999999999999999999999999999999999999876 7999999999974322


Q ss_pred             cc--------------------------CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-
Q 019360          167 VR--------------------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-  219 (342)
Q Consensus       167 ~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-  219 (342)
                      ..                          ......+.+||+.|||||++.+...++.++||||+||++|+|++|+.||.. 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            11                          111234568999999999998766566899999999999999999999944 


Q ss_pred             CcHHHHHHHHHhc------------------------------------------------------CCCCCCCCCHHHH
Q 019360          220 SNLMALYKKIFKA------------------------------------------------------DFKSPPWFSTSAK  245 (342)
Q Consensus       220 ~~~~~~~~~i~~~------------------------------------------------------~~~~~~~~~~~~~  245 (342)
                      .+..+....+...                                                      .......+++++.
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            4444433333210                                                      0011234789999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      |||.+||+.||++|+|++|+|+||||++
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999975

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.4e-60  Score=425.07  Aligned_cols=256  Identities=21%  Similarity=0.333  Sum_probs=222.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      ......+++.++||+|+||+||+|...     .+++.||||++....  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            345677899999999999999999853     467889999996532  2334568999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                      ..+.+++|||||++|+|.+++..+                ..+++.++..|+.|++.||+|||+++|+||||||+|||++
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999653                3589999999999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++++||+|||+++..............+||+.|||||++.+..++ .++|||||||++|||+| |..||.+.+..++..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999865443333344556899999999999987764 99999999999999998 899999999988888


Q ss_pred             HHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          228 KIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       228 ~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+..+.. +.++.+++++.+|+.+||+.||++|||+.|++++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8877654 4567799999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-60  Score=421.70  Aligned_cols=252  Identities=22%  Similarity=0.382  Sum_probs=205.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+++++.++||+|+||+||+|++.   ..||||++.... ......+.+.+|+.+|++++|||||++++++.. +.+|+|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            457889999999999999999864   359999986533 234456789999999999999999999998854 568999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+||+|.+++... ..+++.++..|+.|++.||+|||+++|+||||||+|||++.++++||+|||+|+.........
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999999764 579999999999999999999999999999999999999999999999999998655443444


Q ss_pred             ceecccCCcccCChhhhccCC--CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC------CCCCCCHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKG--YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK------SPPWFSTS  243 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~  243 (342)
                      .....+||+.|||||++.+..  .++.++|||||||++|||+||+.||.+.+.......+......      .+..++++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            456678999999999997432  2358999999999999999999999887655554444433222      23457899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      +.+|+.+||+.||++|||+.|++++.
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            99999999999999999999887543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3e-59  Score=452.69  Aligned_cols=261  Identities=31%  Similarity=0.584  Sum_probs=234.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...++|++++.||+|+||+||+|+++.+|+.||+|++.....   ...+.+.+|+.+|+.++||||++++++|.+.+.+
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            3456899999999999999999999999999999999976432   2345788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC--CCeeEcccccccCCcc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN--GVLKVSDFGLSALPQQ  166 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~--~~~kl~Dfg~~~~~~~  166 (342)
                      |+|||||+||+|.+++.. ++.+++.+++.+++||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+... 
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~-  308 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-  308 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC-
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc-
Confidence            999999999999999864 4679999999999999999999999999999999999999754  899999999998543 


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFST  242 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (342)
                        ........+||+.|||||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+....+.++    ..+++
T Consensus       309 --~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  385 (573)
T 3uto_A          309 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  385 (573)
T ss_dssp             --TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred             --CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence              33445677999999999999988774 899999999999999999999999999999999988776554    45899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      ++++||.+||+.||++|||++|+|+||||+....+
T Consensus       386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            99999999999999999999999999999876544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-57  Score=413.96  Aligned_cols=265  Identities=42%  Similarity=0.840  Sum_probs=241.9

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ......++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+++|+.++||||+++++++...+
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            345678999999999999999999999999999999999976543 3445577889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|+||||+++++|.+++..++.+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....  
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~--  165 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--  165 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS--
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC--
Confidence            999999999999999999988889999999999999999999999999999999999999999999999999987432  


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                       ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+.......+..+++++.+|
T Consensus       166 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          166 -VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL  244 (328)
T ss_dssp             -SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             2233456789999999999998887778999999999999999999999999999999999999998898999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      |.+||+.||.+|||++|+++||||+....
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            99999999999999999999999987554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-58  Score=418.96  Aligned_cols=253  Identities=24%  Similarity=0.405  Sum_probs=213.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC-CcceeEEEEEEe-
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNVIRMYEVMAS-   85 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~-   85 (342)
                      .++|++.+.||+|+||.||+|.+...     ++.||||.+.....  ....+.+.+|+++|++++| ||||+++++|.. 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            36899999999999999999997654     36799999975432  3345678999999999976 899999999865 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA  149 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~  149 (342)
                      .+.+|+|||||++|+|.+++.+.                ..+++.++..++.|++.||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            45789999999999999999753                34899999999999999999999999999999999999999


Q ss_pred             CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHH-HHH
Q 019360          150 NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMA-LYK  227 (342)
Q Consensus       150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~-~~~  227 (342)
                      ++.+||+|||+|+..............+||+.|||||++.+..++ .++|||||||++|||+| |+.||.+.+..+ ...
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999865433332333456789999999999987764 89999999999999998 999998865433 444


Q ss_pred             HHHhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          228 KIFKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       228 ~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+..+ ..+.|..+++++.+|+.+||+.||++|||++|+++|
T Consensus       300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            44443 345677799999999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.3e-56  Score=405.85  Aligned_cols=259  Identities=34%  Similarity=0.642  Sum_probs=237.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+++++.++||||+++++++...+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999987655445556788899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~  160 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA  160 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCC
Confidence            999999999999999888899999999999999999999999999999999999999999999999999874322  222


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..+++++.+||.+|
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  239 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL  239 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            3456789999999999987776 489999999999999999999999999999999999888888889999999999999


Q ss_pred             cCCCCCCCC-----CHHHHhcCccccc
Q 019360          252 LDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       252 L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      |+.||++||     +++|+++||||..
T Consensus       240 L~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          240 LKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            999999999     8999999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-56  Score=411.67  Aligned_cols=262  Identities=33%  Similarity=0.638  Sum_probs=232.7

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~   87 (342)
                      .....++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|.++++.+ +||||+++++++...+
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            345678999999999999999999999999999999999876655556667888999999988 6999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.... 
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-  176 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-  176 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999874322 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                       ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......+..+++++.+|
T Consensus       177 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          177 -NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence             2223456789999999999987766 48999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCH------HHHhcCccccc
Q 019360          248 ISRILDPNPVTRITM------AEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps~------~e~l~h~~~~~  273 (342)
                      |++||+.||++||++      +++++||||+.
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999999998      89999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-57  Score=411.60  Aligned_cols=264  Identities=45%  Similarity=0.872  Sum_probs=234.8

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .++..+++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+
T Consensus         3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            45678999999999999999999999999999999999997655444444567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..++||||+ +|+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-  160 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-  160 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred             EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence            999999999 679999998888899999999999999999999999999999999999999999999999999975432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                        .......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.........+.......+..+++++.+|
T Consensus       161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred             --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence              233455689999999999988776668999999999999999999999887666555555556666777899999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      |.+||+.||.+|||++|+++||||+...
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            9999999999999999999999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-56  Score=400.09  Aligned_cols=257  Identities=36%  Similarity=0.743  Sum_probs=236.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            45789999999999999999999999999999999998765544455678889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +||||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....    
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999975322    


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (342)
                       .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......++.+++++.+||.+
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence             23456899999999999887764 8999999999999999999999999999999999999888888999999999999


Q ss_pred             hcCCCCCCCC-----CHHHHhcCccccc
Q 019360          251 ILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       251 ~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ||+.||++||     +++++++||||+.
T Consensus       237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          237 LITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            9999999999     9999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-55  Score=401.23  Aligned_cols=265  Identities=30%  Similarity=0.591  Sum_probs=235.0

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      |+......++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++.
T Consensus         1 g~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A            1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             --CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CCCCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            345566788999999999999999999999999999999999876655566677889999999887 8999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ..+.+|+||||++|++|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999743


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC---------CcHHHHHHHHHhcCCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE---------SNLMALYKKIFKADFK  235 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~---------~~~~~~~~~i~~~~~~  235 (342)
                      ..  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..         .........+......
T Consensus       161 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  237 (345)
T 3a8x_A          161 LR--PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR  237 (345)
T ss_dssp             CC--TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC
T ss_pred             cC--CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC
Confidence            22  2223456789999999999988776 4899999999999999999999965         3445566777788888


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 019360          236 SPPWFSTSAKKLISRILDPNPVTRITM------AEVIENEWFKK  273 (342)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~------~e~l~h~~~~~  273 (342)
                      .+..++.++.+||.+||+.||++||++      +++++||||+.
T Consensus       238 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            888899999999999999999999995      89999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.5e-56  Score=404.28  Aligned_cols=263  Identities=30%  Similarity=0.577  Sum_probs=235.4

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      ......++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            3456788999999999999999999999999999999999876554444556788899999876 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +.+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999874321


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK  246 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (342)
                        ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+..+++++.+
T Consensus       171 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          171 --GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             --TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             --CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence              1223456789999999999988776 4899999999999999999999999999999999998888888889999999


Q ss_pred             HHHHhcCCCCCCCCCHH-HHhcCccccc
Q 019360          247 LISRILDPNPVTRITMA-EVIENEWFKK  273 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~-e~l~h~~~~~  273 (342)
                      ||.+||+.||++||++. ++++||||+.
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            99999999999999998 9999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-55  Score=401.61  Aligned_cols=260  Identities=34%  Similarity=0.673  Sum_probs=239.1

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ......++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+
T Consensus        35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34556789999999999999999999999999999999998766555555678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|+||||++|++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999975322 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                          .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......+..+++++.+|
T Consensus       194 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  268 (350)
T 1rdq_E          194 ----RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL  268 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred             ----CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence                23456799999999999887764 8999999999999999999999999999999999999888888999999999


Q ss_pred             HHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          248 ISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      |.+||+.||++||+     ++++++||||+.
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999998     999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-55  Score=417.33  Aligned_cols=268  Identities=46%  Similarity=0.893  Sum_probs=243.5

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .........++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A            7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             --CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34456678899999999999999999999999999999999998765544455678899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ..+.+|+||||++|++|.+++.+++.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999999754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (342)
                      ..   .......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+....+..+..+++++
T Consensus       167 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  243 (476)
T 2y94_A          167 SD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV  243 (476)
T ss_dssp             CT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHH
T ss_pred             cc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHH
Confidence            32   233456789999999999998777678999999999999999999999999988999999988888888899999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .+||.+||+.||++|||++++++||||+...
T Consensus       244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            9999999999999999999999999998644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.3e-55  Score=401.63  Aligned_cols=263  Identities=30%  Similarity=0.562  Sum_probs=235.9

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      ......++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|.+++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   93 (353)
T 2i0e_A           14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM   93 (353)
T ss_dssp             -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred             cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence            3456778999999999999999999999999999999999876554555567788999999988 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +.+|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999974321


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK  246 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (342)
                        ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+.......+..+++++.+
T Consensus       174 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          174 --DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             --TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             --CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              2223456789999999999987776 4899999999999999999999999999999999999988888899999999


Q ss_pred             HHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          247 LISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       247 li~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      ||.+||+.||.+||+     ++++++||||+.
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            999999999999994     699999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.4e-55  Score=407.62  Aligned_cols=262  Identities=29%  Similarity=0.581  Sum_probs=230.3

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~   87 (342)
                      .....++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++.++ +||||+++++++...+
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            445678999999999999999999999999999999999876655555556788999999876 7999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.... 
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999974222 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---------cHHHHHHHHHhcCCCCCC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---------NLMALYKKIFKADFKSPP  238 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---------~~~~~~~~i~~~~~~~~~  238 (342)
                       ........+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...         ........+.......+.
T Consensus       206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          206 -PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             -TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             -CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence             22334567899999999999987764 8999999999999999999999632         344567778888888888


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITM------AEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~------~e~l~h~~~~~  273 (342)
                      .+++++.+||++||+.||++||++      +|+++||||+.
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            999999999999999999999985      89999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.6e-55  Score=400.37  Aligned_cols=260  Identities=33%  Similarity=0.601  Sum_probs=231.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            3456789999999999999999999999999999999976443221   1245788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----CeeEccccccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG----VLKVSDFGLSA  162 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~----~~kl~Dfg~~~  162 (342)
                      +.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999999999888899999999999999999999999999999999999998776    79999999997


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----C
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----P  238 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~  238 (342)
                      ....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    .
T Consensus       168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             EcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            5432   223345679999999999987666 4899999999999999999999999999999998888776654    4


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+++++++||.+||+.||++|||++|+++||||+.
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            68999999999999999999999999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-54  Score=384.03  Aligned_cols=265  Identities=35%  Similarity=0.687  Sum_probs=236.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..-..++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            34567899999999999999999999999999999999976655555556788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....  
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--  161 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  161 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999998864322  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                        .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......+..+++++.+||
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          162 --SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             --ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence              22244578999999999987665 489999999999999999999999999999999998888888888999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                      .+||+.||++|||++|+++||||+.....+
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             HHHhccChhhCCCHHHHhhCccccCCccCc
Confidence            999999999999999999999998755443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.2e-54  Score=385.66  Aligned_cols=259  Identities=26%  Similarity=0.469  Sum_probs=226.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+...++|++.+.||+|+||+||+|.+..+|+.||+|++......   ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            344668999999999999999999999999999999999654322   23568899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .|+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  169 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  169 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             EEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc-
Confidence            99999999999999999865 5899999999999999999999999999999999999999999999999998754321 


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~  245 (342)
                       ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+....   ...+..++..+.
T Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T 3fxz_A          170 -QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  247 (297)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred             -ccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence             2233456799999999999887764 89999999999999999999999888777666655443   233556899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +||.+||+.||++|||++|+++||||+..
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-54  Score=398.80  Aligned_cols=262  Identities=32%  Similarity=0.593  Sum_probs=227.5

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHH-HhcCCCCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIST-MKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .....++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++...+
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            34567899999999999999999999999999999999987665545555667778777 57789999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .+|+||||++|++|..++.+...+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++.... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999874221 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                       ........+||+.|+|||++.+..+. .++|||||||++|||++|..||.+.+..+....+.......++.++.++.+|
T Consensus       192 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  269 (373)
T 2r5t_A          192 -HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL  269 (373)
T ss_dssp             -CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred             -CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence             22334567899999999999887764 8999999999999999999999999999999999998888888899999999


Q ss_pred             HHHhcCCCCCCCCCH----HHHhcCccccc
Q 019360          248 ISRILDPNPVTRITM----AEVIENEWFKK  273 (342)
Q Consensus       248 i~~~L~~dP~~Rps~----~e~l~h~~~~~  273 (342)
                      |.+||+.||.+||++    +++++||||+.
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            999999999999986    69999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-54  Score=397.84  Aligned_cols=262  Identities=25%  Similarity=0.528  Sum_probs=233.8

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++...+.
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34567899999999999999999999999999999999987665555566788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||+.|++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....   
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~---  166 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---  166 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc---
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999997543   


Q ss_pred             CCCceecccCCcccCChhhhccC--CCCCcccchhhhhHHHHHHHhCCCCCCC---CcHHHHHHHHHhcCCCCCCCCCHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNK--GYDGAKADLWSCGVILYVLMAGYLPFEE---SNLMALYKKIFKADFKSPPWFSTS  243 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~  243 (342)
                      ........+||+.|+|||++...  ...+.++|||||||++|+|++|+.||..   .........+.......+..++++
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~  246 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE  246 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence            23334567899999999998742  2235889999999999999999999974   445666677777778888889999


Q ss_pred             HHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVTRIT-MAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps-~~e~l~h~~~~~  273 (342)
                      +.+||.+||+.||.+||+ ++++++||||..
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            999999999999999998 899999999974

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.5e-54  Score=384.97  Aligned_cols=258  Identities=31%  Similarity=0.501  Sum_probs=218.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|++++.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.++++++|+||+++++++...+..++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4689999999999999999999999999999999975432 334456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++ ++...+. .++.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....  ...
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  156 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR  156 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence            999976 5555554 467899999999999999999999999999999999999999999999999999975432  122


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCC-CCCCcHHHHHHHHHhcCCC---------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFKADFK---------------  235 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~p-f~~~~~~~~~~~i~~~~~~---------------  235 (342)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+....+......               
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            334567899999999998766556899999999999999987777 6666666666665432111               


Q ss_pred             --------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          236 --------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       236 --------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                    ..+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                          113478899999999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-54  Score=409.38  Aligned_cols=260  Identities=33%  Similarity=0.637  Sum_probs=226.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+++++.++||||+++++++...+.+|
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            35678999999999999999999999999999999998765545555667889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||+++++|..++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....  .
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~  302 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D  302 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence            999999999999999988889999999999999999999998 9999999999999999999999999999874322  2


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS  249 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (342)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+..+++++.+||.
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  381 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS  381 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence            223455789999999999987776 4899999999999999999999999999999999999988888899999999999


Q ss_pred             HhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          250 RILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +||+.||++||     +++|+++||||+.
T Consensus       382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            99999999999     9999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.3e-54  Score=404.21  Aligned_cols=259  Identities=36%  Similarity=0.683  Sum_probs=229.5

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||+||+|.++.+|+.+|+|++..... .....+.+.+|+.+++.++||||+++++++...+..|
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            345789999999999999999999999999999999976543 2344567899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec---CCCCeeEcccccccCCccc
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD---ANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~~  167 (342)
                      +||||++|++|.+.+..++.+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..... 
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~-  165 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-  165 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT-
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC-
Confidence            9999999999999999988999999999999999999999999999999999999998   467899999999975432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTS  243 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~  243 (342)
                       ........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......+    +.++++
T Consensus       166 -~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          166 -EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             -TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             -CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence             22233456899999999999877664 899999999999999999999999999999998888766554    357999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +.+||.+||+.||++|||++|+|+||||+.
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            999999999999999999999999999974

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.5e-54  Score=389.16  Aligned_cols=262  Identities=32%  Similarity=0.623  Sum_probs=223.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .....++|++.+.||+|+||.||+|++.   .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3456789999999999999999999985   68899999999764332 2233456789999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ..+.+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998743


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (342)
                      ..  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......++.+++++
T Consensus       172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  248 (327)
T 3a62_A          172 IH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA  248 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             cc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence            22  1222345679999999999987666 48999999999999999999999999999999999988888888999999


Q ss_pred             HHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      .+||.+||+.||++||     +++++++||||+.
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            9999999999999999     8899999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.8e-54  Score=379.77  Aligned_cols=265  Identities=47%  Similarity=0.907  Sum_probs=230.2

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ......++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            45667899999999999999999999999999999999997655444455678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..... 
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~-  163 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-  163 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999875432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                        ........|++.|+|||.+.+..+.+.++||||||+++|+|++|..||...+.......+.......+..++.++.++
T Consensus       164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  241 (276)
T 2h6d_A          164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL  241 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence              222344578999999999987766568999999999999999999999999888888888888777788899999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      |.+||+.||++|||++++++||||++..
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999999998653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-54  Score=389.25  Aligned_cols=255  Identities=26%  Similarity=0.498  Sum_probs=228.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||+||+|.++.+++.||+|++....    .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            4679999999999999999999999999999999986432    223567899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC--CCCeeEcccccccCCcccc
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~--~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ||||++|++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.  ++.+||+|||++.....  
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--  156 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence            99999999999999765 47999999999999999999999999999999999999987  78999999999975432  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  244 (342)
                       ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+    +.+++++
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence             233455679999999999987655 4899999999999999999999999999998888888777654    3689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||.+||+.||.+|||++|+|+||||++.
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            999999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.9e-54  Score=391.18  Aligned_cols=263  Identities=36%  Similarity=0.669  Sum_probs=222.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      -.++|++++.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            468999999999999999999999999999999998654322  223567899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+++++|.+++.....+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999997543322223


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH-HHHHHHhcCC--CCCCCCCHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA-LYKKIFKADF--KSPPWFSTSAKKLI  248 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~-~~~~i~~~~~--~~~~~~~~~~~~li  248 (342)
                      .....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...+... ..........  .....+++++.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence            34456899999999999887776688999999999999999999998765432 2222222222  22345899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      .+||+.||++|||++|+++||||+....
T Consensus       243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          243 HKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHccCChhhCcCHHHHhhChhhccccc
Confidence            9999999999999999999999986543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=387.78  Aligned_cols=259  Identities=37%  Similarity=0.618  Sum_probs=228.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            445689999999999999999999999999999999975433211   12467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----CeeEcccccccC
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG----VLKVSDFGLSAL  163 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~----~~kl~Dfg~~~~  163 (342)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++    .+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999999999999998888899999999999999999999999999999999999998877    899999999975


Q ss_pred             CccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CC
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PW  239 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~  239 (342)
                      ...   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    ..
T Consensus       168 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          168 IDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             CCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            432   222345679999999999987665 4899999999999999999999999888888888777665543    46


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++..+.+||.+||+.||++|||++++|+||||+.
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            7899999999999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.5e-54  Score=393.64  Aligned_cols=256  Identities=35%  Similarity=0.707  Sum_probs=228.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4579999999999999999999999999999999976443 234456789999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC---CCeeEcccccccCCccccC
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN---GVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~---~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |||++|++|.+.+..+..+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|||++.....   
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~---  183 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---  183 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence            9999999999999988889999999999999999999999999999999999999765   4599999999975432   


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----CCCHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFSTSAK  245 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~  245 (342)
                      .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......+.    .+++++.
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          184 SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            2233456799999999999876664 8999999999999999999999999988888888887665543    4789999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +||.+||+.||++|||++++|+||||..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999999974

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-54  Score=401.77  Aligned_cols=261  Identities=32%  Similarity=0.553  Sum_probs=228.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            35678999999999999999999999999999999997655444444456789999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++...... .
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~  223 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M  223 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence            99999999999999876 468999999999999999999999999999999999999999999999999997533211 1


Q ss_pred             CceecccCCcccCChhhhccCCC---CCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc----CCCCCCCCCHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGY---DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA----DFKSPPWFSTS  243 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~  243 (342)
                      ......+||+.|+|||++.+...   .+.++|||||||++|+|++|+.||.+.+.......+...    .++....++++
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence            12235689999999999986541   357999999999999999999999999999888888764    33444578999


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      +++||.+||+.+|.+  |++++|+++||||+.
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            999999999999999  999999999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-54  Score=384.75  Aligned_cols=264  Identities=36%  Similarity=0.663  Sum_probs=219.1

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh-----------------------hhHHHHHH
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK-----------------------HKMIGQIK   62 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~   62 (342)
                      .+......++|++.+.||+|+||.||+|.+..+++.||+|++.......                       ....+.+.
T Consensus         5 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A            5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             -----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHH
T ss_pred             cCCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            3334456899999999999999999999999999999999997543221                       11235688


Q ss_pred             HHHHHHhcCCCCcceeEEEEEEe--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 019360           63 REISTMKLIRHPNVIRMYEVMAS--KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDL  140 (342)
Q Consensus        63 ~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dl  140 (342)
                      +|+.+++.++||||+++++++..  .+.+|+||||+++++|.+++. ...+++.++..++.|++.||.|||++||+||||
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            99999999999999999999986  568999999999999987654 457999999999999999999999999999999


Q ss_pred             CCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCC--CCcccchhhhhHHHHHHHhCCCCCC
Q 019360          141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY--DGAKADLWSCGVILYVLMAGYLPFE  218 (342)
Q Consensus       141 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~pf~  218 (342)
                      ||+||+++.++.+||+|||++.....  .........||+.|+|||++.+...  .+.++|||||||++|+|++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999875332  1222345679999999999976542  3578999999999999999999999


Q ss_pred             CCcHHHHHHHHHhcCCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          219 ESNLMALYKKIFKADFKSP--PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       219 ~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      ..+.......+.......+  +.+++++.+||.+||+.||++|||++|+++||||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            9888877777776655443  46899999999999999999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.5e-54  Score=393.87  Aligned_cols=259  Identities=40%  Similarity=0.767  Sum_probs=215.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.......    +.+.+|+.+++.++||||+++++++...+.+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            34579999999999999999999999999999999997543322    45779999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--eeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV--LKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~~~  168 (342)
                      +||||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||+++....  
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            99999999999999988888999999999999999999999999999999999999987665  99999999874222  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc----HHHHHHHHHhcCCCCCC--CCCH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN----LMALYKKIFKADFKSPP--WFST  242 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~--~~~~  242 (342)
                       ........||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+..    .......+.......+.  .+++
T Consensus       171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence             2223456799999999999887776566999999999999999999998743    34555556555554443  5899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ++.+||.+||+.||++|||++|+++||||.+...
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            9999999999999999999999999999976543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-54  Score=387.79  Aligned_cols=248  Identities=21%  Similarity=0.343  Sum_probs=193.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----eE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT----KI   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~   89 (342)
                      .+|.+.++||+|+||+||+|++  +|+.||||++......    ....+.|+..+.+++||||+++++++..++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            5689999999999999999987  5899999999654321    123345777778899999999999997653    58


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEecCCCCeeEcccccc
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR--------GVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~--------giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      |+|||||++|+|.+++..+ .++++.+..++.|++.||+|||++        +|+||||||+|||++.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999999864 589999999999999999999987        9999999999999999999999999999


Q ss_pred             cCCccccC--CCceecccCCcccCChhhhccCCC-----CCcccchhhhhHHHHHHHhCCCCCCCC--------------
Q 019360          162 ALPQQVRD--DGLLHTTCGTPNYVAPEVINNKGY-----DGAKADLWSCGVILYVLMAGYLPFEES--------------  220 (342)
Q Consensus       162 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~ll~~l~~g~~pf~~~--------------  220 (342)
                      +.......  .......+||+.|||||++.+...     .+.++|||||||++|||+||..||...              
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            75433211  112234679999999999975421     246899999999999999997765321              


Q ss_pred             -cHHHHHHHHHhcCCCC--CCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          221 -NLMALYKKIFKADFKS--PPW-----FSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       221 -~~~~~~~~i~~~~~~~--~~~-----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ........+......+  +..     .+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             2233444444333322  111     22468899999999999999999999863

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.9e-54  Score=386.01  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=215.7

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++++.||+|+||+||+|.+. +|+.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            4556689999999999999999999995 58999999996543 233345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .++||||+++ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-  171 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-  171 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS-
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC-
Confidence            9999999975 787777664 4599999999999999999999999999999999999999999999999999975432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----------  236 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----------  236 (342)
                       .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.......           
T Consensus       172 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 -PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             -CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             -CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence             12223445789999999999875555689999999999999999999998876665555554311110           


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          237 -------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       237 -------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                         .+.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                               1246789999999999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-53  Score=386.70  Aligned_cols=264  Identities=35%  Similarity=0.581  Sum_probs=238.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            34689999999999999999999999999999999976655555566788999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+++++|.+++..+..+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ..
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~  196 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GE  196 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998754321  12


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+....+.......+..+++++.+||.+|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence            2344678999999999987666 489999999999999999999999998888888888888888888999999999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          252 LDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                      |+.||++|||++|+++||||...+.+.
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ccCChhHCcCHHHHhcCccccCCCccc
Confidence            999999999999999999999876654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-53  Score=377.47  Aligned_cols=261  Identities=36%  Similarity=0.723  Sum_probs=235.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+.
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            45567899999999999999999999999999999999976554444445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....  
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--  166 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--  166 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999864322  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                        .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......++.++.++.+||
T Consensus       167 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (284)
T 2vgo_A          167 --LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI  243 (284)
T ss_dssp             --SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred             --cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence              12234678999999999987666 489999999999999999999999998888888888888888888999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||+.||.+|||++++++||||+..
T Consensus       244 ~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            99999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.1e-54  Score=402.65  Aligned_cols=261  Identities=27%  Similarity=0.509  Sum_probs=226.8

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|+++++||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            45789999999999999999999999999999999976554444444458899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||++||+|.+++.+ .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~  230 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GT  230 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SC
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-CC
Confidence            9999999999999987 577999999999999999999999999999999999999999999999999999643221 11


Q ss_pred             CceecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc--CCCCC---CCCC
Q 019360          171 GLLHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA--DFKSP---PWFS  241 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~---~~~~  241 (342)
                      ......+||+.|+|||++..    ....+.++|||||||++|||++|+.||.+.+..+....+...  .+..+   ..++
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence            12234689999999999872    233358999999999999999999999999988888888653  23333   3489


Q ss_pred             HHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVT--RITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~--Rps~~e~l~h~~~~~  273 (342)
                      +++++||++||..+|++  |++++|+++||||+.
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            99999999999999988  999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.9e-53  Score=377.83  Aligned_cols=265  Identities=35%  Similarity=0.579  Sum_probs=238.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            45678999999999999999999999999999999997665545556678899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +||||+++++|.+++.....+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  .
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence            99999999999999988888999999999999999999999999999999999999999999999999998754321  1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (342)
                      .......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......+....+.......+..+++.+.+||.+
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  248 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  248 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence            22344678999999999987665 48999999999999999999999999888888888888888888899999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          251 ILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       251 ~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                      ||+.||++|||++++++||||.....+.
T Consensus       249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          249 MLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HcccChhhCcCHHHHhhChheecCCcCC
Confidence            9999999999999999999999876554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-53  Score=396.63  Aligned_cols=266  Identities=28%  Similarity=0.413  Sum_probs=213.7

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASK   86 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~   86 (342)
                      ..+...++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ......+++.+|+.+++.+. |+||+++++++...
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            34566789999999999999999999999999999999986532 33444567889999999997 99999999999754


Q ss_pred             C--eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           87 T--KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        87 ~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      +  .+|+||||++ ++|..++.. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             CCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            4  7999999997 589988876 56899999999999999999999999999999999999999999999999999753


Q ss_pred             ccc-------------------cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHH
Q 019360          165 QQV-------------------RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL  225 (342)
Q Consensus       165 ~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~  225 (342)
                      ...                   .........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            221                   1112234568999999999998755556899999999999999999999999888777


Q ss_pred             HHHHHhcCCC-----------------------------------------------CCCCCCHHHHHHHHHhcCCCCCC
Q 019360          226 YKKIFKADFK-----------------------------------------------SPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       226 ~~~i~~~~~~-----------------------------------------------~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      ...+......                                               ....+++++.+||.+||+.||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            7766532111                                               11257889999999999999999


Q ss_pred             CCCHHHHhcCcccccCCC
Q 019360          259 RITMAEVIENEWFKKGYK  276 (342)
Q Consensus       259 Rps~~e~l~h~~~~~~~~  276 (342)
                      |||++|+|+||||+....
T Consensus       320 R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          320 RISANDALKHPFVSIFHN  337 (388)
T ss_dssp             SCCHHHHTTSTTTTTTCC
T ss_pred             CCCHHHHhCCHHHHHhcC
Confidence            999999999999986544

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.7e-54  Score=388.75  Aligned_cols=265  Identities=28%  Similarity=0.433  Sum_probs=213.9

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      .....+..++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++..
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            34467788899999999999999999999999999999999975432 23334567799999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-----CCCCeeEccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-----ANGVLKVSDFGL  160 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~-----~~~~~kl~Dfg~  160 (342)
                      .+.+|+||||+++ +|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++     .++.+||+|||+
T Consensus       105 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          105 NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999999999975 9999999988899999999999999999999999999999999999994     455699999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC---
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP---  237 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---  237 (342)
                      ++.....  ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+.   
T Consensus       184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            8743221  22234457899999999998765556899999999999999999999999888777766654311110   


Q ss_pred             ---------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          238 ---------------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       238 ---------------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                                 ..+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                       1167899999999999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-53  Score=393.00  Aligned_cols=268  Identities=23%  Similarity=0.404  Sum_probs=221.8

Q ss_pred             CCCCceeecCeeeeeeeccc--CceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 019360            6 GGASRTRVGKYELGRTLGEG--SFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM   83 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~   83 (342)
                      .++--...++|++++.||+|  +||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus        17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            44455678899999999999  999999999999999999999976543 345567888999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      ...+.+|+||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            9999999999999999999999875  67999999999999999999999999999999999999999999999999987


Q ss_pred             cCCcccc-----CCCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          162 ALPQQVR-----DDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       162 ~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      .......     .........||+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            5322111     1112233478999999999987  344 5899999999999999999999987654444433332211


Q ss_pred             ----------------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          235 ----------------------------------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       235 ----------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                                                                    +.+..+++++.+||.+||+.||++|||++|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                          1234478899999999999999999999999999


Q ss_pred             cccccCC
Q 019360          269 EWFKKGY  275 (342)
Q Consensus       269 ~~~~~~~  275 (342)
                      |||+...
T Consensus       335 p~f~~~~  341 (389)
T 3gni_B          335 SFFKQIK  341 (389)
T ss_dssp             GGGGGC-
T ss_pred             HHHHHHh
Confidence            9998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.3e-53  Score=374.94  Aligned_cols=262  Identities=39%  Similarity=0.696  Sum_probs=230.3

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      |+..+...++|++.+.||+|+||.||+|.+..++..+|+|++......   ..+.+.+|+.+++.++||||+++++++..
T Consensus         1 Gs~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (277)
T 3f3z_A            1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFED   77 (277)
T ss_dssp             -----CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CcchhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            445666788999999999999999999999999999999999754322   24578899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCeeEccccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSA  162 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli---~~~~~~kl~Dfg~~~  162 (342)
                      .+..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++   +.++.++|+|||++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            99999999999999999999888889999999999999999999999999999999999999   788899999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----  238 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----  238 (342)
                      ....   ........||+.|+|||++.+. + +.++||||||+++|+|++|+.||...+.......+.......+.    
T Consensus       158 ~~~~---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          158 RFKP---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             ECCT---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred             eccC---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence            4332   2233456799999999998754 3 58999999999999999999999999988888888887776654    


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .+++++.+||.+||+.||++|||+.++|+||||++..
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            5899999999999999999999999999999998643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.7e-53  Score=388.24  Aligned_cols=257  Identities=35%  Similarity=0.664  Sum_probs=220.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh--hHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH--KMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++........  ...+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999975433211  13467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---eeEcccccccC
Q 019360           91 IVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV---LKVSDFGLSAL  163 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~---~kl~Dfg~~~~  163 (342)
                      +||||++|++|.+.+...    ..+++..++.++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998877543    35899999999999999999999999999999999999986654   99999999975


Q ss_pred             CccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CC
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PW  239 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~  239 (342)
                      ....  .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ......+........    ..
T Consensus       183 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          183 LGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred             ecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence            4321  122345679999999999987766 489999999999999999999998864 455666666655543    46


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +++++.+||.+||+.||++|||+.++|+||||+.
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            8999999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-53  Score=377.79  Aligned_cols=263  Identities=33%  Similarity=0.651  Sum_probs=209.0

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus         6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            35567899999999999999999999999999999999976554444456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999999875 67999999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKL  247 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (342)
                      .  .......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+.......+..++.++.+|
T Consensus       166 ~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (278)
T 3cok_A          166 H--EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL  242 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred             C--CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence            1  12234578999999999987665 48999999999999999999999887766666666666666777899999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          248 ISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      |.+||+.||++|||++++++||||...
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccCC
Confidence            999999999999999999999999763

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.4e-53  Score=384.15  Aligned_cols=259  Identities=29%  Similarity=0.482  Sum_probs=206.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.....  ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            5689999999999999999999999999999999965432  22235678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           93 LEFVTGGELFDKIASR------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      |||++ ++|.+++...      ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            99997 4999988753      3589999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-----------
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-----------  235 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------  235 (342)
                      .  ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......           
T Consensus       161 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          161 P--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             C--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             C--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            1  122344578999999999986544568999999999999999999999998877776666432110           


Q ss_pred             -----------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          236 -----------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       236 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                             ....++.++.+||.+||+.||++|||++|+|+||||++.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                   11246889999999999999999999999999999987554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-53  Score=389.80  Aligned_cols=260  Identities=28%  Similarity=0.547  Sum_probs=228.4

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+...++|++++.||+|+||.||+|.++.+|+.||+|++.....   .....+.+|+.+|+.++|+||+++++++.....
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            34566899999999999999999999999999999999975432   223478899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC--CCCeeEcccccccCCc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~--~~~~kl~Dfg~~~~~~  165 (342)
                      +++||||+++++|.+++... ..+++.++..++.|++.||+|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999998765 46999999999999999999999999999999999999974  4689999999997543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFS  241 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (342)
                      .   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+    ..++
T Consensus       203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  278 (387)
T 1kob_A          203 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  278 (387)
T ss_dssp             T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             C---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence            2   233455689999999999987666 4899999999999999999999999988888888877655443    4579


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +++.+||.+||+.||++|||++|+|+||||+...
T Consensus       279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.9e-52  Score=371.97  Aligned_cols=260  Identities=35%  Similarity=0.686  Sum_probs=230.1

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++|+||+++++++...+..++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            45789999999999999999999999999999999976543 33445678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---eeEcccccccCCcccc
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV---LKVSDFGLSALPQQVR  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~---~kl~Dfg~~~~~~~~~  168 (342)
                      ||||+++++|.+.+..+..+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||.+.....  
T Consensus        83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~--  160 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--  160 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence            9999999999999988888999999999999999999999999999999999999976655   99999999875332  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  244 (342)
                       ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+    ..+++++
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 -SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             -SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             -CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence             222344678999999999987766 4899999999999999999999999988888888877665543    3578999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      .+||.+||+.||++|||++|+++||||++...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            99999999999999999999999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.7e-53  Score=377.71  Aligned_cols=256  Identities=31%  Similarity=0.494  Sum_probs=214.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|++++.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999999 6789999999965432 222335678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++ +|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  155 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR  155 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence            999975 898888764 67999999999999999999999999999999999999999999999999998743221  12


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----------------  235 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------  235 (342)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......                
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            2334578999999999976554568999999999999999999999988877766665432100                


Q ss_pred             -------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          236 -------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       236 -------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                   ....+++++.+||.+||+.||++|||++|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                         11347889999999999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.6e-53  Score=416.79  Aligned_cols=261  Identities=31%  Similarity=0.568  Sum_probs=237.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCe
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTK   88 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~   88 (342)
                      ....++|++++.||+|+||.||+|+++.+++.||||++.+.........+.+.+|.+++..+ +|++|+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            44678899999999999999999999999999999999876555555567788999999988 69999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....  
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--  494 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--  494 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999974222  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                      ........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+..++...+.......+..+++++.+||
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC  573 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            2233456789999999999988776 489999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCCH-----HHHhcCccccc
Q 019360          249 SRILDPNPVTRITM-----AEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rps~-----~e~l~h~~~~~  273 (342)
                      .+||+.||++||++     +|+++||||+.
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            99999999999997     99999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-53  Score=395.57  Aligned_cols=261  Identities=26%  Similarity=0.484  Sum_probs=225.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..++|+||+++++++.+.+.+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            34678999999999999999999999999999999997655444444556889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||++|++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++...... 
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-  216 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-  216 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence            999999999999999875 479999999999999999999999999999999999999999999999999997533211 


Q ss_pred             CCceecccCCcccCChhhhcc------CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCC---C
Q 019360          170 DGLLHTTCGTPNYVAPEVINN------KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSP---P  238 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~---~  238 (342)
                      .......+||+.|+|||++..      ....+.++|||||||++|||++|+.||.+.+..+....+....  ...+   .
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            111234689999999999973      1223589999999999999999999999999888888887532  2222   5


Q ss_pred             CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTR---ITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~R---ps~~e~l~h~~~~~  273 (342)
                      .+++++++||++||. +|.+|   ++++|+++||||+.
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            689999999999999 99998   59999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=377.97  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=217.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++|+||+++++++...+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            579999999999999999999999999999999986543 2334456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |||+++++|..++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......  ...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  158 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDY  158 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccc
Confidence            999999999999888888999999999999999999999999999999999999999999999999999754321  222


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-------------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD-------------------  233 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~-------------------  233 (342)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....                   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            3455789999999999875555689999999999999999999999887766655443210                   


Q ss_pred             --CCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          234 --FKS----------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       234 --~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                        .+.          .+.++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence              000          13578889999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.4e-53  Score=401.85  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--   86 (342)
                      .....++|++++.||+|+||+||+|.+..+|+.||+|++.+.. ......+++.+|+.+|+.++||||+++++++...  
T Consensus        57 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           57 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             ceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            4456789999999999999999999999999999999997642 3344567888999999999999999999999654  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           87 ----TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        87 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                          ..+|+||||+++ +|.+.+..  .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus       136 ~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             cccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence                467999999976 56666643  48999999999999999999999999999999999999999999999999998


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC-----
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP-----  237 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----  237 (342)
                      ....   .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+......+.     
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -------CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ecCC---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            5432   2334567899999999999987765 899999999999999999999999988877777654321110     


Q ss_pred             ----------------CC---------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          238 ----------------PW---------------------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       238 ----------------~~---------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                      ..                     .++++.+||.+||+.||++|||++|+|+||||+.++.+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence                            00                     04578999999999999999999999999999976653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.2e-53  Score=404.79  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=230.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            45678999999999999999999999999999999998765555555667889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||||++||+|..++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....  
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~--  338 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--  338 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence            9999999999999998754  399999999999999999999999999999999999999999999999999975332  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  244 (342)
                       .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.    ....+...+.......+..+++++
T Consensus       339 -~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~  416 (576)
T 2acx_A          339 -GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA  416 (576)
T ss_dssp             -TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             -CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence             223455689999999999987666 48999999999999999999999875    345666667776777778899999


Q ss_pred             HHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      .+||.+||+.||.+||     +++|+++||||+.
T Consensus       417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            9999999999999999     7999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-53  Score=378.97  Aligned_cols=262  Identities=27%  Similarity=0.423  Sum_probs=212.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh--hhhHHHHHHHHHHHHhcCC---CCcceeEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL--KHKMIGQIKREISTMKLIR---HPNVIRMYEVM   83 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~   83 (342)
                      .....++|++.+.||+|+||+||+|++..+|+.||+|++......  .......+.+|+.+++.++   ||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            445578999999999999999999999999999999998643211  1111234557777776664   99999999999


Q ss_pred             EeCC-----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEc
Q 019360           84 ASKT-----KIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        84 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~  156 (342)
                      ....     .+++||||+. ++|.+++.....  +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            7755     5899999996 599999987654  9999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS  236 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  236 (342)
                      |||+++....   ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus       163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eCccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999975432   223355688999999999987776 489999999999999999999999988888777765431111


Q ss_pred             ---------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          237 ---------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       237 ---------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                                 .+.+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                                       134788999999999999999999999999999998643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-52  Score=398.09  Aligned_cols=264  Identities=28%  Similarity=0.385  Sum_probs=202.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-----
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-----   85 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----   85 (342)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+. .......+++.+|+.+|+.++|+||+++++++..     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            3457899999999999999999999999999999999653 2334455788999999999999999999999843     


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      ...+|+||||+ +++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            35799999998 56999999988889999999999999999999999999999999999999999999999999998643


Q ss_pred             cccCC-------------------------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh--------
Q 019360          166 QVRDD-------------------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA--------  212 (342)
Q Consensus       166 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--------  212 (342)
                      .....                         ......+||+.|+|||++......+.++|||||||++|||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            21111                         123456789999999987544445689999999999999998        


Q ss_pred             ---CCCCCCCCcH--------------------HHHHHHHHhcC----------------------C---------CCCC
Q 019360          213 ---GYLPFEESNL--------------------MALYKKIFKAD----------------------F---------KSPP  238 (342)
Q Consensus       213 ---g~~pf~~~~~--------------------~~~~~~i~~~~----------------------~---------~~~~  238 (342)
                         |+++|.+.+.                    .+....+....                      +         ...+
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               7777766442                    12222221100                      0         0123


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ..++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            46899999999999999999999999999999987544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-52  Score=401.25  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=232.4

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++...+.+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            45668999999999999999999999999999999999876655555567888999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           90 YIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      |+||||++|++|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998763    369999999999999999999999999999999999999999999999999997533


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCCCCCCCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKIFKADFKSPPWFS  241 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~  241 (342)
                      ..  .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.    ....+...+.......+..++
T Consensus       341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s  417 (543)
T 3c4z_A          341 AG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS  417 (543)
T ss_dssp             TT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             CC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence            21  1223445899999999999887664 8999999999999999999999775    456777788888888888899


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      +++.+||.+||+.||++||+     ++++++||||+.
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            99999999999999999996     589999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.5e-52  Score=378.06  Aligned_cols=260  Identities=33%  Similarity=0.593  Sum_probs=229.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3456789999999999999999999999999999999975432211   1245788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----CeeEccccccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG----VLKVSDFGLSA  162 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~----~~kl~Dfg~~~  162 (342)
                      +..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999999888899999999999999999999999999999999999998887    79999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----C
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----P  238 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~  238 (342)
                      ....   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    .
T Consensus       168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            5432   222345578999999999987665 4899999999999999999999999888888888877665544    4


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .++..+.+||.+||+.||++|||++|+++||||+.
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            68899999999999999999999999999999974

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.2e-53  Score=384.06  Aligned_cols=256  Identities=35%  Similarity=0.628  Sum_probs=221.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~   89 (342)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.+...       ...+|++++.++ +||||+++++++.+.+.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            346789999999999999999999999999999999976432       234688888777 799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC----CCeeEcccccccCCc
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN----GVLKVSDFGLSALPQ  165 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~----~~~kl~Dfg~~~~~~  165 (342)
                      |+||||++|++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||+..+    +.+||+|||++....
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999999999988889999999999999999999999999999999999998443    359999999997543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC---CcHHHHHHHHHhcCCCCC----C
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE---SNLMALYKKIFKADFKSP----P  238 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~---~~~~~~~~~i~~~~~~~~----~  238 (342)
                      .  ........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+   .+..++...+....+..+    .
T Consensus       172 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  248 (342)
T 2qr7_A          172 A--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN  248 (342)
T ss_dssp             C--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred             C--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence            2  22234556889999999999876654 899999999999999999999975   456777777877766554    4


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      .+++++.+||.+||+.||++|||++++++||||.++..
T Consensus       249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence            58999999999999999999999999999999976543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-52  Score=399.92  Aligned_cols=261  Identities=36%  Similarity=0.631  Sum_probs=227.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh----------hHHHHHHHHHHHHhcCCCCcceeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH----------KMIGQIKREISTMKLIRHPNVIRM   79 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~l   79 (342)
                      +...++|++++.||+|+||+||+|.++.+++.||+|++.+......          ...+.+.+|+.++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3456789999999999999999999999999999999976543221          334678899999999999999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CeeEc
Q 019360           80 YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVS  156 (342)
Q Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~---~~kl~  156 (342)
                      ++++.....+|+|||||+|++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999999999999998888899999999999999999999999999999999999998776   69999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS  236 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  236 (342)
                      |||++.....   .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus       192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999975432   223455679999999999874 44 589999999999999999999999999999999998877665


Q ss_pred             C----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          237 P----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       237 ~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +    ..+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            4    56899999999999999999999999999999998644

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.8e-52  Score=391.08  Aligned_cols=267  Identities=28%  Similarity=0.425  Sum_probs=214.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--   86 (342)
                      .....++|++++.||+|+||.||+|.++.+|+.||||++... .......+++.+|+.+|+.++|+||+++++++...  
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            344567899999999999999999999999999999999753 23344567889999999999999999999999765  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           87 ---TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                         ..+|+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               57999999995 59999999888899999999999999999999999999999999999999999999999999985


Q ss_pred             CccccCC--------------------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC----------
Q 019360          164 PQQVRDD--------------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG----------  213 (342)
Q Consensus       164 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g----------  213 (342)
                      .......                    ......+||+.|+|||++......+.++|||||||++|||++|          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            4332111                    1235678999999999975545456899999999999999984          


Q ss_pred             -CCCCCCCc-----------------HHHHHHHHHhc------------------------CCCC-------CCCCCHHH
Q 019360          214 -YLPFEESN-----------------LMALYKKIFKA------------------------DFKS-------PPWFSTSA  244 (342)
Q Consensus       214 -~~pf~~~~-----------------~~~~~~~i~~~------------------------~~~~-------~~~~~~~~  244 (342)
                       .++|.+.+                 ..+....+...                        ....       .+.+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence             44444432                 11222222110                        0011       14578999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      .+||.+||+.||++|||++|+|+||||+....+
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999999999875443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.6e-53  Score=381.69  Aligned_cols=260  Identities=24%  Similarity=0.415  Sum_probs=213.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      +++|++++.||+|+||+||+|.+..+++.||+|++......  .....+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            47899999999999999999999999999999999654321  1112345799999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            999974 888888765 45999999999999999999999999999999999999999999999999998753321  22


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---------------
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---------------  236 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------------  236 (342)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+               
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            23445789999999999875555689999999999999999999999988877776665421111               


Q ss_pred             ---------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 ---------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ---------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                     .+.+++++.+||.+||+.||++|||++|+|+||||.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                           12468899999999999999999999999999999875443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.5e-53  Score=402.72  Aligned_cols=261  Identities=36%  Similarity=0.654  Sum_probs=232.2

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.++++++||||+++++++...+.+
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34457899999999999999999999999999999999765544444567889999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCeeEcccccccCCcc
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~  166 (342)
                      |+||||+.+++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999999999988899999999999999999999999999999999999999   5678999999999874322


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFST  242 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (342)
                         .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+.......+    ..+++
T Consensus       182 ---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          182 ---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             ---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             ---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence               233455679999999999976 44 5899999999999999999999999999999888888765543    35899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      ++.+||.+||+.||++|||++|+|+||||+...
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999999999998643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-52  Score=400.26  Aligned_cols=265  Identities=35%  Similarity=0.622  Sum_probs=230.8

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .....+...++|++++.||+|+||+||+|.++.+++.||+|++.+.... ......+.+|+.++++++||||+++++++.
T Consensus        13 ~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   91 (486)
T 3mwu_A           13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE   91 (486)
T ss_dssp             -CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence            3344556778999999999999999999999999999999999754332 233467889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec---CCCCeeEcccccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD---ANGVLKVSDFGLS  161 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~---~~~~~kl~Dfg~~  161 (342)
                      ....+|+||||+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            9999999999999999999998888899999999999999999999999999999999999995   4567999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----  237 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----  237 (342)
                      +....   .......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+.......+    
T Consensus       172 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (486)
T 3mwu_A          172 TCFQQ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW  246 (486)
T ss_dssp             TTBCC---C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred             eECCC---CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            75432   2233456799999999999763 4 5899999999999999999999999999888888887765543    


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      ..+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            35789999999999999999999999999999998754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5e-52  Score=369.91  Aligned_cols=258  Identities=34%  Similarity=0.619  Sum_probs=220.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .++..++|++.+.||+|+||.||+|.++.++..+|+|++.....  ....+.+.+|+++++.++||||+++++++...+.
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            45567899999999999999999999999999999999976432  2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCeeEcccccc
Q 019360           89 IYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLS  161 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli---~~~~~~kl~Dfg~~  161 (342)
                      .++||||+++++|.+.+..    ...+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999998854    3679999999999999999999999999999999999999   45678999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC---C
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP---P  238 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---~  238 (342)
                      .....   ........||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+.......+........   .
T Consensus       175 ~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (285)
T 3is5_A          175 ELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR  249 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred             eecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence            75432   222345678999999999864 34 5899999999999999999999999888887777665544332   3


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            47899999999999999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-52  Score=384.32  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=215.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--   87 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--   87 (342)
                      ....++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+++.+|+++++.++|+||+++++++....  
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            345678999999999999999999999999999999996532 33445678899999999999999999999997653  


Q ss_pred             ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           88 ----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        88 ----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                          .+|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                469999999 8899999876 5699999999999999999999999999999999999999999999999999975


Q ss_pred             CccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC--------
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK--------  235 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------  235 (342)
                      ...     ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......        
T Consensus       178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            332     2345678999999999987444568999999999999999999999998877776666542111        


Q ss_pred             -----------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          236 -----------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       236 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                             ..+..++++.+||.+||+.||++|||++|+|+||||+....+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                                   123468999999999999999999999999999999875544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.1e-52  Score=376.35  Aligned_cols=265  Identities=33%  Similarity=0.588  Sum_probs=218.0

Q ss_pred             CCCCceeecCeeee-eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEE
Q 019360            6 GGASRTRVGKYELG-RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVM   83 (342)
Q Consensus         6 ~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~   83 (342)
                      .+.++.-.++|++. +.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++++ +||||+++++++
T Consensus         4 ~~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~   80 (316)
T 2ac3_A            4 DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFF   80 (316)
T ss_dssp             CSSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            34456667889996 78999999999999999999999999996543   22345788999999885 799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---eeEccccc
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV---LKVSDFGL  160 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~---~kl~Dfg~  160 (342)
                      ...+.+|+||||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++.   +||+|||+
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999999999999998888999999999999999999999999999999999999988765   99999999


Q ss_pred             ccCCccccC-----CCceecccCCcccCChhhhcc-----CCCCCcccchhhhhHHHHHHHhCCCCCCCCc---------
Q 019360          161 SALPQQVRD-----DGLLHTTCGTPNYVAPEVINN-----KGYDGAKADLWSCGVILYVLMAGYLPFEESN---------  221 (342)
Q Consensus       161 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---------  221 (342)
                      +........     .......+||+.|+|||++.+     ..+ +.++|||||||++|+|++|+.||.+..         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            875432111     112234569999999999874     223 478999999999999999999997653         


Q ss_pred             ------HHHHHHHHHhcCCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          222 ------LMALYKKIFKADFKSP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       222 ------~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                            .......+.......+    ..+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                  2345556666655554    3588999999999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3e-52  Score=381.88  Aligned_cols=255  Identities=35%  Similarity=0.660  Sum_probs=208.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....     ..+.+.+|+.++++++|+||+++++++...+..+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34567999999999999999999999999999999997532     2246778999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcccccccCCccc
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~  167 (342)
                      +||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||+++.... 
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~-  203 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-  203 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence            99999999999999998888999999999999999999999999999999999999975   88999999999875432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH-HHHHHHhcCCCCC----CCCCH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA-LYKKIFKADFKSP----PWFST  242 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~----~~~~~  242 (342)
                        .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ....+.......+    ..++.
T Consensus       204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence              222345678999999999987665 489999999999999999999997665443 5566666544332    45789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ++.+||.+||+.||++|||++++|+||||...
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-52  Score=379.92  Aligned_cols=255  Identities=38%  Similarity=0.704  Sum_probs=202.7

Q ss_pred             ecCeeee---eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCe
Q 019360           13 VGKYELG---RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTK   88 (342)
Q Consensus        13 ~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~   88 (342)
                      .++|++.   +.||+|+||.||+|.++.+|+.||+|++.+..      ...+.+|+.+++.+. ||||+++++++.+...
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            3568775   78999999999999999999999999996532      245678999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CeeEcccccccCCc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~---~~kl~Dfg~~~~~~  165 (342)
                      .|+||||+++++|.+++.....+++.++..++.|++.||.|||++||+||||||+||+++.++   .+||+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999999999988999999999999999999999999999999999999997765   89999999997533


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-------HHHHHHHHHhcCCCCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-------LMALYKKIFKADFKSPP  238 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~  238 (342)
                      .  ........+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+       ..+....+....+..+.
T Consensus       161 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          161 P--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             C------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             C--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            2  22233456789999999999877764 89999999999999999999997643       35566677666665542


Q ss_pred             ----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          239 ----WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       239 ----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                          .+++++.+||.+||+.||++|||++++++||||++...
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                47999999999999999999999999999999987543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.6e-53  Score=380.68  Aligned_cols=267  Identities=25%  Similarity=0.461  Sum_probs=225.3

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .+....++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            45667789999999999999999999999999999999998765555666678999999999999999999999987543


Q ss_pred             ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           88 ----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        88 ----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                          ..|+||||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                3599999999999999999888899999999999999999999999999999999999999999999999999975


Q ss_pred             CccccC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----C
Q 019360          164 PQQVRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----P  238 (342)
Q Consensus       164 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~  238 (342)
                      ...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...............+    .
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            433211 122234568999999999987766 4899999999999999999999999888877777666554432    4


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .++.++.+||.+||+.||++||++.+++.|+|++...
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            5899999999999999999999999999999997533

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.1e-52  Score=372.44  Aligned_cols=265  Identities=35%  Similarity=0.653  Sum_probs=227.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh-hhHHHHHHHHHHHHhcCCCCcceeEEEEEE--eCCe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK-HKMIGQIKREISTMKLIRHPNVIRMYEVMA--SKTK   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~   88 (342)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.++|+||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4689999999999999999999999999999999997654322 234568899999999999999999999984  4567


Q ss_pred             EEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           89 IYIVLEFVTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      .|+||||++++ |.+++..  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999999775 7777765  35699999999999999999999999999999999999999999999999999975443


Q ss_pred             ccCCCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                      ...........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||.+.+.......+.......+..+++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~  241 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS  241 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence            33333445567899999999997633 23578999999999999999999999999888888888888888888999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      +||.+||+.||++|||++++++||||++...+
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            99999999999999999999999999875543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5e-53  Score=384.94  Aligned_cols=255  Identities=32%  Similarity=0.549  Sum_probs=222.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh-----hHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH-----KMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++........     ...+.+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            345789999999999999999999999999999999976543211     123356789999999999999999999999


Q ss_pred             CCeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           86 KTKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        86 ~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      .+..++||||+.++ +|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999998766 99999998888999999999999999999999999999999999999999999999999999754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSA  244 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (342)
                      ..   .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.....      ........+..+++++
T Consensus       181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l  251 (335)
T 3dls_A          181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKEL  251 (335)
T ss_dssp             CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHH
T ss_pred             CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHH
Confidence            32   22334567999999999998877767899999999999999999999976432      3334455566789999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||.+||+.||++|||++++++||||++.
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3e-52  Score=382.12  Aligned_cols=265  Identities=27%  Similarity=0.409  Sum_probs=220.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-----
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-----   85 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----   85 (342)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++|+||+++++++..     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            4678999999999999999999999999999999998654322 2223467799999999999999999999976     


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           86 ---KTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        86 ---~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                         .+.+|+||||+++ +|...+... ..+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               4568999999975 777776653 67999999999999999999999999999999999999999999999999998


Q ss_pred             cCCcccc--CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCC
Q 019360          162 ALPQQVR--DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW  239 (342)
Q Consensus       162 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  239 (342)
                      +......  .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            7543211  22233456789999999999875555689999999999999999999999988877777665432222211


Q ss_pred             --------------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          240 --------------------------------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       240 --------------------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                                      .++++.+||.+||+.||++|||++|+|+||||+....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence                                            26779999999999999999999999999999875443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-52  Score=382.70  Aligned_cols=270  Identities=34%  Similarity=0.572  Sum_probs=224.9

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh--hhhHHHHHHHHHHHHhcCCCCcceeEEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL--KHKMIGQIKREISTMKLIRHPNVIRMYEV   82 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~   82 (342)
                      .|+......++|++.+.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.+++.++||||++++++
T Consensus        17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            4445555667899999999999999999999999999999999765432  23455788999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHH
Q 019360           83 MASKTKIYIVLEFVTGGELFDKIAS----------------------------------------RGRLKEDEARKYFQQ  122 (342)
Q Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~~  122 (342)
                      +...+..++||||+++++|.+++..                                        ...+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            9999999999999999999998852                                        112367788999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEecCCC--CeeEcccccccCCccccCC--CceecccCCcccCChhhhccC-CCCCcc
Q 019360          123 LINAVDYCHSRGVCHRDLKPENLLLDANG--VLKVSDFGLSALPQQVRDD--GLLHTTCGTPNYVAPEVINNK-GYDGAK  197 (342)
Q Consensus       123 l~~~L~~LH~~giiH~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~  197 (342)
                      ++.||+|||++||+||||||+||+++.++  .+||+|||++.........  .......||+.|+|||++.+. ...+.+
T Consensus       177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999999999999999999998766  8999999999754322111  123456799999999999752 334589


Q ss_pred             cchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          198 ADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       198 ~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +|||||||++|+|++|+.||.+.+..+....+.......+.    .+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            99999999999999999999999888888888776654432    37899999999999999999999999999999986


Q ss_pred             C
Q 019360          274 G  274 (342)
Q Consensus       274 ~  274 (342)
                      .
T Consensus       337 ~  337 (345)
T 3hko_A          337 F  337 (345)
T ss_dssp             T
T ss_pred             C
Confidence            4

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-52  Score=380.83  Aligned_cols=267  Identities=29%  Similarity=0.418  Sum_probs=216.4

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh--hhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK--HKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      .+...++|++.+.||+|+||.||+|.+..+|+.||+|++.......  ....+.+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3456789999999999999999999999999999999996533221  11224677999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      +..++||||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999999976 888888764 468999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---------
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---------  236 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------  236 (342)
                      ..  .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+......+         
T Consensus       164 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          164 SP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             SC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             CC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            21  2233456789999999999765545689999999999999999999999988877777765431110         


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          237 -------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       237 -------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                                         ...+++++.+||.+||+.||++|||++|+|+||||++...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence                               134578999999999999999999999999999998765443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-52  Score=397.53  Aligned_cols=257  Identities=35%  Similarity=0.653  Sum_probs=222.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||+||+|.++.++..||+|++.+..... .....+.+|+.+++.++||||+++++++.....+|
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34567999999999999999999999999999999997654322 22457889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC---CCeeEcccccccCCccc
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN---GVLKVSDFGLSALPQQV  167 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~---~~~kl~Dfg~~~~~~~~  167 (342)
                      +|||||++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++..   +.+||+|||++..... 
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-  191 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-  191 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence            999999999999999888889999999999999999999999999999999999999764   4599999999875432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTS  243 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~  243 (342)
                        .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+.......+    ..++++
T Consensus       192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence              223445679999999999864 44 5899999999999999999999999999999988888766543    358999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +.+||.+||+.||.+|||++++|+||||+.
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            999999999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-52  Score=368.24  Aligned_cols=262  Identities=36%  Similarity=0.668  Sum_probs=223.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.....  ....+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            46789999999999999999999999999999999965432  2334678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            99999999999999887789999999999999999999999999999999999999999999999999987543222222


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH-HHHHHHhcC--CCCCCCCCHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA-LYKKIFKAD--FKSPPWFSTSAKKLI  248 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~-~~~~i~~~~--~~~~~~~~~~~~~li  248 (342)
                      ......|++.|+|||.+.+..+.+.++||||||+++|+|++|..||....... .........  ......+++.+.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            33456789999999999877665678999999999999999999998765432 222222222  222345889999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      .+||+.||++|||++++++||||++..
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.2e-51  Score=370.93  Aligned_cols=253  Identities=28%  Similarity=0.497  Sum_probs=221.3

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEe
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      .|+..+.||+|+||.||+|.++.+|+.||||++....   ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4888899999999999999999999999999996543   2234578899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCcee
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLH  174 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (342)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  .....
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  199 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK  199 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccc
Confidence            9999999998875 56999999999999999999999999999999999999999999999999998754321  12234


Q ss_pred             cccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---CCCCCHHHHHHHHHh
Q 019360          175 TTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---PPWFSTSAKKLISRI  251 (342)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~~  251 (342)
                      ...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.....+.   ...+++.+.+||.+|
T Consensus       200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            5679999999999987666 489999999999999999999999888877777766554322   335789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccccC
Q 019360          252 LDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      |+.||++|||++++++||||...
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             ccCChhhCcCHHHHhcChhhccC
Confidence            99999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4e-52  Score=378.36  Aligned_cols=263  Identities=29%  Similarity=0.426  Sum_probs=221.1

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .-....++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++|+||+++++++...+
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            34567889999999999999999999999999999999986543 23334567789999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999999999888887788999999999999999999999999999999999999999999999999998753321


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC------------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK------------  235 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------  235 (342)
                        ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......            
T Consensus       178 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 --GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             --ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence              222345678999999999987645568999999999999999999999988776665554321100            


Q ss_pred             -------C------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          236 -------S------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       236 -------~------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                             .            .+.+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                   0            1247899999999999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-51  Score=378.52  Aligned_cols=256  Identities=32%  Similarity=0.616  Sum_probs=224.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchh-----hhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEK-----VLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT   87 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~   87 (342)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++....     .......+.+.+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            57999999999999999999999999999999986532     11223356788999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||++|++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..... 
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~-  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT-
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999875432 


Q ss_pred             cCCCceecccCCcccCChhhhccC-----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----C
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNK-----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----P  238 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~  238 (342)
                        .......+||+.|+|||++.+.     ...+.++|||||||++|+|++|..||...+.......+.......+    .
T Consensus       253 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          253 --GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             --CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence              2233456899999999998642     1235789999999999999999999999888888887777665543    4


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      .++..+.+||.+||+.||++|||++++|+||||+
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            5788999999999999999999999999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-51  Score=366.94  Aligned_cols=265  Identities=31%  Similarity=0.545  Sum_probs=227.1

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchh------hhhhhHHHHHHHHHHHHhcCC-CCcceeE
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEK------VLKHKMIGQIKREISTMKLIR-HPNVIRM   79 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~-h~~iv~l   79 (342)
                      .+.....++|++.+.||+|+||.||+|.++.+|+.||+|++....      .......+.+.+|+.+++++. ||||+++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            345566789999999999999999999999999999999986432      111233567889999999996 9999999


Q ss_pred             EEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           80 YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      ++++...+..++||||+++++|.+++..+..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999999999988889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhcc-----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINN-----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      ++.....   ........|++.|+|||++.+     ....+.++||||||+++|+|++|..||...+.......+.....
T Consensus       170 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (298)
T 1phk_A          170 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  246 (298)
T ss_dssp             TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             chhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence            9875332   223345678999999999862     22235789999999999999999999999888888887777665


Q ss_pred             CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          235 KSP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       235 ~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ..+    ..++..+.+||.+||+.||++|||++++++||||++.
T Consensus       247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            543    3478999999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-51  Score=377.12  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=220.9

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|++++.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+++++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999997654444555678899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||+. |+|.+.+. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....      
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence            9997 57877775 456799999999999999999999999999999999999999999999999999875432      


Q ss_pred             eecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAKKLI  248 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li  248 (342)
                      .....||+.|+|||++.+  ....+.++|||||||++|+|++|+.||.+.+.......+.....+.  +..+++.+.+||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  286 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  286 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            234579999999999852  2223588999999999999999999999888777766666554332  346889999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          249 SRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||+.||++|||++++++||||...
T Consensus       287 ~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          287 DSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHcccChhhCcCHHHHhhChhhhcc
Confidence            99999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.2e-52  Score=381.81  Aligned_cols=253  Identities=33%  Similarity=0.555  Sum_probs=216.8

Q ss_pred             cCeee--eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           14 GKYEL--GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        14 ~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      +.|++  .+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.++++++||||+++++++...+.+++
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34555  6789999999999999999999999999975432   234578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe--cCCCCeeEcccccccCCcccc
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli--~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+  +.++.+||+|||+++....  
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--  241 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--  241 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence            99999999999988654 469999999999999999999999999999999999999  5677899999999975432  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  244 (342)
                       .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+..+    ..+++++
T Consensus       242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence             222344579999999999976655 5899999999999999999999999998888888887765543    4589999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+||.+||+.||.+|||++|+|+||||++
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            99999999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-51  Score=370.02  Aligned_cols=256  Identities=38%  Similarity=0.687  Sum_probs=225.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++......   ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            4567899999999999999999999999999999999754322   2346789999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCeeEcccccccCCccc
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..... 
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            999999999999999888889999999999999999999999999999999999999   7788999999999875322 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTS  243 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~  243 (342)
                         .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......+    ..++++
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          162 ---GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             ---BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             ---CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence               22344578999999999987665 4899999999999999999999999888888888877654432    457899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +.+||.+||+.||++|||++++++||||+..
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-51  Score=367.42  Aligned_cols=262  Identities=24%  Similarity=0.419  Sum_probs=222.8

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++...+.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            44566789999999999999999999999999999999866555555666789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999997543221


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-----CCCCCHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-----PPWFSTS  243 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~  243 (342)
                       ........||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+.............+.     .+.+++.
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred             -ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence             122234578999999999988766 488999999999999999999999988777766665554332     3568899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +.++|.+||+.||++||+..+.+.+.|..
T Consensus       244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            99999999999999999766666667654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.6e-51  Score=365.74  Aligned_cols=257  Identities=36%  Similarity=0.663  Sum_probs=223.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3679999999999999999999999999999999875433211   1246788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----CeeEcccccccCCc
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG----VLKVSDFGLSALPQ  165 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~----~~kl~Dfg~~~~~~  165 (342)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998888899999999999999999999999999999999999998877    89999999987533


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFS  241 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (342)
                      .   ........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+    ..++
T Consensus       164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence            2   122344568999999999987665 4899999999999999999999999888888777776655443    4678


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ..+.+||.+||+.||++|||++++++||||+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.1e-52  Score=383.01  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=212.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-   87 (342)
                      .....++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+ 
T Consensus        20 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   98 (371)
T 2xrw_A           20 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   98 (371)
T ss_dssp             EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred             ccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence            3456789999999999999999999999999999999997533 23444567889999999999999999999997654 


Q ss_pred             -----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           88 -----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        88 -----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                           ..|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        99 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             cccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence                 78999999965 7888875  358999999999999999999999999999999999999999999999999997


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----  238 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----  238 (342)
                      ....   ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+.+    
T Consensus       176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccc---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5332   2223456789999999999887664 8999999999999999999999998887777766543221100    


Q ss_pred             --------------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          239 --------------------------------------WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       239 --------------------------------------~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                                            ..++++.+||.+||+.||++|||++|+|+||||+..+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  328 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  328 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence                                                  014678999999999999999999999999999876553

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.6e-51  Score=376.89  Aligned_cols=261  Identities=27%  Similarity=0.445  Sum_probs=219.8

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----C
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-----T   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~   87 (342)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|++++++++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            458999999999999999999999999999999997432  234456788999999999999999999999654     4


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      ..|+||||+. ++|.+++.. ..+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            6899999996 599998876 45999999999999999999999999999999999999999999999999999754432


Q ss_pred             cC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC----------
Q 019360          168 RD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----------  236 (342)
Q Consensus       168 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----------  236 (342)
                      .. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+          
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            21 2223456899999999998765545689999999999999999999998877666655554211110          


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 ---------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ---------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                           .+.+++++.+||.+||+.||++|||++|+|+||||++...+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                                 13578999999999999999999999999999999976554

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.5e-51  Score=376.19  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=215.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-----CCcceeEEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-----HPNVIRMYEVMA   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~l~~~~~   84 (342)
                      ....++|+++++||+|+||+||+|++..+++.||+|++....    .....+.+|+.+++.+.     |+||+++++++.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            345678999999999999999999999999999999996432    22346678999999886     999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-------------
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-------------  149 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-------------  149 (342)
                      ..+..++||||+ +++|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 889999998754  5999999999999999999999999999999999999975             


Q ss_pred             ------------CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC
Q 019360          150 ------------NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF  217 (342)
Q Consensus       150 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf  217 (342)
                                  ++.+||+|||++.....     ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCC
Confidence                        78999999999975322     22456789999999999887764 8999999999999999999999


Q ss_pred             CCCcHHHHHHHHHhcCCCCCC----------------------------------------------CCCHHHHHHHHHh
Q 019360          218 EESNLMALYKKIFKADFKSPP----------------------------------------------WFSTSAKKLISRI  251 (342)
Q Consensus       218 ~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~li~~~  251 (342)
                      ...+..+....+.....+.+.                                              ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            988877766665443322221                                              1236788999999


Q ss_pred             cCCCCCCCCCHHHHhcCcccc
Q 019360          252 LDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      |+.||++|||++|+|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999995

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-51  Score=380.51  Aligned_cols=260  Identities=27%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC---
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK---   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---   86 (342)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+++.+|+.+++.++|+||+++++++...   
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence            345679999999999999999999999999999999996532 2334456788999999999999999999998654   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           87 ---TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                         ..+|+|+|++ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence               5689999999 7899998876 5699999999999999999999999999999999999999999999999999975


Q ss_pred             CccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-------
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-------  236 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------  236 (342)
                      ...     ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+       
T Consensus       182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            332     23446789999999999874445689999999999999999999999988777766655421110       


Q ss_pred             ------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 ------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                              .+..++++.+||.+||+.||++|||++|+|+||||+....+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                                    12467889999999999999999999999999999876554

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-51  Score=383.18  Aligned_cols=255  Identities=35%  Similarity=0.642  Sum_probs=208.3

Q ss_pred             ceeecCeeee-eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHH-hcCCCCcceeEEEEEEe--
Q 019360           10 RTRVGKYELG-RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIRMYEVMAS--   85 (342)
Q Consensus        10 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~--   85 (342)
                      +...++|.+. +.||+|+||+||+|.++.+|+.||+|++...        ..+.+|+.++ +..+|+||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            4566788887 6899999999999999999999999998642        2456788887 55589999999999875  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEccc
Q 019360           86 --KTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDF  158 (342)
Q Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Df  158 (342)
                        ...+|+||||++|++|.+++....  .+++.+++.++.|++.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567899999999999999998753  5999999999999999999999999999999999999987   789999999


Q ss_pred             ccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH----HHHHHHhcCC
Q 019360          159 GLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA----LYKKIFKADF  234 (342)
Q Consensus       159 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~----~~~~i~~~~~  234 (342)
                      |+++....   .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...    ....+....+
T Consensus       209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~  284 (400)
T 1nxk_A          209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  284 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred             ccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence            99974332   2233567889999999999876664 89999999999999999999997654321    3344444444


Q ss_pred             CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          235 KSP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       235 ~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ..+    ..++.++.+||.+||+.||++|||++|+++||||.....
T Consensus       285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence            433    458999999999999999999999999999999986543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-50  Score=361.42  Aligned_cols=254  Identities=25%  Similarity=0.450  Sum_probs=216.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCe
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----KTK   88 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~   88 (342)
                      ...|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++..    ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3458999999999999999999999999999999976443 34446788999999999999999999999865    456


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEec-CCCCeeEcccccccCCc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLD-ANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~-~~~~~kl~Dfg~~~~~~  165 (342)
                      +++||||+++++|.+++.....+++..++.++.|++.||.|||++|  |+||||||+||+++ .++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            8999999999999999998888999999999999999999999999  99999999999997 78899999999986432


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcCCC--CCCCCCH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFK--SPPWFST  242 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~--~~~~~~~  242 (342)
                          ........||+.|+|||++.+. + +.++|||||||++|+|++|+.||...... .....+.....+  .+...++
T Consensus       184 ----~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          184 ----ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             ----TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ----ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence                2233456799999999988753 4 58999999999999999999999875443 344444333222  2345678


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++.+||.+||+.||.+|||++++++||||++
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            9999999999999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-51  Score=379.79  Aligned_cols=252  Identities=29%  Similarity=0.437  Sum_probs=211.0

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-----
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-----   85 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----   85 (342)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++.....       ...+|+.+|+.++|+||+++++++..     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            456789999999999999999999999999999999865432       12379999999999999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 019360           86 ---------------------------------KTKIYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLINAVD  128 (342)
Q Consensus        86 ---------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~L~  128 (342)
                                                       ...+++||||+++ +|.+.+.    ....+++..++.++.|++.||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3348899999975 7766654    4577999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEec-CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHH
Q 019360          129 YCHSRGVCHRDLKPENLLLD-ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVIL  207 (342)
Q Consensus       129 ~LH~~giiH~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll  207 (342)
                      |||++||+||||||+||+++ .++.+||+|||+++....   ........||+.|+|||++.+....+.++|||||||++
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            99999999999999999997 688999999999975322   22334567899999999998766456899999999999


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhcCCC-----------------------------CCCCCCHHHHHHHHHhcCCCCCC
Q 019360          208 YVLMAGYLPFEESNLMALYKKIFKADFK-----------------------------SPPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       208 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      |+|++|+.||.+.+..+....+......                             .+..+++++.+||.+||+.||++
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            9999999999998877777666532110                             23447889999999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 019360          259 RITMAEVIENEWFKK  273 (342)
Q Consensus       259 Rps~~e~l~h~~~~~  273 (342)
                      |||+.|+|+||||+.
T Consensus       313 R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          313 RINPYEAMAHPFFDH  327 (383)
T ss_dssp             SCCHHHHHTSGGGHH
T ss_pred             CCCHHHHhcCHHHHH
Confidence            999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-51  Score=372.71  Aligned_cols=261  Identities=25%  Similarity=0.462  Sum_probs=213.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC--CcceeEEEEEEeCCeE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH--PNVIRMYEVMASKTKI   89 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~   89 (342)
                      ..++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+|+.++|  +||+++++++.....+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4567999999999999999999984 689999999975432 34445788999999999986  9999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+|||+ .+++|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            999995 5789999999988999999999999999999999999999999999999996 68899999999986543333


Q ss_pred             CCceecccCCcccCChhhhcc----------CCCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhc--CCCC
Q 019360          170 DGLLHTTCGTPNYVAPEVINN----------KGYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKA--DFKS  236 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~--~~~~  236 (342)
                      .......+||+.|+|||++.+          ....+.++|||||||++|+|++|+.||.... .......+...  ....
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  242 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence            323345679999999999864          1233588999999999999999999997643 33333444332  3344


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      +...+.++.+||.+||+.||++|||++|+|+||||+....
T Consensus       243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            5667889999999999999999999999999999986443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6e-51  Score=378.61  Aligned_cols=259  Identities=25%  Similarity=0.458  Sum_probs=214.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR--HPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~l   91 (342)
                      .+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++  |+||+++++++...+.+|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            459999999999999999999865 89999999976433 3445678899999999997  5999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||| +.+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.........
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            999 55889999999888899999999999999999999999999999999999995 6899999999998654332222


Q ss_pred             ceecccCCcccCChhhhccC----------CCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC--CCCCC
Q 019360          172 LLHTTCGTPNYVAPEVINNK----------GYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKAD--FKSPP  238 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~--~~~~~  238 (342)
                      .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|+.||.... .......+....  ...+.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence            33456799999999998752          234589999999999999999999998753 334444555433  34456


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ..+.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            67889999999999999999999999999999986543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-51  Score=377.73  Aligned_cols=263  Identities=31%  Similarity=0.568  Sum_probs=223.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      ....++|++.+.||+|+||.||+|++.   .+++.||+|++.+.... .....+.+.+|+.+++.+ .|+||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            344579999999999999999999984   58899999998653321 112223566899999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ..+.+|+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998753


Q ss_pred             ccccCCCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCC----cHHHHHHHHHhcCCCCCCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEES----NLMALYKKIFKADFKSPPW  239 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~  239 (342)
                      .... .......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...    ....+...+.......+..
T Consensus       210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            3211 12234567999999999998532 2358899999999999999999999643    4455666677777777888


Q ss_pred             CCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          240 FSTSAKKLISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ++..+.+||.+||+.||++||     +++|+++||||+.
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            999999999999999999999     9999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-51  Score=362.40  Aligned_cols=257  Identities=20%  Similarity=0.308  Sum_probs=215.6

Q ss_pred             CCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360            8 ASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus         8 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      +.....++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+..+..+ +||||+++++++...
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A            5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAED   83 (289)
T ss_dssp             CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred             ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            3445568899999999999999999999999999999999754332 23345778899999988 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC------------
Q 019360           87 TKIYIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN------------  150 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~------------  150 (342)
                      +..++||||+++++|.+++...    ..+++.+++.++.|++.||.|||++||+||||||+||+++.+            
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            9999999999999999999764    679999999999999999999999999999999999999844            


Q ss_pred             -------CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH
Q 019360          151 -------GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM  223 (342)
Q Consensus       151 -------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~  223 (342)
                             ..+||+|||.+.....      .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+..... 
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred             ccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence                   4799999999875332      12345899999999998764555799999999999999999988766543 


Q ss_pred             HHHHHHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          224 ALYKKIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       224 ~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                        ...+..... ..+..+++++.+||.+||+.||++|||++++++||||.+.
T Consensus       237 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 --WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             --HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             --HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence              233333333 3456789999999999999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.3e-51  Score=381.83  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=213.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC------CCCcceeEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI------RHPNVIRMYEVM   83 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~l~~~~   83 (342)
                      .....+|++++.||+|+||+||+|.+..+++.||||++....    ...+.+.+|+++++.+      +|+||+++++++
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            345678999999999999999999999999999999997543    2234566788877766      577999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--eeEcccc
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV--LKVSDFG  159 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~--~kl~Dfg  159 (342)
                      .....+++||||+. ++|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999999995 58999888653  4899999999999999999999999999999999999999887  9999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---  236 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---  236 (342)
                      ++....     ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+......+   
T Consensus       248 ~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          248 SSCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             TCEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            986432     22345678999999999988776 489999999999999999999999988777666554321000   


Q ss_pred             --------------------------------------------------------CCCCCHHHHHHHHHhcCCCCCCCC
Q 019360          237 --------------------------------------------------------PPWFSTSAKKLISRILDPNPVTRI  260 (342)
Q Consensus       237 --------------------------------------------------------~~~~~~~~~~li~~~L~~dP~~Rp  260 (342)
                                                                              ....++++.+||.+||+.||++||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                                                                    012367899999999999999999


Q ss_pred             CHHHHhcCcccccCCC
Q 019360          261 TMAEVIENEWFKKGYK  276 (342)
Q Consensus       261 s~~e~l~h~~~~~~~~  276 (342)
                      |++|+|+||||++...
T Consensus       402 ta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          402 TPGQALRHPWLRRRLP  417 (429)
T ss_dssp             CHHHHHTSTTTC----
T ss_pred             CHHHHhCChhhccCCC
Confidence            9999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.3e-51  Score=369.47  Aligned_cols=258  Identities=30%  Similarity=0.518  Sum_probs=220.5

Q ss_pred             ecCeeee-eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEE
Q 019360           13 VGKYELG-RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        13 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~   90 (342)
                      .++|.+. +.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++...+..|
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            3568887 8999999999999999999999999999764332 233457889999999995 699999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcccccccCCc
Q 019360           91 IVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQ  165 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg~~~~~~  165 (342)
                      +||||+++++|.+++...  ..+++.+++.++.|++.||+|||++||+||||||+||+++.   ++.+||+|||+++...
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999988653  67999999999999999999999999999999999999987   7899999999997543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFS  241 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (342)
                      .   ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+    ..++
T Consensus       186 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  261 (327)
T 3lm5_A          186 H---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS  261 (327)
T ss_dssp             -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             C---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence            2   222344679999999999987666 4899999999999999999999999888888777766554432    3578


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +.+.+||.+||+.||++|||++++|+||||+...
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            9999999999999999999999999999998643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-51  Score=367.87  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHH-hcCCCCcceeEEEEEEeCCeEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ++|++.++||+|+||+||+|.++.+|+.||||++......... ......|+..+ +..+|+||+++++++...+.+|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            6799999999999999999999999999999998654332222 23444555555 444899999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+ +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....   ..
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence            9999 66888887764 5699999999999999999999999999999999999999999999999999875432   22


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC--CCCCCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK--SPPWFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~  249 (342)
                      ......||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+...   ...+.....+  .+..+++++.+||.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHH
Confidence            2344568999999999876 44 5899999999999999999777655432   2233322222  23458899999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccccc
Q 019360          250 RILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +||+.||++|||++|+|+||||++
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2e-51  Score=385.31  Aligned_cols=259  Identities=36%  Similarity=0.654  Sum_probs=208.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh-----hhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+....     .......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3457899999999999999999999999999999999764322     1122235789999999999999999999985 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CeeEccccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVSDFGLSA  162 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~---~~kl~Dfg~~~  162 (342)
                      .+..|+||||+++++|.+++.....+++.+++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            456899999999999999998888899999999999999999999999999999999999997544   59999999998


Q ss_pred             CCccccCCCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcCCCCC--
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKSP--  237 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~--  237 (342)
                      ....   .......+||+.|+|||++.+  ....+.++|||||||++|+|++|..||...... .....+........  
T Consensus       291 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~  367 (419)
T 3i6u_A          291 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  367 (419)
T ss_dssp             SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred             ecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence            6432   233345689999999999863  223357999999999999999999999765332 33344444444332  


Q ss_pred             --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          238 --PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       238 --~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                        ..+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence              357899999999999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-51  Score=375.01  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=219.4

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            3445678999999999999999999999999999999997542  23445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .|+||||+++++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999999999999888899999999999999999999996 9999999999999999999999999998643221


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH-------------------
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK-------------------  228 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~-------------------  228 (342)
                          ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......                   
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ----cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                2234578999999999987765 4899999999999999999999987665443221                   


Q ss_pred             -----------------------HHhcCCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          229 -----------------------IFKADFKS--PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       229 -----------------------i~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                             +.......  ...++.++.+||.+||+.||++|||++|+|+||||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                                   12221111  2347889999999999999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.8e-51  Score=372.00  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=208.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT----   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----   87 (342)
                      -.++|++++.||+|+||.||+|+++.+|+.||+|++....  .....+.+.+|+.+|++++||||+++++++....    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4578999999999999999999999999999999997533  2334567899999999999999999999986543    


Q ss_pred             -----------------------------------------------------eEEEEEeccCCCchHHHHHhcCC---C
Q 019360           88 -----------------------------------------------------KIYIVLEFVTGGELFDKIASRGR---L  111 (342)
Q Consensus        88 -----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---l  111 (342)
                                                                           ..++||||+++++|.+++.....   .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 38999999999999999987543   5


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC----------CCceecccCCcc
Q 019360          112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD----------DGLLHTTCGTPN  181 (342)
Q Consensus       112 ~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~gt~~  181 (342)
                      ++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......          ........||+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            6667899999999999999999999999999999999999999999999875433211          112234579999


Q ss_pred             cCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-CCCCCHHHHHHHHHhcCCCCCCCC
Q 019360          182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PPWFSTSAKKLISRILDPNPVTRI  260 (342)
Q Consensus       182 y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rp  260 (342)
                      |+|||++.+..+ +.++|||||||++|+|++|..|+..  .......+.....+. ....++++.+||.+||+.||++||
T Consensus       242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            999999988766 4899999999999999998777532  122223333322221 123567889999999999999999


Q ss_pred             CHHHHhcCccccc
Q 019360          261 TMAEVIENEWFKK  273 (342)
Q Consensus       261 s~~e~l~h~~~~~  273 (342)
                      |++|+++||||++
T Consensus       319 s~~~~l~~~~f~~  331 (332)
T 3qd2_B          319 EATDIIENAIFEN  331 (332)
T ss_dssp             CHHHHHHSTTCCC
T ss_pred             CHHHHhhchhhhc
Confidence            9999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.9e-51  Score=378.36  Aligned_cols=260  Identities=31%  Similarity=0.447  Sum_probs=211.9

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      +........+|++.+.||+|+||+||+|.+..+++ +|+|++......       ..+|+.+++.++|+||+++++++..
T Consensus        32 ~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~  103 (394)
T 4e7w_A           32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYS  103 (394)
T ss_dssp             SSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEe
Confidence            34456667889999999999999999999987665 888887543321       2379999999999999999999854


Q ss_pred             CC------eEEEEEeccCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCeeE
Q 019360           86 KT------KIYIVLEFVTGGELFDKI---ASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLKV  155 (342)
Q Consensus        86 ~~------~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~-~~~~~kl  155 (342)
                      .+      .+++||||++++.+....   .....+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||
T Consensus       104 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             ESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             cCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence            33      388999999774333222   2356799999999999999999999999999999999999998 7999999


Q ss_pred             cccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC
Q 019360          156 SDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK  235 (342)
Q Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  235 (342)
                      +|||+++....   ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.+....
T Consensus       184 ~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  260 (394)
T 4e7w_A          184 IDFGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT  260 (394)
T ss_dssp             CCCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eeCCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999975422   222345678999999999987654568999999999999999999999998877766665542100


Q ss_pred             -----------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          236 -----------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       236 -----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                                   .++.+++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                                         12347889999999999999999999999999999986443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-50  Score=372.54  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=215.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE-
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI-   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-   89 (342)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            34578999999999999999999999999999999997543 3344557888999999999999999999999876654 


Q ss_pred             -----EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           90 -----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        90 -----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                           |+||||+. ++|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             cceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                 99999996 58877764  34899999999999999999999999999999999999999999999999999753


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--------  236 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  236 (342)
                      ..     ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+        
T Consensus       195 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          195 DA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            32     23446789999999999874445689999999999999999999999988777666654321110        


Q ss_pred             -----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 -----------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                             .+.+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                                   2346899999999999999999999999999999986443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-52  Score=387.16  Aligned_cols=249  Identities=16%  Similarity=0.220  Sum_probs=204.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHH---HHhcCCCCcceeEE-------EE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS---TMKLIRHPNVIRMY-------EV   82 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~l~-------~~   82 (342)
                      .++|++.+.||+|+||+||+|.++.+|+.||||++...........+.+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            578999999999999999999999999999999997654444555678899995   55556799999988       77


Q ss_pred             EEeCC-----------------eEEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceee
Q 019360           83 MASKT-----------------KIYIVLEFVTGGELFDKIASRGRLKE-------DEARKYFQQLINAVDYCHSRGVCHR  138 (342)
Q Consensus        83 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~~l~~~L~~LH~~giiH~  138 (342)
                      +...+                 ..|+||||+ +|+|.+++...+.+++       ..+..++.|++.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            76554                 289999999 6799999987555555       7888899999999999999999999


Q ss_pred             cCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccC-----------CCCCcccchhhhhHHH
Q 019360          139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-----------GYDGAKADLWSCGVIL  207 (342)
Q Consensus       139 dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~ll  207 (342)
                      ||||+|||++.++.+||+|||+++...     ......+| +.|+|||++.+.           .+ +.++|||||||++
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il  303 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI  303 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence            999999999999999999999997422     23445677 999999999876           45 5899999999999


Q ss_pred             HHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          208 YVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       208 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      |+|++|+.||.+.+.......+.    .....+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999997765443333222    334668999999999999999999999999999999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.7e-51  Score=375.08  Aligned_cols=259  Identities=26%  Similarity=0.536  Sum_probs=224.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh--------------HHHHHHHHHHHHhcCCCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK--------------MIGQIKREISTMKLIRHP   74 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~   74 (342)
                      .....++|++.+.||+|+||.||+|.+  +|+.||+|++.........              ..+.+.+|+.+++.++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            345578999999999999999999999  8999999999765433221              116788999999999999


Q ss_pred             cceeEEEEEEeCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcE
Q 019360           75 NVIRMYEVMASKTKIYIVLEFVTGGELFDK------IAS--RGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENL  145 (342)
Q Consensus        75 ~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NI  145 (342)
                      ||+++++++...+..|+||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999988      665  5679999999999999999999999 9999999999999


Q ss_pred             EecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCCCCCcH-H
Q 019360          146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPFEESNL-M  223 (342)
Q Consensus       146 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~  223 (342)
                      +++.++.+||+|||.+.....    .......|++.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. .
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999875322    134456789999999999876 4433389999999999999999999988776 6


Q ss_pred             HHHHHHHhcCCCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          224 ALYKKIFKADFKSP-------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       224 ~~~~~i~~~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +....+.......+                   ..+++++.+||.+||+.||.+|||++|+++||||++
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            77777776655555                   568999999999999999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-50  Score=364.79  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=214.9

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      +.......++|++.+.||+|+||+||+|.+  +|+.||+|++..... .....+.+.+|+.++++++||||+++++++..
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            334455678999999999999999999987  588999999975433 33445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCeeEccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      .+..++||||+++++|.+++.....   +++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999999987553   999999999999999999999999  99999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHh--cCCCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK--ADFKSPP  238 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~  238 (342)
                      ++.....  ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..  .....+.
T Consensus       186 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T 3p86_A          186 SRLKAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR  262 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred             Ccccccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence            8753321  122345678999999999987766 4899999999999999999999999888777766643  3445567


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhc--Cccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIE--NEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~--h~~~~~  273 (342)
                      .+++++.+||.+||+.||.+|||++++++  ++++..
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            79999999999999999999999999997  455544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-50  Score=361.38  Aligned_cols=260  Identities=36%  Similarity=0.650  Sum_probs=226.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .++..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|++++++++||||+++++++...+.
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            345667999999999999999999999999999999999754332 2345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC---CCeeEcccccccCCc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN---GVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~---~~~kl~Dfg~~~~~~  165 (342)
                      .|+||||+++++|.+.+.....+++.+++.++.|++.||.|||++|++||||||+||+++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999654   479999999987543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFS  241 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (342)
                      .   ........|++.|+|||.+.+. + +.++||||||+++|+|++|..||.+.+.......+.......+    ..++
T Consensus       176 ~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 2wei_A          176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS  250 (287)
T ss_dssp             C---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred             C---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence            2   2222345688999999998764 3 5899999999999999999999999888888888777655433    4588


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +++.+||.+||+.||++|||++++++||||++.
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.4e-51  Score=360.80  Aligned_cols=260  Identities=32%  Similarity=0.572  Sum_probs=224.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE--eCCe
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA--SKTK   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~   88 (342)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.  ....
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            357899999999999999999999999999999999976433 2344568899999999999999999999874  4678


Q ss_pred             EEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCcEEecCCCCeeEcccc
Q 019360           89 IYIVLEFVTGGELFDKIASR----GRLKEDEARKYFQQLINAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~L~~LH~~g-----iiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      .|+||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|     |+||||||+||+++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999998753    34999999999999999999999999     9999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-CCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-KSPP  238 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~  238 (342)
                      .+.....  .........|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..... ..+.
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          162 LARILNH--DTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             hheeecc--ccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            9874322  1112234578999999999987665 4899999999999999999999999888888877777665 3455


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .++.++.++|.+||+.||++|||++|+++|+|+...
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            789999999999999999999999999999999764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-50  Score=378.09  Aligned_cols=255  Identities=30%  Similarity=0.450  Sum_probs=209.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC----
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK----   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----   86 (342)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++.....       ...+|+++|+.++|+||+++++++...    
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            344579999999999999999999999999999999865322       223799999999999999999988532    


Q ss_pred             --CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCeeEcccc
Q 019360           87 --TKIYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFG  159 (342)
Q Consensus        87 --~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~-~~~kl~Dfg  159 (342)
                        ..+++||||+++ +|...+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence              236799999976 6665554    35679999999999999999999999999999999999999865 578999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhc-------
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA-------  232 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~-------  232 (342)
                      +++....   ........||+.|+|||++.+....+.++|||||||++|||++|+.||.+.+..+....+.+.       
T Consensus       203 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          203 SAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             TCEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             hhhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9975332   222345678999999999977544568999999999999999999999998877666655431       


Q ss_pred             ----------CCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          233 ----------DFK------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       233 ----------~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                .+.            .++.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                      111            12346889999999999999999999999999999986543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-50  Score=359.18  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=203.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++...+..
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            3456899999999999999999999999999999999975432 223334555666668889999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           90 YIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999975 87776643    56799999999999999999999998 9999999999999999999999999998754


Q ss_pred             ccccCCCceecccCCcccCChhhhc---cCCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHhcCC-CC-CC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADF-KS-PP  238 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~~-~~-~~  238 (342)
                      ..   ........||+.|+|||++.   .....+.++|||||||++|+|++|+.||.. ............... .. ..
T Consensus       161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            32   22223457899999999973   223345899999999999999999999985 333333344333332 22 34


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            58999999999999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.6e-50  Score=365.81  Aligned_cols=265  Identities=30%  Similarity=0.441  Sum_probs=218.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--   86 (342)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++|+||+++++++...  
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            3445689999999999999999999999999999999996432  233455778999999999999999999988654  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           87 ---TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                         ...|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence               67999999996 589988876 5699999999999999999999999999999999999999999999999999875


Q ss_pred             CccccCC--------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC
Q 019360          164 PQQVRDD--------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK  235 (342)
Q Consensus       164 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  235 (342)
                      .......        .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            4321111        11233578999999999876444568999999999999999999999988766655444321000


Q ss_pred             --------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          236 --------------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       236 --------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                                      ..+.+++++.+||.+||+.||++|||++|+++||||+....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence                                            013578999999999999999999999999999999875543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-50  Score=366.92  Aligned_cols=261  Identities=36%  Similarity=0.652  Sum_probs=213.7

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh-----hhhHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMKLIRHPNVIRMYEVM   83 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~   83 (342)
                      +....++|++.+.||+|+||.||+|.+..+++.||+|++......     .......+.+|+.+++.++||||+++++++
T Consensus         5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            345567899999999999999999999999999999999754321     122234578999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---eeEccccc
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV---LKVSDFGL  160 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~---~kl~Dfg~  160 (342)
                      .... .|+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7655 8999999999999999988888999999999999999999999999999999999999987654   99999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcCCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKSP  237 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~  237 (342)
                      +.....   ........||+.|+|||++..  ....+.++|||||||++|+|++|..||...... .....+........
T Consensus       164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             ceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            875322   222344578999999999752  233358999999999999999999999765432 23333444433332


Q ss_pred             ----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          238 ----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       238 ----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                          ..++.++.+||.+||+.||++|||++++++||||+.
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence                457899999999999999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.7e-50  Score=370.52  Aligned_cols=264  Identities=23%  Similarity=0.373  Sum_probs=211.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh--------hhhhHHHHHHHHHHHHhcCCCCcceeEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV--------LKHKMIGQIKREISTMKLIRHPNVIRMYEV   82 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~   82 (342)
                      ...++|++.+.||+|+||.||+|.+.. |+.||+|++.....        ......+.+.+|++++++++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345789999999999999999999865 99999999864321        223345788999999999999999999999


Q ss_pred             EEe-----CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEc
Q 019360           83 MAS-----KTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        83 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~  156 (342)
                      +..     ...+|+||||++ ++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            843     346899999997 5888877654 469999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-  235 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-  235 (342)
                      |||++.....   ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...... 
T Consensus       177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999974322   222345678999999999987444568999999999999999999999998877766665431110 


Q ss_pred             -------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCC
Q 019360          236 -------------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS  279 (342)
Q Consensus       236 -------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~~  279 (342)
                                                     ..+.+++.+.+||.+||+.||++|||++|+|+||||+..+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence                                           12346888999999999999999999999999999998665543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.5e-51  Score=373.81  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=206.2

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++.......    ....++++.++.++||||+++++++...+.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            4466789999999999999999999999999999999986543222    245577888888999999999999865333


Q ss_pred             -------EEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCcEEecC-CCCee
Q 019360           89 -------IYIVLEFVTGGELFDKI----ASRGRLKEDEARKYFQQLINAVDYCH--SRGVCHRDLKPENLLLDA-NGVLK  154 (342)
Q Consensus        89 -------~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~~l~~~L~~LH--~~giiH~dlkp~NIli~~-~~~~k  154 (342)
                             +++||||+++ +|...+    .....+++..+..++.|++.||.|||  ++||+||||||+|||++. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                   8899999977 444433    34567899999999999999999999  999999999999999986 89999


Q ss_pred             EcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC
Q 019360          155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF  234 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~  234 (342)
                      |+|||++.....   ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       173 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            999999985432   22234567899999999997766556899999999999999999999999887777766654211


Q ss_pred             C--------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCC
Q 019360          235 K--------------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPS  279 (342)
Q Consensus       235 ~--------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~~  279 (342)
                      .                                .....++++.+||.+||+.||.+|||+.|+|+||||++...+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            1                                11225678999999999999999999999999999998665543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-50  Score=364.60  Aligned_cols=254  Identities=26%  Similarity=0.456  Sum_probs=211.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEe--
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMAS--   85 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~--   85 (342)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++....      .+.+.+|+.+++.++ |+||+++++++..  
T Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            3455689999999999999999999999999999999986432      246789999999997 9999999999987  


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALP  164 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~  164 (342)
                      ....++||||+++++|.+++..   +++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            6678999999999999988764   89999999999999999999999999999999999999776 8999999999753


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC-cHHHHHHHHH-------------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES-NLMALYKKIF-------------  230 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~-~~~~~~~~i~-------------  230 (342)
                      ..   ........|++.|+|||++.+....+.++|||||||++|+|++|+.||... +..+....+.             
T Consensus       182 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CC---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            32   222345678999999999987555568999999999999999999999432 2222222111             


Q ss_pred             hcCCCC------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          231 KADFKS------------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       231 ~~~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ......                        ...+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            111111                        12278999999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.8e-50  Score=359.46  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=225.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++|+||+++++++......|
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            344679999999999999999999999999999999975432  233567899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999999998875 569999999999999999999999999999999999999999999999999987543211  


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLIS  249 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~  249 (342)
                      .......|++.|+|||++.+..+. .++||||||+++|+|++|..||...........+..... ..+..++..+.+||.
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence            122445789999999999877664 899999999999999999999998887777666655443 334568999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +||+.||++|||++++++||||....
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-50  Score=362.25  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=213.0

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE-----
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA-----   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----   84 (342)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            455689999999999999999999999999999999986432   344567889999999999999999999873     


Q ss_pred             ---------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCee
Q 019360           85 ---------SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLK  154 (342)
Q Consensus        85 ---------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~-~~~~~k  154 (342)
                               .....|+||||++ ++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+++ .++.+|
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     3467899999997 599998865 5689999999999999999999999999999999999997 567999


Q ss_pred             EcccccccCCcccc-CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC
Q 019360          155 VSDFGLSALPQQVR-DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD  233 (342)
Q Consensus       155 l~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~  233 (342)
                      |+|||+++...... .........+|+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998543211 12223445679999999998764445689999999999999999999999888777666655432


Q ss_pred             CC------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          234 FK------------------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       234 ~~------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ..                              ..+.++.++.+||.+||+.||++|||++|+|+||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            11                              12357899999999999999999999999999999986443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-50  Score=362.10  Aligned_cols=258  Identities=29%  Similarity=0.469  Sum_probs=217.3

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            44578999999999999999999999999999999986532   233467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||+++++|..++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999999999998875 4669999999999999999999999999999999999999999999999999875321111 


Q ss_pred             CCceecccCCcccCChhhhc----cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC---CCCCCCH
Q 019360          170 DGLLHTTCGTPNYVAPEVIN----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK---SPPWFST  242 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~  242 (342)
                       .......||+.|+|||.+.    .....+.++|||||||++|+|++|..||...+.......+.....+   .+..++.
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence             1123456899999999984    2233358999999999999999999999998887777776665443   2445789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++.+||.+||+.||++|||++++++||||+.
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence            9999999999999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=365.65  Aligned_cols=256  Identities=24%  Similarity=0.429  Sum_probs=211.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--   87 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--   87 (342)
                      ....++|++.+.||+|+||+||+|.+..+|+.||+|++......  ...+.+.+|++++++++||||+++++++....  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            34567899999999999999999999999999999999754332  22456789999999999999999999997655  


Q ss_pred             eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCeeEccccc
Q 019360           88 KIYIVLEFVTGGELFDKIASRGR---LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGL  160 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli----~~~~~~kl~Dfg~  160 (342)
                      ..++||||+++++|.+++.....   +++.+++.++.|++.||+|||++||+||||||+||++    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999986433   9999999999999999999999999999999999999    7778899999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhcc-------CCCCCcccchhhhhHHHHHHHhCCCCCCC----CcHHHHHHHH
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINN-------KGYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKI  229 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~ll~~l~~g~~pf~~----~~~~~~~~~i  229 (342)
                      ++....   ........||+.|+|||++..       ....+.++|||||||++|+|++|+.||..    ....+....+
T Consensus       163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            975432   223345679999999999862       22335899999999999999999999963    2334455555


Q ss_pred             HhcCCC---------------------CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          230 FKADFK---------------------SP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       230 ~~~~~~---------------------~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      ......                     ..    ..++..+.+||.+||+.||++|||++|+|+||-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            543321                     11    123457889999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=377.38  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=196.7

Q ss_pred             eeecCeee-eeeecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--
Q 019360           11 TRVGKYEL-GRTLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--   85 (342)
Q Consensus        11 ~~~~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--   85 (342)
                      ...+.|++ .++||+|+||+||+|.++  .+++.||+|++......     ..+.+|+.+|+.++||||+++++++..  
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            33456887 458999999999999976  56889999999654322     356789999999999999999999954  


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR---------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL----DANGV  152 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli----~~~~~  152 (342)
                      ...+|+||||+.+ +|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            6789999999964 888777532         248999999999999999999999999999999999999    67789


Q ss_pred             eeEcccccccCCcccc-CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH---------
Q 019360          153 LKVSDFGLSALPQQVR-DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL---------  222 (342)
Q Consensus       153 ~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~---------  222 (342)
                      +||+|||+++...... ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+...         
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            9999999998643321 112334567899999999998765556899999999999999999999976543         


Q ss_pred             HHHHHHHHhcCC-CC-------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 019360          223 MALYKKIFKADF-KS-------------------------------------PPWFSTSAKKLISRILDPNPVTRITMAE  264 (342)
Q Consensus       223 ~~~~~~i~~~~~-~~-------------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e  264 (342)
                      .+....+..... +.                                     ....++.+.+||.+||+.||++|||++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            123333322111 00                                     0112678999999999999999999999


Q ss_pred             HhcCcccccCCCCC
Q 019360          265 VIENEWFKKGYKPP  278 (342)
Q Consensus       265 ~l~h~~~~~~~~~~  278 (342)
                      +|+||||.+...+.
T Consensus       331 ~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          331 AMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHTSGGGTSSSCCC
T ss_pred             HhcChhhccCCCCc
Confidence            99999998765543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=358.89  Aligned_cols=258  Identities=29%  Similarity=0.483  Sum_probs=215.7

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++....     ..+.+.+|+.+++.++|+||+++++++...+.
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            3445678999999999999999999999999999999996532     13467899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .|+||||+++++|.+++. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+......
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999999987 3567999999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---CCCCCCCHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---KSPPWFSTSA  244 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~  244 (342)
                        ........|++.|+|||.+.+..+. .++||||||+++|+|++|..||...+.......+.....   ..+..++..+
T Consensus       179 --~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  255 (314)
T 3com_A          179 --MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF  255 (314)
T ss_dssp             --BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             --ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence              1123345789999999999877664 889999999999999999999998777665555544322   2244578999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .+||.+||+.||++|||++++++||||+..
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            999999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.9e-50  Score=364.60  Aligned_cols=263  Identities=22%  Similarity=0.376  Sum_probs=201.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...++|++.+.||+|+||.||+|.+..+++   .||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            345689999999999999999999887765   899999975432 2344578899999999999999999999998766


Q ss_pred             eE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeE
Q 019360           88 KI------YIVLEFVTGGELFDKIASRG------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV  155 (342)
Q Consensus        88 ~~------~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl  155 (342)
                      ..      ++||||+++++|.+++....      .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            54      99999999999999986532      5899999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-
Q 019360          156 SDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-  233 (342)
Q Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-  233 (342)
                      +|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... 
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            99999975433222222334456788999999988766 489999999999999999 999999888777777776554 


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCcccccCC
Q 019360          234 FKSPPWFSTSAKKLISRILDPNPVTRIT-------MAEVIENEWFKKGY  275 (342)
Q Consensus       234 ~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~e~l~h~~~~~~~  275 (342)
                      ...++.+++++.+||.+||+.||++|||       +++++.|||+....
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            4556678999999999999999999999       78888999997643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.7e-50  Score=370.14  Aligned_cols=254  Identities=24%  Similarity=0.461  Sum_probs=217.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNT-------ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVM   83 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~   83 (342)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4578999999999999999999874       345679999997542  344566889999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL  147 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli  147 (342)
                      ...+.+|+||||+++++|.+++....                .+++.++..++.|++.||.|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999998653                47899999999999999999999999999999999999


Q ss_pred             cCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHH
Q 019360          148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALY  226 (342)
Q Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~  226 (342)
                      +.++.+||+|||+++...............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999975433222222334457889999999987666 489999999999999999 99999988877777


Q ss_pred             HHHHhcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          227 KKIFKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       227 ~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+.... ...+..++.++.+||.+||+.||++|||+.|++++
T Consensus       316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7666554 34456789999999999999999999999999964

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.3e-51  Score=364.12  Aligned_cols=262  Identities=30%  Similarity=0.519  Sum_probs=198.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            446789999999999999999999999999999999865432  233457889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           91 IVLEFVTGGELFDKIAS--------RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      +||||+++++|.+++..        ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999999874        4568999999999999999999999999999999999999999999999999986


Q ss_pred             CCcccc---CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----
Q 019360          163 LPQQVR---DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----  235 (342)
Q Consensus       163 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----  235 (342)
                      ......   .........||+.|+|||++.+....+.++|||||||++|+|++|..||..................    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            433211   1112234578999999999876333358999999999999999999999887665555444433222    


Q ss_pred             ------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          236 ------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       236 ------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                            ....++.++.+||.+||+.||.+|||++++++||||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                  124578899999999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-49  Score=357.36  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=210.3

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .....+...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  104 (309)
T 2h34_A           25 AESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE  104 (309)
T ss_dssp             ---------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            34456778899999999999999999999999999999999997665555555678999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ..+..|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999999999999998888999999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC---CCCCCCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF---KSPPWFS  241 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~  241 (342)
                      .... ........|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+.......+.....   ..++.++
T Consensus       185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (309)
T 2h34_A          185 TDEK-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIP  262 (309)
T ss_dssp             -------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCC
T ss_pred             cccc-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCC
Confidence            3221 122234578999999999987665 4899999999999999999999998877655444433222   2245688


Q ss_pred             HHHHHHHHHhcCCCCCCCC-CHHHHhc
Q 019360          242 TSAKKLISRILDPNPVTRI-TMAEVIE  267 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rp-s~~e~l~  267 (342)
                      +++.++|.+||+.||++|| +++++++
T Consensus       263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          263 VAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             THHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999999 7777774

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=364.57  Aligned_cols=257  Identities=27%  Similarity=0.428  Sum_probs=214.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe--
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK--   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--   88 (342)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.  
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            44679999999999999999999999999999999997543 334455678899999999999999999999977653  


Q ss_pred             ----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           89 ----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        89 ----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                          .|+||||+. ++|.+++.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                599999996 58877764  34899999999999999999999999999999999999999999999999998753


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC-----------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD-----------  233 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~-----------  233 (342)
                      ..     ......+|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....           
T Consensus       177 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          177 DA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            32     12345789999999999874444689999999999999999999999888766665554310           


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          234 --------------------FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       234 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                          ....+.+++++.+||.+||+.||++|||++++++||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                                0112457899999999999999999999999999999986443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=359.61  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=215.0

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe--
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS--   85 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~--   85 (342)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++.....    ..+.+.+|+.+++++ +|+||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            34456789999999999999999999999999999999865322    224678999999998 79999999999976  


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           86 ----KTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        86 ----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                          .+..|+||||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence                46799999999999999999864  569999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK  235 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~  235 (342)
                      ++......  ........||+.|+|||++..    ....+.++|||||||++|+|++|..||...+.......+.....+
T Consensus       175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  252 (326)
T 2x7f_A          175 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP  252 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            98754321  112344578999999999862    222358899999999999999999999888777666665554332


Q ss_pred             C--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          236 S--PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       236 ~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      .  ...++..+.+||.+||+.||.+|||++++++||||++.
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            2  34578999999999999999999999999999999863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=371.99  Aligned_cols=258  Identities=21%  Similarity=0.317  Sum_probs=220.4

Q ss_pred             eecCeeeeeeecccCceEEEEEE-----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ..++|++++.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.++++++|+||+++++++...
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            35789999999999999999999     44577899999986432  233345788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CeeEc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR-------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG---VLKVS  156 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~---~~kl~  156 (342)
                      ...|+||||+++++|.+++...       ..+++.+++.++.|++.||+|||++||+||||||+|||++.++   .+||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999999864       3489999999999999999999999999999999999998555   59999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-C
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-F  234 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~  234 (342)
                      |||+++...............||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+.... .
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999744333333334456789999999999877664 89999999999999998 999999999888888777654 3


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      ..+..++..+.+|+.+||+.||++|||++++++|.++.
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            44567899999999999999999999999999998864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-50  Score=365.91  Aligned_cols=257  Identities=32%  Similarity=0.531  Sum_probs=220.3

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcCC--CCcceeEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLIR--HPNVIRMYEVM   83 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~l~~~~   83 (342)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34456789999999999999999999999999999999976433211   11234568999999996  59999999999


Q ss_pred             EeCCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCeeEcccccc
Q 019360           84 ASKTKIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLKVSDFGLS  161 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~-~~~~~kl~Dfg~~  161 (342)
                      ...+..++|||++.+ ++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+|||++
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999999999976 89999999888899999999999999999999999999999999999998 7889999999998


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCC
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFS  241 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  241 (342)
                      .....    .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....      .+.......+..++
T Consensus       198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~  267 (320)
T 3a99_A          198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS  267 (320)
T ss_dssp             EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred             ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence            75432    223345789999999999877776688999999999999999999997643      23445556667799


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +++.+||.+||+.||++|||++++++||||++..
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            9999999999999999999999999999998643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-49  Score=361.91  Aligned_cols=254  Identities=29%  Similarity=0.450  Sum_probs=212.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEE-cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC------cceeEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARN-TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP------NVIRMYE   81 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~l~~   81 (342)
                      .....++|++.+.||+|+||.||+|.+ ..+++.||+|++....    ...+.+.+|+.+++.++|+      +++++++
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            344557999999999999999999998 5678999999996432    2345678899999888655      5999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC----------
Q 019360           82 VMASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA----------  149 (342)
Q Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~----------  149 (342)
                      ++...+..++||||+ +++|.+++...+  .+++..+..++.|++.||+|||++||+||||||+||+++.          
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999999 889999998765  6899999999999999999999999999999999999987          


Q ss_pred             ---------CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          150 ---------NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       150 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                               ++.+||+|||+++....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                     66899999999875322     2234578999999999987766 48999999999999999999999987


Q ss_pred             cHHHHHHHHHhcCCCC--------------------------------------------CCCCCHHHHHHHHHhcCCCC
Q 019360          221 NLMALYKKIFKADFKS--------------------------------------------PPWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       221 ~~~~~~~~i~~~~~~~--------------------------------------------~~~~~~~~~~li~~~L~~dP  256 (342)
                      +..+....+.....+.                                            ....++++.+||.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            7666554443221111                                            11124678999999999999


Q ss_pred             CCCCCHHHHhcCccccc
Q 019360          257 VTRITMAEVIENEWFKK  273 (342)
Q Consensus       257 ~~Rps~~e~l~h~~~~~  273 (342)
                      ++|||++|+++||||+.
T Consensus       318 ~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          318 AKRITLREALKHPFFDL  334 (339)
T ss_dssp             TTSCCHHHHTTSGGGGG
T ss_pred             ccccCHHHHhcCHHHHH
Confidence            99999999999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=359.39  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=217.4

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ....++|++.+.||+|+||.||+|.+..+++   .||+|++....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4456789999999999999999999986655   49999997532  234456789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      +..|+||||+++++|.+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999764 579999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCC-ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCH
Q 019360          166 QVRDDG-LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFST  242 (342)
Q Consensus       166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (342)
                      ...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+... ..+.+..+++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH  281 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence            322111 12233457789999999876664 89999999999999999 99999998888888777665 3445667899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++.+||.+||+.||++|||+.++++
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-50  Score=372.89  Aligned_cols=254  Identities=19%  Similarity=0.210  Sum_probs=194.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC--CCCcceeEE-------EEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI--RHPNVIRMY-------EVM   83 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~-------~~~   83 (342)
                      ...|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            44599999999999999999999999999999999876544455566788885544444  699988755       555


Q ss_pred             EeC-----------------CeEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceeec
Q 019360           84 ASK-----------------TKIYIVLEFVTGGELFDKIASR-GRLKEDEA------RKYFQQLINAVDYCHSRGVCHRD  139 (342)
Q Consensus        84 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~~l~~~L~~LH~~giiH~d  139 (342)
                      ...                 ..+|+||||++ ++|.+++... ..+++..+      ..++.|++.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 33899999998 7999999864 33454455      67779999999999999999999


Q ss_pred             CCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCC
Q 019360          140 LKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPF  217 (342)
Q Consensus       140 lkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf  217 (342)
                      |||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999974322     2224567799999999976  444 58999999999999999999999


Q ss_pred             CCCcHHHH--HHH-----HH--hcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          218 EESNLMAL--YKK-----IF--KADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       218 ~~~~~~~~--~~~-----i~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+......  +..     ..  ...++....+++.+.+||.+||+.||++|||++++|+||||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            87643210  000     00  1112223468999999999999999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.7e-49  Score=356.92  Aligned_cols=259  Identities=29%  Similarity=0.428  Sum_probs=214.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc-CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC---CCCcceeEEEEEE--
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT-ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI---RHPNVIRMYEVMA--   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~--   84 (342)
                      ...++|++.+.||+|+||.||+|.+. .+|+.||+|++...... ......+.+|+.+++.+   +||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34578999999999999999999995 67899999998653321 11112455677777665   8999999999987  


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           85 ---SKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        85 ---~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                         .....++||||++ ++|.+++....  .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence               4567899999997 59999998753  48999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC-----
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-----  234 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~-----  234 (342)
                      ++......   .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.....     
T Consensus       166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            98754321   12344678999999999987665 4899999999999999999999999887777766653210     


Q ss_pred             ----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          235 ----------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       235 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                            .....++..+.+||.+||+.||++|||++++++||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                                  11245788999999999999999999999999999998643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.5e-49  Score=353.52  Aligned_cols=255  Identities=29%  Similarity=0.511  Sum_probs=206.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe------
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS------   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------   85 (342)
                      -.++|++.+.||+|+||.||+|.+..+|+.||+|++...    ....+.+.+|+.+++.++||||+++++++..      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            357899999999999999999999999999999999643    2334678899999999999999999998854      


Q ss_pred             -------CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcc
Q 019360           86 -------KTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSD  157 (342)
Q Consensus        86 -------~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~D  157 (342)
                             .+..|+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   35689999999999999999864 3578899999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccc------------CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHH
Q 019360          158 FGLSALPQQVR------------DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMA  224 (342)
Q Consensus       158 fg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~  224 (342)
                      ||++.......            .........||+.|+|||++.+....+.++|||||||++|+|++   ||.. .+...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            99987543211            01223445789999999999865445689999999999999998   5543 33444


Q ss_pred             HHHHHHhcCCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          225 LYKKIFKADFKSP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       225 ~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ....+.......+    ...+..+.+||.+||+.||++|||++++++||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            4555544443333    345677999999999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-49  Score=364.72  Aligned_cols=256  Identities=24%  Similarity=0.450  Sum_probs=221.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcC-------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTE-------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEV   82 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~   82 (342)
                      ...++|++.+.||+|+||.||+|.+..       .+..||+|++....  .....+.+.+|+++++.+ +||||++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            445789999999999999999999753       33579999997542  344456888999999999 89999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019360           83 MASKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLL  146 (342)
Q Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIl  146 (342)
                      +...+..++||||+++++|.+++....                .+++.+++.++.|++.||.|||++||+||||||+|||
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            999999999999999999999998753                4899999999999999999999999999999999999


Q ss_pred             ecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHH
Q 019360          147 LDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMAL  225 (342)
Q Consensus       147 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~  225 (342)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+.
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999986543332233344567889999999987665 489999999999999999 9999999988888


Q ss_pred             HHHHHhcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          226 YKKIFKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       226 ~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      ...+.... ...+..+++++.+||.+||+.||++|||+++++++-
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            77776653 345667899999999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8e-50  Score=366.82  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=213.0

Q ss_pred             eecCeeeeeeecccCceEEEEEE-----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~   85 (342)
                      ..++|++.+.||+|+||.||+|.     +..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            45789999999999999999999     55677899999997542  233356789999999999 68999999999987


Q ss_pred             CC-eEEEEEeccCCCchHHHHHhcCC------------------------------------------------------
Q 019360           86 KT-KIYIVLEFVTGGELFDKIASRGR------------------------------------------------------  110 (342)
Q Consensus        86 ~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  110 (342)
                      .+ .+++||||+++++|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 48999999999999999986533                                                      


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecccC
Q 019360          111 ------------LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG  178 (342)
Q Consensus       111 ------------l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  178 (342)
                                  +++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............|
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                        89999999999999999999999999999999999999999999999999985433322233345567


Q ss_pred             CcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc--CCCCCCCCCHHHHHHHHHhcCCC
Q 019360          179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA--DFKSPPWFSTSAKKLISRILDPN  255 (342)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~d  255 (342)
                      |+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.............  ....+..+++++.+++.+||+.|
T Consensus       258 t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             CGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            8999999999877664 89999999999999998 99999886644433333322  34456678999999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 019360          256 PVTRITMAEVIEN  268 (342)
Q Consensus       256 P~~Rps~~e~l~h  268 (342)
                      |.+|||++|+++|
T Consensus       337 P~~Rps~~ell~~  349 (359)
T 3vhe_A          337 PSQRPTFSELVEH  349 (359)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-49  Score=361.79  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=219.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++.++||||+++++++..
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34578999999999999999999997     355889999997543  23445688999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR------------------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLK  141 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlk  141 (342)
                      .+..|+||||+++++|.+++...                        ..+++.+++.++.|++.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999864                        568999999999999999999999999999999


Q ss_pred             CCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCC
Q 019360          142 PENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEES  220 (342)
Q Consensus       142 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~  220 (342)
                      |+||+++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999875433222222344567899999999987766 489999999999999999 99999998


Q ss_pred             cHHHHHHHHHhcCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          221 NLMALYKKIFKADF-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       221 ~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +..+....+..... ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            88888877776654 3456789999999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-50  Score=360.86  Aligned_cols=255  Identities=33%  Similarity=0.592  Sum_probs=211.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcC----CCCcceeEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLI----RHPNVIRMYEV   82 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~l~~~   82 (342)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4446789999999999999999999999999999999975433221   1223456789999888    89999999999


Q ss_pred             EEeCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCeeEccccc
Q 019360           83 MASKTKIYIVLEF-VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD-ANGVLKVSDFGL  160 (342)
Q Consensus        83 ~~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~-~~~~~kl~Dfg~  160 (342)
                      +...+..++|||+ +.+++|.+++..+..+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9998999999999 78999999999888899999999999999999999999999999999999998 789999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF  240 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  240 (342)
                      +.....    .......|++.|+|||++.+..+.+.++|||||||++|+|++|+.||....      .+.......+..+
T Consensus       187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~  256 (312)
T 2iwi_A          187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHV  256 (312)
T ss_dssp             CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTS
T ss_pred             hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccC
Confidence            875432    223456689999999999877776568999999999999999999997642      3444556667789


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +.++.+||.+||+.||++|||++|+++||||+..
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            9999999999999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.4e-49  Score=369.60  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=204.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC--------CCcceeEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR--------HPNVIRMYE   81 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~   81 (342)
                      ....++|++.+.||+|+||+||+|++..+++.||+|++....    ...+.+.+|+.+++.++        |+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            344588999999999999999999999999999999996532    33457789999998885        788999999


Q ss_pred             EEE----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCC---
Q 019360           82 VMA----SKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANG---  151 (342)
Q Consensus        82 ~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~---  151 (342)
                      ++.    ....+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            987    456799999999 55666666543  5699999999999999999999998 999999999999998775   


Q ss_pred             ----------------------------------------------CeeEcccccccCCccccCCCceecccCCcccCCh
Q 019360          152 ----------------------------------------------VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP  185 (342)
Q Consensus       152 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  185 (342)
                                                                    .+||+|||++.....     ......||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCC
Confidence                                                          799999999975432     12345789999999


Q ss_pred             hhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc------HHHHHHHHHhcCC-------------------------
Q 019360          186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN------LMALYKKIFKADF-------------------------  234 (342)
Q Consensus       186 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~------~~~~~~~i~~~~~-------------------------  234 (342)
                      |++.+..+. .++|||||||++|+|++|+.||...+      .......+.....                         
T Consensus       263 E~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          263 EVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            999887764 89999999999999999999997543      2222222211100                         


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          235 -----------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       235 -----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                                       ..+...+..+.+||.+||+.||++|||++|+|+||||+
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                             11112345688999999999999999999999999996

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-49  Score=368.73  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=215.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++....  .....+.+.+|+++|++++||||+++++++...+..|+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            3468999999999999999999999999999999986432  23334578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999999865 45999999999999999999999999999999999999999999999999998743221111


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                      .......+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.+.+.......+.... .+.+..+++++.+||
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11111234678999999987665 489999999999999998 999999988877776665543 445667899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc
Q 019360          249 SRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||+.||++|||++++++
T Consensus       349 ~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=355.38  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=210.5

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            4568999999999999999999999999999999998543   2344568899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||+++++|.+++.. ...+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999987 56799999999999999999999999999999999999999999999999999975432211


Q ss_pred             C------------CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH-----HHHHHHhc
Q 019360          170 D------------GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA-----LYKKIFKA  232 (342)
Q Consensus       170 ~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~-----~~~~i~~~  232 (342)
                      .            .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.......     ....... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence            1            011245799999999999887664 89999999999999999999986532110     0111111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          233 DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       233 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                       ...++.+++.+.+|+.+||+.||++|||++++++
T Consensus       242 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 -RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             1234568899999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-49  Score=348.22  Aligned_cols=251  Identities=23%  Similarity=0.402  Sum_probs=217.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++++++||||+++++++...+..+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            44578999999999999999999986 5778999999754322    246889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999999764 5689999999999999999999999999999999999999999999999999875332111


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (342)
                       .......+|+.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....+..+++++.++
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI  239 (269)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             -ccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence             11223456778999999987766 489999999999999999 99999999888888887765 334456689999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcC
Q 019360          248 ISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +.+||+.||++|||++++++|
T Consensus       240 i~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          240 MNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-49  Score=365.08  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=212.3

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CC-----cceeEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HP-----NVIRMYEV   82 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~l~~~   82 (342)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++....    .....+.+|+++++.++ |+     +|++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            3445689999999999999999999999999999999996432    23456778888888775 44     49999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCcEEec--CCCCeeEc
Q 019360           83 MASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCH--SRGVCHRDLKPENLLLD--ANGVLKVS  156 (342)
Q Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH--~~giiH~dlkp~NIli~--~~~~~kl~  156 (342)
                      +...+..|+||||+++ +|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||++  .++.+||+
T Consensus       125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            9999999999999965 999998865  45899999999999999999999  57999999999999995  47789999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS  236 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  236 (342)
                      |||+++....     ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus       204 DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  277 (382)
T 2vx3_A          204 DFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP  277 (382)
T ss_dssp             CCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             eccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999975422     23456789999999999887664 89999999999999999999999988777776665421111


Q ss_pred             C------------------------------------CC----------------------------CCHHHHHHHHHhc
Q 019360          237 P------------------------------------PW----------------------------FSTSAKKLISRIL  252 (342)
Q Consensus       237 ~------------------------------------~~----------------------------~~~~~~~li~~~L  252 (342)
                      +                                    +.                            .++++.+||.+||
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  357 (382)
T 2vx3_A          278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML  357 (382)
T ss_dssp             CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred             CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence            0                                    00                            0036899999999


Q ss_pred             CCCCCCCCCHHHHhcCcccccC
Q 019360          253 DPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       253 ~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +.||++|||++|+|+||||++.
T Consensus       358 ~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          358 DYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CSCTTTSCCHHHHTTSGGGCC-
T ss_pred             CCChhhCCCHHHHhcCcccccC
Confidence            9999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-49  Score=356.93  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=218.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+++++.++||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            344678999999999999999999983     456889999997532  3444578899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRGR------------------------LKEDEARKYFQQLINAVDYCHSRGVCHRDL  140 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~~l~~~L~~LH~~giiH~dl  140 (342)
                      ..+..++||||+++++|.+++.....                        +++.+++.++.|++.||.|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            99999999999999999999987543                        899999999999999999999999999999


Q ss_pred             CCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCC
Q 019360          141 KPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEE  219 (342)
Q Consensus       141 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~  219 (342)
                      ||+||+++.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999875432222112233456788999999987665 489999999999999999 9999998


Q ss_pred             CcHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          220 SNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       220 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .........+.... ...+..+++++.+||.+||+.||++|||+++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            87777766666543 34456789999999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.7e-49  Score=350.11  Aligned_cols=257  Identities=28%  Similarity=0.464  Sum_probs=210.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      ++|.....||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            34444559999999999999999999999999986542   233467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCccccC
Q 019360           94 EFVTGGELFDKIASR---GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++......  
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--  176 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence            999999999999865   24678999999999999999999999999999999999987 899999999998754321  


Q ss_pred             CCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCcHHH--HHH-HHHhcCCCCCCCCCHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESNLMA--LYK-KIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~--~~~-~i~~~~~~~~~~~~~~~~  245 (342)
                      ........|++.|+|||++.+.. ..+.++||||||+++|+|++|+.||.......  ... .........+..+++++.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence            11223457899999999997643 23589999999999999999999997543222  111 122333445667899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +||.+||+.||++|||++++++||||+...
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            999999999999999999999999998643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-49  Score=365.46  Aligned_cols=257  Identities=24%  Similarity=0.434  Sum_probs=207.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-----------CCcceeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-----------HPNVIRMY   80 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~   80 (342)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.....    ..+.+.+|+.++++++           |+||++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            34789999999999999999999999999999999975432    2346778999998876           78999999


Q ss_pred             EEEEeCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecC----
Q 019360           81 EVMASKT----KIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDA----  149 (342)
Q Consensus        81 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~----  149 (342)
                      +++...+    .+++||||+ +++|.+++...  ..+++..+..++.|++.||+|||++ ||+||||||+|||++.    
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9987654    789999999 88999999863  4599999999999999999999998 9999999999999943    


Q ss_pred             --CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH-----
Q 019360          150 --NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-----  222 (342)
Q Consensus       150 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-----  222 (342)
                        .+.+||+|||++.....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.     
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              44799999999875432     2234578999999999988766 4899999999999999999999976541     


Q ss_pred             -HHHHHHHHh------------------------------------------cCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019360          223 -MALYKKIFK------------------------------------------ADFKSPPWFSTSAKKLISRILDPNPVTR  259 (342)
Q Consensus       223 -~~~~~~i~~------------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (342)
                       ......+..                                          .....+..++.++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence             122222211                                          1122223345788999999999999999


Q ss_pred             CCHHHHhcCcccccCCCCCC
Q 019360          260 ITMAEVIENEWFKKGYKPPS  279 (342)
Q Consensus       260 ps~~e~l~h~~~~~~~~~~~  279 (342)
                      ||++|+|+||||++......
T Consensus       326 pt~~ell~hp~f~~~~~~~~  345 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDTLGMEE  345 (373)
T ss_dssp             BCHHHHHTCGGGTTCTTCTT
T ss_pred             CCHHHHhhChhhhcccCccc
Confidence            99999999999997654433

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.8e-49  Score=351.56  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=211.5

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCC-------cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETG-------ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEV   82 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~   82 (342)
                      ....++|++.+.||+|+||+||+|.+..++       ..||+|++....   ....+.+.+|+.++++++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            345689999999999999999999998777       469999986533   3344678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--------e
Q 019360           83 MASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV--------L  153 (342)
Q Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~--------~  153 (342)
                      +...+..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999988887        9


Q ss_pred             eEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHHHhc
Q 019360          154 KVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKA  232 (342)
Q Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~  232 (342)
                      ||+|||++.....      .....||+.|+|||++.+....+.++|||||||++|+|++| .+||...+.... ......
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~  233 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYED  233 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHT
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhc
Confidence            9999999864321      23345789999999998744456899999999999999995 555555554443 344445


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          233 DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       233 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ....+...++++.+|+.+||+.||++|||++++++|
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555666678999999999999999999999999976

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-48  Score=345.05  Aligned_cols=253  Identities=23%  Similarity=0.393  Sum_probs=216.9

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.++++++||||+++++++......
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            345689999999999999999999876 5778999999754332    24678999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998754 59999999999999999999999999999999999999999999999999987433211


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~  246 (342)
                       ........+|+.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+..... ..+..+++.+.+
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          159 -YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ  236 (268)
T ss_dssp             -EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             -hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence             111223345678999999987665 489999999999999999 9999999888887777766544 345567999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCc
Q 019360          247 LISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      ++.+||+.||++|||+++++++-
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.3e-49  Score=358.67  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=210.5

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCC-cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc------ceeEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETG-ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN------VIRMYE   81 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~   81 (342)
                      .....++|++.+.||+|+||.||+|.+..++ +.||+|++....    ...+.+.+|+.+++.++|++      ++.+++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            4455689999999999999999999998777 689999996532    23356778999999887655      899999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe------------
Q 019360           82 VMASKTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL------------  147 (342)
Q Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli------------  147 (342)
                      ++...+..++||||+ +++|.+.+...  ..+++.+++.++.|++.||.|||++||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            999999999999999 55777777654  369999999999999999999999999999999999999            


Q ss_pred             -------cCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          148 -------DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       148 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                             +.++.+||+|||+++....     ......||+.|+|||++.+..+. .++|||||||++|+|++|..||...
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCC
Confidence                   5678999999999875322     22446789999999999877664 8999999999999999999999987


Q ss_pred             cHHHHHHHHHhcCCCCC--------------------------------------------CCCCHHHHHHHHHhcCCCC
Q 019360          221 NLMALYKKIFKADFKSP--------------------------------------------PWFSTSAKKLISRILDPNP  256 (342)
Q Consensus       221 ~~~~~~~~i~~~~~~~~--------------------------------------------~~~~~~~~~li~~~L~~dP  256 (342)
                      +.......+.......+                                            ...+.++.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            76665544433211111                                            1123578899999999999


Q ss_pred             CCCCCHHHHhcCccccc
Q 019360          257 VTRITMAEVIENEWFKK  273 (342)
Q Consensus       257 ~~Rps~~e~l~h~~~~~  273 (342)
                      ++|||++|+|+||||+.
T Consensus       323 ~~Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          323 AQRITLAEALLHPFFAG  339 (355)
T ss_dssp             TTSCCHHHHTTSGGGGG
T ss_pred             hhCcCHHHHhcChhhcC
Confidence            99999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-48  Score=353.74  Aligned_cols=256  Identities=20%  Similarity=0.306  Sum_probs=219.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++|+||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            445578999999999999999999886     457889999997533  2333457889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCee
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR----------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~k  154 (342)
                      ..+..++||||+++++|.+++...          ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            999999999999999999998752          4579999999999999999999999999999999999999999999


Q ss_pred             EcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC
Q 019360          155 VSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD  233 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~  233 (342)
                      |+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  257 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  257 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence            999999875433222222233456889999999987665 489999999999999999 899999988888877777655


Q ss_pred             C-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          234 F-KSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       234 ~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      . ..+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4 3456789999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-48  Score=351.40  Aligned_cols=261  Identities=25%  Similarity=0.455  Sum_probs=210.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR--HPNVIRMYEVMASKTKI   89 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~   89 (342)
                      ..++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++++++  |+||+++++++...+..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3457999999999999999999985 589999999965432 3344578899999999997  59999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |+||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred             EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence            99999 45789999999888899999999999999999999999999999999999995 58999999999986443322


Q ss_pred             CCceecccCCcccCChhhhccC----------CCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcC--CCC
Q 019360          170 DGLLHTTCGTPNYVAPEVINNK----------GYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKAD--FKS  236 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~--~~~  236 (342)
                      ........||+.|+|||++.+.          ...+.++|||||||++|+|++|..||.... .......+....  ...
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  261 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  261 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence            2233455789999999998751          233578999999999999999999997653 333333443332  234


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      +...+.++.+||.+||+.||++|||++|+++||||+....
T Consensus       262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            5567899999999999999999999999999999986543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-48  Score=347.05  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=215.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++++.||+|+||+||+|.+. ++..||+|++......    .+.+.+|+++++.++|+||+++++++...+.
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            3455678999999999999999999886 6778999999754322    2467899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .++||||+++++|.+++.. ...+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999999999986 567999999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      .. .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||...+.......+.... ...+..+++.+.
T Consensus       174 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          174 EY-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             HH-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cc-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence            11 11123346788999999987766 589999999999999998 999999988888887777654 334556789999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          246 KLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      +||.+||+.||.+|||++++++|-
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHH
Confidence            999999999999999999999763

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.9e-49  Score=356.46  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=208.1

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEE----EEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENV----AIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      ....++|++.+.||+|+||+||+|.+..+++.+    |+|.+....  .....+.+.+|+.++++++||||+++++++..
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            345678999999999999999999998887765    777664322  23344678899999999999999999999987


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      .. .++|+||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            55 7899999999999999987 467999999999999999999999999999999999999999999999999999754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCH
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFST  242 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~  242 (342)
                      .............+|+.|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.+.......+.... ...+..++.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  246 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred             cCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence            33322223334556889999999988766 489999999999999999 999999887776666665543 445667899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.+++.+||+.||++|||+.+++++
T Consensus       247 ~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          247 DVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.8e-49  Score=358.85  Aligned_cols=255  Identities=32%  Similarity=0.581  Sum_probs=184.9

Q ss_pred             ceeecCeeeee-eecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe---
Q 019360           10 RTRVGKYELGR-TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS---   85 (342)
Q Consensus        10 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---   85 (342)
                      ....++|++.+ .||+|+||.||+|.++.+|+.||+|++.....       ...+....++.++|+||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            34567899966 69999999999999999999999999865321       11223334577799999999999876   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcccc
Q 019360           86 -KTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFG  159 (342)
Q Consensus        86 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg  159 (342)
                       ...+++||||+++++|.+++....  .+++.+++.++.|++.||.|||++||+||||||+||+++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             455899999999999999998754  6999999999999999999999999999999999999976   4559999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH----HHHHhcCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY----KKIFKADFK  235 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~----~~i~~~~~~  235 (342)
                      ++.....    .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........    ..+......
T Consensus       177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             TCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             cceeccc----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            9874322    22345678999999999976655 48899999999999999999999776544332    222222222


Q ss_pred             C----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          236 S----PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       236 ~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      .    ...+++++.+||.+||+.||++|||++|+++||||++...
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            2    2468999999999999999999999999999999987543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-49  Score=358.48  Aligned_cols=255  Identities=21%  Similarity=0.359  Sum_probs=213.0

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.+++++ +||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            468999999999999999999973     456789999997532  233346788999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG-----------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPE  143 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~  143 (342)
                      +..|+||||+++++|.+++....                       .+++..++.++.|++.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            99999999999999999998643                       2789999999999999999999999999999999


Q ss_pred             cEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcH
Q 019360          144 NLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNL  222 (342)
Q Consensus       144 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~  222 (342)
                      ||+++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+...
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            99999999999999999975543322223334567889999999987666 489999999999999998 9999988765


Q ss_pred             HHHHHHHHhcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          223 MALYKKIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       223 ~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      ...........  ...+..+++++.+||.+||+.||.+|||+.++++|..
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            44444444433  3345668999999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.6e-49  Score=357.27  Aligned_cols=254  Identities=20%  Similarity=0.360  Sum_probs=212.8

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcE----EEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ...++|++.+.||+|+||.||+|.+..+++.    ||+|.+....  .....+.+.+|+.+++.++|+||+++++++. .
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            3457899999999999999999999888876    6667664322  1122245678999999999999999999986 4


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      +..++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            5689999999999999999874 579999999999999999999999999999999999999999999999999998654


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTS  243 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  243 (342)
                      ............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.... ...+..++.+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence            4333333455667889999999987766 489999999999999999 999999887777766666553 4455668889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          244 AKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +.+|+.+||+.||++|||+.++++|
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.6e-48  Score=342.92  Aligned_cols=250  Identities=26%  Similarity=0.488  Sum_probs=204.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh-hhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK-HKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ...++|++.+.||+|+||.||+|.+.  |+.||+|++....... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            35689999999999999999999984  8899999986543222 23346788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeecCCCCcEEecC--------CCCeeEccc
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG---VCHRDLKPENLLLDA--------NGVLKVSDF  158 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~g---iiH~dlkp~NIli~~--------~~~~kl~Df  158 (342)
                      ++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|   |+||||||+||+++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999988864 57999999999999999999999999   999999999999986        678999999


Q ss_pred             ccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--CC
Q 019360          159 GLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--KS  236 (342)
Q Consensus       159 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~  236 (342)
                      |++......    ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+.......+.....  ..
T Consensus       161 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          161 GLAREWHRT----TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             Ccccccccc----cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            998753321    2234578999999999987765 4899999999999999999999999887777666655543  44


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          237 PPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +..+++.+.+++.+||+.||.+|||+.|+++|
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            56789999999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2e-48  Score=353.37  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=218.8

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEE--EEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENV--AIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYE   81 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~   81 (342)
                      +...+....++|++.+.||+|+||.||+|.++.++..+  |+|.+....  .....+.+.+|+++++++ +||||+++++
T Consensus        16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             CcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhce
Confidence            34446677789999999999999999999999888865  999886422  233445788999999999 8999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019360           82 VMASKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENL  145 (342)
Q Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NI  145 (342)
                      ++...+..|+||||+++++|.+++....                .+++.+++.++.|++.||.|||++||+||||||+||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  173 (327)
T 1fvr_A           94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI  173 (327)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             eeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceE
Confidence            9999999999999999999999998654                699999999999999999999999999999999999


Q ss_pred             EecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHH
Q 019360          146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMA  224 (342)
Q Consensus       146 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~  224 (342)
                      +++.++.+||+|||+++......   ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus       174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~  249 (327)
T 1fvr_A          174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  249 (327)
T ss_dssp             EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence            99999999999999987432211   1233456889999999987665 489999999999999998 999999998888


Q ss_pred             HHHHHHhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          225 LYKKIFKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      ....+... ....+..+++++.+||.+||+.||.+|||+++++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            87777665 3344567899999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-48  Score=345.81  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=206.5

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~   85 (342)
                      -....++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.++++++||||+++++++. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            345567999999999999999999998654   4569999986432  3344567899999999999999999999984 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      .+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            566899999999999999998654 6999999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCH
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFST  242 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~  242 (342)
                      .... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.... .+.++.+++
T Consensus       167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          167 EDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             Cccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            3221 111233456788999999987666 489999999999999996 999999887777777766543 345667899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.+++.+||+.||++|||+.+++++
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-48  Score=352.40  Aligned_cols=254  Identities=22%  Similarity=0.392  Sum_probs=214.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARN-----TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~   85 (342)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ....+.+.+|+.+++++ +||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            357899999999999999999985     45678999999975432  23356789999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRG------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL  147 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli  147 (342)
                      .+..++||||+++++|.+++....                  .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            999999999999999999998654                  48999999999999999999999999999999999999


Q ss_pred             cCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHH
Q 019360          148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALY  226 (342)
Q Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~  226 (342)
                      +.++.+||+|||++................+|+.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.......
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            9999999999999976543322222334456789999999987665 489999999999999998 99999886654444


Q ss_pred             HHHHhcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          227 KKIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       227 ~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .......  ...+..++.++.+||.+||+.||.+|||+++++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4444333  23356689999999999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=348.77  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=199.1

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.++..+++.++|+||+++++++...+..|+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            46789999999999999999999999999999999975432 22333445556667888999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+ ++.+..+... ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++.....   
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---  177 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---  177 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC---
Confidence            99999 5566555543 56799999999999999999999995 999999999999999999999999999874332   


Q ss_pred             CCceecccCCcccCChhhhcc----CCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHhcCCCC---CCCCC
Q 019360          170 DGLLHTTCGTPNYVAPEVINN----KGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKADFKS---PPWFS  241 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~---~~~~~  241 (342)
                      ........||+.|+|||++..    ....+.++|||||||++|+|++|+.||.. .........+.......   ...++
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence            122334578999999999852    22335889999999999999999999987 34555555665554332   23578


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +++.+||.+||+.||.+|||++++++||||+.
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            99999999999999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.4e-48  Score=353.83  Aligned_cols=256  Identities=24%  Similarity=0.456  Sum_probs=217.4

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEc-------CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNT-------ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYE   81 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~   81 (342)
                      ....++|++.+.||+|+||.||+|.+.       .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            445689999999999999999999985       456789999997542  234456788999999999 8999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019360           82 VMASKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENL  145 (342)
Q Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NI  145 (342)
                      ++...+..|+||||+++++|.+++....                .+++..++.++.|++.||.|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999998654                389999999999999999999999999999999999


Q ss_pred             EecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHH
Q 019360          146 LLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMA  224 (342)
Q Consensus       146 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~  224 (342)
                      +++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999875433221112233456788999999987665 489999999999999999 999999988888


Q ss_pred             HHHHHHhcC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          225 LYKKIFKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       225 ~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ....+.... ...+..++.++.++|.+||+.||.+|||+++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777766654 34456789999999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.1e-49  Score=355.87  Aligned_cols=261  Identities=20%  Similarity=0.302  Sum_probs=215.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEE-----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM   83 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~   83 (342)
                      .....++|++.+.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.++++++||||+++++++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            34456799999999999999999999     55678899999996432  233445788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCe
Q 019360           84 ASKTKIYIVLEFVTGGELFDKIASRG-------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVL  153 (342)
Q Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~  153 (342)
                      ...+..|+||||+++++|.+++....       .+++..++.++.|++.||.|||++||+||||||+||+++.   +..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99999999999999999999998753       4899999999999999999999999999999999999984   4469


Q ss_pred             eEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc
Q 019360          154 KVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA  232 (342)
Q Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~  232 (342)
                      ||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            9999999864332222222344567899999999987665 489999999999999998 99999998887777777665


Q ss_pred             C-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          233 D-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       233 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      . ...+..++..+.+||.+||+.||.+|||++++++|.|+.
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            3 344567899999999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.6e-48  Score=347.42  Aligned_cols=255  Identities=22%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             CceeecCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .....++|++++.||+|+||+||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34456889999999999999999998    56789999999986532   344567889999999999999999999985


Q ss_pred             e--CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           85 S--KTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        85 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      .  ...+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  356899999999999999998754 4999999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH----------------H
Q 019360          162 ALPQQVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM----------------A  224 (342)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~----------------~  224 (342)
                      ......... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||......                .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            864332111 12233456778999999988776 48999999999999999999998654321                1


Q ss_pred             HHHHHHh-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          225 LYKKIFK-ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       225 ~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ....+.. ...+.+..+++++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1122222 234456678999999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-47  Score=345.90  Aligned_cols=257  Identities=32%  Similarity=0.559  Sum_probs=207.3

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++|+||+++++++...+.
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            34567899999999999999999999999999999999976444445556788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           89 IYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999998864    456899999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC--cHHHHHHHHHhcCCCC--CCCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES--NLMALYKKIFKADFKS--PPWF  240 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~--~~~~  240 (342)
                      ...  ........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.  ........+.....+.  ...+
T Consensus       187 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (310)
T 2wqm_A          187 SSK--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY  263 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred             cCC--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence            321  122234568999999999987665 48999999999999999999999764  3344445555444433  2458


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +.++.+||.+||+.||++|||+++++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8999999999999999999999999964

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=354.11  Aligned_cols=254  Identities=22%  Similarity=0.356  Sum_probs=208.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEE----EEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENV----AIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ...++|++++.||+|+||.||+|.+..+++.+    |+|.+....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            44578999999999999999999998888766    555553321  223456788999999999999999999999875


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      . .++|++|+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 78999999999999999864 569999999999999999999999999999999999999999999999999998654


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTS  243 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  243 (342)
                      ............+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.........+.... .+.+..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            33333333445568899999999887664 89999999999999999 999999887777766665543 4456678999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          244 AKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +.+||.+||+.||.+|||++|+++.
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999963

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-48  Score=340.39  Aligned_cols=249  Identities=19%  Similarity=0.327  Sum_probs=215.0

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC--
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK--   86 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--   86 (342)
                      .....++|++.+.||+|+||.||+|.+.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++...  
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            4556789999999999999999999984  88999999976432 234456789999999999999999999999876  


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCeeEccccccc
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ...++||||+++++|.+++....  .+++.+++.++.|++.||+|||++|  |+||||||+||+++.++.++|+|||.+.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            77899999999999999998765  4899999999999999999999999  9999999999999999999999888765


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCC--cccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC--CCCCC
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG--AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPP  238 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~  238 (342)
                      ...       .....||+.|+|||.+.+..+..  .++|||||||++|+|++|+.||.+.+.......+....  ...+.
T Consensus       162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (271)
T 3kmu_A          162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP  234 (271)
T ss_dssp             TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred             eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence            321       12346899999999998654432  37999999999999999999999988877776666543  34456


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          239 WFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+++++.++|.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999999999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.8e-48  Score=343.77  Aligned_cols=253  Identities=19%  Similarity=0.252  Sum_probs=210.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT   87 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~   87 (342)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++......     +.+.+|+.+++.+ +|+|++++++++....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            345567899999999999999999999999999999998643321     2567899999999 6999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-----eeEcccccc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV-----LKVSDFGLS  161 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~-----~kl~Dfg~~  161 (342)
                      ..++||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.     +||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 89999999875 45999999999999999999999999999999999999987765     999999999


Q ss_pred             cCCccccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---cHHHHHHHHHhcC
Q 019360          162 ALPQQVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---NLMALYKKIFKAD  233 (342)
Q Consensus       162 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---~~~~~~~~i~~~~  233 (342)
                      .........     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.   ........+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            754332211     12345679999999999987665 58999999999999999999999873   3344444443322


Q ss_pred             CC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          234 FK-----SPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       234 ~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..     ....+++++.+|+.+||+.||++|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11     124688999999999999999999999999853

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-48  Score=358.65  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=206.0

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...++|++.+.||+|+||.||+|+++   .++..||+|++....  .....+.+.+|+.++++++||||+++++++...+
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            34568999999999999999999987   467789999996532  2344568899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++||||+++++|.+++... ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999999999875 4699999999999999999999999999999999999999999999999999975433


Q ss_pred             ccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHH
Q 019360          167 VRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTS  243 (342)
Q Consensus       167 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (342)
                      .... .......+++.|+|||++.+..+. .++|||||||++|||++ |+.||...+..+....+... ..+.+..++..
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            2111 111223356789999999877664 89999999999999998 99999988887777776654 33445668899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+|+.+||+.||++||+++++++
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999999886

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.4e-48  Score=343.91  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=219.1

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      -....++|++.+.||+|+||+||+|.+..++..||+|++....    ...+.+.+|+.+++.++|+||+++++++...+.
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3456778999999999999999999999999999999996532    234578899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           89 IYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      .|+||||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999999999999999864  4589999999999999999999999999999999999999999999999999975432


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSA  244 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (342)
                      .. ........+|+.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....+..+++.+
T Consensus       164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (288)
T 3kfa_A          164 DT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  241 (288)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             Cc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence            11 122233456788999999987766 489999999999999999 99999988777666666554 344566789999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+|+.+||+.||.+|||++++++
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-48  Score=353.69  Aligned_cols=248  Identities=22%  Similarity=0.306  Sum_probs=207.8

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~   90 (342)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++......     +.+.+|+.+++.+ +|+||+++++++...+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            346899999999999999999999999999999998653221     2577899999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-----eeEcccccccCC
Q 019360           91 IVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV-----LKVSDFGLSALP  164 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~-----~kl~Dfg~~~~~  164 (342)
                      +||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.     +||+|||+++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 8999999986 467999999999999999999999999999999999999998887     999999999754


Q ss_pred             ccccCCC-----ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC---CcHHHHHHHHHhcCCCC
Q 019360          165 QQVRDDG-----LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE---SNLMALYKKIFKADFKS  236 (342)
Q Consensus       165 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~---~~~~~~~~~i~~~~~~~  236 (342)
                      .......     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+   .+..+....+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            3221111     1245679999999999988766 4899999999999999999999987   34444455544333222


Q ss_pred             C-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          237 P-----PWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       237 ~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +     ..++ ++.+++..||+.||.+||+++++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            2     2234 9999999999999999999988876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-47  Score=343.00  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=212.8

Q ss_pred             eecCeeeee-eecccCceEEEEEEE--cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           12 RVGKYELGR-TLGEGSFAKVKFARN--TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        12 ~~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..++|++.+ .||+|+||+||+|.+  ..+++.||+|++.... ......+.+.+|+++++.++||||+++++++ ..+.
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            456899998 999999999999954  5667899999997543 2334456889999999999999999999999 5667


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      .++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            89999999999999999988889999999999999999999999999999999999999999999999999987543221


Q ss_pred             CC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          169 DD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      .. .......+++.|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+.... ...+..+++++.
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  250 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY  250 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            11 11122346788999999987665 489999999999999999 999999988887777776654 344567899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q 019360          246 KLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++|.+||+.||++|||+.++++
T Consensus       251 ~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          251 DLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3e-48  Score=351.49  Aligned_cols=251  Identities=21%  Similarity=0.275  Sum_probs=201.0

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC---
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT---   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---   87 (342)
                      ...++|++.+.||+|+||+||+|++.  ++.||+|++.....    ......+|+.++++++||||+++++++....   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            34568999999999999999999875  79999999965432    2234567999999999999999999997643   


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeecCCCCcEEecCCCCeeEc
Q 019360           88 -KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR----------GVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        88 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~----------giiH~dlkp~NIli~~~~~~kl~  156 (342)
                       .+++||||+++++|.+++..+ .+++..++.++.|++.||+|||+.          ||+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence             479999999999999999764 589999999999999999999999          99999999999999999999999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCC----CCcccchhhhhHHHHHHHhCCCCCCCCc-----------
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY----DGAKADLWSCGVILYVLMAGYLPFEESN-----------  221 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~ll~~l~~g~~pf~~~~-----------  221 (342)
                      |||+++...............||+.|+|||++.+...    .+.++|||||||++|+|++|+.||.+..           
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999975443333333344679999999999976322    2357899999999999999999996532           


Q ss_pred             -----HHHHHHHHHhcCCCCC--C-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          222 -----LMALYKKIFKADFKSP--P-----WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       222 -----~~~~~~~i~~~~~~~~--~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                           .......+......+.  .     ..+.++.+||.+||+.||++|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 2222222322222211  1     113459999999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-48  Score=350.16  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=213.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEE-----cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARN-----TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      ...++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            3457899999999999999999985     4567899999997543  233446788999999999 6999999999987


Q ss_pred             eCC-eEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 019360           85 SKT-KIYIVLEFVTGGELFDKIASRGR----------------LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL  147 (342)
Q Consensus        85 ~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli  147 (342)
                      ..+ .+++||||+++++|.+++.....                +++..++.++.|++.||.|||++||+||||||+||++
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            654 58999999999999999987543                8999999999999999999999999999999999999


Q ss_pred             cCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHH-
Q 019360          148 DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMAL-  225 (342)
Q Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~-  225 (342)
                      +.++.+||+|||+++...............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+...... 
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            9999999999999975443222222334567889999999987766 489999999999999998 9999987654333 


Q ss_pred             HHHHHhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          226 YKKIFKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      ...+... ....+..+++++.++|.+||+.||.+|||++++++|.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            3333332 3445667899999999999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.6e-48  Score=338.79  Aligned_cols=250  Identities=23%  Similarity=0.394  Sum_probs=215.9

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            3578999999999999999999986 6788999999764332    2468899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            99999999999999875 568999999999999999999999999999999999999999999999999987532211 1


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                      .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+.... ...+..++..+.+++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             cccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence            11123456788999999987666 489999999999999999 999999988888877776653 334556899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcC
Q 019360          249 SRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+||+.||++|||+++++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-47  Score=340.07  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=208.8

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhH----HHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKM----IGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++..........    .+.+.+|+.+++.++|+||+++++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            3455678999999999999999999999999999999986543322211    267889999999999999999999997


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCC-----eeEc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGV-----LKVS  156 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~-----~kl~  156 (342)
                      ...  ++||||+++++|.+.+... ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.     +||+
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            665  6999999999998888654 56999999999999999999999999  999999999999988776     9999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccC-CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH--HHHHHHhcC
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK-GYDGAKADLWSCGVILYVLMAGYLPFEESNLMA--LYKKIFKAD  233 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~--~~~~i~~~~  233 (342)
                      |||+++...     .......||+.|+|||++... ...+.++|||||||++|+|++|+.||...+...  ....+....
T Consensus       172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            999987422     233456789999999998432 223578999999999999999999997654332  233333332


Q ss_pred             --CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          234 --FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       234 --~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                        ...+..+++++.+||.+||+.||++|||++++++
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              3345678999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.8e-48  Score=347.55  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=206.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcC---CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTE---TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ....++|++.+.||+|+||.||+|.+..   ++..||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3445789999999999999999998765   456899999865432 334456788999999999999999999998765


Q ss_pred             C-----eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeE
Q 019360           87 T-----KIYIVLEFVTGGELFDKIAS------RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKV  155 (342)
Q Consensus        87 ~-----~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl  155 (342)
                      +     ..++||||+++++|.+++..      ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            4     35999999999999999843      356999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-
Q 019360          156 SDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-  233 (342)
Q Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-  233 (342)
                      +|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            99999875433222222334457889999999987665 489999999999999999 999999888777777766653 


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          234 FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       234 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34566789999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.5e-48  Score=351.68  Aligned_cols=254  Identities=21%  Similarity=0.382  Sum_probs=213.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCc-----EEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGE-----NVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMAS   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~   85 (342)
                      ..++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            34689999999999999999999977664     79999996543  233456788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR--------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG  151 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~  151 (342)
                      .+..|+||||+++++|.+++...              ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence            99999999999999999998753              3579999999999999999999999999999999999999999


Q ss_pred             CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 019360          152 VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIF  230 (342)
Q Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~  230 (342)
                      .+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            999999999975433222222233456789999999987666 489999999999999998 999998866555444444


Q ss_pred             hcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          231 KAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       231 ~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ...  ...+..+++.+.+||.+||+.||.+|||+++++++
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            433  23456688999999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-47  Score=347.40  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=210.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCC----cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETG----ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ....+|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            34568999999999999999999987553    359999986532  233455788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           87 TKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      +..++||||+++++|.+++... ..+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999999999865 679999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCH
Q 019360          166 QVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFST  242 (342)
Q Consensus       166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (342)
                      ..... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ..+.+..+++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  277 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             cccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence            32111 11222345788999999987665 489999999999999999 99999988888877777665 3445567899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+.+|+.+||+.||++||++.+++++
T Consensus       278 ~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-47  Score=340.50  Aligned_cols=260  Identities=24%  Similarity=0.327  Sum_probs=214.3

Q ss_pred             CCCCCCceeecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEE
Q 019360            4 RTGGASRTRVGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMY   80 (342)
Q Consensus         4 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~   80 (342)
                      -++...+...++|++.+.||+|+||.||+|.+...   +..||+|++....  .....+.+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~   79 (281)
T 3cc6_A            2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLI   79 (281)
T ss_dssp             --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence            34556677789999999999999999999987543   3469999987542  233456889999999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           81 EVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      +++... ..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            998654 568999999999999999765 459999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSP  237 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~  237 (342)
                      ++....... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||...........+... ..+.+
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (281)
T 3cc6_A          159 LSRYIEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP  236 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred             CCccccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence            987543321 112233456889999999987666 489999999999999998 99999877666666555544 34456


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          238 PWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+++.+.++|.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            6789999999999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.1e-48  Score=351.17  Aligned_cols=256  Identities=22%  Similarity=0.377  Sum_probs=190.6

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREIS-TMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ...++|++++.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+. +++.++||||+++++++...+..
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            345789999999999999999999999999999999975422  222334555555 77888999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           90 YIVLEFVTGGELFDKIAS-----RGRLKEDEARKYFQQLINAVDYCHSR-GVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~L~~LH~~-giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      ++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999999975 88777763     56799999999999999999999999 999999999999999999999999999875


Q ss_pred             CccccCCCceecccCCcccCChhhhc----cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH-HHHHHHHhcCCCC--
Q 019360          164 PQQVRDDGLLHTTCGTPNYVAPEVIN----NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM-ALYKKIFKADFKS--  236 (342)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~--  236 (342)
                      ....   .......||+.|+|||++.    +..+ +.++|||||||++|+|++|+.||...... +....+.......  
T Consensus       176 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3aln_A          176 LVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS  251 (327)
T ss_dssp             ---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred             cccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            4321   2223347899999999984    3333 58999999999999999999999875422 2222222222111  


Q ss_pred             ---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          237 ---PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       237 ---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                         ...+++++.+||.+||+.||++|||++++++||||..
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence               1347899999999999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=341.82  Aligned_cols=256  Identities=22%  Similarity=0.337  Sum_probs=215.7

Q ss_pred             eeecCeeeee-eecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGR-TLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            3456788887 9999999999999864  467889999997542  234456889999999999999999999999 456


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            689999999999999999754 5699999999999999999999999999999999999999999999999999875432


Q ss_pred             ccC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHH
Q 019360          167 VRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTS  243 (342)
Q Consensus       167 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  243 (342)
                      ... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |+.||...+..+....+.... ...+..++++
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            111 111223446889999999987665 489999999999999998 999999888777777776654 3456678999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      +.++|.+||+.||++|||+.++++|.+
T Consensus       242 l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-47  Score=341.90  Aligned_cols=252  Identities=23%  Similarity=0.442  Sum_probs=196.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++.+.||+|+||+||+|.+.   ..+|+|++.... ......+.+.+|+.++++++|+||++++++. .....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            344568999999999999999999864   359999996543 2344557889999999999999999999965 45668


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999999964 4569999999999999999999999999999999999999999999999999987544333


Q ss_pred             CCCceecccCCcccCChhhhc---cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH-HHhcCCCC-----CCC
Q 019360          169 DDGLLHTTCGTPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK-IFKADFKS-----PPW  239 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~-----~~~  239 (342)
                      .........||+.|+|||++.   +..+ +.++|||||||++|+|++|+.||.+......... +.......     ...
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN  253 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred             ccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence            333344567899999999986   3333 4789999999999999999999987654444333 33333222     235


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +++++.+||.+||+.||.+|||++++++
T Consensus       254 ~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          254 CPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            7899999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-47  Score=360.89  Aligned_cols=243  Identities=28%  Similarity=0.496  Sum_probs=209.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT-KIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~   90 (342)
                      ..++|++.+.||+|+||.||+|.+.  |+.||||++....     ..+.+.+|+++|++++||||+++++++.... .+|
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            4578999999999999999999885  7899999997543     2357889999999999999999999987654 799


Q ss_pred             EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||||+++++|.+++...+.  +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--  341 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--  341 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc--
Confidence            99999999999999987543  79999999999999999999999999999999999999999999999999874321  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (342)
                         ......+++.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+..+....+..+ ....+..+++++.+
T Consensus       342 ---~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  417 (450)
T 1k9a_A          342 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD  417 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ---cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence               1123356889999999987766 489999999999999998 99999988777777766654 34556778999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhc
Q 019360          247 LISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ||.+||+.||++|||+.++++
T Consensus       418 li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          418 VMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.5e-49  Score=354.51  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            35679999999999999999999974 68999999986542   234567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           91 IVLEFVTGGELFDKIASRG----RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      +||||+++++|.+++....    .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999886543    589999999999999999999999999999999999999999999999999875433


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHH------H-HHHHhcCCC----
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMAL------Y-KKIFKADFK----  235 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~------~-~~i~~~~~~----  235 (342)
                      ...........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......      . .........    
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD  270 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence            222333344568999999999987665 4899999999999999999999976432111      0 111111110    


Q ss_pred             --C----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          236 --S----PPWFSTSAKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       236 --~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                        .    ++..+..+.+++.+||+.||++|||++|+++|..
T Consensus       271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence              1    1123457899999999999999999999998754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.3e-47  Score=340.03  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=206.2

Q ss_pred             CCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE-E
Q 019360            6 GGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM-A   84 (342)
Q Consensus         6 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~   84 (342)
                      |.+.....++|++.+.||+|+||.||+|++..+|+.||+|++......     +.+.+|+.+++.++|++++..+.++ .
T Consensus         1 G~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            1 GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ----CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             CCccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccC
Confidence            345566778999999999999999999999999999999998653321     2577999999999988866655554 6


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec---CCCCeeEccccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD---ANGVLKVSDFGL  160 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~---~~~~~kl~Dfg~  160 (342)
                      ..+..++||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++   .++.+||+|||+
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             CCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            677889999999 8899999974 46799999999999999999999999999999999999994   788999999999


Q ss_pred             ccCCccccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---HHHHHHHHHhc
Q 019360          161 SALPQQVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKA  232 (342)
Q Consensus       161 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---~~~~~~~i~~~  232 (342)
                      +.........     .......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+   .......+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence            8754332211     11245678999999999987765 489999999999999999999997632   22223333222


Q ss_pred             CCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          233 DFKS-----PPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       233 ~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ....     ...+++++.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            2222     2568899999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.8e-47  Score=339.10  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=207.6

Q ss_pred             CceeecCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      ......+|++++.||+|+||.||+|.    +..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++++.
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            33445679999999999999999998    56789999999997543  2334467889999999999999999999998


Q ss_pred             eC--CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           85 SK--TKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        85 ~~--~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      ..  ..+++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence            76  668999999999999999954 467999999999999999999999999999999999999999999999999998


Q ss_pred             cCCccccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC---------------cHHHH
Q 019360          162 ALPQQVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES---------------NLMAL  225 (342)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~---------------~~~~~  225 (342)
                      ......... .......||..|+|||++.+..+. .++|||||||++|+|++|..|+...               .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            754322111 122345678889999999876664 8899999999999999999886432               11222


Q ss_pred             HHHHHh-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          226 YKKIFK-ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       226 ~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ...+.. .....+..+++++.+||.+||+.||.+|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            222222 234456678999999999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=349.42  Aligned_cols=254  Identities=15%  Similarity=0.212  Sum_probs=199.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC---CCcEEEEEEecchhhhhhh--------HHHHHHHHHHHHhcCCCCcceeEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE---TGENVAIKILDKEKVLKHK--------MIGQIKREISTMKLIRHPNVIRMYE   81 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~l~~   81 (342)
                      .++|++.+.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+..++.++|+||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999987   7889999998754321111        1124668889999999999999999


Q ss_pred             EEEe----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC--CeeE
Q 019360           82 VMAS----KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG--VLKV  155 (342)
Q Consensus        82 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~--~~kl  155 (342)
                      ++..    ....|+||||+ +++|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++  .+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9987    77899999999 999999998877899999999999999999999999999999999999998877  9999


Q ss_pred             cccccccCCccccC-----CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC--cHHHHHHH
Q 019360          156 SDFGLSALPQQVRD-----DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES--NLMALYKK  228 (342)
Q Consensus       156 ~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~--~~~~~~~~  228 (342)
                      +|||+++.......     ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.  +.......
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            99999975433211     112244578999999999987665 58999999999999999999999652  22222211


Q ss_pred             HHh--cCCC-------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          229 IFK--ADFK-------SPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       229 i~~--~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ...  ...+       ....++.++.+||.+||+.||++|||++++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            111  1111       112688999999999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-47  Score=338.76  Aligned_cols=249  Identities=26%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----   85 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----   85 (342)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++....       +.+.+|+.+++.++||||+++++++..    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            344578999999999999999999999999999999996532       245689999999999999999998854    


Q ss_pred             ------------CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 019360           86 ------------KTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG  151 (342)
Q Consensus        86 ------------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~  151 (342)
                                  ...+++||||+++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence                        34589999999999999999754  5799999999999999999999999999999999999999999


Q ss_pred             CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHh
Q 019360          152 VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFK  231 (342)
Q Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~  231 (342)
                      .+||+|||++......   .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..|+...  ......+..
T Consensus       160 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~  233 (284)
T 2a19_B          160 QVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD  233 (284)
T ss_dssp             EEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred             CEEECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence            9999999998754322   22344568999999999987665 48999999999999999999987532  222333333


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          232 ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       232 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .  ..+..++..+.+||.+||+.||++|||+.|+++|.+.-.
T Consensus       234 ~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 G--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             T--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             c--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2  334568999999999999999999999999999988654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=337.02  Aligned_cols=251  Identities=22%  Similarity=0.364  Sum_probs=210.0

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE-
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI-   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-   89 (342)
                      -+|++.+.||+|+||+||+|.+..+++   .+|+|++...  ......+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            357788999999999999999765554   7999998642  2334457888999999999999999999999766655 


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||+.+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            899999999999999987 4568999999999999999999999999999999999999999999999999997543221


Q ss_pred             --CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHH
Q 019360          169 --DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSA  244 (342)
Q Consensus       169 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  244 (342)
                        .........+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+.... ...+..+++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence              1222334567889999999987666 489999999999999999 566677766666666665544 34456689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+|+.+||+.||.+|||++++++
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-47  Score=365.96  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=215.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ...+|++.+.||+|+||.||+|.++.++..||||++.....    ..+.+.+|+.+|++++||||+++++++...+.+|+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            34579999999999999999999998899999999975432    24578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            99999999999999864  458999999999999999999999999999999999999999999999999998543211 


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (342)
                      ........++..|+|||++.+..+ +.++|||||||++|||++ |..||.+.+.......+... ....+..+++++.+|
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111123345678999999987665 489999999999999999 99999988777666665544 334566789999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      |.+||+.||++|||++++++
T Consensus       452 i~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=344.69  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE----eCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA----SKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~~~   87 (342)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.    ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            3467999999999999999999999999999999986532   334567889999999999999999999986    234


Q ss_pred             eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           88 KIYIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      ..++||||+++++|.+++..    ...+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            78999999999999998875    46799999999999999999999999999999999999999999999999998864


Q ss_pred             CccccCCC-------ceecccCCcccCChhhhccCCC--CCcccchhhhhHHHHHHHhCCCCCCCCcHH--HHHHHHH-h
Q 019360          164 PQQVRDDG-------LLHTTCGTPNYVAPEVINNKGY--DGAKADLWSCGVILYVLMAGYLPFEESNLM--ALYKKIF-K  231 (342)
Q Consensus       164 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~pf~~~~~~--~~~~~i~-~  231 (342)
                      ........       ......||+.|+|||++.+...  .+.++|||||||++|+|++|+.||......  .....+. .
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            32211110       1123457999999999875432  247999999999999999999999542110  1111111 1


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          232 ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       232 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      ...+..+.+++++.+||.+||+.||.+|||+++++++-.
T Consensus       264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            223344568999999999999999999999999998743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.2e-47  Score=338.39  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=209.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE-Ee
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM-AS   85 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~   85 (342)
                      +....+|++.+.||+|+||+||+|.+..++   ..+|+|.+...  ......+.+.+|+.++++++||||+++++++ ..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS   98 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence            344567999999999999999999976443   35899988642  2334456788999999999999999999985 45


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ++..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            56789999999999999999764 56899999999999999999999999999999999999999999999999999754


Q ss_pred             cccc--CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCC-CCCCC
Q 019360          165 QQVR--DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFK-SPPWF  240 (342)
Q Consensus       165 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~  240 (342)
                      ....  .........+|+.|+|||.+.+..+. .++||||||+++|+|++ |.+||...+.......+...... .+..+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  257 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence            3322  11223345678899999999877664 89999999999999999 77788877766666666655443 35568


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++.+.+++.+||+.||++|||++++++
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.4e-47  Score=359.46  Aligned_cols=248  Identities=23%  Similarity=0.404  Sum_probs=212.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.+. .+..||||++.....    ..+.+.+|+++|++++||||+++++++. .+..|+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            4467999999999999999999985 477899999975332    2457889999999999999999999986 567899


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            99999999999999754  3689999999999999999999999999999999999999999999999999985432110


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (342)
                       .......++..|+|||++....+ +.++|||||||++|||++ |+.||.+.+..+....+... ..+.+..+++++.+|
T Consensus       340 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  417 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  417 (454)
T ss_dssp             -HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             -eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence             11122345778999999987666 489999999999999999 99999998888887777654 344566789999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      |.+||+.||++|||++++++
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            99999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.4e-47  Score=339.12  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=200.5

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE-Ee
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM-AS   85 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~   85 (342)
                      ++.....++|++.+.||+|+||.||+|.+..+++.||+|++......     ..+.+|+.+++.++|++++..+..+ ..
T Consensus         2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            2 SMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ---------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             CcccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            44556678999999999999999999999999999999987543322     2467899999999988777666555 67


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCeeEcccccc
Q 019360           86 KTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLS  161 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli---~~~~~~kl~Dfg~~  161 (342)
                      .+..++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            78899999999 8899999985 4679999999999999999999999999999999999999   78899999999999


Q ss_pred             cCCccccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH---HHHHHHHHhcC
Q 019360          162 ALPQQVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL---MALYKKIFKAD  233 (342)
Q Consensus       162 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~---~~~~~~i~~~~  233 (342)
                      +........     .......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+.   ......+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            754332211     12235678999999999987765 4899999999999999999999976432   12222222222


Q ss_pred             CCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          234 FKS-----PPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       234 ~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ...     ...+++++.+||.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            222     2557899999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-48  Score=358.62  Aligned_cols=253  Identities=24%  Similarity=0.424  Sum_probs=207.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--e
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--K   88 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~   88 (342)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++......  ...+.+.+|++++++++||||+++++++...+  .
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            4467899999999999999999999999999999999754332  22456789999999999999999999998655  7


Q ss_pred             EEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCeeEcccccc
Q 019360           89 IYIVLEFVTGGELFDKIASRG---RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL----DANGVLKVSDFGLS  161 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli----~~~~~~kl~Dfg~~  161 (342)
                      .++||||+++++|.+++....   .+++..++.++.|++.||+|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999999999999997643   39999999999999999999999999999999999999    77788999999999


Q ss_pred             cCCccccCCCceecccCCcccCChhhhccC-------CCCCcccchhhhhHHHHHHHhCCCCCCC----CcHHHHHHHHH
Q 019360          162 ALPQQVRDDGLLHTTCGTPNYVAPEVINNK-------GYDGAKADLWSCGVILYVLMAGYLPFEE----SNLMALYKKIF  230 (342)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~ll~~l~~g~~pf~~----~~~~~~~~~i~  230 (342)
                      +.....   .......||+.|+|||++.+.       ...+.++|||||||++|+|++|+.||..    ....+....+.
T Consensus       164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            754322   223346799999999998652       1224789999999999999999999964    23344555555


Q ss_pred             hcCCC---------------------CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          231 KADFK---------------------SP----PWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       231 ~~~~~---------------------~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .....                     ..    ..++..+.++|.+||+.||++|||+++++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            44321                     11    1134578899999999999999999998653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.9e-47  Score=344.81  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=209.7

Q ss_pred             eecCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE--e
Q 019360           12 RVGKYELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA--S   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~   85 (342)
                      ..++|++.+.||+|+||.||+|.    +..+++.||+|++....   ....+.+.+|+.++++++|+||+++++++.  .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            34689999999999999999999    56788999999997543   334467889999999999999999999886  4


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           86 KTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ....|+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            5679999999999999999986 456999999999999999999999999999999999999999999999999999754


Q ss_pred             ccccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH---------------HHHHH
Q 019360          165 QQVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM---------------ALYKK  228 (342)
Q Consensus       165 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~---------------~~~~~  228 (342)
                      ...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......               .....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            322111 11233457888999999987665 48999999999999999999998654432               12222


Q ss_pred             HHh-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          229 IFK-ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       229 i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +.. .....+..+++++.+||.+||+.||++|||+++++++
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222 2334466789999999999999999999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-47  Score=351.12  Aligned_cols=251  Identities=14%  Similarity=0.216  Sum_probs=199.1

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCC-----CcEEEEEEecchhhhhhhHH--------HHHHHHHHHHhcCCCCcceeEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTET-----GENVAIKILDKEKVLKHKMI--------GQIKREISTMKLIRHPNVIRMY   80 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~iv~l~   80 (342)
                      ++|++.+.||+|+||.||+|.+..+     ++.||+|++...........        ....+|+..++.++|+||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3899999999999999999998764     58899999865432111111        2334567778889999999999


Q ss_pred             EEEEeC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec--CCCCe
Q 019360           81 EVMASK----TKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD--ANGVL  153 (342)
Q Consensus        81 ~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~--~~~~~  153 (342)
                      +++...    ...|+||||+ |++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++  .++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    4589999999 99999999876 6799999999999999999999999999999999999998  88999


Q ss_pred             eEcccccccCCccccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH
Q 019360          154 KVSDFGLSALPQQVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK  228 (342)
Q Consensus       154 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~  228 (342)
                      ||+|||+++........     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            99999999754332211     11234559999999999987765 5899999999999999999999986322111111


Q ss_pred             H------------HhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          229 I------------FKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       229 i------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .            ....+ ....+++++.+++..||+.||++||+++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1            11111 12457899999999999999999999999885

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-47  Score=339.98  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=205.7

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcC-CCc--EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTE-TGE--NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ...++|++.+.||+|+||+||+|.+.. +++  .||+|++...........+.+.+|+++++.++|+||+++++++....
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            345689999999999999999998643 333  68999987654444556678999999999999999999999997765


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                       .++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             88999999999999998764 5699999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC--CCCCCCCH
Q 019360          167 VRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF--KSPPWFST  242 (342)
Q Consensus       167 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~  242 (342)
                      .... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+.....  +.+..++.
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            2111 11223456788999999987665 489999999999999999 9999999988888877766533  34567899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.++|.+||+.||++|||+.+++++
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999999973

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.7e-47  Score=334.71  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=210.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+++++.++|+||+++++++.. +..++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            4578999999999999999999975 567899999865432    23578899999999999999999999864 55899


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            999999999999987543  69999999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                      ........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+....+.... ...+..++.++.+|
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence            111123446788999999987665 489999999999999999 999999988877777766543 34456789999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+||+.||++|||++++++
T Consensus       243 i~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHH
Confidence            99999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.7e-47  Score=335.80  Aligned_cols=244  Identities=27%  Similarity=0.487  Sum_probs=204.0

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC-CeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK-TKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-~~~   89 (342)
                      ...++|++.+.||+|+||.||+|.+.  |+.||+|++....     ..+.+.+|+.++++++|+||+++++++... +..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            44678999999999999999999874  8899999986432     245788999999999999999999987544 578


Q ss_pred             EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           90 YIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      |+||||+++++|.+++.....  +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999999986543  899999999999999999999999999999999999999999999999998743321


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAK  245 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (342)
                           .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+... ....+..+++.+.
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY  244 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred             -----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence                 223457889999999987665 489999999999999998 99999988777766666554 3345667899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q 019360          246 KLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ++|.+||+.||++|||+.++++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-46  Score=356.41  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=208.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|+.+|++++||||+++++++.. +..|+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            34679999999999999999999864 567999999754321    3468899999999999999999999876 67899


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+++++|.+++...  ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  334 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  334 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence            99999999999999753  569999999999999999999999999999999999999999999999999998543211 


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (342)
                      ........++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+....+....+..+ ..+.+..+++.+.+|
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  413 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            112233456788999999987665 489999999999999999 99999998888877777655 344566789999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      |.+||+.||++|||++++++
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-46  Score=340.70  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=206.3

Q ss_pred             CceeecCe-eeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEE
Q 019360            9 SRTRVGKY-ELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVM   83 (342)
Q Consensus         9 ~~~~~~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~   83 (342)
                      +....++| ++++.||+|+||+||++.    +..+++.||+|++....  .....+.+.+|+++++.++||||+++++++
T Consensus        25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (318)
T 3lxp_A           25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCC  102 (318)
T ss_dssp             CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence            34445566 999999999999998775    34578999999997542  234456789999999999999999999999


Q ss_pred             Ee--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccc
Q 019360           84 AS--KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLS  161 (342)
Q Consensus        84 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~  161 (342)
                      ..  ...+++||||+++++|.+++.... +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence            87  467899999999999999997654 899999999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH---------------HH
Q 019360          162 ALPQQVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM---------------AL  225 (342)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~---------------~~  225 (342)
                      ......... .......+|+.|+|||++.+..+. .++|||||||++|+|++|..||......               ..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            754322111 122344578889999999876654 8999999999999999999999764322               11


Q ss_pred             HHHHHh-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          226 YKKIFK-ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       226 ~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ...+.. .....+..++.++.+||.+||+.||++|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            111212 233446678999999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=344.96  Aligned_cols=245  Identities=15%  Similarity=0.207  Sum_probs=201.4

Q ss_pred             cCeeeeeeecccCceEEEEEEEcC--------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCccee-------
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTE--------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIR-------   78 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-------   78 (342)
                      ++|++.+.||+|+||.||+|.+..        .++.||+|++...        +.+.+|++++++++|+||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            799999999999999999999987        4889999998643        25678999999999999887       


Q ss_pred             --------EEEEEEe-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 019360           79 --------MYEVMAS-KTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL  147 (342)
Q Consensus        79 --------l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli  147 (342)
                              +++++.. ....|+||||+ +++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    6777765 67899999999 99999999876  779999999999999999999999999999999999999


Q ss_pred             cCCC--CeeEcccccccCCccccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          148 DANG--VLKVSDFGLSALPQQVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       148 ~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence            9988  9999999999754432211     12234578999999999987665 48999999999999999999999875


Q ss_pred             c--HHHHHHHH---HhcCCCCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          221 N--LMALYKKI---FKADFKSP------PWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       221 ~--~~~~~~~i---~~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .  ........   ........      ..+++++.+||.+||+.||++|||++++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            3  22222222   12111111      2468999999999999999999999999863

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.4e-46  Score=335.52  Aligned_cols=237  Identities=32%  Similarity=0.601  Sum_probs=194.9

Q ss_pred             CCceeecCeeee-eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHH-hcCCCCcceeEEEEEEe
Q 019360            8 ASRTRVGKYELG-RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHPNVIRMYEVMAS   85 (342)
Q Consensus         8 ~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~   85 (342)
                      ..+...++|.+. +.||+|+||.||+|.++.+++.||+|++...        ..+.+|+.++ +.++|+||+++++++..
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            356778899998 7899999999999999999999999998642        2456788887 66689999999999876


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEc
Q 019360           86 ----KTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVS  156 (342)
Q Consensus        86 ----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~  156 (342)
                          ...+++||||+++++|.+++....  .+++..++.++.|++.||.|||++||+||||||+||+++.   ++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence                677999999999999999998754  6999999999999999999999999999999999999988   7899999


Q ss_pred             ccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHH----hc
Q 019360          157 DFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF----KA  232 (342)
Q Consensus       157 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~----~~  232 (342)
                      |||++....                        +..+ +.++|||||||++|+|++|+.||.+.+.........    ..
T Consensus       163 Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  217 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  217 (299)
T ss_dssp             CCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred             ccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence            999886321                        1122 478999999999999999999998765544322211    11


Q ss_pred             CCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          233 DFKSP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       233 ~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                      ....+    ..+++++.+||.+||+.||++|||++|+++||||++....
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence            22222    4578999999999999999999999999999999875443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-46  Score=334.34  Aligned_cols=244  Identities=27%  Similarity=0.478  Sum_probs=198.8

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ....++|++.+.||+|+||.||+|.+.  ++.||+|++...     ...+.+.+|++++++++||||+++++++.+  ..
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            345678999999999999999999874  788999998643     234578899999999999999999998863  47


Q ss_pred             EEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeecCCCCcEEecCCCC-eeEccccccc
Q 019360           90 YIVLEFVTGGELFDKIASRG---RLKEDEARKYFQQLINAVDYCHS---RGVCHRDLKPENLLLDANGV-LKVSDFGLSA  162 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~L~~LH~---~giiH~dlkp~NIli~~~~~-~kl~Dfg~~~  162 (342)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+   +||+||||||+||+++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            89999999999999998754   37899999999999999999999   89999999999999988886 7999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc--HHHHHHHHHhc-CCCCCCC
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN--LMALYKKIFKA-DFKSPPW  239 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~--~~~~~~~i~~~-~~~~~~~  239 (342)
                      ....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....  .......+... ....+..
T Consensus       155 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (307)
T 2eva_A          155 DIQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN  228 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTT
T ss_pred             cccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccc
Confidence            4322     1233468999999999987665 489999999999999999999997542  22233333332 3344566


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++..+.+|+.+||+.||++|||+++++++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            89999999999999999999999999974

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=354.42  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +|++.+.||+|+||+||.. ...+|+.||||++......      .+.+|+.+|+.+ +||||+++++++......|+||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            4999999999999997643 4467899999999654322      245899999999 7999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-----CCCeeEcccccccCCccc
Q 019360           94 EFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-----NGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-----~~~~kl~Dfg~~~~~~~~  167 (342)
                      ||+. ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.     ...+||+|||+++.....
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9996 59999998653 4566677899999999999999999999999999999953     235789999999754322


Q ss_pred             c-CCCceecccCCcccCChhhhccC--CCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCCCC---CCCC
Q 019360          168 R-DDGLLHTTCGTPNYVAPEVINNK--GYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADFKS---PPWF  240 (342)
Q Consensus       168 ~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~---~~~~  240 (342)
                      . ........+||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||...................   ....
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence            1 11223456799999999999742  223578999999999999999 999997665444333222222211   1223


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +..+.+||.+||+.||++|||++++++||||..
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            456899999999999999999999999999964

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.3e-46  Score=352.54  Aligned_cols=253  Identities=28%  Similarity=0.390  Sum_probs=194.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~   89 (342)
                      ...+.|.+.+.||+|+||+||.+. ..+|+.||||++....      .+.+.+|+.+++++ +||||+++++++...+.+
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            344567788999999999998754 4679999999986432      23567899999876 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC------------
Q 019360           90 YIVLEFVTGGELFDKIASRGRL-------KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN------------  150 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~------------  150 (342)
                      |+||||+. ++|.+++......       ++..++.++.|++.||+|||++||+||||||+|||++.+            
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            99999995 5999999875432       223457899999999999999999999999999999654            


Q ss_pred             -CCeeEcccccccCCccccCC--CceecccCCcccCChhhhccC------CCCCcccchhhhhHHHHHHHh-CCCCCCCC
Q 019360          151 -GVLKVSDFGLSALPQQVRDD--GLLHTTCGTPNYVAPEVINNK------GYDGAKADLWSCGVILYVLMA-GYLPFEES  220 (342)
Q Consensus       151 -~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~ll~~l~~-g~~pf~~~  220 (342)
                       +.+||+|||+++........  ......+||+.|+|||++.+.      ...+.++|||||||++|+|++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             48999999999754332111  122345799999999999751      234689999999999999999 99999765


Q ss_pred             cHHHHHHHHHhcCCCCCC-------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          221 NLMALYKKIFKADFKSPP-------WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       221 ~~~~~~~~i~~~~~~~~~-------~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ....  ..+.......+.       .+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            4433  233333332221       23478999999999999999999999999999964

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=341.58  Aligned_cols=251  Identities=31%  Similarity=0.461  Sum_probs=187.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEE--------
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMA--------   84 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~--------   84 (342)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++++. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            37999999999999999999999999999999985432   333457889999999996 999999999984        


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCeeEcccc
Q 019360           85 SKTKIYIVLEFVTGGELFDKIAS---RGRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      ....+++||||+. |+|.+++..   .+.+++.+++.++.|++.||.|||++|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            3345899999995 689888764   467999999999999999999999999  9999999999999999999999999


Q ss_pred             cccCCccccCC----------CceecccCCcccCChhhhc---cCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH
Q 019360          160 LSALPQQVRDD----------GLLHTTCGTPNYVAPEVIN---NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY  226 (342)
Q Consensus       160 ~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~  226 (342)
                      ++.........          .......||+.|+|||++.   +..+ +.++|||||||++|+|++|+.||.........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            99754332111          0112456899999999983   3333 58999999999999999999999876554433


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          227 KKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       227 ~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      ....  ........+..+.+||.+||+.||++|||++|+++|.+-
T Consensus       263 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          263 NGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ---C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            3222  233445577889999999999999999999999998653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.3e-46  Score=334.30  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=195.3

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc--CCCCcceeEEEEEEe-
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL--IRHPNVIRMYEVMAS-   85 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~-   85 (342)
                      .+...++|++.+.||+|+||+||+|.+  +++.||+|++....      ...+.+|.+++..  ++||||+++++++.. 
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            456678999999999999999999987  68999999986532      1234456666655  789999999998653 


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCcEEecCCCCee
Q 019360           86 ---KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH--------SRGVCHRDLKPENLLLDANGVLK  154 (342)
Q Consensus        86 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH--------~~giiH~dlkp~NIli~~~~~~k  154 (342)
                         ...+++||||+++++|.++++. ..+++..+..++.|++.||+|||        +.||+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence               3468999999999999999964 56999999999999999999999        99999999999999999999999


Q ss_pred             EcccccccCCccccCC--CceecccCCcccCChhhhccCCCC-----CcccchhhhhHHHHHHHhC----------CCCC
Q 019360          155 VSDFGLSALPQQVRDD--GLLHTTCGTPNYVAPEVINNKGYD-----GAKADLWSCGVILYVLMAG----------YLPF  217 (342)
Q Consensus       155 l~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~ll~~l~~g----------~~pf  217 (342)
                      |+|||+++........  .......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999998643221111  112334789999999999865322     2689999999999999999          8888


Q ss_pred             CCC----cHHHHHHHHHhcCCCCCC--------CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          218 EES----NLMALYKKIFKADFKSPP--------WFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       218 ~~~----~~~~~~~~i~~~~~~~~~--------~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ...    ................+.        ..++++.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            542    122222232222211111        13467999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-47  Score=348.16  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE-eCCeE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA-SKTKI   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~   89 (342)
                      .+|++.+.||+|+||.||+|.+..++   ..||+|.+...  ......+.+.+|+.++++++||||+++++++. ..+..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            45889999999999999999876433   45899988642  23344578899999999999999999999864 45678


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999865 458999999999999999999999999999999999999999999999999997543211


Q ss_pred             C--CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHH
Q 019360          169 D--DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSA  244 (342)
Q Consensus       169 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~  244 (342)
                      .  ........+|+.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+..... ..+..++..+
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            1  111233456789999999987766 489999999999999999 7889987766666555555433 3456689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          245 KKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+++.+||+.||++|||+++++++
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.4e-46  Score=364.63  Aligned_cols=245  Identities=23%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             eeecccCceEEEEEEE--cCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARN--TETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      +.||+|+||.||+|.+  +.+++.||||++.... ......+.+.+|+.+|++++|+||+++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4899999999999955  4567899999997543 334445789999999999999999999999965 45889999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC-CCceecc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-DGLLHTT  176 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~  176 (342)
                      +++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            999999999888899999999999999999999999999999999999999999999999999975432211 1122334


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~  254 (342)
                      .+|+.|+|||++.+..+. .++|||||||++|||++ |+.||.+.+..+....+.... ...+..+++++.+||..||+.
T Consensus       533 ~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  611 (635)
T 4fl3_A          533 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  611 (635)
T ss_dssp             --CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            567889999999877764 89999999999999998 999999998888888777654 345667899999999999999


Q ss_pred             CCCCCCCHHHHhc
Q 019360          255 NPVTRITMAEVIE  267 (342)
Q Consensus       255 dP~~Rps~~e~l~  267 (342)
                      ||++|||++++++
T Consensus       612 dP~~RPs~~~l~~  624 (635)
T 4fl3_A          612 DVENRPGFAAVEL  624 (635)
T ss_dssp             STTTSCCHHHHHH
T ss_pred             CHhHCcCHHHHHH
Confidence            9999999999975

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.6e-47  Score=342.59  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=204.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++........  ...+.+|+.+++.++|+||+++++++...+..++
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            4568999999999999999999864 689999999976432221  2367899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           92 VLEFVTGGELFDKIASRG----RLKEDEARKYFQQLINAVDYCHSR---GVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~L~~LH~~---giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                      ||||+++++|.+++....    .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999998643    489999999999999999999999   9999999999999999999999999999754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc--------HHHHHHHHHhcC-C-
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN--------LMALYKKIFKAD-F-  234 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~--------~~~~~~~i~~~~-~-  234 (342)
                      ... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....        ............ . 
T Consensus       185 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (326)
T 3uim_A          185 DYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE  262 (326)
T ss_dssp             CSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred             Ccc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence            321 2223344569999999999987665 489999999999999999999995211        111111111110 0 


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          235 ---------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       235 ---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                               ..+...+..+.+++.+||+.||++|||++++++|..-
T Consensus       263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                     0011123679999999999999999999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=346.47  Aligned_cols=246  Identities=15%  Similarity=0.239  Sum_probs=199.1

Q ss_pred             ecCeeeeeeecccCceEEEEE-----EEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC---CCcceeEEEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFA-----RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR---HPNVIRMYEVMA   84 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~   84 (342)
                      .++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+.+|+.+++.++   |+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            467999999999999999999     467789999999996542      235667788777776   999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC----------
Q 019360           85 SKTKIYIVLEFVTGGELFDKIAS-----RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA----------  149 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~----------  149 (342)
                      ..+..|+||||+++++|.+++..     ...+++..++.++.|++.||+|||++||+||||||+|||++.          
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999999974     456999999999999999999999999999999999999988          


Q ss_pred             -CCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH
Q 019360          150 -NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK  228 (342)
Q Consensus       150 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~  228 (342)
                       ++.+||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........  
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~--  294 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--  294 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence             89999999999975433333444566789999999999988776 48999999999999999999999654321100  


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          229 IFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       229 i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                       ....+. ....++.+.+++..||+.+|.+|++..+.+.+.
T Consensus       295 -~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          295 -PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             -ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             -echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence             001111 123467799999999999999997665555543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.5e-47  Score=339.03  Aligned_cols=250  Identities=23%  Similarity=0.347  Sum_probs=202.5

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .|...+.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            345569999999999999986  588999999865322 23344568899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           94 EFVTGGELFDKIAS---RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      ||+++++|.+++..   ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            99999999999874   356999999999999999999999999999999999999999999999999998754432222


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHH----HHHHHHhcC----------C-C
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMA----LYKKIFKAD----------F-K  235 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~----~~~~i~~~~----------~-~  235 (342)
                      .......||+.|+|||.+.+. + +.++||||||+++|+|++|..||.......    ....+....          . .
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             ccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence            223345789999999998753 3 589999999999999999999997654322    222221111          1 1


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          236 SPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .+...+..+.+++.+||+.||++|||+++++++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            112234678999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=362.11  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             Ceeeee-eecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           15 KYELGR-TLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        15 ~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ++.+.+ .||+|+||.||+|.++  .++..||||++....  .....+.+.+|+++|++++|+||+++++++.. +.+|+
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            455555 8999999999999876  345679999997542  22345678999999999999999999999976 56999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC-
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-  169 (342)
                      ||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            99999999999999754 5699999999999999999999999999999999999999999999999999986432211 


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                      ........+++.|+|||++.+..+. .++|||||||++|||++ |+.||.+.+..+....+..+. ...+..+++++.+|
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  571 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL  571 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            1111223456889999999877664 89999999999999998 999999988888887777654 34566799999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      |.+||+.||++||+++++++
T Consensus       572 i~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          572 MSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999853

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-47  Score=372.25  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=205.6

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      ....++...++|++.+.||+|+||.||+|.+..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~p~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~   82 (676)
T 3qa8_A            5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPD   82 (676)
T ss_dssp             ------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred             CCCCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeec
Confidence            44556777899999999999999999999999999999999986532  3344567899999999999999999999875


Q ss_pred             e------CCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---
Q 019360           85 S------KTKIYIVLEFVTGGELFDKIASRG---RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGV---  152 (342)
Q Consensus        85 ~------~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~---  152 (342)
                      .      .+..|+||||++|++|.+++....   .+++..++.++.|++.||+|||++||+||||||+||+++.++.   
T Consensus        83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCE
T ss_pred             ccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCcee
Confidence            5      667899999999999999998754   5899999999999999999999999999999999999987664   


Q ss_pred             eeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHH---
Q 019360          153 LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKI---  229 (342)
Q Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i---  229 (342)
                      +||+|||++.....   ........||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+......+...   
T Consensus       163 vKL~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~  238 (676)
T 3qa8_A          163 HKIIDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE  238 (676)
T ss_dssp             EEECSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred             EEEccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence            99999999985432   223345678999999999987766 48999999999999999999999765332221100   


Q ss_pred             -----------HhcCC------CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          230 -----------FKADF------KSP----PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       230 -----------~~~~~------~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                 ..+..      +.+    ..+++.+.+||.+||+.||++|||++++++||||+.
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                       00111      111    124678999999999999999999999999999973

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6e-46  Score=358.27  Aligned_cols=249  Identities=25%  Similarity=0.381  Sum_probs=212.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|+++|++++|+||+++++++.. +.+|+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            45679999999999999999999864 567999999754321    3468899999999999999999999866 67899


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+++++|.+++...  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999999753  5689999999999999999999999999999999999999999999999999985432110


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                       .......++..|+|||++....+ +.++|||||||++|||++ |+.||.+....+....+.... ...+..++.++.+|
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  496 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             -ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence             11122346788999999987665 489999999999999999 999999988888777776553 34566789999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcC
Q 019360          248 ISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h  268 (342)
                      |.+||+.||++|||++++++.
T Consensus       497 i~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=334.87  Aligned_cols=253  Identities=22%  Similarity=0.387  Sum_probs=206.5

Q ss_pred             eeecCeeeeeeecccCceEEEEEE----EcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFAR----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~   86 (342)
                      ...++|++++.||+|+||.||+|.    +..+|+.||+|++...   .....+.+.+|+.+++.++|+||+++++++...
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            445679999999999999999998    4668999999999653   234456789999999999999999999998654


Q ss_pred             C--eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           87 T--KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        87 ~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      +  .+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            3  689999999999999999875 4599999999999999999999999999999999999999999999999999875


Q ss_pred             CccccCC-CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH----------------HHH
Q 019360          164 PQQVRDD-GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM----------------ALY  226 (342)
Q Consensus       164 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~----------------~~~  226 (342)
                      ....... .......++..|+|||.+.+..+ +.++|||||||++|+|++|..||......                .+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            4322111 11123456778999999987665 48999999999999999999998643211                111


Q ss_pred             HHHHh-cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          227 KKIFK-ADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       227 ~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      ..+.. ...+.+..+++++.+||.+||+.||++|||++++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11211 234456678999999999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=333.70  Aligned_cols=249  Identities=23%  Similarity=0.399  Sum_probs=194.2

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc--CCCCcceeEEEEEEeC--
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL--IRHPNVIRMYEVMASK--   86 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~--   86 (342)
                      ...++|++.+.||+|+||.||+|.+.  ++.||+|++.....      ....+|.+++..  ++|+||+++++++...  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34568999999999999999999885  89999999854321      233445555554  4899999999999877  


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEecCCCCeeEc
Q 019360           87 --TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR--------GVCHRDLKPENLLLDANGVLKVS  156 (342)
Q Consensus        87 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~--------giiH~dlkp~NIli~~~~~~kl~  156 (342)
                        ..+|+||||+++++|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              7899999999999999999764 689999999999999999999998        99999999999999999999999


Q ss_pred             ccccccCCccccCC--CceecccCCcccCChhhhccCCCCCc-----ccchhhhhHHHHHHHhC----------CCCCCC
Q 019360          157 DFGLSALPQQVRDD--GLLHTTCGTPNYVAPEVINNKGYDGA-----KADLWSCGVILYVLMAG----------YLPFEE  219 (342)
Q Consensus       157 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~ll~~l~~g----------~~pf~~  219 (342)
                      |||++.........  .......||+.|+|||++.+......     ++|||||||++|+|++|          ..||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            99998643322111  11224579999999999987655422     38999999999999999          777754


Q ss_pred             C-----cHHHHHHHHHhcCCC--CCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          220 S-----NLMALYKKIFKADFK--SPP-----WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       220 ~-----~~~~~~~~i~~~~~~--~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .     ........+......  .+.     .+++++.+||.+||+.||++|||++++++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2     122222222222211  111     245679999999999999999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=336.44  Aligned_cols=264  Identities=20%  Similarity=0.289  Sum_probs=192.7

Q ss_pred             CCCceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-
Q 019360            7 GASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-   85 (342)
Q Consensus         7 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-   85 (342)
                      .......++|++.+.||+|+||.||+|.+  +++.||+|++.......    .....|+..+..++|+||+++++.+.. 
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh----HHHHHHHHHHHhccCcchhhheeccccc
Confidence            44567789999999999999999999976  68999999996433211    122234444556899999999986532 


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeecCCCCcEEecCCCC
Q 019360           86 ----KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR---------GVCHRDLKPENLLLDANGV  152 (342)
Q Consensus        86 ----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~---------giiH~dlkp~NIli~~~~~  152 (342)
                          ...+++||||+++++|.+++.... .++..+..++.|++.||.|||+.         ||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence                336789999999999999997654 58999999999999999999999         9999999999999999999


Q ss_pred             eeEcccccccCCcccc------CCCceecccCCcccCChhhhccCC------CCCcccchhhhhHHHHHHHhCCCCCCCC
Q 019360          153 LKVSDFGLSALPQQVR------DDGLLHTTCGTPNYVAPEVINNKG------YDGAKADLWSCGVILYVLMAGYLPFEES  220 (342)
Q Consensus       153 ~kl~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~ll~~l~~g~~pf~~~  220 (342)
                      +||+|||+++......      .........||+.|+|||++.+..      ..+.++|||||||++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999997543211      112223457999999999997621      1236899999999999999997765321


Q ss_pred             -c----------------HHHHHHHHHhcC---CCCCCC------CCHHHHHHHHHhcCCCCCCCCCHHHHh------cC
Q 019360          221 -N----------------LMALYKKIFKAD---FKSPPW------FSTSAKKLISRILDPNPVTRITMAEVI------EN  268 (342)
Q Consensus       221 -~----------------~~~~~~~i~~~~---~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~e~l------~h  268 (342)
                       .                ............   ...+..      +++++.+||.+||+.||++|||++|++      .+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence             1                111111111111   111221      334799999999999999999999995      46


Q ss_pred             cccccCCCC
Q 019360          269 EWFKKGYKP  277 (342)
Q Consensus       269 ~~~~~~~~~  277 (342)
                      +|-++....
T Consensus       319 ~~~~~~~~~  327 (336)
T 3g2f_A          319 IWERNKSVS  327 (336)
T ss_dssp             CCCC-----
T ss_pred             HHHhcccCC
Confidence            777665443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=336.99  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=207.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|++..... .....+.+.+|+.++++++|+||+++++++...+..+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            345789999999999999999998853   499999865332 1222345678999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc--
Q 019360           91 IVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV--  167 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  167 (342)
                      +||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++......  
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999999999998754 699999999999999999999999999999999999997 689999999998653221  


Q ss_pred             -cCCCceecccCCcccCChhhhccC--------CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC-
Q 019360          168 -RDDGLLHTTCGTPNYVAPEVINNK--------GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP-  237 (342)
Q Consensus       168 -~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-  237 (342)
                       ..........|++.|+|||++.+.        ...+.++|||||||++|+|++|+.||...........+.....+.. 
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS  264 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC
Confidence             112223345689999999998752        2235789999999999999999999999888877777766544332 


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          238 -PWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       238 -~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ..++.++.+++.+||+.||++|||++++++.
T Consensus       265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence             3478899999999999999999999999963

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-46  Score=351.03  Aligned_cols=249  Identities=19%  Similarity=0.233  Sum_probs=195.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC-Ccc---------ee----
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNV---------IR----   78 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i---------v~----   78 (342)
                      ...|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.         +.    
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3458899999999999999999999999999999874443333445678999999999987 221         11    


Q ss_pred             --------EEEEEEe-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 019360           79 --------MYEVMAS-----KTKIYIVLEFVTGGELFDKIAS-------RGRLKEDEARKYFQQLINAVDYCHSRGVCHR  138 (342)
Q Consensus        79 --------l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~  138 (342)
                              +..++..     ...++++|+++ +++|.++++.       ...+++..+..++.|++.||+|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    1111111     23467888876 6799988852       2347788899999999999999999999999


Q ss_pred             cCCCCcEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhc----------cCCCCCcccchhhhhHHHH
Q 019360          139 DLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN----------NKGYDGAKADLWSCGVILY  208 (342)
Q Consensus       139 dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DiwslG~ll~  208 (342)
                      ||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++.          ...+ +.++|||||||++|
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~  308 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIY  308 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHH
Confidence            99999999999999999999998753322     345677 9999999994          2223 47999999999999


Q ss_pred             HHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          209 VLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       209 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +|++|+.||...+.......+.    .....+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       309 elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            9999999998876544333332    233467899999999999999999999999999999974

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.7e-45  Score=345.19  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=205.3

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~   89 (342)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++......     ..+.+|+++++.++| +++..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4568999999999999999999999999999999988643322     246789999999986 5556666667788889


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCeeEcccccccCCc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLL---DANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli---~~~~~~kl~Dfg~~~~~~  165 (342)
                      ++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8899999985 4679999999999999999999999999999999999999   588999999999997543


Q ss_pred             cccCC-----CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCCC--
Q 019360          166 QVRDD-----GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKADFK--  235 (342)
Q Consensus       166 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---~~~~~~~i~~~~~~--  235 (342)
                      .....     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..   ....+..+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            32211     11235679999999999988766 489999999999999999999997743   33333333322211  


Q ss_pred             ---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          236 ---SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       236 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                         ....++.++.+||..||+.||++||+++++++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence               12457899999999999999999999998875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7e-45  Score=358.02  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=211.8

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCC---CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTET---GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.++++++||||+++++++. ++.
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            346799999999999999999998654   4569999986432  3344567899999999999999999999985 456


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      .|+||||+++++|.+++..+. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            899999999999999998654 6899999999999999999999999999999999999999999999999999864322


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      . ........+|+.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..+....+.... .+.++.+++.+.
T Consensus       545 ~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             c-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            1 111223456789999999987766 489999999999999997 999999988888877776654 445677899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcC
Q 019360          246 KLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +||.+||+.||++|||+.++++.
T Consensus       623 ~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-44  Score=328.83  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=199.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhc--CCCCcceeEEEEEEeCC---
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL--IRHPNVIRMYEVMASKT---   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~---   87 (342)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++....      ...+.+|+++++.  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            36899999999999999999988  48999999986432      2356678888877  78999999999998775   


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCcEEecCCCCeeEccc
Q 019360           88 -KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH--------SRGVCHRDLKPENLLLDANGVLKVSDF  158 (342)
Q Consensus        88 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH--------~~giiH~dlkp~NIli~~~~~~kl~Df  158 (342)
                       ..|+||||+++++|.+++.+ ..+++.+++.++.|++.||.|||        +.||+||||||+||+++.++.+||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             79999999999999999976 46899999999999999999999        899999999999999999999999999


Q ss_pred             ccccCCccccCC--CceecccCCcccCChhhhccCCCC-----CcccchhhhhHHHHHHHhC----------CCCCCCC-
Q 019360          159 GLSALPQQVRDD--GLLHTTCGTPNYVAPEVINNKGYD-----GAKADLWSCGVILYVLMAG----------YLPFEES-  220 (342)
Q Consensus       159 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~ll~~l~~g----------~~pf~~~-  220 (342)
                      |++.........  .......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            998753321110  012345789999999999764322     2579999999999999999          7888654 


Q ss_pred             ----cHHHHHHHHHhcCCCC--CC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          221 ----NLMALYKKIFKADFKS--PP-----WFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       221 ----~~~~~~~~i~~~~~~~--~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                          ........+.......  +.     ..+..+.+|+.+||+.||++|||++++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                2334444443332222  11     123578999999999999999999999976

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-46  Score=342.18  Aligned_cols=243  Identities=22%  Similarity=0.284  Sum_probs=192.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh-----hhhHHHHHHHHHHHHhcCC---------CCccee
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL-----KHKMIGQIKREISTMKLIR---------HPNVIR   78 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~iv~   78 (342)
                      .++|++.+.||+|+||+||+|++  +|+.||+|++......     .....+.+.+|+.+++.++         |+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            47899999999999999999998  6899999999764321     2223457788999888875         777777


Q ss_pred             EEEEEE------------------------------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 019360           79 MYEVMA------------------------------SKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD  128 (342)
Q Consensus        79 l~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~  128 (342)
                      +.+++.                              ..+.+|+||||+++|++.+.+.+ ..+++..++.++.|++.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            777642                              26789999999999977666644 56899999999999999999


Q ss_pred             HHH-hCCceeecCCCCcEEecCCC--------------------CeeEcccccccCCccccCCCceecccCCcccCChhh
Q 019360          129 YCH-SRGVCHRDLKPENLLLDANG--------------------VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV  187 (342)
Q Consensus       129 ~LH-~~giiH~dlkp~NIli~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  187 (342)
                      ||| ++||+||||||+|||++.++                    .+||+|||+++....       ...+||+.|+|||+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~  248 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence            999 99999999999999999887                    899999999985332       13479999999999


Q ss_pred             hccCCCCCcccchhhhhHH-HHHHHhCCCCCCCCcH-HHHHHHHHhc-CCCC------CCCCCHHHHHHHHHhcCCCCCC
Q 019360          188 INNKGYDGAKADLWSCGVI-LYVLMAGYLPFEESNL-MALYKKIFKA-DFKS------PPWFSTSAKKLISRILDPNPVT  258 (342)
Q Consensus       188 ~~~~~~~~~~~DiwslG~l-l~~l~~g~~pf~~~~~-~~~~~~i~~~-~~~~------~~~~~~~~~~li~~~L~~dP~~  258 (342)
                      +.+..  +.++||||||++ .+++++|..||.+... ......+... ....      ++.+++++.+||.+||+.|   
T Consensus       249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred             hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence            98755  589999998777 6688899999855322 1222233321 1111      1136788999999999977   


Q ss_pred             CCCHHHHh-cCcccc
Q 019360          259 RITMAEVI-ENEWFK  272 (342)
Q Consensus       259 Rps~~e~l-~h~~~~  272 (342)
                        |++|+| +||||+
T Consensus       324 --sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 --SATDLLCQHSLFK  336 (336)
T ss_dssp             --SHHHHHHHCGGGC
T ss_pred             --CHHHHHhcCCCcC
Confidence              999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.8e-44  Score=321.25  Aligned_cols=223  Identities=18%  Similarity=0.221  Sum_probs=188.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+..++.++|+||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            37899999999999999999999999999999999866554455667889999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |||++|++|.+++..+  ....++..++.|++.||+|||++||+||||||+|||++.++.+||++++             
T Consensus       110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            9999999999998643  4666789999999999999999999999999999999999999998544             


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHH---HHHhcCCC----CCCCCCHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK---KIFKADFK----SPPWFSTSAK  245 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~---~i~~~~~~----~~~~~~~~~~  245 (342)
                               |++|        .+.++|||||||++|+|++|+.||.+.+......   ........    ..+.+++++.
T Consensus       175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                     2222        3588999999999999999999998765422110   11111111    1245889999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcC
Q 019360          246 KLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      +||.+||+.||++| |++|+++.
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHcccCCccC-CHHHHHHH
Confidence            99999999999999 99999964

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-44  Score=358.77  Aligned_cols=242  Identities=25%  Similarity=0.395  Sum_probs=199.1

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcC-CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe--
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTE-TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK--   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--   88 (342)
                      ..++|++.+.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.++++++||||+++++++...+.  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            34899999999999999999999976 78999999986432  23445678899999999999999999999987655  


Q ss_pred             ---EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           89 ---IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ---~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                         .|+||||++|++|.+++..  .+++.+++.++.|++.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence               7999999999999987765  69999999999999999999999999999999999999875 99999999987533


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                      ..      ....||+.|+|||++.+..  +.++|||||||++|+|++|..||.+......      .........++.+.
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l~  298 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYG  298 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHHH
T ss_pred             cC------CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHHH
Confidence            21      4457999999999997643  5899999999999999999999875321100      00000011357899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      +||.+||+.||++||+..+.+.|+|+.
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4.9e-37  Score=297.15  Aligned_cols=188  Identities=16%  Similarity=0.141  Sum_probs=137.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhh-------hhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeEEE
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKV-------LKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ...+.|++|.+..++....|+.|++|++.+...       ..+...+.+.+|+++|+++ .|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345678888888888888899999999965321       2234456799999999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||++|++|.+++.+++++++.   .|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+++.....  ..
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~  394 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS  394 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence            99999999999999998888875   47899999999999999999999999999999999999999999854332  23


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCC
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY  214 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~  214 (342)
                      ...+.+||+.|||||++.+..  ..++|+|++|++++++.++.
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             cccCceechhhccHHHhCCCC--CCcccccccccchhhhcccc
Confidence            345678999999999998653  36799999999988765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.8e-30  Score=249.91  Aligned_cols=188  Identities=20%  Similarity=0.220  Sum_probs=143.3

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-----hhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-----LKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ...+.||+|+||.||+|.  ..++.+++|.......     ......+++.+|++++++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  4578899998644222     122234568999999999999999965555556777899


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  .+||+|||+++.........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999999876        6689999999999999999999999999999988  99999999998643321111


Q ss_pred             -----ceecccCCcccCChhhhcc--CCCCCcccchhhhhHHHHHHHhCCCCC
Q 019360          172 -----LLHTTCGTPNYVAPEVINN--KGYDGAKADLWSCGVILYVLMAGYLPF  217 (342)
Q Consensus       172 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~pf  217 (342)
                           .....+||+.|||||++..  ..|. ..+|+|+..+-..+-+.++.+|
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence                 1235689999999999976  4443 6789999998888877776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=2.7e-27  Score=209.73  Aligned_cols=146  Identities=18%  Similarity=0.259  Sum_probs=116.6

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---------------hHHHHHHHHHHHHhcCCCCcceeEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---------------KMIGQIKREISTMKLIRHPNVIRMY   80 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~l~   80 (342)
                      |++.+.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+|++++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            34449999999999999999 8899999999964322111               23457889999999999  4 5555


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           81 EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      +++.. +..|+||||++|++|.+ +..      .....++.|++.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            55544 45699999999999987 421      23557999999999999999999999999999999 99999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhc
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVIN  189 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  189 (342)
                      ++.               +..++|||.+.
T Consensus       239 a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          239 SVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CEE---------------TTSTTHHHHHH
T ss_pred             CeE---------------CCCCCHHHHHH
Confidence            862               44578999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=4.6e-23  Score=180.25  Aligned_cols=139  Identities=22%  Similarity=0.293  Sum_probs=108.4

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcE--EEEEEecchhhh---------------------hhhHHHHHHHHHHHHhcCC
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGEN--VAIKILDKEKVL---------------------KHKMIGQIKREISTMKLIR   72 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~   72 (342)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++......                     .......+.+|+.+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999778999  999997543111                     0111236789999999998


Q ss_pred             CCcc--eeEEEEEEeCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCc
Q 019360           73 HPNV--IRMYEVMASKTKIYIVLEFVTG-G----ELFDKIASRGRLKEDEARKYFQQLINAVDYCH-SRGVCHRDLKPEN  144 (342)
Q Consensus        73 h~~i--v~l~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH-~~giiH~dlkp~N  144 (342)
                      |+++  ..+++.    ...++||||+.+ |    +|.+....   .++..+..++.|++.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  344432    246899999942 3    66665432   235578899999999999999 9999999999999


Q ss_pred             EEecCCCCeeEcccccccC
Q 019360          145 LLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus       145 Ili~~~~~~kl~Dfg~~~~  163 (342)
                      ||++.  .++|+|||+|..
T Consensus       202 ILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             EEESS--SEEECCCTTCEE
T ss_pred             EEEcC--cEEEEECccccc
Confidence            99988  999999999863

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=1.1e-19  Score=165.61  Aligned_cols=138  Identities=16%  Similarity=0.214  Sum_probs=100.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh---------------hhhH----HHHHHHHHHHHhcCCCCcc
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL---------------KHKM----IGQIKREISTMKLIRHPNV   76 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------~~~~----~~~~~~E~~~l~~l~h~~i   76 (342)
                      |++.+.||.|++|.||+|.+. +|+.||||+++.....               ....    .-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6999999987532110               0000    0123467778877755444


Q ss_pred             eeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-----
Q 019360           77 IRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-----  151 (342)
Q Consensus        77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-----  151 (342)
                      .-..-+....  .++||||++|.+|..+..      .+....++.|++.+|.+||++|||||||||.|||++.++     
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            2221111122  369999999988865422      234567889999999999999999999999999998776     


Q ss_pred             -----CeeEccccccc
Q 019360          152 -----VLKVSDFGLSA  162 (342)
Q Consensus       152 -----~~kl~Dfg~~~  162 (342)
                           .+.|+||+.+.
T Consensus       248 ~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TSEEEEEEECCCTTCE
T ss_pred             cccccceEEEEeCCcc
Confidence                 38899999765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.53  E-value=4.9e-14  Score=122.93  Aligned_cols=142  Identities=19%  Similarity=0.168  Sum_probs=113.4

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~   89 (342)
                      ..++.|++...++.|+.+.||++...  ++.+++|+........   ...+.+|+++++.+. +..+.++++++...+..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            34678999999999999999999753  6889999986432111   135778999999885 66788899999888999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-------------------------------------  132 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-------------------------------------  132 (342)
                      |+||||++|.+|.+.+.     +......++.+++++|+.||+                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999999876531     223345788999999999998                                     


Q ss_pred             ----------------------CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          133 ----------------------RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       133 ----------------------~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                                            ..++|||++|.||+++.+..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.39  E-value=5.5e-13  Score=115.75  Aligned_cols=136  Identities=15%  Similarity=0.178  Sum_probs=101.2

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc--ceeEEEEEEeCCeE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN--VIRMYEVMASKTKI   89 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~   89 (342)
                      ....|.+....+.|..+.||++.. .+|..+++|+.....      ...+.+|+.+++.+.+.+  +.+++++....+..
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            345577655555677799999964 567889999975431      135678999998886544  45688888887889


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG-----------------------------------  134 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~g-----------------------------------  134 (342)
                      ++||||++|.+|.  ..   ..+   ...++.+++..|+.||+..                                   
T Consensus        91 ~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999999998884  21   112   2356777788888888643                                   


Q ss_pred             -----------------------ceeecCCCCcEEecCCCCeeEccccccc
Q 019360          135 -----------------------VCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       135 -----------------------iiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                                             ++|+|++|.||+++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999877667799999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.29  E-value=1e-11  Score=113.34  Aligned_cols=141  Identities=22%  Similarity=0.358  Sum_probs=105.8

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEec--chhhhhhhHHHHHHHHHHHHhcCC--CCcceeEEEEEEeC---CeE
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILD--KEKVLKHKMIGQIKREISTMKLIR--HPNVIRMYEVMASK---TKI   89 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~---~~~   89 (342)
                      ..++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|+.+++.+.  +..+.+++.++.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            34778999999999998764  4678899875  32211  11246778999999887  44578888888766   458


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-------------------------------------  132 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-------------------------------------  132 (342)
                      |+||||++|..+.+.  .-..++..+...++.+++.+|+.||+                                     
T Consensus       117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            899999999877431  12346788889999999999999997                                     


Q ss_pred             ---------------------CCceeecCCCCcEEecCCCC--eeEcccccccC
Q 019360          133 ---------------------RGVCHRDLKPENLLLDANGV--LKVSDFGLSAL  163 (342)
Q Consensus       133 ---------------------~giiH~dlkp~NIli~~~~~--~kl~Dfg~~~~  163 (342)
                                           ..++|||+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 35899999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.23  E-value=2.9e-12  Score=114.19  Aligned_cols=184  Identities=18%  Similarity=0.230  Sum_probs=121.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCc--ceeEEEEEEeCC---eEEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPN--VIRMYEVMASKT---KIYIV   92 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~l~~~~~~~~---~~~lv   92 (342)
                      ++.++.|....||++.     ..+++|+....     .....+.+|+++|+.+. +..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999999863     46899986532     22357889999998874 332  345555443333   34889


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS----------------------------------------  132 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~----------------------------------------  132 (342)
                      |++++|.+|.....  ..++.++...++.+++..|+.||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988875433  236788888899999999999986                                        


Q ss_pred             ------------------CCceeecCCCCcEEecC--CCCeeEcccccccCCccccCCCceecc---cC---------Cc
Q 019360          133 ------------------RGVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQQVRDDGLLHTT---CG---------TP  180 (342)
Q Consensus       133 ------------------~giiH~dlkp~NIli~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~---~g---------t~  180 (342)
                                        ..++|+|++|.||+++.  ...+.|+||+.+...+...+-......   .+         ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                              13699999999999988  456889999987642211000000000   00         00


Q ss_pred             ccCC-hhhhccCCCCCcccchhhhhHHHHHHHhCCCCC
Q 019360          181 NYVA-PEVINNKGYDGAKADLWSCGVILYVLMAGYLPF  217 (342)
Q Consensus       181 ~y~a-PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf  217 (342)
                      +... |+......   ...+.|++|.++|.+.+|..+|
T Consensus       253 ~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHH
Confidence            1112 22222111   2268999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.85  E-value=6e-08  Score=84.40  Aligned_cols=131  Identities=14%  Similarity=0.191  Sum_probs=96.7

Q ss_pred             ecccCc-eEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeEEEEEeccCCC
Q 019360           22 LGEGSF-AKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKIYIVLEFVTGG   99 (342)
Q Consensus        22 lG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~   99 (342)
                      +..|.- +.||+......+..+++|+-....      ...+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            333443 479998887778889999875432      235778999998775 334678888888899999999999998


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 019360          100 ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR----------------------------------------------  133 (342)
Q Consensus       100 ~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~----------------------------------------------  133 (342)
                      ++.+.....    ......+..++...|+.||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765431    123345566666667766641                                              


Q ss_pred             ------------CceeecCCCCcEEecCCCCeeEccccccc
Q 019360          134 ------------GVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       134 ------------giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                                  .++|+|+++.||+++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        17899999999999887777899999775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.84  E-value=5.5e-08  Score=86.48  Aligned_cols=133  Identities=19%  Similarity=0.234  Sum_probs=94.9

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC---cceeEEEEEE-eCCeEEEEEe
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP---NVIRMYEVMA-SKTKIYIVLE   94 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~-~~~~~~lv~e   94 (342)
                      ++.++.|....||++     |..+++|+....     .....+.+|+++|+.+.+.   .+.+++.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788888899988     567899985321     2235788999999998743   3556666664 4456789999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 019360           95 FVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR-----------------------------------------  133 (342)
Q Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~-----------------------------------------  133 (342)
                      +++|.++....-  ..++..+...++.++...|+.||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988866321  2245555666666666666666642                                         


Q ss_pred             -------------------CceeecCCCCcEEecC---CCC-eeEcccccccC
Q 019360          134 -------------------GVCHRDLKPENLLLDA---NGV-LKVSDFGLSAL  163 (342)
Q Consensus       134 -------------------giiH~dlkp~NIli~~---~~~-~kl~Dfg~~~~  163 (342)
                                         .++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   455 58999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.51  E-value=2.7e-07  Score=85.06  Aligned_cols=80  Identities=18%  Similarity=0.160  Sum_probs=50.0

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhh-hhh---hHHHHHHHHHHHHhcCCC--Cc-ceeEEEEEEeCCeEE
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LKH---KMIGQIKREISTMKLIRH--PN-VIRMYEVMASKTKIY   90 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~~-iv~l~~~~~~~~~~~   90 (342)
                      ..+.||.|..+.||++.+..+++.+++|....... ...   ....++..|+++++.+..  +. +.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            36789999999999998766678899998653211 000   112356778888887742  33 4455544  344567


Q ss_pred             EEEeccCCC
Q 019360           91 IVLEFVTGG   99 (342)
Q Consensus        91 lv~e~~~~~   99 (342)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.43  E-value=2.5e-07  Score=83.94  Aligned_cols=85  Identities=7%  Similarity=0.132  Sum_probs=55.4

Q ss_pred             eeeeee-cccCceEEEEEEEc--C----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-C--CcceeEEEEEEeC
Q 019360           17 ELGRTL-GEGSFAKVKFARNT--E----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-H--PNVIRMYEVMASK   86 (342)
Q Consensus        17 ~~~~~l-G~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~   86 (342)
                      ...+.| +.|....+|++...  .    +++.+++|+..............+.+|+.+++.+. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            445778 88989999988653  1    25679999875432000000124668888888775 2  3466788777554


Q ss_pred             ---CeEEEEEeccCCCch
Q 019360           87 ---TKIYIVLEFVTGGEL  101 (342)
Q Consensus        87 ---~~~~lv~e~~~~~~L  101 (342)
                         +..|+|||+++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=1.1e-05  Score=72.21  Aligned_cols=135  Identities=14%  Similarity=0.192  Sum_probs=76.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-----CCcceeEE-E--EEEeCCeEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-----HPNVIRMY-E--VMASKTKIY   90 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~l~-~--~~~~~~~~~   90 (342)
                      ++.|+.|..+.||++...  +..+++|+.....       ..+..|..+++.|.     .|.++... +  +....+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            456666778999998763  3459999986521       12334555555443     23333310 0  123466789


Q ss_pred             EEEeccCCCchH--------------HHHHh-cCCC-------------CHHH---------------------------
Q 019360           91 IVLEFVTGGELF--------------DKIAS-RGRL-------------KEDE---------------------------  115 (342)
Q Consensus        91 lv~e~~~~~~L~--------------~~l~~-~~~l-------------~~~~---------------------------  115 (342)
                      +||+|++|..+.              ..++. ...+             .+..                           
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986431              11111 0101             1110                           


Q ss_pred             ----HHHHHHHHHHHHHHHH-------------hCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          116 ----ARKYFQQLINAVDYCH-------------SRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       116 ----~~~i~~~l~~~L~~LH-------------~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                          +..+...+..++.+|+             ..+++|||+++.||+++.++.+.|+||+.+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                1111122334566665             3579999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.09  E-value=2.8e-05  Score=69.02  Aligned_cols=76  Identities=17%  Similarity=0.250  Sum_probs=59.8

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeEEEEEe
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR---HPNVIRMYEVMASKTKIYIVLE   94 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~e   94 (342)
                      -.+.|+.|....+|++..  ++..+++|+.....      ...+..|++.|+.|.   ...+.+++.+....+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            467889999999999875  46789999875421      346778999888874   3567788888887888999999


Q ss_pred             ccCCCch
Q 019360           95 FVTGGEL  101 (342)
Q Consensus        95 ~~~~~~L  101 (342)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.07  E-value=4.1e-05  Score=63.36  Aligned_cols=122  Identities=16%  Similarity=0.137  Sum_probs=81.9

Q ss_pred             CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceecc
Q 019360           99 GELFDKIAS-RGRLKEDEARKYFQQLINAVDYCH-SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT  176 (342)
Q Consensus        99 ~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH-~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  176 (342)
                      .+|.++|.. ..+++++++|.++.|.+.+|..+- ...-..+=+.|..|++..+|.|.+.+ +.+.              
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence            478999886 468999999999999999988872 22222444567899999999998874 2111              


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (342)
                      .....+.|||...  ...+.+.=|||||+++|..+--..|=                 .-+..+|+++.+||..|.+.
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            1133466888763  22347789999999999877533331                 12334899999999999866

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.07  E-value=1.8e-05  Score=73.28  Aligned_cols=32  Identities=19%  Similarity=0.330  Sum_probs=27.7

Q ss_pred             HhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360          131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus       131 H~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      +...++|||++|.||+++.++ ++++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            356799999999999998776 99999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.92  E-value=3e-05  Score=68.43  Aligned_cols=71  Identities=13%  Similarity=0.022  Sum_probs=45.2

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeEEEEEecc-
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKIYIVLEFV-   96 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~-   96 (342)
                      ++.|+.|....+|++      +.+++|+.......   . -...+|+.+++.+...++ .+++.+.  .+.-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---Y-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc---e-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            788999999999998      45899988643111   0 122468887777753333 3555543  33346899999 


Q ss_pred             CCCch
Q 019360           97 TGGEL  101 (342)
Q Consensus        97 ~~~~L  101 (342)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            76554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.69  E-value=6.2e-05  Score=66.86  Aligned_cols=139  Identities=14%  Similarity=0.161  Sum_probs=77.1

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc--ceeEEEE------EEeCCe
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN--VIRMYEV------MASKTK   88 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~------~~~~~~   88 (342)
                      .-++.|+.|....+|++... + ..+++|+.....  .   ...+..|+.+++.|...+  +.+++..      ....+.
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-S-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             eEeeccCCCcccceEEEEeC-C-ccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            44667888888999998763 3 368899986521  1   124456777776664222  2222211      123456


Q ss_pred             EEEEEeccCCCchHH--------------HHHhc-CC--------CCHHHHHH---------------HHHHHHHHHHHH
Q 019360           89 IYIVLEFVTGGELFD--------------KIASR-GR--------LKEDEARK---------------YFQQLINAVDYC  130 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~--------------~l~~~-~~--------l~~~~~~~---------------i~~~l~~~L~~L  130 (342)
                      .+++++|++|..+..              .++.. ..        ........               +-..+...+..+
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            789999998864310              11110 00        01110000               001133445555


Q ss_pred             Hh-------CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          131 HS-------RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       131 H~-------~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ..       .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            42       369999999999999877666899998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.66  E-value=0.00033  Score=61.23  Aligned_cols=78  Identities=12%  Similarity=0.059  Sum_probs=54.7

Q ss_pred             CeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC---CcceeEEEEEEeCCeEEE
Q 019360           15 KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH---PNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        15 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~l~~~~~~~~~~~l   91 (342)
                      +..-++.+|.|..+.||++.. .+|+.|.+|+........   ...+..|++.|+.|..   -.+.+++.+.  .  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence            466788999999999999986 578999999875432211   2356789999888742   2344555542  2  368


Q ss_pred             EEeccCCCc
Q 019360           92 VLEFVTGGE  100 (342)
Q Consensus        92 v~e~~~~~~  100 (342)
                      ||||++++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.66  E-value=0.00013  Score=65.27  Aligned_cols=136  Identities=17%  Similarity=0.235  Sum_probs=70.8

Q ss_pred             eeeecccCceE-EEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC--CcceeEEEEEEeCCeEEEEEec
Q 019360           19 GRTLGEGSFAK-VKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH--PNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        19 ~~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      .+.|+.|+... +|+... .+|+.+++|.......      ..+..|+.+++.+..  -.+.+++.+....+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            44565554444 556643 2367788886543210      123456777766642  23456666543333  689999


Q ss_pred             cCCCchHHHHHhc--------------------------CCCCHHHHHH--------HH------------HHHHHHHHH
Q 019360           96 VTGGELFDKIASR--------------------------GRLKEDEARK--------YF------------QQLINAVDY  129 (342)
Q Consensus        96 ~~~~~L~~~l~~~--------------------------~~l~~~~~~~--------i~------------~~l~~~L~~  129 (342)
                      +.+..+.+.+...                          ..++......        +.            ..+...+..
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9776664433211                          0122211100        00            011122222


Q ss_pred             H------HhCCceeecCCCCcEEecCC----CCeeEcccccccC
Q 019360          130 C------HSRGVCHRDLKPENLLLDAN----GVLKVSDFGLSAL  163 (342)
Q Consensus       130 L------H~~giiH~dlkp~NIli~~~----~~~kl~Dfg~~~~  163 (342)
                      +      +...++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            2      23469999999999999874    6799999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.63  E-value=0.00012  Score=66.80  Aligned_cols=136  Identities=15%  Similarity=0.208  Sum_probs=81.2

Q ss_pred             eeeecccCceEEEEEEEcC-------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeEE
Q 019360           19 GRTLGEGSFAKVKFARNTE-------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-VIRMYEVMASKTKIY   90 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~   90 (342)
                      ++.|..|-...+|++....       .++.+++|+.....    .....+.+|.++++.|...+ ..++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            4567677778889987642       35789999864311    11235568999998886323 3566666543    2


Q ss_pred             EEEeccCCCchH--------------HHH---Hhc-----CCCC--HHHHHHHHHHHHH-------------------HH
Q 019360           91 IVLEFVTGGELF--------------DKI---ASR-----GRLK--EDEARKYFQQLIN-------------------AV  127 (342)
Q Consensus        91 lv~e~~~~~~L~--------------~~l---~~~-----~~l~--~~~~~~i~~~l~~-------------------~L  127 (342)
                      +||||++|..|.              ..+   +.-     ....  +.++.++..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            899999885542              111   111     1111  3455555544422                   23


Q ss_pred             HHHH----h----CCceeecCCCCcEEecCC----CCeeEccccccc
Q 019360          128 DYCH----S----RGVCHRDLKPENLLLDAN----GVLKVSDFGLSA  162 (342)
Q Consensus       128 ~~LH----~----~giiH~dlkp~NIli~~~----~~~kl~Dfg~~~  162 (342)
                      ..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3332    2    258999999999999876    789999999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.61  E-value=0.00015  Score=67.29  Aligned_cols=75  Identities=12%  Similarity=0.198  Sum_probs=49.9

Q ss_pred             eeeeecccCceEEEEEEEcC-------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeE
Q 019360           18 LGRTLGEGSFAKVKFARNTE-------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKI   89 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~   89 (342)
                      -++.|+.|....||++....       .++.+++|+.....  .   ...+.+|..+++.|...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35678888889999998653       25789999984311  1   1234478888888763334 566766542    


Q ss_pred             EEEEeccCCCch
Q 019360           90 YIVLEFVTGGEL  101 (342)
Q Consensus        90 ~lv~e~~~~~~L  101 (342)
                      .+|+||++|.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            289999987443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.57  E-value=0.00023  Score=63.38  Aligned_cols=135  Identities=18%  Similarity=0.131  Sum_probs=76.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc--ceeEEEE-----EEeCCeEEEE
Q 019360           20 RTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN--VIRMYEV-----MASKTKIYIV   92 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~-----~~~~~~~~lv   92 (342)
                      ..|+ |....||++.. .+|+.+++|+...... .   ...+..|..+++.+...+  +.+++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 77788998754 3566899999863221 1   234566777777664222  3333332     1234567889


Q ss_pred             EeccCCCchH----H-------H---HHh---c------CCCCHHHH----------------------HHHHHHHHHHH
Q 019360           93 LEFVTGGELF----D-------K---IAS---R------GRLKEDEA----------------------RKYFQQLINAV  127 (342)
Q Consensus        93 ~e~~~~~~L~----~-------~---l~~---~------~~l~~~~~----------------------~~i~~~l~~~L  127 (342)
                      |++++|..+.    .       .   ++.   .      ...+....                      ...+..++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999885431    0       1   111   0      01121111                      11111222222


Q ss_pred             HHH----HhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          128 DYC----HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       128 ~~L----H~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ..+    ....++|||+++.||+++ + .+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            222    234589999999999998 4 89999998765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.47  E-value=0.00028  Score=63.98  Aligned_cols=75  Identities=13%  Similarity=0.107  Sum_probs=44.7

Q ss_pred             eeeecccCceEEEEEEEcC--------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeE
Q 019360           19 GRTLGEGSFAKVKFARNTE--------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-VIRMYEVMASKTKI   89 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~   89 (342)
                      .+.|+.|....+|++....        .++.+++|+......   . ......|..+++.+...+ +.++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            5677888888999997643        136899998754221   1 112357888888775334 34666544  22  


Q ss_pred             EEEEeccCCCch
Q 019360           90 YIVLEFVTGGEL  101 (342)
Q Consensus        90 ~lv~e~~~~~~L  101 (342)
                      ++||||++|..+
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999988543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.29  E-value=0.001  Score=59.62  Aligned_cols=31  Identities=23%  Similarity=0.466  Sum_probs=27.4

Q ss_pred             CCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360          133 RGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus       133 ~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999998888899999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.08  E-value=0.0026  Score=59.37  Aligned_cols=76  Identities=14%  Similarity=0.218  Sum_probs=49.2

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeEEEEEecc
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKIYIVLEFV   96 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~   96 (342)
                      -++.|+.|-...+|++.....+..+++|+.....   ...+ ...+|..+++.|...++ .++++++.  +  .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            3567888888999999875445789999875321   1111 12478999988875555 46777663  2  2599999


Q ss_pred             CCCch
Q 019360           97 TGGEL  101 (342)
Q Consensus        97 ~~~~L  101 (342)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.03  E-value=0.038  Score=50.85  Aligned_cols=75  Identities=15%  Similarity=0.184  Sum_probs=47.8

Q ss_pred             eeeecccCceEEEEEEEcCC-------CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeEE
Q 019360           19 GRTLGEGSFAKVKFARNTET-------GENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-VIRMYEVMASKTKIY   90 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~   90 (342)
                      ++.|..|-...+|++.....       ++.+++++.....   .... ...+|.++++.+...+ ..++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFY-DSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            56677788888999987521       5789999875421   1111 2357888888775333 34556543  22  6


Q ss_pred             EEEeccCCCch
Q 019360           91 IVLEFVTGGEL  101 (342)
Q Consensus        91 lv~e~~~~~~L  101 (342)
                      .||||++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.98  E-value=0.067  Score=48.84  Aligned_cols=29  Identities=34%  Similarity=0.590  Sum_probs=25.0

Q ss_pred             ceeecCCCCcEEe------cCCCCeeEcccccccC
Q 019360          135 VCHRDLKPENLLL------DANGVLKVSDFGLSAL  163 (342)
Q Consensus       135 iiH~dlkp~NIli------~~~~~~kl~Dfg~~~~  163 (342)
                      ++|+|+.+.||++      +.+..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567899999998863

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.52  E-value=1  Score=37.10  Aligned_cols=83  Identities=14%  Similarity=0.098  Sum_probs=60.4

Q ss_pred             CCCcceeEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeecCCCCcEEecCC
Q 019360           72 RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD-YCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        72 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~-~LH~~giiH~dlkp~NIli~~~  150 (342)
                      .||+.  -..+-..++.+.+.++.-+++.=...+++   ++....++++..|+.... ++  ..-+|--++|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57777  44455677777777776544433344443   788899999998887665 44  445777899999999999


Q ss_pred             CCeeEcccccc
Q 019360          151 GVLKVSDFGLS  161 (342)
Q Consensus       151 ~~~kl~Dfg~~  161 (342)
                      +.+++.-.|+-
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999987753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.49  E-value=0.61  Score=38.32  Aligned_cols=113  Identities=18%  Similarity=0.266  Sum_probs=76.0

Q ss_pred             CCCcceeEEEEEEeCCeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           72 RHPNVIRMYEVMASKTKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        72 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                      .||+.+.. .+-..++.+.+.++.-+.+ ++.. +.+   .+....++++..|+....++  ..-+|--++|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~---~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS---FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG---SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh---cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            57888866 5666777777766654322 3322 333   68889999999998877444  344788899999999999


Q ss_pred             CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccch-hhhhHHHHHHHhCCCCC
Q 019360          151 GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADL-WSCGVILYVLMAGYLPF  217 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~ll~~l~~g~~pf  217 (342)
                      +.+++.--|+...                   ++|..     .  ...|. -..=|++..+++++..|
T Consensus       116 ~~p~i~~RGik~~-------------------l~P~~-----~--~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          116 GLPIAKTRGLQNV-------------------VDPLP-----V--SEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             SCEEESCCEETTT-------------------BSCCC-----C--CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCEEEEEccCccC-------------------CCCCC-----C--CHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999997775331                   12221     0  12233 34667888888888776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.22  E-value=0.037  Score=51.66  Aligned_cols=64  Identities=8%  Similarity=0.099  Sum_probs=18.1

Q ss_pred             eeeeeecccCceEEEEEEEcCCCcEEEE------EEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEE
Q 019360           17 ELGRTLGEGSFAKVKFARNTETGENVAI------KILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMA   84 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~   84 (342)
                      .+.+.||   ||.||++.......+||+      |...... ...+....+.+|..+++.++|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEE
Confidence            3456676   999999988765567888      6554322 22333456778999999999999999887754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	342
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-96
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-94
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-90
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-88
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-88
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-87
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-87
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-85
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-84
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-83
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-83
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-81
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-81
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-80
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-79
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-79
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-79
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-77
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-76
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-76
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-76
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-75
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-74
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-72
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-71
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-70
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-69
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-69
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-68
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-68
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-68
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-68
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-68
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-67
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-66
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-65
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-65
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-64
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-63
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-63
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-62
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-61
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-60
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-60
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-57
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-54
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-47
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-25

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  283 bits (726), Expect = 5e-96
 Identities = 95/259 (36%), Positives = 148/259 (57%), Gaps = 5/259 (1%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E+GR LG+G F  V  AR  ++   +A+K+L K ++ K  +  Q++RE+     +RHP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+Y      T++Y++LE+   G ++ ++    +  E     Y  +L NA+ YCHS+ 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V HRD+KPENLLL + G LK++DFG S             T CGT +Y+ PE+I  + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
             K DLWS GV+ Y  + G  PFE +     YK+I + +F  P + +  A+ LISR+L  
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241

Query: 255 NPVTRITMAEVIENEWFKK 273
           NP  R  + EV+E+ W   
Sbjct: 242 NPSQRPMLREVLEHPWITA 260

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  278 bits (712), Expect = 9e-94
 Identities = 98/267 (36%), Positives = 156/267 (58%), Gaps = 5/267 (1%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           V  ++L +TLGEG++ +V+ A N  T E VA+KI+D ++ +       IK+EI   K++ 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
           H NV++ Y         Y+ LE+ +GGELFD+I     + E +A+++F QL+  V Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
            G+ HRD+KPENLLLD    LK+SDFGL+ + +    + LL+  CGT  YVAPE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 193 YDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKADFKSPPW--FSTSAKKLIS 249
           +     D+WSCG++L  ++AG LP+ + S+    Y    +      PW    ++   L+ 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 250 RILDPNPVTRITMAEVIENEWFKKGYK 276
           +IL  NP  RIT+ ++ ++ W+ K  K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLK 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  270 bits (691), Expect = 2e-90
 Identities = 83/264 (31%), Positives = 137/264 (51%), Gaps = 1/264 (0%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + R   ++ G+ LGEGSF+ V  AR   T    AIKIL+K  ++K   +  + RE   M 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            + HP  +++Y       K+Y  L +   GEL   I   G   E   R Y  ++++A++Y
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            H +G+ HRDLKPEN+LL+ +  ++++DFG + +          ++  GT  YV+PE++ 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
            K      +DLW+ G I+Y L+AG  PF   N   +++KI K ++  P  F   A+ L+ 
Sbjct: 184 EKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242

Query: 250 RILDPNPVTRITMAEVIENEWFKK 273
           ++L  +   R+   E+      K 
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKA 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  264 bits (677), Expect = 5e-88
 Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 11/276 (3%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +   R +G GSF  V FAR+    E VAIK +       ++    I +E+  ++ +RHP
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N I+       +   ++V+E+  G         +  L+E E        +  + Y HS  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI--NNKG 192
           + HRD+K  N+LL   G++K+ DFG +++          ++  GTP ++APEVI   ++G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW--FSTSAKKLISR 250
               K D+WS G+    L     P    N M+    I + +  +     +S   +  +  
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNID 286
            L   P  R T   ++++ +  +  +PP+     I 
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQ 284

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  266 bits (680), Expect = 6e-88
 Identities = 76/302 (25%), Positives = 141/302 (46%), Gaps = 14/302 (4%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
            +    Y++   LG G+F  V       TG     K ++    L       +K EIS M 
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMN 81

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVD 128
            + HP +I +++    K ++ ++LEF++GGELFD+IA+   ++ E E   Y +Q    + 
Sbjct: 82  QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 129 YCHSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
           + H   + H D+KPEN++ +      +K+ DFGL+    ++  D ++  T  T  + APE
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPE 198

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFST 242
           +++ +       D+W+ GV+ YVL++G  PF   + +   + + + D++         S 
Sbjct: 199 IVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
            AK  I  +L   P  R+T+ + +E+ W K  +   +   P+   + +     E      
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 317

Query: 303 LV 304
             
Sbjct: 318 AP 319

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  263 bits (674), Expect = 5e-87
 Identities = 84/296 (28%), Positives = 141/296 (47%), Gaps = 15/296 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y++   LG G+F  V       TG N A K +        +    +++EI TM ++RHP
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVLRHP 83

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSR 133
            ++ +++      ++ ++ EF++GGELF+K+A    ++ EDEA +Y +Q+   + + H  
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 134 GVCHRDLKPENLLL--DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
              H DLKPEN++     +  LK+ DFGL+A    +     +  T GT  + APEV   K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSAKKL 247
              G   D+WS GV+ Y+L++G  PF   N     + +   D+          S   K  
Sbjct: 201 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQ-PNIDLDDVDSIFNESMDSRN 302
           I ++L  +P TR+T+ + +E+ W   G  P    Q P+     +        D+  
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  261 bits (667), Expect = 9e-87
 Identities = 75/271 (27%), Positives = 137/271 (50%), Gaps = 13/271 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +E+   LG+G+F KV  A+N ET    A K++D +     + +     EI  +    HPN
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 70

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR-LKEDEARKYFQQLINAVDYCHSRG 134
           ++++ +    +  ++I++EF  GG +   +    R L E + +   +Q ++A++Y H   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRDLK  N+L   +G +K++DFG+SA  +  R      +  GTP ++APEV+  +   
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 195 ----GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKL 247
                 KAD+WS G+ L  +     P  E N M +  KI K++      P  +S++ K  
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPP 278
           + + L+ N   R T ++++++ +       P
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  258 bits (660), Expect = 1e-85
 Identities = 75/275 (27%), Positives = 141/275 (51%), Gaps = 11/275 (4%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            KY     +G+G+   V  A +  TG+ VAI+ ++ ++  K +    I  EI  M+  ++
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           PN++   +      ++++V+E++ GG L D + +   + E +     ++ + A+++ HS 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            V HRD+K +N+LL  +G +K++DFG  A  Q   +     T  GTP ++APEV+  K Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---DFKSPPWFSTSAKKLISR 250
              K D+WS G++   ++ G  P+   N +     I      + ++P   S   +  ++R
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
            LD +   R +  E++++++ K   KP S   P I
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKI-AKPLSSLTPLI 286

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (648), Expect = 4e-84
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 16/272 (5%)

Query: 11  TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           +R   YE+  T+G GS+ + +  R    G+ +  K LD    +       +  E++ ++ 
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE 59

Query: 71  IRHPNVIRMYEVMASKT--KIYIVLEFVTGGELFDKIA----SRGRLKEDEARKYFQQLI 124
           ++HPN++R Y+ +  +T   +YIV+E+  GG+L   I      R  L E+   +   QL 
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 125 NAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
            A+  CH R      V HRDLKP N+ LD    +K+ DFGL+ +     D        GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGT 177

Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-PP 238
           P Y++PE +N   Y+  K+D+WS G +LY L A   PF   +   L  KI +  F+  P 
Sbjct: 178 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236

Query: 239 WFSTSAKKLISRILDPNPVTRITMAEVIENEW 270
            +S    ++I+R+L+     R ++ E++EN  
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  252 bits (644), Expect = 2e-83
 Identities = 88/275 (32%), Positives = 141/275 (51%), Gaps = 19/275 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH------KMIGQIKREISTM 68
            YE    LG G  + V+   +  T +  A+KI+D             ++     +E+  +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 69  KLIR-HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAV 127
           + +  HPN+I++ +   + T  ++V + +  GELFD +  +  L E E RK  + L+  +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 128 DYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
              H   + HRDLKPEN+LLD +  +K++DFG S    Q+     L   CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180

Query: 188 I-----NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW- 239
           I     +N    G + D+WS GVI+Y L+AG  PF     M + + I   +  F SP W 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 240 -FSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
            +S + K L+SR L   P  R T  E + + +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (645), Expect = 3e-83
 Identities = 100/278 (35%), Positives = 156/278 (56%), Gaps = 13/278 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y+    LG G+F++V  A +  T + VAIK + K+ +      G ++ EI+ +  I+HP
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++ + ++  S   +Y++++ V+GGELFD+I  +G   E +A +   Q+++AV Y H  G
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 135 VCHRDLKPENLLL---DANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           + HRDLKPENLL    D +  + +SDFGLS   +      +L T CGTP YVAPEV+  K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD--FKSPPW--FSTSAKKL 247
            Y     D WS GVI Y+L+ GY PF + N   L+++I KA+  F SP W   S SAK  
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           I  +++ +P  R T  + +++ W             ++
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSV 281

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 2e-81
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 15/272 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY +   LG G F  V     T + +    K +      K      +K+EIS + + RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSR 133
           N++ ++E   S  ++ ++ EF++G ++F++I +    L E E   Y  Q+  A+ + HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 134 GVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
            + H D++PEN++     +  +K+ +FG +   +Q++           P Y APEV  + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 192 GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSAKKL 247
                  D+WS G ++YVL++G  PF       + + I  A++          S  A   
Sbjct: 179 VVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPS 279
           + R+L     +R+T +E +++ W K+  +  S
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 2e-81
 Identities = 88/318 (27%), Positives = 154/318 (48%), Gaps = 16/318 (5%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL-IRHP 74
           + L + LG+GSF KV  A   +T +  AIK L K+ VL    +     E   + L   HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            +  M+    +K  ++ V+E++ GG+L   I S  +     A  Y  ++I  + + HS+G
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + +RDLK +N+LLD +G +K++DFG+    + +  D   +T CGTP+Y+APE++  + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
               D WS GV+LY ++ G  PF   +   L+  I   +   P W    AK L+ ++   
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 255 NPVTRITMA-EVIENEWFK---------KGYKPPSFEQPNIDLDDVDSIFNESMDSRNLV 304
            P  R+ +  ++ ++  F+         K   PP   +P +      S F++   +    
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPPF--RPKVKSPFDCSNFDKEFLNEKPR 298

Query: 305 VERREEGPVAPLTMNAFE 322
           +   +   +  +  N F 
Sbjct: 299 LSFADRALINSMDQNMFR 316

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (622), Expect = 3e-80
 Identities = 84/279 (30%), Positives = 131/279 (46%), Gaps = 17/279 (6%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG---QIKREISTMKL 70
            +Y++G  LG G F  V           VAIK ++K+++     +    ++  E+  +K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 71  IR--HPNVIRMYEVMASKTKIYIVLEFVTGG-ELFDKIASRGRLKEDEARKYFQQLINAV 127
           +      VIR+ +         ++LE      +LFD I  RG L+E+ AR +F Q++ AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 128 DYCHSRGVCHRDLKPENLLLDAN-GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPE 186
            +CH+ GV HRD+K EN+L+D N G LK+ DFG  AL      D +     GT  Y  PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179

Query: 187 VINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKK 246
            I    Y G  A +WS G++LY ++ G +PFE         +I +         S+  + 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233

Query: 247 LISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNI 285
           LI   L   P  R T  E+  + W +    P    + ++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHL 272

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (622), Expect = 1e-79
 Identities = 66/304 (21%), Positives = 121/304 (39%), Gaps = 52/304 (17%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            +E    LG G+   V    +  +G  +A K++  E  +K  +  QI RE+  +     P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR- 133
            ++  Y    S  +I I +E + GG L   +   GR+ E    K    +I  + Y   + 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            + HRD+KP N+L+++ G +K+ DFG+S        D + ++  GT +Y++PE +    Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHY 180

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESN-------------------------------- 221
              ++D+WS G+ L  +  G  P    +                                
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 222 ----------LMALYKKIFKADFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENE 269
                     +  L   I        P   FS   +  +++ L  NP  R  + +++ + 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 270 WFKK 273
           + K+
Sbjct: 300 FIKR 303

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  243 bits (620), Expect = 3e-79
 Identities = 99/302 (32%), Positives = 165/302 (54%), Gaps = 23/302 (7%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
           +++ RTLG GSF +V   R+   G   A+K+L KE V++ K +     E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGV 135
           +IRM+       +I+++++++ GGELF  +    R     A+ Y  ++  A++Y HS+ +
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 136 CHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDG 195
            +RDLKPEN+LLD NG +K++DFG +     V      +T CGTP+Y+APEV++ K Y+ 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN- 179

Query: 196 AKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDPN 255
              D WS G+++Y ++AGY PF +SN M  Y+KI  A+ + PP+F+   K L+SR++  +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

Query: 256 PVTRI-----TMAEVIENEWFK---------KGYKP---PSFEQPNIDLDDVDSIFNESM 298
              R+        +V  + WFK         +  +    P  +Q   D    D    E +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDI 299

Query: 299 DS 300
           + 
Sbjct: 300 NY 301

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 5e-79
 Identities = 98/287 (34%), Positives = 150/287 (52%), Gaps = 24/287 (8%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK---MIGQIKREISTMKLI 71
            Y+ G  LG G FA VK  R   TG   A K + K +    +       I+RE+S +K I
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           +HPNVI ++EV  +KT + ++LE V GGELFD +A +  L E+EA ++ +Q++N V Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 132 SRGVCHRDLKPENLLLDANGV----LKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEV 187
           S  + H DLKPEN++L    V    +K+ DFGL+    ++          GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187

Query: 188 INNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTS 243
           +N +     +AD+WS GVI Y+L++G  PF           +   +++         S  
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 244 AKKLISRILDPNPVTRITMAEVIENEWFK---------KGYKPPSFE 281
           AK  I R+L  +P  R+T+ + +++ W K           +  P FE
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 9e-79
 Identities = 67/270 (24%), Positives = 125/270 (46%), Gaps = 18/270 (6%)

Query: 14  GKY-ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
           G++ +    +G GSF  V    +TET   VA   L   K+ K +   + K E   +K ++
Sbjct: 8   GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQ 66

Query: 73  HPNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           HPN++R Y+   S  K    I +V E +T G L   +     +K    R + +Q++  + 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126

Query: 129 YCHSRG--VCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAP 185
           + H+R   + HRDLK +N+ +    G +K+ D GL+ L    +         GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAP 182

Query: 186 EVINNKGYDGAKADLWSCGVILYVLMAGYLPFEES-NLMALYKKIFKA--DFKSPPWFST 242
           E+   K YD    D+++ G+ +  +     P+ E  N   +Y+++               
Sbjct: 183 EMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 243 SAKKLISRILDPNPVTRITMAEVIENEWFK 272
             K++I   +  N   R ++ +++ + +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 7e-77
 Identities = 95/328 (28%), Positives = 157/328 (47%), Gaps = 39/328 (11%)

Query: 10  RTRVGKYE-LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM 68
              +  Y+   + LG G   KV    N  T E  A+K+L            + +RE+   
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELH 58

Query: 69  -KLIRHPNVIRMYEV----MASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQ 121
            +  + P+++R+ +V     A +  + IV+E + GGELF +I  RG     E EA +  +
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 122 QLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
            +  A+ Y HS  + HRD+KPENLL  +   N +LK++DFG +   ++      L T C 
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCY 175

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF------KA 232
           TP YVAPEV+  + YD    D+WS GVI+Y+L+ GY PF  ++ +A+   +       + 
Sbjct: 176 TPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 233 DFKSPPW--FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP--------SFEQ 282
           +F +P W   S   K LI  +L   P  R+T+ E + + W  +  K P          ++
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294

Query: 283 PNIDLDDVDSIFNESMDSRNLVVERREE 310
                +DV      ++ +  +  E+ + 
Sbjct: 295 DKERWEDVKEEMTSALATMRVDYEQIKI 322

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (604), Expect = 1e-76
 Identities = 91/311 (29%), Positives = 159/311 (51%), Gaps = 19/311 (6%)

Query: 10  RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           +  +  ++  + LG+G+F KV   R   TG   A+KIL KE ++    +     E   ++
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
             RHP +  +     +  ++  V+E+  GGELF  ++      E+ AR Y  ++++A++Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            HSR V +RD+K ENL+LD +G +K++DFGL    + + D   + T CGTP Y+APEV+ 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 178

Query: 190 NKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLIS 249
           +  Y     D W  GV++Y +M G LPF   +   L++ I   + + P   S  AK L++
Sbjct: 179 DNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237

Query: 250 RILDPNPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNIDLDDVDSIFN 295
            +L  +P  R+        EV+E+ +F          K   PP   +P +  +     F+
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF--KPQVTSEVDTRYFD 295

Query: 296 ESMDSRNLVVE 306
           +   ++++ + 
Sbjct: 296 DEFTAQSITIT 306

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  234 bits (598), Expect = 1e-76
 Identities = 68/268 (25%), Positives = 124/268 (46%), Gaps = 10/268 (3%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +YELG  LG G  ++V  AR+     +VA+K+L  +         + +RE      + H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 74  PNVIRMYEVMASKTK----IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           P ++ +Y+   ++T      YIV+E+V G  L D + + G +    A +       A+++
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVI 188
            H  G+ HRD+KP N+++ A   +KV DFG++  +              GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSA 244
                D A++D++S G +LY ++ G  PF   + +++  +  + D   P       S   
Sbjct: 187 RGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245

Query: 245 KKLISRILDPNPVTRITMAEVIENEWFK 272
             ++ + L  NP  R   A  +  +  +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (598), Expect = 2e-76
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 14/263 (5%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
           G+  +G+ +G GSF  V   +      +VA+K+L+       + +   K E+  ++  RH
Sbjct: 8   GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRH 63

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKI-ASRGRLKEDEARKYFQQLINAVDYCHS 132
            N++       +  ++ IV ++  G  L+  +     + +  +     +Q    +DY H+
Sbjct: 64  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVIN--N 190
           + + HRDLK  N+ L  +  +K+ DFGL+ +  +           G+  ++APEVI   +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP------PWFSTSA 244
           K     ++D+++ G++LY LM G LP+   N       +    + SP           + 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 245 KKLISRILDPNPVTRITMAEVIE 267
           K+L++  L      R    +++ 
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  235 bits (600), Expect = 1e-75
 Identities = 78/332 (23%), Positives = 143/332 (43%), Gaps = 30/332 (9%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR--- 72
           + + R +G G F +V   R  +TG+  A+K LDK+++   +       E   + L+    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
            P ++ M     +  K+  +L+ + GG+L   ++  G   E + R Y  ++I  +++ H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R V +RDLKP N+LLD +G +++SD GL+            H + GT  Y+APEV+    
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181

Query: 193 YDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKADFKSPPWFSTSAKKLIS 249
              + AD +S G +L+ L+ G+ PF +        + +       + P  FS   + L+ 
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 250 RILDPNPVTRITM-----AEVIENEWFK---------KGYKPPSFEQPNIDLDDVDSIFN 295
            +L  +   R+        EV E+ +F+         + Y PP    P     +    F 
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP--LIPPRGEVNAADAF- 298

Query: 296 ESMDSRNLVVERREEGPVAPLTMNAFELISTS 327
              D  +   E  +   +       +     +
Sbjct: 299 ---DIGSFDEEDTKGIKLLDSDQELYRNFPLT 327

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  230 bits (588), Expect = 4e-74
 Identities = 95/296 (32%), Positives = 156/296 (52%), Gaps = 22/296 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +++  +TLG GSF +V   ++ E+G + A+KILDK+KV+K K I     E   ++ +  P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
            ++++       + +Y+V+E+V GGE+F  +   GR  E  AR Y  Q++   +Y HS  
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + +RDLKPENLL+D  G ++V+DFG +      R  G   T CGTP  +APE+I +KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIILSKGYN 216

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRILDP 254
               D W+ GV++Y + AGY PF     + +Y+KI     + P  FS+  K L+  +L  
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275

Query: 255 NPVTRI-----TMAEVIENEWFK---------KGYKPPSFEQPNIDLDDVDSIFNE 296
           +   R       + ++  ++WF          +  + P    P        S F++
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP--FIPKFKGPGDTSNFDD 329

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 5e-72
 Identities = 67/258 (25%), Positives = 119/258 (46%), Gaps = 18/258 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           + +L +T+G+G F  V        G  VA+K +  +   +         E S M  +RH 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60

Query: 75  NVIRMYEVMA-SKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCH 131
           N++++  V+   K  +YIV E++  G L D + SRGR  L  D   K+   +  A++Y  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
                HRDL   N+L+  + V KVSDFGL+      +D     T      + APE +  K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175

Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLIS 249
            +   K+D+WS G++L+ + + G +P+    L  +  ++ K     +P     +  +++ 
Sbjct: 176 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 250 RILDPNPVTRITMAEVIE 267
                +   R +  ++ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 2e-71
 Identities = 76/333 (22%), Positives = 131/333 (39%), Gaps = 46/333 (13%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +Y     +GEG++  V  A +      VAIK +   +        +  REI  +   RH
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65

Query: 74  PNVIRMYEVMASKT----KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            N+I + +++ + T    K   ++  + G +L+  +     L  D    +  Q++  + Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT-CGTPNYVAPEVI 188
            HS  V HRDLKP NLLL+    LK+ DFGL+ +     D     T    T  Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------- 234
            N        D+WS G IL  +++    F   + +     I                   
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 235 -----------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                            +  P   + A  L+ ++L  NP  RI + + + + + ++ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

Query: 278 PSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
                   D    ++ F   M+  +L  E+ +E
Sbjct: 305 S-------DEPIAEAPFKFDMELDDLPKEKLKE 330

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 5e-70
 Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 43/312 (13%)

Query: 12  RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
            V KYE    +G+G+F +V  AR+ +TG+ VA+K +  E   K        REI  ++L+
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLL 66

Query: 72  RHPNVIRMYEVMASKT--------KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQL 123
           +H NV+ + E+  +K          IY+V +F              +    E ++  Q L
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 124 INAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD--GLLHTTCGTPN 181
           +N + Y H   + HRD+K  N+L+  +GVLK++DFGL+      ++           T  
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP--- 238
           Y  PE++  +   G   DLW  G I+  +       + +        I +      P   
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 239 -----------------------------WFSTSAKKLISRILDPNPVTRITMAEVIENE 269
                                             A  LI ++L  +P  RI   + + ++
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 270 WFKKGYKPPSFE 281
           +F     P   +
Sbjct: 307 FFWSDPMPSDLK 318

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 7e-70
 Identities = 76/301 (25%), Positives = 117/301 (38%), Gaps = 35/301 (11%)

Query: 17  ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK--MIGQIKREISTMKLIRHP 74
           E    LGEG FA V  AR+  T + VAIK +      + K  +     REI  ++ + HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N+I + +    K+ I +V +F+          +   L     + Y    +  ++Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           + HRDLKP NLLLD NGVLK++DFGL+        +        T  Y APE++      
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----------------- 237
           G   D+W+ G IL  L+         + +    +IF+                       
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 238 -----------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP---PSFEQP 283
                               LI  +   NP  RIT  + ++ ++F     P       +P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

Query: 284 N 284
           N
Sbjct: 299 N 299

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 2e-69
 Identities = 84/322 (26%), Positives = 135/322 (41%), Gaps = 48/322 (14%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            Y   + +G G++  V  A +  TG  VAIK L +          +  RE+  +K +RH 
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHE 77

Query: 75  NVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVD 128
           NVI + +V          T  Y+V+ F+  G    K+    +L ED  +    Q++  + 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 129 YCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVI 188
           Y H+ G+ HRDLKP NL ++ +  LK+ DFGL+        D  +     T  Y APEVI
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVI 190

Query: 189 NNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF-------- 240
            N        D+WS G I+  ++ G   F+ S+ +   K+I K     P  F        
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 241 -----------------------STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP 277
                                  S  A  L+ ++L  +   R+T  E + + +F+  +  
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310

Query: 278 ---PSFEQPNIDLDDVDSIFNE 296
              P  ++ +   DDVD   +E
Sbjct: 311 EDEPQVQKYDDSFDDVDRTLDE 332

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 3e-69
 Identities = 88/341 (25%), Positives = 147/341 (43%), Gaps = 52/341 (15%)

Query: 1   MASRTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQ 60
           +A+   G  R +   Y   + +G GSF  V  A+  ++GE VAIK + ++K  K      
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------ 60

Query: 61  IKREISTMKLIRHPNVIRMYEVMAS------KTKIYIVLEFVTGG---ELFDKIASRGRL 111
             RE+  M+ + H N++R+     S      +  + +VL++V             ++  L
Sbjct: 61  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119

Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDD 170
                + Y  QL  ++ Y HS G+CHRD+KP+NLLLD +  VLK+ DFG +   +Q+   
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRG 176

Query: 171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF 230
               +   +  Y APE+I       +  D+WS G +L  L+ G   F   + +    +I 
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

Query: 231 KA----------------------DFKSPPW-------FSTSAKKLISRILDPNPVTRIT 261
           K                         K+ PW           A  L SR+L+  P  R+T
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296

Query: 262 MAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRN 302
             E   + +F +  + P+ + PN    D  ++FN +    +
Sbjct: 297 PLEACAHSFFDE-LRDPNVKLPNG--RDTPALFNFTTQELS 334

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-68
 Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 8/259 (3%)

Query: 16  YELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
             L   LG+GSF  V+       +    +VA+K L  + + + + +    RE++ M  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCH 131
           H N+IR+Y V+ +   + +V E    G L D++    G        +Y  Q+   + Y  
Sbjct: 70  HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNK 191
           S+   HRDL   NLLL    ++K+ DFGL     Q  D  ++      P           
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 192 GYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD--FKSPPWFSTSAKKLI 248
                 +D W  GV L+ +   G  P+   N   +  KI K       P         ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248

Query: 249 SRILDPNPVTRITMAEVIE 267
            +     P  R T   + +
Sbjct: 249 VQCWAHKPEDRPTFVALRD 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-68
 Identities = 59/261 (22%), Positives = 105/261 (40%), Gaps = 10/261 (3%)

Query: 20  RTLGEGSFAKVKFA--RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI 77
           + LG G+F  VK    +  +  + VA+KIL  E      +  ++  E + M+ + +P ++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71

Query: 78  RMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCH 137
           RM  +  ++    +V+E    G L   +     +K+    +   Q+   + Y       H
Sbjct: 72  RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 138 RDLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGA 196
           RDL   N+LL      K+SDFGLS AL                  + APE IN   +  +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189

Query: 197 KADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDP 254
           K+D+WS GV+++   + G  P+       +   + K +    P         L++     
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249

Query: 255 NPVTRITMAEVIE--NEWFKK 273
           +   R   A V      ++  
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 7e-68
 Identities = 56/285 (19%), Positives = 113/285 (39%), Gaps = 35/285 (12%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-----VAIKILDKEKVLKHKMIGQIKREISTM- 68
             E G+ LG G+F KV  A      +      VA+K+L ++          +  E+  M 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-------------------- 108
           +L  H N++ +         IY++ E+   G+L + + S+                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 109 ---GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ 165
                L  ++   +  Q+   +++   +   HRDL   N+L+    V+K+ DFGL+    
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMA 224
              +  +         ++APE +    Y   K+D+WS G++L+ + + G  P+    + A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 225 LYKKIFKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            + K+ +  FK   P + +     ++      +   R +   +  
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  212 bits (541), Expect = 7e-68
 Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 33/288 (11%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KY     +GEG++  V  A+N   GE  A+K +  EK     +     REIS +K ++H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++++Y+V+ +K ++ +V E +            G L+   A+ +  QL+N + YCH R 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V HRDLKP+NLL++  G LK++DFGL+                 T  Y AP+V+      
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 195 GAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF-------------------- 234
               D+WS G I   ++ G   F   +      +IF+                       
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 235 ---------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK 273
                            S   L+S++L  +P  RIT  + +E+ +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 9e-68
 Identities = 77/303 (25%), Positives = 135/303 (44%), Gaps = 37/303 (12%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
            ++    +GEG++  V  ARN  TGE VA+K +  +      +     REIS +K + HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61

Query: 75  NVIRMYEVMASKTKIYIVLEFV-TGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           N++++ +V+ ++ K+Y+V EF+    + F   ++   +     + Y  QL+  + +CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            V HRDLKP+NLL++  G +K++DFGL+                 T  Y APE++    Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 194 DGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF------------------- 234
                D+WS G I   ++     F   + +    +IF+                      
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 235 ----------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPN 284
                     K  P      + L+S++L  +P  RI+    + + +F+   KP     P+
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV----PH 295

Query: 285 IDL 287
           + L
Sbjct: 296 LRL 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-67
 Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 10/252 (3%)

Query: 22  LGEGSFAKVKFA--RNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRM 79
           LG G+F  V+    R  +   +VAIK+L +    +     ++ RE   M  + +P ++R+
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 80  YEVMASKTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHR 138
             V      + +V+E   GG L   +   R  +      +   Q+   + Y   +   HR
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133

Query: 139 DLKPENLLLDANGVLKVSDFGLS-ALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAK 197
           DL   N+LL      K+SDFGLS AL                  + APE IN + +  ++
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192

Query: 198 ADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDPN 255
           +D+WS GV ++  ++ G  P+++     +   I +    + PP        L+S      
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252

Query: 256 PVTRITMAEVIE 267
              R     V +
Sbjct: 253 WEDRPDFLTVEQ 264

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-66
 Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 34/294 (11%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           KYE    +GEG++  V  A+N ET E VA+K +  +      +     REI  +K ++H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG 134
           N++R+++V+ S  K+ +V EF          +  G L  +  + +  QL+  + +CHSR 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V HRDLKP+NLL++ NG LK+++FGL+                 T  Y  P+V+      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 195 GAKADLWSCGVILYVLMAGYLP-FEESNLMALYKKIFKADF------------------- 234
               D+WS G I   L     P F  +++    K+IF+                      
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 235 ----------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP 278
                        P  + + + L+  +L  NPV RI+  E +++ +F   + PP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD-FCPP 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-66
 Identities = 58/256 (22%), Positives = 113/256 (44%), Gaps = 10/256 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
               + LG G F  VK+ +      +VAIK++ +  + +     +   E   M  + H  
Sbjct: 6   LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED----EFIEEAKVMMNLSHEK 60

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRG 134
           ++++Y V   +  I+I+ E++  G L + +   R R +  +  +  + +  A++Y  S+ 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
             HRDL   N L++  GV+KVSDFGLS       +      +     +  PEV+    + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 195 GAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISRIL 252
            +K+D+W+ GV+++ + + G +P+E        + I +      P   S     ++    
Sbjct: 180 -SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238

Query: 253 DPNPVTRITMAEVIEN 268
                 R T   ++ N
Sbjct: 239 HEKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 1e-65
 Identities = 83/286 (29%), Positives = 148/286 (51%), Gaps = 14/286 (4%)

Query: 2   ASRTGGASRTRVGKYELGRTLGEGSFAKVKFAR---NTETGENVAIKILDKEKVL-KHKM 57
           A+ TG A +  +  +EL + LG G++ KV   R     +TG+  A+K+L K  ++ K K 
Sbjct: 12  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71

Query: 58  IGQIKREISTMKLIRH-PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEA 116
               + E   ++ IR  P ++ ++    ++TK++++L+++ GGELF  ++ R R  E E 
Sbjct: 72  TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131

Query: 117 RKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT 176
           + Y  +++ A+++ H  G+ +RD+K EN+LLD+NG + ++DFGLS        +      
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191

Query: 177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF----EESNLMALYKKIFKA 232
                     V           D WS GV++Y L+ G  PF    E+++   + ++I K+
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251

Query: 233 DFKSPPWFSTSAKKLISRILDPNPVTRITMA-----EVIENEWFKK 273
           +   P   S  AK LI R+L  +P  R+        E+ E+ +F+K
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 3e-65
 Identities = 74/331 (22%), Positives = 133/331 (40%), Gaps = 52/331 (15%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
           +Y+    +G G++  V  A +T+TG  VA+K L +          +  RE+  +K ++H 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77

Query: 75  NVIRMYEVMASKTKI----YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYC 130
           NVI + +V      +     + L     G   + I    +L +D  +    Q++  + Y 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           HS  + HRDLKP NL ++ +  LK+ DFGL+                 T  Y APE++ N
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWF---------- 240
             +     D+WS G I+  L+ G   F  ++ +   K I +                   
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 241 ---------------------STSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP-- 277
                                +  A  L+ ++L  +   RIT A+ + + +F + + P  
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312

Query: 278 --------PSFEQPNIDLDDVDS-IFNESMD 299
                    SFE  ++ +D+  S  ++E + 
Sbjct: 313 EPVADPYDQSFESRDLLIDEWKSLTYDEVIS 343

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (524), Expect = 3e-65
 Identities = 60/261 (22%), Positives = 106/261 (40%), Gaps = 12/261 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLIR 72
            ++ + +G G F +V        G+    VAIK L        K       E S M    
Sbjct: 28  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85

Query: 73  HPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCH 131
           HPNVI +  V+   T + I+ EF+  G L   +    G+    +     + +   + Y  
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 132 SRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT---CGTPNYVAPEVI 188
                HRDL   N+L+++N V KVSDFGLS   +    D    +         + APE I
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 189 NNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKK 246
             + +    +D+WS G++++ +M+ G  P+ +     +   I +      P    ++  +
Sbjct: 206 QYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264

Query: 247 LISRILDPNPVTRITMAEVIE 267
           L+      +   R    +++ 
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 8e-65
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 17/279 (6%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
              L   LG+G F +V       T   VAIK L    +          +E   MK +RH 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE----AFLQEAQVMKKLRHE 72

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR--LKEDEARKYFQQLINAVDYCHS 132
            ++++Y V+ S+  IYIV E+++ G L D +       L+  +      Q+ + + Y   
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
               HRDL+  N+L+  N V KV+DFGL+ L +   +            + APE      
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190

Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISR 250
           +   K+D+WS G++L  +   G +P+       +  ++ +      PP    S   L+ +
Sbjct: 191 FT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249

Query: 251 ILDPNPVTRITMAEVIE--NEWFKKGYKPPSFEQPNIDL 287
                P  R T   +     ++F      P + QP  +L
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTS--TEPQY-QPGENL 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-64
 Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 16/307 (5%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKE--KVLKHKMIGQIKREISTMKLIRH 73
           ++  + LG G+F  V        GE V I +  KE  +    K   +I  E   M  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 74  PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSR 133
           P+V R+  +  + T   I      G  L      +  +       +  Q+   ++Y   R
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 134 GVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGY 193
            + HRDL   N+L+     +K++DFGL+ L      +           ++A E I ++ Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 194 DGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRI 251
              ++D+WS GV ++ LM  G  P++      +   + K +    PP  +     ++ + 
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 252 LDPNPVTRITMAEVIENEWFKKGYKPPSF-------EQPNIDLDDVDSIFNESMDSRNL- 303
              +  +R    E+I    F K  + P         E+ ++      + +   MD  ++ 
Sbjct: 250 WMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 307

Query: 304 -VVERRE 309
            VV+  E
Sbjct: 308 DVVDADE 314

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (515), Expect = 7e-64
 Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 12/271 (4%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
              +   LG G + +V      +    VA+K L ++       + +  +E + MK I+HP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI--ASRGRLKEDEARKYFQQLINAVDYCHS 132
           N++++  V   +   YI+ EF+T G L D +   +R  +          Q+ +A++Y   
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           +   HRDL   N L+  N ++KV+DFGLS L                  + APE +    
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 193 YDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFK-ADFKSPPWFSTSAKKLISR 250
           +   K+D+W+ GV+L+ +   G  P+   +L  +Y+ + K    + P        +L+  
Sbjct: 193 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251

Query: 251 ILDPNPVTRITMAEVIENEWFKKGYKPPSFE 281
               NP  R + AE+   + F+  ++  S  
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSIS 280

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 9e-64
 Identities = 59/263 (22%), Positives = 110/263 (41%), Gaps = 14/263 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP 74
             +L   LG G F +V           VA+K L +  +           E + MK ++H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQ 68

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG--RLKEDEARKYFQQLINAVDYCHS 132
            ++R+Y V+ ++  IYI+ E++  G L D + +    +L  ++      Q+   + +   
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 133 RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG 192
           R   HRDL+  N+L+      K++DFGL+ L +   +            + APE IN  G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINY-G 185

Query: 193 YDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISR 250
               K+D+WS G++L  ++  G +P+       + + + +      P        +L+  
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 251 ILDPNPVTRITMAEVIE--NEWF 271
                P  R T   +     ++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 58/271 (21%), Positives = 108/271 (39%), Gaps = 23/271 (8%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTM-KLIRHP 74
            +    +GEG+F +V  AR  + G  +   I   ++            E+  + KL  HP
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 75  NVIRMYEVMASKTKIYIVLEFVTGGELFDKI----------------ASRGRLKEDEARK 118
           N+I +      +  +Y+ +E+   G L D +                ++   L   +   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 119 YFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCG 178
           +   +   +DY   +   HRDL   N+L+  N V K++DFGLS   +             
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRL 188

Query: 179 TPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKA-DFKS 236
              ++A E +N   Y    +D+WS GV+L+ ++  G  P+       LY+K+ +    + 
Sbjct: 189 PVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247

Query: 237 PPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
           P         L+ +     P  R + A+++ 
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 278

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 34/284 (11%)

Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
             E  R +GEG+F +V  AR       E    VA+K+L +E      M    +RE + M 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR------------------- 110
              +PN++++  V A    + ++ E++  G+L + + S                      
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 111 -----LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ 165
                L   E     +Q+   + Y   R   HRDL   N L+  N V+K++DFGLS    
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYL-PFEESNLMA 224
                           ++ PE I    Y   ++D+W+ GV+L+ + +  L P+       
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 225 LYKKIFKADFKS-PPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
           +   +   +  + P         L+       P  R +   +  
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-63
 Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 10/255 (3%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN 75
               + +G G F  V         + VAIK + +  + +         E   M  + HP 
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEE----DFIEEAEVMMKLSHPK 61

Query: 76  VIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLK-EDEARKYFQQLINAVDYCHSRG 134
           ++++Y V   +  I +V EF+  G L D + ++  L   +        +   + Y     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 135 VCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYD 194
           V HRDL   N L+  N V+KVSDFG++              T     + +PEV +   Y 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 195 GAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKLISRIL 252
            +K+D+WS GV+++ + + G +P+E  +   + + I        P   ST   ++++   
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239

Query: 253 DPNPVTRITMAEVIE 267
              P  R   + ++ 
Sbjct: 240 KERPEDRPAFSRLLR 254

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 42/297 (14%)

Query: 13  VGKYELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
             +YE    +GEG++ KV  AR+ +  G  VA+K +  +   +  M     RE++ ++ +
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHL 64

Query: 72  ---RHPNVIRMYEVMAS-----KTKIYIVLEFVTGGEL-FDKIASRGRLKEDEARKYFQQ 122
               HPNV+R+++V        +TK+ +V E V      +        +  +  +    Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 123 LINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNY 182
           L+  +D+ HS  V HRDLKP+N+L+ ++G +K++DFGL+ +           +   T  Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 181

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKA---------- 232
            APEV+    Y     DLWS G I   +      F  S+ +    KI             
Sbjct: 182 RAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 233 -----------------DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFK 272
                              K         K L+ + L  NP  RI+    + + +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-62
 Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 15/261 (5%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN---VAIKILDKEKVLKHKMIGQIKREISTMKLI 71
           + ELGR +GEG F  V              VAIK           +  +  +E  TM+  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYC 130
            HP+++++  V+ ++  ++I++E  T GEL   +  R   L       Y  QL  A+ Y 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC--GTPNYVAPEVI 188
            S+   HRD+   N+L+ +N  +K+ DFGLS   + + D      +       ++APE I
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 189 NNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKK 246
           N + +    +D+W  GV ++ +LM G  PF+      +  +I   +    PP    +   
Sbjct: 182 NFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240

Query: 247 LISRILDPNPVTRITMAEVIE 267
           L+++    +P  R    E+  
Sbjct: 241 LMTKCWAYDPSRRPRFTELKA 261

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 9e-62
 Identities = 58/280 (20%), Positives = 114/280 (40%), Gaps = 30/280 (10%)

Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTM- 68
           +   G+TLG G+F KV  A       ++    VA+K+L     L  +    +  E+  + 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLS 81

Query: 69  KLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKI------------------ASRGR 110
            L  H N++ +           ++ E+   G+L + +                       
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 111 LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
           L  ++   +  Q+   + +  S+   HRDL   N+LL    + K+ DFGL+   +   + 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKI 229
            +         ++APE I N      ++D+WS G+ L+ L + G  P+    + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 230 FKADFK--SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            K  F+  SP         ++    D +P+ R T  ++++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 5e-61
 Identities = 57/287 (19%), Positives = 101/287 (35%), Gaps = 27/287 (9%)

Query: 12  RVG-KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKL 70
           RVG +Y LGR +G GSF  +    +   GE VAIK+   +         Q+  E    K+
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKM 58

Query: 71  IRHPNVIR-MYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
           ++    I  +    A      +V+E +             +           Q+I+ ++Y
Sbjct: 59  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118

Query: 130 CHSRGVCHRDLKPENLL---LDANGVLKVSDFGLS-----ALPQQVRDDGLLHTTCGTPN 181
            HS+   HRD+KP+N L        ++ + DFGL+     A   Q           GT  
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 182 YVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----- 236
           Y +            + DL S G +L     G LP++        +K  +   K      
Sbjct: 179 YASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 237 ---PPWFSTSAKKLISRILDPNPVTRITMAEV---IENEWFKKGYKP 277
                 + +     ++         +   + +     N + ++G+  
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  195 bits (496), Expect = 1e-60
 Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 54/300 (18%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRH 73
            Y+L R LG G +++V  A N    E V +KIL   K        +IKREI  ++ L   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89

Query: 74  PNVIRMYEVMASKTK--IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCH 131
           PN+I + +++         +V E V   +          L + + R Y  +++ A+DYCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 132 SRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINN 190
           S G+ HRD+KP N+++D  +  L++ D+GL+            +    +  +  PE++ +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203

Query: 191 KGYDGAKADLWSCGVILYVLMAGYLPFEESN--------------LMALYKKIFKADFKS 236
                   D+WS G +L  ++    PF   +                 LY  I K + + 
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 237 PPWF------------------------STSAKKLISRILDPNPVTRITMAEVIENEWFK 272
            P F                        S  A   + ++L  +  +R+T  E +E+ +F 
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-60
 Identities = 58/260 (22%), Positives = 106/260 (40%), Gaps = 11/260 (4%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGEN----VAIKILDKEKVLKHKMIGQIKREISTMKLI 71
               + +G G F +V       +       VAIK L      K ++      E   M   
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQF 66

Query: 72  RHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYC 130
            H N+IR+  V++    + I+ E++  G L   +  + G     +     + +   + Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 131 HSRGVCHRDLKPENLLLDANGVLKVSDFGLSA-LPQQVRDDGLLHTTCGTPNYVAPEVIN 189
            +    HRDL   N+L+++N V KVSDFGLS  L                  + APE I+
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 190 NKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL 247
            + +    +D+WS G++++ +M  G  P+ E +   + K I       +P    ++  +L
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245

Query: 248 ISRILDPNPVTRITMAEVIE 267
           + +        R   A+++ 
Sbjct: 246 MMQCWQQERARRPKFADIVS 265

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 3e-60
 Identities = 76/355 (21%), Positives = 142/355 (40%), Gaps = 62/355 (17%)

Query: 4   RTGGASRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKR 63
             G ++ T + +Y+  + +G G+   V  A +     NVAIK L +          +  R
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYR 65

Query: 64  EISTMKLIRHPNVIRMYEVMASK------TKIYIVLEFVTGGELFDKIASRGRLKEDEAR 117
           E+  MK + H N+I +  V   +        +Y+V+E +           +  L  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMS 122

Query: 118 KYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTC 177
               Q++  + + HS G+ HRDLKP N+++ ++  LK+ DFGL+          ++    
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYV 179

Query: 178 GTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP 237
            T  Y APEVI   GY     D+WS G I+  ++   + F   + +  + K+ +      
Sbjct: 180 VTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 238 PWF------------------------------------------STSAKKLISRILDPN 255
           P F                                          ++ A+ L+S++L  +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 256 PVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDVDSIFNESMDSRNLVVERREE 310
           P  RI++ + +++ +    Y P   E P         I+++ +D R   +E  +E
Sbjct: 299 PAKRISVDDALQHPYINVWYDPAEVEAPP------PQIYDKQLDEREHTIEEWKE 347

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 4e-60
 Identities = 60/279 (21%), Positives = 121/279 (43%), Gaps = 29/279 (10%)

Query: 15  KYELGRTLGEGSFAKVKFARNTETGEN-------VAIKILDKEKVLKHKMIGQIKREIST 67
           +  LG+ LGEG+F +V  A      ++       VA+K+L  +     K +  +  E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71

Query: 68  MK-LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRG----------------R 110
           MK + +H N+I +         +Y+++E+ + G L + + +R                 +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 111 LKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD 170
           L   +      Q+   ++Y  S+   HRDL   N+L+  + V+K++DFGL+     +   
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILY-VLMAGYLPFEESNLMALYKKI 229
                      ++APE + ++ Y   ++D+WS GV+L+ +   G  P+    +  L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 230 FKAD-FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            +      P   +     ++       P  R T  +++E
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-59
 Identities = 55/285 (19%), Positives = 117/285 (41%), Gaps = 22/285 (7%)

Query: 15  KYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           K  + R LG+GSF  V           E    VAIK +++   ++ ++  +   E S MK
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 78

Query: 70  LIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGR----------LKEDEARKY 119
                +V+R+  V++      +++E +T G+L   + S                 +  + 
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 120 FQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGT 179
             ++ + + Y ++    HRDL   N ++  +  +K+ DFG++    +             
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 180 PNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKAD-FKSP 237
             +++PE + +  +    +D+WS GV+L+ +      P++  +   + + + +      P
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 238 PWFSTSAKKLISRILDPNPVTRITMAEVIE--NEWFKKGYKPPSF 280
                   +L+      NP  R +  E+I    E  + G++  SF
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 5e-57
 Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 12/262 (4%)

Query: 15  KYELGRTLGEGSFAKV---KFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI 71
                  +G G F  V       N     + A+K L++        + Q   E   MK  
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDF 85

Query: 72  RHPNVIRMYEV-MASKTKIYIVLEFVTGGELFD-KIASRGRLKEDEARKYFQQLINAVDY 129
            HPNV+ +  + + S+    +VL ++  G+L +            +   +  Q+   + +
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 130 CHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTT--CGTPNYVAPEV 187
             S+   HRDL   N +LD    +KV+DFGL+        D + + T       ++A E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 188 INNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK 245
           +  + +   K+D+WS GV+L+ LM  G  P+ + N   +   + +      P +      
Sbjct: 206 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264

Query: 246 KLISRILDPNPVTRITMAEVIE 267
           +++ +   P    R + +E++ 
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVS 286

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  182 bits (462), Expect = 5e-56
 Identities = 52/296 (17%), Positives = 97/296 (32%), Gaps = 32/296 (10%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
             Y++GR +GEGSF  +    N    + VAIK   +          Q++ E  T KL+  
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAG 59

Query: 74  -PNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS 132
              +  +Y          +V++ +             +          +Q++  V   H 
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 133 RGVCHRDLKPENLLLDA-----NGVLKVSDFGLSAL-----PQQVRDDGLLHTTCGTPNY 182
           + + +RD+KP+N L+         ++ V DFG+         +Q           GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 183 VAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW--- 239
           ++      +     + DL + G +    + G LP++        +K  +   K       
Sbjct: 180 MSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 240 -----FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDLDDV 290
                F     K +    +           +     F K       E+ N   D+ 
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ--GLFSK-----VLERLNTTEDEN 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-55
 Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 29/279 (10%)

Query: 15  KYELGRTLGEGSFAKVKFAR-----NTETGENVAIKILDKEKVLKHKMIGQIKREISTMK 69
           + +LG+ LG G+F +V  A       T T   VA+K+L +           +  E+  + 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 71

Query: 70  LIRHPNVIRMYE--VMASKTKIYIVLEFVTGGELFDKIASRGR----------------L 111
            I H   +             + +++EF   G L   + S+                  L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 112 KEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG 171
             +    Y  Q+   +++  SR   HRDL   N+LL    V+K+ DFGL+    +  D  
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY-LPFEESNLMALYKKIF 230
                     ++APE I ++ Y   ++D+WS GV+L+ + +    P+    +   + +  
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 231 KAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
           K     ++P + +    + +       P  R T +E++E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 3e-54
 Identities = 54/295 (18%), Positives = 113/295 (38%), Gaps = 48/295 (16%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
               L  ++G+G F +V   +    GE VA+KI       + +     + EI    ++RH
Sbjct: 3   RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56

Query: 74  PNVIRMYEVM----ASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDY 129
            N++           + T++++V ++   G LFD + +R  +  +   K      + + +
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115

Query: 130 CHS--------RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--DGLLHTTCGT 179
            H           + HRDLK +N+L+  NG   ++D GL+       D  D   +   GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 180 PNYVAPEVINNK-----GYDGAKADLWSCGVILYVLMAGYLPFE---------------E 219
             Y+APEV+++           +AD+++ G++ + +                       +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 220 SNLMALYKKIFKADFK-------SPPWFSTSAKKLISRILDPNPVTRITMAEVIE 267
            ++  + K + +   +                 K++      N   R+T   + +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (408), Expect = 2e-47
 Identities = 58/340 (17%), Positives = 112/340 (32%), Gaps = 71/340 (20%)

Query: 14  GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH 73
            +Y L R LG G F+ V  A++     +VA+KI+  +KV         + EI  ++ +  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVND 68

Query: 74  PNVIR-------------MYEVMASKTKIYIVLEFVTGG---ELFDKIASRGRLKEDEAR 117
            +  +              +        +++V+ F   G       K      +     +
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 118 KYFQQLINAVDYC-HSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQVRDDGLLHT 175
           +  +QL+  +DY     G+ H D+KPEN+L++       +    ++ L      D     
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYK-------- 227
           +  T  Y +PEV+    +    AD+WS   +++ L+ G   FE     +  K        
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 228 ----------------------------------------KIFKADFKSPPWFSTSAKKL 247
                                                    +    +K     +      
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 248 ISRILDPNPVTRITMAEVIENEWFKKGYKPPSFEQPNIDL 287
           +S +L  +P  R     ++ + W K          P+ +L
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 347

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 99.1 bits (246), Expect = 2e-25
 Identities = 33/213 (15%), Positives = 69/213 (32%), Gaps = 42/213 (19%)

Query: 16  YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIG---------------Q 60
             +G+ +GEG  + V    + E      +K          K+                  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 61  IKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYF 120
            + E   ++ ++   V ++Y          +++E +   EL+           +   +  
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVR-------VENPDEVL 109

Query: 121 QQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTP 180
             ++  V   + RG+ H DL   N+L+   G+  + DF  S    +     +L       
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDV--- 165

Query: 181 NYVAPEVIN---NKGYDGAKADLWSCGVILYVL 210
                  I    ++ Y   + D+ S   I  +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	342
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.24
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.37
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.01

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-67  Score=457.95  Aligned_cols=257  Identities=37%  Similarity=0.713  Sum_probs=239.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      .+++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+++|+.++||||+++++++.+++.+|+
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            36789999999999999999999999999999999987666556666788999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||||++|+|.+++.+.+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....    .
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~  159 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----S  159 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----C
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----C
Confidence            999999999999999888999999999999999999999999999999999999999999999999999975432    2


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.+..+..+..+++++++||.+|
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            34567899999999999987764 89999999999999999999999999999999999999988999999999999999


Q ss_pred             cCCCCCCCCCHHHHhcCccccc
Q 019360          252 LDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       252 L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      |+.||++|||++|+|+||||+.
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-66  Score=457.63  Aligned_cols=262  Identities=32%  Similarity=0.615  Sum_probs=235.9

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++||||+++++++.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            34578999999999999999999999999999999998766655666678999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999865544344


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (342)
                      ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...+...+.+..+..+..+++++++||.+
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  243 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK  243 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred             cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            445567899999999999887764 8999999999999999999999999999999999999988888999999999999


Q ss_pred             hcCCCCCCCCCHHH------HhcCccccc
Q 019360          251 ILDPNPVTRITMAE------VIENEWFKK  273 (342)
Q Consensus       251 ~L~~dP~~Rps~~e------~l~h~~~~~  273 (342)
                      ||+.||++|||++|      +++||||+.
T Consensus       244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         244 LLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            99999999999988      578999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-66  Score=454.92  Aligned_cols=261  Identities=36%  Similarity=0.657  Sum_probs=223.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.....  ....+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            4689999999999999999999999999999999976432  22345788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||||+||+|.+++.+++.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999986543333334


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH-HHHHhcCC--CCCCCCCHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY-KKIFKADF--KSPPWFSTSAKKLIS  249 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~-~~i~~~~~--~~~~~~~~~~~~li~  249 (342)
                      ....+||+.|||||++.+..+++.++|||||||++|+|++|+.||......... ........  .....+++++.+||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            456789999999999998887778899999999999999999999775543322 22222222  223458999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +||+.||++|||++|+|+||||++..
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            99999999999999999999998643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-64  Score=453.32  Aligned_cols=260  Identities=33%  Similarity=0.630  Sum_probs=241.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ..+++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            35688999999999999999999999999999999998776655566778899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           91 IVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      +|||||+||+|..++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+....  ..
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~  159 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999985432  23


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISR  250 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (342)
                      ......+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+...+...+.......+..+++++++||++
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence            344567899999999999988874 8999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCC-----HHHHhcCccccc
Q 019360          251 ILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       251 ~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      ||++||++|++     ++|+++||||++
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hccCCchhhcccccccHHHHHcCccccc
Confidence            99999999995     899999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-64  Score=445.27  Aligned_cols=254  Identities=27%  Similarity=0.488  Sum_probs=225.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++......   ..+.+.+|+.+|++++||||+++++++...+.+|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            35899999999999999999999999999999999754332   245788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||||+||+|.+++.+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....  ....
T Consensus        96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~  172 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK  172 (293)
T ss_dssp             EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred             EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence            999999999988775 4699999999999999999999999999999999999999999999999999975432  2233


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcC---CCCCCCCCHHHHHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKAD---FKSPPWFSTSAKKLIS  249 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~  249 (342)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+....   ...+..+++++++||.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            4566899999999999987774 89999999999999999999999988777766666543   3335668999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCccccc
Q 019360          250 RILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +||+.||++|||++|+|+||||+.
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHccCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-63  Score=445.93  Aligned_cols=255  Identities=36%  Similarity=0.752  Sum_probs=237.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ++.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            56899999999999999999999999999999999876655556677899999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||||+|++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....     .
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence            99999999999999999999999999999999999999999999999999999999999999999999985432     2


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRIL  252 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  252 (342)
                      ..+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......++.+++++.++|.+||
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            3457899999999999887775 899999999999999999999999999999999999999989999999999999999


Q ss_pred             CCCCCCCC-----CHHHHhcCccccc
Q 019360          253 DPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       253 ~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +.||.+|+     |++++++||||++
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hhCHHhccccchhhHHHHHcCccccc
Confidence            99999996     8999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-63  Score=444.88  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=228.6

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999999999999999998766555666778999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCce
Q 019360           94 EFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLL  173 (342)
Q Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (342)
                      |||++|+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....      .
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence            9999999988888888899999999999999999999999999999999999999999999999999985332      2


Q ss_pred             ecccCCcccCChhhhccC--CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--CCCCCHHHHHHHH
Q 019360          174 HTTCGTPNYVAPEVINNK--GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--PPWFSTSAKKLIS  249 (342)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~  249 (342)
                      ...+||+.|||||++.+.  ..++.++|||||||++|+|++|..||.+.+..+....+.....+.  +..+++++.+||.
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~  248 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            346799999999998642  223579999999999999999999999988888888877765543  3458999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcccccC
Q 019360          250 RILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +||+.||++|||++|+|+||||...
T Consensus       249 ~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         249 SCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999999999999999999999863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=437.27  Aligned_cols=256  Identities=33%  Similarity=0.587  Sum_probs=216.9

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS--KTKI   89 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~   89 (342)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++|++++||||+++++++.+  .+.+
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            46789999999999999999999999999999999976543 34446788999999999999999999999864  4568


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCcEEecCCCCeeEccccc
Q 019360           90 YIVLEFVTGGELFDKIAS----RGRLKEDEARKYFQQLINAVDYCHSRG-----VCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~LH~~g-----iiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      |+|||||++|+|.+++.+    +..+++..++.++.|++.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999998864    467999999999999999999999976     99999999999999999999999999


Q ss_pred             ccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-CCCC
Q 019360          161 SALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-SPPW  239 (342)
Q Consensus       161 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~  239 (342)
                      ++....  ........+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+..++...+...... .+..
T Consensus       161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             eeeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            985432  22234567899999999999887764 8999999999999999999999999999998888887764 4567


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 019360          240 FSTSAKKLISRILDPNPVTRITMAEVIENEWF  271 (342)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~  271 (342)
                      +++++.+||.+||+.||++|||++|+|+|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-63  Score=444.03  Aligned_cols=256  Identities=37%  Similarity=0.709  Sum_probs=214.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+.....  ..+.+.+|+.+|++++||||+++++++.+++.+|+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3567999999999999999999999999999999997654332  23568899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec---CCCCeeEcccccccCCcccc
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD---ANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |||||+|++|.+++.+++.+++.++..++.||+.||+|||++||+||||||+||++.   .++.+||+|||+|+....  
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--  162 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--  162 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence            999999999999999988999999999999999999999999999999999999995   478999999999985432  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  244 (342)
                       .....+.+||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......+    +.+++++
T Consensus       163 -~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         163 -GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             -CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence             2334567899999999999887764 899999999999999999999999999999999888766543    4689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .+||.+||+.||++|||++|+++||||+.
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-63  Score=448.30  Aligned_cols=259  Identities=34%  Similarity=0.676  Sum_probs=239.9

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ....+++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+++|+.++||||+++++++.....
T Consensus        36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  115 (350)
T d1rdqe_          36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence            34457899999999999999999999999999999999987666556667789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +++||||+.+|+|..++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....  
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999985432  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLI  248 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (342)
                         .....+||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.......+..+++++.+||
T Consensus       194 ---~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         194 ---RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             ---ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence               23456899999999999987775 89999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          249 SRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      ++||+.||.+|+     |++++++||||+.
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccC
Confidence            999999999995     8999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-62  Score=430.30  Aligned_cols=252  Identities=25%  Similarity=0.478  Sum_probs=216.9

Q ss_pred             cCe-eeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCe
Q 019360           14 GKY-ELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS----KTK   88 (342)
Q Consensus        14 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~   88 (342)
                      +|| ++.++||+|+||+||+|.++.+++.||+|++..... .....+.+.+|+++|++++||||+++++++..    ...
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            455 778899999999999999999999999999976543 33445789999999999999999999999864    356


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEec-CCCCeeEcccccccCCc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRG--VCHRDLKPENLLLD-ANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~g--iiH~dlkp~NIli~-~~~~~kl~Dfg~~~~~~  165 (342)
                      +|+||||+++|+|.+++.+...+++..++.++.|++.||+|||++|  |+||||||+|||++ .++.+||+|||+++...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            8999999999999999998889999999999999999999999998  99999999999996 47899999999997532


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc-HHHHHHHHHhcCCC--CCCCCCH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN-LMALYKKIFKADFK--SPPWFST  242 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~-~~~~~~~i~~~~~~--~~~~~~~  242 (342)
                          .......+||+.|||||++.+ .+ +.++|||||||++|+|++|+.||.+.. ...+...+.....+  .+...++
T Consensus       167 ----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         167 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence                233456789999999999875 44 589999999999999999999997654 44455555544332  2345789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      ++.+||.+||+.||++|||++|+|+||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=441.18  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=223.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVL   93 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~   93 (342)
                      +.|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+++|++++||||+++++++.+.+.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999997543   233457889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           94 EFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        94 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      |||++|+|.+++.+ .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            99999999998765 467999999999999999999999999999999999999999999999999998743321  112


Q ss_pred             eecccCCcccCChhhhccC----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC---CCCCCHHHH
Q 019360          173 LHTTCGTPNYVAPEVINNK----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS---PPWFSTSAK  245 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~  245 (342)
                      ....+||+.|+|||++...    ..++.++|||||||++|+|++|+.||.+.+..+....+.+...+.   +..+++++.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            2356799999999998532    223588999999999999999999999988888888888765433   456899999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      +||.+||+.||++|||++|+|+||||+.
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-62  Score=445.68  Aligned_cols=260  Identities=28%  Similarity=0.545  Sum_probs=232.5

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+...++|++++.||+|+||.||+|+++.+|+.||+|++.+....   ..+.+.+|+.+|++++||||++++++|.+++.
T Consensus        24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            345678899999999999999999999999999999999764322   23578899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec--CCCCeeEcccccccCCc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD--ANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~--~~~~~kl~Dfg~~~~~~  165 (342)
                      +|+|||||+||+|.+.+... .++++.+++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+...
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            99999999999999887664 4699999999999999999999999999999999999997  57899999999998543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCC
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFS  241 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (342)
                         .........||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......+    +.++
T Consensus       181 ---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  256 (352)
T d1koba_         181 ---PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  256 (352)
T ss_dssp             ---TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             ---CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence               23445667899999999999887774 899999999999999999999999999999999988776554    4589


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          242 TSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                      +++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999999999999999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-62  Score=445.33  Aligned_cols=260  Identities=30%  Similarity=0.576  Sum_probs=232.6

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      +...++|++++.||+|+||.||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++||||+++++++.+++.+
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4567899999999999999999999999999999999975432   3346788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC--CCCeeEcccccccCCcc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA--NGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~--~~~~kl~Dfg~~~~~~~  166 (342)
                      |+|||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++... 
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence            999999999999999854 567999999999999999999999999999999999999964  5789999999997543 


Q ss_pred             ccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCCCH
Q 019360          167 VRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWFST  242 (342)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (342)
                        .........||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......+    +.+++
T Consensus       178 --~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         178 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             --TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             --cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence              23445667899999999999987775 899999999999999999999999999999999988776554    35899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ++++||.+||+.||++|||++|+|+||||+....
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            9999999999999999999999999999987544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-62  Score=435.64  Aligned_cols=258  Identities=37%  Similarity=0.620  Sum_probs=231.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhh---hHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKH---KMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34689999999999999999999999999999999976443222   235678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----CeeEcccccccCC
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG----VLKVSDFGLSALP  164 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~----~~kl~Dfg~~~~~  164 (342)
                      +|+|||||+||+|.+++..++.+++.+++.++.|++.||+|||++||+||||||+|||++.++    .+|++|||++...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999999999888999999999999999999999999999999999999998776    5999999999754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC----CCC
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP----PWF  240 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~  240 (342)
                      ..   ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......+    +.+
T Consensus       168 ~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         168 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             TT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             CC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            32   233455678999999999988766 4899999999999999999999999999999888888776654    568


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      ++++++||++||+.||++|||++|+|+||||+.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-62  Score=438.24  Aligned_cols=258  Identities=31%  Similarity=0.579  Sum_probs=234.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHh-cCCCCcceeEEEEEEeCCeEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|..++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            478999999999999999999999999999999998765555555566777777764 7899999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||+++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence            999999999999999989999999999999999999999999999999999999999999999999999975432  223


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAKKLISRI  251 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (342)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...+...+....+..+..+++++.+||.+|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~  237 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL  237 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence            34556899999999999988775 89999999999999999999999999999999999998888889999999999999


Q ss_pred             cCCCCCCCCCHH-HHhcCccccc
Q 019360          252 LDPNPVTRITMA-EVIENEWFKK  273 (342)
Q Consensus       252 L~~dP~~Rps~~-e~l~h~~~~~  273 (342)
                      |+.||++|||+. ++++||||++
T Consensus       238 L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         238 FVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             cccCCCCCcCHHHHHHhCchhcc
Confidence            999999999995 8999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-63  Score=445.61  Aligned_cols=255  Identities=25%  Similarity=0.432  Sum_probs=216.9

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++....  .....+.+.+|+.+|++++||||++++++|.+++.+|+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3578999999999999999999999999999999997542  23445688999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           92 VLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||||+||+|.+++.+++.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+....    
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----  157 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  157 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence            99999999999999988899999999999999999999997 5999999999999999999999999999985332    


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHH------------------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALY------------------------  226 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~------------------------  226 (342)
                      ....+.+||+.|+|||++.+..++ .++||||+||++|||++|+.||.+.+.....                        
T Consensus       158 ~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence            123456899999999999987765 8999999999999999999999765432211                        


Q ss_pred             ------------------HHHHhcCCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          227 ------------------KKIFKADFKS--PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       227 ------------------~~i~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                        ..+.....+.  ...++.++.+||.+||+.||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                              0111111111  1236789999999999999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-61  Score=425.91  Aligned_cols=258  Identities=32%  Similarity=0.566  Sum_probs=229.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh------hhHHHHHHHHHHHHhcCC-CCcceeEEEEEEe
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK------HKMIGQIKREISTMKLIR-HPNVIRMYEVMAS   85 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~   85 (342)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.....      ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999999999999999997643221      233457889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           86 KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                      ++.+|+|||||++|+|.+++..++.+++.+++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCceecccCCcccCChhhhccC-----CCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCC---
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNK-----GYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSP---  237 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---  237 (342)
                      .   ........||+.|+|||.+.+.     ...+.++||||+||++|+|++|+.||.+.+.......+.......+   
T Consensus       162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            3   2233557899999999998642     2235789999999999999999999999999998888887765443   


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          238 -PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       238 -~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                       +.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence             358999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.1e-61  Score=441.24  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=223.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHH---HHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIK---REISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.   +|+.+++.++||||+++++++...+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            467899999999999999999999999999999999765544333333333   45777888899999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +|+|||||+||+|.+++.++..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....  
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--  159 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--  159 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence            999999999999999999989999999999999999999999999999999999999999999999999999974332  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                        ......+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+   ...+...+.......+..++++++
T Consensus       160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred             --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence              233456899999999999755444689999999999999999999997654   334444555556666778999999


Q ss_pred             HHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 019360          246 KLISRILDPNPVTRIT-----MAEVIENEWFKK  273 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps-----~~e~l~h~~~~~  273 (342)
                      +||.+||+.||++|||     ++|+++||||++
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            9999999999999999     799999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-61  Score=432.08  Aligned_cols=255  Identities=26%  Similarity=0.503  Sum_probs=229.5

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..+||++++.||+|+||+||+|+++.+|+.||+|++.+....    ...+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999999999999999999764322    2467899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC--CCeeEcccccccCCcccc
Q 019360           92 VLEFVTGGELFDKIASRG-RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN--GVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~--~~~kl~Dfg~~~~~~~~~  168 (342)
                      |||||+|++|.+++.+++ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++...   
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---  155 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---  155 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence            999999999999998765 79999999999999999999999999999999999999754  489999999987532   


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCC----CCCHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPP----WFSTSA  244 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~  244 (342)
                      .........+|+.|+|||.+.+..+. .++|||||||++|+|++|..||.+.+..+....+.+....++.    .+++++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            23345667899999999999877664 8999999999999999999999999999999999988776653    689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          245 KKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      ++||.+||+.||++|||++|+|+||||++.
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-61  Score=428.40  Aligned_cols=258  Identities=28%  Similarity=0.386  Sum_probs=217.4

Q ss_pred             eeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhh--hhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEec
Q 019360           18 LGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLK--HKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEF   95 (342)
Q Consensus        18 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~   95 (342)
                      .+++||+|+||+||+|+++.+|+.||||++.......  ....+.+.+|+.+|++++||||+++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            5789999999999999999999999999996543322  12235688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCceec
Q 019360           96 VTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGLLHT  175 (342)
Q Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (342)
                      +.++++..+...+..+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence            998887777766778999999999999999999999999999999999999999999999999999754332  223345


Q ss_pred             ccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC-------------------
Q 019360          176 TCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS-------------------  236 (342)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------------------  236 (342)
                      .+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+......+                   
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            6799999999999766555689999999999999999999999998888877765421110                   


Q ss_pred             ---------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 ---------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                               .+.+++++.+||.+||+.||++|||++|+|+||||++...|
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                     12467899999999999999999999999999999875443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-61  Score=424.01  Aligned_cols=252  Identities=32%  Similarity=0.542  Sum_probs=220.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhh---HHHHHHHHHHHHhcCC--CCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHK---MIGQIKREISTMKLIR--HPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~   87 (342)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.......   ...++.+|+.+|++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46899999999999999999999999999999999764432211   1234568999999987  899999999999999


Q ss_pred             eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCeeEcccccccCCc
Q 019360           88 KIYIVLEFVTG-GELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-NGVLKVSDFGLSALPQ  165 (342)
Q Consensus        88 ~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-~~~~kl~Dfg~~~~~~  165 (342)
                      ..|+||||+.+ +++.+++..+..+++.+++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 678888888889999999999999999999999999999999999999985 4799999999997533


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCCCCHHHH
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPWFSTSAK  245 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (342)
                      .    .......||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+      .+.+.....+..+|++++
T Consensus       163 ~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~  232 (273)
T d1xwsa_         163 D----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ  232 (273)
T ss_dssp             S----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred             c----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence            2    234557899999999999887777788999999999999999999997643      456677778888999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          246 KLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                      +||.+||+.||++|||++|+|+||||++.
T Consensus       233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         233 HLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=418.78  Aligned_cols=261  Identities=29%  Similarity=0.484  Sum_probs=219.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+.+|+++|++++||||+++++++.+.+.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            4789999999999999999999999999999999965432 233456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIA-S-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~-~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+.++ +..++. . ...+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+....  ..
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~  156 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV  156 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence            9999664 444443 3 45699999999999999999999999999999999999999999999999999975332  22


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--------------
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--------------  236 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------------  236 (342)
                      .......||+.|+|||.+....+.+.++|||||||++|+|++|+.||.+.+..+....+.+....+              
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            333456799999999998887777789999999999999999999999988877776665321110              


Q ss_pred             ---------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 ---------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 ---------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                     .+.+++++.+||.+||+.||++|||++|+|+||||++-..|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                           12457889999999999999999999999999999875443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.6e-59  Score=412.47  Aligned_cols=257  Identities=30%  Similarity=0.468  Sum_probs=218.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+||+++++||+|+||+||+|+++ +|+.||||++..... .....+++.+|+.+|++++||||+++++++...+..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            379999999999999999999996 789999999976543 333456888999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ||++.++.+..+....+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+|++|||.+......  ...
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~  156 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK  156 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence            999988777777777788999999999999999999999999999999999999999999999999998753321  222


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC-----------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK-----------------  235 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------  235 (342)
                      .....+++.|+|||.+.+..+.+.++|||||||++|||++|+.||.+.+..+....+......                 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            344568999999999987777679999999999999999999999988877776665432111                 


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          236 ------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       236 ------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                  ..+.+++++.+||++||+.||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                        12346889999999999999999999999999999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.3e-59  Score=409.55  Aligned_cols=262  Identities=26%  Similarity=0.467  Sum_probs=220.4

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT--   87 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--   87 (342)
                      ....++|++.+.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+++|+.++||||+++++++...+  
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence            445678999999999999999999999999999999998766666666778999999999999999999999987643  


Q ss_pred             --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           88 --KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        88 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                        .+|+||||++|++|..++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++..+++|||.+....
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence              489999999999999999988899999999999999999999999999999999999999999999999999886432


Q ss_pred             cc-cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC----CCCC
Q 019360          166 QV-RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS----PPWF  240 (342)
Q Consensus       166 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~  240 (342)
                      .. .........+||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+.+..+....+......+    .+.+
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            22 222234556899999999999887664 89999999999999999999999999888888877765543    3568


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 019360          241 STSAKKLISRILDPNPVTRITMAEVIENEWFK  272 (342)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~  272 (342)
                      |+++.+||.+||++||++||+..+.|.|+|.+
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            99999999999999999999555555577754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-59  Score=422.28  Aligned_cols=256  Identities=34%  Similarity=0.613  Sum_probs=213.6

Q ss_pred             CceeecCeeeee-eecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHh-cCCCCcceeEEEEEEe-
Q 019360            9 SRTRVGKYELGR-TLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMK-LIRHPNVIRMYEVMAS-   85 (342)
Q Consensus         9 ~~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~-   85 (342)
                      ....+++|++++ .||+|+||+||+|+++.+|+.||||++...        ..+.+|+.++. .++||||++++++|.+ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            456688999986 599999999999999999999999998643        24568998865 4589999999999875 


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcc
Q 019360           86 ---KTKIYIVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSD  157 (342)
Q Consensus        86 ---~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~D  157 (342)
                         ...+|+|||||+||+|.+++.++  ..+++.+++.++.|++.||+|||++||+||||||+|||++.   .+.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               46689999999999999999875  36999999999999999999999999999999999999975   56799999


Q ss_pred             cccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHH----HHhcC
Q 019360          158 FGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKK----IFKAD  233 (342)
Q Consensus       158 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~----i~~~~  233 (342)
                      ||+++....   .......+||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+.+.......    +....
T Consensus       158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  233 (335)
T ss_dssp             CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred             cceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence            999975432   2334567899999999999887765 899999999999999999999987654443333    33333


Q ss_pred             CCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          234 FKSPP----WFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       234 ~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                      ...+.    .+++++.+||.+||+.||++|||++|+++||||++...
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence            33332    47899999999999999999999999999999976443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=413.37  Aligned_cols=264  Identities=27%  Similarity=0.372  Sum_probs=217.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe------
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS------   85 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------   85 (342)
                      .++||+++++||+|+||+||+|+++.+|+.||||++..... ......++.+|+.+|++++|+||+++++++..      
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            47999999999999999999999999999999999876433 23344678899999999999999999998854      


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccC
Q 019360           86 --KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSAL  163 (342)
Q Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~  163 (342)
                        ...+|+||||+.++.+.........+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence              346899999998877665555667899999999999999999999999999999999999999999999999999975


Q ss_pred             Cccc--cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCCCCC--
Q 019360          164 PQQV--RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKSPPW--  239 (342)
Q Consensus       164 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  239 (342)
                      ....  .........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+......+++.  
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            4322  122333456799999999999876555689999999999999999999999888777776665432222110  


Q ss_pred             ------------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          240 ------------------------------FSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       240 ------------------------------~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                                    .++++.+||.+||+.||++|||++|+|+||||+..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence                                          2667889999999999999999999999999986543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-58  Score=404.13  Aligned_cols=252  Identities=22%  Similarity=0.401  Sum_probs=206.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||+||+|+..   ..||||++..... .....+.+.+|+.+|++++||||+++++++. .+.+++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence            468999999999999999999753   4699999975433 3345678999999999999999999999875 4568999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      ||||++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999999999764 569999999999999999999999999999999999999999999999999998655444444


Q ss_pred             ceecccCCcccCChhhhccCC--CCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC------CCCCCCHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKG--YDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK------SPPWFSTS  243 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~  243 (342)
                      ......||+.|||||++.+..  ..+.++|||||||++|||+||+.||.+.+..............      .+..++++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            455678999999999987432  2358999999999999999999999887655544444433222      24468899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIENE  269 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~h~  269 (342)
                      +.+|+.+||+.||++|||++|++++-
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            99999999999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-57  Score=404.32  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=208.1

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCc---EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGE---NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTK   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~   88 (342)
                      ..++|++.+.||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+.+|++++||||+++++++...+.
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            35789999999999999999999987765   58888876432  23445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  167 (342)
                      +|+|||||++|+|.+++... +.+++.++..++.|++.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999999988774 56999999999999999999999999999999999999999999999999999865432


Q ss_pred             cCCC---ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCH
Q 019360          168 RDDG---LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFST  242 (342)
Q Consensus       168 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~  242 (342)
                      ....   ......||+.|||||.+.+..++ .++|||||||++|||+| |+.||.+.+..++...+.... .+.+..+++
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS  260 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence            2211   11224578999999999877664 89999999999999998 899999998888888877653 455667899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          243 SAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ++.+|+.+||+.||++|||++|++++
T Consensus       261 ~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999865

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-57  Score=412.16  Aligned_cols=254  Identities=30%  Similarity=0.398  Sum_probs=211.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe------C
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS------K   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~   86 (342)
                      .-+|+.+++||+|+||+||+|+++.+|+.||||++.+...       ...+|+++|++++|+||++++++|..      .
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            4479999999999999999999999999999999975432       22479999999999999999999853      3


Q ss_pred             CeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEccccccc
Q 019360           87 TKIYIVLEFVTGGELFDK---IASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSA  162 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~  162 (342)
                      .++|+|||||+++.+..+   ......+++.+++.+++|++.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            358999999976543332   23456799999999999999999999999999999999999999775 89999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--------  234 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--------  234 (342)
                      ....   .....+.+||+.|+|||.+.+...++.++||||+||++|||++|+.||...+..+....+.+...        
T Consensus       172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            5432   23345568999999999988765556999999999999999999999998887777666543110        


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          235 ---------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       235 ---------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                           ...+.+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                                 012347889999999999999999999999999999986433

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-58  Score=412.19  Aligned_cols=252  Identities=21%  Similarity=0.380  Sum_probs=214.3

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCc-----EEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGE-----NVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASKT   87 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~   87 (342)
                      ++|++.+.||+|+||+||+|++...++     .||+|.+....  .......+.+|+.+|.++ +||||+++++++...+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            689999999999999999999876544     69999986533  233345788999999988 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCc
Q 019360           88 KIYIVLEFVTGGELFDKIASRG-----------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPEN  144 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~N  144 (342)
                      .+|+|||||++|+|.+++.++.                       .+++..++.++.|++.||+|||++||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            9999999999999999997642                       48899999999999999999999999999999999


Q ss_pred             EEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHH
Q 019360          145 LLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLM  223 (342)
Q Consensus       145 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~  223 (342)
                      ||++.++++||+|||+|+...............||+.|||||++.+..++ .++|||||||++|||+| |+.||.+.+..
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999865544333334456789999999999887764 89999999999999997 89999887665


Q ss_pred             HHHHHHHhcC--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          224 ALYKKIFKAD--FKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       224 ~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      .....+....  ++.+..+++++.+||.+||+.||++|||++|+++|
T Consensus       274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5555555543  34566789999999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-58  Score=402.59  Aligned_cols=249  Identities=23%  Similarity=0.365  Sum_probs=210.1

Q ss_pred             eeecccCceEEEEEEEc--CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEEEeccC
Q 019360           20 RTLGEGSFAKVKFARNT--ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIVLEFVT   97 (342)
Q Consensus        20 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~   97 (342)
                      ++||+|+||+||+|.+.  .+++.||||++.... .+....+.+.+|+++|++++||||+++++++..+ ..|+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            47999999999999864  455789999996543 3344557899999999999999999999999654 5789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC-CCceecc
Q 019360           98 GGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD-DGLLHTT  176 (342)
Q Consensus        98 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~  176 (342)
                      +|+|.+++.+...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            999999999988999999999999999999999999999999999999999999999999999975432211 1122345


Q ss_pred             cCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHHHHhcCC
Q 019360          177 CGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLISRILDP  254 (342)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~  254 (342)
                      .||+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+..++...+.++. .+.+..+++++.+||.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            68999999999987766 489999999999999998 899999998888888777654 455677999999999999999


Q ss_pred             CCCCCCCHHHH---hcCccc
Q 019360          255 NPVTRITMAEV---IENEWF  271 (342)
Q Consensus       255 dP~~Rps~~e~---l~h~~~  271 (342)
                      ||++|||++++   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   456665

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=406.45  Aligned_cols=257  Identities=29%  Similarity=0.415  Sum_probs=212.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCC-CcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC---CCCcceeEEEEEEe---
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTET-GENVAIKILDKEKVLKHKMIGQIKREISTMKLI---RHPNVIRMYEVMAS---   85 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~---   85 (342)
                      .++|++++.||+|+||+||+|++..+ ++.||||++...... ......+.+|+.+|+.|   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47999999999999999999999765 567999998654322 11222455777777665   79999999999853   


Q ss_pred             --CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           86 --KTKIYIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                        ...++++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              3468999999988776554443 4568999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCC--------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADF--------  234 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~--------  234 (342)
                      ....   ........||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+..+....+.....        
T Consensus       165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            5432   2234567899999999999887775 899999999999999999999999988887777654211        


Q ss_pred             -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 019360          235 -------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKG  274 (342)
Q Consensus       235 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~  274 (342)
                                         .....+++++.+||.+||+.||++|||++|+|+||||++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                               1123468899999999999999999999999999999863

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-57  Score=399.72  Aligned_cols=258  Identities=30%  Similarity=0.475  Sum_probs=222.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+||++++.||+|+||+||+|+++.+|+.||||++.... .......++.+|+.+|+.++|+||+++++++......++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            369999999999999999999999999999999997644 3345567899999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCCc
Q 019360           93 LEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDGL  172 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (342)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.....  ...
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~  157 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC  157 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence            999999999998888889999999999999999999999999999999999999999999999999999754332  222


Q ss_pred             eecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCC-CCCcHHHHHHHHHhcCC-----------------
Q 019360          173 LHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPF-EESNLMALYKKIFKADF-----------------  234 (342)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf-~~~~~~~~~~~i~~~~~-----------------  234 (342)
                      .....+++.|+|||.+....+.+.++|||||||++|+|++|+.|| .+.+..+....+.....                 
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            334567889999999987766678999999999999999999885 55555555555432111                 


Q ss_pred             ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          235 ------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       235 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                                  .....+++++.+||++||+.||++|||++|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                        112346789999999999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-57  Score=410.38  Aligned_cols=256  Identities=29%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT----   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----   87 (342)
                      ..++|+++++||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||++++++|...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            4579999999999999999999999999999999997643 34455678899999999999999999999997654    


Q ss_pred             --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCc
Q 019360           88 --KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQ  165 (342)
Q Consensus        88 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~  165 (342)
                        .+|+||||+ +.+|..+.. +..+++..++.+++|++.||+|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence              579999999 667777665 4679999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----------
Q 019360          166 QVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----------  235 (342)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------  235 (342)
                      .     ......||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.......+......          
T Consensus       173 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         173 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             C-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            2     2345679999999999987666678999999999999999999999988776665544332111          


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 019360          236 ---------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGY  275 (342)
Q Consensus       236 ---------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~  275 (342)
                                           ....+++++.+||.+||+.||++|||++|+|+||||+.-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                                 1235689999999999999999999999999999998644

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-57  Score=402.08  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=214.3

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||+||+|.++.+|+.||||++.....    ..+++.+|+++|++++||||+++++++.+.+.+|+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            34689999999999999999999999999999999865432    23578899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      |||||++|+|..++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~  169 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  169 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence            99999999999999764  56899999999999999999999999999999999999999999999999999864332 1


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCC-CCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYL-PFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~-pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (342)
                      ........|++.|+|||++.+..+ +.++|||||||++|||++|.. ||.+.+.......+... ..+.+..+++++.+|
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  248 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  248 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence            122233457899999999988776 489999999999999999655 45666666665555443 344566799999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc
Q 019360          248 ISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~  267 (342)
                      |.+||+.||++|||++|+++
T Consensus       249 i~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         249 MRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-57  Score=395.79  Aligned_cols=249  Identities=23%  Similarity=0.395  Sum_probs=207.8

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      ..+|++++.||+|+||+||+|.++ +++.||||++......    .+.+.+|++++++++||||+++++++...+..|+|
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            357999999999999999999986 5778999999754322    24688999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....... .
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            9999999999998765 5689999999999999999999999999999999999999999999999999986443221 2


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC-CCCCCCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF-KSPPWFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~  249 (342)
                      ......||+.|+|||++.+..++ .++|||||||++|||+| |.+||...+..+....+..+.. ..+..+++++.+|+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            23345789999999999887764 89999999999999999 6788888888888887776543 345668999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q 019360          250 RILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h  268 (342)
                      +||+.||++|||++|+++|
T Consensus       237 ~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=405.76  Aligned_cols=263  Identities=27%  Similarity=0.442  Sum_probs=215.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT----   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----   87 (342)
                      ...||++++.||+|+||+||+|.++.+|+.||||++.+..  .....+++.+|+.+|++++||||+++++++....    
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            4568999999999999999999999999999999997543  3444568889999999999999999999986543    


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 -KIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                       .+|++ +++.+++|.+++..+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          84 KDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             CCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence             34555 556689999999764 699999999999999999999999999999999999999999999999999975433


Q ss_pred             c-cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCC----------
Q 019360          167 V-RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFK----------  235 (342)
Q Consensus       167 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------  235 (342)
                      . .........+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........          
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            2 12223455679999999999876666678999999999999999999999887765555443321100          


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 019360          236 ---------------------SPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKPP  278 (342)
Q Consensus       236 ---------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~~  278 (342)
                                           ..+.+++++.+||.+||+.||++|||++|+|+||||+....+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence                                 1235678999999999999999999999999999998765543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-57  Score=391.78  Aligned_cols=249  Identities=23%  Similarity=0.404  Sum_probs=219.5

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .+.|+++++||+|+||+||+|+++ +++.||||++.+....    .+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            368999999999999999999985 7889999999764432    24688999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCCC
Q 019360           93 LEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDDG  171 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  171 (342)
                      |||+++|+|..++.. ...+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~  156 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYT  156 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Cce
Confidence            999999999998765 467899999999999999999999999999999999999999999999999999755432 222


Q ss_pred             ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHHH
Q 019360          172 LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLIS  249 (342)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~  249 (342)
                      ......||+.|+|||.+.+..++ .++|||||||++|||+| |+.||.+.+..++...+.... ...+..+++++.+||.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence            33446789999999999987765 89999999999999998 899999999988888887753 3456678899999999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q 019360          250 RILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       250 ~~L~~dP~~Rps~~e~l~h  268 (342)
                      +||+.||++|||++++++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-57  Score=398.59  Aligned_cols=256  Identities=22%  Similarity=0.351  Sum_probs=217.1

Q ss_pred             ecCeeeeee-ecccCceEEEEEEEcC--CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRT-LGEGSFAKVKFARNTE--TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      -++|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+.+.+|+++|++++||||+++++++.. +.+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            356888884 9999999999998764  34579999996532  33445789999999999999999999999865 458


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      |+|||||++|+|.+++.. +..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999999998865 4679999999999999999999999999999999999999999999999999998543321


Q ss_pred             C-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHH
Q 019360          169 D-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAK  245 (342)
Q Consensus       169 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  245 (342)
                      . ........||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++...+..+. .+.++.+++++.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  242 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  242 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            1 112234568899999999987766 489999999999999998 999999988888888777654 455678999999


Q ss_pred             HHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 019360          246 KLISRILDPNPVTRITMAEV---IENEWFK  272 (342)
Q Consensus       246 ~li~~~L~~dP~~Rps~~e~---l~h~~~~  272 (342)
                      +||.+||+.||++|||+.++   |+|+|+.
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999888   6678874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=397.25  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=215.1

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYIV   92 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv   92 (342)
                      .++|++.+.||+|+||+||+|.++ +++.||||++......    .+.+.+|+.+|++++||||+++++++.+ +.+|+|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            468999999999999999999985 5788999999654322    3468899999999999999999998854 567999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccCC
Q 019360           93 LEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRDD  170 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  170 (342)
                      |||+++|+|.+++...  ..+++.++..|+.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~  164 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY  164 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence            9999999999877543  35999999999999999999999999999999999999999999999999999864321 11


Q ss_pred             CceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHHH
Q 019360          171 GLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKLI  248 (342)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (342)
                      .......||+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+..+....+.... ...+..+++++.+|+
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  243 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM  243 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence            12234568999999999987666 489999999999999999 566677777777777776653 345667999999999


Q ss_pred             HHhcCCCCCCCCCHHHHhc--Cccccc
Q 019360          249 SRILDPNPVTRITMAEVIE--NEWFKK  273 (342)
Q Consensus       249 ~~~L~~dP~~Rps~~e~l~--h~~~~~  273 (342)
                      .+||+.||++|||++++++  |+||..
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999998  788853

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=402.86  Aligned_cols=268  Identities=32%  Similarity=0.578  Sum_probs=226.9

Q ss_pred             CCCCCceeecCeeeeeeecccCceEEEEEEEc---CCCcEEEEEEecchhhh-hhhHHHHHHHHHHHHhcCCC-CcceeE
Q 019360            5 TGGASRTRVGKYELGRTLGEGSFAKVKFARNT---ETGENVAIKILDKEKVL-KHKMIGQIKREISTMKLIRH-PNVIRM   79 (342)
Q Consensus         5 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~l   79 (342)
                      ++...+...++|++++.||+|+||+||+|++.   .+|+.||||++.+.... +....+.+.+|+++|++++| |||+++
T Consensus        15 ~~~~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~   94 (322)
T d1vzoa_          15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL   94 (322)
T ss_dssp             SSCCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             CCCCcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEe
Confidence            44455567799999999999999999999974   46899999998754322 22234567899999999987 799999


Q ss_pred             EEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccc
Q 019360           80 YEVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFG  159 (342)
Q Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg  159 (342)
                      ++++.+...++++|||+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_          95 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeecc
Confidence            99999999999999999999999999998889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccCCCceecccCCcccCChhhhccCC-CCCcccchhhhhHHHHHHHhCCCCCCCCc----HHHHHHHHHhcCC
Q 019360          160 LSALPQQVRDDGLLHTTCGTPNYVAPEVINNKG-YDGAKADLWSCGVILYVLMAGYLPFEESN----LMALYKKIFKADF  234 (342)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~pf~~~~----~~~~~~~i~~~~~  234 (342)
                      +++..... .........|++.|+|||.+.+.. +.+.++|||||||++|+|++|+.||.+.+    ...+.........
T Consensus       175 ~a~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~  253 (322)
T d1vzoa_         175 LSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP  253 (322)
T ss_dssp             EEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred             chhhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC
Confidence            98754322 222345568999999999997644 34578999999999999999999997654    3344455555666


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 019360          235 KSPPWFSTSAKKLISRILDPNPVTRI-----TMAEVIENEWFKK  273 (342)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~h~~~~~  273 (342)
                      +.+..+++++.+||.+||++||++||     |++|+++||||+.
T Consensus       254 ~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            77778999999999999999999999     5899999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-56  Score=404.71  Aligned_cols=261  Identities=26%  Similarity=0.373  Sum_probs=218.3

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeC---
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASK---   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---   86 (342)
                      ....+||+++++||+|+||+||+|+++.+|+.||||++.+.. ......+++.+|+++|++++|+||+++++++...   
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence            344679999999999999999999999999999999997643 2334456788999999999999999999998633   


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCC
Q 019360           87 --TKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALP  164 (342)
Q Consensus        87 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~  164 (342)
                        ...+++++++.|++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence              234566677779999998865 56999999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC--------
Q 019360          165 QQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS--------  236 (342)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  236 (342)
                      ..     ......|++.|+|||.+.+..+.+.++|||||||++|+|++|+.||.+.+.......+.......        
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            32     23456789999999998877766789999999999999999999999988777776665432211        


Q ss_pred             -----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 019360          237 -----------------------PPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYKP  277 (342)
Q Consensus       237 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~~  277 (342)
                                             ...+++++++||.+||+.||++|||++|+|+||||++...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence                                   12468899999999999999999999999999999875543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-56  Score=406.12  Aligned_cols=260  Identities=26%  Similarity=0.438  Sum_probs=207.7

Q ss_pred             CceeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe---
Q 019360            9 SRTRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS---   85 (342)
Q Consensus         9 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---   85 (342)
                      ..+..++|+++++||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|++++||||++++++|..   
T Consensus        12 ~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          12 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT   90 (355)
T ss_dssp             EEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             ceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence            44566899999999999999999999999999999999976543 34455688999999999999999999999953   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360           86 ---KTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus        86 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                         ...+|+|||||.++ +...+  ...+++..++.+++|++.||.|||++||+||||||+|||++.++.+|++|||+++
T Consensus        91 ~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence               36899999999765 44444  3458999999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHHhcCCCC------
Q 019360          163 LPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIFKADFKS------  236 (342)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------  236 (342)
                      ....   .......++|+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+.......+......+      
T Consensus       168 ~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccc---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            5432   2334556789999999999887664 89999999999999999999999887666655543211110      


Q ss_pred             ----------------C--------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 019360          237 ----------------P--------------------PWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKKGYK  276 (342)
Q Consensus       237 ----------------~--------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~~~~  276 (342)
                                      .                    ...++++.+||++||+.||++|||++|+|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence                            0                    013567899999999999999999999999999997654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=395.77  Aligned_cols=253  Identities=22%  Similarity=0.341  Sum_probs=210.1

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCc----EEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGE----NVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      ..|++++.||+|+||+||+|.+..+|+    .||+|.+....  .....+.+.+|+.+|++++||||+++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            579999999999999999999988876    47788775432  233456889999999999999999999999765 56


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++++|++.+++|.+.+..+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            7888999899998877764 679999999999999999999999999999999999999999999999999998654433


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~  246 (342)
                      .........||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+..+. .+.++.+++++.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            3333344568999999999988776 489999999999999998 899999888777777776654 4556779999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcc
Q 019360          247 LISRILDPNPVTRITMAEVIENEW  270 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h~~  270 (342)
                      |+.+||+.||++|||+.|+++|..
T Consensus       245 li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhCCCChhhCcCHHHHHHHHH
Confidence            999999999999999999998843

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=387.69  Aligned_cols=250  Identities=25%  Similarity=0.410  Sum_probs=205.7

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIY   90 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~   90 (342)
                      ++|++.+.||+|+||.||+|.+..++   ..||+|.+...  ......+.+.+|+.+|++++||||+++++++. ++.+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            68999999999999999999987544   45888887543  23444568899999999999999999999995 46789


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           91 IVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      +||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~  162 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T  162 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-c
Confidence            99999999999998765 457999999999999999999999999999999999999999999999999999854332 1


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                      ........||+.|+|||++.+..++ .++|||||||++|||++ |.+||.+.+..+....+..+. .+.++.+++++.+|
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  241 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  241 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            2223445689999999999887764 89999999999999998 899999988888888877764 45677899999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcC
Q 019360          248 ISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h  268 (342)
                      |.+||+.||++|||++|+++|
T Consensus       242 i~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         242 MTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-55  Score=385.08  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=206.8

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCC----cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETG----ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      ....|++.+.||+|+||.||+|.++.++    ..||||++....  .......+.+|+++|++++||||+++++++...+
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            3467999999999999999999987654    469999986533  2333457889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  166 (342)
                      ..++||||+.++++.+.+... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999999887654 6799999999999999999999999999999999999999999999999999986443


Q ss_pred             ccC-CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCCHH
Q 019360          167 VRD-DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKAD-FKSPPWFSTS  243 (342)
Q Consensus       167 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  243 (342)
                      ... ........||+.|+|||++.+..++ .++|||||||++|||++| .+|+...+..+....+..+. .+.+..++.+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            222 1223345689999999999887764 899999999999999995 56666677777777666543 3445668899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          244 AKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      +.+||.+||+.||++|||+.|+++
T Consensus       242 l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-55  Score=396.48  Aligned_cols=250  Identities=27%  Similarity=0.469  Sum_probs=207.4

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEe--CCe
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMAS--KTK   88 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~--~~~   88 (342)
                      ..++|+++++||+|+||+||+|+++.+|+.||||++....      .+++.+|+.+|++++ ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            4578999999999999999999999999999999986532      246789999999996 9999999999974  356


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CeeEcccccccCCccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANG-VLKVSDFGLSALPQQV  167 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~  167 (342)
                      +++|||||.+++|....   ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-  182 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-  182 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence            99999999999997653   4599999999999999999999999999999999999998655 699999999975432 


Q ss_pred             cCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcH-HHHHHHHHh-------------cC
Q 019360          168 RDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNL-MALYKKIFK-------------AD  233 (342)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~-~~~~~~i~~-------------~~  233 (342)
                        .......++|+.|+|||.+.+....+.++||||+||++|+|++|..||..... ......+..             ..
T Consensus       183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence              22345567899999999988766556899999999999999999999965432 222111110             00


Q ss_pred             C------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 019360          234 F------------------------KSPPWFSTSAKKLISRILDPNPVTRITMAEVIENEWFKK  273 (342)
Q Consensus       234 ~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h~~~~~  273 (342)
                      .                        .....+++++.+||++||+.||++|||++|+|+||||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            0                        011236789999999999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-55  Score=385.63  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=211.6

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeEEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l   91 (342)
                      ..++|++.+.||+|+||.||+|.++. ++.||||++......    .+.+.+|+.+|++++|+||+++++++.. +.+++
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            45789999999999999999999865 467999999754322    2578899999999999999999999854 56899


Q ss_pred             EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC
Q 019360           92 VLEFVTGGELFDKIAS--RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD  169 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  169 (342)
                      ||||+++|+|..++..  ...+++.++..++.|++.||+|||++||+||||||+|||++.++++||+|||+++..... .
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~  167 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-E  167 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-C
Confidence            9999999999988764  356999999999999999999999999999999999999999999999999999854322 1


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (342)
                      ........||+.|+|||++....++ .++|||||||++|||++| .+|+.+....+....+... ..+.++.+++++.+|
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  246 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence            2223446789999999999887764 899999999999999995 5666777777777777654 345677799999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhc--CcccccC
Q 019360          248 ISRILDPNPVTRITMAEVIE--NEWFKKG  274 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~--h~~~~~~  274 (342)
                      |.+||+.||++|||++++++  |+||...
T Consensus       247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999987  8888653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=384.74  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=205.7

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC-CC--cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE-TG--ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKTKI   89 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~   89 (342)
                      .++|++++.||+|+||.||+|+... ++  ..||||++.+.........+.+.+|+.+|++++||||+++++++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998653 33  3689999977665566667889999999999999999999999975 467


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           90 YIVLEFVTGGELFDKIAS-RGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      ++||||++++++.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            899999999999987765 4569999999999999999999999999999999999999999999999999998643322


Q ss_pred             CCC-ceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhcCC--CCCCCCCHHH
Q 019360          169 DDG-LLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKADF--KSPPWFSTSA  244 (342)
Q Consensus       169 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~  244 (342)
                      ... ......|+..|+|||.+.+..+ +.++|||||||++|||+| |+.||.+.+..+....+.+...  +.++.+++++
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  244 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  244 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence            211 2233457889999999988665 588999999999999998 8999999999999888877654  3456789999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q 019360          245 KKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+||.+||+.||++|||++|+++
T Consensus       245 ~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         245 YNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-54  Score=386.60  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=217.9

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .++|++++.||+|+||+||+|+.+     .+++.||||++....  .....+++.+|+.+|++++||||+++++++...+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            467999999999999999999875     356789999986533  2344568899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 019360           88 KIYIVLEFVTGGELFDKIASRG------------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPE  143 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~  143 (342)
                      ..+++|||+++|+|.+++....                        .+++.++..|+.|++.||+|||++||+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999986532                        3789999999999999999999999999999999


Q ss_pred             cEEecCCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCC-CCCCCCcH
Q 019360          144 NLLLDANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGY-LPFEESNL  222 (342)
Q Consensus       144 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~-~pf~~~~~  222 (342)
                      |||++.++.+||+|||+|+...............||+.|+|||.+.+..++ .++|||||||++|||++|. +||.+.+.
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            999999999999999999754443333444556789999999999987765 8999999999999999985 78999999


Q ss_pred             HHHHHHHHhcCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          223 MALYKKIFKADFK-SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       223 ~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+....+..+..+ .+..+++++.+||.+||+.||++|||+.|+++
T Consensus       249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9988888877654 35678999999999999999999999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=387.12  Aligned_cols=253  Identities=23%  Similarity=0.382  Sum_probs=214.7

Q ss_pred             ceeecCeeeeeeecccCceEEEEEEEcCCCcE--EEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360           10 RTRVGKYELGRTLGEGSFAKVKFARNTETGEN--VAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus        10 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      ....++|++.+.||+|+||+||+|.++.+|..  ||||.+...  ......+.+.+|+++|+++ +||||+++++++...
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            34567999999999999999999999888875  666766432  2233456789999999998 699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                      +.+|+||||+++|+|.+++..+                ..+++.++..++.|++.||.|||++||+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999999654                568999999999999999999999999999999999999999


Q ss_pred             CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHH
Q 019360          151 GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKI  229 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i  229 (342)
                      +.+||+|||+++.......   .....||..|+|||.+.+..+ +.++|||||||++|||++| .+||.+.+..++...+
T Consensus       164 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CceEEcccccccccccccc---ccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999999975443222   234568999999999988776 4899999999999999996 5689999988888887


Q ss_pred             Hhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          230 FKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       230 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ..+ ....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            765 344566789999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=385.71  Aligned_cols=252  Identities=24%  Similarity=0.387  Sum_probs=200.9

Q ss_pred             cCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC-
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK-   86 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-   86 (342)
                      ++|++.+.||+|+||.||+|.+..     +++.||||++.....  ....+.+.+|...+.++ .|+||+.+++++... 
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            689999999999999999999754     446899999865332  33345677888888776 588999999987654 


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 019360           87 TKIYIVLEFVTGGELFDKIASR----------------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDAN  150 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~  150 (342)
                      ..+++|||||++|+|.+++...                ..+++.++..++.|++.||+|||++||+||||||+|||++.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            5689999999999999999753                248899999999999999999999999999999999999999


Q ss_pred             CCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHH
Q 019360          151 GVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKI  229 (342)
Q Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i  229 (342)
                      +++||+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|||++| .+||.+.+........
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999986544333334445679999999999988766 4899999999999999986 5688776544444333


Q ss_pred             -Hhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          230 -FKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       230 -~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ..+ ....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             332 344566789999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=382.14  Aligned_cols=252  Identities=24%  Similarity=0.465  Sum_probs=214.6

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCC-------cEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETG-------ENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMA   84 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~   84 (342)
                      .++|++++.||+|+||.||+|++..++       ..||||++.+..  .......+.+|...+.++ +||||+++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            478999999999999999999976544       479999997543  233456788899999888 7999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360           85 SKTKIYIVLEFVTGGELFDKIASRG----------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                      +++.+++||||+++|+|.+++..+.                .+++.++..++.|++.||+|||++||+||||||+|||++
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence            9999999999999999999997543                489999999999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++.+||+|||+++...............||+.|+|||.+.+..++ .++|||||||++|||++ |.+||.+.+......
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            9999999999999876554444445567789999999999887764 89999999999999998 799999988888877


Q ss_pred             HHHhc-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          228 KIFKA-DFKSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       228 ~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+..+ .+..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            77654 34456678999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=377.16  Aligned_cols=244  Identities=26%  Similarity=0.473  Sum_probs=205.7

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-KTKIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~   90 (342)
                      ..++|++.+.||+|+||.||+|.++  |..||||++.++.     ..+.+.+|++++++++||||+++++++.. .+.+|
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            3567999999999999999999984  7889999996532     23578899999999999999999998854 46689


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCcccc
Q 019360           91 IVLEFVTGGELFDKIASR--GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVR  168 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  168 (342)
                      +||||+++|+|.+++.++  ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....  
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--  155 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--  155 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence            999999999999999754  3589999999999999999999999999999999999999999999999999985322  


Q ss_pred             CCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHHHHHhc-CCCCCCCCCHHHHH
Q 019360          169 DDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYKKIFKA-DFKSPPWFSTSAKK  246 (342)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (342)
                         ......+|+.|+|||++.+..+ +.++|||||||++|||+| |++||...+..++...+..+ ..+.+..+++++.+
T Consensus       156 ---~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (262)
T d1byga_         156 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE  231 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred             ---CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence               2234567899999999988766 589999999999999998 79999998888888887654 44556778999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcC
Q 019360          247 LISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       247 li~~~L~~dP~~Rps~~e~l~h  268 (342)
                      ||.+||+.||++|||+.+++++
T Consensus       232 li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         232 VMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=380.76  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=219.4

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcC-----CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTE-----TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT   87 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~   87 (342)
                      .++|++.+.||+|+||+||+|.++.     ++..||||++....  .......+.+|+.++++++||||+++++++..++
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            4789999999999999999998752     35789999997543  3344567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcc
Q 019360           88 KIYIVLEFVTGGELFDKIASR----------GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSD  157 (342)
Q Consensus        88 ~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~D  157 (342)
                      ..++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999999988642          2468999999999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhC-CCCCCCCcHHHHHHHHHhcCCC-
Q 019360          158 FGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAG-YLPFEESNLMALYKKIFKADFK-  235 (342)
Q Consensus       158 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~pf~~~~~~~~~~~i~~~~~~-  235 (342)
                      ||+++...............||+.|+|||.+.+..+. .++|||||||++|||+|| .+||.+.+..+....+.++... 
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~  255 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  255 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            9999865444333333445689999999999887765 899999999999999998 5889999999988888776543 


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          236 SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+..+++.+.+||.+||+.||++|||++++++
T Consensus       256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            45678999999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=378.24  Aligned_cols=252  Identities=23%  Similarity=0.403  Sum_probs=214.2

Q ss_pred             ecCeeeeeeecccCceEEEEEEEc-----CCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcC-CCCcceeEEEEEEeC
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNT-----ETGENVAIKILDKEKVLKHKMIGQIKREISTMKLI-RHPNVIRMYEVMASK   86 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~   86 (342)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||++.....  ......+.+|+.+++++ +||||+++++++...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            478999999999999999999863     4567899999975432  33445788999999999 699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 019360           87 TKIYIVLEFVTGGELFDKIASRG------------------RLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLD  148 (342)
Q Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~  148 (342)
                      +..|+|||||++|+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999987543                  589999999999999999999999999999999999999


Q ss_pred             CCCCeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHh-CCCCCCCCcHHHHHH
Q 019360          149 ANGVLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMA-GYLPFEESNLMALYK  227 (342)
Q Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~pf~~~~~~~~~~  227 (342)
                      .++.+|++|||+++..............+||+.|+|||.+.+..+ +.++|||||||++|||+| |.+||.+.+......
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999986554333333445678999999999987665 589999999999999998 677777766655555


Q ss_pred             HHHhcCC--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          228 KIFKADF--KSPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       228 ~i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                      .+.....  ..+..+++++.+||.+||+.||++|||++++++
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5544433  334568999999999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=365.99  Aligned_cols=249  Identities=21%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             eeeeeecccCceEEEEEEEcCCC---cEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeEEEE
Q 019360           17 ELGRTLGEGSFAKVKFARNTETG---ENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMAS-KTKIYIV   92 (342)
Q Consensus        17 ~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv   92 (342)
                      ...++||+|+||+||+|.+..++   ..||||.+.+.  ......+++.+|+++|++++||||+++++++.. ++..++|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            34678999999999999987644   35899998642  234556789999999999999999999999765 5689999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEcccccccCCccccC--
Q 019360           93 LEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGLSALPQQVRD--  169 (342)
Q Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~--  169 (342)
                      ||||++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999999988754 4578889999999999999999999999999999999999999999999999986433211  


Q ss_pred             CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCC-CcHHHHHHHHHhcC-CCCCCCCCHHHHHH
Q 019360          170 DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEE-SNLMALYKKIFKAD-FKSPPWFSTSAKKL  247 (342)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~-~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (342)
                      ........||+.|+|||.+.+..+ +.++||||||+++|||++|..||.. .+..+....+..+. ...++.+++++.+|
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence            112233568999999999987766 5899999999999999997666644 44445555555543 34456789999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcC
Q 019360          248 ISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       248 i~~~L~~dP~~Rps~~e~l~h  268 (342)
                      |.+||+.||++|||+.|+++|
T Consensus       267 i~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-51  Score=363.36  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=201.9

Q ss_pred             eecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcce-eEEEEEEeCCeEE
Q 019360           12 RVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVI-RMYEVMASKTKIY   90 (342)
Q Consensus        12 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~   90 (342)
                      ..+||++++.||+|+||.||+|++..+|+.||||++......     ..+.+|+++++.++|++++ .+.+++...+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            346899999999999999999999999999999998654322     2467899999999877654 5556667888899


Q ss_pred             EEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCeeEcccccccCCcc
Q 019360           91 IVLEFVTGGELFDKIA-SRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA---NGVLKVSDFGLSALPQQ  166 (342)
Q Consensus        91 lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~  166 (342)
                      +||||+.+ +|...+. ....+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+....
T Consensus        80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999954 6655554 4567999999999999999999999999999999999999853   55799999999986443


Q ss_pred             ccC-----CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHHHHHHHHH---hc--CC--
Q 019360          167 VRD-----DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLMALYKKIF---KA--DF--  234 (342)
Q Consensus       167 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~~~~~~i~---~~--~~--  234 (342)
                      ...     ........||+.|+|||++.+..++ .++|||||||++|||++|+.||...........+.   ..  ..  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            221     1123456799999999999987764 89999999999999999999998755443322221   11  11  


Q ss_pred             -CCCCCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCcccccCC
Q 019360          235 -KSPPWFSTSAKKLISRILDPNPVTRITMA---EVIENEWFKKGY  275 (342)
Q Consensus       235 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~---e~l~h~~~~~~~  275 (342)
                       .....+++++.+|+..||+.||++||+++   ++|+|+|.+...
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence             12346889999999999999999999986   557788776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-49  Score=351.32  Aligned_cols=248  Identities=20%  Similarity=0.263  Sum_probs=204.1

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCeEEE
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRH-PNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~l   91 (342)
                      .++|++++.||+|+||+||+|+++.+|+.||||++......     ..+.+|++.++.++| +|++.+++++......++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            47899999999999999999999999999999998653321     246789999999975 899999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-----CCCeeEcccccccCCc
Q 019360           92 VLEFVTGGELFDKIASR-GRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDA-----NGVLKVSDFGLSALPQ  165 (342)
Q Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~-----~~~~kl~Dfg~~~~~~  165 (342)
                      ||||+ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+...
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 67999888765 46999999999999999999999999999999999999964     5789999999998643


Q ss_pred             cccC-----CCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCc---HHHHHHHHHhcCCC--
Q 019360          166 QVRD-----DGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESN---LMALYKKIFKADFK--  235 (342)
Q Consensus       166 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~---~~~~~~~i~~~~~~--  235 (342)
                      ....     .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+..   .......+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            3211     122345679999999999998776 489999999999999999999997543   23333333221111  


Q ss_pred             ---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 019360          236 ---SPPWFSTSAKKLISRILDPNPVTRITMAEVIE  267 (342)
Q Consensus       236 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  267 (342)
                         ..+.+++++.+++..|++.+|++||+.+.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence               13457899999999999999999999877653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=356.54  Aligned_cols=249  Identities=21%  Similarity=0.329  Sum_probs=193.3

Q ss_pred             ecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----e
Q 019360           13 VGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNVIRMYEVMASKT----K   88 (342)
Q Consensus        13 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~   88 (342)
                      ..+|.+.+.||+|+||+||+|+.  +|+.||||++......    ....+.|+..+.+++||||+++++++...+    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            35799999999999999999986  5899999999654321    122345666667889999999999997543    5


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeecCCCCcEEecCCCCeeEccccc
Q 019360           89 IYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS--------RGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~--------~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      +|+|||||++|+|..++++. .+++..+..++.|++.||.|||+        +||+||||||+|||++.++.+||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            89999999999999999875 58999999999999999999996        5999999999999999999999999999


Q ss_pred             ccCCccccC--CCceecccCCcccCChhhhccCCC-----CCcccchhhhhHHHHHHHhCCCCCCC--------------
Q 019360          161 SALPQQVRD--DGLLHTTCGTPNYVAPEVINNKGY-----DGAKADLWSCGVILYVLMAGYLPFEE--------------  219 (342)
Q Consensus       161 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~ll~~l~~g~~pf~~--------------  219 (342)
                      ++.......  ........||+.|+|||++.+...     .+.++|||||||++|||+||..||..              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            875432211  112345679999999999875432     24689999999999999999887743              


Q ss_pred             -CcHHHHHHHHHhcCCCCC--CC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 019360          220 -SNLMALYKKIFKADFKSP--PW-----FSTSAKKLISRILDPNPVTRITMAEVIEN  268 (342)
Q Consensus       220 -~~~~~~~~~i~~~~~~~~--~~-----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  268 (342)
                       ................+.  ..     ....+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             123333333333333221  11     12358899999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9e-49  Score=358.39  Aligned_cols=260  Identities=23%  Similarity=0.414  Sum_probs=197.5

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-----------CCcceeEEEE
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-----------HPNVIRMYEV   82 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~   82 (342)
                      +||+++++||+|+||+||+|+++.+|+.||||++.+....    .+.+.+|+++++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            5799999999999999999999999999999999764322    246678888888775           5789999988


Q ss_pred             EEe--CCeEEEEEeccCCCchHHH-HH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCC-----
Q 019360           83 MAS--KTKIYIVLEFVTGGELFDK-IA--SRGRLKEDEARKYFQQLINAVDYCHS-RGVCHRDLKPENLLLDANG-----  151 (342)
Q Consensus        83 ~~~--~~~~~lv~e~~~~~~L~~~-l~--~~~~l~~~~~~~i~~~l~~~L~~LH~-~giiH~dlkp~NIli~~~~-----  151 (342)
                      +..  ....+++++++..+..... ..  ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++     
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            753  4566677776655443322 22  34568999999999999999999998 8999999999999997665     


Q ss_pred             -CeeEcccccccCCccccCCCceecccCCcccCChhhhccCCCCCcccchhhhhHHHHHHHhCCCCCCCCcHH------H
Q 019360          152 -VLKVSDFGLSALPQQVRDDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWSCGVILYVLMAGYLPFEESNLM------A  224 (342)
Q Consensus       152 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~pf~~~~~~------~  224 (342)
                       .++++|||.+.....     .....+||+.|+|||++.+..++ .++||||+||++++|++|+.||...+..      +
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence             399999999874332     23456799999999999987775 8999999999999999999999654321      1


Q ss_pred             HHHHHHh------------------------------------------cCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 019360          225 LYKKIFK------------------------------------------ADFKSPPWFSTSAKKLISRILDPNPVTRITM  262 (342)
Q Consensus       225 ~~~~i~~------------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  262 (342)
                      .......                                          .........++++.+||.+||+.||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            1111100                                          0011111235679999999999999999999


Q ss_pred             HHHhcCcccccCCCCCCCCCC
Q 019360          263 AEVIENEWFKKGYKPPSFEQP  283 (342)
Q Consensus       263 ~e~l~h~~~~~~~~~~~~~~~  283 (342)
                      +|+|+||||++.....+...|
T Consensus       323 ~e~L~Hp~f~~~~~~~~~~~p  343 (362)
T d1q8ya_         323 GGLVNHPWLKDTLGMEEIRVP  343 (362)
T ss_dssp             HHHHTCGGGTTCTTCTTCCCT
T ss_pred             HHHhcCcccCCCCCcccCCCC
Confidence            999999999965544444333

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.5e-26  Score=191.25  Aligned_cols=135  Identities=18%  Similarity=0.283  Sum_probs=107.2

Q ss_pred             eeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhh---------------hhhHHHHHHHHHHHHhcCCCCcceeEE
Q 019360           16 YELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVL---------------KHKMIGQIKREISTMKLIRHPNVIRMY   80 (342)
Q Consensus        16 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~l~   80 (342)
                      +.+.++||+|+||+||+|.+. +|+.||||++......               .........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468899999999999999985 6899999987532110               011123456789999999999999988


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCeeEccccc
Q 019360           81 EVMASKTKIYIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHSRGVCHRDLKPENLLLDANGVLKVSDFGL  160 (342)
Q Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~~giiH~dlkp~NIli~~~~~~kl~Dfg~  160 (342)
                      ++..    .+++|||+++..+..       ++......++.|++.+|.|||++||+||||||+|||++.+ .++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    269999998865532       4556677899999999999999999999999999999865 589999998


Q ss_pred             ccC
Q 019360          161 SAL  163 (342)
Q Consensus       161 ~~~  163 (342)
                      |..
T Consensus       149 a~~  151 (191)
T d1zara2         149 SVE  151 (191)
T ss_dssp             CEE
T ss_pred             ccc
Confidence            863

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=4.5e-08  Score=82.65  Aligned_cols=142  Identities=18%  Similarity=0.158  Sum_probs=96.1

Q ss_pred             eeecCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeE
Q 019360           11 TRVGKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIR-HPNVIRMYEVMASKTKI   89 (342)
Q Consensus        11 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~   89 (342)
                      ..+..|+..+..+.++.+.||++.  .+++.+++|.........   ...+.+|...++.+. +--+.+++.+...++..
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            345678888877666678999875  356778889876433222   224667888887764 33456788888888999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019360           90 YIVLEFVTGGELFDKIASRGRLKEDEARKYFQQLINAVDYCHS-------------------------------------  132 (342)
Q Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~L~~LH~-------------------------------------  132 (342)
                      ++||++++|.++.......     .....++.++...++.||+                                     
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999998775443211     1122233344444444442                                     


Q ss_pred             ----------------------CCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          133 ----------------------RGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       133 ----------------------~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                                            ..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  127899999999999877667799999765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.35  E-value=8.3e-07  Score=79.43  Aligned_cols=81  Identities=17%  Similarity=0.144  Sum_probs=49.8

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecchhh-hh---hhHHHHHHHHHHHHhcCC-C--CcceeEEEEEEeCCeEEE
Q 019360           19 GRTLGEGSFAKVKFARNTETGENVAIKILDKEKV-LK---HKMIGQIKREISTMKLIR-H--PNVIRMYEVMASKTKIYI   91 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~~~~~l   91 (342)
                      .+.||.|....||++.+..+++.+++|.-..... ..   .....+...|.+.|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5578999999999999877788999997542111 00   011235567888887663 2  345556554  3445578


Q ss_pred             EEeccCCCch
Q 019360           92 VLEFVTGGEL  101 (342)
Q Consensus        92 v~e~~~~~~L  101 (342)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.24  E-value=1.1e-06  Score=73.52  Aligned_cols=73  Identities=14%  Similarity=0.147  Sum_probs=50.9

Q ss_pred             ecccC-ceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCC--cceeEEEEEEeCCeEEEEEeccCC
Q 019360           22 LGEGS-FAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHP--NVIRMYEVMASKTKIYIVLEFVTG   98 (342)
Q Consensus        22 lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~l~~~~~~~~~~~lv~e~~~~   98 (342)
                      +..|. .+.||++.. ..+..+++|.......      ..+..|+..++.+...  .+.+++.+..+++..++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            33443 467898875 4577789998754322      2456788888776533  356778888888889999999988


Q ss_pred             Cch
Q 019360           99 GEL  101 (342)
Q Consensus        99 ~~L  101 (342)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.55  E-value=8.1e-05  Score=64.31  Aligned_cols=68  Identities=16%  Similarity=0.162  Sum_probs=42.9

Q ss_pred             eEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc--eeEE-----EEEEeCCeEEEEEeccCCCc
Q 019360           28 AKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV--IRMY-----EVMASKTKIYIVLEFVTGGE  100 (342)
Q Consensus        28 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~l~-----~~~~~~~~~~lv~e~~~~~~  100 (342)
                      -.||++.. .+|+.|++|+...... +   .+.+..|...+..|...++  +..+     ..+...+..+.++++++|..
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            47999976 5788999999865322 1   2356678887776642222  1111     12244667889999997743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.37  E-value=0.00038  Score=61.64  Aligned_cols=74  Identities=12%  Similarity=0.214  Sum_probs=49.7

Q ss_pred             eeeecccCceEEEEEEEcC-------CCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeEE
Q 019360           19 GRTLGEGSFAKVKFARNTE-------TGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPNV-IRMYEVMASKTKIY   90 (342)
Q Consensus        19 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~   90 (342)
                      ++.|+.|--=.+|++....       .++.|.+++.....    .. -...+|..+++.+.-.++ .++++++..    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4678888888999998753       34568888765211    11 235589999988863344 477777642    5


Q ss_pred             EEEeccCCCch
Q 019360           91 IVLEFVTGGEL  101 (342)
Q Consensus        91 lv~e~~~~~~L  101 (342)
                      +|+||++|..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.01  E-value=0.00095  Score=56.86  Aligned_cols=142  Identities=15%  Similarity=0.158  Sum_probs=74.2

Q ss_pred             cCeeeeeeecccCceEEEEEEEcCCCcEEEEEEecchhhhhhhHHHHHHHHHHHHhcCCCCc-----ceeEE---EEEEe
Q 019360           14 GKYELGRTLGEGSFAKVKFARNTETGENVAIKILDKEKVLKHKMIGQIKREISTMKLIRHPN-----VIRMY---EVMAS   85 (342)
Q Consensus        14 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-----iv~l~---~~~~~   85 (342)
                      +...-.+.|..|---+.|++... + ..+++|++....  +.   +.+..|+++|..|...+     .+...   .+...
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t~-~-g~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEES-S-CCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CCceEeecCCCCcccCeEEEEEC-C-CcEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence            34444556667777788998764 3 459999986432  11   24455676776664222     11110   01123


Q ss_pred             CCeEEEEEeccCCCchH--------------HHHHh---cC------CC------------------CHHHHHHHHHHHH
Q 019360           86 KTKIYIVLEFVTGGELF--------------DKIAS---RG------RL------------------KEDEARKYFQQLI  124 (342)
Q Consensus        86 ~~~~~lv~e~~~~~~L~--------------~~l~~---~~------~l------------------~~~~~~~i~~~l~  124 (342)
                      ......++.+..|....              ..++.   ..      ..                  ........+....
T Consensus        91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  170 (316)
T d2ppqa1          91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  170 (316)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence            44566667766654321              00000   00      00                  0111222233333


Q ss_pred             HHHHHHH----hCCceeecCCCCcEEecCCCCeeEccccccc
Q 019360          125 NAVDYCH----SRGVCHRDLKPENLLLDANGVLKVSDFGLSA  162 (342)
Q Consensus       125 ~~L~~LH----~~giiH~dlkp~NIli~~~~~~kl~Dfg~~~  162 (342)
                      ..+...+    ..|+||+|+.++||+++.+...-|.||+.+.
T Consensus       171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            3333333    2479999999999999988778899999764